11933 lines
4.1 MiB
11933 lines
4.1 MiB
Year,Locationabbr,Locationdesc,Class,Topic,Question,Response,Break_Out,Break_Out_Category,Sample_Size,Data_value,Confidence_limit_Low,Confidence_limit_High,Display_order,Data_value_unit,Data_value_type,Data_Value_Footnote_Symbol,Data_Value_Footnote,DataSource,ClassId,TopicId,LocationID,BreakoutID,BreakOutCategoryID,QuestionID,ResponseID,GeoLocation
|
|
2012,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,119,29.8,24,35.6,2717,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,01,AGE06,CAT3,_RFPSA21,RESP046,"(32.840571122, -86.631860762)"
|
|
2012,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,247,70.2,64.4,76,2721,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,01,AGE06,CAT3,_RFPSA21,RESP054,"(32.840571122, -86.631860762)"
|
|
2012,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,266,46.3,40.9,51.7,2718,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,01,AGE07,CAT3,_RFPSA21,RESP046,"(32.840571122, -86.631860762)"
|
|
2012,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,261,53.7,48.3,59.1,2722,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,01,AGE07,CAT3,_RFPSA21,RESP054,"(32.840571122, -86.631860762)"
|
|
2012,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,236,64.9,58.4,71.3,2719,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,01,AGE08,CAT3,_RFPSA21,RESP046,"(32.840571122, -86.631860762)"
|
|
2012,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,120,35.1,28.7,41.6,2723,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,01,AGE08,CAT3,_RFPSA21,RESP054,"(32.840571122, -86.631860762)"
|
|
2012,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,617,69.2,65.1,73.3,2720,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,01,AGE09,CAT3,_RFPSA21,RESP046,"(32.840571122, -86.631860762)"
|
|
2012,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,250,30.8,26.7,34.9,2724,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,01,AGE09,CAT3,_RFPSA21,RESP054,"(32.840571122, -86.631860762)"
|
|
2012,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1238,50.7,47.8,53.5,2713,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,01,BO1,CAT1,_RFPSA21,RESP046,"(32.840571122, -86.631860762)"
|
|
2012,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,878,49.3,46.5,52.2,2714,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,01,BO1,CAT1,_RFPSA21,RESP054,"(32.840571122, -86.631860762)"
|
|
2012,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,94,29.2,22.4,36,2735,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,01,EDUCA1,CAT5,_RFPSA21,RESP046,"(32.840571122, -86.631860762)"
|
|
2012,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,159,70.8,64,77.6,2739,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,01,EDUCA1,CAT5,_RFPSA21,RESP054,"(32.840571122, -86.631860762)"
|
|
2012,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,343,47.1,42.2,52.1,2736,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,01,EDUCA2,CAT5,_RFPSA21,RESP046,"(32.840571122, -86.631860762)"
|
|
2012,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,309,52.9,47.9,57.8,2740,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,01,EDUCA2,CAT5,_RFPSA21,RESP054,"(32.840571122, -86.631860762)"
|
|
2012,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,331,58.3,52.9,63.7,2737,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,01,EDUCA3,CAT5,_RFPSA21,RESP046,"(32.840571122, -86.631860762)"
|
|
2012,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,206,41.7,36.3,47.1,2741,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,01,EDUCA3,CAT5,_RFPSA21,RESP054,"(32.840571122, -86.631860762)"
|
|
2012,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,470,65.7,61,70.3,2738,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,01,EDUCA4,CAT5,_RFPSA21,RESP046,"(32.840571122, -86.631860762)"
|
|
2012,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,203,34.3,29.7,39,2742,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,01,EDUCA4,CAT5,_RFPSA21,RESP054,"(32.840571122, -86.631860762)"
|
|
2012,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,77,24.4,17.1,31.8,2743,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,01,INCOME1,CAT6,_RFPSA21,RESP046,"(32.840571122, -86.631860762)"
|
|
2012,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,147,75.6,68.2,82.9,2748,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,01,INCOME1,CAT6,_RFPSA21,RESP054,"(32.840571122, -86.631860762)"
|
|
2012,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,178,43,36,50.1,2744,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,01,INCOME2,CAT6,_RFPSA21,RESP046,"(32.840571122, -86.631860762)"
|
|
2012,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,156,57,49.9,64.1,2749,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,01,INCOME2,CAT6,_RFPSA21,RESP054,"(32.840571122, -86.631860762)"
|
|
2012,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,121,48.3,38.6,58,2745,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,01,INCOME3,CAT6,_RFPSA21,RESP046,"(32.840571122, -86.631860762)"
|
|
2012,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,95,51.7,42,61.4,2750,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,01,INCOME3,CAT6,_RFPSA21,RESP054,"(32.840571122, -86.631860762)"
|
|
2012,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,181,58.6,50.5,66.7,2746,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,01,INCOME4,CAT6,_RFPSA21,RESP046,"(32.840571122, -86.631860762)"
|
|
2012,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,100,41.4,33.3,49.5,2751,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,01,INCOME4,CAT6,_RFPSA21,RESP054,"(32.840571122, -86.631860762)"
|
|
2012,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,535,63,58.7,67.4,2747,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,01,INCOME5,CAT6,_RFPSA21,RESP046,"(32.840571122, -86.631860762)"
|
|
2012,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,251,37,32.6,41.3,2752,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,01,INCOME5,CAT6,_RFPSA21,RESP054,"(32.840571122, -86.631860762)"
|
|
2012,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,953,51.8,48.5,55.1,2725,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,01,RACE1,CAT4,_RFPSA21,RESP046,"(32.840571122, -86.631860762)"
|
|
2012,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,624,48.2,44.9,51.5,2730,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,01,RACE1,CAT4,_RFPSA21,RESP054,"(32.840571122, -86.631860762)"
|
|
2012,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,213,48.7,42.1,55.4,2726,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,01,RACE2,CAT4,_RFPSA21,RESP046,"(32.840571122, -86.631860762)"
|
|
2012,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,192,51.3,44.6,58,2731,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,01,RACE2,CAT4,_RFPSA21,RESP054,"(32.840571122, -86.631860762)"
|
|
2012,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,13,,,,2727,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,01,RACE3,CAT4,_RFPSA21,RESP046,"(32.840571122, -86.631860762)"
|
|
2012,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,9,,,,2732,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,01,RACE3,CAT4,_RFPSA21,RESP054,"(32.840571122, -86.631860762)"
|
|
2012,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,33,44.7,29.8,59.6,2728,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,01,RACE4,CAT4,_RFPSA21,RESP046,"(32.840571122, -86.631860762)"
|
|
2012,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,31,55.3,40.4,70.2,2733,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,01,RACE4,CAT4,_RFPSA21,RESP054,"(32.840571122, -86.631860762)"
|
|
2012,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,12,,,,2729,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,01,RACE5,CAT4,_RFPSA21,RESP046,"(32.840571122, -86.631860762)"
|
|
2012,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,13,,,,2734,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,01,RACE5,CAT4,_RFPSA21,RESP054,"(32.840571122, -86.631860762)"
|
|
2012,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1238,50.7,47.8,53.5,2715,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,01,SEX1,CAT2,_RFPSA21,RESP046,"(32.840571122, -86.631860762)"
|
|
2012,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,878,49.3,46.5,52.2,2716,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,01,SEX1,CAT2,_RFPSA21,RESP054,"(32.840571122, -86.631860762)"
|
|
2012,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,53,18.1,12.5,23.8,2713,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,02,AGE06,CAT3,_RFPSA21,RESP046,"(64.845079957001, -147.722059036)"
|
|
2012,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,225,81.9,76.2,87.5,2717,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,02,AGE06,CAT3,_RFPSA21,RESP054,"(64.845079957001, -147.722059036)"
|
|
2012,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,170,40.9,34.3,47.6,2714,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,02,AGE07,CAT3,_RFPSA21,RESP046,"(64.845079957001, -147.722059036)"
|
|
2012,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,262,59.1,52.4,65.7,2718,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,02,AGE07,CAT3,_RFPSA21,RESP054,"(64.845079957001, -147.722059036)"
|
|
2012,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,102,50.5,40.2,60.7,2715,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,02,AGE08,CAT3,_RFPSA21,RESP046,"(64.845079957001, -147.722059036)"
|
|
2012,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,89,49.5,39.3,59.8,2719,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,02,AGE08,CAT3,_RFPSA21,RESP054,"(64.845079957001, -147.722059036)"
|
|
2012,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,190,61.1,53.7,68.4,2716,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,02,AGE09,CAT3,_RFPSA21,RESP046,"(64.845079957001, -147.722059036)"
|
|
2012,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,123,38.9,31.6,46.3,2720,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,02,AGE09,CAT3,_RFPSA21,RESP054,"(64.845079957001, -147.722059036)"
|
|
2012,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,515,39.9,36.1,43.7,2709,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,02,BO1,CAT1,_RFPSA21,RESP046,"(64.845079957001, -147.722059036)"
|
|
2012,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,699,60.1,56.3,63.9,2710,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,02,BO1,CAT1,_RFPSA21,RESP054,"(64.845079957001, -147.722059036)"
|
|
2012,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,20,23,11.4,34.7,2731,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,02,EDUCA1,CAT5,_RFPSA21,RESP046,"(64.845079957001, -147.722059036)"
|
|
2012,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,68,77,65.3,88.6,2735,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,02,EDUCA1,CAT5,_RFPSA21,RESP054,"(64.845079957001, -147.722059036)"
|
|
2012,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,120,32.8,26.4,39.2,2732,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,02,EDUCA2,CAT5,_RFPSA21,RESP046,"(64.845079957001, -147.722059036)"
|
|
2012,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,226,67.2,60.8,73.6,2736,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,02,EDUCA2,CAT5,_RFPSA21,RESP054,"(64.845079957001, -147.722059036)"
|
|
2012,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,156,42.1,35,49.2,2733,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,02,EDUCA3,CAT5,_RFPSA21,RESP046,"(64.845079957001, -147.722059036)"
|
|
2012,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,200,58,50.9,65.1,2737,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,02,EDUCA3,CAT5,_RFPSA21,RESP054,"(64.845079957001, -147.722059036)"
|
|
2012,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,216,50.1,43.7,56.5,2734,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,02,EDUCA4,CAT5,_RFPSA21,RESP046,"(64.845079957001, -147.722059036)"
|
|
2012,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,204,49.9,43.5,56.3,2738,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,02,EDUCA4,CAT5,_RFPSA21,RESP054,"(64.845079957001, -147.722059036)"
|
|
2012,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,27,22.2,10.7,33.7,2739,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,02,INCOME1,CAT6,_RFPSA21,RESP046,"(64.845079957001, -147.722059036)"
|
|
2012,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,76,77.8,66.3,89.3,2744,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,02,INCOME1,CAT6,_RFPSA21,RESP054,"(64.845079957001, -147.722059036)"
|
|
2012,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,43,27.3,17.2,37.3,2740,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,02,INCOME2,CAT6,_RFPSA21,RESP046,"(64.845079957001, -147.722059036)"
|
|
2012,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,89,72.7,62.7,82.8,2745,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,02,INCOME2,CAT6,_RFPSA21,RESP054,"(64.845079957001, -147.722059036)"
|
|
2012,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,39,38,25,51.1,2741,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,02,INCOME3,CAT6,_RFPSA21,RESP046,"(64.845079957001, -147.722059036)"
|
|
2012,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,53,62,49,75,2746,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,02,INCOME3,CAT6,_RFPSA21,RESP054,"(64.845079957001, -147.722059036)"
|
|
2012,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,58,37.5,26.9,48.1,2742,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,02,INCOME4,CAT6,_RFPSA21,RESP046,"(64.845079957001, -147.722059036)"
|
|
2012,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,81,62.5,51.9,73.1,2747,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,02,INCOME4,CAT6,_RFPSA21,RESP054,"(64.845079957001, -147.722059036)"
|
|
2012,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,305,46.1,40.7,51.6,2743,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,02,INCOME5,CAT6,_RFPSA21,RESP046,"(64.845079957001, -147.722059036)"
|
|
2012,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,333,53.9,48.5,59.3,2748,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,02,INCOME5,CAT6,_RFPSA21,RESP054,"(64.845079957001, -147.722059036)"
|
|
2012,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,408,44.1,39.7,48.4,2721,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,02,RACE1,CAT4,_RFPSA21,RESP046,"(64.845079957001, -147.722059036)"
|
|
2012,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,446,55.9,51.6,60.3,2726,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,02,RACE1,CAT4,_RFPSA21,RESP054,"(64.845079957001, -147.722059036)"
|
|
2012,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,3,,,,2722,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,02,RACE2,CAT4,_RFPSA21,RESP046,"(64.845079957001, -147.722059036)"
|
|
2012,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,6,,,,2727,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,02,RACE2,CAT4,_RFPSA21,RESP054,"(64.845079957001, -147.722059036)"
|
|
2012,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,13,,,,2723,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,02,RACE3,CAT4,_RFPSA21,RESP046,"(64.845079957001, -147.722059036)"
|
|
2012,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,17,,,,2728,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,02,RACE3,CAT4,_RFPSA21,RESP054,"(64.845079957001, -147.722059036)"
|
|
2012,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,64,22.3,14.5,30,2724,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,02,RACE4,CAT4,_RFPSA21,RESP046,"(64.845079957001, -147.722059036)"
|
|
2012,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,187,77.8,70,85.5,2729,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,02,RACE4,CAT4,_RFPSA21,RESP054,"(64.845079957001, -147.722059036)"
|
|
2012,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,15,,,,2725,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,02,RACE5,CAT4,_RFPSA21,RESP046,"(64.845079957001, -147.722059036)"
|
|
2012,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,30,,,,2730,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,02,RACE5,CAT4,_RFPSA21,RESP054,"(64.845079957001, -147.722059036)"
|
|
2012,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,515,39.9,36.1,43.7,2711,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,02,SEX1,CAT2,_RFPSA21,RESP046,"(64.845079957001, -147.722059036)"
|
|
2012,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,699,60.1,56.3,63.9,2712,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,02,SEX1,CAT2,_RFPSA21,RESP054,"(64.845079957001, -147.722059036)"
|
|
2012,UW,All States and DC (median) **,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,51,45.2,,,2684,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,98,BO1,CAT1,_RFPSA21,RESP046,
|
|
2012,UW,All States and DC (median) **,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,51,54.8,,,2685,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,98,BO1,CAT1,_RFPSA21,RESP054,
|
|
2012,US,"All States, DC and Territories (median) **",Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,53,45.2,,,2685,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,99,BO1,CAT1,_RFPSA21,RESP046,
|
|
2012,US,"All States, DC and Territories (median) **",Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,53,54.8,,,2686,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,99,BO1,CAT1,_RFPSA21,RESP054,
|
|
2012,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,276,57.3,50.9,63.6,2725,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,04,AGE07,CAT3,_RFPSA21,RESP054,"(34.86597028, -111.763811277)"
|
|
2012,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,61,16.4,11.4,21.5,2720,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,04,AGE06,CAT3,_RFPSA21,RESP046,"(34.86597028, -111.763811277)"
|
|
2012,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,269,83.6,78.5,88.6,2724,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,04,AGE06,CAT3,_RFPSA21,RESP054,"(34.86597028, -111.763811277)"
|
|
2012,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,230,42.7,36.4,49.1,2721,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,04,AGE07,CAT3,_RFPSA21,RESP046,"(34.86597028, -111.763811277)"
|
|
2012,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,174,69.2,61.7,76.7,2722,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,04,AGE08,CAT3,_RFPSA21,RESP046,"(34.86597028, -111.763811277)"
|
|
2012,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,109,30.8,23.3,38.3,2726,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,04,AGE08,CAT3,_RFPSA21,RESP054,"(34.86597028, -111.763811277)"
|
|
2012,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,686,63.8,59,68.6,2723,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,04,AGE09,CAT3,_RFPSA21,RESP046,"(34.86597028, -111.763811277)"
|
|
2012,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,336,36.2,31.4,41,2727,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,04,AGE09,CAT3,_RFPSA21,RESP054,"(34.86597028, -111.763811277)"
|
|
2012,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1151,45.2,41.9,48.4,2716,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,04,BO1,CAT1,_RFPSA21,RESP046,"(34.86597028, -111.763811277)"
|
|
2012,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,990,54.8,51.6,58.1,2717,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,04,BO1,CAT1,_RFPSA21,RESP054,"(34.86597028, -111.763811277)"
|
|
2012,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,57,32.7,21.2,44.2,2738,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,04,EDUCA1,CAT5,_RFPSA21,RESP046,"(34.86597028, -111.763811277)"
|
|
2012,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,100,67.3,55.8,78.9,2742,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,04,EDUCA1,CAT5,_RFPSA21,RESP054,"(34.86597028, -111.763811277)"
|
|
2012,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,220,34.3,28.3,40.4,2739,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,04,EDUCA2,CAT5,_RFPSA21,RESP046,"(34.86597028, -111.763811277)"
|
|
2012,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,267,65.7,59.6,71.7,2743,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,04,EDUCA2,CAT5,_RFPSA21,RESP054,"(34.86597028, -111.763811277)"
|
|
2012,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,329,47,41.2,52.7,2740,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,04,EDUCA3,CAT5,_RFPSA21,RESP046,"(34.86597028, -111.763811277)"
|
|
2012,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,287,53,47.3,58.8,2744,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,04,EDUCA3,CAT5,_RFPSA21,RESP054,"(34.86597028, -111.763811277)"
|
|
2012,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,542,57,51.9,62.1,2741,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,04,EDUCA4,CAT5,_RFPSA21,RESP046,"(34.86597028, -111.763811277)"
|
|
2012,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,331,43,37.9,48.1,2745,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,04,EDUCA4,CAT5,_RFPSA21,RESP054,"(34.86597028, -111.763811277)"
|
|
2012,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,72,32.7,21.5,43.8,2746,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,04,INCOME1,CAT6,_RFPSA21,RESP046,"(34.86597028, -111.763811277)"
|
|
2012,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,144,67.4,56.2,78.5,2751,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,04,INCOME1,CAT6,_RFPSA21,RESP054,"(34.86597028, -111.763811277)"
|
|
2012,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,123,32,24.5,39.6,2747,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,04,INCOME2,CAT6,_RFPSA21,RESP046,"(34.86597028, -111.763811277)"
|
|
2012,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,179,68,60.4,75.5,2752,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,04,INCOME2,CAT6,_RFPSA21,RESP054,"(34.86597028, -111.763811277)"
|
|
2012,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,106,42.2,32.7,51.8,2748,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,04,INCOME3,CAT6,_RFPSA21,RESP046,"(34.86597028, -111.763811277)"
|
|
2012,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,106,57.8,48.2,67.3,2753,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,04,INCOME3,CAT6,_RFPSA21,RESP054,"(34.86597028, -111.763811277)"
|
|
2012,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,193,52.8,43.4,62.1,2749,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,04,INCOME4,CAT6,_RFPSA21,RESP046,"(34.86597028, -111.763811277)"
|
|
2012,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,113,47.2,37.9,56.6,2754,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,04,INCOME4,CAT6,_RFPSA21,RESP054,"(34.86597028, -111.763811277)"
|
|
2012,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,553,54.5,49.3,59.7,2750,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,04,INCOME5,CAT6,_RFPSA21,RESP046,"(34.86597028, -111.763811277)"
|
|
2012,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,333,45.5,40.3,50.7,2755,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,04,INCOME5,CAT6,_RFPSA21,RESP054,"(34.86597028, -111.763811277)"
|
|
2012,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,957,50.8,47.2,54.3,2728,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,04,RACE1,CAT4,_RFPSA21,RESP046,"(34.86597028, -111.763811277)"
|
|
2012,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,720,49.3,45.7,52.8,2733,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,04,RACE1,CAT4,_RFPSA21,RESP054,"(34.86597028, -111.763811277)"
|
|
2012,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,19,,,,2729,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,04,RACE2,CAT4,_RFPSA21,RESP046,"(34.86597028, -111.763811277)"
|
|
2012,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,21,,,,2734,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,04,RACE2,CAT4,_RFPSA21,RESP054,"(34.86597028, -111.763811277)"
|
|
2012,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,109,34.5,25.3,43.7,2730,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,04,RACE3,CAT4,_RFPSA21,RESP046,"(34.86597028, -111.763811277)"
|
|
2012,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,149,65.5,56.3,74.8,2735,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,04,RACE3,CAT4,_RFPSA21,RESP054,"(34.86597028, -111.763811277)"
|
|
2012,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,26,,,,2731,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,04,RACE4,CAT4,_RFPSA21,RESP046,"(34.86597028, -111.763811277)"
|
|
2012,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,71,82.5,71.1,93.8,2736,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,04,RACE4,CAT4,_RFPSA21,RESP054,"(34.86597028, -111.763811277)"
|
|
2012,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,12,,,,2732,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,04,RACE5,CAT4,_RFPSA21,RESP046,"(34.86597028, -111.763811277)"
|
|
2012,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,9,,,,2737,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,04,RACE5,CAT4,_RFPSA21,RESP054,"(34.86597028, -111.763811277)"
|
|
2012,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1151,45.2,41.9,48.4,2718,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,04,SEX1,CAT2,_RFPSA21,RESP046,"(34.86597028, -111.763811277)"
|
|
2012,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,990,54.8,51.6,58.1,2719,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,04,SEX1,CAT2,_RFPSA21,RESP054,"(34.86597028, -111.763811277)"
|
|
2012,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,61,17.9,12.8,23,2713,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,05,AGE06,CAT3,_RFPSA21,RESP046,"(34.748650124, -92.274490743)"
|
|
2012,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,207,82.1,77,87.2,2717,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,05,AGE06,CAT3,_RFPSA21,RESP054,"(34.748650124, -92.274490743)"
|
|
2012,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,152,40.4,34.1,46.6,2714,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,05,AGE07,CAT3,_RFPSA21,RESP046,"(34.748650124, -92.274490743)"
|
|
2012,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,193,59.6,53.4,65.9,2718,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,05,AGE07,CAT3,_RFPSA21,RESP054,"(34.748650124, -92.274490743)"
|
|
2012,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,107,54,45.4,62.7,2715,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,05,AGE08,CAT3,_RFPSA21,RESP046,"(34.748650124, -92.274490743)"
|
|
2012,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,81,46,37.3,54.6,2719,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,05,AGE08,CAT3,_RFPSA21,RESP054,"(34.748650124, -92.274490743)"
|
|
2012,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,370,65.1,60.5,69.7,2716,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,05,AGE09,CAT3,_RFPSA21,RESP046,"(34.748650124, -92.274490743)"
|
|
2012,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,225,34.9,30.3,39.5,2720,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,05,AGE09,CAT3,_RFPSA21,RESP054,"(34.748650124, -92.274490743)"
|
|
2012,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,690,42.5,39.3,45.6,2709,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,05,BO1,CAT1,_RFPSA21,RESP046,"(34.748650124, -92.274490743)"
|
|
2012,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,706,57.5,54.4,60.7,2710,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,05,BO1,CAT1,_RFPSA21,RESP054,"(34.748650124, -92.274490743)"
|
|
2012,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,63,28.6,21,36.3,2731,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,05,EDUCA1,CAT5,_RFPSA21,RESP046,"(34.748650124, -92.274490743)"
|
|
2012,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,132,71.4,63.7,79,2735,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,05,EDUCA1,CAT5,_RFPSA21,RESP054,"(34.748650124, -92.274490743)"
|
|
2012,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,226,39.6,34.4,44.7,2732,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,05,EDUCA2,CAT5,_RFPSA21,RESP046,"(34.748650124, -92.274490743)"
|
|
2012,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,259,60.4,55.3,65.6,2736,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,05,EDUCA2,CAT5,_RFPSA21,RESP054,"(34.748650124, -92.274490743)"
|
|
2012,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,179,48.5,41.8,55.2,2733,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,05,EDUCA3,CAT5,_RFPSA21,RESP046,"(34.748650124, -92.274490743)"
|
|
2012,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,142,51.5,44.8,58.2,2737,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,05,EDUCA3,CAT5,_RFPSA21,RESP054,"(34.748650124, -92.274490743)"
|
|
2012,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,220,53.2,47.2,59.2,2734,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,05,EDUCA4,CAT5,_RFPSA21,RESP046,"(34.748650124, -92.274490743)"
|
|
2012,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,172,46.8,40.8,52.8,2738,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,05,EDUCA4,CAT5,_RFPSA21,RESP054,"(34.748650124, -92.274490743)"
|
|
2012,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,56,26.5,18.3,34.8,2739,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,05,INCOME1,CAT6,_RFPSA21,RESP046,"(34.748650124, -92.274490743)"
|
|
2012,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,108,73.5,65.2,81.8,2744,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,05,INCOME1,CAT6,_RFPSA21,RESP054,"(34.748650124, -92.274490743)"
|
|
2012,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,92,33.5,25.7,41.3,2740,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,05,INCOME2,CAT6,_RFPSA21,RESP046,"(34.748650124, -92.274490743)"
|
|
2012,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,140,66.6,58.8,74.4,2745,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,05,INCOME2,CAT6,_RFPSA21,RESP054,"(34.748650124, -92.274490743)"
|
|
2012,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,74,40,30.5,49.5,2741,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,05,INCOME3,CAT6,_RFPSA21,RESP046,"(34.748650124, -92.274490743)"
|
|
2012,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,84,60,50.5,69.5,2746,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,05,INCOME3,CAT6,_RFPSA21,RESP054,"(34.748650124, -92.274490743)"
|
|
2012,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,121,48.5,40.4,56.7,2742,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,05,INCOME4,CAT6,_RFPSA21,RESP046,"(34.748650124, -92.274490743)"
|
|
2012,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,100,51.5,43.4,59.6,2747,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,05,INCOME4,CAT6,_RFPSA21,RESP054,"(34.748650124, -92.274490743)"
|
|
2012,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,274,51.9,46.5,57.4,2743,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,05,INCOME5,CAT6,_RFPSA21,RESP046,"(34.748650124, -92.274490743)"
|
|
2012,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,201,48.1,42.6,53.6,2748,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,05,INCOME5,CAT6,_RFPSA21,RESP054,"(34.748650124, -92.274490743)"
|
|
2012,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,565,45.1,41.6,48.7,2721,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,05,RACE1,CAT4,_RFPSA21,RESP046,"(34.748650124, -92.274490743)"
|
|
2012,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,533,54.9,51.3,58.4,2726,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,05,RACE1,CAT4,_RFPSA21,RESP054,"(34.748650124, -92.274490743)"
|
|
2012,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,73,34.2,24.4,44,2722,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,05,RACE2,CAT4,_RFPSA21,RESP046,"(34.748650124, -92.274490743)"
|
|
2012,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,95,65.8,56,75.6,2727,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,05,RACE2,CAT4,_RFPSA21,RESP054,"(34.748650124, -92.274490743)"
|
|
2012,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,12,,,,2723,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,05,RACE3,CAT4,_RFPSA21,RESP046,"(34.748650124, -92.274490743)"
|
|
2012,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,24,,,,2728,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,05,RACE3,CAT4,_RFPSA21,RESP054,"(34.748650124, -92.274490743)"
|
|
2012,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,17,,,,2724,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,05,RACE4,CAT4,_RFPSA21,RESP046,"(34.748650124, -92.274490743)"
|
|
2012,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,31,,,,2729,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,05,RACE4,CAT4,_RFPSA21,RESP054,"(34.748650124, -92.274490743)"
|
|
2012,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,6,,,,2725,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,05,RACE5,CAT4,_RFPSA21,RESP046,"(34.748650124, -92.274490743)"
|
|
2012,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,12,,,,2730,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,05,RACE5,CAT4,_RFPSA21,RESP054,"(34.748650124, -92.274490743)"
|
|
2012,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,690,42.5,39.3,45.6,2711,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,05,SEX1,CAT2,_RFPSA21,RESP046,"(34.748650124, -92.274490743)"
|
|
2012,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,706,57.5,54.4,60.7,2712,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,05,SEX1,CAT2,_RFPSA21,RESP054,"(34.748650124, -92.274490743)"
|
|
2012,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,99,12.5,9.5,15.4,2726,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,AGE06,CAT3,_RFPSA21,RESP046,"(37.638640123, -120.999999538)"
|
|
2012,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,674,87.5,84.6,90.5,2730,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,AGE06,CAT3,_RFPSA21,RESP054,"(37.638640123, -120.999999538)"
|
|
2012,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,420,39.7,35.7,43.7,2727,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,AGE07,CAT3,_RFPSA21,RESP046,"(37.638640123, -120.999999538)"
|
|
2012,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,562,60.3,56.3,64.3,2731,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,AGE07,CAT3,_RFPSA21,RESP054,"(37.638640123, -120.999999538)"
|
|
2012,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,296,60.5,54.4,66.5,2728,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,AGE08,CAT3,_RFPSA21,RESP046,"(37.638640123, -120.999999538)"
|
|
2012,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,205,39.5,33.5,45.6,2732,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,AGE08,CAT3,_RFPSA21,RESP054,"(37.638640123, -120.999999538)"
|
|
2012,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,904,66.2,62.3,70.1,2729,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,AGE09,CAT3,_RFPSA21,RESP046,"(37.638640123, -120.999999538)"
|
|
2012,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,448,33.9,30,37.8,2733,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,AGE09,CAT3,_RFPSA21,RESP054,"(37.638640123, -120.999999538)"
|
|
2012,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1719,40.4,38.2,42.6,2722,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,BO1,CAT1,_RFPSA21,RESP046,"(37.638640123, -120.999999538)"
|
|
2012,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1889,59.6,57.4,61.8,2723,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,BO1,CAT1,_RFPSA21,RESP054,"(37.638640123, -120.999999538)"
|
|
2012,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,102,30.4,24.1,36.8,2744,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,EDUCA1,CAT5,_RFPSA21,RESP046,"(37.638640123, -120.999999538)"
|
|
2012,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,238,69.6,63.2,75.9,2748,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,EDUCA1,CAT5,_RFPSA21,RESP054,"(37.638640123, -120.999999538)"
|
|
2012,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,225,36.3,31.4,41.2,2745,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,EDUCA2,CAT5,_RFPSA21,RESP046,"(37.638640123, -120.999999538)"
|
|
2012,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,331,63.7,58.8,68.6,2749,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,EDUCA2,CAT5,_RFPSA21,RESP054,"(37.638640123, -120.999999538)"
|
|
2012,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,441,44.7,40.4,49,2746,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,EDUCA3,CAT5,_RFPSA21,RESP046,"(37.638640123, -120.999999538)"
|
|
2012,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,462,55.3,51,59.6,2750,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,EDUCA3,CAT5,_RFPSA21,RESP054,"(37.638640123, -120.999999538)"
|
|
2012,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,951,43.8,40.8,46.8,2747,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,EDUCA4,CAT5,_RFPSA21,RESP046,"(37.638640123, -120.999999538)"
|
|
2012,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,857,56.3,53.3,59.3,2751,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,EDUCA4,CAT5,_RFPSA21,RESP054,"(37.638640123, -120.999999538)"
|
|
2012,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,122,29.5,22.5,36.5,2752,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,INCOME1,CAT6,_RFPSA21,RESP046,"(37.638640123, -120.999999538)"
|
|
2012,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,258,70.5,63.5,77.5,2757,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,INCOME1,CAT6,_RFPSA21,RESP054,"(37.638640123, -120.999999538)"
|
|
2012,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,125,25.7,19.7,31.7,2753,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,INCOME2,CAT6,_RFPSA21,RESP046,"(37.638640123, -120.999999538)"
|
|
2012,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,242,74.3,68.3,80.3,2758,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,INCOME2,CAT6,_RFPSA21,RESP054,"(37.638640123, -120.999999538)"
|
|
2012,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,119,33.3,25.7,40.9,2754,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,INCOME3,CAT6,_RFPSA21,RESP046,"(37.638640123, -120.999999538)"
|
|
2012,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,162,66.7,59.1,74.3,2759,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,INCOME3,CAT6,_RFPSA21,RESP054,"(37.638640123, -120.999999538)"
|
|
2012,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,208,38.3,32.2,44.5,2755,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,INCOME4,CAT6,_RFPSA21,RESP046,"(37.638640123, -120.999999538)"
|
|
2012,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,209,61.7,55.5,67.8,2760,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,INCOME4,CAT6,_RFPSA21,RESP054,"(37.638640123, -120.999999538)"
|
|
2012,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,1046,46.2,43.2,49.2,2756,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,INCOME5,CAT6,_RFPSA21,RESP046,"(37.638640123, -120.999999538)"
|
|
2012,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,950,53.8,50.8,56.8,2761,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,INCOME5,CAT6,_RFPSA21,RESP054,"(37.638640123, -120.999999538)"
|
|
2012,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1304,47.2,44.7,49.6,2734,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,RACE1,CAT4,_RFPSA21,RESP046,"(37.638640123, -120.999999538)"
|
|
2012,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1190,52.9,50.4,55.3,2739,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,RACE1,CAT4,_RFPSA21,RESP054,"(37.638640123, -120.999999538)"
|
|
2012,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,89,43.7,34.7,52.8,2735,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,RACE2,CAT4,_RFPSA21,RESP046,"(37.638640123, -120.999999538)"
|
|
2012,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,84,56.3,47.2,65.4,2740,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,RACE2,CAT4,_RFPSA21,RESP054,"(37.638640123, -120.999999538)"
|
|
2012,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,203,30.9,26.1,35.6,2736,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,RACE3,CAT4,_RFPSA21,RESP046,"(37.638640123, -120.999999538)"
|
|
2012,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,410,69.1,64.4,73.9,2741,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,RACE3,CAT4,_RFPSA21,RESP054,"(37.638640123, -120.999999538)"
|
|
2012,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,72,31.6,23.4,39.9,2737,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,RACE4,CAT4,_RFPSA21,RESP046,"(37.638640123, -120.999999538)"
|
|
2012,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,147,68.4,60.1,76.6,2742,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,RACE4,CAT4,_RFPSA21,RESP054,"(37.638640123, -120.999999538)"
|
|
2012,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,47,45.5,32.7,58.3,2738,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,RACE5,CAT4,_RFPSA21,RESP046,"(37.638640123, -120.999999538)"
|
|
2012,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,48,54.5,41.7,67.3,2743,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,RACE5,CAT4,_RFPSA21,RESP054,"(37.638640123, -120.999999538)"
|
|
2012,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1719,40.4,38.2,42.6,2724,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,SEX1,CAT2,_RFPSA21,RESP046,"(37.638640123, -120.999999538)"
|
|
2012,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1889,59.6,57.4,61.8,2725,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,SEX1,CAT2,_RFPSA21,RESP054,"(37.638640123, -120.999999538)"
|
|
2012,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,595,83.4,80.3,86.6,2724,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,AGE06,CAT3,_RFPSA21,RESP054,"(38.843840757, -106.133610921)"
|
|
2012,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,458,44.2,40.3,48,2721,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,AGE07,CAT3,_RFPSA21,RESP046,"(38.843840757, -106.133610921)"
|
|
2012,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,135,16.6,13.4,19.7,2720,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,AGE06,CAT3,_RFPSA21,RESP046,"(38.843840757, -106.133610921)"
|
|
2012,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,530,55.8,52,59.7,2725,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,AGE07,CAT3,_RFPSA21,RESP054,"(38.843840757, -106.133610921)"
|
|
2012,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,345,59.2,53.9,64.5,2722,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,AGE08,CAT3,_RFPSA21,RESP046,"(38.843840757, -106.133610921)"
|
|
2012,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,219,40.8,35.5,46.1,2726,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,AGE08,CAT3,_RFPSA21,RESP054,"(38.843840757, -106.133610921)"
|
|
2012,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,824,66.9,63.6,70.2,2723,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,AGE09,CAT3,_RFPSA21,RESP046,"(38.843840757, -106.133610921)"
|
|
2012,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,409,33.1,29.8,36.4,2727,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,AGE09,CAT3,_RFPSA21,RESP054,"(38.843840757, -106.133610921)"
|
|
2012,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1762,42.8,40.7,44.8,2716,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,BO1,CAT1,_RFPSA21,RESP046,"(38.843840757, -106.133610921)"
|
|
2012,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1753,57.3,55.2,59.3,2717,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,BO1,CAT1,_RFPSA21,RESP054,"(38.843840757, -106.133610921)"
|
|
2012,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,45,20.5,13.7,27.4,2738,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,EDUCA1,CAT5,_RFPSA21,RESP046,"(38.843840757, -106.133610921)"
|
|
2012,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,138,79.5,72.6,86.3,2742,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,EDUCA1,CAT5,_RFPSA21,RESP054,"(38.843840757, -106.133610921)"
|
|
2012,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,345,38.2,33.8,42.5,2739,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,EDUCA2,CAT5,_RFPSA21,RESP046,"(38.843840757, -106.133610921)"
|
|
2012,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,432,61.8,57.5,66.2,2743,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,EDUCA2,CAT5,_RFPSA21,RESP054,"(38.843840757, -106.133610921)"
|
|
2012,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,423,43.2,39.1,47.3,2740,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,EDUCA3,CAT5,_RFPSA21,RESP046,"(38.843840757, -106.133610921)"
|
|
2012,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,450,56.8,52.7,60.9,2744,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,EDUCA3,CAT5,_RFPSA21,RESP054,"(38.843840757, -106.133610921)"
|
|
2012,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,947,50.7,47.8,53.5,2741,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,EDUCA4,CAT5,_RFPSA21,RESP046,"(38.843840757, -106.133610921)"
|
|
2012,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,731,49.4,46.5,52.2,2745,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,EDUCA4,CAT5,_RFPSA21,RESP054,"(38.843840757, -106.133610921)"
|
|
2012,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,61,24.4,16.8,32.1,2746,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,INCOME1,CAT6,_RFPSA21,RESP046,"(38.843840757, -106.133610921)"
|
|
2012,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,144,75.6,67.9,83.3,2751,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,INCOME1,CAT6,_RFPSA21,RESP054,"(38.843840757, -106.133610921)"
|
|
2012,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,154,29,23.1,34.9,2747,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,INCOME2,CAT6,_RFPSA21,RESP046,"(38.843840757, -106.133610921)"
|
|
2012,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,238,71,65.1,77,2752,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,INCOME2,CAT6,_RFPSA21,RESP054,"(38.843840757, -106.133610921)"
|
|
2012,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,148,38.3,31.3,45.3,2748,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,INCOME3,CAT6,_RFPSA21,RESP046,"(38.843840757, -106.133610921)"
|
|
2012,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,164,61.8,54.8,68.8,2753,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,INCOME3,CAT6,_RFPSA21,RESP054,"(38.843840757, -106.133610921)"
|
|
2012,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,253,43.3,37.5,49,2749,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,INCOME4,CAT6,_RFPSA21,RESP046,"(38.843840757, -106.133610921)"
|
|
2012,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,223,56.7,51,62.5,2754,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,INCOME4,CAT6,_RFPSA21,RESP054,"(38.843840757, -106.133610921)"
|
|
2012,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,1000,47.3,44.5,50.1,2750,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,INCOME5,CAT6,_RFPSA21,RESP046,"(38.843840757, -106.133610921)"
|
|
2012,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,855,52.7,49.9,55.5,2755,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,INCOME5,CAT6,_RFPSA21,RESP054,"(38.843840757, -106.133610921)"
|
|
2012,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1523,46.4,44.1,48.7,2728,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,RACE1,CAT4,_RFPSA21,RESP046,"(38.843840757, -106.133610921)"
|
|
2012,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1373,53.6,51.3,55.9,2733,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,RACE1,CAT4,_RFPSA21,RESP054,"(38.843840757, -106.133610921)"
|
|
2012,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,29,40,26.6,53.4,2729,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,RACE2,CAT4,_RFPSA21,RESP046,"(38.843840757, -106.133610921)"
|
|
2012,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,35,60,46.6,73.4,2734,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,RACE2,CAT4,_RFPSA21,RESP054,"(38.843840757, -106.133610921)"
|
|
2012,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,114,27.8,21.9,33.7,2730,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,RACE3,CAT4,_RFPSA21,RESP046,"(38.843840757, -106.133610921)"
|
|
2012,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,222,72.2,66.3,78.1,2735,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,RACE3,CAT4,_RFPSA21,RESP054,"(38.843840757, -106.133610921)"
|
|
2012,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,36,28.2,17.6,38.9,2731,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,RACE4,CAT4,_RFPSA21,RESP046,"(38.843840757, -106.133610921)"
|
|
2012,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,56,71.8,61.2,82.4,2736,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,RACE4,CAT4,_RFPSA21,RESP054,"(38.843840757, -106.133610921)"
|
|
2012,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,24,46.9,30.2,63.7,2732,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,RACE5,CAT4,_RFPSA21,RESP046,"(38.843840757, -106.133610921)"
|
|
2012,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,27,53.1,36.3,69.8,2737,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,RACE5,CAT4,_RFPSA21,RESP054,"(38.843840757, -106.133610921)"
|
|
2012,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1762,42.8,40.7,44.8,2718,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,SEX1,CAT2,_RFPSA21,RESP046,"(38.843840757, -106.133610921)"
|
|
2012,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1753,57.3,55.2,59.3,2719,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,SEX1,CAT2,_RFPSA21,RESP054,"(38.843840757, -106.133610921)"
|
|
2012,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,97,21.2,16.3,26.1,2714,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,AGE06,CAT3,_RFPSA21,RESP046,"(41.56266102, -72.649840952)"
|
|
2012,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,427,78.8,73.9,83.7,2718,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,AGE06,CAT3,_RFPSA21,RESP054,"(41.56266102, -72.649840952)"
|
|
2012,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,326,45.5,40.6,50.3,2715,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,AGE07,CAT3,_RFPSA21,RESP046,"(41.56266102, -72.649840952)"
|
|
2012,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,376,54.6,49.7,59.4,2719,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,AGE07,CAT3,_RFPSA21,RESP054,"(41.56266102, -72.649840952)"
|
|
2012,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,210,65.5,58.7,72.2,2716,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,AGE08,CAT3,_RFPSA21,RESP046,"(41.56266102, -72.649840952)"
|
|
2012,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,118,34.5,27.8,41.3,2720,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,AGE08,CAT3,_RFPSA21,RESP054,"(41.56266102, -72.649840952)"
|
|
2012,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,636,70.5,66.7,74.2,2717,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,AGE09,CAT3,_RFPSA21,RESP046,"(41.56266102, -72.649840952)"
|
|
2012,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,296,29.5,25.8,33.3,2721,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,AGE09,CAT3,_RFPSA21,RESP054,"(41.56266102, -72.649840952)"
|
|
2012,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1269,47.6,45,50.2,2710,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,BO1,CAT1,_RFPSA21,RESP046,"(41.56266102, -72.649840952)"
|
|
2012,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1217,52.4,49.8,55,2711,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,BO1,CAT1,_RFPSA21,RESP054,"(41.56266102, -72.649840952)"
|
|
2012,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,60,37.1,26.8,47.4,2732,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,EDUCA1,CAT5,_RFPSA21,RESP046,"(41.56266102, -72.649840952)"
|
|
2012,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,101,62.9,52.6,73.2,2736,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,EDUCA1,CAT5,_RFPSA21,RESP054,"(41.56266102, -72.649840952)"
|
|
2012,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,279,43.9,38.8,49,2733,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,EDUCA2,CAT5,_RFPSA21,RESP046,"(41.56266102, -72.649840952)"
|
|
2012,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,331,56.1,51,61.2,2737,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,EDUCA2,CAT5,_RFPSA21,RESP054,"(41.56266102, -72.649840952)"
|
|
2012,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,265,47.9,42.4,53.4,2734,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,EDUCA3,CAT5,_RFPSA21,RESP046,"(41.56266102, -72.649840952)"
|
|
2012,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,265,52.1,46.6,57.6,2738,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,EDUCA3,CAT5,_RFPSA21,RESP054,"(41.56266102, -72.649840952)"
|
|
2012,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,663,53.8,50.2,57.4,2735,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,EDUCA4,CAT5,_RFPSA21,RESP046,"(41.56266102, -72.649840952)"
|
|
2012,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,517,46.2,42.6,49.8,2739,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,EDUCA4,CAT5,_RFPSA21,RESP054,"(41.56266102, -72.649840952)"
|
|
2012,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,43,31.8,21,42.5,2740,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,INCOME1,CAT6,_RFPSA21,RESP046,"(41.56266102, -72.649840952)"
|
|
2012,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,87,68.2,57.5,79,2745,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,INCOME1,CAT6,_RFPSA21,RESP054,"(41.56266102, -72.649840952)"
|
|
2012,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,107,37.6,29.4,45.8,2741,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,INCOME2,CAT6,_RFPSA21,RESP046,"(41.56266102, -72.649840952)"
|
|
2012,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,145,62.4,54.2,70.6,2746,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,INCOME2,CAT6,_RFPSA21,RESP054,"(41.56266102, -72.649840952)"
|
|
2012,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,82,40.4,29.6,51.2,2742,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,INCOME3,CAT6,_RFPSA21,RESP046,"(41.56266102, -72.649840952)"
|
|
2012,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,94,59.6,48.8,70.4,2747,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,INCOME3,CAT6,_RFPSA21,RESP054,"(41.56266102, -72.649840952)"
|
|
2012,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,158,48.8,41.4,56.3,2743,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,INCOME4,CAT6,_RFPSA21,RESP046,"(41.56266102, -72.649840952)"
|
|
2012,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,148,51.2,43.7,58.7,2748,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,INCOME4,CAT6,_RFPSA21,RESP054,"(41.56266102, -72.649840952)"
|
|
2012,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,751,51.9,48.5,55.4,2744,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,INCOME5,CAT6,_RFPSA21,RESP046,"(41.56266102, -72.649840952)"
|
|
2012,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,626,48.1,44.6,51.5,2749,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,INCOME5,CAT6,_RFPSA21,RESP054,"(41.56266102, -72.649840952)"
|
|
2012,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1096,50.2,47.4,53,2722,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,RACE1,CAT4,_RFPSA21,RESP046,"(41.56266102, -72.649840952)"
|
|
2012,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,963,49.8,47,52.6,2727,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,RACE1,CAT4,_RFPSA21,RESP054,"(41.56266102, -72.649840952)"
|
|
2012,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,69,44.7,34.2,55.2,2723,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,RACE2,CAT4,_RFPSA21,RESP046,"(41.56266102, -72.649840952)"
|
|
2012,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,75,55.3,44.8,65.8,2728,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,RACE2,CAT4,_RFPSA21,RESP054,"(41.56266102, -72.649840952)"
|
|
2012,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,46,35.9,25.4,46.5,2724,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,RACE3,CAT4,_RFPSA21,RESP046,"(41.56266102, -72.649840952)"
|
|
2012,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,83,64.1,53.5,74.6,2729,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,RACE3,CAT4,_RFPSA21,RESP054,"(41.56266102, -72.649840952)"
|
|
2012,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,27,27.3,15,39.7,2725,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,RACE4,CAT4,_RFPSA21,RESP046,"(41.56266102, -72.649840952)"
|
|
2012,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,66,72.7,60.3,85,2730,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,RACE4,CAT4,_RFPSA21,RESP054,"(41.56266102, -72.649840952)"
|
|
2012,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,6,,,,2726,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,09,RACE5,CAT4,_RFPSA21,RESP046,"(41.56266102, -72.649840952)"
|
|
2012,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,6,,,,2731,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,09,RACE5,CAT4,_RFPSA21,RESP054,"(41.56266102, -72.649840952)"
|
|
2012,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1269,47.6,45,50.2,2712,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,SEX1,CAT2,_RFPSA21,RESP046,"(41.56266102, -72.649840952)"
|
|
2012,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1217,52.4,49.8,55,2713,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,SEX1,CAT2,_RFPSA21,RESP054,"(41.56266102, -72.649840952)"
|
|
2012,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,73,27.3,20.9,33.8,2708,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,10,AGE06,CAT3,_RFPSA21,RESP046,"(39.008830667, -75.577741168)"
|
|
2012,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,207,72.7,66.2,79.1,2712,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,10,AGE06,CAT3,_RFPSA21,RESP054,"(39.008830667, -75.577741168)"
|
|
2012,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,176,51.1,44,58.3,2709,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,10,AGE07,CAT3,_RFPSA21,RESP046,"(39.008830667, -75.577741168)"
|
|
2012,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,164,48.9,41.7,56,2713,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,10,AGE07,CAT3,_RFPSA21,RESP054,"(39.008830667, -75.577741168)"
|
|
2012,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,143,67.4,58.7,76.1,2710,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,10,AGE08,CAT3,_RFPSA21,RESP046,"(39.008830667, -75.577741168)"
|
|
2012,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,56,32.6,23.9,41.3,2714,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,10,AGE08,CAT3,_RFPSA21,RESP054,"(39.008830667, -75.577741168)"
|
|
2012,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,436,72.2,67.5,76.8,2711,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,10,AGE09,CAT3,_RFPSA21,RESP046,"(39.008830667, -75.577741168)"
|
|
2012,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,156,27.8,23.2,32.5,2715,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,10,AGE09,CAT3,_RFPSA21,RESP054,"(39.008830667, -75.577741168)"
|
|
2012,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,828,52.7,49.2,56.2,2704,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,10,BO1,CAT1,_RFPSA21,RESP046,"(39.008830667, -75.577741168)"
|
|
2012,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,583,47.3,43.8,50.8,2705,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,10,BO1,CAT1,_RFPSA21,RESP054,"(39.008830667, -75.577741168)"
|
|
2012,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,53,40.8,29.4,52.2,2726,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,10,EDUCA1,CAT5,_RFPSA21,RESP046,"(39.008830667, -75.577741168)"
|
|
2012,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,60,59.2,47.8,70.6,2730,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,10,EDUCA1,CAT5,_RFPSA21,RESP054,"(39.008830667, -75.577741168)"
|
|
2012,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,217,49.8,43.4,56.1,2727,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,10,EDUCA2,CAT5,_RFPSA21,RESP046,"(39.008830667, -75.577741168)"
|
|
2012,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,178,50.3,43.9,56.6,2731,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,10,EDUCA2,CAT5,_RFPSA21,RESP054,"(39.008830667, -75.577741168)"
|
|
2012,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,210,56.8,50.2,63.4,2728,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,10,EDUCA3,CAT5,_RFPSA21,RESP046,"(39.008830667, -75.577741168)"
|
|
2012,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,141,43.2,36.6,49.8,2732,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,10,EDUCA3,CAT5,_RFPSA21,RESP054,"(39.008830667, -75.577741168)"
|
|
2012,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,348,57.7,52.2,63.2,2729,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,10,EDUCA4,CAT5,_RFPSA21,RESP046,"(39.008830667, -75.577741168)"
|
|
2012,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,204,42.3,36.8,47.8,2733,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,10,EDUCA4,CAT5,_RFPSA21,RESP054,"(39.008830667, -75.577741168)"
|
|
2012,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,72,49.3,38.4,60.3,2734,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,10,INCOME1,CAT6,_RFPSA21,RESP046,"(39.008830667, -75.577741168)"
|
|
2012,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,75,50.7,39.7,61.6,2739,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,10,INCOME1,CAT6,_RFPSA21,RESP054,"(39.008830667, -75.577741168)"
|
|
2012,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,57,41.1,28.7,53.6,2735,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,10,INCOME2,CAT6,_RFPSA21,RESP046,"(39.008830667, -75.577741168)"
|
|
2012,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,67,58.9,46.4,71.4,2740,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,10,INCOME2,CAT6,_RFPSA21,RESP054,"(39.008830667, -75.577741168)"
|
|
2012,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,73,49.3,37.4,61.3,2736,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,10,INCOME3,CAT6,_RFPSA21,RESP046,"(39.008830667, -75.577741168)"
|
|
2012,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,48,50.7,38.7,62.6,2741,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,10,INCOME3,CAT6,_RFPSA21,RESP054,"(39.008830667, -75.577741168)"
|
|
2012,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,108,52.6,42.7,62.4,2737,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,10,INCOME4,CAT6,_RFPSA21,RESP046,"(39.008830667, -75.577741168)"
|
|
2012,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,68,47.4,37.6,57.3,2742,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,10,INCOME4,CAT6,_RFPSA21,RESP054,"(39.008830667, -75.577741168)"
|
|
2012,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,435,54.6,49.8,59.3,2738,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,10,INCOME5,CAT6,_RFPSA21,RESP046,"(39.008830667, -75.577741168)"
|
|
2012,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,278,45.4,40.7,50.2,2743,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,10,INCOME5,CAT6,_RFPSA21,RESP054,"(39.008830667, -75.577741168)"
|
|
2012,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,702,56.6,52.9,60.3,2716,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,10,RACE1,CAT4,_RFPSA21,RESP046,"(39.008830667, -75.577741168)"
|
|
2012,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,453,43.4,39.7,47.1,2721,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,10,RACE1,CAT4,_RFPSA21,RESP054,"(39.008830667, -75.577741168)"
|
|
2012,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,81,46.2,36.2,56.1,2717,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,10,RACE2,CAT4,_RFPSA21,RESP046,"(39.008830667, -75.577741168)"
|
|
2012,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,73,53.9,43.9,63.8,2722,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,10,RACE2,CAT4,_RFPSA21,RESP054,"(39.008830667, -75.577741168)"
|
|
2012,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,9,,,,2718,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,10,RACE3,CAT4,_RFPSA21,RESP046,"(39.008830667, -75.577741168)"
|
|
2012,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,27,,,,2723,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,10,RACE3,CAT4,_RFPSA21,RESP054,"(39.008830667, -75.577741168)"
|
|
2012,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,20,,,,2719,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,10,RACE4,CAT4,_RFPSA21,RESP046,"(39.008830667, -75.577741168)"
|
|
2012,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,21,,,,2724,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,10,RACE4,CAT4,_RFPSA21,RESP054,"(39.008830667, -75.577741168)"
|
|
2012,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,12,,,,2720,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,10,RACE5,CAT4,_RFPSA21,RESP046,"(39.008830667, -75.577741168)"
|
|
2012,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,7,,,,2725,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,10,RACE5,CAT4,_RFPSA21,RESP054,"(39.008830667, -75.577741168)"
|
|
2012,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,828,52.7,49.2,56.2,2706,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,10,SEX1,CAT2,_RFPSA21,RESP046,"(39.008830667, -75.577741168)"
|
|
2012,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,583,47.3,43.8,50.8,2707,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,10,SEX1,CAT2,_RFPSA21,RESP054,"(39.008830667, -75.577741168)"
|
|
2012,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,48,21,14.2,27.8,2698,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,11,AGE06,CAT3,_RFPSA21,RESP046,"(38.890371385, -77.031961127)"
|
|
2012,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,172,79,72.2,85.8,2702,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,11,AGE06,CAT3,_RFPSA21,RESP054,"(38.890371385, -77.031961127)"
|
|
2012,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,124,46.3,37.2,55.5,2699,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,11,AGE07,CAT3,_RFPSA21,RESP046,"(38.890371385, -77.031961127)"
|
|
2012,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,141,53.7,44.5,62.8,2703,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,11,AGE07,CAT3,_RFPSA21,RESP054,"(38.890371385, -77.031961127)"
|
|
2012,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,98,52.6,41.7,63.6,2700,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,11,AGE08,CAT3,_RFPSA21,RESP046,"(38.890371385, -77.031961127)"
|
|
2012,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,61,47.4,36.4,58.3,2704,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,11,AGE08,CAT3,_RFPSA21,RESP054,"(38.890371385, -77.031961127)"
|
|
2012,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,287,68.8,62,75.6,2701,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,11,AGE09,CAT3,_RFPSA21,RESP046,"(38.890371385, -77.031961127)"
|
|
2012,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,111,31.2,24.4,38,2705,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,11,AGE09,CAT3,_RFPSA21,RESP054,"(38.890371385, -77.031961127)"
|
|
2012,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,557,44.5,40,48.9,2694,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,11,BO1,CAT1,_RFPSA21,RESP046,"(38.890371385, -77.031961127)"
|
|
2012,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,485,55.5,51.1,60,2695,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,11,BO1,CAT1,_RFPSA21,RESP054,"(38.890371385, -77.031961127)"
|
|
2012,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,30,35.2,20.4,50,2716,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,11,EDUCA1,CAT5,_RFPSA21,RESP046,"(38.890371385, -77.031961127)"
|
|
2012,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,44,64.8,50,79.6,2720,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,11,EDUCA1,CAT5,_RFPSA21,RESP054,"(38.890371385, -77.031961127)"
|
|
2012,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,63,32.5,23.3,41.7,2717,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,11,EDUCA2,CAT5,_RFPSA21,RESP046,"(38.890371385, -77.031961127)"
|
|
2012,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,95,67.5,58.3,76.7,2721,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,11,EDUCA2,CAT5,_RFPSA21,RESP054,"(38.890371385, -77.031961127)"
|
|
2012,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,79,56,44.7,67.2,2718,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,11,EDUCA3,CAT5,_RFPSA21,RESP046,"(38.890371385, -77.031961127)"
|
|
2012,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,52,44,32.8,55.3,2722,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,11,EDUCA3,CAT5,_RFPSA21,RESP054,"(38.890371385, -77.031961127)"
|
|
2012,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,383,48.4,43.5,53.4,2719,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,11,EDUCA4,CAT5,_RFPSA21,RESP046,"(38.890371385, -77.031961127)"
|
|
2012,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,292,51.6,46.6,56.5,2723,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,11,EDUCA4,CAT5,_RFPSA21,RESP054,"(38.890371385, -77.031961127)"
|
|
2012,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,52,41.8,28,55.6,2724,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,11,INCOME1,CAT6,_RFPSA21,RESP046,"(38.890371385, -77.031961127)"
|
|
2012,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,51,58.3,44.5,72.1,2729,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,11,INCOME1,CAT6,_RFPSA21,RESP054,"(38.890371385, -77.031961127)"
|
|
2012,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,53,37.1,24.8,49.4,2725,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,11,INCOME2,CAT6,_RFPSA21,RESP046,"(38.890371385, -77.031961127)"
|
|
2012,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,55,62.9,50.6,75.2,2730,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,11,INCOME2,CAT6,_RFPSA21,RESP054,"(38.890371385, -77.031961127)"
|
|
2012,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,17,,,,2726,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,11,INCOME3,CAT6,_RFPSA21,RESP046,"(38.890371385, -77.031961127)"
|
|
2012,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,32,,,,2731,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,11,INCOME3,CAT6,_RFPSA21,RESP054,"(38.890371385, -77.031961127)"
|
|
2012,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,40,54.5,35,74.1,2727,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,11,INCOME4,CAT6,_RFPSA21,RESP046,"(38.890371385, -77.031961127)"
|
|
2012,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,32,45.5,25.9,65,2732,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,11,INCOME4,CAT6,_RFPSA21,RESP054,"(38.890371385, -77.031961127)"
|
|
2012,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,337,48.6,43.1,54.1,2728,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,11,INCOME5,CAT6,_RFPSA21,RESP046,"(38.890371385, -77.031961127)"
|
|
2012,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,266,51.4,45.9,56.9,2733,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,11,INCOME5,CAT6,_RFPSA21,RESP054,"(38.890371385, -77.031961127)"
|
|
2012,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,295,49.2,43.5,54.9,2706,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,11,RACE1,CAT4,_RFPSA21,RESP046,"(38.890371385, -77.031961127)"
|
|
2012,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,247,50.8,45.1,56.5,2711,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,11,RACE1,CAT4,_RFPSA21,RESP054,"(38.890371385, -77.031961127)"
|
|
2012,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,225,43.2,36.6,49.8,2707,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,11,RACE2,CAT4,_RFPSA21,RESP046,"(38.890371385, -77.031961127)"
|
|
2012,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,185,56.8,50.2,63.5,2712,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,11,RACE2,CAT4,_RFPSA21,RESP054,"(38.890371385, -77.031961127)"
|
|
2012,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,6,,,,2708,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,11,RACE3,CAT4,_RFPSA21,RESP046,"(38.890371385, -77.031961127)"
|
|
2012,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,17,,,,2713,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,11,RACE3,CAT4,_RFPSA21,RESP054,"(38.890371385, -77.031961127)"
|
|
2012,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,12,,,,2709,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,11,RACE4,CAT4,_RFPSA21,RESP046,"(38.890371385, -77.031961127)"
|
|
2012,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,14,,,,2714,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,11,RACE4,CAT4,_RFPSA21,RESP054,"(38.890371385, -77.031961127)"
|
|
2012,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,3,,,,2710,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,11,RACE5,CAT4,_RFPSA21,RESP046,"(38.890371385, -77.031961127)"
|
|
2012,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,8,,,,2715,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,11,RACE5,CAT4,_RFPSA21,RESP054,"(38.890371385, -77.031961127)"
|
|
2012,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,557,44.5,40,48.9,2696,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,11,SEX1,CAT2,_RFPSA21,RESP046,"(38.890371385, -77.031961127)"
|
|
2012,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,485,55.5,51.1,60,2697,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,11,SEX1,CAT2,_RFPSA21,RESP054,"(38.890371385, -77.031961127)"
|
|
2012,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,89,21.6,16,27.2,2724,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,12,AGE06,CAT3,_RFPSA21,RESP046,"(28.932040377, -81.928960539)"
|
|
2012,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,285,78.4,72.8,84,2728,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,12,AGE06,CAT3,_RFPSA21,RESP054,"(28.932040377, -81.928960539)"
|
|
2012,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,257,50.6,44.1,57.2,2725,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,12,AGE07,CAT3,_RFPSA21,RESP046,"(28.932040377, -81.928960539)"
|
|
2012,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,238,49.4,42.9,56,2729,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,12,AGE07,CAT3,_RFPSA21,RESP054,"(28.932040377, -81.928960539)"
|
|
2012,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,217,64.7,56.9,72.5,2726,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,12,AGE08,CAT3,_RFPSA21,RESP046,"(28.932040377, -81.928960539)"
|
|
2012,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,87,35.3,27.5,43.1,2730,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,12,AGE08,CAT3,_RFPSA21,RESP054,"(28.932040377, -81.928960539)"
|
|
2012,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,732,70.6,66,75.3,2727,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,12,AGE09,CAT3,_RFPSA21,RESP046,"(28.932040377, -81.928960539)"
|
|
2012,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,275,29.4,24.7,34,2731,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,12,AGE09,CAT3,_RFPSA21,RESP054,"(28.932040377, -81.928960539)"
|
|
2012,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1295,51.2,48.1,54.4,2720,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,12,BO1,CAT1,_RFPSA21,RESP046,"(28.932040377, -81.928960539)"
|
|
2012,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,885,48.8,45.6,51.9,2721,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,12,BO1,CAT1,_RFPSA21,RESP054,"(28.932040377, -81.928960539)"
|
|
2012,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,67,32.1,22.2,41.9,2742,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,12,EDUCA1,CAT5,_RFPSA21,RESP046,"(28.932040377, -81.928960539)"
|
|
2012,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,111,68,58.1,77.8,2746,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,12,EDUCA1,CAT5,_RFPSA21,RESP054,"(28.932040377, -81.928960539)"
|
|
2012,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,336,50.5,44.8,56.2,2743,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,12,EDUCA2,CAT5,_RFPSA21,RESP046,"(28.932040377, -81.928960539)"
|
|
2012,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,263,49.5,43.8,55.2,2747,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,12,EDUCA2,CAT5,_RFPSA21,RESP054,"(28.932040377, -81.928960539)"
|
|
2012,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,295,52.3,46.2,58.5,2744,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,12,EDUCA3,CAT5,_RFPSA21,RESP046,"(28.932040377, -81.928960539)"
|
|
2012,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,218,47.7,41.5,53.8,2748,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,12,EDUCA3,CAT5,_RFPSA21,RESP054,"(28.932040377, -81.928960539)"
|
|
2012,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,595,61,56.4,65.7,2745,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,12,EDUCA4,CAT5,_RFPSA21,RESP046,"(28.932040377, -81.928960539)"
|
|
2012,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,290,39,34.3,43.6,2749,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,12,EDUCA4,CAT5,_RFPSA21,RESP054,"(28.932040377, -81.928960539)"
|
|
2012,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,79,35,25.2,44.8,2750,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,12,INCOME1,CAT6,_RFPSA21,RESP046,"(28.932040377, -81.928960539)"
|
|
2012,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,138,65,55.2,74.8,2755,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,12,INCOME1,CAT6,_RFPSA21,RESP054,"(28.932040377, -81.928960539)"
|
|
2012,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,184,42.3,34,50.7,2751,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,12,INCOME2,CAT6,_RFPSA21,RESP046,"(28.932040377, -81.928960539)"
|
|
2012,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,153,57.7,49.3,66,2756,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,12,INCOME2,CAT6,_RFPSA21,RESP054,"(28.932040377, -81.928960539)"
|
|
2012,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,144,52.2,42.8,61.7,2752,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,12,INCOME3,CAT6,_RFPSA21,RESP046,"(28.932040377, -81.928960539)"
|
|
2012,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,92,47.8,38.4,57.2,2757,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,12,INCOME3,CAT6,_RFPSA21,RESP054,"(28.932040377, -81.928960539)"
|
|
2012,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,175,55.9,47.5,64.4,2753,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,12,INCOME4,CAT6,_RFPSA21,RESP046,"(28.932040377, -81.928960539)"
|
|
2012,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,127,44.1,35.6,52.5,2758,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,12,INCOME4,CAT6,_RFPSA21,RESP054,"(28.932040377, -81.928960539)"
|
|
2012,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,591,57.7,52.8,62.6,2754,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,12,INCOME5,CAT6,_RFPSA21,RESP046,"(28.932040377, -81.928960539)"
|
|
2012,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,291,42.3,37.4,47.3,2759,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,12,INCOME5,CAT6,_RFPSA21,RESP054,"(28.932040377, -81.928960539)"
|
|
2012,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1050,53.7,50.2,57.1,2732,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,12,RACE1,CAT4,_RFPSA21,RESP046,"(28.932040377, -81.928960539)"
|
|
2012,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,643,46.3,42.9,49.8,2737,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,12,RACE1,CAT4,_RFPSA21,RESP054,"(28.932040377, -81.928960539)"
|
|
2012,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,89,54.7,43.7,65.7,2733,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,12,RACE2,CAT4,_RFPSA21,RESP046,"(28.932040377, -81.928960539)"
|
|
2012,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,65,45.3,34.3,56.3,2738,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,12,RACE2,CAT4,_RFPSA21,RESP054,"(28.932040377, -81.928960539)"
|
|
2012,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,102,44.7,35.3,54.1,2734,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,12,RACE3,CAT4,_RFPSA21,RESP046,"(28.932040377, -81.928960539)"
|
|
2012,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,105,55.3,45.9,64.7,2739,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,12,RACE3,CAT4,_RFPSA21,RESP054,"(28.932040377, -81.928960539)"
|
|
2012,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,18,,,,2735,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,12,RACE4,CAT4,_RFPSA21,RESP046,"(28.932040377, -81.928960539)"
|
|
2012,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,30,,,,2740,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,12,RACE4,CAT4,_RFPSA21,RESP054,"(28.932040377, -81.928960539)"
|
|
2012,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,16,,,,2736,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,12,RACE5,CAT4,_RFPSA21,RESP046,"(28.932040377, -81.928960539)"
|
|
2012,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,18,,,,2741,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,12,RACE5,CAT4,_RFPSA21,RESP054,"(28.932040377, -81.928960539)"
|
|
2012,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1295,51.2,48.1,54.4,2722,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,12,SEX1,CAT2,_RFPSA21,RESP046,"(28.932040377, -81.928960539)"
|
|
2012,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,885,48.8,45.6,51.9,2723,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,12,SEX1,CAT2,_RFPSA21,RESP054,"(28.932040377, -81.928960539)"
|
|
2012,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,241,54.1,48.1,60,2722,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,13,AGE07,CAT3,_RFPSA21,RESP046,"(32.839681093, -83.627580346)"
|
|
2012,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,85,27.7,21.7,33.8,2721,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,13,AGE06,CAT3,_RFPSA21,RESP046,"(32.839681093, -83.627580346)"
|
|
2012,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,233,72.3,66.3,78.3,2725,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,13,AGE06,CAT3,_RFPSA21,RESP054,"(32.839681093, -83.627580346)"
|
|
2012,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,190,45.9,40,51.9,2726,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,13,AGE07,CAT3,_RFPSA21,RESP054,"(32.839681093, -83.627580346)"
|
|
2012,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,171,66.7,58.7,74.6,2723,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,13,AGE08,CAT3,_RFPSA21,RESP046,"(32.839681093, -83.627580346)"
|
|
2012,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,77,33.4,25.4,41.3,2727,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,13,AGE08,CAT3,_RFPSA21,RESP054,"(32.839681093, -83.627580346)"
|
|
2012,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,430,72.4,67.8,77,2724,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,13,AGE09,CAT3,_RFPSA21,RESP046,"(32.839681093, -83.627580346)"
|
|
2012,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,173,27.6,23,32.3,2728,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,13,AGE09,CAT3,_RFPSA21,RESP054,"(32.839681093, -83.627580346)"
|
|
2012,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,927,51.8,48.5,55.1,2717,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,13,BO1,CAT1,_RFPSA21,RESP046,"(32.839681093, -83.627580346)"
|
|
2012,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,673,48.2,44.9,51.5,2718,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,13,BO1,CAT1,_RFPSA21,RESP054,"(32.839681093, -83.627580346)"
|
|
2012,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,80,34.8,26.5,43.2,2739,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,13,EDUCA1,CAT5,_RFPSA21,RESP046,"(32.839681093, -83.627580346)"
|
|
2012,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,121,65.2,56.8,73.5,2743,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,13,EDUCA1,CAT5,_RFPSA21,RESP054,"(32.839681093, -83.627580346)"
|
|
2012,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,220,50.2,43.8,56.5,2740,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,13,EDUCA2,CAT5,_RFPSA21,RESP046,"(32.839681093, -83.627580346)"
|
|
2012,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,195,49.8,43.5,56.2,2744,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,13,EDUCA2,CAT5,_RFPSA21,RESP054,"(32.839681093, -83.627580346)"
|
|
2012,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,234,57.6,51.1,64.1,2741,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,13,EDUCA3,CAT5,_RFPSA21,RESP046,"(32.839681093, -83.627580346)"
|
|
2012,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,146,42.4,35.9,48.9,2745,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,13,EDUCA3,CAT5,_RFPSA21,RESP054,"(32.839681093, -83.627580346)"
|
|
2012,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,391,58.8,53.6,63.9,2742,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,13,EDUCA4,CAT5,_RFPSA21,RESP046,"(32.839681093, -83.627580346)"
|
|
2012,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,209,41.2,36.1,46.4,2746,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,13,EDUCA4,CAT5,_RFPSA21,RESP054,"(32.839681093, -83.627580346)"
|
|
2012,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,60,31.6,21.9,41.4,2747,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,13,INCOME1,CAT6,_RFPSA21,RESP046,"(32.839681093, -83.627580346)"
|
|
2012,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,91,68.4,58.7,78.1,2752,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,13,INCOME1,CAT6,_RFPSA21,RESP054,"(32.839681093, -83.627580346)"
|
|
2012,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,109,42.4,33.6,51.2,2748,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,13,INCOME2,CAT6,_RFPSA21,RESP046,"(32.839681093, -83.627580346)"
|
|
2012,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,115,57.6,48.8,66.4,2753,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,13,INCOME2,CAT6,_RFPSA21,RESP054,"(32.839681093, -83.627580346)"
|
|
2012,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,81,45.7,35.2,56.3,2749,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,13,INCOME3,CAT6,_RFPSA21,RESP046,"(32.839681093, -83.627580346)"
|
|
2012,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,84,54.3,43.7,64.8,2754,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,13,INCOME3,CAT6,_RFPSA21,RESP054,"(32.839681093, -83.627580346)"
|
|
2012,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,121,55.9,47.3,64.6,2750,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,13,INCOME4,CAT6,_RFPSA21,RESP046,"(32.839681093, -83.627580346)"
|
|
2012,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,80,44.1,35.5,52.7,2755,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,13,INCOME4,CAT6,_RFPSA21,RESP054,"(32.839681093, -83.627580346)"
|
|
2012,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,461,60.7,56,65.4,2751,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,13,INCOME5,CAT6,_RFPSA21,RESP046,"(32.839681093, -83.627580346)"
|
|
2012,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,231,39.3,34.6,44,2756,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,13,INCOME5,CAT6,_RFPSA21,RESP054,"(32.839681093, -83.627580346)"
|
|
2012,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,691,54.5,50.7,58.2,2729,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,13,RACE1,CAT4,_RFPSA21,RESP046,"(32.839681093, -83.627580346)"
|
|
2012,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,474,45.6,41.8,49.3,2734,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,13,RACE1,CAT4,_RFPSA21,RESP054,"(32.839681093, -83.627580346)"
|
|
2012,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,164,49.9,42.6,57.1,2730,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,13,RACE2,CAT4,_RFPSA21,RESP046,"(32.839681093, -83.627580346)"
|
|
2012,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,135,50.1,42.9,57.4,2735,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,13,RACE2,CAT4,_RFPSA21,RESP054,"(32.839681093, -83.627580346)"
|
|
2012,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,18,,,,2731,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,13,RACE3,CAT4,_RFPSA21,RESP046,"(32.839681093, -83.627580346)"
|
|
2012,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,20,,,,2736,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,13,RACE3,CAT4,_RFPSA21,RESP054,"(32.839681093, -83.627580346)"
|
|
2012,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,32,52.8,36.4,69.2,2732,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,13,RACE4,CAT4,_RFPSA21,RESP046,"(32.839681093, -83.627580346)"
|
|
2012,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,25,47.2,30.8,63.6,2737,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,13,RACE4,CAT4,_RFPSA21,RESP054,"(32.839681093, -83.627580346)"
|
|
2012,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,6,,,,2733,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,13,RACE5,CAT4,_RFPSA21,RESP046,"(32.839681093, -83.627580346)"
|
|
2012,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,8,,,,2738,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,13,RACE5,CAT4,_RFPSA21,RESP054,"(32.839681093, -83.627580346)"
|
|
2012,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,927,51.8,48.5,55.1,2719,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,13,SEX1,CAT2,_RFPSA21,RESP046,"(32.839681093, -83.627580346)"
|
|
2012,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,673,48.2,44.9,51.5,2720,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,13,SEX1,CAT2,_RFPSA21,RESP054,"(32.839681093, -83.627580346)"
|
|
2012,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,16,8.6,3.8,13.4,2683,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,66,AGE06,CAT3,_RFPSA21,RESP046,"(13.444304, 144.793731)"
|
|
2012,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,141,91.4,86.6,96.2,2687,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,66,AGE06,CAT3,_RFPSA21,RESP054,"(13.444304, 144.793731)"
|
|
2012,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,39,22,14.2,29.8,2684,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,66,AGE07,CAT3,_RFPSA21,RESP046,"(13.444304, 144.793731)"
|
|
2012,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,114,78,70.2,85.8,2688,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,66,AGE07,CAT3,_RFPSA21,RESP054,"(13.444304, 144.793731)"
|
|
2012,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,17,31.5,15.2,47.9,2685,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,66,AGE08,CAT3,_RFPSA21,RESP046,"(13.444304, 144.793731)"
|
|
2012,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,37,68.5,52.1,84.9,2689,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,66,AGE08,CAT3,_RFPSA21,RESP054,"(13.444304, 144.793731)"
|
|
2012,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,33,35,22.6,47.4,2686,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,66,AGE09,CAT3,_RFPSA21,RESP046,"(13.444304, 144.793731)"
|
|
2012,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,50,65,52.7,77.4,2690,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,66,AGE09,CAT3,_RFPSA21,RESP054,"(13.444304, 144.793731)"
|
|
2012,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,105,19.9,15.6,24.2,2679,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,66,BO1,CAT1,_RFPSA21,RESP046,"(13.444304, 144.793731)"
|
|
2012,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,342,80.1,75.8,84.4,2680,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,66,BO1,CAT1,_RFPSA21,RESP054,"(13.444304, 144.793731)"
|
|
2012,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,6,,,,2701,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,66,EDUCA1,CAT5,_RFPSA21,RESP046,"(13.444304, 144.793731)"
|
|
2012,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,36,,,,2705,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,66,EDUCA1,CAT5,_RFPSA21,RESP054,"(13.444304, 144.793731)"
|
|
2012,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,29,15.2,9,21.5,2702,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,66,EDUCA2,CAT5,_RFPSA21,RESP046,"(13.444304, 144.793731)"
|
|
2012,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,142,84.8,78.5,91,2706,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,66,EDUCA2,CAT5,_RFPSA21,RESP054,"(13.444304, 144.793731)"
|
|
2012,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,25,21.7,12.4,31.1,2703,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,66,EDUCA3,CAT5,_RFPSA21,RESP046,"(13.444304, 144.793731)"
|
|
2012,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,72,78.3,68.9,87.7,2707,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,66,EDUCA3,CAT5,_RFPSA21,RESP054,"(13.444304, 144.793731)"
|
|
2012,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,45,30.4,20.9,39.8,2704,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,66,EDUCA4,CAT5,_RFPSA21,RESP046,"(13.444304, 144.793731)"
|
|
2012,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,91,69.7,60.2,79.1,2708,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,66,EDUCA4,CAT5,_RFPSA21,RESP054,"(13.444304, 144.793731)"
|
|
2012,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,9,,,,2709,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,66,INCOME1,CAT6,_RFPSA21,RESP046,"(13.444304, 144.793731)"
|
|
2012,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,45,86.9,76.9,97,2714,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,66,INCOME1,CAT6,_RFPSA21,RESP054,"(13.444304, 144.793731)"
|
|
2012,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,14,,,,2710,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,66,INCOME2,CAT6,_RFPSA21,RESP046,"(13.444304, 144.793731)"
|
|
2012,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,67,87.1,79.5,94.8,2715,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,66,INCOME2,CAT6,_RFPSA21,RESP054,"(13.444304, 144.793731)"
|
|
2012,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,11,,,,2711,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,66,INCOME3,CAT6,_RFPSA21,RESP046,"(13.444304, 144.793731)"
|
|
2012,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,54,82.4,71.3,93.6,2716,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,66,INCOME3,CAT6,_RFPSA21,RESP054,"(13.444304, 144.793731)"
|
|
2012,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,13,,,,2712,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,66,INCOME4,CAT6,_RFPSA21,RESP046,"(13.444304, 144.793731)"
|
|
2012,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,54,81,69.5,92.4,2717,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,66,INCOME4,CAT6,_RFPSA21,RESP054,"(13.444304, 144.793731)"
|
|
2012,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,54,31,22,39.9,2713,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,66,INCOME5,CAT6,_RFPSA21,RESP046,"(13.444304, 144.793731)"
|
|
2012,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,97,69,60.1,78,2718,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,66,INCOME5,CAT6,_RFPSA21,RESP054,"(13.444304, 144.793731)"
|
|
2012,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,26,42.7,27.9,57.4,2691,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,66,RACE1,CAT4,_RFPSA21,RESP046,"(13.444304, 144.793731)"
|
|
2012,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,33,57.3,42.6,72.1,2696,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,66,RACE1,CAT4,_RFPSA21,RESP054,"(13.444304, 144.793731)"
|
|
2012,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,2,,,,2692,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,66,RACE2,CAT4,_RFPSA21,RESP046,"(13.444304, 144.793731)"
|
|
2012,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,2,,,,2697,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,66,RACE2,CAT4,_RFPSA21,RESP054,"(13.444304, 144.793731)"
|
|
2012,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,8,,,,2693,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,66,RACE3,CAT4,_RFPSA21,RESP046,"(13.444304, 144.793731)"
|
|
2012,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,24,,,,2698,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,66,RACE3,CAT4,_RFPSA21,RESP054,"(13.444304, 144.793731)"
|
|
2012,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,61,17.5,12.5,22.5,2694,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,66,RACE4,CAT4,_RFPSA21,RESP046,"(13.444304, 144.793731)"
|
|
2012,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,231,82.5,77.5,87.5,2699,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,66,RACE4,CAT4,_RFPSA21,RESP054,"(13.444304, 144.793731)"
|
|
2012,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,4,,,,2695,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,66,RACE5,CAT4,_RFPSA21,RESP046,"(13.444304, 144.793731)"
|
|
2012,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,39,,,,2700,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,66,RACE5,CAT4,_RFPSA21,RESP054,"(13.444304, 144.793731)"
|
|
2012,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,105,19.9,15.6,24.2,2681,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,66,SEX1,CAT2,_RFPSA21,RESP046,"(13.444304, 144.793731)"
|
|
2012,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,342,80.1,75.8,84.4,2682,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,66,SEX1,CAT2,_RFPSA21,RESP054,"(13.444304, 144.793731)"
|
|
2012,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,51,8.9,5.8,12,2719,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,15,AGE06,CAT3,_RFPSA21,RESP046,"(21.304850435, -157.857749403)"
|
|
2012,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,423,91.1,88,94.2,2723,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,15,AGE06,CAT3,_RFPSA21,RESP054,"(21.304850435, -157.857749403)"
|
|
2012,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,176,28.1,22.9,33.2,2720,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,15,AGE07,CAT3,_RFPSA21,RESP046,"(21.304850435, -157.857749403)"
|
|
2012,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,408,72,66.8,77.1,2724,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,15,AGE07,CAT3,_RFPSA21,RESP054,"(21.304850435, -157.857749403)"
|
|
2012,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,167,46.6,38.9,54.4,2721,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,15,AGE08,CAT3,_RFPSA21,RESP046,"(21.304850435, -157.857749403)"
|
|
2012,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,182,53.4,45.6,61.1,2725,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,15,AGE08,CAT3,_RFPSA21,RESP054,"(21.304850435, -157.857749403)"
|
|
2012,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,444,58.9,53.8,63.9,2722,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,15,AGE09,CAT3,_RFPSA21,RESP046,"(21.304850435, -157.857749403)"
|
|
2012,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,305,41.1,36.1,46.2,2726,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,15,AGE09,CAT3,_RFPSA21,RESP054,"(21.304850435, -157.857749403)"
|
|
2012,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,838,34.6,31.8,37.5,2715,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,15,BO1,CAT1,_RFPSA21,RESP046,"(21.304850435, -157.857749403)"
|
|
2012,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1318,65.4,62.5,68.2,2716,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,15,BO1,CAT1,_RFPSA21,RESP054,"(21.304850435, -157.857749403)"
|
|
2012,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,20,19.7,9.9,29.4,2737,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,15,EDUCA1,CAT5,_RFPSA21,RESP046,"(21.304850435, -157.857749403)"
|
|
2012,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,67,80.3,70.6,90.1,2741,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,15,EDUCA1,CAT5,_RFPSA21,RESP054,"(21.304850435, -157.857749403)"
|
|
2012,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,152,27.2,21.9,32.5,2738,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,15,EDUCA2,CAT5,_RFPSA21,RESP046,"(21.304850435, -157.857749403)"
|
|
2012,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,386,72.8,67.5,78.1,2742,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,15,EDUCA2,CAT5,_RFPSA21,RESP054,"(21.304850435, -157.857749403)"
|
|
2012,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,204,36.7,31.1,42.3,2739,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,15,EDUCA3,CAT5,_RFPSA21,RESP046,"(21.304850435, -157.857749403)"
|
|
2012,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,338,63.3,57.8,68.9,2743,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,15,EDUCA3,CAT5,_RFPSA21,RESP054,"(21.304850435, -157.857749403)"
|
|
2012,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,462,44.3,40.1,48.5,2740,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,15,EDUCA4,CAT5,_RFPSA21,RESP046,"(21.304850435, -157.857749403)"
|
|
2012,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,526,55.7,51.5,59.9,2744,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,15,EDUCA4,CAT5,_RFPSA21,RESP054,"(21.304850435, -157.857749403)"
|
|
2012,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,27,,,,2745,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,15,INCOME1,CAT6,_RFPSA21,RESP046,"(21.304850435, -157.857749403)"
|
|
2012,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,131,85.2,75.5,94.8,2750,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,15,INCOME1,CAT6,_RFPSA21,RESP054,"(21.304850435, -157.857749403)"
|
|
2012,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,73,28.2,20.5,36,2746,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,15,INCOME2,CAT6,_RFPSA21,RESP046,"(21.304850435, -157.857749403)"
|
|
2012,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,173,71.8,64,79.5,2751,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,15,INCOME2,CAT6,_RFPSA21,RESP054,"(21.304850435, -157.857749403)"
|
|
2012,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,66,26.5,18,35.1,2747,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,15,INCOME3,CAT6,_RFPSA21,RESP046,"(21.304850435, -157.857749403)"
|
|
2012,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,121,73.5,64.9,82,2752,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,15,INCOME3,CAT6,_RFPSA21,RESP054,"(21.304850435, -157.857749403)"
|
|
2012,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,119,37.1,29.6,44.7,2748,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,15,INCOME4,CAT6,_RFPSA21,RESP046,"(21.304850435, -157.857749403)"
|
|
2012,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,192,62.9,55.3,70.4,2753,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,15,INCOME4,CAT6,_RFPSA21,RESP054,"(21.304850435, -157.857749403)"
|
|
2012,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,504,39.2,35.2,43.1,2749,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,15,INCOME5,CAT6,_RFPSA21,RESP046,"(21.304850435, -157.857749403)"
|
|
2012,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,628,60.9,56.9,64.8,2754,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,15,INCOME5,CAT6,_RFPSA21,RESP054,"(21.304850435, -157.857749403)"
|
|
2012,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,383,44,39.2,48.8,2727,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,15,RACE1,CAT4,_RFPSA21,RESP046,"(21.304850435, -157.857749403)"
|
|
2012,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,437,56,51.2,60.8,2732,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,15,RACE1,CAT4,_RFPSA21,RESP054,"(21.304850435, -157.857749403)"
|
|
2012,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,9,,,,2728,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,15,RACE2,CAT4,_RFPSA21,RESP046,"(21.304850435, -157.857749403)"
|
|
2012,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,25,,,,2733,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,15,RACE2,CAT4,_RFPSA21,RESP054,"(21.304850435, -157.857749403)"
|
|
2012,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,30,24.5,12.1,37,2729,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,15,RACE3,CAT4,_RFPSA21,RESP046,"(21.304850435, -157.857749403)"
|
|
2012,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,90,75.5,63,87.9,2734,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,15,RACE3,CAT4,_RFPSA21,RESP054,"(21.304850435, -157.857749403)"
|
|
2012,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,298,34.2,29.6,38.9,2730,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,15,RACE4,CAT4,_RFPSA21,RESP046,"(21.304850435, -157.857749403)"
|
|
2012,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,457,65.8,61.1,70.4,2735,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,15,RACE4,CAT4,_RFPSA21,RESP054,"(21.304850435, -157.857749403)"
|
|
2012,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,113,24,18.4,29.6,2731,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,15,RACE5,CAT4,_RFPSA21,RESP046,"(21.304850435, -157.857749403)"
|
|
2012,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,286,76,70.4,81.6,2736,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,15,RACE5,CAT4,_RFPSA21,RESP054,"(21.304850435, -157.857749403)"
|
|
2012,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,838,34.6,31.8,37.5,2717,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,15,SEX1,CAT2,_RFPSA21,RESP046,"(21.304850435, -157.857749403)"
|
|
2012,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1318,65.4,62.5,68.2,2718,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,15,SEX1,CAT2,_RFPSA21,RESP054,"(21.304850435, -157.857749403)"
|
|
2012,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,42,11.7,6.2,17.2,2690,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,16,AGE06,CAT3,_RFPSA21,RESP046,"(43.682630005, -114.363730042)"
|
|
2012,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,252,88.3,82.8,93.8,2694,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,16,AGE06,CAT3,_RFPSA21,RESP054,"(43.682630005, -114.363730042)"
|
|
2012,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,163,42.5,35.1,49.9,2691,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,16,AGE07,CAT3,_RFPSA21,RESP046,"(43.682630005, -114.363730042)"
|
|
2012,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,277,57.5,50.1,64.9,2695,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,16,AGE07,CAT3,_RFPSA21,RESP054,"(43.682630005, -114.363730042)"
|
|
2012,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,173,60.9,51.4,70.5,2692,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,16,AGE08,CAT3,_RFPSA21,RESP046,"(43.682630005, -114.363730042)"
|
|
2012,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,110,39.1,29.5,48.6,2696,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,16,AGE08,CAT3,_RFPSA21,RESP054,"(43.682630005, -114.363730042)"
|
|
2012,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,473,66.6,61.5,71.8,2693,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,16,AGE09,CAT3,_RFPSA21,RESP046,"(43.682630005, -114.363730042)"
|
|
2012,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,252,33.4,28.3,38.5,2697,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,16,AGE09,CAT3,_RFPSA21,RESP054,"(43.682630005, -114.363730042)"
|
|
2012,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,851,43.2,39.5,46.9,2686,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,16,BO1,CAT1,_RFPSA21,RESP046,"(43.682630005, -114.363730042)"
|
|
2012,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,891,56.8,53.1,60.5,2687,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,16,BO1,CAT1,_RFPSA21,RESP054,"(43.682630005, -114.363730042)"
|
|
2012,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,34,24.4,13.3,35.5,2708,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,16,EDUCA1,CAT5,_RFPSA21,RESP046,"(43.682630005, -114.363730042)"
|
|
2012,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,75,75.6,64.5,86.7,2712,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,16,EDUCA1,CAT5,_RFPSA21,RESP054,"(43.682630005, -114.363730042)"
|
|
2012,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,201,35.9,29.4,42.4,2709,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,16,EDUCA2,CAT5,_RFPSA21,RESP046,"(43.682630005, -114.363730042)"
|
|
2012,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,283,64.1,57.6,70.6,2713,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,16,EDUCA2,CAT5,_RFPSA21,RESP054,"(43.682630005, -114.363730042)"
|
|
2012,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,248,51.1,44,58.1,2710,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,16,EDUCA3,CAT5,_RFPSA21,RESP046,"(43.682630005, -114.363730042)"
|
|
2012,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,244,48.9,41.9,56,2714,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,16,EDUCA3,CAT5,_RFPSA21,RESP054,"(43.682630005, -114.363730042)"
|
|
2012,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,367,48.2,42.3,54.1,2711,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,16,EDUCA4,CAT5,_RFPSA21,RESP046,"(43.682630005, -114.363730042)"
|
|
2012,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,289,51.8,45.9,57.7,2715,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,16,EDUCA4,CAT5,_RFPSA21,RESP054,"(43.682630005, -114.363730042)"
|
|
2012,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,39,22.5,11.2,33.9,2716,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,16,INCOME1,CAT6,_RFPSA21,RESP046,"(43.682630005, -114.363730042)"
|
|
2012,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,101,77.5,66.2,88.8,2721,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,16,INCOME1,CAT6,_RFPSA21,RESP054,"(43.682630005, -114.363730042)"
|
|
2012,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,100,31.5,23.2,39.9,2717,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,16,INCOME2,CAT6,_RFPSA21,RESP046,"(43.682630005, -114.363730042)"
|
|
2012,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,162,68.5,60.1,76.8,2722,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,16,INCOME2,CAT6,_RFPSA21,RESP054,"(43.682630005, -114.363730042)"
|
|
2012,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,98,38,28.3,47.8,2718,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,16,INCOME3,CAT6,_RFPSA21,RESP046,"(43.682630005, -114.363730042)"
|
|
2012,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,112,62,52.2,71.7,2723,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,16,INCOME3,CAT6,_RFPSA21,RESP054,"(43.682630005, -114.363730042)"
|
|
2012,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,169,46,37,55,2719,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,16,INCOME4,CAT6,_RFPSA21,RESP046,"(43.682630005, -114.363730042)"
|
|
2012,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,134,54,45,63,2724,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,16,INCOME4,CAT6,_RFPSA21,RESP054,"(43.682630005, -114.363730042)"
|
|
2012,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,378,48.9,43.1,54.7,2720,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,16,INCOME5,CAT6,_RFPSA21,RESP046,"(43.682630005, -114.363730042)"
|
|
2012,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,320,51.1,45.3,56.9,2725,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,16,INCOME5,CAT6,_RFPSA21,RESP054,"(43.682630005, -114.363730042)"
|
|
2012,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,794,44.7,40.8,48.5,2698,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,16,RACE1,CAT4,_RFPSA21,RESP046,"(43.682630005, -114.363730042)"
|
|
2012,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,796,55.3,51.5,59.2,2703,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,16,RACE1,CAT4,_RFPSA21,RESP054,"(43.682630005, -114.363730042)"
|
|
2012,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,4,,,,2699,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,16,RACE2,CAT4,_RFPSA21,RESP046,"(43.682630005, -114.363730042)"
|
|
2012,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,1,,,,2704,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,16,RACE2,CAT4,_RFPSA21,RESP054,"(43.682630005, -114.363730042)"
|
|
2012,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,16,,,,2700,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,16,RACE3,CAT4,_RFPSA21,RESP046,"(43.682630005, -114.363730042)"
|
|
2012,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,47,83.3,72.8,93.8,2705,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,16,RACE3,CAT4,_RFPSA21,RESP054,"(43.682630005, -114.363730042)"
|
|
2012,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,7,,,,2701,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,16,RACE4,CAT4,_RFPSA21,RESP046,"(43.682630005, -114.363730042)"
|
|
2012,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,12,,,,2706,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,16,RACE4,CAT4,_RFPSA21,RESP054,"(43.682630005, -114.363730042)"
|
|
2012,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,6,,,,2702,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,16,RACE5,CAT4,_RFPSA21,RESP046,"(43.682630005, -114.363730042)"
|
|
2012,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,14,,,,2707,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,16,RACE5,CAT4,_RFPSA21,RESP054,"(43.682630005, -114.363730042)"
|
|
2012,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,851,43.2,39.5,46.9,2688,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,16,SEX1,CAT2,_RFPSA21,RESP046,"(43.682630005, -114.363730042)"
|
|
2012,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,891,56.8,53.1,60.5,2689,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,16,SEX1,CAT2,_RFPSA21,RESP054,"(43.682630005, -114.363730042)"
|
|
2012,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,37,12.6,8.1,17.2,2710,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,17,AGE06,CAT3,_RFPSA21,RESP046,"(40.485010283, -88.997710178)"
|
|
2012,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,242,87.4,82.9,92,2714,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,17,AGE06,CAT3,_RFPSA21,RESP054,"(40.485010283, -88.997710178)"
|
|
2012,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,206,42.5,36.5,48.4,2711,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,17,AGE07,CAT3,_RFPSA21,RESP046,"(40.485010283, -88.997710178)"
|
|
2012,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,246,57.5,51.6,63.5,2715,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,17,AGE07,CAT3,_RFPSA21,RESP054,"(40.485010283, -88.997710178)"
|
|
2012,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,137,67.1,58.7,75.4,2712,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,17,AGE08,CAT3,_RFPSA21,RESP046,"(40.485010283, -88.997710178)"
|
|
2012,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,71,33,24.6,41.3,2716,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,17,AGE08,CAT3,_RFPSA21,RESP054,"(40.485010283, -88.997710178)"
|
|
2012,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,413,65.3,60.6,69.9,2713,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,17,AGE09,CAT3,_RFPSA21,RESP046,"(40.485010283, -88.997710178)"
|
|
2012,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,226,34.7,30.1,39.4,2717,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,17,AGE09,CAT3,_RFPSA21,RESP054,"(40.485010283, -88.997710178)"
|
|
2012,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,793,43.2,40,46.4,2706,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,17,BO1,CAT1,_RFPSA21,RESP046,"(40.485010283, -88.997710178)"
|
|
2012,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,785,56.8,53.6,60,2707,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,17,BO1,CAT1,_RFPSA21,RESP054,"(40.485010283, -88.997710178)"
|
|
2012,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,42,42.6,29.7,55.5,2728,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,17,EDUCA1,CAT5,_RFPSA21,RESP046,"(40.485010283, -88.997710178)"
|
|
2012,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,52,57.5,44.6,70.4,2732,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,17,EDUCA1,CAT5,_RFPSA21,RESP054,"(40.485010283, -88.997710178)"
|
|
2012,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,243,43.7,37.9,49.5,2729,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,17,EDUCA2,CAT5,_RFPSA21,RESP046,"(40.485010283, -88.997710178)"
|
|
2012,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,215,56.3,50.5,62.1,2733,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,17,EDUCA2,CAT5,_RFPSA21,RESP054,"(40.485010283, -88.997710178)"
|
|
2012,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,165,38.6,32.3,44.8,2730,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,17,EDUCA3,CAT5,_RFPSA21,RESP046,"(40.485010283, -88.997710178)"
|
|
2012,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,196,61.5,55.2,67.7,2734,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,17,EDUCA3,CAT5,_RFPSA21,RESP054,"(40.485010283, -88.997710178)"
|
|
2012,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,343,47,42.1,51.8,2731,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,17,EDUCA4,CAT5,_RFPSA21,RESP046,"(40.485010283, -88.997710178)"
|
|
2012,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,322,53,48.2,57.9,2735,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,17,EDUCA4,CAT5,_RFPSA21,RESP054,"(40.485010283, -88.997710178)"
|
|
2012,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,36,22.9,12.8,32.9,2736,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,17,INCOME1,CAT6,_RFPSA21,RESP046,"(40.485010283, -88.997710178)"
|
|
2012,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,65,77.1,67.1,87.2,2741,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,17,INCOME1,CAT6,_RFPSA21,RESP054,"(40.485010283, -88.997710178)"
|
|
2012,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,91,45.1,34.6,55.6,2737,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,17,INCOME2,CAT6,_RFPSA21,RESP046,"(40.485010283, -88.997710178)"
|
|
2012,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,93,54.9,44.4,65.4,2742,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,17,INCOME2,CAT6,_RFPSA21,RESP054,"(40.485010283, -88.997710178)"
|
|
2012,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,66,45,34.1,56,2738,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,17,INCOME3,CAT6,_RFPSA21,RESP046,"(40.485010283, -88.997710178)"
|
|
2012,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,74,55,44,65.9,2743,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,17,INCOME3,CAT6,_RFPSA21,RESP054,"(40.485010283, -88.997710178)"
|
|
2012,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,128,41.3,33.4,49.2,2739,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,17,INCOME4,CAT6,_RFPSA21,RESP046,"(40.485010283, -88.997710178)"
|
|
2012,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,113,58.7,50.8,66.6,2744,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,17,INCOME4,CAT6,_RFPSA21,RESP054,"(40.485010283, -88.997710178)"
|
|
2012,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,433,46.2,41.9,50.5,2740,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,17,INCOME5,CAT6,_RFPSA21,RESP046,"(40.485010283, -88.997710178)"
|
|
2012,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,402,53.8,49.5,58.1,2745,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,17,INCOME5,CAT6,_RFPSA21,RESP054,"(40.485010283, -88.997710178)"
|
|
2012,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,681,45.6,42.2,49.1,2718,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,17,RACE1,CAT4,_RFPSA21,RESP046,"(40.485010283, -88.997710178)"
|
|
2012,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,636,54.4,50.9,57.8,2723,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,17,RACE1,CAT4,_RFPSA21,RESP054,"(40.485010283, -88.997710178)"
|
|
2012,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,60,40.7,29.7,51.6,2719,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,17,RACE2,CAT4,_RFPSA21,RESP046,"(40.485010283, -88.997710178)"
|
|
2012,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,60,59.4,48.4,70.3,2724,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,17,RACE2,CAT4,_RFPSA21,RESP054,"(40.485010283, -88.997710178)"
|
|
2012,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,21,29.4,16.3,42.6,2720,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,17,RACE3,CAT4,_RFPSA21,RESP046,"(40.485010283, -88.997710178)"
|
|
2012,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,47,70.6,57.4,83.7,2725,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,17,RACE3,CAT4,_RFPSA21,RESP054,"(40.485010283, -88.997710178)"
|
|
2012,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,15,,,,2721,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,17,RACE4,CAT4,_RFPSA21,RESP046,"(40.485010283, -88.997710178)"
|
|
2012,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,29,,,,2726,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,17,RACE4,CAT4,_RFPSA21,RESP054,"(40.485010283, -88.997710178)"
|
|
2012,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,10,,,,2722,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,17,RACE5,CAT4,_RFPSA21,RESP046,"(40.485010283, -88.997710178)"
|
|
2012,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,13,,,,2727,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,17,RACE5,CAT4,_RFPSA21,RESP054,"(40.485010283, -88.997710178)"
|
|
2012,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,793,43.2,40,46.4,2708,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,17,SEX1,CAT2,_RFPSA21,RESP046,"(40.485010283, -88.997710178)"
|
|
2012,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,785,56.8,53.6,60,2709,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,17,SEX1,CAT2,_RFPSA21,RESP054,"(40.485010283, -88.997710178)"
|
|
2012,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,88,20.7,16.2,25.2,2719,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,18,AGE06,CAT3,_RFPSA21,RESP046,"(39.766910452, -86.149960194)"
|
|
2012,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,380,79.3,74.8,83.8,2723,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,18,AGE06,CAT3,_RFPSA21,RESP054,"(39.766910452, -86.149960194)"
|
|
2012,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,296,48.6,43.8,53.3,2720,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,18,AGE07,CAT3,_RFPSA21,RESP046,"(39.766910452, -86.149960194)"
|
|
2012,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,337,51.5,46.7,56.2,2724,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,18,AGE07,CAT3,_RFPSA21,RESP054,"(39.766910452, -86.149960194)"
|
|
2012,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,203,60.6,54.4,66.9,2721,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,18,AGE08,CAT3,_RFPSA21,RESP046,"(39.766910452, -86.149960194)"
|
|
2012,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,135,39.4,33.1,45.6,2725,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,18,AGE08,CAT3,_RFPSA21,RESP054,"(39.766910452, -86.149960194)"
|
|
2012,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,530,65.1,61,69.1,2722,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,18,AGE09,CAT3,_RFPSA21,RESP046,"(39.766910452, -86.149960194)"
|
|
2012,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,311,34.9,30.9,39,2726,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,18,AGE09,CAT3,_RFPSA21,RESP054,"(39.766910452, -86.149960194)"
|
|
2012,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1117,46.6,44,49.1,2715,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,18,BO1,CAT1,_RFPSA21,RESP046,"(39.766910452, -86.149960194)"
|
|
2012,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1163,53.4,50.9,56,2716,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,18,BO1,CAT1,_RFPSA21,RESP054,"(39.766910452, -86.149960194)"
|
|
2012,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,81,39.1,30.8,47.4,2737,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,18,EDUCA1,CAT5,_RFPSA21,RESP046,"(39.766910452, -86.149960194)"
|
|
2012,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,118,60.9,52.6,69.2,2741,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,18,EDUCA1,CAT5,_RFPSA21,RESP054,"(39.766910452, -86.149960194)"
|
|
2012,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,377,44,39.8,48.1,2738,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,18,EDUCA2,CAT5,_RFPSA21,RESP046,"(39.766910452, -86.149960194)"
|
|
2012,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,456,56.1,51.9,60.2,2742,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,18,EDUCA2,CAT5,_RFPSA21,RESP054,"(39.766910452, -86.149960194)"
|
|
2012,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,265,46.9,41.6,52.1,2739,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,18,EDUCA3,CAT5,_RFPSA21,RESP046,"(39.766910452, -86.149960194)"
|
|
2012,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,279,53.2,47.9,58.4,2743,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,18,EDUCA3,CAT5,_RFPSA21,RESP054,"(39.766910452, -86.149960194)"
|
|
2012,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,392,54.4,50,58.9,2740,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,18,EDUCA4,CAT5,_RFPSA21,RESP046,"(39.766910452, -86.149960194)"
|
|
2012,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,307,45.6,41.1,50,2744,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,18,EDUCA4,CAT5,_RFPSA21,RESP054,"(39.766910452, -86.149960194)"
|
|
2012,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,51,24.4,16.2,32.7,2745,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,18,INCOME1,CAT6,_RFPSA21,RESP046,"(39.766910452, -86.149960194)"
|
|
2012,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,134,75.6,67.4,83.9,2750,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,18,INCOME1,CAT6,_RFPSA21,RESP054,"(39.766910452, -86.149960194)"
|
|
2012,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,155,36.4,30.3,42.4,2746,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,18,INCOME2,CAT6,_RFPSA21,RESP046,"(39.766910452, -86.149960194)"
|
|
2012,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,229,63.6,57.6,69.7,2751,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,18,INCOME2,CAT6,_RFPSA21,RESP054,"(39.766910452, -86.149960194)"
|
|
2012,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,121,44,36.4,51.6,2747,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,18,INCOME3,CAT6,_RFPSA21,RESP046,"(39.766910452, -86.149960194)"
|
|
2012,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,119,56,48.4,63.6,2752,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,18,INCOME3,CAT6,_RFPSA21,RESP054,"(39.766910452, -86.149960194)"
|
|
2012,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,189,52.2,45.7,58.6,2748,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,18,INCOME4,CAT6,_RFPSA21,RESP046,"(39.766910452, -86.149960194)"
|
|
2012,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,158,47.9,41.4,54.3,2753,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,18,INCOME4,CAT6,_RFPSA21,RESP054,"(39.766910452, -86.149960194)"
|
|
2012,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,489,51,47,55,2749,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,18,INCOME5,CAT6,_RFPSA21,RESP046,"(39.766910452, -86.149960194)"
|
|
2012,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,427,49,45,53,2754,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,18,INCOME5,CAT6,_RFPSA21,RESP054,"(39.766910452, -86.149960194)"
|
|
2012,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,961,48.1,45.4,50.8,2727,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,18,RACE1,CAT4,_RFPSA21,RESP046,"(39.766910452, -86.149960194)"
|
|
2012,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,946,51.9,49.2,54.6,2732,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,18,RACE1,CAT4,_RFPSA21,RESP054,"(39.766910452, -86.149960194)"
|
|
2012,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,103,43.5,32.5,54.5,2728,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,18,RACE2,CAT4,_RFPSA21,RESP046,"(39.766910452, -86.149960194)"
|
|
2012,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,108,56.5,45.5,67.5,2733,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,18,RACE2,CAT4,_RFPSA21,RESP054,"(39.766910452, -86.149960194)"
|
|
2012,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,12,,,,2729,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,18,RACE3,CAT4,_RFPSA21,RESP046,"(39.766910452, -86.149960194)"
|
|
2012,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,42,78.1,63,93.2,2734,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,18,RACE3,CAT4,_RFPSA21,RESP054,"(39.766910452, -86.149960194)"
|
|
2012,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,8,,,,2730,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,18,RACE4,CAT4,_RFPSA21,RESP046,"(39.766910452, -86.149960194)"
|
|
2012,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,21,,,,2735,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,18,RACE4,CAT4,_RFPSA21,RESP054,"(39.766910452, -86.149960194)"
|
|
2012,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,11,,,,2731,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,18,RACE5,CAT4,_RFPSA21,RESP046,"(39.766910452, -86.149960194)"
|
|
2012,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,23,,,,2736,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,18,RACE5,CAT4,_RFPSA21,RESP054,"(39.766910452, -86.149960194)"
|
|
2012,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1117,46.6,44,49.1,2717,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,18,SEX1,CAT2,_RFPSA21,RESP046,"(39.766910452, -86.149960194)"
|
|
2012,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1163,53.4,50.9,56,2718,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,18,SEX1,CAT2,_RFPSA21,RESP054,"(39.766910452, -86.149960194)"
|
|
2012,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,49,13.8,10,17.7,2709,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,19,AGE06,CAT3,_RFPSA21,RESP046,"(42.469400913, -93.816490556)"
|
|
2012,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,323,86.2,82.3,90.1,2713,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,19,AGE06,CAT3,_RFPSA21,RESP054,"(42.469400913, -93.816490556)"
|
|
2012,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,237,40.7,36.1,45.3,2710,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,19,AGE07,CAT3,_RFPSA21,RESP046,"(42.469400913, -93.816490556)"
|
|
2012,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,310,59.3,54.7,63.9,2714,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,19,AGE07,CAT3,_RFPSA21,RESP054,"(42.469400913, -93.816490556)"
|
|
2012,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,188,60.6,54.6,66.6,2711,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,19,AGE08,CAT3,_RFPSA21,RESP046,"(42.469400913, -93.816490556)"
|
|
2012,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,115,39.4,33.4,45.5,2715,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,19,AGE08,CAT3,_RFPSA21,RESP054,"(42.469400913, -93.816490556)"
|
|
2012,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,527,67.8,64.2,71.3,2712,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,19,AGE09,CAT3,_RFPSA21,RESP046,"(42.469400913, -93.816490556)"
|
|
2012,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,260,32.3,28.7,35.8,2716,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,19,AGE09,CAT3,_RFPSA21,RESP054,"(42.469400913, -93.816490556)"
|
|
2012,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1001,44.4,42,46.9,2705,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,19,BO1,CAT1,_RFPSA21,RESP046,"(42.469400913, -93.816490556)"
|
|
2012,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1008,55.6,53.1,58,2706,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,19,BO1,CAT1,_RFPSA21,RESP054,"(42.469400913, -93.816490556)"
|
|
2012,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,70,50.1,40.7,59.5,2727,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,19,EDUCA1,CAT5,_RFPSA21,RESP046,"(42.469400913, -93.816490556)"
|
|
2012,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,70,49.9,40.5,59.3,2731,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,19,EDUCA1,CAT5,_RFPSA21,RESP054,"(42.469400913, -93.816490556)"
|
|
2012,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,315,40.6,36.6,44.6,2728,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,19,EDUCA2,CAT5,_RFPSA21,RESP046,"(42.469400913, -93.816490556)"
|
|
2012,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,376,59.4,55.4,63.4,2732,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,19,EDUCA2,CAT5,_RFPSA21,RESP054,"(42.469400913, -93.816490556)"
|
|
2012,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,253,44.4,39.6,49.1,2729,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,19,EDUCA3,CAT5,_RFPSA21,RESP046,"(42.469400913, -93.816490556)"
|
|
2012,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,259,55.6,50.9,60.4,2733,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,19,EDUCA3,CAT5,_RFPSA21,RESP054,"(42.469400913, -93.816490556)"
|
|
2012,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,361,47.7,43.5,52,2730,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,19,EDUCA4,CAT5,_RFPSA21,RESP046,"(42.469400913, -93.816490556)"
|
|
2012,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,301,52.3,48,56.5,2734,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,19,EDUCA4,CAT5,_RFPSA21,RESP054,"(42.469400913, -93.816490556)"
|
|
2012,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,42,31.7,22.4,41,2735,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,19,INCOME1,CAT6,_RFPSA21,RESP046,"(42.469400913, -93.816490556)"
|
|
2012,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,79,68.3,59,77.6,2740,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,19,INCOME1,CAT6,_RFPSA21,RESP054,"(42.469400913, -93.816490556)"
|
|
2012,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,112,41.4,34.4,48.4,2736,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,19,INCOME2,CAT6,_RFPSA21,RESP046,"(42.469400913, -93.816490556)"
|
|
2012,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,133,58.6,51.7,65.6,2741,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,19,INCOME2,CAT6,_RFPSA21,RESP054,"(42.469400913, -93.816490556)"
|
|
2012,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,108,43.4,35.6,51.2,2737,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,19,INCOME3,CAT6,_RFPSA21,RESP046,"(42.469400913, -93.816490556)"
|
|
2012,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,106,56.6,48.8,64.4,2742,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,19,INCOME3,CAT6,_RFPSA21,RESP054,"(42.469400913, -93.816490556)"
|
|
2012,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,185,51,44.8,57.1,2738,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,19,INCOME4,CAT6,_RFPSA21,RESP046,"(42.469400913, -93.816490556)"
|
|
2012,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,144,49,42.9,55.2,2743,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,19,INCOME4,CAT6,_RFPSA21,RESP054,"(42.469400913, -93.816490556)"
|
|
2012,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,488,45.5,42,49.1,2739,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,19,INCOME5,CAT6,_RFPSA21,RESP046,"(42.469400913, -93.816490556)"
|
|
2012,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,464,54.5,50.9,58,2744,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,19,INCOME5,CAT6,_RFPSA21,RESP054,"(42.469400913, -93.816490556)"
|
|
2012,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,960,45.3,42.7,47.8,2717,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,19,RACE1,CAT4,_RFPSA21,RESP046,"(42.469400913, -93.816490556)"
|
|
2012,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,933,54.7,52.2,57.3,2722,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,19,RACE1,CAT4,_RFPSA21,RESP054,"(42.469400913, -93.816490556)"
|
|
2012,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,10,,,,2718,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,19,RACE2,CAT4,_RFPSA21,RESP046,"(42.469400913, -93.816490556)"
|
|
2012,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,9,,,,2723,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,19,RACE2,CAT4,_RFPSA21,RESP054,"(42.469400913, -93.816490556)"
|
|
2012,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,12,,,,2719,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,19,RACE3,CAT4,_RFPSA21,RESP046,"(42.469400913, -93.816490556)"
|
|
2012,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,26,,,,2724,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,19,RACE3,CAT4,_RFPSA21,RESP054,"(42.469400913, -93.816490556)"
|
|
2012,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,7,,,,2720,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,19,RACE4,CAT4,_RFPSA21,RESP046,"(42.469400913, -93.816490556)"
|
|
2012,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,22,,,,2725,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,19,RACE4,CAT4,_RFPSA21,RESP054,"(42.469400913, -93.816490556)"
|
|
2012,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,8,,,,2721,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,19,RACE5,CAT4,_RFPSA21,RESP046,"(42.469400913, -93.816490556)"
|
|
2012,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,11,,,,2726,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,19,RACE5,CAT4,_RFPSA21,RESP054,"(42.469400913, -93.816490556)"
|
|
2012,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1001,44.4,42,46.9,2707,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,19,SEX1,CAT2,_RFPSA21,RESP046,"(42.469400913, -93.816490556)"
|
|
2012,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1008,55.6,53.1,58,2708,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,19,SEX1,CAT2,_RFPSA21,RESP054,"(42.469400913, -93.816490556)"
|
|
2012,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,136,22.4,18.4,26.3,2725,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,AGE06,CAT3,_RFPSA21,RESP046,"(38.3477403, -98.200781227)"
|
|
2012,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,427,77.6,73.7,81.6,2729,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,AGE06,CAT3,_RFPSA21,RESP054,"(38.3477403, -98.200781227)"
|
|
2012,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,470,48.6,44.5,52.8,2726,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,AGE07,CAT3,_RFPSA21,RESP046,"(38.3477403, -98.200781227)"
|
|
2012,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,429,51.4,47.2,55.5,2730,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,AGE07,CAT3,_RFPSA21,RESP054,"(38.3477403, -98.200781227)"
|
|
2012,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,340,66.2,61.3,71.2,2727,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,AGE08,CAT3,_RFPSA21,RESP046,"(38.3477403, -98.200781227)"
|
|
2012,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,164,33.8,28.8,38.7,2731,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,AGE08,CAT3,_RFPSA21,RESP054,"(38.3477403, -98.200781227)"
|
|
2012,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,985,76,73.3,78.7,2728,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,AGE09,CAT3,_RFPSA21,RESP046,"(38.3477403, -98.200781227)"
|
|
2012,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,311,24,21.3,26.7,2732,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,AGE09,CAT3,_RFPSA21,RESP054,"(38.3477403, -98.200781227)"
|
|
2012,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1931,52.3,50.1,54.5,2721,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,BO1,CAT1,_RFPSA21,RESP046,"(38.3477403, -98.200781227)"
|
|
2012,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1331,47.7,45.5,49.9,2722,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,BO1,CAT1,_RFPSA21,RESP054,"(38.3477403, -98.200781227)"
|
|
2012,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,82,39.6,30.1,49,2743,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,EDUCA1,CAT5,_RFPSA21,RESP046,"(38.3477403, -98.200781227)"
|
|
2012,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,81,60.4,51,69.9,2747,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,EDUCA1,CAT5,_RFPSA21,RESP054,"(38.3477403, -98.200781227)"
|
|
2012,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,496,46.9,43,50.8,2744,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,EDUCA2,CAT5,_RFPSA21,RESP046,"(38.3477403, -98.200781227)"
|
|
2012,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,411,53.1,49.3,57,2748,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,EDUCA2,CAT5,_RFPSA21,RESP054,"(38.3477403, -98.200781227)"
|
|
2012,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,487,54.8,50.8,58.9,2745,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,EDUCA3,CAT5,_RFPSA21,RESP046,"(38.3477403, -98.200781227)"
|
|
2012,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,335,45.2,41.1,49.2,2749,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,EDUCA3,CAT5,_RFPSA21,RESP054,"(38.3477403, -98.200781227)"
|
|
2012,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,864,59,55.8,62.2,2746,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,EDUCA4,CAT5,_RFPSA21,RESP046,"(38.3477403, -98.200781227)"
|
|
2012,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,503,41,37.8,44.3,2750,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,EDUCA4,CAT5,_RFPSA21,RESP054,"(38.3477403, -98.200781227)"
|
|
2012,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,70,28.6,20.3,36.9,2751,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,INCOME1,CAT6,_RFPSA21,RESP046,"(38.3477403, -98.200781227)"
|
|
2012,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,115,71.4,63.1,79.7,2756,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,INCOME1,CAT6,_RFPSA21,RESP054,"(38.3477403, -98.200781227)"
|
|
2012,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,239,47.4,40.8,53.9,2752,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,INCOME2,CAT6,_RFPSA21,RESP046,"(38.3477403, -98.200781227)"
|
|
2012,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,181,52.6,46.1,59.2,2757,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,INCOME2,CAT6,_RFPSA21,RESP054,"(38.3477403, -98.200781227)"
|
|
2012,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,215,52.2,45.9,58.5,2753,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,INCOME3,CAT6,_RFPSA21,RESP046,"(38.3477403, -98.200781227)"
|
|
2012,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,156,47.8,41.5,54.1,2758,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,INCOME3,CAT6,_RFPSA21,RESP054,"(38.3477403, -98.200781227)"
|
|
2012,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,311,53.1,47.6,58.6,2754,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,INCOME4,CAT6,_RFPSA21,RESP046,"(38.3477403, -98.200781227)"
|
|
2012,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,202,46.9,41.5,52.4,2759,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,INCOME4,CAT6,_RFPSA21,RESP054,"(38.3477403, -98.200781227)"
|
|
2012,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,952,57,54,60.1,2755,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,INCOME5,CAT6,_RFPSA21,RESP046,"(38.3477403, -98.200781227)"
|
|
2012,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,558,43,39.9,46,2760,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,INCOME5,CAT6,_RFPSA21,RESP054,"(38.3477403, -98.200781227)"
|
|
2012,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1755,54.4,52.3,56.6,2733,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,RACE1,CAT4,_RFPSA21,RESP046,"(38.3477403, -98.200781227)"
|
|
2012,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1180,45.6,43.4,47.7,2738,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,RACE1,CAT4,_RFPSA21,RESP054,"(38.3477403, -98.200781227)"
|
|
2012,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,73,57.2,45,69.4,2734,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,RACE2,CAT4,_RFPSA21,RESP046,"(38.3477403, -98.200781227)"
|
|
2012,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,48,42.8,30.6,55,2739,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,RACE2,CAT4,_RFPSA21,RESP054,"(38.3477403, -98.200781227)"
|
|
2012,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,39,34.2,22.6,45.8,2735,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,RACE3,CAT4,_RFPSA21,RESP046,"(38.3477403, -98.200781227)"
|
|
2012,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,43,65.8,54.2,77.4,2740,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,RACE3,CAT4,_RFPSA21,RESP054,"(38.3477403, -98.200781227)"
|
|
2012,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,37,43,28.5,57.6,2736,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,RACE4,CAT4,_RFPSA21,RESP046,"(38.3477403, -98.200781227)"
|
|
2012,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,31,57,42.4,71.5,2741,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,RACE4,CAT4,_RFPSA21,RESP054,"(38.3477403, -98.200781227)"
|
|
2012,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,21,,,,2737,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,20,RACE5,CAT4,_RFPSA21,RESP046,"(38.3477403, -98.200781227)"
|
|
2012,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,22,,,,2742,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,20,RACE5,CAT4,_RFPSA21,RESP054,"(38.3477403, -98.200781227)"
|
|
2012,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1931,52.3,50.1,54.5,2723,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,SEX1,CAT2,_RFPSA21,RESP046,"(38.3477403, -98.200781227)"
|
|
2012,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1331,47.7,45.5,49.9,2724,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,SEX1,CAT2,_RFPSA21,RESP054,"(38.3477403, -98.200781227)"
|
|
2012,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,127,22.6,17.8,27.4,2723,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,21,AGE06,CAT3,_RFPSA21,RESP046,"(37.645970271, -84.774971048)"
|
|
2012,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,415,77.4,72.6,82.2,2727,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,21,AGE06,CAT3,_RFPSA21,RESP054,"(37.645970271, -84.774971048)"
|
|
2012,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,374,42.3,37.4,47.1,2724,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,21,AGE07,CAT3,_RFPSA21,RESP046,"(37.645970271, -84.774971048)"
|
|
2012,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,458,57.7,52.9,62.6,2728,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,21,AGE07,CAT3,_RFPSA21,RESP054,"(37.645970271, -84.774971048)"
|
|
2012,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,278,59.2,52.6,65.8,2725,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,21,AGE08,CAT3,_RFPSA21,RESP046,"(37.645970271, -84.774971048)"
|
|
2012,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,183,40.8,34.2,47.4,2729,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,21,AGE08,CAT3,_RFPSA21,RESP054,"(37.645970271, -84.774971048)"
|
|
2012,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,625,65.2,60.5,69.8,2726,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,21,AGE09,CAT3,_RFPSA21,RESP046,"(37.645970271, -84.774971048)"
|
|
2012,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,311,34.8,30.2,39.5,2730,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,21,AGE09,CAT3,_RFPSA21,RESP054,"(37.645970271, -84.774971048)"
|
|
2012,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1404,45,42.3,47.7,2719,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,21,BO1,CAT1,_RFPSA21,RESP046,"(37.645970271, -84.774971048)"
|
|
2012,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1367,55,52.3,57.7,2720,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,21,BO1,CAT1,_RFPSA21,RESP054,"(37.645970271, -84.774971048)"
|
|
2012,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,134,32.4,26.1,38.7,2741,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,21,EDUCA1,CAT5,_RFPSA21,RESP046,"(37.645970271, -84.774971048)"
|
|
2012,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,238,67.6,61.3,74,2745,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,21,EDUCA1,CAT5,_RFPSA21,RESP054,"(37.645970271, -84.774971048)"
|
|
2012,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,480,43.8,39.4,48.2,2742,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,21,EDUCA2,CAT5,_RFPSA21,RESP046,"(37.645970271, -84.774971048)"
|
|
2012,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,517,56.2,51.9,60.6,2746,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,21,EDUCA2,CAT5,_RFPSA21,RESP054,"(37.645970271, -84.774971048)"
|
|
2012,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,339,49.4,44,54.9,2743,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,21,EDUCA3,CAT5,_RFPSA21,RESP046,"(37.645970271, -84.774971048)"
|
|
2012,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,310,50.6,45.2,56.1,2747,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,21,EDUCA3,CAT5,_RFPSA21,RESP054,"(37.645970271, -84.774971048)"
|
|
2012,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,450,54.7,49.8,59.6,2744,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,21,EDUCA4,CAT5,_RFPSA21,RESP046,"(37.645970271, -84.774971048)"
|
|
2012,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,300,45.3,40.4,50.2,2748,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,21,EDUCA4,CAT5,_RFPSA21,RESP054,"(37.645970271, -84.774971048)"
|
|
2012,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,89,26.5,19,33.9,2749,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,21,INCOME1,CAT6,_RFPSA21,RESP046,"(37.645970271, -84.774971048)"
|
|
2012,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,244,73.5,66.1,81,2754,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,21,INCOME1,CAT6,_RFPSA21,RESP054,"(37.645970271, -84.774971048)"
|
|
2012,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,201,38,31.5,44.5,2750,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,21,INCOME2,CAT6,_RFPSA21,RESP046,"(37.645970271, -84.774971048)"
|
|
2012,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,263,62,55.5,68.6,2755,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,21,INCOME2,CAT6,_RFPSA21,RESP054,"(37.645970271, -84.774971048)"
|
|
2012,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,163,43.7,35.6,51.8,2751,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,21,INCOME3,CAT6,_RFPSA21,RESP046,"(37.645970271, -84.774971048)"
|
|
2012,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,137,56.3,48.2,64.4,2756,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,21,INCOME3,CAT6,_RFPSA21,RESP054,"(37.645970271, -84.774971048)"
|
|
2012,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,226,49.3,42.6,56,2752,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,21,INCOME4,CAT6,_RFPSA21,RESP046,"(37.645970271, -84.774971048)"
|
|
2012,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,179,50.7,44,57.4,2757,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,21,INCOME4,CAT6,_RFPSA21,RESP054,"(37.645970271, -84.774971048)"
|
|
2012,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,610,51.9,47.6,56.2,2753,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,21,INCOME5,CAT6,_RFPSA21,RESP046,"(37.645970271, -84.774971048)"
|
|
2012,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,423,48.1,43.8,52.4,2758,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,21,INCOME5,CAT6,_RFPSA21,RESP054,"(37.645970271, -84.774971048)"
|
|
2012,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1210,44.8,42,47.6,2731,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,21,RACE1,CAT4,_RFPSA21,RESP046,"(37.645970271, -84.774971048)"
|
|
2012,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1166,55.2,52.5,58,2736,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,21,RACE1,CAT4,_RFPSA21,RESP054,"(37.645970271, -84.774971048)"
|
|
2012,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,112,51.1,38.3,63.9,2732,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,21,RACE2,CAT4,_RFPSA21,RESP046,"(37.645970271, -84.774971048)"
|
|
2012,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,93,48.9,36.2,61.7,2737,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,21,RACE2,CAT4,_RFPSA21,RESP054,"(37.645970271, -84.774971048)"
|
|
2012,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,18,,,,2733,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,21,RACE3,CAT4,_RFPSA21,RESP046,"(37.645970271, -84.774971048)"
|
|
2012,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,24,,,,2738,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,21,RACE3,CAT4,_RFPSA21,RESP054,"(37.645970271, -84.774971048)"
|
|
2012,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,19,,,,2734,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,21,RACE4,CAT4,_RFPSA21,RESP046,"(37.645970271, -84.774971048)"
|
|
2012,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,32,63.5,40.7,86.4,2739,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,21,RACE4,CAT4,_RFPSA21,RESP054,"(37.645970271, -84.774971048)"
|
|
2012,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,29,46.2,30.1,62.3,2735,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,21,RACE5,CAT4,_RFPSA21,RESP046,"(37.645970271, -84.774971048)"
|
|
2012,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,34,53.8,37.7,69.9,2740,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,21,RACE5,CAT4,_RFPSA21,RESP054,"(37.645970271, -84.774971048)"
|
|
2012,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1404,45,42.3,47.7,2721,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,21,SEX1,CAT2,_RFPSA21,RESP046,"(37.645970271, -84.774971048)"
|
|
2012,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1367,55,52.3,57.7,2722,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,21,SEX1,CAT2,_RFPSA21,RESP054,"(37.645970271, -84.774971048)"
|
|
2012,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,99,25.5,19.7,31.3,2723,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,22,AGE06,CAT3,_RFPSA21,RESP046,"(31.312660644, -92.445680071)"
|
|
2012,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,274,74.5,68.7,80.3,2727,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,22,AGE06,CAT3,_RFPSA21,RESP054,"(31.312660644, -92.445680071)"
|
|
2012,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,290,50.2,44.4,56,2724,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,22,AGE07,CAT3,_RFPSA21,RESP046,"(31.312660644, -92.445680071)"
|
|
2012,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,264,49.8,44.1,55.6,2728,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,22,AGE07,CAT3,_RFPSA21,RESP054,"(31.312660644, -92.445680071)"
|
|
2012,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,229,64.1,56.8,71.3,2725,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,22,AGE08,CAT3,_RFPSA21,RESP046,"(31.312660644, -92.445680071)"
|
|
2012,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,119,35.9,28.7,43.2,2729,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,22,AGE08,CAT3,_RFPSA21,RESP054,"(31.312660644, -92.445680071)"
|
|
2012,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,580,68.7,63.9,73.4,2726,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,22,AGE09,CAT3,_RFPSA21,RESP046,"(31.312660644, -92.445680071)"
|
|
2012,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,248,31.4,26.6,36.1,2730,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,22,AGE09,CAT3,_RFPSA21,RESP054,"(31.312660644, -92.445680071)"
|
|
2012,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1198,49.6,46.5,52.7,2719,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,22,BO1,CAT1,_RFPSA21,RESP046,"(31.312660644, -92.445680071)"
|
|
2012,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,905,50.4,47.3,53.5,2720,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,22,BO1,CAT1,_RFPSA21,RESP054,"(31.312660644, -92.445680071)"
|
|
2012,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,119,34.4,26.3,42.4,2741,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,22,EDUCA1,CAT5,_RFPSA21,RESP046,"(31.312660644, -92.445680071)"
|
|
2012,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,174,65.6,57.6,73.7,2745,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,22,EDUCA1,CAT5,_RFPSA21,RESP054,"(31.312660644, -92.445680071)"
|
|
2012,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,386,51.1,45.9,56.3,2742,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,22,EDUCA2,CAT5,_RFPSA21,RESP046,"(31.312660644, -92.445680071)"
|
|
2012,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,334,48.9,43.7,54.1,2746,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,22,EDUCA2,CAT5,_RFPSA21,RESP054,"(31.312660644, -92.445680071)"
|
|
2012,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,300,50.9,45,56.8,2743,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,22,EDUCA3,CAT5,_RFPSA21,RESP046,"(31.312660644, -92.445680071)"
|
|
2012,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,194,49.1,43.2,55,2747,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,22,EDUCA3,CAT5,_RFPSA21,RESP054,"(31.312660644, -92.445680071)"
|
|
2012,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,393,61.7,56.4,67,2744,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,22,EDUCA4,CAT5,_RFPSA21,RESP046,"(31.312660644, -92.445680071)"
|
|
2012,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,202,38.3,33,43.6,2748,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,22,EDUCA4,CAT5,_RFPSA21,RESP054,"(31.312660644, -92.445680071)"
|
|
2012,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,83,34.1,23.4,44.7,2749,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,22,INCOME1,CAT6,_RFPSA21,RESP046,"(31.312660644, -92.445680071)"
|
|
2012,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,141,65.9,55.3,76.6,2754,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,22,INCOME1,CAT6,_RFPSA21,RESP054,"(31.312660644, -92.445680071)"
|
|
2012,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,184,41.6,34.1,49.1,2750,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,22,INCOME2,CAT6,_RFPSA21,RESP046,"(31.312660644, -92.445680071)"
|
|
2012,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,188,58.4,50.9,65.9,2755,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,22,INCOME2,CAT6,_RFPSA21,RESP054,"(31.312660644, -92.445680071)"
|
|
2012,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,139,55.2,45.2,65.2,2751,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,22,INCOME3,CAT6,_RFPSA21,RESP046,"(31.312660644, -92.445680071)"
|
|
2012,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,85,44.8,34.8,54.8,2756,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,22,INCOME3,CAT6,_RFPSA21,RESP054,"(31.312660644, -92.445680071)"
|
|
2012,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,163,61.9,52.5,71.3,2752,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,22,INCOME4,CAT6,_RFPSA21,RESP046,"(31.312660644, -92.445680071)"
|
|
2012,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,77,38.1,28.7,47.5,2757,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,22,INCOME4,CAT6,_RFPSA21,RESP054,"(31.312660644, -92.445680071)"
|
|
2012,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,494,53.7,49,58.3,2753,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,22,INCOME5,CAT6,_RFPSA21,RESP046,"(31.312660644, -92.445680071)"
|
|
2012,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,310,46.4,41.7,51,2758,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,22,INCOME5,CAT6,_RFPSA21,RESP054,"(31.312660644, -92.445680071)"
|
|
2012,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,916,53.9,50.3,57.6,2731,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,22,RACE1,CAT4,_RFPSA21,RESP046,"(31.312660644, -92.445680071)"
|
|
2012,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,575,46.1,42.4,49.7,2736,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,22,RACE1,CAT4,_RFPSA21,RESP054,"(31.312660644, -92.445680071)"
|
|
2012,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,228,38.8,32.4,45.3,2732,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,22,RACE2,CAT4,_RFPSA21,RESP046,"(31.312660644, -92.445680071)"
|
|
2012,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,275,61.2,54.7,67.6,2737,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,22,RACE2,CAT4,_RFPSA21,RESP054,"(31.312660644, -92.445680071)"
|
|
2012,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,12,,,,2733,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,22,RACE3,CAT4,_RFPSA21,RESP046,"(31.312660644, -92.445680071)"
|
|
2012,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,20,,,,2738,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,22,RACE3,CAT4,_RFPSA21,RESP054,"(31.312660644, -92.445680071)"
|
|
2012,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,21,,,,2734,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,22,RACE4,CAT4,_RFPSA21,RESP046,"(31.312660644, -92.445680071)"
|
|
2012,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,25,,,,2739,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,22,RACE4,CAT4,_RFPSA21,RESP054,"(31.312660644, -92.445680071)"
|
|
2012,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,14,,,,2735,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,22,RACE5,CAT4,_RFPSA21,RESP046,"(31.312660644, -92.445680071)"
|
|
2012,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,7,,,,2740,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,22,RACE5,CAT4,_RFPSA21,RESP054,"(31.312660644, -92.445680071)"
|
|
2012,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1198,49.6,46.5,52.7,2721,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,22,SEX1,CAT2,_RFPSA21,RESP046,"(31.312660644, -92.445680071)"
|
|
2012,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,905,50.4,47.3,53.5,2722,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,22,SEX1,CAT2,_RFPSA21,RESP054,"(31.312660644, -92.445680071)"
|
|
2012,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1723,60.2,58.2,62.2,2705,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,23,BO1,CAT1,_RFPSA21,RESP054,"(45.254228894001, -68.985031336)"
|
|
2012,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,53,31.6,23.5,39.7,2726,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,23,EDUCA1,CAT5,_RFPSA21,RESP046,"(45.254228894001, -68.985031336)"
|
|
2012,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,82,13.3,10.2,16.4,2708,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,23,AGE06,CAT3,_RFPSA21,RESP046,"(45.254228894001, -68.985031336)"
|
|
2012,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,544,86.7,83.6,89.8,2712,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,23,AGE06,CAT3,_RFPSA21,RESP054,"(45.254228894001, -68.985031336)"
|
|
2012,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,319,38.1,34.3,41.9,2709,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,23,AGE07,CAT3,_RFPSA21,RESP046,"(45.254228894001, -68.985031336)"
|
|
2012,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,506,61.9,58.1,65.7,2713,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,23,AGE07,CAT3,_RFPSA21,RESP054,"(45.254228894001, -68.985031336)"
|
|
2012,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,241,55.1,49.6,60.5,2710,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,23,AGE08,CAT3,_RFPSA21,RESP046,"(45.254228894001, -68.985031336)"
|
|
2012,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,202,45,39.5,50.4,2714,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,23,AGE08,CAT3,_RFPSA21,RESP054,"(45.254228894001, -68.985031336)"
|
|
2012,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,653,58.9,55.4,62.3,2711,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,23,AGE09,CAT3,_RFPSA21,RESP046,"(45.254228894001, -68.985031336)"
|
|
2012,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,471,41.1,37.7,44.6,2715,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,23,AGE09,CAT3,_RFPSA21,RESP054,"(45.254228894001, -68.985031336)"
|
|
2012,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1295,39.8,37.8,41.9,2704,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,23,BO1,CAT1,_RFPSA21,RESP046,"(45.254228894001, -68.985031336)"
|
|
2012,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,116,68.4,60.3,76.5,2730,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,23,EDUCA1,CAT5,_RFPSA21,RESP054,"(45.254228894001, -68.985031336)"
|
|
2012,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,375,37.4,33.9,40.8,2727,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,23,EDUCA2,CAT5,_RFPSA21,RESP046,"(45.254228894001, -68.985031336)"
|
|
2012,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,601,62.7,59.2,66.1,2731,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,23,EDUCA2,CAT5,_RFPSA21,RESP054,"(45.254228894001, -68.985031336)"
|
|
2012,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,324,41,37,45,2728,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,23,EDUCA3,CAT5,_RFPSA21,RESP046,"(45.254228894001, -68.985031336)"
|
|
2012,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,403,59,55,63.1,2732,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,23,EDUCA3,CAT5,_RFPSA21,RESP054,"(45.254228894001, -68.985031336)"
|
|
2012,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,540,44.9,41.7,48.2,2729,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,23,EDUCA4,CAT5,_RFPSA21,RESP046,"(45.254228894001, -68.985031336)"
|
|
2012,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,603,55.1,51.8,58.3,2733,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,23,EDUCA4,CAT5,_RFPSA21,RESP054,"(45.254228894001, -68.985031336)"
|
|
2012,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,84,31.2,23.7,38.6,2734,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,23,INCOME1,CAT6,_RFPSA21,RESP046,"(45.254228894001, -68.985031336)"
|
|
2012,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,181,68.8,61.4,76.3,2739,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,23,INCOME1,CAT6,_RFPSA21,RESP054,"(45.254228894001, -68.985031336)"
|
|
2012,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,151,29.9,25,34.9,2735,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,23,INCOME2,CAT6,_RFPSA21,RESP046,"(45.254228894001, -68.985031336)"
|
|
2012,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,291,70.1,65.1,75,2740,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,23,INCOME2,CAT6,_RFPSA21,RESP054,"(45.254228894001, -68.985031336)"
|
|
2012,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,144,44.9,38.4,51.5,2736,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,23,INCOME3,CAT6,_RFPSA21,RESP046,"(45.254228894001, -68.985031336)"
|
|
2012,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,176,55.1,48.5,61.6,2741,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,23,INCOME3,CAT6,_RFPSA21,RESP054,"(45.254228894001, -68.985031336)"
|
|
2012,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,221,40.3,35.3,45.3,2737,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,23,INCOME4,CAT6,_RFPSA21,RESP046,"(45.254228894001, -68.985031336)"
|
|
2012,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,281,59.7,54.7,64.7,2742,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,23,INCOME4,CAT6,_RFPSA21,RESP054,"(45.254228894001, -68.985031336)"
|
|
2012,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,604,43.5,40.4,46.7,2738,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,23,INCOME5,CAT6,_RFPSA21,RESP046,"(45.254228894001, -68.985031336)"
|
|
2012,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,674,56.5,53.3,59.6,2743,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,23,INCOME5,CAT6,_RFPSA21,RESP054,"(45.254228894001, -68.985031336)"
|
|
2012,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1224,39.9,37.8,42.1,2716,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,23,RACE1,CAT4,_RFPSA21,RESP046,"(45.254228894001, -68.985031336)"
|
|
2012,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1604,60.1,58,62.2,2721,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,23,RACE1,CAT4,_RFPSA21,RESP054,"(45.254228894001, -68.985031336)"
|
|
2012,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,8,,,,2717,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,23,RACE2,CAT4,_RFPSA21,RESP046,"(45.254228894001, -68.985031336)"
|
|
2012,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,7,,,,2722,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,23,RACE2,CAT4,_RFPSA21,RESP054,"(45.254228894001, -68.985031336)"
|
|
2012,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,14,,,,2718,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,23,RACE3,CAT4,_RFPSA21,RESP046,"(45.254228894001, -68.985031336)"
|
|
2012,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,13,,,,2723,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,23,RACE3,CAT4,_RFPSA21,RESP054,"(45.254228894001, -68.985031336)"
|
|
2012,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,17,,,,2719,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,23,RACE4,CAT4,_RFPSA21,RESP046,"(45.254228894001, -68.985031336)"
|
|
2012,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,27,,,,2724,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,23,RACE4,CAT4,_RFPSA21,RESP054,"(45.254228894001, -68.985031336)"
|
|
2012,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,11,,,,2720,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,23,RACE5,CAT4,_RFPSA21,RESP046,"(45.254228894001, -68.985031336)"
|
|
2012,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,30,,,,2725,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,23,RACE5,CAT4,_RFPSA21,RESP054,"(45.254228894001, -68.985031336)"
|
|
2012,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1295,39.8,37.8,41.9,2706,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,23,SEX1,CAT2,_RFPSA21,RESP046,"(45.254228894001, -68.985031336)"
|
|
2012,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1723,60.2,58.2,62.2,2707,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,23,SEX1,CAT2,_RFPSA21,RESP054,"(45.254228894001, -68.985031336)"
|
|
2012,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,579,74.9,70.3,79.6,2726,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,AGE06,CAT3,_RFPSA21,RESP054,"(39.290580964, -76.609260111)"
|
|
2012,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,184,25.1,20.4,29.7,2722,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,AGE06,CAT3,_RFPSA21,RESP046,"(39.290580964, -76.609260111)"
|
|
2012,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,493,47.6,42.8,52.3,2723,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,AGE07,CAT3,_RFPSA21,RESP046,"(39.290580964, -76.609260111)"
|
|
2012,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,444,52.5,47.7,57.2,2727,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,AGE07,CAT3,_RFPSA21,RESP054,"(39.290580964, -76.609260111)"
|
|
2012,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,346,61.6,55.1,68.2,2724,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,AGE08,CAT3,_RFPSA21,RESP046,"(39.290580964, -76.609260111)"
|
|
2012,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,180,38.4,31.8,44.9,2728,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,AGE08,CAT3,_RFPSA21,RESP054,"(39.290580964, -76.609260111)"
|
|
2012,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,959,70.5,66.6,74.5,2725,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,AGE09,CAT3,_RFPSA21,RESP046,"(39.290580964, -76.609260111)"
|
|
2012,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,392,29.5,25.5,33.4,2729,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,AGE09,CAT3,_RFPSA21,RESP054,"(39.290580964, -76.609260111)"
|
|
2012,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1982,48.9,46.4,51.4,2718,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,BO1,CAT1,_RFPSA21,RESP046,"(39.290580964, -76.609260111)"
|
|
2012,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1595,51.1,48.6,53.6,2719,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,BO1,CAT1,_RFPSA21,RESP054,"(39.290580964, -76.609260111)"
|
|
2012,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,95,38.7,29.1,48.3,2740,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,EDUCA1,CAT5,_RFPSA21,RESP046,"(39.290580964, -76.609260111)"
|
|
2012,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,137,61.3,51.7,70.9,2744,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,EDUCA1,CAT5,_RFPSA21,RESP054,"(39.290580964, -76.609260111)"
|
|
2012,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,428,47.1,41.9,52.3,2741,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,EDUCA2,CAT5,_RFPSA21,RESP046,"(39.290580964, -76.609260111)"
|
|
2012,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,422,52.9,47.7,58.1,2745,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,EDUCA2,CAT5,_RFPSA21,RESP054,"(39.290580964, -76.609260111)"
|
|
2012,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,416,48.7,43.5,53.9,2742,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,EDUCA3,CAT5,_RFPSA21,RESP046,"(39.290580964, -76.609260111)"
|
|
2012,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,336,51.3,46.1,56.5,2746,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,EDUCA3,CAT5,_RFPSA21,RESP054,"(39.290580964, -76.609260111)"
|
|
2012,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,1040,53.6,50.1,57,2743,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,EDUCA4,CAT5,_RFPSA21,RESP046,"(39.290580964, -76.609260111)"
|
|
2012,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,697,46.5,43,49.9,2747,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,EDUCA4,CAT5,_RFPSA21,RESP054,"(39.290580964, -76.609260111)"
|
|
2012,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,56,20.5,12.3,28.6,2748,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,INCOME1,CAT6,_RFPSA21,RESP046,"(39.290580964, -76.609260111)"
|
|
2012,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,97,79.5,71.4,87.7,2753,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,INCOME1,CAT6,_RFPSA21,RESP054,"(39.290580964, -76.609260111)"
|
|
2012,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,160,42.5,33.5,51.5,2749,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,INCOME2,CAT6,_RFPSA21,RESP046,"(39.290580964, -76.609260111)"
|
|
2012,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,181,57.6,48.6,66.6,2754,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,INCOME2,CAT6,_RFPSA21,RESP054,"(39.290580964, -76.609260111)"
|
|
2012,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,151,43.9,34.1,53.7,2750,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,INCOME3,CAT6,_RFPSA21,RESP046,"(39.290580964, -76.609260111)"
|
|
2012,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,118,56.1,46.3,65.9,2755,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,INCOME3,CAT6,_RFPSA21,RESP054,"(39.290580964, -76.609260111)"
|
|
2012,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,220,45.8,37.4,54.2,2751,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,INCOME4,CAT6,_RFPSA21,RESP046,"(39.290580964, -76.609260111)"
|
|
2012,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,162,54.2,45.8,62.6,2756,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,INCOME4,CAT6,_RFPSA21,RESP054,"(39.290580964, -76.609260111)"
|
|
2012,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,1185,52.4,49.2,55.6,2752,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,INCOME5,CAT6,_RFPSA21,RESP046,"(39.290580964, -76.609260111)"
|
|
2012,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,886,47.6,44.4,50.8,2757,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,INCOME5,CAT6,_RFPSA21,RESP054,"(39.290580964, -76.609260111)"
|
|
2012,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1555,50.3,47.6,53,2730,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,RACE1,CAT4,_RFPSA21,RESP046,"(39.290580964, -76.609260111)"
|
|
2012,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1207,49.7,47.1,52.4,2735,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,RACE1,CAT4,_RFPSA21,RESP054,"(39.290580964, -76.609260111)"
|
|
2012,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,282,48.4,42.6,54.2,2731,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,RACE2,CAT4,_RFPSA21,RESP046,"(39.290580964, -76.609260111)"
|
|
2012,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,247,51.6,45.8,57.4,2736,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,RACE2,CAT4,_RFPSA21,RESP054,"(39.290580964, -76.609260111)"
|
|
2012,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,27,42.7,25.3,60.2,2732,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,RACE3,CAT4,_RFPSA21,RESP046,"(39.290580964, -76.609260111)"
|
|
2012,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,36,57.3,39.8,74.7,2737,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,RACE3,CAT4,_RFPSA21,RESP054,"(39.290580964, -76.609260111)"
|
|
2012,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,55,39.2,25.9,52.4,2733,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,RACE4,CAT4,_RFPSA21,RESP046,"(39.290580964, -76.609260111)"
|
|
2012,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,66,60.8,47.6,74.1,2738,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,RACE4,CAT4,_RFPSA21,RESP054,"(39.290580964, -76.609260111)"
|
|
2012,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,24,,,,2734,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,24,RACE5,CAT4,_RFPSA21,RESP046,"(39.290580964, -76.609260111)"
|
|
2012,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,8,,,,2739,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,24,RACE5,CAT4,_RFPSA21,RESP054,"(39.290580964, -76.609260111)"
|
|
2012,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1982,48.9,46.4,51.4,2720,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,SEX1,CAT2,_RFPSA21,RESP046,"(39.290580964, -76.609260111)"
|
|
2012,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1595,51.1,48.6,53.6,2721,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,SEX1,CAT2,_RFPSA21,RESP054,"(39.290580964, -76.609260111)"
|
|
2012,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,317,38.6,33.6,43.6,2734,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,AGE08,CAT3,_RFPSA21,RESP054,"(42.27687047, -72.082690675)"
|
|
2012,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,252,16.4,13.7,19,2728,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,AGE06,CAT3,_RFPSA21,RESP046,"(42.27687047, -72.082690675)"
|
|
2012,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,1103,83.7,81,86.3,2732,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,AGE06,CAT3,_RFPSA21,RESP054,"(42.27687047, -72.082690675)"
|
|
2012,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,733,46.7,43,50.3,2729,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,AGE07,CAT3,_RFPSA21,RESP046,"(42.27687047, -72.082690675)"
|
|
2012,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,806,53.3,49.7,57,2733,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,AGE07,CAT3,_RFPSA21,RESP054,"(42.27687047, -72.082690675)"
|
|
2012,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,504,61.4,56.4,66.4,2730,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,AGE08,CAT3,_RFPSA21,RESP046,"(42.27687047, -72.082690675)"
|
|
2012,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,1209,65,61.9,68.2,2731,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,AGE09,CAT3,_RFPSA21,RESP046,"(42.27687047, -72.082690675)"
|
|
2012,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,725,35,31.8,38.1,2735,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,AGE09,CAT3,_RFPSA21,RESP054,"(42.27687047, -72.082690675)"
|
|
2012,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,2698,43.8,41.9,45.7,2724,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,BO1,CAT1,_RFPSA21,RESP046,"(42.27687047, -72.082690675)"
|
|
2012,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,2951,56.2,54.4,58.1,2725,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,BO1,CAT1,_RFPSA21,RESP054,"(42.27687047, -72.082690675)"
|
|
2012,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,179,33.7,27,40.4,2746,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,EDUCA1,CAT5,_RFPSA21,RESP046,"(42.27687047, -72.082690675)"
|
|
2012,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,309,66.3,59.6,73,2750,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,EDUCA1,CAT5,_RFPSA21,RESP054,"(42.27687047, -72.082690675)"
|
|
2012,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,576,37.7,34.1,41.4,2747,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,EDUCA2,CAT5,_RFPSA21,RESP046,"(42.27687047, -72.082690675)"
|
|
2012,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,835,62.3,58.6,65.9,2751,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,EDUCA2,CAT5,_RFPSA21,RESP054,"(42.27687047, -72.082690675)"
|
|
2012,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,568,46.6,42.5,50.8,2748,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,EDUCA3,CAT5,_RFPSA21,RESP046,"(42.27687047, -72.082690675)"
|
|
2012,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,585,53.4,49.2,57.6,2752,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,EDUCA3,CAT5,_RFPSA21,RESP054,"(42.27687047, -72.082690675)"
|
|
2012,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,1373,49.8,47.2,52.4,2749,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,EDUCA4,CAT5,_RFPSA21,RESP046,"(42.27687047, -72.082690675)"
|
|
2012,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,1207,50.2,47.6,52.8,2753,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,EDUCA4,CAT5,_RFPSA21,RESP054,"(42.27687047, -72.082690675)"
|
|
2012,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,187,31.4,25.1,37.6,2754,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,INCOME1,CAT6,_RFPSA21,RESP046,"(42.27687047, -72.082690675)"
|
|
2012,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,317,68.7,62.4,74.9,2759,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,INCOME1,CAT6,_RFPSA21,RESP054,"(42.27687047, -72.082690675)"
|
|
2012,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,315,39.2,33.4,45,2755,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,INCOME2,CAT6,_RFPSA21,RESP046,"(42.27687047, -72.082690675)"
|
|
2012,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,375,60.8,55,66.6,2760,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,INCOME2,CAT6,_RFPSA21,RESP054,"(42.27687047, -72.082690675)"
|
|
2012,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,222,39.6,32.8,46.4,2756,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,INCOME3,CAT6,_RFPSA21,RESP046,"(42.27687047, -72.082690675)"
|
|
2012,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,245,60.4,53.6,67.2,2761,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,INCOME3,CAT6,_RFPSA21,RESP054,"(42.27687047, -72.082690675)"
|
|
2012,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,309,50.3,44.2,56.4,2757,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,INCOME4,CAT6,_RFPSA21,RESP046,"(42.27687047, -72.082690675)"
|
|
2012,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,290,49.7,43.6,55.8,2762,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,INCOME4,CAT6,_RFPSA21,RESP054,"(42.27687047, -72.082690675)"
|
|
2012,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,1425,46.5,44,49.1,2758,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,INCOME5,CAT6,_RFPSA21,RESP046,"(42.27687047, -72.082690675)"
|
|
2012,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,1388,53.5,50.9,56,2763,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,INCOME5,CAT6,_RFPSA21,RESP054,"(42.27687047, -72.082690675)"
|
|
2012,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,2313,46.2,44.1,48.2,2736,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,RACE1,CAT4,_RFPSA21,RESP046,"(42.27687047, -72.082690675)"
|
|
2012,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,2366,53.9,51.8,55.9,2741,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,RACE1,CAT4,_RFPSA21,RESP054,"(42.27687047, -72.082690675)"
|
|
2012,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,132,42.6,33.7,51.5,2737,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,RACE2,CAT4,_RFPSA21,RESP046,"(42.27687047, -72.082690675)"
|
|
2012,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,141,57.5,48.6,66.4,2742,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,RACE2,CAT4,_RFPSA21,RESP054,"(42.27687047, -72.082690675)"
|
|
2012,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,110,30.2,22.1,38.2,2738,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,RACE3,CAT4,_RFPSA21,RESP046,"(42.27687047, -72.082690675)"
|
|
2012,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,192,69.9,61.8,77.9,2743,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,RACE3,CAT4,_RFPSA21,RESP054,"(42.27687047, -72.082690675)"
|
|
2012,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,88,28.8,20.6,37,2739,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,RACE4,CAT4,_RFPSA21,RESP046,"(42.27687047, -72.082690675)"
|
|
2012,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,162,71.2,63,79.4,2744,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,RACE4,CAT4,_RFPSA21,RESP054,"(42.27687047, -72.082690675)"
|
|
2012,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,21,35,15,55,2740,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,RACE5,CAT4,_RFPSA21,RESP046,"(42.27687047, -72.082690675)"
|
|
2012,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,36,65,45,85,2745,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,RACE5,CAT4,_RFPSA21,RESP054,"(42.27687047, -72.082690675)"
|
|
2012,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,2698,43.8,41.9,45.7,2726,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,SEX1,CAT2,_RFPSA21,RESP046,"(42.27687047, -72.082690675)"
|
|
2012,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,2951,56.2,54.4,58.1,2727,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,SEX1,CAT2,_RFPSA21,RESP054,"(42.27687047, -72.082690675)"
|
|
2012,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,384,48.7,44.3,53.2,2726,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,26,AGE07,CAT3,_RFPSA21,RESP054,"(44.661319543001, -84.71439027)"
|
|
2012,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,115,19.7,15.7,23.7,2721,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,26,AGE06,CAT3,_RFPSA21,RESP046,"(44.661319543001, -84.71439027)"
|
|
2012,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,434,80.3,76.4,84.3,2725,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,26,AGE06,CAT3,_RFPSA21,RESP054,"(44.661319543001, -84.71439027)"
|
|
2012,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,412,51.3,46.8,55.8,2722,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,26,AGE07,CAT3,_RFPSA21,RESP046,"(44.661319543001, -84.71439027)"
|
|
2012,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,311,61.8,56.3,67.2,2723,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,26,AGE08,CAT3,_RFPSA21,RESP046,"(44.661319543001, -84.71439027)"
|
|
2012,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,173,38.2,32.8,43.7,2727,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,26,AGE08,CAT3,_RFPSA21,RESP054,"(44.661319543001, -84.71439027)"
|
|
2012,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,815,65,61.5,68.5,2724,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,26,AGE09,CAT3,_RFPSA21,RESP046,"(44.661319543001, -84.71439027)"
|
|
2012,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,402,35,31.5,38.5,2728,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,26,AGE09,CAT3,_RFPSA21,RESP054,"(44.661319543001, -84.71439027)"
|
|
2012,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1653,47.8,45.5,50,2717,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,26,BO1,CAT1,_RFPSA21,RESP046,"(44.661319543001, -84.71439027)"
|
|
2012,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1393,52.2,50,54.5,2718,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,26,BO1,CAT1,_RFPSA21,RESP054,"(44.661319543001, -84.71439027)"
|
|
2012,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,74,32.9,24.7,41.1,2739,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,26,EDUCA1,CAT5,_RFPSA21,RESP046,"(44.661319543001, -84.71439027)"
|
|
2012,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,131,67.1,58.9,75.3,2743,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,26,EDUCA1,CAT5,_RFPSA21,RESP054,"(44.661319543001, -84.71439027)"
|
|
2012,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,424,48.3,44.2,52.5,2740,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,26,EDUCA2,CAT5,_RFPSA21,RESP046,"(44.661319543001, -84.71439027)"
|
|
2012,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,424,51.7,47.5,55.8,2744,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,26,EDUCA2,CAT5,_RFPSA21,RESP054,"(44.661319543001, -84.71439027)"
|
|
2012,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,465,48.2,44.2,52.2,2741,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,26,EDUCA3,CAT5,_RFPSA21,RESP046,"(44.661319543001, -84.71439027)"
|
|
2012,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,382,51.8,47.8,55.9,2745,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,26,EDUCA3,CAT5,_RFPSA21,RESP054,"(44.661319543001, -84.71439027)"
|
|
2012,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,689,54.1,50.6,57.6,2742,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,26,EDUCA4,CAT5,_RFPSA21,RESP046,"(44.661319543001, -84.71439027)"
|
|
2012,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,454,45.9,42.4,49.4,2746,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,26,EDUCA4,CAT5,_RFPSA21,RESP054,"(44.661319543001, -84.71439027)"
|
|
2012,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,65,27,18.3,35.7,2747,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,26,INCOME1,CAT6,_RFPSA21,RESP046,"(44.661319543001, -84.71439027)"
|
|
2012,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,143,73.1,64.4,81.8,2752,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,26,INCOME1,CAT6,_RFPSA21,RESP054,"(44.661319543001, -84.71439027)"
|
|
2012,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,204,39,32.8,45.1,2748,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,26,INCOME2,CAT6,_RFPSA21,RESP046,"(44.661319543001, -84.71439027)"
|
|
2012,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,231,61,54.9,67.2,2753,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,26,INCOME2,CAT6,_RFPSA21,RESP054,"(44.661319543001, -84.71439027)"
|
|
2012,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,183,45.4,38.6,52.2,2749,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,26,INCOME3,CAT6,_RFPSA21,RESP046,"(44.661319543001, -84.71439027)"
|
|
2012,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,181,54.6,47.8,61.4,2754,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,26,INCOME3,CAT6,_RFPSA21,RESP054,"(44.661319543001, -84.71439027)"
|
|
2012,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,286,54.3,48.3,60.2,2750,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,26,INCOME4,CAT6,_RFPSA21,RESP046,"(44.661319543001, -84.71439027)"
|
|
2012,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,186,45.7,39.8,51.7,2755,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,26,INCOME4,CAT6,_RFPSA21,RESP054,"(44.661319543001, -84.71439027)"
|
|
2012,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,774,51.6,48.3,54.9,2751,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,26,INCOME5,CAT6,_RFPSA21,RESP046,"(44.661319543001, -84.71439027)"
|
|
2012,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,544,48.4,45.1,51.7,2756,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,26,INCOME5,CAT6,_RFPSA21,RESP054,"(44.661319543001, -84.71439027)"
|
|
2012,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1357,48.6,46.2,51,2729,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,26,RACE1,CAT4,_RFPSA21,RESP046,"(44.661319543001, -84.71439027)"
|
|
2012,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1129,51.4,49,53.8,2734,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,26,RACE1,CAT4,_RFPSA21,RESP054,"(44.661319543001, -84.71439027)"
|
|
2012,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,196,47.1,38,56.1,2730,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,26,RACE2,CAT4,_RFPSA21,RESP046,"(44.661319543001, -84.71439027)"
|
|
2012,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,141,53,43.9,62,2735,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,26,RACE2,CAT4,_RFPSA21,RESP054,"(44.661319543001, -84.71439027)"
|
|
2012,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,21,,,,2731,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,26,RACE3,CAT4,_RFPSA21,RESP046,"(44.661319543001, -84.71439027)"
|
|
2012,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,26,,,,2736,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,26,RACE3,CAT4,_RFPSA21,RESP054,"(44.661319543001, -84.71439027)"
|
|
2012,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,29,32.9,19.1,46.6,2732,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,26,RACE4,CAT4,_RFPSA21,RESP046,"(44.661319543001, -84.71439027)"
|
|
2012,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,43,67.2,53.4,80.9,2737,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,26,RACE4,CAT4,_RFPSA21,RESP054,"(44.661319543001, -84.71439027)"
|
|
2012,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,28,34.4,21.4,47.5,2733,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,26,RACE5,CAT4,_RFPSA21,RESP046,"(44.661319543001, -84.71439027)"
|
|
2012,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,37,65.6,52.5,78.7,2738,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,26,RACE5,CAT4,_RFPSA21,RESP054,"(44.661319543001, -84.71439027)"
|
|
2012,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1653,47.8,45.5,50,2719,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,26,SEX1,CAT2,_RFPSA21,RESP046,"(44.661319543001, -84.71439027)"
|
|
2012,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1393,52.2,50,54.5,2720,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,26,SEX1,CAT2,_RFPSA21,RESP054,"(44.661319543001, -84.71439027)"
|
|
2012,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,106,11.3,8.9,13.8,2721,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,27,AGE06,CAT3,_RFPSA21,RESP046,"(46.355648736, -94.794200503)"
|
|
2012,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,718,88.7,86.2,91.1,2725,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,27,AGE06,CAT3,_RFPSA21,RESP054,"(46.355648736, -94.794200503)"
|
|
2012,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,429,39.3,35.6,43,2722,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,27,AGE07,CAT3,_RFPSA21,RESP046,"(46.355648736, -94.794200503)"
|
|
2012,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,657,60.7,57,64.4,2726,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,27,AGE07,CAT3,_RFPSA21,RESP054,"(46.355648736, -94.794200503)"
|
|
2012,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,264,57.2,51.6,62.8,2723,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,27,AGE08,CAT3,_RFPSA21,RESP046,"(46.355648736, -94.794200503)"
|
|
2012,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,226,42.8,37.2,48.4,2727,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,27,AGE08,CAT3,_RFPSA21,RESP054,"(46.355648736, -94.794200503)"
|
|
2012,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,692,63.6,59.7,67.6,2724,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,27,AGE09,CAT3,_RFPSA21,RESP046,"(46.355648736, -94.794200503)"
|
|
2012,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,410,36.4,32.4,40.3,2728,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,27,AGE09,CAT3,_RFPSA21,RESP054,"(46.355648736, -94.794200503)"
|
|
2012,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1491,39.8,37.8,41.8,2717,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,27,BO1,CAT1,_RFPSA21,RESP046,"(46.355648736, -94.794200503)"
|
|
2012,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,2011,60.2,58.2,62.2,2718,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,27,BO1,CAT1,_RFPSA21,RESP054,"(46.355648736, -94.794200503)"
|
|
2012,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,52,29.8,21.2,38.4,2739,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,27,EDUCA1,CAT5,_RFPSA21,RESP046,"(46.355648736, -94.794200503)"
|
|
2012,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,103,70.2,61.6,78.9,2743,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,27,EDUCA1,CAT5,_RFPSA21,RESP054,"(46.355648736, -94.794200503)"
|
|
2012,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,320,33.9,30.1,37.7,2740,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,27,EDUCA2,CAT5,_RFPSA21,RESP046,"(46.355648736, -94.794200503)"
|
|
2012,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,532,66.1,62.3,69.9,2744,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,27,EDUCA2,CAT5,_RFPSA21,RESP054,"(46.355648736, -94.794200503)"
|
|
2012,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,414,40.1,36.3,43.8,2741,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,27,EDUCA3,CAT5,_RFPSA21,RESP046,"(46.355648736, -94.794200503)"
|
|
2012,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,584,59.9,56.2,63.7,2745,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,27,EDUCA3,CAT5,_RFPSA21,RESP054,"(46.355648736, -94.794200503)"
|
|
2012,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,705,47.5,44.4,50.7,2742,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,27,EDUCA4,CAT5,_RFPSA21,RESP046,"(46.355648736, -94.794200503)"
|
|
2012,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,789,52.5,49.3,55.6,2746,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,27,EDUCA4,CAT5,_RFPSA21,RESP054,"(46.355648736, -94.794200503)"
|
|
2012,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,52,24,15.4,32.6,2747,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,27,INCOME1,CAT6,_RFPSA21,RESP046,"(46.355648736, -94.794200503)"
|
|
2012,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,129,76,67.4,84.6,2752,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,27,INCOME1,CAT6,_RFPSA21,RESP054,"(46.355648736, -94.794200503)"
|
|
2012,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,165,35.4,29.1,41.6,2748,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,27,INCOME2,CAT6,_RFPSA21,RESP046,"(46.355648736, -94.794200503)"
|
|
2012,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,252,64.6,58.4,70.9,2753,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,27,INCOME2,CAT6,_RFPSA21,RESP054,"(46.355648736, -94.794200503)"
|
|
2012,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,121,41.2,33.5,48.8,2749,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,27,INCOME3,CAT6,_RFPSA21,RESP046,"(46.355648736, -94.794200503)"
|
|
2012,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,165,58.9,51.2,66.5,2754,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,27,INCOME3,CAT6,_RFPSA21,RESP054,"(46.355648736, -94.794200503)"
|
|
2012,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,228,41.3,36,46.5,2750,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,27,INCOME4,CAT6,_RFPSA21,RESP046,"(46.355648736, -94.794200503)"
|
|
2012,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,285,58.7,53.5,64,2755,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,27,INCOME4,CAT6,_RFPSA21,RESP054,"(46.355648736, -94.794200503)"
|
|
2012,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,784,41.4,38.6,44.2,2751,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,27,INCOME5,CAT6,_RFPSA21,RESP046,"(46.355648736, -94.794200503)"
|
|
2012,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,1025,58.6,55.8,61.4,2756,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,27,INCOME5,CAT6,_RFPSA21,RESP054,"(46.355648736, -94.794200503)"
|
|
2012,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1388,41.4,39.3,43.5,2729,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,27,RACE1,CAT4,_RFPSA21,RESP046,"(46.355648736, -94.794200503)"
|
|
2012,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1826,58.6,56.5,60.7,2734,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,27,RACE1,CAT4,_RFPSA21,RESP054,"(46.355648736, -94.794200503)"
|
|
2012,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,37,24.4,13.4,35.4,2730,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,27,RACE2,CAT4,_RFPSA21,RESP046,"(46.355648736, -94.794200503)"
|
|
2012,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,63,75.6,64.6,86.6,2735,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,27,RACE2,CAT4,_RFPSA21,RESP054,"(46.355648736, -94.794200503)"
|
|
2012,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,13,,,,2731,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,27,RACE3,CAT4,_RFPSA21,RESP046,"(46.355648736, -94.794200503)"
|
|
2012,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,44,84.2,73.2,95.2,2736,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,27,RACE3,CAT4,_RFPSA21,RESP054,"(46.355648736, -94.794200503)"
|
|
2012,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,28,28.1,16.9,39.2,2732,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,27,RACE4,CAT4,_RFPSA21,RESP046,"(46.355648736, -94.794200503)"
|
|
2012,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,52,71.9,60.8,83.1,2737,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,27,RACE4,CAT4,_RFPSA21,RESP054,"(46.355648736, -94.794200503)"
|
|
2012,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,9,,,,2733,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,27,RACE5,CAT4,_RFPSA21,RESP046,"(46.355648736, -94.794200503)"
|
|
2012,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,14,,,,2738,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,27,RACE5,CAT4,_RFPSA21,RESP054,"(46.355648736, -94.794200503)"
|
|
2012,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1491,39.8,37.8,41.8,2719,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,27,SEX1,CAT2,_RFPSA21,RESP046,"(46.355648736, -94.794200503)"
|
|
2012,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,2011,60.2,58.2,62.2,2720,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,27,SEX1,CAT2,_RFPSA21,RESP054,"(46.355648736, -94.794200503)"
|
|
2012,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,83,23.6,18.3,28.9,2713,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,28,AGE06,CAT3,_RFPSA21,RESP046,"(32.745510099, -89.538030825)"
|
|
2012,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,260,76.4,71.1,81.7,2717,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,28,AGE06,CAT3,_RFPSA21,RESP054,"(32.745510099, -89.538030825)"
|
|
2012,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,265,45.8,40.4,51.1,2714,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,28,AGE07,CAT3,_RFPSA21,RESP046,"(32.745510099, -89.538030825)"
|
|
2012,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,255,54.2,48.9,59.6,2718,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,28,AGE07,CAT3,_RFPSA21,RESP054,"(32.745510099, -89.538030825)"
|
|
2012,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,185,62,55.1,68.8,2715,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,28,AGE08,CAT3,_RFPSA21,RESP046,"(32.745510099, -89.538030825)"
|
|
2012,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,109,38,31.2,44.9,2719,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,28,AGE08,CAT3,_RFPSA21,RESP054,"(32.745510099, -89.538030825)"
|
|
2012,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,535,66,62,70,2716,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,28,AGE09,CAT3,_RFPSA21,RESP046,"(32.745510099, -89.538030825)"
|
|
2012,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,267,34,30,38,2720,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,28,AGE09,CAT3,_RFPSA21,RESP054,"(32.745510099, -89.538030825)"
|
|
2012,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1068,46.5,43.8,49.3,2709,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,28,BO1,CAT1,_RFPSA21,RESP046,"(32.745510099, -89.538030825)"
|
|
2012,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,891,53.5,50.7,56.2,2710,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,28,BO1,CAT1,_RFPSA21,RESP054,"(32.745510099, -89.538030825)"
|
|
2012,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,135,35.2,28.8,41.6,2731,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,28,EDUCA1,CAT5,_RFPSA21,RESP046,"(32.745510099, -89.538030825)"
|
|
2012,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,208,64.8,58.4,71.2,2735,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,28,EDUCA1,CAT5,_RFPSA21,RESP054,"(32.745510099, -89.538030825)"
|
|
2012,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,305,42.6,37.8,47.4,2732,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,28,EDUCA2,CAT5,_RFPSA21,RESP046,"(32.745510099, -89.538030825)"
|
|
2012,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,304,57.4,52.6,62.2,2736,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,28,EDUCA2,CAT5,_RFPSA21,RESP054,"(32.745510099, -89.538030825)"
|
|
2012,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,271,50.9,45.3,56.5,2733,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,28,EDUCA3,CAT5,_RFPSA21,RESP046,"(32.745510099, -89.538030825)"
|
|
2012,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,195,49.1,43.5,54.8,2737,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,28,EDUCA3,CAT5,_RFPSA21,RESP054,"(32.745510099, -89.538030825)"
|
|
2012,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,356,60,54.7,65.2,2734,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,28,EDUCA4,CAT5,_RFPSA21,RESP046,"(32.745510099, -89.538030825)"
|
|
2012,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,180,40.1,34.8,45.3,2738,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,28,EDUCA4,CAT5,_RFPSA21,RESP054,"(32.745510099, -89.538030825)"
|
|
2012,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,85,30.3,22.6,38,2739,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,28,INCOME1,CAT6,_RFPSA21,RESP046,"(32.745510099, -89.538030825)"
|
|
2012,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,157,69.7,62,77.4,2744,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,28,INCOME1,CAT6,_RFPSA21,RESP054,"(32.745510099, -89.538030825)"
|
|
2012,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,177,39.3,32.8,45.9,2740,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,28,INCOME2,CAT6,_RFPSA21,RESP046,"(32.745510099, -89.538030825)"
|
|
2012,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,194,60.7,54.1,67.2,2745,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,28,INCOME2,CAT6,_RFPSA21,RESP054,"(32.745510099, -89.538030825)"
|
|
2012,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,141,50.7,42.4,59,2741,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,28,INCOME3,CAT6,_RFPSA21,RESP046,"(32.745510099, -89.538030825)"
|
|
2012,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,89,49.3,41,57.6,2746,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,28,INCOME3,CAT6,_RFPSA21,RESP054,"(32.745510099, -89.538030825)"
|
|
2012,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,147,53.1,45,61.1,2742,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,28,INCOME4,CAT6,_RFPSA21,RESP046,"(32.745510099, -89.538030825)"
|
|
2012,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,87,47,38.9,55,2747,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,28,INCOME4,CAT6,_RFPSA21,RESP054,"(32.745510099, -89.538030825)"
|
|
2012,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,420,53.7,48.9,58.6,2743,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,28,INCOME5,CAT6,_RFPSA21,RESP046,"(32.745510099, -89.538030825)"
|
|
2012,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,243,46.3,41.4,51.2,2748,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,28,INCOME5,CAT6,_RFPSA21,RESP054,"(32.745510099, -89.538030825)"
|
|
2012,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,781,49,45.6,52.4,2721,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,28,RACE1,CAT4,_RFPSA21,RESP046,"(32.745510099, -89.538030825)"
|
|
2012,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,572,51,47.6,54.4,2726,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,28,RACE1,CAT4,_RFPSA21,RESP054,"(32.745510099, -89.538030825)"
|
|
2012,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,253,43,37.6,48.4,2722,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,28,RACE2,CAT4,_RFPSA21,RESP046,"(32.745510099, -89.538030825)"
|
|
2012,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,274,57,51.6,62.4,2727,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,28,RACE2,CAT4,_RFPSA21,RESP054,"(32.745510099, -89.538030825)"
|
|
2012,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,13,,,,2723,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,28,RACE3,CAT4,_RFPSA21,RESP046,"(32.745510099, -89.538030825)"
|
|
2012,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,10,,,,2728,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,28,RACE3,CAT4,_RFPSA21,RESP054,"(32.745510099, -89.538030825)"
|
|
2012,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,11,,,,2724,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,28,RACE4,CAT4,_RFPSA21,RESP046,"(32.745510099, -89.538030825)"
|
|
2012,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,20,,,,2729,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,28,RACE4,CAT4,_RFPSA21,RESP054,"(32.745510099, -89.538030825)"
|
|
2012,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,7,,,,2725,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,28,RACE5,CAT4,_RFPSA21,RESP046,"(32.745510099, -89.538030825)"
|
|
2012,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,6,,,,2730,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,28,RACE5,CAT4,_RFPSA21,RESP054,"(32.745510099, -89.538030825)"
|
|
2012,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1068,46.5,43.8,49.3,2711,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,28,SEX1,CAT2,_RFPSA21,RESP046,"(32.745510099, -89.538030825)"
|
|
2012,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,891,53.5,50.7,56.2,2712,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,28,SEX1,CAT2,_RFPSA21,RESP054,"(32.745510099, -89.538030825)"
|
|
2012,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,79,22,16.2,27.8,2717,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,29,AGE06,CAT3,_RFPSA21,RESP046,"(38.635790776, -92.566300053)"
|
|
2012,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,240,78,72.2,83.8,2721,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,29,AGE06,CAT3,_RFPSA21,RESP054,"(38.635790776, -92.566300053)"
|
|
2012,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,246,49.3,43.4,55.3,2718,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,29,AGE07,CAT3,_RFPSA21,RESP046,"(38.635790776, -92.566300053)"
|
|
2012,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,256,50.7,44.7,56.6,2722,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,29,AGE07,CAT3,_RFPSA21,RESP054,"(38.635790776, -92.566300053)"
|
|
2012,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,156,63.1,55.2,71,2719,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,29,AGE08,CAT3,_RFPSA21,RESP046,"(38.635790776, -92.566300053)"
|
|
2012,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,92,36.9,29,44.8,2723,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,29,AGE08,CAT3,_RFPSA21,RESP054,"(38.635790776, -92.566300053)"
|
|
2012,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,496,71.1,66.7,75.4,2720,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,29,AGE09,CAT3,_RFPSA21,RESP046,"(38.635790776, -92.566300053)"
|
|
2012,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,251,28.9,24.6,33.3,2724,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,29,AGE09,CAT3,_RFPSA21,RESP054,"(38.635790776, -92.566300053)"
|
|
2012,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,977,50.2,47,53.4,2713,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,29,BO1,CAT1,_RFPSA21,RESP046,"(38.635790776, -92.566300053)"
|
|
2012,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,839,49.8,46.6,53,2714,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,29,BO1,CAT1,_RFPSA21,RESP054,"(38.635790776, -92.566300053)"
|
|
2012,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,76,36,26.8,45.3,2735,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,29,EDUCA1,CAT5,_RFPSA21,RESP046,"(38.635790776, -92.566300053)"
|
|
2012,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,123,64,54.7,73.2,2739,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,29,EDUCA1,CAT5,_RFPSA21,RESP054,"(38.635790776, -92.566300053)"
|
|
2012,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,321,45.5,39.9,51,2736,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,29,EDUCA2,CAT5,_RFPSA21,RESP046,"(38.635790776, -92.566300053)"
|
|
2012,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,303,54.5,49,60.1,2740,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,29,EDUCA2,CAT5,_RFPSA21,RESP054,"(38.635790776, -92.566300053)"
|
|
2012,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,245,54,47.6,60.4,2737,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,29,EDUCA3,CAT5,_RFPSA21,RESP046,"(38.635790776, -92.566300053)"
|
|
2012,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,200,46,39.6,52.4,2741,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,29,EDUCA3,CAT5,_RFPSA21,RESP054,"(38.635790776, -92.566300053)"
|
|
2012,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,335,60.3,54.9,65.8,2738,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,29,EDUCA4,CAT5,_RFPSA21,RESP046,"(38.635790776, -92.566300053)"
|
|
2012,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,211,39.7,34.2,45.1,2742,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,29,EDUCA4,CAT5,_RFPSA21,RESP054,"(38.635790776, -92.566300053)"
|
|
2012,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,79,35.9,25.3,46.5,2743,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,29,INCOME1,CAT6,_RFPSA21,RESP046,"(38.635790776, -92.566300053)"
|
|
2012,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,111,64.1,53.6,74.7,2748,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,29,INCOME1,CAT6,_RFPSA21,RESP054,"(38.635790776, -92.566300053)"
|
|
2012,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,152,45.8,38.1,53.4,2744,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,29,INCOME2,CAT6,_RFPSA21,RESP046,"(38.635790776, -92.566300053)"
|
|
2012,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,161,54.2,46.6,61.9,2749,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,29,INCOME2,CAT6,_RFPSA21,RESP054,"(38.635790776, -92.566300053)"
|
|
2012,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,104,46.4,37.2,55.7,2745,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,29,INCOME3,CAT6,_RFPSA21,RESP046,"(38.635790776, -92.566300053)"
|
|
2012,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,97,53.6,44.4,62.8,2750,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,29,INCOME3,CAT6,_RFPSA21,RESP054,"(38.635790776, -92.566300053)"
|
|
2012,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,161,56,47.6,64.4,2746,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,29,INCOME4,CAT6,_RFPSA21,RESP046,"(38.635790776, -92.566300053)"
|
|
2012,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,104,44,35.6,52.4,2751,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,29,INCOME4,CAT6,_RFPSA21,RESP054,"(38.635790776, -92.566300053)"
|
|
2012,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,379,53.5,48.2,58.8,2747,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,29,INCOME5,CAT6,_RFPSA21,RESP046,"(38.635790776, -92.566300053)"
|
|
2012,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,269,46.5,41.2,51.9,2752,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,29,INCOME5,CAT6,_RFPSA21,RESP054,"(38.635790776, -92.566300053)"
|
|
2012,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,829,51,47.6,54.4,2725,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,29,RACE1,CAT4,_RFPSA21,RESP046,"(38.635790776, -92.566300053)"
|
|
2012,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,696,49,45.6,52.4,2730,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,29,RACE1,CAT4,_RFPSA21,RESP054,"(38.635790776, -92.566300053)"
|
|
2012,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,99,45.6,33.9,57.4,2726,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,29,RACE2,CAT4,_RFPSA21,RESP046,"(38.635790776, -92.566300053)"
|
|
2012,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,91,54.4,42.7,66.1,2731,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,29,RACE2,CAT4,_RFPSA21,RESP054,"(38.635790776, -92.566300053)"
|
|
2012,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,8,,,,2727,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,29,RACE3,CAT4,_RFPSA21,RESP046,"(38.635790776, -92.566300053)"
|
|
2012,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,16,,,,2732,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,29,RACE3,CAT4,_RFPSA21,RESP054,"(38.635790776, -92.566300053)"
|
|
2012,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,16,,,,2728,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,29,RACE4,CAT4,_RFPSA21,RESP046,"(38.635790776, -92.566300053)"
|
|
2012,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,12,,,,2733,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,29,RACE4,CAT4,_RFPSA21,RESP054,"(38.635790776, -92.566300053)"
|
|
2012,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,18,,,,2729,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,29,RACE5,CAT4,_RFPSA21,RESP046,"(38.635790776, -92.566300053)"
|
|
2012,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,17,,,,2734,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,29,RACE5,CAT4,_RFPSA21,RESP054,"(38.635790776, -92.566300053)"
|
|
2012,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,977,50.2,47,53.4,2715,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,29,SEX1,CAT2,_RFPSA21,RESP046,"(38.635790776, -92.566300053)"
|
|
2012,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,839,49.8,46.6,53,2716,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,29,SEX1,CAT2,_RFPSA21,RESP054,"(38.635790776, -92.566300053)"
|
|
2012,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1247,54.3,51.8,56.7,2702,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,30,BO1,CAT1,_RFPSA21,RESP054,"(47.066528972, -109.424420645)"
|
|
2012,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,73,15.3,11.3,19.4,2705,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,30,AGE06,CAT3,_RFPSA21,RESP046,"(47.066528972, -109.424420645)"
|
|
2012,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,363,84.7,80.6,88.7,2709,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,30,AGE06,CAT3,_RFPSA21,RESP054,"(47.066528972, -109.424420645)"
|
|
2012,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,307,44.4,39.7,49,2706,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,30,AGE07,CAT3,_RFPSA21,RESP046,"(47.066528972, -109.424420645)"
|
|
2012,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,388,55.6,51,60.3,2710,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,30,AGE07,CAT3,_RFPSA21,RESP054,"(47.066528972, -109.424420645)"
|
|
2012,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,221,61,54.8,67.1,2707,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,30,AGE08,CAT3,_RFPSA21,RESP046,"(47.066528972, -109.424420645)"
|
|
2012,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,138,39,32.9,45.2,2711,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,30,AGE08,CAT3,_RFPSA21,RESP054,"(47.066528972, -109.424420645)"
|
|
2012,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,640,63.8,60,67.6,2708,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,30,AGE09,CAT3,_RFPSA21,RESP046,"(47.066528972, -109.424420645)"
|
|
2012,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,358,36.2,32.4,40,2712,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,30,AGE09,CAT3,_RFPSA21,RESP054,"(47.066528972, -109.424420645)"
|
|
2012,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1241,45.7,43.3,48.2,2701,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,30,BO1,CAT1,_RFPSA21,RESP046,"(47.066528972, -109.424420645)"
|
|
2012,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,56,35.3,26,44.7,2723,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,30,EDUCA1,CAT5,_RFPSA21,RESP046,"(47.066528972, -109.424420645)"
|
|
2012,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,111,64.7,55.3,74,2727,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,30,EDUCA1,CAT5,_RFPSA21,RESP054,"(47.066528972, -109.424420645)"
|
|
2012,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,354,40.3,36.1,44.5,2724,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,30,EDUCA2,CAT5,_RFPSA21,RESP046,"(47.066528972, -109.424420645)"
|
|
2012,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,440,59.7,55.5,63.9,2728,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,30,EDUCA2,CAT5,_RFPSA21,RESP054,"(47.066528972, -109.424420645)"
|
|
2012,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,313,46.2,41.4,51.1,2725,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,30,EDUCA3,CAT5,_RFPSA21,RESP046,"(47.066528972, -109.424420645)"
|
|
2012,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,314,53.8,48.9,58.6,2729,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,30,EDUCA3,CAT5,_RFPSA21,RESP054,"(47.066528972, -109.424420645)"
|
|
2012,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,514,54.5,50.6,58.5,2726,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,30,EDUCA4,CAT5,_RFPSA21,RESP046,"(47.066528972, -109.424420645)"
|
|
2012,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,379,45.5,41.5,49.4,2730,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,30,EDUCA4,CAT5,_RFPSA21,RESP054,"(47.066528972, -109.424420645)"
|
|
2012,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,76,30.3,22.7,37.9,2731,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,30,INCOME1,CAT6,_RFPSA21,RESP046,"(47.066528972, -109.424420645)"
|
|
2012,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,163,69.7,62.1,77.3,2736,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,30,INCOME1,CAT6,_RFPSA21,RESP054,"(47.066528972, -109.424420645)"
|
|
2012,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,179,39.6,33.4,45.8,2732,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,30,INCOME2,CAT6,_RFPSA21,RESP046,"(47.066528972, -109.424420645)"
|
|
2012,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,226,60.4,54.2,66.6,2737,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,30,INCOME2,CAT6,_RFPSA21,RESP054,"(47.066528972, -109.424420645)"
|
|
2012,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,169,47.5,40.5,54.5,2733,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,30,INCOME3,CAT6,_RFPSA21,RESP046,"(47.066528972, -109.424420645)"
|
|
2012,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,160,52.5,45.5,59.5,2738,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,30,INCOME3,CAT6,_RFPSA21,RESP054,"(47.066528972, -109.424420645)"
|
|
2012,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,210,45.7,39.6,51.8,2734,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,30,INCOME4,CAT6,_RFPSA21,RESP046,"(47.066528972, -109.424420645)"
|
|
2012,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,177,54.3,48.2,60.5,2739,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,30,INCOME4,CAT6,_RFPSA21,RESP054,"(47.066528972, -109.424420645)"
|
|
2012,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,511,50.7,46.8,54.7,2735,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,30,INCOME5,CAT6,_RFPSA21,RESP046,"(47.066528972, -109.424420645)"
|
|
2012,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,424,49.3,45.3,53.2,2740,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,30,INCOME5,CAT6,_RFPSA21,RESP054,"(47.066528972, -109.424420645)"
|
|
2012,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1147,47.2,44.7,49.8,2713,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,30,RACE1,CAT4,_RFPSA21,RESP046,"(47.066528972, -109.424420645)"
|
|
2012,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1074,52.8,50.2,55.3,2718,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,30,RACE1,CAT4,_RFPSA21,RESP054,"(47.066528972, -109.424420645)"
|
|
2012,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,2,,,,2714,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,30,RACE2,CAT4,_RFPSA21,RESP046,"(47.066528972, -109.424420645)"
|
|
2012,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,3,,,,2719,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,30,RACE2,CAT4,_RFPSA21,RESP054,"(47.066528972, -109.424420645)"
|
|
2012,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,9,,,,2715,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,30,RACE3,CAT4,_RFPSA21,RESP046,"(47.066528972, -109.424420645)"
|
|
2012,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,14,,,,2720,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,30,RACE3,CAT4,_RFPSA21,RESP054,"(47.066528972, -109.424420645)"
|
|
2012,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,61,36.7,25.6,47.9,2716,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,30,RACE4,CAT4,_RFPSA21,RESP046,"(47.066528972, -109.424420645)"
|
|
2012,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,96,63.3,52.2,74.4,2721,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,30,RACE4,CAT4,_RFPSA21,RESP054,"(47.066528972, -109.424420645)"
|
|
2012,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,13,,,,2717,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,30,RACE5,CAT4,_RFPSA21,RESP046,"(47.066528972, -109.424420645)"
|
|
2012,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,34,,,,2722,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,30,RACE5,CAT4,_RFPSA21,RESP054,"(47.066528972, -109.424420645)"
|
|
2012,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1241,45.7,43.3,48.2,2703,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,30,SEX1,CAT2,_RFPSA21,RESP046,"(47.066528972, -109.424420645)"
|
|
2012,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1247,54.3,51.8,56.7,2704,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,30,SEX1,CAT2,_RFPSA21,RESP054,"(47.066528972, -109.424420645)"
|
|
2012,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,163,18,14.7,21.3,2729,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,AGE06,CAT3,_RFPSA21,RESP046,"(41.641040988001, -99.365720623)"
|
|
2012,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,701,82,78.7,85.3,2733,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,AGE06,CAT3,_RFPSA21,RESP054,"(41.641040988001, -99.365720623)"
|
|
2012,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,658,43,39.5,46.5,2730,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,AGE07,CAT3,_RFPSA21,RESP046,"(41.641040988001, -99.365720623)"
|
|
2012,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,823,57,53.5,60.5,2734,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,AGE07,CAT3,_RFPSA21,RESP054,"(41.641040988001, -99.365720623)"
|
|
2012,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,433,58.6,53.8,63.5,2731,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,AGE08,CAT3,_RFPSA21,RESP046,"(41.641040988001, -99.365720623)"
|
|
2012,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,306,41.4,36.5,46.2,2735,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,AGE08,CAT3,_RFPSA21,RESP054,"(41.641040988001, -99.365720623)"
|
|
2012,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,1353,66.1,63.2,69,2732,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,AGE09,CAT3,_RFPSA21,RESP046,"(41.641040988001, -99.365720623)"
|
|
2012,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,694,33.9,31,36.8,2736,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,AGE09,CAT3,_RFPSA21,RESP054,"(41.641040988001, -99.365720623)"
|
|
2012,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,2607,44.9,43,46.8,2725,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,BO1,CAT1,_RFPSA21,RESP046,"(41.641040988001, -99.365720623)"
|
|
2012,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,2524,55.1,53.3,57,2726,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,BO1,CAT1,_RFPSA21,RESP054,"(41.641040988001, -99.365720623)"
|
|
2012,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,122,29.4,22.6,36.1,2747,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,EDUCA1,CAT5,_RFPSA21,RESP046,"(41.641040988001, -99.365720623)"
|
|
2012,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,242,70.6,63.9,77.4,2751,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,EDUCA1,CAT5,_RFPSA21,RESP054,"(41.641040988001, -99.365720623)"
|
|
2012,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,916,43.5,40.5,46.6,2748,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,EDUCA2,CAT5,_RFPSA21,RESP046,"(41.641040988001, -99.365720623)"
|
|
2012,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,962,56.5,53.4,59.5,2752,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,EDUCA2,CAT5,_RFPSA21,RESP054,"(41.641040988001, -99.365720623)"
|
|
2012,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,692,44.9,41.3,48.5,2749,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,EDUCA3,CAT5,_RFPSA21,RESP046,"(41.641040988001, -99.365720623)"
|
|
2012,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,688,55.1,51.5,58.7,2753,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,EDUCA3,CAT5,_RFPSA21,RESP054,"(41.641040988001, -99.365720623)"
|
|
2012,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,872,52.6,49.3,56,2750,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,EDUCA4,CAT5,_RFPSA21,RESP046,"(41.641040988001, -99.365720623)"
|
|
2012,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,629,47.4,44,50.8,2754,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,EDUCA4,CAT5,_RFPSA21,RESP054,"(41.641040988001, -99.365720623)"
|
|
2012,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,95,25.9,18.8,33,2755,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,INCOME1,CAT6,_RFPSA21,RESP046,"(41.641040988001, -99.365720623)"
|
|
2012,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,210,74.1,67,81.2,2760,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,INCOME1,CAT6,_RFPSA21,RESP054,"(41.641040988001, -99.365720623)"
|
|
2012,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,337,34.5,29.6,39.4,2756,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,INCOME2,CAT6,_RFPSA21,RESP046,"(41.641040988001, -99.365720623)"
|
|
2012,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,426,65.5,60.6,70.4,2761,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,INCOME2,CAT6,_RFPSA21,RESP054,"(41.641040988001, -99.365720623)"
|
|
2012,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,340,45.4,40,50.7,2757,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,INCOME3,CAT6,_RFPSA21,RESP046,"(41.641040988001, -99.365720623)"
|
|
2012,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,317,54.7,49.3,60,2762,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,INCOME3,CAT6,_RFPSA21,RESP054,"(41.641040988001, -99.365720623)"
|
|
2012,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,463,48.1,43.5,52.6,2758,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,INCOME4,CAT6,_RFPSA21,RESP046,"(41.641040988001, -99.365720623)"
|
|
2012,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,397,52,47.4,56.5,2763,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,INCOME4,CAT6,_RFPSA21,RESP054,"(41.641040988001, -99.365720623)"
|
|
2012,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,1215,48.3,45.5,51.1,2759,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,INCOME5,CAT6,_RFPSA21,RESP046,"(41.641040988001, -99.365720623)"
|
|
2012,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,1024,51.7,48.9,54.5,2764,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,INCOME5,CAT6,_RFPSA21,RESP054,"(41.641040988001, -99.365720623)"
|
|
2012,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,2483,47.6,45.7,49.6,2737,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,RACE1,CAT4,_RFPSA21,RESP046,"(41.641040988001, -99.365720623)"
|
|
2012,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,2260,52.4,50.4,54.3,2742,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,RACE1,CAT4,_RFPSA21,RESP054,"(41.641040988001, -99.365720623)"
|
|
2012,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,32,34.5,21.4,47.6,2738,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,RACE2,CAT4,_RFPSA21,RESP046,"(41.641040988001, -99.365720623)"
|
|
2012,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,55,65.5,52.4,78.6,2743,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,RACE2,CAT4,_RFPSA21,RESP054,"(41.641040988001, -99.365720623)"
|
|
2012,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,35,19.9,11.1,28.6,2739,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,RACE3,CAT4,_RFPSA21,RESP046,"(41.641040988001, -99.365720623)"
|
|
2012,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,110,80.1,71.4,88.9,2744,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,RACE3,CAT4,_RFPSA21,RESP054,"(41.641040988001, -99.365720623)"
|
|
2012,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,30,31.1,17.4,44.9,2740,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,RACE4,CAT4,_RFPSA21,RESP046,"(41.641040988001, -99.365720623)"
|
|
2012,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,57,68.9,55.1,82.6,2745,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,RACE4,CAT4,_RFPSA21,RESP054,"(41.641040988001, -99.365720623)"
|
|
2012,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,17,,,,2741,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,31,RACE5,CAT4,_RFPSA21,RESP046,"(41.641040988001, -99.365720623)"
|
|
2012,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,20,,,,2746,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,31,RACE5,CAT4,_RFPSA21,RESP054,"(41.641040988001, -99.365720623)"
|
|
2012,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,2607,44.9,43,46.8,2727,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,SEX1,CAT2,_RFPSA21,RESP046,"(41.641040988001, -99.365720623)"
|
|
2012,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,2524,55.1,53.3,57,2728,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,SEX1,CAT2,_RFPSA21,RESP054,"(41.641040988001, -99.365720623)"
|
|
2012,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,51,22,15.1,28.8,2718,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,32,AGE06,CAT3,_RFPSA21,RESP046,"(39.49324039, -117.071840564)"
|
|
2012,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,182,78.1,71.2,84.9,2722,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,32,AGE06,CAT3,_RFPSA21,RESP054,"(39.49324039, -117.071840564)"
|
|
2012,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,169,45.8,38.1,53.4,2719,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,32,AGE07,CAT3,_RFPSA21,RESP046,"(39.49324039, -117.071840564)"
|
|
2012,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,197,54.2,46.6,61.9,2723,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,32,AGE07,CAT3,_RFPSA21,RESP054,"(39.49324039, -117.071840564)"
|
|
2012,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,116,65.2,54.1,76.4,2720,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,32,AGE08,CAT3,_RFPSA21,RESP046,"(39.49324039, -117.071840564)"
|
|
2012,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,60,34.8,23.7,46,2724,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,32,AGE08,CAT3,_RFPSA21,RESP054,"(39.49324039, -117.071840564)"
|
|
2012,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,392,69.7,63.9,75.5,2721,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,32,AGE09,CAT3,_RFPSA21,RESP046,"(39.49324039, -117.071840564)"
|
|
2012,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,174,30.3,24.5,36.2,2725,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,32,AGE09,CAT3,_RFPSA21,RESP054,"(39.49324039, -117.071840564)"
|
|
2012,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,728,48.8,44.7,52.8,2714,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,32,BO1,CAT1,_RFPSA21,RESP046,"(39.49324039, -117.071840564)"
|
|
2012,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,613,51.3,47.2,55.3,2715,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,32,BO1,CAT1,_RFPSA21,RESP054,"(39.49324039, -117.071840564)"
|
|
2012,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,36,24.8,14,35.6,2736,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,32,EDUCA1,CAT5,_RFPSA21,RESP046,"(39.49324039, -117.071840564)"
|
|
2012,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,82,75.2,64.4,86,2740,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,32,EDUCA1,CAT5,_RFPSA21,RESP054,"(39.49324039, -117.071840564)"
|
|
2012,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,145,46.9,39,54.7,2737,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,32,EDUCA2,CAT5,_RFPSA21,RESP046,"(39.49324039, -117.071840564)"
|
|
2012,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,180,53.1,45.3,61,2741,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,32,EDUCA2,CAT5,_RFPSA21,RESP054,"(39.49324039, -117.071840564)"
|
|
2012,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,233,53.9,46.4,61.4,2738,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,32,EDUCA3,CAT5,_RFPSA21,RESP046,"(39.49324039, -117.071840564)"
|
|
2012,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,173,46.1,38.6,53.6,2742,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,32,EDUCA3,CAT5,_RFPSA21,RESP054,"(39.49324039, -117.071840564)"
|
|
2012,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,313,61.1,54.6,67.7,2739,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,32,EDUCA4,CAT5,_RFPSA21,RESP046,"(39.49324039, -117.071840564)"
|
|
2012,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,178,38.9,32.4,45.5,2743,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,32,EDUCA4,CAT5,_RFPSA21,RESP054,"(39.49324039, -117.071840564)"
|
|
2012,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,21,26.3,12.8,39.9,2744,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,32,INCOME1,CAT6,_RFPSA21,RESP046,"(39.49324039, -117.071840564)"
|
|
2012,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,67,73.7,60.1,87.2,2749,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,32,INCOME1,CAT6,_RFPSA21,RESP054,"(39.49324039, -117.071840564)"
|
|
2012,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,69,31.4,20.2,42.7,2745,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,32,INCOME2,CAT6,_RFPSA21,RESP046,"(39.49324039, -117.071840564)"
|
|
2012,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,121,68.6,57.4,79.8,2750,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,32,INCOME2,CAT6,_RFPSA21,RESP054,"(39.49324039, -117.071840564)"
|
|
2012,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,53,40.8,27.6,54.1,2746,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,32,INCOME3,CAT6,_RFPSA21,RESP046,"(39.49324039, -117.071840564)"
|
|
2012,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,53,59.2,46,72.4,2751,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,32,INCOME3,CAT6,_RFPSA21,RESP054,"(39.49324039, -117.071840564)"
|
|
2012,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,111,47.3,37.7,57,2747,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,32,INCOME4,CAT6,_RFPSA21,RESP046,"(39.49324039, -117.071840564)"
|
|
2012,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,94,52.7,43,62.3,2752,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,32,INCOME4,CAT6,_RFPSA21,RESP054,"(39.49324039, -117.071840564)"
|
|
2012,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,401,59.3,53.5,65,2748,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,32,INCOME5,CAT6,_RFPSA21,RESP046,"(39.49324039, -117.071840564)"
|
|
2012,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,234,40.8,35,46.5,2753,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,32,INCOME5,CAT6,_RFPSA21,RESP054,"(39.49324039, -117.071840564)"
|
|
2012,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,596,53.1,48.7,57.4,2726,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,32,RACE1,CAT4,_RFPSA21,RESP046,"(39.49324039, -117.071840564)"
|
|
2012,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,435,47,42.6,51.3,2731,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,32,RACE1,CAT4,_RFPSA21,RESP054,"(39.49324039, -117.071840564)"
|
|
2012,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,16,,,,2727,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,32,RACE2,CAT4,_RFPSA21,RESP046,"(39.49324039, -117.071840564)"
|
|
2012,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,16,,,,2732,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,32,RACE2,CAT4,_RFPSA21,RESP054,"(39.49324039, -117.071840564)"
|
|
2012,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,39,23.3,14.4,32.2,2728,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,32,RACE3,CAT4,_RFPSA21,RESP046,"(39.49324039, -117.071840564)"
|
|
2012,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,93,76.7,67.8,85.6,2733,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,32,RACE3,CAT4,_RFPSA21,RESP054,"(39.49324039, -117.071840564)"
|
|
2012,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,37,54.8,35.1,74.5,2729,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,32,RACE4,CAT4,_RFPSA21,RESP046,"(39.49324039, -117.071840564)"
|
|
2012,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,42,45.2,25.5,64.9,2734,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,32,RACE4,CAT4,_RFPSA21,RESP054,"(39.49324039, -117.071840564)"
|
|
2012,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,24,,,,2730,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,32,RACE5,CAT4,_RFPSA21,RESP046,"(39.49324039, -117.071840564)"
|
|
2012,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,23,,,,2735,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,32,RACE5,CAT4,_RFPSA21,RESP054,"(39.49324039, -117.071840564)"
|
|
2012,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,728,48.8,44.7,52.8,2716,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,32,SEX1,CAT2,_RFPSA21,RESP046,"(39.49324039, -117.071840564)"
|
|
2012,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,613,51.3,47.2,55.3,2717,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,32,SEX1,CAT2,_RFPSA21,RESP054,"(39.49324039, -117.071840564)"
|
|
2012,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,55,13.2,9.3,17.2,2711,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,33,AGE06,CAT3,_RFPSA21,RESP046,"(43.655950113, -71.50036092)"
|
|
2012,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,374,86.8,82.9,90.7,2715,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,33,AGE06,CAT3,_RFPSA21,RESP054,"(43.655950113, -71.50036092)"
|
|
2012,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,241,40.3,35.3,45.3,2712,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,33,AGE07,CAT3,_RFPSA21,RESP046,"(43.655950113, -71.50036092)"
|
|
2012,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,362,59.7,54.7,64.7,2716,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,33,AGE07,CAT3,_RFPSA21,RESP054,"(43.655950113, -71.50036092)"
|
|
2012,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,206,61.7,55.3,68,2713,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,33,AGE08,CAT3,_RFPSA21,RESP046,"(43.655950113, -71.50036092)"
|
|
2012,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,140,38.4,32,44.7,2717,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,33,AGE08,CAT3,_RFPSA21,RESP054,"(43.655950113, -71.50036092)"
|
|
2012,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,615,69.3,65.6,73,2714,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,33,AGE09,CAT3,_RFPSA21,RESP046,"(43.655950113, -71.50036092)"
|
|
2012,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,313,30.7,27,34.4,2718,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,33,AGE09,CAT3,_RFPSA21,RESP054,"(43.655950113, -71.50036092)"
|
|
2012,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1117,43.2,40.5,45.8,2707,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,33,BO1,CAT1,_RFPSA21,RESP046,"(43.655950113, -71.50036092)"
|
|
2012,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1189,56.8,54.2,59.5,2708,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,33,BO1,CAT1,_RFPSA21,RESP054,"(43.655950113, -71.50036092)"
|
|
2012,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,44,30,19.8,40.1,2729,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,33,EDUCA1,CAT5,_RFPSA21,RESP046,"(43.655950113, -71.50036092)"
|
|
2012,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,84,70,59.9,80.2,2733,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,33,EDUCA1,CAT5,_RFPSA21,RESP054,"(43.655950113, -71.50036092)"
|
|
2012,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,248,39.1,34.1,44.1,2730,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,33,EDUCA2,CAT5,_RFPSA21,RESP046,"(43.655950113, -71.50036092)"
|
|
2012,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,363,60.9,55.9,65.9,2734,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,33,EDUCA2,CAT5,_RFPSA21,RESP054,"(43.655950113, -71.50036092)"
|
|
2012,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,262,45.1,39.7,50.5,2731,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,33,EDUCA3,CAT5,_RFPSA21,RESP046,"(43.655950113, -71.50036092)"
|
|
2012,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,278,54.9,49.5,60.3,2735,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,33,EDUCA3,CAT5,_RFPSA21,RESP054,"(43.655950113, -71.50036092)"
|
|
2012,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,562,48.6,44.7,52.4,2732,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,33,EDUCA4,CAT5,_RFPSA21,RESP046,"(43.655950113, -71.50036092)"
|
|
2012,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,462,51.4,47.6,55.3,2736,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,33,EDUCA4,CAT5,_RFPSA21,RESP054,"(43.655950113, -71.50036092)"
|
|
2012,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,36,32.8,21.4,44.1,2737,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,33,INCOME1,CAT6,_RFPSA21,RESP046,"(43.655950113, -71.50036092)"
|
|
2012,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,92,67.2,55.9,78.6,2742,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,33,INCOME1,CAT6,_RFPSA21,RESP054,"(43.655950113, -71.50036092)"
|
|
2012,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,119,41.8,33.7,49.9,2738,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,33,INCOME2,CAT6,_RFPSA21,RESP046,"(43.655950113, -71.50036092)"
|
|
2012,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,151,58.2,50.1,66.3,2743,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,33,INCOME2,CAT6,_RFPSA21,RESP054,"(43.655950113, -71.50036092)"
|
|
2012,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,99,37.2,28.7,45.7,2739,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,33,INCOME3,CAT6,_RFPSA21,RESP046,"(43.655950113, -71.50036092)"
|
|
2012,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,131,62.8,54.3,71.3,2744,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,33,INCOME3,CAT6,_RFPSA21,RESP054,"(43.655950113, -71.50036092)"
|
|
2012,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,159,37.2,30.6,43.9,2740,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,33,INCOME4,CAT6,_RFPSA21,RESP046,"(43.655950113, -71.50036092)"
|
|
2012,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,163,62.8,56.1,69.4,2745,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,33,INCOME4,CAT6,_RFPSA21,RESP054,"(43.655950113, -71.50036092)"
|
|
2012,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,613,47.5,43.8,51.1,2741,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,33,INCOME5,CAT6,_RFPSA21,RESP046,"(43.655950113, -71.50036092)"
|
|
2012,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,548,52.5,48.9,56.2,2746,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,33,INCOME5,CAT6,_RFPSA21,RESP054,"(43.655950113, -71.50036092)"
|
|
2012,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1057,44.5,41.7,47.2,2719,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,33,RACE1,CAT4,_RFPSA21,RESP046,"(43.655950113, -71.50036092)"
|
|
2012,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1085,55.5,52.8,58.3,2724,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,33,RACE1,CAT4,_RFPSA21,RESP054,"(43.655950113, -71.50036092)"
|
|
2012,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,4,,,,2720,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,33,RACE2,CAT4,_RFPSA21,RESP046,"(43.655950113, -71.50036092)"
|
|
2012,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,11,,,,2725,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,33,RACE2,CAT4,_RFPSA21,RESP054,"(43.655950113, -71.50036092)"
|
|
2012,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,7,,,,2721,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,33,RACE3,CAT4,_RFPSA21,RESP046,"(43.655950113, -71.50036092)"
|
|
2012,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,21,,,,2726,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,33,RACE3,CAT4,_RFPSA21,RESP054,"(43.655950113, -71.50036092)"
|
|
2012,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,21,32.4,17.3,47.6,2722,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,33,RACE4,CAT4,_RFPSA21,RESP046,"(43.655950113, -71.50036092)"
|
|
2012,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,32,67.6,52.4,82.7,2727,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,33,RACE4,CAT4,_RFPSA21,RESP054,"(43.655950113, -71.50036092)"
|
|
2012,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,12,,,,2723,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,33,RACE5,CAT4,_RFPSA21,RESP046,"(43.655950113, -71.50036092)"
|
|
2012,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,19,,,,2728,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,33,RACE5,CAT4,_RFPSA21,RESP054,"(43.655950113, -71.50036092)"
|
|
2012,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1117,43.2,40.5,45.8,2709,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,33,SEX1,CAT2,_RFPSA21,RESP046,"(43.655950113, -71.50036092)"
|
|
2012,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1189,56.8,54.2,59.5,2710,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,33,SEX1,CAT2,_RFPSA21,RESP054,"(43.655950113, -71.50036092)"
|
|
2012,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,211,19.2,16.1,22.3,2724,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,AGE06,CAT3,_RFPSA21,RESP046,"(40.130570048, -74.273691288)"
|
|
2012,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,763,80.8,77.7,83.9,2728,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,AGE06,CAT3,_RFPSA21,RESP054,"(40.130570048, -74.273691288)"
|
|
2012,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,624,47.3,43.4,51.2,2725,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,AGE07,CAT3,_RFPSA21,RESP046,"(40.130570048, -74.273691288)"
|
|
2012,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,581,52.7,48.8,56.6,2729,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,AGE07,CAT3,_RFPSA21,RESP054,"(40.130570048, -74.273691288)"
|
|
2012,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,376,62.3,56.6,67.9,2726,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,AGE08,CAT3,_RFPSA21,RESP046,"(40.130570048, -74.273691288)"
|
|
2012,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,195,37.7,32.1,43.4,2730,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,AGE08,CAT3,_RFPSA21,RESP054,"(40.130570048, -74.273691288)"
|
|
2012,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,1091,73.8,70.3,77.3,2727,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,AGE09,CAT3,_RFPSA21,RESP046,"(40.130570048, -74.273691288)"
|
|
2012,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,389,26.2,22.7,29.7,2731,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,AGE09,CAT3,_RFPSA21,RESP054,"(40.130570048, -74.273691288)"
|
|
2012,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,2302,47.6,45.5,49.7,2720,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,BO1,CAT1,_RFPSA21,RESP046,"(40.130570048, -74.273691288)"
|
|
2012,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1928,52.4,50.3,54.5,2721,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,BO1,CAT1,_RFPSA21,RESP054,"(40.130570048, -74.273691288)"
|
|
2012,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,130,37.3,30.4,44.2,2742,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,EDUCA1,CAT5,_RFPSA21,RESP046,"(40.130570048, -74.273691288)"
|
|
2012,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,184,62.7,55.8,69.6,2746,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,EDUCA1,CAT5,_RFPSA21,RESP054,"(40.130570048, -74.273691288)"
|
|
2012,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,569,44.6,40.7,48.5,2743,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,EDUCA2,CAT5,_RFPSA21,RESP046,"(40.130570048, -74.273691288)"
|
|
2012,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,591,55.4,51.5,59.4,2747,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,EDUCA2,CAT5,_RFPSA21,RESP054,"(40.130570048, -74.273691288)"
|
|
2012,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,482,45.9,41.3,50.5,2744,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,EDUCA3,CAT5,_RFPSA21,RESP046,"(40.130570048, -74.273691288)"
|
|
2012,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,406,54.1,49.5,58.7,2748,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,EDUCA3,CAT5,_RFPSA21,RESP054,"(40.130570048, -74.273691288)"
|
|
2012,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,1117,54.8,51.6,58,2745,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,EDUCA4,CAT5,_RFPSA21,RESP046,"(40.130570048, -74.273691288)"
|
|
2012,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,742,45.2,42,48.4,2749,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,EDUCA4,CAT5,_RFPSA21,RESP054,"(40.130570048, -74.273691288)"
|
|
2012,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,80,30.1,22.4,37.8,2750,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,INCOME1,CAT6,_RFPSA21,RESP046,"(40.130570048, -74.273691288)"
|
|
2012,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,154,69.9,62.2,77.6,2755,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,INCOME1,CAT6,_RFPSA21,RESP054,"(40.130570048, -74.273691288)"
|
|
2012,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,222,40.4,34.3,46.5,2751,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,INCOME2,CAT6,_RFPSA21,RESP046,"(40.130570048, -74.273691288)"
|
|
2012,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,276,59.6,53.5,65.7,2756,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,INCOME2,CAT6,_RFPSA21,RESP054,"(40.130570048, -74.273691288)"
|
|
2012,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,156,45.6,36.8,54.4,2752,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,INCOME3,CAT6,_RFPSA21,RESP046,"(40.130570048, -74.273691288)"
|
|
2012,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,148,54.4,45.6,63.2,2757,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,INCOME3,CAT6,_RFPSA21,RESP054,"(40.130570048, -74.273691288)"
|
|
2012,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,264,46.1,39.6,52.6,2753,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,INCOME4,CAT6,_RFPSA21,RESP046,"(40.130570048, -74.273691288)"
|
|
2012,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,213,53.9,47.4,60.5,2758,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,INCOME4,CAT6,_RFPSA21,RESP054,"(40.130570048, -74.273691288)"
|
|
2012,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,1326,51.2,48.4,54.1,2754,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,INCOME5,CAT6,_RFPSA21,RESP046,"(40.130570048, -74.273691288)"
|
|
2012,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,948,48.8,45.9,51.6,2759,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,INCOME5,CAT6,_RFPSA21,RESP054,"(40.130570048, -74.273691288)"
|
|
2012,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1849,52.8,50.4,55.2,2732,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,RACE1,CAT4,_RFPSA21,RESP046,"(40.130570048, -74.273691288)"
|
|
2012,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1338,47.2,44.8,49.6,2737,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,RACE1,CAT4,_RFPSA21,RESP054,"(40.130570048, -74.273691288)"
|
|
2012,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,192,42.9,36.5,49.4,2733,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,RACE2,CAT4,_RFPSA21,RESP046,"(40.130570048, -74.273691288)"
|
|
2012,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,191,57.1,50.6,63.6,2738,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,RACE2,CAT4,_RFPSA21,RESP054,"(40.130570048, -74.273691288)"
|
|
2012,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,136,34.5,28.2,40.9,2734,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,RACE3,CAT4,_RFPSA21,RESP046,"(40.130570048, -74.273691288)"
|
|
2012,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,216,65.5,59.1,71.8,2739,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,RACE3,CAT4,_RFPSA21,RESP054,"(40.130570048, -74.273691288)"
|
|
2012,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,76,34.5,25.1,43.9,2735,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,RACE4,CAT4,_RFPSA21,RESP046,"(40.130570048, -74.273691288)"
|
|
2012,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,133,65.5,56.1,74.9,2740,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,RACE4,CAT4,_RFPSA21,RESP054,"(40.130570048, -74.273691288)"
|
|
2012,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,7,,,,2736,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,34,RACE5,CAT4,_RFPSA21,RESP046,"(40.130570048, -74.273691288)"
|
|
2012,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,12,,,,2741,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,34,RACE5,CAT4,_RFPSA21,RESP054,"(40.130570048, -74.273691288)"
|
|
2012,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,2302,47.6,45.5,49.7,2722,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,SEX1,CAT2,_RFPSA21,RESP046,"(40.130570048, -74.273691288)"
|
|
2012,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1928,52.4,50.3,54.5,2723,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,SEX1,CAT2,_RFPSA21,RESP054,"(40.130570048, -74.273691288)"
|
|
2012,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,380,84.9,81,88.8,2722,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,35,AGE06,CAT3,_RFPSA21,RESP054,"(34.520880952, -106.240580985)"
|
|
2012,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,78,15.1,11.2,19,2718,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,35,AGE06,CAT3,_RFPSA21,RESP046,"(34.520880952, -106.240580985)"
|
|
2012,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,260,36.5,32.2,40.8,2719,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,35,AGE07,CAT3,_RFPSA21,RESP046,"(34.520880952, -106.240580985)"
|
|
2012,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,379,63.5,59.2,67.9,2723,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,35,AGE07,CAT3,_RFPSA21,RESP054,"(34.520880952, -106.240580985)"
|
|
2012,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,184,48.5,42.5,54.5,2720,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,35,AGE08,CAT3,_RFPSA21,RESP046,"(34.520880952, -106.240580985)"
|
|
2012,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,189,51.5,45.5,57.5,2724,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,35,AGE08,CAT3,_RFPSA21,RESP054,"(34.520880952, -106.240580985)"
|
|
2012,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,533,62.5,58.6,66.4,2721,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,35,AGE09,CAT3,_RFPSA21,RESP046,"(34.520880952, -106.240580985)"
|
|
2012,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,304,37.5,33.6,41.4,2725,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,35,AGE09,CAT3,_RFPSA21,RESP054,"(34.520880952, -106.240580985)"
|
|
2012,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1055,39.9,37.6,42.2,2714,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,35,BO1,CAT1,_RFPSA21,RESP046,"(34.520880952, -106.240580985)"
|
|
2012,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1252,60.1,57.8,62.4,2715,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,35,BO1,CAT1,_RFPSA21,RESP054,"(34.520880952, -106.240580985)"
|
|
2012,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,69,25.7,19.3,32,2736,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,35,EDUCA1,CAT5,_RFPSA21,RESP046,"(34.520880952, -106.240580985)"
|
|
2012,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,165,74.3,68,80.7,2740,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,35,EDUCA1,CAT5,_RFPSA21,RESP054,"(34.520880952, -106.240580985)"
|
|
2012,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,221,35.4,30.9,39.9,2737,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,35,EDUCA2,CAT5,_RFPSA21,RESP046,"(34.520880952, -106.240580985)"
|
|
2012,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,351,64.6,60.1,69.1,2741,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,35,EDUCA2,CAT5,_RFPSA21,RESP054,"(34.520880952, -106.240580985)"
|
|
2012,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,236,37.2,32.6,41.7,2738,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,35,EDUCA3,CAT5,_RFPSA21,RESP046,"(34.520880952, -106.240580985)"
|
|
2012,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,335,62.9,58.3,67.4,2742,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,35,EDUCA3,CAT5,_RFPSA21,RESP054,"(34.520880952, -106.240580985)"
|
|
2012,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,527,54.2,50.5,57.9,2739,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,35,EDUCA4,CAT5,_RFPSA21,RESP046,"(34.520880952, -106.240580985)"
|
|
2012,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,399,45.8,42.1,49.5,2743,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,35,EDUCA4,CAT5,_RFPSA21,RESP054,"(34.520880952, -106.240580985)"
|
|
2012,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,78,27.7,20.8,34.6,2744,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,35,INCOME1,CAT6,_RFPSA21,RESP046,"(34.520880952, -106.240580985)"
|
|
2012,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,174,72.3,65.4,79.2,2749,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,35,INCOME1,CAT6,_RFPSA21,RESP054,"(34.520880952, -106.240580985)"
|
|
2012,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,127,27.6,22.5,32.7,2745,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,35,INCOME2,CAT6,_RFPSA21,RESP046,"(34.520880952, -106.240580985)"
|
|
2012,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,244,72.4,67.3,77.5,2750,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,35,INCOME2,CAT6,_RFPSA21,RESP054,"(34.520880952, -106.240580985)"
|
|
2012,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,101,37.4,30.2,44.6,2746,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,35,INCOME3,CAT6,_RFPSA21,RESP046,"(34.520880952, -106.240580985)"
|
|
2012,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,126,62.6,55.5,69.8,2751,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,35,INCOME3,CAT6,_RFPSA21,RESP054,"(34.520880952, -106.240580985)"
|
|
2012,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,162,47,40.6,53.5,2747,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,35,INCOME4,CAT6,_RFPSA21,RESP046,"(34.520880952, -106.240580985)"
|
|
2012,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,157,53,46.5,59.4,2752,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,35,INCOME4,CAT6,_RFPSA21,RESP054,"(34.520880952, -106.240580985)"
|
|
2012,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,504,47.6,43.9,51.4,2748,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,35,INCOME5,CAT6,_RFPSA21,RESP046,"(34.520880952, -106.240580985)"
|
|
2012,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,459,52.4,48.6,56.1,2753,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,35,INCOME5,CAT6,_RFPSA21,RESP054,"(34.520880952, -106.240580985)"
|
|
2012,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,741,49.5,46.4,52.6,2726,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,35,RACE1,CAT4,_RFPSA21,RESP046,"(34.520880952, -106.240580985)"
|
|
2012,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,642,50.5,47.4,53.6,2731,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,35,RACE1,CAT4,_RFPSA21,RESP054,"(34.520880952, -106.240580985)"
|
|
2012,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,12,,,,2727,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,35,RACE2,CAT4,_RFPSA21,RESP046,"(34.520880952, -106.240580985)"
|
|
2012,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,19,,,,2732,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,35,RACE2,CAT4,_RFPSA21,RESP054,"(34.520880952, -106.240580985)"
|
|
2012,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,241,31,27,34.9,2728,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,35,RACE3,CAT4,_RFPSA21,RESP046,"(34.520880952, -106.240580985)"
|
|
2012,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,461,69.1,65.1,73,2733,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,35,RACE3,CAT4,_RFPSA21,RESP054,"(34.520880952, -106.240580985)"
|
|
2012,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,34,19.6,12.5,26.7,2729,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,35,RACE4,CAT4,_RFPSA21,RESP046,"(34.520880952, -106.240580985)"
|
|
2012,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,103,80.4,73.3,87.5,2734,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,35,RACE4,CAT4,_RFPSA21,RESP054,"(34.520880952, -106.240580985)"
|
|
2012,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,10,,,,2730,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,35,RACE5,CAT4,_RFPSA21,RESP046,"(34.520880952, -106.240580985)"
|
|
2012,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,18,,,,2735,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,35,RACE5,CAT4,_RFPSA21,RESP054,"(34.520880952, -106.240580985)"
|
|
2012,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1055,39.9,37.6,42.2,2716,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,35,SEX1,CAT2,_RFPSA21,RESP046,"(34.520880952, -106.240580985)"
|
|
2012,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1252,60.1,57.8,62.4,2717,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,35,SEX1,CAT2,_RFPSA21,RESP054,"(34.520880952, -106.240580985)"
|
|
2012,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,83,21.8,16.1,27.4,2716,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,36,AGE06,CAT3,_RFPSA21,RESP046,"(42.827001032, -75.543970427)"
|
|
2012,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,252,78.2,72.6,83.9,2720,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,36,AGE06,CAT3,_RFPSA21,RESP054,"(42.827001032, -75.543970427)"
|
|
2012,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,189,44.9,38.9,50.9,2717,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,36,AGE07,CAT3,_RFPSA21,RESP046,"(42.827001032, -75.543970427)"
|
|
2012,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,250,55.1,49.2,61.1,2721,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,36,AGE07,CAT3,_RFPSA21,RESP054,"(42.827001032, -75.543970427)"
|
|
2012,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,151,63.4,54.4,72.4,2718,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,36,AGE08,CAT3,_RFPSA21,RESP046,"(42.827001032, -75.543970427)"
|
|
2012,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,84,36.6,27.7,45.6,2722,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,36,AGE08,CAT3,_RFPSA21,RESP054,"(42.827001032, -75.543970427)"
|
|
2012,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,387,69.2,63.7,74.7,2719,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,36,AGE09,CAT3,_RFPSA21,RESP046,"(42.827001032, -75.543970427)"
|
|
2012,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,178,30.8,25.3,36.3,2723,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,36,AGE09,CAT3,_RFPSA21,RESP054,"(42.827001032, -75.543970427)"
|
|
2012,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,810,47.4,44,50.8,2712,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,36,BO1,CAT1,_RFPSA21,RESP046,"(42.827001032, -75.543970427)"
|
|
2012,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,764,52.6,49.2,56,2713,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,36,BO1,CAT1,_RFPSA21,RESP054,"(42.827001032, -75.543970427)"
|
|
2012,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,50,38.4,27.2,49.6,2734,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,36,EDUCA1,CAT5,_RFPSA21,RESP046,"(42.827001032, -75.543970427)"
|
|
2012,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,89,61.6,50.4,72.8,2738,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,36,EDUCA1,CAT5,_RFPSA21,RESP054,"(42.827001032, -75.543970427)"
|
|
2012,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,206,48.7,42.5,54.9,2735,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,36,EDUCA2,CAT5,_RFPSA21,RESP046,"(42.827001032, -75.543970427)"
|
|
2012,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,219,51.3,45.1,57.5,2739,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,36,EDUCA2,CAT5,_RFPSA21,RESP054,"(42.827001032, -75.543970427)"
|
|
2012,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,177,46.2,39.3,53.1,2736,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,36,EDUCA3,CAT5,_RFPSA21,RESP046,"(42.827001032, -75.543970427)"
|
|
2012,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,161,53.8,46.9,60.7,2740,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,36,EDUCA3,CAT5,_RFPSA21,RESP054,"(42.827001032, -75.543970427)"
|
|
2012,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,375,52,47,57,2737,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,36,EDUCA4,CAT5,_RFPSA21,RESP046,"(42.827001032, -75.543970427)"
|
|
2012,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,293,48,43,53.1,2741,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,36,EDUCA4,CAT5,_RFPSA21,RESP054,"(42.827001032, -75.543970427)"
|
|
2012,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,61,38.7,28,49.4,2742,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,36,INCOME1,CAT6,_RFPSA21,RESP046,"(42.827001032, -75.543970427)"
|
|
2012,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,85,61.3,50.6,72,2747,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,36,INCOME1,CAT6,_RFPSA21,RESP054,"(42.827001032, -75.543970427)"
|
|
2012,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,90,51.1,41.3,60.8,2743,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,36,INCOME2,CAT6,_RFPSA21,RESP046,"(42.827001032, -75.543970427)"
|
|
2012,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,106,48.9,39.2,58.7,2748,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,36,INCOME2,CAT6,_RFPSA21,RESP054,"(42.827001032, -75.543970427)"
|
|
2012,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,61,33.5,22.7,44.3,2744,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,36,INCOME3,CAT6,_RFPSA21,RESP046,"(42.827001032, -75.543970427)"
|
|
2012,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,71,66.5,55.7,77.3,2749,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,36,INCOME3,CAT6,_RFPSA21,RESP054,"(42.827001032, -75.543970427)"
|
|
2012,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,105,48.6,39.2,58,2745,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,36,INCOME4,CAT6,_RFPSA21,RESP046,"(42.827001032, -75.543970427)"
|
|
2012,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,92,51.4,42,60.8,2750,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,36,INCOME4,CAT6,_RFPSA21,RESP054,"(42.827001032, -75.543970427)"
|
|
2012,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,415,50.1,45.5,54.6,2746,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,36,INCOME5,CAT6,_RFPSA21,RESP046,"(42.827001032, -75.543970427)"
|
|
2012,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,345,49.9,45.4,54.5,2751,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,36,INCOME5,CAT6,_RFPSA21,RESP054,"(42.827001032, -75.543970427)"
|
|
2012,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,670,50.5,47.1,53.9,2724,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,36,RACE1,CAT4,_RFPSA21,RESP046,"(42.827001032, -75.543970427)"
|
|
2012,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,590,49.5,46.1,52.9,2729,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,36,RACE1,CAT4,_RFPSA21,RESP054,"(42.827001032, -75.543970427)"
|
|
2012,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,43,48.2,35.5,60.9,2725,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,36,RACE2,CAT4,_RFPSA21,RESP046,"(42.827001032, -75.543970427)"
|
|
2012,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,50,51.8,39.1,64.5,2730,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,36,RACE2,CAT4,_RFPSA21,RESP054,"(42.827001032, -75.543970427)"
|
|
2012,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,58,40.7,30.4,51,2726,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,36,RACE3,CAT4,_RFPSA21,RESP046,"(42.827001032, -75.543970427)"
|
|
2012,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,68,59.3,49,69.6,2731,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,36,RACE3,CAT4,_RFPSA21,RESP054,"(42.827001032, -75.543970427)"
|
|
2012,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,11,,,,2727,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,36,RACE4,CAT4,_RFPSA21,RESP046,"(42.827001032, -75.543970427)"
|
|
2012,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,31,,,,2732,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,36,RACE4,CAT4,_RFPSA21,RESP054,"(42.827001032, -75.543970427)"
|
|
2012,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,5,,,,2728,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,36,RACE5,CAT4,_RFPSA21,RESP046,"(42.827001032, -75.543970427)"
|
|
2012,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,10,,,,2733,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,36,RACE5,CAT4,_RFPSA21,RESP054,"(42.827001032, -75.543970427)"
|
|
2012,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,810,47.4,44,50.8,2714,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,36,SEX1,CAT2,_RFPSA21,RESP046,"(42.827001032, -75.543970427)"
|
|
2012,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,764,52.6,49.2,56,2715,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,36,SEX1,CAT2,_RFPSA21,RESP054,"(42.827001032, -75.543970427)"
|
|
2012,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,165,22.2,18.7,25.8,2725,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,AGE06,CAT3,_RFPSA21,RESP046,"(35.466220975, -79.159250463)"
|
|
2012,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,541,77.8,74.2,81.3,2729,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,AGE06,CAT3,_RFPSA21,RESP054,"(35.466220975, -79.159250463)"
|
|
2012,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,393,49.3,44.8,53.8,2726,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,AGE07,CAT3,_RFPSA21,RESP046,"(35.466220975, -79.159250463)"
|
|
2012,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,380,50.7,46.2,55.2,2730,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,AGE07,CAT3,_RFPSA21,RESP054,"(35.466220975, -79.159250463)"
|
|
2012,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,317,65.5,59.8,71.1,2727,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,AGE08,CAT3,_RFPSA21,RESP046,"(35.466220975, -79.159250463)"
|
|
2012,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,144,34.6,28.9,40.2,2731,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,AGE08,CAT3,_RFPSA21,RESP054,"(35.466220975, -79.159250463)"
|
|
2012,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,816,70.3,66.8,73.7,2728,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,AGE09,CAT3,_RFPSA21,RESP046,"(35.466220975, -79.159250463)"
|
|
2012,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,348,29.7,26.3,33.2,2732,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,AGE09,CAT3,_RFPSA21,RESP054,"(35.466220975, -79.159250463)"
|
|
2012,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1691,48.7,46.5,50.9,2721,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,BO1,CAT1,_RFPSA21,RESP046,"(35.466220975, -79.159250463)"
|
|
2012,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1413,51.3,49.1,53.5,2722,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,BO1,CAT1,_RFPSA21,RESP054,"(35.466220975, -79.159250463)"
|
|
2012,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,137,29.8,24.3,35.2,2743,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,EDUCA1,CAT5,_RFPSA21,RESP046,"(35.466220975, -79.159250463)"
|
|
2012,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,265,70.3,64.8,75.7,2747,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,EDUCA1,CAT5,_RFPSA21,RESP054,"(35.466220975, -79.159250463)"
|
|
2012,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,406,43.2,39.1,47.3,2744,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,EDUCA2,CAT5,_RFPSA21,RESP046,"(35.466220975, -79.159250463)"
|
|
2012,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,441,56.8,52.8,60.9,2748,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,EDUCA2,CAT5,_RFPSA21,RESP054,"(35.466220975, -79.159250463)"
|
|
2012,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,446,54.5,50.2,58.8,2745,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,EDUCA3,CAT5,_RFPSA21,RESP046,"(35.466220975, -79.159250463)"
|
|
2012,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,321,45.5,41.2,49.8,2749,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,EDUCA3,CAT5,_RFPSA21,RESP054,"(35.466220975, -79.159250463)"
|
|
2012,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,698,60.9,57.2,64.7,2746,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,EDUCA4,CAT5,_RFPSA21,RESP046,"(35.466220975, -79.159250463)"
|
|
2012,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,381,39.1,35.3,42.8,2750,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,EDUCA4,CAT5,_RFPSA21,RESP054,"(35.466220975, -79.159250463)"
|
|
2012,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,112,30.3,24.2,36.3,2751,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,INCOME1,CAT6,_RFPSA21,RESP046,"(35.466220975, -79.159250463)"
|
|
2012,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,207,69.7,63.7,75.8,2756,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,INCOME1,CAT6,_RFPSA21,RESP054,"(35.466220975, -79.159250463)"
|
|
2012,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,200,38.2,32.7,43.7,2752,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,INCOME2,CAT6,_RFPSA21,RESP046,"(35.466220975, -79.159250463)"
|
|
2012,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,266,61.8,56.3,67.3,2757,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,INCOME2,CAT6,_RFPSA21,RESP054,"(35.466220975, -79.159250463)"
|
|
2012,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,176,47.3,41,53.7,2753,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,INCOME3,CAT6,_RFPSA21,RESP046,"(35.466220975, -79.159250463)"
|
|
2012,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,163,52.7,46.4,59.1,2758,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,INCOME3,CAT6,_RFPSA21,RESP054,"(35.466220975, -79.159250463)"
|
|
2012,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,245,48.5,42.2,54.7,2754,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,INCOME4,CAT6,_RFPSA21,RESP046,"(35.466220975, -79.159250463)"
|
|
2012,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,171,51.6,45.3,57.8,2759,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,INCOME4,CAT6,_RFPSA21,RESP054,"(35.466220975, -79.159250463)"
|
|
2012,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,761,59.1,55.6,62.7,2755,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,INCOME5,CAT6,_RFPSA21,RESP046,"(35.466220975, -79.159250463)"
|
|
2012,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,438,40.9,37.4,44.5,2760,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,INCOME5,CAT6,_RFPSA21,RESP054,"(35.466220975, -79.159250463)"
|
|
2012,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1280,50.2,47.6,52.8,2733,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,RACE1,CAT4,_RFPSA21,RESP046,"(35.466220975, -79.159250463)"
|
|
2012,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,992,49.8,47.2,52.4,2738,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,RACE1,CAT4,_RFPSA21,RESP054,"(35.466220975, -79.159250463)"
|
|
2012,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,266,51.6,46,57.2,2734,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,RACE2,CAT4,_RFPSA21,RESP046,"(35.466220975, -79.159250463)"
|
|
2012,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,203,48.4,42.8,54,2739,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,RACE2,CAT4,_RFPSA21,RESP054,"(35.466220975, -79.159250463)"
|
|
2012,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,29,23.5,13.9,33.2,2735,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,RACE3,CAT4,_RFPSA21,RESP046,"(35.466220975, -79.159250463)"
|
|
2012,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,89,76.5,66.8,86.1,2740,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,RACE3,CAT4,_RFPSA21,RESP054,"(35.466220975, -79.159250463)"
|
|
2012,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,87,37.3,27,47.7,2736,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,RACE4,CAT4,_RFPSA21,RESP046,"(35.466220975, -79.159250463)"
|
|
2012,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,95,62.7,52.3,73,2741,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,RACE4,CAT4,_RFPSA21,RESP054,"(35.466220975, -79.159250463)"
|
|
2012,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,20,,,,2737,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,37,RACE5,CAT4,_RFPSA21,RESP046,"(35.466220975, -79.159250463)"
|
|
2012,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,23,,,,2742,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,37,RACE5,CAT4,_RFPSA21,RESP054,"(35.466220975, -79.159250463)"
|
|
2012,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1691,48.7,46.5,50.9,2723,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,SEX1,CAT2,_RFPSA21,RESP046,"(35.466220975, -79.159250463)"
|
|
2012,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1413,51.3,49.1,53.5,2724,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,SEX1,CAT2,_RFPSA21,RESP054,"(35.466220975, -79.159250463)"
|
|
2012,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,50,16.7,11.3,22.2,2686,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,38,AGE06,CAT3,_RFPSA21,RESP046,"(47.475319779, -100.118421049)"
|
|
2012,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,239,83.3,77.8,88.7,2690,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,38,AGE06,CAT3,_RFPSA21,RESP054,"(47.475319779, -100.118421049)"
|
|
2012,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,178,37.3,31.8,42.7,2687,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,38,AGE07,CAT3,_RFPSA21,RESP046,"(47.475319779, -100.118421049)"
|
|
2012,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,260,62.7,57.3,68.2,2691,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,38,AGE07,CAT3,_RFPSA21,RESP054,"(47.475319779, -100.118421049)"
|
|
2012,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,158,62.9,55.4,70.3,2688,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,38,AGE08,CAT3,_RFPSA21,RESP046,"(47.475319779, -100.118421049)"
|
|
2012,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,85,37.1,29.7,44.6,2692,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,38,AGE08,CAT3,_RFPSA21,RESP054,"(47.475319779, -100.118421049)"
|
|
2012,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,343,66.7,62,71.4,2689,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,38,AGE09,CAT3,_RFPSA21,RESP046,"(47.475319779, -100.118421049)"
|
|
2012,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,180,33.3,28.6,38.1,2693,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,38,AGE09,CAT3,_RFPSA21,RESP054,"(47.475319779, -100.118421049)"
|
|
2012,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,729,44.8,41.7,47.8,2682,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,38,BO1,CAT1,_RFPSA21,RESP046,"(47.475319779, -100.118421049)"
|
|
2012,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,764,55.2,52.2,58.3,2683,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,38,BO1,CAT1,_RFPSA21,RESP054,"(47.475319779, -100.118421049)"
|
|
2012,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,56,44.1,33.6,54.7,2704,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,38,EDUCA1,CAT5,_RFPSA21,RESP046,"(47.475319779, -100.118421049)"
|
|
2012,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,63,55.9,45.3,66.5,2708,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,38,EDUCA1,CAT5,_RFPSA21,RESP054,"(47.475319779, -100.118421049)"
|
|
2012,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,206,42.4,37,47.9,2705,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,38,EDUCA2,CAT5,_RFPSA21,RESP046,"(47.475319779, -100.118421049)"
|
|
2012,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,255,57.6,52.1,63,2709,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,38,EDUCA2,CAT5,_RFPSA21,RESP054,"(47.475319779, -100.118421049)"
|
|
2012,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,212,43.9,38.4,49.4,2706,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,38,EDUCA3,CAT5,_RFPSA21,RESP046,"(47.475319779, -100.118421049)"
|
|
2012,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,230,56.1,50.6,61.6,2710,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,38,EDUCA3,CAT5,_RFPSA21,RESP054,"(47.475319779, -100.118421049)"
|
|
2012,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,254,49.3,44,54.7,2707,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,38,EDUCA4,CAT5,_RFPSA21,RESP046,"(47.475319779, -100.118421049)"
|
|
2012,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,216,50.7,45.3,56,2711,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,38,EDUCA4,CAT5,_RFPSA21,RESP054,"(47.475319779, -100.118421049)"
|
|
2012,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,24,28.7,16.4,41.1,2712,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,38,INCOME1,CAT6,_RFPSA21,RESP046,"(47.475319779, -100.118421049)"
|
|
2012,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,51,71.3,58.9,83.6,2717,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,38,INCOME1,CAT6,_RFPSA21,RESP054,"(47.475319779, -100.118421049)"
|
|
2012,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,75,39,29.9,48.1,2713,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,38,INCOME2,CAT6,_RFPSA21,RESP046,"(47.475319779, -100.118421049)"
|
|
2012,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,96,61,51.9,70.1,2718,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,38,INCOME2,CAT6,_RFPSA21,RESP054,"(47.475319779, -100.118421049)"
|
|
2012,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,74,49.9,39.5,60.2,2714,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,38,INCOME3,CAT6,_RFPSA21,RESP046,"(47.475319779, -100.118421049)"
|
|
2012,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,76,50.1,39.8,60.5,2719,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,38,INCOME3,CAT6,_RFPSA21,RESP054,"(47.475319779, -100.118421049)"
|
|
2012,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,143,44.3,37.3,51.2,2715,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,38,INCOME4,CAT6,_RFPSA21,RESP046,"(47.475319779, -100.118421049)"
|
|
2012,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,136,55.7,48.8,62.7,2720,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,38,INCOME4,CAT6,_RFPSA21,RESP054,"(47.475319779, -100.118421049)"
|
|
2012,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,367,46.1,41.7,50.5,2716,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,38,INCOME5,CAT6,_RFPSA21,RESP046,"(47.475319779, -100.118421049)"
|
|
2012,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,360,53.9,49.5,58.3,2721,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,38,INCOME5,CAT6,_RFPSA21,RESP054,"(47.475319779, -100.118421049)"
|
|
2012,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,699,46.3,43.1,49.5,2694,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,38,RACE1,CAT4,_RFPSA21,RESP046,"(47.475319779, -100.118421049)"
|
|
2012,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,703,53.7,50.5,56.9,2699,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,38,RACE1,CAT4,_RFPSA21,RESP054,"(47.475319779, -100.118421049)"
|
|
2012,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,1,,,,2695,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,38,RACE2,CAT4,_RFPSA21,RESP046,"(47.475319779, -100.118421049)"
|
|
2012,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,4,,,,2700,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,38,RACE2,CAT4,_RFPSA21,RESP054,"(47.475319779, -100.118421049)"
|
|
2012,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,7,,,,2696,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,38,RACE3,CAT4,_RFPSA21,RESP046,"(47.475319779, -100.118421049)"
|
|
2012,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,10,,,,2701,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,38,RACE3,CAT4,_RFPSA21,RESP054,"(47.475319779, -100.118421049)"
|
|
2012,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,9,,,,2697,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,38,RACE4,CAT4,_RFPSA21,RESP046,"(47.475319779, -100.118421049)"
|
|
2012,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,25,,,,2702,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,38,RACE4,CAT4,_RFPSA21,RESP054,"(47.475319779, -100.118421049)"
|
|
2012,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,3,,,,2698,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,38,RACE5,CAT4,_RFPSA21,RESP046,"(47.475319779, -100.118421049)"
|
|
2012,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,5,,,,2703,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,38,RACE5,CAT4,_RFPSA21,RESP054,"(47.475319779, -100.118421049)"
|
|
2012,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,729,44.8,41.7,47.8,2684,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,38,SEX1,CAT2,_RFPSA21,RESP046,"(47.475319779, -100.118421049)"
|
|
2012,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,764,55.2,52.2,58.3,2685,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,38,SEX1,CAT2,_RFPSA21,RESP054,"(47.475319779, -100.118421049)"
|
|
2012,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,132,18.6,14.9,22.3,2725,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,39,AGE06,CAT3,_RFPSA21,RESP046,"(40.060210141, -82.404260056)"
|
|
2012,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,559,81.4,77.7,85.1,2729,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,39,AGE06,CAT3,_RFPSA21,RESP054,"(40.060210141, -82.404260056)"
|
|
2012,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,508,44.2,40.3,48.2,2726,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,39,AGE07,CAT3,_RFPSA21,RESP046,"(40.060210141, -82.404260056)"
|
|
2012,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,602,55.8,51.8,59.8,2730,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,39,AGE07,CAT3,_RFPSA21,RESP054,"(40.060210141, -82.404260056)"
|
|
2012,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,345,62.3,56.6,68.1,2727,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,39,AGE08,CAT3,_RFPSA21,RESP046,"(40.060210141, -82.404260056)"
|
|
2012,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,188,37.7,31.9,43.4,2731,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,39,AGE08,CAT3,_RFPSA21,RESP054,"(40.060210141, -82.404260056)"
|
|
2012,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,840,65.5,61.8,69.2,2728,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,39,AGE09,CAT3,_RFPSA21,RESP046,"(40.060210141, -82.404260056)"
|
|
2012,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,419,34.5,30.8,38.2,2732,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,39,AGE09,CAT3,_RFPSA21,RESP054,"(40.060210141, -82.404260056)"
|
|
2012,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1825,45.1,42.9,47.3,2721,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,39,BO1,CAT1,_RFPSA21,RESP046,"(40.060210141, -82.404260056)"
|
|
2012,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1768,54.9,52.7,57.1,2722,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,39,BO1,CAT1,_RFPSA21,RESP054,"(40.060210141, -82.404260056)"
|
|
2012,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,98,34.1,26.8,41.3,2743,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,39,EDUCA1,CAT5,_RFPSA21,RESP046,"(40.060210141, -82.404260056)"
|
|
2012,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,173,65.9,58.7,73.2,2747,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,39,EDUCA1,CAT5,_RFPSA21,RESP054,"(40.060210141, -82.404260056)"
|
|
2012,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,619,42.8,39.3,46.3,2744,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,39,EDUCA2,CAT5,_RFPSA21,RESP046,"(40.060210141, -82.404260056)"
|
|
2012,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,709,57.2,53.7,60.7,2748,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,39,EDUCA2,CAT5,_RFPSA21,RESP054,"(40.060210141, -82.404260056)"
|
|
2012,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,426,46.5,42,51.1,2745,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,39,EDUCA3,CAT5,_RFPSA21,RESP046,"(40.060210141, -82.404260056)"
|
|
2012,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,406,53.5,48.9,58,2749,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,39,EDUCA3,CAT5,_RFPSA21,RESP054,"(40.060210141, -82.404260056)"
|
|
2012,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,680,53.3,49.5,57,2746,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,39,EDUCA4,CAT5,_RFPSA21,RESP046,"(40.060210141, -82.404260056)"
|
|
2012,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,477,46.7,43,50.5,2750,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,39,EDUCA4,CAT5,_RFPSA21,RESP054,"(40.060210141, -82.404260056)"
|
|
2012,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,85,26.9,19.7,34,2751,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,39,INCOME1,CAT6,_RFPSA21,RESP046,"(40.060210141, -82.404260056)"
|
|
2012,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,200,73.1,66,80.3,2756,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,39,INCOME1,CAT6,_RFPSA21,RESP054,"(40.060210141, -82.404260056)"
|
|
2012,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,255,36.5,31.4,41.7,2752,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,39,INCOME2,CAT6,_RFPSA21,RESP046,"(40.060210141, -82.404260056)"
|
|
2012,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,328,63.5,58.3,68.6,2757,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,39,INCOME2,CAT6,_RFPSA21,RESP054,"(40.060210141, -82.404260056)"
|
|
2012,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,218,45,38.3,51.6,2753,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,39,INCOME3,CAT6,_RFPSA21,RESP046,"(40.060210141, -82.404260056)"
|
|
2012,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,197,55,48.4,61.7,2758,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,39,INCOME3,CAT6,_RFPSA21,RESP054,"(40.060210141, -82.404260056)"
|
|
2012,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,305,48.4,42.7,54.1,2754,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,39,INCOME4,CAT6,_RFPSA21,RESP046,"(40.060210141, -82.404260056)"
|
|
2012,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,257,51.6,45.9,57.3,2759,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,39,INCOME4,CAT6,_RFPSA21,RESP054,"(40.060210141, -82.404260056)"
|
|
2012,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,783,49,45.6,52.5,2755,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,39,INCOME5,CAT6,_RFPSA21,RESP046,"(40.060210141, -82.404260056)"
|
|
2012,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,634,51,47.5,54.4,2760,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,39,INCOME5,CAT6,_RFPSA21,RESP054,"(40.060210141, -82.404260056)"
|
|
2012,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1647,46.1,43.8,48.4,2733,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,39,RACE1,CAT4,_RFPSA21,RESP046,"(40.060210141, -82.404260056)"
|
|
2012,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1519,53.9,51.6,56.2,2738,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,39,RACE1,CAT4,_RFPSA21,RESP054,"(40.060210141, -82.404260056)"
|
|
2012,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,99,43.1,34.8,51.5,2734,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,39,RACE2,CAT4,_RFPSA21,RESP046,"(40.060210141, -82.404260056)"
|
|
2012,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,120,56.9,48.5,65.2,2739,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,39,RACE2,CAT4,_RFPSA21,RESP054,"(40.060210141, -82.404260056)"
|
|
2012,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,18,,,,2735,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,39,RACE3,CAT4,_RFPSA21,RESP046,"(40.060210141, -82.404260056)"
|
|
2012,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,29,,,,2740,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,39,RACE3,CAT4,_RFPSA21,RESP054,"(40.060210141, -82.404260056)"
|
|
2012,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,30,30.6,16.8,44.4,2736,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,39,RACE4,CAT4,_RFPSA21,RESP046,"(40.060210141, -82.404260056)"
|
|
2012,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,50,69.4,55.6,83.2,2741,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,39,RACE4,CAT4,_RFPSA21,RESP054,"(40.060210141, -82.404260056)"
|
|
2012,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,13,,,,2737,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,39,RACE5,CAT4,_RFPSA21,RESP046,"(40.060210141, -82.404260056)"
|
|
2012,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,32,,,,2742,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,39,RACE5,CAT4,_RFPSA21,RESP054,"(40.060210141, -82.404260056)"
|
|
2012,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1825,45.1,42.9,47.3,2723,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,39,SEX1,CAT2,_RFPSA21,RESP046,"(40.060210141, -82.404260056)"
|
|
2012,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1768,54.9,52.7,57.1,2724,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,39,SEX1,CAT2,_RFPSA21,RESP054,"(40.060210141, -82.404260056)"
|
|
2012,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,85,23.3,18.4,28.2,2725,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,AGE06,CAT3,_RFPSA21,RESP046,"(35.472031356, -97.521070214)"
|
|
2012,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,273,76.7,71.8,81.6,2729,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,AGE06,CAT3,_RFPSA21,RESP054,"(35.472031356, -97.521070214)"
|
|
2012,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,292,47.1,42.3,51.9,2726,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,AGE07,CAT3,_RFPSA21,RESP046,"(35.472031356, -97.521070214)"
|
|
2012,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,314,52.9,48.1,57.7,2730,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,AGE07,CAT3,_RFPSA21,RESP054,"(35.472031356, -97.521070214)"
|
|
2012,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,192,59.4,53,65.8,2727,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,AGE08,CAT3,_RFPSA21,RESP046,"(35.472031356, -97.521070214)"
|
|
2012,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,128,40.6,34.2,47,2731,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,AGE08,CAT3,_RFPSA21,RESP054,"(35.472031356, -97.521070214)"
|
|
2012,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,580,69.5,65.9,73.2,2728,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,AGE09,CAT3,_RFPSA21,RESP046,"(35.472031356, -97.521070214)"
|
|
2012,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,285,30.5,26.8,34.2,2732,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,AGE09,CAT3,_RFPSA21,RESP054,"(35.472031356, -97.521070214)"
|
|
2012,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1149,49.5,46.8,52.1,2721,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,BO1,CAT1,_RFPSA21,RESP046,"(35.472031356, -97.521070214)"
|
|
2012,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1000,50.5,47.9,53.2,2722,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,BO1,CAT1,_RFPSA21,RESP054,"(35.472031356, -97.521070214)"
|
|
2012,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,85,37.2,29.4,45.1,2743,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,EDUCA1,CAT5,_RFPSA21,RESP046,"(35.472031356, -97.521070214)"
|
|
2012,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,141,62.8,54.9,70.6,2747,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,EDUCA1,CAT5,_RFPSA21,RESP054,"(35.472031356, -97.521070214)"
|
|
2012,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,350,46,41.5,50.5,2744,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,EDUCA2,CAT5,_RFPSA21,RESP046,"(35.472031356, -97.521070214)"
|
|
2012,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,332,54,49.5,58.5,2748,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,EDUCA2,CAT5,_RFPSA21,RESP054,"(35.472031356, -97.521070214)"
|
|
2012,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,312,52.8,47.7,57.8,2745,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,EDUCA3,CAT5,_RFPSA21,RESP046,"(35.472031356, -97.521070214)"
|
|
2012,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,254,47.2,42.2,52.3,2749,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,EDUCA3,CAT5,_RFPSA21,RESP054,"(35.472031356, -97.521070214)"
|
|
2012,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,402,57.3,52.8,61.7,2746,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,EDUCA4,CAT5,_RFPSA21,RESP046,"(35.472031356, -97.521070214)"
|
|
2012,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,272,42.8,38.3,47.2,2750,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,EDUCA4,CAT5,_RFPSA21,RESP054,"(35.472031356, -97.521070214)"
|
|
2012,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,94,33.3,25.6,40.9,2751,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,INCOME1,CAT6,_RFPSA21,RESP046,"(35.472031356, -97.521070214)"
|
|
2012,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,148,66.7,59.1,74.4,2756,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,INCOME1,CAT6,_RFPSA21,RESP054,"(35.472031356, -97.521070214)"
|
|
2012,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,159,42.5,35.7,49.2,2752,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,INCOME2,CAT6,_RFPSA21,RESP046,"(35.472031356, -97.521070214)"
|
|
2012,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,183,57.5,50.8,64.3,2757,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,INCOME2,CAT6,_RFPSA21,RESP054,"(35.472031356, -97.521070214)"
|
|
2012,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,132,44.4,36.7,52,2753,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,INCOME3,CAT6,_RFPSA21,RESP046,"(35.472031356, -97.521070214)"
|
|
2012,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,128,55.6,48,63.3,2758,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,INCOME3,CAT6,_RFPSA21,RESP054,"(35.472031356, -97.521070214)"
|
|
2012,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,172,47.1,40.6,53.6,2754,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,INCOME4,CAT6,_RFPSA21,RESP046,"(35.472031356, -97.521070214)"
|
|
2012,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,157,52.9,46.4,59.4,2759,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,INCOME4,CAT6,_RFPSA21,RESP054,"(35.472031356, -97.521070214)"
|
|
2012,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,492,57.1,52.9,61.2,2755,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,INCOME5,CAT6,_RFPSA21,RESP046,"(35.472031356, -97.521070214)"
|
|
2012,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,317,43,38.8,47.1,2760,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,INCOME5,CAT6,_RFPSA21,RESP054,"(35.472031356, -97.521070214)"
|
|
2012,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,948,52.2,49.3,55,2733,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,RACE1,CAT4,_RFPSA21,RESP046,"(35.472031356, -97.521070214)"
|
|
2012,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,745,47.9,45,50.7,2738,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,RACE1,CAT4,_RFPSA21,RESP054,"(35.472031356, -97.521070214)"
|
|
2012,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,44,50.6,38.2,63.1,2734,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,RACE2,CAT4,_RFPSA21,RESP046,"(35.472031356, -97.521070214)"
|
|
2012,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,45,49.4,36.9,61.9,2739,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,RACE2,CAT4,_RFPSA21,RESP054,"(35.472031356, -97.521070214)"
|
|
2012,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,25,30.3,17.3,43.4,2735,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,RACE3,CAT4,_RFPSA21,RESP046,"(35.472031356, -97.521070214)"
|
|
2012,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,47,69.7,56.7,82.7,2740,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,RACE3,CAT4,_RFPSA21,RESP054,"(35.472031356, -97.521070214)"
|
|
2012,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,59,42,32.1,51.8,2736,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,RACE4,CAT4,_RFPSA21,RESP046,"(35.472031356, -97.521070214)"
|
|
2012,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,79,58,48.2,67.9,2741,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,RACE4,CAT4,_RFPSA21,RESP054,"(35.472031356, -97.521070214)"
|
|
2012,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,67,37.3,27.3,47.2,2737,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,RACE5,CAT4,_RFPSA21,RESP046,"(35.472031356, -97.521070214)"
|
|
2012,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,79,62.7,52.8,72.7,2742,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,RACE5,CAT4,_RFPSA21,RESP054,"(35.472031356, -97.521070214)"
|
|
2012,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1149,49.5,46.8,52.1,2723,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,SEX1,CAT2,_RFPSA21,RESP046,"(35.472031356, -97.521070214)"
|
|
2012,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1000,50.5,47.9,53.2,2724,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,SEX1,CAT2,_RFPSA21,RESP054,"(35.472031356, -97.521070214)"
|
|
2012,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,27,12.9,7.2,18.5,2704,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,41,AGE06,CAT3,_RFPSA21,RESP046,"(44.567449424, -120.155031326)"
|
|
2012,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,215,87.2,81.5,92.8,2708,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,41,AGE06,CAT3,_RFPSA21,RESP054,"(44.567449424, -120.155031326)"
|
|
2012,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,156,36.2,30.2,42.2,2705,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,41,AGE07,CAT3,_RFPSA21,RESP046,"(44.567449424, -120.155031326)"
|
|
2012,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,232,63.8,57.8,69.8,2709,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,41,AGE07,CAT3,_RFPSA21,RESP054,"(44.567449424, -120.155031326)"
|
|
2012,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,149,56.7,49.5,63.9,2706,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,41,AGE08,CAT3,_RFPSA21,RESP046,"(44.567449424, -120.155031326)"
|
|
2012,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,114,43.3,36.1,50.5,2710,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,41,AGE08,CAT3,_RFPSA21,RESP054,"(44.567449424, -120.155031326)"
|
|
2012,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,361,62.6,58,67.2,2707,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,41,AGE09,CAT3,_RFPSA21,RESP046,"(44.567449424, -120.155031326)"
|
|
2012,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,227,37.4,32.8,42,2711,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,41,AGE09,CAT3,_RFPSA21,RESP054,"(44.567449424, -120.155031326)"
|
|
2012,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,693,39.9,36.7,43.1,2700,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,41,BO1,CAT1,_RFPSA21,RESP046,"(44.567449424, -120.155031326)"
|
|
2012,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,788,60.1,56.9,63.3,2701,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,41,BO1,CAT1,_RFPSA21,RESP054,"(44.567449424, -120.155031326)"
|
|
2012,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,29,29.7,18.1,41.2,2722,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,41,EDUCA1,CAT5,_RFPSA21,RESP046,"(44.567449424, -120.155031326)"
|
|
2012,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,57,70.3,58.8,81.9,2726,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,41,EDUCA1,CAT5,_RFPSA21,RESP054,"(44.567449424, -120.155031326)"
|
|
2012,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,152,38.1,31.7,44.5,2723,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,41,EDUCA2,CAT5,_RFPSA21,RESP046,"(44.567449424, -120.155031326)"
|
|
2012,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,203,61.9,55.5,68.3,2727,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,41,EDUCA2,CAT5,_RFPSA21,RESP054,"(44.567449424, -120.155031326)"
|
|
2012,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,175,39,33.3,44.8,2724,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,41,EDUCA3,CAT5,_RFPSA21,RESP046,"(44.567449424, -120.155031326)"
|
|
2012,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,221,61,55.2,66.7,2728,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,41,EDUCA3,CAT5,_RFPSA21,RESP054,"(44.567449424, -120.155031326)"
|
|
2012,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,333,46,41.4,50.7,2725,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,41,EDUCA4,CAT5,_RFPSA21,RESP046,"(44.567449424, -120.155031326)"
|
|
2012,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,307,54,49.3,58.6,2729,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,41,EDUCA4,CAT5,_RFPSA21,RESP054,"(44.567449424, -120.155031326)"
|
|
2012,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,37,26.5,16.5,36.5,2730,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,41,INCOME1,CAT6,_RFPSA21,RESP046,"(44.567449424, -120.155031326)"
|
|
2012,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,92,73.5,63.5,83.5,2735,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,41,INCOME1,CAT6,_RFPSA21,RESP054,"(44.567449424, -120.155031326)"
|
|
2012,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,74,33.9,24.9,42.8,2731,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,41,INCOME2,CAT6,_RFPSA21,RESP046,"(44.567449424, -120.155031326)"
|
|
2012,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,111,66.2,57.2,75.1,2736,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,41,INCOME2,CAT6,_RFPSA21,RESP054,"(44.567449424, -120.155031326)"
|
|
2012,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,61,34.5,25,44.1,2732,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,41,INCOME3,CAT6,_RFPSA21,RESP046,"(44.567449424, -120.155031326)"
|
|
2012,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,80,65.5,55.9,75,2737,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,41,INCOME3,CAT6,_RFPSA21,RESP054,"(44.567449424, -120.155031326)"
|
|
2012,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,120,47.4,39.1,55.8,2733,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,41,INCOME4,CAT6,_RFPSA21,RESP046,"(44.567449424, -120.155031326)"
|
|
2012,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,117,52.6,44.2,60.9,2738,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,41,INCOME4,CAT6,_RFPSA21,RESP054,"(44.567449424, -120.155031326)"
|
|
2012,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,328,43.3,38.5,48.1,2734,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,41,INCOME5,CAT6,_RFPSA21,RESP046,"(44.567449424, -120.155031326)"
|
|
2012,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,314,56.7,51.9,61.5,2739,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,41,INCOME5,CAT6,_RFPSA21,RESP054,"(44.567449424, -120.155031326)"
|
|
2012,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,589,39.7,36.5,42.9,2712,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,41,RACE1,CAT4,_RFPSA21,RESP046,"(44.567449424, -120.155031326)"
|
|
2012,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,641,60.3,57.1,63.5,2717,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,41,RACE1,CAT4,_RFPSA21,RESP054,"(44.567449424, -120.155031326)"
|
|
2012,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,9,,,,2713,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,41,RACE2,CAT4,_RFPSA21,RESP046,"(44.567449424, -120.155031326)"
|
|
2012,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,7,,,,2718,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,41,RACE2,CAT4,_RFPSA21,RESP054,"(44.567449424, -120.155031326)"
|
|
2012,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,15,,,,2714,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,41,RACE3,CAT4,_RFPSA21,RESP046,"(44.567449424, -120.155031326)"
|
|
2012,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,21,,,,2719,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,41,RACE3,CAT4,_RFPSA21,RESP054,"(44.567449424, -120.155031326)"
|
|
2012,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,18,,,,2715,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,41,RACE4,CAT4,_RFPSA21,RESP046,"(44.567449424, -120.155031326)"
|
|
2012,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,25,,,,2720,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,41,RACE4,CAT4,_RFPSA21,RESP054,"(44.567449424, -120.155031326)"
|
|
2012,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,46,33.9,23.8,43.9,2716,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,41,RACE5,CAT4,_RFPSA21,RESP046,"(44.567449424, -120.155031326)"
|
|
2012,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,78,66.1,56.1,76.2,2721,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,41,RACE5,CAT4,_RFPSA21,RESP054,"(44.567449424, -120.155031326)"
|
|
2012,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,693,39.9,36.7,43.1,2702,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,41,SEX1,CAT2,_RFPSA21,RESP046,"(44.567449424, -120.155031326)"
|
|
2012,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,788,60.1,56.9,63.3,2703,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,41,SEX1,CAT2,_RFPSA21,RESP054,"(44.567449424, -120.155031326)"
|
|
2012,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,201,16.2,13.4,19,2725,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,42,AGE06,CAT3,_RFPSA21,RESP046,"(40.793730152, -77.860700294)"
|
|
2012,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,967,83.8,81,86.6,2729,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,42,AGE06,CAT3,_RFPSA21,RESP054,"(40.793730152, -77.860700294)"
|
|
2012,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,747,46.6,43,50.3,2726,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,42,AGE07,CAT3,_RFPSA21,RESP046,"(40.793730152, -77.860700294)"
|
|
2012,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,872,53.4,49.7,57,2730,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,42,AGE07,CAT3,_RFPSA21,RESP054,"(40.793730152, -77.860700294)"
|
|
2012,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,450,57.9,52.8,63.1,2727,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,42,AGE08,CAT3,_RFPSA21,RESP046,"(40.793730152, -77.860700294)"
|
|
2012,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,319,42.1,37,47.3,2731,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,42,AGE08,CAT3,_RFPSA21,RESP054,"(40.793730152, -77.860700294)"
|
|
2012,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,1528,67.8,64.9,70.6,2728,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,42,AGE09,CAT3,_RFPSA21,RESP046,"(40.793730152, -77.860700294)"
|
|
2012,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,716,32.2,29.4,35.1,2732,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,42,AGE09,CAT3,_RFPSA21,RESP054,"(40.793730152, -77.860700294)"
|
|
2012,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,2926,45.7,43.8,47.6,2721,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,42,BO1,CAT1,_RFPSA21,RESP046,"(40.793730152, -77.860700294)"
|
|
2012,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,2874,54.3,52.4,56.2,2722,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,42,BO1,CAT1,_RFPSA21,RESP054,"(40.793730152, -77.860700294)"
|
|
2012,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,151,33.1,26.8,39.5,2743,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,42,EDUCA1,CAT5,_RFPSA21,RESP046,"(40.793730152, -77.860700294)"
|
|
2012,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,276,66.9,60.6,73.2,2747,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,42,EDUCA1,CAT5,_RFPSA21,RESP054,"(40.793730152, -77.860700294)"
|
|
2012,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,1065,46.1,43,49.2,2744,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,42,EDUCA2,CAT5,_RFPSA21,RESP046,"(40.793730152, -77.860700294)"
|
|
2012,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,1155,53.9,50.8,57,2748,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,42,EDUCA2,CAT5,_RFPSA21,RESP054,"(40.793730152, -77.860700294)"
|
|
2012,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,590,43.2,39.1,47.2,2745,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,42,EDUCA3,CAT5,_RFPSA21,RESP046,"(40.793730152, -77.860700294)"
|
|
2012,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,593,56.8,52.8,60.9,2749,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,42,EDUCA3,CAT5,_RFPSA21,RESP054,"(40.793730152, -77.860700294)"
|
|
2012,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,1115,53.1,49.8,56.3,2746,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,42,EDUCA4,CAT5,_RFPSA21,RESP046,"(40.793730152, -77.860700294)"
|
|
2012,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,845,46.9,43.7,50.2,2750,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,42,EDUCA4,CAT5,_RFPSA21,RESP054,"(40.793730152, -77.860700294)"
|
|
2012,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,173,31.2,25.5,37,2751,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,42,INCOME1,CAT6,_RFPSA21,RESP046,"(40.793730152, -77.860700294)"
|
|
2012,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,291,68.8,63,74.5,2756,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,42,INCOME1,CAT6,_RFPSA21,RESP054,"(40.793730152, -77.860700294)"
|
|
2012,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,409,46.4,41.2,51.5,2752,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,42,INCOME2,CAT6,_RFPSA21,RESP046,"(40.793730152, -77.860700294)"
|
|
2012,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,466,53.6,48.5,58.8,2757,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,42,INCOME2,CAT6,_RFPSA21,RESP054,"(40.793730152, -77.860700294)"
|
|
2012,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,325,42.3,36.7,48,2753,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,42,INCOME3,CAT6,_RFPSA21,RESP046,"(40.793730152, -77.860700294)"
|
|
2012,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,315,57.7,52.1,63.3,2758,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,42,INCOME3,CAT6,_RFPSA21,RESP054,"(40.793730152, -77.860700294)"
|
|
2012,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,436,45.4,40.5,50.2,2754,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,42,INCOME4,CAT6,_RFPSA21,RESP046,"(40.793730152, -77.860700294)"
|
|
2012,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,426,54.7,49.8,59.5,2759,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,42,INCOME4,CAT6,_RFPSA21,RESP054,"(40.793730152, -77.860700294)"
|
|
2012,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,1296,48.7,45.7,51.6,2755,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,42,INCOME5,CAT6,_RFPSA21,RESP046,"(40.793730152, -77.860700294)"
|
|
2012,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,1105,51.3,48.4,54.3,2760,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,42,INCOME5,CAT6,_RFPSA21,RESP054,"(40.793730152, -77.860700294)"
|
|
2012,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,2615,46.9,44.9,49,2733,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,42,RACE1,CAT4,_RFPSA21,RESP046,"(40.793730152, -77.860700294)"
|
|
2012,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,2482,53.1,51,55.1,2738,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,42,RACE1,CAT4,_RFPSA21,RESP054,"(40.793730152, -77.860700294)"
|
|
2012,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,154,45.5,37.8,53.2,2734,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,42,RACE2,CAT4,_RFPSA21,RESP046,"(40.793730152, -77.860700294)"
|
|
2012,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,157,54.5,46.8,62.2,2739,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,42,RACE2,CAT4,_RFPSA21,RESP054,"(40.793730152, -77.860700294)"
|
|
2012,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,43,23.8,13.1,34.5,2735,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,42,RACE3,CAT4,_RFPSA21,RESP046,"(40.793730152, -77.860700294)"
|
|
2012,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,72,76.2,65.5,86.9,2740,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,42,RACE3,CAT4,_RFPSA21,RESP054,"(40.793730152, -77.860700294)"
|
|
2012,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,29,29.4,14.1,44.7,2736,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,42,RACE4,CAT4,_RFPSA21,RESP046,"(40.793730152, -77.860700294)"
|
|
2012,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,67,70.6,55.3,85.9,2741,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,42,RACE4,CAT4,_RFPSA21,RESP054,"(40.793730152, -77.860700294)"
|
|
2012,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,22,44.9,26.1,63.6,2737,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,42,RACE5,CAT4,_RFPSA21,RESP046,"(40.793730152, -77.860700294)"
|
|
2012,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,36,55.1,36.4,73.9,2742,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,42,RACE5,CAT4,_RFPSA21,RESP054,"(40.793730152, -77.860700294)"
|
|
2012,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,2926,45.7,43.8,47.6,2723,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,42,SEX1,CAT2,_RFPSA21,RESP046,"(40.793730152, -77.860700294)"
|
|
2012,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,2874,54.3,52.4,56.2,2724,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,42,SEX1,CAT2,_RFPSA21,RESP054,"(40.793730152, -77.860700294)"
|
|
2012,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,99,18.5,14.8,22.1,2488,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,72,AGE09,CAT3,_RFPSA21,RESP054,"(18.220833, -66.590149)"
|
|
2012,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,135,66.4,58.8,74,2481,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,72,AGE06,CAT3,_RFPSA21,RESP046,"(18.220833, -66.590149)"
|
|
2012,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,63,33.6,26,41.2,2485,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,72,AGE06,CAT3,_RFPSA21,RESP054,"(18.220833, -66.590149)"
|
|
2012,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,250,75.6,70.4,80.8,2482,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,72,AGE07,CAT3,_RFPSA21,RESP046,"(18.220833, -66.590149)"
|
|
2012,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,78,24.4,19.2,29.7,2486,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,72,AGE07,CAT3,_RFPSA21,RESP054,"(18.220833, -66.590149)"
|
|
2012,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,121,82.8,76.3,89.4,2483,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,72,AGE08,CAT3,_RFPSA21,RESP046,"(18.220833, -66.590149)"
|
|
2012,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,26,17.2,10.7,23.7,2487,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,72,AGE08,CAT3,_RFPSA21,RESP054,"(18.220833, -66.590149)"
|
|
2012,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,443,81.5,77.9,85.2,2484,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,72,AGE09,CAT3,_RFPSA21,RESP046,"(18.220833, -66.590149)"
|
|
2012,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,949,76.8,74,79.5,2477,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,72,BO1,CAT1,_RFPSA21,RESP046,"(18.220833, -66.590149)"
|
|
2012,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,266,23.2,20.5,26,2478,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,72,BO1,CAT1,_RFPSA21,RESP054,"(18.220833, -66.590149)"
|
|
2012,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,282,76.7,72,81.5,2496,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,72,EDUCA1,CAT5,_RFPSA21,RESP046,"(18.220833, -66.590149)"
|
|
2012,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,83,23.3,18.5,28,2500,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,72,EDUCA1,CAT5,_RFPSA21,RESP054,"(18.220833, -66.590149)"
|
|
2012,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,235,74.9,69.4,80.4,2497,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,72,EDUCA2,CAT5,_RFPSA21,RESP046,"(18.220833, -66.590149)"
|
|
2012,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,71,25.1,19.6,30.6,2501,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,72,EDUCA2,CAT5,_RFPSA21,RESP054,"(18.220833, -66.590149)"
|
|
2012,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,187,77.6,71.9,83.2,2498,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,72,EDUCA3,CAT5,_RFPSA21,RESP046,"(18.220833, -66.590149)"
|
|
2012,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,57,22.5,16.8,28.1,2502,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,72,EDUCA3,CAT5,_RFPSA21,RESP054,"(18.220833, -66.590149)"
|
|
2012,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,244,79.8,74.8,84.9,2499,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,72,EDUCA4,CAT5,_RFPSA21,RESP046,"(18.220833, -66.590149)"
|
|
2012,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,53,20.2,15.1,25.2,2503,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,72,EDUCA4,CAT5,_RFPSA21,RESP054,"(18.220833, -66.590149)"
|
|
2012,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,338,72.3,67.7,76.9,2504,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,72,INCOME1,CAT6,_RFPSA21,RESP046,"(18.220833, -66.590149)"
|
|
2012,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,125,27.7,23.1,32.3,2509,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,72,INCOME1,CAT6,_RFPSA21,RESP054,"(18.220833, -66.590149)"
|
|
2012,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,220,81,75.6,86.3,2505,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,72,INCOME2,CAT6,_RFPSA21,RESP046,"(18.220833, -66.590149)"
|
|
2012,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,48,19,13.7,24.4,2510,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,72,INCOME2,CAT6,_RFPSA21,RESP054,"(18.220833, -66.590149)"
|
|
2012,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,102,83.9,76.7,91,2506,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,72,INCOME3,CAT6,_RFPSA21,RESP046,"(18.220833, -66.590149)"
|
|
2012,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,20,16.2,9,23.3,2511,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,72,INCOME3,CAT6,_RFPSA21,RESP054,"(18.220833, -66.590149)"
|
|
2012,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,84,81,72.8,89.2,2507,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,72,INCOME4,CAT6,_RFPSA21,RESP046,"(18.220833, -66.590149)"
|
|
2012,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,20,19,10.8,27.2,2512,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,72,INCOME4,CAT6,_RFPSA21,RESP054,"(18.220833, -66.590149)"
|
|
2012,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,90,75.6,66.6,84.6,2508,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,72,INCOME5,CAT6,_RFPSA21,RESP046,"(18.220833, -66.590149)"
|
|
2012,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,24,24.4,15.4,33.4,2513,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,72,INCOME5,CAT6,_RFPSA21,RESP054,"(18.220833, -66.590149)"
|
|
2012,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,8,,,,2489,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,72,RACE1,CAT4,_RFPSA21,RESP046,"(18.220833, -66.590149)"
|
|
2012,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1,,,,2493,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,72,RACE1,CAT4,_RFPSA21,RESP054,"(18.220833, -66.590149)"
|
|
2012,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,2,,,,2490,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,72,RACE2,CAT4,_RFPSA21,RESP046,"(18.220833, -66.590149)"
|
|
2012,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,936,76.7,74,79.5,2491,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,72,RACE3,CAT4,_RFPSA21,RESP046,"(18.220833, -66.590149)"
|
|
2012,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,264,23.3,20.5,26.1,2494,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,72,RACE3,CAT4,_RFPSA21,RESP054,"(18.220833, -66.590149)"
|
|
2012,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,3,,,,2492,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,72,RACE4,CAT4,_RFPSA21,RESP046,"(18.220833, -66.590149)"
|
|
2012,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,1,,,,2495,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,72,RACE4,CAT4,_RFPSA21,RESP054,"(18.220833, -66.590149)"
|
|
2012,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,949,76.8,74,79.5,2479,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,72,SEX1,CAT2,_RFPSA21,RESP046,"(18.220833, -66.590149)"
|
|
2012,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,266,23.2,20.5,26,2480,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,72,SEX1,CAT2,_RFPSA21,RESP054,"(18.220833, -66.590149)"
|
|
2012,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,52,15.9,11,20.9,2706,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,44,AGE06,CAT3,_RFPSA21,RESP046,"(41.708280193, -71.522470314)"
|
|
2012,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,264,84.1,79.1,89,2710,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,44,AGE06,CAT3,_RFPSA21,RESP054,"(41.708280193, -71.522470314)"
|
|
2012,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,189,45.1,39.4,50.8,2707,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,44,AGE07,CAT3,_RFPSA21,RESP046,"(41.708280193, -71.522470314)"
|
|
2012,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,224,54.9,49.2,60.6,2711,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,44,AGE07,CAT3,_RFPSA21,RESP054,"(41.708280193, -71.522470314)"
|
|
2012,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,137,64.9,56.3,73.6,2708,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,44,AGE08,CAT3,_RFPSA21,RESP046,"(41.708280193, -71.522470314)"
|
|
2012,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,70,35.1,26.4,43.7,2712,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,44,AGE08,CAT3,_RFPSA21,RESP054,"(41.708280193, -71.522470314)"
|
|
2012,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,384,71.2,66.6,75.8,2709,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,44,AGE09,CAT3,_RFPSA21,RESP046,"(41.708280193, -71.522470314)"
|
|
2012,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,163,28.8,24.2,33.4,2713,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,44,AGE09,CAT3,_RFPSA21,RESP054,"(41.708280193, -71.522470314)"
|
|
2012,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,762,46.1,43,49.3,2702,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,44,BO1,CAT1,_RFPSA21,RESP046,"(41.708280193, -71.522470314)"
|
|
2012,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,721,53.9,50.8,57,2703,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,44,BO1,CAT1,_RFPSA21,RESP054,"(41.708280193, -71.522470314)"
|
|
2012,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,53,32.5,23.8,41.1,2724,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,44,EDUCA1,CAT5,_RFPSA21,RESP046,"(41.708280193, -71.522470314)"
|
|
2012,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,91,67.5,58.9,76.2,2728,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,44,EDUCA1,CAT5,_RFPSA21,RESP054,"(41.708280193, -71.522470314)"
|
|
2012,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,192,49.1,42.9,55.2,2725,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,44,EDUCA2,CAT5,_RFPSA21,RESP046,"(41.708280193, -71.522470314)"
|
|
2012,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,180,51,44.8,57.1,2729,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,44,EDUCA2,CAT5,_RFPSA21,RESP054,"(41.708280193, -71.522470314)"
|
|
2012,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,160,47.7,41,54.5,2726,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,44,EDUCA3,CAT5,_RFPSA21,RESP046,"(41.708280193, -71.522470314)"
|
|
2012,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,151,52.3,45.5,59,2730,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,44,EDUCA3,CAT5,_RFPSA21,RESP054,"(41.708280193, -71.522470314)"
|
|
2012,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,356,49.8,45.4,54.2,2727,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,44,EDUCA4,CAT5,_RFPSA21,RESP046,"(41.708280193, -71.522470314)"
|
|
2012,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,296,50.2,45.8,54.6,2731,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,44,EDUCA4,CAT5,_RFPSA21,RESP054,"(41.708280193, -71.522470314)"
|
|
2012,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,39,23.9,15.1,32.7,2732,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,44,INCOME1,CAT6,_RFPSA21,RESP046,"(41.708280193, -71.522470314)"
|
|
2012,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,74,76.1,67.3,84.9,2737,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,44,INCOME1,CAT6,_RFPSA21,RESP054,"(41.708280193, -71.522470314)"
|
|
2012,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,71,34.8,26.3,43.3,2733,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,44,INCOME2,CAT6,_RFPSA21,RESP046,"(41.708280193, -71.522470314)"
|
|
2012,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,86,65.2,56.7,73.7,2738,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,44,INCOME2,CAT6,_RFPSA21,RESP054,"(41.708280193, -71.522470314)"
|
|
2012,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,60,41.8,31,52.7,2734,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,44,INCOME3,CAT6,_RFPSA21,RESP046,"(41.708280193, -71.522470314)"
|
|
2012,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,64,58.2,47.3,69,2739,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,44,INCOME3,CAT6,_RFPSA21,RESP054,"(41.708280193, -71.522470314)"
|
|
2012,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,100,52.8,44.3,61.3,2735,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,44,INCOME4,CAT6,_RFPSA21,RESP046,"(41.708280193, -71.522470314)"
|
|
2012,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,86,47.2,38.7,55.7,2740,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,44,INCOME4,CAT6,_RFPSA21,RESP054,"(41.708280193, -71.522470314)"
|
|
2012,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,410,51.2,46.7,55.6,2736,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,44,INCOME5,CAT6,_RFPSA21,RESP046,"(41.708280193, -71.522470314)"
|
|
2012,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,340,48.8,44.4,53.3,2741,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,44,INCOME5,CAT6,_RFPSA21,RESP054,"(41.708280193, -71.522470314)"
|
|
2012,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,698,48.8,45.5,52.1,2714,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,44,RACE1,CAT4,_RFPSA21,RESP046,"(41.708280193, -71.522470314)"
|
|
2012,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,624,51.2,48,54.5,2719,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,44,RACE1,CAT4,_RFPSA21,RESP054,"(41.708280193, -71.522470314)"
|
|
2012,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,13,,,,2715,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,44,RACE2,CAT4,_RFPSA21,RESP046,"(41.708280193, -71.522470314)"
|
|
2012,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,23,,,,2720,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,44,RACE2,CAT4,_RFPSA21,RESP054,"(41.708280193, -71.522470314)"
|
|
2012,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,30,33.5,21.2,45.7,2716,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,44,RACE3,CAT4,_RFPSA21,RESP046,"(41.708280193, -71.522470314)"
|
|
2012,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,37,66.6,54.3,78.8,2721,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,44,RACE3,CAT4,_RFPSA21,RESP054,"(41.708280193, -71.522470314)"
|
|
2012,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,7,,,,2717,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,44,RACE4,CAT4,_RFPSA21,RESP046,"(41.708280193, -71.522470314)"
|
|
2012,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,27,,,,2722,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,44,RACE4,CAT4,_RFPSA21,RESP054,"(41.708280193, -71.522470314)"
|
|
2012,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,4,,,,2718,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,44,RACE5,CAT4,_RFPSA21,RESP046,"(41.708280193, -71.522470314)"
|
|
2012,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,3,,,,2723,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,44,RACE5,CAT4,_RFPSA21,RESP054,"(41.708280193, -71.522470314)"
|
|
2012,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,762,46.1,43,49.3,2704,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,44,SEX1,CAT2,_RFPSA21,RESP046,"(41.708280193, -71.522470314)"
|
|
2012,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,721,53.9,50.8,57,2705,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,44,SEX1,CAT2,_RFPSA21,RESP054,"(41.708280193, -71.522470314)"
|
|
2012,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,146,21.6,17.5,25.7,2726,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,AGE06,CAT3,_RFPSA21,RESP046,"(33.998821303, -81.045371207)"
|
|
2012,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,477,78.5,74.4,82.6,2730,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,AGE06,CAT3,_RFPSA21,RESP054,"(33.998821303, -81.045371207)"
|
|
2012,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,411,48.1,43.5,52.8,2727,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,AGE07,CAT3,_RFPSA21,RESP046,"(33.998821303, -81.045371207)"
|
|
2012,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,448,51.9,47.2,56.5,2731,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,AGE07,CAT3,_RFPSA21,RESP054,"(33.998821303, -81.045371207)"
|
|
2012,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,321,63.6,57.8,69.4,2728,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,AGE08,CAT3,_RFPSA21,RESP046,"(33.998821303, -81.045371207)"
|
|
2012,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,183,36.4,30.6,42.2,2732,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,AGE08,CAT3,_RFPSA21,RESP054,"(33.998821303, -81.045371207)"
|
|
2012,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,1030,71.1,67.6,74.6,2729,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,AGE09,CAT3,_RFPSA21,RESP046,"(33.998821303, -81.045371207)"
|
|
2012,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,395,28.9,25.5,32.4,2733,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,AGE09,CAT3,_RFPSA21,RESP054,"(33.998821303, -81.045371207)"
|
|
2012,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1908,49.6,47.2,51.9,2722,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,BO1,CAT1,_RFPSA21,RESP046,"(33.998821303, -81.045371207)"
|
|
2012,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1503,50.5,48.1,52.8,2723,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,BO1,CAT1,_RFPSA21,RESP054,"(33.998821303, -81.045371207)"
|
|
2012,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,163,32.9,26.5,39.3,2744,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,EDUCA1,CAT5,_RFPSA21,RESP046,"(33.998821303, -81.045371207)"
|
|
2012,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,259,67.1,60.7,73.5,2748,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,EDUCA1,CAT5,_RFPSA21,RESP054,"(33.998821303, -81.045371207)"
|
|
2012,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,476,42.9,38.8,47.1,2745,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,EDUCA2,CAT5,_RFPSA21,RESP046,"(33.998821303, -81.045371207)"
|
|
2012,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,516,57.1,52.9,61.2,2749,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,EDUCA2,CAT5,_RFPSA21,RESP054,"(33.998821303, -81.045371207)"
|
|
2012,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,455,56,51.3,60.6,2746,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,EDUCA3,CAT5,_RFPSA21,RESP046,"(33.998821303, -81.045371207)"
|
|
2012,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,335,44,39.4,48.7,2750,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,EDUCA3,CAT5,_RFPSA21,RESP054,"(33.998821303, -81.045371207)"
|
|
2012,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,809,61.3,57.3,65.2,2747,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,EDUCA4,CAT5,_RFPSA21,RESP046,"(33.998821303, -81.045371207)"
|
|
2012,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,391,38.7,34.8,42.7,2751,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,EDUCA4,CAT5,_RFPSA21,RESP054,"(33.998821303, -81.045371207)"
|
|
2012,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,135,34.8,27.3,42.2,2752,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,INCOME1,CAT6,_RFPSA21,RESP046,"(33.998821303, -81.045371207)"
|
|
2012,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,217,65.3,57.8,72.7,2757,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,INCOME1,CAT6,_RFPSA21,RESP054,"(33.998821303, -81.045371207)"
|
|
2012,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,236,37.2,31.6,42.9,2753,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,INCOME2,CAT6,_RFPSA21,RESP046,"(33.998821303, -81.045371207)"
|
|
2012,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,289,62.8,57.2,68.4,2758,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,INCOME2,CAT6,_RFPSA21,RESP054,"(33.998821303, -81.045371207)"
|
|
2012,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,179,40.6,33.5,47.7,2754,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,INCOME3,CAT6,_RFPSA21,RESP046,"(33.998821303, -81.045371207)"
|
|
2012,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,172,59.4,52.3,66.5,2759,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,INCOME3,CAT6,_RFPSA21,RESP054,"(33.998821303, -81.045371207)"
|
|
2012,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,307,55.2,48.4,61.9,2755,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,INCOME4,CAT6,_RFPSA21,RESP046,"(33.998821303, -81.045371207)"
|
|
2012,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,168,44.9,38.1,51.6,2760,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,INCOME4,CAT6,_RFPSA21,RESP054,"(33.998821303, -81.045371207)"
|
|
2012,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,862,57.8,54.3,61.3,2756,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,INCOME5,CAT6,_RFPSA21,RESP046,"(33.998821303, -81.045371207)"
|
|
2012,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,514,42.2,38.7,45.7,2761,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,INCOME5,CAT6,_RFPSA21,RESP054,"(33.998821303, -81.045371207)"
|
|
2012,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1431,53.1,50.4,55.8,2734,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,RACE1,CAT4,_RFPSA21,RESP046,"(33.998821303, -81.045371207)"
|
|
2012,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,996,46.9,44.2,49.6,2739,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,RACE1,CAT4,_RFPSA21,RESP054,"(33.998821303, -81.045371207)"
|
|
2012,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,364,46.3,41,51.6,2735,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,RACE2,CAT4,_RFPSA21,RESP046,"(33.998821303, -81.045371207)"
|
|
2012,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,378,53.7,48.4,59,2740,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,RACE2,CAT4,_RFPSA21,RESP054,"(33.998821303, -81.045371207)"
|
|
2012,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,14,,,,2736,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,45,RACE3,CAT4,_RFPSA21,RESP046,"(33.998821303, -81.045371207)"
|
|
2012,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,27,,,,2741,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,45,RACE3,CAT4,_RFPSA21,RESP054,"(33.998821303, -81.045371207)"
|
|
2012,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,29,28,13.9,42,2737,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,RACE4,CAT4,_RFPSA21,RESP046,"(33.998821303, -81.045371207)"
|
|
2012,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,41,72,58,86.1,2742,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,RACE4,CAT4,_RFPSA21,RESP054,"(33.998821303, -81.045371207)"
|
|
2012,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,25,33.4,17.9,48.9,2738,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,RACE5,CAT4,_RFPSA21,RESP046,"(33.998821303, -81.045371207)"
|
|
2012,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,28,66.6,51.1,82.1,2743,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,RACE5,CAT4,_RFPSA21,RESP054,"(33.998821303, -81.045371207)"
|
|
2012,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1908,49.6,47.2,51.9,2724,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,SEX1,CAT2,_RFPSA21,RESP046,"(33.998821303, -81.045371207)"
|
|
2012,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1503,50.5,48.1,52.8,2725,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,SEX1,CAT2,_RFPSA21,RESP054,"(33.998821303, -81.045371207)"
|
|
2012,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,63,14.4,9.4,19.5,2710,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,46,AGE06,CAT3,_RFPSA21,RESP046,"(44.353130053, -100.373530637)"
|
|
2012,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,361,85.6,80.5,90.7,2714,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,46,AGE06,CAT3,_RFPSA21,RESP054,"(44.353130053, -100.373530637)"
|
|
2012,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,320,46.4,40.3,52.5,2711,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,46,AGE07,CAT3,_RFPSA21,RESP046,"(44.353130053, -100.373530637)"
|
|
2012,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,334,53.6,47.6,59.7,2715,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,46,AGE07,CAT3,_RFPSA21,RESP054,"(44.353130053, -100.373530637)"
|
|
2012,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,176,56,46.4,65.6,2712,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,46,AGE08,CAT3,_RFPSA21,RESP046,"(44.353130053, -100.373530637)"
|
|
2012,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,133,44,34.4,53.6,2716,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,46,AGE08,CAT3,_RFPSA21,RESP054,"(44.353130053, -100.373530637)"
|
|
2012,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,555,65.7,59.5,71.9,2713,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,46,AGE09,CAT3,_RFPSA21,RESP046,"(44.353130053, -100.373530637)"
|
|
2012,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,245,34.3,28.1,40.5,2717,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,46,AGE09,CAT3,_RFPSA21,RESP054,"(44.353130053, -100.373530637)"
|
|
2012,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1114,44.5,41.1,48,2706,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,46,BO1,CAT1,_RFPSA21,RESP046,"(44.353130053, -100.373530637)"
|
|
2012,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1073,55.5,52.1,59,2707,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,46,BO1,CAT1,_RFPSA21,RESP054,"(44.353130053, -100.373530637)"
|
|
2012,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,81,37.2,26,48.3,2728,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,46,EDUCA1,CAT5,_RFPSA21,RESP046,"(44.353130053, -100.373530637)"
|
|
2012,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,111,62.9,51.7,74,2732,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,46,EDUCA1,CAT5,_RFPSA21,RESP054,"(44.353130053, -100.373530637)"
|
|
2012,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,339,42,36,48,2729,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,46,EDUCA2,CAT5,_RFPSA21,RESP046,"(44.353130053, -100.373530637)"
|
|
2012,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,384,58,52,64,2733,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,46,EDUCA2,CAT5,_RFPSA21,RESP054,"(44.353130053, -100.373530637)"
|
|
2012,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,271,45.8,39.4,52.1,2730,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,46,EDUCA3,CAT5,_RFPSA21,RESP046,"(44.353130053, -100.373530637)"
|
|
2012,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,285,54.2,47.9,60.6,2734,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,46,EDUCA3,CAT5,_RFPSA21,RESP054,"(44.353130053, -100.373530637)"
|
|
2012,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,422,50.1,43.9,56.2,2731,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,46,EDUCA4,CAT5,_RFPSA21,RESP046,"(44.353130053, -100.373530637)"
|
|
2012,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,292,50,43.8,56.1,2735,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,46,EDUCA4,CAT5,_RFPSA21,RESP054,"(44.353130053, -100.373530637)"
|
|
2012,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,60,33.8,19.6,47.9,2736,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,46,INCOME1,CAT6,_RFPSA21,RESP046,"(44.353130053, -100.373530637)"
|
|
2012,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,107,66.3,52.1,80.4,2741,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,46,INCOME1,CAT6,_RFPSA21,RESP054,"(44.353130053, -100.373530637)"
|
|
2012,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,110,35.9,26.3,45.5,2737,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,46,INCOME2,CAT6,_RFPSA21,RESP046,"(44.353130053, -100.373530637)"
|
|
2012,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,147,64.1,54.6,73.7,2742,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,46,INCOME2,CAT6,_RFPSA21,RESP054,"(44.353130053, -100.373530637)"
|
|
2012,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,115,47.5,36.6,58.5,2738,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,46,INCOME3,CAT6,_RFPSA21,RESP046,"(44.353130053, -100.373530637)"
|
|
2012,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,111,52.5,41.6,63.4,2743,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,46,INCOME3,CAT6,_RFPSA21,RESP054,"(44.353130053, -100.373530637)"
|
|
2012,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,210,47.3,39.2,55.4,2739,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,46,INCOME4,CAT6,_RFPSA21,RESP046,"(44.353130053, -100.373530637)"
|
|
2012,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,168,52.7,44.6,60.8,2744,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,46,INCOME4,CAT6,_RFPSA21,RESP054,"(44.353130053, -100.373530637)"
|
|
2012,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,522,46.9,41.7,52.1,2740,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,46,INCOME5,CAT6,_RFPSA21,RESP046,"(44.353130053, -100.373530637)"
|
|
2012,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,446,53.1,47.9,58.3,2745,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,46,INCOME5,CAT6,_RFPSA21,RESP054,"(44.353130053, -100.373530637)"
|
|
2012,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1019,46.2,42.5,49.9,2718,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,46,RACE1,CAT4,_RFPSA21,RESP046,"(44.353130053, -100.373530637)"
|
|
2012,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,915,53.8,50.1,57.5,2723,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,46,RACE1,CAT4,_RFPSA21,RESP054,"(44.353130053, -100.373530637)"
|
|
2012,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,1,,,,2719,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,46,RACE2,CAT4,_RFPSA21,RESP046,"(44.353130053, -100.373530637)"
|
|
2012,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,3,,,,2724,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,46,RACE2,CAT4,_RFPSA21,RESP054,"(44.353130053, -100.373530637)"
|
|
2012,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,5,,,,2720,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,46,RACE3,CAT4,_RFPSA21,RESP046,"(44.353130053, -100.373530637)"
|
|
2012,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,11,,,,2725,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,46,RACE3,CAT4,_RFPSA21,RESP054,"(44.353130053, -100.373530637)"
|
|
2012,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,71,32.4,21.3,43.5,2721,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,46,RACE4,CAT4,_RFPSA21,RESP046,"(44.353130053, -100.373530637)"
|
|
2012,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,121,67.6,56.5,78.7,2726,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,46,RACE4,CAT4,_RFPSA21,RESP054,"(44.353130053, -100.373530637)"
|
|
2012,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,8,,,,2722,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,46,RACE5,CAT4,_RFPSA21,RESP046,"(44.353130053, -100.373530637)"
|
|
2012,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,18,,,,2727,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,46,RACE5,CAT4,_RFPSA21,RESP054,"(44.353130053, -100.373530637)"
|
|
2012,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1114,44.5,41.1,48,2708,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,46,SEX1,CAT2,_RFPSA21,RESP046,"(44.353130053, -100.373530637)"
|
|
2012,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1073,55.5,52.1,59,2709,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,46,SEX1,CAT2,_RFPSA21,RESP054,"(44.353130053, -100.373530637)"
|
|
2012,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,78,23.8,18.3,29.4,2712,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,47,AGE06,CAT3,_RFPSA21,RESP046,"(35.68094058, -85.774490914)"
|
|
2012,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,250,76.2,70.6,81.8,2716,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,47,AGE06,CAT3,_RFPSA21,RESP054,"(35.68094058, -85.774490914)"
|
|
2012,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,237,53.6,47.5,59.7,2713,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,47,AGE07,CAT3,_RFPSA21,RESP046,"(35.68094058, -85.774490914)"
|
|
2012,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,218,46.4,40.3,52.5,2717,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,47,AGE07,CAT3,_RFPSA21,RESP054,"(35.68094058, -85.774490914)"
|
|
2012,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,171,59.8,52.3,67.4,2714,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,47,AGE08,CAT3,_RFPSA21,RESP046,"(35.68094058, -85.774490914)"
|
|
2012,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,105,40.2,32.6,47.7,2718,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,47,AGE08,CAT3,_RFPSA21,RESP054,"(35.68094058, -85.774490914)"
|
|
2012,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,458,72.5,67.8,77.2,2715,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,47,AGE09,CAT3,_RFPSA21,RESP046,"(35.68094058, -85.774490914)"
|
|
2012,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,170,27.5,22.8,32.2,2719,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,47,AGE09,CAT3,_RFPSA21,RESP054,"(35.68094058, -85.774490914)"
|
|
2012,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,944,51.2,48.1,54.3,2708,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,47,BO1,CAT1,_RFPSA21,RESP046,"(35.68094058, -85.774490914)"
|
|
2012,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,743,48.8,45.7,51.9,2709,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,47,BO1,CAT1,_RFPSA21,RESP054,"(35.68094058, -85.774490914)"
|
|
2012,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,82,41,31.5,50.6,2730,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,47,EDUCA1,CAT5,_RFPSA21,RESP046,"(35.68094058, -85.774490914)"
|
|
2012,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,106,59,49.4,68.5,2734,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,47,EDUCA1,CAT5,_RFPSA21,RESP054,"(35.68094058, -85.774490914)"
|
|
2012,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,270,44.5,39.4,49.7,2731,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,47,EDUCA2,CAT5,_RFPSA21,RESP046,"(35.68094058, -85.774490914)"
|
|
2012,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,286,55.5,50.3,60.6,2735,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,47,EDUCA2,CAT5,_RFPSA21,RESP054,"(35.68094058, -85.774490914)"
|
|
2012,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,274,56,50.3,61.7,2732,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,47,EDUCA3,CAT5,_RFPSA21,RESP046,"(35.68094058, -85.774490914)"
|
|
2012,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,190,44,38.3,49.7,2736,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,47,EDUCA3,CAT5,_RFPSA21,RESP054,"(35.68094058, -85.774490914)"
|
|
2012,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,316,63.1,57.4,68.8,2733,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,47,EDUCA4,CAT5,_RFPSA21,RESP046,"(35.68094058, -85.774490914)"
|
|
2012,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,161,36.9,31.2,42.6,2737,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,47,EDUCA4,CAT5,_RFPSA21,RESP054,"(35.68094058, -85.774490914)"
|
|
2012,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,52,28.6,19.2,38,2738,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,47,INCOME1,CAT6,_RFPSA21,RESP046,"(35.68094058, -85.774490914)"
|
|
2012,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,104,71.4,62,80.8,2743,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,47,INCOME1,CAT6,_RFPSA21,RESP054,"(35.68094058, -85.774490914)"
|
|
2012,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,138,46.7,38.2,55.1,2739,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,47,INCOME2,CAT6,_RFPSA21,RESP046,"(35.68094058, -85.774490914)"
|
|
2012,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,138,53.4,44.9,61.8,2744,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,47,INCOME2,CAT6,_RFPSA21,RESP054,"(35.68094058, -85.774490914)"
|
|
2012,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,104,53,43.2,62.7,2740,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,47,INCOME3,CAT6,_RFPSA21,RESP046,"(35.68094058, -85.774490914)"
|
|
2012,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,72,47,37.3,56.8,2745,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,47,INCOME3,CAT6,_RFPSA21,RESP054,"(35.68094058, -85.774490914)"
|
|
2012,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,129,53.1,44.6,61.6,2741,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,47,INCOME4,CAT6,_RFPSA21,RESP046,"(35.68094058, -85.774490914)"
|
|
2012,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,88,46.9,38.4,55.4,2746,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,47,INCOME4,CAT6,_RFPSA21,RESP054,"(35.68094058, -85.774490914)"
|
|
2012,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,323,57.2,51.9,62.5,2742,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,47,INCOME5,CAT6,_RFPSA21,RESP046,"(35.68094058, -85.774490914)"
|
|
2012,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,205,42.8,37.6,48.1,2747,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,47,INCOME5,CAT6,_RFPSA21,RESP054,"(35.68094058, -85.774490914)"
|
|
2012,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,814,51.7,48.4,54.9,2720,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,47,RACE1,CAT4,_RFPSA21,RESP046,"(35.68094058, -85.774490914)"
|
|
2012,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,635,48.4,45.1,51.6,2725,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,47,RACE1,CAT4,_RFPSA21,RESP054,"(35.68094058, -85.774490914)"
|
|
2012,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,102,54.7,44.6,64.8,2721,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,47,RACE2,CAT4,_RFPSA21,RESP046,"(35.68094058, -85.774490914)"
|
|
2012,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,79,45.3,35.3,55.4,2726,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,47,RACE2,CAT4,_RFPSA21,RESP054,"(35.68094058, -85.774490914)"
|
|
2012,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,7,,,,2722,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,47,RACE3,CAT4,_RFPSA21,RESP046,"(35.68094058, -85.774490914)"
|
|
2012,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,8,,,,2727,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,47,RACE3,CAT4,_RFPSA21,RESP054,"(35.68094058, -85.774490914)"
|
|
2012,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,4,,,,2723,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,47,RACE4,CAT4,_RFPSA21,RESP046,"(35.68094058, -85.774490914)"
|
|
2012,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,15,,,,2728,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,47,RACE4,CAT4,_RFPSA21,RESP054,"(35.68094058, -85.774490914)"
|
|
2012,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,7,,,,2724,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,47,RACE5,CAT4,_RFPSA21,RESP046,"(35.68094058, -85.774490914)"
|
|
2012,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,5,,,,2729,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,47,RACE5,CAT4,_RFPSA21,RESP054,"(35.68094058, -85.774490914)"
|
|
2012,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,944,51.2,48.1,54.3,2710,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,47,SEX1,CAT2,_RFPSA21,RESP046,"(35.68094058, -85.774490914)"
|
|
2012,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,743,48.8,45.7,51.9,2711,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,47,SEX1,CAT2,_RFPSA21,RESP054,"(35.68094058, -85.774490914)"
|
|
2012,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,119,22.4,18.1,26.8,2721,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,48,AGE06,CAT3,_RFPSA21,RESP046,"(31.827240407, -99.426770206)"
|
|
2012,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,410,77.6,73.2,81.9,2725,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,48,AGE06,CAT3,_RFPSA21,RESP054,"(31.827240407, -99.426770206)"
|
|
2012,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,265,35.8,30.9,40.7,2722,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,48,AGE07,CAT3,_RFPSA21,RESP046,"(31.827240407, -99.426770206)"
|
|
2012,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,356,64.2,59.3,69.1,2726,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,48,AGE07,CAT3,_RFPSA21,RESP054,"(31.827240407, -99.426770206)"
|
|
2012,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,210,56.3,48.9,63.7,2723,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,48,AGE08,CAT3,_RFPSA21,RESP046,"(31.827240407, -99.426770206)"
|
|
2012,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,125,43.7,36.3,51.1,2727,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,48,AGE08,CAT3,_RFPSA21,RESP054,"(31.827240407, -99.426770206)"
|
|
2012,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,626,69,64.8,73.2,2724,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,48,AGE09,CAT3,_RFPSA21,RESP046,"(31.827240407, -99.426770206)"
|
|
2012,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,279,31,26.8,35.3,2728,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,48,AGE09,CAT3,_RFPSA21,RESP054,"(31.827240407, -99.426770206)"
|
|
2012,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1220,41.8,39.2,44.4,2717,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,48,BO1,CAT1,_RFPSA21,RESP046,"(31.827240407, -99.426770206)"
|
|
2012,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1170,58.2,55.6,60.8,2718,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,48,BO1,CAT1,_RFPSA21,RESP054,"(31.827240407, -99.426770206)"
|
|
2012,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,77,17.3,12.5,22,2739,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,48,EDUCA1,CAT5,_RFPSA21,RESP046,"(31.827240407, -99.426770206)"
|
|
2012,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,220,82.7,78,87.5,2743,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,48,EDUCA1,CAT5,_RFPSA21,RESP054,"(31.827240407, -99.426770206)"
|
|
2012,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,238,38.6,33.5,43.7,2740,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,48,EDUCA2,CAT5,_RFPSA21,RESP046,"(31.827240407, -99.426770206)"
|
|
2012,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,302,61.4,56.3,66.5,2744,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,48,EDUCA2,CAT5,_RFPSA21,RESP054,"(31.827240407, -99.426770206)"
|
|
2012,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,279,48.5,42.8,54.1,2741,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,48,EDUCA3,CAT5,_RFPSA21,RESP046,"(31.827240407, -99.426770206)"
|
|
2012,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,225,51.5,45.9,57.2,2745,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,48,EDUCA3,CAT5,_RFPSA21,RESP054,"(31.827240407, -99.426770206)"
|
|
2012,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,624,54.1,49.9,58.4,2742,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,48,EDUCA4,CAT5,_RFPSA21,RESP046,"(31.827240407, -99.426770206)"
|
|
2012,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,420,45.9,41.6,50.1,2746,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,48,EDUCA4,CAT5,_RFPSA21,RESP054,"(31.827240407, -99.426770206)"
|
|
2012,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,68,24.8,17.8,31.8,2747,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,48,INCOME1,CAT6,_RFPSA21,RESP046,"(31.827240407, -99.426770206)"
|
|
2012,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,154,75.2,68.3,82.2,2752,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,48,INCOME1,CAT6,_RFPSA21,RESP054,"(31.827240407, -99.426770206)"
|
|
2012,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,123,26,20,32,2748,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,48,INCOME2,CAT6,_RFPSA21,RESP046,"(31.827240407, -99.426770206)"
|
|
2012,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,210,74,68.1,80,2753,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,48,INCOME2,CAT6,_RFPSA21,RESP054,"(31.827240407, -99.426770206)"
|
|
2012,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,94,33.5,25.4,41.5,2749,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,48,INCOME3,CAT6,_RFPSA21,RESP046,"(31.827240407, -99.426770206)"
|
|
2012,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,120,66.6,58.5,74.6,2754,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,48,INCOME3,CAT6,_RFPSA21,RESP054,"(31.827240407, -99.426770206)"
|
|
2012,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,161,48.2,40,56.3,2750,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,48,INCOME4,CAT6,_RFPSA21,RESP046,"(31.827240407, -99.426770206)"
|
|
2012,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,119,51.9,43.7,60,2755,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,48,INCOME4,CAT6,_RFPSA21,RESP054,"(31.827240407, -99.426770206)"
|
|
2012,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,667,49.7,45.7,53.6,2751,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,48,INCOME5,CAT6,_RFPSA21,RESP046,"(31.827240407, -99.426770206)"
|
|
2012,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,477,50.3,46.4,54.3,2756,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,48,INCOME5,CAT6,_RFPSA21,RESP054,"(31.827240407, -99.426770206)"
|
|
2012,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,910,50.5,47.2,53.7,2729,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,48,RACE1,CAT4,_RFPSA21,RESP046,"(31.827240407, -99.426770206)"
|
|
2012,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,694,49.5,46.3,52.8,2734,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,48,RACE1,CAT4,_RFPSA21,RESP054,"(31.827240407, -99.426770206)"
|
|
2012,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,76,47.4,37.1,57.8,2730,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,48,RACE2,CAT4,_RFPSA21,RESP046,"(31.827240407, -99.426770206)"
|
|
2012,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,65,52.6,42.2,62.9,2735,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,48,RACE2,CAT4,_RFPSA21,RESP054,"(31.827240407, -99.426770206)"
|
|
2012,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,166,25.1,20.4,29.8,2731,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,48,RACE3,CAT4,_RFPSA21,RESP046,"(31.827240407, -99.426770206)"
|
|
2012,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,331,74.9,70.2,79.6,2736,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,48,RACE3,CAT4,_RFPSA21,RESP054,"(31.827240407, -99.426770206)"
|
|
2012,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,22,31.2,16.7,45.8,2732,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,48,RACE4,CAT4,_RFPSA21,RESP046,"(31.827240407, -99.426770206)"
|
|
2012,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,41,68.8,54.2,83.4,2737,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,48,RACE4,CAT4,_RFPSA21,RESP054,"(31.827240407, -99.426770206)"
|
|
2012,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,13,,,,2733,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,48,RACE5,CAT4,_RFPSA21,RESP046,"(31.827240407, -99.426770206)"
|
|
2012,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,13,,,,2738,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,48,RACE5,CAT4,_RFPSA21,RESP054,"(31.827240407, -99.426770206)"
|
|
2012,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1220,41.8,39.2,44.4,2719,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,48,SEX1,CAT2,_RFPSA21,RESP046,"(31.827240407, -99.426770206)"
|
|
2012,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1170,58.2,55.6,60.8,2720,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,48,SEX1,CAT2,_RFPSA21,RESP054,"(31.827240407, -99.426770206)"
|
|
2012,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,126,13.3,10.5,16.1,2720,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,49,AGE06,CAT3,_RFPSA21,RESP046,"(39.360700171, -111.587130635)"
|
|
2012,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,669,86.7,83.9,89.5,2724,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,49,AGE06,CAT3,_RFPSA21,RESP054,"(39.360700171, -111.587130635)"
|
|
2012,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,358,39.2,35.2,43.2,2721,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,49,AGE07,CAT3,_RFPSA21,RESP046,"(39.360700171, -111.587130635)"
|
|
2012,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,543,60.8,56.8,64.8,2725,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,49,AGE07,CAT3,_RFPSA21,RESP054,"(39.360700171, -111.587130635)"
|
|
2012,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,275,59.6,54,65.2,2722,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,49,AGE08,CAT3,_RFPSA21,RESP046,"(39.360700171, -111.587130635)"
|
|
2012,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,188,40.4,34.8,46,2726,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,49,AGE08,CAT3,_RFPSA21,RESP054,"(39.360700171, -111.587130635)"
|
|
2012,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,750,62.2,58.8,65.7,2723,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,49,AGE09,CAT3,_RFPSA21,RESP046,"(39.360700171, -111.587130635)"
|
|
2012,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,427,37.8,34.3,41.2,2727,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,49,AGE09,CAT3,_RFPSA21,RESP054,"(39.360700171, -111.587130635)"
|
|
2012,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1509,38.4,36.3,40.5,2716,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,49,BO1,CAT1,_RFPSA21,RESP046,"(39.360700171, -111.587130635)"
|
|
2012,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1827,61.6,59.5,63.7,2717,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,49,BO1,CAT1,_RFPSA21,RESP054,"(39.360700171, -111.587130635)"
|
|
2012,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,35,18.3,10.7,25.9,2738,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,49,EDUCA1,CAT5,_RFPSA21,RESP046,"(39.360700171, -111.587130635)"
|
|
2012,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,108,81.7,74.1,89.3,2742,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,49,EDUCA1,CAT5,_RFPSA21,RESP054,"(39.360700171, -111.587130635)"
|
|
2012,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,285,33.1,28.7,37.4,2739,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,49,EDUCA2,CAT5,_RFPSA21,RESP046,"(39.360700171, -111.587130635)"
|
|
2012,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,428,67,62.6,71.3,2743,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,49,EDUCA2,CAT5,_RFPSA21,RESP054,"(39.360700171, -111.587130635)"
|
|
2012,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,443,39.6,35.9,43.3,2740,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,49,EDUCA3,CAT5,_RFPSA21,RESP046,"(39.360700171, -111.587130635)"
|
|
2012,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,557,60.4,56.7,64.1,2744,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,49,EDUCA3,CAT5,_RFPSA21,RESP054,"(39.360700171, -111.587130635)"
|
|
2012,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,744,45.9,42.8,49,2741,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,49,EDUCA4,CAT5,_RFPSA21,RESP046,"(39.360700171, -111.587130635)"
|
|
2012,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,728,54.1,51,57.2,2745,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,49,EDUCA4,CAT5,_RFPSA21,RESP054,"(39.360700171, -111.587130635)"
|
|
2012,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,34,19.7,11.4,28,2746,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,49,INCOME1,CAT6,_RFPSA21,RESP046,"(39.360700171, -111.587130635)"
|
|
2012,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,118,80.3,72,88.6,2751,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,49,INCOME1,CAT6,_RFPSA21,RESP054,"(39.360700171, -111.587130635)"
|
|
2012,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,151,34.6,28.1,41,2747,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,49,INCOME2,CAT6,_RFPSA21,RESP046,"(39.360700171, -111.587130635)"
|
|
2012,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,194,65.5,59,71.9,2752,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,49,INCOME2,CAT6,_RFPSA21,RESP054,"(39.360700171, -111.587130635)"
|
|
2012,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,141,40.5,33,47.9,2748,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,49,INCOME3,CAT6,_RFPSA21,RESP046,"(39.360700171, -111.587130635)"
|
|
2012,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,161,59.6,52.1,67,2753,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,49,INCOME3,CAT6,_RFPSA21,RESP054,"(39.360700171, -111.587130635)"
|
|
2012,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,206,38.6,32.7,44.4,2749,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,49,INCOME4,CAT6,_RFPSA21,RESP046,"(39.360700171, -111.587130635)"
|
|
2012,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,244,61.4,55.6,67.3,2754,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,49,INCOME4,CAT6,_RFPSA21,RESP054,"(39.360700171, -111.587130635)"
|
|
2012,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,877,41.4,38.7,44.2,2750,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,49,INCOME5,CAT6,_RFPSA21,RESP046,"(39.360700171, -111.587130635)"
|
|
2012,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,961,58.6,55.8,61.3,2755,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,49,INCOME5,CAT6,_RFPSA21,RESP054,"(39.360700171, -111.587130635)"
|
|
2012,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1396,40.9,38.7,43.1,2728,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,49,RACE1,CAT4,_RFPSA21,RESP046,"(39.360700171, -111.587130635)"
|
|
2012,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1613,59.1,56.9,61.3,2733,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,49,RACE1,CAT4,_RFPSA21,RESP054,"(39.360700171, -111.587130635)"
|
|
2012,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,2,,,,2729,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,49,RACE2,CAT4,_RFPSA21,RESP046,"(39.360700171, -111.587130635)"
|
|
2012,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,10,,,,2734,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,49,RACE2,CAT4,_RFPSA21,RESP054,"(39.360700171, -111.587130635)"
|
|
2012,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,55,24.2,16.6,31.8,2730,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,49,RACE3,CAT4,_RFPSA21,RESP046,"(39.360700171, -111.587130635)"
|
|
2012,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,123,75.8,68.2,83.4,2735,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,49,RACE3,CAT4,_RFPSA21,RESP054,"(39.360700171, -111.587130635)"
|
|
2012,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,30,33.6,21.5,45.8,2731,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,49,RACE4,CAT4,_RFPSA21,RESP046,"(39.360700171, -111.587130635)"
|
|
2012,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,48,66.4,54.3,78.5,2736,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,49,RACE4,CAT4,_RFPSA21,RESP054,"(39.360700171, -111.587130635)"
|
|
2012,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,8,,,,2732,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,49,RACE5,CAT4,_RFPSA21,RESP046,"(39.360700171, -111.587130635)"
|
|
2012,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,15,,,,2737,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,49,RACE5,CAT4,_RFPSA21,RESP054,"(39.360700171, -111.587130635)"
|
|
2012,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1509,38.4,36.3,40.5,2718,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,49,SEX1,CAT2,_RFPSA21,RESP046,"(39.360700171, -111.587130635)"
|
|
2012,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1827,61.6,59.5,63.7,2719,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,49,SEX1,CAT2,_RFPSA21,RESP054,"(39.360700171, -111.587130635)"
|
|
2012,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,39,10.1,6.6,13.5,2700,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,50,AGE06,CAT3,_RFPSA21,RESP046,"(43.625381239, -72.517640791)"
|
|
2012,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,312,89.9,86.5,93.4,2704,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,50,AGE06,CAT3,_RFPSA21,RESP054,"(43.625381239, -72.517640791)"
|
|
2012,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,186,32.7,28.1,37.3,2701,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,50,AGE07,CAT3,_RFPSA21,RESP046,"(43.625381239, -72.517640791)"
|
|
2012,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,344,67.3,62.7,71.9,2705,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,50,AGE07,CAT3,_RFPSA21,RESP054,"(43.625381239, -72.517640791)"
|
|
2012,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,180,59.7,53.1,66.2,2702,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,50,AGE08,CAT3,_RFPSA21,RESP046,"(43.625381239, -72.517640791)"
|
|
2012,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,125,40.4,33.8,46.9,2706,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,50,AGE08,CAT3,_RFPSA21,RESP054,"(43.625381239, -72.517640791)"
|
|
2012,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,409,60.8,56.3,65.2,2703,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,50,AGE09,CAT3,_RFPSA21,RESP046,"(43.625381239, -72.517640791)"
|
|
2012,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,281,39.2,34.8,43.7,2707,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,50,AGE09,CAT3,_RFPSA21,RESP054,"(43.625381239, -72.517640791)"
|
|
2012,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,814,38.4,35.8,40.9,2696,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,50,BO1,CAT1,_RFPSA21,RESP046,"(43.625381239, -72.517640791)"
|
|
2012,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1062,61.6,59.1,64.2,2697,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,50,BO1,CAT1,_RFPSA21,RESP054,"(43.625381239, -72.517640791)"
|
|
2012,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,52,32.1,23.5,40.7,2718,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,50,EDUCA1,CAT5,_RFPSA21,RESP046,"(43.625381239, -72.517640791)"
|
|
2012,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,98,67.9,59.3,76.5,2722,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,50,EDUCA1,CAT5,_RFPSA21,RESP054,"(43.625381239, -72.517640791)"
|
|
2012,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,226,36.3,31.8,40.9,2719,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,50,EDUCA2,CAT5,_RFPSA21,RESP046,"(43.625381239, -72.517640791)"
|
|
2012,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,346,63.7,59.1,68.2,2723,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,50,EDUCA2,CAT5,_RFPSA21,RESP054,"(43.625381239, -72.517640791)"
|
|
2012,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,146,34.4,28.9,39.9,2720,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,50,EDUCA3,CAT5,_RFPSA21,RESP046,"(43.625381239, -72.517640791)"
|
|
2012,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,228,65.6,60.1,71.1,2724,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,50,EDUCA3,CAT5,_RFPSA21,RESP054,"(43.625381239, -72.517640791)"
|
|
2012,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,388,45.8,41.7,49.9,2721,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,50,EDUCA4,CAT5,_RFPSA21,RESP046,"(43.625381239, -72.517640791)"
|
|
2012,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,387,54.2,50.2,58.3,2725,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,50,EDUCA4,CAT5,_RFPSA21,RESP054,"(43.625381239, -72.517640791)"
|
|
2012,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,41,22.8,13.8,31.9,2726,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,50,INCOME1,CAT6,_RFPSA21,RESP046,"(43.625381239, -72.517640791)"
|
|
2012,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,104,77.2,68.1,86.2,2731,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,50,INCOME1,CAT6,_RFPSA21,RESP054,"(43.625381239, -72.517640791)"
|
|
2012,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,88,29.6,22.7,36.4,2727,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,50,INCOME2,CAT6,_RFPSA21,RESP046,"(43.625381239, -72.517640791)"
|
|
2012,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,148,70.4,63.6,77.3,2732,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,50,INCOME2,CAT6,_RFPSA21,RESP054,"(43.625381239, -72.517640791)"
|
|
2012,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,76,35.8,27.4,44.2,2728,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,50,INCOME3,CAT6,_RFPSA21,RESP046,"(43.625381239, -72.517640791)"
|
|
2012,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,105,64.2,55.8,72.6,2733,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,50,INCOME3,CAT6,_RFPSA21,RESP054,"(43.625381239, -72.517640791)"
|
|
2012,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,135,45.3,38.3,52.3,2729,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,50,INCOME4,CAT6,_RFPSA21,RESP046,"(43.625381239, -72.517640791)"
|
|
2012,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,139,54.7,47.7,61.7,2734,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,50,INCOME4,CAT6,_RFPSA21,RESP054,"(43.625381239, -72.517640791)"
|
|
2012,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,400,40.4,36.6,44.1,2730,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,50,INCOME5,CAT6,_RFPSA21,RESP046,"(43.625381239, -72.517640791)"
|
|
2012,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,471,59.6,55.9,63.4,2735,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,50,INCOME5,CAT6,_RFPSA21,RESP054,"(43.625381239, -72.517640791)"
|
|
2012,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,766,38.4,35.8,41,2708,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,50,RACE1,CAT4,_RFPSA21,RESP046,"(43.625381239, -72.517640791)"
|
|
2012,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,986,61.6,59,64.3,2713,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,50,RACE1,CAT4,_RFPSA21,RESP054,"(43.625381239, -72.517640791)"
|
|
2012,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,3,,,,2709,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,50,RACE2,CAT4,_RFPSA21,RESP046,"(43.625381239, -72.517640791)"
|
|
2012,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,5,,,,2714,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,50,RACE2,CAT4,_RFPSA21,RESP054,"(43.625381239, -72.517640791)"
|
|
2012,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,9,,,,2710,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,50,RACE3,CAT4,_RFPSA21,RESP046,"(43.625381239, -72.517640791)"
|
|
2012,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,13,,,,2715,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,50,RACE3,CAT4,_RFPSA21,RESP054,"(43.625381239, -72.517640791)"
|
|
2012,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,11,,,,2711,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,50,RACE4,CAT4,_RFPSA21,RESP046,"(43.625381239, -72.517640791)"
|
|
2012,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,26,,,,2716,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,50,RACE4,CAT4,_RFPSA21,RESP054,"(43.625381239, -72.517640791)"
|
|
2012,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,9,,,,2712,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,50,RACE5,CAT4,_RFPSA21,RESP046,"(43.625381239, -72.517640791)"
|
|
2012,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,13,,,,2717,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,50,RACE5,CAT4,_RFPSA21,RESP054,"(43.625381239, -72.517640791)"
|
|
2012,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,814,38.4,35.8,40.9,2698,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,50,SEX1,CAT2,_RFPSA21,RESP046,"(43.625381239, -72.517640791)"
|
|
2012,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1062,61.6,59.1,64.2,2699,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,50,SEX1,CAT2,_RFPSA21,RESP054,"(43.625381239, -72.517640791)"
|
|
2012,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,102,24.2,19.4,29.1,2718,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,AGE06,CAT3,_RFPSA21,RESP046,"(37.542680674, -78.457890463)"
|
|
2012,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,341,75.8,70.9,80.7,2722,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,AGE06,CAT3,_RFPSA21,RESP054,"(37.542680674, -78.457890463)"
|
|
2012,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,305,46.3,41.5,51.1,2719,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,AGE07,CAT3,_RFPSA21,RESP046,"(37.542680674, -78.457890463)"
|
|
2012,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,294,53.7,48.9,58.5,2723,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,AGE07,CAT3,_RFPSA21,RESP054,"(37.542680674, -78.457890463)"
|
|
2012,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,173,58,50.9,65.1,2720,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,AGE08,CAT3,_RFPSA21,RESP046,"(37.542680674, -78.457890463)"
|
|
2012,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,104,42,34.9,49.1,2724,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,AGE08,CAT3,_RFPSA21,RESP054,"(37.542680674, -78.457890463)"
|
|
2012,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,519,67.1,63.1,71.2,2721,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,AGE09,CAT3,_RFPSA21,RESP046,"(37.542680674, -78.457890463)"
|
|
2012,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,241,32.9,28.8,36.9,2725,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,AGE09,CAT3,_RFPSA21,RESP054,"(37.542680674, -78.457890463)"
|
|
2012,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1099,46.5,43.9,49.2,2714,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,BO1,CAT1,_RFPSA21,RESP046,"(37.542680674, -78.457890463)"
|
|
2012,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,980,53.5,50.8,56.1,2715,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,BO1,CAT1,_RFPSA21,RESP054,"(37.542680674, -78.457890463)"
|
|
2012,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,63,32.5,24.7,40.3,2736,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,EDUCA1,CAT5,_RFPSA21,RESP046,"(37.542680674, -78.457890463)"
|
|
2012,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,116,67.5,59.7,75.3,2740,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,EDUCA1,CAT5,_RFPSA21,RESP054,"(37.542680674, -78.457890463)"
|
|
2012,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,225,41.4,36.3,46.6,2737,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,EDUCA2,CAT5,_RFPSA21,RESP046,"(37.542680674, -78.457890463)"
|
|
2012,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,254,58.6,53.5,63.7,2741,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,EDUCA2,CAT5,_RFPSA21,RESP054,"(37.542680674, -78.457890463)"
|
|
2012,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,260,52.6,47.1,58,2738,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,EDUCA3,CAT5,_RFPSA21,RESP046,"(37.542680674, -78.457890463)"
|
|
2012,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,201,47.5,42,52.9,2742,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,EDUCA3,CAT5,_RFPSA21,RESP054,"(37.542680674, -78.457890463)"
|
|
2012,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,550,52.1,48.4,55.8,2739,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,EDUCA4,CAT5,_RFPSA21,RESP046,"(37.542680674, -78.457890463)"
|
|
2012,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,408,47.9,44.2,51.6,2743,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,EDUCA4,CAT5,_RFPSA21,RESP054,"(37.542680674, -78.457890463)"
|
|
2012,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,24,18.2,9.3,27.2,2744,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,INCOME1,CAT6,_RFPSA21,RESP046,"(37.542680674, -78.457890463)"
|
|
2012,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,79,81.8,72.8,90.7,2749,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,INCOME1,CAT6,_RFPSA21,RESP054,"(37.542680674, -78.457890463)"
|
|
2012,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,92,39,31.1,47,2745,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,INCOME2,CAT6,_RFPSA21,RESP046,"(37.542680674, -78.457890463)"
|
|
2012,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,120,61,53,69,2750,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,INCOME2,CAT6,_RFPSA21,RESP054,"(37.542680674, -78.457890463)"
|
|
2012,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,86,53.9,44.3,63.6,2746,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,INCOME3,CAT6,_RFPSA21,RESP046,"(37.542680674, -78.457890463)"
|
|
2012,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,71,46.1,36.4,55.8,2751,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,INCOME3,CAT6,_RFPSA21,RESP054,"(37.542680674, -78.457890463)"
|
|
2012,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,125,43.7,36.2,51.2,2747,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,INCOME4,CAT6,_RFPSA21,RESP046,"(37.542680674, -78.457890463)"
|
|
2012,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,118,56.3,48.8,63.8,2752,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,INCOME4,CAT6,_RFPSA21,RESP054,"(37.542680674, -78.457890463)"
|
|
2012,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,625,50.5,46.9,54,2748,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,INCOME5,CAT6,_RFPSA21,RESP046,"(37.542680674, -78.457890463)"
|
|
2012,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,492,49.5,46,53.1,2753,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,INCOME5,CAT6,_RFPSA21,RESP054,"(37.542680674, -78.457890463)"
|
|
2012,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,873,47.1,44.2,49.9,2726,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,RACE1,CAT4,_RFPSA21,RESP046,"(37.542680674, -78.457890463)"
|
|
2012,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,759,52.9,50.1,55.8,2731,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,RACE1,CAT4,_RFPSA21,RESP054,"(37.542680674, -78.457890463)"
|
|
2012,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,138,49.7,42.2,57.2,2727,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,RACE2,CAT4,_RFPSA21,RESP046,"(37.542680674, -78.457890463)"
|
|
2012,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,114,50.3,42.9,57.8,2732,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,RACE2,CAT4,_RFPSA21,RESP054,"(37.542680674, -78.457890463)"
|
|
2012,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,16,27.1,12.9,41.3,2728,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,RACE3,CAT4,_RFPSA21,RESP046,"(37.542680674, -78.457890463)"
|
|
2012,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,35,72.9,58.7,87.1,2733,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,RACE3,CAT4,_RFPSA21,RESP054,"(37.542680674, -78.457890463)"
|
|
2012,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,38,39.2,26.4,52.1,2729,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,RACE4,CAT4,_RFPSA21,RESP046,"(37.542680674, -78.457890463)"
|
|
2012,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,42,60.8,47.9,73.6,2734,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,RACE4,CAT4,_RFPSA21,RESP054,"(37.542680674, -78.457890463)"
|
|
2012,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,17,,,,2730,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,51,RACE5,CAT4,_RFPSA21,RESP046,"(37.542680674, -78.457890463)"
|
|
2012,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,8,,,,2735,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,51,RACE5,CAT4,_RFPSA21,RESP054,"(37.542680674, -78.457890463)"
|
|
2012,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1099,46.5,43.9,49.2,2716,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,SEX1,CAT2,_RFPSA21,RESP046,"(37.542680674, -78.457890463)"
|
|
2012,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,980,53.5,50.8,56.1,2717,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,SEX1,CAT2,_RFPSA21,RESP054,"(37.542680674, -78.457890463)"
|
|
2012,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,2062,36.9,35.1,38.6,2721,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,SEX1,CAT2,_RFPSA21,RESP046,"(47.522278629, -120.47001079)"
|
|
2012,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,119,12,9.4,14.6,2723,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,AGE06,CAT3,_RFPSA21,RESP046,"(47.522278629, -120.47001079)"
|
|
2012,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,766,88,85.4,90.6,2727,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,AGE06,CAT3,_RFPSA21,RESP054,"(47.522278629, -120.47001079)"
|
|
2012,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,476,34.7,31.4,38,2724,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,AGE07,CAT3,_RFPSA21,RESP046,"(47.522278629, -120.47001079)"
|
|
2012,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,774,65.3,62,68.6,2728,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,AGE07,CAT3,_RFPSA21,RESP054,"(47.522278629, -120.47001079)"
|
|
2012,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,398,53.1,48.5,57.7,2725,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,AGE08,CAT3,_RFPSA21,RESP046,"(47.522278629, -120.47001079)"
|
|
2012,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,319,46.9,42.3,51.5,2729,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,AGE08,CAT3,_RFPSA21,RESP054,"(47.522278629, -120.47001079)"
|
|
2012,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,1069,58.7,55.6,61.7,2726,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,AGE09,CAT3,_RFPSA21,RESP046,"(47.522278629, -120.47001079)"
|
|
2012,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,717,41.3,38.3,44.4,2730,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,AGE09,CAT3,_RFPSA21,RESP054,"(47.522278629, -120.47001079)"
|
|
2012,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,2062,36.9,35.1,38.6,2719,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,BO1,CAT1,_RFPSA21,RESP046,"(47.522278629, -120.47001079)"
|
|
2012,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,2576,63.1,61.4,64.9,2720,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,BO1,CAT1,_RFPSA21,RESP054,"(47.522278629, -120.47001079)"
|
|
2012,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,54,20.6,13.7,27.4,2741,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,EDUCA1,CAT5,_RFPSA21,RESP046,"(47.522278629, -120.47001079)"
|
|
2012,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,154,79.5,72.6,86.3,2745,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,EDUCA1,CAT5,_RFPSA21,RESP054,"(47.522278629, -120.47001079)"
|
|
2012,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,376,33.2,29.6,36.8,2742,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,EDUCA2,CAT5,_RFPSA21,RESP046,"(47.522278629, -120.47001079)"
|
|
2012,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,617,66.8,63.2,70.4,2746,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,EDUCA2,CAT5,_RFPSA21,RESP054,"(47.522278629, -120.47001079)"
|
|
2012,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,522,36.4,33.2,39.6,2743,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,EDUCA3,CAT5,_RFPSA21,RESP046,"(47.522278629, -120.47001079)"
|
|
2012,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,717,63.6,60.4,66.8,2747,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,EDUCA3,CAT5,_RFPSA21,RESP054,"(47.522278629, -120.47001079)"
|
|
2012,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,1109,44.7,42.1,47.2,2744,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,EDUCA4,CAT5,_RFPSA21,RESP046,"(47.522278629, -120.47001079)"
|
|
2012,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,1086,55.3,52.8,57.9,2748,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,EDUCA4,CAT5,_RFPSA21,RESP054,"(47.522278629, -120.47001079)"
|
|
2012,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,71,19.9,13.8,26,2749,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,INCOME1,CAT6,_RFPSA21,RESP046,"(47.522278629, -120.47001079)"
|
|
2012,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,208,80.1,74,86.2,2754,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,INCOME1,CAT6,_RFPSA21,RESP054,"(47.522278629, -120.47001079)"
|
|
2012,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,152,28.3,22.6,33.9,2750,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,INCOME2,CAT6,_RFPSA21,RESP046,"(47.522278629, -120.47001079)"
|
|
2012,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,286,71.7,66.1,77.4,2755,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,INCOME2,CAT6,_RFPSA21,RESP054,"(47.522278629, -120.47001079)"
|
|
2012,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,171,32.9,26.9,38.9,2751,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,INCOME3,CAT6,_RFPSA21,RESP046,"(47.522278629, -120.47001079)"
|
|
2012,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,233,67.1,61.1,73.1,2756,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,INCOME3,CAT6,_RFPSA21,RESP054,"(47.522278629, -120.47001079)"
|
|
2012,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,282,36.5,31.9,41.1,2752,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,INCOME4,CAT6,_RFPSA21,RESP046,"(47.522278629, -120.47001079)"
|
|
2012,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,366,63.5,58.9,68.1,2757,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,INCOME4,CAT6,_RFPSA21,RESP054,"(47.522278629, -120.47001079)"
|
|
2012,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,1237,42.6,40.2,45.1,2753,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,INCOME5,CAT6,_RFPSA21,RESP046,"(47.522278629, -120.47001079)"
|
|
2012,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,1248,57.4,54.9,59.8,2758,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,INCOME5,CAT6,_RFPSA21,RESP054,"(47.522278629, -120.47001079)"
|
|
2012,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1890,40.1,38.2,41.9,2731,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,RACE1,CAT4,_RFPSA21,RESP046,"(47.522278629, -120.47001079)"
|
|
2012,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,2194,60,58.1,61.8,2736,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,RACE1,CAT4,_RFPSA21,RESP054,"(47.522278629, -120.47001079)"
|
|
2012,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,30,42,28.5,55.5,2732,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,RACE2,CAT4,_RFPSA21,RESP046,"(47.522278629, -120.47001079)"
|
|
2012,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,41,58,44.5,71.5,2737,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,RACE2,CAT4,_RFPSA21,RESP054,"(47.522278629, -120.47001079)"
|
|
2012,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,46,19.1,12.6,25.6,2733,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,RACE3,CAT4,_RFPSA21,RESP046,"(47.522278629, -120.47001079)"
|
|
2012,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,124,80.9,74.4,87.4,2738,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,RACE3,CAT4,_RFPSA21,RESP054,"(47.522278629, -120.47001079)"
|
|
2012,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,46,21,13.8,28.1,2734,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,RACE4,CAT4,_RFPSA21,RESP046,"(47.522278629, -120.47001079)"
|
|
2012,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,141,79,71.9,86.2,2739,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,RACE4,CAT4,_RFPSA21,RESP054,"(47.522278629, -120.47001079)"
|
|
2012,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,23,32.1,18,46.3,2735,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,RACE5,CAT4,_RFPSA21,RESP046,"(47.522278629, -120.47001079)"
|
|
2012,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,37,67.9,53.7,82,2740,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,RACE5,CAT4,_RFPSA21,RESP054,"(47.522278629, -120.47001079)"
|
|
2012,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,2576,63.1,61.4,64.9,2722,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,SEX1,CAT2,_RFPSA21,RESP054,"(47.522278629, -120.47001079)"
|
|
2012,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,56,18.9,14.1,23.8,2705,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,54,AGE06,CAT3,_RFPSA21,RESP046,"(38.665510202, -80.712640135)"
|
|
2012,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,222,81.1,76.2,85.9,2709,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,54,AGE06,CAT3,_RFPSA21,RESP054,"(38.665510202, -80.712640135)"
|
|
2012,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,225,49.3,43.9,54.7,2706,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,54,AGE07,CAT3,_RFPSA21,RESP046,"(38.665510202, -80.712640135)"
|
|
2012,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,209,50.7,45.3,56.1,2710,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,54,AGE07,CAT3,_RFPSA21,RESP054,"(38.665510202, -80.712640135)"
|
|
2012,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,182,63.2,57,69.3,2707,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,54,AGE08,CAT3,_RFPSA21,RESP046,"(38.665510202, -80.712640135)"
|
|
2012,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,109,36.8,30.7,43,2711,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,54,AGE08,CAT3,_RFPSA21,RESP054,"(38.665510202, -80.712640135)"
|
|
2012,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,366,62.8,58.3,67.3,2708,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,54,AGE09,CAT3,_RFPSA21,RESP046,"(38.665510202, -80.712640135)"
|
|
2012,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,204,37.2,32.7,41.7,2712,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,54,AGE09,CAT3,_RFPSA21,RESP054,"(38.665510202, -80.712640135)"
|
|
2012,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,829,48.1,45.3,50.9,2701,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,54,BO1,CAT1,_RFPSA21,RESP046,"(38.665510202, -80.712640135)"
|
|
2012,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,744,51.9,49.1,54.7,2702,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,54,BO1,CAT1,_RFPSA21,RESP054,"(38.665510202, -80.712640135)"
|
|
2012,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,86,35.3,28.3,42.2,2723,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,54,EDUCA1,CAT5,_RFPSA21,RESP046,"(38.665510202, -80.712640135)"
|
|
2012,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,145,64.7,57.8,71.7,2727,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,54,EDUCA1,CAT5,_RFPSA21,RESP054,"(38.665510202, -80.712640135)"
|
|
2012,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,326,45.3,41.1,49.5,2724,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,54,EDUCA2,CAT5,_RFPSA21,RESP046,"(38.665510202, -80.712640135)"
|
|
2012,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,321,54.7,50.5,59,2728,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,54,EDUCA2,CAT5,_RFPSA21,RESP054,"(38.665510202, -80.712640135)"
|
|
2012,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,192,55.6,49.7,61.5,2725,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,54,EDUCA3,CAT5,_RFPSA21,RESP046,"(38.665510202, -80.712640135)"
|
|
2012,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,139,44.4,38.5,50.4,2729,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,54,EDUCA3,CAT5,_RFPSA21,RESP054,"(38.665510202, -80.712640135)"
|
|
2012,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,225,60.2,54.7,65.8,2726,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,54,EDUCA4,CAT5,_RFPSA21,RESP046,"(38.665510202, -80.712640135)"
|
|
2012,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,138,39.8,34.2,45.4,2730,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,54,EDUCA4,CAT5,_RFPSA21,RESP054,"(38.665510202, -80.712640135)"
|
|
2012,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,54,29.7,21.7,37.7,2731,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,54,INCOME1,CAT6,_RFPSA21,RESP046,"(38.665510202, -80.712640135)"
|
|
2012,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,113,70.3,62.3,78.3,2736,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,54,INCOME1,CAT6,_RFPSA21,RESP054,"(38.665510202, -80.712640135)"
|
|
2012,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,123,40.4,33.7,47.1,2732,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,54,INCOME2,CAT6,_RFPSA21,RESP046,"(38.665510202, -80.712640135)"
|
|
2012,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,147,59.7,53,66.4,2737,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,54,INCOME2,CAT6,_RFPSA21,RESP054,"(38.665510202, -80.712640135)"
|
|
2012,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,112,45.9,38.6,53.3,2733,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,54,INCOME3,CAT6,_RFPSA21,RESP046,"(38.665510202, -80.712640135)"
|
|
2012,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,107,54.1,46.7,61.4,2738,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,54,INCOME3,CAT6,_RFPSA21,RESP054,"(38.665510202, -80.712640135)"
|
|
2012,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,134,55.2,47.7,62.8,2734,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,54,INCOME4,CAT6,_RFPSA21,RESP046,"(38.665510202, -80.712640135)"
|
|
2012,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,87,44.8,37.3,52.3,2739,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,54,INCOME4,CAT6,_RFPSA21,RESP054,"(38.665510202, -80.712640135)"
|
|
2012,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,322,54.4,49.6,59.2,2735,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,54,INCOME5,CAT6,_RFPSA21,RESP046,"(38.665510202, -80.712640135)"
|
|
2012,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,216,45.6,40.8,50.4,2740,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,54,INCOME5,CAT6,_RFPSA21,RESP054,"(38.665510202, -80.712640135)"
|
|
2012,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,792,48.4,45.6,51.3,2713,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,54,RACE1,CAT4,_RFPSA21,RESP046,"(38.665510202, -80.712640135)"
|
|
2012,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,700,51.6,48.7,54.5,2718,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,54,RACE1,CAT4,_RFPSA21,RESP054,"(38.665510202, -80.712640135)"
|
|
2012,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,12,,,,2714,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,54,RACE2,CAT4,_RFPSA21,RESP046,"(38.665510202, -80.712640135)"
|
|
2012,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,11,,,,2719,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,54,RACE2,CAT4,_RFPSA21,RESP054,"(38.665510202, -80.712640135)"
|
|
2012,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,9,,,,2715,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,54,RACE3,CAT4,_RFPSA21,RESP046,"(38.665510202, -80.712640135)"
|
|
2012,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,11,,,,2720,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,54,RACE3,CAT4,_RFPSA21,RESP054,"(38.665510202, -80.712640135)"
|
|
2012,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,4,,,,2716,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,54,RACE4,CAT4,_RFPSA21,RESP046,"(38.665510202, -80.712640135)"
|
|
2012,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,12,,,,2721,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,54,RACE4,CAT4,_RFPSA21,RESP054,"(38.665510202, -80.712640135)"
|
|
2012,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,9,,,,2717,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,54,RACE5,CAT4,_RFPSA21,RESP046,"(38.665510202, -80.712640135)"
|
|
2012,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,9,,,,2722,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,54,RACE5,CAT4,_RFPSA21,RESP054,"(38.665510202, -80.712640135)"
|
|
2012,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,829,48.1,45.3,50.9,2703,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,54,SEX1,CAT2,_RFPSA21,RESP046,"(38.665510202, -80.712640135)"
|
|
2012,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,744,51.9,49.1,54.7,2704,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,54,SEX1,CAT2,_RFPSA21,RESP054,"(38.665510202, -80.712640135)"
|
|
2012,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,47,16.2,10.1,22.3,2709,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,55,AGE06,CAT3,_RFPSA21,RESP046,"(44.393191174, -89.816370742)"
|
|
2012,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,256,83.8,77.7,89.9,2713,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,55,AGE06,CAT3,_RFPSA21,RESP054,"(44.393191174, -89.816370742)"
|
|
2012,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,187,38.6,31.5,45.6,2710,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,55,AGE07,CAT3,_RFPSA21,RESP046,"(44.393191174, -89.816370742)"
|
|
2012,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,255,61.4,54.4,68.5,2714,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,55,AGE07,CAT3,_RFPSA21,RESP054,"(44.393191174, -89.816370742)"
|
|
2012,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,137,52.4,43.7,61.1,2711,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,55,AGE08,CAT3,_RFPSA21,RESP046,"(44.393191174, -89.816370742)"
|
|
2012,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,116,47.6,38.9,56.3,2715,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,55,AGE08,CAT3,_RFPSA21,RESP054,"(44.393191174, -89.816370742)"
|
|
2012,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,342,63.9,57.7,70.1,2712,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,55,AGE09,CAT3,_RFPSA21,RESP046,"(44.393191174, -89.816370742)"
|
|
2012,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,192,36.1,29.9,42.3,2716,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,55,AGE09,CAT3,_RFPSA21,RESP054,"(44.393191174, -89.816370742)"
|
|
2012,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,713,41,37.4,44.7,2705,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,55,BO1,CAT1,_RFPSA21,RESP046,"(44.393191174, -89.816370742)"
|
|
2012,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,819,59,55.3,62.7,2706,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,55,BO1,CAT1,_RFPSA21,RESP054,"(44.393191174, -89.816370742)"
|
|
2012,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,35,30.8,17.9,43.7,2727,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,55,EDUCA1,CAT5,_RFPSA21,RESP046,"(44.393191174, -89.816370742)"
|
|
2012,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,74,69.2,56.3,82.1,2731,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,55,EDUCA1,CAT5,_RFPSA21,RESP054,"(44.393191174, -89.816370742)"
|
|
2012,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,236,40.2,34.5,45.9,2728,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,55,EDUCA2,CAT5,_RFPSA21,RESP046,"(44.393191174, -89.816370742)"
|
|
2012,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,307,59.8,54.1,65.5,2732,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,55,EDUCA2,CAT5,_RFPSA21,RESP054,"(44.393191174, -89.816370742)"
|
|
2012,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,175,40,32.6,47.4,2729,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,55,EDUCA3,CAT5,_RFPSA21,RESP046,"(44.393191174, -89.816370742)"
|
|
2012,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,209,60,52.6,67.4,2733,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,55,EDUCA3,CAT5,_RFPSA21,RESP054,"(44.393191174, -89.816370742)"
|
|
2012,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,266,48,41.3,54.7,2730,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,55,EDUCA4,CAT5,_RFPSA21,RESP046,"(44.393191174, -89.816370742)"
|
|
2012,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,229,52,45.3,58.7,2734,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,55,EDUCA4,CAT5,_RFPSA21,RESP054,"(44.393191174, -89.816370742)"
|
|
2012,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,32,31.2,19.2,43.2,2735,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,55,INCOME1,CAT6,_RFPSA21,RESP046,"(44.393191174, -89.816370742)"
|
|
2012,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,79,68.8,56.8,80.8,2740,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,55,INCOME1,CAT6,_RFPSA21,RESP054,"(44.393191174, -89.816370742)"
|
|
2012,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,114,41.3,31.3,51.2,2736,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,55,INCOME2,CAT6,_RFPSA21,RESP046,"(44.393191174, -89.816370742)"
|
|
2012,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,120,58.7,48.8,68.7,2741,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,55,INCOME2,CAT6,_RFPSA21,RESP054,"(44.393191174, -89.816370742)"
|
|
2012,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,79,45.1,31.3,58.9,2737,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,55,INCOME3,CAT6,_RFPSA21,RESP046,"(44.393191174, -89.816370742)"
|
|
2012,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,85,54.9,41.2,68.7,2742,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,55,INCOME3,CAT6,_RFPSA21,RESP054,"(44.393191174, -89.816370742)"
|
|
2012,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,123,45.1,36.6,53.6,2738,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,55,INCOME4,CAT6,_RFPSA21,RESP046,"(44.393191174, -89.816370742)"
|
|
2012,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,131,54.9,46.5,63.4,2743,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,55,INCOME4,CAT6,_RFPSA21,RESP054,"(44.393191174, -89.816370742)"
|
|
2012,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,316,39.8,34.6,44.9,2739,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,55,INCOME5,CAT6,_RFPSA21,RESP046,"(44.393191174, -89.816370742)"
|
|
2012,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,353,60.2,55.1,65.4,2744,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,55,INCOME5,CAT6,_RFPSA21,RESP054,"(44.393191174, -89.816370742)"
|
|
2012,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,643,41.9,38,45.7,2717,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,55,RACE1,CAT4,_RFPSA21,RESP046,"(44.393191174, -89.816370742)"
|
|
2012,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,721,58.1,54.3,62,2722,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,55,RACE1,CAT4,_RFPSA21,RESP054,"(44.393191174, -89.816370742)"
|
|
2012,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,40,35.1,16.8,53.4,2718,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,55,RACE2,CAT4,_RFPSA21,RESP046,"(44.393191174, -89.816370742)"
|
|
2012,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,37,64.9,46.6,83.2,2723,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,55,RACE2,CAT4,_RFPSA21,RESP054,"(44.393191174, -89.816370742)"
|
|
2012,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,4,,,,2719,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,55,RACE3,CAT4,_RFPSA21,RESP046,"(44.393191174, -89.816370742)"
|
|
2012,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,9,,,,2724,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,55,RACE3,CAT4,_RFPSA21,RESP054,"(44.393191174, -89.816370742)"
|
|
2012,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,16,,,,2720,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,55,RACE4,CAT4,_RFPSA21,RESP046,"(44.393191174, -89.816370742)"
|
|
2012,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,30,,,,2725,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,55,RACE4,CAT4,_RFPSA21,RESP054,"(44.393191174, -89.816370742)"
|
|
2012,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,6,,,,2721,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,55,RACE5,CAT4,_RFPSA21,RESP046,"(44.393191174, -89.816370742)"
|
|
2012,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,9,,,,2726,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,55,RACE5,CAT4,_RFPSA21,RESP054,"(44.393191174, -89.816370742)"
|
|
2012,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,713,41,37.4,44.7,2707,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,55,SEX1,CAT2,_RFPSA21,RESP046,"(44.393191174, -89.816370742)"
|
|
2012,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,819,59,55.3,62.7,2708,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,55,SEX1,CAT2,_RFPSA21,RESP054,"(44.393191174, -89.816370742)"
|
|
2012,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,70,23.4,16.7,30.1,2701,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,56,AGE06,CAT3,_RFPSA21,RESP046,"(43.235541343, -108.109830353)"
|
|
2012,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,193,76.6,69.9,83.3,2705,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,56,AGE06,CAT3,_RFPSA21,RESP054,"(43.235541343, -108.109830353)"
|
|
2012,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,288,51.3,45.2,57.5,2702,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,56,AGE07,CAT3,_RFPSA21,RESP046,"(43.235541343, -108.109830353)"
|
|
2012,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,246,48.7,42.5,54.8,2706,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,56,AGE07,CAT3,_RFPSA21,RESP054,"(43.235541343, -108.109830353)"
|
|
2012,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,209,68.1,60.6,75.7,2703,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,56,AGE08,CAT3,_RFPSA21,RESP046,"(43.235541343, -108.109830353)"
|
|
2012,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,99,31.9,24.3,39.4,2707,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,56,AGE08,CAT3,_RFPSA21,RESP054,"(43.235541343, -108.109830353)"
|
|
2012,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,576,69.6,65,74.2,2704,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,56,AGE09,CAT3,_RFPSA21,RESP046,"(43.235541343, -108.109830353)"
|
|
2012,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,248,30.4,25.8,35,2708,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,56,AGE09,CAT3,_RFPSA21,RESP054,"(43.235541343, -108.109830353)"
|
|
2012,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1143,52.2,48.8,55.6,2697,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,56,BO1,CAT1,_RFPSA21,RESP046,"(43.235541343, -108.109830353)"
|
|
2012,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,786,47.8,44.4,51.2,2698,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,56,BO1,CAT1,_RFPSA21,RESP054,"(43.235541343, -108.109830353)"
|
|
2012,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,37,31,18.4,43.6,2718,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,56,EDUCA1,CAT5,_RFPSA21,RESP046,"(43.235541343, -108.109830353)"
|
|
2012,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,65,69,56.4,81.6,2722,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,56,EDUCA1,CAT5,_RFPSA21,RESP054,"(43.235541343, -108.109830353)"
|
|
2012,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,321,49.1,43,55.1,2719,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,56,EDUCA2,CAT5,_RFPSA21,RESP046,"(43.235541343, -108.109830353)"
|
|
2012,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,256,50.9,44.9,57,2723,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,56,EDUCA2,CAT5,_RFPSA21,RESP054,"(43.235541343, -108.109830353)"
|
|
2012,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,305,50.8,44.5,57.1,2720,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,56,EDUCA3,CAT5,_RFPSA21,RESP046,"(43.235541343, -108.109830353)"
|
|
2012,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,238,49.2,42.9,55.5,2724,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,56,EDUCA3,CAT5,_RFPSA21,RESP054,"(43.235541343, -108.109830353)"
|
|
2012,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,480,63.2,57.8,68.6,2721,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,56,EDUCA4,CAT5,_RFPSA21,RESP046,"(43.235541343, -108.109830353)"
|
|
2012,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,224,36.8,31.4,42.2,2725,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,56,EDUCA4,CAT5,_RFPSA21,RESP054,"(43.235541343, -108.109830353)"
|
|
2012,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,38,23.7,13.2,34.3,2726,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,56,INCOME1,CAT6,_RFPSA21,RESP046,"(43.235541343, -108.109830353)"
|
|
2012,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,73,76.3,65.7,86.8,2731,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,56,INCOME1,CAT6,_RFPSA21,RESP054,"(43.235541343, -108.109830353)"
|
|
2012,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,118,44.8,35.2,54.5,2727,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,56,INCOME2,CAT6,_RFPSA21,RESP046,"(43.235541343, -108.109830353)"
|
|
2012,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,125,55.2,45.6,64.8,2732,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,56,INCOME2,CAT6,_RFPSA21,RESP054,"(43.235541343, -108.109830353)"
|
|
2012,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,118,55.6,44.9,66.2,2728,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,56,INCOME3,CAT6,_RFPSA21,RESP046,"(43.235541343, -108.109830353)"
|
|
2012,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,82,44.4,33.8,55.1,2733,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,56,INCOME3,CAT6,_RFPSA21,RESP054,"(43.235541343, -108.109830353)"
|
|
2012,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,176,53.5,44.5,62.4,2729,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,56,INCOME4,CAT6,_RFPSA21,RESP046,"(43.235541343, -108.109830353)"
|
|
2012,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,114,46.5,37.6,55.5,2734,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,56,INCOME4,CAT6,_RFPSA21,RESP054,"(43.235541343, -108.109830353)"
|
|
2012,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,572,54.8,49.7,59.8,2730,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,56,INCOME5,CAT6,_RFPSA21,RESP046,"(43.235541343, -108.109830353)"
|
|
2012,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,313,45.3,40.2,50.3,2735,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,56,INCOME5,CAT6,_RFPSA21,RESP054,"(43.235541343, -108.109830353)"
|
|
2012,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1075,54.2,50.6,57.8,2709,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,56,RACE1,CAT4,_RFPSA21,RESP046,"(43.235541343, -108.109830353)"
|
|
2012,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,693,45.8,42.2,49.4,2713,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,56,RACE1,CAT4,_RFPSA21,RESP054,"(43.235541343, -108.109830353)"
|
|
2012,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,5,,,,2714,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,56,RACE2,CAT4,_RFPSA21,RESP054,"(43.235541343, -108.109830353)"
|
|
2012,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,22,28,12.1,43.9,2710,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,56,RACE3,CAT4,_RFPSA21,RESP046,"(43.235541343, -108.109830353)"
|
|
2012,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,39,72,56.1,87.9,2715,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,56,RACE3,CAT4,_RFPSA21,RESP054,"(43.235541343, -108.109830353)"
|
|
2012,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,16,,,,2711,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,56,RACE4,CAT4,_RFPSA21,RESP046,"(43.235541343, -108.109830353)"
|
|
2012,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,23,,,,2716,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,56,RACE4,CAT4,_RFPSA21,RESP054,"(43.235541343, -108.109830353)"
|
|
2012,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,11,,,,2712,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,56,RACE5,CAT4,_RFPSA21,RESP046,"(43.235541343, -108.109830353)"
|
|
2012,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,12,,,,2717,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,56,RACE5,CAT4,_RFPSA21,RESP054,"(43.235541343, -108.109830353)"
|
|
2012,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1143,52.2,48.8,55.6,2699,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,56,SEX1,CAT2,_RFPSA21,RESP046,"(43.235541343, -108.109830353)"
|
|
2012,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,786,47.8,44.4,51.2,2700,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,56,SEX1,CAT2,_RFPSA21,RESP054,"(43.235541343, -108.109830353)"
|
|
2014,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,303,55.1,49.9,60.2,3463,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,01,AGE07,CAT3,_RFPSA21,RESP054,"(32.840571122, -86.631860762)"
|
|
2014,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,206,61.7,55.1,68.4,3460,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,01,AGE08,CAT3,_RFPSA21,RESP046,"(32.840571122, -86.631860762)"
|
|
2014,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,92,23.7,18.4,29,3458,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,01,AGE06,CAT3,_RFPSA21,RESP046,"(32.840571122, -86.631860762)"
|
|
2014,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,265,76.3,71,81.6,3462,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,01,AGE06,CAT3,_RFPSA21,RESP054,"(32.840571122, -86.631860762)"
|
|
2014,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,270,44.9,39.8,50.1,3459,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,01,AGE07,CAT3,_RFPSA21,RESP046,"(32.840571122, -86.631860762)"
|
|
2014,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,123,38.3,31.6,44.9,3464,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,01,AGE08,CAT3,_RFPSA21,RESP054,"(32.840571122, -86.631860762)"
|
|
2014,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,628,71.2,67.4,75,3461,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,01,AGE09,CAT3,_RFPSA21,RESP046,"(32.840571122, -86.631860762)"
|
|
2014,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,267,28.8,25,32.6,3465,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,01,AGE09,CAT3,_RFPSA21,RESP054,"(32.840571122, -86.631860762)"
|
|
2014,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1196,49.6,46.9,52.4,3454,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,01,BO1,CAT1,_RFPSA21,RESP046,"(32.840571122, -86.631860762)"
|
|
2014,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,958,50.4,47.6,53.1,3455,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,01,BO1,CAT1,_RFPSA21,RESP054,"(32.840571122, -86.631860762)"
|
|
2014,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,77,31.6,24,39.1,3476,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,01,EDUCA1,CAT5,_RFPSA21,RESP046,"(32.840571122, -86.631860762)"
|
|
2014,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,150,68.4,60.9,76,3480,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,01,EDUCA1,CAT5,_RFPSA21,RESP054,"(32.840571122, -86.631860762)"
|
|
2014,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,316,44.9,40,49.8,3477,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,01,EDUCA2,CAT5,_RFPSA21,RESP046,"(32.840571122, -86.631860762)"
|
|
2014,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,330,55.1,50.2,60,3481,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,01,EDUCA2,CAT5,_RFPSA21,RESP054,"(32.840571122, -86.631860762)"
|
|
2014,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,350,56.5,51.3,61.8,3478,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,01,EDUCA3,CAT5,_RFPSA21,RESP046,"(32.840571122, -86.631860762)"
|
|
2014,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,222,43.5,38.3,48.7,3482,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,01,EDUCA3,CAT5,_RFPSA21,RESP054,"(32.840571122, -86.631860762)"
|
|
2014,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,453,59.7,55,64.4,3479,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,01,EDUCA4,CAT5,_RFPSA21,RESP046,"(32.840571122, -86.631860762)"
|
|
2014,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,256,40.3,35.6,45,3483,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,01,EDUCA4,CAT5,_RFPSA21,RESP054,"(32.840571122, -86.631860762)"
|
|
2014,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,71,32,23.8,40.1,3484,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,01,INCOME1,CAT6,_RFPSA21,RESP046,"(32.840571122, -86.631860762)"
|
|
2014,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,141,68,59.9,76.2,3489,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,01,INCOME1,CAT6,_RFPSA21,RESP054,"(32.840571122, -86.631860762)"
|
|
2014,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,150,46.7,39.1,54.3,3485,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,01,INCOME2,CAT6,_RFPSA21,RESP046,"(32.840571122, -86.631860762)"
|
|
2014,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,164,53.3,45.7,60.9,3490,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,01,INCOME2,CAT6,_RFPSA21,RESP054,"(32.840571122, -86.631860762)"
|
|
2014,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,107,43,33.8,52.2,3486,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,01,INCOME3,CAT6,_RFPSA21,RESP046,"(32.840571122, -86.631860762)"
|
|
2014,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,92,57,47.8,66.2,3491,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,01,INCOME3,CAT6,_RFPSA21,RESP054,"(32.840571122, -86.631860762)"
|
|
2014,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,192,56.5,48.8,64.1,3487,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,01,INCOME4,CAT6,_RFPSA21,RESP046,"(32.840571122, -86.631860762)"
|
|
2014,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,102,43.5,35.9,51.2,3492,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,01,INCOME4,CAT6,_RFPSA21,RESP054,"(32.840571122, -86.631860762)"
|
|
2014,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,507,53.5,49.2,57.8,3488,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,01,INCOME5,CAT6,_RFPSA21,RESP046,"(32.840571122, -86.631860762)"
|
|
2014,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,334,46.5,42.2,50.8,3493,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,01,INCOME5,CAT6,_RFPSA21,RESP054,"(32.840571122, -86.631860762)"
|
|
2014,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,909,50.2,47,53.4,3466,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,01,RACE1,CAT4,_RFPSA21,RESP046,"(32.840571122, -86.631860762)"
|
|
2014,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,690,49.8,46.6,53,3471,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,01,RACE1,CAT4,_RFPSA21,RESP054,"(32.840571122, -86.631860762)"
|
|
2014,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,246,52.1,45.8,58.3,3467,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,01,RACE2,CAT4,_RFPSA21,RESP046,"(32.840571122, -86.631860762)"
|
|
2014,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,201,48,41.7,54.2,3472,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,01,RACE2,CAT4,_RFPSA21,RESP054,"(32.840571122, -86.631860762)"
|
|
2014,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,2,,,,3468,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,01,RACE3,CAT4,_RFPSA21,RESP046,"(32.840571122, -86.631860762)"
|
|
2014,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,6,,,,3473,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,01,RACE3,CAT4,_RFPSA21,RESP054,"(32.840571122, -86.631860762)"
|
|
2014,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,17,,,,3469,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,01,RACE4,CAT4,_RFPSA21,RESP046,"(32.840571122, -86.631860762)"
|
|
2014,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,38,73.8,52.9,94.6,3474,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,01,RACE4,CAT4,_RFPSA21,RESP054,"(32.840571122, -86.631860762)"
|
|
2014,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,8,,,,3470,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,01,RACE5,CAT4,_RFPSA21,RESP046,"(32.840571122, -86.631860762)"
|
|
2014,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,13,,,,3475,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,01,RACE5,CAT4,_RFPSA21,RESP054,"(32.840571122, -86.631860762)"
|
|
2014,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1196,49.6,46.9,52.4,3456,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,01,SEX1,CAT2,_RFPSA21,RESP046,"(32.840571122, -86.631860762)"
|
|
2014,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,958,50.4,47.6,53.1,3457,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,01,SEX1,CAT2,_RFPSA21,RESP054,"(32.840571122, -86.631860762)"
|
|
2014,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,35,11.9,7.4,16.4,3453,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,02,AGE06,CAT3,_RFPSA21,RESP046,"(64.845079957001, -147.722059036)"
|
|
2014,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,229,88.1,83.6,92.6,3457,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,02,AGE06,CAT3,_RFPSA21,RESP054,"(64.845079957001, -147.722059036)"
|
|
2014,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,132,31.8,25.7,37.9,3454,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,02,AGE07,CAT3,_RFPSA21,RESP046,"(64.845079957001, -147.722059036)"
|
|
2014,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,298,68.2,62.1,74.3,3458,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,02,AGE07,CAT3,_RFPSA21,RESP054,"(64.845079957001, -147.722059036)"
|
|
2014,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,113,50.5,41.5,59.4,3455,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,02,AGE08,CAT3,_RFPSA21,RESP046,"(64.845079957001, -147.722059036)"
|
|
2014,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,107,49.5,40.6,58.5,3459,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,02,AGE08,CAT3,_RFPSA21,RESP054,"(64.845079957001, -147.722059036)"
|
|
2014,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,223,60.1,53.5,66.6,3456,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,02,AGE09,CAT3,_RFPSA21,RESP046,"(64.845079957001, -147.722059036)"
|
|
2014,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,152,40,33.4,46.5,3460,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,02,AGE09,CAT3,_RFPSA21,RESP054,"(64.845079957001, -147.722059036)"
|
|
2014,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,503,34.8,31.3,38.2,3449,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,02,BO1,CAT1,_RFPSA21,RESP046,"(64.845079957001, -147.722059036)"
|
|
2014,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,786,65.3,61.8,68.7,3450,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,02,BO1,CAT1,_RFPSA21,RESP054,"(64.845079957001, -147.722059036)"
|
|
2014,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,14,,,,3471,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,02,EDUCA1,CAT5,_RFPSA21,RESP046,"(64.845079957001, -147.722059036)"
|
|
2014,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,56,84.9,75.9,94,3475,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,02,EDUCA1,CAT5,_RFPSA21,RESP054,"(64.845079957001, -147.722059036)"
|
|
2014,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,120,34.4,27.8,41.1,3472,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,02,EDUCA2,CAT5,_RFPSA21,RESP046,"(64.845079957001, -147.722059036)"
|
|
2014,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,217,65.6,58.9,72.2,3476,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,02,EDUCA2,CAT5,_RFPSA21,RESP054,"(64.845079957001, -147.722059036)"
|
|
2014,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,136,36.7,30.4,43,3473,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,02,EDUCA3,CAT5,_RFPSA21,RESP046,"(64.845079957001, -147.722059036)"
|
|
2014,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,212,63.3,57,69.6,3477,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,02,EDUCA3,CAT5,_RFPSA21,RESP054,"(64.845079957001, -147.722059036)"
|
|
2014,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,230,40.6,35.1,46.2,3474,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,02,EDUCA4,CAT5,_RFPSA21,RESP046,"(64.845079957001, -147.722059036)"
|
|
2014,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,295,59.4,53.8,64.9,3478,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,02,EDUCA4,CAT5,_RFPSA21,RESP054,"(64.845079957001, -147.722059036)"
|
|
2014,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,19,18.5,8,29,3479,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,02,INCOME1,CAT6,_RFPSA21,RESP046,"(64.845079957001, -147.722059036)"
|
|
2014,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,76,81.5,71,92,3484,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,02,INCOME1,CAT6,_RFPSA21,RESP054,"(64.845079957001, -147.722059036)"
|
|
2014,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,33,21.5,12.1,31,3480,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,02,INCOME2,CAT6,_RFPSA21,RESP046,"(64.845079957001, -147.722059036)"
|
|
2014,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,84,78.5,69.1,87.9,3485,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,02,INCOME2,CAT6,_RFPSA21,RESP054,"(64.845079957001, -147.722059036)"
|
|
2014,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,26,31,16.8,45.3,3481,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,02,INCOME3,CAT6,_RFPSA21,RESP046,"(64.845079957001, -147.722059036)"
|
|
2014,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,53,69,54.7,83.2,3486,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,02,INCOME3,CAT6,_RFPSA21,RESP054,"(64.845079957001, -147.722059036)"
|
|
2014,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,49,27.3,18.7,36,3482,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,02,INCOME4,CAT6,_RFPSA21,RESP046,"(64.845079957001, -147.722059036)"
|
|
2014,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,87,72.7,64,81.3,3487,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,02,INCOME4,CAT6,_RFPSA21,RESP054,"(64.845079957001, -147.722059036)"
|
|
2014,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,328,39.1,34.4,43.7,3483,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,02,INCOME5,CAT6,_RFPSA21,RESP046,"(64.845079957001, -147.722059036)"
|
|
2014,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,439,60.9,56.3,65.6,3488,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,02,INCOME5,CAT6,_RFPSA21,RESP054,"(64.845079957001, -147.722059036)"
|
|
2014,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,416,37.2,33.4,40.9,3461,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,02,RACE1,CAT4,_RFPSA21,RESP046,"(64.845079957001, -147.722059036)"
|
|
2014,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,599,62.9,59.1,66.6,3466,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,02,RACE1,CAT4,_RFPSA21,RESP054,"(64.845079957001, -147.722059036)"
|
|
2014,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,6,,,,3462,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,02,RACE2,CAT4,_RFPSA21,RESP046,"(64.845079957001, -147.722059036)"
|
|
2014,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,9,,,,3467,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,02,RACE2,CAT4,_RFPSA21,RESP054,"(64.845079957001, -147.722059036)"
|
|
2014,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,12,,,,3463,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,02,RACE3,CAT4,_RFPSA21,RESP046,"(64.845079957001, -147.722059036)"
|
|
2014,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,15,,,,3468,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,02,RACE3,CAT4,_RFPSA21,RESP054,"(64.845079957001, -147.722059036)"
|
|
2014,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,30,21,12.2,29.9,3464,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,02,RACE4,CAT4,_RFPSA21,RESP046,"(64.845079957001, -147.722059036)"
|
|
2014,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,108,79,70.1,87.8,3469,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,02,RACE4,CAT4,_RFPSA21,RESP054,"(64.845079957001, -147.722059036)"
|
|
2014,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,19,,,,3465,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,02,RACE5,CAT4,_RFPSA21,RESP046,"(64.845079957001, -147.722059036)"
|
|
2014,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,18,,,,3470,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,02,RACE5,CAT4,_RFPSA21,RESP054,"(64.845079957001, -147.722059036)"
|
|
2014,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,503,34.8,31.3,38.2,3451,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,02,SEX1,CAT2,_RFPSA21,RESP046,"(64.845079957001, -147.722059036)"
|
|
2014,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,786,65.3,61.8,68.7,3452,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,02,SEX1,CAT2,_RFPSA21,RESP054,"(64.845079957001, -147.722059036)"
|
|
2014,UW,All States and DC (median) **,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,51,42.8,,,3440,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,98,BO1,CAT1,_RFPSA21,RESP046,
|
|
2014,UW,All States and DC (median) **,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,51,57.2,,,3441,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,98,BO1,CAT1,_RFPSA21,RESP054,
|
|
2014,US,"All States, DC and Territories (median) **",Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,53,42.8,,,3442,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,99,BO1,CAT1,_RFPSA21,RESP046,
|
|
2014,US,"All States, DC and Territories (median) **",Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,53,57.2,,,3443,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,99,BO1,CAT1,_RFPSA21,RESP054,
|
|
2014,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,496,84.7,81.3,88.1,3470,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,04,AGE06,CAT3,_RFPSA21,RESP054,"(34.86597028, -111.763811277)"
|
|
2014,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,120,15.3,11.9,18.7,3466,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,04,AGE06,CAT3,_RFPSA21,RESP046,"(34.86597028, -111.763811277)"
|
|
2014,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,396,39.7,35.2,44.3,3467,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,04,AGE07,CAT3,_RFPSA21,RESP046,"(34.86597028, -111.763811277)"
|
|
2014,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,501,60.3,55.7,64.8,3471,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,04,AGE07,CAT3,_RFPSA21,RESP054,"(34.86597028, -111.763811277)"
|
|
2014,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,384,55,49.3,60.6,3468,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,04,AGE08,CAT3,_RFPSA21,RESP046,"(34.86597028, -111.763811277)"
|
|
2014,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,249,45.1,39.4,50.7,3472,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,04,AGE08,CAT3,_RFPSA21,RESP054,"(34.86597028, -111.763811277)"
|
|
2014,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,1469,64.6,61.6,67.6,3469,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,04,AGE09,CAT3,_RFPSA21,RESP046,"(34.86597028, -111.763811277)"
|
|
2014,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,693,35.5,32.5,38.5,3473,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,04,AGE09,CAT3,_RFPSA21,RESP054,"(34.86597028, -111.763811277)"
|
|
2014,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,2369,42.8,40.7,45,3462,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,04,BO1,CAT1,_RFPSA21,RESP046,"(34.86597028, -111.763811277)"
|
|
2014,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1939,57.2,55,59.3,3463,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,04,BO1,CAT1,_RFPSA21,RESP054,"(34.86597028, -111.763811277)"
|
|
2014,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,96,27,19.9,34.1,3484,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,04,EDUCA1,CAT5,_RFPSA21,RESP046,"(34.86597028, -111.763811277)"
|
|
2014,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,188,73,66,80.1,3488,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,04,EDUCA1,CAT5,_RFPSA21,RESP054,"(34.86597028, -111.763811277)"
|
|
2014,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,396,38,33.8,42.3,3485,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,04,EDUCA2,CAT5,_RFPSA21,RESP046,"(34.86597028, -111.763811277)"
|
|
2014,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,454,62,57.7,66.2,3489,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,04,EDUCA2,CAT5,_RFPSA21,RESP054,"(34.86597028, -111.763811277)"
|
|
2014,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,631,44.7,40.9,48.6,3486,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,04,EDUCA3,CAT5,_RFPSA21,RESP046,"(34.86597028, -111.763811277)"
|
|
2014,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,538,55.3,51.5,59.1,3490,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,04,EDUCA3,CAT5,_RFPSA21,RESP054,"(34.86597028, -111.763811277)"
|
|
2014,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,1243,53.5,50.6,56.5,3487,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,04,EDUCA4,CAT5,_RFPSA21,RESP046,"(34.86597028, -111.763811277)"
|
|
2014,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,746,46.5,43.5,49.4,3491,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,04,EDUCA4,CAT5,_RFPSA21,RESP054,"(34.86597028, -111.763811277)"
|
|
2014,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,109,29.8,22.2,37.4,3492,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,04,INCOME1,CAT6,_RFPSA21,RESP046,"(34.86597028, -111.763811277)"
|
|
2014,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,202,70.2,62.6,77.8,3497,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,04,INCOME1,CAT6,_RFPSA21,RESP054,"(34.86597028, -111.763811277)"
|
|
2014,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,230,31.9,25.8,38.1,3493,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,04,INCOME2,CAT6,_RFPSA21,RESP046,"(34.86597028, -111.763811277)"
|
|
2014,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,288,68.1,61.9,74.3,3498,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,04,INCOME2,CAT6,_RFPSA21,RESP054,"(34.86597028, -111.763811277)"
|
|
2014,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,192,41.5,34.2,48.7,3494,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,04,INCOME3,CAT6,_RFPSA21,RESP046,"(34.86597028, -111.763811277)"
|
|
2014,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,196,58.6,51.3,65.8,3499,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,04,INCOME3,CAT6,_RFPSA21,RESP054,"(34.86597028, -111.763811277)"
|
|
2014,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,323,39.9,34,45.7,3495,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,04,INCOME4,CAT6,_RFPSA21,RESP046,"(34.86597028, -111.763811277)"
|
|
2014,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,258,60.1,54.3,66,3500,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,04,INCOME4,CAT6,_RFPSA21,RESP054,"(34.86597028, -111.763811277)"
|
|
2014,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,1261,51.1,48,54.1,3496,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,04,INCOME5,CAT6,_RFPSA21,RESP046,"(34.86597028, -111.763811277)"
|
|
2014,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,788,48.9,45.9,52,3501,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,04,INCOME5,CAT6,_RFPSA21,RESP054,"(34.86597028, -111.763811277)"
|
|
2014,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,2012,47.9,45.6,50.3,3474,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,04,RACE1,CAT4,_RFPSA21,RESP046,"(34.86597028, -111.763811277)"
|
|
2014,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1446,52.1,49.7,54.4,3479,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,04,RACE1,CAT4,_RFPSA21,RESP054,"(34.86597028, -111.763811277)"
|
|
2014,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,58,35.5,24.5,46.6,3475,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,04,RACE2,CAT4,_RFPSA21,RESP046,"(34.86597028, -111.763811277)"
|
|
2014,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,57,64.5,53.5,75.5,3480,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,04,RACE2,CAT4,_RFPSA21,RESP054,"(34.86597028, -111.763811277)"
|
|
2014,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,160,31.4,25.2,37.6,3476,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,04,RACE3,CAT4,_RFPSA21,RESP046,"(34.86597028, -111.763811277)"
|
|
2014,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,261,68.6,62.4,74.8,3481,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,04,RACE3,CAT4,_RFPSA21,RESP054,"(34.86597028, -111.763811277)"
|
|
2014,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,53,23.6,15.8,31.3,3477,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,04,RACE4,CAT4,_RFPSA21,RESP046,"(34.86597028, -111.763811277)"
|
|
2014,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,103,76.4,68.7,84.2,3482,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,04,RACE4,CAT4,_RFPSA21,RESP054,"(34.86597028, -111.763811277)"
|
|
2014,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,21,,,,3478,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,04,RACE5,CAT4,_RFPSA21,RESP046,"(34.86597028, -111.763811277)"
|
|
2014,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,27,,,,3483,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,04,RACE5,CAT4,_RFPSA21,RESP054,"(34.86597028, -111.763811277)"
|
|
2014,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,2369,42.8,40.7,45,3464,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,04,SEX1,CAT2,_RFPSA21,RESP046,"(34.86597028, -111.763811277)"
|
|
2014,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1939,57.2,55,59.3,3465,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,04,SEX1,CAT2,_RFPSA21,RESP054,"(34.86597028, -111.763811277)"
|
|
2014,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,44,24.7,17,32.4,3457,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,05,AGE06,CAT3,_RFPSA21,RESP046,"(34.748650124, -92.274490743)"
|
|
2014,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,141,75.3,67.6,83,3461,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,05,AGE06,CAT3,_RFPSA21,RESP054,"(34.748650124, -92.274490743)"
|
|
2014,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,132,40.3,33.2,47.4,3458,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,05,AGE07,CAT3,_RFPSA21,RESP046,"(34.748650124, -92.274490743)"
|
|
2014,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,177,59.7,52.6,66.8,3462,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,05,AGE07,CAT3,_RFPSA21,RESP054,"(34.748650124, -92.274490743)"
|
|
2014,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,118,56.7,48.2,65.2,3459,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,05,AGE08,CAT3,_RFPSA21,RESP046,"(34.748650124, -92.274490743)"
|
|
2014,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,91,43.3,34.8,51.9,3463,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,05,AGE08,CAT3,_RFPSA21,RESP054,"(34.748650124, -92.274490743)"
|
|
2014,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,445,63.8,59.3,68.4,3460,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,05,AGE09,CAT3,_RFPSA21,RESP046,"(34.748650124, -92.274490743)"
|
|
2014,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,243,36.2,31.6,40.8,3464,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,05,AGE09,CAT3,_RFPSA21,RESP054,"(34.748650124, -92.274490743)"
|
|
2014,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,739,45.3,41.7,49,3453,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,05,BO1,CAT1,_RFPSA21,RESP046,"(34.748650124, -92.274490743)"
|
|
2014,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,652,54.7,51,58.3,3454,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,05,BO1,CAT1,_RFPSA21,RESP054,"(34.748650124, -92.274490743)"
|
|
2014,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,51,37.8,25.9,49.8,3475,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,05,EDUCA1,CAT5,_RFPSA21,RESP046,"(34.748650124, -92.274490743)"
|
|
2014,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,81,62.2,50.2,74.1,3479,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,05,EDUCA1,CAT5,_RFPSA21,RESP054,"(34.748650124, -92.274490743)"
|
|
2014,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,219,40.9,35.1,46.8,3476,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,05,EDUCA2,CAT5,_RFPSA21,RESP046,"(34.748650124, -92.274490743)"
|
|
2014,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,233,59.1,53.2,64.9,3480,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,05,EDUCA2,CAT5,_RFPSA21,RESP054,"(34.748650124, -92.274490743)"
|
|
2014,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,225,50.8,44,57.6,3477,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,05,EDUCA3,CAT5,_RFPSA21,RESP046,"(34.748650124, -92.274490743)"
|
|
2014,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,156,49.2,42.4,56,3481,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,05,EDUCA3,CAT5,_RFPSA21,RESP054,"(34.748650124, -92.274490743)"
|
|
2014,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,243,50,43.6,56.4,3478,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,05,EDUCA4,CAT5,_RFPSA21,RESP046,"(34.748650124, -92.274490743)"
|
|
2014,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,180,50,43.6,56.4,3482,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,05,EDUCA4,CAT5,_RFPSA21,RESP054,"(34.748650124, -92.274490743)"
|
|
2014,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,49,26.8,17.1,36.6,3483,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,05,INCOME1,CAT6,_RFPSA21,RESP046,"(34.748650124, -92.274490743)"
|
|
2014,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,97,73.2,63.4,82.9,3488,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,05,INCOME1,CAT6,_RFPSA21,RESP054,"(34.748650124, -92.274490743)"
|
|
2014,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,101,35.4,26.1,44.6,3484,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,05,INCOME2,CAT6,_RFPSA21,RESP046,"(34.748650124, -92.274490743)"
|
|
2014,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,133,64.7,55.4,73.9,3489,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,05,INCOME2,CAT6,_RFPSA21,RESP054,"(34.748650124, -92.274490743)"
|
|
2014,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,68,42,30.7,53.3,3485,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,05,INCOME3,CAT6,_RFPSA21,RESP046,"(34.748650124, -92.274490743)"
|
|
2014,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,77,58,46.7,69.3,3490,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,05,INCOME3,CAT6,_RFPSA21,RESP054,"(34.748650124, -92.274490743)"
|
|
2014,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,119,49.8,40.3,59.3,3486,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,05,INCOME4,CAT6,_RFPSA21,RESP046,"(34.748650124, -92.274490743)"
|
|
2014,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,80,50.2,40.7,59.7,3491,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,05,INCOME4,CAT6,_RFPSA21,RESP054,"(34.748650124, -92.274490743)"
|
|
2014,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,307,54.8,48.9,60.7,3487,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,05,INCOME5,CAT6,_RFPSA21,RESP046,"(34.748650124, -92.274490743)"
|
|
2014,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,186,45.2,39.3,51.1,3492,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,05,INCOME5,CAT6,_RFPSA21,RESP054,"(34.748650124, -92.274490743)"
|
|
2014,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,620,48.1,44.1,52.2,3465,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,05,RACE1,CAT4,_RFPSA21,RESP046,"(34.748650124, -92.274490743)"
|
|
2014,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,502,51.9,47.8,55.9,3470,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,05,RACE1,CAT4,_RFPSA21,RESP054,"(34.748650124, -92.274490743)"
|
|
2014,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,76,36.2,25.3,47.2,3466,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,05,RACE2,CAT4,_RFPSA21,RESP046,"(34.748650124, -92.274490743)"
|
|
2014,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,84,63.8,52.9,74.7,3471,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,05,RACE2,CAT4,_RFPSA21,RESP054,"(34.748650124, -92.274490743)"
|
|
2014,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,8,,,,3467,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,05,RACE3,CAT4,_RFPSA21,RESP046,"(34.748650124, -92.274490743)"
|
|
2014,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,13,,,,3472,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,05,RACE3,CAT4,_RFPSA21,RESP054,"(34.748650124, -92.274490743)"
|
|
2014,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,18,,,,3468,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,05,RACE4,CAT4,_RFPSA21,RESP046,"(34.748650124, -92.274490743)"
|
|
2014,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,25,,,,3473,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,05,RACE4,CAT4,_RFPSA21,RESP054,"(34.748650124, -92.274490743)"
|
|
2014,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,11,,,,3469,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,05,RACE5,CAT4,_RFPSA21,RESP046,"(34.748650124, -92.274490743)"
|
|
2014,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,15,,,,3474,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,05,RACE5,CAT4,_RFPSA21,RESP054,"(34.748650124, -92.274490743)"
|
|
2014,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,739,45.3,41.7,49,3455,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,05,SEX1,CAT2,_RFPSA21,RESP046,"(34.748650124, -92.274490743)"
|
|
2014,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,652,54.7,51,58.3,3456,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,05,SEX1,CAT2,_RFPSA21,RESP054,"(34.748650124, -92.274490743)"
|
|
2014,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,46,13.5,8.7,18.3,3466,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,AGE06,CAT3,_RFPSA21,RESP046,"(37.638640123, -120.999999538)"
|
|
2014,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,357,86.5,81.7,91.3,3470,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,AGE06,CAT3,_RFPSA21,RESP054,"(37.638640123, -120.999999538)"
|
|
2014,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,235,35.9,31.2,40.6,3467,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,AGE07,CAT3,_RFPSA21,RESP046,"(37.638640123, -120.999999538)"
|
|
2014,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,355,64.1,59.4,68.8,3471,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,AGE07,CAT3,_RFPSA21,RESP054,"(37.638640123, -120.999999538)"
|
|
2014,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,157,49,41.3,56.8,3468,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,AGE08,CAT3,_RFPSA21,RESP046,"(37.638640123, -120.999999538)"
|
|
2014,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,135,51,43.3,58.7,3472,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,AGE08,CAT3,_RFPSA21,RESP054,"(37.638640123, -120.999999538)"
|
|
2014,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,455,61.6,56.9,66.3,3469,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,AGE09,CAT3,_RFPSA21,RESP046,"(37.638640123, -120.999999538)"
|
|
2014,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,249,38.4,33.7,43.1,3473,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,AGE09,CAT3,_RFPSA21,RESP054,"(37.638640123, -120.999999538)"
|
|
2014,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,893,38.6,35.9,41.3,3462,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,BO1,CAT1,_RFPSA21,RESP046,"(37.638640123, -120.999999538)"
|
|
2014,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1096,61.4,58.7,64.1,3463,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,BO1,CAT1,_RFPSA21,RESP054,"(37.638640123, -120.999999538)"
|
|
2014,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,67,26.9,20.1,33.7,3484,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,EDUCA1,CAT5,_RFPSA21,RESP046,"(37.638640123, -120.999999538)"
|
|
2014,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,169,73.1,66.3,79.9,3488,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,EDUCA1,CAT5,_RFPSA21,RESP054,"(37.638640123, -120.999999538)"
|
|
2014,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,109,33.5,27.2,39.8,3485,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,EDUCA2,CAT5,_RFPSA21,RESP046,"(37.638640123, -120.999999538)"
|
|
2014,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,186,66.5,60.3,72.8,3489,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,EDUCA2,CAT5,_RFPSA21,RESP054,"(37.638640123, -120.999999538)"
|
|
2014,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,208,43,37.8,48.3,3486,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,EDUCA3,CAT5,_RFPSA21,RESP046,"(37.638640123, -120.999999538)"
|
|
2014,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,260,57,51.7,62.2,3490,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,EDUCA3,CAT5,_RFPSA21,RESP054,"(37.638640123, -120.999999538)"
|
|
2014,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,509,44.7,40.8,48.6,3487,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,EDUCA4,CAT5,_RFPSA21,RESP046,"(37.638640123, -120.999999538)"
|
|
2014,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,479,55.3,51.4,59.2,3491,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,EDUCA4,CAT5,_RFPSA21,RESP054,"(37.638640123, -120.999999538)"
|
|
2014,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,74,32.1,23.6,40.5,3492,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,INCOME1,CAT6,_RFPSA21,RESP046,"(37.638640123, -120.999999538)"
|
|
2014,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,153,68,59.5,76.4,3497,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,INCOME1,CAT6,_RFPSA21,RESP054,"(37.638640123, -120.999999538)"
|
|
2014,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,73,26.8,20,33.5,3493,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,INCOME2,CAT6,_RFPSA21,RESP046,"(37.638640123, -120.999999538)"
|
|
2014,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,145,73.2,66.5,80,3498,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,INCOME2,CAT6,_RFPSA21,RESP054,"(37.638640123, -120.999999538)"
|
|
2014,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,66,36,26.4,45.6,3494,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,INCOME3,CAT6,_RFPSA21,RESP046,"(37.638640123, -120.999999538)"
|
|
2014,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,86,64,54.4,73.6,3499,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,INCOME3,CAT6,_RFPSA21,RESP054,"(37.638640123, -120.999999538)"
|
|
2014,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,90,43.7,34.8,52.6,3495,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,INCOME4,CAT6,_RFPSA21,RESP046,"(37.638640123, -120.999999538)"
|
|
2014,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,100,56.3,47.4,65.2,3500,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,INCOME4,CAT6,_RFPSA21,RESP054,"(37.638640123, -120.999999538)"
|
|
2014,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,530,43.6,39.9,47.4,3496,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,INCOME5,CAT6,_RFPSA21,RESP046,"(37.638640123, -120.999999538)"
|
|
2014,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,525,56.4,52.7,60.1,3501,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,INCOME5,CAT6,_RFPSA21,RESP054,"(37.638640123, -120.999999538)"
|
|
2014,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,645,45.6,42.3,49,3474,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,RACE1,CAT4,_RFPSA21,RESP046,"(37.638640123, -120.999999538)"
|
|
2014,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,614,54.4,51,57.7,3479,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,RACE1,CAT4,_RFPSA21,RESP054,"(37.638640123, -120.999999538)"
|
|
2014,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,53,49.1,37.9,60.4,3475,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,RACE2,CAT4,_RFPSA21,RESP046,"(37.638640123, -120.999999538)"
|
|
2014,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,55,50.9,39.6,62.1,3480,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,RACE2,CAT4,_RFPSA21,RESP054,"(37.638640123, -120.999999538)"
|
|
2014,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,124,29.3,23.8,34.7,3476,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,RACE3,CAT4,_RFPSA21,RESP046,"(37.638640123, -120.999999538)"
|
|
2014,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,273,70.7,65.3,76.2,3481,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,RACE3,CAT4,_RFPSA21,RESP054,"(37.638640123, -120.999999538)"
|
|
2014,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,45,24.6,16.2,32.9,3477,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,RACE4,CAT4,_RFPSA21,RESP046,"(37.638640123, -120.999999538)"
|
|
2014,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,116,75.5,67.1,83.8,3482,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,RACE4,CAT4,_RFPSA21,RESP054,"(37.638640123, -120.999999538)"
|
|
2014,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,16,,,,3478,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,06,RACE5,CAT4,_RFPSA21,RESP046,"(37.638640123, -120.999999538)"
|
|
2014,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,21,,,,3483,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,06,RACE5,CAT4,_RFPSA21,RESP054,"(37.638640123, -120.999999538)"
|
|
2014,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,893,38.6,35.9,41.3,3464,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,SEX1,CAT2,_RFPSA21,RESP046,"(37.638640123, -120.999999538)"
|
|
2014,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1096,61.4,58.7,64.1,3465,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,06,SEX1,CAT2,_RFPSA21,RESP054,"(37.638640123, -120.999999538)"
|
|
2014,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,108,13.2,10.6,15.8,3463,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,AGE06,CAT3,_RFPSA21,RESP046,"(38.843840757, -106.133610921)"
|
|
2014,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,606,86.8,84.2,89.4,3467,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,AGE06,CAT3,_RFPSA21,RESP054,"(38.843840757, -106.133610921)"
|
|
2014,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,442,41.9,38.3,45.4,3464,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,AGE07,CAT3,_RFPSA21,RESP046,"(38.843840757, -106.133610921)"
|
|
2014,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,588,58.1,54.6,61.7,3468,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,AGE07,CAT3,_RFPSA21,RESP054,"(38.843840757, -106.133610921)"
|
|
2014,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,354,56.2,51.4,60.9,3465,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,AGE08,CAT3,_RFPSA21,RESP046,"(38.843840757, -106.133610921)"
|
|
2014,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,254,43.8,39.1,48.6,3469,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,AGE08,CAT3,_RFPSA21,RESP054,"(38.843840757, -106.133610921)"
|
|
2014,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,950,63.7,60.7,66.7,3466,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,AGE09,CAT3,_RFPSA21,RESP046,"(38.843840757, -106.133610921)"
|
|
2014,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,499,36.3,33.3,39.3,3470,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,AGE09,CAT3,_RFPSA21,RESP054,"(38.843840757, -106.133610921)"
|
|
2014,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1854,41.1,39.2,43,3459,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,BO1,CAT1,_RFPSA21,RESP046,"(38.843840757, -106.133610921)"
|
|
2014,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1947,58.9,57,60.8,3460,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,BO1,CAT1,_RFPSA21,RESP054,"(38.843840757, -106.133610921)"
|
|
2014,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,43,21.5,14.8,28.3,3481,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,EDUCA1,CAT5,_RFPSA21,RESP046,"(38.843840757, -106.133610921)"
|
|
2014,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,132,78.5,71.7,85.2,3485,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,EDUCA1,CAT5,_RFPSA21,RESP054,"(38.843840757, -106.133610921)"
|
|
2014,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,340,34.9,31.1,38.7,3482,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,EDUCA2,CAT5,_RFPSA21,RESP046,"(38.843840757, -106.133610921)"
|
|
2014,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,496,65.1,61.3,68.9,3486,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,EDUCA2,CAT5,_RFPSA21,RESP054,"(38.843840757, -106.133610921)"
|
|
2014,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,428,41.4,37.6,45.2,3483,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,EDUCA3,CAT5,_RFPSA21,RESP046,"(38.843840757, -106.133610921)"
|
|
2014,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,451,58.6,54.8,62.4,3487,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,EDUCA3,CAT5,_RFPSA21,RESP054,"(38.843840757, -106.133610921)"
|
|
2014,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,1041,48.6,45.9,51.2,3484,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,EDUCA4,CAT5,_RFPSA21,RESP046,"(38.843840757, -106.133610921)"
|
|
2014,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,865,51.4,48.8,54.1,3488,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,EDUCA4,CAT5,_RFPSA21,RESP054,"(38.843840757, -106.133610921)"
|
|
2014,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,66,28.4,20.6,36.2,3489,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,INCOME1,CAT6,_RFPSA21,RESP046,"(38.843840757, -106.133610921)"
|
|
2014,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,131,71.6,63.8,79.4,3494,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,INCOME1,CAT6,_RFPSA21,RESP054,"(38.843840757, -106.133610921)"
|
|
2014,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,146,33,27,38.9,3490,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,INCOME2,CAT6,_RFPSA21,RESP046,"(38.843840757, -106.133610921)"
|
|
2014,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,204,67.1,61.1,73,3495,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,INCOME2,CAT6,_RFPSA21,RESP054,"(38.843840757, -106.133610921)"
|
|
2014,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,128,36.5,30,43.1,3491,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,INCOME3,CAT6,_RFPSA21,RESP046,"(38.843840757, -106.133610921)"
|
|
2014,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,170,63.5,56.9,70,3496,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,INCOME3,CAT6,_RFPSA21,RESP054,"(38.843840757, -106.133610921)"
|
|
2014,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,245,39.3,34,44.6,3492,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,INCOME4,CAT6,_RFPSA21,RESP046,"(38.843840757, -106.133610921)"
|
|
2014,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,269,60.7,55.4,66,3497,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,INCOME4,CAT6,_RFPSA21,RESP054,"(38.843840757, -106.133610921)"
|
|
2014,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,1108,44.2,41.7,46.6,3493,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,INCOME5,CAT6,_RFPSA21,RESP046,"(38.843840757, -106.133610921)"
|
|
2014,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,1021,55.8,53.4,58.3,3498,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,INCOME5,CAT6,_RFPSA21,RESP054,"(38.843840757, -106.133610921)"
|
|
2014,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1618,44.7,42.7,46.8,3471,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,RACE1,CAT4,_RFPSA21,RESP046,"(38.843840757, -106.133610921)"
|
|
2014,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1547,55.3,53.2,57.3,3476,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,RACE1,CAT4,_RFPSA21,RESP054,"(38.843840757, -106.133610921)"
|
|
2014,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,33,34.2,22.6,45.9,3472,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,RACE2,CAT4,_RFPSA21,RESP046,"(38.843840757, -106.133610921)"
|
|
2014,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,47,65.8,54.1,77.5,3477,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,RACE2,CAT4,_RFPSA21,RESP054,"(38.843840757, -106.133610921)"
|
|
2014,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,109,27.3,21.9,32.7,3473,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,RACE3,CAT4,_RFPSA21,RESP046,"(38.843840757, -106.133610921)"
|
|
2014,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,223,72.7,67.3,78.1,3478,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,RACE3,CAT4,_RFPSA21,RESP054,"(38.843840757, -106.133610921)"
|
|
2014,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,30,25.3,15,35.5,3474,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,RACE4,CAT4,_RFPSA21,RESP046,"(38.843840757, -106.133610921)"
|
|
2014,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,49,74.7,64.5,85,3479,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,RACE4,CAT4,_RFPSA21,RESP054,"(38.843840757, -106.133610921)"
|
|
2014,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,19,,,,3475,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,08,RACE5,CAT4,_RFPSA21,RESP046,"(38.843840757, -106.133610921)"
|
|
2014,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,26,,,,3480,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,08,RACE5,CAT4,_RFPSA21,RESP054,"(38.843840757, -106.133610921)"
|
|
2014,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1854,41.1,39.2,43,3461,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,SEX1,CAT2,_RFPSA21,RESP046,"(38.843840757, -106.133610921)"
|
|
2014,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1947,58.9,57,60.8,3462,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,08,SEX1,CAT2,_RFPSA21,RESP054,"(38.843840757, -106.133610921)"
|
|
2014,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,74,17.3,12.4,22.1,3451,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,AGE06,CAT3,_RFPSA21,RESP046,"(41.56266102, -72.649840952)"
|
|
2014,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,365,82.8,77.9,87.6,3455,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,AGE06,CAT3,_RFPSA21,RESP054,"(41.56266102, -72.649840952)"
|
|
2014,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,276,41.5,36.6,46.4,3452,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,AGE07,CAT3,_RFPSA21,RESP046,"(41.56266102, -72.649840952)"
|
|
2014,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,369,58.5,53.6,63.4,3456,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,AGE07,CAT3,_RFPSA21,RESP054,"(41.56266102, -72.649840952)"
|
|
2014,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,193,56.6,49.4,63.7,3453,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,AGE08,CAT3,_RFPSA21,RESP046,"(41.56266102, -72.649840952)"
|
|
2014,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,127,43.4,36.3,50.6,3457,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,AGE08,CAT3,_RFPSA21,RESP054,"(41.56266102, -72.649840952)"
|
|
2014,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,602,62.9,58.6,67.1,3454,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,AGE09,CAT3,_RFPSA21,RESP046,"(41.56266102, -72.649840952)"
|
|
2014,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,323,37.2,32.9,41.4,3458,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,AGE09,CAT3,_RFPSA21,RESP054,"(41.56266102, -72.649840952)"
|
|
2014,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1145,42.8,40.2,45.5,3447,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,BO1,CAT1,_RFPSA21,RESP046,"(41.56266102, -72.649840952)"
|
|
2014,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1184,57.2,54.6,59.9,3448,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,BO1,CAT1,_RFPSA21,RESP054,"(41.56266102, -72.649840952)"
|
|
2014,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,47,26.4,17.8,34.9,3469,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,EDUCA1,CAT5,_RFPSA21,RESP046,"(41.56266102, -72.649840952)"
|
|
2014,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,96,73.6,65.1,82.2,3473,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,EDUCA1,CAT5,_RFPSA21,RESP054,"(41.56266102, -72.649840952)"
|
|
2014,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,190,33.7,28.5,39,3470,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,EDUCA2,CAT5,_RFPSA21,RESP046,"(41.56266102, -72.649840952)"
|
|
2014,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,329,66.3,61,71.6,3474,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,EDUCA2,CAT5,_RFPSA21,RESP054,"(41.56266102, -72.649840952)"
|
|
2014,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,217,45.8,39.8,51.7,3471,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,EDUCA3,CAT5,_RFPSA21,RESP046,"(41.56266102, -72.649840952)"
|
|
2014,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,223,54.3,48.3,60.2,3475,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,EDUCA3,CAT5,_RFPSA21,RESP054,"(41.56266102, -72.649840952)"
|
|
2014,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,690,52.7,49,56.3,3472,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,EDUCA4,CAT5,_RFPSA21,RESP046,"(41.56266102, -72.649840952)"
|
|
2014,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,533,47.4,43.7,51,3476,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,EDUCA4,CAT5,_RFPSA21,RESP054,"(41.56266102, -72.649840952)"
|
|
2014,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,38,23.6,14.7,32.5,3477,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,INCOME1,CAT6,_RFPSA21,RESP046,"(41.56266102, -72.649840952)"
|
|
2014,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,88,76.4,67.5,85.3,3482,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,INCOME1,CAT6,_RFPSA21,RESP054,"(41.56266102, -72.649840952)"
|
|
2014,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,74,35.7,27.1,44.3,3478,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,INCOME2,CAT6,_RFPSA21,RESP046,"(41.56266102, -72.649840952)"
|
|
2014,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,130,64.3,55.7,72.9,3483,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,INCOME2,CAT6,_RFPSA21,RESP054,"(41.56266102, -72.649840952)"
|
|
2014,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,89,44,33,55,3479,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,INCOME3,CAT6,_RFPSA21,RESP046,"(41.56266102, -72.649840952)"
|
|
2014,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,78,56,45,67,3484,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,INCOME3,CAT6,_RFPSA21,RESP054,"(41.56266102, -72.649840952)"
|
|
2014,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,102,40.8,32.5,49.1,3480,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,INCOME4,CAT6,_RFPSA21,RESP046,"(41.56266102, -72.649840952)"
|
|
2014,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,109,59.2,50.9,67.5,3485,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,INCOME4,CAT6,_RFPSA21,RESP054,"(41.56266102, -72.649840952)"
|
|
2014,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,707,46.2,42.7,49.8,3481,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,INCOME5,CAT6,_RFPSA21,RESP046,"(41.56266102, -72.649840952)"
|
|
2014,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,652,53.8,50.3,57.4,3486,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,INCOME5,CAT6,_RFPSA21,RESP054,"(41.56266102, -72.649840952)"
|
|
2014,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,998,45.9,43,48.8,3459,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,RACE1,CAT4,_RFPSA21,RESP046,"(41.56266102, -72.649840952)"
|
|
2014,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,951,54.1,51.2,57,3464,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,RACE1,CAT4,_RFPSA21,RESP054,"(41.56266102, -72.649840952)"
|
|
2014,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,49,30,20.6,39.5,3460,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,RACE2,CAT4,_RFPSA21,RESP046,"(41.56266102, -72.649840952)"
|
|
2014,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,69,70,60.5,79.5,3465,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,RACE2,CAT4,_RFPSA21,RESP054,"(41.56266102, -72.649840952)"
|
|
2014,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,39,31.6,20.8,42.4,3461,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,RACE3,CAT4,_RFPSA21,RESP046,"(41.56266102, -72.649840952)"
|
|
2014,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,84,68.4,57.6,79.2,3466,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,RACE3,CAT4,_RFPSA21,RESP054,"(41.56266102, -72.649840952)"
|
|
2014,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,26,25.2,12.6,37.8,3462,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,RACE4,CAT4,_RFPSA21,RESP046,"(41.56266102, -72.649840952)"
|
|
2014,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,45,74.8,62.2,87.4,3467,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,RACE4,CAT4,_RFPSA21,RESP054,"(41.56266102, -72.649840952)"
|
|
2014,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,6,,,,3463,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,09,RACE5,CAT4,_RFPSA21,RESP046,"(41.56266102, -72.649840952)"
|
|
2014,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,14,,,,3468,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,09,RACE5,CAT4,_RFPSA21,RESP054,"(41.56266102, -72.649840952)"
|
|
2014,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1145,42.8,40.2,45.5,3449,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,SEX1,CAT2,_RFPSA21,RESP046,"(41.56266102, -72.649840952)"
|
|
2014,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1184,57.2,54.6,59.9,3450,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,09,SEX1,CAT2,_RFPSA21,RESP054,"(41.56266102, -72.649840952)"
|
|
2014,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,32,11.4,5.8,17.1,3453,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,10,AGE06,CAT3,_RFPSA21,RESP046,"(39.008830667, -75.577741168)"
|
|
2014,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,166,88.6,82.9,94.2,3457,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,10,AGE06,CAT3,_RFPSA21,RESP054,"(39.008830667, -75.577741168)"
|
|
2014,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,148,41.4,34.8,48,3454,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,10,AGE07,CAT3,_RFPSA21,RESP046,"(39.008830667, -75.577741168)"
|
|
2014,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,199,58.6,52,65.2,3458,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,10,AGE07,CAT3,_RFPSA21,RESP054,"(39.008830667, -75.577741168)"
|
|
2014,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,119,64.6,56.5,72.8,3455,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,10,AGE08,CAT3,_RFPSA21,RESP046,"(39.008830667, -75.577741168)"
|
|
2014,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,67,35.4,27.2,43.5,3459,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,10,AGE08,CAT3,_RFPSA21,RESP054,"(39.008830667, -75.577741168)"
|
|
2014,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,396,68,62.6,73.4,3456,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,10,AGE09,CAT3,_RFPSA21,RESP046,"(39.008830667, -75.577741168)"
|
|
2014,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,177,32,26.6,37.4,3460,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,10,AGE09,CAT3,_RFPSA21,RESP054,"(39.008830667, -75.577741168)"
|
|
2014,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,695,45.1,41.5,48.7,3449,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,10,BO1,CAT1,_RFPSA21,RESP046,"(39.008830667, -75.577741168)"
|
|
2014,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,609,54.9,51.3,58.5,3450,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,10,BO1,CAT1,_RFPSA21,RESP054,"(39.008830667, -75.577741168)"
|
|
2014,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,38,25.1,16,34.2,3471,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,10,EDUCA1,CAT5,_RFPSA21,RESP046,"(39.008830667, -75.577741168)"
|
|
2014,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,88,74.9,65.8,84,3475,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,10,EDUCA1,CAT5,_RFPSA21,RESP054,"(39.008830667, -75.577741168)"
|
|
2014,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,186,43.1,36.9,49.4,3472,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,10,EDUCA2,CAT5,_RFPSA21,RESP046,"(39.008830667, -75.577741168)"
|
|
2014,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,188,56.9,50.6,63.1,3476,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,10,EDUCA2,CAT5,_RFPSA21,RESP054,"(39.008830667, -75.577741168)"
|
|
2014,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,175,52.3,44.2,60.3,3473,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,10,EDUCA3,CAT5,_RFPSA21,RESP046,"(39.008830667, -75.577741168)"
|
|
2014,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,117,47.8,39.7,55.8,3477,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,10,EDUCA3,CAT5,_RFPSA21,RESP054,"(39.008830667, -75.577741168)"
|
|
2014,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,296,51,45.6,56.5,3474,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,10,EDUCA4,CAT5,_RFPSA21,RESP046,"(39.008830667, -75.577741168)"
|
|
2014,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,215,49,43.5,54.4,3478,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,10,EDUCA4,CAT5,_RFPSA21,RESP054,"(39.008830667, -75.577741168)"
|
|
2014,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,23,19.8,10,29.5,3479,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,10,INCOME1,CAT6,_RFPSA21,RESP046,"(39.008830667, -75.577741168)"
|
|
2014,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,59,80.2,70.5,90,3484,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,10,INCOME1,CAT6,_RFPSA21,RESP054,"(39.008830667, -75.577741168)"
|
|
2014,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,85,44.3,34.8,53.7,3480,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,10,INCOME2,CAT6,_RFPSA21,RESP046,"(39.008830667, -75.577741168)"
|
|
2014,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,99,55.8,46.3,65.2,3485,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,10,INCOME2,CAT6,_RFPSA21,RESP054,"(39.008830667, -75.577741168)"
|
|
2014,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,49,57.6,44.1,71.1,3481,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,10,INCOME3,CAT6,_RFPSA21,RESP046,"(39.008830667, -75.577741168)"
|
|
2014,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,36,42.4,28.9,55.9,3486,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,10,INCOME3,CAT6,_RFPSA21,RESP054,"(39.008830667, -75.577741168)"
|
|
2014,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,109,46.7,37.6,55.7,3482,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,10,INCOME4,CAT6,_RFPSA21,RESP046,"(39.008830667, -75.577741168)"
|
|
2014,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,77,53.3,44.3,62.4,3487,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,10,INCOME4,CAT6,_RFPSA21,RESP054,"(39.008830667, -75.577741168)"
|
|
2014,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,337,45.9,40.4,51.4,3483,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,10,INCOME5,CAT6,_RFPSA21,RESP046,"(39.008830667, -75.577741168)"
|
|
2014,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,266,54.1,48.6,59.6,3488,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,10,INCOME5,CAT6,_RFPSA21,RESP054,"(39.008830667, -75.577741168)"
|
|
2014,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,522,46.9,42.9,50.8,3461,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,10,RACE1,CAT4,_RFPSA21,RESP046,"(39.008830667, -75.577741168)"
|
|
2014,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,430,53.2,49.2,57.1,3466,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,10,RACE1,CAT4,_RFPSA21,RESP054,"(39.008830667, -75.577741168)"
|
|
2014,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,86,45.4,34.5,56.3,3462,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,10,RACE2,CAT4,_RFPSA21,RESP046,"(39.008830667, -75.577741168)"
|
|
2014,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,70,54.6,43.7,65.5,3467,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,10,RACE2,CAT4,_RFPSA21,RESP054,"(39.008830667, -75.577741168)"
|
|
2014,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,16,31.6,15.8,47.5,3463,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,10,RACE3,CAT4,_RFPSA21,RESP046,"(39.008830667, -75.577741168)"
|
|
2014,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,35,68.4,52.5,84.2,3468,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,10,RACE3,CAT4,_RFPSA21,RESP054,"(39.008830667, -75.577741168)"
|
|
2014,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,5,,,,3464,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,10,RACE4,CAT4,_RFPSA21,RESP046,"(39.008830667, -75.577741168)"
|
|
2014,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,12,,,,3469,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,10,RACE4,CAT4,_RFPSA21,RESP054,"(39.008830667, -75.577741168)"
|
|
2014,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,57,44.3,32,56.6,3465,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,10,RACE5,CAT4,_RFPSA21,RESP046,"(39.008830667, -75.577741168)"
|
|
2014,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,47,55.7,43.5,68,3470,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,10,RACE5,CAT4,_RFPSA21,RESP054,"(39.008830667, -75.577741168)"
|
|
2014,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,695,45.1,41.5,48.7,3451,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,10,SEX1,CAT2,_RFPSA21,RESP046,"(39.008830667, -75.577741168)"
|
|
2014,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,609,54.9,51.3,58.5,3452,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,10,SEX1,CAT2,_RFPSA21,RESP054,"(39.008830667, -75.577741168)"
|
|
2014,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,50,20.3,13.4,27.1,3436,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,11,AGE06,CAT3,_RFPSA21,RESP046,"(38.890371385, -77.031961127)"
|
|
2014,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,155,79.8,72.9,86.6,3440,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,11,AGE06,CAT3,_RFPSA21,RESP054,"(38.890371385, -77.031961127)"
|
|
2014,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,147,51.2,42.3,60.1,3437,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,11,AGE07,CAT3,_RFPSA21,RESP046,"(38.890371385, -77.031961127)"
|
|
2014,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,126,48.8,40,57.7,3441,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,11,AGE07,CAT3,_RFPSA21,RESP054,"(38.890371385, -77.031961127)"
|
|
2014,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,76,50.5,38.9,62.1,3438,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,11,AGE08,CAT3,_RFPSA21,RESP046,"(38.890371385, -77.031961127)"
|
|
2014,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,70,49.5,37.9,61.2,3442,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,11,AGE08,CAT3,_RFPSA21,RESP054,"(38.890371385, -77.031961127)"
|
|
2014,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,308,62.9,56.2,69.7,3439,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,11,AGE09,CAT3,_RFPSA21,RESP046,"(38.890371385, -77.031961127)"
|
|
2014,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,165,37.1,30.3,43.8,3443,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,11,AGE09,CAT3,_RFPSA21,RESP054,"(38.890371385, -77.031961127)"
|
|
2014,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,581,43.8,39.3,48.4,3432,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,11,BO1,CAT1,_RFPSA21,RESP046,"(38.890371385, -77.031961127)"
|
|
2014,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,516,56.2,51.6,60.7,3433,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,11,BO1,CAT1,_RFPSA21,RESP054,"(38.890371385, -77.031961127)"
|
|
2014,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,25,36.5,20.7,52.3,3454,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,11,EDUCA1,CAT5,_RFPSA21,RESP046,"(38.890371385, -77.031961127)"
|
|
2014,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,43,63.5,47.7,79.3,3458,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,11,EDUCA1,CAT5,_RFPSA21,RESP054,"(38.890371385, -77.031961127)"
|
|
2014,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,75,37.8,27.9,47.7,3455,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,11,EDUCA2,CAT5,_RFPSA21,RESP046,"(38.890371385, -77.031961127)"
|
|
2014,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,86,62.2,52.3,72.1,3459,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,11,EDUCA2,CAT5,_RFPSA21,RESP054,"(38.890371385, -77.031961127)"
|
|
2014,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,80,40.9,30.6,51.1,3456,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,11,EDUCA3,CAT5,_RFPSA21,RESP046,"(38.890371385, -77.031961127)"
|
|
2014,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,88,59.1,48.9,69.4,3460,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,11,EDUCA3,CAT5,_RFPSA21,RESP054,"(38.890371385, -77.031961127)"
|
|
2014,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,398,49.8,44.6,55.1,3457,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,11,EDUCA4,CAT5,_RFPSA21,RESP046,"(38.890371385, -77.031961127)"
|
|
2014,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,299,50.2,44.9,55.4,3461,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,11,EDUCA4,CAT5,_RFPSA21,RESP054,"(38.890371385, -77.031961127)"
|
|
2014,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,36,30.9,17.4,44.5,3462,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,11,INCOME1,CAT6,_RFPSA21,RESP046,"(38.890371385, -77.031961127)"
|
|
2014,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,66,69.1,55.5,82.7,3467,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,11,INCOME1,CAT6,_RFPSA21,RESP054,"(38.890371385, -77.031961127)"
|
|
2014,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,48,34.3,18.8,49.9,3463,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,11,INCOME2,CAT6,_RFPSA21,RESP046,"(38.890371385, -77.031961127)"
|
|
2014,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,60,65.7,50.1,81.2,3468,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,11,INCOME2,CAT6,_RFPSA21,RESP054,"(38.890371385, -77.031961127)"
|
|
2014,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,30,46.9,27,66.8,3464,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,11,INCOME3,CAT6,_RFPSA21,RESP046,"(38.890371385, -77.031961127)"
|
|
2014,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,32,53.1,33.2,73,3469,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,11,INCOME3,CAT6,_RFPSA21,RESP054,"(38.890371385, -77.031961127)"
|
|
2014,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,41,52.2,35,69.4,3465,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,11,INCOME4,CAT6,_RFPSA21,RESP046,"(38.890371385, -77.031961127)"
|
|
2014,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,31,47.8,30.6,65,3470,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,11,INCOME4,CAT6,_RFPSA21,RESP054,"(38.890371385, -77.031961127)"
|
|
2014,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,359,48.7,43.3,54.2,3466,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,11,INCOME5,CAT6,_RFPSA21,RESP046,"(38.890371385, -77.031961127)"
|
|
2014,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,270,51.3,45.9,56.8,3471,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,11,INCOME5,CAT6,_RFPSA21,RESP054,"(38.890371385, -77.031961127)"
|
|
2014,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,297,49.8,43.7,55.8,3444,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,11,RACE1,CAT4,_RFPSA21,RESP046,"(38.890371385, -77.031961127)"
|
|
2014,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,234,50.2,44.2,56.3,3449,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,11,RACE1,CAT4,_RFPSA21,RESP054,"(38.890371385, -77.031961127)"
|
|
2014,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,240,40.1,33.1,47,3445,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,11,RACE2,CAT4,_RFPSA21,RESP046,"(38.890371385, -77.031961127)"
|
|
2014,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,237,59.9,53,66.9,3450,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,11,RACE2,CAT4,_RFPSA21,RESP054,"(38.890371385, -77.031961127)"
|
|
2014,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,9,,,,3446,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,11,RACE3,CAT4,_RFPSA21,RESP046,"(38.890371385, -77.031961127)"
|
|
2014,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,16,,,,3451,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,11,RACE3,CAT4,_RFPSA21,RESP054,"(38.890371385, -77.031961127)"
|
|
2014,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,12,,,,3447,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,11,RACE4,CAT4,_RFPSA21,RESP046,"(38.890371385, -77.031961127)"
|
|
2014,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,15,,,,3452,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,11,RACE4,CAT4,_RFPSA21,RESP054,"(38.890371385, -77.031961127)"
|
|
2014,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,7,,,,3448,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,11,RACE5,CAT4,_RFPSA21,RESP046,"(38.890371385, -77.031961127)"
|
|
2014,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,7,,,,3453,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,11,RACE5,CAT4,_RFPSA21,RESP054,"(38.890371385, -77.031961127)"
|
|
2014,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,581,43.8,39.3,48.4,3434,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,11,SEX1,CAT2,_RFPSA21,RESP046,"(38.890371385, -77.031961127)"
|
|
2014,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,516,56.2,51.6,60.7,3435,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,11,SEX1,CAT2,_RFPSA21,RESP054,"(38.890371385, -77.031961127)"
|
|
2014,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,79,23.7,18.1,29.2,3465,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,12,AGE06,CAT3,_RFPSA21,RESP046,"(28.932040377, -81.928960539)"
|
|
2014,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,275,76.3,70.8,81.9,3469,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,12,AGE06,CAT3,_RFPSA21,RESP054,"(28.932040377, -81.928960539)"
|
|
2014,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,290,40.9,36.3,45.5,3466,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,12,AGE07,CAT3,_RFPSA21,RESP046,"(28.932040377, -81.928960539)"
|
|
2014,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,361,59.1,54.5,63.7,3470,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,12,AGE07,CAT3,_RFPSA21,RESP054,"(28.932040377, -81.928960539)"
|
|
2014,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,227,62.1,56,68.2,3467,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,12,AGE08,CAT3,_RFPSA21,RESP046,"(28.932040377, -81.928960539)"
|
|
2014,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,130,37.9,31.8,44.1,3471,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,12,AGE08,CAT3,_RFPSA21,RESP054,"(28.932040377, -81.928960539)"
|
|
2014,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,1011,68.5,65.1,71.9,3468,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,12,AGE09,CAT3,_RFPSA21,RESP046,"(28.932040377, -81.928960539)"
|
|
2014,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,429,31.5,28.1,34.9,3472,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,12,AGE09,CAT3,_RFPSA21,RESP054,"(28.932040377, -81.928960539)"
|
|
2014,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1607,49.7,47.2,52.1,3461,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,12,BO1,CAT1,_RFPSA21,RESP046,"(28.932040377, -81.928960539)"
|
|
2014,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1195,50.3,47.9,52.8,3462,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,12,BO1,CAT1,_RFPSA21,RESP054,"(28.932040377, -81.928960539)"
|
|
2014,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,87,37.8,29.7,45.8,3483,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,12,EDUCA1,CAT5,_RFPSA21,RESP046,"(28.932040377, -81.928960539)"
|
|
2014,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,122,62.2,54.2,70.3,3487,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,12,EDUCA1,CAT5,_RFPSA21,RESP054,"(28.932040377, -81.928960539)"
|
|
2014,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,320,48.1,43.3,52.9,3484,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,12,EDUCA2,CAT5,_RFPSA21,RESP046,"(28.932040377, -81.928960539)"
|
|
2014,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,307,51.9,47.1,56.7,3488,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,12,EDUCA2,CAT5,_RFPSA21,RESP054,"(28.932040377, -81.928960539)"
|
|
2014,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,403,49.5,45.1,53.8,3485,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,12,EDUCA3,CAT5,_RFPSA21,RESP046,"(28.932040377, -81.928960539)"
|
|
2014,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,328,50.5,46.2,54.9,3489,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,12,EDUCA3,CAT5,_RFPSA21,RESP054,"(28.932040377, -81.928960539)"
|
|
2014,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,793,58.2,54.8,61.6,3486,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,12,EDUCA4,CAT5,_RFPSA21,RESP046,"(28.932040377, -81.928960539)"
|
|
2014,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,437,41.8,38.4,45.2,3490,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,12,EDUCA4,CAT5,_RFPSA21,RESP054,"(28.932040377, -81.928960539)"
|
|
2014,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,88,31.7,24.1,39.4,3491,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,12,INCOME1,CAT6,_RFPSA21,RESP046,"(28.932040377, -81.928960539)"
|
|
2014,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,139,68.3,60.6,75.9,3496,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,12,INCOME1,CAT6,_RFPSA21,RESP054,"(28.932040377, -81.928960539)"
|
|
2014,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,209,42.4,36,48.8,3492,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,12,INCOME2,CAT6,_RFPSA21,RESP046,"(28.932040377, -81.928960539)"
|
|
2014,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,205,57.6,51.2,64.1,3497,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,12,INCOME2,CAT6,_RFPSA21,RESP054,"(28.932040377, -81.928960539)"
|
|
2014,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,120,51.7,43.5,59.9,3493,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,12,INCOME3,CAT6,_RFPSA21,RESP046,"(28.932040377, -81.928960539)"
|
|
2014,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,107,48.3,40.1,56.6,3498,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,12,INCOME3,CAT6,_RFPSA21,RESP054,"(28.932040377, -81.928960539)"
|
|
2014,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,220,56.3,49.4,63.2,3494,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,12,INCOME4,CAT6,_RFPSA21,RESP046,"(28.932040377, -81.928960539)"
|
|
2014,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,137,43.7,36.8,50.6,3499,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,12,INCOME4,CAT6,_RFPSA21,RESP054,"(28.932040377, -81.928960539)"
|
|
2014,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,809,54.6,51,58.1,3495,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,12,INCOME5,CAT6,_RFPSA21,RESP046,"(28.932040377, -81.928960539)"
|
|
2014,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,484,45.4,41.9,49,3500,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,12,INCOME5,CAT6,_RFPSA21,RESP054,"(28.932040377, -81.928960539)"
|
|
2014,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1284,54.1,51.4,56.8,3473,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,12,RACE1,CAT4,_RFPSA21,RESP046,"(28.932040377, -81.928960539)"
|
|
2014,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,852,46,43.3,48.7,3478,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,12,RACE1,CAT4,_RFPSA21,RESP054,"(28.932040377, -81.928960539)"
|
|
2014,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,116,49.1,40.5,57.6,3474,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,12,RACE2,CAT4,_RFPSA21,RESP046,"(28.932040377, -81.928960539)"
|
|
2014,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,101,50.9,42.4,59.5,3479,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,12,RACE2,CAT4,_RFPSA21,RESP054,"(28.932040377, -81.928960539)"
|
|
2014,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,122,37.5,30.7,44.3,3475,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,12,RACE3,CAT4,_RFPSA21,RESP046,"(28.932040377, -81.928960539)"
|
|
2014,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,154,62.5,55.7,69.3,3480,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,12,RACE3,CAT4,_RFPSA21,RESP054,"(28.932040377, -81.928960539)"
|
|
2014,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,34,42.6,28.6,56.6,3476,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,12,RACE4,CAT4,_RFPSA21,RESP046,"(28.932040377, -81.928960539)"
|
|
2014,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,35,57.4,43.4,71.4,3481,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,12,RACE4,CAT4,_RFPSA21,RESP054,"(28.932040377, -81.928960539)"
|
|
2014,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,16,,,,3477,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,12,RACE5,CAT4,_RFPSA21,RESP046,"(28.932040377, -81.928960539)"
|
|
2014,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,19,,,,3482,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,12,RACE5,CAT4,_RFPSA21,RESP054,"(28.932040377, -81.928960539)"
|
|
2014,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1607,49.7,47.2,52.1,3463,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,12,SEX1,CAT2,_RFPSA21,RESP046,"(28.932040377, -81.928960539)"
|
|
2014,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1195,50.3,47.9,52.8,3464,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,12,SEX1,CAT2,_RFPSA21,RESP054,"(28.932040377, -81.928960539)"
|
|
2014,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,73,22.6,16.9,28.4,3461,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,13,AGE06,CAT3,_RFPSA21,RESP046,"(32.839681093, -83.627580346)"
|
|
2014,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,235,77.4,71.6,83.2,3465,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,13,AGE06,CAT3,_RFPSA21,RESP054,"(32.839681093, -83.627580346)"
|
|
2014,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,210,47.8,42.1,53.5,3462,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,13,AGE07,CAT3,_RFPSA21,RESP046,"(32.839681093, -83.627580346)"
|
|
2014,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,222,52.2,46.5,57.9,3466,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,13,AGE07,CAT3,_RFPSA21,RESP054,"(32.839681093, -83.627580346)"
|
|
2014,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,141,57.8,49.6,65.9,3463,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,13,AGE08,CAT3,_RFPSA21,RESP046,"(32.839681093, -83.627580346)"
|
|
2014,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,86,42.2,34.1,50.4,3467,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,13,AGE08,CAT3,_RFPSA21,RESP054,"(32.839681093, -83.627580346)"
|
|
2014,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,466,68.5,64.2,72.8,3464,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,13,AGE09,CAT3,_RFPSA21,RESP046,"(32.839681093, -83.627580346)"
|
|
2014,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,223,31.5,27.2,35.8,3468,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,13,AGE09,CAT3,_RFPSA21,RESP054,"(32.839681093, -83.627580346)"
|
|
2014,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,890,46.4,43.2,49.5,3457,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,13,BO1,CAT1,_RFPSA21,RESP046,"(32.839681093, -83.627580346)"
|
|
2014,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,766,53.6,50.5,56.8,3458,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,13,BO1,CAT1,_RFPSA21,RESP054,"(32.839681093, -83.627580346)"
|
|
2014,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,52,26.6,17.7,35.5,3479,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,13,EDUCA1,CAT5,_RFPSA21,RESP046,"(32.839681093, -83.627580346)"
|
|
2014,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,114,73.4,64.5,82.3,3483,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,13,EDUCA1,CAT5,_RFPSA21,RESP054,"(32.839681093, -83.627580346)"
|
|
2014,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,192,39.9,34.2,45.5,3480,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,13,EDUCA2,CAT5,_RFPSA21,RESP046,"(32.839681093, -83.627580346)"
|
|
2014,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,221,60.1,54.5,65.8,3484,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,13,EDUCA2,CAT5,_RFPSA21,RESP054,"(32.839681093, -83.627580346)"
|
|
2014,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,236,56.7,50.5,62.8,3481,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,13,EDUCA3,CAT5,_RFPSA21,RESP046,"(32.839681093, -83.627580346)"
|
|
2014,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,157,43.3,37.2,49.5,3485,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,13,EDUCA3,CAT5,_RFPSA21,RESP054,"(32.839681093, -83.627580346)"
|
|
2014,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,407,54.8,50.1,59.4,3482,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,13,EDUCA4,CAT5,_RFPSA21,RESP046,"(32.839681093, -83.627580346)"
|
|
2014,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,273,45.3,40.6,49.9,3486,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,13,EDUCA4,CAT5,_RFPSA21,RESP054,"(32.839681093, -83.627580346)"
|
|
2014,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,51,31.1,21.1,41.1,3487,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,13,INCOME1,CAT6,_RFPSA21,RESP046,"(32.839681093, -83.627580346)"
|
|
2014,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,91,68.9,58.9,78.9,3492,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,13,INCOME1,CAT6,_RFPSA21,RESP054,"(32.839681093, -83.627580346)"
|
|
2014,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,92,35.2,27.3,43.1,3488,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,13,INCOME2,CAT6,_RFPSA21,RESP046,"(32.839681093, -83.627580346)"
|
|
2014,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,140,64.8,57,72.7,3493,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,13,INCOME2,CAT6,_RFPSA21,RESP054,"(32.839681093, -83.627580346)"
|
|
2014,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,78,46.5,35.6,57.4,3489,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,13,INCOME3,CAT6,_RFPSA21,RESP046,"(32.839681093, -83.627580346)"
|
|
2014,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,77,53.5,42.6,64.4,3494,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,13,INCOME3,CAT6,_RFPSA21,RESP054,"(32.839681093, -83.627580346)"
|
|
2014,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,113,52.2,42.7,61.6,3490,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,13,INCOME4,CAT6,_RFPSA21,RESP046,"(32.839681093, -83.627580346)"
|
|
2014,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,78,47.8,38.4,57.3,3495,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,13,INCOME4,CAT6,_RFPSA21,RESP054,"(32.839681093, -83.627580346)"
|
|
2014,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,474,52.5,48.1,57,3491,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,13,INCOME5,CAT6,_RFPSA21,RESP046,"(32.839681093, -83.627580346)"
|
|
2014,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,312,47.5,43.1,52,3496,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,13,INCOME5,CAT6,_RFPSA21,RESP054,"(32.839681093, -83.627580346)"
|
|
2014,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,665,47.7,44.1,51.2,3469,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,13,RACE1,CAT4,_RFPSA21,RESP046,"(32.839681093, -83.627580346)"
|
|
2014,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,538,52.4,48.8,55.9,3474,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,13,RACE1,CAT4,_RFPSA21,RESP054,"(32.839681093, -83.627580346)"
|
|
2014,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,170,48.7,41.8,55.6,3470,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,13,RACE2,CAT4,_RFPSA21,RESP046,"(32.839681093, -83.627580346)"
|
|
2014,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,149,51.3,44.4,58.2,3475,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,13,RACE2,CAT4,_RFPSA21,RESP054,"(32.839681093, -83.627580346)"
|
|
2014,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,15,,,,3471,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,13,RACE3,CAT4,_RFPSA21,RESP046,"(32.839681093, -83.627580346)"
|
|
2014,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,33,,,,3476,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,13,RACE3,CAT4,_RFPSA21,RESP054,"(32.839681093, -83.627580346)"
|
|
2014,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,17,,,,3472,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,13,RACE4,CAT4,_RFPSA21,RESP046,"(32.839681093, -83.627580346)"
|
|
2014,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,21,,,,3477,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,13,RACE4,CAT4,_RFPSA21,RESP054,"(32.839681093, -83.627580346)"
|
|
2014,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,10,,,,3473,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,13,RACE5,CAT4,_RFPSA21,RESP046,"(32.839681093, -83.627580346)"
|
|
2014,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,10,,,,3478,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,13,RACE5,CAT4,_RFPSA21,RESP054,"(32.839681093, -83.627580346)"
|
|
2014,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,890,46.4,43.2,49.5,3459,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,13,SEX1,CAT2,_RFPSA21,RESP046,"(32.839681093, -83.627580346)"
|
|
2014,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,766,53.6,50.5,56.8,3460,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,13,SEX1,CAT2,_RFPSA21,RESP054,"(32.839681093, -83.627580346)"
|
|
2014,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,17,,,,3417,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,66,AGE06,CAT3,_RFPSA21,RESP046,"(13.444304, 144.793731)"
|
|
2014,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,173,87.9,79.3,96.6,3421,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,66,AGE06,CAT3,_RFPSA21,RESP054,"(13.444304, 144.793731)"
|
|
2014,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,42,20,13.2,26.7,3418,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,66,AGE07,CAT3,_RFPSA21,RESP046,"(13.444304, 144.793731)"
|
|
2014,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,143,80.1,73.3,86.8,3422,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,66,AGE07,CAT3,_RFPSA21,RESP054,"(13.444304, 144.793731)"
|
|
2014,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,24,34.1,19.7,48.5,3419,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,66,AGE08,CAT3,_RFPSA21,RESP046,"(13.444304, 144.793731)"
|
|
2014,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,47,65.9,51.5,80.3,3423,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,66,AGE08,CAT3,_RFPSA21,RESP054,"(13.444304, 144.793731)"
|
|
2014,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,48,44,32.4,55.6,3420,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,66,AGE09,CAT3,_RFPSA21,RESP046,"(13.444304, 144.793731)"
|
|
2014,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,67,56,44.4,67.6,3424,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,66,AGE09,CAT3,_RFPSA21,RESP054,"(13.444304, 144.793731)"
|
|
2014,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,131,22.9,18,27.8,3413,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,66,BO1,CAT1,_RFPSA21,RESP046,"(13.444304, 144.793731)"
|
|
2014,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,430,77.1,72.2,82,3414,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,66,BO1,CAT1,_RFPSA21,RESP054,"(13.444304, 144.793731)"
|
|
2014,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,8,,,,3435,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,66,EDUCA1,CAT5,_RFPSA21,RESP046,"(13.444304, 144.793731)"
|
|
2014,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,34,,,,3439,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,66,EDUCA1,CAT5,_RFPSA21,RESP054,"(13.444304, 144.793731)"
|
|
2014,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,27,20,10,30,3436,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,66,EDUCA2,CAT5,_RFPSA21,RESP046,"(13.444304, 144.793731)"
|
|
2014,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,146,80,70,90,3440,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,66,EDUCA2,CAT5,_RFPSA21,RESP054,"(13.444304, 144.793731)"
|
|
2014,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,25,18.6,9.3,27.9,3437,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,66,EDUCA3,CAT5,_RFPSA21,RESP046,"(13.444304, 144.793731)"
|
|
2014,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,111,81.4,72.1,90.7,3441,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,66,EDUCA3,CAT5,_RFPSA21,RESP054,"(13.444304, 144.793731)"
|
|
2014,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,71,33.8,26.1,41.5,3438,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,66,EDUCA4,CAT5,_RFPSA21,RESP046,"(13.444304, 144.793731)"
|
|
2014,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,139,66.2,58.5,73.9,3442,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,66,EDUCA4,CAT5,_RFPSA21,RESP054,"(13.444304, 144.793731)"
|
|
2014,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,3,,,,3443,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,66,INCOME1,CAT6,_RFPSA21,RESP046,"(13.444304, 144.793731)"
|
|
2014,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,57,93.5,82.9,100,3448,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,66,INCOME1,CAT6,_RFPSA21,RESP054,"(13.444304, 144.793731)"
|
|
2014,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,16,20.5,9.9,31.1,3444,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,66,INCOME2,CAT6,_RFPSA21,RESP046,"(13.444304, 144.793731)"
|
|
2014,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,77,79.5,68.9,90.1,3449,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,66,INCOME2,CAT6,_RFPSA21,RESP054,"(13.444304, 144.793731)"
|
|
2014,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,16,24.3,10.6,38.1,3445,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,66,INCOME3,CAT6,_RFPSA21,RESP046,"(13.444304, 144.793731)"
|
|
2014,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,52,75.7,61.9,89.4,3450,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,66,INCOME3,CAT6,_RFPSA21,RESP054,"(13.444304, 144.793731)"
|
|
2014,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,12,,,,3446,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,66,INCOME4,CAT6,_RFPSA21,RESP046,"(13.444304, 144.793731)"
|
|
2014,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,77,88.9,81.6,96.2,3451,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,66,INCOME4,CAT6,_RFPSA21,RESP054,"(13.444304, 144.793731)"
|
|
2014,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,75,33,23.7,42.3,3447,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,66,INCOME5,CAT6,_RFPSA21,RESP046,"(13.444304, 144.793731)"
|
|
2014,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,152,67,57.7,76.3,3452,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,66,INCOME5,CAT6,_RFPSA21,RESP054,"(13.444304, 144.793731)"
|
|
2014,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,29,34.4,21,47.7,3425,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,66,RACE1,CAT4,_RFPSA21,RESP046,"(13.444304, 144.793731)"
|
|
2014,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,55,65.6,52.3,79,3430,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,66,RACE1,CAT4,_RFPSA21,RESP054,"(13.444304, 144.793731)"
|
|
2014,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,2,,,,3426,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,66,RACE2,CAT4,_RFPSA21,RESP046,"(13.444304, 144.793731)"
|
|
2014,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,1,,,,3431,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,66,RACE2,CAT4,_RFPSA21,RESP054,"(13.444304, 144.793731)"
|
|
2014,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,18,,,,3427,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,66,RACE3,CAT4,_RFPSA21,RESP046,"(13.444304, 144.793731)"
|
|
2014,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,39,62.2,39.7,84.6,3432,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,66,RACE3,CAT4,_RFPSA21,RESP054,"(13.444304, 144.793731)"
|
|
2014,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,64,19.2,13.7,24.7,3428,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,66,RACE4,CAT4,_RFPSA21,RESP046,"(13.444304, 144.793731)"
|
|
2014,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,276,80.8,75.4,86.3,3433,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,66,RACE4,CAT4,_RFPSA21,RESP054,"(13.444304, 144.793731)"
|
|
2014,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,15,,,,3429,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,66,RACE5,CAT4,_RFPSA21,RESP046,"(13.444304, 144.793731)"
|
|
2014,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,51,81.5,70.5,92.4,3434,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,66,RACE5,CAT4,_RFPSA21,RESP054,"(13.444304, 144.793731)"
|
|
2014,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,131,22.9,18,27.8,3415,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,66,SEX1,CAT2,_RFPSA21,RESP046,"(13.444304, 144.793731)"
|
|
2014,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,430,77.1,72.2,82,3416,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,66,SEX1,CAT2,_RFPSA21,RESP054,"(13.444304, 144.793731)"
|
|
2014,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,32,7.3,3.8,10.8,3462,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,15,AGE06,CAT3,_RFPSA21,RESP046,"(21.304850435, -157.857749403)"
|
|
2014,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,368,92.7,89.2,96.2,3466,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,15,AGE06,CAT3,_RFPSA21,RESP054,"(21.304850435, -157.857749403)"
|
|
2014,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,179,29.1,24.4,33.9,3463,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,15,AGE07,CAT3,_RFPSA21,RESP046,"(21.304850435, -157.857749403)"
|
|
2014,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,421,70.9,66.1,75.6,3467,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,15,AGE07,CAT3,_RFPSA21,RESP054,"(21.304850435, -157.857749403)"
|
|
2014,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,171,46.2,39.6,52.8,3464,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,15,AGE08,CAT3,_RFPSA21,RESP046,"(21.304850435, -157.857749403)"
|
|
2014,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,203,53.8,47.2,60.5,3468,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,15,AGE08,CAT3,_RFPSA21,RESP054,"(21.304850435, -157.857749403)"
|
|
2014,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,453,57.7,53.2,62.3,3465,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,15,AGE09,CAT3,_RFPSA21,RESP046,"(21.304850435, -157.857749403)"
|
|
2014,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,368,42.3,37.7,46.9,3469,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,15,AGE09,CAT3,_RFPSA21,RESP054,"(21.304850435, -157.857749403)"
|
|
2014,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,835,35.4,32.7,38.1,3458,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,15,BO1,CAT1,_RFPSA21,RESP046,"(21.304850435, -157.857749403)"
|
|
2014,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1360,64.6,61.9,67.3,3459,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,15,BO1,CAT1,_RFPSA21,RESP054,"(21.304850435, -157.857749403)"
|
|
2014,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,21,24,12.5,35.5,3480,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,15,EDUCA1,CAT5,_RFPSA21,RESP046,"(21.304850435, -157.857749403)"
|
|
2014,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,77,76,64.5,87.5,3484,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,15,EDUCA1,CAT5,_RFPSA21,RESP054,"(21.304850435, -157.857749403)"
|
|
2014,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,155,28.5,23.6,33.3,3481,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,15,EDUCA2,CAT5,_RFPSA21,RESP046,"(21.304850435, -157.857749403)"
|
|
2014,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,395,71.5,66.7,76.4,3485,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,15,EDUCA2,CAT5,_RFPSA21,RESP054,"(21.304850435, -157.857749403)"
|
|
2014,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,234,38.8,33.6,44.1,3482,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,15,EDUCA3,CAT5,_RFPSA21,RESP046,"(21.304850435, -157.857749403)"
|
|
2014,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,358,61.2,55.9,66.5,3486,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,15,EDUCA3,CAT5,_RFPSA21,RESP054,"(21.304850435, -157.857749403)"
|
|
2014,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,423,40.9,36.9,44.9,3483,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,15,EDUCA4,CAT5,_RFPSA21,RESP046,"(21.304850435, -157.857749403)"
|
|
2014,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,530,59.1,55.1,63.1,3487,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,15,EDUCA4,CAT5,_RFPSA21,RESP054,"(21.304850435, -157.857749403)"
|
|
2014,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,48,16.2,10.2,22.2,3488,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,15,INCOME1,CAT6,_RFPSA21,RESP046,"(21.304850435, -157.857749403)"
|
|
2014,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,162,83.8,77.8,89.8,3493,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,15,INCOME1,CAT6,_RFPSA21,RESP054,"(21.304850435, -157.857749403)"
|
|
2014,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,78,29.5,21.9,37.1,3489,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,15,INCOME2,CAT6,_RFPSA21,RESP046,"(21.304850435, -157.857749403)"
|
|
2014,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,193,70.5,62.9,78.1,3494,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,15,INCOME2,CAT6,_RFPSA21,RESP054,"(21.304850435, -157.857749403)"
|
|
2014,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,61,32.5,22.8,42.2,3490,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,15,INCOME3,CAT6,_RFPSA21,RESP046,"(21.304850435, -157.857749403)"
|
|
2014,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,138,67.5,57.8,77.2,3495,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,15,INCOME3,CAT6,_RFPSA21,RESP054,"(21.304850435, -157.857749403)"
|
|
2014,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,109,36.1,28.7,43.5,3491,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,15,INCOME4,CAT6,_RFPSA21,RESP046,"(21.304850435, -157.857749403)"
|
|
2014,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,178,63.9,56.5,71.4,3496,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,15,INCOME4,CAT6,_RFPSA21,RESP054,"(21.304850435, -157.857749403)"
|
|
2014,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,484,38.6,34.7,42.4,3492,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,15,INCOME5,CAT6,_RFPSA21,RESP046,"(21.304850435, -157.857749403)"
|
|
2014,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,614,61.4,57.6,65.3,3497,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,15,INCOME5,CAT6,_RFPSA21,RESP054,"(21.304850435, -157.857749403)"
|
|
2014,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,377,41.8,37.1,46.6,3470,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,15,RACE1,CAT4,_RFPSA21,RESP046,"(21.304850435, -157.857749403)"
|
|
2014,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,450,58.2,53.4,62.9,3475,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,15,RACE1,CAT4,_RFPSA21,RESP054,"(21.304850435, -157.857749403)"
|
|
2014,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,7,,,,3471,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,15,RACE2,CAT4,_RFPSA21,RESP046,"(21.304850435, -157.857749403)"
|
|
2014,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,17,,,,3476,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,15,RACE2,CAT4,_RFPSA21,RESP054,"(21.304850435, -157.857749403)"
|
|
2014,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,40,24.4,16.3,32.5,3472,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,15,RACE3,CAT4,_RFPSA21,RESP046,"(21.304850435, -157.857749403)"
|
|
2014,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,106,75.6,67.5,83.7,3477,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,15,RACE3,CAT4,_RFPSA21,RESP054,"(21.304850435, -157.857749403)"
|
|
2014,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,260,34.7,30.2,39.2,3473,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,15,RACE4,CAT4,_RFPSA21,RESP046,"(21.304850435, -157.857749403)"
|
|
2014,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,454,65.3,60.8,69.8,3478,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,15,RACE4,CAT4,_RFPSA21,RESP054,"(21.304850435, -157.857749403)"
|
|
2014,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,140,28,22.9,33.2,3474,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,15,RACE5,CAT4,_RFPSA21,RESP046,"(21.304850435, -157.857749403)"
|
|
2014,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,320,72,66.8,77.1,3479,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,15,RACE5,CAT4,_RFPSA21,RESP054,"(21.304850435, -157.857749403)"
|
|
2014,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,835,35.4,32.7,38.1,3460,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,15,SEX1,CAT2,_RFPSA21,RESP046,"(21.304850435, -157.857749403)"
|
|
2014,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1360,64.6,61.9,67.3,3461,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,15,SEX1,CAT2,_RFPSA21,RESP054,"(21.304850435, -157.857749403)"
|
|
2014,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,38,13.7,8.5,18.9,3432,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,16,AGE06,CAT3,_RFPSA21,RESP046,"(43.682630005, -114.363730042)"
|
|
2014,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,224,86.3,81.1,91.5,3436,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,16,AGE06,CAT3,_RFPSA21,RESP054,"(43.682630005, -114.363730042)"
|
|
2014,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,154,42.1,35.7,48.5,3433,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,16,AGE07,CAT3,_RFPSA21,RESP046,"(43.682630005, -114.363730042)"
|
|
2014,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,253,57.9,51.5,64.3,3437,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,16,AGE07,CAT3,_RFPSA21,RESP054,"(43.682630005, -114.363730042)"
|
|
2014,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,125,51.8,43.9,59.6,3434,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,16,AGE08,CAT3,_RFPSA21,RESP046,"(43.682630005, -114.363730042)"
|
|
2014,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,128,48.2,40.4,56.1,3438,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,16,AGE08,CAT3,_RFPSA21,RESP054,"(43.682630005, -114.363730042)"
|
|
2014,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,381,59,54.1,63.8,3435,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,16,AGE09,CAT3,_RFPSA21,RESP046,"(43.682630005, -114.363730042)"
|
|
2014,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,289,41.1,36.2,45.9,3439,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,16,AGE09,CAT3,_RFPSA21,RESP054,"(43.682630005, -114.363730042)"
|
|
2014,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,698,41.2,37.9,44.5,3428,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,16,BO1,CAT1,_RFPSA21,RESP046,"(43.682630005, -114.363730042)"
|
|
2014,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,894,58.8,55.5,62.1,3429,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,16,BO1,CAT1,_RFPSA21,RESP054,"(43.682630005, -114.363730042)"
|
|
2014,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,35,27.6,16.9,38.4,3449,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,16,EDUCA1,CAT5,_RFPSA21,RESP046,"(43.682630005, -114.363730042)"
|
|
2014,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,71,72.4,61.6,83.1,3453,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,16,EDUCA1,CAT5,_RFPSA21,RESP054,"(43.682630005, -114.363730042)"
|
|
2014,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,179,38.3,32.6,44,3450,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,16,EDUCA2,CAT5,_RFPSA21,RESP046,"(43.682630005, -114.363730042)"
|
|
2014,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,297,61.7,56,67.4,3454,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,16,EDUCA2,CAT5,_RFPSA21,RESP054,"(43.682630005, -114.363730042)"
|
|
2014,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,178,39.9,33.7,46.2,3451,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,16,EDUCA3,CAT5,_RFPSA21,RESP046,"(43.682630005, -114.363730042)"
|
|
2014,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,255,60.1,53.8,66.3,3455,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,16,EDUCA3,CAT5,_RFPSA21,RESP054,"(43.682630005, -114.363730042)"
|
|
2014,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,305,51.9,46.3,57.6,3452,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,16,EDUCA4,CAT5,_RFPSA21,RESP046,"(43.682630005, -114.363730042)"
|
|
2014,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,270,48.1,42.5,53.7,3456,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,16,EDUCA4,CAT5,_RFPSA21,RESP054,"(43.682630005, -114.363730042)"
|
|
2014,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,37,30.1,19.2,41,3457,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,16,INCOME1,CAT6,_RFPSA21,RESP046,"(43.682630005, -114.363730042)"
|
|
2014,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,87,69.9,59,80.9,3462,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,16,INCOME1,CAT6,_RFPSA21,RESP054,"(43.682630005, -114.363730042)"
|
|
2014,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,77,33.4,24.5,42.3,3458,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,16,INCOME2,CAT6,_RFPSA21,RESP046,"(43.682630005, -114.363730042)"
|
|
2014,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,160,66.6,57.7,75.5,3463,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,16,INCOME2,CAT6,_RFPSA21,RESP054,"(43.682630005, -114.363730042)"
|
|
2014,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,74,35.3,26.7,44,3459,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,16,INCOME3,CAT6,_RFPSA21,RESP046,"(43.682630005, -114.363730042)"
|
|
2014,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,127,64.7,56,73.3,3464,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,16,INCOME3,CAT6,_RFPSA21,RESP054,"(43.682630005, -114.363730042)"
|
|
2014,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,136,49.1,41,57.3,3460,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,16,INCOME4,CAT6,_RFPSA21,RESP046,"(43.682630005, -114.363730042)"
|
|
2014,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,122,50.9,42.8,59.1,3465,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,16,INCOME4,CAT6,_RFPSA21,RESP054,"(43.682630005, -114.363730042)"
|
|
2014,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,333,44.4,39.3,49.5,3461,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,16,INCOME5,CAT6,_RFPSA21,RESP046,"(43.682630005, -114.363730042)"
|
|
2014,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,333,55.6,50.6,60.7,3466,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,16,INCOME5,CAT6,_RFPSA21,RESP054,"(43.682630005, -114.363730042)"
|
|
2014,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,658,42.9,39.5,46.4,3440,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,16,RACE1,CAT4,_RFPSA21,RESP046,"(43.682630005, -114.363730042)"
|
|
2014,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,789,57.1,53.6,60.5,3444,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,16,RACE1,CAT4,_RFPSA21,RESP054,"(43.682630005, -114.363730042)"
|
|
2014,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,4,,,,3445,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,16,RACE2,CAT4,_RFPSA21,RESP054,"(43.682630005, -114.363730042)"
|
|
2014,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,13,,,,3441,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,16,RACE3,CAT4,_RFPSA21,RESP046,"(43.682630005, -114.363730042)"
|
|
2014,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,49,77.3,62.7,91.9,3446,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,16,RACE3,CAT4,_RFPSA21,RESP054,"(43.682630005, -114.363730042)"
|
|
2014,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,7,,,,3442,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,16,RACE4,CAT4,_RFPSA21,RESP046,"(43.682630005, -114.363730042)"
|
|
2014,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,22,,,,3447,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,16,RACE4,CAT4,_RFPSA21,RESP054,"(43.682630005, -114.363730042)"
|
|
2014,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,5,,,,3443,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,16,RACE5,CAT4,_RFPSA21,RESP046,"(43.682630005, -114.363730042)"
|
|
2014,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,12,,,,3448,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,16,RACE5,CAT4,_RFPSA21,RESP054,"(43.682630005, -114.363730042)"
|
|
2014,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,698,41.2,37.9,44.5,3430,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,16,SEX1,CAT2,_RFPSA21,RESP046,"(43.682630005, -114.363730042)"
|
|
2014,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,894,58.8,55.5,62.1,3431,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,16,SEX1,CAT2,_RFPSA21,RESP054,"(43.682630005, -114.363730042)"
|
|
2014,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,40,12.7,8.4,17,3454,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,17,AGE06,CAT3,_RFPSA21,RESP046,"(40.485010283, -88.997710178)"
|
|
2014,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,248,87.3,83,91.6,3458,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,17,AGE06,CAT3,_RFPSA21,RESP054,"(40.485010283, -88.997710178)"
|
|
2014,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,166,42.3,36.1,48.5,3455,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,17,AGE07,CAT3,_RFPSA21,RESP046,"(40.485010283, -88.997710178)"
|
|
2014,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,220,57.7,51.5,63.9,3459,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,17,AGE07,CAT3,_RFPSA21,RESP054,"(40.485010283, -88.997710178)"
|
|
2014,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,109,56.3,47.6,65.1,3456,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,17,AGE08,CAT3,_RFPSA21,RESP046,"(40.485010283, -88.997710178)"
|
|
2014,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,84,43.7,34.9,52.4,3460,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,17,AGE08,CAT3,_RFPSA21,RESP054,"(40.485010283, -88.997710178)"
|
|
2014,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,393,59.9,54.7,65,3457,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,17,AGE09,CAT3,_RFPSA21,RESP046,"(40.485010283, -88.997710178)"
|
|
2014,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,227,40.1,35,45.3,3461,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,17,AGE09,CAT3,_RFPSA21,RESP054,"(40.485010283, -88.997710178)"
|
|
2014,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,708,40.4,37.3,43.6,3450,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,17,BO1,CAT1,_RFPSA21,RESP046,"(40.485010283, -88.997710178)"
|
|
2014,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,779,59.6,56.4,62.8,3451,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,17,BO1,CAT1,_RFPSA21,RESP054,"(40.485010283, -88.997710178)"
|
|
2014,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,24,26.4,15.8,37,3472,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,17,EDUCA1,CAT5,_RFPSA21,RESP046,"(40.485010283, -88.997710178)"
|
|
2014,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,68,73.6,63,84.2,3476,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,17,EDUCA1,CAT5,_RFPSA21,RESP054,"(40.485010283, -88.997710178)"
|
|
2014,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,155,40.2,34,46.3,3473,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,17,EDUCA2,CAT5,_RFPSA21,RESP046,"(40.485010283, -88.997710178)"
|
|
2014,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,196,59.9,53.7,66,3477,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,17,EDUCA2,CAT5,_RFPSA21,RESP054,"(40.485010283, -88.997710178)"
|
|
2014,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,169,44.5,38.3,50.7,3474,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,17,EDUCA3,CAT5,_RFPSA21,RESP046,"(40.485010283, -88.997710178)"
|
|
2014,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,191,55.5,49.3,61.7,3478,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,17,EDUCA3,CAT5,_RFPSA21,RESP054,"(40.485010283, -88.997710178)"
|
|
2014,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,359,42.7,38.3,47.2,3475,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,17,EDUCA4,CAT5,_RFPSA21,RESP046,"(40.485010283, -88.997710178)"
|
|
2014,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,324,57.3,52.8,61.7,3479,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,17,EDUCA4,CAT5,_RFPSA21,RESP054,"(40.485010283, -88.997710178)"
|
|
2014,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,31,30.3,18.2,42.4,3480,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,17,INCOME1,CAT6,_RFPSA21,RESP046,"(40.485010283, -88.997710178)"
|
|
2014,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,62,69.7,57.6,81.8,3485,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,17,INCOME1,CAT6,_RFPSA21,RESP054,"(40.485010283, -88.997710178)"
|
|
2014,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,62,27.6,19.6,35.6,3481,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,17,INCOME2,CAT6,_RFPSA21,RESP046,"(40.485010283, -88.997710178)"
|
|
2014,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,108,72.4,64.4,80.5,3486,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,17,INCOME2,CAT6,_RFPSA21,RESP054,"(40.485010283, -88.997710178)"
|
|
2014,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,46,40.9,29,52.8,3482,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,17,INCOME3,CAT6,_RFPSA21,RESP046,"(40.485010283, -88.997710178)"
|
|
2014,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,58,59.1,47.2,71,3487,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,17,INCOME3,CAT6,_RFPSA21,RESP054,"(40.485010283, -88.997710178)"
|
|
2014,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,102,52.7,43.5,61.9,3483,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,17,INCOME4,CAT6,_RFPSA21,RESP046,"(40.485010283, -88.997710178)"
|
|
2014,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,83,47.3,38.1,56.5,3488,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,17,INCOME4,CAT6,_RFPSA21,RESP054,"(40.485010283, -88.997710178)"
|
|
2014,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,441,42.3,38.2,46.4,3484,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,17,INCOME5,CAT6,_RFPSA21,RESP046,"(40.485010283, -88.997710178)"
|
|
2014,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,427,57.7,53.6,61.8,3489,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,17,INCOME5,CAT6,_RFPSA21,RESP054,"(40.485010283, -88.997710178)"
|
|
2014,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,611,43.5,39.9,47,3462,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,17,RACE1,CAT4,_RFPSA21,RESP046,"(40.485010283, -88.997710178)"
|
|
2014,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,595,56.5,53,60.1,3467,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,17,RACE1,CAT4,_RFPSA21,RESP054,"(40.485010283, -88.997710178)"
|
|
2014,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,56,42.3,31.9,52.7,3463,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,17,RACE2,CAT4,_RFPSA21,RESP046,"(40.485010283, -88.997710178)"
|
|
2014,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,66,57.7,47.4,68.1,3468,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,17,RACE2,CAT4,_RFPSA21,RESP054,"(40.485010283, -88.997710178)"
|
|
2014,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,25,25.8,14.9,36.7,3464,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,17,RACE3,CAT4,_RFPSA21,RESP046,"(40.485010283, -88.997710178)"
|
|
2014,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,70,74.3,63.4,85.2,3469,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,17,RACE3,CAT4,_RFPSA21,RESP054,"(40.485010283, -88.997710178)"
|
|
2014,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,12,,,,3465,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,17,RACE4,CAT4,_RFPSA21,RESP046,"(40.485010283, -88.997710178)"
|
|
2014,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,35,,,,3470,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,17,RACE4,CAT4,_RFPSA21,RESP054,"(40.485010283, -88.997710178)"
|
|
2014,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,1,,,,3466,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,17,RACE5,CAT4,_RFPSA21,RESP046,"(40.485010283, -88.997710178)"
|
|
2014,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,7,,,,3471,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,17,RACE5,CAT4,_RFPSA21,RESP054,"(40.485010283, -88.997710178)"
|
|
2014,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,708,40.4,37.3,43.6,3452,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,17,SEX1,CAT2,_RFPSA21,RESP046,"(40.485010283, -88.997710178)"
|
|
2014,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,779,59.6,56.4,62.8,3453,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,17,SEX1,CAT2,_RFPSA21,RESP054,"(40.485010283, -88.997710178)"
|
|
2014,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,39,73,59.2,86.7,3477,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,18,RACE3,CAT4,_RFPSA21,RESP054,"(39.766910452, -86.149960194)"
|
|
2014,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,102,15.4,12.1,18.8,3462,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,18,AGE06,CAT3,_RFPSA21,RESP046,"(39.766910452, -86.149960194)"
|
|
2014,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,518,84.6,81.2,87.9,3466,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,18,AGE06,CAT3,_RFPSA21,RESP054,"(39.766910452, -86.149960194)"
|
|
2014,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,359,37,33.3,40.8,3463,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,18,AGE07,CAT3,_RFPSA21,RESP046,"(39.766910452, -86.149960194)"
|
|
2014,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,553,63,59.2,66.7,3467,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,18,AGE07,CAT3,_RFPSA21,RESP054,"(39.766910452, -86.149960194)"
|
|
2014,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,278,56.6,51.5,61.8,3464,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,18,AGE08,CAT3,_RFPSA21,RESP046,"(39.766910452, -86.149960194)"
|
|
2014,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,211,43.4,38.3,48.6,3468,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,18,AGE08,CAT3,_RFPSA21,RESP054,"(39.766910452, -86.149960194)"
|
|
2014,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,799,61,57.8,64.3,3465,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,18,AGE09,CAT3,_RFPSA21,RESP046,"(39.766910452, -86.149960194)"
|
|
2014,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,506,39,35.7,42.3,3469,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,18,AGE09,CAT3,_RFPSA21,RESP054,"(39.766910452, -86.149960194)"
|
|
2014,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1538,40.2,38.2,42.2,3458,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,18,BO1,CAT1,_RFPSA21,RESP046,"(39.766910452, -86.149960194)"
|
|
2014,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1788,59.8,57.8,61.9,3459,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,18,BO1,CAT1,_RFPSA21,RESP054,"(39.766910452, -86.149960194)"
|
|
2014,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,85,28.5,21.9,35.1,3480,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,18,EDUCA1,CAT5,_RFPSA21,RESP046,"(39.766910452, -86.149960194)"
|
|
2014,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,165,71.5,64.9,78.1,3484,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,18,EDUCA1,CAT5,_RFPSA21,RESP054,"(39.766910452, -86.149960194)"
|
|
2014,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,464,39.1,35.7,42.5,3481,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,18,EDUCA2,CAT5,_RFPSA21,RESP046,"(39.766910452, -86.149960194)"
|
|
2014,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,633,60.9,57.5,64.3,3485,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,18,EDUCA2,CAT5,_RFPSA21,RESP054,"(39.766910452, -86.149960194)"
|
|
2014,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,358,41.6,37.4,45.7,3482,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,18,EDUCA3,CAT5,_RFPSA21,RESP046,"(39.766910452, -86.149960194)"
|
|
2014,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,417,58.5,54.3,62.6,3486,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,18,EDUCA3,CAT5,_RFPSA21,RESP054,"(39.766910452, -86.149960194)"
|
|
2014,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,628,45.7,42.3,49.1,3483,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,18,EDUCA4,CAT5,_RFPSA21,RESP046,"(39.766910452, -86.149960194)"
|
|
2014,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,569,54.3,50.9,57.7,3487,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,18,EDUCA4,CAT5,_RFPSA21,RESP054,"(39.766910452, -86.149960194)"
|
|
2014,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,77,27.5,20.8,34.3,3488,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,18,INCOME1,CAT6,_RFPSA21,RESP046,"(39.766910452, -86.149960194)"
|
|
2014,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,176,72.5,65.7,79.2,3493,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,18,INCOME1,CAT6,_RFPSA21,RESP054,"(39.766910452, -86.149960194)"
|
|
2014,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,162,33.6,28,39.1,3489,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,18,INCOME2,CAT6,_RFPSA21,RESP046,"(39.766910452, -86.149960194)"
|
|
2014,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,253,66.4,60.9,72,3494,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,18,INCOME2,CAT6,_RFPSA21,RESP054,"(39.766910452, -86.149960194)"
|
|
2014,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,155,40.9,34.5,47.4,3490,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,18,INCOME3,CAT6,_RFPSA21,RESP046,"(39.766910452, -86.149960194)"
|
|
2014,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,178,59.1,52.6,65.6,3495,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,18,INCOME3,CAT6,_RFPSA21,RESP054,"(39.766910452, -86.149960194)"
|
|
2014,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,240,41.1,35.8,46.4,3491,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,18,INCOME4,CAT6,_RFPSA21,RESP046,"(39.766910452, -86.149960194)"
|
|
2014,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,254,58.9,53.6,64.2,3496,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,18,INCOME4,CAT6,_RFPSA21,RESP054,"(39.766910452, -86.149960194)"
|
|
2014,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,751,42.6,39.6,45.6,3492,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,18,INCOME5,CAT6,_RFPSA21,RESP046,"(39.766910452, -86.149960194)"
|
|
2014,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,773,57.4,54.4,60.4,3497,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,18,INCOME5,CAT6,_RFPSA21,RESP054,"(39.766910452, -86.149960194)"
|
|
2014,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1407,40.7,38.6,42.8,3470,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,18,RACE1,CAT4,_RFPSA21,RESP046,"(39.766910452, -86.149960194)"
|
|
2014,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1586,59.3,57.2,61.5,3475,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,18,RACE1,CAT4,_RFPSA21,RESP054,"(39.766910452, -86.149960194)"
|
|
2014,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,58,41.7,31.8,51.6,3471,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,18,RACE2,CAT4,_RFPSA21,RESP046,"(39.766910452, -86.149960194)"
|
|
2014,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,78,58.3,48.4,68.3,3476,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,18,RACE2,CAT4,_RFPSA21,RESP054,"(39.766910452, -86.149960194)"
|
|
2014,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,16,27.1,13.3,40.8,3472,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,18,RACE3,CAT4,_RFPSA21,RESP046,"(39.766910452, -86.149960194)"
|
|
2014,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,17,27.5,13,41.9,3473,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,18,RACE4,CAT4,_RFPSA21,RESP046,"(39.766910452, -86.149960194)"
|
|
2014,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,41,72.5,58.1,87,3478,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,18,RACE4,CAT4,_RFPSA21,RESP054,"(39.766910452, -86.149960194)"
|
|
2014,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,15,,,,3474,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,18,RACE5,CAT4,_RFPSA21,RESP046,"(39.766910452, -86.149960194)"
|
|
2014,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,18,,,,3479,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,18,RACE5,CAT4,_RFPSA21,RESP054,"(39.766910452, -86.149960194)"
|
|
2014,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1538,40.2,38.2,42.2,3460,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,18,SEX1,CAT2,_RFPSA21,RESP046,"(39.766910452, -86.149960194)"
|
|
2014,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1788,59.8,57.8,61.9,3461,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,18,SEX1,CAT2,_RFPSA21,RESP054,"(39.766910452, -86.149960194)"
|
|
2014,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,139,39.8,33.9,45.7,3466,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,19,AGE08,CAT3,_RFPSA21,RESP054,"(42.469400913, -93.816490556)"
|
|
2014,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,55,14.1,10.2,18.1,3460,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,19,AGE06,CAT3,_RFPSA21,RESP046,"(42.469400913, -93.816490556)"
|
|
2014,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,358,85.9,81.9,89.8,3464,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,19,AGE06,CAT3,_RFPSA21,RESP054,"(42.469400913, -93.816490556)"
|
|
2014,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,280,41.6,37.2,46,3461,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,19,AGE07,CAT3,_RFPSA21,RESP046,"(42.469400913, -93.816490556)"
|
|
2014,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,368,58.4,54,62.8,3465,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,19,AGE07,CAT3,_RFPSA21,RESP054,"(42.469400913, -93.816490556)"
|
|
2014,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,221,60.2,54.3,66.1,3462,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,19,AGE08,CAT3,_RFPSA21,RESP046,"(42.469400913, -93.816490556)"
|
|
2014,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,599,63.6,60.1,67.2,3463,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,19,AGE09,CAT3,_RFPSA21,RESP046,"(42.469400913, -93.816490556)"
|
|
2014,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,371,36.4,32.9,40,3467,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,19,AGE09,CAT3,_RFPSA21,RESP054,"(42.469400913, -93.816490556)"
|
|
2014,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1155,43.8,41.4,46.2,3456,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,19,BO1,CAT1,_RFPSA21,RESP046,"(42.469400913, -93.816490556)"
|
|
2014,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1236,56.2,53.8,58.6,3457,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,19,BO1,CAT1,_RFPSA21,RESP054,"(42.469400913, -93.816490556)"
|
|
2014,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,44,27.8,19.2,36.5,3478,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,19,EDUCA1,CAT5,_RFPSA21,RESP046,"(42.469400913, -93.816490556)"
|
|
2014,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,91,72.2,63.6,80.8,3482,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,19,EDUCA1,CAT5,_RFPSA21,RESP054,"(42.469400913, -93.816490556)"
|
|
2014,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,397,42.4,38.6,46.1,3479,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,19,EDUCA2,CAT5,_RFPSA21,RESP046,"(42.469400913, -93.816490556)"
|
|
2014,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,464,57.6,53.9,61.4,3483,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,19,EDUCA2,CAT5,_RFPSA21,RESP054,"(42.469400913, -93.816490556)"
|
|
2014,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,289,46.8,42,51.5,3480,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,19,EDUCA3,CAT5,_RFPSA21,RESP046,"(42.469400913, -93.816490556)"
|
|
2014,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,295,53.2,48.5,58,3484,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,19,EDUCA3,CAT5,_RFPSA21,RESP054,"(42.469400913, -93.816490556)"
|
|
2014,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,425,48.5,44.6,52.5,3481,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,19,EDUCA4,CAT5,_RFPSA21,RESP046,"(42.469400913, -93.816490556)"
|
|
2014,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,386,51.5,47.5,55.4,3485,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,19,EDUCA4,CAT5,_RFPSA21,RESP054,"(42.469400913, -93.816490556)"
|
|
2014,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,29,19.6,11.2,28,3486,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,19,INCOME1,CAT6,_RFPSA21,RESP046,"(42.469400913, -93.816490556)"
|
|
2014,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,87,80.4,72,88.8,3491,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,19,INCOME1,CAT6,_RFPSA21,RESP054,"(42.469400913, -93.816490556)"
|
|
2014,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,109,37.5,30.3,44.8,3487,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,19,INCOME2,CAT6,_RFPSA21,RESP046,"(42.469400913, -93.816490556)"
|
|
2014,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,160,62.5,55.2,69.7,3492,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,19,INCOME2,CAT6,_RFPSA21,RESP054,"(42.469400913, -93.816490556)"
|
|
2014,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,118,41.3,34.1,48.5,3488,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,19,INCOME3,CAT6,_RFPSA21,RESP046,"(42.469400913, -93.816490556)"
|
|
2014,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,132,58.7,51.5,65.9,3493,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,19,INCOME3,CAT6,_RFPSA21,RESP054,"(42.469400913, -93.816490556)"
|
|
2014,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,203,45.9,40.2,51.6,3489,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,19,INCOME4,CAT6,_RFPSA21,RESP046,"(42.469400913, -93.816490556)"
|
|
2014,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,210,54.1,48.5,59.8,3494,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,19,INCOME4,CAT6,_RFPSA21,RESP054,"(42.469400913, -93.816490556)"
|
|
2014,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,599,46.7,43.4,50.1,3490,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,19,INCOME5,CAT6,_RFPSA21,RESP046,"(42.469400913, -93.816490556)"
|
|
2014,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,552,53.3,49.9,56.7,3495,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,19,INCOME5,CAT6,_RFPSA21,RESP054,"(42.469400913, -93.816490556)"
|
|
2014,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1095,44.5,42.1,46.9,3468,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,19,RACE1,CAT4,_RFPSA21,RESP046,"(42.469400913, -93.816490556)"
|
|
2014,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1160,55.5,53.1,57.9,3473,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,19,RACE1,CAT4,_RFPSA21,RESP054,"(42.469400913, -93.816490556)"
|
|
2014,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,15,,,,3469,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,19,RACE2,CAT4,_RFPSA21,RESP046,"(42.469400913, -93.816490556)"
|
|
2014,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,11,,,,3474,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,19,RACE2,CAT4,_RFPSA21,RESP054,"(42.469400913, -93.816490556)"
|
|
2014,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,14,,,,3470,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,19,RACE3,CAT4,_RFPSA21,RESP046,"(42.469400913, -93.816490556)"
|
|
2014,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,29,,,,3475,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,19,RACE3,CAT4,_RFPSA21,RESP054,"(42.469400913, -93.816490556)"
|
|
2014,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,10,,,,3471,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,19,RACE4,CAT4,_RFPSA21,RESP046,"(42.469400913, -93.816490556)"
|
|
2014,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,17,,,,3476,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,19,RACE4,CAT4,_RFPSA21,RESP054,"(42.469400913, -93.816490556)"
|
|
2014,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,9,,,,3472,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,19,RACE5,CAT4,_RFPSA21,RESP046,"(42.469400913, -93.816490556)"
|
|
2014,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,9,,,,3477,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,19,RACE5,CAT4,_RFPSA21,RESP054,"(42.469400913, -93.816490556)"
|
|
2014,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1155,43.8,41.4,46.2,3458,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,19,SEX1,CAT2,_RFPSA21,RESP046,"(42.469400913, -93.816490556)"
|
|
2014,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1236,56.2,53.8,58.6,3459,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,19,SEX1,CAT2,_RFPSA21,RESP054,"(42.469400913, -93.816490556)"
|
|
2014,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,128,16.4,13.4,19.3,3468,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,AGE06,CAT3,_RFPSA21,RESP046,"(38.3477403, -98.200781227)"
|
|
2014,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,611,83.6,80.7,86.6,3472,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,AGE06,CAT3,_RFPSA21,RESP054,"(38.3477403, -98.200781227)"
|
|
2014,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,473,43.6,40.2,46.9,3469,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,AGE07,CAT3,_RFPSA21,RESP046,"(38.3477403, -98.200781227)"
|
|
2014,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,590,56.5,53.1,59.8,3473,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,AGE07,CAT3,_RFPSA21,RESP054,"(38.3477403, -98.200781227)"
|
|
2014,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,362,56.8,52.4,61.3,3470,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,AGE08,CAT3,_RFPSA21,RESP046,"(38.3477403, -98.200781227)"
|
|
2014,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,253,43.2,38.7,47.6,3474,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,AGE08,CAT3,_RFPSA21,RESP054,"(38.3477403, -98.200781227)"
|
|
2014,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,976,66.8,64.1,69.5,3471,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,AGE09,CAT3,_RFPSA21,RESP046,"(38.3477403, -98.200781227)"
|
|
2014,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,468,33.2,30.5,35.9,3475,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,AGE09,CAT3,_RFPSA21,RESP054,"(38.3477403, -98.200781227)"
|
|
2014,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1939,44.8,43,46.6,3464,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,BO1,CAT1,_RFPSA21,RESP046,"(38.3477403, -98.200781227)"
|
|
2014,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1922,55.2,53.4,57,3465,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,BO1,CAT1,_RFPSA21,RESP054,"(38.3477403, -98.200781227)"
|
|
2014,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,57,24.7,18.3,31,3486,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,EDUCA1,CAT5,_RFPSA21,RESP046,"(38.3477403, -98.200781227)"
|
|
2014,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,142,75.3,69,81.7,3490,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,EDUCA1,CAT5,_RFPSA21,RESP054,"(38.3477403, -98.200781227)"
|
|
2014,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,513,43.7,40.4,46.9,3487,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,EDUCA2,CAT5,_RFPSA21,RESP046,"(38.3477403, -98.200781227)"
|
|
2014,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,565,56.3,53.1,59.6,3491,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,EDUCA2,CAT5,_RFPSA21,RESP054,"(38.3477403, -98.200781227)"
|
|
2014,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,524,47.6,44.2,50.9,3488,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,EDUCA3,CAT5,_RFPSA21,RESP046,"(38.3477403, -98.200781227)"
|
|
2014,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,507,52.4,49.1,55.8,3492,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,EDUCA3,CAT5,_RFPSA21,RESP054,"(38.3477403, -98.200781227)"
|
|
2014,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,845,49.6,46.8,52.4,3489,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,EDUCA4,CAT5,_RFPSA21,RESP046,"(38.3477403, -98.200781227)"
|
|
2014,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,705,50.4,47.6,53.2,3493,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,EDUCA4,CAT5,_RFPSA21,RESP054,"(38.3477403, -98.200781227)"
|
|
2014,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,54,19.9,13.8,25.9,3494,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,INCOME1,CAT6,_RFPSA21,RESP046,"(38.3477403, -98.200781227)"
|
|
2014,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,150,80.1,74.1,86.2,3499,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,INCOME1,CAT6,_RFPSA21,RESP054,"(38.3477403, -98.200781227)"
|
|
2014,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,165,32.8,27.6,37.9,3495,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,INCOME2,CAT6,_RFPSA21,RESP046,"(38.3477403, -98.200781227)"
|
|
2014,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,249,67.2,62.1,72.4,3500,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,INCOME2,CAT6,_RFPSA21,RESP054,"(38.3477403, -98.200781227)"
|
|
2014,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,181,44.9,39.1,50.7,3496,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,INCOME3,CAT6,_RFPSA21,RESP046,"(38.3477403, -98.200781227)"
|
|
2014,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,174,55.1,49.3,60.9,3501,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,INCOME3,CAT6,_RFPSA21,RESP054,"(38.3477403, -98.200781227)"
|
|
2014,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,315,48.8,44.1,53.4,3497,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,INCOME4,CAT6,_RFPSA21,RESP046,"(38.3477403, -98.200781227)"
|
|
2014,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,262,51.2,46.6,55.9,3502,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,INCOME4,CAT6,_RFPSA21,RESP054,"(38.3477403, -98.200781227)"
|
|
2014,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,1043,49.1,46.6,51.7,3498,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,INCOME5,CAT6,_RFPSA21,RESP046,"(38.3477403, -98.200781227)"
|
|
2014,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,891,50.9,48.4,53.5,3503,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,INCOME5,CAT6,_RFPSA21,RESP054,"(38.3477403, -98.200781227)"
|
|
2014,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1750,46.7,44.8,48.6,3476,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,RACE1,CAT4,_RFPSA21,RESP046,"(38.3477403, -98.200781227)"
|
|
2014,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1650,53.3,51.4,55.2,3481,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,RACE1,CAT4,_RFPSA21,RESP054,"(38.3477403, -98.200781227)"
|
|
2014,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,55,43.7,33.5,53.8,3477,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,RACE2,CAT4,_RFPSA21,RESP046,"(38.3477403, -98.200781227)"
|
|
2014,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,67,56.3,46.2,66.5,3482,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,RACE2,CAT4,_RFPSA21,RESP054,"(38.3477403, -98.200781227)"
|
|
2014,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,41,22.9,15.6,30.3,3478,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,RACE3,CAT4,_RFPSA21,RESP046,"(38.3477403, -98.200781227)"
|
|
2014,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,97,77.1,69.7,84.5,3483,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,RACE3,CAT4,_RFPSA21,RESP054,"(38.3477403, -98.200781227)"
|
|
2014,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,35,39.2,26.9,51.6,3479,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,RACE4,CAT4,_RFPSA21,RESP046,"(38.3477403, -98.200781227)"
|
|
2014,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,44,60.8,48.4,73.1,3484,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,RACE4,CAT4,_RFPSA21,RESP054,"(38.3477403, -98.200781227)"
|
|
2014,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,33,38.8,26.5,51,3480,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,RACE5,CAT4,_RFPSA21,RESP046,"(38.3477403, -98.200781227)"
|
|
2014,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,38,61.2,49,73.5,3485,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,RACE5,CAT4,_RFPSA21,RESP054,"(38.3477403, -98.200781227)"
|
|
2014,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1939,44.8,43,46.6,3466,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,SEX1,CAT2,_RFPSA21,RESP046,"(38.3477403, -98.200781227)"
|
|
2014,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1922,55.2,53.4,57,3467,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,20,SEX1,CAT2,_RFPSA21,RESP054,"(38.3477403, -98.200781227)"
|
|
2014,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1345,56.5,53.7,59.2,3459,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,21,BO1,CAT1,_RFPSA21,RESP054,"(37.645970271, -84.774971048)"
|
|
2014,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,87,16.8,12,21.7,3462,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,21,AGE06,CAT3,_RFPSA21,RESP046,"(37.645970271, -84.774971048)"
|
|
2014,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,405,83.2,78.4,88,3466,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,21,AGE06,CAT3,_RFPSA21,RESP054,"(37.645970271, -84.774971048)"
|
|
2014,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,345,40.4,35.5,45.4,3463,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,21,AGE07,CAT3,_RFPSA21,RESP046,"(37.645970271, -84.774971048)"
|
|
2014,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,414,59.6,54.6,64.5,3467,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,21,AGE07,CAT3,_RFPSA21,RESP054,"(37.645970271, -84.774971048)"
|
|
2014,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,264,59.5,52.8,66.2,3464,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,21,AGE08,CAT3,_RFPSA21,RESP046,"(37.645970271, -84.774971048)"
|
|
2014,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,179,40.5,33.8,47.2,3468,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,21,AGE08,CAT3,_RFPSA21,RESP054,"(37.645970271, -84.774971048)"
|
|
2014,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,713,66,61.6,70.3,3465,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,21,AGE09,CAT3,_RFPSA21,RESP046,"(37.645970271, -84.774971048)"
|
|
2014,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,347,34,29.7,38.4,3469,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,21,AGE09,CAT3,_RFPSA21,RESP054,"(37.645970271, -84.774971048)"
|
|
2014,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1409,43.5,40.8,46.3,3458,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,21,BO1,CAT1,_RFPSA21,RESP046,"(37.645970271, -84.774971048)"
|
|
2014,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,95,27.8,20.6,34.9,3480,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,21,EDUCA1,CAT5,_RFPSA21,RESP046,"(37.645970271, -84.774971048)"
|
|
2014,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,216,72.3,65.1,79.4,3484,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,21,EDUCA1,CAT5,_RFPSA21,RESP054,"(37.645970271, -84.774971048)"
|
|
2014,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,432,42.9,38.5,47.4,3481,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,21,EDUCA2,CAT5,_RFPSA21,RESP046,"(37.645970271, -84.774971048)"
|
|
2014,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,474,57.1,52.6,61.5,3485,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,21,EDUCA2,CAT5,_RFPSA21,RESP054,"(37.645970271, -84.774971048)"
|
|
2014,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,384,49.5,44,54.9,3482,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,21,EDUCA3,CAT5,_RFPSA21,RESP046,"(37.645970271, -84.774971048)"
|
|
2014,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,299,50.5,45.1,56,3486,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,21,EDUCA3,CAT5,_RFPSA21,RESP054,"(37.645970271, -84.774971048)"
|
|
2014,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,495,52.9,48.2,57.7,3483,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,21,EDUCA4,CAT5,_RFPSA21,RESP046,"(37.645970271, -84.774971048)"
|
|
2014,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,355,47.1,42.3,51.8,3487,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,21,EDUCA4,CAT5,_RFPSA21,RESP054,"(37.645970271, -84.774971048)"
|
|
2014,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,90,23.2,16.6,29.9,3488,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,21,INCOME1,CAT6,_RFPSA21,RESP046,"(37.645970271, -84.774971048)"
|
|
2014,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,191,76.8,70.2,83.4,3493,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,21,INCOME1,CAT6,_RFPSA21,RESP054,"(37.645970271, -84.774971048)"
|
|
2014,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,165,33.3,26.7,40,3489,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,21,INCOME2,CAT6,_RFPSA21,RESP046,"(37.645970271, -84.774971048)"
|
|
2014,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,235,66.7,60,73.3,3494,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,21,INCOME2,CAT6,_RFPSA21,RESP054,"(37.645970271, -84.774971048)"
|
|
2014,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,155,45.8,37,54.5,3490,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,21,INCOME3,CAT6,_RFPSA21,RESP046,"(37.645970271, -84.774971048)"
|
|
2014,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,149,54.2,45.5,63,3495,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,21,INCOME3,CAT6,_RFPSA21,RESP054,"(37.645970271, -84.774971048)"
|
|
2014,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,208,46.2,38.8,53.6,3491,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,21,INCOME4,CAT6,_RFPSA21,RESP046,"(37.645970271, -84.774971048)"
|
|
2014,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,180,53.8,46.4,61.2,3496,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,21,INCOME4,CAT6,_RFPSA21,RESP054,"(37.645970271, -84.774971048)"
|
|
2014,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,639,52.8,48.6,57,3492,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,21,INCOME5,CAT6,_RFPSA21,RESP046,"(37.645970271, -84.774971048)"
|
|
2014,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,442,47.2,43,51.4,3497,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,21,INCOME5,CAT6,_RFPSA21,RESP054,"(37.645970271, -84.774971048)"
|
|
2014,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1239,43.7,40.9,46.5,3470,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,21,RACE1,CAT4,_RFPSA21,RESP046,"(37.645970271, -84.774971048)"
|
|
2014,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1190,56.3,53.5,59.1,3475,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,21,RACE1,CAT4,_RFPSA21,RESP054,"(37.645970271, -84.774971048)"
|
|
2014,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,103,38.5,25.2,51.9,3471,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,21,RACE2,CAT4,_RFPSA21,RESP046,"(37.645970271, -84.774971048)"
|
|
2014,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,93,61.5,48.1,74.9,3476,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,21,RACE2,CAT4,_RFPSA21,RESP054,"(37.645970271, -84.774971048)"
|
|
2014,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,9,,,,3472,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,21,RACE3,CAT4,_RFPSA21,RESP046,"(37.645970271, -84.774971048)"
|
|
2014,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,11,,,,3477,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,21,RACE3,CAT4,_RFPSA21,RESP054,"(37.645970271, -84.774971048)"
|
|
2014,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,21,,,,3473,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,21,RACE4,CAT4,_RFPSA21,RESP046,"(37.645970271, -84.774971048)"
|
|
2014,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,21,,,,3478,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,21,RACE4,CAT4,_RFPSA21,RESP054,"(37.645970271, -84.774971048)"
|
|
2014,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,26,,,,3474,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,21,RACE5,CAT4,_RFPSA21,RESP046,"(37.645970271, -84.774971048)"
|
|
2014,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,20,,,,3479,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,21,RACE5,CAT4,_RFPSA21,RESP054,"(37.645970271, -84.774971048)"
|
|
2014,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1409,43.5,40.8,46.3,3460,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,21,SEX1,CAT2,_RFPSA21,RESP046,"(37.645970271, -84.774971048)"
|
|
2014,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1345,56.5,53.7,59.2,3461,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,21,SEX1,CAT2,_RFPSA21,RESP054,"(37.645970271, -84.774971048)"
|
|
2014,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,97,27.4,22.1,32.7,3462,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,22,AGE06,CAT3,_RFPSA21,RESP046,"(31.312660644, -92.445680071)"
|
|
2014,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,239,72.6,67.3,77.9,3466,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,22,AGE06,CAT3,_RFPSA21,RESP054,"(31.312660644, -92.445680071)"
|
|
2014,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,218,44.6,39.5,49.7,3463,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,22,AGE07,CAT3,_RFPSA21,RESP046,"(31.312660644, -92.445680071)"
|
|
2014,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,247,55.4,50.3,60.5,3467,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,22,AGE07,CAT3,_RFPSA21,RESP054,"(31.312660644, -92.445680071)"
|
|
2014,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,157,59.5,52.8,66.3,3464,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,22,AGE08,CAT3,_RFPSA21,RESP046,"(31.312660644, -92.445680071)"
|
|
2014,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,97,40.5,33.7,47.2,3468,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,22,AGE08,CAT3,_RFPSA21,RESP054,"(31.312660644, -92.445680071)"
|
|
2014,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,496,75,71.2,78.9,3465,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,22,AGE09,CAT3,_RFPSA21,RESP046,"(31.312660644, -92.445680071)"
|
|
2014,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,162,25,21.1,28.8,3469,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,22,AGE09,CAT3,_RFPSA21,RESP054,"(31.312660644, -92.445680071)"
|
|
2014,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,968,50.2,47.4,52.9,3458,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,22,BO1,CAT1,_RFPSA21,RESP046,"(31.312660644, -92.445680071)"
|
|
2014,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,745,49.9,47.1,52.6,3459,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,22,BO1,CAT1,_RFPSA21,RESP054,"(31.312660644, -92.445680071)"
|
|
2014,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,81,31.3,24.6,38.1,3480,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,22,EDUCA1,CAT5,_RFPSA21,RESP046,"(31.312660644, -92.445680071)"
|
|
2014,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,140,68.7,61.9,75.4,3484,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,22,EDUCA1,CAT5,_RFPSA21,RESP054,"(31.312660644, -92.445680071)"
|
|
2014,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,261,47.5,42.7,52.3,3481,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,22,EDUCA2,CAT5,_RFPSA21,RESP046,"(31.312660644, -92.445680071)"
|
|
2014,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,258,52.5,47.7,57.3,3485,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,22,EDUCA2,CAT5,_RFPSA21,RESP054,"(31.312660644, -92.445680071)"
|
|
2014,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,250,56,50.7,61.4,3482,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,22,EDUCA3,CAT5,_RFPSA21,RESP046,"(31.312660644, -92.445680071)"
|
|
2014,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,182,44,38.6,49.3,3486,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,22,EDUCA3,CAT5,_RFPSA21,RESP054,"(31.312660644, -92.445680071)"
|
|
2014,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,375,65.3,60.6,70,3483,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,22,EDUCA4,CAT5,_RFPSA21,RESP046,"(31.312660644, -92.445680071)"
|
|
2014,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,165,34.7,30,39.5,3487,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,22,EDUCA4,CAT5,_RFPSA21,RESP054,"(31.312660644, -92.445680071)"
|
|
2014,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,48,26.1,18.2,34.1,3488,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,22,INCOME1,CAT6,_RFPSA21,RESP046,"(31.312660644, -92.445680071)"
|
|
2014,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,103,73.9,65.9,81.8,3493,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,22,INCOME1,CAT6,_RFPSA21,RESP054,"(31.312660644, -92.445680071)"
|
|
2014,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,126,42.3,35.2,49.4,3489,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,22,INCOME2,CAT6,_RFPSA21,RESP046,"(31.312660644, -92.445680071)"
|
|
2014,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,131,57.7,50.6,64.8,3494,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,22,INCOME2,CAT6,_RFPSA21,RESP054,"(31.312660644, -92.445680071)"
|
|
2014,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,84,49.7,40.4,59.1,3490,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,22,INCOME3,CAT6,_RFPSA21,RESP046,"(31.312660644, -92.445680071)"
|
|
2014,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,63,50.3,40.9,59.6,3495,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,22,INCOME3,CAT6,_RFPSA21,RESP054,"(31.312660644, -92.445680071)"
|
|
2014,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,122,54.6,46.4,62.8,3491,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,22,INCOME4,CAT6,_RFPSA21,RESP046,"(31.312660644, -92.445680071)"
|
|
2014,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,87,45.4,37.2,53.7,3496,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,22,INCOME4,CAT6,_RFPSA21,RESP054,"(31.312660644, -92.445680071)"
|
|
2014,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,473,55.9,51.7,60.1,3492,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,22,INCOME5,CAT6,_RFPSA21,RESP046,"(31.312660644, -92.445680071)"
|
|
2014,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,285,44.1,40,48.3,3497,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,22,INCOME5,CAT6,_RFPSA21,RESP054,"(31.312660644, -92.445680071)"
|
|
2014,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,742,53.6,50.3,56.9,3470,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,22,RACE1,CAT4,_RFPSA21,RESP046,"(31.312660644, -92.445680071)"
|
|
2014,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,499,46.4,43.1,49.7,3475,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,22,RACE1,CAT4,_RFPSA21,RESP054,"(31.312660644, -92.445680071)"
|
|
2014,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,169,41.6,36,47.2,3471,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,22,RACE2,CAT4,_RFPSA21,RESP046,"(31.312660644, -92.445680071)"
|
|
2014,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,199,58.4,52.8,64,3476,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,22,RACE2,CAT4,_RFPSA21,RESP054,"(31.312660644, -92.445680071)"
|
|
2014,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,16,,,,3472,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,22,RACE3,CAT4,_RFPSA21,RESP046,"(31.312660644, -92.445680071)"
|
|
2014,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,15,,,,3477,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,22,RACE3,CAT4,_RFPSA21,RESP054,"(31.312660644, -92.445680071)"
|
|
2014,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,17,,,,3473,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,22,RACE4,CAT4,_RFPSA21,RESP046,"(31.312660644, -92.445680071)"
|
|
2014,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,19,,,,3478,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,22,RACE4,CAT4,_RFPSA21,RESP054,"(31.312660644, -92.445680071)"
|
|
2014,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,9,,,,3474,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,22,RACE5,CAT4,_RFPSA21,RESP046,"(31.312660644, -92.445680071)"
|
|
2014,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,7,,,,3479,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,22,RACE5,CAT4,_RFPSA21,RESP054,"(31.312660644, -92.445680071)"
|
|
2014,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,968,50.2,47.4,52.9,3460,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,22,SEX1,CAT2,_RFPSA21,RESP046,"(31.312660644, -92.445680071)"
|
|
2014,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,745,49.9,47.1,52.6,3461,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,22,SEX1,CAT2,_RFPSA21,RESP054,"(31.312660644, -92.445680071)"
|
|
2014,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,521,71.4,67.5,75.4,3447,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,23,AGE07,CAT3,_RFPSA21,RESP054,"(45.254228894001, -68.985031336)"
|
|
2014,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,47,10.2,6.8,13.6,3442,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,23,AGE06,CAT3,_RFPSA21,RESP046,"(45.254228894001, -68.985031336)"
|
|
2014,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,410,89.8,86.4,93.2,3446,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,23,AGE06,CAT3,_RFPSA21,RESP054,"(45.254228894001, -68.985031336)"
|
|
2014,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,239,28.6,24.6,32.5,3443,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,23,AGE07,CAT3,_RFPSA21,RESP046,"(45.254228894001, -68.985031336)"
|
|
2014,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,195,43.6,37.8,49.3,3444,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,23,AGE08,CAT3,_RFPSA21,RESP046,"(45.254228894001, -68.985031336)"
|
|
2014,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,231,56.4,50.7,62.2,3448,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,23,AGE08,CAT3,_RFPSA21,RESP054,"(45.254228894001, -68.985031336)"
|
|
2014,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,632,54.4,50.8,58,3445,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,23,AGE09,CAT3,_RFPSA21,RESP046,"(45.254228894001, -68.985031336)"
|
|
2014,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,541,45.6,42,49.2,3449,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,23,AGE09,CAT3,_RFPSA21,RESP054,"(45.254228894001, -68.985031336)"
|
|
2014,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1113,34.3,32.1,36.4,3438,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,23,BO1,CAT1,_RFPSA21,RESP046,"(45.254228894001, -68.985031336)"
|
|
2014,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1703,65.7,63.6,67.9,3439,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,23,BO1,CAT1,_RFPSA21,RESP054,"(45.254228894001, -68.985031336)"
|
|
2014,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,38,20.2,12.8,27.5,3460,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,23,EDUCA1,CAT5,_RFPSA21,RESP046,"(45.254228894001, -68.985031336)"
|
|
2014,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,125,79.8,72.5,87.2,3464,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,23,EDUCA1,CAT5,_RFPSA21,RESP054,"(45.254228894001, -68.985031336)"
|
|
2014,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,256,29.1,25.4,32.7,3461,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,23,EDUCA2,CAT5,_RFPSA21,RESP046,"(45.254228894001, -68.985031336)"
|
|
2014,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,547,70.9,67.3,74.6,3465,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,23,EDUCA2,CAT5,_RFPSA21,RESP054,"(45.254228894001, -68.985031336)"
|
|
2014,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,263,36.1,31.7,40.4,3462,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,23,EDUCA3,CAT5,_RFPSA21,RESP046,"(45.254228894001, -68.985031336)"
|
|
2014,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,392,63.9,59.6,68.3,3466,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,23,EDUCA3,CAT5,_RFPSA21,RESP054,"(45.254228894001, -68.985031336)"
|
|
2014,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,554,44.2,40.8,47.5,3463,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,23,EDUCA4,CAT5,_RFPSA21,RESP046,"(45.254228894001, -68.985031336)"
|
|
2014,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,636,55.9,52.5,59.2,3467,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,23,EDUCA4,CAT5,_RFPSA21,RESP054,"(45.254228894001, -68.985031336)"
|
|
2014,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,63,21,14.4,27.6,3468,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,23,INCOME1,CAT6,_RFPSA21,RESP046,"(45.254228894001, -68.985031336)"
|
|
2014,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,195,79,72.4,85.6,3473,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,23,INCOME1,CAT6,_RFPSA21,RESP054,"(45.254228894001, -68.985031336)"
|
|
2014,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,135,31.8,26.1,37.4,3469,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,23,INCOME2,CAT6,_RFPSA21,RESP046,"(45.254228894001, -68.985031336)"
|
|
2014,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,248,68.2,62.6,73.9,3474,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,23,INCOME2,CAT6,_RFPSA21,RESP054,"(45.254228894001, -68.985031336)"
|
|
2014,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,101,31.9,25.2,38.6,3470,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,23,INCOME3,CAT6,_RFPSA21,RESP046,"(45.254228894001, -68.985031336)"
|
|
2014,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,179,68.1,61.4,74.8,3475,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,23,INCOME3,CAT6,_RFPSA21,RESP054,"(45.254228894001, -68.985031336)"
|
|
2014,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,165,33.1,27.5,38.8,3471,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,23,INCOME4,CAT6,_RFPSA21,RESP046,"(45.254228894001, -68.985031336)"
|
|
2014,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,257,66.9,61.2,72.5,3476,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,23,INCOME4,CAT6,_RFPSA21,RESP054,"(45.254228894001, -68.985031336)"
|
|
2014,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,560,37.1,33.8,40.3,3472,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,23,INCOME5,CAT6,_RFPSA21,RESP046,"(45.254228894001, -68.985031336)"
|
|
2014,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,711,62.9,59.7,66.2,3477,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,23,INCOME5,CAT6,_RFPSA21,RESP054,"(45.254228894001, -68.985031336)"
|
|
2014,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1067,35,32.8,37.2,3450,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,23,RACE1,CAT4,_RFPSA21,RESP046,"(45.254228894001, -68.985031336)"
|
|
2014,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1594,65,62.8,67.2,3455,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,23,RACE1,CAT4,_RFPSA21,RESP054,"(45.254228894001, -68.985031336)"
|
|
2014,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,2,,,,3451,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,23,RACE2,CAT4,_RFPSA21,RESP046,"(45.254228894001, -68.985031336)"
|
|
2014,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,8,,,,3456,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,23,RACE2,CAT4,_RFPSA21,RESP054,"(45.254228894001, -68.985031336)"
|
|
2014,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,2,,,,3452,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,23,RACE3,CAT4,_RFPSA21,RESP046,"(45.254228894001, -68.985031336)"
|
|
2014,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,11,,,,3457,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,23,RACE3,CAT4,_RFPSA21,RESP054,"(45.254228894001, -68.985031336)"
|
|
2014,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,12,,,,3453,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,23,RACE4,CAT4,_RFPSA21,RESP046,"(45.254228894001, -68.985031336)"
|
|
2014,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,38,78.8,66.1,91.6,3458,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,23,RACE4,CAT4,_RFPSA21,RESP054,"(45.254228894001, -68.985031336)"
|
|
2014,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,7,,,,3454,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,23,RACE5,CAT4,_RFPSA21,RESP046,"(45.254228894001, -68.985031336)"
|
|
2014,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,17,,,,3459,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,23,RACE5,CAT4,_RFPSA21,RESP054,"(45.254228894001, -68.985031336)"
|
|
2014,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1113,34.3,32.1,36.4,3440,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,23,SEX1,CAT2,_RFPSA21,RESP046,"(45.254228894001, -68.985031336)"
|
|
2014,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1703,65.7,63.6,67.9,3441,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,23,SEX1,CAT2,_RFPSA21,RESP054,"(45.254228894001, -68.985031336)"
|
|
2014,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,129,18.9,14.7,23.1,3467,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,AGE06,CAT3,_RFPSA21,RESP046,"(39.290580964, -76.609260111)"
|
|
2014,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,461,81.1,76.9,85.3,3471,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,AGE06,CAT3,_RFPSA21,RESP054,"(39.290580964, -76.609260111)"
|
|
2014,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,451,46.3,41.3,51.3,3468,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,AGE07,CAT3,_RFPSA21,RESP046,"(39.290580964, -76.609260111)"
|
|
2014,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,485,53.7,48.7,58.8,3472,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,AGE07,CAT3,_RFPSA21,RESP054,"(39.290580964, -76.609260111)"
|
|
2014,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,321,59.9,53,66.7,3469,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,AGE08,CAT3,_RFPSA21,RESP046,"(39.290580964, -76.609260111)"
|
|
2014,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,182,40.1,33.3,47,3473,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,AGE08,CAT3,_RFPSA21,RESP054,"(39.290580964, -76.609260111)"
|
|
2014,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,1080,71.4,67.4,75.4,3470,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,AGE09,CAT3,_RFPSA21,RESP046,"(39.290580964, -76.609260111)"
|
|
2014,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,490,28.6,24.6,32.6,3474,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,AGE09,CAT3,_RFPSA21,RESP054,"(39.290580964, -76.609260111)"
|
|
2014,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1981,46.9,44.2,49.6,3463,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,BO1,CAT1,_RFPSA21,RESP046,"(39.290580964, -76.609260111)"
|
|
2014,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1618,53.1,50.4,55.8,3464,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,BO1,CAT1,_RFPSA21,RESP054,"(39.290580964, -76.609260111)"
|
|
2014,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,91,35.1,25,45.3,3485,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,EDUCA1,CAT5,_RFPSA21,RESP046,"(39.290580964, -76.609260111)"
|
|
2014,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,112,64.9,54.7,75,3489,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,EDUCA1,CAT5,_RFPSA21,RESP054,"(39.290580964, -76.609260111)"
|
|
2014,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,432,44.7,39.4,50.1,3486,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,EDUCA2,CAT5,_RFPSA21,RESP046,"(39.290580964, -76.609260111)"
|
|
2014,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,438,55.3,49.9,60.6,3490,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,EDUCA2,CAT5,_RFPSA21,RESP054,"(39.290580964, -76.609260111)"
|
|
2014,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,370,41.8,36.4,47.3,3487,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,EDUCA3,CAT5,_RFPSA21,RESP046,"(39.290580964, -76.609260111)"
|
|
2014,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,354,58.2,52.7,63.6,3491,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,EDUCA3,CAT5,_RFPSA21,RESP054,"(39.290580964, -76.609260111)"
|
|
2014,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,1082,56.1,52.8,59.3,3488,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,EDUCA4,CAT5,_RFPSA21,RESP046,"(39.290580964, -76.609260111)"
|
|
2014,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,710,44,40.7,47.2,3492,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,EDUCA4,CAT5,_RFPSA21,RESP054,"(39.290580964, -76.609260111)"
|
|
2014,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,52,35.3,20.7,49.9,3493,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,INCOME1,CAT6,_RFPSA21,RESP046,"(39.290580964, -76.609260111)"
|
|
2014,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,85,64.7,50.1,79.3,3498,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,INCOME1,CAT6,_RFPSA21,RESP054,"(39.290580964, -76.609260111)"
|
|
2014,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,165,39.5,30.1,48.8,3494,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,INCOME2,CAT6,_RFPSA21,RESP046,"(39.290580964, -76.609260111)"
|
|
2014,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,181,60.5,51.2,69.9,3499,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,INCOME2,CAT6,_RFPSA21,RESP054,"(39.290580964, -76.609260111)"
|
|
2014,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,117,40.1,30.3,49.9,3495,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,INCOME3,CAT6,_RFPSA21,RESP046,"(39.290580964, -76.609260111)"
|
|
2014,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,133,60,50.2,69.8,3500,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,INCOME3,CAT6,_RFPSA21,RESP054,"(39.290580964, -76.609260111)"
|
|
2014,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,197,48.9,39.3,58.5,3496,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,INCOME4,CAT6,_RFPSA21,RESP046,"(39.290580964, -76.609260111)"
|
|
2014,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,152,51.1,41.5,60.7,3501,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,INCOME4,CAT6,_RFPSA21,RESP054,"(39.290580964, -76.609260111)"
|
|
2014,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,1190,48.8,45.4,52.2,3497,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,INCOME5,CAT6,_RFPSA21,RESP046,"(39.290580964, -76.609260111)"
|
|
2014,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,895,51.2,47.8,54.7,3502,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,INCOME5,CAT6,_RFPSA21,RESP054,"(39.290580964, -76.609260111)"
|
|
2014,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1508,50,47.1,52.9,3475,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,RACE1,CAT4,_RFPSA21,RESP046,"(39.290580964, -76.609260111)"
|
|
2014,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1199,50,47.1,52.9,3480,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,RACE1,CAT4,_RFPSA21,RESP054,"(39.290580964, -76.609260111)"
|
|
2014,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,328,47.6,41,54.1,3476,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,RACE2,CAT4,_RFPSA21,RESP046,"(39.290580964, -76.609260111)"
|
|
2014,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,240,52.4,45.9,59,3481,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,RACE2,CAT4,_RFPSA21,RESP054,"(39.290580964, -76.609260111)"
|
|
2014,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,30,20,9.4,30.6,3477,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,RACE3,CAT4,_RFPSA21,RESP046,"(39.290580964, -76.609260111)"
|
|
2014,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,55,80,69.4,90.6,3482,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,RACE3,CAT4,_RFPSA21,RESP054,"(39.290580964, -76.609260111)"
|
|
2014,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,52,41.5,28.6,54.4,3478,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,RACE4,CAT4,_RFPSA21,RESP046,"(39.290580964, -76.609260111)"
|
|
2014,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,70,58.5,45.6,71.4,3483,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,RACE4,CAT4,_RFPSA21,RESP054,"(39.290580964, -76.609260111)"
|
|
2014,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,23,,,,3479,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,24,RACE5,CAT4,_RFPSA21,RESP046,"(39.290580964, -76.609260111)"
|
|
2014,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,20,,,,3484,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,24,RACE5,CAT4,_RFPSA21,RESP054,"(39.290580964, -76.609260111)"
|
|
2014,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1981,46.9,44.2,49.6,3465,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,SEX1,CAT2,_RFPSA21,RESP046,"(39.290580964, -76.609260111)"
|
|
2014,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1618,53.1,50.4,55.8,3466,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,24,SEX1,CAT2,_RFPSA21,RESP054,"(39.290580964, -76.609260111)"
|
|
2014,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,102,12.9,9.9,15.9,3466,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,AGE06,CAT3,_RFPSA21,RESP046,"(42.27687047, -72.082690675)"
|
|
2014,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,583,87.1,84.1,90.2,3470,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,AGE06,CAT3,_RFPSA21,RESP054,"(42.27687047, -72.082690675)"
|
|
2014,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,422,38.6,34.4,42.7,3467,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,AGE07,CAT3,_RFPSA21,RESP046,"(42.27687047, -72.082690675)"
|
|
2014,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,661,61.4,57.3,65.6,3471,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,AGE07,CAT3,_RFPSA21,RESP054,"(42.27687047, -72.082690675)"
|
|
2014,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,349,56,50.5,61.5,3468,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,AGE08,CAT3,_RFPSA21,RESP046,"(42.27687047, -72.082690675)"
|
|
2014,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,266,44,38.5,49.5,3472,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,AGE08,CAT3,_RFPSA21,RESP054,"(42.27687047, -72.082690675)"
|
|
2014,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,1025,59.2,55.6,62.8,3469,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,AGE09,CAT3,_RFPSA21,RESP046,"(42.27687047, -72.082690675)"
|
|
2014,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,692,40.8,37.3,44.4,3473,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,AGE09,CAT3,_RFPSA21,RESP054,"(42.27687047, -72.082690675)"
|
|
2014,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1898,39.8,37.6,41.9,3462,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,BO1,CAT1,_RFPSA21,RESP046,"(42.27687047, -72.082690675)"
|
|
2014,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,2202,60.2,58.1,62.4,3463,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,BO1,CAT1,_RFPSA21,RESP054,"(42.27687047, -72.082690675)"
|
|
2014,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,82,27.7,20,35.5,3484,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,EDUCA1,CAT5,_RFPSA21,RESP046,"(42.27687047, -72.082690675)"
|
|
2014,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,172,72.3,64.5,80.1,3488,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,EDUCA1,CAT5,_RFPSA21,RESP054,"(42.27687047, -72.082690675)"
|
|
2014,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,369,39.7,35.2,44.2,3485,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,EDUCA2,CAT5,_RFPSA21,RESP046,"(42.27687047, -72.082690675)"
|
|
2014,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,526,60.3,55.8,64.8,3489,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,EDUCA2,CAT5,_RFPSA21,RESP054,"(42.27687047, -72.082690675)"
|
|
2014,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,412,40.2,35.7,44.7,3486,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,EDUCA3,CAT5,_RFPSA21,RESP046,"(42.27687047, -72.082690675)"
|
|
2014,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,472,59.8,55.3,64.3,3490,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,EDUCA3,CAT5,_RFPSA21,RESP054,"(42.27687047, -72.082690675)"
|
|
2014,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,1034,43.7,40.9,46.5,3487,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,EDUCA4,CAT5,_RFPSA21,RESP046,"(42.27687047, -72.082690675)"
|
|
2014,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,1024,56.3,53.5,59.1,3491,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,EDUCA4,CAT5,_RFPSA21,RESP054,"(42.27687047, -72.082690675)"
|
|
2014,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,76,27.1,18.6,35.6,3492,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,INCOME1,CAT6,_RFPSA21,RESP046,"(42.27687047, -72.082690675)"
|
|
2014,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,168,72.9,64.4,81.4,3497,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,INCOME1,CAT6,_RFPSA21,RESP054,"(42.27687047, -72.082690675)"
|
|
2014,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,223,35.3,28.3,42.3,3493,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,INCOME2,CAT6,_RFPSA21,RESP046,"(42.27687047, -72.082690675)"
|
|
2014,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,316,64.7,57.8,71.7,3498,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,INCOME2,CAT6,_RFPSA21,RESP054,"(42.27687047, -72.082690675)"
|
|
2014,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,150,41.7,33.5,50,3494,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,INCOME3,CAT6,_RFPSA21,RESP046,"(42.27687047, -72.082690675)"
|
|
2014,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,182,58.3,50,66.5,3499,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,INCOME3,CAT6,_RFPSA21,RESP054,"(42.27687047, -72.082690675)"
|
|
2014,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,235,41.1,34.5,47.7,3495,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,INCOME4,CAT6,_RFPSA21,RESP046,"(42.27687047, -72.082690675)"
|
|
2014,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,249,58.9,52.3,65.5,3500,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,INCOME4,CAT6,_RFPSA21,RESP054,"(42.27687047, -72.082690675)"
|
|
2014,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,1013,41.8,39,44.6,3496,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,INCOME5,CAT6,_RFPSA21,RESP046,"(42.27687047, -72.082690675)"
|
|
2014,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,1071,58.2,55.4,61,3501,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,INCOME5,CAT6,_RFPSA21,RESP054,"(42.27687047, -72.082690675)"
|
|
2014,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1671,42.3,39.9,44.6,3474,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,RACE1,CAT4,_RFPSA21,RESP046,"(42.27687047, -72.082690675)"
|
|
2014,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1821,57.8,55.4,60.1,3479,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,RACE1,CAT4,_RFPSA21,RESP054,"(42.27687047, -72.082690675)"
|
|
2014,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,59,31.3,20.8,41.8,3475,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,RACE2,CAT4,_RFPSA21,RESP046,"(42.27687047, -72.082690675)"
|
|
2014,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,93,68.7,58.2,79.2,3480,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,RACE2,CAT4,_RFPSA21,RESP054,"(42.27687047, -72.082690675)"
|
|
2014,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,51,27.3,16.1,38.5,3476,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,RACE3,CAT4,_RFPSA21,RESP046,"(42.27687047, -72.082690675)"
|
|
2014,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,97,72.7,61.5,83.9,3481,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,RACE3,CAT4,_RFPSA21,RESP054,"(42.27687047, -72.082690675)"
|
|
2014,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,36,19.5,10.9,28.1,3477,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,RACE4,CAT4,_RFPSA21,RESP046,"(42.27687047, -72.082690675)"
|
|
2014,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,89,80.5,71.9,89.1,3482,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,RACE4,CAT4,_RFPSA21,RESP054,"(42.27687047, -72.082690675)"
|
|
2014,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,29,39.3,23.2,55.4,3478,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,RACE5,CAT4,_RFPSA21,RESP046,"(42.27687047, -72.082690675)"
|
|
2014,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,43,60.7,44.6,76.8,3483,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,RACE5,CAT4,_RFPSA21,RESP054,"(42.27687047, -72.082690675)"
|
|
2014,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1898,39.8,37.6,41.9,3464,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,SEX1,CAT2,_RFPSA21,RESP046,"(42.27687047, -72.082690675)"
|
|
2014,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,2202,60.2,58.1,62.4,3465,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,25,SEX1,CAT2,_RFPSA21,RESP054,"(42.27687047, -72.082690675)"
|
|
2014,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,79,18.6,14.5,22.8,3469,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,26,AGE06,CAT3,_RFPSA21,RESP046,"(44.661319543001, -84.71439027)"
|
|
2014,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,321,81.4,77.2,85.6,3473,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,26,AGE06,CAT3,_RFPSA21,RESP054,"(44.661319543001, -84.71439027)"
|
|
2014,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,347,44.9,40.6,49.1,3470,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,26,AGE07,CAT3,_RFPSA21,RESP046,"(44.661319543001, -84.71439027)"
|
|
2014,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,391,55.1,50.9,59.4,3474,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,26,AGE07,CAT3,_RFPSA21,RESP054,"(44.661319543001, -84.71439027)"
|
|
2014,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,263,60.8,55.2,66.4,3471,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,26,AGE08,CAT3,_RFPSA21,RESP046,"(44.661319543001, -84.71439027)"
|
|
2014,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,151,39.2,33.6,44.8,3475,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,26,AGE08,CAT3,_RFPSA21,RESP054,"(44.661319543001, -84.71439027)"
|
|
2014,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,698,68.1,64.6,71.6,3472,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,26,AGE09,CAT3,_RFPSA21,RESP046,"(44.661319543001, -84.71439027)"
|
|
2014,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,313,31.9,28.4,35.4,3476,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,26,AGE09,CAT3,_RFPSA21,RESP054,"(44.661319543001, -84.71439027)"
|
|
2014,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1387,47.5,45.2,49.8,3465,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,26,BO1,CAT1,_RFPSA21,RESP046,"(44.661319543001, -84.71439027)"
|
|
2014,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1176,52.5,50.2,54.8,3466,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,26,BO1,CAT1,_RFPSA21,RESP054,"(44.661319543001, -84.71439027)"
|
|
2014,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,42,35.2,25.7,44.8,3487,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,26,EDUCA1,CAT5,_RFPSA21,RESP046,"(44.661319543001, -84.71439027)"
|
|
2014,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,80,64.8,55.2,74.3,3491,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,26,EDUCA1,CAT5,_RFPSA21,RESP054,"(44.661319543001, -84.71439027)"
|
|
2014,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,283,39.3,35.1,43.6,3488,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,26,EDUCA2,CAT5,_RFPSA21,RESP046,"(44.661319543001, -84.71439027)"
|
|
2014,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,358,60.7,56.5,65,3492,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,26,EDUCA2,CAT5,_RFPSA21,RESP054,"(44.661319543001, -84.71439027)"
|
|
2014,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,411,56.1,51.8,60.4,3489,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,26,EDUCA3,CAT5,_RFPSA21,RESP046,"(44.661319543001, -84.71439027)"
|
|
2014,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,276,43.9,39.6,48.2,3493,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,26,EDUCA3,CAT5,_RFPSA21,RESP054,"(44.661319543001, -84.71439027)"
|
|
2014,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,649,51.7,48.3,55.1,3490,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,26,EDUCA4,CAT5,_RFPSA21,RESP046,"(44.661319543001, -84.71439027)"
|
|
2014,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,459,48.3,44.9,51.7,3494,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,26,EDUCA4,CAT5,_RFPSA21,RESP054,"(44.661319543001, -84.71439027)"
|
|
2014,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,50,28.7,20.6,36.8,3495,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,26,INCOME1,CAT6,_RFPSA21,RESP046,"(44.661319543001, -84.71439027)"
|
|
2014,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,107,71.3,63.2,79.4,3500,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,26,INCOME1,CAT6,_RFPSA21,RESP054,"(44.661319543001, -84.71439027)"
|
|
2014,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,129,37,30.3,43.6,3496,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,26,INCOME2,CAT6,_RFPSA21,RESP046,"(44.661319543001, -84.71439027)"
|
|
2014,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,173,63,56.4,69.7,3501,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,26,INCOME2,CAT6,_RFPSA21,RESP054,"(44.661319543001, -84.71439027)"
|
|
2014,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,155,48.1,41,55.1,3497,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,26,INCOME3,CAT6,_RFPSA21,RESP046,"(44.661319543001, -84.71439027)"
|
|
2014,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,129,51.9,44.9,59,3502,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,26,INCOME3,CAT6,_RFPSA21,RESP054,"(44.661319543001, -84.71439027)"
|
|
2014,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,217,57.3,51,63.6,3498,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,26,INCOME4,CAT6,_RFPSA21,RESP046,"(44.661319543001, -84.71439027)"
|
|
2014,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,132,42.7,36.4,49,3503,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,26,INCOME4,CAT6,_RFPSA21,RESP054,"(44.661319543001, -84.71439027)"
|
|
2014,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,717,51.4,48.1,54.8,3499,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,26,INCOME5,CAT6,_RFPSA21,RESP046,"(44.661319543001, -84.71439027)"
|
|
2014,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,516,48.6,45.2,51.9,3504,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,26,INCOME5,CAT6,_RFPSA21,RESP054,"(44.661319543001, -84.71439027)"
|
|
2014,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1188,48.6,46.1,51.1,3477,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,26,RACE1,CAT4,_RFPSA21,RESP046,"(44.661319543001, -84.71439027)"
|
|
2014,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,964,51.4,48.9,53.9,3482,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,26,RACE1,CAT4,_RFPSA21,RESP054,"(44.661319543001, -84.71439027)"
|
|
2014,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,121,49.3,41.3,57.3,3478,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,26,RACE2,CAT4,_RFPSA21,RESP046,"(44.661319543001, -84.71439027)"
|
|
2014,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,99,50.7,42.7,58.8,3483,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,26,RACE2,CAT4,_RFPSA21,RESP054,"(44.661319543001, -84.71439027)"
|
|
2014,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,13,,,,3479,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,26,RACE3,CAT4,_RFPSA21,RESP046,"(44.661319543001, -84.71439027)"
|
|
2014,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,21,,,,3484,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,26,RACE3,CAT4,_RFPSA21,RESP054,"(44.661319543001, -84.71439027)"
|
|
2014,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,27,32.8,19.6,46.1,3480,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,26,RACE4,CAT4,_RFPSA21,RESP046,"(44.661319543001, -84.71439027)"
|
|
2014,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,35,67.2,54,80.4,3485,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,26,RACE4,CAT4,_RFPSA21,RESP054,"(44.661319543001, -84.71439027)"
|
|
2014,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,16,,,,3481,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,26,RACE5,CAT4,_RFPSA21,RESP046,"(44.661319543001, -84.71439027)"
|
|
2014,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,27,,,,3486,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,26,RACE5,CAT4,_RFPSA21,RESP054,"(44.661319543001, -84.71439027)"
|
|
2014,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1387,47.5,45.2,49.8,3467,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,26,SEX1,CAT2,_RFPSA21,RESP046,"(44.661319543001, -84.71439027)"
|
|
2014,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1176,52.5,50.2,54.8,3468,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,26,SEX1,CAT2,_RFPSA21,RESP054,"(44.661319543001, -84.71439027)"
|
|
2014,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,657,42.1,39.2,44.9,3477,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,27,AGE09,CAT3,_RFPSA21,RESP054,"(46.355648736, -94.794200503)"
|
|
2014,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1993,36.7,35.2,38.3,3466,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,27,BO1,CAT1,_RFPSA21,RESP046,"(46.355648736, -94.794200503)"
|
|
2014,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,114,10.4,8.3,12.4,3470,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,27,AGE06,CAT3,_RFPSA21,RESP046,"(46.355648736, -94.794200503)"
|
|
2014,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,874,89.6,87.6,91.7,3474,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,27,AGE06,CAT3,_RFPSA21,RESP054,"(46.355648736, -94.794200503)"
|
|
2014,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,522,34.7,31.8,37.5,3471,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,27,AGE07,CAT3,_RFPSA21,RESP046,"(46.355648736, -94.794200503)"
|
|
2014,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,965,65.4,62.5,68.2,3475,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,27,AGE07,CAT3,_RFPSA21,RESP054,"(46.355648736, -94.794200503)"
|
|
2014,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,373,48,43.8,52.1,3472,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,27,AGE08,CAT3,_RFPSA21,RESP046,"(46.355648736, -94.794200503)"
|
|
2014,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,363,52.1,47.9,56.2,3476,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,27,AGE08,CAT3,_RFPSA21,RESP054,"(46.355648736, -94.794200503)"
|
|
2014,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,984,58,55.1,60.8,3473,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,27,AGE09,CAT3,_RFPSA21,RESP046,"(46.355648736, -94.794200503)"
|
|
2014,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,2859,63.3,61.7,64.8,3467,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,27,BO1,CAT1,_RFPSA21,RESP054,"(46.355648736, -94.794200503)"
|
|
2014,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,56,26.5,19.6,33.5,3488,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,27,EDUCA1,CAT5,_RFPSA21,RESP046,"(46.355648736, -94.794200503)"
|
|
2014,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,145,73.5,66.6,80.4,3492,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,27,EDUCA1,CAT5,_RFPSA21,RESP054,"(46.355648736, -94.794200503)"
|
|
2014,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,443,35.6,32.5,38.6,3489,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,27,EDUCA2,CAT5,_RFPSA21,RESP046,"(46.355648736, -94.794200503)"
|
|
2014,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,720,64.5,61.4,67.5,3493,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,27,EDUCA2,CAT5,_RFPSA21,RESP054,"(46.355648736, -94.794200503)"
|
|
2014,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,597,37.1,34.3,39.8,3490,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,27,EDUCA3,CAT5,_RFPSA21,RESP046,"(46.355648736, -94.794200503)"
|
|
2014,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,867,63,60.2,65.7,3494,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,27,EDUCA3,CAT5,_RFPSA21,RESP054,"(46.355648736, -94.794200503)"
|
|
2014,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,895,40.1,37.7,42.5,3491,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,27,EDUCA4,CAT5,_RFPSA21,RESP046,"(46.355648736, -94.794200503)"
|
|
2014,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,1121,59.9,57.5,62.3,3495,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,27,EDUCA4,CAT5,_RFPSA21,RESP054,"(46.355648736, -94.794200503)"
|
|
2014,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,71,28.7,21.6,35.7,3496,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,27,INCOME1,CAT6,_RFPSA21,RESP046,"(46.355648736, -94.794200503)"
|
|
2014,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,160,71.3,64.3,78.4,3501,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,27,INCOME1,CAT6,_RFPSA21,RESP054,"(46.355648736, -94.794200503)"
|
|
2014,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,159,31.9,26.8,37.1,3497,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,27,INCOME2,CAT6,_RFPSA21,RESP046,"(46.355648736, -94.794200503)"
|
|
2014,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,300,68.1,62.9,73.2,3502,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,27,INCOME2,CAT6,_RFPSA21,RESP054,"(46.355648736, -94.794200503)"
|
|
2014,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,154,32.6,27.2,38.1,3498,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,27,INCOME3,CAT6,_RFPSA21,RESP046,"(46.355648736, -94.794200503)"
|
|
2014,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,266,67.4,61.9,72.8,3503,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,27,INCOME3,CAT6,_RFPSA21,RESP054,"(46.355648736, -94.794200503)"
|
|
2014,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,285,38.3,34,42.6,3499,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,27,INCOME4,CAT6,_RFPSA21,RESP046,"(46.355648736, -94.794200503)"
|
|
2014,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,385,61.7,57.5,66,3504,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,27,INCOME4,CAT6,_RFPSA21,RESP054,"(46.355648736, -94.794200503)"
|
|
2014,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,1137,37.9,35.8,39.9,3500,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,27,INCOME5,CAT6,_RFPSA21,RESP046,"(46.355648736, -94.794200503)"
|
|
2014,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,1547,62.2,60.1,64.2,3505,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,27,INCOME5,CAT6,_RFPSA21,RESP054,"(46.355648736, -94.794200503)"
|
|
2014,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1880,38.1,36.5,39.7,3478,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,27,RACE1,CAT4,_RFPSA21,RESP046,"(46.355648736, -94.794200503)"
|
|
2014,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,2597,61.9,60.3,63.5,3483,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,27,RACE1,CAT4,_RFPSA21,RESP054,"(46.355648736, -94.794200503)"
|
|
2014,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,26,26.6,16.1,37.1,3479,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,27,RACE2,CAT4,_RFPSA21,RESP046,"(46.355648736, -94.794200503)"
|
|
2014,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,66,73.4,62.9,83.9,3484,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,27,RACE2,CAT4,_RFPSA21,RESP054,"(46.355648736, -94.794200503)"
|
|
2014,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,23,27.8,16.4,39.1,3480,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,27,RACE3,CAT4,_RFPSA21,RESP046,"(46.355648736, -94.794200503)"
|
|
2014,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,54,72.2,60.9,83.6,3485,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,27,RACE3,CAT4,_RFPSA21,RESP054,"(46.355648736, -94.794200503)"
|
|
2014,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,22,21.2,11.7,30.7,3481,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,27,RACE4,CAT4,_RFPSA21,RESP046,"(46.355648736, -94.794200503)"
|
|
2014,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,88,78.8,69.3,88.3,3486,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,27,RACE4,CAT4,_RFPSA21,RESP054,"(46.355648736, -94.794200503)"
|
|
2014,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,19,,,,3482,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,27,RACE5,CAT4,_RFPSA21,RESP046,"(46.355648736, -94.794200503)"
|
|
2014,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,16,,,,3487,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,27,RACE5,CAT4,_RFPSA21,RESP054,"(46.355648736, -94.794200503)"
|
|
2014,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1993,36.7,35.2,38.3,3468,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,27,SEX1,CAT2,_RFPSA21,RESP046,"(46.355648736, -94.794200503)"
|
|
2014,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,2859,63.3,61.7,64.8,3469,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,27,SEX1,CAT2,_RFPSA21,RESP054,"(46.355648736, -94.794200503)"
|
|
2014,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,56,27.2,19.9,34.5,3426,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,28,AGE06,CAT3,_RFPSA21,RESP046,"(32.745510099, -89.538030825)"
|
|
2014,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,120,72.8,65.5,80.1,3430,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,28,AGE06,CAT3,_RFPSA21,RESP054,"(32.745510099, -89.538030825)"
|
|
2014,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,126,41.5,34.5,48.6,3427,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,28,AGE07,CAT3,_RFPSA21,RESP046,"(32.745510099, -89.538030825)"
|
|
2014,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,160,58.5,51.4,65.5,3431,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,28,AGE07,CAT3,_RFPSA21,RESP054,"(32.745510099, -89.538030825)"
|
|
2014,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,90,48.5,38.3,58.6,3428,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,28,AGE08,CAT3,_RFPSA21,RESP046,"(32.745510099, -89.538030825)"
|
|
2014,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,66,51.5,41.4,61.7,3432,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,28,AGE08,CAT3,_RFPSA21,RESP054,"(32.745510099, -89.538030825)"
|
|
2014,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,322,70.7,65.3,76.1,3429,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,28,AGE09,CAT3,_RFPSA21,RESP046,"(32.745510099, -89.538030825)"
|
|
2014,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,132,29.3,23.9,34.7,3433,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,28,AGE09,CAT3,_RFPSA21,RESP054,"(32.745510099, -89.538030825)"
|
|
2014,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,594,47.3,43.5,51.1,3422,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,28,BO1,CAT1,_RFPSA21,RESP046,"(32.745510099, -89.538030825)"
|
|
2014,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,478,52.7,48.9,56.5,3423,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,28,BO1,CAT1,_RFPSA21,RESP054,"(32.745510099, -89.538030825)"
|
|
2014,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,53,29.4,20.8,37.9,3444,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,28,EDUCA1,CAT5,_RFPSA21,RESP046,"(32.745510099, -89.538030825)"
|
|
2014,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,109,70.6,62.1,79.2,3448,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,28,EDUCA1,CAT5,_RFPSA21,RESP054,"(32.745510099, -89.538030825)"
|
|
2014,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,166,44.1,37.6,50.6,3445,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,28,EDUCA2,CAT5,_RFPSA21,RESP046,"(32.745510099, -89.538030825)"
|
|
2014,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,161,55.9,49.4,62.4,3449,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,28,EDUCA2,CAT5,_RFPSA21,RESP054,"(32.745510099, -89.538030825)"
|
|
2014,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,175,55,47.8,62.2,3446,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,28,EDUCA3,CAT5,_RFPSA21,RESP046,"(32.745510099, -89.538030825)"
|
|
2014,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,101,45,37.8,52.2,3450,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,28,EDUCA3,CAT5,_RFPSA21,RESP054,"(32.745510099, -89.538030825)"
|
|
2014,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,198,61.8,54.8,68.8,3447,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,28,EDUCA4,CAT5,_RFPSA21,RESP046,"(32.745510099, -89.538030825)"
|
|
2014,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,106,38.2,31.2,45.2,3451,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,28,EDUCA4,CAT5,_RFPSA21,RESP054,"(32.745510099, -89.538030825)"
|
|
2014,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,38,26.6,17,36.2,3452,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,28,INCOME1,CAT6,_RFPSA21,RESP046,"(32.745510099, -89.538030825)"
|
|
2014,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,91,73.4,63.8,83,3457,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,28,INCOME1,CAT6,_RFPSA21,RESP054,"(32.745510099, -89.538030825)"
|
|
2014,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,92,41.6,32.6,50.5,3453,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,28,INCOME2,CAT6,_RFPSA21,RESP046,"(32.745510099, -89.538030825)"
|
|
2014,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,87,58.4,49.5,67.4,3458,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,28,INCOME2,CAT6,_RFPSA21,RESP054,"(32.745510099, -89.538030825)"
|
|
2014,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,72,54,42.9,65.1,3454,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,28,INCOME3,CAT6,_RFPSA21,RESP046,"(32.745510099, -89.538030825)"
|
|
2014,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,56,46,34.9,57.1,3459,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,28,INCOME3,CAT6,_RFPSA21,RESP054,"(32.745510099, -89.538030825)"
|
|
2014,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,77,40.4,30.4,50.4,3455,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,28,INCOME4,CAT6,_RFPSA21,RESP046,"(32.745510099, -89.538030825)"
|
|
2014,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,67,59.6,49.6,69.6,3460,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,28,INCOME4,CAT6,_RFPSA21,RESP054,"(32.745510099, -89.538030825)"
|
|
2014,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,245,57.6,51,64.3,3456,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,28,INCOME5,CAT6,_RFPSA21,RESP046,"(32.745510099, -89.538030825)"
|
|
2014,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,123,42.4,35.7,49,3461,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,28,INCOME5,CAT6,_RFPSA21,RESP054,"(32.745510099, -89.538030825)"
|
|
2014,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,417,50.8,46.1,55.5,3434,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,28,RACE1,CAT4,_RFPSA21,RESP046,"(32.745510099, -89.538030825)"
|
|
2014,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,287,49.2,44.5,53.9,3439,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,28,RACE1,CAT4,_RFPSA21,RESP054,"(32.745510099, -89.538030825)"
|
|
2014,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,162,39.7,33.1,46.4,3435,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,28,RACE2,CAT4,_RFPSA21,RESP046,"(32.745510099, -89.538030825)"
|
|
2014,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,173,60.3,53.6,66.9,3440,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,28,RACE2,CAT4,_RFPSA21,RESP054,"(32.745510099, -89.538030825)"
|
|
2014,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,5,,,,3436,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,28,RACE3,CAT4,_RFPSA21,RESP046,"(32.745510099, -89.538030825)"
|
|
2014,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,2,,,,3441,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,28,RACE3,CAT4,_RFPSA21,RESP054,"(32.745510099, -89.538030825)"
|
|
2014,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,5,,,,3437,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,28,RACE4,CAT4,_RFPSA21,RESP046,"(32.745510099, -89.538030825)"
|
|
2014,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,9,,,,3442,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,28,RACE4,CAT4,_RFPSA21,RESP054,"(32.745510099, -89.538030825)"
|
|
2014,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,4,,,,3438,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,28,RACE5,CAT4,_RFPSA21,RESP046,"(32.745510099, -89.538030825)"
|
|
2014,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,1,,,,3443,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,28,RACE5,CAT4,_RFPSA21,RESP054,"(32.745510099, -89.538030825)"
|
|
2014,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,594,47.3,43.5,51.1,3424,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,28,SEX1,CAT2,_RFPSA21,RESP046,"(32.745510099, -89.538030825)"
|
|
2014,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,478,52.7,48.9,56.5,3425,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,28,SEX1,CAT2,_RFPSA21,RESP054,"(32.745510099, -89.538030825)"
|
|
2014,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,47,17,11.4,22.7,3461,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,29,AGE06,CAT3,_RFPSA21,RESP046,"(38.635790776, -92.566300053)"
|
|
2014,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,268,83,77.3,88.7,3465,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,29,AGE06,CAT3,_RFPSA21,RESP054,"(38.635790776, -92.566300053)"
|
|
2014,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,221,43.9,38.1,49.7,3462,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,29,AGE07,CAT3,_RFPSA21,RESP046,"(38.635790776, -92.566300053)"
|
|
2014,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,312,56.1,50.3,61.9,3466,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,29,AGE07,CAT3,_RFPSA21,RESP054,"(38.635790776, -92.566300053)"
|
|
2014,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,192,50.1,42.8,57.5,3463,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,29,AGE08,CAT3,_RFPSA21,RESP046,"(38.635790776, -92.566300053)"
|
|
2014,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,145,49.9,42.5,57.2,3467,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,29,AGE08,CAT3,_RFPSA21,RESP054,"(38.635790776, -92.566300053)"
|
|
2014,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,567,64.5,60.2,68.9,3464,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,29,AGE09,CAT3,_RFPSA21,RESP046,"(38.635790776, -92.566300053)"
|
|
2014,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,310,35.5,31.1,39.8,3468,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,29,AGE09,CAT3,_RFPSA21,RESP054,"(38.635790776, -92.566300053)"
|
|
2014,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1027,43.9,40.9,46.9,3457,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,29,BO1,CAT1,_RFPSA21,RESP046,"(38.635790776, -92.566300053)"
|
|
2014,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1035,56.1,53.1,59.1,3458,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,29,BO1,CAT1,_RFPSA21,RESP054,"(38.635790776, -92.566300053)"
|
|
2014,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,63,29.6,20.7,38.5,3479,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,29,EDUCA1,CAT5,_RFPSA21,RESP046,"(38.635790776, -92.566300053)"
|
|
2014,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,127,70.4,61.5,79.3,3483,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,29,EDUCA1,CAT5,_RFPSA21,RESP054,"(38.635790776, -92.566300053)"
|
|
2014,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,327,41.6,36.6,46.6,3480,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,29,EDUCA2,CAT5,_RFPSA21,RESP046,"(38.635790776, -92.566300053)"
|
|
2014,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,386,58.4,53.4,63.4,3484,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,29,EDUCA2,CAT5,_RFPSA21,RESP054,"(38.635790776, -92.566300053)"
|
|
2014,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,247,46.9,40.8,52.9,3481,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,29,EDUCA3,CAT5,_RFPSA21,RESP046,"(38.635790776, -92.566300053)"
|
|
2014,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,250,53.1,47.1,59.2,3485,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,29,EDUCA3,CAT5,_RFPSA21,RESP054,"(38.635790776, -92.566300053)"
|
|
2014,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,390,51.3,46.1,56.6,3482,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,29,EDUCA4,CAT5,_RFPSA21,RESP046,"(38.635790776, -92.566300053)"
|
|
2014,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,270,48.7,43.4,53.9,3486,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,29,EDUCA4,CAT5,_RFPSA21,RESP054,"(38.635790776, -92.566300053)"
|
|
2014,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,49,33.2,21.3,45,3487,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,29,INCOME1,CAT6,_RFPSA21,RESP046,"(38.635790776, -92.566300053)"
|
|
2014,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,109,66.8,55,78.7,3492,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,29,INCOME1,CAT6,_RFPSA21,RESP054,"(38.635790776, -92.566300053)"
|
|
2014,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,124,37.9,30.3,45.5,3488,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,29,INCOME2,CAT6,_RFPSA21,RESP046,"(38.635790776, -92.566300053)"
|
|
2014,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,175,62.1,54.5,69.7,3493,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,29,INCOME2,CAT6,_RFPSA21,RESP054,"(38.635790776, -92.566300053)"
|
|
2014,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,107,40.8,32.4,49.3,3489,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,29,INCOME3,CAT6,_RFPSA21,RESP046,"(38.635790776, -92.566300053)"
|
|
2014,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,120,59.2,50.7,67.6,3494,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,29,INCOME3,CAT6,_RFPSA21,RESP054,"(38.635790776, -92.566300053)"
|
|
2014,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,178,49.1,41.7,56.6,3490,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,29,INCOME4,CAT6,_RFPSA21,RESP046,"(38.635790776, -92.566300053)"
|
|
2014,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,151,50.9,43.4,58.3,3495,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,29,INCOME4,CAT6,_RFPSA21,RESP054,"(38.635790776, -92.566300053)"
|
|
2014,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,461,46.6,41.9,51.2,3491,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,29,INCOME5,CAT6,_RFPSA21,RESP046,"(38.635790776, -92.566300053)"
|
|
2014,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,376,53.4,48.8,58.1,3496,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,29,INCOME5,CAT6,_RFPSA21,RESP054,"(38.635790776, -92.566300053)"
|
|
2014,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,863,43.2,40.1,46.4,3469,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,29,RACE1,CAT4,_RFPSA21,RESP046,"(38.635790776, -92.566300053)"
|
|
2014,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,877,56.8,53.6,59.9,3474,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,29,RACE1,CAT4,_RFPSA21,RESP054,"(38.635790776, -92.566300053)"
|
|
2014,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,112,56.7,44.4,68.9,3470,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,29,RACE2,CAT4,_RFPSA21,RESP046,"(38.635790776, -92.566300053)"
|
|
2014,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,79,43.3,31.1,55.6,3475,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,29,RACE2,CAT4,_RFPSA21,RESP054,"(38.635790776, -92.566300053)"
|
|
2014,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,6,,,,3471,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,29,RACE3,CAT4,_RFPSA21,RESP046,"(38.635790776, -92.566300053)"
|
|
2014,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,11,,,,3476,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,29,RACE3,CAT4,_RFPSA21,RESP054,"(38.635790776, -92.566300053)"
|
|
2014,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,18,,,,3472,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,29,RACE4,CAT4,_RFPSA21,RESP046,"(38.635790776, -92.566300053)"
|
|
2014,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,34,77.1,61.5,92.6,3477,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,29,RACE4,CAT4,_RFPSA21,RESP054,"(38.635790776, -92.566300053)"
|
|
2014,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,20,,,,3473,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,29,RACE5,CAT4,_RFPSA21,RESP046,"(38.635790776, -92.566300053)"
|
|
2014,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,24,,,,3478,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,29,RACE5,CAT4,_RFPSA21,RESP054,"(38.635790776, -92.566300053)"
|
|
2014,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1027,43.9,40.9,46.9,3459,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,29,SEX1,CAT2,_RFPSA21,RESP046,"(38.635790776, -92.566300053)"
|
|
2014,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1035,56.1,53.1,59.1,3460,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,29,SEX1,CAT2,_RFPSA21,RESP054,"(38.635790776, -92.566300053)"
|
|
2014,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,301,83.5,78.7,88.2,3447,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,30,AGE06,CAT3,_RFPSA21,RESP054,"(47.066528972, -109.424420645)"
|
|
2014,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,59,16.5,11.8,21.3,3443,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,30,AGE06,CAT3,_RFPSA21,RESP046,"(47.066528972, -109.424420645)"
|
|
2014,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,247,37.3,32.3,42.2,3444,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,30,AGE07,CAT3,_RFPSA21,RESP046,"(47.066528972, -109.424420645)"
|
|
2014,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,364,62.8,57.8,67.7,3448,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,30,AGE07,CAT3,_RFPSA21,RESP054,"(47.066528972, -109.424420645)"
|
|
2014,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,224,56.4,49.8,63,3445,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,30,AGE08,CAT3,_RFPSA21,RESP046,"(47.066528972, -109.424420645)"
|
|
2014,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,182,43.6,37,50.2,3449,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,30,AGE08,CAT3,_RFPSA21,RESP054,"(47.066528972, -109.424420645)"
|
|
2014,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,625,60.1,56.1,64.1,3446,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,30,AGE09,CAT3,_RFPSA21,RESP046,"(47.066528972, -109.424420645)"
|
|
2014,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,412,39.9,35.9,43.9,3450,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,30,AGE09,CAT3,_RFPSA21,RESP054,"(47.066528972, -109.424420645)"
|
|
2014,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1155,42.4,39.7,45,3439,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,30,BO1,CAT1,_RFPSA21,RESP046,"(47.066528972, -109.424420645)"
|
|
2014,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1259,57.6,55,60.3,3440,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,30,BO1,CAT1,_RFPSA21,RESP054,"(47.066528972, -109.424420645)"
|
|
2014,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,43,25,16.4,33.6,3461,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,30,EDUCA1,CAT5,_RFPSA21,RESP046,"(47.066528972, -109.424420645)"
|
|
2014,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,104,75,66.4,83.6,3465,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,30,EDUCA1,CAT5,_RFPSA21,RESP054,"(47.066528972, -109.424420645)"
|
|
2014,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,287,34.6,30,39.1,3462,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,30,EDUCA2,CAT5,_RFPSA21,RESP046,"(47.066528972, -109.424420645)"
|
|
2014,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,439,65.4,60.9,70,3466,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,30,EDUCA2,CAT5,_RFPSA21,RESP054,"(47.066528972, -109.424420645)"
|
|
2014,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,313,44.3,39.2,49.4,3463,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,30,EDUCA3,CAT5,_RFPSA21,RESP046,"(47.066528972, -109.424420645)"
|
|
2014,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,338,55.7,50.6,60.8,3467,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,30,EDUCA3,CAT5,_RFPSA21,RESP054,"(47.066528972, -109.424420645)"
|
|
2014,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,511,53.8,49.4,58.2,3464,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,30,EDUCA4,CAT5,_RFPSA21,RESP046,"(47.066528972, -109.424420645)"
|
|
2014,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,376,46.2,41.8,50.6,3468,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,30,EDUCA4,CAT5,_RFPSA21,RESP054,"(47.066528972, -109.424420645)"
|
|
2014,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,49,25.7,16.6,34.7,3469,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,30,INCOME1,CAT6,_RFPSA21,RESP046,"(47.066528972, -109.424420645)"
|
|
2014,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,134,74.3,65.3,83.4,3474,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,30,INCOME1,CAT6,_RFPSA21,RESP054,"(47.066528972, -109.424420645)"
|
|
2014,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,140,33.4,26.9,40,3470,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,30,INCOME2,CAT6,_RFPSA21,RESP046,"(47.066528972, -109.424420645)"
|
|
2014,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,222,66.6,60,73.1,3475,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,30,INCOME2,CAT6,_RFPSA21,RESP054,"(47.066528972, -109.424420645)"
|
|
2014,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,115,40.1,32.5,47.7,3471,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,30,INCOME3,CAT6,_RFPSA21,RESP046,"(47.066528972, -109.424420645)"
|
|
2014,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,154,59.9,52.3,67.6,3476,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,30,INCOME3,CAT6,_RFPSA21,RESP054,"(47.066528972, -109.424420645)"
|
|
2014,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,201,45.7,38.9,52.6,3472,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,30,INCOME4,CAT6,_RFPSA21,RESP046,"(47.066528972, -109.424420645)"
|
|
2014,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,175,54.3,47.5,61.1,3477,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,30,INCOME4,CAT6,_RFPSA21,RESP054,"(47.066528972, -109.424420645)"
|
|
2014,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,529,46.9,42.8,51,3473,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,30,INCOME5,CAT6,_RFPSA21,RESP046,"(47.066528972, -109.424420645)"
|
|
2014,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,460,53.1,49,57.2,3478,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,30,INCOME5,CAT6,_RFPSA21,RESP054,"(47.066528972, -109.424420645)"
|
|
2014,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1059,43.9,41.1,46.7,3451,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,30,RACE1,CAT4,_RFPSA21,RESP046,"(47.066528972, -109.424420645)"
|
|
2014,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1055,56.2,53.4,59,3456,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,30,RACE1,CAT4,_RFPSA21,RESP054,"(47.066528972, -109.424420645)"
|
|
2014,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,2,,,,3452,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,30,RACE2,CAT4,_RFPSA21,RESP046,"(47.066528972, -109.424420645)"
|
|
2014,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,5,,,,3457,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,30,RACE2,CAT4,_RFPSA21,RESP054,"(47.066528972, -109.424420645)"
|
|
2014,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,8,,,,3453,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,30,RACE3,CAT4,_RFPSA21,RESP046,"(47.066528972, -109.424420645)"
|
|
2014,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,30,,,,3458,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,30,RACE3,CAT4,_RFPSA21,RESP054,"(47.066528972, -109.424420645)"
|
|
2014,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,46,25.7,15.9,35.5,3454,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,30,RACE4,CAT4,_RFPSA21,RESP046,"(47.066528972, -109.424420645)"
|
|
2014,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,116,74.3,64.5,84.1,3459,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,30,RACE4,CAT4,_RFPSA21,RESP054,"(47.066528972, -109.424420645)"
|
|
2014,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,21,,,,3455,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,30,RACE5,CAT4,_RFPSA21,RESP046,"(47.066528972, -109.424420645)"
|
|
2014,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,20,,,,3460,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,30,RACE5,CAT4,_RFPSA21,RESP054,"(47.066528972, -109.424420645)"
|
|
2014,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1155,42.4,39.7,45,3441,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,30,SEX1,CAT2,_RFPSA21,RESP046,"(47.066528972, -109.424420645)"
|
|
2014,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1259,57.6,55,60.3,3442,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,30,SEX1,CAT2,_RFPSA21,RESP054,"(47.066528972, -109.424420645)"
|
|
2014,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,144,12,9.4,14.6,3468,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,AGE06,CAT3,_RFPSA21,RESP046,"(41.641040988001, -99.365720623)"
|
|
2014,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,993,88,85.4,90.7,3472,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,AGE06,CAT3,_RFPSA21,RESP054,"(41.641040988001, -99.365720623)"
|
|
2014,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,689,37,33.7,40.4,3469,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,AGE07,CAT3,_RFPSA21,RESP046,"(41.641040988001, -99.365720623)"
|
|
2014,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,1083,63,59.6,66.3,3473,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,AGE07,CAT3,_RFPSA21,RESP054,"(41.641040988001, -99.365720623)"
|
|
2014,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,525,52.8,48.2,57.3,3470,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,AGE08,CAT3,_RFPSA21,RESP046,"(41.641040988001, -99.365720623)"
|
|
2014,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,494,47.3,42.7,51.8,3474,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,AGE08,CAT3,_RFPSA21,RESP054,"(41.641040988001, -99.365720623)"
|
|
2014,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,1699,59.9,57.4,62.5,3471,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,AGE09,CAT3,_RFPSA21,RESP046,"(41.641040988001, -99.365720623)"
|
|
2014,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,1091,40.1,37.5,42.6,3475,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,AGE09,CAT3,_RFPSA21,RESP054,"(41.641040988001, -99.365720623)"
|
|
2014,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,3057,39.6,37.8,41.3,3464,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,BO1,CAT1,_RFPSA21,RESP046,"(41.641040988001, -99.365720623)"
|
|
2014,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,3661,60.4,58.7,62.2,3465,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,BO1,CAT1,_RFPSA21,RESP054,"(41.641040988001, -99.365720623)"
|
|
2014,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,119,22.4,17,27.7,3486,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,EDUCA1,CAT5,_RFPSA21,RESP046,"(41.641040988001, -99.365720623)"
|
|
2014,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,282,77.6,72.3,83,3490,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,EDUCA1,CAT5,_RFPSA21,RESP054,"(41.641040988001, -99.365720623)"
|
|
2014,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,1042,36.8,34,39.5,3487,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,EDUCA2,CAT5,_RFPSA21,RESP046,"(41.641040988001, -99.365720623)"
|
|
2014,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,1381,63.2,60.5,66,3491,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,EDUCA2,CAT5,_RFPSA21,RESP054,"(41.641040988001, -99.365720623)"
|
|
2014,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,814,43.7,40.2,47.1,3488,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,EDUCA3,CAT5,_RFPSA21,RESP046,"(41.641040988001, -99.365720623)"
|
|
2014,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,969,56.3,52.9,59.8,3492,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,EDUCA3,CAT5,_RFPSA21,RESP054,"(41.641040988001, -99.365720623)"
|
|
2014,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,1080,44.1,41.1,47.1,3489,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,EDUCA4,CAT5,_RFPSA21,RESP046,"(41.641040988001, -99.365720623)"
|
|
2014,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,1023,55.9,52.9,58.9,3493,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,EDUCA4,CAT5,_RFPSA21,RESP054,"(41.641040988001, -99.365720623)"
|
|
2014,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,104,20.1,14.5,25.8,3494,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,INCOME1,CAT6,_RFPSA21,RESP046,"(41.641040988001, -99.365720623)"
|
|
2014,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,278,79.9,74.2,85.5,3499,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,INCOME1,CAT6,_RFPSA21,RESP054,"(41.641040988001, -99.365720623)"
|
|
2014,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,327,33.7,29,38.3,3495,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,INCOME2,CAT6,_RFPSA21,RESP046,"(41.641040988001, -99.365720623)"
|
|
2014,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,545,66.4,61.7,71,3500,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,INCOME2,CAT6,_RFPSA21,RESP054,"(41.641040988001, -99.365720623)"
|
|
2014,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,357,36.7,31.5,41.8,3496,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,INCOME3,CAT6,_RFPSA21,RESP046,"(41.641040988001, -99.365720623)"
|
|
2014,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,439,63.4,58.2,68.5,3501,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,INCOME3,CAT6,_RFPSA21,RESP054,"(41.641040988001, -99.365720623)"
|
|
2014,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,556,40.8,36.6,45.1,3497,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,INCOME4,CAT6,_RFPSA21,RESP046,"(41.641040988001, -99.365720623)"
|
|
2014,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,591,59.2,55,63.4,3502,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,INCOME4,CAT6,_RFPSA21,RESP054,"(41.641040988001, -99.365720623)"
|
|
2014,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,1486,43.7,41.1,46.3,3498,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,INCOME5,CAT6,_RFPSA21,RESP046,"(41.641040988001, -99.365720623)"
|
|
2014,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,1551,56.3,53.7,59,3503,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,INCOME5,CAT6,_RFPSA21,RESP054,"(41.641040988001, -99.365720623)"
|
|
2014,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,2909,41.6,39.8,43.4,3476,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,RACE1,CAT4,_RFPSA21,RESP046,"(41.641040988001, -99.365720623)"
|
|
2014,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,3344,58.4,56.6,60.2,3481,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,RACE1,CAT4,_RFPSA21,RESP054,"(41.641040988001, -99.365720623)"
|
|
2014,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,38,36.3,22.2,50.4,3477,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,RACE2,CAT4,_RFPSA21,RESP046,"(41.641040988001, -99.365720623)"
|
|
2014,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,51,63.7,49.6,77.8,3482,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,RACE2,CAT4,_RFPSA21,RESP054,"(41.641040988001, -99.365720623)"
|
|
2014,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,37,19.4,11.8,27,3478,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,RACE3,CAT4,_RFPSA21,RESP046,"(41.641040988001, -99.365720623)"
|
|
2014,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,142,80.6,73,88.2,3483,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,RACE3,CAT4,_RFPSA21,RESP054,"(41.641040988001, -99.365720623)"
|
|
2014,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,33,32.4,17.4,47.3,3479,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,RACE4,CAT4,_RFPSA21,RESP046,"(41.641040988001, -99.365720623)"
|
|
2014,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,64,67.7,52.7,82.6,3484,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,RACE4,CAT4,_RFPSA21,RESP054,"(41.641040988001, -99.365720623)"
|
|
2014,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,14,,,,3480,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,31,RACE5,CAT4,_RFPSA21,RESP046,"(41.641040988001, -99.365720623)"
|
|
2014,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,23,,,,3485,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,31,RACE5,CAT4,_RFPSA21,RESP054,"(41.641040988001, -99.365720623)"
|
|
2014,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,3057,39.6,37.8,41.3,3466,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,SEX1,CAT2,_RFPSA21,RESP046,"(41.641040988001, -99.365720623)"
|
|
2014,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,3661,60.4,58.7,62.2,3467,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,31,SEX1,CAT2,_RFPSA21,RESP054,"(41.641040988001, -99.365720623)"
|
|
2014,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,180,83.9,77.2,90.6,3460,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,32,AGE06,CAT3,_RFPSA21,RESP054,"(39.49324039, -117.071840564)"
|
|
2014,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,116,33.6,26,41.1,3457,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,32,AGE07,CAT3,_RFPSA21,RESP046,"(39.49324039, -117.071840564)"
|
|
2014,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,27,16.1,9.4,22.8,3456,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,32,AGE06,CAT3,_RFPSA21,RESP046,"(39.49324039, -117.071840564)"
|
|
2014,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,175,66.5,58.9,74,3461,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,32,AGE07,CAT3,_RFPSA21,RESP054,"(39.49324039, -117.071840564)"
|
|
2014,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,83,59.8,46.9,72.8,3458,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,32,AGE08,CAT3,_RFPSA21,RESP046,"(39.49324039, -117.071840564)"
|
|
2014,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,62,40.2,27.2,53.1,3462,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,32,AGE08,CAT3,_RFPSA21,RESP054,"(39.49324039, -117.071840564)"
|
|
2014,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,307,66.1,59.8,72.4,3459,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,32,AGE09,CAT3,_RFPSA21,RESP046,"(39.49324039, -117.071840564)"
|
|
2014,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,146,33.9,27.6,40.2,3463,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,32,AGE09,CAT3,_RFPSA21,RESP054,"(39.49324039, -117.071840564)"
|
|
2014,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,533,41.2,36.8,45.5,3452,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,32,BO1,CAT1,_RFPSA21,RESP046,"(39.49324039, -117.071840564)"
|
|
2014,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,563,58.9,54.5,63.2,3453,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,32,BO1,CAT1,_RFPSA21,RESP054,"(39.49324039, -117.071840564)"
|
|
2014,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,25,24.9,12.2,37.6,3474,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,32,EDUCA1,CAT5,_RFPSA21,RESP046,"(39.49324039, -117.071840564)"
|
|
2014,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,52,75.1,62.4,87.8,3478,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,32,EDUCA1,CAT5,_RFPSA21,RESP054,"(39.49324039, -117.071840564)"
|
|
2014,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,93,27.1,20,34.3,3475,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,32,EDUCA2,CAT5,_RFPSA21,RESP046,"(39.49324039, -117.071840564)"
|
|
2014,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,168,72.9,65.8,80,3479,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,32,EDUCA2,CAT5,_RFPSA21,RESP054,"(39.49324039, -117.071840564)"
|
|
2014,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,180,52.2,44.6,59.7,3476,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,32,EDUCA3,CAT5,_RFPSA21,RESP046,"(39.49324039, -117.071840564)"
|
|
2014,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,145,47.8,40.3,55.4,3480,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,32,EDUCA3,CAT5,_RFPSA21,RESP054,"(39.49324039, -117.071840564)"
|
|
2014,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,233,52.4,45.5,59.3,3477,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,32,EDUCA4,CAT5,_RFPSA21,RESP046,"(39.49324039, -117.071840564)"
|
|
2014,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,196,47.6,40.7,54.5,3481,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,32,EDUCA4,CAT5,_RFPSA21,RESP054,"(39.49324039, -117.071840564)"
|
|
2014,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,13,,,,3482,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,32,INCOME1,CAT6,_RFPSA21,RESP046,"(39.49324039, -117.071840564)"
|
|
2014,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,54,90.9,82.1,99.8,3487,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,32,INCOME1,CAT6,_RFPSA21,RESP054,"(39.49324039, -117.071840564)"
|
|
2014,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,56,34.9,22.3,47.5,3483,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,32,INCOME2,CAT6,_RFPSA21,RESP046,"(39.49324039, -117.071840564)"
|
|
2014,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,84,65.1,52.5,77.7,3488,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,32,INCOME2,CAT6,_RFPSA21,RESP054,"(39.49324039, -117.071840564)"
|
|
2014,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,43,34.5,20.3,48.7,3484,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,32,INCOME3,CAT6,_RFPSA21,RESP046,"(39.49324039, -117.071840564)"
|
|
2014,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,50,65.5,51.3,79.7,3489,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,32,INCOME3,CAT6,_RFPSA21,RESP054,"(39.49324039, -117.071840564)"
|
|
2014,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,83,44.6,32.9,56.3,3485,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,32,INCOME4,CAT6,_RFPSA21,RESP046,"(39.49324039, -117.071840564)"
|
|
2014,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,79,55.4,43.7,67.1,3490,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,32,INCOME4,CAT6,_RFPSA21,RESP054,"(39.49324039, -117.071840564)"
|
|
2014,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,289,49.6,43.5,55.7,3486,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,32,INCOME5,CAT6,_RFPSA21,RESP046,"(39.49324039, -117.071840564)"
|
|
2014,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,243,50.4,44.3,56.5,3491,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,32,INCOME5,CAT6,_RFPSA21,RESP054,"(39.49324039, -117.071840564)"
|
|
2014,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,445,46.5,41.6,51.4,3464,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,32,RACE1,CAT4,_RFPSA21,RESP046,"(39.49324039, -117.071840564)"
|
|
2014,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,414,53.5,48.6,58.4,3469,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,32,RACE1,CAT4,_RFPSA21,RESP054,"(39.49324039, -117.071840564)"
|
|
2014,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,21,,,,3465,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,32,RACE2,CAT4,_RFPSA21,RESP046,"(39.49324039, -117.071840564)"
|
|
2014,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,23,,,,3470,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,32,RACE2,CAT4,_RFPSA21,RESP054,"(39.49324039, -117.071840564)"
|
|
2014,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,21,21.8,11.1,32.5,3466,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,32,RACE3,CAT4,_RFPSA21,RESP046,"(39.49324039, -117.071840564)"
|
|
2014,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,72,78.2,67.5,88.9,3471,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,32,RACE3,CAT4,_RFPSA21,RESP054,"(39.49324039, -117.071840564)"
|
|
2014,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,18,,,,3467,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,32,RACE4,CAT4,_RFPSA21,RESP046,"(39.49324039, -117.071840564)"
|
|
2014,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,28,,,,3472,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,32,RACE4,CAT4,_RFPSA21,RESP054,"(39.49324039, -117.071840564)"
|
|
2014,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,15,,,,3468,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,32,RACE5,CAT4,_RFPSA21,RESP046,"(39.49324039, -117.071840564)"
|
|
2014,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,17,,,,3473,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,32,RACE5,CAT4,_RFPSA21,RESP054,"(39.49324039, -117.071840564)"
|
|
2014,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,533,41.2,36.8,45.5,3454,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,32,SEX1,CAT2,_RFPSA21,RESP046,"(39.49324039, -117.071840564)"
|
|
2014,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,563,58.9,54.5,63.2,3455,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,32,SEX1,CAT2,_RFPSA21,RESP054,"(39.49324039, -117.071840564)"
|
|
2014,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,38,10.8,6.8,14.7,3434,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,33,AGE06,CAT3,_RFPSA21,RESP046,"(43.655950113, -71.50036092)"
|
|
2014,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,288,89.2,85.3,93.2,3438,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,33,AGE06,CAT3,_RFPSA21,RESP054,"(43.655950113, -71.50036092)"
|
|
2014,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,155,34.9,29.3,40.6,3435,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,33,AGE07,CAT3,_RFPSA21,RESP046,"(43.655950113, -71.50036092)"
|
|
2014,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,294,65.1,59.4,70.7,3439,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,33,AGE07,CAT3,_RFPSA21,RESP054,"(43.655950113, -71.50036092)"
|
|
2014,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,153,58,50.9,65.1,3436,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,33,AGE08,CAT3,_RFPSA21,RESP046,"(43.655950113, -71.50036092)"
|
|
2014,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,124,42,34.9,49.1,3440,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,33,AGE08,CAT3,_RFPSA21,RESP054,"(43.655950113, -71.50036092)"
|
|
2014,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,454,61.6,57.1,66.1,3437,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,33,AGE09,CAT3,_RFPSA21,RESP046,"(43.655950113, -71.50036092)"
|
|
2014,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,316,38.4,33.9,42.9,3441,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,33,AGE09,CAT3,_RFPSA21,RESP054,"(43.655950113, -71.50036092)"
|
|
2014,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,800,39.4,36.5,42.3,3430,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,33,BO1,CAT1,_RFPSA21,RESP046,"(43.655950113, -71.50036092)"
|
|
2014,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1022,60.6,57.8,63.5,3431,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,33,BO1,CAT1,_RFPSA21,RESP054,"(43.655950113, -71.50036092)"
|
|
2014,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,31,29.7,18.7,40.7,3452,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,33,EDUCA1,CAT5,_RFPSA21,RESP046,"(43.655950113, -71.50036092)"
|
|
2014,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,67,70.3,59.3,81.3,3456,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,33,EDUCA1,CAT5,_RFPSA21,RESP054,"(43.655950113, -71.50036092)"
|
|
2014,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,175,29.4,24.5,34.3,3453,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,33,EDUCA2,CAT5,_RFPSA21,RESP046,"(43.655950113, -71.50036092)"
|
|
2014,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,347,70.6,65.7,75.5,3457,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,33,EDUCA2,CAT5,_RFPSA21,RESP054,"(43.655950113, -71.50036092)"
|
|
2014,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,194,45.3,39,51.5,3454,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,33,EDUCA3,CAT5,_RFPSA21,RESP046,"(43.655950113, -71.50036092)"
|
|
2014,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,221,54.8,48.5,61,3458,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,33,EDUCA3,CAT5,_RFPSA21,RESP054,"(43.655950113, -71.50036092)"
|
|
2014,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,398,46.7,42.4,51.1,3455,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,33,EDUCA4,CAT5,_RFPSA21,RESP046,"(43.655950113, -71.50036092)"
|
|
2014,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,384,53.3,48.9,57.6,3459,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,33,EDUCA4,CAT5,_RFPSA21,RESP054,"(43.655950113, -71.50036092)"
|
|
2014,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,23,23.1,11.7,34.5,3460,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,33,INCOME1,CAT6,_RFPSA21,RESP046,"(43.655950113, -71.50036092)"
|
|
2014,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,78,76.9,65.5,88.3,3465,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,33,INCOME1,CAT6,_RFPSA21,RESP054,"(43.655950113, -71.50036092)"
|
|
2014,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,68,30.7,22.3,39,3461,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,33,INCOME2,CAT6,_RFPSA21,RESP046,"(43.655950113, -71.50036092)"
|
|
2014,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,128,69.4,61,77.7,3466,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,33,INCOME2,CAT6,_RFPSA21,RESP054,"(43.655950113, -71.50036092)"
|
|
2014,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,63,38.1,27.2,49,3462,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,33,INCOME3,CAT6,_RFPSA21,RESP046,"(43.655950113, -71.50036092)"
|
|
2014,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,84,61.9,51,72.8,3467,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,33,INCOME3,CAT6,_RFPSA21,RESP054,"(43.655950113, -71.50036092)"
|
|
2014,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,111,41.7,33.7,49.8,3463,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,33,INCOME4,CAT6,_RFPSA21,RESP046,"(43.655950113, -71.50036092)"
|
|
2014,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,115,58.3,50.3,66.3,3468,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,33,INCOME4,CAT6,_RFPSA21,RESP054,"(43.655950113, -71.50036092)"
|
|
2014,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,454,42.4,38.4,46.3,3464,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,33,INCOME5,CAT6,_RFPSA21,RESP046,"(43.655950113, -71.50036092)"
|
|
2014,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,515,57.6,53.7,61.6,3469,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,33,INCOME5,CAT6,_RFPSA21,RESP054,"(43.655950113, -71.50036092)"
|
|
2014,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,758,39.9,36.9,42.9,3442,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,33,RACE1,CAT4,_RFPSA21,RESP046,"(43.655950113, -71.50036092)"
|
|
2014,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,951,60.1,57.2,63.1,3447,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,33,RACE1,CAT4,_RFPSA21,RESP054,"(43.655950113, -71.50036092)"
|
|
2014,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,2,,,,3443,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,33,RACE2,CAT4,_RFPSA21,RESP046,"(43.655950113, -71.50036092)"
|
|
2014,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,7,,,,3448,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,33,RACE2,CAT4,_RFPSA21,RESP054,"(43.655950113, -71.50036092)"
|
|
2014,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,8,,,,3444,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,33,RACE3,CAT4,_RFPSA21,RESP046,"(43.655950113, -71.50036092)"
|
|
2014,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,5,,,,3449,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,33,RACE3,CAT4,_RFPSA21,RESP054,"(43.655950113, -71.50036092)"
|
|
2014,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,15,,,,3445,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,33,RACE4,CAT4,_RFPSA21,RESP046,"(43.655950113, -71.50036092)"
|
|
2014,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,32,,,,3450,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,33,RACE4,CAT4,_RFPSA21,RESP054,"(43.655950113, -71.50036092)"
|
|
2014,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,6,,,,3446,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,33,RACE5,CAT4,_RFPSA21,RESP046,"(43.655950113, -71.50036092)"
|
|
2014,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,11,,,,3451,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,33,RACE5,CAT4,_RFPSA21,RESP054,"(43.655950113, -71.50036092)"
|
|
2014,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,800,39.4,36.5,42.3,3432,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,33,SEX1,CAT2,_RFPSA21,RESP046,"(43.655950113, -71.50036092)"
|
|
2014,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1022,60.6,57.8,63.5,3433,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,33,SEX1,CAT2,_RFPSA21,RESP054,"(43.655950113, -71.50036092)"
|
|
2014,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,147,17.4,13.8,21.1,3465,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,AGE06,CAT3,_RFPSA21,RESP046,"(40.130570048, -74.273691288)"
|
|
2014,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,595,82.6,78.9,86.2,3469,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,AGE06,CAT3,_RFPSA21,RESP054,"(40.130570048, -74.273691288)"
|
|
2014,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,505,46.7,42.4,51.1,3466,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,AGE07,CAT3,_RFPSA21,RESP046,"(40.130570048, -74.273691288)"
|
|
2014,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,534,53.3,49,57.6,3470,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,AGE07,CAT3,_RFPSA21,RESP054,"(40.130570048, -74.273691288)"
|
|
2014,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,330,57.1,50.3,63.9,3467,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,AGE08,CAT3,_RFPSA21,RESP046,"(40.130570048, -74.273691288)"
|
|
2014,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,182,42.9,36.1,49.7,3471,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,AGE08,CAT3,_RFPSA21,RESP054,"(40.130570048, -74.273691288)"
|
|
2014,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,897,66.8,62.9,70.7,3468,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,AGE09,CAT3,_RFPSA21,RESP046,"(40.130570048, -74.273691288)"
|
|
2014,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,407,33.2,29.3,37.1,3472,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,AGE09,CAT3,_RFPSA21,RESP054,"(40.130570048, -74.273691288)"
|
|
2014,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1879,44.8,42.5,47.2,3461,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,BO1,CAT1,_RFPSA21,RESP046,"(40.130570048, -74.273691288)"
|
|
2014,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1718,55.2,52.8,57.5,3462,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,BO1,CAT1,_RFPSA21,RESP054,"(40.130570048, -74.273691288)"
|
|
2014,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,91,29.3,22.5,36.2,3483,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,EDUCA1,CAT5,_RFPSA21,RESP046,"(40.130570048, -74.273691288)"
|
|
2014,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,157,70.7,63.8,77.5,3487,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,EDUCA1,CAT5,_RFPSA21,RESP054,"(40.130570048, -74.273691288)"
|
|
2014,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,453,43.8,39.4,48.2,3484,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,EDUCA2,CAT5,_RFPSA21,RESP046,"(40.130570048, -74.273691288)"
|
|
2014,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,484,56.2,51.8,60.6,3488,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,EDUCA2,CAT5,_RFPSA21,RESP054,"(40.130570048, -74.273691288)"
|
|
2014,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,396,44.6,39.4,49.7,3485,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,EDUCA3,CAT5,_RFPSA21,RESP046,"(40.130570048, -74.273691288)"
|
|
2014,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,380,55.5,50.3,60.6,3489,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,EDUCA3,CAT5,_RFPSA21,RESP054,"(40.130570048, -74.273691288)"
|
|
2014,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,936,51.4,47.7,55,3486,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,EDUCA4,CAT5,_RFPSA21,RESP046,"(40.130570048, -74.273691288)"
|
|
2014,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,687,48.6,45,52.3,3490,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,EDUCA4,CAT5,_RFPSA21,RESP054,"(40.130570048, -74.273691288)"
|
|
2014,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,59,22.8,15.5,30.1,3491,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,INCOME1,CAT6,_RFPSA21,RESP046,"(40.130570048, -74.273691288)"
|
|
2014,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,118,77.2,69.9,84.5,3496,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,INCOME1,CAT6,_RFPSA21,RESP054,"(40.130570048, -74.273691288)"
|
|
2014,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,193,41.6,35,48.2,3492,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,INCOME2,CAT6,_RFPSA21,RESP046,"(40.130570048, -74.273691288)"
|
|
2014,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,217,58.4,51.8,65.1,3497,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,INCOME2,CAT6,_RFPSA21,RESP054,"(40.130570048, -74.273691288)"
|
|
2014,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,107,37.2,28.3,46.1,3493,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,INCOME3,CAT6,_RFPSA21,RESP046,"(40.130570048, -74.273691288)"
|
|
2014,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,132,62.8,53.9,71.7,3498,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,INCOME3,CAT6,_RFPSA21,RESP054,"(40.130570048, -74.273691288)"
|
|
2014,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,213,56,48.8,63.1,3494,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,INCOME4,CAT6,_RFPSA21,RESP046,"(40.130570048, -74.273691288)"
|
|
2014,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,153,44,36.9,51.2,3499,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,INCOME4,CAT6,_RFPSA21,RESP054,"(40.130570048, -74.273691288)"
|
|
2014,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,1109,47.3,44.1,50.5,3495,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,INCOME5,CAT6,_RFPSA21,RESP046,"(40.130570048, -74.273691288)"
|
|
2014,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,924,52.7,49.5,55.9,3500,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,INCOME5,CAT6,_RFPSA21,RESP054,"(40.130570048, -74.273691288)"
|
|
2014,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1508,50.5,47.8,53.2,3473,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,RACE1,CAT4,_RFPSA21,RESP046,"(40.130570048, -74.273691288)"
|
|
2014,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1187,49.5,46.8,52.3,3478,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,RACE1,CAT4,_RFPSA21,RESP054,"(40.130570048, -74.273691288)"
|
|
2014,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,159,43.5,35.7,51.3,3474,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,RACE2,CAT4,_RFPSA21,RESP046,"(40.130570048, -74.273691288)"
|
|
2014,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,168,56.5,48.7,64.3,3479,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,RACE2,CAT4,_RFPSA21,RESP054,"(40.130570048, -74.273691288)"
|
|
2014,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,117,29.5,23.5,35.6,3475,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,RACE3,CAT4,_RFPSA21,RESP046,"(40.130570048, -74.273691288)"
|
|
2014,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,204,70.5,64.4,76.5,3480,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,RACE3,CAT4,_RFPSA21,RESP054,"(40.130570048, -74.273691288)"
|
|
2014,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,48,30.2,20.9,39.5,3476,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,RACE4,CAT4,_RFPSA21,RESP046,"(40.130570048, -74.273691288)"
|
|
2014,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,104,69.8,60.5,79.1,3481,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,RACE4,CAT4,_RFPSA21,RESP054,"(40.130570048, -74.273691288)"
|
|
2014,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,12,,,,3477,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,34,RACE5,CAT4,_RFPSA21,RESP046,"(40.130570048, -74.273691288)"
|
|
2014,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,7,,,,3482,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,34,RACE5,CAT4,_RFPSA21,RESP054,"(40.130570048, -74.273691288)"
|
|
2014,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1879,44.8,42.5,47.2,3463,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,SEX1,CAT2,_RFPSA21,RESP046,"(40.130570048, -74.273691288)"
|
|
2014,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1718,55.2,52.8,57.5,3464,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,34,SEX1,CAT2,_RFPSA21,RESP054,"(40.130570048, -74.273691288)"
|
|
2014,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,52,13.8,8.9,18.7,3457,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,35,AGE06,CAT3,_RFPSA21,RESP046,"(34.520880952, -106.240580985)"
|
|
2014,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,334,86.2,81.3,91.1,3461,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,35,AGE06,CAT3,_RFPSA21,RESP054,"(34.520880952, -106.240580985)"
|
|
2014,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,279,39.2,34.2,44.2,3458,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,35,AGE07,CAT3,_RFPSA21,RESP046,"(34.520880952, -106.240580985)"
|
|
2014,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,437,60.8,55.8,65.8,3462,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,35,AGE07,CAT3,_RFPSA21,RESP054,"(34.520880952, -106.240580985)"
|
|
2014,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,193,49.5,42.8,56.2,3459,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,35,AGE08,CAT3,_RFPSA21,RESP046,"(34.520880952, -106.240580985)"
|
|
2014,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,195,50.5,43.8,57.2,3463,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,35,AGE08,CAT3,_RFPSA21,RESP054,"(34.520880952, -106.240580985)"
|
|
2014,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,626,57.1,52.7,61.4,3460,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,35,AGE09,CAT3,_RFPSA21,RESP046,"(34.520880952, -106.240580985)"
|
|
2014,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,409,43,38.6,47.3,3464,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,35,AGE09,CAT3,_RFPSA21,RESP054,"(34.520880952, -106.240580985)"
|
|
2014,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1150,40.1,37.4,42.8,3453,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,35,BO1,CAT1,_RFPSA21,RESP046,"(34.520880952, -106.240580985)"
|
|
2014,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1375,59.9,57.2,62.6,3454,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,35,BO1,CAT1,_RFPSA21,RESP054,"(34.520880952, -106.240580985)"
|
|
2014,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,74,24.8,17.9,31.6,3475,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,35,EDUCA1,CAT5,_RFPSA21,RESP046,"(34.520880952, -106.240580985)"
|
|
2014,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,190,75.2,68.4,82.1,3479,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,35,EDUCA1,CAT5,_RFPSA21,RESP054,"(34.520880952, -106.240580985)"
|
|
2014,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,237,33.1,28,38.2,3476,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,35,EDUCA2,CAT5,_RFPSA21,RESP046,"(34.520880952, -106.240580985)"
|
|
2014,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,414,66.9,61.8,72,3480,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,35,EDUCA2,CAT5,_RFPSA21,RESP054,"(34.520880952, -106.240580985)"
|
|
2014,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,258,42.2,36.6,47.8,3477,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,35,EDUCA3,CAT5,_RFPSA21,RESP046,"(34.520880952, -106.240580985)"
|
|
2014,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,332,57.8,52.2,63.4,3481,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,35,EDUCA3,CAT5,_RFPSA21,RESP054,"(34.520880952, -106.240580985)"
|
|
2014,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,579,52.8,48.7,56.9,3478,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,35,EDUCA4,CAT5,_RFPSA21,RESP046,"(34.520880952, -106.240580985)"
|
|
2014,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,437,47.2,43.1,51.3,3482,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,35,EDUCA4,CAT5,_RFPSA21,RESP054,"(34.520880952, -106.240580985)"
|
|
2014,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,51,17.3,11,23.5,3483,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,35,INCOME1,CAT6,_RFPSA21,RESP046,"(34.520880952, -106.240580985)"
|
|
2014,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,199,82.8,76.5,89,3488,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,35,INCOME1,CAT6,_RFPSA21,RESP054,"(34.520880952, -106.240580985)"
|
|
2014,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,147,31.6,25.5,37.6,3484,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,35,INCOME2,CAT6,_RFPSA21,RESP046,"(34.520880952, -106.240580985)"
|
|
2014,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,265,68.4,62.4,74.5,3489,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,35,INCOME2,CAT6,_RFPSA21,RESP054,"(34.520880952, -106.240580985)"
|
|
2014,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,109,38.2,29.4,46.9,3485,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,35,INCOME3,CAT6,_RFPSA21,RESP046,"(34.520880952, -106.240580985)"
|
|
2014,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,145,61.8,53.1,70.6,3490,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,35,INCOME3,CAT6,_RFPSA21,RESP054,"(34.520880952, -106.240580985)"
|
|
2014,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,151,42.6,35,50.2,3486,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,35,INCOME4,CAT6,_RFPSA21,RESP046,"(34.520880952, -106.240580985)"
|
|
2014,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,161,57.4,49.8,65,3491,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,35,INCOME4,CAT6,_RFPSA21,RESP054,"(34.520880952, -106.240580985)"
|
|
2014,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,581,47.9,43.7,52.2,3487,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,35,INCOME5,CAT6,_RFPSA21,RESP046,"(34.520880952, -106.240580985)"
|
|
2014,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,503,52.1,47.8,56.4,3492,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,35,INCOME5,CAT6,_RFPSA21,RESP054,"(34.520880952, -106.240580985)"
|
|
2014,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,771,46.8,43.2,50.3,3465,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,35,RACE1,CAT4,_RFPSA21,RESP046,"(34.520880952, -106.240580985)"
|
|
2014,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,745,53.2,49.7,56.8,3470,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,35,RACE1,CAT4,_RFPSA21,RESP054,"(34.520880952, -106.240580985)"
|
|
2014,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,20,,,,3466,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,35,RACE2,CAT4,_RFPSA21,RESP046,"(34.520880952, -106.240580985)"
|
|
2014,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,16,,,,3471,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,35,RACE2,CAT4,_RFPSA21,RESP054,"(34.520880952, -106.240580985)"
|
|
2014,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,248,31.4,26.7,36.1,3467,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,35,RACE3,CAT4,_RFPSA21,RESP046,"(34.520880952, -106.240580985)"
|
|
2014,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,434,68.6,63.9,73.3,3472,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,35,RACE3,CAT4,_RFPSA21,RESP054,"(34.520880952, -106.240580985)"
|
|
2014,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,61,32.5,23.7,41.4,3468,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,35,RACE4,CAT4,_RFPSA21,RESP046,"(34.520880952, -106.240580985)"
|
|
2014,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,143,67.5,58.6,76.3,3473,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,35,RACE4,CAT4,_RFPSA21,RESP054,"(34.520880952, -106.240580985)"
|
|
2014,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,10,,,,3469,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,35,RACE5,CAT4,_RFPSA21,RESP046,"(34.520880952, -106.240580985)"
|
|
2014,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,17,,,,3474,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,35,RACE5,CAT4,_RFPSA21,RESP054,"(34.520880952, -106.240580985)"
|
|
2014,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1150,40.1,37.4,42.8,3455,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,35,SEX1,CAT2,_RFPSA21,RESP046,"(34.520880952, -106.240580985)"
|
|
2014,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1375,59.9,57.2,62.6,3456,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,35,SEX1,CAT2,_RFPSA21,RESP054,"(34.520880952, -106.240580985)"
|
|
2014,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,66,18,13.5,22.5,3456,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,36,AGE06,CAT3,_RFPSA21,RESP046,"(42.827001032, -75.543970427)"
|
|
2014,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,280,82,77.5,86.5,3460,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,36,AGE06,CAT3,_RFPSA21,RESP054,"(42.827001032, -75.543970427)"
|
|
2014,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,211,40.1,34.9,45.2,3457,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,36,AGE07,CAT3,_RFPSA21,RESP046,"(42.827001032, -75.543970427)"
|
|
2014,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,295,59.9,54.8,65.1,3461,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,36,AGE07,CAT3,_RFPSA21,RESP054,"(42.827001032, -75.543970427)"
|
|
2014,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,147,57.3,50.1,64.6,3458,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,36,AGE08,CAT3,_RFPSA21,RESP046,"(42.827001032, -75.543970427)"
|
|
2014,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,118,42.7,35.4,49.9,3462,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,36,AGE08,CAT3,_RFPSA21,RESP054,"(42.827001032, -75.543970427)"
|
|
2014,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,445,59,54.2,63.8,3459,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,36,AGE09,CAT3,_RFPSA21,RESP046,"(42.827001032, -75.543970427)"
|
|
2014,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,278,41,36.2,45.8,3463,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,36,AGE09,CAT3,_RFPSA21,RESP054,"(42.827001032, -75.543970427)"
|
|
2014,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,869,41.8,39.1,44.6,3452,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,36,BO1,CAT1,_RFPSA21,RESP046,"(42.827001032, -75.543970427)"
|
|
2014,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,971,58.2,55.4,60.9,3453,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,36,BO1,CAT1,_RFPSA21,RESP054,"(42.827001032, -75.543970427)"
|
|
2014,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,50,28.3,20,36.5,3474,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,36,EDUCA1,CAT5,_RFPSA21,RESP046,"(42.827001032, -75.543970427)"
|
|
2014,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,97,71.7,63.5,80,3478,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,36,EDUCA1,CAT5,_RFPSA21,RESP054,"(42.827001032, -75.543970427)"
|
|
2014,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,177,38.5,33,44,3475,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,36,EDUCA2,CAT5,_RFPSA21,RESP046,"(42.827001032, -75.543970427)"
|
|
2014,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,238,61.5,56,67,3479,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,36,EDUCA2,CAT5,_RFPSA21,RESP054,"(42.827001032, -75.543970427)"
|
|
2014,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,194,43.9,38.4,49.4,3476,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,36,EDUCA3,CAT5,_RFPSA21,RESP046,"(42.827001032, -75.543970427)"
|
|
2014,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,228,56.1,50.6,61.6,3480,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,36,EDUCA3,CAT5,_RFPSA21,RESP054,"(42.827001032, -75.543970427)"
|
|
2014,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,444,49.2,45.2,53.1,3477,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,36,EDUCA4,CAT5,_RFPSA21,RESP046,"(42.827001032, -75.543970427)"
|
|
2014,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,399,50.9,46.9,54.8,3481,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,36,EDUCA4,CAT5,_RFPSA21,RESP054,"(42.827001032, -75.543970427)"
|
|
2014,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,58,28.6,19.9,37.3,3482,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,36,INCOME1,CAT6,_RFPSA21,RESP046,"(42.827001032, -75.543970427)"
|
|
2014,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,107,71.4,62.7,80.1,3487,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,36,INCOME1,CAT6,_RFPSA21,RESP054,"(42.827001032, -75.543970427)"
|
|
2014,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,99,34.6,27.6,41.5,3483,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,36,INCOME2,CAT6,_RFPSA21,RESP046,"(42.827001032, -75.543970427)"
|
|
2014,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,149,65.4,58.5,72.4,3488,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,36,INCOME2,CAT6,_RFPSA21,RESP054,"(42.827001032, -75.543970427)"
|
|
2014,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,52,33.1,23.2,42.9,3484,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,36,INCOME3,CAT6,_RFPSA21,RESP046,"(42.827001032, -75.543970427)"
|
|
2014,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,74,67,57.1,76.8,3489,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,36,INCOME3,CAT6,_RFPSA21,RESP054,"(42.827001032, -75.543970427)"
|
|
2014,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,116,45.2,37.3,53,3485,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,36,INCOME4,CAT6,_RFPSA21,RESP046,"(42.827001032, -75.543970427)"
|
|
2014,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,128,54.8,47,62.7,3490,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,36,INCOME4,CAT6,_RFPSA21,RESP054,"(42.827001032, -75.543970427)"
|
|
2014,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,453,46,42.1,49.9,3486,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,36,INCOME5,CAT6,_RFPSA21,RESP046,"(42.827001032, -75.543970427)"
|
|
2014,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,435,54,50.1,57.9,3491,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,36,INCOME5,CAT6,_RFPSA21,RESP054,"(42.827001032, -75.543970427)"
|
|
2014,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,663,44.4,41.3,47.6,3464,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,36,RACE1,CAT4,_RFPSA21,RESP046,"(42.827001032, -75.543970427)"
|
|
2014,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,687,55.6,52.4,58.7,3469,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,36,RACE1,CAT4,_RFPSA21,RESP054,"(42.827001032, -75.543970427)"
|
|
2014,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,84,46.8,37.6,55.9,3465,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,36,RACE2,CAT4,_RFPSA21,RESP046,"(42.827001032, -75.543970427)"
|
|
2014,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,87,53.2,44.1,62.4,3470,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,36,RACE2,CAT4,_RFPSA21,RESP054,"(42.827001032, -75.543970427)"
|
|
2014,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,55,30.8,22.4,39.3,3466,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,36,RACE3,CAT4,_RFPSA21,RESP046,"(42.827001032, -75.543970427)"
|
|
2014,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,103,69.2,60.7,77.6,3471,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,36,RACE3,CAT4,_RFPSA21,RESP054,"(42.827001032, -75.543970427)"
|
|
2014,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,27,26.2,15.3,37.1,3467,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,36,RACE4,CAT4,_RFPSA21,RESP046,"(42.827001032, -75.543970427)"
|
|
2014,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,64,73.8,62.9,84.7,3472,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,36,RACE4,CAT4,_RFPSA21,RESP054,"(42.827001032, -75.543970427)"
|
|
2014,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,5,,,,3468,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,36,RACE5,CAT4,_RFPSA21,RESP046,"(42.827001032, -75.543970427)"
|
|
2014,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,6,,,,3473,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,36,RACE5,CAT4,_RFPSA21,RESP054,"(42.827001032, -75.543970427)"
|
|
2014,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,869,41.8,39.1,44.6,3454,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,36,SEX1,CAT2,_RFPSA21,RESP046,"(42.827001032, -75.543970427)"
|
|
2014,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,971,58.2,55.4,60.9,3455,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,36,SEX1,CAT2,_RFPSA21,RESP054,"(42.827001032, -75.543970427)"
|
|
2014,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,85,19.5,15.3,23.6,3463,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,AGE06,CAT3,_RFPSA21,RESP046,"(35.466220975, -79.159250463)"
|
|
2014,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,345,80.5,76.4,84.7,3467,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,AGE06,CAT3,_RFPSA21,RESP054,"(35.466220975, -79.159250463)"
|
|
2014,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,224,45.1,40.1,50,3464,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,AGE07,CAT3,_RFPSA21,RESP046,"(35.466220975, -79.159250463)"
|
|
2014,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,279,54.9,50,59.9,3468,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,AGE07,CAT3,_RFPSA21,RESP054,"(35.466220975, -79.159250463)"
|
|
2014,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,177,58,51.5,64.5,3465,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,AGE08,CAT3,_RFPSA21,RESP046,"(35.466220975, -79.159250463)"
|
|
2014,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,124,42,35.5,48.5,3469,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,AGE08,CAT3,_RFPSA21,RESP054,"(35.466220975, -79.159250463)"
|
|
2014,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,501,64.7,60.6,68.7,3466,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,AGE09,CAT3,_RFPSA21,RESP046,"(35.466220975, -79.159250463)"
|
|
2014,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,252,35.3,31.3,39.4,3470,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,AGE09,CAT3,_RFPSA21,RESP054,"(35.466220975, -79.159250463)"
|
|
2014,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,987,44.3,41.8,46.9,3459,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,BO1,CAT1,_RFPSA21,RESP046,"(35.466220975, -79.159250463)"
|
|
2014,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1000,55.7,53.1,58.2,3460,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,BO1,CAT1,_RFPSA21,RESP054,"(35.466220975, -79.159250463)"
|
|
2014,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,96,31.3,25.2,37.3,3481,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,EDUCA1,CAT5,_RFPSA21,RESP046,"(35.466220975, -79.159250463)"
|
|
2014,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,176,68.7,62.7,74.8,3485,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,EDUCA1,CAT5,_RFPSA21,RESP054,"(35.466220975, -79.159250463)"
|
|
2014,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,222,40.1,35.3,44.8,3482,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,EDUCA2,CAT5,_RFPSA21,RESP046,"(35.466220975, -79.159250463)"
|
|
2014,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,298,59.9,55.2,64.7,3486,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,EDUCA2,CAT5,_RFPSA21,RESP054,"(35.466220975, -79.159250463)"
|
|
2014,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,255,49,43.8,54.1,3483,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,EDUCA3,CAT5,_RFPSA21,RESP046,"(35.466220975, -79.159250463)"
|
|
2014,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,228,51.1,45.9,56.2,3487,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,EDUCA3,CAT5,_RFPSA21,RESP054,"(35.466220975, -79.159250463)"
|
|
2014,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,411,52.7,48.4,56.9,3484,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,EDUCA4,CAT5,_RFPSA21,RESP046,"(35.466220975, -79.159250463)"
|
|
2014,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,295,47.3,43.1,51.6,3488,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,EDUCA4,CAT5,_RFPSA21,RESP054,"(35.466220975, -79.159250463)"
|
|
2014,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,51,26.5,19.2,33.9,3489,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,INCOME1,CAT6,_RFPSA21,RESP046,"(35.466220975, -79.159250463)"
|
|
2014,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,127,73.5,66.1,80.8,3494,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,INCOME1,CAT6,_RFPSA21,RESP054,"(35.466220975, -79.159250463)"
|
|
2014,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,103,31.6,25.6,37.6,3490,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,INCOME2,CAT6,_RFPSA21,RESP046,"(35.466220975, -79.159250463)"
|
|
2014,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,191,68.4,62.4,74.4,3495,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,INCOME2,CAT6,_RFPSA21,RESP054,"(35.466220975, -79.159250463)"
|
|
2014,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,80,41.2,32.6,49.7,3491,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,INCOME3,CAT6,_RFPSA21,RESP046,"(35.466220975, -79.159250463)"
|
|
2014,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,95,58.9,50.3,67.4,3496,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,INCOME3,CAT6,_RFPSA21,RESP054,"(35.466220975, -79.159250463)"
|
|
2014,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,132,46.3,38.9,53.6,3492,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,INCOME4,CAT6,_RFPSA21,RESP046,"(35.466220975, -79.159250463)"
|
|
2014,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,107,53.8,46.4,61.1,3497,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,INCOME4,CAT6,_RFPSA21,RESP054,"(35.466220975, -79.159250463)"
|
|
2014,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,456,50.6,46.5,54.6,3493,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,INCOME5,CAT6,_RFPSA21,RESP046,"(35.466220975, -79.159250463)"
|
|
2014,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,347,49.4,45.4,53.5,3498,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,INCOME5,CAT6,_RFPSA21,RESP054,"(35.466220975, -79.159250463)"
|
|
2014,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,784,47.2,44.2,50.1,3471,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,RACE1,CAT4,_RFPSA21,RESP046,"(35.466220975, -79.159250463)"
|
|
2014,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,688,52.9,49.9,55.8,3476,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,RACE1,CAT4,_RFPSA21,RESP054,"(35.466220975, -79.159250463)"
|
|
2014,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,146,41.7,35.5,47.9,3472,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,RACE2,CAT4,_RFPSA21,RESP046,"(35.466220975, -79.159250463)"
|
|
2014,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,176,58.3,52.1,64.5,3477,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,RACE2,CAT4,_RFPSA21,RESP054,"(35.466220975, -79.159250463)"
|
|
2014,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,24,23,13.8,32.1,3473,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,RACE3,CAT4,_RFPSA21,RESP046,"(35.466220975, -79.159250463)"
|
|
2014,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,68,77.1,67.9,86.2,3478,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,RACE3,CAT4,_RFPSA21,RESP054,"(35.466220975, -79.159250463)"
|
|
2014,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,19,26.5,13.8,39.3,3474,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,RACE4,CAT4,_RFPSA21,RESP046,"(35.466220975, -79.159250463)"
|
|
2014,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,47,73.5,60.7,86.2,3479,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,RACE4,CAT4,_RFPSA21,RESP054,"(35.466220975, -79.159250463)"
|
|
2014,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,5,,,,3475,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,37,RACE5,CAT4,_RFPSA21,RESP046,"(35.466220975, -79.159250463)"
|
|
2014,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,15,,,,3480,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,37,RACE5,CAT4,_RFPSA21,RESP054,"(35.466220975, -79.159250463)"
|
|
2014,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,987,44.3,41.8,46.9,3461,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,SEX1,CAT2,_RFPSA21,RESP046,"(35.466220975, -79.159250463)"
|
|
2014,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1000,55.7,53.1,58.2,3462,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,37,SEX1,CAT2,_RFPSA21,RESP054,"(35.466220975, -79.159250463)"
|
|
2014,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,64,13.5,8.7,18.4,3412,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,38,AGE06,CAT3,_RFPSA21,RESP046,"(47.475319779, -100.118421049)"
|
|
2014,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,304,86.5,81.7,91.3,3416,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,38,AGE06,CAT3,_RFPSA21,RESP054,"(47.475319779, -100.118421049)"
|
|
2014,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,238,36.9,31.8,41.9,3413,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,38,AGE07,CAT3,_RFPSA21,RESP046,"(47.475319779, -100.118421049)"
|
|
2014,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,403,63.1,58.1,68.2,3417,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,38,AGE07,CAT3,_RFPSA21,RESP054,"(47.475319779, -100.118421049)"
|
|
2014,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,206,51.5,44.4,58.6,3414,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,38,AGE08,CAT3,_RFPSA21,RESP046,"(47.475319779, -100.118421049)"
|
|
2014,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,162,48.5,41.4,55.6,3418,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,38,AGE08,CAT3,_RFPSA21,RESP054,"(47.475319779, -100.118421049)"
|
|
2014,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,604,62,57.7,66.3,3415,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,38,AGE09,CAT3,_RFPSA21,RESP046,"(47.475319779, -100.118421049)"
|
|
2014,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,342,38,33.7,42.3,3419,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,38,AGE09,CAT3,_RFPSA21,RESP054,"(47.475319779, -100.118421049)"
|
|
2014,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1112,41.2,38.4,44,3408,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,38,BO1,CAT1,_RFPSA21,RESP046,"(47.475319779, -100.118421049)"
|
|
2014,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1211,58.8,56,61.6,3409,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,38,BO1,CAT1,_RFPSA21,RESP054,"(47.475319779, -100.118421049)"
|
|
2014,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,55,34.2,24.1,44.3,3430,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,38,EDUCA1,CAT5,_RFPSA21,RESP046,"(47.475319779, -100.118421049)"
|
|
2014,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,100,65.8,55.7,75.9,3434,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,38,EDUCA1,CAT5,_RFPSA21,RESP054,"(47.475319779, -100.118421049)"
|
|
2014,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,310,37,32.3,41.7,3431,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,38,EDUCA2,CAT5,_RFPSA21,RESP046,"(47.475319779, -100.118421049)"
|
|
2014,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,406,63,58.4,67.7,3435,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,38,EDUCA2,CAT5,_RFPSA21,RESP054,"(47.475319779, -100.118421049)"
|
|
2014,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,341,43,38,48.1,3432,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,38,EDUCA3,CAT5,_RFPSA21,RESP046,"(47.475319779, -100.118421049)"
|
|
2014,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,356,57,51.9,62,3436,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,38,EDUCA3,CAT5,_RFPSA21,RESP054,"(47.475319779, -100.118421049)"
|
|
2014,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,403,46.3,41.6,51,3433,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,38,EDUCA4,CAT5,_RFPSA21,RESP046,"(47.475319779, -100.118421049)"
|
|
2014,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,349,53.8,49.1,58.5,3437,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,38,EDUCA4,CAT5,_RFPSA21,RESP054,"(47.475319779, -100.118421049)"
|
|
2014,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,37,35.2,22.5,47.9,3438,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,38,INCOME1,CAT6,_RFPSA21,RESP046,"(47.475319779, -100.118421049)"
|
|
2014,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,71,64.8,52.1,77.5,3443,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,38,INCOME1,CAT6,_RFPSA21,RESP054,"(47.475319779, -100.118421049)"
|
|
2014,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,90,38.1,29.2,47,3439,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,38,INCOME2,CAT6,_RFPSA21,RESP046,"(47.475319779, -100.118421049)"
|
|
2014,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,117,61.9,53,70.8,3444,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,38,INCOME2,CAT6,_RFPSA21,RESP054,"(47.475319779, -100.118421049)"
|
|
2014,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,86,31,22.7,39.2,3440,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,38,INCOME3,CAT6,_RFPSA21,RESP046,"(47.475319779, -100.118421049)"
|
|
2014,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,103,69,60.8,77.3,3445,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,38,INCOME3,CAT6,_RFPSA21,RESP054,"(47.475319779, -100.118421049)"
|
|
2014,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,156,42.8,35,50.7,3441,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,38,INCOME4,CAT6,_RFPSA21,RESP046,"(47.475319779, -100.118421049)"
|
|
2014,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,160,57.2,49.4,65,3446,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,38,INCOME4,CAT6,_RFPSA21,RESP054,"(47.475319779, -100.118421049)"
|
|
2014,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,661,43.8,40,47.6,3442,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,38,INCOME5,CAT6,_RFPSA21,RESP046,"(47.475319779, -100.118421049)"
|
|
2014,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,676,56.2,52.5,60,3447,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,38,INCOME5,CAT6,_RFPSA21,RESP054,"(47.475319779, -100.118421049)"
|
|
2014,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1064,42.4,39.6,45.3,3420,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,38,RACE1,CAT4,_RFPSA21,RESP046,"(47.475319779, -100.118421049)"
|
|
2014,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1123,57.6,54.7,60.4,3425,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,38,RACE1,CAT4,_RFPSA21,RESP054,"(47.475319779, -100.118421049)"
|
|
2014,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,2,,,,3421,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,38,RACE2,CAT4,_RFPSA21,RESP046,"(47.475319779, -100.118421049)"
|
|
2014,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,6,,,,3426,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,38,RACE2,CAT4,_RFPSA21,RESP054,"(47.475319779, -100.118421049)"
|
|
2014,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,4,,,,3422,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,38,RACE3,CAT4,_RFPSA21,RESP046,"(47.475319779, -100.118421049)"
|
|
2014,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,9,,,,3427,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,38,RACE3,CAT4,_RFPSA21,RESP054,"(47.475319779, -100.118421049)"
|
|
2014,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,16,,,,3423,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,38,RACE4,CAT4,_RFPSA21,RESP046,"(47.475319779, -100.118421049)"
|
|
2014,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,38,74.2,56,92.3,3428,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,38,RACE4,CAT4,_RFPSA21,RESP054,"(47.475319779, -100.118421049)"
|
|
2014,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,2,,,,3424,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,38,RACE5,CAT4,_RFPSA21,RESP046,"(47.475319779, -100.118421049)"
|
|
2014,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,3,,,,3429,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,38,RACE5,CAT4,_RFPSA21,RESP054,"(47.475319779, -100.118421049)"
|
|
2014,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1112,41.2,38.4,44,3410,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,38,SEX1,CAT2,_RFPSA21,RESP046,"(47.475319779, -100.118421049)"
|
|
2014,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1211,58.8,56,61.6,3411,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,38,SEX1,CAT2,_RFPSA21,RESP054,"(47.475319779, -100.118421049)"
|
|
2014,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,95,14.4,10.8,18.1,3465,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,39,AGE06,CAT3,_RFPSA21,RESP046,"(40.060210141, -82.404260056)"
|
|
2014,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,449,85.6,81.9,89.3,3469,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,39,AGE06,CAT3,_RFPSA21,RESP054,"(40.060210141, -82.404260056)"
|
|
2014,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,378,44.3,39.7,49,3466,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,39,AGE07,CAT3,_RFPSA21,RESP046,"(40.060210141, -82.404260056)"
|
|
2014,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,482,55.7,51,60.3,3470,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,39,AGE07,CAT3,_RFPSA21,RESP054,"(40.060210141, -82.404260056)"
|
|
2014,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,286,56.7,50.4,63.1,3467,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,39,AGE08,CAT3,_RFPSA21,RESP046,"(40.060210141, -82.404260056)"
|
|
2014,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,205,43.3,36.9,49.6,3471,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,39,AGE08,CAT3,_RFPSA21,RESP054,"(40.060210141, -82.404260056)"
|
|
2014,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,784,61.7,57.8,65.5,3468,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,39,AGE09,CAT3,_RFPSA21,RESP046,"(40.060210141, -82.404260056)"
|
|
2014,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,470,38.3,34.5,42.2,3472,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,39,AGE09,CAT3,_RFPSA21,RESP054,"(40.060210141, -82.404260056)"
|
|
2014,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1543,43.3,40.8,45.7,3461,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,39,BO1,CAT1,_RFPSA21,RESP046,"(40.060210141, -82.404260056)"
|
|
2014,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1606,56.7,54.3,59.2,3462,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,39,BO1,CAT1,_RFPSA21,RESP054,"(40.060210141, -82.404260056)"
|
|
2014,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,71,39.6,29.5,49.8,3483,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,39,EDUCA1,CAT5,_RFPSA21,RESP046,"(40.060210141, -82.404260056)"
|
|
2014,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,125,60.4,50.2,70.5,3487,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,39,EDUCA1,CAT5,_RFPSA21,RESP054,"(40.060210141, -82.404260056)"
|
|
2014,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,511,40.9,36.8,45,3484,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,39,EDUCA2,CAT5,_RFPSA21,RESP046,"(40.060210141, -82.404260056)"
|
|
2014,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,630,59.1,55.1,63.2,3488,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,39,EDUCA2,CAT5,_RFPSA21,RESP054,"(40.060210141, -82.404260056)"
|
|
2014,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,335,41.3,36.3,46.3,3485,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,39,EDUCA3,CAT5,_RFPSA21,RESP046,"(40.060210141, -82.404260056)"
|
|
2014,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,355,58.7,53.7,63.7,3489,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,39,EDUCA3,CAT5,_RFPSA21,RESP054,"(40.060210141, -82.404260056)"
|
|
2014,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,626,50.6,46.8,54.4,3486,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,39,EDUCA4,CAT5,_RFPSA21,RESP046,"(40.060210141, -82.404260056)"
|
|
2014,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,493,49.4,45.6,53.3,3490,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,39,EDUCA4,CAT5,_RFPSA21,RESP054,"(40.060210141, -82.404260056)"
|
|
2014,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,64,30.6,20.5,40.6,3491,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,39,INCOME1,CAT6,_RFPSA21,RESP046,"(40.060210141, -82.404260056)"
|
|
2014,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,165,69.5,59.4,79.5,3496,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,39,INCOME1,CAT6,_RFPSA21,RESP054,"(40.060210141, -82.404260056)"
|
|
2014,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,184,40,33.1,46.8,3492,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,39,INCOME2,CAT6,_RFPSA21,RESP046,"(40.060210141, -82.404260056)"
|
|
2014,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,254,60.1,53.2,66.9,3497,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,39,INCOME2,CAT6,_RFPSA21,RESP054,"(40.060210141, -82.404260056)"
|
|
2014,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,159,48.3,39.7,56.9,3493,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,39,INCOME3,CAT6,_RFPSA21,RESP046,"(40.060210141, -82.404260056)"
|
|
2014,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,164,51.7,43.1,60.3,3498,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,39,INCOME3,CAT6,_RFPSA21,RESP054,"(40.060210141, -82.404260056)"
|
|
2014,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,240,43.2,36.7,49.7,3494,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,39,INCOME4,CAT6,_RFPSA21,RESP046,"(40.060210141, -82.404260056)"
|
|
2014,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,218,56.8,50.3,63.3,3499,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,39,INCOME4,CAT6,_RFPSA21,RESP054,"(40.060210141, -82.404260056)"
|
|
2014,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,745,46.7,43.1,50.3,3495,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,39,INCOME5,CAT6,_RFPSA21,RESP046,"(40.060210141, -82.404260056)"
|
|
2014,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,622,53.3,49.7,56.9,3500,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,39,INCOME5,CAT6,_RFPSA21,RESP054,"(40.060210141, -82.404260056)"
|
|
2014,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1373,43.6,41,46.2,3473,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,39,RACE1,CAT4,_RFPSA21,RESP046,"(40.060210141, -82.404260056)"
|
|
2014,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1392,56.4,53.8,59,3478,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,39,RACE1,CAT4,_RFPSA21,RESP054,"(40.060210141, -82.404260056)"
|
|
2014,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,77,44.1,34.2,54.1,3474,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,39,RACE2,CAT4,_RFPSA21,RESP046,"(40.060210141, -82.404260056)"
|
|
2014,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,86,55.9,45.9,65.8,3479,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,39,RACE2,CAT4,_RFPSA21,RESP054,"(40.060210141, -82.404260056)"
|
|
2014,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,17,,,,3475,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,39,RACE3,CAT4,_RFPSA21,RESP046,"(40.060210141, -82.404260056)"
|
|
2014,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,12,,,,3480,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,39,RACE3,CAT4,_RFPSA21,RESP054,"(40.060210141, -82.404260056)"
|
|
2014,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,32,,,,3476,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,39,RACE4,CAT4,_RFPSA21,RESP046,"(40.060210141, -82.404260056)"
|
|
2014,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,43,63.7,41.3,86,3481,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,39,RACE4,CAT4,_RFPSA21,RESP054,"(40.060210141, -82.404260056)"
|
|
2014,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,18,,,,3477,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,39,RACE5,CAT4,_RFPSA21,RESP046,"(40.060210141, -82.404260056)"
|
|
2014,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,29,,,,3482,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,39,RACE5,CAT4,_RFPSA21,RESP054,"(40.060210141, -82.404260056)"
|
|
2014,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1543,43.3,40.8,45.7,3463,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,39,SEX1,CAT2,_RFPSA21,RESP046,"(40.060210141, -82.404260056)"
|
|
2014,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1606,56.7,54.3,59.2,3464,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,39,SEX1,CAT2,_RFPSA21,RESP054,"(40.060210141, -82.404260056)"
|
|
2014,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,240,36.7,32.3,41.1,3468,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,AGE07,CAT3,_RFPSA21,RESP046,"(35.472031356, -97.521070214)"
|
|
2014,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,83,18.7,14.6,22.9,3467,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,AGE06,CAT3,_RFPSA21,RESP046,"(35.472031356, -97.521070214)"
|
|
2014,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,331,81.3,77.1,85.4,3471,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,AGE06,CAT3,_RFPSA21,RESP054,"(35.472031356, -97.521070214)"
|
|
2014,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,377,63.3,58.9,67.7,3472,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,AGE07,CAT3,_RFPSA21,RESP054,"(35.472031356, -97.521070214)"
|
|
2014,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,190,52,46,58.1,3469,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,AGE08,CAT3,_RFPSA21,RESP046,"(35.472031356, -97.521070214)"
|
|
2014,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,169,48,41.9,54.1,3473,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,AGE08,CAT3,_RFPSA21,RESP054,"(35.472031356, -97.521070214)"
|
|
2014,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,669,64.7,61.3,68.2,3470,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,AGE09,CAT3,_RFPSA21,RESP046,"(35.472031356, -97.521070214)"
|
|
2014,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,343,35.3,31.8,38.7,3474,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,AGE09,CAT3,_RFPSA21,RESP054,"(35.472031356, -97.521070214)"
|
|
2014,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1182,42.5,40.1,44.8,3463,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,BO1,CAT1,_RFPSA21,RESP046,"(35.472031356, -97.521070214)"
|
|
2014,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1220,57.5,55.2,59.9,3464,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,BO1,CAT1,_RFPSA21,RESP054,"(35.472031356, -97.521070214)"
|
|
2014,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,61,27.3,19.8,34.9,3485,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,EDUCA1,CAT5,_RFPSA21,RESP046,"(35.472031356, -97.521070214)"
|
|
2014,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,139,72.7,65.1,80.2,3489,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,EDUCA1,CAT5,_RFPSA21,RESP054,"(35.472031356, -97.521070214)"
|
|
2014,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,325,39.5,35.6,43.5,3486,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,EDUCA2,CAT5,_RFPSA21,RESP046,"(35.472031356, -97.521070214)"
|
|
2014,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,415,60.5,56.5,64.4,3490,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,EDUCA2,CAT5,_RFPSA21,RESP054,"(35.472031356, -97.521070214)"
|
|
2014,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,299,43.9,39.4,48.4,3487,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,EDUCA3,CAT5,_RFPSA21,RESP046,"(35.472031356, -97.521070214)"
|
|
2014,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,308,56.1,51.6,60.6,3491,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,EDUCA3,CAT5,_RFPSA21,RESP054,"(35.472031356, -97.521070214)"
|
|
2014,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,495,52.8,48.8,56.7,3488,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,EDUCA4,CAT5,_RFPSA21,RESP046,"(35.472031356, -97.521070214)"
|
|
2014,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,356,47.2,43.3,51.2,3492,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,EDUCA4,CAT5,_RFPSA21,RESP054,"(35.472031356, -97.521070214)"
|
|
2014,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,56,19.7,13.9,25.6,3493,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,INCOME1,CAT6,_RFPSA21,RESP046,"(35.472031356, -97.521070214)"
|
|
2014,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,146,80.3,74.4,86.2,3498,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,INCOME1,CAT6,_RFPSA21,RESP054,"(35.472031356, -97.521070214)"
|
|
2014,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,136,34.3,28.1,40.5,3494,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,INCOME2,CAT6,_RFPSA21,RESP046,"(35.472031356, -97.521070214)"
|
|
2014,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,217,65.7,59.5,71.9,3499,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,INCOME2,CAT6,_RFPSA21,RESP054,"(35.472031356, -97.521070214)"
|
|
2014,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,122,42.9,35.5,50.3,3495,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,INCOME3,CAT6,_RFPSA21,RESP046,"(35.472031356, -97.521070214)"
|
|
2014,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,135,57.1,49.7,64.5,3500,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,INCOME3,CAT6,_RFPSA21,RESP054,"(35.472031356, -97.521070214)"
|
|
2014,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,183,47.9,41.6,54.1,3496,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,INCOME4,CAT6,_RFPSA21,RESP046,"(35.472031356, -97.521070214)"
|
|
2014,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,149,52.1,45.9,58.4,3501,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,INCOME4,CAT6,_RFPSA21,RESP054,"(35.472031356, -97.521070214)"
|
|
2014,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,570,47.1,43.6,50.6,3497,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,INCOME5,CAT6,_RFPSA21,RESP046,"(35.472031356, -97.521070214)"
|
|
2014,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,474,52.9,49.4,56.4,3502,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,INCOME5,CAT6,_RFPSA21,RESP054,"(35.472031356, -97.521070214)"
|
|
2014,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,969,44.8,42.2,47.4,3475,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,RACE1,CAT4,_RFPSA21,RESP046,"(35.472031356, -97.521070214)"
|
|
2014,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,903,55.2,52.6,57.8,3480,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,RACE1,CAT4,_RFPSA21,RESP054,"(35.472031356, -97.521070214)"
|
|
2014,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,50,39.2,29.3,49.1,3476,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,RACE2,CAT4,_RFPSA21,RESP046,"(35.472031356, -97.521070214)"
|
|
2014,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,71,60.8,50.9,70.7,3481,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,RACE2,CAT4,_RFPSA21,RESP054,"(35.472031356, -97.521070214)"
|
|
2014,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,17,16.6,7.7,25.5,3477,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,RACE3,CAT4,_RFPSA21,RESP046,"(35.472031356, -97.521070214)"
|
|
2014,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,68,83.4,74.5,92.3,3482,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,RACE3,CAT4,_RFPSA21,RESP054,"(35.472031356, -97.521070214)"
|
|
2014,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,66,41.6,32.1,51.1,3478,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,RACE4,CAT4,_RFPSA21,RESP046,"(35.472031356, -97.521070214)"
|
|
2014,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,95,58.4,48.9,67.9,3483,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,RACE4,CAT4,_RFPSA21,RESP054,"(35.472031356, -97.521070214)"
|
|
2014,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,75,40.7,31,50.4,3479,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,RACE5,CAT4,_RFPSA21,RESP046,"(35.472031356, -97.521070214)"
|
|
2014,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,76,59.3,49.6,69,3484,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,RACE5,CAT4,_RFPSA21,RESP054,"(35.472031356, -97.521070214)"
|
|
2014,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1182,42.5,40.1,44.8,3465,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,SEX1,CAT2,_RFPSA21,RESP046,"(35.472031356, -97.521070214)"
|
|
2014,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1220,57.5,55.2,59.9,3466,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,40,SEX1,CAT2,_RFPSA21,RESP054,"(35.472031356, -97.521070214)"
|
|
2014,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,23,8.6,4.8,12.3,3453,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,41,AGE06,CAT3,_RFPSA21,RESP046,"(44.567449424, -120.155031326)"
|
|
2014,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,217,91.5,87.7,95.2,3457,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,41,AGE06,CAT3,_RFPSA21,RESP054,"(44.567449424, -120.155031326)"
|
|
2014,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,113,29.4,23.9,35,3454,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,41,AGE07,CAT3,_RFPSA21,RESP046,"(44.567449424, -120.155031326)"
|
|
2014,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,248,70.6,65.1,76.1,3458,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,41,AGE07,CAT3,_RFPSA21,RESP054,"(44.567449424, -120.155031326)"
|
|
2014,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,98,46.3,38.5,54.2,3455,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,41,AGE08,CAT3,_RFPSA21,RESP046,"(44.567449424, -120.155031326)"
|
|
2014,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,112,53.7,45.8,61.5,3459,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,41,AGE08,CAT3,_RFPSA21,RESP054,"(44.567449424, -120.155031326)"
|
|
2014,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,370,56.5,52,61,3456,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,41,AGE09,CAT3,_RFPSA21,RESP046,"(44.567449424, -120.155031326)"
|
|
2014,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,278,43.5,39,48,3460,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,41,AGE09,CAT3,_RFPSA21,RESP054,"(44.567449424, -120.155031326)"
|
|
2014,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,604,35,32.1,37.8,3449,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,41,BO1,CAT1,_RFPSA21,RESP046,"(44.567449424, -120.155031326)"
|
|
2014,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,855,65,62.2,67.9,3450,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,41,BO1,CAT1,_RFPSA21,RESP054,"(44.567449424, -120.155031326)"
|
|
2014,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,20,25.9,15,36.7,3471,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,41,EDUCA1,CAT5,_RFPSA21,RESP046,"(44.567449424, -120.155031326)"
|
|
2014,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,51,74.2,63.3,85,3475,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,41,EDUCA1,CAT5,_RFPSA21,RESP054,"(44.567449424, -120.155031326)"
|
|
2014,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,116,32.9,27,38.8,3472,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,41,EDUCA2,CAT5,_RFPSA21,RESP046,"(44.567449424, -120.155031326)"
|
|
2014,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,194,67.1,61.3,73,3476,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,41,EDUCA2,CAT5,_RFPSA21,RESP054,"(44.567449424, -120.155031326)"
|
|
2014,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,162,35.5,30.2,40.8,3473,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,41,EDUCA3,CAT5,_RFPSA21,RESP046,"(44.567449424, -120.155031326)"
|
|
2014,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,246,64.5,59.2,69.8,3477,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,41,EDUCA3,CAT5,_RFPSA21,RESP054,"(44.567449424, -120.155031326)"
|
|
2014,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,305,38.9,34.6,43.1,3474,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,41,EDUCA4,CAT5,_RFPSA21,RESP046,"(44.567449424, -120.155031326)"
|
|
2014,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,360,61.1,56.9,65.4,3478,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,41,EDUCA4,CAT5,_RFPSA21,RESP054,"(44.567449424, -120.155031326)"
|
|
2014,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,31,23.4,14.1,32.7,3479,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,41,INCOME1,CAT6,_RFPSA21,RESP046,"(44.567449424, -120.155031326)"
|
|
2014,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,76,76.6,67.3,85.9,3484,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,41,INCOME1,CAT6,_RFPSA21,RESP054,"(44.567449424, -120.155031326)"
|
|
2014,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,64,30.6,23,38.3,3480,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,41,INCOME2,CAT6,_RFPSA21,RESP046,"(44.567449424, -120.155031326)"
|
|
2014,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,112,69.4,61.7,77,3485,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,41,INCOME2,CAT6,_RFPSA21,RESP054,"(44.567449424, -120.155031326)"
|
|
2014,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,57,38.2,28.1,48.3,3481,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,41,INCOME3,CAT6,_RFPSA21,RESP046,"(44.567449424, -120.155031326)"
|
|
2014,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,76,61.8,51.7,71.9,3486,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,41,INCOME3,CAT6,_RFPSA21,RESP054,"(44.567449424, -120.155031326)"
|
|
2014,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,84,34.2,26.9,41.4,3482,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,41,INCOME4,CAT6,_RFPSA21,RESP046,"(44.567449424, -120.155031326)"
|
|
2014,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,131,65.8,58.6,73.1,3487,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,41,INCOME4,CAT6,_RFPSA21,RESP054,"(44.567449424, -120.155031326)"
|
|
2014,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,304,38.1,33.8,42.4,3483,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,41,INCOME5,CAT6,_RFPSA21,RESP046,"(44.567449424, -120.155031326)"
|
|
2014,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,375,61.9,57.6,66.3,3488,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,41,INCOME5,CAT6,_RFPSA21,RESP054,"(44.567449424, -120.155031326)"
|
|
2014,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,540,37.7,34.6,40.8,3461,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,41,RACE1,CAT4,_RFPSA21,RESP046,"(44.567449424, -120.155031326)"
|
|
2014,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,706,62.3,59.2,65.4,3466,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,41,RACE1,CAT4,_RFPSA21,RESP054,"(44.567449424, -120.155031326)"
|
|
2014,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,8,,,,3462,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,41,RACE2,CAT4,_RFPSA21,RESP046,"(44.567449424, -120.155031326)"
|
|
2014,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,7,,,,3467,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,41,RACE2,CAT4,_RFPSA21,RESP054,"(44.567449424, -120.155031326)"
|
|
2014,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,9,,,,3463,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,41,RACE3,CAT4,_RFPSA21,RESP046,"(44.567449424, -120.155031326)"
|
|
2014,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,34,,,,3468,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,41,RACE3,CAT4,_RFPSA21,RESP054,"(44.567449424, -120.155031326)"
|
|
2014,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,5,,,,3464,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,41,RACE4,CAT4,_RFPSA21,RESP046,"(44.567449424, -120.155031326)"
|
|
2014,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,31,,,,3469,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,41,RACE4,CAT4,_RFPSA21,RESP054,"(44.567449424, -120.155031326)"
|
|
2014,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,28,33.2,19.7,46.7,3465,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,41,RACE5,CAT4,_RFPSA21,RESP046,"(44.567449424, -120.155031326)"
|
|
2014,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,58,66.8,53.3,80.3,3470,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,41,RACE5,CAT4,_RFPSA21,RESP054,"(44.567449424, -120.155031326)"
|
|
2014,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,604,35,32.1,37.8,3451,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,41,SEX1,CAT2,_RFPSA21,RESP046,"(44.567449424, -120.155031326)"
|
|
2014,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,855,65,62.2,67.9,3452,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,41,SEX1,CAT2,_RFPSA21,RESP054,"(44.567449424, -120.155031326)"
|
|
2014,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,67,13.9,10,17.8,3460,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,42,AGE06,CAT3,_RFPSA21,RESP046,"(40.793730152, -77.860700294)"
|
|
2014,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,442,86.1,82.2,90,3464,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,42,AGE06,CAT3,_RFPSA21,RESP054,"(40.793730152, -77.860700294)"
|
|
2014,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,345,37.1,33.2,41,3461,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,42,AGE07,CAT3,_RFPSA21,RESP046,"(40.793730152, -77.860700294)"
|
|
2014,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,538,62.9,59,66.8,3465,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,42,AGE07,CAT3,_RFPSA21,RESP054,"(40.793730152, -77.860700294)"
|
|
2014,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,274,54.1,48.4,59.7,3462,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,42,AGE08,CAT3,_RFPSA21,RESP046,"(40.793730152, -77.860700294)"
|
|
2014,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,206,45.9,40.3,51.6,3466,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,42,AGE08,CAT3,_RFPSA21,RESP054,"(40.793730152, -77.860700294)"
|
|
2014,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,829,62.5,59.1,65.9,3463,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,42,AGE09,CAT3,_RFPSA21,RESP046,"(40.793730152, -77.860700294)"
|
|
2014,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,484,37.5,34.1,40.9,3467,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,42,AGE09,CAT3,_RFPSA21,RESP054,"(40.793730152, -77.860700294)"
|
|
2014,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1515,40.9,38.8,43.1,3456,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,42,BO1,CAT1,_RFPSA21,RESP046,"(40.793730152, -77.860700294)"
|
|
2014,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1670,59.1,56.9,61.3,3457,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,42,BO1,CAT1,_RFPSA21,RESP054,"(40.793730152, -77.860700294)"
|
|
2014,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,75,29.3,21.9,36.8,3478,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,42,EDUCA1,CAT5,_RFPSA21,RESP046,"(40.793730152, -77.860700294)"
|
|
2014,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,128,70.7,63.3,78.1,3482,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,42,EDUCA1,CAT5,_RFPSA21,RESP054,"(40.793730152, -77.860700294)"
|
|
2014,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,502,37.5,34.1,40.9,3479,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,42,EDUCA2,CAT5,_RFPSA21,RESP046,"(40.793730152, -77.860700294)"
|
|
2014,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,699,62.5,59.1,65.9,3483,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,42,EDUCA2,CAT5,_RFPSA21,RESP054,"(40.793730152, -77.860700294)"
|
|
2014,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,343,46.9,42.2,51.5,3480,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,42,EDUCA3,CAT5,_RFPSA21,RESP046,"(40.793730152, -77.860700294)"
|
|
2014,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,337,53.1,48.5,57.8,3484,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,42,EDUCA3,CAT5,_RFPSA21,RESP054,"(40.793730152, -77.860700294)"
|
|
2014,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,591,46.6,42.9,50.4,3481,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,42,EDUCA4,CAT5,_RFPSA21,RESP046,"(40.793730152, -77.860700294)"
|
|
2014,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,500,53.4,49.6,57.1,3485,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,42,EDUCA4,CAT5,_RFPSA21,RESP054,"(40.793730152, -77.860700294)"
|
|
2014,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,70,21.8,15.1,28.4,3486,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,42,INCOME1,CAT6,_RFPSA21,RESP046,"(40.793730152, -77.860700294)"
|
|
2014,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,183,78.2,71.6,84.9,3491,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,42,INCOME1,CAT6,_RFPSA21,RESP054,"(40.793730152, -77.860700294)"
|
|
2014,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,173,36.9,30.9,42.8,3487,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,42,INCOME2,CAT6,_RFPSA21,RESP046,"(40.793730152, -77.860700294)"
|
|
2014,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,250,63.2,57.2,69.1,3492,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,42,INCOME2,CAT6,_RFPSA21,RESP054,"(40.793730152, -77.860700294)"
|
|
2014,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,183,43.8,37.1,50.5,3488,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,42,INCOME3,CAT6,_RFPSA21,RESP046,"(40.793730152, -77.860700294)"
|
|
2014,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,197,56.2,49.5,62.9,3493,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,42,INCOME3,CAT6,_RFPSA21,RESP054,"(40.793730152, -77.860700294)"
|
|
2014,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,257,46.8,41.3,52.3,3489,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,42,INCOME4,CAT6,_RFPSA21,RESP046,"(40.793730152, -77.860700294)"
|
|
2014,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,218,53.2,47.8,58.7,3494,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,42,INCOME4,CAT6,_RFPSA21,RESP054,"(40.793730152, -77.860700294)"
|
|
2014,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,676,42.2,38.9,45.5,3490,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,42,INCOME5,CAT6,_RFPSA21,RESP046,"(40.793730152, -77.860700294)"
|
|
2014,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,671,57.8,54.5,61.1,3495,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,42,INCOME5,CAT6,_RFPSA21,RESP054,"(40.793730152, -77.860700294)"
|
|
2014,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1397,43.4,41.1,45.7,3468,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,42,RACE1,CAT4,_RFPSA21,RESP046,"(40.793730152, -77.860700294)"
|
|
2014,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1454,56.6,54.3,58.9,3473,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,42,RACE1,CAT4,_RFPSA21,RESP054,"(40.793730152, -77.860700294)"
|
|
2014,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,62,32.5,23.9,41,3469,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,42,RACE2,CAT4,_RFPSA21,RESP046,"(40.793730152, -77.860700294)"
|
|
2014,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,108,67.5,59,76.1,3474,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,42,RACE2,CAT4,_RFPSA21,RESP054,"(40.793730152, -77.860700294)"
|
|
2014,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,13,,,,3470,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,42,RACE3,CAT4,_RFPSA21,RESP046,"(40.793730152, -77.860700294)"
|
|
2014,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,33,,,,3475,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,42,RACE3,CAT4,_RFPSA21,RESP054,"(40.793730152, -77.860700294)"
|
|
2014,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,12,,,,3471,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,42,RACE4,CAT4,_RFPSA21,RESP046,"(40.793730152, -77.860700294)"
|
|
2014,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,28,,,,3476,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,42,RACE4,CAT4,_RFPSA21,RESP054,"(40.793730152, -77.860700294)"
|
|
2014,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,7,,,,3472,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,42,RACE5,CAT4,_RFPSA21,RESP046,"(40.793730152, -77.860700294)"
|
|
2014,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,15,,,,3477,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,42,RACE5,CAT4,_RFPSA21,RESP054,"(40.793730152, -77.860700294)"
|
|
2014,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1515,40.9,38.8,43.1,3458,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,42,SEX1,CAT2,_RFPSA21,RESP046,"(40.793730152, -77.860700294)"
|
|
2014,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1670,59.1,56.9,61.3,3459,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,42,SEX1,CAT2,_RFPSA21,RESP054,"(40.793730152, -77.860700294)"
|
|
2014,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,115,42.3,35.7,48.8,3246,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,72,EDUCA3,CAT5,_RFPSA21,RESP054,"(18.220833, -66.590149)"
|
|
2014,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,133,38.9,32.5,45.2,3224,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,72,AGE06,CAT3,_RFPSA21,RESP046,"(18.220833, -66.590149)"
|
|
2014,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,184,61.1,54.8,67.5,3228,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,72,AGE06,CAT3,_RFPSA21,RESP054,"(18.220833, -66.590149)"
|
|
2014,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,213,59,52.9,65.2,3225,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,72,AGE07,CAT3,_RFPSA21,RESP046,"(18.220833, -66.590149)"
|
|
2014,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,142,41,34.8,47.1,3229,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,72,AGE07,CAT3,_RFPSA21,RESP054,"(18.220833, -66.590149)"
|
|
2014,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,142,67.9,59.2,76.5,3226,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,72,AGE08,CAT3,_RFPSA21,RESP046,"(18.220833, -66.590149)"
|
|
2014,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,48,32.1,23.5,40.8,3230,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,72,AGE08,CAT3,_RFPSA21,RESP054,"(18.220833, -66.590149)"
|
|
2014,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,502,73.8,69.4,78.2,3227,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,72,AGE09,CAT3,_RFPSA21,RESP046,"(18.220833, -66.590149)"
|
|
2014,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,147,26.2,21.8,30.6,3231,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,72,AGE09,CAT3,_RFPSA21,RESP054,"(18.220833, -66.590149)"
|
|
2014,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,990,58.7,55.5,61.9,3220,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,72,BO1,CAT1,_RFPSA21,RESP046,"(18.220833, -66.590149)"
|
|
2014,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,521,41.3,38.1,44.5,3221,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,72,BO1,CAT1,_RFPSA21,RESP054,"(18.220833, -66.590149)"
|
|
2014,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,238,59.2,53,65.4,3240,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,72,EDUCA1,CAT5,_RFPSA21,RESP046,"(18.220833, -66.590149)"
|
|
2014,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,121,40.8,34.6,47.1,3244,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,72,EDUCA1,CAT5,_RFPSA21,RESP054,"(18.220833, -66.590149)"
|
|
2014,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,255,52.4,46.7,58.1,3241,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,72,EDUCA2,CAT5,_RFPSA21,RESP046,"(18.220833, -66.590149)"
|
|
2014,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,169,47.6,41.9,53.3,3245,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,72,EDUCA2,CAT5,_RFPSA21,RESP054,"(18.220833, -66.590149)"
|
|
2014,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,204,57.8,51.2,64.3,3242,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,72,EDUCA3,CAT5,_RFPSA21,RESP046,"(18.220833, -66.590149)"
|
|
2014,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,293,66.7,61,72.3,3243,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,72,EDUCA4,CAT5,_RFPSA21,RESP046,"(18.220833, -66.590149)"
|
|
2014,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,114,33.3,27.7,39,3247,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,72,EDUCA4,CAT5,_RFPSA21,RESP054,"(18.220833, -66.590149)"
|
|
2014,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,339,56.1,50.9,61.4,3248,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,72,INCOME1,CAT6,_RFPSA21,RESP046,"(18.220833, -66.590149)"
|
|
2014,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,207,43.9,38.6,49.1,3253,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,72,INCOME1,CAT6,_RFPSA21,RESP054,"(18.220833, -66.590149)"
|
|
2014,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,249,61.9,55.7,68.1,3249,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,72,INCOME2,CAT6,_RFPSA21,RESP046,"(18.220833, -66.590149)"
|
|
2014,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,112,38.1,31.9,44.3,3254,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,72,INCOME2,CAT6,_RFPSA21,RESP054,"(18.220833, -66.590149)"
|
|
2014,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,110,60.1,50.1,70.1,3250,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,72,INCOME3,CAT6,_RFPSA21,RESP046,"(18.220833, -66.590149)"
|
|
2014,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,49,40,30,50,3255,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,72,INCOME3,CAT6,_RFPSA21,RESP054,"(18.220833, -66.590149)"
|
|
2014,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,81,54,43.3,64.6,3251,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,72,INCOME4,CAT6,_RFPSA21,RESP046,"(18.220833, -66.590149)"
|
|
2014,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,43,46,35.4,56.7,3256,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,72,INCOME4,CAT6,_RFPSA21,RESP054,"(18.220833, -66.590149)"
|
|
2014,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,105,69,60.1,77.9,3252,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,72,INCOME5,CAT6,_RFPSA21,RESP046,"(18.220833, -66.590149)"
|
|
2014,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,46,31,22.1,39.9,3257,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,72,INCOME5,CAT6,_RFPSA21,RESP054,"(18.220833, -66.590149)"
|
|
2014,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,6,,,,3232,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,72,RACE1,CAT4,_RFPSA21,RESP046,"(18.220833, -66.590149)"
|
|
2014,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,2,,,,3236,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,72,RACE1,CAT4,_RFPSA21,RESP054,"(18.220833, -66.590149)"
|
|
2014,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,2,,,,3233,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,72,RACE2,CAT4,_RFPSA21,RESP046,"(18.220833, -66.590149)"
|
|
2014,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,976,58.4,55.2,61.6,3234,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,72,RACE3,CAT4,_RFPSA21,RESP046,"(18.220833, -66.590149)"
|
|
2014,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,516,41.6,38.4,44.8,3237,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,72,RACE3,CAT4,_RFPSA21,RESP054,"(18.220833, -66.590149)"
|
|
2014,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,5,,,,3235,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,72,RACE4,CAT4,_RFPSA21,RESP046,"(18.220833, -66.590149)"
|
|
2014,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,2,,,,3238,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,72,RACE4,CAT4,_RFPSA21,RESP054,"(18.220833, -66.590149)"
|
|
2014,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,1,,,,3239,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,72,RACE5,CAT4,_RFPSA21,RESP054,"(18.220833, -66.590149)"
|
|
2014,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,990,58.7,55.5,61.9,3222,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,72,SEX1,CAT2,_RFPSA21,RESP046,"(18.220833, -66.590149)"
|
|
2014,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,521,41.3,38.1,44.5,3223,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,72,SEX1,CAT2,_RFPSA21,RESP054,"(18.220833, -66.590149)"
|
|
2014,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,91,31.8,25.2,38.4,3457,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,44,AGE08,CAT3,_RFPSA21,RESP054,"(41.708280193, -71.522470314)"
|
|
2014,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,56,18.5,13.3,23.7,3451,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,44,AGE06,CAT3,_RFPSA21,RESP046,"(41.708280193, -71.522470314)"
|
|
2014,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,262,81.5,76.3,86.7,3455,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,44,AGE06,CAT3,_RFPSA21,RESP054,"(41.708280193, -71.522470314)"
|
|
2014,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,201,39.3,33.9,44.6,3452,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,44,AGE07,CAT3,_RFPSA21,RESP046,"(41.708280193, -71.522470314)"
|
|
2014,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,261,60.7,55.4,66.1,3456,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,44,AGE07,CAT3,_RFPSA21,RESP054,"(41.708280193, -71.522470314)"
|
|
2014,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,186,68.2,61.7,74.8,3453,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,44,AGE08,CAT3,_RFPSA21,RESP046,"(41.708280193, -71.522470314)"
|
|
2014,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,458,63.9,59.5,68.2,3454,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,44,AGE09,CAT3,_RFPSA21,RESP046,"(41.708280193, -71.522470314)"
|
|
2014,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,251,36.2,31.8,40.5,3458,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,44,AGE09,CAT3,_RFPSA21,RESP054,"(41.708280193, -71.522470314)"
|
|
2014,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,901,44.5,41.6,47.4,3447,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,44,BO1,CAT1,_RFPSA21,RESP046,"(41.708280193, -71.522470314)"
|
|
2014,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,865,55.5,52.6,58.4,3448,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,44,BO1,CAT1,_RFPSA21,RESP054,"(41.708280193, -71.522470314)"
|
|
2014,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,39,26.3,17.3,35.3,3469,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,44,EDUCA1,CAT5,_RFPSA21,RESP046,"(41.708280193, -71.522470314)"
|
|
2014,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,88,73.7,64.7,82.7,3473,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,44,EDUCA1,CAT5,_RFPSA21,RESP054,"(41.708280193, -71.522470314)"
|
|
2014,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,198,44.1,38.5,49.7,3470,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,44,EDUCA2,CAT5,_RFPSA21,RESP046,"(41.708280193, -71.522470314)"
|
|
2014,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,205,55.9,50.3,61.5,3474,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,44,EDUCA2,CAT5,_RFPSA21,RESP054,"(41.708280193, -71.522470314)"
|
|
2014,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,188,46.7,40.7,52.7,3471,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,44,EDUCA3,CAT5,_RFPSA21,RESP046,"(41.708280193, -71.522470314)"
|
|
2014,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,180,53.3,47.3,59.3,3475,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,44,EDUCA3,CAT5,_RFPSA21,RESP054,"(41.708280193, -71.522470314)"
|
|
2014,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,471,51.6,47.6,55.5,3472,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,44,EDUCA4,CAT5,_RFPSA21,RESP046,"(41.708280193, -71.522470314)"
|
|
2014,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,386,48.4,44.5,52.4,3476,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,44,EDUCA4,CAT5,_RFPSA21,RESP054,"(41.708280193, -71.522470314)"
|
|
2014,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,46,30.8,21.2,40.4,3477,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,44,INCOME1,CAT6,_RFPSA21,RESP046,"(41.708280193, -71.522470314)"
|
|
2014,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,84,69.2,59.7,78.8,3482,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,44,INCOME1,CAT6,_RFPSA21,RESP054,"(41.708280193, -71.522470314)"
|
|
2014,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,85,36.3,27.9,44.7,3478,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,44,INCOME2,CAT6,_RFPSA21,RESP046,"(41.708280193, -71.522470314)"
|
|
2014,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,101,63.7,55.3,72.1,3483,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,44,INCOME2,CAT6,_RFPSA21,RESP054,"(41.708280193, -71.522470314)"
|
|
2014,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,53,44,32.1,55.8,3479,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,44,INCOME3,CAT6,_RFPSA21,RESP046,"(41.708280193, -71.522470314)"
|
|
2014,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,63,56,44.2,67.9,3484,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,44,INCOME3,CAT6,_RFPSA21,RESP054,"(41.708280193, -71.522470314)"
|
|
2014,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,113,46.7,38.3,55.1,3480,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,44,INCOME4,CAT6,_RFPSA21,RESP046,"(41.708280193, -71.522470314)"
|
|
2014,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,108,53.3,44.9,61.8,3485,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,44,INCOME4,CAT6,_RFPSA21,RESP054,"(41.708280193, -71.522470314)"
|
|
2014,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,516,47.1,43.1,51.1,3481,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,44,INCOME5,CAT6,_RFPSA21,RESP046,"(41.708280193, -71.522470314)"
|
|
2014,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,422,52.9,48.9,56.9,3486,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,44,INCOME5,CAT6,_RFPSA21,RESP054,"(41.708280193, -71.522470314)"
|
|
2014,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,811,47.5,44.4,50.6,3459,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,44,RACE1,CAT4,_RFPSA21,RESP046,"(41.708280193, -71.522470314)"
|
|
2014,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,719,52.5,49.4,55.6,3464,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,44,RACE1,CAT4,_RFPSA21,RESP054,"(41.708280193, -71.522470314)"
|
|
2014,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,19,,,,3460,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,44,RACE2,CAT4,_RFPSA21,RESP046,"(41.708280193, -71.522470314)"
|
|
2014,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,26,,,,3465,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,44,RACE2,CAT4,_RFPSA21,RESP054,"(41.708280193, -71.522470314)"
|
|
2014,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,34,32.3,21,43.6,3461,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,44,RACE3,CAT4,_RFPSA21,RESP046,"(41.708280193, -71.522470314)"
|
|
2014,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,58,67.7,56.4,79,3466,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,44,RACE3,CAT4,_RFPSA21,RESP054,"(41.708280193, -71.522470314)"
|
|
2014,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,22,28.9,15.9,41.9,3462,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,44,RACE4,CAT4,_RFPSA21,RESP046,"(41.708280193, -71.522470314)"
|
|
2014,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,34,71.1,58.1,84.1,3467,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,44,RACE4,CAT4,_RFPSA21,RESP054,"(41.708280193, -71.522470314)"
|
|
2014,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,4,,,,3463,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,44,RACE5,CAT4,_RFPSA21,RESP046,"(41.708280193, -71.522470314)"
|
|
2014,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,10,,,,3468,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,44,RACE5,CAT4,_RFPSA21,RESP054,"(41.708280193, -71.522470314)"
|
|
2014,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,901,44.5,41.6,47.4,3449,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,44,SEX1,CAT2,_RFPSA21,RESP046,"(41.708280193, -71.522470314)"
|
|
2014,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,865,55.5,52.6,58.4,3450,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,44,SEX1,CAT2,_RFPSA21,RESP054,"(41.708280193, -71.522470314)"
|
|
2014,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,109,18.1,14.4,21.8,3469,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,AGE06,CAT3,_RFPSA21,RESP046,"(33.998821303, -81.045371207)"
|
|
2014,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,427,81.9,78.2,85.6,3473,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,AGE06,CAT3,_RFPSA21,RESP054,"(33.998821303, -81.045371207)"
|
|
2014,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,356,42.7,38.5,46.9,3470,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,AGE07,CAT3,_RFPSA21,RESP046,"(33.998821303, -81.045371207)"
|
|
2014,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,420,57.3,53.1,61.5,3474,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,AGE07,CAT3,_RFPSA21,RESP054,"(33.998821303, -81.045371207)"
|
|
2014,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,282,57.2,51.9,62.4,3471,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,AGE08,CAT3,_RFPSA21,RESP046,"(33.998821303, -81.045371207)"
|
|
2014,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,221,42.8,37.6,48.1,3475,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,AGE08,CAT3,_RFPSA21,RESP054,"(33.998821303, -81.045371207)"
|
|
2014,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,987,68,65,71.1,3472,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,AGE09,CAT3,_RFPSA21,RESP046,"(33.998821303, -81.045371207)"
|
|
2014,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,427,32,28.9,35.1,3476,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,AGE09,CAT3,_RFPSA21,RESP054,"(33.998821303, -81.045371207)"
|
|
2014,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1734,46,43.9,48.2,3465,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,BO1,CAT1,_RFPSA21,RESP046,"(33.998821303, -81.045371207)"
|
|
2014,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1495,54,51.8,56.1,3466,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,BO1,CAT1,_RFPSA21,RESP054,"(33.998821303, -81.045371207)"
|
|
2014,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,124,27.8,22.6,33,3487,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,EDUCA1,CAT5,_RFPSA21,RESP046,"(33.998821303, -81.045371207)"
|
|
2014,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,253,72.2,67,77.4,3491,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,EDUCA1,CAT5,_RFPSA21,RESP054,"(33.998821303, -81.045371207)"
|
|
2014,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,418,40.3,36.5,44.1,3488,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,EDUCA2,CAT5,_RFPSA21,RESP046,"(33.998821303, -81.045371207)"
|
|
2014,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,489,59.7,55.9,63.5,3492,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,EDUCA2,CAT5,_RFPSA21,RESP054,"(33.998821303, -81.045371207)"
|
|
2014,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,443,51.6,47.2,56.1,3489,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,EDUCA3,CAT5,_RFPSA21,RESP046,"(33.998821303, -81.045371207)"
|
|
2014,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,327,48.4,44,52.8,3493,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,EDUCA3,CAT5,_RFPSA21,RESP054,"(33.998821303, -81.045371207)"
|
|
2014,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,748,58.4,54.8,62,3490,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,EDUCA4,CAT5,_RFPSA21,RESP046,"(33.998821303, -81.045371207)"
|
|
2014,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,424,41.6,38,45.2,3494,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,EDUCA4,CAT5,_RFPSA21,RESP054,"(33.998821303, -81.045371207)"
|
|
2014,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,82,21.6,16,27.1,3495,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,INCOME1,CAT6,_RFPSA21,RESP046,"(33.998821303, -81.045371207)"
|
|
2014,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,210,78.5,72.9,84,3500,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,INCOME1,CAT6,_RFPSA21,RESP054,"(33.998821303, -81.045371207)"
|
|
2014,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,199,37.5,32.2,42.9,3496,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,INCOME2,CAT6,_RFPSA21,RESP046,"(33.998821303, -81.045371207)"
|
|
2014,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,256,62.5,57.1,67.8,3501,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,INCOME2,CAT6,_RFPSA21,RESP054,"(33.998821303, -81.045371207)"
|
|
2014,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,176,43.3,36.7,49.9,3497,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,INCOME3,CAT6,_RFPSA21,RESP046,"(33.998821303, -81.045371207)"
|
|
2014,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,158,56.7,50.1,63.3,3502,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,INCOME3,CAT6,_RFPSA21,RESP054,"(33.998821303, -81.045371207)"
|
|
2014,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,268,49.4,43.8,55,3498,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,INCOME4,CAT6,_RFPSA21,RESP046,"(33.998821303, -81.045371207)"
|
|
2014,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,209,50.6,45,56.2,3503,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,INCOME4,CAT6,_RFPSA21,RESP054,"(33.998821303, -81.045371207)"
|
|
2014,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,843,54.8,51.4,58.2,3499,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,INCOME5,CAT6,_RFPSA21,RESP046,"(33.998821303, -81.045371207)"
|
|
2014,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,512,45.2,41.8,48.6,3504,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,INCOME5,CAT6,_RFPSA21,RESP054,"(33.998821303, -81.045371207)"
|
|
2014,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1305,48,45.5,50.5,3477,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,RACE1,CAT4,_RFPSA21,RESP046,"(33.998821303, -81.045371207)"
|
|
2014,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1034,52,49.5,54.5,3482,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,RACE1,CAT4,_RFPSA21,RESP054,"(33.998821303, -81.045371207)"
|
|
2014,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,342,45.2,40.4,50,3478,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,RACE2,CAT4,_RFPSA21,RESP046,"(33.998821303, -81.045371207)"
|
|
2014,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,325,54.8,50,59.6,3483,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,RACE2,CAT4,_RFPSA21,RESP054,"(33.998821303, -81.045371207)"
|
|
2014,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,16,24.2,11.4,36.9,3479,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,RACE3,CAT4,_RFPSA21,RESP046,"(33.998821303, -81.045371207)"
|
|
2014,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,38,75.8,63.1,88.6,3484,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,RACE3,CAT4,_RFPSA21,RESP054,"(33.998821303, -81.045371207)"
|
|
2014,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,22,32.7,18.8,46.5,3480,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,RACE4,CAT4,_RFPSA21,RESP046,"(33.998821303, -81.045371207)"
|
|
2014,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,35,67.3,53.5,81.2,3485,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,RACE4,CAT4,_RFPSA21,RESP054,"(33.998821303, -81.045371207)"
|
|
2014,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,16,,,,3481,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,45,RACE5,CAT4,_RFPSA21,RESP046,"(33.998821303, -81.045371207)"
|
|
2014,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,18,,,,3486,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,45,RACE5,CAT4,_RFPSA21,RESP054,"(33.998821303, -81.045371207)"
|
|
2014,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1734,46,43.9,48.2,3467,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,SEX1,CAT2,_RFPSA21,RESP046,"(33.998821303, -81.045371207)"
|
|
2014,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1495,54,51.8,56.1,3468,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,45,SEX1,CAT2,_RFPSA21,RESP054,"(33.998821303, -81.045371207)"
|
|
2014,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,216,37.6,30.9,44.3,3452,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,46,AGE07,CAT3,_RFPSA21,RESP046,"(44.353130053, -100.373530637)"
|
|
2014,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,54,9.9,6.1,13.7,3451,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,46,AGE06,CAT3,_RFPSA21,RESP046,"(44.353130053, -100.373530637)"
|
|
2014,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,328,90.1,86.3,93.9,3455,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,46,AGE06,CAT3,_RFPSA21,RESP054,"(44.353130053, -100.373530637)"
|
|
2014,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,332,62.5,55.8,69.2,3456,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,46,AGE07,CAT3,_RFPSA21,RESP054,"(44.353130053, -100.373530637)"
|
|
2014,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,208,59.6,50.2,68.9,3453,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,46,AGE08,CAT3,_RFPSA21,RESP046,"(44.353130053, -100.373530637)"
|
|
2014,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,140,40.4,31.1,49.8,3457,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,46,AGE08,CAT3,_RFPSA21,RESP054,"(44.353130053, -100.373530637)"
|
|
2014,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,610,68.9,63.8,74,3454,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,46,AGE09,CAT3,_RFPSA21,RESP046,"(44.353130053, -100.373530637)"
|
|
2014,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,306,31.2,26.1,36.3,3458,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,46,AGE09,CAT3,_RFPSA21,RESP054,"(44.353130053, -100.373530637)"
|
|
2014,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1088,44,40.5,47.4,3447,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,46,BO1,CAT1,_RFPSA21,RESP046,"(44.353130053, -100.373530637)"
|
|
2014,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1106,56,52.6,59.5,3448,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,46,BO1,CAT1,_RFPSA21,RESP054,"(44.353130053, -100.373530637)"
|
|
2014,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,62,35.3,23.2,47.4,3469,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,46,EDUCA1,CAT5,_RFPSA21,RESP046,"(44.353130053, -100.373530637)"
|
|
2014,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,98,64.7,52.6,76.8,3473,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,46,EDUCA1,CAT5,_RFPSA21,RESP054,"(44.353130053, -100.373530637)"
|
|
2014,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,315,45.1,39.1,51.1,3470,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,46,EDUCA2,CAT5,_RFPSA21,RESP046,"(44.353130053, -100.373530637)"
|
|
2014,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,361,54.9,48.9,61,3474,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,46,EDUCA2,CAT5,_RFPSA21,RESP054,"(44.353130053, -100.373530637)"
|
|
2014,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,294,41.1,34.8,47.3,3471,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,46,EDUCA3,CAT5,_RFPSA21,RESP046,"(44.353130053, -100.373530637)"
|
|
2014,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,313,58.9,52.7,65.2,3475,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,46,EDUCA3,CAT5,_RFPSA21,RESP054,"(44.353130053, -100.373530637)"
|
|
2014,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,416,51.3,45.6,56.9,3472,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,46,EDUCA4,CAT5,_RFPSA21,RESP046,"(44.353130053, -100.373530637)"
|
|
2014,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,332,48.7,43.1,54.4,3476,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,46,EDUCA4,CAT5,_RFPSA21,RESP054,"(44.353130053, -100.373530637)"
|
|
2014,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,49,45,28.3,61.7,3477,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,46,INCOME1,CAT6,_RFPSA21,RESP046,"(44.353130053, -100.373530637)"
|
|
2014,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,73,55,38.3,71.7,3482,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,46,INCOME1,CAT6,_RFPSA21,RESP054,"(44.353130053, -100.373530637)"
|
|
2014,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,98,29.7,20.7,38.6,3478,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,46,INCOME2,CAT6,_RFPSA21,RESP046,"(44.353130053, -100.373530637)"
|
|
2014,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,165,70.3,61.4,79.3,3483,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,46,INCOME2,CAT6,_RFPSA21,RESP054,"(44.353130053, -100.373530637)"
|
|
2014,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,107,40.1,28.9,51.2,3479,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,46,INCOME3,CAT6,_RFPSA21,RESP046,"(44.353130053, -100.373530637)"
|
|
2014,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,121,59.9,48.8,71.1,3484,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,46,INCOME3,CAT6,_RFPSA21,RESP054,"(44.353130053, -100.373530637)"
|
|
2014,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,188,49.5,40.5,58.4,3480,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,46,INCOME4,CAT6,_RFPSA21,RESP046,"(44.353130053, -100.373530637)"
|
|
2014,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,166,50.5,41.6,59.5,3485,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,46,INCOME4,CAT6,_RFPSA21,RESP054,"(44.353130053, -100.373530637)"
|
|
2014,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,547,43.6,38.8,48.5,3481,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,46,INCOME5,CAT6,_RFPSA21,RESP046,"(44.353130053, -100.373530637)"
|
|
2014,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,486,56.4,51.6,61.2,3486,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,46,INCOME5,CAT6,_RFPSA21,RESP054,"(44.353130053, -100.373530637)"
|
|
2014,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1003,46.5,42.8,50.1,3459,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,46,RACE1,CAT4,_RFPSA21,RESP046,"(44.353130053, -100.373530637)"
|
|
2014,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,946,53.5,49.9,57.2,3464,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,46,RACE1,CAT4,_RFPSA21,RESP054,"(44.353130053, -100.373530637)"
|
|
2014,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,2,,,,3460,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,46,RACE2,CAT4,_RFPSA21,RESP046,"(44.353130053, -100.373530637)"
|
|
2014,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,9,,,,3465,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,46,RACE2,CAT4,_RFPSA21,RESP054,"(44.353130053, -100.373530637)"
|
|
2014,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,5,,,,3461,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,46,RACE3,CAT4,_RFPSA21,RESP046,"(44.353130053, -100.373530637)"
|
|
2014,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,18,,,,3466,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,46,RACE3,CAT4,_RFPSA21,RESP054,"(44.353130053, -100.373530637)"
|
|
2014,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,58,33.7,19.6,47.7,3462,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,46,RACE4,CAT4,_RFPSA21,RESP046,"(44.353130053, -100.373530637)"
|
|
2014,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,109,66.3,52.3,80.4,3467,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,46,RACE4,CAT4,_RFPSA21,RESP054,"(44.353130053, -100.373530637)"
|
|
2014,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,13,,,,3463,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,46,RACE5,CAT4,_RFPSA21,RESP046,"(44.353130053, -100.373530637)"
|
|
2014,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,14,,,,3468,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,46,RACE5,CAT4,_RFPSA21,RESP054,"(44.353130053, -100.373530637)"
|
|
2014,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1088,44,40.5,47.4,3449,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,46,SEX1,CAT2,_RFPSA21,RESP046,"(44.353130053, -100.373530637)"
|
|
2014,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1106,56,52.6,59.5,3450,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,46,SEX1,CAT2,_RFPSA21,RESP054,"(44.353130053, -100.373530637)"
|
|
2014,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,41,15.9,10.3,21.5,3448,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,47,AGE06,CAT3,_RFPSA21,RESP046,"(35.68094058, -85.774490914)"
|
|
2014,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,159,84.1,78.5,89.7,3452,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,47,AGE06,CAT3,_RFPSA21,RESP054,"(35.68094058, -85.774490914)"
|
|
2014,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,147,42.8,36.2,49.3,3449,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,47,AGE07,CAT3,_RFPSA21,RESP046,"(35.68094058, -85.774490914)"
|
|
2014,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,198,57.2,50.7,63.8,3453,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,47,AGE07,CAT3,_RFPSA21,RESP054,"(35.68094058, -85.774490914)"
|
|
2014,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,102,46.1,37.3,54.9,3450,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,47,AGE08,CAT3,_RFPSA21,RESP046,"(35.68094058, -85.774490914)"
|
|
2014,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,101,53.9,45.1,62.7,3454,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,47,AGE08,CAT3,_RFPSA21,RESP054,"(35.68094058, -85.774490914)"
|
|
2014,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,385,63.7,58.7,68.7,3451,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,47,AGE09,CAT3,_RFPSA21,RESP046,"(35.68094058, -85.774490914)"
|
|
2014,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,196,36.3,31.3,41.3,3455,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,47,AGE09,CAT3,_RFPSA21,RESP054,"(35.68094058, -85.774490914)"
|
|
2014,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,675,41.4,37.9,45,3444,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,47,BO1,CAT1,_RFPSA21,RESP046,"(35.68094058, -85.774490914)"
|
|
2014,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,654,58.6,55,62.1,3445,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,47,BO1,CAT1,_RFPSA21,RESP054,"(35.68094058, -85.774490914)"
|
|
2014,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,57,25.2,18,32.5,3466,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,47,EDUCA1,CAT5,_RFPSA21,RESP046,"(35.68094058, -85.774490914)"
|
|
2014,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,112,74.8,67.5,82,3470,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,47,EDUCA1,CAT5,_RFPSA21,RESP054,"(35.68094058, -85.774490914)"
|
|
2014,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,190,38.3,32.3,44.3,3467,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,47,EDUCA2,CAT5,_RFPSA21,RESP046,"(35.68094058, -85.774490914)"
|
|
2014,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,248,61.7,55.7,67.7,3471,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,47,EDUCA2,CAT5,_RFPSA21,RESP054,"(35.68094058, -85.774490914)"
|
|
2014,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,163,47.2,38.8,55.6,3468,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,47,EDUCA3,CAT5,_RFPSA21,RESP046,"(35.68094058, -85.774490914)"
|
|
2014,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,122,52.8,44.4,61.2,3472,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,47,EDUCA3,CAT5,_RFPSA21,RESP054,"(35.68094058, -85.774490914)"
|
|
2014,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,265,51.1,45,57.2,3469,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,47,EDUCA4,CAT5,_RFPSA21,RESP046,"(35.68094058, -85.774490914)"
|
|
2014,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,172,48.9,42.8,55,3473,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,47,EDUCA4,CAT5,_RFPSA21,RESP054,"(35.68094058, -85.774490914)"
|
|
2014,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,52,26.7,18.1,35.2,3474,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,47,INCOME1,CAT6,_RFPSA21,RESP046,"(35.68094058, -85.774490914)"
|
|
2014,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,100,73.3,64.8,81.9,3479,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,47,INCOME1,CAT6,_RFPSA21,RESP054,"(35.68094058, -85.774490914)"
|
|
2014,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,80,28.3,20.5,36.2,3475,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,47,INCOME2,CAT6,_RFPSA21,RESP046,"(35.68094058, -85.774490914)"
|
|
2014,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,116,71.7,63.8,79.5,3480,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,47,INCOME2,CAT6,_RFPSA21,RESP054,"(35.68094058, -85.774490914)"
|
|
2014,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,75,44.3,33.3,55.3,3476,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,47,INCOME3,CAT6,_RFPSA21,RESP046,"(35.68094058, -85.774490914)"
|
|
2014,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,68,55.7,44.8,66.7,3481,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,47,INCOME3,CAT6,_RFPSA21,RESP054,"(35.68094058, -85.774490914)"
|
|
2014,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,115,54.3,45.6,62.9,3477,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,47,INCOME4,CAT6,_RFPSA21,RESP046,"(35.68094058, -85.774490914)"
|
|
2014,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,83,45.7,37.1,54.4,3482,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,47,INCOME4,CAT6,_RFPSA21,RESP054,"(35.68094058, -85.774490914)"
|
|
2014,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,266,43.6,37.7,49.6,3478,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,47,INCOME5,CAT6,_RFPSA21,RESP046,"(35.68094058, -85.774490914)"
|
|
2014,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,211,56.4,50.4,62.4,3483,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,47,INCOME5,CAT6,_RFPSA21,RESP054,"(35.68094058, -85.774490914)"
|
|
2014,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,584,41.2,37.4,44.9,3456,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,47,RACE1,CAT4,_RFPSA21,RESP046,"(35.68094058, -85.774490914)"
|
|
2014,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,556,58.8,55.1,62.6,3461,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,47,RACE1,CAT4,_RFPSA21,RESP054,"(35.68094058, -85.774490914)"
|
|
2014,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,58,41.3,29.7,53,3457,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,47,RACE2,CAT4,_RFPSA21,RESP046,"(35.68094058, -85.774490914)"
|
|
2014,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,67,58.7,47,70.4,3462,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,47,RACE2,CAT4,_RFPSA21,RESP054,"(35.68094058, -85.774490914)"
|
|
2014,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,4,,,,3458,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,47,RACE3,CAT4,_RFPSA21,RESP046,"(35.68094058, -85.774490914)"
|
|
2014,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,4,,,,3463,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,47,RACE3,CAT4,_RFPSA21,RESP054,"(35.68094058, -85.774490914)"
|
|
2014,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,10,,,,3459,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,47,RACE4,CAT4,_RFPSA21,RESP046,"(35.68094058, -85.774490914)"
|
|
2014,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,16,,,,3464,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,47,RACE4,CAT4,_RFPSA21,RESP054,"(35.68094058, -85.774490914)"
|
|
2014,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,9,,,,3460,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,47,RACE5,CAT4,_RFPSA21,RESP046,"(35.68094058, -85.774490914)"
|
|
2014,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,8,,,,3465,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,47,RACE5,CAT4,_RFPSA21,RESP054,"(35.68094058, -85.774490914)"
|
|
2014,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,675,41.4,37.9,45,3446,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,47,SEX1,CAT2,_RFPSA21,RESP046,"(35.68094058, -85.774490914)"
|
|
2014,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,654,58.6,55,62.1,3447,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,47,SEX1,CAT2,_RFPSA21,RESP054,"(35.68094058, -85.774490914)"
|
|
2014,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,168,21.5,17,26.1,3467,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,48,AGE06,CAT3,_RFPSA21,RESP046,"(31.827240407, -99.426770206)"
|
|
2014,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,602,78.5,73.9,83,3471,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,48,AGE06,CAT3,_RFPSA21,RESP054,"(31.827240407, -99.426770206)"
|
|
2014,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,437,44.4,39.4,49.4,3468,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,48,AGE07,CAT3,_RFPSA21,RESP046,"(31.827240407, -99.426770206)"
|
|
2014,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,577,55.6,50.6,60.7,3472,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,48,AGE07,CAT3,_RFPSA21,RESP054,"(31.827240407, -99.426770206)"
|
|
2014,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,314,55.6,48.8,62.4,3469,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,48,AGE08,CAT3,_RFPSA21,RESP046,"(31.827240407, -99.426770206)"
|
|
2014,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,238,44.4,37.6,51.2,3473,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,48,AGE08,CAT3,_RFPSA21,RESP054,"(31.827240407, -99.426770206)"
|
|
2014,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,1125,64.9,60.4,69.3,3470,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,48,AGE09,CAT3,_RFPSA21,RESP046,"(31.827240407, -99.426770206)"
|
|
2014,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,547,35.2,30.7,39.6,3474,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,48,AGE09,CAT3,_RFPSA21,RESP054,"(31.827240407, -99.426770206)"
|
|
2014,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,2044,43.9,41.3,46.5,3463,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,48,BO1,CAT1,_RFPSA21,RESP046,"(31.827240407, -99.426770206)"
|
|
2014,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1964,56.1,53.5,58.7,3464,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,48,BO1,CAT1,_RFPSA21,RESP054,"(31.827240407, -99.426770206)"
|
|
2014,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,129,26.7,20.5,32.9,3485,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,48,EDUCA1,CAT5,_RFPSA21,RESP046,"(31.827240407, -99.426770206)"
|
|
2014,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,325,73.3,67.1,79.5,3489,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,48,EDUCA1,CAT5,_RFPSA21,RESP054,"(31.827240407, -99.426770206)"
|
|
2014,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,359,40.1,34.6,45.5,3486,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,48,EDUCA2,CAT5,_RFPSA21,RESP046,"(31.827240407, -99.426770206)"
|
|
2014,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,436,59.9,54.5,65.4,3490,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,48,EDUCA2,CAT5,_RFPSA21,RESP054,"(31.827240407, -99.426770206)"
|
|
2014,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,469,49.9,44.6,55.2,3487,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,48,EDUCA3,CAT5,_RFPSA21,RESP046,"(31.827240407, -99.426770206)"
|
|
2014,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,451,50.1,44.8,55.4,3491,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,48,EDUCA3,CAT5,_RFPSA21,RESP054,"(31.827240407, -99.426770206)"
|
|
2014,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,1080,53.7,49.7,57.6,3488,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,48,EDUCA4,CAT5,_RFPSA21,RESP046,"(31.827240407, -99.426770206)"
|
|
2014,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,743,46.3,42.4,50.3,3492,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,48,EDUCA4,CAT5,_RFPSA21,RESP054,"(31.827240407, -99.426770206)"
|
|
2014,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,79,31.4,22,40.9,3493,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,48,INCOME1,CAT6,_RFPSA21,RESP046,"(31.827240407, -99.426770206)"
|
|
2014,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,210,68.6,59.1,78,3498,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,48,INCOME1,CAT6,_RFPSA21,RESP054,"(31.827240407, -99.426770206)"
|
|
2014,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,198,31,24.4,37.6,3494,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,48,INCOME2,CAT6,_RFPSA21,RESP046,"(31.827240407, -99.426770206)"
|
|
2014,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,336,69,62.4,75.6,3499,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,48,INCOME2,CAT6,_RFPSA21,RESP054,"(31.827240407, -99.426770206)"
|
|
2014,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,168,37.8,29.4,46.3,3495,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,48,INCOME3,CAT6,_RFPSA21,RESP046,"(31.827240407, -99.426770206)"
|
|
2014,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,180,62.2,53.7,70.6,3500,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,48,INCOME3,CAT6,_RFPSA21,RESP054,"(31.827240407, -99.426770206)"
|
|
2014,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,226,49.7,41.3,58.1,3496,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,48,INCOME4,CAT6,_RFPSA21,RESP046,"(31.827240407, -99.426770206)"
|
|
2014,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,204,50.3,41.9,58.7,3501,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,48,INCOME4,CAT6,_RFPSA21,RESP054,"(31.827240407, -99.426770206)"
|
|
2014,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,1136,50.4,46.6,54.2,3497,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,48,INCOME5,CAT6,_RFPSA21,RESP046,"(31.827240407, -99.426770206)"
|
|
2014,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,819,49.6,45.8,53.4,3502,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,48,INCOME5,CAT6,_RFPSA21,RESP054,"(31.827240407, -99.426770206)"
|
|
2014,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1544,52.5,49.3,55.7,3475,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,48,RACE1,CAT4,_RFPSA21,RESP046,"(31.827240407, -99.426770206)"
|
|
2014,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1121,47.5,44.3,50.8,3480,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,48,RACE1,CAT4,_RFPSA21,RESP054,"(31.827240407, -99.426770206)"
|
|
2014,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,126,55.7,45.6,65.7,3476,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,48,RACE2,CAT4,_RFPSA21,RESP046,"(31.827240407, -99.426770206)"
|
|
2014,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,110,44.3,34.3,54.4,3481,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,48,RACE2,CAT4,_RFPSA21,RESP054,"(31.827240407, -99.426770206)"
|
|
2014,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,268,28.6,23.8,33.3,3477,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,48,RACE3,CAT4,_RFPSA21,RESP046,"(31.827240407, -99.426770206)"
|
|
2014,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,573,71.4,66.7,76.2,3482,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,48,RACE3,CAT4,_RFPSA21,RESP054,"(31.827240407, -99.426770206)"
|
|
2014,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,32,,,,3478,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,48,RACE4,CAT4,_RFPSA21,RESP046,"(31.827240407, -99.426770206)"
|
|
2014,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,78,86.6,77.5,95.6,3483,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,48,RACE4,CAT4,_RFPSA21,RESP054,"(31.827240407, -99.426770206)"
|
|
2014,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,19,,,,3479,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,48,RACE5,CAT4,_RFPSA21,RESP046,"(31.827240407, -99.426770206)"
|
|
2014,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,28,,,,3484,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,48,RACE5,CAT4,_RFPSA21,RESP054,"(31.827240407, -99.426770206)"
|
|
2014,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,2044,43.9,41.3,46.5,3465,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,48,SEX1,CAT2,_RFPSA21,RESP046,"(31.827240407, -99.426770206)"
|
|
2014,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1964,56.1,53.5,58.7,3466,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,48,SEX1,CAT2,_RFPSA21,RESP054,"(31.827240407, -99.426770206)"
|
|
2014,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,125,11.5,9.4,13.7,3467,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,49,AGE06,CAT3,_RFPSA21,RESP046,"(39.360700171, -111.587130635)"
|
|
2014,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,949,88.5,86.3,90.6,3471,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,49,AGE06,CAT3,_RFPSA21,RESP054,"(39.360700171, -111.587130635)"
|
|
2014,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,401,33.8,30.6,37,3468,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,49,AGE07,CAT3,_RFPSA21,RESP046,"(39.360700171, -111.587130635)"
|
|
2014,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,711,66.2,63.1,69.4,3472,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,49,AGE07,CAT3,_RFPSA21,RESP054,"(39.360700171, -111.587130635)"
|
|
2014,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,291,53,48.1,57.9,3469,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,49,AGE08,CAT3,_RFPSA21,RESP046,"(39.360700171, -111.587130635)"
|
|
2014,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,250,47,42.1,51.9,3473,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,49,AGE08,CAT3,_RFPSA21,RESP054,"(39.360700171, -111.587130635)"
|
|
2014,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,751,53.7,50.5,57,3470,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,49,AGE09,CAT3,_RFPSA21,RESP046,"(39.360700171, -111.587130635)"
|
|
2014,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,604,46.3,43,49.5,3474,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,49,AGE09,CAT3,_RFPSA21,RESP054,"(39.360700171, -111.587130635)"
|
|
2014,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1568,34.2,32.5,35.9,3463,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,49,BO1,CAT1,_RFPSA21,RESP046,"(39.360700171, -111.587130635)"
|
|
2014,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,2514,65.8,64.1,67.5,3464,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,49,BO1,CAT1,_RFPSA21,RESP054,"(39.360700171, -111.587130635)"
|
|
2014,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,40,19.7,13,26.3,3485,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,49,EDUCA1,CAT5,_RFPSA21,RESP046,"(39.360700171, -111.587130635)"
|
|
2014,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,138,80.3,73.7,87,3489,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,49,EDUCA1,CAT5,_RFPSA21,RESP054,"(39.360700171, -111.587130635)"
|
|
2014,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,286,28.4,25,31.7,3486,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,49,EDUCA2,CAT5,_RFPSA21,RESP046,"(39.360700171, -111.587130635)"
|
|
2014,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,609,71.6,68.3,75,3490,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,49,EDUCA2,CAT5,_RFPSA21,RESP054,"(39.360700171, -111.587130635)"
|
|
2014,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,405,34,30.9,37.1,3487,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,49,EDUCA3,CAT5,_RFPSA21,RESP046,"(39.360700171, -111.587130635)"
|
|
2014,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,708,66,62.9,69.1,3491,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,49,EDUCA3,CAT5,_RFPSA21,RESP054,"(39.360700171, -111.587130635)"
|
|
2014,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,830,41.3,38.8,43.8,3488,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,49,EDUCA4,CAT5,_RFPSA21,RESP046,"(39.360700171, -111.587130635)"
|
|
2014,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,1053,58.7,56.2,61.2,3492,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,49,EDUCA4,CAT5,_RFPSA21,RESP054,"(39.360700171, -111.587130635)"
|
|
2014,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,34,17.2,10.4,24,3493,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,49,INCOME1,CAT6,_RFPSA21,RESP046,"(39.360700171, -111.587130635)"
|
|
2014,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,129,82.8,76,89.6,3498,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,49,INCOME1,CAT6,_RFPSA21,RESP054,"(39.360700171, -111.587130635)"
|
|
2014,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,102,27.2,21.4,33,3494,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,49,INCOME2,CAT6,_RFPSA21,RESP046,"(39.360700171, -111.587130635)"
|
|
2014,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,238,72.8,67,78.6,3499,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,49,INCOME2,CAT6,_RFPSA21,RESP054,"(39.360700171, -111.587130635)"
|
|
2014,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,103,31.5,25,37.9,3495,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,49,INCOME3,CAT6,_RFPSA21,RESP046,"(39.360700171, -111.587130635)"
|
|
2014,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,184,68.5,62.1,75,3500,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,49,INCOME3,CAT6,_RFPSA21,RESP054,"(39.360700171, -111.587130635)"
|
|
2014,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,225,37.1,32.3,41.9,3496,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,49,INCOME4,CAT6,_RFPSA21,RESP046,"(39.360700171, -111.587130635)"
|
|
2014,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,324,62.9,58.1,67.7,3501,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,49,INCOME4,CAT6,_RFPSA21,RESP054,"(39.360700171, -111.587130635)"
|
|
2014,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,952,36.6,34.4,38.8,3497,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,49,INCOME5,CAT6,_RFPSA21,RESP046,"(39.360700171, -111.587130635)"
|
|
2014,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,1404,63.4,61.2,65.6,3502,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,49,INCOME5,CAT6,_RFPSA21,RESP054,"(39.360700171, -111.587130635)"
|
|
2014,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1460,36.6,34.8,38.4,3475,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,49,RACE1,CAT4,_RFPSA21,RESP046,"(39.360700171, -111.587130635)"
|
|
2014,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,2209,63.4,61.6,65.2,3480,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,49,RACE1,CAT4,_RFPSA21,RESP054,"(39.360700171, -111.587130635)"
|
|
2014,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,7,,,,3476,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,49,RACE2,CAT4,_RFPSA21,RESP046,"(39.360700171, -111.587130635)"
|
|
2014,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,9,,,,3481,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,49,RACE2,CAT4,_RFPSA21,RESP054,"(39.360700171, -111.587130635)"
|
|
2014,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,41,18.3,12.5,24.2,3477,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,49,RACE3,CAT4,_RFPSA21,RESP046,"(39.360700171, -111.587130635)"
|
|
2014,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,161,81.7,75.8,87.5,3482,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,49,RACE3,CAT4,_RFPSA21,RESP054,"(39.360700171, -111.587130635)"
|
|
2014,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,25,17.7,9.9,25.5,3478,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,49,RACE4,CAT4,_RFPSA21,RESP046,"(39.360700171, -111.587130635)"
|
|
2014,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,71,82.3,74.5,90.1,3483,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,49,RACE4,CAT4,_RFPSA21,RESP054,"(39.360700171, -111.587130635)"
|
|
2014,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,4,,,,3479,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,49,RACE5,CAT4,_RFPSA21,RESP046,"(39.360700171, -111.587130635)"
|
|
2014,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,15,,,,3484,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,49,RACE5,CAT4,_RFPSA21,RESP054,"(39.360700171, -111.587130635)"
|
|
2014,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1568,34.2,32.5,35.9,3465,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,49,SEX1,CAT2,_RFPSA21,RESP046,"(39.360700171, -111.587130635)"
|
|
2014,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,2514,65.8,64.1,67.5,3466,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,49,SEX1,CAT2,_RFPSA21,RESP054,"(39.360700171, -111.587130635)"
|
|
2014,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,30,7.3,4.5,10,3422,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,50,AGE06,CAT3,_RFPSA21,RESP046,"(43.625381239, -72.517640791)"
|
|
2014,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,370,92.7,90,95.5,3426,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,50,AGE06,CAT3,_RFPSA21,RESP054,"(43.625381239, -72.517640791)"
|
|
2014,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,163,27.9,23.8,32,3423,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,50,AGE07,CAT3,_RFPSA21,RESP046,"(43.625381239, -72.517640791)"
|
|
2014,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,405,72.1,68,76.2,3427,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,50,AGE07,CAT3,_RFPSA21,RESP054,"(43.625381239, -72.517640791)"
|
|
2014,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,136,45.1,38.7,51.5,3424,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,50,AGE08,CAT3,_RFPSA21,RESP046,"(43.625381239, -72.517640791)"
|
|
2014,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,162,54.9,48.5,61.3,3428,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,50,AGE08,CAT3,_RFPSA21,RESP054,"(43.625381239, -72.517640791)"
|
|
2014,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,384,52,47.7,56.3,3425,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,50,AGE09,CAT3,_RFPSA21,RESP046,"(43.625381239, -72.517640791)"
|
|
2014,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,328,48,43.7,52.3,3429,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,50,AGE09,CAT3,_RFPSA21,RESP054,"(43.625381239, -72.517640791)"
|
|
2014,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,713,32.6,30.3,34.9,3418,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,50,BO1,CAT1,_RFPSA21,RESP046,"(43.625381239, -72.517640791)"
|
|
2014,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1265,67.4,65.1,69.7,3419,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,50,BO1,CAT1,_RFPSA21,RESP054,"(43.625381239, -72.517640791)"
|
|
2014,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,23,18.6,11.2,26,3439,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,50,EDUCA1,CAT5,_RFPSA21,RESP046,"(43.625381239, -72.517640791)"
|
|
2014,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,89,81.4,74,88.8,3443,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,50,EDUCA1,CAT5,_RFPSA21,RESP054,"(43.625381239, -72.517640791)"
|
|
2014,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,188,28.2,24.3,32,3440,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,50,EDUCA2,CAT5,_RFPSA21,RESP046,"(43.625381239, -72.517640791)"
|
|
2014,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,416,71.8,68,75.7,3444,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,50,EDUCA2,CAT5,_RFPSA21,RESP054,"(43.625381239, -72.517640791)"
|
|
2014,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,145,41.6,35.9,47.2,3441,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,50,EDUCA3,CAT5,_RFPSA21,RESP046,"(43.625381239, -72.517640791)"
|
|
2014,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,205,58.4,52.8,64.1,3445,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,50,EDUCA3,CAT5,_RFPSA21,RESP054,"(43.625381239, -72.517640791)"
|
|
2014,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,354,34.8,31.5,38.2,3442,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,50,EDUCA4,CAT5,_RFPSA21,RESP046,"(43.625381239, -72.517640791)"
|
|
2014,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,553,65.2,61.8,68.5,3446,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,50,EDUCA4,CAT5,_RFPSA21,RESP054,"(43.625381239, -72.517640791)"
|
|
2014,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,17,10,4.8,15.1,3447,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,50,INCOME1,CAT6,_RFPSA21,RESP046,"(43.625381239, -72.517640791)"
|
|
2014,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,103,90,84.9,95.2,3452,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,50,INCOME1,CAT6,_RFPSA21,RESP054,"(43.625381239, -72.517640791)"
|
|
2014,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,71,31.4,24.5,38.2,3448,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,50,INCOME2,CAT6,_RFPSA21,RESP046,"(43.625381239, -72.517640791)"
|
|
2014,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,153,68.7,61.8,75.5,3453,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,50,INCOME2,CAT6,_RFPSA21,RESP054,"(43.625381239, -72.517640791)"
|
|
2014,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,51,32.7,24.5,41,3449,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,50,INCOME3,CAT6,_RFPSA21,RESP046,"(43.625381239, -72.517640791)"
|
|
2014,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,103,67.3,59,75.5,3454,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,50,INCOME3,CAT6,_RFPSA21,RESP054,"(43.625381239, -72.517640791)"
|
|
2014,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,104,34.8,28.3,41.3,3450,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,50,INCOME4,CAT6,_RFPSA21,RESP046,"(43.625381239, -72.517640791)"
|
|
2014,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,156,65.2,58.7,71.7,3455,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,50,INCOME4,CAT6,_RFPSA21,RESP054,"(43.625381239, -72.517640791)"
|
|
2014,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,394,35.1,31.9,38.4,3451,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,50,INCOME5,CAT6,_RFPSA21,RESP046,"(43.625381239, -72.517640791)"
|
|
2014,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,627,64.9,61.6,68.1,3456,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,50,INCOME5,CAT6,_RFPSA21,RESP054,"(43.625381239, -72.517640791)"
|
|
2014,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,688,33.8,31.4,36.2,3430,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,50,RACE1,CAT4,_RFPSA21,RESP046,"(43.625381239, -72.517640791)"
|
|
2014,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1174,66.2,63.9,68.6,3434,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,50,RACE1,CAT4,_RFPSA21,RESP054,"(43.625381239, -72.517640791)"
|
|
2014,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,4,,,,3431,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,50,RACE2,CAT4,_RFPSA21,RESP046,"(43.625381239, -72.517640791)"
|
|
2014,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,12,,,,3435,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,50,RACE2,CAT4,_RFPSA21,RESP054,"(43.625381239, -72.517640791)"
|
|
2014,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,4,,,,3436,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,50,RACE3,CAT4,_RFPSA21,RESP054,"(43.625381239, -72.517640791)"
|
|
2014,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,7,,,,3432,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,50,RACE4,CAT4,_RFPSA21,RESP046,"(43.625381239, -72.517640791)"
|
|
2014,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,30,,,,3437,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,50,RACE4,CAT4,_RFPSA21,RESP054,"(43.625381239, -72.517640791)"
|
|
2014,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,2,,,,3433,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,50,RACE5,CAT4,_RFPSA21,RESP046,"(43.625381239, -72.517640791)"
|
|
2014,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,22,,,,3438,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,50,RACE5,CAT4,_RFPSA21,RESP054,"(43.625381239, -72.517640791)"
|
|
2014,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,713,32.6,30.3,34.9,3420,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,50,SEX1,CAT2,_RFPSA21,RESP046,"(43.625381239, -72.517640791)"
|
|
2014,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1265,67.4,65.1,69.7,3421,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,50,SEX1,CAT2,_RFPSA21,RESP054,"(43.625381239, -72.517640791)"
|
|
2014,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,112,19.4,15.6,23.2,3464,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,AGE06,CAT3,_RFPSA21,RESP046,"(37.542680674, -78.457890463)"
|
|
2014,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,431,80.6,76.8,84.4,3468,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,AGE06,CAT3,_RFPSA21,RESP054,"(37.542680674, -78.457890463)"
|
|
2014,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,345,43.9,39.4,48.5,3465,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,AGE07,CAT3,_RFPSA21,RESP046,"(37.542680674, -78.457890463)"
|
|
2014,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,393,56.1,51.5,60.6,3469,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,AGE07,CAT3,_RFPSA21,RESP054,"(37.542680674, -78.457890463)"
|
|
2014,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,260,57.6,51.7,63.6,3466,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,AGE08,CAT3,_RFPSA21,RESP046,"(37.542680674, -78.457890463)"
|
|
2014,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,175,42.4,36.5,48.3,3470,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,AGE08,CAT3,_RFPSA21,RESP054,"(37.542680674, -78.457890463)"
|
|
2014,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,701,68.2,64.7,71.8,3467,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,AGE09,CAT3,_RFPSA21,RESP046,"(37.542680674, -78.457890463)"
|
|
2014,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,337,31.8,28.3,35.3,3471,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,AGE09,CAT3,_RFPSA21,RESP054,"(37.542680674, -78.457890463)"
|
|
2014,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1418,45.2,42.9,47.6,3460,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,BO1,CAT1,_RFPSA21,RESP046,"(37.542680674, -78.457890463)"
|
|
2014,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1336,54.8,52.4,57.1,3461,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,BO1,CAT1,_RFPSA21,RESP054,"(37.542680674, -78.457890463)"
|
|
2014,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,91,38,30.2,45.9,3482,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,EDUCA1,CAT5,_RFPSA21,RESP046,"(37.542680674, -78.457890463)"
|
|
2014,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,135,62,54.1,69.8,3486,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,EDUCA1,CAT5,_RFPSA21,RESP054,"(37.542680674, -78.457890463)"
|
|
2014,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,315,38.6,34.2,43,3483,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,EDUCA2,CAT5,_RFPSA21,RESP046,"(37.542680674, -78.457890463)"
|
|
2014,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,381,61.4,57,65.8,3487,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,EDUCA2,CAT5,_RFPSA21,RESP054,"(37.542680674, -78.457890463)"
|
|
2014,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,324,46.7,41.7,51.8,3484,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,EDUCA3,CAT5,_RFPSA21,RESP046,"(37.542680674, -78.457890463)"
|
|
2014,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,278,53.3,48.2,58.3,3488,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,EDUCA3,CAT5,_RFPSA21,RESP054,"(37.542680674, -78.457890463)"
|
|
2014,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,686,51.7,48.2,55.2,3485,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,EDUCA4,CAT5,_RFPSA21,RESP046,"(37.542680674, -78.457890463)"
|
|
2014,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,537,48.3,44.8,51.8,3489,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,EDUCA4,CAT5,_RFPSA21,RESP054,"(37.542680674, -78.457890463)"
|
|
2014,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,42,31.2,21.3,41,3490,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,INCOME1,CAT6,_RFPSA21,RESP046,"(37.542680674, -78.457890463)"
|
|
2014,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,99,68.9,59,78.7,3495,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,INCOME1,CAT6,_RFPSA21,RESP054,"(37.542680674, -78.457890463)"
|
|
2014,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,137,37.4,30.3,44.5,3491,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,INCOME2,CAT6,_RFPSA21,RESP046,"(37.542680674, -78.457890463)"
|
|
2014,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,178,62.6,55.5,69.7,3496,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,INCOME2,CAT6,_RFPSA21,RESP054,"(37.542680674, -78.457890463)"
|
|
2014,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,103,42,33.1,50.8,3492,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,INCOME3,CAT6,_RFPSA21,RESP046,"(37.542680674, -78.457890463)"
|
|
2014,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,101,58.1,49.2,66.9,3497,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,INCOME3,CAT6,_RFPSA21,RESP054,"(37.542680674, -78.457890463)"
|
|
2014,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,180,50,42.5,57.5,3493,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,INCOME4,CAT6,_RFPSA21,RESP046,"(37.542680674, -78.457890463)"
|
|
2014,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,133,50,42.6,57.5,3498,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,INCOME4,CAT6,_RFPSA21,RESP054,"(37.542680674, -78.457890463)"
|
|
2014,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,794,47.5,44.4,50.7,3494,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,INCOME5,CAT6,_RFPSA21,RESP046,"(37.542680674, -78.457890463)"
|
|
2014,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,696,52.5,49.3,55.7,3499,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,INCOME5,CAT6,_RFPSA21,RESP054,"(37.542680674, -78.457890463)"
|
|
2014,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1165,47.4,44.8,50,3472,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,RACE1,CAT4,_RFPSA21,RESP046,"(37.542680674, -78.457890463)"
|
|
2014,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1044,52.6,50,55.2,3477,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,RACE1,CAT4,_RFPSA21,RESP054,"(37.542680674, -78.457890463)"
|
|
2014,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,161,41.9,35.4,48.5,3473,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,RACE2,CAT4,_RFPSA21,RESP046,"(37.542680674, -78.457890463)"
|
|
2014,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,169,58.1,51.6,64.6,3478,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,RACE2,CAT4,_RFPSA21,RESP054,"(37.542680674, -78.457890463)"
|
|
2014,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,24,39.9,25,54.8,3474,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,RACE3,CAT4,_RFPSA21,RESP046,"(37.542680674, -78.457890463)"
|
|
2014,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,40,60.1,45.2,75,3479,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,RACE3,CAT4,_RFPSA21,RESP054,"(37.542680674, -78.457890463)"
|
|
2014,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,20,27.1,13.9,40.3,3475,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,RACE4,CAT4,_RFPSA21,RESP046,"(37.542680674, -78.457890463)"
|
|
2014,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,47,72.9,59.7,86.1,3480,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,RACE4,CAT4,_RFPSA21,RESP054,"(37.542680674, -78.457890463)"
|
|
2014,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,17,,,,3476,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,51,RACE5,CAT4,_RFPSA21,RESP046,"(37.542680674, -78.457890463)"
|
|
2014,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,18,,,,3481,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,51,RACE5,CAT4,_RFPSA21,RESP054,"(37.542680674, -78.457890463)"
|
|
2014,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1418,45.2,42.9,47.6,3462,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,SEX1,CAT2,_RFPSA21,RESP046,"(37.542680674, -78.457890463)"
|
|
2014,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1336,54.8,52.4,57.1,3463,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,51,SEX1,CAT2,_RFPSA21,RESP054,"(37.542680674, -78.457890463)"
|
|
2014,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,214,45,39.3,50.8,3467,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,AGE08,CAT3,_RFPSA21,RESP046,"(47.522278629, -120.47001079)"
|
|
2014,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,54,10.4,6.9,13.9,3465,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,AGE06,CAT3,_RFPSA21,RESP046,"(47.522278629, -120.47001079)"
|
|
2014,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,445,89.6,86.1,93.1,3469,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,AGE06,CAT3,_RFPSA21,RESP054,"(47.522278629, -120.47001079)"
|
|
2014,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,254,32,27.8,36.2,3466,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,AGE07,CAT3,_RFPSA21,RESP046,"(47.522278629, -120.47001079)"
|
|
2014,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,493,68,63.9,72.2,3470,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,AGE07,CAT3,_RFPSA21,RESP054,"(47.522278629, -120.47001079)"
|
|
2014,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,239,55,49.2,60.7,3471,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,AGE08,CAT3,_RFPSA21,RESP054,"(47.522278629, -120.47001079)"
|
|
2014,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,705,56.1,52.7,59.5,3468,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,AGE09,CAT3,_RFPSA21,RESP046,"(47.522278629, -120.47001079)"
|
|
2014,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,541,43.9,40.5,47.3,3472,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,AGE09,CAT3,_RFPSA21,RESP054,"(47.522278629, -120.47001079)"
|
|
2014,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1227,34.7,32.5,36.9,3461,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,BO1,CAT1,_RFPSA21,RESP046,"(47.522278629, -120.47001079)"
|
|
2014,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1718,65.3,63.2,67.5,3462,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,BO1,CAT1,_RFPSA21,RESP054,"(47.522278629, -120.47001079)"
|
|
2014,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,31,21.2,12.3,30,3483,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,EDUCA1,CAT5,_RFPSA21,RESP046,"(47.522278629, -120.47001079)"
|
|
2014,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,80,78.8,70,87.7,3487,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,EDUCA1,CAT5,_RFPSA21,RESP054,"(47.522278629, -120.47001079)"
|
|
2014,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,209,30.8,26.4,35.2,3484,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,EDUCA2,CAT5,_RFPSA21,RESP046,"(47.522278629, -120.47001079)"
|
|
2014,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,379,69.2,64.8,73.6,3488,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,EDUCA2,CAT5,_RFPSA21,RESP054,"(47.522278629, -120.47001079)"
|
|
2014,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,328,35.9,31.9,40,3485,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,EDUCA3,CAT5,_RFPSA21,RESP046,"(47.522278629, -120.47001079)"
|
|
2014,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,465,64.1,60.1,68.1,3489,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,EDUCA3,CAT5,_RFPSA21,RESP054,"(47.522278629, -120.47001079)"
|
|
2014,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,659,40.1,37.2,43,3486,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,EDUCA4,CAT5,_RFPSA21,RESP046,"(47.522278629, -120.47001079)"
|
|
2014,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,793,59.9,57,62.8,3490,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,EDUCA4,CAT5,_RFPSA21,RESP054,"(47.522278629, -120.47001079)"
|
|
2014,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,32,13.7,7.6,19.8,3491,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,INCOME1,CAT6,_RFPSA21,RESP046,"(47.522278629, -120.47001079)"
|
|
2014,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,130,86.3,80.2,92.5,3496,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,INCOME1,CAT6,_RFPSA21,RESP054,"(47.522278629, -120.47001079)"
|
|
2014,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,78,21.2,15.4,27.1,3492,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,INCOME2,CAT6,_RFPSA21,RESP046,"(47.522278629, -120.47001079)"
|
|
2014,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,199,78.8,72.9,84.6,3497,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,INCOME2,CAT6,_RFPSA21,RESP054,"(47.522278629, -120.47001079)"
|
|
2014,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,96,29.6,22.4,36.9,3493,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,INCOME3,CAT6,_RFPSA21,RESP046,"(47.522278629, -120.47001079)"
|
|
2014,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,145,70.4,63.1,77.6,3498,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,INCOME3,CAT6,_RFPSA21,RESP054,"(47.522278629, -120.47001079)"
|
|
2014,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,175,38.7,32.2,45.3,3494,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,INCOME4,CAT6,_RFPSA21,RESP046,"(47.522278629, -120.47001079)"
|
|
2014,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,215,61.3,54.7,67.8,3499,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,INCOME4,CAT6,_RFPSA21,RESP054,"(47.522278629, -120.47001079)"
|
|
2014,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,765,38.8,36,41.7,3495,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,INCOME5,CAT6,_RFPSA21,RESP046,"(47.522278629, -120.47001079)"
|
|
2014,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,919,61.2,58.3,64.1,3500,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,INCOME5,CAT6,_RFPSA21,RESP054,"(47.522278629, -120.47001079)"
|
|
2014,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1117,37.7,35.4,40,3473,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,RACE1,CAT4,_RFPSA21,RESP046,"(47.522278629, -120.47001079)"
|
|
2014,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1452,62.3,60,64.6,3478,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,RACE1,CAT4,_RFPSA21,RESP054,"(47.522278629, -120.47001079)"
|
|
2014,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,23,36.6,21.4,51.8,3474,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,RACE2,CAT4,_RFPSA21,RESP046,"(47.522278629, -120.47001079)"
|
|
2014,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,32,63.4,48.2,78.6,3479,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,RACE2,CAT4,_RFPSA21,RESP054,"(47.522278629, -120.47001079)"
|
|
2014,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,24,20.6,11.1,30.2,3475,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,RACE3,CAT4,_RFPSA21,RESP046,"(47.522278629, -120.47001079)"
|
|
2014,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,84,79.4,69.9,88.9,3480,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,RACE3,CAT4,_RFPSA21,RESP054,"(47.522278629, -120.47001079)"
|
|
2014,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,29,15.1,8.8,21.3,3476,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,RACE4,CAT4,_RFPSA21,RESP046,"(47.522278629, -120.47001079)"
|
|
2014,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,103,84.9,78.7,91.2,3481,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,RACE4,CAT4,_RFPSA21,RESP054,"(47.522278629, -120.47001079)"
|
|
2014,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,17,,,,3477,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,53,RACE5,CAT4,_RFPSA21,RESP046,"(47.522278629, -120.47001079)"
|
|
2014,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,23,,,,3482,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,53,RACE5,CAT4,_RFPSA21,RESP054,"(47.522278629, -120.47001079)"
|
|
2014,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1227,34.7,32.5,36.9,3463,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,SEX1,CAT2,_RFPSA21,RESP046,"(47.522278629, -120.47001079)"
|
|
2014,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1718,65.3,63.2,67.5,3464,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,53,SEX1,CAT2,_RFPSA21,RESP054,"(47.522278629, -120.47001079)"
|
|
2014,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,71,17,12.9,21.1,3441,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,54,AGE06,CAT3,_RFPSA21,RESP046,"(38.665510202, -80.712640135)"
|
|
2014,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,304,83,78.9,87.1,3445,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,54,AGE06,CAT3,_RFPSA21,RESP054,"(38.665510202, -80.712640135)"
|
|
2014,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,215,38.8,34.1,43.4,3442,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,54,AGE07,CAT3,_RFPSA21,RESP046,"(38.665510202, -80.712640135)"
|
|
2014,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,301,61.2,56.6,65.9,3446,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,54,AGE07,CAT3,_RFPSA21,RESP054,"(38.665510202, -80.712640135)"
|
|
2014,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,187,59.9,53.6,66.3,3443,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,54,AGE08,CAT3,_RFPSA21,RESP046,"(38.665510202, -80.712640135)"
|
|
2014,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,122,40.1,33.8,46.4,3447,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,54,AGE08,CAT3,_RFPSA21,RESP054,"(38.665510202, -80.712640135)"
|
|
2014,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,496,67.9,64,71.7,3444,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,54,AGE09,CAT3,_RFPSA21,RESP046,"(38.665510202, -80.712640135)"
|
|
2014,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,231,32.1,28.3,36,3448,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,54,AGE09,CAT3,_RFPSA21,RESP054,"(38.665510202, -80.712640135)"
|
|
2014,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,969,44.9,42.4,47.4,3437,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,54,BO1,CAT1,_RFPSA21,RESP046,"(38.665510202, -80.712640135)"
|
|
2014,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,958,55.1,52.6,57.6,3438,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,54,BO1,CAT1,_RFPSA21,RESP054,"(38.665510202, -80.712640135)"
|
|
2014,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,99,36.6,30.2,43,3459,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,54,EDUCA1,CAT5,_RFPSA21,RESP046,"(38.665510202, -80.712640135)"
|
|
2014,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,156,63.4,57,69.8,3463,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,54,EDUCA1,CAT5,_RFPSA21,RESP054,"(38.665510202, -80.712640135)"
|
|
2014,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,363,42.5,38.6,46.3,3460,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,54,EDUCA2,CAT5,_RFPSA21,RESP046,"(38.665510202, -80.712640135)"
|
|
2014,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,409,57.6,53.7,61.4,3464,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,54,EDUCA2,CAT5,_RFPSA21,RESP054,"(38.665510202, -80.712640135)"
|
|
2014,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,207,49.8,44.4,55.3,3461,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,54,EDUCA3,CAT5,_RFPSA21,RESP046,"(38.665510202, -80.712640135)"
|
|
2014,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,193,50.2,44.7,55.6,3465,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,54,EDUCA3,CAT5,_RFPSA21,RESP054,"(38.665510202, -80.712640135)"
|
|
2014,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,300,55.4,50.4,60.4,3462,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,54,EDUCA4,CAT5,_RFPSA21,RESP046,"(38.665510202, -80.712640135)"
|
|
2014,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,197,44.6,39.6,49.6,3466,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,54,EDUCA4,CAT5,_RFPSA21,RESP054,"(38.665510202, -80.712640135)"
|
|
2014,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,54,26.3,19.3,33.3,3467,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,54,INCOME1,CAT6,_RFPSA21,RESP046,"(38.665510202, -80.712640135)"
|
|
2014,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,133,73.7,66.7,80.7,3472,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,54,INCOME1,CAT6,_RFPSA21,RESP054,"(38.665510202, -80.712640135)"
|
|
2014,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,130,37.3,31.2,43.4,3468,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,54,INCOME2,CAT6,_RFPSA21,RESP046,"(38.665510202, -80.712640135)"
|
|
2014,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,174,62.7,56.6,68.8,3473,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,54,INCOME2,CAT6,_RFPSA21,RESP054,"(38.665510202, -80.712640135)"
|
|
2014,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,111,43.6,36.3,51,3469,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,54,INCOME3,CAT6,_RFPSA21,RESP046,"(38.665510202, -80.712640135)"
|
|
2014,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,112,56.4,49,63.7,3474,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,54,INCOME3,CAT6,_RFPSA21,RESP054,"(38.665510202, -80.712640135)"
|
|
2014,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,167,50.4,43.9,57,3470,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,54,INCOME4,CAT6,_RFPSA21,RESP046,"(38.665510202, -80.712640135)"
|
|
2014,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,128,49.6,43.1,56.2,3475,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,54,INCOME4,CAT6,_RFPSA21,RESP054,"(38.665510202, -80.712640135)"
|
|
2014,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,373,51.7,47.3,56.2,3471,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,54,INCOME5,CAT6,_RFPSA21,RESP046,"(38.665510202, -80.712640135)"
|
|
2014,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,280,48.3,43.8,52.7,3476,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,54,INCOME5,CAT6,_RFPSA21,RESP054,"(38.665510202, -80.712640135)"
|
|
2014,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,922,45.1,42.5,47.7,3449,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,54,RACE1,CAT4,_RFPSA21,RESP046,"(38.665510202, -80.712640135)"
|
|
2014,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,903,54.9,52.4,57.5,3454,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,54,RACE1,CAT4,_RFPSA21,RESP054,"(38.665510202, -80.712640135)"
|
|
2014,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,22,,,,3450,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,54,RACE2,CAT4,_RFPSA21,RESP046,"(38.665510202, -80.712640135)"
|
|
2014,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,20,,,,3455,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,54,RACE2,CAT4,_RFPSA21,RESP054,"(38.665510202, -80.712640135)"
|
|
2014,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,3,,,,3451,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,54,RACE3,CAT4,_RFPSA21,RESP046,"(38.665510202, -80.712640135)"
|
|
2014,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,5,,,,3456,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,54,RACE3,CAT4,_RFPSA21,RESP054,"(38.665510202, -80.712640135)"
|
|
2014,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,6,,,,3452,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,54,RACE4,CAT4,_RFPSA21,RESP046,"(38.665510202, -80.712640135)"
|
|
2014,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,14,,,,3457,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,54,RACE4,CAT4,_RFPSA21,RESP054,"(38.665510202, -80.712640135)"
|
|
2014,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,14,,,,3453,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,54,RACE5,CAT4,_RFPSA21,RESP046,"(38.665510202, -80.712640135)"
|
|
2014,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,10,,,,3458,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,54,RACE5,CAT4,_RFPSA21,RESP054,"(38.665510202, -80.712640135)"
|
|
2014,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,969,44.9,42.4,47.4,3439,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,54,SEX1,CAT2,_RFPSA21,RESP046,"(38.665510202, -80.712640135)"
|
|
2014,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,958,55.1,52.6,57.6,3440,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,54,SEX1,CAT2,_RFPSA21,RESP054,"(38.665510202, -80.712640135)"
|
|
2014,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,356,86.8,82.1,91.5,3458,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,55,AGE06,CAT3,_RFPSA21,RESP054,"(44.393191174, -89.816370742)"
|
|
2014,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,56,13.2,8.5,17.9,3454,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,55,AGE06,CAT3,_RFPSA21,RESP046,"(44.393191174, -89.816370742)"
|
|
2014,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,222,35.8,30.7,41,3455,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,55,AGE07,CAT3,_RFPSA21,RESP046,"(44.393191174, -89.816370742)"
|
|
2014,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,381,64.2,59.1,69.4,3459,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,55,AGE07,CAT3,_RFPSA21,RESP054,"(44.393191174, -89.816370742)"
|
|
2014,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,183,52.1,45.1,59.1,3456,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,55,AGE08,CAT3,_RFPSA21,RESP046,"(44.393191174, -89.816370742)"
|
|
2014,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,170,47.9,40.9,55,3460,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,55,AGE08,CAT3,_RFPSA21,RESP054,"(44.393191174, -89.816370742)"
|
|
2014,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,476,61.5,56.9,66.2,3457,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,55,AGE09,CAT3,_RFPSA21,RESP046,"(44.393191174, -89.816370742)"
|
|
2014,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,325,38.5,33.8,43.2,3461,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,55,AGE09,CAT3,_RFPSA21,RESP054,"(44.393191174, -89.816370742)"
|
|
2014,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,937,39.3,36.5,42.1,3450,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,55,BO1,CAT1,_RFPSA21,RESP046,"(44.393191174, -89.816370742)"
|
|
2014,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1232,60.7,57.9,63.5,3451,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,55,BO1,CAT1,_RFPSA21,RESP054,"(44.393191174, -89.816370742)"
|
|
2014,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,36,34.8,22.5,47.2,3472,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,55,EDUCA1,CAT5,_RFPSA21,RESP046,"(44.393191174, -89.816370742)"
|
|
2014,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,77,65.2,52.8,77.5,3476,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,55,EDUCA1,CAT5,_RFPSA21,RESP054,"(44.393191174, -89.816370742)"
|
|
2014,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,290,34.6,30,39.1,3473,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,55,EDUCA2,CAT5,_RFPSA21,RESP046,"(44.393191174, -89.816370742)"
|
|
2014,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,453,65.4,60.9,70,3477,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,55,EDUCA2,CAT5,_RFPSA21,RESP054,"(44.393191174, -89.816370742)"
|
|
2014,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,260,41.2,35.9,46.6,3474,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,55,EDUCA3,CAT5,_RFPSA21,RESP046,"(44.393191174, -89.816370742)"
|
|
2014,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,340,58.8,53.5,64.1,3478,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,55,EDUCA3,CAT5,_RFPSA21,RESP054,"(44.393191174, -89.816370742)"
|
|
2014,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,350,45.3,40.5,50.1,3475,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,55,EDUCA4,CAT5,_RFPSA21,RESP046,"(44.393191174, -89.816370742)"
|
|
2014,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,362,54.7,49.9,59.5,3479,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,55,EDUCA4,CAT5,_RFPSA21,RESP054,"(44.393191174, -89.816370742)"
|
|
2014,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,44,34.8,20.3,49.3,3480,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,55,INCOME1,CAT6,_RFPSA21,RESP046,"(44.393191174, -89.816370742)"
|
|
2014,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,98,65.2,50.7,79.7,3485,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,55,INCOME1,CAT6,_RFPSA21,RESP054,"(44.393191174, -89.816370742)"
|
|
2014,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,126,43.1,34.5,51.7,3481,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,55,INCOME2,CAT6,_RFPSA21,RESP046,"(44.393191174, -89.816370742)"
|
|
2014,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,161,56.9,48.3,65.5,3486,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,55,INCOME2,CAT6,_RFPSA21,RESP054,"(44.393191174, -89.816370742)"
|
|
2014,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,89,40.4,31.6,49.2,3482,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,55,INCOME3,CAT6,_RFPSA21,RESP046,"(44.393191174, -89.816370742)"
|
|
2014,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,117,59.6,50.8,68.4,3487,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,55,INCOME3,CAT6,_RFPSA21,RESP054,"(44.393191174, -89.816370742)"
|
|
2014,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,168,40.4,33,47.8,3483,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,55,INCOME4,CAT6,_RFPSA21,RESP046,"(44.393191174, -89.816370742)"
|
|
2014,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,183,59.6,52.2,67,3488,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,55,INCOME4,CAT6,_RFPSA21,RESP054,"(44.393191174, -89.816370742)"
|
|
2014,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,458,39.1,35.4,42.9,3484,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,55,INCOME5,CAT6,_RFPSA21,RESP046,"(44.393191174, -89.816370742)"
|
|
2014,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,587,60.9,57.1,64.6,3489,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,55,INCOME5,CAT6,_RFPSA21,RESP054,"(44.393191174, -89.816370742)"
|
|
2014,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,866,39.8,37,42.6,3462,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,55,RACE1,CAT4,_RFPSA21,RESP046,"(44.393191174, -89.816370742)"
|
|
2014,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1124,60.2,57.4,63,3467,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,55,RACE1,CAT4,_RFPSA21,RESP054,"(44.393191174, -89.816370742)"
|
|
2014,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,27,46.5,25,68.1,3463,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,55,RACE2,CAT4,_RFPSA21,RESP046,"(44.393191174, -89.816370742)"
|
|
2014,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,38,53.5,31.9,75,3468,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,55,RACE2,CAT4,_RFPSA21,RESP054,"(44.393191174, -89.816370742)"
|
|
2014,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,5,,,,3464,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,55,RACE3,CAT4,_RFPSA21,RESP046,"(44.393191174, -89.816370742)"
|
|
2014,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,21,,,,3469,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,55,RACE3,CAT4,_RFPSA21,RESP054,"(44.393191174, -89.816370742)"
|
|
2014,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,23,37.9,18.1,57.7,3465,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,55,RACE4,CAT4,_RFPSA21,RESP046,"(44.393191174, -89.816370742)"
|
|
2014,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,31,62.1,42.3,81.9,3470,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,55,RACE4,CAT4,_RFPSA21,RESP054,"(44.393191174, -89.816370742)"
|
|
2014,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,9,,,,3466,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,55,RACE5,CAT4,_RFPSA21,RESP046,"(44.393191174, -89.816370742)"
|
|
2014,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,9,,,,3471,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,55,RACE5,CAT4,_RFPSA21,RESP054,"(44.393191174, -89.816370742)"
|
|
2014,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,937,39.3,36.5,42.1,3452,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,55,SEX1,CAT2,_RFPSA21,RESP046,"(44.393191174, -89.816370742)"
|
|
2014,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1232,60.7,57.9,63.5,3453,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,55,SEX1,CAT2,_RFPSA21,RESP054,"(44.393191174, -89.816370742)"
|
|
2014,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,50,18.8,12.4,25.1,3450,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,56,AGE06,CAT3,_RFPSA21,RESP046,"(43.235541343, -108.109830353)"
|
|
2014,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,186,81.3,74.9,87.6,3454,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,56,AGE06,CAT3,_RFPSA21,RESP054,"(43.235541343, -108.109830353)"
|
|
2014,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,227,43.6,37.2,49.9,3451,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,56,AGE07,CAT3,_RFPSA21,RESP046,"(43.235541343, -108.109830353)"
|
|
2014,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,223,56.5,50.1,62.8,3455,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,56,AGE07,CAT3,_RFPSA21,RESP054,"(43.235541343, -108.109830353)"
|
|
2014,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,228,61.3,54.5,68,3452,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,56,AGE08,CAT3,_RFPSA21,RESP046,"(43.235541343, -108.109830353)"
|
|
2014,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,118,38.8,32,45.5,3456,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,56,AGE08,CAT3,_RFPSA21,RESP054,"(43.235541343, -108.109830353)"
|
|
2014,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,581,65.4,61.3,69.5,3453,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,56,AGE09,CAT3,_RFPSA21,RESP046,"(43.235541343, -108.109830353)"
|
|
2014,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,329,34.6,30.5,38.7,3457,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,56,AGE09,CAT3,_RFPSA21,RESP054,"(43.235541343, -108.109830353)"
|
|
2014,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1086,46,42.7,49.3,3446,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,56,BO1,CAT1,_RFPSA21,RESP046,"(43.235541343, -108.109830353)"
|
|
2014,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,856,54,50.7,57.3,3447,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,56,BO1,CAT1,_RFPSA21,RESP054,"(43.235541343, -108.109830353)"
|
|
2014,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,31,25,12.8,37.1,3468,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,56,EDUCA1,CAT5,_RFPSA21,RESP046,"(43.235541343, -108.109830353)"
|
|
2014,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,64,75.1,62.9,87.2,3472,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,56,EDUCA1,CAT5,_RFPSA21,RESP054,"(43.235541343, -108.109830353)"
|
|
2014,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,271,40.8,34.9,46.7,3469,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,56,EDUCA2,CAT5,_RFPSA21,RESP046,"(43.235541343, -108.109830353)"
|
|
2014,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,276,59.2,53.3,65.1,3473,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,56,EDUCA2,CAT5,_RFPSA21,RESP054,"(43.235541343, -108.109830353)"
|
|
2014,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,294,46.2,40.2,52.2,3470,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,56,EDUCA3,CAT5,_RFPSA21,RESP046,"(43.235541343, -108.109830353)"
|
|
2014,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,247,53.8,47.8,59.8,3474,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,56,EDUCA3,CAT5,_RFPSA21,RESP054,"(43.235541343, -108.109830353)"
|
|
2014,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,490,58.8,53.8,63.9,3471,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,56,EDUCA4,CAT5,_RFPSA21,RESP046,"(43.235541343, -108.109830353)"
|
|
2014,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,268,41.2,36.1,46.3,3475,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,56,EDUCA4,CAT5,_RFPSA21,RESP054,"(43.235541343, -108.109830353)"
|
|
2014,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,29,18.9,8.9,29,3476,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,56,INCOME1,CAT6,_RFPSA21,RESP046,"(43.235541343, -108.109830353)"
|
|
2014,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,66,81.1,71.1,91.1,3481,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,56,INCOME1,CAT6,_RFPSA21,RESP054,"(43.235541343, -108.109830353)"
|
|
2014,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,88,33,24.1,41.9,3477,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,56,INCOME2,CAT6,_RFPSA21,RESP046,"(43.235541343, -108.109830353)"
|
|
2014,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,142,67,58.1,75.9,3482,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,56,INCOME2,CAT6,_RFPSA21,RESP054,"(43.235541343, -108.109830353)"
|
|
2014,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,92,48.4,37.2,59.5,3478,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,56,INCOME3,CAT6,_RFPSA21,RESP046,"(43.235541343, -108.109830353)"
|
|
2014,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,81,51.6,40.5,62.8,3483,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,56,INCOME3,CAT6,_RFPSA21,RESP054,"(43.235541343, -108.109830353)"
|
|
2014,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,153,52,41.8,62.2,3479,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,56,INCOME4,CAT6,_RFPSA21,RESP046,"(43.235541343, -108.109830353)"
|
|
2014,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,93,48,37.8,58.2,3484,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,56,INCOME4,CAT6,_RFPSA21,RESP054,"(43.235541343, -108.109830353)"
|
|
2014,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,592,49.7,45,54.4,3480,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,56,INCOME5,CAT6,_RFPSA21,RESP046,"(43.235541343, -108.109830353)"
|
|
2014,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,362,50.3,45.6,55,3485,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,56,INCOME5,CAT6,_RFPSA21,RESP054,"(43.235541343, -108.109830353)"
|
|
2014,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1009,47.7,44.3,51.2,3458,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,56,RACE1,CAT4,_RFPSA21,RESP046,"(43.235541343, -108.109830353)"
|
|
2014,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,758,52.3,48.8,55.7,3463,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,56,RACE1,CAT4,_RFPSA21,RESP054,"(43.235541343, -108.109830353)"
|
|
2014,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,2,,,,3459,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,56,RACE2,CAT4,_RFPSA21,RESP046,"(43.235541343, -108.109830353)"
|
|
2014,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,4,,,,3464,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,56,RACE2,CAT4,_RFPSA21,RESP054,"(43.235541343, -108.109830353)"
|
|
2014,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,17,,,,3460,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,56,RACE3,CAT4,_RFPSA21,RESP046,"(43.235541343, -108.109830353)"
|
|
2014,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,32,,,,3465,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,56,RACE3,CAT4,_RFPSA21,RESP054,"(43.235541343, -108.109830353)"
|
|
2014,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,24,41.9,22.5,61.3,3461,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,56,RACE4,CAT4,_RFPSA21,RESP046,"(43.235541343, -108.109830353)"
|
|
2014,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,30,58.1,38.8,77.5,3466,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,56,RACE4,CAT4,_RFPSA21,RESP054,"(43.235541343, -108.109830353)"
|
|
2014,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,7,,,,3462,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,56,RACE5,CAT4,_RFPSA21,RESP046,"(43.235541343, -108.109830353)"
|
|
2014,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,10,,,,3467,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,Topic47,56,RACE5,CAT4,_RFPSA21,RESP054,"(43.235541343, -108.109830353)"
|
|
2014,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1086,46,42.7,49.3,3448,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,56,SEX1,CAT2,_RFPSA21,RESP046,"(43.235541343, -108.109830353)"
|
|
2014,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,856,54,50.7,57.3,3449,%,Crude Prevalence,,,BRFSS,CLASS16,Topic47,56,SEX1,CAT2,_RFPSA21,RESP054,"(43.235541343, -108.109830353)"
|
|
2016,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,68,17.9,13.1,22.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,AGE06,CAT3,_RFPSA21,RESP046,"(32.84057112200048, -86.63186076199969)"
|
|
2016,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,268,82.1,77.3,86.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,AGE06,CAT3,_RFPSA21,RESP054,"(32.84057112200048, -86.63186076199969)"
|
|
2016,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,220,39.9,34.6,45.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,AGE07,CAT3,_RFPSA21,RESP046,"(32.84057112200048, -86.63186076199969)"
|
|
2016,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,286,60.1,54.7,65.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,AGE07,CAT3,_RFPSA21,RESP054,"(32.84057112200048, -86.63186076199969)"
|
|
2016,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,163,57.9,50.5,65.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,AGE08,CAT3,_RFPSA21,RESP046,"(32.84057112200048, -86.63186076199969)"
|
|
2016,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,106,42.1,34.8,49.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,AGE08,CAT3,_RFPSA21,RESP054,"(32.84057112200048, -86.63186076199969)"
|
|
2016,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,514,69.2,65.2,73.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,AGE09,CAT3,_RFPSA21,RESP046,"(32.84057112200048, -86.63186076199969)"
|
|
2016,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,240,30.8,26.7,34.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,AGE09,CAT3,_RFPSA21,RESP054,"(32.84057112200048, -86.63186076199969)"
|
|
2016,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,965,45.4,42.5,48.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,BO1,CAT1,_RFPSA21,RESP046,"(32.84057112200048, -86.63186076199969)"
|
|
2016,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,900,54.6,51.7,57.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,BO1,CAT1,_RFPSA21,RESP054,"(32.84057112200048, -86.63186076199969)"
|
|
2016,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,61,23.4,16.9,30,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,EDUCA1,CAT5,_RFPSA21,RESP046,"(32.84057112200048, -86.63186076199969)"
|
|
2016,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,156,76.6,70,83.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,EDUCA1,CAT5,_RFPSA21,RESP054,"(32.84057112200048, -86.63186076199969)"
|
|
2016,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,288,42.6,37.7,47.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,EDUCA2,CAT5,_RFPSA21,RESP046,"(32.84057112200048, -86.63186076199969)"
|
|
2016,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,323,57.4,52.6,62.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,EDUCA2,CAT5,_RFPSA21,RESP054,"(32.84057112200048, -86.63186076199969)"
|
|
2016,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,262,51.5,45.9,57,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,EDUCA3,CAT5,_RFPSA21,RESP046,"(32.84057112200048, -86.63186076199969)"
|
|
2016,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,215,48.5,43,54.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,EDUCA3,CAT5,_RFPSA21,RESP054,"(32.84057112200048, -86.63186076199969)"
|
|
2016,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,352,59.1,54,64.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,EDUCA4,CAT5,_RFPSA21,RESP046,"(32.84057112200048, -86.63186076199969)"
|
|
2016,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,203,40.9,35.8,46,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,EDUCA4,CAT5,_RFPSA21,RESP054,"(32.84057112200048, -86.63186076199969)"
|
|
2016,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,59,32,23.5,40.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,INCOME1,CAT6,_RFPSA21,RESP046,"(32.84057112200048, -86.63186076199969)"
|
|
2016,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,117,68,59.4,76.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,INCOME1,CAT6,_RFPSA21,RESP054,"(32.84057112200048, -86.63186076199969)"
|
|
2016,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,107,32.2,25.5,38.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,INCOME2,CAT6,_RFPSA21,RESP046,"(32.84057112200048, -86.63186076199969)"
|
|
2016,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,164,67.8,61.1,74.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,INCOME2,CAT6,_RFPSA21,RESP054,"(32.84057112200048, -86.63186076199969)"
|
|
2016,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,75,37.7,28.5,46.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,INCOME3,CAT6,_RFPSA21,RESP046,"(32.84057112200048, -86.63186076199969)"
|
|
2016,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,85,62.3,53.1,71.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,INCOME3,CAT6,_RFPSA21,RESP054,"(32.84057112200048, -86.63186076199969)"
|
|
2016,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,115,42.3,33.7,50.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,INCOME4,CAT6,_RFPSA21,RESP046,"(32.84057112200048, -86.63186076199969)"
|
|
2016,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,107,57.7,49.2,66.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,INCOME4,CAT6,_RFPSA21,RESP054,"(32.84057112200048, -86.63186076199969)"
|
|
2016,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,472,55.5,51.1,59.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,INCOME5,CAT6,_RFPSA21,RESP046,"(32.84057112200048, -86.63186076199969)"
|
|
2016,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,298,44.5,40.1,48.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,INCOME5,CAT6,_RFPSA21,RESP054,"(32.84057112200048, -86.63186076199969)"
|
|
2016,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,720,47.2,43.9,50.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,RACE01,CAT4,_RFPSA21,RESP046,"(32.84057112200048, -86.63186076199969)"
|
|
2016,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,643,52.8,49.5,56.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,RACE01,CAT4,_RFPSA21,RESP054,"(32.84057112200048, -86.63186076199969)"
|
|
2016,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,214,45.1,39,51.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,RACE02,CAT4,_RFPSA21,RESP046,"(32.84057112200048, -86.63186076199969)"
|
|
2016,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,201,54.9,48.7,61,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,RACE02,CAT4,_RFPSA21,RESP054,"(32.84057112200048, -86.63186076199969)"
|
|
2016,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,01,RACE03,CAT4,_RFPSA21,RESP046,"(32.84057112200048, -86.63186076199969)"
|
|
2016,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,14,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,01,RACE03,CAT4,_RFPSA21,RESP054,"(32.84057112200048, -86.63186076199969)"
|
|
2016,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,01,RACE04,CAT4,_RFPSA21,RESP046,"(32.84057112200048, -86.63186076199969)"
|
|
2016,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,01,RACE04,CAT4,_RFPSA21,RESP054,"(32.84057112200048, -86.63186076199969)"
|
|
2016,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,01,RACE05,CAT4,_RFPSA21,RESP046,"(32.84057112200048, -86.63186076199969)"
|
|
2016,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,01,RACE05,CAT4,_RFPSA21,RESP054,"(32.84057112200048, -86.63186076199969)"
|
|
2016,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,9,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,01,RACE06,CAT4,_RFPSA21,RESP046,"(32.84057112200048, -86.63186076199969)"
|
|
2016,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,11,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,01,RACE06,CAT4,_RFPSA21,RESP054,"(32.84057112200048, -86.63186076199969)"
|
|
2016,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,9,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,01,RACE07,CAT4,_RFPSA21,RESP046,"(32.84057112200048, -86.63186076199969)"
|
|
2016,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,15,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,01,RACE07,CAT4,_RFPSA21,RESP054,"(32.84057112200048, -86.63186076199969)"
|
|
2016,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,01,RACE08,CAT4,_RFPSA21,RESP046,"(32.84057112200048, -86.63186076199969)"
|
|
2016,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,13,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,01,RACE08,CAT4,_RFPSA21,RESP054,"(32.84057112200048, -86.63186076199969)"
|
|
2016,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,965,45.4,42.5,48.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,SEX1,CAT2,_RFPSA21,RESP046,"(32.84057112200048, -86.63186076199969)"
|
|
2016,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,900,54.6,51.7,57.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,SEX1,CAT2,_RFPSA21,RESP054,"(32.84057112200048, -86.63186076199969)"
|
|
2016,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,01,SEX2,CAT2,_RFPSA21,RESP046,"(32.84057112200048, -86.63186076199969)"
|
|
2016,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,01,SEX2,CAT2,_RFPSA21,RESP054,"(32.84057112200048, -86.63186076199969)"
|
|
2016,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,346,38.2,32.6,43.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,SEX1,CAT2,_RFPSA21,RESP046,"(64.84507995700051, -147.72205903599973)"
|
|
2016,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,19,11.4,5,17.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,AGE06,CAT3,_RFPSA21,RESP046,"(64.84507995700051, -147.72205903599973)"
|
|
2016,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,143,88.6,82.2,95,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,AGE06,CAT3,_RFPSA21,RESP054,"(64.84507995700051, -147.72205903599973)"
|
|
2016,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,72,36.8,26.9,46.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,AGE07,CAT3,_RFPSA21,RESP046,"(64.84507995700051, -147.72205903599973)"
|
|
2016,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,169,63.2,53.4,73.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,AGE07,CAT3,_RFPSA21,RESP054,"(64.84507995700051, -147.72205903599973)"
|
|
2016,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,74,48.8,35.9,61.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,AGE08,CAT3,_RFPSA21,RESP046,"(64.84507995700051, -147.72205903599973)"
|
|
2016,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,104,51.2,38.4,64.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,AGE08,CAT3,_RFPSA21,RESP054,"(64.84507995700051, -147.72205903599973)"
|
|
2016,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,181,56.3,45.5,67.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,AGE09,CAT3,_RFPSA21,RESP046,"(64.84507995700051, -147.72205903599973)"
|
|
2016,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,158,43.7,32.9,54.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,AGE09,CAT3,_RFPSA21,RESP054,"(64.84507995700051, -147.72205903599973)"
|
|
2016,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,346,38.2,32.6,43.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,BO1,CAT1,_RFPSA21,RESP046,"(64.84507995700051, -147.72205903599973)"
|
|
2016,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,574,61.8,56.1,67.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,BO1,CAT1,_RFPSA21,RESP054,"(64.84507995700051, -147.72205903599973)"
|
|
2016,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,02,EDUCA1,CAT5,_RFPSA21,RESP046,"(64.84507995700051, -147.72205903599973)"
|
|
2016,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,36,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,02,EDUCA1,CAT5,_RFPSA21,RESP054,"(64.84507995700051, -147.72205903599973)"
|
|
2016,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,70,33.5,21.3,45.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,EDUCA2,CAT5,_RFPSA21,RESP046,"(64.84507995700051, -147.72205903599973)"
|
|
2016,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,193,66.5,54.3,78.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,EDUCA2,CAT5,_RFPSA21,RESP054,"(64.84507995700051, -147.72205903599973)"
|
|
2016,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,100,41,30.8,51.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,EDUCA3,CAT5,_RFPSA21,RESP046,"(64.84507995700051, -147.72205903599973)"
|
|
2016,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,152,59,48.8,69.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,EDUCA3,CAT5,_RFPSA21,RESP054,"(64.84507995700051, -147.72205903599973)"
|
|
2016,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,167,44.7,36.7,52.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,EDUCA4,CAT5,_RFPSA21,RESP046,"(64.84507995700051, -147.72205903599973)"
|
|
2016,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,190,55.3,47.4,63.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,EDUCA4,CAT5,_RFPSA21,RESP054,"(64.84507995700051, -147.72205903599973)"
|
|
2016,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,12,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,02,INCOME1,CAT6,_RFPSA21,RESP046,"(64.84507995700051, -147.72205903599973)"
|
|
2016,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,61,89.3,80.8,97.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,INCOME1,CAT6,_RFPSA21,RESP054,"(64.84507995700051, -147.72205903599973)"
|
|
2016,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,23,24.1,13.4,34.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,INCOME2,CAT6,_RFPSA21,RESP046,"(64.84507995700051, -147.72205903599973)"
|
|
2016,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,67,75.9,65.2,86.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,INCOME2,CAT6,_RFPSA21,RESP054,"(64.84507995700051, -147.72205903599973)"
|
|
2016,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,28,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,02,INCOME3,CAT6,_RFPSA21,RESP046,"(64.84507995700051, -147.72205903599973)"
|
|
2016,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,40,65.2,39.3,91.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,INCOME3,CAT6,_RFPSA21,RESP054,"(64.84507995700051, -147.72205903599973)"
|
|
2016,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,26,51.5,30.1,72.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,INCOME4,CAT6,_RFPSA21,RESP046,"(64.84507995700051, -147.72205903599973)"
|
|
2016,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,46,48.5,27.2,69.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,INCOME4,CAT6,_RFPSA21,RESP054,"(64.84507995700051, -147.72205903599973)"
|
|
2016,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,240,42.2,35.3,49,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,INCOME5,CAT6,_RFPSA21,RESP046,"(64.84507995700051, -147.72205903599973)"
|
|
2016,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,318,57.8,51,64.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,INCOME5,CAT6,_RFPSA21,RESP054,"(64.84507995700051, -147.72205903599973)"
|
|
2016,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,300,38.6,33.4,43.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,RACE01,CAT4,_RFPSA21,RESP046,"(64.84507995700051, -147.72205903599973)"
|
|
2016,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,419,61.4,56.2,66.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,RACE01,CAT4,_RFPSA21,RESP054,"(64.84507995700051, -147.72205903599973)"
|
|
2016,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,9,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,02,RACE02,CAT4,_RFPSA21,RESP046,"(64.84507995700051, -147.72205903599973)"
|
|
2016,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,02,RACE02,CAT4,_RFPSA21,RESP054,"(64.84507995700051, -147.72205903599973)"
|
|
2016,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,26,17.3,9.1,25.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,RACE03,CAT4,_RFPSA21,RESP046,"(64.84507995700051, -147.72205903599973)"
|
|
2016,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,96,82.7,74.5,90.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,RACE03,CAT4,_RFPSA21,RESP054,"(64.84507995700051, -147.72205903599973)"
|
|
2016,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,02,RACE04,CAT4,_RFPSA21,RESP046,"(64.84507995700051, -147.72205903599973)"
|
|
2016,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,11,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,02,RACE04,CAT4,_RFPSA21,RESP054,"(64.84507995700051, -147.72205903599973)"
|
|
2016,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,02,RACE05,CAT4,_RFPSA21,RESP046,"(64.84507995700051, -147.72205903599973)"
|
|
2016,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,02,RACE05,CAT4,_RFPSA21,RESP054,"(64.84507995700051, -147.72205903599973)"
|
|
2016,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,02,RACE06,CAT4,_RFPSA21,RESP046,"(64.84507995700051, -147.72205903599973)"
|
|
2016,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,02,RACE06,CAT4,_RFPSA21,RESP054,"(64.84507995700051, -147.72205903599973)"
|
|
2016,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,02,RACE07,CAT4,_RFPSA21,RESP046,"(64.84507995700051, -147.72205903599973)"
|
|
2016,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,25,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,02,RACE07,CAT4,_RFPSA21,RESP054,"(64.84507995700051, -147.72205903599973)"
|
|
2016,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,02,RACE08,CAT4,_RFPSA21,RESP046,"(64.84507995700051, -147.72205903599973)"
|
|
2016,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,16,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,02,RACE08,CAT4,_RFPSA21,RESP054,"(64.84507995700051, -147.72205903599973)"
|
|
2016,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,574,61.8,56.1,67.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,SEX1,CAT2,_RFPSA21,RESP054,"(64.84507995700051, -147.72205903599973)"
|
|
2016,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,02,SEX2,CAT2,_RFPSA21,RESP046,"(64.84507995700051, -147.72205903599973)"
|
|
2016,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,02,SEX2,CAT2,_RFPSA21,RESP054,"(64.84507995700051, -147.72205903599973)"
|
|
2016,UW,All States and DC (median) **,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,51,39.5,,,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,98,BO1,CAT1,_RFPSA21,RESP046,
|
|
2016,UW,All States and DC (median) **,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,51,60.5,,,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,98,BO1,CAT1,_RFPSA21,RESP054,
|
|
2016,US,"All States, DC and Territories (median) **",Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,54,39.7,,,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,99,BO1,CAT1,_RFPSA21,RESP046,
|
|
2016,US,"All States, DC and Territories (median) **",Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,54,60.3,,,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,99,BO1,CAT1,_RFPSA21,RESP054,
|
|
2016,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,62,13.7,9.4,18.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,AGE06,CAT3,_RFPSA21,RESP046,"(34.865970280000454, -111.76381127699972)"
|
|
2016,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,347,86.3,81.9,90.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,AGE06,CAT3,_RFPSA21,RESP054,"(34.865970280000454, -111.76381127699972)"
|
|
2016,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,263,34.8,29.8,39.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,AGE07,CAT3,_RFPSA21,RESP046,"(34.865970280000454, -111.76381127699972)"
|
|
2016,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,395,65.2,60.3,70.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,AGE07,CAT3,_RFPSA21,RESP054,"(34.865970280000454, -111.76381127699972)"
|
|
2016,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,249,46.9,40.1,53.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,AGE08,CAT3,_RFPSA21,RESP046,"(34.865970280000454, -111.76381127699972)"
|
|
2016,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,236,53.1,46.4,59.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,AGE08,CAT3,_RFPSA21,RESP054,"(34.865970280000454, -111.76381127699972)"
|
|
2016,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,1110,62.3,59.1,65.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,AGE09,CAT3,_RFPSA21,RESP046,"(34.865970280000454, -111.76381127699972)"
|
|
2016,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,661,37.7,34.5,40.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,AGE09,CAT3,_RFPSA21,RESP054,"(34.865970280000454, -111.76381127699972)"
|
|
2016,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1684,40.6,38.1,43.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,BO1,CAT1,_RFPSA21,RESP046,"(34.865970280000454, -111.76381127699972)"
|
|
2016,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1639,59.4,56.9,61.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,BO1,CAT1,_RFPSA21,RESP054,"(34.865970280000454, -111.76381127699972)"
|
|
2016,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,44,16.6,10.2,23.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,EDUCA1,CAT5,_RFPSA21,RESP046,"(34.865970280000454, -111.76381127699972)"
|
|
2016,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,132,83.4,76.9,89.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,EDUCA1,CAT5,_RFPSA21,RESP054,"(34.865970280000454, -111.76381127699972)"
|
|
2016,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,270,35.3,30.2,40.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,EDUCA2,CAT5,_RFPSA21,RESP046,"(34.865970280000454, -111.76381127699972)"
|
|
2016,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,402,64.7,59.6,69.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,EDUCA2,CAT5,_RFPSA21,RESP054,"(34.865970280000454, -111.76381127699972)"
|
|
2016,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,467,44,39.5,48.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,EDUCA3,CAT5,_RFPSA21,RESP046,"(34.865970280000454, -111.76381127699972)"
|
|
2016,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,447,56,51.6,60.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,EDUCA3,CAT5,_RFPSA21,RESP054,"(34.865970280000454, -111.76381127699972)"
|
|
2016,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,898,52.6,49.1,56.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,EDUCA4,CAT5,_RFPSA21,RESP046,"(34.865970280000454, -111.76381127699972)"
|
|
2016,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,655,47.4,43.9,50.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,EDUCA4,CAT5,_RFPSA21,RESP054,"(34.865970280000454, -111.76381127699972)"
|
|
2016,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,81,24.4,16.7,32.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,INCOME1,CAT6,_RFPSA21,RESP046,"(34.865970280000454, -111.76381127699972)"
|
|
2016,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,166,75.6,67.8,83.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,INCOME1,CAT6,_RFPSA21,RESP054,"(34.865970280000454, -111.76381127699972)"
|
|
2016,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,106,20.8,15,26.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,INCOME2,CAT6,_RFPSA21,RESP046,"(34.865970280000454, -111.76381127699972)"
|
|
2016,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,249,79.2,73.5,85,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,INCOME2,CAT6,_RFPSA21,RESP054,"(34.865970280000454, -111.76381127699972)"
|
|
2016,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,149,40.4,31.1,49.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,INCOME3,CAT6,_RFPSA21,RESP046,"(34.865970280000454, -111.76381127699972)"
|
|
2016,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,143,59.6,50.2,68.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,INCOME3,CAT6,_RFPSA21,RESP054,"(34.865970280000454, -111.76381127699972)"
|
|
2016,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,233,46.5,39.7,53.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,INCOME4,CAT6,_RFPSA21,RESP046,"(34.865970280000454, -111.76381127699972)"
|
|
2016,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,222,53.5,46.7,60.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,INCOME4,CAT6,_RFPSA21,RESP054,"(34.865970280000454, -111.76381127699972)"
|
|
2016,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,881,47.1,43.4,50.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,INCOME5,CAT6,_RFPSA21,RESP046,"(34.865970280000454, -111.76381127699972)"
|
|
2016,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,666,52.9,49.2,56.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,INCOME5,CAT6,_RFPSA21,RESP054,"(34.865970280000454, -111.76381127699972)"
|
|
2016,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1456,46,43.4,48.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,RACE01,CAT4,_RFPSA21,RESP046,"(34.865970280000454, -111.76381127699972)"
|
|
2016,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1283,54,51.3,56.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,RACE01,CAT4,_RFPSA21,RESP054,"(34.865970280000454, -111.76381127699972)"
|
|
2016,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,30,31,18.6,43.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,RACE02,CAT4,_RFPSA21,RESP046,"(34.865970280000454, -111.76381127699972)"
|
|
2016,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,41,69,56.5,81.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,RACE02,CAT4,_RFPSA21,RESP054,"(34.865970280000454, -111.76381127699972)"
|
|
2016,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,04,SEX2,CAT2,_RFPSA21,RESP054,"(34.865970280000454, -111.76381127699972)"
|
|
2016,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,23,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,04,RACE03,CAT4,_RFPSA21,RESP046,"(34.865970280000454, -111.76381127699972)"
|
|
2016,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,82,89.6,83.1,96.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,RACE03,CAT4,_RFPSA21,RESP054,"(34.865970280000454, -111.76381127699972)"
|
|
2016,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,11,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,04,RACE04,CAT4,_RFPSA21,RESP046,"(34.865970280000454, -111.76381127699972)"
|
|
2016,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,16,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,04,RACE04,CAT4,_RFPSA21,RESP054,"(34.865970280000454, -111.76381127699972)"
|
|
2016,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,04,RACE05,CAT4,_RFPSA21,RESP046,"(34.865970280000454, -111.76381127699972)"
|
|
2016,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,04,RACE05,CAT4,_RFPSA21,RESP054,"(34.865970280000454, -111.76381127699972)"
|
|
2016,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,20,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,04,RACE06,CAT4,_RFPSA21,RESP046,"(34.865970280000454, -111.76381127699972)"
|
|
2016,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,18,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,04,RACE06,CAT4,_RFPSA21,RESP054,"(34.865970280000454, -111.76381127699972)"
|
|
2016,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,22,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,04,RACE07,CAT4,_RFPSA21,RESP046,"(34.865970280000454, -111.76381127699972)"
|
|
2016,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,19,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,04,RACE07,CAT4,_RFPSA21,RESP054,"(34.865970280000454, -111.76381127699972)"
|
|
2016,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,121,29.4,22.8,36,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,RACE08,CAT4,_RFPSA21,RESP046,"(34.865970280000454, -111.76381127699972)"
|
|
2016,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,172,70.6,64,77.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,RACE08,CAT4,_RFPSA21,RESP054,"(34.865970280000454, -111.76381127699972)"
|
|
2016,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1684,40.6,38.1,43.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,SEX1,CAT2,_RFPSA21,RESP046,"(34.865970280000454, -111.76381127699972)"
|
|
2016,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1639,59.4,56.9,61.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,SEX1,CAT2,_RFPSA21,RESP054,"(34.865970280000454, -111.76381127699972)"
|
|
2016,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,04,SEX2,CAT2,_RFPSA21,RESP046,"(34.865970280000454, -111.76381127699972)"
|
|
2016,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,29,9.3,4.3,14.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,AGE06,CAT3,_RFPSA21,RESP046,"(34.74865012400045, -92.27449074299966)"
|
|
2016,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,140,90.7,85.7,95.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,AGE06,CAT3,_RFPSA21,RESP054,"(34.74865012400045, -92.27449074299966)"
|
|
2016,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,172,47.2,39.4,55.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,AGE07,CAT3,_RFPSA21,RESP046,"(34.74865012400045, -92.27449074299966)"
|
|
2016,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,155,52.8,44.9,60.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,AGE07,CAT3,_RFPSA21,RESP054,"(34.74865012400045, -92.27449074299966)"
|
|
2016,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,132,57.4,47.5,67.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,AGE08,CAT3,_RFPSA21,RESP046,"(34.74865012400045, -92.27449074299966)"
|
|
2016,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,93,42.6,32.7,52.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,AGE08,CAT3,_RFPSA21,RESP054,"(34.74865012400045, -92.27449074299966)"
|
|
2016,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,502,63.4,58.3,68.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,AGE09,CAT3,_RFPSA21,RESP046,"(34.74865012400045, -92.27449074299966)"
|
|
2016,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,286,36.6,31.6,41.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,AGE09,CAT3,_RFPSA21,RESP054,"(34.74865012400045, -92.27449074299966)"
|
|
2016,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,835,42.8,38.8,46.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,BO1,CAT1,_RFPSA21,RESP046,"(34.74865012400045, -92.27449074299966)"
|
|
2016,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,674,57.2,53.1,61.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,BO1,CAT1,_RFPSA21,RESP054,"(34.74865012400045, -92.27449074299966)"
|
|
2016,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,62,33.7,22.2,45.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,EDUCA1,CAT5,_RFPSA21,RESP046,"(34.74865012400045, -92.27449074299966)"
|
|
2016,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,84,66.3,54.8,77.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,EDUCA1,CAT5,_RFPSA21,RESP054,"(34.74865012400045, -92.27449074299966)"
|
|
2016,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,230,39,32.4,45.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,EDUCA2,CAT5,_RFPSA21,RESP046,"(34.74865012400045, -92.27449074299966)"
|
|
2016,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,247,61,54.5,67.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,EDUCA2,CAT5,_RFPSA21,RESP054,"(34.74865012400045, -92.27449074299966)"
|
|
2016,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,208,45.8,37.8,53.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,EDUCA3,CAT5,_RFPSA21,RESP046,"(34.74865012400045, -92.27449074299966)"
|
|
2016,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,148,54.2,46.1,62.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,EDUCA3,CAT5,_RFPSA21,RESP054,"(34.74865012400045, -92.27449074299966)"
|
|
2016,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,333,53.2,46.4,60,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,EDUCA4,CAT5,_RFPSA21,RESP046,"(34.74865012400045, -92.27449074299966)"
|
|
2016,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,193,46.8,40,53.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,EDUCA4,CAT5,_RFPSA21,RESP054,"(34.74865012400045, -92.27449074299966)"
|
|
2016,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,43,19.5,9.7,29.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,INCOME1,CAT6,_RFPSA21,RESP046,"(34.74865012400045, -92.27449074299966)"
|
|
2016,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,90,80.5,70.7,90.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,INCOME1,CAT6,_RFPSA21,RESP054,"(34.74865012400045, -92.27449074299966)"
|
|
2016,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,101,38,27.6,48.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,INCOME2,CAT6,_RFPSA21,RESP046,"(34.74865012400045, -92.27449074299966)"
|
|
2016,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,114,62,51.6,72.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,INCOME2,CAT6,_RFPSA21,RESP054,"(34.74865012400045, -92.27449074299966)"
|
|
2016,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,99,50.2,38.2,62.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,INCOME3,CAT6,_RFPSA21,RESP046,"(34.74865012400045, -92.27449074299966)"
|
|
2016,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,73,49.8,37.8,61.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,INCOME3,CAT6,_RFPSA21,RESP054,"(34.74865012400045, -92.27449074299966)"
|
|
2016,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,99,39.4,28.6,50.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,INCOME4,CAT6,_RFPSA21,RESP046,"(34.74865012400045, -92.27449074299966)"
|
|
2016,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,79,60.6,49.8,71.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,INCOME4,CAT6,_RFPSA21,RESP054,"(34.74865012400045, -92.27449074299966)"
|
|
2016,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,374,51.2,44.4,58,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,INCOME5,CAT6,_RFPSA21,RESP046,"(34.74865012400045, -92.27449074299966)"
|
|
2016,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,229,48.8,42,55.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,INCOME5,CAT6,_RFPSA21,RESP054,"(34.74865012400045, -92.27449074299966)"
|
|
2016,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,686,44.8,40.4,49.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,RACE01,CAT4,_RFPSA21,RESP046,"(34.74865012400045, -92.27449074299966)"
|
|
2016,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,557,55.2,50.9,59.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,RACE01,CAT4,_RFPSA21,RESP054,"(34.74865012400045, -92.27449074299966)"
|
|
2016,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,103,37.1,24.4,49.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,RACE02,CAT4,_RFPSA21,RESP046,"(34.74865012400045, -92.27449074299966)"
|
|
2016,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,68,62.9,50.2,75.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,RACE02,CAT4,_RFPSA21,RESP054,"(34.74865012400045, -92.27449074299966)"
|
|
2016,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,16,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,05,RACE03,CAT4,_RFPSA21,RESP046,"(34.74865012400045, -92.27449074299966)"
|
|
2016,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,17,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,05,RACE03,CAT4,_RFPSA21,RESP054,"(34.74865012400045, -92.27449074299966)"
|
|
2016,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,05,RACE04,CAT4,_RFPSA21,RESP046,"(34.74865012400045, -92.27449074299966)"
|
|
2016,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,05,RACE04,CAT4,_RFPSA21,RESP054,"(34.74865012400045, -92.27449074299966)"
|
|
2016,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,05,RACE05,CAT4,_RFPSA21,RESP046,"(34.74865012400045, -92.27449074299966)"
|
|
2016,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,05,RACE05,CAT4,_RFPSA21,RESP054,"(34.74865012400045, -92.27449074299966)"
|
|
2016,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,05,RACE06,CAT4,_RFPSA21,RESP046,"(34.74865012400045, -92.27449074299966)"
|
|
2016,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,05,RACE06,CAT4,_RFPSA21,RESP054,"(34.74865012400045, -92.27449074299966)"
|
|
2016,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,14,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,05,RACE07,CAT4,_RFPSA21,RESP046,"(34.74865012400045, -92.27449074299966)"
|
|
2016,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,13,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,05,RACE07,CAT4,_RFPSA21,RESP054,"(34.74865012400045, -92.27449074299966)"
|
|
2016,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,05,RACE08,CAT4,_RFPSA21,RESP046,"(34.74865012400045, -92.27449074299966)"
|
|
2016,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,12,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,05,RACE08,CAT4,_RFPSA21,RESP054,"(34.74865012400045, -92.27449074299966)"
|
|
2016,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,835,42.8,38.8,46.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,SEX1,CAT2,_RFPSA21,RESP046,"(34.74865012400045, -92.27449074299966)"
|
|
2016,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,674,57.2,53.1,61.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,SEX1,CAT2,_RFPSA21,RESP054,"(34.74865012400045, -92.27449074299966)"
|
|
2016,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,05,SEX2,CAT2,_RFPSA21,RESP046,"(34.74865012400045, -92.27449074299966)"
|
|
2016,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,05,SEX2,CAT2,_RFPSA21,RESP054,"(34.74865012400045, -92.27449074299966)"
|
|
2016,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,62,9.4,6.7,12.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,AGE06,CAT3,_RFPSA21,RESP046,"(37.63864012300047, -120.99999953799971)"
|
|
2016,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,638,90.6,87.9,93.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,AGE06,CAT3,_RFPSA21,RESP054,"(37.63864012300047, -120.99999953799971)"
|
|
2016,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,276,33.3,29.2,37.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,AGE07,CAT3,_RFPSA21,RESP046,"(37.63864012300047, -120.99999953799971)"
|
|
2016,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,501,66.7,62.7,70.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,AGE07,CAT3,_RFPSA21,RESP054,"(37.63864012300047, -120.99999953799971)"
|
|
2016,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,200,47.2,40.3,54.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,AGE08,CAT3,_RFPSA21,RESP046,"(37.63864012300047, -120.99999953799971)"
|
|
2016,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,213,52.8,45.9,59.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,AGE08,CAT3,_RFPSA21,RESP054,"(37.63864012300047, -120.99999953799971)"
|
|
2016,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,568,58.1,53.7,62.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,AGE09,CAT3,_RFPSA21,RESP046,"(37.63864012300047, -120.99999953799971)"
|
|
2016,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,390,41.9,37.5,46.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,AGE09,CAT3,_RFPSA21,RESP054,"(37.63864012300047, -120.99999953799971)"
|
|
2016,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1106,35.5,33.2,37.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,BO1,CAT1,_RFPSA21,RESP046,"(37.63864012300047, -120.99999953799971)"
|
|
2016,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1742,64.5,62.2,66.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,BO1,CAT1,_RFPSA21,RESP054,"(37.63864012300047, -120.99999953799971)"
|
|
2016,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,92,25.6,20.3,30.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,EDUCA1,CAT5,_RFPSA21,RESP046,"(37.63864012300047, -120.99999953799971)"
|
|
2016,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,292,74.4,69.1,79.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,EDUCA1,CAT5,_RFPSA21,RESP054,"(37.63864012300047, -120.99999953799971)"
|
|
2016,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,144,27.1,22.2,32,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,EDUCA2,CAT5,_RFPSA21,RESP046,"(37.63864012300047, -120.99999953799971)"
|
|
2016,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,319,72.9,68,77.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,EDUCA2,CAT5,_RFPSA21,RESP054,"(37.63864012300047, -120.99999953799971)"
|
|
2016,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,248,40,35.1,44.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,EDUCA3,CAT5,_RFPSA21,RESP046,"(37.63864012300047, -120.99999953799971)"
|
|
2016,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,368,60,55.1,64.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,EDUCA3,CAT5,_RFPSA21,RESP054,"(37.63864012300047, -120.99999953799971)"
|
|
2016,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,620,42.6,39.3,45.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,EDUCA4,CAT5,_RFPSA21,RESP046,"(37.63864012300047, -120.99999953799971)"
|
|
2016,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,758,57.4,54.1,60.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,EDUCA4,CAT5,_RFPSA21,RESP054,"(37.63864012300047, -120.99999953799971)"
|
|
2016,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,66,20.8,15.1,26.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,INCOME1,CAT6,_RFPSA21,RESP046,"(37.63864012300047, -120.99999953799971)"
|
|
2016,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,217,79.2,73.6,84.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,INCOME1,CAT6,_RFPSA21,RESP054,"(37.63864012300047, -120.99999953799971)"
|
|
2016,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,84,28.6,21.7,35.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,INCOME2,CAT6,_RFPSA21,RESP046,"(37.63864012300047, -120.99999953799971)"
|
|
2016,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,204,71.4,64.6,78.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,INCOME2,CAT6,_RFPSA21,RESP054,"(37.63864012300047, -120.99999953799971)"
|
|
2016,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,68,33.4,24.5,42.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,INCOME3,CAT6,_RFPSA21,RESP046,"(37.63864012300047, -120.99999953799971)"
|
|
2016,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,143,66.6,57.6,75.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,INCOME3,CAT6,_RFPSA21,RESP054,"(37.63864012300047, -120.99999953799971)"
|
|
2016,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,102,32.8,25.8,39.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,INCOME4,CAT6,_RFPSA21,RESP046,"(37.63864012300047, -120.99999953799971)"
|
|
2016,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,169,67.2,60.2,74.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,INCOME4,CAT6,_RFPSA21,RESP054,"(37.63864012300047, -120.99999953799971)"
|
|
2016,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,676,40.1,36.8,43.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,INCOME5,CAT6,_RFPSA21,RESP046,"(37.63864012300047, -120.99999953799971)"
|
|
2016,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,846,59.9,56.7,63.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,INCOME5,CAT6,_RFPSA21,RESP054,"(37.63864012300047, -120.99999953799971)"
|
|
2016,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,759,40.6,37.7,43.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,RACE01,CAT4,_RFPSA21,RESP046,"(37.63864012300047, -120.99999953799971)"
|
|
2016,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,910,59.4,56.5,62.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,RACE01,CAT4,_RFPSA21,RESP054,"(37.63864012300047, -120.99999953799971)"
|
|
2016,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,54,36.6,26.6,46.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,RACE02,CAT4,_RFPSA21,RESP046,"(37.63864012300047, -120.99999953799971)"
|
|
2016,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,79,63.4,53.5,73.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,RACE02,CAT4,_RFPSA21,RESP054,"(37.63864012300047, -120.99999953799971)"
|
|
2016,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,06,RACE03,CAT4,_RFPSA21,RESP046,"(37.63864012300047, -120.99999953799971)"
|
|
2016,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,16,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,06,RACE03,CAT4,_RFPSA21,RESP054,"(37.63864012300047, -120.99999953799971)"
|
|
2016,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,57,34.8,26,43.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,RACE04,CAT4,_RFPSA21,RESP046,"(37.63864012300047, -120.99999953799971)"
|
|
2016,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,145,65.2,56.3,74,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,RACE04,CAT4,_RFPSA21,RESP054,"(37.63864012300047, -120.99999953799971)"
|
|
2016,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,06,RACE05,CAT4,_RFPSA21,RESP046,"(37.63864012300047, -120.99999953799971)"
|
|
2016,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,06,RACE05,CAT4,_RFPSA21,RESP054,"(37.63864012300047, -120.99999953799971)"
|
|
2016,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,14,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,06,RACE06,CAT4,_RFPSA21,RESP046,"(37.63864012300047, -120.99999953799971)"
|
|
2016,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,21,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,06,RACE06,CAT4,_RFPSA21,RESP054,"(37.63864012300047, -120.99999953799971)"
|
|
2016,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,17,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,06,RACE07,CAT4,_RFPSA21,RESP046,"(37.63864012300047, -120.99999953799971)"
|
|
2016,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,30,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,06,RACE07,CAT4,_RFPSA21,RESP054,"(37.63864012300047, -120.99999953799971)"
|
|
2016,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,193,26.7,22.8,30.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,RACE08,CAT4,_RFPSA21,RESP046,"(37.63864012300047, -120.99999953799971)"
|
|
2016,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,536,73.3,69.3,77.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,RACE08,CAT4,_RFPSA21,RESP054,"(37.63864012300047, -120.99999953799971)"
|
|
2016,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1106,35.5,33.2,37.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,SEX1,CAT2,_RFPSA21,RESP046,"(37.63864012300047, -120.99999953799971)"
|
|
2016,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1742,64.5,62.2,66.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,SEX1,CAT2,_RFPSA21,RESP054,"(37.63864012300047, -120.99999953799971)"
|
|
2016,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,06,SEX2,CAT2,_RFPSA21,RESP046,"(37.63864012300047, -120.99999953799971)"
|
|
2016,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,06,SEX2,CAT2,_RFPSA21,RESP054,"(37.63864012300047, -120.99999953799971)"
|
|
2016,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,88,10.3,7.9,12.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,AGE06,CAT3,_RFPSA21,RESP046,"(38.843840757000464, -106.13361092099967)"
|
|
2016,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,674,89.7,87.2,92.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,AGE06,CAT3,_RFPSA21,RESP054,"(38.843840757000464, -106.13361092099967)"
|
|
2016,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,392,35.2,31.7,38.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,AGE07,CAT3,_RFPSA21,RESP046,"(38.843840757000464, -106.13361092099967)"
|
|
2016,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,654,64.8,61.4,68.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,AGE07,CAT3,_RFPSA21,RESP054,"(38.843840757000464, -106.13361092099967)"
|
|
2016,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,366,50.9,46.4,55.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,AGE08,CAT3,_RFPSA21,RESP046,"(38.843840757000464, -106.13361092099967)"
|
|
2016,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,324,49.1,44.6,53.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,AGE08,CAT3,_RFPSA21,RESP054,"(38.843840757000464, -106.13361092099967)"
|
|
2016,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,1011,54.1,51.3,56.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,AGE09,CAT3,_RFPSA21,RESP046,"(38.843840757000464, -106.13361092099967)"
|
|
2016,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,773,45.9,43.1,48.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,AGE09,CAT3,_RFPSA21,RESP054,"(38.843840757000464, -106.13361092099967)"
|
|
2016,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1857,35.6,33.9,37.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,BO1,CAT1,_RFPSA21,RESP046,"(38.843840757000464, -106.13361092099967)"
|
|
2016,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,2425,64.4,62.7,66.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,BO1,CAT1,_RFPSA21,RESP054,"(38.843840757000464, -106.13361092099967)"
|
|
2016,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,44,16,10.8,21.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,EDUCA1,CAT5,_RFPSA21,RESP046,"(38.843840757000464, -106.13361092099967)"
|
|
2016,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,189,84,78.9,89.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,EDUCA1,CAT5,_RFPSA21,RESP054,"(38.843840757000464, -106.13361092099967)"
|
|
2016,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,306,30.7,26.9,34.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,EDUCA2,CAT5,_RFPSA21,RESP046,"(38.843840757000464, -106.13361092099967)"
|
|
2016,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,518,69.3,65.6,73.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,EDUCA2,CAT5,_RFPSA21,RESP054,"(38.843840757000464, -106.13361092099967)"
|
|
2016,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,447,36.2,32.7,39.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,EDUCA3,CAT5,_RFPSA21,RESP046,"(38.843840757000464, -106.13361092099967)"
|
|
2016,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,608,63.8,60.2,67.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,EDUCA3,CAT5,_RFPSA21,RESP054,"(38.843840757000464, -106.13361092099967)"
|
|
2016,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,1058,43,40.5,45.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,EDUCA4,CAT5,_RFPSA21,RESP046,"(38.843840757000464, -106.13361092099967)"
|
|
2016,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,1103,57,54.5,59.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,EDUCA4,CAT5,_RFPSA21,RESP054,"(38.843840757000464, -106.13361092099967)"
|
|
2016,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,62,20.1,14.4,25.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,INCOME1,CAT6,_RFPSA21,RESP046,"(38.843840757000464, -106.13361092099967)"
|
|
2016,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,170,79.9,74.2,85.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,INCOME1,CAT6,_RFPSA21,RESP054,"(38.843840757000464, -106.13361092099967)"
|
|
2016,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,121,23.8,18.9,28.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,INCOME2,CAT6,_RFPSA21,RESP046,"(38.843840757000464, -106.13361092099967)"
|
|
2016,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,263,76.2,71.2,81.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,INCOME2,CAT6,_RFPSA21,RESP054,"(38.843840757000464, -106.13361092099967)"
|
|
2016,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,119,30.8,24.4,37.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,INCOME3,CAT6,_RFPSA21,RESP046,"(38.843840757000464, -106.13361092099967)"
|
|
2016,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,185,69.2,62.8,75.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,INCOME3,CAT6,_RFPSA21,RESP054,"(38.843840757000464, -106.13361092099967)"
|
|
2016,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,218,33.2,28.2,38.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,INCOME4,CAT6,_RFPSA21,RESP046,"(38.843840757000464, -106.13361092099967)"
|
|
2016,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,297,66.8,61.8,71.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,INCOME4,CAT6,_RFPSA21,RESP054,"(38.843840757000464, -106.13361092099967)"
|
|
2016,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,1156,39.6,37.2,41.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,INCOME5,CAT6,_RFPSA21,RESP046,"(38.843840757000464, -106.13361092099967)"
|
|
2016,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,1280,60.4,58.1,62.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,INCOME5,CAT6,_RFPSA21,RESP054,"(38.843840757000464, -106.13361092099967)"
|
|
2016,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1637,38.7,36.7,40.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,RACE01,CAT4,_RFPSA21,RESP046,"(38.843840757000464, -106.13361092099967)"
|
|
2016,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1947,61.3,59.4,63.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,RACE01,CAT4,_RFPSA21,RESP054,"(38.843840757000464, -106.13361092099967)"
|
|
2016,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,28,19.1,11.1,27.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,RACE02,CAT4,_RFPSA21,RESP046,"(38.843840757000464, -106.13361092099967)"
|
|
2016,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,64,80.9,72.9,88.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,RACE02,CAT4,_RFPSA21,RESP054,"(38.843840757000464, -106.13361092099967)"
|
|
2016,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,13,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,08,RACE03,CAT4,_RFPSA21,RESP046,"(38.843840757000464, -106.13361092099967)"
|
|
2016,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,25,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,08,RACE03,CAT4,_RFPSA21,RESP054,"(38.843840757000464, -106.13361092099967)"
|
|
2016,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,13,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,08,RACE04,CAT4,_RFPSA21,RESP046,"(38.843840757000464, -106.13361092099967)"
|
|
2016,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,29,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,08,RACE04,CAT4,_RFPSA21,RESP054,"(38.843840757000464, -106.13361092099967)"
|
|
2016,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,08,RACE05,CAT4,_RFPSA21,RESP046,"(38.843840757000464, -106.13361092099967)"
|
|
2016,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,08,RACE05,CAT4,_RFPSA21,RESP054,"(38.843840757000464, -106.13361092099967)"
|
|
2016,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,18,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,08,RACE06,CAT4,_RFPSA21,RESP046,"(38.843840757000464, -106.13361092099967)"
|
|
2016,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,18,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,08,RACE06,CAT4,_RFPSA21,RESP054,"(38.843840757000464, -106.13361092099967)"
|
|
2016,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,26,24.4,13,35.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,RACE07,CAT4,_RFPSA21,RESP046,"(38.843840757000464, -106.13361092099967)"
|
|
2016,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,39,75.6,64.3,87,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,RACE07,CAT4,_RFPSA21,RESP054,"(38.843840757000464, -106.13361092099967)"
|
|
2016,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,121,23.6,19,28.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,RACE08,CAT4,_RFPSA21,RESP046,"(38.843840757000464, -106.13361092099967)"
|
|
2016,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,302,76.4,71.8,81,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,RACE08,CAT4,_RFPSA21,RESP054,"(38.843840757000464, -106.13361092099967)"
|
|
2016,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1857,35.6,33.9,37.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,SEX1,CAT2,_RFPSA21,RESP046,"(38.843840757000464, -106.13361092099967)"
|
|
2016,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,2425,64.4,62.7,66.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,SEX1,CAT2,_RFPSA21,RESP054,"(38.843840757000464, -106.13361092099967)"
|
|
2016,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,08,SEX2,CAT2,_RFPSA21,RESP046,"(38.843840757000464, -106.13361092099967)"
|
|
2016,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,08,SEX2,CAT2,_RFPSA21,RESP054,"(38.843840757000464, -106.13361092099967)"
|
|
2016,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1704,59.3,57.2,61.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,SEX1,CAT2,_RFPSA21,RESP054,"(41.56266102000046, -72.64984095199964)"
|
|
2016,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,77,13.6,10.3,16.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,AGE06,CAT3,_RFPSA21,RESP046,"(41.56266102000046, -72.64984095199964)"
|
|
2016,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,470,86.4,83.2,89.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,AGE06,CAT3,_RFPSA21,RESP054,"(41.56266102000046, -72.64984095199964)"
|
|
2016,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,356,38.2,34.2,42.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,AGE07,CAT3,_RFPSA21,RESP046,"(41.56266102000046, -72.64984095199964)"
|
|
2016,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,506,61.8,57.9,65.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,AGE07,CAT3,_RFPSA21,RESP054,"(41.56266102000046, -72.64984095199964)"
|
|
2016,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,275,54.5,49,60,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,AGE08,CAT3,_RFPSA21,RESP046,"(41.56266102000046, -72.64984095199964)"
|
|
2016,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,216,45.5,40,51,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,AGE08,CAT3,_RFPSA21,RESP054,"(41.56266102000046, -72.64984095199964)"
|
|
2016,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,916,60.3,57,63.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,AGE09,CAT3,_RFPSA21,RESP046,"(41.56266102000046, -72.64984095199964)"
|
|
2016,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,512,39.7,36.4,43,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,AGE09,CAT3,_RFPSA21,RESP054,"(41.56266102000046, -72.64984095199964)"
|
|
2016,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1624,40.7,38.7,42.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,BO1,CAT1,_RFPSA21,RESP046,"(41.56266102000046, -72.64984095199964)"
|
|
2016,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1704,59.3,57.2,61.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,BO1,CAT1,_RFPSA21,RESP054,"(41.56266102000046, -72.64984095199964)"
|
|
2016,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,42,24.1,16.6,31.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,EDUCA1,CAT5,_RFPSA21,RESP046,"(41.56266102000046, -72.64984095199964)"
|
|
2016,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,117,75.9,68.5,83.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,EDUCA1,CAT5,_RFPSA21,RESP054,"(41.56266102000046, -72.64984095199964)"
|
|
2016,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,304,39.1,34.8,43.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,EDUCA2,CAT5,_RFPSA21,RESP046,"(41.56266102000046, -72.64984095199964)"
|
|
2016,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,415,60.9,56.7,65.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,EDUCA2,CAT5,_RFPSA21,RESP054,"(41.56266102000046, -72.64984095199964)"
|
|
2016,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,334,43.5,39.1,48,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,EDUCA3,CAT5,_RFPSA21,RESP046,"(41.56266102000046, -72.64984095199964)"
|
|
2016,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,353,56.5,52,60.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,EDUCA3,CAT5,_RFPSA21,RESP054,"(41.56266102000046, -72.64984095199964)"
|
|
2016,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,943,45.2,42.4,47.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,EDUCA4,CAT5,_RFPSA21,RESP046,"(41.56266102000046, -72.64984095199964)"
|
|
2016,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,816,54.8,52.1,57.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,EDUCA4,CAT5,_RFPSA21,RESP054,"(41.56266102000046, -72.64984095199964)"
|
|
2016,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,44,27,18.1,35.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,INCOME1,CAT6,_RFPSA21,RESP046,"(41.56266102000046, -72.64984095199964)"
|
|
2016,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,112,73,64.1,81.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,INCOME1,CAT6,_RFPSA21,RESP054,"(41.56266102000046, -72.64984095199964)"
|
|
2016,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,97,26.4,20.2,32.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,INCOME2,CAT6,_RFPSA21,RESP046,"(41.56266102000046, -72.64984095199964)"
|
|
2016,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,185,73.6,67.4,79.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,INCOME2,CAT6,_RFPSA21,RESP054,"(41.56266102000046, -72.64984095199964)"
|
|
2016,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,98,40.6,32.2,49.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,INCOME3,CAT6,_RFPSA21,RESP046,"(41.56266102000046, -72.64984095199964)"
|
|
2016,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,105,59.4,50.9,67.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,INCOME3,CAT6,_RFPSA21,RESP054,"(41.56266102000046, -72.64984095199964)"
|
|
2016,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,125,40.5,33.2,47.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,INCOME4,CAT6,_RFPSA21,RESP046,"(41.56266102000046, -72.64984095199964)"
|
|
2016,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,151,59.5,52.2,66.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,INCOME4,CAT6,_RFPSA21,RESP054,"(41.56266102000046, -72.64984095199964)"
|
|
2016,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,1055,44.4,41.6,47.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,INCOME5,CAT6,_RFPSA21,RESP046,"(41.56266102000046, -72.64984095199964)"
|
|
2016,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,949,55.6,52.9,58.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,INCOME5,CAT6,_RFPSA21,RESP054,"(41.56266102000046, -72.64984095199964)"
|
|
2016,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1442,45.3,43,47.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,RACE01,CAT4,_RFPSA21,RESP046,"(41.56266102000046, -72.64984095199964)"
|
|
2016,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1339,54.7,52.4,57,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,RACE01,CAT4,_RFPSA21,RESP054,"(41.56266102000046, -72.64984095199964)"
|
|
2016,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,60,32.4,23.9,40.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,RACE02,CAT4,_RFPSA21,RESP046,"(41.56266102000046, -72.64984095199964)"
|
|
2016,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,106,67.6,59.2,76.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,RACE02,CAT4,_RFPSA21,RESP054,"(41.56266102000046, -72.64984095199964)"
|
|
2016,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,09,RACE03,CAT4,_RFPSA21,RESP046,"(41.56266102000046, -72.64984095199964)"
|
|
2016,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,09,RACE03,CAT4,_RFPSA21,RESP054,"(41.56266102000046, -72.64984095199964)"
|
|
2016,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,12,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,09,RACE04,CAT4,_RFPSA21,RESP046,"(41.56266102000046, -72.64984095199964)"
|
|
2016,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,50,88.9,81.4,96.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,RACE04,CAT4,_RFPSA21,RESP054,"(41.56266102000046, -72.64984095199964)"
|
|
2016,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,09,RACE05,CAT4,_RFPSA21,RESP046,"(41.56266102000046, -72.64984095199964)"
|
|
2016,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,09,RACE05,CAT4,_RFPSA21,RESP054,"(41.56266102000046, -72.64984095199964)"
|
|
2016,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,09,RACE06,CAT4,_RFPSA21,RESP046,"(41.56266102000046, -72.64984095199964)"
|
|
2016,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,20,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,09,RACE06,CAT4,_RFPSA21,RESP054,"(41.56266102000046, -72.64984095199964)"
|
|
2016,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,13,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,09,RACE07,CAT4,_RFPSA21,RESP046,"(41.56266102000046, -72.64984095199964)"
|
|
2016,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,19,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,09,RACE07,CAT4,_RFPSA21,RESP054,"(41.56266102000046, -72.64984095199964)"
|
|
2016,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,83,26.5,19.9,33.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,RACE08,CAT4,_RFPSA21,RESP046,"(41.56266102000046, -72.64984095199964)"
|
|
2016,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,160,73.5,66.8,80.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,RACE08,CAT4,_RFPSA21,RESP054,"(41.56266102000046, -72.64984095199964)"
|
|
2016,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1624,40.7,38.7,42.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,SEX1,CAT2,_RFPSA21,RESP046,"(41.56266102000046, -72.64984095199964)"
|
|
2016,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,09,SEX2,CAT2,_RFPSA21,RESP046,"(41.56266102000046, -72.64984095199964)"
|
|
2016,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,09,SEX2,CAT2,_RFPSA21,RESP054,"(41.56266102000046, -72.64984095199964)"
|
|
2016,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,27,14.5,8,20.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,AGE06,CAT3,_RFPSA21,RESP046,"(39.008830667000495, -75.57774116799965)"
|
|
2016,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,173,85.5,79.1,92,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,AGE06,CAT3,_RFPSA21,RESP054,"(39.008830667000495, -75.57774116799965)"
|
|
2016,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,132,44,36.7,51.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,AGE07,CAT3,_RFPSA21,RESP046,"(39.008830667000495, -75.57774116799965)"
|
|
2016,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,181,56,48.6,63.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,AGE07,CAT3,_RFPSA21,RESP054,"(39.008830667000495, -75.57774116799965)"
|
|
2016,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,82,48.1,38.2,57.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,AGE08,CAT3,_RFPSA21,RESP046,"(39.008830667000495, -75.57774116799965)"
|
|
2016,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,75,51.9,42.1,61.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,AGE08,CAT3,_RFPSA21,RESP054,"(39.008830667000495, -75.57774116799965)"
|
|
2016,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,336,65.4,60.2,70.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,AGE09,CAT3,_RFPSA21,RESP046,"(39.008830667000495, -75.57774116799965)"
|
|
2016,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,171,34.6,29.4,39.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,AGE09,CAT3,_RFPSA21,RESP054,"(39.008830667000495, -75.57774116799965)"
|
|
2016,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,577,44.7,41.1,48.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,BO1,CAT1,_RFPSA21,RESP046,"(39.008830667000495, -75.57774116799965)"
|
|
2016,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,600,55.3,51.6,58.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,BO1,CAT1,_RFPSA21,RESP054,"(39.008830667000495, -75.57774116799965)"
|
|
2016,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,29,27.4,17.3,37.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,EDUCA1,CAT5,_RFPSA21,RESP046,"(39.008830667000495, -75.57774116799965)"
|
|
2016,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,74,72.6,62.4,82.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,EDUCA1,CAT5,_RFPSA21,RESP054,"(39.008830667000495, -75.57774116799965)"
|
|
2016,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,150,41.5,34.7,48.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,EDUCA2,CAT5,_RFPSA21,RESP046,"(39.008830667000495, -75.57774116799965)"
|
|
2016,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,210,58.5,51.8,65.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,EDUCA2,CAT5,_RFPSA21,RESP054,"(39.008830667000495, -75.57774116799965)"
|
|
2016,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,139,46.8,39.2,54.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,EDUCA3,CAT5,_RFPSA21,RESP046,"(39.008830667000495, -75.57774116799965)"
|
|
2016,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,125,53.2,45.6,60.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,EDUCA3,CAT5,_RFPSA21,RESP054,"(39.008830667000495, -75.57774116799965)"
|
|
2016,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,259,53.2,47.1,59.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,EDUCA4,CAT5,_RFPSA21,RESP046,"(39.008830667000495, -75.57774116799965)"
|
|
2016,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,188,46.8,40.8,52.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,EDUCA4,CAT5,_RFPSA21,RESP054,"(39.008830667000495, -75.57774116799965)"
|
|
2016,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,17,29.5,16,43,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,INCOME1,CAT6,_RFPSA21,RESP046,"(39.008830667000495, -75.57774116799965)"
|
|
2016,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,45,70.5,57,84,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,INCOME1,CAT6,_RFPSA21,RESP054,"(39.008830667000495, -75.57774116799965)"
|
|
2016,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,57,35.1,25.6,44.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,INCOME2,CAT6,_RFPSA21,RESP046,"(39.008830667000495, -75.57774116799965)"
|
|
2016,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,115,64.9,55.4,74.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,INCOME2,CAT6,_RFPSA21,RESP054,"(39.008830667000495, -75.57774116799965)"
|
|
2016,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,36,36,23,49,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,INCOME3,CAT6,_RFPSA21,RESP046,"(39.008830667000495, -75.57774116799965)"
|
|
2016,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,42,64,51,77,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,INCOME3,CAT6,_RFPSA21,RESP054,"(39.008830667000495, -75.57774116799965)"
|
|
2016,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,76,40.7,31.7,49.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,INCOME4,CAT6,_RFPSA21,RESP046,"(39.008830667000495, -75.57774116799965)"
|
|
2016,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,91,59.3,50.4,68.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,INCOME4,CAT6,_RFPSA21,RESP054,"(39.008830667000495, -75.57774116799965)"
|
|
2016,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,321,52.3,46.7,57.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,INCOME5,CAT6,_RFPSA21,RESP046,"(39.008830667000495, -75.57774116799965)"
|
|
2016,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,226,47.7,42.1,53.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,INCOME5,CAT6,_RFPSA21,RESP054,"(39.008830667000495, -75.57774116799965)"
|
|
2016,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,482,46.8,42.7,50.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,RACE01,CAT4,_RFPSA21,RESP046,"(39.008830667000495, -75.57774116799965)"
|
|
2016,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,448,53.2,49.2,57.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,RACE01,CAT4,_RFPSA21,RESP054,"(39.008830667000495, -75.57774116799965)"
|
|
2016,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,60,45.6,34.5,56.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,RACE02,CAT4,_RFPSA21,RESP046,"(39.008830667000495, -75.57774116799965)"
|
|
2016,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,71,54.4,43.3,65.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,RACE02,CAT4,_RFPSA21,RESP054,"(39.008830667000495, -75.57774116799965)"
|
|
2016,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,10,RACE03,CAT4,_RFPSA21,RESP046,"(39.008830667000495, -75.57774116799965)"
|
|
2016,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,10,RACE03,CAT4,_RFPSA21,RESP054,"(39.008830667000495, -75.57774116799965)"
|
|
2016,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,10,RACE04,CAT4,_RFPSA21,RESP046,"(39.008830667000495, -75.57774116799965)"
|
|
2016,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,13,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,10,RACE04,CAT4,_RFPSA21,RESP054,"(39.008830667000495, -75.57774116799965)"
|
|
2016,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,10,RACE05,CAT4,_RFPSA21,RESP046,"(39.008830667000495, -75.57774116799965)"
|
|
2016,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,10,RACE05,CAT4,_RFPSA21,RESP054,"(39.008830667000495, -75.57774116799965)"
|
|
2016,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,10,RACE06,CAT4,_RFPSA21,RESP046,"(39.008830667000495, -75.57774116799965)"
|
|
2016,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,10,RACE06,CAT4,_RFPSA21,RESP054,"(39.008830667000495, -75.57774116799965)"
|
|
2016,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,10,RACE07,CAT4,_RFPSA21,RESP046,"(39.008830667000495, -75.57774116799965)"
|
|
2016,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,10,RACE07,CAT4,_RFPSA21,RESP054,"(39.008830667000495, -75.57774116799965)"
|
|
2016,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,14,23,10.3,35.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,RACE08,CAT4,_RFPSA21,RESP046,"(39.008830667000495, -75.57774116799965)"
|
|
2016,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,51,77,64.3,89.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,RACE08,CAT4,_RFPSA21,RESP054,"(39.008830667000495, -75.57774116799965)"
|
|
2016,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,577,44.7,41.1,48.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,SEX1,CAT2,_RFPSA21,RESP046,"(39.008830667000495, -75.57774116799965)"
|
|
2016,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,600,55.3,51.6,58.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,SEX1,CAT2,_RFPSA21,RESP054,"(39.008830667000495, -75.57774116799965)"
|
|
2016,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,10,SEX2,CAT2,_RFPSA21,RESP046,"(39.008830667000495, -75.57774116799965)"
|
|
2016,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,10,SEX2,CAT2,_RFPSA21,RESP054,"(39.008830667000495, -75.57774116799965)"
|
|
2016,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,80,33.7,26.9,40.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,EDUCA2,CAT5,_RFPSA21,RESP046,"(38.89037138500049, -77.03196112699965)"
|
|
2016,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,36,14.6,9.5,19.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,AGE06,CAT3,_RFPSA21,RESP046,"(38.89037138500049, -77.03196112699965)"
|
|
2016,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,177,85.4,80.2,90.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,AGE06,CAT3,_RFPSA21,RESP054,"(38.89037138500049, -77.03196112699965)"
|
|
2016,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,126,42,35.5,48.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,AGE07,CAT3,_RFPSA21,RESP046,"(38.89037138500049, -77.03196112699965)"
|
|
2016,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,171,58,51.5,64.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,AGE07,CAT3,_RFPSA21,RESP054,"(38.89037138500049, -77.03196112699965)"
|
|
2016,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,65,49.9,40.3,59.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,AGE08,CAT3,_RFPSA21,RESP046,"(38.89037138500049, -77.03196112699965)"
|
|
2016,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,68,50.1,40.6,59.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,AGE08,CAT3,_RFPSA21,RESP054,"(38.89037138500049, -77.03196112699965)"
|
|
2016,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,221,59.6,53.5,65.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,AGE09,CAT3,_RFPSA21,RESP046,"(38.89037138500049, -77.03196112699965)"
|
|
2016,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,131,40.4,34.3,46.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,AGE09,CAT3,_RFPSA21,RESP054,"(38.89037138500049, -77.03196112699965)"
|
|
2016,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,448,38.6,35.1,42.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,BO1,CAT1,_RFPSA21,RESP046,"(38.89037138500049, -77.03196112699965)"
|
|
2016,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,547,61.4,57.9,64.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,BO1,CAT1,_RFPSA21,RESP054,"(38.89037138500049, -77.03196112699965)"
|
|
2016,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,19,33.8,20.1,47.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,EDUCA1,CAT5,_RFPSA21,RESP046,"(38.89037138500049, -77.03196112699965)"
|
|
2016,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,33,66.2,52.6,79.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,EDUCA1,CAT5,_RFPSA21,RESP054,"(38.89037138500049, -77.03196112699965)"
|
|
2016,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,130,66.3,59.4,73.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,EDUCA2,CAT5,_RFPSA21,RESP054,"(38.89037138500049, -77.03196112699965)"
|
|
2016,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,65,38.2,29.9,46.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,EDUCA3,CAT5,_RFPSA21,RESP046,"(38.89037138500049, -77.03196112699965)"
|
|
2016,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,91,61.8,53.4,70.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,EDUCA3,CAT5,_RFPSA21,RESP054,"(38.89037138500049, -77.03196112699965)"
|
|
2016,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,283,41.1,36.4,45.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,EDUCA4,CAT5,_RFPSA21,RESP046,"(38.89037138500049, -77.03196112699965)"
|
|
2016,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,293,58.9,54.3,63.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,EDUCA4,CAT5,_RFPSA21,RESP054,"(38.89037138500049, -77.03196112699965)"
|
|
2016,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,31,36,24.1,47.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,INCOME1,CAT6,_RFPSA21,RESP046,"(38.89037138500049, -77.03196112699965)"
|
|
2016,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,47,64,52.1,75.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,INCOME1,CAT6,_RFPSA21,RESP054,"(38.89037138500049, -77.03196112699965)"
|
|
2016,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,28,28.4,17.6,39.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,INCOME2,CAT6,_RFPSA21,RESP046,"(38.89037138500049, -77.03196112699965)"
|
|
2016,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,56,71.6,60.9,82.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,INCOME2,CAT6,_RFPSA21,RESP054,"(38.89037138500049, -77.03196112699965)"
|
|
2016,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,18,36.6,20.4,52.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,INCOME3,CAT6,_RFPSA21,RESP046,"(38.89037138500049, -77.03196112699965)"
|
|
2016,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,35,63.4,47.3,79.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,INCOME3,CAT6,_RFPSA21,RESP054,"(38.89037138500049, -77.03196112699965)"
|
|
2016,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,35,39.6,27.1,52.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,INCOME4,CAT6,_RFPSA21,RESP046,"(38.89037138500049, -77.03196112699965)"
|
|
2016,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,43,60.4,47.9,72.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,INCOME4,CAT6,_RFPSA21,RESP054,"(38.89037138500049, -77.03196112699965)"
|
|
2016,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,250,39.4,34.5,44.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,INCOME5,CAT6,_RFPSA21,RESP046,"(38.89037138500049, -77.03196112699965)"
|
|
2016,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,266,60.6,55.8,65.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,INCOME5,CAT6,_RFPSA21,RESP054,"(38.89037138500049, -77.03196112699965)"
|
|
2016,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,181,36.4,31,41.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,RACE01,CAT4,_RFPSA21,RESP046,"(38.89037138500049, -77.03196112699965)"
|
|
2016,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,216,63.6,58.3,69,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,RACE01,CAT4,_RFPSA21,RESP054,"(38.89037138500049, -77.03196112699965)"
|
|
2016,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,244,41.1,36.3,45.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,RACE02,CAT4,_RFPSA21,RESP046,"(38.89037138500049, -77.03196112699965)"
|
|
2016,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,297,58.9,54.2,63.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,RACE02,CAT4,_RFPSA21,RESP054,"(38.89037138500049, -77.03196112699965)"
|
|
2016,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,11,RACE03,CAT4,_RFPSA21,RESP046,"(38.89037138500049, -77.03196112699965)"
|
|
2016,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,11,RACE03,CAT4,_RFPSA21,RESP054,"(38.89037138500049, -77.03196112699965)"
|
|
2016,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,11,RACE04,CAT4,_RFPSA21,RESP046,"(38.89037138500049, -77.03196112699965)"
|
|
2016,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,11,RACE04,CAT4,_RFPSA21,RESP054,"(38.89037138500049, -77.03196112699965)"
|
|
2016,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,11,RACE05,CAT4,_RFPSA21,RESP046,"(38.89037138500049, -77.03196112699965)"
|
|
2016,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,11,RACE05,CAT4,_RFPSA21,RESP054,"(38.89037138500049, -77.03196112699965)"
|
|
2016,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,11,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,11,RACE06,CAT4,_RFPSA21,RESP046,"(38.89037138500049, -77.03196112699965)"
|
|
2016,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,12,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,11,RACE06,CAT4,_RFPSA21,RESP054,"(38.89037138500049, -77.03196112699965)"
|
|
2016,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,11,RACE07,CAT4,_RFPSA21,RESP046,"(38.89037138500049, -77.03196112699965)"
|
|
2016,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,11,RACE07,CAT4,_RFPSA21,RESP054,"(38.89037138500049, -77.03196112699965)"
|
|
2016,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,11,RACE08,CAT4,_RFPSA21,RESP046,"(38.89037138500049, -77.03196112699965)"
|
|
2016,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,12,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,11,RACE08,CAT4,_RFPSA21,RESP054,"(38.89037138500049, -77.03196112699965)"
|
|
2016,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,448,38.6,35.1,42.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,SEX1,CAT2,_RFPSA21,RESP046,"(38.89037138500049, -77.03196112699965)"
|
|
2016,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,547,61.4,57.9,64.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,SEX1,CAT2,_RFPSA21,RESP054,"(38.89037138500049, -77.03196112699965)"
|
|
2016,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,11,SEX2,CAT2,_RFPSA21,RESP046,"(38.89037138500049, -77.03196112699965)"
|
|
2016,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,11,SEX2,CAT2,_RFPSA21,RESP054,"(38.89037138500049, -77.03196112699965)"
|
|
2016,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,320,18.7,15.5,21.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,AGE06,CAT3,_RFPSA21,RESP046,"(28.932040377000476, -81.92896053899966)"
|
|
2016,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,1308,81.3,78.2,84.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,AGE06,CAT3,_RFPSA21,RESP054,"(28.932040377000476, -81.92896053899966)"
|
|
2016,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,1026,39.5,35.8,43.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,AGE07,CAT3,_RFPSA21,RESP046,"(28.932040377000476, -81.92896053899966)"
|
|
2016,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,1448,60.5,56.8,64.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,AGE07,CAT3,_RFPSA21,RESP054,"(28.932040377000476, -81.92896053899966)"
|
|
2016,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,719,58.2,52.5,63.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,AGE08,CAT3,_RFPSA21,RESP046,"(28.932040377000476, -81.92896053899966)"
|
|
2016,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,615,41.8,36.1,47.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,AGE08,CAT3,_RFPSA21,RESP054,"(28.932040377000476, -81.92896053899966)"
|
|
2016,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,3248,65.1,62.1,68.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,AGE09,CAT3,_RFPSA21,RESP046,"(28.932040377000476, -81.92896053899966)"
|
|
2016,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,1676,34.9,31.9,37.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,AGE09,CAT3,_RFPSA21,RESP054,"(28.932040377000476, -81.92896053899966)"
|
|
2016,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,5313,46.2,44.2,48.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,BO1,CAT1,_RFPSA21,RESP046,"(28.932040377000476, -81.92896053899966)"
|
|
2016,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,5047,53.8,51.8,55.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,BO1,CAT1,_RFPSA21,RESP054,"(28.932040377000476, -81.92896053899966)"
|
|
2016,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,335,28.5,22.2,34.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,EDUCA1,CAT5,_RFPSA21,RESP046,"(28.932040377000476, -81.92896053899966)"
|
|
2016,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,730,71.5,65.1,77.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,EDUCA1,CAT5,_RFPSA21,RESP054,"(28.932040377000476, -81.92896053899966)"
|
|
2016,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,1264,42.8,39,46.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,EDUCA2,CAT5,_RFPSA21,RESP046,"(28.932040377000476, -81.92896053899966)"
|
|
2016,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,1641,57.2,53.5,61,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,EDUCA2,CAT5,_RFPSA21,RESP054,"(28.932040377000476, -81.92896053899966)"
|
|
2016,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,1437,49.3,45.7,53,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,EDUCA3,CAT5,_RFPSA21,RESP046,"(28.932040377000476, -81.92896053899966)"
|
|
2016,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,1278,50.7,47,54.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,EDUCA3,CAT5,_RFPSA21,RESP054,"(28.932040377000476, -81.92896053899966)"
|
|
2016,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,2263,55.9,52.8,59.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,EDUCA4,CAT5,_RFPSA21,RESP046,"(28.932040377000476, -81.92896053899966)"
|
|
2016,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,1379,44.1,40.9,47.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,EDUCA4,CAT5,_RFPSA21,RESP054,"(28.932040377000476, -81.92896053899966)"
|
|
2016,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,253,29.1,22.3,35.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,INCOME1,CAT6,_RFPSA21,RESP046,"(28.932040377000476, -81.92896053899966)"
|
|
2016,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,557,70.9,64.1,77.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,INCOME1,CAT6,_RFPSA21,RESP054,"(28.932040377000476, -81.92896053899966)"
|
|
2016,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,661,35.4,30.6,40.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,INCOME2,CAT6,_RFPSA21,RESP046,"(28.932040377000476, -81.92896053899966)"
|
|
2016,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,998,64.6,59.8,69.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,INCOME2,CAT6,_RFPSA21,RESP054,"(28.932040377000476, -81.92896053899966)"
|
|
2016,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,472,36.5,30.4,42.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,INCOME3,CAT6,_RFPSA21,RESP046,"(28.932040377000476, -81.92896053899966)"
|
|
2016,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,561,63.5,57.3,69.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,INCOME3,CAT6,_RFPSA21,RESP054,"(28.932040377000476, -81.92896053899966)"
|
|
2016,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,769,50.8,45.2,56.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,INCOME4,CAT6,_RFPSA21,RESP046,"(28.932040377000476, -81.92896053899966)"
|
|
2016,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,617,49.2,43.7,54.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,INCOME4,CAT6,_RFPSA21,RESP054,"(28.932040377000476, -81.92896053899966)"
|
|
2016,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,2434,54.9,51.8,57.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,INCOME5,CAT6,_RFPSA21,RESP046,"(28.932040377000476, -81.92896053899966)"
|
|
2016,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,1591,45.1,42.1,48.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,INCOME5,CAT6,_RFPSA21,RESP054,"(28.932040377000476, -81.92896053899966)"
|
|
2016,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,4381,50.9,48.8,53,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,RACE01,CAT4,_RFPSA21,RESP046,"(28.932040377000476, -81.92896053899966)"
|
|
2016,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,3756,49.1,47,51.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,RACE01,CAT4,_RFPSA21,RESP054,"(28.932040377000476, -81.92896053899966)"
|
|
2016,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,386,39.8,32.9,46.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,RACE02,CAT4,_RFPSA21,RESP046,"(28.932040377000476, -81.92896053899966)"
|
|
2016,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,477,60.2,53.3,67.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,RACE02,CAT4,_RFPSA21,RESP054,"(28.932040377000476, -81.92896053899966)"
|
|
2016,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,64,38.2,22.9,53.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,RACE03,CAT4,_RFPSA21,RESP046,"(28.932040377000476, -81.92896053899966)"
|
|
2016,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,92,61.8,46.5,77.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,RACE03,CAT4,_RFPSA21,RESP054,"(28.932040377000476, -81.92896053899966)"
|
|
2016,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,23,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,12,RACE04,CAT4,_RFPSA21,RESP046,"(28.932040377000476, -81.92896053899966)"
|
|
2016,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,50,77.2,61.5,92.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,RACE04,CAT4,_RFPSA21,RESP054,"(28.932040377000476, -81.92896053899966)"
|
|
2016,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,12,RACE05,CAT4,_RFPSA21,RESP046,"(28.932040377000476, -81.92896053899966)"
|
|
2016,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,12,RACE05,CAT4,_RFPSA21,RESP054,"(28.932040377000476, -81.92896053899966)"
|
|
2016,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,19,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,12,RACE06,CAT4,_RFPSA21,RESP046,"(28.932040377000476, -81.92896053899966)"
|
|
2016,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,25,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,12,RACE06,CAT4,_RFPSA21,RESP054,"(28.932040377000476, -81.92896053899966)"
|
|
2016,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,55,37.5,18.6,56.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,RACE07,CAT4,_RFPSA21,RESP046,"(28.932040377000476, -81.92896053899966)"
|
|
2016,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,70,62.5,43.5,81.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,RACE07,CAT4,_RFPSA21,RESP054,"(28.932040377000476, -81.92896053899966)"
|
|
2016,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,380,37.2,31.8,42.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,RACE08,CAT4,_RFPSA21,RESP046,"(28.932040377000476, -81.92896053899966)"
|
|
2016,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,569,62.8,57.3,68.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,RACE08,CAT4,_RFPSA21,RESP054,"(28.932040377000476, -81.92896053899966)"
|
|
2016,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,5313,46.2,44.2,48.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,SEX1,CAT2,_RFPSA21,RESP046,"(28.932040377000476, -81.92896053899966)"
|
|
2016,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,5047,53.8,51.8,55.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,SEX1,CAT2,_RFPSA21,RESP054,"(28.932040377000476, -81.92896053899966)"
|
|
2016,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,12,SEX2,CAT2,_RFPSA21,RESP046,"(28.932040377000476, -81.92896053899966)"
|
|
2016,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,12,SEX2,CAT2,_RFPSA21,RESP054,"(28.932040377000476, -81.92896053899966)"
|
|
2016,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,52,18.2,13,23.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,AGE06,CAT3,_RFPSA21,RESP046,"(32.83968109300048, -83.62758034599966)"
|
|
2016,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,216,81.8,76.7,87,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,AGE06,CAT3,_RFPSA21,RESP054,"(32.83968109300048, -83.62758034599966)"
|
|
2016,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,160,39.9,34,45.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,AGE07,CAT3,_RFPSA21,RESP046,"(32.83968109300048, -83.62758034599966)"
|
|
2016,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,217,60.1,54.2,66,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,AGE07,CAT3,_RFPSA21,RESP054,"(32.83968109300048, -83.62758034599966)"
|
|
2016,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,125,65.4,57.4,73.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,AGE08,CAT3,_RFPSA21,RESP046,"(32.83968109300048, -83.62758034599966)"
|
|
2016,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,69,34.6,26.6,42.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,AGE08,CAT3,_RFPSA21,RESP054,"(32.83968109300048, -83.62758034599966)"
|
|
2016,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,404,63.7,58.9,68.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,AGE09,CAT3,_RFPSA21,RESP046,"(32.83968109300048, -83.62758034599966)"
|
|
2016,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,211,36.3,31.5,41.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,AGE09,CAT3,_RFPSA21,RESP054,"(32.83968109300048, -83.62758034599966)"
|
|
2016,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,741,43.3,40.1,46.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,BO1,CAT1,_RFPSA21,RESP046,"(32.83968109300048, -83.62758034599966)"
|
|
2016,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,713,56.7,53.5,59.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,BO1,CAT1,_RFPSA21,RESP054,"(32.83968109300048, -83.62758034599966)"
|
|
2016,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,46,23.7,16.4,31.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,EDUCA1,CAT5,_RFPSA21,RESP046,"(32.83968109300048, -83.62758034599966)"
|
|
2016,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,119,76.3,68.9,83.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,EDUCA1,CAT5,_RFPSA21,RESP054,"(32.83968109300048, -83.62758034599966)"
|
|
2016,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,176,42.7,36.3,49,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,EDUCA2,CAT5,_RFPSA21,RESP046,"(32.83968109300048, -83.62758034599966)"
|
|
2016,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,183,57.3,51,63.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,EDUCA2,CAT5,_RFPSA21,RESP054,"(32.83968109300048, -83.62758034599966)"
|
|
2016,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,206,51.3,45,57.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,EDUCA3,CAT5,_RFPSA21,RESP046,"(32.83968109300048, -83.62758034599966)"
|
|
2016,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,170,48.7,42.5,55,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,EDUCA3,CAT5,_RFPSA21,RESP054,"(32.83968109300048, -83.62758034599966)"
|
|
2016,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,312,49.3,44.3,54.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,EDUCA4,CAT5,_RFPSA21,RESP046,"(32.83968109300048, -83.62758034599966)"
|
|
2016,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,240,50.7,45.7,55.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,EDUCA4,CAT5,_RFPSA21,RESP054,"(32.83968109300048, -83.62758034599966)"
|
|
2016,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,40,26.3,17.3,35.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,INCOME1,CAT6,_RFPSA21,RESP046,"(32.83968109300048, -83.62758034599966)"
|
|
2016,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,84,73.7,64.7,82.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,INCOME1,CAT6,_RFPSA21,RESP054,"(32.83968109300048, -83.62758034599966)"
|
|
2016,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,88,32,24.2,39.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,INCOME2,CAT6,_RFPSA21,RESP046,"(32.83968109300048, -83.62758034599966)"
|
|
2016,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,128,68,60.1,75.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,INCOME2,CAT6,_RFPSA21,RESP054,"(32.83968109300048, -83.62758034599966)"
|
|
2016,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,61,35.3,24.3,46.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,INCOME3,CAT6,_RFPSA21,RESP046,"(32.83968109300048, -83.62758034599966)"
|
|
2016,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,58,64.7,53.7,75.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,INCOME3,CAT6,_RFPSA21,RESP054,"(32.83968109300048, -83.62758034599966)"
|
|
2016,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,86,43.3,33.8,52.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,INCOME4,CAT6,_RFPSA21,RESP046,"(32.83968109300048, -83.62758034599966)"
|
|
2016,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,90,56.7,47.2,66.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,INCOME4,CAT6,_RFPSA21,RESP054,"(32.83968109300048, -83.62758034599966)"
|
|
2016,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,363,49.8,45,54.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,INCOME5,CAT6,_RFPSA21,RESP046,"(32.83968109300048, -83.62758034599966)"
|
|
2016,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,268,50.2,45.5,55,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,INCOME5,CAT6,_RFPSA21,RESP054,"(32.83968109300048, -83.62758034599966)"
|
|
2016,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,541,46.1,42.3,50,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,RACE01,CAT4,_RFPSA21,RESP046,"(32.83968109300048, -83.62758034599966)"
|
|
2016,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,463,53.9,50,57.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,RACE01,CAT4,_RFPSA21,RESP054,"(32.83968109300048, -83.62758034599966)"
|
|
2016,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,160,44.5,37.7,51.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,RACE02,CAT4,_RFPSA21,RESP046,"(32.83968109300048, -83.62758034599966)"
|
|
2016,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,168,55.5,48.6,62.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,RACE02,CAT4,_RFPSA21,RESP054,"(32.83968109300048, -83.62758034599966)"
|
|
2016,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,13,RACE03,CAT4,_RFPSA21,RESP046,"(32.83968109300048, -83.62758034599966)"
|
|
2016,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,13,RACE03,CAT4,_RFPSA21,RESP054,"(32.83968109300048, -83.62758034599966)"
|
|
2016,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,13,RACE04,CAT4,_RFPSA21,RESP046,"(32.83968109300048, -83.62758034599966)"
|
|
2016,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,16,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,13,RACE04,CAT4,_RFPSA21,RESP054,"(32.83968109300048, -83.62758034599966)"
|
|
2016,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,13,RACE05,CAT4,_RFPSA21,RESP046,"(32.83968109300048, -83.62758034599966)"
|
|
2016,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,13,RACE05,CAT4,_RFPSA21,RESP054,"(32.83968109300048, -83.62758034599966)"
|
|
2016,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,13,RACE06,CAT4,_RFPSA21,RESP046,"(32.83968109300048, -83.62758034599966)"
|
|
2016,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,13,RACE06,CAT4,_RFPSA21,RESP054,"(32.83968109300048, -83.62758034599966)"
|
|
2016,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,9,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,13,RACE07,CAT4,_RFPSA21,RESP046,"(32.83968109300048, -83.62758034599966)"
|
|
2016,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,16,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,13,RACE07,CAT4,_RFPSA21,RESP054,"(32.83968109300048, -83.62758034599966)"
|
|
2016,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,19,23.6,11.8,35.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,RACE08,CAT4,_RFPSA21,RESP046,"(32.83968109300048, -83.62758034599966)"
|
|
2016,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,40,76.4,64.5,88.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,RACE08,CAT4,_RFPSA21,RESP054,"(32.83968109300048, -83.62758034599966)"
|
|
2016,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,741,43.3,40.1,46.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,SEX1,CAT2,_RFPSA21,RESP046,"(32.83968109300048, -83.62758034599966)"
|
|
2016,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,713,56.7,53.5,59.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,SEX1,CAT2,_RFPSA21,RESP054,"(32.83968109300048, -83.62758034599966)"
|
|
2016,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,13,SEX2,CAT2,_RFPSA21,RESP046,"(32.83968109300048, -83.62758034599966)"
|
|
2016,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,13,SEX2,CAT2,_RFPSA21,RESP054,"(32.83968109300048, -83.62758034599966)"
|
|
2016,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,66,AGE06,CAT3,_RFPSA21,RESP046,"(13.444304, 144.793731)"
|
|
2016,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,108,89,80.1,98,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,AGE06,CAT3,_RFPSA21,RESP054,"(13.444304, 144.793731)"
|
|
2016,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,37,20.3,11.9,28.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,AGE07,CAT3,_RFPSA21,RESP046,"(13.444304, 144.793731)"
|
|
2016,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,83,79.7,71.2,88.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,AGE07,CAT3,_RFPSA21,RESP054,"(13.444304, 144.793731)"
|
|
2016,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,20,22.4,10.5,34.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,AGE08,CAT3,_RFPSA21,RESP046,"(13.444304, 144.793731)"
|
|
2016,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,42,77.6,65.8,89.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,AGE08,CAT3,_RFPSA21,RESP054,"(13.444304, 144.793731)"
|
|
2016,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,46,43.4,30.3,56.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,AGE09,CAT3,_RFPSA21,RESP046,"(13.444304, 144.793731)"
|
|
2016,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,59,56.6,43.5,69.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,AGE09,CAT3,_RFPSA21,RESP054,"(13.444304, 144.793731)"
|
|
2016,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,113,20.9,15.5,26.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,BO1,CAT1,_RFPSA21,RESP046,"(13.444304, 144.793731)"
|
|
2016,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,292,79.1,73.7,84.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,BO1,CAT1,_RFPSA21,RESP054,"(13.444304, 144.793731)"
|
|
2016,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,66,EDUCA1,CAT5,_RFPSA21,RESP046,"(13.444304, 144.793731)"
|
|
2016,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,26,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,66,EDUCA1,CAT5,_RFPSA21,RESP054,"(13.444304, 144.793731)"
|
|
2016,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,22,17.3,8.3,26.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,EDUCA2,CAT5,_RFPSA21,RESP046,"(13.444304, 144.793731)"
|
|
2016,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,105,82.7,73.6,91.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,EDUCA2,CAT5,_RFPSA21,RESP054,"(13.444304, 144.793731)"
|
|
2016,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,31,21.7,13,30.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,EDUCA3,CAT5,_RFPSA21,RESP046,"(13.444304, 144.793731)"
|
|
2016,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,70,78.3,69.5,87,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,EDUCA3,CAT5,_RFPSA21,RESP054,"(13.444304, 144.793731)"
|
|
2016,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,56,32.2,22,42.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,EDUCA4,CAT5,_RFPSA21,RESP046,"(13.444304, 144.793731)"
|
|
2016,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,90,67.8,57.6,78,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,EDUCA4,CAT5,_RFPSA21,RESP054,"(13.444304, 144.793731)"
|
|
2016,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,66,INCOME1,CAT6,_RFPSA21,RESP046,"(13.444304, 144.793731)"
|
|
2016,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,33,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,66,INCOME1,CAT6,_RFPSA21,RESP054,"(13.444304, 144.793731)"
|
|
2016,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,16,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,66,INCOME2,CAT6,_RFPSA21,RESP046,"(13.444304, 144.793731)"
|
|
2016,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,57,81.7,67.4,96,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,INCOME2,CAT6,_RFPSA21,RESP054,"(13.444304, 144.793731)"
|
|
2016,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,66,INCOME3,CAT6,_RFPSA21,RESP046,"(13.444304, 144.793731)"
|
|
2016,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,32,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,66,INCOME3,CAT6,_RFPSA21,RESP054,"(13.444304, 144.793731)"
|
|
2016,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,18,19.9,9,30.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,INCOME4,CAT6,_RFPSA21,RESP046,"(13.444304, 144.793731)"
|
|
2016,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,44,80.1,69.3,91,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,INCOME4,CAT6,_RFPSA21,RESP054,"(13.444304, 144.793731)"
|
|
2016,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,63,28.1,19.8,36.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,INCOME5,CAT6,_RFPSA21,RESP046,"(13.444304, 144.793731)"
|
|
2016,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,113,71.9,63.6,80.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,INCOME5,CAT6,_RFPSA21,RESP054,"(13.444304, 144.793731)"
|
|
2016,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,19,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,66,RACE01,CAT4,_RFPSA21,RESP046,"(13.444304, 144.793731)"
|
|
2016,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,30,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,66,RACE01,CAT4,_RFPSA21,RESP054,"(13.444304, 144.793731)"
|
|
2016,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,66,RACE02,CAT4,_RFPSA21,RESP046,"(13.444304, 144.793731)"
|
|
2016,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,66,RACE02,CAT4,_RFPSA21,RESP054,"(13.444304, 144.793731)"
|
|
2016,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,66,RACE03,CAT4,_RFPSA21,RESP046,"(13.444304, 144.793731)"
|
|
2016,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,66,RACE03,CAT4,_RFPSA21,RESP054,"(13.444304, 144.793731)"
|
|
2016,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,35,24.4,13,35.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,RACE04,CAT4,_RFPSA21,RESP046,"(13.444304, 144.793731)"
|
|
2016,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,88,75.6,64.2,87,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,RACE04,CAT4,_RFPSA21,RESP054,"(13.444304, 144.793731)"
|
|
2016,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,23,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,66,RACE05,CAT4,_RFPSA21,RESP046,"(13.444304, 144.793731)"
|
|
2016,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,94,86.9,78.9,94.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,RACE05,CAT4,_RFPSA21,RESP054,"(13.444304, 144.793731)"
|
|
2016,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,66,RACE06,CAT4,_RFPSA21,RESP046,"(13.444304, 144.793731)"
|
|
2016,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,14,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,66,RACE06,CAT4,_RFPSA21,RESP054,"(13.444304, 144.793731)"
|
|
2016,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,9,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,66,RACE07,CAT4,_RFPSA21,RESP046,"(13.444304, 144.793731)"
|
|
2016,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,36,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,66,RACE07,CAT4,_RFPSA21,RESP054,"(13.444304, 144.793731)"
|
|
2016,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,18,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,66,RACE08,CAT4,_RFPSA21,RESP046,"(13.444304, 144.793731)"
|
|
2016,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,28,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,66,RACE08,CAT4,_RFPSA21,RESP054,"(13.444304, 144.793731)"
|
|
2016,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,113,20.9,15.5,26.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,SEX1,CAT2,_RFPSA21,RESP046,"(13.444304, 144.793731)"
|
|
2016,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,292,79.1,73.7,84.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,SEX1,CAT2,_RFPSA21,RESP054,"(13.444304, 144.793731)"
|
|
2016,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,66,SEX2,CAT2,_RFPSA21,RESP046,"(13.444304, 144.793731)"
|
|
2016,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,66,SEX2,CAT2,_RFPSA21,RESP054,"(13.444304, 144.793731)"
|
|
2016,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,169,41.8,35.3,48.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,AGE08,CAT3,_RFPSA21,RESP046,"(21.304850435000446, -157.85774940299973)"
|
|
2016,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,451,68.1,63.4,72.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,AGE07,CAT3,_RFPSA21,RESP054,"(21.304850435000446, -157.85774940299973)"
|
|
2016,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,40,10.2,5.3,15.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,AGE06,CAT3,_RFPSA21,RESP046,"(21.304850435000446, -157.85774940299973)"
|
|
2016,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,366,89.8,84.9,94.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,AGE06,CAT3,_RFPSA21,RESP054,"(21.304850435000446, -157.85774940299973)"
|
|
2016,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,211,31.9,27.3,36.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,AGE07,CAT3,_RFPSA21,RESP046,"(21.304850435000446, -157.85774940299973)"
|
|
2016,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,248,58.2,51.6,64.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,AGE08,CAT3,_RFPSA21,RESP054,"(21.304850435000446, -157.85774940299973)"
|
|
2016,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,555,53.8,49.5,58.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,AGE09,CAT3,_RFPSA21,RESP046,"(21.304850435000446, -157.85774940299973)"
|
|
2016,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,470,46.2,41.9,50.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,AGE09,CAT3,_RFPSA21,RESP054,"(21.304850435000446, -157.85774940299973)"
|
|
2016,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,975,35.2,32.7,37.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,BO1,CAT1,_RFPSA21,RESP046,"(21.304850435000446, -157.85774940299973)"
|
|
2016,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1535,64.8,62.2,67.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,BO1,CAT1,_RFPSA21,RESP054,"(21.304850435000446, -157.85774940299973)"
|
|
2016,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,32,38.9,25,52.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,EDUCA1,CAT5,_RFPSA21,RESP046,"(21.304850435000446, -157.85774940299973)"
|
|
2016,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,54,61.1,47.2,75,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,EDUCA1,CAT5,_RFPSA21,RESP054,"(21.304850435000446, -157.85774940299973)"
|
|
2016,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,147,22.7,18.4,27.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,EDUCA2,CAT5,_RFPSA21,RESP046,"(21.304850435000446, -157.85774940299973)"
|
|
2016,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,469,77.3,72.9,81.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,EDUCA2,CAT5,_RFPSA21,RESP054,"(21.304850435000446, -157.85774940299973)"
|
|
2016,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,275,37.4,32.8,42,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,EDUCA3,CAT5,_RFPSA21,RESP046,"(21.304850435000446, -157.85774940299973)"
|
|
2016,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,397,62.6,58,67.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,EDUCA3,CAT5,_RFPSA21,RESP054,"(21.304850435000446, -157.85774940299973)"
|
|
2016,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,520,43.4,39.6,47.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,EDUCA4,CAT5,_RFPSA21,RESP046,"(21.304850435000446, -157.85774940299973)"
|
|
2016,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,611,56.6,52.8,60.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,EDUCA4,CAT5,_RFPSA21,RESP054,"(21.304850435000446, -157.85774940299973)"
|
|
2016,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,51,26.4,17.4,35.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,INCOME1,CAT6,_RFPSA21,RESP046,"(21.304850435000446, -157.85774940299973)"
|
|
2016,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,149,73.6,64.8,82.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,INCOME1,CAT6,_RFPSA21,RESP054,"(21.304850435000446, -157.85774940299973)"
|
|
2016,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,86,27.4,20.3,34.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,INCOME2,CAT6,_RFPSA21,RESP046,"(21.304850435000446, -157.85774940299973)"
|
|
2016,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,181,72.6,65.5,79.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,INCOME2,CAT6,_RFPSA21,RESP054,"(21.304850435000446, -157.85774940299973)"
|
|
2016,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,68,31.3,22.6,40,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,INCOME3,CAT6,_RFPSA21,RESP046,"(21.304850435000446, -157.85774940299973)"
|
|
2016,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,140,68.7,60,77.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,INCOME3,CAT6,_RFPSA21,RESP054,"(21.304850435000446, -157.85774940299973)"
|
|
2016,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,112,32.2,25.2,39.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,INCOME4,CAT6,_RFPSA21,RESP046,"(21.304850435000446, -157.85774940299973)"
|
|
2016,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,201,67.8,60.8,74.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,INCOME4,CAT6,_RFPSA21,RESP054,"(21.304850435000446, -157.85774940299973)"
|
|
2016,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,600,38.8,35.3,42.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,INCOME5,CAT6,_RFPSA21,RESP046,"(21.304850435000446, -157.85774940299973)"
|
|
2016,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,774,61.2,57.7,64.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,INCOME5,CAT6,_RFPSA21,RESP054,"(21.304850435000446, -157.85774940299973)"
|
|
2016,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,462,42,37.3,46.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,RACE01,CAT4,_RFPSA21,RESP046,"(21.304850435000446, -157.85774940299973)"
|
|
2016,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,535,58,53.4,62.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,RACE01,CAT4,_RFPSA21,RESP054,"(21.304850435000446, -157.85774940299973)"
|
|
2016,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,11,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,15,RACE02,CAT4,_RFPSA21,RESP046,"(21.304850435000446, -157.85774940299973)"
|
|
2016,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,14,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,15,RACE02,CAT4,_RFPSA21,RESP054,"(21.304850435000446, -157.85774940299973)"
|
|
2016,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,15,RACE03,CAT4,_RFPSA21,RESP046,"(21.304850435000446, -157.85774940299973)"
|
|
2016,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,15,RACE03,CAT4,_RFPSA21,RESP054,"(21.304850435000446, -157.85774940299973)"
|
|
2016,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,300,36.6,32.3,41,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,RACE04,CAT4,_RFPSA21,RESP046,"(21.304850435000446, -157.85774940299973)"
|
|
2016,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,469,63.4,59,67.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,RACE04,CAT4,_RFPSA21,RESP054,"(21.304850435000446, -157.85774940299973)"
|
|
2016,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,16,17.2,7.6,26.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,RACE05,CAT4,_RFPSA21,RESP046,"(21.304850435000446, -157.85774940299973)"
|
|
2016,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,59,82.8,73.2,92.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,RACE05,CAT4,_RFPSA21,RESP054,"(21.304850435000446, -157.85774940299973)"
|
|
2016,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,15,RACE06,CAT4,_RFPSA21,RESP046,"(21.304850435000446, -157.85774940299973)"
|
|
2016,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,15,RACE06,CAT4,_RFPSA21,RESP054,"(21.304850435000446, -157.85774940299973)"
|
|
2016,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,144,27.2,22.2,32.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,RACE07,CAT4,_RFPSA21,RESP046,"(21.304850435000446, -157.85774940299973)"
|
|
2016,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,333,72.8,67.8,77.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,RACE07,CAT4,_RFPSA21,RESP054,"(21.304850435000446, -157.85774940299973)"
|
|
2016,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,38,23.1,14.3,31.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,RACE08,CAT4,_RFPSA21,RESP046,"(21.304850435000446, -157.85774940299973)"
|
|
2016,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,113,76.9,68.1,85.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,RACE08,CAT4,_RFPSA21,RESP054,"(21.304850435000446, -157.85774940299973)"
|
|
2016,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,975,35.2,32.7,37.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,SEX1,CAT2,_RFPSA21,RESP046,"(21.304850435000446, -157.85774940299973)"
|
|
2016,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1535,64.8,62.2,67.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,SEX1,CAT2,_RFPSA21,RESP054,"(21.304850435000446, -157.85774940299973)"
|
|
2016,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,15,SEX2,CAT2,_RFPSA21,RESP046,"(21.304850435000446, -157.85774940299973)"
|
|
2016,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,15,SEX2,CAT2,_RFPSA21,RESP054,"(21.304850435000446, -157.85774940299973)"
|
|
2016,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,27,8.5,4.1,12.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,AGE06,CAT3,_RFPSA21,RESP046,"(43.682630005000476, -114.3637300419997)"
|
|
2016,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,242,91.5,87.1,95.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,AGE06,CAT3,_RFPSA21,RESP054,"(43.682630005000476, -114.3637300419997)"
|
|
2016,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,134,37.9,31.2,44.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,AGE07,CAT3,_RFPSA21,RESP046,"(43.682630005000476, -114.3637300419997)"
|
|
2016,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,223,62.1,55.4,68.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,AGE07,CAT3,_RFPSA21,RESP054,"(43.682630005000476, -114.3637300419997)"
|
|
2016,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,119,54.2,44.9,63.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,AGE08,CAT3,_RFPSA21,RESP046,"(43.682630005000476, -114.3637300419997)"
|
|
2016,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,102,45.8,36.6,55.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,AGE08,CAT3,_RFPSA21,RESP054,"(43.682630005000476, -114.3637300419997)"
|
|
2016,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,392,55.3,50.5,60.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,AGE09,CAT3,_RFPSA21,RESP046,"(43.682630005000476, -114.3637300419997)"
|
|
2016,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,331,44.7,39.9,49.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,AGE09,CAT3,_RFPSA21,RESP054,"(43.682630005000476, -114.3637300419997)"
|
|
2016,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,672,38.5,35.2,41.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,BO1,CAT1,_RFPSA21,RESP046,"(43.682630005000476, -114.3637300419997)"
|
|
2016,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,898,61.5,58.2,64.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,BO1,CAT1,_RFPSA21,RESP054,"(43.682630005000476, -114.3637300419997)"
|
|
2016,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,23,26.3,15.3,37.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,EDUCA1,CAT5,_RFPSA21,RESP046,"(43.682630005000476, -114.3637300419997)"
|
|
2016,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,65,73.7,62.6,84.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,EDUCA1,CAT5,_RFPSA21,RESP054,"(43.682630005000476, -114.3637300419997)"
|
|
2016,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,150,34.6,28.6,40.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,EDUCA2,CAT5,_RFPSA21,RESP046,"(43.682630005000476, -114.3637300419997)"
|
|
2016,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,252,65.4,59.4,71.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,EDUCA2,CAT5,_RFPSA21,RESP054,"(43.682630005000476, -114.3637300419997)"
|
|
2016,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,189,38.4,32.4,44.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,EDUCA3,CAT5,_RFPSA21,RESP046,"(43.682630005000476, -114.3637300419997)"
|
|
2016,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,272,61.6,55.6,67.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,EDUCA3,CAT5,_RFPSA21,RESP054,"(43.682630005000476, -114.3637300419997)"
|
|
2016,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,308,46.2,40.8,51.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,EDUCA4,CAT5,_RFPSA21,RESP046,"(43.682630005000476, -114.3637300419997)"
|
|
2016,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,305,53.8,48.3,59.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,EDUCA4,CAT5,_RFPSA21,RESP054,"(43.682630005000476, -114.3637300419997)"
|
|
2016,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,28,18.4,9.9,26.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,INCOME1,CAT6,_RFPSA21,RESP046,"(43.682630005000476, -114.3637300419997)"
|
|
2016,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,80,81.6,73.1,90.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,INCOME1,CAT6,_RFPSA21,RESP054,"(43.682630005000476, -114.3637300419997)"
|
|
2016,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,65,31.9,23.7,40.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,INCOME2,CAT6,_RFPSA21,RESP046,"(43.682630005000476, -114.3637300419997)"
|
|
2016,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,134,68.1,59.8,76.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,INCOME2,CAT6,_RFPSA21,RESP054,"(43.682630005000476, -114.3637300419997)"
|
|
2016,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,61,32.4,22.7,42.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,INCOME3,CAT6,_RFPSA21,RESP046,"(43.682630005000476, -114.3637300419997)"
|
|
2016,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,118,67.6,57.9,77.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,INCOME3,CAT6,_RFPSA21,RESP054,"(43.682630005000476, -114.3637300419997)"
|
|
2016,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,108,39.2,31,47.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,INCOME4,CAT6,_RFPSA21,RESP046,"(43.682630005000476, -114.3637300419997)"
|
|
2016,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,131,60.8,52.6,69,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,INCOME4,CAT6,_RFPSA21,RESP054,"(43.682630005000476, -114.3637300419997)"
|
|
2016,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,352,42.8,37.7,47.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,INCOME5,CAT6,_RFPSA21,RESP046,"(43.682630005000476, -114.3637300419997)"
|
|
2016,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,378,57.2,52.1,62.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,INCOME5,CAT6,_RFPSA21,RESP054,"(43.682630005000476, -114.3637300419997)"
|
|
2016,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,647,40,36.6,43.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,RACE01,CAT4,_RFPSA21,RESP046,"(43.682630005000476, -114.3637300419997)"
|
|
2016,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,814,60,56.5,63.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,RACE01,CAT4,_RFPSA21,RESP054,"(43.682630005000476, -114.3637300419997)"
|
|
2016,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,16,RACE02,CAT4,_RFPSA21,RESP046,"(43.682630005000476, -114.3637300419997)"
|
|
2016,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,16,RACE02,CAT4,_RFPSA21,RESP054,"(43.682630005000476, -114.3637300419997)"
|
|
2016,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,16,RACE03,CAT4,_RFPSA21,RESP046,"(43.682630005000476, -114.3637300419997)"
|
|
2016,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,16,RACE03,CAT4,_RFPSA21,RESP054,"(43.682630005000476, -114.3637300419997)"
|
|
2016,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,16,RACE04,CAT4,_RFPSA21,RESP046,"(43.682630005000476, -114.3637300419997)"
|
|
2016,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,16,RACE04,CAT4,_RFPSA21,RESP054,"(43.682630005000476, -114.3637300419997)"
|
|
2016,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,16,RACE05,CAT4,_RFPSA21,RESP046,"(43.682630005000476, -114.3637300419997)"
|
|
2016,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,16,RACE05,CAT4,_RFPSA21,RESP054,"(43.682630005000476, -114.3637300419997)"
|
|
2016,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,16,RACE06,CAT4,_RFPSA21,RESP046,"(43.682630005000476, -114.3637300419997)"
|
|
2016,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,16,RACE06,CAT4,_RFPSA21,RESP054,"(43.682630005000476, -114.3637300419997)"
|
|
2016,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,16,RACE07,CAT4,_RFPSA21,RESP046,"(43.682630005000476, -114.3637300419997)"
|
|
2016,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,17,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,16,RACE07,CAT4,_RFPSA21,RESP054,"(43.682630005000476, -114.3637300419997)"
|
|
2016,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,16,RACE08,CAT4,_RFPSA21,RESP046,"(43.682630005000476, -114.3637300419997)"
|
|
2016,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,49,86.2,75.3,97,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,RACE08,CAT4,_RFPSA21,RESP054,"(43.682630005000476, -114.3637300419997)"
|
|
2016,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,672,38.5,35.2,41.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,SEX1,CAT2,_RFPSA21,RESP046,"(43.682630005000476, -114.3637300419997)"
|
|
2016,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,898,61.5,58.2,64.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,SEX1,CAT2,_RFPSA21,RESP054,"(43.682630005000476, -114.3637300419997)"
|
|
2016,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,16,SEX2,CAT2,_RFPSA21,RESP046,"(43.682630005000476, -114.3637300419997)"
|
|
2016,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,16,SEX2,CAT2,_RFPSA21,RESP054,"(43.682630005000476, -114.3637300419997)"
|
|
2016,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,37,13.2,8.6,17.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,AGE06,CAT3,_RFPSA21,RESP046,"(40.48501028300046, -88.99771017799969)"
|
|
2016,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,216,86.8,82.2,91.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,AGE06,CAT3,_RFPSA21,RESP054,"(40.48501028300046, -88.99771017799969)"
|
|
2016,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,149,36.4,30.8,42,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,AGE07,CAT3,_RFPSA21,RESP046,"(40.48501028300046, -88.99771017799969)"
|
|
2016,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,215,63.6,58,69.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,AGE07,CAT3,_RFPSA21,RESP054,"(40.48501028300046, -88.99771017799969)"
|
|
2016,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,124,56,48.1,63.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,AGE08,CAT3,_RFPSA21,RESP046,"(40.48501028300046, -88.99771017799969)"
|
|
2016,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,85,44,36.2,51.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,AGE08,CAT3,_RFPSA21,RESP054,"(40.48501028300046, -88.99771017799969)"
|
|
2016,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,321,59.3,54.2,64.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,AGE09,CAT3,_RFPSA21,RESP046,"(40.48501028300046, -88.99771017799969)"
|
|
2016,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,219,40.7,35.6,45.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,AGE09,CAT3,_RFPSA21,RESP054,"(40.48501028300046, -88.99771017799969)"
|
|
2016,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,631,39.9,36.8,42.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,BO1,CAT1,_RFPSA21,RESP046,"(40.48501028300046, -88.99771017799969)"
|
|
2016,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,735,60.1,57.1,63.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,BO1,CAT1,_RFPSA21,RESP054,"(40.48501028300046, -88.99771017799969)"
|
|
2016,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,28,26.6,17,36.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,EDUCA1,CAT5,_RFPSA21,RESP046,"(40.48501028300046, -88.99771017799969)"
|
|
2016,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,69,73.4,63.8,83,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,EDUCA1,CAT5,_RFPSA21,RESP054,"(40.48501028300046, -88.99771017799969)"
|
|
2016,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,130,37.6,31.8,43.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,EDUCA2,CAT5,_RFPSA21,RESP046,"(40.48501028300046, -88.99771017799969)"
|
|
2016,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,193,62.4,56.5,68.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,EDUCA2,CAT5,_RFPSA21,RESP054,"(40.48501028300046, -88.99771017799969)"
|
|
2016,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,167,42.2,36.3,48,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,EDUCA3,CAT5,_RFPSA21,RESP046,"(40.48501028300046, -88.99771017799969)"
|
|
2016,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,183,57.8,52,63.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,EDUCA3,CAT5,_RFPSA21,RESP054,"(40.48501028300046, -88.99771017799969)"
|
|
2016,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,305,46.4,41.8,51.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,EDUCA4,CAT5,_RFPSA21,RESP046,"(40.48501028300046, -88.99771017799969)"
|
|
2016,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,290,53.6,48.9,58.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,EDUCA4,CAT5,_RFPSA21,RESP054,"(40.48501028300046, -88.99771017799969)"
|
|
2016,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,27,23,12.8,33.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,INCOME1,CAT6,_RFPSA21,RESP046,"(40.48501028300046, -88.99771017799969)"
|
|
2016,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,68,77,66.8,87.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,INCOME1,CAT6,_RFPSA21,RESP054,"(40.48501028300046, -88.99771017799969)"
|
|
2016,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,58,36.5,27.1,45.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,INCOME2,CAT6,_RFPSA21,RESP046,"(40.48501028300046, -88.99771017799969)"
|
|
2016,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,84,63.5,54.1,72.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,INCOME2,CAT6,_RFPSA21,RESP054,"(40.48501028300046, -88.99771017799969)"
|
|
2016,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,38,29.7,19.2,40.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,INCOME3,CAT6,_RFPSA21,RESP046,"(40.48501028300046, -88.99771017799969)"
|
|
2016,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,69,70.3,59.8,80.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,INCOME3,CAT6,_RFPSA21,RESP054,"(40.48501028300046, -88.99771017799969)"
|
|
2016,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,86,50.4,41.4,59.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,INCOME4,CAT6,_RFPSA21,RESP046,"(40.48501028300046, -88.99771017799969)"
|
|
2016,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,77,49.6,40.6,58.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,INCOME4,CAT6,_RFPSA21,RESP054,"(40.48501028300046, -88.99771017799969)"
|
|
2016,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,390,42,38,46,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,INCOME5,CAT6,_RFPSA21,RESP046,"(40.48501028300046, -88.99771017799969)"
|
|
2016,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,405,58,54,62,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,INCOME5,CAT6,_RFPSA21,RESP054,"(40.48501028300046, -88.99771017799969)"
|
|
2016,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,522,42.6,39.2,46.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,RACE01,CAT4,_RFPSA21,RESP046,"(40.48501028300046, -88.99771017799969)"
|
|
2016,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,554,57.4,53.9,60.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,RACE01,CAT4,_RFPSA21,RESP054,"(40.48501028300046, -88.99771017799969)"
|
|
2016,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,58,37.1,27.4,46.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,RACE02,CAT4,_RFPSA21,RESP046,"(40.48501028300046, -88.99771017799969)"
|
|
2016,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,84,62.9,53.3,72.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,RACE02,CAT4,_RFPSA21,RESP054,"(40.48501028300046, -88.99771017799969)"
|
|
2016,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,17,RACE03,CAT4,_RFPSA21,RESP046,"(40.48501028300046, -88.99771017799969)"
|
|
2016,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,17,RACE03,CAT4,_RFPSA21,RESP054,"(40.48501028300046, -88.99771017799969)"
|
|
2016,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,11,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,17,RACE04,CAT4,_RFPSA21,RESP046,"(40.48501028300046, -88.99771017799969)"
|
|
2016,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,27,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,17,RACE04,CAT4,_RFPSA21,RESP054,"(40.48501028300046, -88.99771017799969)"
|
|
2016,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,17,RACE05,CAT4,_RFPSA21,RESP046,"(40.48501028300046, -88.99771017799969)"
|
|
2016,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,17,RACE05,CAT4,_RFPSA21,RESP054,"(40.48501028300046, -88.99771017799969)"
|
|
2016,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,17,RACE06,CAT4,_RFPSA21,RESP046,"(40.48501028300046, -88.99771017799969)"
|
|
2016,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,17,RACE06,CAT4,_RFPSA21,RESP054,"(40.48501028300046, -88.99771017799969)"
|
|
2016,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,17,RACE07,CAT4,_RFPSA21,RESP046,"(40.48501028300046, -88.99771017799969)"
|
|
2016,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,17,RACE07,CAT4,_RFPSA21,RESP054,"(40.48501028300046, -88.99771017799969)"
|
|
2016,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,30,31.4,20.4,42.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,RACE08,CAT4,_RFPSA21,RESP046,"(40.48501028300046, -88.99771017799969)"
|
|
2016,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,60,68.6,57.6,79.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,RACE08,CAT4,_RFPSA21,RESP054,"(40.48501028300046, -88.99771017799969)"
|
|
2016,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,631,39.9,36.8,42.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,SEX1,CAT2,_RFPSA21,RESP046,"(40.48501028300046, -88.99771017799969)"
|
|
2016,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,735,60.1,57.1,63.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,SEX1,CAT2,_RFPSA21,RESP054,"(40.48501028300046, -88.99771017799969)"
|
|
2016,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,17,SEX2,CAT2,_RFPSA21,RESP046,"(40.48501028300046, -88.99771017799969)"
|
|
2016,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,17,SEX2,CAT2,_RFPSA21,RESP054,"(40.48501028300046, -88.99771017799969)"
|
|
2016,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,509,64.1,60.1,68.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,AGE07,CAT3,_RFPSA21,RESP054,"(39.766910452000445, -86.14996019399968)"
|
|
2016,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,68,11.2,7.7,14.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,AGE06,CAT3,_RFPSA21,RESP046,"(39.766910452000445, -86.14996019399968)"
|
|
2016,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,455,88.8,85.3,92.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,AGE06,CAT3,_RFPSA21,RESP054,"(39.766910452000445, -86.14996019399968)"
|
|
2016,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,320,35.9,31.8,39.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,AGE07,CAT3,_RFPSA21,RESP046,"(39.766910452000445, -86.14996019399968)"
|
|
2016,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,233,49.2,43.5,54.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,AGE08,CAT3,_RFPSA21,RESP046,"(39.766910452000445, -86.14996019399968)"
|
|
2016,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,222,50.8,45.2,56.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,AGE08,CAT3,_RFPSA21,RESP054,"(39.766910452000445, -86.14996019399968)"
|
|
2016,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,847,56.7,53.5,60,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,AGE09,CAT3,_RFPSA21,RESP046,"(39.766910452000445, -86.14996019399968)"
|
|
2016,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,654,43.3,40,46.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,AGE09,CAT3,_RFPSA21,RESP054,"(39.766910452000445, -86.14996019399968)"
|
|
2016,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1468,37.2,35.1,39.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,BO1,CAT1,_RFPSA21,RESP046,"(39.766910452000445, -86.14996019399968)"
|
|
2016,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1840,62.8,60.6,64.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,BO1,CAT1,_RFPSA21,RESP054,"(39.766910452000445, -86.14996019399968)"
|
|
2016,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,60,19.8,13.7,25.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,EDUCA1,CAT5,_RFPSA21,RESP046,"(39.766910452000445, -86.14996019399968)"
|
|
2016,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,190,80.2,74.1,86.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,EDUCA1,CAT5,_RFPSA21,RESP054,"(39.766910452000445, -86.14996019399968)"
|
|
2016,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,444,37.7,34,41.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,EDUCA2,CAT5,_RFPSA21,RESP046,"(39.766910452000445, -86.14996019399968)"
|
|
2016,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,625,62.3,58.6,66,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,EDUCA2,CAT5,_RFPSA21,RESP054,"(39.766910452000445, -86.14996019399968)"
|
|
2016,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,330,38.6,34.3,43,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,EDUCA3,CAT5,_RFPSA21,RESP046,"(39.766910452000445, -86.14996019399968)"
|
|
2016,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,404,61.4,57,65.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,EDUCA3,CAT5,_RFPSA21,RESP054,"(39.766910452000445, -86.14996019399968)"
|
|
2016,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,634,44.3,40.7,47.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,EDUCA4,CAT5,_RFPSA21,RESP046,"(39.766910452000445, -86.14996019399968)"
|
|
2016,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,618,55.7,52.2,59.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,EDUCA4,CAT5,_RFPSA21,RESP054,"(39.766910452000445, -86.14996019399968)"
|
|
2016,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,54,21.2,14,28.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,INCOME1,CAT6,_RFPSA21,RESP046,"(39.766910452000445, -86.14996019399968)"
|
|
2016,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,167,78.8,71.7,86,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,INCOME1,CAT6,_RFPSA21,RESP054,"(39.766910452000445, -86.14996019399968)"
|
|
2016,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,172,32.3,26.3,38.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,INCOME2,CAT6,_RFPSA21,RESP046,"(39.766910452000445, -86.14996019399968)"
|
|
2016,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,289,67.7,61.8,73.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,INCOME2,CAT6,_RFPSA21,RESP054,"(39.766910452000445, -86.14996019399968)"
|
|
2016,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,126,34.1,27.4,40.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,INCOME3,CAT6,_RFPSA21,RESP046,"(39.766910452000445, -86.14996019399968)"
|
|
2016,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,205,65.9,59.1,72.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,INCOME3,CAT6,_RFPSA21,RESP054,"(39.766910452000445, -86.14996019399968)"
|
|
2016,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,214,36.5,31,42.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,INCOME4,CAT6,_RFPSA21,RESP046,"(39.766910452000445, -86.14996019399968)"
|
|
2016,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,260,63.5,57.9,69,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,INCOME4,CAT6,_RFPSA21,RESP054,"(39.766910452000445, -86.14996019399968)"
|
|
2016,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,770,41.6,38.4,44.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,INCOME5,CAT6,_RFPSA21,RESP046,"(39.766910452000445, -86.14996019399968)"
|
|
2016,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,765,58.4,55.2,61.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,INCOME5,CAT6,_RFPSA21,RESP054,"(39.766910452000445, -86.14996019399968)"
|
|
2016,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1330,37.8,35.5,40,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,RACE01,CAT4,_RFPSA21,RESP046,"(39.766910452000445, -86.14996019399968)"
|
|
2016,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1609,62.2,60,64.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,RACE01,CAT4,_RFPSA21,RESP054,"(39.766910452000445, -86.14996019399968)"
|
|
2016,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,78,36.7,27.7,45.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,RACE02,CAT4,_RFPSA21,RESP046,"(39.766910452000445, -86.14996019399968)"
|
|
2016,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,109,63.3,54.3,72.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,RACE02,CAT4,_RFPSA21,RESP054,"(39.766910452000445, -86.14996019399968)"
|
|
2016,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,13,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,18,RACE03,CAT4,_RFPSA21,RESP046,"(39.766910452000445, -86.14996019399968)"
|
|
2016,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,28,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,18,RACE03,CAT4,_RFPSA21,RESP054,"(39.766910452000445, -86.14996019399968)"
|
|
2016,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,18,RACE04,CAT4,_RFPSA21,RESP046,"(39.766910452000445, -86.14996019399968)"
|
|
2016,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,20,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,18,RACE04,CAT4,_RFPSA21,RESP054,"(39.766910452000445, -86.14996019399968)"
|
|
2016,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,18,RACE05,CAT4,_RFPSA21,RESP046,"(39.766910452000445, -86.14996019399968)"
|
|
2016,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,18,RACE05,CAT4,_RFPSA21,RESP054,"(39.766910452000445, -86.14996019399968)"
|
|
2016,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,18,RACE06,CAT4,_RFPSA21,RESP046,"(39.766910452000445, -86.14996019399968)"
|
|
2016,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,18,RACE06,CAT4,_RFPSA21,RESP054,"(39.766910452000445, -86.14996019399968)"
|
|
2016,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,17,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,18,RACE07,CAT4,_RFPSA21,RESP046,"(39.766910452000445, -86.14996019399968)"
|
|
2016,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,28,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,18,RACE07,CAT4,_RFPSA21,RESP054,"(39.766910452000445, -86.14996019399968)"
|
|
2016,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,25,36.2,20.5,51.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,RACE08,CAT4,_RFPSA21,RESP046,"(39.766910452000445, -86.14996019399968)"
|
|
2016,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,43,63.8,48.1,79.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,RACE08,CAT4,_RFPSA21,RESP054,"(39.766910452000445, -86.14996019399968)"
|
|
2016,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1468,37.2,35.1,39.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,SEX1,CAT2,_RFPSA21,RESP046,"(39.766910452000445, -86.14996019399968)"
|
|
2016,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1840,62.8,60.6,64.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,SEX1,CAT2,_RFPSA21,RESP054,"(39.766910452000445, -86.14996019399968)"
|
|
2016,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,18,SEX2,CAT2,_RFPSA21,RESP046,"(39.766910452000445, -86.14996019399968)"
|
|
2016,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,18,SEX2,CAT2,_RFPSA21,RESP054,"(39.766910452000445, -86.14996019399968)"
|
|
2016,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,37,9.8,6.2,13.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,AGE06,CAT3,_RFPSA21,RESP046,"(42.46940091300047, -93.81649055599968)"
|
|
2016,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,332,90.2,86.7,93.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,AGE06,CAT3,_RFPSA21,RESP054,"(42.46940091300047, -93.81649055599968)"
|
|
2016,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,186,34.2,29.5,38.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,AGE07,CAT3,_RFPSA21,RESP046,"(42.46940091300047, -93.81649055599968)"
|
|
2016,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,349,65.8,61.2,70.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,AGE07,CAT3,_RFPSA21,RESP054,"(42.46940091300047, -93.81649055599968)"
|
|
2016,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,219,54.3,48.5,60.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,AGE08,CAT3,_RFPSA21,RESP046,"(42.46940091300047, -93.81649055599968)"
|
|
2016,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,166,45.7,39.8,51.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,AGE08,CAT3,_RFPSA21,RESP054,"(42.46940091300047, -93.81649055599968)"
|
|
2016,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,531,56.7,52.9,60.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,AGE09,CAT3,_RFPSA21,RESP046,"(42.46940091300047, -93.81649055599968)"
|
|
2016,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,402,43.3,39.4,47.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,AGE09,CAT3,_RFPSA21,RESP054,"(42.46940091300047, -93.81649055599968)"
|
|
2016,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,973,38.4,36,40.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,BO1,CAT1,_RFPSA21,RESP046,"(42.46940091300047, -93.81649055599968)"
|
|
2016,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1249,61.6,59.2,64,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,BO1,CAT1,_RFPSA21,RESP054,"(42.46940091300047, -93.81649055599968)"
|
|
2016,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,36,28.1,18.8,37.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,EDUCA1,CAT5,_RFPSA21,RESP046,"(42.46940091300047, -93.81649055599968)"
|
|
2016,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,77,71.9,62.7,81.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,EDUCA1,CAT5,_RFPSA21,RESP054,"(42.46940091300047, -93.81649055599968)"
|
|
2016,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,303,35.3,31.5,39.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,EDUCA2,CAT5,_RFPSA21,RESP046,"(42.46940091300047, -93.81649055599968)"
|
|
2016,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,464,64.7,60.8,68.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,EDUCA2,CAT5,_RFPSA21,RESP054,"(42.46940091300047, -93.81649055599968)"
|
|
2016,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,270,40.2,35.7,44.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,EDUCA3,CAT5,_RFPSA21,RESP046,"(42.46940091300047, -93.81649055599968)"
|
|
2016,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,338,59.8,55.3,64.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,EDUCA3,CAT5,_RFPSA21,RESP054,"(42.46940091300047, -93.81649055599968)"
|
|
2016,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,362,43.6,39.4,47.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,EDUCA4,CAT5,_RFPSA21,RESP046,"(42.46940091300047, -93.81649055599968)"
|
|
2016,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,370,56.4,52.2,60.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,EDUCA4,CAT5,_RFPSA21,RESP054,"(42.46940091300047, -93.81649055599968)"
|
|
2016,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,28,23.3,14.3,32.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,INCOME1,CAT6,_RFPSA21,RESP046,"(42.46940091300047, -93.81649055599968)"
|
|
2016,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,86,76.7,67.7,85.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,INCOME1,CAT6,_RFPSA21,RESP054,"(42.46940091300047, -93.81649055599968)"
|
|
2016,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,79,34.7,26.5,42.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,INCOME2,CAT6,_RFPSA21,RESP046,"(42.46940091300047, -93.81649055599968)"
|
|
2016,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,132,65.3,57.2,73.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,INCOME2,CAT6,_RFPSA21,RESP054,"(42.46940091300047, -93.81649055599968)"
|
|
2016,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,78,38.3,29.8,46.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,INCOME3,CAT6,_RFPSA21,RESP046,"(42.46940091300047, -93.81649055599968)"
|
|
2016,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,116,61.7,53.2,70.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,INCOME3,CAT6,_RFPSA21,RESP054,"(42.46940091300047, -93.81649055599968)"
|
|
2016,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,139,37.2,31,43.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,INCOME4,CAT6,_RFPSA21,RESP046,"(42.46940091300047, -93.81649055599968)"
|
|
2016,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,181,62.8,56.7,69,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,INCOME4,CAT6,_RFPSA21,RESP054,"(42.46940091300047, -93.81649055599968)"
|
|
2016,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,559,40.5,37.3,43.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,INCOME5,CAT6,_RFPSA21,RESP046,"(42.46940091300047, -93.81649055599968)"
|
|
2016,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,611,59.5,56.2,62.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,INCOME5,CAT6,_RFPSA21,RESP054,"(42.46940091300047, -93.81649055599968)"
|
|
2016,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,944,39.6,37.2,42,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,RACE01,CAT4,_RFPSA21,RESP046,"(42.46940091300047, -93.81649055599968)"
|
|
2016,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1171,60.4,58,62.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,RACE01,CAT4,_RFPSA21,RESP054,"(42.46940091300047, -93.81649055599968)"
|
|
2016,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,19,RACE02,CAT4,_RFPSA21,RESP046,"(42.46940091300047, -93.81649055599968)"
|
|
2016,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,20,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,19,RACE02,CAT4,_RFPSA21,RESP054,"(42.46940091300047, -93.81649055599968)"
|
|
2016,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,19,RACE03,CAT4,_RFPSA21,RESP046,"(42.46940091300047, -93.81649055599968)"
|
|
2016,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,19,RACE03,CAT4,_RFPSA21,RESP054,"(42.46940091300047, -93.81649055599968)"
|
|
2016,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,19,RACE04,CAT4,_RFPSA21,RESP046,"(42.46940091300047, -93.81649055599968)"
|
|
2016,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,19,RACE04,CAT4,_RFPSA21,RESP054,"(42.46940091300047, -93.81649055599968)"
|
|
2016,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,19,RACE05,CAT4,_RFPSA21,RESP046,"(42.46940091300047, -93.81649055599968)"
|
|
2016,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,19,RACE05,CAT4,_RFPSA21,RESP054,"(42.46940091300047, -93.81649055599968)"
|
|
2016,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,19,RACE06,CAT4,_RFPSA21,RESP046,"(42.46940091300047, -93.81649055599968)"
|
|
2016,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,19,RACE06,CAT4,_RFPSA21,RESP054,"(42.46940091300047, -93.81649055599968)"
|
|
2016,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,19,RACE07,CAT4,_RFPSA21,RESP046,"(42.46940091300047, -93.81649055599968)"
|
|
2016,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,19,RACE07,CAT4,_RFPSA21,RESP054,"(42.46940091300047, -93.81649055599968)"
|
|
2016,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,19,RACE08,CAT4,_RFPSA21,RESP046,"(42.46940091300047, -93.81649055599968)"
|
|
2016,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,35,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,19,RACE08,CAT4,_RFPSA21,RESP054,"(42.46940091300047, -93.81649055599968)"
|
|
2016,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,973,38.4,36,40.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,SEX1,CAT2,_RFPSA21,RESP046,"(42.46940091300047, -93.81649055599968)"
|
|
2016,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1249,61.6,59.2,64,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,SEX1,CAT2,_RFPSA21,RESP054,"(42.46940091300047, -93.81649055599968)"
|
|
2016,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,19,SEX2,CAT2,_RFPSA21,RESP046,"(42.46940091300047, -93.81649055599968)"
|
|
2016,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,19,SEX2,CAT2,_RFPSA21,RESP054,"(42.46940091300047, -93.81649055599968)"
|
|
2016,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,83,12.4,9.5,15.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,AGE06,CAT3,_RFPSA21,RESP046,"(38.34774030000045, -98.20078122699965)"
|
|
2016,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,490,87.6,84.6,90.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,AGE06,CAT3,_RFPSA21,RESP054,"(38.34774030000045, -98.20078122699965)"
|
|
2016,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,315,35.3,31.6,39,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,AGE07,CAT3,_RFPSA21,RESP046,"(38.34774030000045, -98.20078122699965)"
|
|
2016,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,529,64.7,61,68.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,AGE07,CAT3,_RFPSA21,RESP054,"(38.34774030000045, -98.20078122699965)"
|
|
2016,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,296,54.9,49.8,60,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,AGE08,CAT3,_RFPSA21,RESP046,"(38.34774030000045, -98.20078122699965)"
|
|
2016,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,225,45.1,40,50.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,AGE08,CAT3,_RFPSA21,RESP054,"(38.34774030000045, -98.20078122699965)"
|
|
2016,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,912,60.3,57.4,63.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,AGE09,CAT3,_RFPSA21,RESP046,"(38.34774030000045, -98.20078122699965)"
|
|
2016,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,565,39.7,36.8,42.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,AGE09,CAT3,_RFPSA21,RESP054,"(38.34774030000045, -98.20078122699965)"
|
|
2016,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1606,40,38.1,42,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,BO1,CAT1,_RFPSA21,RESP046,"(38.34774030000045, -98.20078122699965)"
|
|
2016,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1809,60,58,61.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,BO1,CAT1,_RFPSA21,RESP054,"(38.34774030000045, -98.20078122699965)"
|
|
2016,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,46,23.6,16.6,30.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,EDUCA1,CAT5,_RFPSA21,RESP046,"(38.34774030000045, -98.20078122699965)"
|
|
2016,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,118,76.4,69.4,83.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,EDUCA1,CAT5,_RFPSA21,RESP054,"(38.34774030000045, -98.20078122699965)"
|
|
2016,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,357,37.2,33.6,40.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,EDUCA2,CAT5,_RFPSA21,RESP046,"(38.34774030000045, -98.20078122699965)"
|
|
2016,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,527,62.8,59.1,66.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,EDUCA2,CAT5,_RFPSA21,RESP054,"(38.34774030000045, -98.20078122699965)"
|
|
2016,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,408,40,36.4,43.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,EDUCA3,CAT5,_RFPSA21,RESP046,"(38.34774030000045, -98.20078122699965)"
|
|
2016,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,497,60,56.3,63.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,EDUCA3,CAT5,_RFPSA21,RESP054,"(38.34774030000045, -98.20078122699965)"
|
|
2016,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,790,47.6,44.6,50.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,EDUCA4,CAT5,_RFPSA21,RESP046,"(38.34774030000045, -98.20078122699965)"
|
|
2016,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,665,52.4,49.4,55.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,EDUCA4,CAT5,_RFPSA21,RESP054,"(38.34774030000045, -98.20078122699965)"
|
|
2016,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,39,20.2,13,27.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,INCOME1,CAT6,_RFPSA21,RESP046,"(38.34774030000045, -98.20078122699965)"
|
|
2016,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,119,79.8,72.6,87,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,INCOME1,CAT6,_RFPSA21,RESP054,"(38.34774030000045, -98.20078122699965)"
|
|
2016,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,142,32.5,26.9,38.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,INCOME2,CAT6,_RFPSA21,RESP046,"(38.34774030000045, -98.20078122699965)"
|
|
2016,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,237,67.5,61.8,73.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,INCOME2,CAT6,_RFPSA21,RESP054,"(38.34774030000045, -98.20078122699965)"
|
|
2016,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,137,35.5,29.3,41.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,INCOME3,CAT6,_RFPSA21,RESP046,"(38.34774030000045, -98.20078122699965)"
|
|
2016,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,181,64.5,58.2,70.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,INCOME3,CAT6,_RFPSA21,RESP054,"(38.34774030000045, -98.20078122699965)"
|
|
2016,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,216,38.1,33.1,43.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,INCOME4,CAT6,_RFPSA21,RESP046,"(38.34774030000045, -98.20078122699965)"
|
|
2016,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,278,61.9,56.9,66.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,INCOME4,CAT6,_RFPSA21,RESP054,"(38.34774030000045, -98.20078122699965)"
|
|
2016,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,904,45,42.2,47.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,INCOME5,CAT6,_RFPSA21,RESP046,"(38.34774030000045, -98.20078122699965)"
|
|
2016,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,819,55,52.2,57.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,INCOME5,CAT6,_RFPSA21,RESP054,"(38.34774030000045, -98.20078122699965)"
|
|
2016,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1490,42.6,40.6,44.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,RACE01,CAT4,_RFPSA21,RESP046,"(38.34774030000045, -98.20078122699965)"
|
|
2016,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1592,57.4,55.4,59.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,RACE01,CAT4,_RFPSA21,RESP054,"(38.34774030000045, -98.20078122699965)"
|
|
2016,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,49,33.6,23.7,43.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,RACE02,CAT4,_RFPSA21,RESP046,"(38.34774030000045, -98.20078122699965)"
|
|
2016,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,66,66.4,56.5,76.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,RACE02,CAT4,_RFPSA21,RESP054,"(38.34774030000045, -98.20078122699965)"
|
|
2016,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,17,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,20,RACE03,CAT4,_RFPSA21,RESP046,"(38.34774030000045, -98.20078122699965)"
|
|
2016,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,23,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,20,RACE03,CAT4,_RFPSA21,RESP054,"(38.34774030000045, -98.20078122699965)"
|
|
2016,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,20,RACE04,CAT4,_RFPSA21,RESP046,"(38.34774030000045, -98.20078122699965)"
|
|
2016,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,14,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,20,RACE04,CAT4,_RFPSA21,RESP054,"(38.34774030000045, -98.20078122699965)"
|
|
2016,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,20,RACE05,CAT4,_RFPSA21,RESP046,"(38.34774030000045, -98.20078122699965)"
|
|
2016,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,20,RACE05,CAT4,_RFPSA21,RESP054,"(38.34774030000045, -98.20078122699965)"
|
|
2016,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,20,RACE06,CAT4,_RFPSA21,RESP046,"(38.34774030000045, -98.20078122699965)"
|
|
2016,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,20,RACE06,CAT4,_RFPSA21,RESP054,"(38.34774030000045, -98.20078122699965)"
|
|
2016,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,18,25.6,12.4,38.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,RACE07,CAT4,_RFPSA21,RESP046,"(38.34774030000045, -98.20078122699965)"
|
|
2016,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,35,74.4,61.2,87.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,RACE07,CAT4,_RFPSA21,RESP054,"(38.34774030000045, -98.20078122699965)"
|
|
2016,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,25,20.3,11.4,29.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,RACE08,CAT4,_RFPSA21,RESP046,"(38.34774030000045, -98.20078122699965)"
|
|
2016,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,77,79.7,70.8,88.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,RACE08,CAT4,_RFPSA21,RESP054,"(38.34774030000045, -98.20078122699965)"
|
|
2016,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1606,40,38.1,42,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,SEX1,CAT2,_RFPSA21,RESP046,"(38.34774030000045, -98.20078122699965)"
|
|
2016,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1809,60,58,61.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,SEX1,CAT2,_RFPSA21,RESP054,"(38.34774030000045, -98.20078122699965)"
|
|
2016,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,20,SEX2,CAT2,_RFPSA21,RESP046,"(38.34774030000045, -98.20078122699965)"
|
|
2016,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,20,SEX2,CAT2,_RFPSA21,RESP054,"(38.34774030000045, -98.20078122699965)"
|
|
2016,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1440,58.9,56.2,61.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,BO1,CAT1,_RFPSA21,RESP054,"(37.645970271000465, -84.77497104799966)"
|
|
2016,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,88,17.5,12.8,22.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,AGE06,CAT3,_RFPSA21,RESP046,"(37.645970271000465, -84.77497104799966)"
|
|
2016,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,414,82.5,77.8,87.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,AGE06,CAT3,_RFPSA21,RESP054,"(37.645970271000465, -84.77497104799966)"
|
|
2016,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,308,37.6,32.4,42.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,AGE07,CAT3,_RFPSA21,RESP046,"(37.645970271000465, -84.77497104799966)"
|
|
2016,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,440,62.4,57.2,67.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,AGE07,CAT3,_RFPSA21,RESP054,"(37.645970271000465, -84.77497104799966)"
|
|
2016,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,226,49.4,43.2,55.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,AGE08,CAT3,_RFPSA21,RESP046,"(37.645970271000465, -84.77497104799966)"
|
|
2016,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,203,50.6,44.4,56.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,AGE08,CAT3,_RFPSA21,RESP054,"(37.645970271000465, -84.77497104799966)"
|
|
2016,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,704,60.2,55.8,64.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,AGE09,CAT3,_RFPSA21,RESP046,"(37.645970271000465, -84.77497104799966)"
|
|
2016,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,383,39.8,35.3,44.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,AGE09,CAT3,_RFPSA21,RESP054,"(37.645970271000465, -84.77497104799966)"
|
|
2016,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1326,41.1,38.4,43.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,BO1,CAT1,_RFPSA21,RESP046,"(37.645970271000465, -84.77497104799966)"
|
|
2016,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,81,29.7,22,37.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,EDUCA1,CAT5,_RFPSA21,RESP046,"(37.645970271000465, -84.77497104799966)"
|
|
2016,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,189,70.3,62.6,78,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,EDUCA1,CAT5,_RFPSA21,RESP054,"(37.645970271000465, -84.77497104799966)"
|
|
2016,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,383,37.6,33.1,42.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,EDUCA2,CAT5,_RFPSA21,RESP046,"(37.645970271000465, -84.77497104799966)"
|
|
2016,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,532,62.4,57.9,66.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,EDUCA2,CAT5,_RFPSA21,RESP054,"(37.645970271000465, -84.77497104799966)"
|
|
2016,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,335,47.2,41.9,52.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,EDUCA3,CAT5,_RFPSA21,RESP046,"(37.645970271000465, -84.77497104799966)"
|
|
2016,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,312,52.8,47.5,58.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,EDUCA3,CAT5,_RFPSA21,RESP054,"(37.645970271000465, -84.77497104799966)"
|
|
2016,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,527,51.2,46.4,56,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,EDUCA4,CAT5,_RFPSA21,RESP046,"(37.645970271000465, -84.77497104799966)"
|
|
2016,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,403,48.8,44,53.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,EDUCA4,CAT5,_RFPSA21,RESP054,"(37.645970271000465, -84.77497104799966)"
|
|
2016,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,63,21.1,15,27.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,INCOME1,CAT6,_RFPSA21,RESP046,"(37.645970271000465, -84.77497104799966)"
|
|
2016,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,183,78.9,72.7,85,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,INCOME1,CAT6,_RFPSA21,RESP054,"(37.645970271000465, -84.77497104799966)"
|
|
2016,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,147,38,31,44.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,INCOME2,CAT6,_RFPSA21,RESP046,"(37.645970271000465, -84.77497104799966)"
|
|
2016,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,194,62,55.1,69,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,INCOME2,CAT6,_RFPSA21,RESP054,"(37.645970271000465, -84.77497104799966)"
|
|
2016,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,113,41.9,32.3,51.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,INCOME3,CAT6,_RFPSA21,RESP046,"(37.645970271000465, -84.77497104799966)"
|
|
2016,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,116,58.1,48.5,67.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,INCOME3,CAT6,_RFPSA21,RESP054,"(37.645970271000465, -84.77497104799966)"
|
|
2016,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,151,43,35.1,50.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,INCOME4,CAT6,_RFPSA21,RESP046,"(37.645970271000465, -84.77497104799966)"
|
|
2016,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,161,57,49.1,64.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,INCOME4,CAT6,_RFPSA21,RESP054,"(37.645970271000465, -84.77497104799966)"
|
|
2016,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,668,46.7,42.4,50.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,INCOME5,CAT6,_RFPSA21,RESP046,"(37.645970271000465, -84.77497104799966)"
|
|
2016,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,570,53.3,49.1,57.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,INCOME5,CAT6,_RFPSA21,RESP054,"(37.645970271000465, -84.77497104799966)"
|
|
2016,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1164,42.1,39.3,45,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,RACE01,CAT4,_RFPSA21,RESP046,"(37.645970271000465, -84.77497104799966)"
|
|
2016,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1248,57.9,55,60.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,RACE01,CAT4,_RFPSA21,RESP054,"(37.645970271000465, -84.77497104799966)"
|
|
2016,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,110,39,28.5,49.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,RACE02,CAT4,_RFPSA21,RESP046,"(37.645970271000465, -84.77497104799966)"
|
|
2016,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,97,61,50.5,71.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,RACE02,CAT4,_RFPSA21,RESP054,"(37.645970271000465, -84.77497104799966)"
|
|
2016,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,9,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,21,RACE03,CAT4,_RFPSA21,RESP046,"(37.645970271000465, -84.77497104799966)"
|
|
2016,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,20,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,21,RACE03,CAT4,_RFPSA21,RESP054,"(37.645970271000465, -84.77497104799966)"
|
|
2016,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,21,RACE04,CAT4,_RFPSA21,RESP046,"(37.645970271000465, -84.77497104799966)"
|
|
2016,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,21,RACE04,CAT4,_RFPSA21,RESP054,"(37.645970271000465, -84.77497104799966)"
|
|
2016,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,21,RACE05,CAT4,_RFPSA21,RESP046,"(37.645970271000465, -84.77497104799966)"
|
|
2016,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,21,RACE05,CAT4,_RFPSA21,RESP054,"(37.645970271000465, -84.77497104799966)"
|
|
2016,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,21,RACE06,CAT4,_RFPSA21,RESP046,"(37.645970271000465, -84.77497104799966)"
|
|
2016,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,21,RACE06,CAT4,_RFPSA21,RESP054,"(37.645970271000465, -84.77497104799966)"
|
|
2016,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,27,26.2,14.2,38.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,RACE07,CAT4,_RFPSA21,RESP046,"(37.645970271000465, -84.77497104799966)"
|
|
2016,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,52,73.8,61.8,85.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,RACE07,CAT4,_RFPSA21,RESP054,"(37.645970271000465, -84.77497104799966)"
|
|
2016,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,21,RACE08,CAT4,_RFPSA21,RESP046,"(37.645970271000465, -84.77497104799966)"
|
|
2016,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,13,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,21,RACE08,CAT4,_RFPSA21,RESP054,"(37.645970271000465, -84.77497104799966)"
|
|
2016,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1326,41.1,38.4,43.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,SEX1,CAT2,_RFPSA21,RESP046,"(37.645970271000465, -84.77497104799966)"
|
|
2016,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1440,58.9,56.2,61.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,SEX1,CAT2,_RFPSA21,RESP054,"(37.645970271000465, -84.77497104799966)"
|
|
2016,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,21,SEX2,CAT2,_RFPSA21,RESP046,"(37.645970271000465, -84.77497104799966)"
|
|
2016,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,21,SEX2,CAT2,_RFPSA21,RESP054,"(37.645970271000465, -84.77497104799966)"
|
|
2016,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,616,55.5,51.7,59.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,BO1,CAT1,_RFPSA21,RESP054,"(31.31266064400046, -92.44568007099969)"
|
|
2016,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,42,18.3,11.2,25.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,AGE06,CAT3,_RFPSA21,RESP046,"(31.31266064400046, -92.44568007099969)"
|
|
2016,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,162,81.7,74.6,88.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,AGE06,CAT3,_RFPSA21,RESP054,"(31.31266064400046, -92.44568007099969)"
|
|
2016,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,147,40.8,33.6,48,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,AGE07,CAT3,_RFPSA21,RESP046,"(31.31266064400046, -92.44568007099969)"
|
|
2016,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,177,59.2,52,66.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,AGE07,CAT3,_RFPSA21,RESP054,"(31.31266064400046, -92.44568007099969)"
|
|
2016,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,141,64,55.9,72,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,AGE08,CAT3,_RFPSA21,RESP046,"(31.31266064400046, -92.44568007099969)"
|
|
2016,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,89,36,28,44.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,AGE08,CAT3,_RFPSA21,RESP054,"(31.31266064400046, -92.44568007099969)"
|
|
2016,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,390,62.6,56.8,68.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,AGE09,CAT3,_RFPSA21,RESP046,"(31.31266064400046, -92.44568007099969)"
|
|
2016,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,188,37.4,31.6,43.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,AGE09,CAT3,_RFPSA21,RESP054,"(31.31266064400046, -92.44568007099969)"
|
|
2016,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,720,44.5,40.7,48.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,BO1,CAT1,_RFPSA21,RESP046,"(31.31266064400046, -92.44568007099969)"
|
|
2016,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,55,31.3,21,41.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,EDUCA1,CAT5,_RFPSA21,RESP046,"(31.31266064400046, -92.44568007099969)"
|
|
2016,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,103,68.7,58.5,79,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,EDUCA1,CAT5,_RFPSA21,RESP054,"(31.31266064400046, -92.44568007099969)"
|
|
2016,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,219,39.5,33.4,45.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,EDUCA2,CAT5,_RFPSA21,RESP046,"(31.31266064400046, -92.44568007099969)"
|
|
2016,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,238,60.5,54.4,66.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,EDUCA2,CAT5,_RFPSA21,RESP054,"(31.31266064400046, -92.44568007099969)"
|
|
2016,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,180,51.4,43.8,59,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,EDUCA3,CAT5,_RFPSA21,RESP046,"(31.31266064400046, -92.44568007099969)"
|
|
2016,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,128,48.6,41,56.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,EDUCA3,CAT5,_RFPSA21,RESP054,"(31.31266064400046, -92.44568007099969)"
|
|
2016,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,265,58.3,52,64.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,EDUCA4,CAT5,_RFPSA21,RESP046,"(31.31266064400046, -92.44568007099969)"
|
|
2016,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,146,41.7,35.4,48,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,EDUCA4,CAT5,_RFPSA21,RESP054,"(31.31266064400046, -92.44568007099969)"
|
|
2016,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,46,22.9,14.6,31.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,INCOME1,CAT6,_RFPSA21,RESP046,"(31.31266064400046, -92.44568007099969)"
|
|
2016,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,94,77.1,68.8,85.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,INCOME1,CAT6,_RFPSA21,RESP054,"(31.31266064400046, -92.44568007099969)"
|
|
2016,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,86,30.4,20.7,40,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,INCOME2,CAT6,_RFPSA21,RESP046,"(31.31266064400046, -92.44568007099969)"
|
|
2016,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,101,69.6,60,79.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,INCOME2,CAT6,_RFPSA21,RESP054,"(31.31266064400046, -92.44568007099969)"
|
|
2016,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,68,49.7,33.8,65.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,INCOME3,CAT6,_RFPSA21,RESP046,"(31.31266064400046, -92.44568007099969)"
|
|
2016,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,58,50.3,34.5,66.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,INCOME3,CAT6,_RFPSA21,RESP054,"(31.31266064400046, -92.44568007099969)"
|
|
2016,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,98,43.6,34,53.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,INCOME4,CAT6,_RFPSA21,RESP046,"(31.31266064400046, -92.44568007099969)"
|
|
2016,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,79,56.4,46.8,66,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,INCOME4,CAT6,_RFPSA21,RESP054,"(31.31266064400046, -92.44568007099969)"
|
|
2016,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,341,53.3,47.5,59.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,INCOME5,CAT6,_RFPSA21,RESP046,"(31.31266064400046, -92.44568007099969)"
|
|
2016,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,221,46.7,40.9,52.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,INCOME5,CAT6,_RFPSA21,RESP054,"(31.31266064400046, -92.44568007099969)"
|
|
2016,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,545,50,45.6,54.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,RACE01,CAT4,_RFPSA21,RESP046,"(31.31266064400046, -92.44568007099969)"
|
|
2016,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,412,50,45.6,54.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,RACE01,CAT4,_RFPSA21,RESP054,"(31.31266064400046, -92.44568007099969)"
|
|
2016,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,136,38.6,30.4,46.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,RACE02,CAT4,_RFPSA21,RESP046,"(31.31266064400046, -92.44568007099969)"
|
|
2016,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,149,61.4,53.2,69.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,RACE02,CAT4,_RFPSA21,RESP054,"(31.31266064400046, -92.44568007099969)"
|
|
2016,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,22,RACE03,CAT4,_RFPSA21,RESP046,"(31.31266064400046, -92.44568007099969)"
|
|
2016,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,12,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,22,RACE03,CAT4,_RFPSA21,RESP054,"(31.31266064400046, -92.44568007099969)"
|
|
2016,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,22,RACE04,CAT4,_RFPSA21,RESP046,"(31.31266064400046, -92.44568007099969)"
|
|
2016,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,22,RACE04,CAT4,_RFPSA21,RESP054,"(31.31266064400046, -92.44568007099969)"
|
|
2016,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,22,RACE05,CAT4,_RFPSA21,RESP046,"(31.31266064400046, -92.44568007099969)"
|
|
2016,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,22,RACE05,CAT4,_RFPSA21,RESP054,"(31.31266064400046, -92.44568007099969)"
|
|
2016,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,22,RACE06,CAT4,_RFPSA21,RESP046,"(31.31266064400046, -92.44568007099969)"
|
|
2016,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,22,RACE06,CAT4,_RFPSA21,RESP054,"(31.31266064400046, -92.44568007099969)"
|
|
2016,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,11,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,22,RACE07,CAT4,_RFPSA21,RESP046,"(31.31266064400046, -92.44568007099969)"
|
|
2016,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,11,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,22,RACE07,CAT4,_RFPSA21,RESP054,"(31.31266064400046, -92.44568007099969)"
|
|
2016,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,9,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,22,RACE08,CAT4,_RFPSA21,RESP046,"(31.31266064400046, -92.44568007099969)"
|
|
2016,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,20,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,22,RACE08,CAT4,_RFPSA21,RESP054,"(31.31266064400046, -92.44568007099969)"
|
|
2016,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,720,44.5,40.7,48.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,SEX1,CAT2,_RFPSA21,RESP046,"(31.31266064400046, -92.44568007099969)"
|
|
2016,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,616,55.5,51.7,59.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,SEX1,CAT2,_RFPSA21,RESP054,"(31.31266064400046, -92.44568007099969)"
|
|
2016,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,22,SEX2,CAT2,_RFPSA21,RESP046,"(31.31266064400046, -92.44568007099969)"
|
|
2016,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,22,SEX2,CAT2,_RFPSA21,RESP054,"(31.31266064400046, -92.44568007099969)"
|
|
2016,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,27,4,2.1,5.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,AGE06,CAT3,_RFPSA21,RESP046,"(45.254228894000505, -68.98503133599962)"
|
|
2016,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,458,96,94.2,97.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,AGE06,CAT3,_RFPSA21,RESP054,"(45.254228894000505, -68.98503133599962)"
|
|
2016,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,200,24.5,20.6,28.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,AGE07,CAT3,_RFPSA21,RESP046,"(45.254228894000505, -68.98503133599962)"
|
|
2016,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,612,75.5,71.6,79.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,AGE07,CAT3,_RFPSA21,RESP054,"(45.254228894000505, -68.98503133599962)"
|
|
2016,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,184,41.9,35.8,48,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,AGE08,CAT3,_RFPSA21,RESP046,"(45.254228894000505, -68.98503133599962)"
|
|
2016,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,266,58.1,52,64.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,AGE08,CAT3,_RFPSA21,RESP054,"(45.254228894000505, -68.98503133599962)"
|
|
2016,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,668,43.7,40.2,47.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,AGE09,CAT3,_RFPSA21,RESP046,"(45.254228894000505, -68.98503133599962)"
|
|
2016,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,779,56.3,52.8,59.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,AGE09,CAT3,_RFPSA21,RESP054,"(45.254228894000505, -68.98503133599962)"
|
|
2016,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1079,28.9,26.9,31,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,BO1,CAT1,_RFPSA21,RESP046,"(45.254228894000505, -68.98503133599962)"
|
|
2016,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,2115,71.1,69,73.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,BO1,CAT1,_RFPSA21,RESP054,"(45.254228894000505, -68.98503133599962)"
|
|
2016,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,34,18.7,10.9,26.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,EDUCA1,CAT5,_RFPSA21,RESP046,"(45.254228894000505, -68.98503133599962)"
|
|
2016,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,117,81.3,73.5,89.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,EDUCA1,CAT5,_RFPSA21,RESP054,"(45.254228894000505, -68.98503133599962)"
|
|
2016,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,262,24.4,20.9,27.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,EDUCA2,CAT5,_RFPSA21,RESP046,"(45.254228894000505, -68.98503133599962)"
|
|
2016,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,677,75.6,72.1,79.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,EDUCA2,CAT5,_RFPSA21,RESP054,"(45.254228894000505, -68.98503133599962)"
|
|
2016,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,255,30.2,26,34.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,EDUCA3,CAT5,_RFPSA21,RESP046,"(45.254228894000505, -68.98503133599962)"
|
|
2016,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,512,69.8,65.5,74,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,EDUCA3,CAT5,_RFPSA21,RESP054,"(45.254228894000505, -68.98503133599962)"
|
|
2016,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,528,35.9,32.6,39.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,EDUCA4,CAT5,_RFPSA21,RESP046,"(45.254228894000505, -68.98503133599962)"
|
|
2016,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,805,64.1,60.8,67.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,EDUCA4,CAT5,_RFPSA21,RESP054,"(45.254228894000505, -68.98503133599962)"
|
|
2016,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,62,17.2,11.2,23.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,INCOME1,CAT6,_RFPSA21,RESP046,"(45.254228894000505, -68.98503133599962)"
|
|
2016,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,179,82.8,76.7,88.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,INCOME1,CAT6,_RFPSA21,RESP054,"(45.254228894000505, -68.98503133599962)"
|
|
2016,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,138,27.2,21.6,32.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,INCOME2,CAT6,_RFPSA21,RESP046,"(45.254228894000505, -68.98503133599962)"
|
|
2016,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,311,72.8,67.2,78.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,INCOME2,CAT6,_RFPSA21,RESP054,"(45.254228894000505, -68.98503133599962)"
|
|
2016,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,102,30.7,23.6,37.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,INCOME3,CAT6,_RFPSA21,RESP046,"(45.254228894000505, -68.98503133599962)"
|
|
2016,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,206,69.3,62.2,76.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,INCOME3,CAT6,_RFPSA21,RESP054,"(45.254228894000505, -68.98503133599962)"
|
|
2016,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,155,28.8,23.2,34.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,INCOME4,CAT6,_RFPSA21,RESP046,"(45.254228894000505, -68.98503133599962)"
|
|
2016,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,298,71.2,65.6,76.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,INCOME4,CAT6,_RFPSA21,RESP054,"(45.254228894000505, -68.98503133599962)"
|
|
2016,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,555,30.6,27.6,33.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,INCOME5,CAT6,_RFPSA21,RESP046,"(45.254228894000505, -68.98503133599962)"
|
|
2016,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,1004,69.4,66.4,72.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,INCOME5,CAT6,_RFPSA21,RESP054,"(45.254228894000505, -68.98503133599962)"
|
|
2016,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1055,29.2,27,31.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,RACE01,CAT4,_RFPSA21,RESP046,"(45.254228894000505, -68.98503133599962)"
|
|
2016,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,2025,70.8,68.7,73,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,RACE01,CAT4,_RFPSA21,RESP054,"(45.254228894000505, -68.98503133599962)"
|
|
2016,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,23,RACE02,CAT4,_RFPSA21,RESP046,"(45.254228894000505, -68.98503133599962)"
|
|
2016,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,23,RACE02,CAT4,_RFPSA21,RESP054,"(45.254228894000505, -68.98503133599962)"
|
|
2016,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,23,RACE03,CAT4,_RFPSA21,RESP046,"(45.254228894000505, -68.98503133599962)"
|
|
2016,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,28,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,23,RACE03,CAT4,_RFPSA21,RESP054,"(45.254228894000505, -68.98503133599962)"
|
|
2016,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,23,RACE04,CAT4,_RFPSA21,RESP046,"(45.254228894000505, -68.98503133599962)"
|
|
2016,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,23,RACE04,CAT4,_RFPSA21,RESP054,"(45.254228894000505, -68.98503133599962)"
|
|
2016,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,23,RACE05,CAT4,_RFPSA21,RESP046,"(45.254228894000505, -68.98503133599962)"
|
|
2016,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,23,RACE05,CAT4,_RFPSA21,RESP054,"(45.254228894000505, -68.98503133599962)"
|
|
2016,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,23,RACE06,CAT4,_RFPSA21,RESP046,"(45.254228894000505, -68.98503133599962)"
|
|
2016,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,23,RACE06,CAT4,_RFPSA21,RESP054,"(45.254228894000505, -68.98503133599962)"
|
|
2016,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,23,RACE07,CAT4,_RFPSA21,RESP046,"(45.254228894000505, -68.98503133599962)"
|
|
2016,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,35,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,23,RACE07,CAT4,_RFPSA21,RESP054,"(45.254228894000505, -68.98503133599962)"
|
|
2016,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,23,RACE08,CAT4,_RFPSA21,RESP046,"(45.254228894000505, -68.98503133599962)"
|
|
2016,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,14,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,23,RACE08,CAT4,_RFPSA21,RESP054,"(45.254228894000505, -68.98503133599962)"
|
|
2016,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1079,28.9,26.9,31,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,SEX1,CAT2,_RFPSA21,RESP046,"(45.254228894000505, -68.98503133599962)"
|
|
2016,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,2115,71.1,69,73.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,SEX1,CAT2,_RFPSA21,RESP054,"(45.254228894000505, -68.98503133599962)"
|
|
2016,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,23,SEX2,CAT2,_RFPSA21,RESP046,"(45.254228894000505, -68.98503133599962)"
|
|
2016,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,23,SEX2,CAT2,_RFPSA21,RESP054,"(45.254228894000505, -68.98503133599962)"
|
|
2016,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,118,14,10.8,17.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,AGE06,CAT3,_RFPSA21,RESP046,"(39.29058096400047, -76.60926011099963)"
|
|
2016,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,723,86,82.9,89.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,AGE06,CAT3,_RFPSA21,RESP054,"(39.29058096400047, -76.60926011099963)"
|
|
2016,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,552,39.9,36.2,43.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,AGE07,CAT3,_RFPSA21,RESP046,"(39.29058096400047, -76.60926011099963)"
|
|
2016,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,783,60.1,56.3,63.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,AGE07,CAT3,_RFPSA21,RESP054,"(39.29058096400047, -76.60926011099963)"
|
|
2016,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,426,59.1,54.1,64.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,AGE08,CAT3,_RFPSA21,RESP046,"(39.29058096400047, -76.60926011099963)"
|
|
2016,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,301,40.9,35.8,45.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,AGE08,CAT3,_RFPSA21,RESP054,"(39.29058096400047, -76.60926011099963)"
|
|
2016,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,1399,60.7,57.8,63.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,AGE09,CAT3,_RFPSA21,RESP046,"(39.29058096400047, -76.60926011099963)"
|
|
2016,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,840,39.3,36.4,42.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,AGE09,CAT3,_RFPSA21,RESP054,"(39.29058096400047, -76.60926011099963)"
|
|
2016,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,2495,41.4,39.5,43.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,BO1,CAT1,_RFPSA21,RESP046,"(39.29058096400047, -76.60926011099963)"
|
|
2016,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,2647,58.6,56.6,60.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,BO1,CAT1,_RFPSA21,RESP054,"(39.29058096400047, -76.60926011099963)"
|
|
2016,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,83,28.6,20.6,36.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,EDUCA1,CAT5,_RFPSA21,RESP046,"(39.29058096400047, -76.60926011099963)"
|
|
2016,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,180,71.4,63.4,79.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,EDUCA1,CAT5,_RFPSA21,RESP054,"(39.29058096400047, -76.60926011099963)"
|
|
2016,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,521,39.7,35.8,43.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,EDUCA2,CAT5,_RFPSA21,RESP046,"(39.29058096400047, -76.60926011099963)"
|
|
2016,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,701,60.3,56.4,64.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,EDUCA2,CAT5,_RFPSA21,RESP054,"(39.29058096400047, -76.60926011099963)"
|
|
2016,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,502,44.5,40.3,48.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,EDUCA3,CAT5,_RFPSA21,RESP046,"(39.29058096400047, -76.60926011099963)"
|
|
2016,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,525,55.5,51.4,59.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,EDUCA3,CAT5,_RFPSA21,RESP054,"(39.29058096400047, -76.60926011099963)"
|
|
2016,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,1389,44.5,42,47,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,EDUCA4,CAT5,_RFPSA21,RESP046,"(39.29058096400047, -76.60926011099963)"
|
|
2016,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,1235,55.5,53,58,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,EDUCA4,CAT5,_RFPSA21,RESP054,"(39.29058096400047, -76.60926011099963)"
|
|
2016,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,63,28.9,20.1,37.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,INCOME1,CAT6,_RFPSA21,RESP046,"(39.29058096400047, -76.60926011099963)"
|
|
2016,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,152,71.1,62.3,79.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,INCOME1,CAT6,_RFPSA21,RESP054,"(39.29058096400047, -76.60926011099963)"
|
|
2016,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,166,31.3,24.6,38,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,INCOME2,CAT6,_RFPSA21,RESP046,"(39.29058096400047, -76.60926011099963)"
|
|
2016,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,265,68.7,62,75.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,INCOME2,CAT6,_RFPSA21,RESP054,"(39.29058096400047, -76.60926011099963)"
|
|
2016,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,128,40.3,30.1,50.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,INCOME3,CAT6,_RFPSA21,RESP046,"(39.29058096400047, -76.60926011099963)"
|
|
2016,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,158,59.7,49.4,69.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,INCOME3,CAT6,_RFPSA21,RESP054,"(39.29058096400047, -76.60926011099963)"
|
|
2016,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,235,45,37.6,52.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,INCOME4,CAT6,_RFPSA21,RESP046,"(39.29058096400047, -76.60926011099963)"
|
|
2016,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,248,55,47.7,62.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,INCOME4,CAT6,_RFPSA21,RESP054,"(39.29058096400047, -76.60926011099963)"
|
|
2016,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,1576,42.9,40.5,45.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,INCOME5,CAT6,_RFPSA21,RESP046,"(39.29058096400047, -76.60926011099963)"
|
|
2016,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,1519,57.1,54.7,59.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,INCOME5,CAT6,_RFPSA21,RESP054,"(39.29058096400047, -76.60926011099963)"
|
|
2016,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1930,43.2,41,45.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,RACE01,CAT4,_RFPSA21,RESP046,"(39.29058096400047, -76.60926011099963)"
|
|
2016,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1952,56.8,54.7,59,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,RACE01,CAT4,_RFPSA21,RESP054,"(39.29058096400047, -76.60926011099963)"
|
|
2016,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,434,43.6,39.3,47.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,RACE02,CAT4,_RFPSA21,RESP046,"(39.29058096400047, -76.60926011099963)"
|
|
2016,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,458,56.4,52.1,60.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,RACE02,CAT4,_RFPSA21,RESP054,"(39.29058096400047, -76.60926011099963)"
|
|
2016,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,9,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,24,RACE03,CAT4,_RFPSA21,RESP046,"(39.29058096400047, -76.60926011099963)"
|
|
2016,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,24,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,24,RACE03,CAT4,_RFPSA21,RESP054,"(39.29058096400047, -76.60926011099963)"
|
|
2016,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,21,19,10.2,27.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,RACE04,CAT4,_RFPSA21,RESP046,"(39.29058096400047, -76.60926011099963)"
|
|
2016,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,71,81,72.2,89.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,RACE04,CAT4,_RFPSA21,RESP054,"(39.29058096400047, -76.60926011099963)"
|
|
2016,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,24,RACE05,CAT4,_RFPSA21,RESP046,"(39.29058096400047, -76.60926011099963)"
|
|
2016,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,24,RACE05,CAT4,_RFPSA21,RESP054,"(39.29058096400047, -76.60926011099963)"
|
|
2016,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,32,41.5,24.7,58.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,RACE06,CAT4,_RFPSA21,RESP046,"(39.29058096400047, -76.60926011099963)"
|
|
2016,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,29,58.5,41.7,75.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,RACE06,CAT4,_RFPSA21,RESP054,"(39.29058096400047, -76.60926011099963)"
|
|
2016,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,23,29.9,15.2,44.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,RACE07,CAT4,_RFPSA21,RESP046,"(39.29058096400047, -76.60926011099963)"
|
|
2016,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,34,70.1,55.4,84.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,RACE07,CAT4,_RFPSA21,RESP054,"(39.29058096400047, -76.60926011099963)"
|
|
2016,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,44,33.1,21.9,44.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,RACE08,CAT4,_RFPSA21,RESP046,"(39.29058096400047, -76.60926011099963)"
|
|
2016,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,76,66.9,55.7,78.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,RACE08,CAT4,_RFPSA21,RESP054,"(39.29058096400047, -76.60926011099963)"
|
|
2016,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,2495,41.4,39.5,43.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,SEX1,CAT2,_RFPSA21,RESP046,"(39.29058096400047, -76.60926011099963)"
|
|
2016,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,2647,58.6,56.6,60.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,SEX1,CAT2,_RFPSA21,RESP054,"(39.29058096400047, -76.60926011099963)"
|
|
2016,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,24,SEX2,CAT2,_RFPSA21,RESP046,"(39.29058096400047, -76.60926011099963)"
|
|
2016,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,24,SEX2,CAT2,_RFPSA21,RESP054,"(39.29058096400047, -76.60926011099963)"
|
|
2016,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,47,10.2,6.6,13.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,AGE06,CAT3,_RFPSA21,RESP046,"(42.27687047000046, -72.08269067499964)"
|
|
2016,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,397,89.8,86.3,93.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,AGE06,CAT3,_RFPSA21,RESP054,"(42.27687047000046, -72.08269067499964)"
|
|
2016,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,241,38.4,33.2,43.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,AGE07,CAT3,_RFPSA21,RESP046,"(42.27687047000046, -72.08269067499964)"
|
|
2016,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,411,61.6,56.5,66.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,AGE07,CAT3,_RFPSA21,RESP054,"(42.27687047000046, -72.08269067499964)"
|
|
2016,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,178,51.6,44.7,58.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,AGE08,CAT3,_RFPSA21,RESP046,"(42.27687047000046, -72.08269067499964)"
|
|
2016,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,151,48.4,41.6,55.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,AGE08,CAT3,_RFPSA21,RESP054,"(42.27687047000046, -72.08269067499964)"
|
|
2016,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,506,53.1,48.3,57.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,AGE09,CAT3,_RFPSA21,RESP046,"(42.27687047000046, -72.08269067499964)"
|
|
2016,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,384,46.9,42.1,51.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,AGE09,CAT3,_RFPSA21,RESP054,"(42.27687047000046, -72.08269067499964)"
|
|
2016,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,972,37.7,35,40.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,BO1,CAT1,_RFPSA21,RESP046,"(42.27687047000046, -72.08269067499964)"
|
|
2016,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1343,62.3,59.6,65,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,BO1,CAT1,_RFPSA21,RESP054,"(42.27687047000046, -72.08269067499964)"
|
|
2016,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,43,33.7,23,44.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,EDUCA1,CAT5,_RFPSA21,RESP046,"(42.27687047000046, -72.08269067499964)"
|
|
2016,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,84,66.3,55.6,77,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,EDUCA1,CAT5,_RFPSA21,RESP054,"(42.27687047000046, -72.08269067499964)"
|
|
2016,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,206,36.3,30.8,41.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,EDUCA2,CAT5,_RFPSA21,RESP046,"(42.27687047000046, -72.08269067499964)"
|
|
2016,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,321,63.7,58.1,69.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,EDUCA2,CAT5,_RFPSA21,RESP054,"(42.27687047000046, -72.08269067499964)"
|
|
2016,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,203,39.5,34,45.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,EDUCA3,CAT5,_RFPSA21,RESP046,"(42.27687047000046, -72.08269067499964)"
|
|
2016,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,287,60.5,54.9,66,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,EDUCA3,CAT5,_RFPSA21,RESP054,"(42.27687047000046, -72.08269067499964)"
|
|
2016,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,516,38.7,35.4,42.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,EDUCA4,CAT5,_RFPSA21,RESP046,"(42.27687047000046, -72.08269067499964)"
|
|
2016,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,643,61.3,57.9,64.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,EDUCA4,CAT5,_RFPSA21,RESP054,"(42.27687047000046, -72.08269067499964)"
|
|
2016,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,48,31,19.6,42.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,INCOME1,CAT6,_RFPSA21,RESP046,"(42.27687047000046, -72.08269067499964)"
|
|
2016,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,85,69,57.6,80.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,INCOME1,CAT6,_RFPSA21,RESP054,"(42.27687047000046, -72.08269067499964)"
|
|
2016,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,34,27.7,15.5,39.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,INCOME2,CAT6,_RFPSA21,RESP046,"(42.27687047000046, -72.08269067499964)"
|
|
2016,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,68,72.3,60.2,84.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,INCOME2,CAT6,_RFPSA21,RESP054,"(42.27687047000046, -72.08269067499964)"
|
|
2016,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,59,33.7,23,44.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,INCOME3,CAT6,_RFPSA21,RESP046,"(42.27687047000046, -72.08269067499964)"
|
|
2016,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,77,66.3,55.6,77,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,INCOME3,CAT6,_RFPSA21,RESP054,"(42.27687047000046, -72.08269067499964)"
|
|
2016,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,97,40.4,31.6,49.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,INCOME4,CAT6,_RFPSA21,RESP046,"(42.27687047000046, -72.08269067499964)"
|
|
2016,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,131,59.6,50.8,68.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,INCOME4,CAT6,_RFPSA21,RESP054,"(42.27687047000046, -72.08269067499964)"
|
|
2016,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,553,40.2,36.6,43.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,INCOME5,CAT6,_RFPSA21,RESP046,"(42.27687047000046, -72.08269067499964)"
|
|
2016,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,713,59.8,56.2,63.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,INCOME5,CAT6,_RFPSA21,RESP054,"(42.27687047000046, -72.08269067499964)"
|
|
2016,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,869,40,37.1,42.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,RACE01,CAT4,_RFPSA21,RESP046,"(42.27687047000046, -72.08269067499964)"
|
|
2016,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1103,60,57.1,62.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,RACE01,CAT4,_RFPSA21,RESP054,"(42.27687047000046, -72.08269067499964)"
|
|
2016,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,35,30.1,16.6,43.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,RACE02,CAT4,_RFPSA21,RESP046,"(42.27687047000046, -72.08269067499964)"
|
|
2016,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,61,69.9,56.3,83.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,RACE02,CAT4,_RFPSA21,RESP054,"(42.27687047000046, -72.08269067499964)"
|
|
2016,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,25,RACE03,CAT4,_RFPSA21,RESP046,"(42.27687047000046, -72.08269067499964)"
|
|
2016,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,11,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,25,RACE03,CAT4,_RFPSA21,RESP054,"(42.27687047000046, -72.08269067499964)"
|
|
2016,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,25,RACE04,CAT4,_RFPSA21,RESP046,"(42.27687047000046, -72.08269067499964)"
|
|
2016,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,42,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,25,RACE04,CAT4,_RFPSA21,RESP054,"(42.27687047000046, -72.08269067499964)"
|
|
2016,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,25,RACE05,CAT4,_RFPSA21,RESP046,"(42.27687047000046, -72.08269067499964)"
|
|
2016,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,25,RACE05,CAT4,_RFPSA21,RESP054,"(42.27687047000046, -72.08269067499964)"
|
|
2016,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,25,RACE06,CAT4,_RFPSA21,RESP046,"(42.27687047000046, -72.08269067499964)"
|
|
2016,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,12,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,25,RACE06,CAT4,_RFPSA21,RESP054,"(42.27687047000046, -72.08269067499964)"
|
|
2016,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,11,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,25,RACE07,CAT4,_RFPSA21,RESP046,"(42.27687047000046, -72.08269067499964)"
|
|
2016,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,16,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,25,RACE07,CAT4,_RFPSA21,RESP054,"(42.27687047000046, -72.08269067499964)"
|
|
2016,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,40,29.9,20.1,39.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,RACE08,CAT4,_RFPSA21,RESP046,"(42.27687047000046, -72.08269067499964)"
|
|
2016,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,95,70.1,60.2,79.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,RACE08,CAT4,_RFPSA21,RESP054,"(42.27687047000046, -72.08269067499964)"
|
|
2016,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,972,37.7,35,40.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,SEX1,CAT2,_RFPSA21,RESP046,"(42.27687047000046, -72.08269067499964)"
|
|
2016,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1343,62.3,59.6,65,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,SEX1,CAT2,_RFPSA21,RESP054,"(42.27687047000046, -72.08269067499964)"
|
|
2016,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,25,SEX2,CAT2,_RFPSA21,RESP046,"(42.27687047000046, -72.08269067499964)"
|
|
2016,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,25,SEX2,CAT2,_RFPSA21,RESP054,"(42.27687047000046, -72.08269067499964)"
|
|
2016,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,96,14.7,11.5,18,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,AGE06,CAT3,_RFPSA21,RESP046,"(44.6613195430005, -84.71439026999968)"
|
|
2016,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,491,85.3,82,88.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,AGE06,CAT3,_RFPSA21,RESP054,"(44.6613195430005, -84.71439026999968)"
|
|
2016,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,379,38.6,34.8,42.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,AGE07,CAT3,_RFPSA21,RESP046,"(44.6613195430005, -84.71439026999968)"
|
|
2016,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,571,61.4,57.7,65.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,AGE07,CAT3,_RFPSA21,RESP054,"(44.6613195430005, -84.71439026999968)"
|
|
2016,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,299,55.6,50.4,60.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,AGE08,CAT3,_RFPSA21,RESP046,"(44.6613195430005, -84.71439026999968)"
|
|
2016,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,220,44.4,39.3,49.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,AGE08,CAT3,_RFPSA21,RESP054,"(44.6613195430005, -84.71439026999968)"
|
|
2016,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,942,62.1,59.1,65.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,AGE09,CAT3,_RFPSA21,RESP046,"(44.6613195430005, -84.71439026999968)"
|
|
2016,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,533,37.9,34.8,40.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,AGE09,CAT3,_RFPSA21,RESP054,"(44.6613195430005, -84.71439026999968)"
|
|
2016,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1716,42.8,40.8,44.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,BO1,CAT1,_RFPSA21,RESP046,"(44.6613195430005, -84.71439026999968)"
|
|
2016,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1815,57.2,55.2,59.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,BO1,CAT1,_RFPSA21,RESP054,"(44.6613195430005, -84.71439026999968)"
|
|
2016,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,60,32.7,24.7,40.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,EDUCA1,CAT5,_RFPSA21,RESP046,"(44.6613195430005, -84.71439026999968)"
|
|
2016,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,126,67.3,59.3,75.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,EDUCA1,CAT5,_RFPSA21,RESP054,"(44.6613195430005, -84.71439026999968)"
|
|
2016,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,356,36,32.5,39.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,EDUCA2,CAT5,_RFPSA21,RESP046,"(44.6613195430005, -84.71439026999968)"
|
|
2016,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,569,64,60.5,67.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,EDUCA2,CAT5,_RFPSA21,RESP054,"(44.6613195430005, -84.71439026999968)"
|
|
2016,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,475,44.5,40.8,48.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,EDUCA3,CAT5,_RFPSA21,RESP046,"(44.6613195430005, -84.71439026999968)"
|
|
2016,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,509,55.5,51.9,59.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,EDUCA3,CAT5,_RFPSA21,RESP054,"(44.6613195430005, -84.71439026999968)"
|
|
2016,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,822,53,50,56,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,EDUCA4,CAT5,_RFPSA21,RESP046,"(44.6613195430005, -84.71439026999968)"
|
|
2016,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,609,47,44,50,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,EDUCA4,CAT5,_RFPSA21,RESP054,"(44.6613195430005, -84.71439026999968)"
|
|
2016,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,60,21.9,15,28.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,INCOME1,CAT6,_RFPSA21,RESP046,"(44.6613195430005, -84.71439026999968)"
|
|
2016,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,171,78.1,71.3,85,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,INCOME1,CAT6,_RFPSA21,RESP054,"(44.6613195430005, -84.71439026999968)"
|
|
2016,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,144,33,27,39.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,INCOME2,CAT6,_RFPSA21,RESP046,"(44.6613195430005, -84.71439026999968)"
|
|
2016,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,256,67,60.9,73,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,INCOME2,CAT6,_RFPSA21,RESP054,"(44.6613195430005, -84.71439026999968)"
|
|
2016,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,118,35.2,28.4,42,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,INCOME3,CAT6,_RFPSA21,RESP046,"(44.6613195430005, -84.71439026999968)"
|
|
2016,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,175,64.8,58,71.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,INCOME3,CAT6,_RFPSA21,RESP054,"(44.6613195430005, -84.71439026999968)"
|
|
2016,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,293,46.6,41.4,51.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,INCOME4,CAT6,_RFPSA21,RESP046,"(44.6613195430005, -84.71439026999968)"
|
|
2016,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,243,53.4,48.2,58.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,INCOME4,CAT6,_RFPSA21,RESP054,"(44.6613195430005, -84.71439026999968)"
|
|
2016,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,916,49.6,46.8,52.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,INCOME5,CAT6,_RFPSA21,RESP046,"(44.6613195430005, -84.71439026999968)"
|
|
2016,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,758,50.4,47.5,53.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,INCOME5,CAT6,_RFPSA21,RESP054,"(44.6613195430005, -84.71439026999968)"
|
|
2016,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1523,43.8,41.7,45.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,RACE01,CAT4,_RFPSA21,RESP046,"(44.6613195430005, -84.71439026999968)"
|
|
2016,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1535,56.2,54.1,58.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,RACE01,CAT4,_RFPSA21,RESP054,"(44.6613195430005, -84.71439026999968)"
|
|
2016,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,115,41.2,33.8,48.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,RACE02,CAT4,_RFPSA21,RESP046,"(44.6613195430005, -84.71439026999968)"
|
|
2016,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,142,58.8,51.4,66.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,RACE02,CAT4,_RFPSA21,RESP054,"(44.6613195430005, -84.71439026999968)"
|
|
2016,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,11,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,26,RACE03,CAT4,_RFPSA21,RESP046,"(44.6613195430005, -84.71439026999968)"
|
|
2016,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,25,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,26,RACE03,CAT4,_RFPSA21,RESP054,"(44.6613195430005, -84.71439026999968)"
|
|
2016,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,26,RACE04,CAT4,_RFPSA21,RESP046,"(44.6613195430005, -84.71439026999968)"
|
|
2016,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,25,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,26,RACE04,CAT4,_RFPSA21,RESP054,"(44.6613195430005, -84.71439026999968)"
|
|
2016,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,26,RACE05,CAT4,_RFPSA21,RESP046,"(44.6613195430005, -84.71439026999968)"
|
|
2016,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,26,RACE05,CAT4,_RFPSA21,RESP054,"(44.6613195430005, -84.71439026999968)"
|
|
2016,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,26,RACE06,CAT4,_RFPSA21,RESP046,"(44.6613195430005, -84.71439026999968)"
|
|
2016,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,26,RACE06,CAT4,_RFPSA21,RESP054,"(44.6613195430005, -84.71439026999968)"
|
|
2016,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,28,40.6,27,54.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,RACE07,CAT4,_RFPSA21,RESP046,"(44.6613195430005, -84.71439026999968)"
|
|
2016,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,46,59.4,45.7,73,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,RACE07,CAT4,_RFPSA21,RESP054,"(44.6613195430005, -84.71439026999968)"
|
|
2016,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,24,42.1,26.7,57.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,RACE08,CAT4,_RFPSA21,RESP046,"(44.6613195430005, -84.71439026999968)"
|
|
2016,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,34,57.9,42.4,73.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,RACE08,CAT4,_RFPSA21,RESP054,"(44.6613195430005, -84.71439026999968)"
|
|
2016,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1716,42.8,40.8,44.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,SEX1,CAT2,_RFPSA21,RESP046,"(44.6613195430005, -84.71439026999968)"
|
|
2016,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1815,57.2,55.2,59.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,SEX1,CAT2,_RFPSA21,RESP054,"(44.6613195430005, -84.71439026999968)"
|
|
2016,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,26,SEX2,CAT2,_RFPSA21,RESP046,"(44.6613195430005, -84.71439026999968)"
|
|
2016,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,26,SEX2,CAT2,_RFPSA21,RESP054,"(44.6613195430005, -84.71439026999968)"
|
|
2016,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,81,8,6.1,9.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,AGE06,CAT3,_RFPSA21,RESP046,"(46.35564873600049, -94.79420050299967)"
|
|
2016,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,956,92,90.2,93.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,AGE06,CAT3,_RFPSA21,RESP054,"(46.35564873600049, -94.79420050299967)"
|
|
2016,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,416,29,26.2,31.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,AGE07,CAT3,_RFPSA21,RESP046,"(46.35564873600049, -94.79420050299967)"
|
|
2016,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,963,71,68.2,73.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,AGE07,CAT3,_RFPSA21,RESP054,"(46.35564873600049, -94.79420050299967)"
|
|
2016,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,360,45.2,41.2,49.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,AGE08,CAT3,_RFPSA21,RESP046,"(46.35564873600049, -94.79420050299967)"
|
|
2016,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,418,54.8,50.7,58.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,AGE08,CAT3,_RFPSA21,RESP054,"(46.35564873600049, -94.79420050299967)"
|
|
2016,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,969,52.4,49.8,55.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,AGE09,CAT3,_RFPSA21,RESP046,"(46.35564873600049, -94.79420050299967)"
|
|
2016,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,855,47.6,44.9,50.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,AGE09,CAT3,_RFPSA21,RESP054,"(46.35564873600049, -94.79420050299967)"
|
|
2016,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1826,32.8,31.3,34.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,BO1,CAT1,_RFPSA21,RESP046,"(46.35564873600049, -94.79420050299967)"
|
|
2016,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,3192,67.2,65.8,68.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,BO1,CAT1,_RFPSA21,RESP054,"(46.35564873600049, -94.79420050299967)"
|
|
2016,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,61,26.3,19.8,32.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,EDUCA1,CAT5,_RFPSA21,RESP046,"(46.35564873600049, -94.79420050299967)"
|
|
2016,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,180,73.7,67.2,80.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,EDUCA1,CAT5,_RFPSA21,RESP054,"(46.35564873600049, -94.79420050299967)"
|
|
2016,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,401,29.9,27,32.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,EDUCA2,CAT5,_RFPSA21,RESP046,"(46.35564873600049, -94.79420050299967)"
|
|
2016,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,832,70.1,67.3,73,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,EDUCA2,CAT5,_RFPSA21,RESP054,"(46.35564873600049, -94.79420050299967)"
|
|
2016,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,553,34.1,31.4,36.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,EDUCA3,CAT5,_RFPSA21,RESP046,"(46.35564873600049, -94.79420050299967)"
|
|
2016,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,948,65.9,63.3,68.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,EDUCA3,CAT5,_RFPSA21,RESP054,"(46.35564873600049, -94.79420050299967)"
|
|
2016,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,805,35.7,33.4,38,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,EDUCA4,CAT5,_RFPSA21,RESP046,"(46.35564873600049, -94.79420050299967)"
|
|
2016,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,1226,64.3,62,66.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,EDUCA4,CAT5,_RFPSA21,RESP054,"(46.35564873600049, -94.79420050299967)"
|
|
2016,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,56,21.8,15.6,28,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,INCOME1,CAT6,_RFPSA21,RESP046,"(46.35564873600049, -94.79420050299967)"
|
|
2016,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,156,78.2,72,84.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,INCOME1,CAT6,_RFPSA21,RESP054,"(46.35564873600049, -94.79420050299967)"
|
|
2016,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,170,31.2,26.3,36,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,INCOME2,CAT6,_RFPSA21,RESP046,"(46.35564873600049, -94.79420050299967)"
|
|
2016,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,342,68.8,64,73.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,INCOME2,CAT6,_RFPSA21,RESP054,"(46.35564873600049, -94.79420050299967)"
|
|
2016,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,151,30.6,25.6,35.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,INCOME3,CAT6,_RFPSA21,RESP046,"(46.35564873600049, -94.79420050299967)"
|
|
2016,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,274,69.4,64.4,74.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,INCOME3,CAT6,_RFPSA21,RESP054,"(46.35564873600049, -94.79420050299967)"
|
|
2016,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,264,37.3,32.9,41.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,INCOME4,CAT6,_RFPSA21,RESP046,"(46.35564873600049, -94.79420050299967)"
|
|
2016,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,409,62.7,58.4,67.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,INCOME4,CAT6,_RFPSA21,RESP054,"(46.35564873600049, -94.79420050299967)"
|
|
2016,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,1028,33.2,31.2,35.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,INCOME5,CAT6,_RFPSA21,RESP046,"(46.35564873600049, -94.79420050299967)"
|
|
2016,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,1727,66.8,64.8,68.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,INCOME5,CAT6,_RFPSA21,RESP054,"(46.35564873600049, -94.79420050299967)"
|
|
2016,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1745,34.8,33.2,36.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,RACE01,CAT4,_RFPSA21,RESP046,"(46.35564873600049, -94.79420050299967)"
|
|
2016,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,2885,65.2,63.6,66.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,RACE01,CAT4,_RFPSA21,RESP054,"(46.35564873600049, -94.79420050299967)"
|
|
2016,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,20,16.7,8.6,24.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,RACE02,CAT4,_RFPSA21,RESP046,"(46.35564873600049, -94.79420050299967)"
|
|
2016,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,76,83.3,75.2,91.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,RACE02,CAT4,_RFPSA21,RESP054,"(46.35564873600049, -94.79420050299967)"
|
|
2016,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,9,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,27,RACE03,CAT4,_RFPSA21,RESP046,"(46.35564873600049, -94.79420050299967)"
|
|
2016,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,41,85.2,75.2,95.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,RACE03,CAT4,_RFPSA21,RESP054,"(46.35564873600049, -94.79420050299967)"
|
|
2016,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,15,17.2,7.6,26.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,RACE04,CAT4,_RFPSA21,RESP046,"(46.35564873600049, -94.79420050299967)"
|
|
2016,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,43,82.8,73.2,92.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,RACE04,CAT4,_RFPSA21,RESP054,"(46.35564873600049, -94.79420050299967)"
|
|
2016,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,27,RACE05,CAT4,_RFPSA21,RESP046,"(46.35564873600049, -94.79420050299967)"
|
|
2016,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,27,RACE05,CAT4,_RFPSA21,RESP054,"(46.35564873600049, -94.79420050299967)"
|
|
2016,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,27,RACE06,CAT4,_RFPSA21,RESP046,"(46.35564873600049, -94.79420050299967)"
|
|
2016,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,13,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,27,RACE06,CAT4,_RFPSA21,RESP054,"(46.35564873600049, -94.79420050299967)"
|
|
2016,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,9,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,27,RACE07,CAT4,_RFPSA21,RESP046,"(46.35564873600049, -94.79420050299967)"
|
|
2016,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,12,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,27,RACE07,CAT4,_RFPSA21,RESP054,"(46.35564873600049, -94.79420050299967)"
|
|
2016,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,24,14.5,8.3,20.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,RACE08,CAT4,_RFPSA21,RESP046,"(46.35564873600049, -94.79420050299967)"
|
|
2016,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,118,85.5,79.3,91.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,RACE08,CAT4,_RFPSA21,RESP054,"(46.35564873600049, -94.79420050299967)"
|
|
2016,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1826,32.8,31.3,34.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,SEX1,CAT2,_RFPSA21,RESP046,"(46.35564873600049, -94.79420050299967)"
|
|
2016,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,3192,67.2,65.8,68.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,SEX1,CAT2,_RFPSA21,RESP054,"(46.35564873600049, -94.79420050299967)"
|
|
2016,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,27,SEX2,CAT2,_RFPSA21,RESP046,"(46.35564873600049, -94.79420050299967)"
|
|
2016,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,27,SEX2,CAT2,_RFPSA21,RESP054,"(46.35564873600049, -94.79420050299967)"
|
|
2016,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,57,23,16.3,29.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,AGE06,CAT3,_RFPSA21,RESP046,"(32.745510099000455, -89.53803082499968)"
|
|
2016,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,181,77,70.2,83.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,AGE06,CAT3,_RFPSA21,RESP054,"(32.745510099000455, -89.53803082499968)"
|
|
2016,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,151,38.8,32.8,44.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,AGE07,CAT3,_RFPSA21,RESP046,"(32.745510099000455, -89.53803082499968)"
|
|
2016,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,224,61.2,55.1,67.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,AGE07,CAT3,_RFPSA21,RESP054,"(32.745510099000455, -89.53803082499968)"
|
|
2016,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,111,53,44.6,61.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,AGE08,CAT3,_RFPSA21,RESP046,"(32.745510099000455, -89.53803082499968)"
|
|
2016,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,90,47,38.7,55.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,AGE08,CAT3,_RFPSA21,RESP054,"(32.745510099000455, -89.53803082499968)"
|
|
2016,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,343,61.3,56,66.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,AGE09,CAT3,_RFPSA21,RESP046,"(32.745510099000455, -89.53803082499968)"
|
|
2016,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,164,38.7,33.3,44,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,AGE09,CAT3,_RFPSA21,RESP054,"(32.745510099000455, -89.53803082499968)"
|
|
2016,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,662,43.6,40.3,46.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,BO1,CAT1,_RFPSA21,RESP046,"(32.745510099000455, -89.53803082499968)"
|
|
2016,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,659,56.4,53.1,59.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,BO1,CAT1,_RFPSA21,RESP054,"(32.745510099000455, -89.53803082499968)"
|
|
2016,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,66,31.3,23.4,39.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,EDUCA1,CAT5,_RFPSA21,RESP046,"(32.745510099000455, -89.53803082499968)"
|
|
2016,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,135,68.7,60.8,76.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,EDUCA1,CAT5,_RFPSA21,RESP054,"(32.745510099000455, -89.53803082499968)"
|
|
2016,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,192,39.6,34.1,45,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,EDUCA2,CAT5,_RFPSA21,RESP046,"(32.745510099000455, -89.53803082499968)"
|
|
2016,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,244,60.4,55,65.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,EDUCA2,CAT5,_RFPSA21,RESP054,"(32.745510099000455, -89.53803082499968)"
|
|
2016,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,160,48.9,42.2,55.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,EDUCA3,CAT5,_RFPSA21,RESP046,"(32.745510099000455, -89.53803082499968)"
|
|
2016,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,147,51.1,44.5,57.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,EDUCA3,CAT5,_RFPSA21,RESP054,"(32.745510099000455, -89.53803082499968)"
|
|
2016,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,244,56.3,50.1,62.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,EDUCA4,CAT5,_RFPSA21,RESP046,"(32.745510099000455, -89.53803082499968)"
|
|
2016,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,131,43.7,37.5,49.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,EDUCA4,CAT5,_RFPSA21,RESP054,"(32.745510099000455, -89.53803082499968)"
|
|
2016,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,56,29.4,21.3,37.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,INCOME1,CAT6,_RFPSA21,RESP046,"(32.745510099000455, -89.53803082499968)"
|
|
2016,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,99,70.6,62.6,78.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,INCOME1,CAT6,_RFPSA21,RESP054,"(32.745510099000455, -89.53803082499968)"
|
|
2016,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,107,40.9,33.3,48.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,INCOME2,CAT6,_RFPSA21,RESP046,"(32.745510099000455, -89.53803082499968)"
|
|
2016,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,133,59.1,51.5,66.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,INCOME2,CAT6,_RFPSA21,RESP054,"(32.745510099000455, -89.53803082499968)"
|
|
2016,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,65,40.6,30.9,50.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,INCOME3,CAT6,_RFPSA21,RESP046,"(32.745510099000455, -89.53803082499968)"
|
|
2016,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,80,59.4,49.7,69.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,INCOME3,CAT6,_RFPSA21,RESP054,"(32.745510099000455, -89.53803082499968)"
|
|
2016,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,78,45.3,36,54.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,INCOME4,CAT6,_RFPSA21,RESP046,"(32.745510099000455, -89.53803082499968)"
|
|
2016,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,77,54.7,45.3,64,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,INCOME4,CAT6,_RFPSA21,RESP054,"(32.745510099000455, -89.53803082499968)"
|
|
2016,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,267,49,43.2,54.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,INCOME5,CAT6,_RFPSA21,RESP046,"(32.745510099000455, -89.53803082499968)"
|
|
2016,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,180,51,45.2,56.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,INCOME5,CAT6,_RFPSA21,RESP054,"(32.745510099000455, -89.53803082499968)"
|
|
2016,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,462,45.2,41.1,49.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,RACE01,CAT4,_RFPSA21,RESP046,"(32.745510099000455, -89.53803082499968)"
|
|
2016,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,397,54.8,50.8,58.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,RACE01,CAT4,_RFPSA21,RESP054,"(32.745510099000455, -89.53803082499968)"
|
|
2016,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,190,41.5,35.6,47.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,RACE02,CAT4,_RFPSA21,RESP046,"(32.745510099000455, -89.53803082499968)"
|
|
2016,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,239,58.5,52.5,64.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,RACE02,CAT4,_RFPSA21,RESP054,"(32.745510099000455, -89.53803082499968)"
|
|
2016,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,28,RACE03,CAT4,_RFPSA21,RESP046,"(32.745510099000455, -89.53803082499968)"
|
|
2016,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,28,RACE03,CAT4,_RFPSA21,RESP054,"(32.745510099000455, -89.53803082499968)"
|
|
2016,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,28,RACE04,CAT4,_RFPSA21,RESP046,"(32.745510099000455, -89.53803082499968)"
|
|
2016,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,28,RACE04,CAT4,_RFPSA21,RESP054,"(32.745510099000455, -89.53803082499968)"
|
|
2016,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,28,RACE05,CAT4,_RFPSA21,RESP046,"(32.745510099000455, -89.53803082499968)"
|
|
2016,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,28,RACE05,CAT4,_RFPSA21,RESP054,"(32.745510099000455, -89.53803082499968)"
|
|
2016,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,28,RACE06,CAT4,_RFPSA21,RESP046,"(32.745510099000455, -89.53803082499968)"
|
|
2016,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,28,RACE06,CAT4,_RFPSA21,RESP054,"(32.745510099000455, -89.53803082499968)"
|
|
2016,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,28,RACE07,CAT4,_RFPSA21,RESP046,"(32.745510099000455, -89.53803082499968)"
|
|
2016,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,28,RACE07,CAT4,_RFPSA21,RESP054,"(32.745510099000455, -89.53803082499968)"
|
|
2016,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,28,RACE08,CAT4,_RFPSA21,RESP046,"(32.745510099000455, -89.53803082499968)"
|
|
2016,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,28,RACE08,CAT4,_RFPSA21,RESP054,"(32.745510099000455, -89.53803082499968)"
|
|
2016,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,662,43.6,40.3,46.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,SEX1,CAT2,_RFPSA21,RESP046,"(32.745510099000455, -89.53803082499968)"
|
|
2016,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,659,56.4,53.1,59.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,SEX1,CAT2,_RFPSA21,RESP054,"(32.745510099000455, -89.53803082499968)"
|
|
2016,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,28,SEX2,CAT2,_RFPSA21,RESP046,"(32.745510099000455, -89.53803082499968)"
|
|
2016,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,28,SEX2,CAT2,_RFPSA21,RESP054,"(32.745510099000455, -89.53803082499968)"
|
|
2016,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1107,56.8,53.7,59.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,SEX1,CAT2,_RFPSA21,RESP054,"(38.635790776000476, -92.56630005299968)"
|
|
2016,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1107,56.8,53.7,59.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,BO1,CAT1,_RFPSA21,RESP054,"(38.635790776000476, -92.56630005299968)"
|
|
2016,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,47,13.8,8.4,19.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,AGE06,CAT3,_RFPSA21,RESP046,"(38.635790776000476, -92.56630005299968)"
|
|
2016,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,283,86.2,80.8,91.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,AGE06,CAT3,_RFPSA21,RESP054,"(38.635790776000476, -92.56630005299968)"
|
|
2016,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,193,36.1,30.5,41.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,AGE07,CAT3,_RFPSA21,RESP046,"(38.635790776000476, -92.56630005299968)"
|
|
2016,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,326,63.9,58.2,69.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,AGE07,CAT3,_RFPSA21,RESP054,"(38.635790776000476, -92.56630005299968)"
|
|
2016,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,178,61,53.1,68.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,AGE08,CAT3,_RFPSA21,RESP046,"(38.635790776000476, -92.56630005299968)"
|
|
2016,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,118,39,31.1,46.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,AGE08,CAT3,_RFPSA21,RESP054,"(38.635790776000476, -92.56630005299968)"
|
|
2016,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,578,64.3,60.3,68.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,AGE09,CAT3,_RFPSA21,RESP046,"(38.635790776000476, -92.56630005299968)"
|
|
2016,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,380,35.7,31.7,39.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,AGE09,CAT3,_RFPSA21,RESP054,"(38.635790776000476, -92.56630005299968)"
|
|
2016,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,996,43.2,40.1,46.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,BO1,CAT1,_RFPSA21,RESP046,"(38.635790776000476, -92.56630005299968)"
|
|
2016,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,64,28.5,19.5,37.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,EDUCA1,CAT5,_RFPSA21,RESP046,"(38.635790776000476, -92.56630005299968)"
|
|
2016,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,130,71.5,62.5,80.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,EDUCA1,CAT5,_RFPSA21,RESP054,"(38.635790776000476, -92.56630005299968)"
|
|
2016,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,290,40,34.8,45.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,EDUCA2,CAT5,_RFPSA21,RESP046,"(38.635790776000476, -92.56630005299968)"
|
|
2016,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,408,60,54.7,65.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,EDUCA2,CAT5,_RFPSA21,RESP054,"(38.635790776000476, -92.56630005299968)"
|
|
2016,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,230,47,40.6,53.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,EDUCA3,CAT5,_RFPSA21,RESP046,"(38.635790776000476, -92.56630005299968)"
|
|
2016,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,264,53,46.6,59.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,EDUCA3,CAT5,_RFPSA21,RESP054,"(38.635790776000476, -92.56630005299968)"
|
|
2016,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,412,51,45.7,56.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,EDUCA4,CAT5,_RFPSA21,RESP046,"(38.635790776000476, -92.56630005299968)"
|
|
2016,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,305,49,43.7,54.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,EDUCA4,CAT5,_RFPSA21,RESP054,"(38.635790776000476, -92.56630005299968)"
|
|
2016,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,40,25.3,14.3,36.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,INCOME1,CAT6,_RFPSA21,RESP046,"(38.635790776000476, -92.56630005299968)"
|
|
2016,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,110,74.7,63.7,85.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,INCOME1,CAT6,_RFPSA21,RESP054,"(38.635790776000476, -92.56630005299968)"
|
|
2016,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,106,30.9,22.5,39.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,INCOME2,CAT6,_RFPSA21,RESP046,"(38.635790776000476, -92.56630005299968)"
|
|
2016,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,172,69.1,60.7,77.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,INCOME2,CAT6,_RFPSA21,RESP054,"(38.635790776000476, -92.56630005299968)"
|
|
2016,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,86,42.7,32.4,53,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,INCOME3,CAT6,_RFPSA21,RESP046,"(38.635790776000476, -92.56630005299968)"
|
|
2016,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,105,57.3,47,67.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,INCOME3,CAT6,_RFPSA21,RESP054,"(38.635790776000476, -92.56630005299968)"
|
|
2016,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,158,48.1,39.8,56.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,INCOME4,CAT6,_RFPSA21,RESP046,"(38.635790776000476, -92.56630005299968)"
|
|
2016,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,152,51.9,43.7,60.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,INCOME4,CAT6,_RFPSA21,RESP054,"(38.635790776000476, -92.56630005299968)"
|
|
2016,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,484,47,42.2,51.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,INCOME5,CAT6,_RFPSA21,RESP046,"(38.635790776000476, -92.56630005299968)"
|
|
2016,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,411,53,48.2,57.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,INCOME5,CAT6,_RFPSA21,RESP054,"(38.635790776000476, -92.56630005299968)"
|
|
2016,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,874,45,41.7,48.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,RACE01,CAT4,_RFPSA21,RESP046,"(38.635790776000476, -92.56630005299968)"
|
|
2016,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,921,55,51.7,58.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,RACE01,CAT4,_RFPSA21,RESP054,"(38.635790776000476, -92.56630005299968)"
|
|
2016,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,70,41.9,29.8,54,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,RACE02,CAT4,_RFPSA21,RESP046,"(38.635790776000476, -92.56630005299968)"
|
|
2016,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,101,58.1,46,70.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,RACE02,CAT4,_RFPSA21,RESP054,"(38.635790776000476, -92.56630005299968)"
|
|
2016,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,29,RACE03,CAT4,_RFPSA21,RESP046,"(38.635790776000476, -92.56630005299968)"
|
|
2016,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,22,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,29,RACE03,CAT4,_RFPSA21,RESP054,"(38.635790776000476, -92.56630005299968)"
|
|
2016,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,29,RACE04,CAT4,_RFPSA21,RESP046,"(38.635790776000476, -92.56630005299968)"
|
|
2016,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,9,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,29,RACE04,CAT4,_RFPSA21,RESP054,"(38.635790776000476, -92.56630005299968)"
|
|
2016,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,29,RACE05,CAT4,_RFPSA21,RESP046,"(38.635790776000476, -92.56630005299968)"
|
|
2016,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,29,RACE05,CAT4,_RFPSA21,RESP054,"(38.635790776000476, -92.56630005299968)"
|
|
2016,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,29,RACE06,CAT4,_RFPSA21,RESP046,"(38.635790776000476, -92.56630005299968)"
|
|
2016,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,29,RACE06,CAT4,_RFPSA21,RESP054,"(38.635790776000476, -92.56630005299968)"
|
|
2016,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,29,36.4,16.6,56.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,RACE07,CAT4,_RFPSA21,RESP046,"(38.635790776000476, -92.56630005299968)"
|
|
2016,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,27,63.6,43.7,83.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,RACE07,CAT4,_RFPSA21,RESP054,"(38.635790776000476, -92.56630005299968)"
|
|
2016,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,12,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,29,RACE08,CAT4,_RFPSA21,RESP046,"(38.635790776000476, -92.56630005299968)"
|
|
2016,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,20,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,29,RACE08,CAT4,_RFPSA21,RESP054,"(38.635790776000476, -92.56630005299968)"
|
|
2016,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,996,43.2,40.1,46.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,SEX1,CAT2,_RFPSA21,RESP046,"(38.635790776000476, -92.56630005299968)"
|
|
2016,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,29,SEX2,CAT2,_RFPSA21,RESP046,"(38.635790776000476, -92.56630005299968)"
|
|
2016,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,29,SEX2,CAT2,_RFPSA21,RESP054,"(38.635790776000476, -92.56630005299968)"
|
|
2016,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,173,31.1,26,36.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,AGE07,CAT3,_RFPSA21,RESP046,"(47.06652897200047, -109.42442064499971)"
|
|
2016,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,40,13.6,8.1,19.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,AGE06,CAT3,_RFPSA21,RESP046,"(47.06652897200047, -109.42442064499971)"
|
|
2016,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,239,86.4,80.8,91.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,AGE06,CAT3,_RFPSA21,RESP054,"(47.06652897200047, -109.42442064499971)"
|
|
2016,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,311,68.9,63.7,74,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,AGE07,CAT3,_RFPSA21,RESP054,"(47.06652897200047, -109.42442064499971)"
|
|
2016,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,150,52.2,44.2,60.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,AGE08,CAT3,_RFPSA21,RESP046,"(47.06652897200047, -109.42442064499971)"
|
|
2016,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,128,47.8,39.7,55.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,AGE08,CAT3,_RFPSA21,RESP054,"(47.06652897200047, -109.42442064499971)"
|
|
2016,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,521,57.6,53,62.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,AGE09,CAT3,_RFPSA21,RESP046,"(47.06652897200047, -109.42442064499971)"
|
|
2016,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,343,42.4,37.9,47,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,AGE09,CAT3,_RFPSA21,RESP054,"(47.06652897200047, -109.42442064499971)"
|
|
2016,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,884,39.2,36.3,42.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,BO1,CAT1,_RFPSA21,RESP046,"(47.06652897200047, -109.42442064499971)"
|
|
2016,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1021,60.8,57.8,63.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,BO1,CAT1,_RFPSA21,RESP054,"(47.06652897200047, -109.42442064499971)"
|
|
2016,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,30,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,30,EDUCA1,CAT5,_RFPSA21,RESP046,"(47.06652897200047, -109.42442064499971)"
|
|
2016,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,100,88.7,82,95.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,EDUCA1,CAT5,_RFPSA21,RESP054,"(47.06652897200047, -109.42442064499971)"
|
|
2016,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,228,35.5,30.3,40.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,EDUCA2,CAT5,_RFPSA21,RESP046,"(47.06652897200047, -109.42442064499971)"
|
|
2016,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,350,64.5,59.3,69.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,EDUCA2,CAT5,_RFPSA21,RESP054,"(47.06652897200047, -109.42442064499971)"
|
|
2016,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,269,44.7,38.9,50.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,EDUCA3,CAT5,_RFPSA21,RESP046,"(47.06652897200047, -109.42442064499971)"
|
|
2016,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,267,55.3,49.6,61.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,EDUCA3,CAT5,_RFPSA21,RESP054,"(47.06652897200047, -109.42442064499971)"
|
|
2016,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,356,46.2,41.3,51.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,EDUCA4,CAT5,_RFPSA21,RESP046,"(47.06652897200047, -109.42442064499971)"
|
|
2016,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,303,53.8,48.9,58.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,EDUCA4,CAT5,_RFPSA21,RESP054,"(47.06652897200047, -109.42442064499971)"
|
|
2016,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,40,18.2,11.2,25.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,INCOME1,CAT6,_RFPSA21,RESP046,"(47.06652897200047, -109.42442064499971)"
|
|
2016,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,106,81.8,74.7,88.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,INCOME1,CAT6,_RFPSA21,RESP054,"(47.06652897200047, -109.42442064499971)"
|
|
2016,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,106,29,21.9,36.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,INCOME2,CAT6,_RFPSA21,RESP046,"(47.06652897200047, -109.42442064499971)"
|
|
2016,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,174,71,63.8,78.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,INCOME2,CAT6,_RFPSA21,RESP054,"(47.06652897200047, -109.42442064499971)"
|
|
2016,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,98,38.3,28.9,47.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,INCOME3,CAT6,_RFPSA21,RESP046,"(47.06652897200047, -109.42442064499971)"
|
|
2016,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,110,61.7,52.3,71.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,INCOME3,CAT6,_RFPSA21,RESP054,"(47.06652897200047, -109.42442064499971)"
|
|
2016,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,138,43.9,36.2,51.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,INCOME4,CAT6,_RFPSA21,RESP046,"(47.06652897200047, -109.42442064499971)"
|
|
2016,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,142,56.1,48.4,63.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,INCOME4,CAT6,_RFPSA21,RESP054,"(47.06652897200047, -109.42442064499971)"
|
|
2016,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,412,45.4,40.8,50.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,INCOME5,CAT6,_RFPSA21,RESP046,"(47.06652897200047, -109.42442064499971)"
|
|
2016,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,372,54.6,49.9,59.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,INCOME5,CAT6,_RFPSA21,RESP054,"(47.06652897200047, -109.42442064499971)"
|
|
2016,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,801,40.4,37.2,43.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,RACE01,CAT4,_RFPSA21,RESP046,"(47.06652897200047, -109.42442064499971)"
|
|
2016,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,850,59.6,56.6,62.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,RACE01,CAT4,_RFPSA21,RESP054,"(47.06652897200047, -109.42442064499971)"
|
|
2016,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,30,RACE02,CAT4,_RFPSA21,RESP046,"(47.06652897200047, -109.42442064499971)"
|
|
2016,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,30,RACE02,CAT4,_RFPSA21,RESP054,"(47.06652897200047, -109.42442064499971)"
|
|
2016,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,48,22.3,12.1,32.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,RACE03,CAT4,_RFPSA21,RESP046,"(47.06652897200047, -109.42442064499971)"
|
|
2016,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,114,77.7,67.4,87.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,RACE03,CAT4,_RFPSA21,RESP054,"(47.06652897200047, -109.42442064499971)"
|
|
2016,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,30,RACE04,CAT4,_RFPSA21,RESP046,"(47.06652897200047, -109.42442064499971)"
|
|
2016,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,30,RACE04,CAT4,_RFPSA21,RESP054,"(47.06652897200047, -109.42442064499971)"
|
|
2016,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,30,RACE05,CAT4,_RFPSA21,RESP046,"(47.06652897200047, -109.42442064499971)"
|
|
2016,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,30,RACE05,CAT4,_RFPSA21,RESP054,"(47.06652897200047, -109.42442064499971)"
|
|
2016,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,30,RACE06,CAT4,_RFPSA21,RESP046,"(47.06652897200047, -109.42442064499971)"
|
|
2016,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,13,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,30,RACE06,CAT4,_RFPSA21,RESP054,"(47.06652897200047, -109.42442064499971)"
|
|
2016,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,15,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,30,RACE07,CAT4,_RFPSA21,RESP046,"(47.06652897200047, -109.42442064499971)"
|
|
2016,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,24,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,30,RACE07,CAT4,_RFPSA21,RESP054,"(47.06652897200047, -109.42442064499971)"
|
|
2016,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,30,RACE08,CAT4,_RFPSA21,RESP046,"(47.06652897200047, -109.42442064499971)"
|
|
2016,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,15,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,30,RACE08,CAT4,_RFPSA21,RESP054,"(47.06652897200047, -109.42442064499971)"
|
|
2016,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,884,39.2,36.3,42.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,SEX1,CAT2,_RFPSA21,RESP046,"(47.06652897200047, -109.42442064499971)"
|
|
2016,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1021,60.8,57.8,63.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,SEX1,CAT2,_RFPSA21,RESP054,"(47.06652897200047, -109.42442064499971)"
|
|
2016,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,30,SEX2,CAT2,_RFPSA21,RESP046,"(47.06652897200047, -109.42442064499971)"
|
|
2016,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,30,SEX2,CAT2,_RFPSA21,RESP054,"(47.06652897200047, -109.42442064499971)"
|
|
2016,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,745,42.7,39.5,45.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,AGE09,CAT3,_RFPSA21,RESP054,"(41.6410409880005, -99.36572062299967)"
|
|
2016,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1970,38.3,36.2,40.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,BO1,CAT1,_RFPSA21,RESP046,"(41.6410409880005, -99.36572062299967)"
|
|
2016,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,103,15.2,11,19.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,AGE06,CAT3,_RFPSA21,RESP046,"(41.6410409880005, -99.36572062299967)"
|
|
2016,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,656,84.8,80.8,89,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,AGE06,CAT3,_RFPSA21,RESP054,"(41.6410409880005, -99.36572062299967)"
|
|
2016,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,453,36.5,32.7,40.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,AGE07,CAT3,_RFPSA21,RESP046,"(41.6410409880005, -99.36572062299967)"
|
|
2016,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,772,63.5,59.7,67.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,AGE07,CAT3,_RFPSA21,RESP054,"(41.6410409880005, -99.36572062299967)"
|
|
2016,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,344,45.7,40.4,51,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,AGE08,CAT3,_RFPSA21,RESP046,"(41.6410409880005, -99.36572062299967)"
|
|
2016,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,331,54.3,49,59.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,AGE08,CAT3,_RFPSA21,RESP054,"(41.6410409880005, -99.36572062299967)"
|
|
2016,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,1070,57.3,54.2,60.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,AGE09,CAT3,_RFPSA21,RESP046,"(41.6410409880005, -99.36572062299967)"
|
|
2016,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,2504,61.7,59.6,63.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,BO1,CAT1,_RFPSA21,RESP054,"(41.6410409880005, -99.36572062299967)"
|
|
2016,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,85,24.4,17.6,31.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,EDUCA1,CAT5,_RFPSA21,RESP046,"(41.6410409880005, -99.36572062299967)"
|
|
2016,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,192,75.6,68.7,82.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,EDUCA1,CAT5,_RFPSA21,RESP054,"(41.6410409880005, -99.36572062299967)"
|
|
2016,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,651,36.8,33.5,40.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,EDUCA2,CAT5,_RFPSA21,RESP046,"(41.6410409880005, -99.36572062299967)"
|
|
2016,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,935,63.2,59.8,66.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,EDUCA2,CAT5,_RFPSA21,RESP054,"(41.6410409880005, -99.36572062299967)"
|
|
2016,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,530,38.9,34.9,42.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,EDUCA3,CAT5,_RFPSA21,RESP046,"(41.6410409880005, -99.36572062299967)"
|
|
2016,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,710,61.1,57.1,65.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,EDUCA3,CAT5,_RFPSA21,RESP054,"(41.6410409880005, -99.36572062299967)"
|
|
2016,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,702,43.8,40,47.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,EDUCA4,CAT5,_RFPSA21,RESP046,"(41.6410409880005, -99.36572062299967)"
|
|
2016,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,665,56.2,52.5,60,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,EDUCA4,CAT5,_RFPSA21,RESP054,"(41.6410409880005, -99.36572062299967)"
|
|
2016,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,65,26,16.7,35.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,INCOME1,CAT6,_RFPSA21,RESP046,"(41.6410409880005, -99.36572062299967)"
|
|
2016,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,173,74,64.6,83.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,INCOME1,CAT6,_RFPSA21,RESP054,"(41.6410409880005, -99.36572062299967)"
|
|
2016,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,200,32.2,26,38.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,INCOME2,CAT6,_RFPSA21,RESP046,"(41.6410409880005, -99.36572062299967)"
|
|
2016,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,335,67.8,61.6,74,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,INCOME2,CAT6,_RFPSA21,RESP054,"(41.6410409880005, -99.36572062299967)"
|
|
2016,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,189,34,28.2,39.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,INCOME3,CAT6,_RFPSA21,RESP046,"(41.6410409880005, -99.36572062299967)"
|
|
2016,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,295,66,60.2,71.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,INCOME3,CAT6,_RFPSA21,RESP054,"(41.6410409880005, -99.36572062299967)"
|
|
2016,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,318,35.9,31,40.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,INCOME4,CAT6,_RFPSA21,RESP046,"(41.6410409880005, -99.36572062299967)"
|
|
2016,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,395,64.1,59.2,69,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,INCOME4,CAT6,_RFPSA21,RESP054,"(41.6410409880005, -99.36572062299967)"
|
|
2016,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,1063,42.5,39.5,45.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,INCOME5,CAT6,_RFPSA21,RESP046,"(41.6410409880005, -99.36572062299967)"
|
|
2016,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,1128,57.5,54.5,60.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,INCOME5,CAT6,_RFPSA21,RESP054,"(41.6410409880005, -99.36572062299967)"
|
|
2016,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1878,40.5,38.3,42.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,RACE01,CAT4,_RFPSA21,RESP046,"(41.6410409880005, -99.36572062299967)"
|
|
2016,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,2284,59.5,57.3,61.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,RACE01,CAT4,_RFPSA21,RESP054,"(41.6410409880005, -99.36572062299967)"
|
|
2016,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,14,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,31,RACE02,CAT4,_RFPSA21,RESP046,"(41.6410409880005, -99.36572062299967)"
|
|
2016,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,30,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,31,RACE02,CAT4,_RFPSA21,RESP054,"(41.6410409880005, -99.36572062299967)"
|
|
2016,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,14,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,31,RACE03,CAT4,_RFPSA21,RESP046,"(41.6410409880005, -99.36572062299967)"
|
|
2016,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,24,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,31,RACE03,CAT4,_RFPSA21,RESP054,"(41.6410409880005, -99.36572062299967)"
|
|
2016,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,31,RACE04,CAT4,_RFPSA21,RESP046,"(41.6410409880005, -99.36572062299967)"
|
|
2016,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,11,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,31,RACE04,CAT4,_RFPSA21,RESP054,"(41.6410409880005, -99.36572062299967)"
|
|
2016,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,31,RACE05,CAT4,_RFPSA21,RESP046,"(41.6410409880005, -99.36572062299967)"
|
|
2016,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,31,RACE05,CAT4,_RFPSA21,RESP054,"(41.6410409880005, -99.36572062299967)"
|
|
2016,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,31,RACE06,CAT4,_RFPSA21,RESP046,"(41.6410409880005, -99.36572062299967)"
|
|
2016,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,31,RACE06,CAT4,_RFPSA21,RESP054,"(41.6410409880005, -99.36572062299967)"
|
|
2016,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,13,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,31,RACE07,CAT4,_RFPSA21,RESP046,"(41.6410409880005, -99.36572062299967)"
|
|
2016,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,25,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,31,RACE07,CAT4,_RFPSA21,RESP054,"(41.6410409880005, -99.36572062299967)"
|
|
2016,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,44,20.8,13.4,28.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,RACE08,CAT4,_RFPSA21,RESP046,"(41.6410409880005, -99.36572062299967)"
|
|
2016,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,124,79.2,71.8,86.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,RACE08,CAT4,_RFPSA21,RESP054,"(41.6410409880005, -99.36572062299967)"
|
|
2016,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1970,38.3,36.2,40.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,SEX1,CAT2,_RFPSA21,RESP046,"(41.6410409880005, -99.36572062299967)"
|
|
2016,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,2504,61.7,59.6,63.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,SEX1,CAT2,_RFPSA21,RESP054,"(41.6410409880005, -99.36572062299967)"
|
|
2016,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,31,SEX2,CAT2,_RFPSA21,RESP046,"(41.6410409880005, -99.36572062299967)"
|
|
2016,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,31,SEX2,CAT2,_RFPSA21,RESP054,"(41.6410409880005, -99.36572062299967)"
|
|
2016,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,92,49.6,39.4,59.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,AGE08,CAT3,_RFPSA21,RESP046,"(39.493240390000494, -117.07184056399967)"
|
|
2016,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,35,13.9,8.2,19.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,AGE06,CAT3,_RFPSA21,RESP046,"(39.493240390000494, -117.07184056399967)"
|
|
2016,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,227,86.1,80.4,91.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,AGE06,CAT3,_RFPSA21,RESP054,"(39.493240390000494, -117.07184056399967)"
|
|
2016,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,106,34.6,26.7,42.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,AGE07,CAT3,_RFPSA21,RESP046,"(39.493240390000494, -117.07184056399967)"
|
|
2016,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,210,65.4,57.5,73.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,AGE07,CAT3,_RFPSA21,RESP054,"(39.493240390000494, -117.07184056399967)"
|
|
2016,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,90,50.4,40.3,60.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,AGE08,CAT3,_RFPSA21,RESP054,"(39.493240390000494, -117.07184056399967)"
|
|
2016,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,332,63.4,57.3,69.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,AGE09,CAT3,_RFPSA21,RESP046,"(39.493240390000494, -117.07184056399967)"
|
|
2016,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,191,36.6,30.4,42.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,AGE09,CAT3,_RFPSA21,RESP054,"(39.493240390000494, -117.07184056399967)"
|
|
2016,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,565,39.5,35.6,43.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,BO1,CAT1,_RFPSA21,RESP046,"(39.493240390000494, -117.07184056399967)"
|
|
2016,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,718,60.5,56.7,64.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,BO1,CAT1,_RFPSA21,RESP054,"(39.493240390000494, -117.07184056399967)"
|
|
2016,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,33,35,22.5,47.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,EDUCA1,CAT5,_RFPSA21,RESP046,"(39.493240390000494, -117.07184056399967)"
|
|
2016,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,69,65,52.6,77.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,EDUCA1,CAT5,_RFPSA21,RESP054,"(39.493240390000494, -117.07184056399967)"
|
|
2016,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,106,33.2,26.1,40.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,EDUCA2,CAT5,_RFPSA21,RESP046,"(39.493240390000494, -117.07184056399967)"
|
|
2016,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,198,66.8,59.7,73.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,EDUCA2,CAT5,_RFPSA21,RESP054,"(39.493240390000494, -117.07184056399967)"
|
|
2016,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,161,39.1,32.3,46,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,EDUCA3,CAT5,_RFPSA21,RESP046,"(39.493240390000494, -117.07184056399967)"
|
|
2016,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,214,60.9,54,67.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,EDUCA3,CAT5,_RFPSA21,RESP054,"(39.493240390000494, -117.07184056399967)"
|
|
2016,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,263,48.1,41.9,54.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,EDUCA4,CAT5,_RFPSA21,RESP046,"(39.493240390000494, -117.07184056399967)"
|
|
2016,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,235,51.9,45.6,58.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,EDUCA4,CAT5,_RFPSA21,RESP054,"(39.493240390000494, -117.07184056399967)"
|
|
2016,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,27,31.2,17.8,44.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,INCOME1,CAT6,_RFPSA21,RESP046,"(39.493240390000494, -117.07184056399967)"
|
|
2016,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,60,68.8,55.5,82.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,INCOME1,CAT6,_RFPSA21,RESP054,"(39.493240390000494, -117.07184056399967)"
|
|
2016,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,43,23.3,14.3,32.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,INCOME2,CAT6,_RFPSA21,RESP046,"(39.493240390000494, -117.07184056399967)"
|
|
2016,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,115,76.7,67.6,85.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,INCOME2,CAT6,_RFPSA21,RESP054,"(39.493240390000494, -117.07184056399967)"
|
|
2016,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,39,43.8,28.2,59.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,INCOME3,CAT6,_RFPSA21,RESP046,"(39.493240390000494, -117.07184056399967)"
|
|
2016,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,57,56.2,40.5,71.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,INCOME3,CAT6,_RFPSA21,RESP054,"(39.493240390000494, -117.07184056399967)"
|
|
2016,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,74,40.2,29.6,50.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,INCOME4,CAT6,_RFPSA21,RESP046,"(39.493240390000494, -117.07184056399967)"
|
|
2016,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,93,59.8,49.3,70.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,INCOME4,CAT6,_RFPSA21,RESP054,"(39.493240390000494, -117.07184056399967)"
|
|
2016,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,320,45.7,40.1,51.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,INCOME5,CAT6,_RFPSA21,RESP046,"(39.493240390000494, -117.07184056399967)"
|
|
2016,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,317,54.3,48.7,59.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,INCOME5,CAT6,_RFPSA21,RESP054,"(39.493240390000494, -117.07184056399967)"
|
|
2016,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,455,45.3,40.6,49.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,RACE01,CAT4,_RFPSA21,RESP046,"(39.493240390000494, -117.07184056399967)"
|
|
2016,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,491,54.7,50.1,59.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,RACE01,CAT4,_RFPSA21,RESP054,"(39.493240390000494, -117.07184056399967)"
|
|
2016,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,24,36.1,20.1,52,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,RACE02,CAT4,_RFPSA21,RESP046,"(39.493240390000494, -117.07184056399967)"
|
|
2016,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,27,63.9,48,79.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,RACE02,CAT4,_RFPSA21,RESP054,"(39.493240390000494, -117.07184056399967)"
|
|
2016,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,32,RACE03,CAT4,_RFPSA21,RESP046,"(39.493240390000494, -117.07184056399967)"
|
|
2016,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,11,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,32,RACE03,CAT4,_RFPSA21,RESP054,"(39.493240390000494, -117.07184056399967)"
|
|
2016,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,9,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,32,RACE04,CAT4,_RFPSA21,RESP046,"(39.493240390000494, -117.07184056399967)"
|
|
2016,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,28,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,32,RACE04,CAT4,_RFPSA21,RESP054,"(39.493240390000494, -117.07184056399967)"
|
|
2016,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,32,RACE05,CAT4,_RFPSA21,RESP046,"(39.493240390000494, -117.07184056399967)"
|
|
2016,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,32,RACE05,CAT4,_RFPSA21,RESP054,"(39.493240390000494, -117.07184056399967)"
|
|
2016,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,9,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,32,RACE06,CAT4,_RFPSA21,RESP046,"(39.493240390000494, -117.07184056399967)"
|
|
2016,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,15,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,32,RACE06,CAT4,_RFPSA21,RESP054,"(39.493240390000494, -117.07184056399967)"
|
|
2016,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,12,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,32,RACE07,CAT4,_RFPSA21,RESP046,"(39.493240390000494, -117.07184056399967)"
|
|
2016,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,20,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,32,RACE07,CAT4,_RFPSA21,RESP054,"(39.493240390000494, -117.07184056399967)"
|
|
2016,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,50,26.9,18.4,35.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,RACE08,CAT4,_RFPSA21,RESP046,"(39.493240390000494, -117.07184056399967)"
|
|
2016,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,118,73.1,64.6,81.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,RACE08,CAT4,_RFPSA21,RESP054,"(39.493240390000494, -117.07184056399967)"
|
|
2016,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,565,39.5,35.6,43.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,SEX1,CAT2,_RFPSA21,RESP046,"(39.493240390000494, -117.07184056399967)"
|
|
2016,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,718,60.5,56.7,64.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,SEX1,CAT2,_RFPSA21,RESP054,"(39.493240390000494, -117.07184056399967)"
|
|
2016,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,32,SEX2,CAT2,_RFPSA21,RESP046,"(39.493240390000494, -117.07184056399967)"
|
|
2016,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,32,SEX2,CAT2,_RFPSA21,RESP054,"(39.493240390000494, -117.07184056399967)"
|
|
2016,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,32,10.2,6.3,14.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,AGE06,CAT3,_RFPSA21,RESP046,"(43.65595011300047, -71.50036091999965)"
|
|
2016,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,264,89.8,85.9,93.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,AGE06,CAT3,_RFPSA21,RESP054,"(43.65595011300047, -71.50036091999965)"
|
|
2016,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,160,30.4,25.5,35.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,AGE07,CAT3,_RFPSA21,RESP046,"(43.65595011300047, -71.50036091999965)"
|
|
2016,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,379,69.6,64.7,74.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,AGE07,CAT3,_RFPSA21,RESP054,"(43.65595011300047, -71.50036091999965)"
|
|
2016,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,143,52.4,45.2,59.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,AGE08,CAT3,_RFPSA21,RESP046,"(43.65595011300047, -71.50036091999965)"
|
|
2016,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,153,47.6,40.3,54.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,AGE08,CAT3,_RFPSA21,RESP054,"(43.65595011300047, -71.50036091999965)"
|
|
2016,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,514,58.9,55,62.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,AGE09,CAT3,_RFPSA21,RESP046,"(43.65595011300047, -71.50036091999965)"
|
|
2016,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,379,41.1,37.1,45,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,AGE09,CAT3,_RFPSA21,RESP054,"(43.65595011300047, -71.50036091999965)"
|
|
2016,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,849,37.4,34.7,40,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,BO1,CAT1,_RFPSA21,RESP046,"(43.65595011300047, -71.50036091999965)"
|
|
2016,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1175,62.6,60,65.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,BO1,CAT1,_RFPSA21,RESP054,"(43.65595011300047, -71.50036091999965)"
|
|
2016,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,25,22.4,13.1,31.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,EDUCA1,CAT5,_RFPSA21,RESP046,"(43.65595011300047, -71.50036091999965)"
|
|
2016,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,81,77.6,68.2,86.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,EDUCA1,CAT5,_RFPSA21,RESP054,"(43.65595011300047, -71.50036091999965)"
|
|
2016,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,175,34,28.7,39.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,EDUCA2,CAT5,_RFPSA21,RESP046,"(43.65595011300047, -71.50036091999965)"
|
|
2016,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,337,66,60.6,71.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,EDUCA2,CAT5,_RFPSA21,RESP054,"(43.65595011300047, -71.50036091999965)"
|
|
2016,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,172,35.2,29.7,40.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,EDUCA3,CAT5,_RFPSA21,RESP046,"(43.65595011300047, -71.50036091999965)"
|
|
2016,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,276,64.8,59.4,70.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,EDUCA3,CAT5,_RFPSA21,RESP054,"(43.65595011300047, -71.50036091999965)"
|
|
2016,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,477,44.5,40.6,48.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,EDUCA4,CAT5,_RFPSA21,RESP046,"(43.65595011300047, -71.50036091999965)"
|
|
2016,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,480,55.5,51.6,59.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,EDUCA4,CAT5,_RFPSA21,RESP054,"(43.65595011300047, -71.50036091999965)"
|
|
2016,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,22,20.5,8.7,32.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,INCOME1,CAT6,_RFPSA21,RESP046,"(43.65595011300047, -71.50036091999965)"
|
|
2016,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,76,79.5,67.7,91.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,INCOME1,CAT6,_RFPSA21,RESP054,"(43.65595011300047, -71.50036091999965)"
|
|
2016,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,61,29,20.7,37.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,INCOME2,CAT6,_RFPSA21,RESP046,"(43.65595011300047, -71.50036091999965)"
|
|
2016,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,129,71,62.7,79.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,INCOME2,CAT6,_RFPSA21,RESP054,"(43.65595011300047, -71.50036091999965)"
|
|
2016,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,52,26.9,18.3,35.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,INCOME3,CAT6,_RFPSA21,RESP046,"(43.65595011300047, -71.50036091999965)"
|
|
2016,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,103,73.1,64.4,81.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,INCOME3,CAT6,_RFPSA21,RESP054,"(43.65595011300047, -71.50036091999965)"
|
|
2016,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,108,36.8,29.6,44,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,INCOME4,CAT6,_RFPSA21,RESP046,"(43.65595011300047, -71.50036091999965)"
|
|
2016,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,148,63.2,56,70.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,INCOME4,CAT6,_RFPSA21,RESP054,"(43.65595011300047, -71.50036091999965)"
|
|
2016,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,490,40.6,36.9,44.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,INCOME5,CAT6,_RFPSA21,RESP046,"(43.65595011300047, -71.50036091999965)"
|
|
2016,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,571,59.4,55.7,63.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,INCOME5,CAT6,_RFPSA21,RESP054,"(43.65595011300047, -71.50036091999965)"
|
|
2016,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,817,38.2,35.5,40.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,RACE01,CAT4,_RFPSA21,RESP046,"(43.65595011300047, -71.50036091999965)"
|
|
2016,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1102,61.8,59.1,64.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,RACE01,CAT4,_RFPSA21,RESP054,"(43.65595011300047, -71.50036091999965)"
|
|
2016,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,33,RACE02,CAT4,_RFPSA21,RESP046,"(43.65595011300047, -71.50036091999965)"
|
|
2016,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,33,RACE02,CAT4,_RFPSA21,RESP054,"(43.65595011300047, -71.50036091999965)"
|
|
2016,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,33,RACE03,CAT4,_RFPSA21,RESP046,"(43.65595011300047, -71.50036091999965)"
|
|
2016,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,13,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,33,RACE03,CAT4,_RFPSA21,RESP054,"(43.65595011300047, -71.50036091999965)"
|
|
2016,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,33,RACE04,CAT4,_RFPSA21,RESP046,"(43.65595011300047, -71.50036091999965)"
|
|
2016,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,11,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,33,RACE04,CAT4,_RFPSA21,RESP054,"(43.65595011300047, -71.50036091999965)"
|
|
2016,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,33,RACE05,CAT4,_RFPSA21,RESP046,"(43.65595011300047, -71.50036091999965)"
|
|
2016,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,33,RACE05,CAT4,_RFPSA21,RESP054,"(43.65595011300047, -71.50036091999965)"
|
|
2016,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,33,RACE06,CAT4,_RFPSA21,RESP046,"(43.65595011300047, -71.50036091999965)"
|
|
2016,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,18,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,33,RACE06,CAT4,_RFPSA21,RESP054,"(43.65595011300047, -71.50036091999965)"
|
|
2016,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,33,RACE07,CAT4,_RFPSA21,RESP046,"(43.65595011300047, -71.50036091999965)"
|
|
2016,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,13,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,33,RACE07,CAT4,_RFPSA21,RESP054,"(43.65595011300047, -71.50036091999965)"
|
|
2016,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,33,RACE08,CAT4,_RFPSA21,RESP046,"(43.65595011300047, -71.50036091999965)"
|
|
2016,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,33,RACE08,CAT4,_RFPSA21,RESP054,"(43.65595011300047, -71.50036091999965)"
|
|
2016,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,849,37.4,34.7,40,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,SEX1,CAT2,_RFPSA21,RESP046,"(43.65595011300047, -71.50036091999965)"
|
|
2016,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1175,62.6,60,65.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,SEX1,CAT2,_RFPSA21,RESP054,"(43.65595011300047, -71.50036091999965)"
|
|
2016,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,33,SEX2,CAT2,_RFPSA21,RESP046,"(43.65595011300047, -71.50036091999965)"
|
|
2016,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,33,SEX2,CAT2,_RFPSA21,RESP054,"(43.65595011300047, -71.50036091999965)"
|
|
2016,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,301,33,27.9,38.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,AGE09,CAT3,_RFPSA21,RESP054,"(40.13057004800049, -74.27369128799967)"
|
|
2016,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,88,22.9,17.2,28.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,AGE06,CAT3,_RFPSA21,RESP046,"(40.13057004800049, -74.27369128799967)"
|
|
2016,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,320,77.1,71.4,82.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,AGE06,CAT3,_RFPSA21,RESP054,"(40.13057004800049, -74.27369128799967)"
|
|
2016,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,283,49.5,43.5,55.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,AGE07,CAT3,_RFPSA21,RESP046,"(40.13057004800049, -74.27369128799967)"
|
|
2016,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,297,50.5,44.4,56.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,AGE07,CAT3,_RFPSA21,RESP054,"(40.13057004800049, -74.27369128799967)"
|
|
2016,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,218,69.6,63,76.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,AGE08,CAT3,_RFPSA21,RESP046,"(40.13057004800049, -74.27369128799967)"
|
|
2016,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,127,30.4,23.8,37,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,AGE08,CAT3,_RFPSA21,RESP054,"(40.13057004800049, -74.27369128799967)"
|
|
2016,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,559,67,61.9,72.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,AGE09,CAT3,_RFPSA21,RESP046,"(40.13057004800049, -74.27369128799967)"
|
|
2016,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1148,50,46.8,53.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,BO1,CAT1,_RFPSA21,RESP046,"(40.13057004800049, -74.27369128799967)"
|
|
2016,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1045,50,46.8,53.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,BO1,CAT1,_RFPSA21,RESP054,"(40.13057004800049, -74.27369128799967)"
|
|
2016,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,58,43.9,32.3,55.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,EDUCA1,CAT5,_RFPSA21,RESP046,"(40.13057004800049, -74.27369128799967)"
|
|
2016,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,103,56.1,44.5,67.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,EDUCA1,CAT5,_RFPSA21,RESP054,"(40.13057004800049, -74.27369128799967)"
|
|
2016,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,277,51.6,45.4,57.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,EDUCA2,CAT5,_RFPSA21,RESP046,"(40.13057004800049, -74.27369128799967)"
|
|
2016,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,290,48.4,42.3,54.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,EDUCA2,CAT5,_RFPSA21,RESP054,"(40.13057004800049, -74.27369128799967)"
|
|
2016,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,240,49.7,43,56.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,EDUCA3,CAT5,_RFPSA21,RESP046,"(40.13057004800049, -74.27369128799967)"
|
|
2016,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,214,50.3,43.6,57,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,EDUCA3,CAT5,_RFPSA21,RESP054,"(40.13057004800049, -74.27369128799967)"
|
|
2016,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,571,51.3,46.7,55.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,EDUCA4,CAT5,_RFPSA21,RESP046,"(40.13057004800049, -74.27369128799967)"
|
|
2016,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,435,48.7,44.2,53.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,EDUCA4,CAT5,_RFPSA21,RESP054,"(40.13057004800049, -74.27369128799967)"
|
|
2016,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,38,37.2,22.5,51.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,INCOME1,CAT6,_RFPSA21,RESP046,"(40.13057004800049, -74.27369128799967)"
|
|
2016,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,71,62.8,48.1,77.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,INCOME1,CAT6,_RFPSA21,RESP054,"(40.13057004800049, -74.27369128799967)"
|
|
2016,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,108,44.1,34.8,53.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,INCOME2,CAT6,_RFPSA21,RESP046,"(40.13057004800049, -74.27369128799967)"
|
|
2016,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,149,55.9,46.6,65.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,INCOME2,CAT6,_RFPSA21,RESP054,"(40.13057004800049, -74.27369128799967)"
|
|
2016,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,65,49.6,36.9,62.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,INCOME3,CAT6,_RFPSA21,RESP046,"(40.13057004800049, -74.27369128799967)"
|
|
2016,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,80,50.4,37.7,63.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,INCOME3,CAT6,_RFPSA21,RESP054,"(40.13057004800049, -74.27369128799967)"
|
|
2016,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,105,52.7,40.3,65,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,INCOME4,CAT6,_RFPSA21,RESP046,"(40.13057004800049, -74.27369128799967)"
|
|
2016,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,97,47.3,35,59.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,INCOME4,CAT6,_RFPSA21,RESP054,"(40.13057004800049, -74.27369128799967)"
|
|
2016,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,693,51.8,47.7,56,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,INCOME5,CAT6,_RFPSA21,RESP046,"(40.13057004800049, -74.27369128799967)"
|
|
2016,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,514,48.2,44,52.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,INCOME5,CAT6,_RFPSA21,RESP054,"(40.13057004800049, -74.27369128799967)"
|
|
2016,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,942,57.1,53.5,60.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,RACE01,CAT4,_RFPSA21,RESP046,"(40.13057004800049, -74.27369128799967)"
|
|
2016,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,719,42.9,39.3,46.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,RACE01,CAT4,_RFPSA21,RESP054,"(40.13057004800049, -74.27369128799967)"
|
|
2016,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,88,47.8,38.1,57.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,RACE02,CAT4,_RFPSA21,RESP046,"(40.13057004800049, -74.27369128799967)"
|
|
2016,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,111,52.2,42.5,61.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,RACE02,CAT4,_RFPSA21,RESP054,"(40.13057004800049, -74.27369128799967)"
|
|
2016,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,34,RACE03,CAT4,_RFPSA21,RESP046,"(40.13057004800049, -74.27369128799967)"
|
|
2016,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,34,RACE03,CAT4,_RFPSA21,RESP054,"(40.13057004800049, -74.27369128799967)"
|
|
2016,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,34,RACE04,CAT4,_RFPSA21,RESP046,"(40.13057004800049, -74.27369128799967)"
|
|
2016,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,63,89.9,81.6,98.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,RACE04,CAT4,_RFPSA21,RESP054,"(40.13057004800049, -74.27369128799967)"
|
|
2016,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,34,RACE05,CAT4,_RFPSA21,RESP046,"(40.13057004800049, -74.27369128799967)"
|
|
2016,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,34,RACE05,CAT4,_RFPSA21,RESP054,"(40.13057004800049, -74.27369128799967)"
|
|
2016,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,34,RACE06,CAT4,_RFPSA21,RESP046,"(40.13057004800049, -74.27369128799967)"
|
|
2016,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,34,RACE06,CAT4,_RFPSA21,RESP054,"(40.13057004800049, -74.27369128799967)"
|
|
2016,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,9,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,34,RACE07,CAT4,_RFPSA21,RESP046,"(40.13057004800049, -74.27369128799967)"
|
|
2016,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,9,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,34,RACE07,CAT4,_RFPSA21,RESP054,"(40.13057004800049, -74.27369128799967)"
|
|
2016,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,91,42.4,33.2,51.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,RACE08,CAT4,_RFPSA21,RESP046,"(40.13057004800049, -74.27369128799967)"
|
|
2016,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,134,57.6,48.3,66.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,RACE08,CAT4,_RFPSA21,RESP054,"(40.13057004800049, -74.27369128799967)"
|
|
2016,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1148,50,46.8,53.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,SEX1,CAT2,_RFPSA21,RESP046,"(40.13057004800049, -74.27369128799967)"
|
|
2016,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1045,50,46.8,53.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,SEX1,CAT2,_RFPSA21,RESP054,"(40.13057004800049, -74.27369128799967)"
|
|
2016,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,34,SEX2,CAT2,_RFPSA21,RESP046,"(40.13057004800049, -74.27369128799967)"
|
|
2016,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,34,SEX2,CAT2,_RFPSA21,RESP054,"(40.13057004800049, -74.27369128799967)"
|
|
2016,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,28,7.6,4.2,11,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,AGE06,CAT3,_RFPSA21,RESP046,"(34.52088095200048, -106.24058098499967)"
|
|
2016,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,266,92.4,89,95.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,AGE06,CAT3,_RFPSA21,RESP054,"(34.52088095200048, -106.24058098499967)"
|
|
2016,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,140,26.3,21.1,31.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,AGE07,CAT3,_RFPSA21,RESP046,"(34.52088095200048, -106.24058098499967)"
|
|
2016,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,347,73.7,68.5,78.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,AGE07,CAT3,_RFPSA21,RESP054,"(34.52088095200048, -106.24058098499967)"
|
|
2016,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,111,43.5,35.3,51.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,AGE08,CAT3,_RFPSA21,RESP046,"(34.52088095200048, -106.24058098499967)"
|
|
2016,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,158,56.5,48.2,64.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,AGE08,CAT3,_RFPSA21,RESP054,"(34.52088095200048, -106.24058098499967)"
|
|
2016,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,394,48.2,43.2,53.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,AGE09,CAT3,_RFPSA21,RESP046,"(34.52088095200048, -106.24058098499967)"
|
|
2016,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,360,51.8,46.7,56.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,AGE09,CAT3,_RFPSA21,RESP054,"(34.52088095200048, -106.24058098499967)"
|
|
2016,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,673,30.5,27.7,33.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,BO1,CAT1,_RFPSA21,RESP046,"(34.52088095200048, -106.24058098499967)"
|
|
2016,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1131,69.5,66.6,72.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,BO1,CAT1,_RFPSA21,RESP054,"(34.52088095200048, -106.24058098499967)"
|
|
2016,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,44,18.9,12.9,24.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,EDUCA1,CAT5,_RFPSA21,RESP046,"(34.52088095200048, -106.24058098499967)"
|
|
2016,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,160,81.1,75.1,87.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,EDUCA1,CAT5,_RFPSA21,RESP054,"(34.52088095200048, -106.24058098499967)"
|
|
2016,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,132,21.8,17.1,26.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,EDUCA2,CAT5,_RFPSA21,RESP046,"(34.52088095200048, -106.24058098499967)"
|
|
2016,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,319,78.2,73.5,82.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,EDUCA2,CAT5,_RFPSA21,RESP054,"(34.52088095200048, -106.24058098499967)"
|
|
2016,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,177,32.9,27,38.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,EDUCA3,CAT5,_RFPSA21,RESP046,"(34.52088095200048, -106.24058098499967)"
|
|
2016,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,290,67.1,61.2,73,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,EDUCA3,CAT5,_RFPSA21,RESP054,"(34.52088095200048, -106.24058098499967)"
|
|
2016,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,319,42,36.8,47.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,EDUCA4,CAT5,_RFPSA21,RESP046,"(34.52088095200048, -106.24058098499967)"
|
|
2016,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,361,58,52.9,63.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,EDUCA4,CAT5,_RFPSA21,RESP054,"(34.52088095200048, -106.24058098499967)"
|
|
2016,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,30,14.6,7.8,21.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,INCOME1,CAT6,_RFPSA21,RESP046,"(34.52088095200048, -106.24058098499967)"
|
|
2016,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,162,85.4,78.6,92.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,INCOME1,CAT6,_RFPSA21,RESP054,"(34.52088095200048, -106.24058098499967)"
|
|
2016,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,94,23.1,17.3,28.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,INCOME2,CAT6,_RFPSA21,RESP046,"(34.52088095200048, -106.24058098499967)"
|
|
2016,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,223,76.9,71.1,82.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,INCOME2,CAT6,_RFPSA21,RESP054,"(34.52088095200048, -106.24058098499967)"
|
|
2016,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,59,24.7,17,32.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,INCOME3,CAT6,_RFPSA21,RESP046,"(34.52088095200048, -106.24058098499967)"
|
|
2016,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,106,75.3,67.6,83,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,INCOME3,CAT6,_RFPSA21,RESP054,"(34.52088095200048, -106.24058098499967)"
|
|
2016,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,109,36.7,28.5,44.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,INCOME4,CAT6,_RFPSA21,RESP046,"(34.52088095200048, -106.24058098499967)"
|
|
2016,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,136,63.3,55.2,71.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,INCOME4,CAT6,_RFPSA21,RESP054,"(34.52088095200048, -106.24058098499967)"
|
|
2016,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,316,37.1,32.3,42,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,INCOME5,CAT6,_RFPSA21,RESP046,"(34.52088095200048, -106.24058098499967)"
|
|
2016,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,400,62.9,58,67.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,INCOME5,CAT6,_RFPSA21,RESP054,"(34.52088095200048, -106.24058098499967)"
|
|
2016,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,490,38.9,34.8,42.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,RACE01,CAT4,_RFPSA21,RESP046,"(34.52088095200048, -106.24058098499967)"
|
|
2016,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,590,61.1,57.1,65.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,RACE01,CAT4,_RFPSA21,RESP054,"(34.52088095200048, -106.24058098499967)"
|
|
2016,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,35,RACE02,CAT4,_RFPSA21,RESP046,"(34.52088095200048, -106.24058098499967)"
|
|
2016,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,17,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,35,RACE02,CAT4,_RFPSA21,RESP054,"(34.52088095200048, -106.24058098499967)"
|
|
2016,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,23,18.6,10.1,27.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,RACE03,CAT4,_RFPSA21,RESP046,"(34.52088095200048, -106.24058098499967)"
|
|
2016,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,106,81.4,72.8,89.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,RACE03,CAT4,_RFPSA21,RESP054,"(34.52088095200048, -106.24058098499967)"
|
|
2016,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,35,RACE04,CAT4,_RFPSA21,RESP046,"(34.52088095200048, -106.24058098499967)"
|
|
2016,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,12,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,35,RACE04,CAT4,_RFPSA21,RESP054,"(34.52088095200048, -106.24058098499967)"
|
|
2016,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,35,RACE05,CAT4,_RFPSA21,RESP046,"(34.52088095200048, -106.24058098499967)"
|
|
2016,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,35,RACE05,CAT4,_RFPSA21,RESP054,"(34.52088095200048, -106.24058098499967)"
|
|
2016,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,35,RACE06,CAT4,_RFPSA21,RESP046,"(34.52088095200048, -106.24058098499967)"
|
|
2016,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,35,RACE06,CAT4,_RFPSA21,RESP054,"(34.52088095200048, -106.24058098499967)"
|
|
2016,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,9,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,35,RACE07,CAT4,_RFPSA21,RESP046,"(34.52088095200048, -106.24058098499967)"
|
|
2016,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,12,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,35,RACE07,CAT4,_RFPSA21,RESP054,"(34.52088095200048, -106.24058098499967)"
|
|
2016,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,143,23.4,18.9,27.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,RACE08,CAT4,_RFPSA21,RESP046,"(34.52088095200048, -106.24058098499967)"
|
|
2016,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,391,76.6,72.1,81.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,RACE08,CAT4,_RFPSA21,RESP054,"(34.52088095200048, -106.24058098499967)"
|
|
2016,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,673,30.5,27.7,33.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,SEX1,CAT2,_RFPSA21,RESP046,"(34.52088095200048, -106.24058098499967)"
|
|
2016,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1131,69.5,66.6,72.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,SEX1,CAT2,_RFPSA21,RESP054,"(34.52088095200048, -106.24058098499967)"
|
|
2016,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,35,SEX2,CAT2,_RFPSA21,RESP046,"(34.52088095200048, -106.24058098499967)"
|
|
2016,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,35,SEX2,CAT2,_RFPSA21,RESP054,"(34.52088095200048, -106.24058098499967)"
|
|
2016,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,1675,38.1,34.8,41.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,AGE09,CAT3,_RFPSA21,RESP054,"(42.82700103200045, -75.54397042699964)"
|
|
2016,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,4341,39,37.1,41,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,BO1,CAT1,_RFPSA21,RESP046,"(42.82700103200045, -75.54397042699964)"
|
|
2016,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,198,11.9,9.2,14.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,AGE06,CAT3,_RFPSA21,RESP046,"(42.82700103200045, -75.54397042699964)"
|
|
2016,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,1423,88.1,85.4,90.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,AGE06,CAT3,_RFPSA21,RESP054,"(42.82700103200045, -75.54397042699964)"
|
|
2016,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,958,35.4,31.6,39.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,AGE07,CAT3,_RFPSA21,RESP046,"(42.82700103200045, -75.54397042699964)"
|
|
2016,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,1689,64.6,60.8,68.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,AGE07,CAT3,_RFPSA21,RESP054,"(42.82700103200045, -75.54397042699964)"
|
|
2016,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,790,49.2,44,54.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,AGE08,CAT3,_RFPSA21,RESP046,"(42.82700103200045, -75.54397042699964)"
|
|
2016,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,736,50.8,45.7,56,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,AGE08,CAT3,_RFPSA21,RESP054,"(42.82700103200045, -75.54397042699964)"
|
|
2016,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,2395,61.9,58.5,65.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,AGE09,CAT3,_RFPSA21,RESP046,"(42.82700103200045, -75.54397042699964)"
|
|
2016,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,5523,61,59,62.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,BO1,CAT1,_RFPSA21,RESP054,"(42.82700103200045, -75.54397042699964)"
|
|
2016,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,231,24,18.9,29.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,EDUCA1,CAT5,_RFPSA21,RESP046,"(42.82700103200045, -75.54397042699964)"
|
|
2016,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,625,76,70.8,81.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,EDUCA1,CAT5,_RFPSA21,RESP054,"(42.82700103200045, -75.54397042699964)"
|
|
2016,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,1171,35.3,31.5,39,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,EDUCA2,CAT5,_RFPSA21,RESP046,"(42.82700103200045, -75.54397042699964)"
|
|
2016,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,1780,64.7,61,68.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,EDUCA2,CAT5,_RFPSA21,RESP054,"(42.82700103200045, -75.54397042699964)"
|
|
2016,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,1040,42.6,38.4,46.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,EDUCA3,CAT5,_RFPSA21,RESP046,"(42.82700103200045, -75.54397042699964)"
|
|
2016,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,1294,57.4,53.1,61.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,EDUCA3,CAT5,_RFPSA21,RESP054,"(42.82700103200045, -75.54397042699964)"
|
|
2016,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,1884,46.3,43.1,49.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,EDUCA4,CAT5,_RFPSA21,RESP046,"(42.82700103200045, -75.54397042699964)"
|
|
2016,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,1811,53.7,50.5,56.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,EDUCA4,CAT5,_RFPSA21,RESP054,"(42.82700103200045, -75.54397042699964)"
|
|
2016,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,270,28.2,22.3,34.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,INCOME1,CAT6,_RFPSA21,RESP046,"(42.82700103200045, -75.54397042699964)"
|
|
2016,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,592,71.8,65.8,77.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,INCOME1,CAT6,_RFPSA21,RESP054,"(42.82700103200045, -75.54397042699964)"
|
|
2016,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,442,30.8,25.4,36.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,INCOME2,CAT6,_RFPSA21,RESP046,"(42.82700103200045, -75.54397042699964)"
|
|
2016,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,913,69.2,63.7,74.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,INCOME2,CAT6,_RFPSA21,RESP054,"(42.82700103200045, -75.54397042699964)"
|
|
2016,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,389,41.3,34.1,48.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,INCOME3,CAT6,_RFPSA21,RESP046,"(42.82700103200045, -75.54397042699964)"
|
|
2016,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,516,58.7,51.4,65.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,INCOME3,CAT6,_RFPSA21,RESP054,"(42.82700103200045, -75.54397042699964)"
|
|
2016,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,594,34.6,28.8,40.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,INCOME4,CAT6,_RFPSA21,RESP046,"(42.82700103200045, -75.54397042699964)"
|
|
2016,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,711,65.4,59.6,71.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,INCOME4,CAT6,_RFPSA21,RESP054,"(42.82700103200045, -75.54397042699964)"
|
|
2016,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,2280,44.3,41.4,47.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,INCOME5,CAT6,_RFPSA21,RESP046,"(42.82700103200045, -75.54397042699964)"
|
|
2016,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,2357,55.7,52.8,58.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,INCOME5,CAT6,_RFPSA21,RESP054,"(42.82700103200045, -75.54397042699964)"
|
|
2016,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,3908,43.3,41.2,45.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,RACE01,CAT4,_RFPSA21,RESP046,"(42.82700103200045, -75.54397042699964)"
|
|
2016,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,4743,56.7,54.5,58.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,RACE01,CAT4,_RFPSA21,RESP054,"(42.82700103200045, -75.54397042699964)"
|
|
2016,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,157,36.4,29.5,43.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,RACE02,CAT4,_RFPSA21,RESP046,"(42.82700103200045, -75.54397042699964)"
|
|
2016,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,232,63.6,56.7,70.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,RACE02,CAT4,_RFPSA21,RESP054,"(42.82700103200045, -75.54397042699964)"
|
|
2016,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,38,34.3,16.5,52.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,RACE03,CAT4,_RFPSA21,RESP046,"(42.82700103200045, -75.54397042699964)"
|
|
2016,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,63,65.7,47.9,83.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,RACE03,CAT4,_RFPSA21,RESP054,"(42.82700103200045, -75.54397042699964)"
|
|
2016,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,45,24.3,15.1,33.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,RACE04,CAT4,_RFPSA21,RESP046,"(42.82700103200045, -75.54397042699964)"
|
|
2016,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,99,75.7,66.5,84.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,RACE04,CAT4,_RFPSA21,RESP054,"(42.82700103200045, -75.54397042699964)"
|
|
2016,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,36,RACE05,CAT4,_RFPSA21,RESP046,"(42.82700103200045, -75.54397042699964)"
|
|
2016,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,36,RACE05,CAT4,_RFPSA21,RESP054,"(42.82700103200045, -75.54397042699964)"
|
|
2016,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,36,RACE06,CAT4,_RFPSA21,RESP046,"(42.82700103200045, -75.54397042699964)"
|
|
2016,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,36,RACE06,CAT4,_RFPSA21,RESP054,"(42.82700103200045, -75.54397042699964)"
|
|
2016,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,34,42.9,19.5,66.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,RACE07,CAT4,_RFPSA21,RESP046,"(42.82700103200045, -75.54397042699964)"
|
|
2016,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,70,57.1,33.7,80.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,RACE07,CAT4,_RFPSA21,RESP054,"(42.82700103200045, -75.54397042699964)"
|
|
2016,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,156,29.6,24.1,35.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,RACE08,CAT4,_RFPSA21,RESP046,"(42.82700103200045, -75.54397042699964)"
|
|
2016,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,307,70.4,64.8,75.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,RACE08,CAT4,_RFPSA21,RESP054,"(42.82700103200045, -75.54397042699964)"
|
|
2016,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,4341,39,37.1,41,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,SEX1,CAT2,_RFPSA21,RESP046,"(42.82700103200045, -75.54397042699964)"
|
|
2016,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,5523,61,59,62.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,SEX1,CAT2,_RFPSA21,RESP054,"(42.82700103200045, -75.54397042699964)"
|
|
2016,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,36,SEX2,CAT2,_RFPSA21,RESP046,"(42.82700103200045, -75.54397042699964)"
|
|
2016,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,36,SEX2,CAT2,_RFPSA21,RESP054,"(42.82700103200045, -75.54397042699964)"
|
|
2016,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,60,14.8,10.7,18.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,AGE06,CAT3,_RFPSA21,RESP046,"(35.466220975000454, -79.15925046299964)"
|
|
2016,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,317,85.2,81.2,89.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,AGE06,CAT3,_RFPSA21,RESP054,"(35.466220975000454, -79.15925046299964)"
|
|
2016,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,200,41,35.8,46.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,AGE07,CAT3,_RFPSA21,RESP046,"(35.466220975000454, -79.15925046299964)"
|
|
2016,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,283,59,53.7,64.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,AGE07,CAT3,_RFPSA21,RESP054,"(35.466220975000454, -79.15925046299964)"
|
|
2016,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,145,55.3,47.9,62.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,AGE08,CAT3,_RFPSA21,RESP046,"(35.466220975000454, -79.15925046299964)"
|
|
2016,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,117,44.7,37.2,52.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,AGE08,CAT3,_RFPSA21,RESP054,"(35.466220975000454, -79.15925046299964)"
|
|
2016,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,470,66.1,61.7,70.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,AGE09,CAT3,_RFPSA21,RESP046,"(35.466220975000454, -79.15925046299964)"
|
|
2016,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,232,33.9,29.5,38.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,AGE09,CAT3,_RFPSA21,RESP054,"(35.466220975000454, -79.15925046299964)"
|
|
2016,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,875,43.8,41,46.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,BO1,CAT1,_RFPSA21,RESP046,"(35.466220975000454, -79.15925046299964)"
|
|
2016,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,949,56.2,53.5,59,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,BO1,CAT1,_RFPSA21,RESP054,"(35.466220975000454, -79.15925046299964)"
|
|
2016,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,62,27.4,20.3,34.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,EDUCA1,CAT5,_RFPSA21,RESP046,"(35.466220975000454, -79.15925046299964)"
|
|
2016,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,162,72.6,65.5,79.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,EDUCA1,CAT5,_RFPSA21,RESP054,"(35.466220975000454, -79.15925046299964)"
|
|
2016,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,199,39,33.8,44.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,EDUCA2,CAT5,_RFPSA21,RESP046,"(35.466220975000454, -79.15925046299964)"
|
|
2016,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,299,61,55.9,66.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,EDUCA2,CAT5,_RFPSA21,RESP054,"(35.466220975000454, -79.15925046299964)"
|
|
2016,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,247,48.1,42.7,53.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,EDUCA3,CAT5,_RFPSA21,RESP046,"(35.466220975000454, -79.15925046299964)"
|
|
2016,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,231,51.9,46.6,57.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,EDUCA3,CAT5,_RFPSA21,RESP054,"(35.466220975000454, -79.15925046299964)"
|
|
2016,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,364,54,49.4,58.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,EDUCA4,CAT5,_RFPSA21,RESP046,"(35.466220975000454, -79.15925046299964)"
|
|
2016,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,256,46,41.3,50.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,EDUCA4,CAT5,_RFPSA21,RESP054,"(35.466220975000454, -79.15925046299964)"
|
|
2016,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,49,35.4,24,46.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,INCOME1,CAT6,_RFPSA21,RESP046,"(35.466220975000454, -79.15925046299964)"
|
|
2016,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,91,64.6,53.3,76,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,INCOME1,CAT6,_RFPSA21,RESP054,"(35.466220975000454, -79.15925046299964)"
|
|
2016,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,94,32,25.4,38.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,INCOME2,CAT6,_RFPSA21,RESP046,"(35.466220975000454, -79.15925046299964)"
|
|
2016,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,167,68,61.5,74.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,INCOME2,CAT6,_RFPSA21,RESP054,"(35.466220975000454, -79.15925046299964)"
|
|
2016,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,73,44,34.9,53.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,INCOME3,CAT6,_RFPSA21,RESP046,"(35.466220975000454, -79.15925046299964)"
|
|
2016,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,93,56,46.9,65.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,INCOME3,CAT6,_RFPSA21,RESP054,"(35.466220975000454, -79.15925046299964)"
|
|
2016,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,108,45.3,37.1,53.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,INCOME4,CAT6,_RFPSA21,RESP046,"(35.466220975000454, -79.15925046299964)"
|
|
2016,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,101,54.7,46.6,62.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,INCOME4,CAT6,_RFPSA21,RESP054,"(35.466220975000454, -79.15925046299964)"
|
|
2016,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,432,49.1,44.9,53.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,INCOME5,CAT6,_RFPSA21,RESP046,"(35.466220975000454, -79.15925046299964)"
|
|
2016,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,364,50.9,46.8,55.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,INCOME5,CAT6,_RFPSA21,RESP054,"(35.466220975000454, -79.15925046299964)"
|
|
2016,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,688,46.3,43.1,49.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,RACE01,CAT4,_RFPSA21,RESP046,"(35.466220975000454, -79.15925046299964)"
|
|
2016,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,646,53.7,50.4,56.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,RACE01,CAT4,_RFPSA21,RESP054,"(35.466220975000454, -79.15925046299964)"
|
|
2016,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,134,41,34.4,47.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,RACE02,CAT4,_RFPSA21,RESP046,"(35.466220975000454, -79.15925046299964)"
|
|
2016,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,177,59,52.4,65.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,RACE02,CAT4,_RFPSA21,RESP054,"(35.466220975000454, -79.15925046299964)"
|
|
2016,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,37,RACE03,CAT4,_RFPSA21,RESP046,"(35.466220975000454, -79.15925046299964)"
|
|
2016,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,18,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,37,RACE03,CAT4,_RFPSA21,RESP054,"(35.466220975000454, -79.15925046299964)"
|
|
2016,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,37,RACE04,CAT4,_RFPSA21,RESP046,"(35.466220975000454, -79.15925046299964)"
|
|
2016,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,14,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,37,RACE04,CAT4,_RFPSA21,RESP054,"(35.466220975000454, -79.15925046299964)"
|
|
2016,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,37,RACE05,CAT4,_RFPSA21,RESP046,"(35.466220975000454, -79.15925046299964)"
|
|
2016,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,37,RACE05,CAT4,_RFPSA21,RESP054,"(35.466220975000454, -79.15925046299964)"
|
|
2016,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,37,RACE06,CAT4,_RFPSA21,RESP046,"(35.466220975000454, -79.15925046299964)"
|
|
2016,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,9,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,37,RACE06,CAT4,_RFPSA21,RESP054,"(35.466220975000454, -79.15925046299964)"
|
|
2016,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,13,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,37,RACE07,CAT4,_RFPSA21,RESP046,"(35.466220975000454, -79.15925046299964)"
|
|
2016,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,16,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,37,RACE07,CAT4,_RFPSA21,RESP054,"(35.466220975000454, -79.15925046299964)"
|
|
2016,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,15,23,11.2,34.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,RACE08,CAT4,_RFPSA21,RESP046,"(35.466220975000454, -79.15925046299964)"
|
|
2016,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,68,77,65.2,88.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,RACE08,CAT4,_RFPSA21,RESP054,"(35.466220975000454, -79.15925046299964)"
|
|
2016,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,875,43.8,41,46.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,SEX1,CAT2,_RFPSA21,RESP046,"(35.466220975000454, -79.15925046299964)"
|
|
2016,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,949,56.2,53.5,59,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,SEX1,CAT2,_RFPSA21,RESP054,"(35.466220975000454, -79.15925046299964)"
|
|
2016,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,37,SEX2,CAT2,_RFPSA21,RESP046,"(35.466220975000454, -79.15925046299964)"
|
|
2016,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,37,SEX2,CAT2,_RFPSA21,RESP054,"(35.466220975000454, -79.15925046299964)"
|
|
2016,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,395,56.8,52.5,61,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,AGE09,CAT3,_RFPSA21,RESP046,"(47.47531977900047, -100.11842104899966)"
|
|
2016,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,36,12.1,8,16.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,AGE06,CAT3,_RFPSA21,RESP046,"(47.47531977900047, -100.11842104899966)"
|
|
2016,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,245,87.9,83.7,92,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,AGE06,CAT3,_RFPSA21,RESP054,"(47.47531977900047, -100.11842104899966)"
|
|
2016,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,154,29.6,25,34.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,AGE07,CAT3,_RFPSA21,RESP046,"(47.47531977900047, -100.11842104899966)"
|
|
2016,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,326,70.4,65.9,75,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,AGE07,CAT3,_RFPSA21,RESP054,"(47.47531977900047, -100.11842104899966)"
|
|
2016,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,170,50,44,56,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,AGE08,CAT3,_RFPSA21,RESP046,"(47.47531977900047, -100.11842104899966)"
|
|
2016,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,158,50,44,56,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,AGE08,CAT3,_RFPSA21,RESP054,"(47.47531977900047, -100.11842104899966)"
|
|
2016,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,295,43.2,39,47.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,AGE09,CAT3,_RFPSA21,RESP054,"(47.47531977900047, -100.11842104899966)"
|
|
2016,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,755,37.2,34.6,39.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,BO1,CAT1,_RFPSA21,RESP046,"(47.47531977900047, -100.11842104899966)"
|
|
2016,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1024,62.8,60.3,65.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,BO1,CAT1,_RFPSA21,RESP054,"(47.47531977900047, -100.11842104899966)"
|
|
2016,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,29,26.8,17.4,36.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,EDUCA1,CAT5,_RFPSA21,RESP046,"(47.47531977900047, -100.11842104899966)"
|
|
2016,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,69,73.2,63.7,82.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,EDUCA1,CAT5,_RFPSA21,RESP054,"(47.47531977900047, -100.11842104899966)"
|
|
2016,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,227,36.4,32,40.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,EDUCA2,CAT5,_RFPSA21,RESP046,"(47.47531977900047, -100.11842104899966)"
|
|
2016,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,324,63.6,59.2,68,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,EDUCA2,CAT5,_RFPSA21,RESP054,"(47.47531977900047, -100.11842104899966)"
|
|
2016,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,238,37.3,32.8,41.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,EDUCA3,CAT5,_RFPSA21,RESP046,"(47.47531977900047, -100.11842104899966)"
|
|
2016,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,323,62.7,58.3,67.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,EDUCA3,CAT5,_RFPSA21,RESP054,"(47.47531977900047, -100.11842104899966)"
|
|
2016,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,258,41.1,36.6,45.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,EDUCA4,CAT5,_RFPSA21,RESP046,"(47.47531977900047, -100.11842104899966)"
|
|
2016,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,306,58.9,54.4,63.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,EDUCA4,CAT5,_RFPSA21,RESP054,"(47.47531977900047, -100.11842104899966)"
|
|
2016,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,21,26.6,14.9,38.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,INCOME1,CAT6,_RFPSA21,RESP046,"(47.47531977900047, -100.11842104899966)"
|
|
2016,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,47,73.4,61.6,85.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,INCOME1,CAT6,_RFPSA21,RESP054,"(47.47531977900047, -100.11842104899966)"
|
|
2016,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,54,27.4,20,34.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,INCOME2,CAT6,_RFPSA21,RESP046,"(47.47531977900047, -100.11842104899966)"
|
|
2016,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,111,72.6,65.2,80,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,INCOME2,CAT6,_RFPSA21,RESP054,"(47.47531977900047, -100.11842104899966)"
|
|
2016,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,56,37,28,46,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,INCOME3,CAT6,_RFPSA21,RESP046,"(47.47531977900047, -100.11842104899966)"
|
|
2016,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,84,63,54,72,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,INCOME3,CAT6,_RFPSA21,RESP054,"(47.47531977900047, -100.11842104899966)"
|
|
2016,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,114,34,27.8,40.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,INCOME4,CAT6,_RFPSA21,RESP046,"(47.47531977900047, -100.11842104899966)"
|
|
2016,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,176,66,59.8,72.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,INCOME4,CAT6,_RFPSA21,RESP054,"(47.47531977900047, -100.11842104899966)"
|
|
2016,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,457,40,36.6,43.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,INCOME5,CAT6,_RFPSA21,RESP046,"(47.47531977900047, -100.11842104899966)"
|
|
2016,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,544,60,56.6,63.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,INCOME5,CAT6,_RFPSA21,RESP054,"(47.47531977900047, -100.11842104899966)"
|
|
2016,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,726,37.9,35.3,40.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,RACE01,CAT4,_RFPSA21,RESP046,"(47.47531977900047, -100.11842104899966)"
|
|
2016,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,960,62.1,59.5,64.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,RACE01,CAT4,_RFPSA21,RESP054,"(47.47531977900047, -100.11842104899966)"
|
|
2016,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,38,RACE02,CAT4,_RFPSA21,RESP046,"(47.47531977900047, -100.11842104899966)"
|
|
2016,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,38,RACE02,CAT4,_RFPSA21,RESP054,"(47.47531977900047, -100.11842104899966)"
|
|
2016,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,13,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,38,RACE03,CAT4,_RFPSA21,RESP046,"(47.47531977900047, -100.11842104899966)"
|
|
2016,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,25,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,38,RACE03,CAT4,_RFPSA21,RESP054,"(47.47531977900047, -100.11842104899966)"
|
|
2016,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,38,RACE04,CAT4,_RFPSA21,RESP046,"(47.47531977900047, -100.11842104899966)"
|
|
2016,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,38,RACE04,CAT4,_RFPSA21,RESP054,"(47.47531977900047, -100.11842104899966)"
|
|
2016,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,38,RACE05,CAT4,_RFPSA21,RESP046,"(47.47531977900047, -100.11842104899966)"
|
|
2016,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,38,RACE05,CAT4,_RFPSA21,RESP054,"(47.47531977900047, -100.11842104899966)"
|
|
2016,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,38,RACE06,CAT4,_RFPSA21,RESP046,"(47.47531977900047, -100.11842104899966)"
|
|
2016,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,38,RACE06,CAT4,_RFPSA21,RESP054,"(47.47531977900047, -100.11842104899966)"
|
|
2016,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,38,RACE07,CAT4,_RFPSA21,RESP046,"(47.47531977900047, -100.11842104899966)"
|
|
2016,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,9,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,38,RACE07,CAT4,_RFPSA21,RESP054,"(47.47531977900047, -100.11842104899966)"
|
|
2016,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,38,RACE08,CAT4,_RFPSA21,RESP046,"(47.47531977900047, -100.11842104899966)"
|
|
2016,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,17,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,38,RACE08,CAT4,_RFPSA21,RESP054,"(47.47531977900047, -100.11842104899966)"
|
|
2016,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,755,37.2,34.6,39.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,SEX1,CAT2,_RFPSA21,RESP046,"(47.47531977900047, -100.11842104899966)"
|
|
2016,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1024,62.8,60.3,65.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,SEX1,CAT2,_RFPSA21,RESP054,"(47.47531977900047, -100.11842104899966)"
|
|
2016,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,38,SEX2,CAT2,_RFPSA21,RESP046,"(47.47531977900047, -100.11842104899966)"
|
|
2016,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,38,SEX2,CAT2,_RFPSA21,RESP054,"(47.47531977900047, -100.11842104899966)"
|
|
2016,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,102,15.4,11.4,19.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,AGE06,CAT3,_RFPSA21,RESP046,"(40.06021014100048, -82.40426005599966)"
|
|
2016,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,525,84.6,80.6,88.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,AGE06,CAT3,_RFPSA21,RESP054,"(40.06021014100048, -82.40426005599966)"
|
|
2016,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,362,34.4,30.2,38.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,AGE07,CAT3,_RFPSA21,RESP046,"(40.06021014100048, -82.40426005599966)"
|
|
2016,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,537,65.6,61.4,69.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,AGE07,CAT3,_RFPSA21,RESP054,"(40.06021014100048, -82.40426005599966)"
|
|
2016,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,296,53.5,47,59.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,AGE08,CAT3,_RFPSA21,RESP046,"(40.06021014100048, -82.40426005599966)"
|
|
2016,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,242,46.5,40.1,53,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,AGE08,CAT3,_RFPSA21,RESP054,"(40.06021014100048, -82.40426005599966)"
|
|
2016,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,913,57.6,53.8,61.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,AGE09,CAT3,_RFPSA21,RESP046,"(40.06021014100048, -82.40426005599966)"
|
|
2016,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,612,42.4,38.7,46.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,AGE09,CAT3,_RFPSA21,RESP054,"(40.06021014100048, -82.40426005599966)"
|
|
2016,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1673,39.4,37.1,41.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,BO1,CAT1,_RFPSA21,RESP046,"(40.06021014100048, -82.40426005599966)"
|
|
2016,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1916,60.6,58.2,62.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,BO1,CAT1,_RFPSA21,RESP054,"(40.06021014100048, -82.40426005599966)"
|
|
2016,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,76,22.9,15.4,30.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,EDUCA1,CAT5,_RFPSA21,RESP046,"(40.06021014100048, -82.40426005599966)"
|
|
2016,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,168,77.1,69.6,84.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,EDUCA1,CAT5,_RFPSA21,RESP054,"(40.06021014100048, -82.40426005599966)"
|
|
2016,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,530,36,32.3,39.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,EDUCA2,CAT5,_RFPSA21,RESP046,"(40.06021014100048, -82.40426005599966)"
|
|
2016,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,756,64,60.3,67.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,EDUCA2,CAT5,_RFPSA21,RESP054,"(40.06021014100048, -82.40426005599966)"
|
|
2016,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,447,45.3,40.6,50,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,EDUCA3,CAT5,_RFPSA21,RESP046,"(40.06021014100048, -82.40426005599966)"
|
|
2016,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,433,54.7,50,59.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,EDUCA3,CAT5,_RFPSA21,RESP054,"(40.06021014100048, -82.40426005599966)"
|
|
2016,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,618,45.9,42.1,49.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,EDUCA4,CAT5,_RFPSA21,RESP046,"(40.06021014100048, -82.40426005599966)"
|
|
2016,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,557,54.1,50.3,57.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,EDUCA4,CAT5,_RFPSA21,RESP054,"(40.06021014100048, -82.40426005599966)"
|
|
2016,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,76,27.2,17.7,36.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,INCOME1,CAT6,_RFPSA21,RESP046,"(40.06021014100048, -82.40426005599966)"
|
|
2016,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,166,72.8,63.3,82.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,INCOME1,CAT6,_RFPSA21,RESP054,"(40.06021014100048, -82.40426005599966)"
|
|
2016,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,180,31.8,25.4,38.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,INCOME2,CAT6,_RFPSA21,RESP046,"(40.06021014100048, -82.40426005599966)"
|
|
2016,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,319,68.2,61.7,74.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,INCOME2,CAT6,_RFPSA21,RESP054,"(40.06021014100048, -82.40426005599966)"
|
|
2016,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,186,39.6,32.4,46.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,INCOME3,CAT6,_RFPSA21,RESP046,"(40.06021014100048, -82.40426005599966)"
|
|
2016,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,189,60.4,53.2,67.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,INCOME3,CAT6,_RFPSA21,RESP054,"(40.06021014100048, -82.40426005599966)"
|
|
2016,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,256,41.2,35.1,47.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,INCOME4,CAT6,_RFPSA21,RESP046,"(40.06021014100048, -82.40426005599966)"
|
|
2016,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,239,58.8,52.8,64.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,INCOME4,CAT6,_RFPSA21,RESP054,"(40.06021014100048, -82.40426005599966)"
|
|
2016,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,781,41.7,38.3,45,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,INCOME5,CAT6,_RFPSA21,RESP046,"(40.06021014100048, -82.40426005599966)"
|
|
2016,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,798,58.3,55,61.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,INCOME5,CAT6,_RFPSA21,RESP054,"(40.06021014100048, -82.40426005599966)"
|
|
2016,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1541,39.9,37.5,42.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,RACE01,CAT4,_RFPSA21,RESP046,"(40.06021014100048, -82.40426005599966)"
|
|
2016,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1716,60.1,57.7,62.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,RACE01,CAT4,_RFPSA21,RESP054,"(40.06021014100048, -82.40426005599966)"
|
|
2016,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,78,38.8,29.7,48,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,RACE02,CAT4,_RFPSA21,RESP046,"(40.06021014100048, -82.40426005599966)"
|
|
2016,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,108,61.2,52,70.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,RACE02,CAT4,_RFPSA21,RESP054,"(40.06021014100048, -82.40426005599966)"
|
|
2016,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,15,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,39,RACE03,CAT4,_RFPSA21,RESP046,"(40.06021014100048, -82.40426005599966)"
|
|
2016,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,25,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,39,RACE03,CAT4,_RFPSA21,RESP054,"(40.06021014100048, -82.40426005599966)"
|
|
2016,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,39,RACE04,CAT4,_RFPSA21,RESP046,"(40.06021014100048, -82.40426005599966)"
|
|
2016,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,20,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,39,RACE04,CAT4,_RFPSA21,RESP054,"(40.06021014100048, -82.40426005599966)"
|
|
2016,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,39,RACE05,CAT4,_RFPSA21,RESP046,"(40.06021014100048, -82.40426005599966)"
|
|
2016,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,39,RACE05,CAT4,_RFPSA21,RESP054,"(40.06021014100048, -82.40426005599966)"
|
|
2016,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,39,RACE06,CAT4,_RFPSA21,RESP046,"(40.06021014100048, -82.40426005599966)"
|
|
2016,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,39,RACE06,CAT4,_RFPSA21,RESP054,"(40.06021014100048, -82.40426005599966)"
|
|
2016,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,21,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,39,RACE07,CAT4,_RFPSA21,RESP046,"(40.06021014100048, -82.40426005599966)"
|
|
2016,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,23,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,39,RACE07,CAT4,_RFPSA21,RESP054,"(40.06021014100048, -82.40426005599966)"
|
|
2016,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,39,RACE08,CAT4,_RFPSA21,RESP046,"(40.06021014100048, -82.40426005599966)"
|
|
2016,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,17,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,39,RACE08,CAT4,_RFPSA21,RESP054,"(40.06021014100048, -82.40426005599966)"
|
|
2016,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1673,39.4,37.1,41.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,SEX1,CAT2,_RFPSA21,RESP046,"(40.06021014100048, -82.40426005599966)"
|
|
2016,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1916,60.6,58.2,62.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,SEX1,CAT2,_RFPSA21,RESP054,"(40.06021014100048, -82.40426005599966)"
|
|
2016,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,39,SEX2,CAT2,_RFPSA21,RESP046,"(40.06021014100048, -82.40426005599966)"
|
|
2016,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,39,SEX2,CAT2,_RFPSA21,RESP054,"(40.06021014100048, -82.40426005599966)"
|
|
2016,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,66,22.8,16.9,28.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,AGE06,CAT3,_RFPSA21,RESP046,"(35.47203135600046, -97.52107021399968)"
|
|
2016,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,205,77.2,71.4,83.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,AGE06,CAT3,_RFPSA21,RESP054,"(35.47203135600046, -97.52107021399968)"
|
|
2016,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,201,39.5,34.2,44.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,AGE07,CAT3,_RFPSA21,RESP046,"(35.47203135600046, -97.52107021399968)"
|
|
2016,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,252,60.5,55.2,65.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,AGE07,CAT3,_RFPSA21,RESP054,"(35.47203135600046, -97.52107021399968)"
|
|
2016,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,171,56.2,49.5,62.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,AGE08,CAT3,_RFPSA21,RESP046,"(35.47203135600046, -97.52107021399968)"
|
|
2016,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,122,43.8,37.1,50.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,AGE08,CAT3,_RFPSA21,RESP054,"(35.47203135600046, -97.52107021399968)"
|
|
2016,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,603,65.6,61.9,69.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,AGE09,CAT3,_RFPSA21,RESP046,"(35.47203135600046, -97.52107021399968)"
|
|
2016,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,304,34.4,30.7,38.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,AGE09,CAT3,_RFPSA21,RESP054,"(35.47203135600046, -97.52107021399968)"
|
|
2016,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1041,45.9,43.2,48.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,BO1,CAT1,_RFPSA21,RESP046,"(35.47203135600046, -97.52107021399968)"
|
|
2016,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,883,54.1,51.3,56.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,BO1,CAT1,_RFPSA21,RESP054,"(35.47203135600046, -97.52107021399968)"
|
|
2016,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,43,27.3,18.9,35.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,EDUCA1,CAT5,_RFPSA21,RESP046,"(35.47203135600046, -97.52107021399968)"
|
|
2016,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,89,72.7,64.2,81.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,EDUCA1,CAT5,_RFPSA21,RESP054,"(35.47203135600046, -97.52107021399968)"
|
|
2016,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,239,40.4,35.3,45.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,EDUCA2,CAT5,_RFPSA21,RESP046,"(35.47203135600046, -97.52107021399968)"
|
|
2016,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,264,59.6,54.6,64.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,EDUCA2,CAT5,_RFPSA21,RESP054,"(35.47203135600046, -97.52107021399968)"
|
|
2016,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,327,49.5,44.6,54.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,EDUCA3,CAT5,_RFPSA21,RESP046,"(35.47203135600046, -97.52107021399968)"
|
|
2016,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,284,50.5,45.6,55.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,EDUCA3,CAT5,_RFPSA21,RESP054,"(35.47203135600046, -97.52107021399968)"
|
|
2016,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,429,57.1,52.3,61.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,EDUCA4,CAT5,_RFPSA21,RESP046,"(35.47203135600046, -97.52107021399968)"
|
|
2016,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,244,42.9,38.1,47.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,EDUCA4,CAT5,_RFPSA21,RESP054,"(35.47203135600046, -97.52107021399968)"
|
|
2016,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,44,26.8,17.5,36.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,INCOME1,CAT6,_RFPSA21,RESP046,"(35.47203135600046, -97.52107021399968)"
|
|
2016,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,91,73.2,63.9,82.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,INCOME1,CAT6,_RFPSA21,RESP054,"(35.47203135600046, -97.52107021399968)"
|
|
2016,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,97,37.5,29.8,45.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,INCOME2,CAT6,_RFPSA21,RESP046,"(35.47203135600046, -97.52107021399968)"
|
|
2016,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,136,62.5,54.8,70.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,INCOME2,CAT6,_RFPSA21,RESP054,"(35.47203135600046, -97.52107021399968)"
|
|
2016,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,97,46.9,37.6,56.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,INCOME3,CAT6,_RFPSA21,RESP046,"(35.47203135600046, -97.52107021399968)"
|
|
2016,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,82,53.1,43.8,62.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,INCOME3,CAT6,_RFPSA21,RESP054,"(35.47203135600046, -97.52107021399968)"
|
|
2016,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,155,48.6,41.3,55.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,INCOME4,CAT6,_RFPSA21,RESP046,"(35.47203135600046, -97.52107021399968)"
|
|
2016,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,130,51.4,44.1,58.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,INCOME4,CAT6,_RFPSA21,RESP054,"(35.47203135600046, -97.52107021399968)"
|
|
2016,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,455,48.9,44.4,53.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,INCOME5,CAT6,_RFPSA21,RESP046,"(35.47203135600046, -97.52107021399968)"
|
|
2016,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,319,51.1,46.7,55.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,INCOME5,CAT6,_RFPSA21,RESP054,"(35.47203135600046, -97.52107021399968)"
|
|
2016,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,844,46.8,43.8,50,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,RACE01,CAT4,_RFPSA21,RESP046,"(35.47203135600046, -97.52107021399968)"
|
|
2016,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,686,53.2,50,56.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,RACE01,CAT4,_RFPSA21,RESP054,"(35.47203135600046, -97.52107021399968)"
|
|
2016,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,60,52.8,40.7,64.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,RACE02,CAT4,_RFPSA21,RESP046,"(35.47203135600046, -97.52107021399968)"
|
|
2016,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,44,47.2,35.2,59.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,RACE02,CAT4,_RFPSA21,RESP054,"(35.47203135600046, -97.52107021399968)"
|
|
2016,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,61,42.4,31.2,53.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,RACE03,CAT4,_RFPSA21,RESP046,"(35.47203135600046, -97.52107021399968)"
|
|
2016,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,57,57.6,46.5,68.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,RACE03,CAT4,_RFPSA21,RESP054,"(35.47203135600046, -97.52107021399968)"
|
|
2016,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,40,RACE04,CAT4,_RFPSA21,RESP046,"(35.47203135600046, -97.52107021399968)"
|
|
2016,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,40,RACE04,CAT4,_RFPSA21,RESP054,"(35.47203135600046, -97.52107021399968)"
|
|
2016,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,40,RACE05,CAT4,_RFPSA21,RESP046,"(35.47203135600046, -97.52107021399968)"
|
|
2016,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,40,RACE05,CAT4,_RFPSA21,RESP054,"(35.47203135600046, -97.52107021399968)"
|
|
2016,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,40,RACE06,CAT4,_RFPSA21,RESP046,"(35.47203135600046, -97.52107021399968)"
|
|
2016,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,40,RACE06,CAT4,_RFPSA21,RESP054,"(35.47203135600046, -97.52107021399968)"
|
|
2016,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,53,42.1,30.4,53.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,RACE07,CAT4,_RFPSA21,RESP046,"(35.47203135600046, -97.52107021399968)"
|
|
2016,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,56,57.9,46.1,69.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,RACE07,CAT4,_RFPSA21,RESP054,"(35.47203135600046, -97.52107021399968)"
|
|
2016,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,15,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,40,RACE08,CAT4,_RFPSA21,RESP046,"(35.47203135600046, -97.52107021399968)"
|
|
2016,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,30,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,40,RACE08,CAT4,_RFPSA21,RESP054,"(35.47203135600046, -97.52107021399968)"
|
|
2016,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1041,45.9,43.2,48.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,SEX1,CAT2,_RFPSA21,RESP046,"(35.47203135600046, -97.52107021399968)"
|
|
2016,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,883,54.1,51.3,56.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,SEX1,CAT2,_RFPSA21,RESP054,"(35.47203135600046, -97.52107021399968)"
|
|
2016,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,40,SEX2,CAT2,_RFPSA21,RESP046,"(35.47203135600046, -97.52107021399968)"
|
|
2016,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,40,SEX2,CAT2,_RFPSA21,RESP054,"(35.47203135600046, -97.52107021399968)"
|
|
2016,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,27,7.5,4.4,10.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,AGE06,CAT3,_RFPSA21,RESP046,"(44.56744942400047, -120.15503132599969)"
|
|
2016,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,282,92.5,89.4,95.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,AGE06,CAT3,_RFPSA21,RESP054,"(44.56744942400047, -120.15503132599969)"
|
|
2016,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,94,29.6,24,35.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,AGE07,CAT3,_RFPSA21,RESP046,"(44.56744942400047, -120.15503132599969)"
|
|
2016,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,217,70.4,64.7,76,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,AGE07,CAT3,_RFPSA21,RESP054,"(44.56744942400047, -120.15503132599969)"
|
|
2016,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,99,43.9,36.7,51.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,AGE08,CAT3,_RFPSA21,RESP046,"(44.56744942400047, -120.15503132599969)"
|
|
2016,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,125,56.1,48.9,63.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,AGE08,CAT3,_RFPSA21,RESP054,"(44.56744942400047, -120.15503132599969)"
|
|
2016,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,321,56.3,51.7,60.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,AGE09,CAT3,_RFPSA21,RESP046,"(44.56744942400047, -120.15503132599969)"
|
|
2016,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,248,43.7,39.2,48.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,AGE09,CAT3,_RFPSA21,RESP054,"(44.56744942400047, -120.15503132599969)"
|
|
2016,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,541,34.5,31.7,37.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,BO1,CAT1,_RFPSA21,RESP046,"(44.56744942400047, -120.15503132599969)"
|
|
2016,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,872,65.5,62.8,68.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,BO1,CAT1,_RFPSA21,RESP054,"(44.56744942400047, -120.15503132599969)"
|
|
2016,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,15,16.9,8.4,25.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,EDUCA1,CAT5,_RFPSA21,RESP046,"(44.56744942400047, -120.15503132599969)"
|
|
2016,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,56,83.1,74.7,91.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,EDUCA1,CAT5,_RFPSA21,RESP054,"(44.56744942400047, -120.15503132599969)"
|
|
2016,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,96,29.8,24.2,35.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,EDUCA2,CAT5,_RFPSA21,RESP046,"(44.56744942400047, -120.15503132599969)"
|
|
2016,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,202,70.2,64.6,75.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,EDUCA2,CAT5,_RFPSA21,RESP054,"(44.56744942400047, -120.15503132599969)"
|
|
2016,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,154,37.5,32.4,42.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,EDUCA3,CAT5,_RFPSA21,RESP046,"(44.56744942400047, -120.15503132599969)"
|
|
2016,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,249,62.5,57.4,67.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,EDUCA3,CAT5,_RFPSA21,RESP054,"(44.56744942400047, -120.15503132599969)"
|
|
2016,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,276,40.2,36.1,44.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,EDUCA4,CAT5,_RFPSA21,RESP046,"(44.56744942400047, -120.15503132599969)"
|
|
2016,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,364,59.8,55.7,63.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,EDUCA4,CAT5,_RFPSA21,RESP054,"(44.56744942400047, -120.15503132599969)"
|
|
2016,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,22,19.8,11.1,28.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,INCOME1,CAT6,_RFPSA21,RESP046,"(44.56744942400047, -120.15503132599969)"
|
|
2016,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,78,80.2,71.4,88.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,INCOME1,CAT6,_RFPSA21,RESP054,"(44.56744942400047, -120.15503132599969)"
|
|
2016,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,40,24.3,16.5,32.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,INCOME2,CAT6,_RFPSA21,RESP046,"(44.56744942400047, -120.15503132599969)"
|
|
2016,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,98,75.7,67.9,83.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,INCOME2,CAT6,_RFPSA21,RESP054,"(44.56744942400047, -120.15503132599969)"
|
|
2016,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,53,41.3,31.2,51.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,INCOME3,CAT6,_RFPSA21,RESP046,"(44.56744942400047, -120.15503132599969)"
|
|
2016,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,66,58.7,48.6,68.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,INCOME3,CAT6,_RFPSA21,RESP054,"(44.56744942400047, -120.15503132599969)"
|
|
2016,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,73,39.1,30.6,47.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,INCOME4,CAT6,_RFPSA21,RESP046,"(44.56744942400047, -120.15503132599969)"
|
|
2016,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,94,60.9,52.4,69.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,INCOME4,CAT6,_RFPSA21,RESP054,"(44.56744942400047, -120.15503132599969)"
|
|
2016,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,286,36,32.2,39.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,INCOME5,CAT6,_RFPSA21,RESP046,"(44.56744942400047, -120.15503132599969)"
|
|
2016,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,437,64,60.2,67.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,INCOME5,CAT6,_RFPSA21,RESP054,"(44.56744942400047, -120.15503132599969)"
|
|
2016,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,480,36,33.1,38.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,RACE01,CAT4,_RFPSA21,RESP046,"(44.56744942400047, -120.15503132599969)"
|
|
2016,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,748,64,61.1,66.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,RACE01,CAT4,_RFPSA21,RESP054,"(44.56744942400047, -120.15503132599969)"
|
|
2016,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,41,RACE02,CAT4,_RFPSA21,RESP046,"(44.56744942400047, -120.15503132599969)"
|
|
2016,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,41,RACE02,CAT4,_RFPSA21,RESP054,"(44.56744942400047, -120.15503132599969)"
|
|
2016,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,41,RACE03,CAT4,_RFPSA21,RESP046,"(44.56744942400047, -120.15503132599969)"
|
|
2016,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,41,RACE03,CAT4,_RFPSA21,RESP054,"(44.56744942400047, -120.15503132599969)"
|
|
2016,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,41,RACE04,CAT4,_RFPSA21,RESP046,"(44.56744942400047, -120.15503132599969)"
|
|
2016,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,41,RACE04,CAT4,_RFPSA21,RESP054,"(44.56744942400047, -120.15503132599969)"
|
|
2016,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,41,RACE05,CAT4,_RFPSA21,RESP046,"(44.56744942400047, -120.15503132599969)"
|
|
2016,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,41,RACE05,CAT4,_RFPSA21,RESP054,"(44.56744942400047, -120.15503132599969)"
|
|
2016,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,41,RACE06,CAT4,_RFPSA21,RESP046,"(44.56744942400047, -120.15503132599969)"
|
|
2016,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,41,RACE06,CAT4,_RFPSA21,RESP054,"(44.56744942400047, -120.15503132599969)"
|
|
2016,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,29,32.5,21,43.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,RACE07,CAT4,_RFPSA21,RESP046,"(44.56744942400047, -120.15503132599969)"
|
|
2016,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,48,67.5,56.1,79,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,RACE07,CAT4,_RFPSA21,RESP054,"(44.56744942400047, -120.15503132599969)"
|
|
2016,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,11,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,41,RACE08,CAT4,_RFPSA21,RESP046,"(44.56744942400047, -120.15503132599969)"
|
|
2016,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,46,85.5,76.6,94.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,RACE08,CAT4,_RFPSA21,RESP054,"(44.56744942400047, -120.15503132599969)"
|
|
2016,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,541,34.5,31.7,37.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,SEX1,CAT2,_RFPSA21,RESP046,"(44.56744942400047, -120.15503132599969)"
|
|
2016,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,872,65.5,62.8,68.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,SEX1,CAT2,_RFPSA21,RESP054,"(44.56744942400047, -120.15503132599969)"
|
|
2016,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,41,SEX2,CAT2,_RFPSA21,RESP046,"(44.56744942400047, -120.15503132599969)"
|
|
2016,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,41,SEX2,CAT2,_RFPSA21,RESP054,"(44.56744942400047, -120.15503132599969)"
|
|
2016,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,44,11,7.2,14.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,AGE06,CAT3,_RFPSA21,RESP046,"(40.79373015200048, -77.86070029399963)"
|
|
2016,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,333,89,85.2,92.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,AGE06,CAT3,_RFPSA21,RESP054,"(40.79373015200048, -77.86070029399963)"
|
|
2016,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,212,34.8,30,39.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,AGE07,CAT3,_RFPSA21,RESP046,"(40.79373015200048, -77.86070029399963)"
|
|
2016,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,362,65.2,60.4,70,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,AGE07,CAT3,_RFPSA21,RESP054,"(40.79373015200048, -77.86070029399963)"
|
|
2016,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,136,47.2,40,54.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,AGE08,CAT3,_RFPSA21,RESP046,"(40.79373015200048, -77.86070029399963)"
|
|
2016,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,148,52.8,45.6,60,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,AGE08,CAT3,_RFPSA21,RESP054,"(40.79373015200048, -77.86070029399963)"
|
|
2016,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,453,60.9,56,65.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,AGE09,CAT3,_RFPSA21,RESP046,"(40.79373015200048, -77.86070029399963)"
|
|
2016,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,262,39.1,34.2,44,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,AGE09,CAT3,_RFPSA21,RESP054,"(40.79373015200048, -77.86070029399963)"
|
|
2016,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,845,39.3,36.6,42,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,BO1,CAT1,_RFPSA21,RESP046,"(40.79373015200048, -77.86070029399963)"
|
|
2016,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1105,60.7,58,63.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,BO1,CAT1,_RFPSA21,RESP054,"(40.79373015200048, -77.86070029399963)"
|
|
2016,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,30,21.5,13.1,30,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,EDUCA1,CAT5,_RFPSA21,RESP046,"(40.79373015200048, -77.86070029399963)"
|
|
2016,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,87,78.5,70,86.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,EDUCA1,CAT5,_RFPSA21,RESP054,"(40.79373015200048, -77.86070029399963)"
|
|
2016,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,253,39.7,35.3,44.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,EDUCA2,CAT5,_RFPSA21,RESP046,"(40.79373015200048, -77.86070029399963)"
|
|
2016,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,379,60.3,55.9,64.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,EDUCA2,CAT5,_RFPSA21,RESP054,"(40.79373015200048, -77.86070029399963)"
|
|
2016,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,183,41.8,36.1,47.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,EDUCA3,CAT5,_RFPSA21,RESP046,"(40.79373015200048, -77.86070029399963)"
|
|
2016,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,223,58.2,52.5,63.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,EDUCA3,CAT5,_RFPSA21,RESP054,"(40.79373015200048, -77.86070029399963)"
|
|
2016,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,377,44.7,40.5,48.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,EDUCA4,CAT5,_RFPSA21,RESP046,"(40.79373015200048, -77.86070029399963)"
|
|
2016,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,414,55.3,51.2,59.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,EDUCA4,CAT5,_RFPSA21,RESP054,"(40.79373015200048, -77.86070029399963)"
|
|
2016,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,37,21.1,12.5,29.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,INCOME1,CAT6,_RFPSA21,RESP046,"(40.79373015200048, -77.86070029399963)"
|
|
2016,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,81,78.9,70.3,87.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,INCOME1,CAT6,_RFPSA21,RESP054,"(40.79373015200048, -77.86070029399963)"
|
|
2016,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,83,37.6,30,45.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,INCOME2,CAT6,_RFPSA21,RESP046,"(40.79373015200048, -77.86070029399963)"
|
|
2016,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,143,62.4,54.8,70,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,INCOME2,CAT6,_RFPSA21,RESP054,"(40.79373015200048, -77.86070029399963)"
|
|
2016,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,76,39.1,29.3,49,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,INCOME3,CAT6,_RFPSA21,RESP046,"(40.79373015200048, -77.86070029399963)"
|
|
2016,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,77,60.9,51,70.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,INCOME3,CAT6,_RFPSA21,RESP054,"(40.79373015200048, -77.86070029399963)"
|
|
2016,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,129,42.9,35.5,50.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,INCOME4,CAT6,_RFPSA21,RESP046,"(40.79373015200048, -77.86070029399963)"
|
|
2016,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,156,57.1,49.6,64.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,INCOME4,CAT6,_RFPSA21,RESP054,"(40.79373015200048, -77.86070029399963)"
|
|
2016,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,445,39.9,36.2,43.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,INCOME5,CAT6,_RFPSA21,RESP046,"(40.79373015200048, -77.86070029399963)"
|
|
2016,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,560,60.1,56.4,63.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,INCOME5,CAT6,_RFPSA21,RESP054,"(40.79373015200048, -77.86070029399963)"
|
|
2016,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,756,40.8,37.9,43.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,RACE01,CAT4,_RFPSA21,RESP046,"(40.79373015200048, -77.86070029399963)"
|
|
2016,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,964,59.2,56.3,62.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,RACE01,CAT4,_RFPSA21,RESP054,"(40.79373015200048, -77.86070029399963)"
|
|
2016,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,59,36,26,46.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,RACE02,CAT4,_RFPSA21,RESP046,"(40.79373015200048, -77.86070029399963)"
|
|
2016,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,68,64,53.9,74,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,RACE02,CAT4,_RFPSA21,RESP054,"(40.79373015200048, -77.86070029399963)"
|
|
2016,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,42,RACE03,CAT4,_RFPSA21,RESP046,"(40.79373015200048, -77.86070029399963)"
|
|
2016,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,9,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,42,RACE03,CAT4,_RFPSA21,RESP054,"(40.79373015200048, -77.86070029399963)"
|
|
2016,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,9,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,42,RACE04,CAT4,_RFPSA21,RESP046,"(40.79373015200048, -77.86070029399963)"
|
|
2016,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,18,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,42,RACE04,CAT4,_RFPSA21,RESP054,"(40.79373015200048, -77.86070029399963)"
|
|
2016,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,42,RACE05,CAT4,_RFPSA21,RESP046,"(40.79373015200048, -77.86070029399963)"
|
|
2016,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,42,RACE05,CAT4,_RFPSA21,RESP054,"(40.79373015200048, -77.86070029399963)"
|
|
2016,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,42,RACE06,CAT4,_RFPSA21,RESP046,"(40.79373015200048, -77.86070029399963)"
|
|
2016,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,42,RACE06,CAT4,_RFPSA21,RESP054,"(40.79373015200048, -77.86070029399963)"
|
|
2016,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,42,RACE07,CAT4,_RFPSA21,RESP046,"(40.79373015200048, -77.86070029399963)"
|
|
2016,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,14,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,42,RACE07,CAT4,_RFPSA21,RESP054,"(40.79373015200048, -77.86070029399963)"
|
|
2016,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,13,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,42,RACE08,CAT4,_RFPSA21,RESP046,"(40.79373015200048, -77.86070029399963)"
|
|
2016,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,30,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,42,RACE08,CAT4,_RFPSA21,RESP054,"(40.79373015200048, -77.86070029399963)"
|
|
2016,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,845,39.3,36.6,42,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,SEX1,CAT2,_RFPSA21,RESP046,"(40.79373015200048, -77.86070029399963)"
|
|
2016,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1105,60.7,58,63.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,SEX1,CAT2,_RFPSA21,RESP054,"(40.79373015200048, -77.86070029399963)"
|
|
2016,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,42,SEX2,CAT2,_RFPSA21,RESP046,"(40.79373015200048, -77.86070029399963)"
|
|
2016,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,42,SEX2,CAT2,_RFPSA21,RESP054,"(40.79373015200048, -77.86070029399963)"
|
|
2016,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,132,43,35.2,50.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,AGE06,CAT3,_RFPSA21,RESP046,"(18.220833, -66.590149)"
|
|
2016,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,153,57,49.2,64.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,AGE06,CAT3,_RFPSA21,RESP054,"(18.220833, -66.590149)"
|
|
2016,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,252,63.4,56.9,69.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,AGE07,CAT3,_RFPSA21,RESP046,"(18.220833, -66.590149)"
|
|
2016,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,132,36.6,30.1,43.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,AGE07,CAT3,_RFPSA21,RESP054,"(18.220833, -66.590149)"
|
|
2016,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,144,65.4,57,73.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,AGE08,CAT3,_RFPSA21,RESP046,"(18.220833, -66.590149)"
|
|
2016,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,63,34.6,26.1,43,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,AGE08,CAT3,_RFPSA21,RESP054,"(18.220833, -66.590149)"
|
|
2016,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,501,74,69.2,78.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,AGE09,CAT3,_RFPSA21,RESP046,"(18.220833, -66.590149)"
|
|
2016,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,145,26,21.3,30.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,AGE09,CAT3,_RFPSA21,RESP054,"(18.220833, -66.590149)"
|
|
2016,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1029,61,57.5,64.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,BO1,CAT1,_RFPSA21,RESP046,"(18.220833, -66.590149)"
|
|
2016,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,493,39,35.5,42.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,BO1,CAT1,_RFPSA21,RESP054,"(18.220833, -66.590149)"
|
|
2016,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,231,57,49.9,64.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,EDUCA1,CAT5,_RFPSA21,RESP046,"(18.220833, -66.590149)"
|
|
2016,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,129,43,35.8,50.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,EDUCA1,CAT5,_RFPSA21,RESP054,"(18.220833, -66.590149)"
|
|
2016,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,257,57.8,51.6,64,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,EDUCA2,CAT5,_RFPSA21,RESP046,"(18.220833, -66.590149)"
|
|
2016,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,150,42.2,36,48.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,EDUCA2,CAT5,_RFPSA21,RESP054,"(18.220833, -66.590149)"
|
|
2016,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,209,63.8,56.7,71,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,EDUCA3,CAT5,_RFPSA21,RESP046,"(18.220833, -66.590149)"
|
|
2016,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,99,36.2,29,43.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,EDUCA3,CAT5,_RFPSA21,RESP054,"(18.220833, -66.590149)"
|
|
2016,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,328,70.1,64.5,75.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,EDUCA4,CAT5,_RFPSA21,RESP046,"(18.220833, -66.590149)"
|
|
2016,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,113,29.9,24.3,35.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,EDUCA4,CAT5,_RFPSA21,RESP054,"(18.220833, -66.590149)"
|
|
2016,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,326,59.2,53.2,65.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,INCOME1,CAT6,_RFPSA21,RESP046,"(18.220833, -66.590149)"
|
|
2016,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,175,40.8,34.8,46.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,INCOME1,CAT6,_RFPSA21,RESP054,"(18.220833, -66.590149)"
|
|
2016,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,274,61.3,54.7,68,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,INCOME2,CAT6,_RFPSA21,RESP046,"(18.220833, -66.590149)"
|
|
2016,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,133,38.7,32,45.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,INCOME2,CAT6,_RFPSA21,RESP054,"(18.220833, -66.590149)"
|
|
2016,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,101,61.9,50,73.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,INCOME3,CAT6,_RFPSA21,RESP046,"(18.220833, -66.590149)"
|
|
2016,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,47,38.1,26.3,50,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,INCOME3,CAT6,_RFPSA21,RESP054,"(18.220833, -66.590149)"
|
|
2016,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,81,61.6,49.8,73.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,INCOME4,CAT6,_RFPSA21,RESP046,"(18.220833, -66.590149)"
|
|
2016,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,31,38.4,26.6,50.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,INCOME4,CAT6,_RFPSA21,RESP054,"(18.220833, -66.590149)"
|
|
2016,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,105,66.9,56.8,77,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,INCOME5,CAT6,_RFPSA21,RESP046,"(18.220833, -66.590149)"
|
|
2016,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,42,33.1,23,43.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,INCOME5,CAT6,_RFPSA21,RESP054,"(18.220833, -66.590149)"
|
|
2016,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,72,RACE01,CAT4,_RFPSA21,RESP046,"(18.220833, -66.590149)"
|
|
2016,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,72,RACE01,CAT4,_RFPSA21,RESP054,"(18.220833, -66.590149)"
|
|
2016,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,72,RACE02,CAT4,_RFPSA21,RESP046,"(18.220833, -66.590149)"
|
|
2016,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,72,RACE02,CAT4,_RFPSA21,RESP054,"(18.220833, -66.590149)"
|
|
2016,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,72,RACE03,CAT4,_RFPSA21,RESP046,"(18.220833, -66.590149)"
|
|
2016,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,72,RACE03,CAT4,_RFPSA21,RESP054,"(18.220833, -66.590149)"
|
|
2016,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,72,RACE04,CAT4,_RFPSA21,RESP046,"(18.220833, -66.590149)"
|
|
2016,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,72,RACE04,CAT4,_RFPSA21,RESP054,"(18.220833, -66.590149)"
|
|
2016,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,72,RACE05,CAT4,_RFPSA21,RESP046,"(18.220833, -66.590149)"
|
|
2016,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,72,RACE05,CAT4,_RFPSA21,RESP054,"(18.220833, -66.590149)"
|
|
2016,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,72,RACE06,CAT4,_RFPSA21,RESP046,"(18.220833, -66.590149)"
|
|
2016,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,72,RACE06,CAT4,_RFPSA21,RESP054,"(18.220833, -66.590149)"
|
|
2016,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,72,RACE07,CAT4,_RFPSA21,RESP046,"(18.220833, -66.590149)"
|
|
2016,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,72,RACE07,CAT4,_RFPSA21,RESP054,"(18.220833, -66.590149)"
|
|
2016,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,1016,61,57.5,64.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,RACE08,CAT4,_RFPSA21,RESP046,"(18.220833, -66.590149)"
|
|
2016,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,485,39,35.5,42.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,RACE08,CAT4,_RFPSA21,RESP054,"(18.220833, -66.590149)"
|
|
2016,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1029,61,57.5,64.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,SEX1,CAT2,_RFPSA21,RESP046,"(18.220833, -66.590149)"
|
|
2016,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,493,39,35.5,42.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,SEX1,CAT2,_RFPSA21,RESP054,"(18.220833, -66.590149)"
|
|
2016,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,72,SEX2,CAT2,_RFPSA21,RESP046,"(18.220833, -66.590149)"
|
|
2016,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,72,SEX2,CAT2,_RFPSA21,RESP054,"(18.220833, -66.590149)"
|
|
2016,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,45,15,9.8,20.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,AGE06,CAT3,_RFPSA21,RESP046,"(41.70828019300046, -71.52247031399963)"
|
|
2016,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,229,85,79.8,90.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,AGE06,CAT3,_RFPSA21,RESP054,"(41.70828019300046, -71.52247031399963)"
|
|
2016,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,154,38,31.8,44.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,AGE07,CAT3,_RFPSA21,RESP046,"(41.70828019300046, -71.52247031399963)"
|
|
2016,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,231,62,55.9,68.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,AGE07,CAT3,_RFPSA21,RESP054,"(41.70828019300046, -71.52247031399963)"
|
|
2016,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,115,52.9,45.2,60.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,AGE08,CAT3,_RFPSA21,RESP046,"(41.70828019300046, -71.52247031399963)"
|
|
2016,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,126,47.1,39.4,54.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,AGE08,CAT3,_RFPSA21,RESP054,"(41.70828019300046, -71.52247031399963)"
|
|
2016,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,386,60.6,55.8,65.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,AGE09,CAT3,_RFPSA21,RESP046,"(41.70828019300046, -71.52247031399963)"
|
|
2016,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,226,39.4,34.6,44.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,AGE09,CAT3,_RFPSA21,RESP054,"(41.70828019300046, -71.52247031399963)"
|
|
2016,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,700,41.5,38.4,44.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,BO1,CAT1,_RFPSA21,RESP046,"(41.70828019300046, -71.52247031399963)"
|
|
2016,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,812,58.5,55.4,61.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,BO1,CAT1,_RFPSA21,RESP054,"(41.70828019300046, -71.52247031399963)"
|
|
2016,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,32,32,20.9,43,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,EDUCA1,CAT5,_RFPSA21,RESP046,"(41.70828019300046, -71.52247031399963)"
|
|
2016,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,72,68,57,79.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,EDUCA1,CAT5,_RFPSA21,RESP054,"(41.70828019300046, -71.52247031399963)"
|
|
2016,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,141,35.4,29.6,41.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,EDUCA2,CAT5,_RFPSA21,RESP046,"(41.70828019300046, -71.52247031399963)"
|
|
2016,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,235,64.6,58.9,70.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,EDUCA2,CAT5,_RFPSA21,RESP054,"(41.70828019300046, -71.52247031399963)"
|
|
2016,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,152,43.3,37,49.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,EDUCA3,CAT5,_RFPSA21,RESP046,"(41.70828019300046, -71.52247031399963)"
|
|
2016,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,194,56.7,50.4,63,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,EDUCA3,CAT5,_RFPSA21,RESP054,"(41.70828019300046, -71.52247031399963)"
|
|
2016,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,374,48.9,44.4,53.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,EDUCA4,CAT5,_RFPSA21,RESP046,"(41.70828019300046, -71.52247031399963)"
|
|
2016,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,310,51.1,46.6,55.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,EDUCA4,CAT5,_RFPSA21,RESP054,"(41.70828019300046, -71.52247031399963)"
|
|
2016,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,23,32.4,18.4,46.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,INCOME1,CAT6,_RFPSA21,RESP046,"(41.70828019300046, -71.52247031399963)"
|
|
2016,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,56,67.6,53.6,81.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,INCOME1,CAT6,_RFPSA21,RESP054,"(41.70828019300046, -71.52247031399963)"
|
|
2016,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,64,38.2,28.5,47.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,INCOME2,CAT6,_RFPSA21,RESP046,"(41.70828019300046, -71.52247031399963)"
|
|
2016,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,110,61.8,52.1,71.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,INCOME2,CAT6,_RFPSA21,RESP054,"(41.70828019300046, -71.52247031399963)"
|
|
2016,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,35,30.7,18.8,42.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,INCOME3,CAT6,_RFPSA21,RESP046,"(41.70828019300046, -71.52247031399963)"
|
|
2016,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,58,69.3,57.4,81.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,INCOME3,CAT6,_RFPSA21,RESP054,"(41.70828019300046, -71.52247031399963)"
|
|
2016,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,94,42.6,33.6,51.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,INCOME4,CAT6,_RFPSA21,RESP046,"(41.70828019300046, -71.52247031399963)"
|
|
2016,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,92,57.4,48.4,66.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,INCOME4,CAT6,_RFPSA21,RESP054,"(41.70828019300046, -71.52247031399963)"
|
|
2016,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,387,43.8,39.5,48.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,INCOME5,CAT6,_RFPSA21,RESP046,"(41.70828019300046, -71.52247031399963)"
|
|
2016,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,401,56.2,51.9,60.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,INCOME5,CAT6,_RFPSA21,RESP054,"(41.70828019300046, -71.52247031399963)"
|
|
2016,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,647,44.7,41.3,48,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,RACE01,CAT4,_RFPSA21,RESP046,"(41.70828019300046, -71.52247031399963)"
|
|
2016,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,680,55.3,52,58.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,RACE01,CAT4,_RFPSA21,RESP054,"(41.70828019300046, -71.52247031399963)"
|
|
2016,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,14,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,44,RACE02,CAT4,_RFPSA21,RESP046,"(41.70828019300046, -71.52247031399963)"
|
|
2016,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,31,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,44,RACE02,CAT4,_RFPSA21,RESP054,"(41.70828019300046, -71.52247031399963)"
|
|
2016,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,44,RACE03,CAT4,_RFPSA21,RESP046,"(41.70828019300046, -71.52247031399963)"
|
|
2016,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,9,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,44,RACE03,CAT4,_RFPSA21,RESP054,"(41.70828019300046, -71.52247031399963)"
|
|
2016,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,44,RACE04,CAT4,_RFPSA21,RESP046,"(41.70828019300046, -71.52247031399963)"
|
|
2016,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,12,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,44,RACE04,CAT4,_RFPSA21,RESP054,"(41.70828019300046, -71.52247031399963)"
|
|
2016,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,44,RACE05,CAT4,_RFPSA21,RESP046,"(41.70828019300046, -71.52247031399963)"
|
|
2016,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,44,RACE05,CAT4,_RFPSA21,RESP054,"(41.70828019300046, -71.52247031399963)"
|
|
2016,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,44,RACE06,CAT4,_RFPSA21,RESP046,"(41.70828019300046, -71.52247031399963)"
|
|
2016,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,13,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,44,RACE06,CAT4,_RFPSA21,RESP054,"(41.70828019300046, -71.52247031399963)"
|
|
2016,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,44,RACE07,CAT4,_RFPSA21,RESP046,"(41.70828019300046, -71.52247031399963)"
|
|
2016,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,44,RACE07,CAT4,_RFPSA21,RESP054,"(41.70828019300046, -71.52247031399963)"
|
|
2016,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,17,27.2,13.6,40.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,RACE08,CAT4,_RFPSA21,RESP046,"(41.70828019300046, -71.52247031399963)"
|
|
2016,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,53,72.8,59.3,86.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,RACE08,CAT4,_RFPSA21,RESP054,"(41.70828019300046, -71.52247031399963)"
|
|
2016,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,700,41.5,38.4,44.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,SEX1,CAT2,_RFPSA21,RESP046,"(41.70828019300046, -71.52247031399963)"
|
|
2016,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,812,58.5,55.4,61.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,SEX1,CAT2,_RFPSA21,RESP054,"(41.70828019300046, -71.52247031399963)"
|
|
2016,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,44,SEX2,CAT2,_RFPSA21,RESP046,"(41.70828019300046, -71.52247031399963)"
|
|
2016,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,44,SEX2,CAT2,_RFPSA21,RESP054,"(41.70828019300046, -71.52247031399963)"
|
|
2016,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,87,15.1,11.4,18.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,AGE06,CAT3,_RFPSA21,RESP046,"(33.998821303000454, -81.04537120699968)"
|
|
2016,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,394,84.9,81.3,88.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,AGE06,CAT3,_RFPSA21,RESP054,"(33.998821303000454, -81.04537120699968)"
|
|
2016,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,299,38.2,33.7,42.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,AGE07,CAT3,_RFPSA21,RESP046,"(33.998821303000454, -81.04537120699968)"
|
|
2016,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,438,61.8,57.3,66.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,AGE07,CAT3,_RFPSA21,RESP054,"(33.998821303000454, -81.04537120699968)"
|
|
2016,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,245,53.8,47.6,60.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,AGE08,CAT3,_RFPSA21,RESP046,"(33.998821303000454, -81.04537120699968)"
|
|
2016,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,197,46.2,39.9,52.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,AGE08,CAT3,_RFPSA21,RESP054,"(33.998821303000454, -81.04537120699968)"
|
|
2016,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,1031,65.6,62.5,68.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,AGE09,CAT3,_RFPSA21,RESP046,"(33.998821303000454, -81.04537120699968)"
|
|
2016,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,514,34.4,31.3,37.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,AGE09,CAT3,_RFPSA21,RESP054,"(33.998821303000454, -81.04537120699968)"
|
|
2016,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1662,43.7,41.4,46,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,BO1,CAT1,_RFPSA21,RESP046,"(33.998821303000454, -81.04537120699968)"
|
|
2016,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1543,56.3,54,58.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,BO1,CAT1,_RFPSA21,RESP054,"(33.998821303000454, -81.04537120699968)"
|
|
2016,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,107,26.8,21,32.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,EDUCA1,CAT5,_RFPSA21,RESP046,"(33.998821303000454, -81.04537120699968)"
|
|
2016,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,234,73.2,67.4,79,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,EDUCA1,CAT5,_RFPSA21,RESP054,"(33.998821303000454, -81.04537120699968)"
|
|
2016,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,398,39.2,35,43.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,EDUCA2,CAT5,_RFPSA21,RESP046,"(33.998821303000454, -81.04537120699968)"
|
|
2016,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,498,60.8,56.6,65,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,EDUCA2,CAT5,_RFPSA21,RESP054,"(33.998821303000454, -81.04537120699968)"
|
|
2016,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,453,47.9,43.5,52.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,EDUCA3,CAT5,_RFPSA21,RESP046,"(33.998821303000454, -81.04537120699968)"
|
|
2016,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,375,52.1,47.7,56.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,EDUCA3,CAT5,_RFPSA21,RESP054,"(33.998821303000454, -81.04537120699968)"
|
|
2016,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,704,55.2,51.4,59,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,EDUCA4,CAT5,_RFPSA21,RESP046,"(33.998821303000454, -81.04537120699968)"
|
|
2016,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,432,44.8,41,48.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,EDUCA4,CAT5,_RFPSA21,RESP054,"(33.998821303000454, -81.04537120699968)"
|
|
2016,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,60,21.1,14.1,28.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,INCOME1,CAT6,_RFPSA21,RESP046,"(33.998821303000454, -81.04537120699968)"
|
|
2016,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,164,78.9,71.8,85.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,INCOME1,CAT6,_RFPSA21,RESP054,"(33.998821303000454, -81.04537120699968)"
|
|
2016,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,186,36,29.8,42.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,INCOME2,CAT6,_RFPSA21,RESP046,"(33.998821303000454, -81.04537120699968)"
|
|
2016,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,246,64,57.8,70.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,INCOME2,CAT6,_RFPSA21,RESP054,"(33.998821303000454, -81.04537120699968)"
|
|
2016,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,161,43.1,35.8,50.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,INCOME3,CAT6,_RFPSA21,RESP046,"(33.998821303000454, -81.04537120699968)"
|
|
2016,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,167,56.9,49.6,64.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,INCOME3,CAT6,_RFPSA21,RESP054,"(33.998821303000454, -81.04537120699968)"
|
|
2016,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,220,46.8,40.2,53.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,INCOME4,CAT6,_RFPSA21,RESP046,"(33.998821303000454, -81.04537120699968)"
|
|
2016,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,181,53.2,46.6,59.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,INCOME4,CAT6,_RFPSA21,RESP054,"(33.998821303000454, -81.04537120699968)"
|
|
2016,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,844,49.5,46,53,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,INCOME5,CAT6,_RFPSA21,RESP046,"(33.998821303000454, -81.04537120699968)"
|
|
2016,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,590,50.5,47,54,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,INCOME5,CAT6,_RFPSA21,RESP054,"(33.998821303000454, -81.04537120699968)"
|
|
2016,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1255,44.7,42,47.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,RACE01,CAT4,_RFPSA21,RESP046,"(33.998821303000454, -81.04537120699968)"
|
|
2016,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1073,55.3,52.6,58,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,RACE01,CAT4,_RFPSA21,RESP054,"(33.998821303000454, -81.04537120699968)"
|
|
2016,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,333,43,37.9,48,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,RACE02,CAT4,_RFPSA21,RESP046,"(33.998821303000454, -81.04537120699968)"
|
|
2016,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,359,57,52,62.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,RACE02,CAT4,_RFPSA21,RESP054,"(33.998821303000454, -81.04537120699968)"
|
|
2016,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,13,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,45,RACE03,CAT4,_RFPSA21,RESP046,"(33.998821303000454, -81.04537120699968)"
|
|
2016,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,24,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,45,RACE03,CAT4,_RFPSA21,RESP054,"(33.998821303000454, -81.04537120699968)"
|
|
2016,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,45,RACE04,CAT4,_RFPSA21,RESP046,"(33.998821303000454, -81.04537120699968)"
|
|
2016,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,45,RACE04,CAT4,_RFPSA21,RESP054,"(33.998821303000454, -81.04537120699968)"
|
|
2016,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,45,RACE05,CAT4,_RFPSA21,RESP046,"(33.998821303000454, -81.04537120699968)"
|
|
2016,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,45,RACE05,CAT4,_RFPSA21,RESP054,"(33.998821303000454, -81.04537120699968)"
|
|
2016,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,14,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,45,RACE06,CAT4,_RFPSA21,RESP046,"(33.998821303000454, -81.04537120699968)"
|
|
2016,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,15,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,45,RACE06,CAT4,_RFPSA21,RESP054,"(33.998821303000454, -81.04537120699968)"
|
|
2016,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,31,34.8,21.3,48.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,RACE07,CAT4,_RFPSA21,RESP046,"(33.998821303000454, -81.04537120699968)"
|
|
2016,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,39,65.2,51.8,78.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,RACE07,CAT4,_RFPSA21,RESP054,"(33.998821303000454, -81.04537120699968)"
|
|
2016,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,45,RACE08,CAT4,_RFPSA21,RESP046,"(33.998821303000454, -81.04537120699968)"
|
|
2016,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,22,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,45,RACE08,CAT4,_RFPSA21,RESP054,"(33.998821303000454, -81.04537120699968)"
|
|
2016,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1662,43.7,41.4,46,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,SEX1,CAT2,_RFPSA21,RESP046,"(33.998821303000454, -81.04537120699968)"
|
|
2016,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1543,56.3,54,58.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,SEX1,CAT2,_RFPSA21,RESP054,"(33.998821303000454, -81.04537120699968)"
|
|
2016,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,45,SEX2,CAT2,_RFPSA21,RESP046,"(33.998821303000454, -81.04537120699968)"
|
|
2016,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,45,SEX2,CAT2,_RFPSA21,RESP054,"(33.998821303000454, -81.04537120699968)"
|
|
2016,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,163,54.6,45.3,63.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,AGE08,CAT3,_RFPSA21,RESP046,"(44.353130053000484, -100.3735306369997)"
|
|
2016,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,30,11,4.8,17.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,AGE06,CAT3,_RFPSA21,RESP046,"(44.353130053000484, -100.3735306369997)"
|
|
2016,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,253,89,82.9,95.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,AGE06,CAT3,_RFPSA21,RESP054,"(44.353130053000484, -100.3735306369997)"
|
|
2016,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,158,31.7,24.8,38.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,AGE07,CAT3,_RFPSA21,RESP046,"(44.353130053000484, -100.3735306369997)"
|
|
2016,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,277,68.3,61.5,75.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,AGE07,CAT3,_RFPSA21,RESP054,"(44.353130053000484, -100.3735306369997)"
|
|
2016,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,124,45.4,36.2,54.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,AGE08,CAT3,_RFPSA21,RESP054,"(44.353130053000484, -100.3735306369997)"
|
|
2016,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,504,64.6,58.2,71.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,AGE09,CAT3,_RFPSA21,RESP046,"(44.353130053000484, -100.3735306369997)"
|
|
2016,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,246,35.4,28.9,41.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,AGE09,CAT3,_RFPSA21,RESP054,"(44.353130053000484, -100.3735306369997)"
|
|
2016,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,855,40.8,37,44.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,BO1,CAT1,_RFPSA21,RESP046,"(44.353130053000484, -100.3735306369997)"
|
|
2016,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,900,59.2,55.3,63,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,BO1,CAT1,_RFPSA21,RESP054,"(44.353130053000484, -100.3735306369997)"
|
|
2016,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,34,24.1,12.3,36,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,EDUCA1,CAT5,_RFPSA21,RESP046,"(44.353130053000484, -100.3735306369997)"
|
|
2016,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,71,75.9,64,87.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,EDUCA1,CAT5,_RFPSA21,RESP054,"(44.353130053000484, -100.3735306369997)"
|
|
2016,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,240,41.4,34.6,48.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,EDUCA2,CAT5,_RFPSA21,RESP046,"(44.353130053000484, -100.3735306369997)"
|
|
2016,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,288,58.6,51.8,65.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,EDUCA2,CAT5,_RFPSA21,RESP054,"(44.353130053000484, -100.3735306369997)"
|
|
2016,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,245,42.2,35.5,48.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,EDUCA3,CAT5,_RFPSA21,RESP046,"(44.353130053000484, -100.3735306369997)"
|
|
2016,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,246,57.8,51.2,64.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,EDUCA3,CAT5,_RFPSA21,RESP054,"(44.353130053000484, -100.3735306369997)"
|
|
2016,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,336,47.8,41.6,54.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,EDUCA4,CAT5,_RFPSA21,RESP046,"(44.353130053000484, -100.3735306369997)"
|
|
2016,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,294,52.2,45.9,58.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,EDUCA4,CAT5,_RFPSA21,RESP054,"(44.353130053000484, -100.3735306369997)"
|
|
2016,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,35,36.2,20.9,51.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,INCOME1,CAT6,_RFPSA21,RESP046,"(44.353130053000484, -100.3735306369997)"
|
|
2016,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,58,63.8,48.6,79.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,INCOME1,CAT6,_RFPSA21,RESP054,"(44.353130053000484, -100.3735306369997)"
|
|
2016,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,94,49.5,36.8,62.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,INCOME2,CAT6,_RFPSA21,RESP046,"(44.353130053000484, -100.3735306369997)"
|
|
2016,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,76,50.5,37.8,63.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,INCOME2,CAT6,_RFPSA21,RESP054,"(44.353130053000484, -100.3735306369997)"
|
|
2016,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,60,45.7,31,60.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,INCOME3,CAT6,_RFPSA21,RESP046,"(44.353130053000484, -100.3735306369997)"
|
|
2016,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,76,54.3,39.6,69,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,INCOME3,CAT6,_RFPSA21,RESP054,"(44.353130053000484, -100.3735306369997)"
|
|
2016,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,144,38.3,28.8,47.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,INCOME4,CAT6,_RFPSA21,RESP046,"(44.353130053000484, -100.3735306369997)"
|
|
2016,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,140,61.7,52.2,71.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,INCOME4,CAT6,_RFPSA21,RESP054,"(44.353130053000484, -100.3735306369997)"
|
|
2016,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,437,40,34.9,45.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,INCOME5,CAT6,_RFPSA21,RESP046,"(44.353130053000484, -100.3735306369997)"
|
|
2016,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,444,60,54.9,65.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,INCOME5,CAT6,_RFPSA21,RESP054,"(44.353130053000484, -100.3735306369997)"
|
|
2016,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,794,43.5,39.5,47.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,RACE01,CAT4,_RFPSA21,RESP046,"(44.353130053000484, -100.3735306369997)"
|
|
2016,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,796,56.5,52.5,60.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,RACE01,CAT4,_RFPSA21,RESP054,"(44.353130053000484, -100.3735306369997)"
|
|
2016,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,46,RACE02,CAT4,_RFPSA21,RESP046,"(44.353130053000484, -100.3735306369997)"
|
|
2016,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,46,RACE02,CAT4,_RFPSA21,RESP054,"(44.353130053000484, -100.3735306369997)"
|
|
2016,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,39,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,46,RACE03,CAT4,_RFPSA21,RESP046,"(44.353130053000484, -100.3735306369997)"
|
|
2016,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,68,72.4,55.2,89.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,RACE03,CAT4,_RFPSA21,RESP054,"(44.353130053000484, -100.3735306369997)"
|
|
2016,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,46,RACE04,CAT4,_RFPSA21,RESP046,"(44.353130053000484, -100.3735306369997)"
|
|
2016,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,46,RACE04,CAT4,_RFPSA21,RESP054,"(44.353130053000484, -100.3735306369997)"
|
|
2016,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,46,RACE05,CAT4,_RFPSA21,RESP046,"(44.353130053000484, -100.3735306369997)"
|
|
2016,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,46,RACE05,CAT4,_RFPSA21,RESP054,"(44.353130053000484, -100.3735306369997)"
|
|
2016,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,46,RACE06,CAT4,_RFPSA21,RESP046,"(44.353130053000484, -100.3735306369997)"
|
|
2016,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,46,RACE06,CAT4,_RFPSA21,RESP054,"(44.353130053000484, -100.3735306369997)"
|
|
2016,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,11,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,46,RACE07,CAT4,_RFPSA21,RESP046,"(44.353130053000484, -100.3735306369997)"
|
|
2016,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,17,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,46,RACE07,CAT4,_RFPSA21,RESP054,"(44.353130053000484, -100.3735306369997)"
|
|
2016,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,46,RACE08,CAT4,_RFPSA21,RESP046,"(44.353130053000484, -100.3735306369997)"
|
|
2016,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,9,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,46,RACE08,CAT4,_RFPSA21,RESP054,"(44.353130053000484, -100.3735306369997)"
|
|
2016,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,855,40.8,37,44.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,SEX1,CAT2,_RFPSA21,RESP046,"(44.353130053000484, -100.3735306369997)"
|
|
2016,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,900,59.2,55.3,63,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,SEX1,CAT2,_RFPSA21,RESP054,"(44.353130053000484, -100.3735306369997)"
|
|
2016,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,46,SEX2,CAT2,_RFPSA21,RESP046,"(44.353130053000484, -100.3735306369997)"
|
|
2016,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,46,SEX2,CAT2,_RFPSA21,RESP054,"(44.353130053000484, -100.3735306369997)"
|
|
2016,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,58,17.5,12,22.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,AGE06,CAT3,_RFPSA21,RESP046,"(35.68094058000048, -85.77449091399967)"
|
|
2016,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,237,82.5,77.1,88,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,AGE06,CAT3,_RFPSA21,RESP054,"(35.68094058000048, -85.77449091399967)"
|
|
2016,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,180,41.6,35.2,47.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,AGE07,CAT3,_RFPSA21,RESP046,"(35.68094058000048, -85.77449091399967)"
|
|
2016,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,254,58.4,52.1,64.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,AGE07,CAT3,_RFPSA21,RESP054,"(35.68094058000048, -85.77449091399967)"
|
|
2016,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,147,49.8,42.1,57.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,AGE08,CAT3,_RFPSA21,RESP046,"(35.68094058000048, -85.77449091399967)"
|
|
2016,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,123,50.2,42.4,57.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,AGE08,CAT3,_RFPSA21,RESP054,"(35.68094058000048, -85.77449091399967)"
|
|
2016,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,448,64.9,60.3,69.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,AGE09,CAT3,_RFPSA21,RESP046,"(35.68094058000048, -85.77449091399967)"
|
|
2016,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,234,35.1,30.4,39.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,AGE09,CAT3,_RFPSA21,RESP054,"(35.68094058000048, -85.77449091399967)"
|
|
2016,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,833,43.2,39.9,46.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,BO1,CAT1,_RFPSA21,RESP046,"(35.68094058000048, -85.77449091399967)"
|
|
2016,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,848,56.8,53.5,60.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,BO1,CAT1,_RFPSA21,RESP054,"(35.68094058000048, -85.77449091399967)"
|
|
2016,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,52,29.3,19.9,38.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,EDUCA1,CAT5,_RFPSA21,RESP046,"(35.68094058000048, -85.77449091399967)"
|
|
2016,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,112,70.7,61.3,80.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,EDUCA1,CAT5,_RFPSA21,RESP054,"(35.68094058000048, -85.77449091399967)"
|
|
2016,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,236,39.3,33.7,44.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,EDUCA2,CAT5,_RFPSA21,RESP046,"(35.68094058000048, -85.77449091399967)"
|
|
2016,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,312,60.7,55.1,66.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,EDUCA2,CAT5,_RFPSA21,RESP054,"(35.68094058000048, -85.77449091399967)"
|
|
2016,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,196,43.9,37.5,50.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,EDUCA3,CAT5,_RFPSA21,RESP046,"(35.68094058000048, -85.77449091399967)"
|
|
2016,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,200,56.1,49.6,62.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,EDUCA3,CAT5,_RFPSA21,RESP054,"(35.68094058000048, -85.77449091399967)"
|
|
2016,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,349,57.9,52.5,63.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,EDUCA4,CAT5,_RFPSA21,RESP046,"(35.68094058000048, -85.77449091399967)"
|
|
2016,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,223,42.1,36.7,47.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,EDUCA4,CAT5,_RFPSA21,RESP054,"(35.68094058000048, -85.77449091399967)"
|
|
2016,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,34,21.8,13.2,30.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,INCOME1,CAT6,_RFPSA21,RESP046,"(35.68094058000048, -85.77449091399967)"
|
|
2016,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,108,78.2,69.7,86.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,INCOME1,CAT6,_RFPSA21,RESP054,"(35.68094058000048, -85.77449091399967)"
|
|
2016,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,90,34.7,26.1,43.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,INCOME2,CAT6,_RFPSA21,RESP046,"(35.68094058000048, -85.77449091399967)"
|
|
2016,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,132,65.3,56.8,73.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,INCOME2,CAT6,_RFPSA21,RESP054,"(35.68094058000048, -85.77449091399967)"
|
|
2016,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,73,36.1,26.8,45.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,INCOME3,CAT6,_RFPSA21,RESP046,"(35.68094058000048, -85.77449091399967)"
|
|
2016,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,96,63.9,54.6,73.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,INCOME3,CAT6,_RFPSA21,RESP054,"(35.68094058000048, -85.77449091399967)"
|
|
2016,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,118,39.8,31.3,48.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,INCOME4,CAT6,_RFPSA21,RESP046,"(35.68094058000048, -85.77449091399967)"
|
|
2016,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,116,60.2,51.7,68.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,INCOME4,CAT6,_RFPSA21,RESP054,"(35.68094058000048, -85.77449091399967)"
|
|
2016,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,407,49.9,44.4,55.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,INCOME5,CAT6,_RFPSA21,RESP046,"(35.68094058000048, -85.77449091399967)"
|
|
2016,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,307,50.1,44.5,55.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,INCOME5,CAT6,_RFPSA21,RESP054,"(35.68094058000048, -85.77449091399967)"
|
|
2016,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,714,44.9,41.4,48.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,RACE01,CAT4,_RFPSA21,RESP046,"(35.68094058000048, -85.77449091399967)"
|
|
2016,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,701,55.1,51.6,58.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,RACE01,CAT4,_RFPSA21,RESP054,"(35.68094058000048, -85.77449091399967)"
|
|
2016,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,72,37.8,27,48.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,RACE02,CAT4,_RFPSA21,RESP046,"(35.68094058000048, -85.77449091399967)"
|
|
2016,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,94,62.2,51.3,73,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,RACE02,CAT4,_RFPSA21,RESP054,"(35.68094058000048, -85.77449091399967)"
|
|
2016,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,47,RACE03,CAT4,_RFPSA21,RESP046,"(35.68094058000048, -85.77449091399967)"
|
|
2016,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,13,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,47,RACE03,CAT4,_RFPSA21,RESP054,"(35.68094058000048, -85.77449091399967)"
|
|
2016,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,47,RACE04,CAT4,_RFPSA21,RESP046,"(35.68094058000048, -85.77449091399967)"
|
|
2016,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,47,RACE04,CAT4,_RFPSA21,RESP054,"(35.68094058000048, -85.77449091399967)"
|
|
2016,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,47,RACE05,CAT4,_RFPSA21,RESP046,"(35.68094058000048, -85.77449091399967)"
|
|
2016,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,47,RACE05,CAT4,_RFPSA21,RESP054,"(35.68094058000048, -85.77449091399967)"
|
|
2016,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,47,RACE06,CAT4,_RFPSA21,RESP046,"(35.68094058000048, -85.77449091399967)"
|
|
2016,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,47,RACE06,CAT4,_RFPSA21,RESP054,"(35.68094058000048, -85.77449091399967)"
|
|
2016,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,16,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,47,RACE07,CAT4,_RFPSA21,RESP046,"(35.68094058000048, -85.77449091399967)"
|
|
2016,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,17,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,47,RACE07,CAT4,_RFPSA21,RESP054,"(35.68094058000048, -85.77449091399967)"
|
|
2016,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,14,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,47,RACE08,CAT4,_RFPSA21,RESP046,"(35.68094058000048, -85.77449091399967)"
|
|
2016,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,12,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,47,RACE08,CAT4,_RFPSA21,RESP054,"(35.68094058000048, -85.77449091399967)"
|
|
2016,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,833,43.2,39.9,46.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,SEX1,CAT2,_RFPSA21,RESP046,"(35.68094058000048, -85.77449091399967)"
|
|
2016,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,848,56.8,53.5,60.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,SEX1,CAT2,_RFPSA21,RESP054,"(35.68094058000048, -85.77449091399967)"
|
|
2016,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,47,SEX2,CAT2,_RFPSA21,RESP046,"(35.68094058000048, -85.77449091399967)"
|
|
2016,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,47,SEX2,CAT2,_RFPSA21,RESP054,"(35.68094058000048, -85.77449091399967)"
|
|
2016,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,84,14.4,9.9,18.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,AGE06,CAT3,_RFPSA21,RESP046,"(31.827240407000488, -99.42677020599967)"
|
|
2016,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,419,85.6,81.1,90.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,AGE06,CAT3,_RFPSA21,RESP054,"(31.827240407000488, -99.42677020599967)"
|
|
2016,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,314,41.4,34.9,47.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,AGE07,CAT3,_RFPSA21,RESP046,"(31.827240407000488, -99.42677020599967)"
|
|
2016,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,412,58.6,52.1,65.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,AGE07,CAT3,_RFPSA21,RESP054,"(31.827240407000488, -99.42677020599967)"
|
|
2016,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,239,41.9,33.2,50.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,AGE08,CAT3,_RFPSA21,RESP046,"(31.827240407000488, -99.42677020599967)"
|
|
2016,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,212,58.1,49.3,66.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,AGE08,CAT3,_RFPSA21,RESP054,"(31.827240407000488, -99.42677020599967)"
|
|
2016,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,914,51.9,46.2,57.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,AGE09,CAT3,_RFPSA21,RESP046,"(31.827240407000488, -99.42677020599967)"
|
|
2016,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,538,48.1,42.3,53.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,AGE09,CAT3,_RFPSA21,RESP054,"(31.827240407000488, -99.42677020599967)"
|
|
2016,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1551,36.8,33.6,40,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,BO1,CAT1,_RFPSA21,RESP046,"(31.827240407000488, -99.42677020599967)"
|
|
2016,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1581,63.2,60,66.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,BO1,CAT1,_RFPSA21,RESP054,"(31.827240407000488, -99.42677020599967)"
|
|
2016,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,81,19.5,12.3,26.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,EDUCA1,CAT5,_RFPSA21,RESP046,"(31.827240407000488, -99.42677020599967)"
|
|
2016,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,224,80.5,73.4,87.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,EDUCA1,CAT5,_RFPSA21,RESP054,"(31.827240407000488, -99.42677020599967)"
|
|
2016,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,268,27.6,21.5,33.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,EDUCA2,CAT5,_RFPSA21,RESP046,"(31.827240407000488, -99.42677020599967)"
|
|
2016,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,405,72.4,66.3,78.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,EDUCA2,CAT5,_RFPSA21,RESP054,"(31.827240407000488, -99.42677020599967)"
|
|
2016,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,369,39.8,33.4,46.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,EDUCA3,CAT5,_RFPSA21,RESP046,"(31.827240407000488, -99.42677020599967)"
|
|
2016,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,366,60.2,53.8,66.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,EDUCA3,CAT5,_RFPSA21,RESP054,"(31.827240407000488, -99.42677020599967)"
|
|
2016,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,832,53.2,48.2,58.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,EDUCA4,CAT5,_RFPSA21,RESP046,"(31.827240407000488, -99.42677020599967)"
|
|
2016,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,583,46.8,41.8,51.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,EDUCA4,CAT5,_RFPSA21,RESP054,"(31.827240407000488, -99.42677020599967)"
|
|
2016,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,75,15.6,8.7,22.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,INCOME1,CAT6,_RFPSA21,RESP046,"(31.827240407000488, -99.42677020599967)"
|
|
2016,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,177,84.4,77.6,91.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,INCOME1,CAT6,_RFPSA21,RESP054,"(31.827240407000488, -99.42677020599967)"
|
|
2016,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,133,20.4,14,26.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,INCOME2,CAT6,_RFPSA21,RESP046,"(31.827240407000488, -99.42677020599967)"
|
|
2016,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,244,79.6,73.2,86,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,INCOME2,CAT6,_RFPSA21,RESP054,"(31.827240407000488, -99.42677020599967)"
|
|
2016,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,97,24,13.9,34,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,INCOME3,CAT6,_RFPSA21,RESP046,"(31.827240407000488, -99.42677020599967)"
|
|
2016,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,140,76,66,86.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,INCOME3,CAT6,_RFPSA21,RESP054,"(31.827240407000488, -99.42677020599967)"
|
|
2016,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,176,41.2,30.9,51.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,INCOME4,CAT6,_RFPSA21,RESP046,"(31.827240407000488, -99.42677020599967)"
|
|
2016,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,191,58.8,48.5,69.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,INCOME4,CAT6,_RFPSA21,RESP054,"(31.827240407000488, -99.42677020599967)"
|
|
2016,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,939,46.5,41.9,51.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,INCOME5,CAT6,_RFPSA21,RESP046,"(31.827240407000488, -99.42677020599967)"
|
|
2016,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,704,53.5,48.9,58.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,INCOME5,CAT6,_RFPSA21,RESP054,"(31.827240407000488, -99.42677020599967)"
|
|
2016,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1210,43.2,39.2,47.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,RACE01,CAT4,_RFPSA21,RESP046,"(31.827240407000488, -99.42677020599967)"
|
|
2016,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1038,56.8,52.9,60.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,RACE01,CAT4,_RFPSA21,RESP054,"(31.827240407000488, -99.42677020599967)"
|
|
2016,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,102,42.8,31.1,54.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,RACE02,CAT4,_RFPSA21,RESP046,"(31.827240407000488, -99.42677020599967)"
|
|
2016,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,115,57.2,45.6,68.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,RACE02,CAT4,_RFPSA21,RESP054,"(31.827240407000488, -99.42677020599967)"
|
|
2016,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,26,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,48,RACE03,CAT4,_RFPSA21,RESP046,"(31.827240407000488, -99.42677020599967)"
|
|
2016,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,25,70.8,47.3,94.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,RACE03,CAT4,_RFPSA21,RESP054,"(31.827240407000488, -99.42677020599967)"
|
|
2016,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,13,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,48,RACE04,CAT4,_RFPSA21,RESP046,"(31.827240407000488, -99.42677020599967)"
|
|
2016,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,30,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,48,RACE04,CAT4,_RFPSA21,RESP054,"(31.827240407000488, -99.42677020599967)"
|
|
2016,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,48,RACE05,CAT4,_RFPSA21,RESP046,"(31.827240407000488, -99.42677020599967)"
|
|
2016,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,48,RACE05,CAT4,_RFPSA21,RESP054,"(31.827240407000488, -99.42677020599967)"
|
|
2016,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,48,RACE06,CAT4,_RFPSA21,RESP046,"(31.827240407000488, -99.42677020599967)"
|
|
2016,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,48,RACE06,CAT4,_RFPSA21,RESP054,"(31.827240407000488, -99.42677020599967)"
|
|
2016,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,21,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,48,RACE07,CAT4,_RFPSA21,RESP046,"(31.827240407000488, -99.42677020599967)"
|
|
2016,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,19,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,48,RACE07,CAT4,_RFPSA21,RESP054,"(31.827240407000488, -99.42677020599967)"
|
|
2016,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,177,25.8,19.9,31.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,RACE08,CAT4,_RFPSA21,RESP046,"(31.827240407000488, -99.42677020599967)"
|
|
2016,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,352,74.2,68.4,80.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,RACE08,CAT4,_RFPSA21,RESP054,"(31.827240407000488, -99.42677020599967)"
|
|
2016,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1551,36.8,33.6,40,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,SEX1,CAT2,_RFPSA21,RESP046,"(31.827240407000488, -99.42677020599967)"
|
|
2016,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1581,63.2,60,66.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,SEX1,CAT2,_RFPSA21,RESP054,"(31.827240407000488, -99.42677020599967)"
|
|
2016,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,48,SEX2,CAT2,_RFPSA21,RESP046,"(31.827240407000488, -99.42677020599967)"
|
|
2016,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,48,SEX2,CAT2,_RFPSA21,RESP054,"(31.827240407000488, -99.42677020599967)"
|
|
2016,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1771,64.9,62.7,67.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,BO1,CAT1,_RFPSA21,RESP054,"(39.360700171000474, -111.58713063499971)"
|
|
2016,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,80,11,7.9,14.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,AGE06,CAT3,_RFPSA21,RESP046,"(39.360700171000474, -111.58713063499971)"
|
|
2016,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,596,89,85.8,92.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,AGE06,CAT3,_RFPSA21,RESP054,"(39.360700171000474, -111.58713063499971)"
|
|
2016,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,267,32.4,28.1,36.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,AGE07,CAT3,_RFPSA21,RESP046,"(39.360700171000474, -111.58713063499971)"
|
|
2016,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,486,67.6,63.3,71.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,AGE07,CAT3,_RFPSA21,RESP054,"(39.360700171000474, -111.58713063499971)"
|
|
2016,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,219,51.5,44.8,58.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,AGE08,CAT3,_RFPSA21,RESP046,"(39.360700171000474, -111.58713063499971)"
|
|
2016,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,178,48.5,41.9,55.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,AGE08,CAT3,_RFPSA21,RESP054,"(39.360700171000474, -111.58713063499971)"
|
|
2016,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,696,56.9,53.2,60.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,AGE09,CAT3,_RFPSA21,RESP046,"(39.360700171000474, -111.58713063499971)"
|
|
2016,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,511,43.1,39.4,46.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,AGE09,CAT3,_RFPSA21,RESP054,"(39.360700171000474, -111.58713063499971)"
|
|
2016,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1262,35.1,32.9,37.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,BO1,CAT1,_RFPSA21,RESP046,"(39.360700171000474, -111.58713063499971)"
|
|
2016,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,32,19.3,10.4,28.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,EDUCA1,CAT5,_RFPSA21,RESP046,"(39.360700171000474, -111.58713063499971)"
|
|
2016,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,93,80.7,71.9,89.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,EDUCA1,CAT5,_RFPSA21,RESP054,"(39.360700171000474, -111.58713063499971)"
|
|
2016,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,243,30.4,26,34.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,EDUCA2,CAT5,_RFPSA21,RESP046,"(39.360700171000474, -111.58713063499971)"
|
|
2016,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,451,69.6,65.1,74,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,EDUCA2,CAT5,_RFPSA21,RESP054,"(39.360700171000474, -111.58713063499971)"
|
|
2016,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,355,37.8,33.6,41.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,EDUCA3,CAT5,_RFPSA21,RESP046,"(39.360700171000474, -111.58713063499971)"
|
|
2016,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,474,62.2,58.1,66.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,EDUCA3,CAT5,_RFPSA21,RESP054,"(39.360700171000474, -111.58713063499971)"
|
|
2016,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,629,39.5,36.4,42.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,EDUCA4,CAT5,_RFPSA21,RESP046,"(39.360700171000474, -111.58713063499971)"
|
|
2016,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,746,60.5,57.3,63.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,EDUCA4,CAT5,_RFPSA21,RESP054,"(39.360700171000474, -111.58713063499971)"
|
|
2016,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,27,26.4,14.6,38.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,INCOME1,CAT6,_RFPSA21,RESP046,"(39.360700171000474, -111.58713063499971)"
|
|
2016,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,64,73.6,61.8,85.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,INCOME1,CAT6,_RFPSA21,RESP054,"(39.360700171000474, -111.58713063499971)"
|
|
2016,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,105,26.9,20.1,33.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,INCOME2,CAT6,_RFPSA21,RESP046,"(39.360700171000474, -111.58713063499971)"
|
|
2016,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,173,73.1,66.3,79.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,INCOME2,CAT6,_RFPSA21,RESP054,"(39.360700171000474, -111.58713063499971)"
|
|
2016,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,86,37.2,28.2,46.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,INCOME3,CAT6,_RFPSA21,RESP046,"(39.360700171000474, -111.58713063499971)"
|
|
2016,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,119,62.8,53.7,71.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,INCOME3,CAT6,_RFPSA21,RESP054,"(39.360700171000474, -111.58713063499971)"
|
|
2016,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,143,34.2,27.4,41,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,INCOME4,CAT6,_RFPSA21,RESP046,"(39.360700171000474, -111.58713063499971)"
|
|
2016,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,229,65.8,59,72.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,INCOME4,CAT6,_RFPSA21,RESP054,"(39.360700171000474, -111.58713063499971)"
|
|
2016,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,749,36.2,33.4,39,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,INCOME5,CAT6,_RFPSA21,RESP046,"(39.360700171000474, -111.58713063499971)"
|
|
2016,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,992,63.8,61,66.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,INCOME5,CAT6,_RFPSA21,RESP054,"(39.360700171000474, -111.58713063499971)"
|
|
2016,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1203,37.6,35.4,39.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,RACE01,CAT4,_RFPSA21,RESP046,"(39.360700171000474, -111.58713063499971)"
|
|
2016,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1589,62.4,60.1,64.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,RACE01,CAT4,_RFPSA21,RESP054,"(39.360700171000474, -111.58713063499971)"
|
|
2016,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,49,RACE02,CAT4,_RFPSA21,RESP046,"(39.360700171000474, -111.58713063499971)"
|
|
2016,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,14,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,49,RACE02,CAT4,_RFPSA21,RESP054,"(39.360700171000474, -111.58713063499971)"
|
|
2016,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,9,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,49,RACE03,CAT4,_RFPSA21,RESP046,"(39.360700171000474, -111.58713063499971)"
|
|
2016,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,26,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,49,RACE03,CAT4,_RFPSA21,RESP054,"(39.360700171000474, -111.58713063499971)"
|
|
2016,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,49,RACE04,CAT4,_RFPSA21,RESP046,"(39.360700171000474, -111.58713063499971)"
|
|
2016,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,16,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,49,RACE04,CAT4,_RFPSA21,RESP054,"(39.360700171000474, -111.58713063499971)"
|
|
2016,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,49,RACE05,CAT4,_RFPSA21,RESP046,"(39.360700171000474, -111.58713063499971)"
|
|
2016,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,49,RACE05,CAT4,_RFPSA21,RESP054,"(39.360700171000474, -111.58713063499971)"
|
|
2016,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,49,RACE06,CAT4,_RFPSA21,RESP046,"(39.360700171000474, -111.58713063499971)"
|
|
2016,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,49,RACE06,CAT4,_RFPSA21,RESP054,"(39.360700171000474, -111.58713063499971)"
|
|
2016,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,9,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,49,RACE07,CAT4,_RFPSA21,RESP046,"(39.360700171000474, -111.58713063499971)"
|
|
2016,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,13,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,49,RACE07,CAT4,_RFPSA21,RESP054,"(39.360700171000474, -111.58713063499971)"
|
|
2016,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,24,18.2,9.7,26.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,RACE08,CAT4,_RFPSA21,RESP046,"(39.360700171000474, -111.58713063499971)"
|
|
2016,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,99,81.8,73.3,90.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,RACE08,CAT4,_RFPSA21,RESP054,"(39.360700171000474, -111.58713063499971)"
|
|
2016,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1262,35.1,32.9,37.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,SEX1,CAT2,_RFPSA21,RESP046,"(39.360700171000474, -111.58713063499971)"
|
|
2016,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1771,64.9,62.7,67.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,SEX1,CAT2,_RFPSA21,RESP054,"(39.360700171000474, -111.58713063499971)"
|
|
2016,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,49,SEX2,CAT2,_RFPSA21,RESP046,"(39.360700171000474, -111.58713063499971)"
|
|
2016,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,49,SEX2,CAT2,_RFPSA21,RESP054,"(39.360700171000474, -111.58713063499971)"
|
|
2016,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,26,8.1,4.5,11.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,AGE06,CAT3,_RFPSA21,RESP046,"(43.62538123900049, -72.51764079099962)"
|
|
2016,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,307,91.9,88.3,95.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,AGE06,CAT3,_RFPSA21,RESP054,"(43.62538123900049, -72.51764079099962)"
|
|
2016,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,140,24.4,20.1,28.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,AGE07,CAT3,_RFPSA21,RESP046,"(43.62538123900049, -72.51764079099962)"
|
|
2016,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,406,75.6,71.2,79.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,AGE07,CAT3,_RFPSA21,RESP054,"(43.62538123900049, -72.51764079099962)"
|
|
2016,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,145,44.5,37.9,51.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,AGE08,CAT3,_RFPSA21,RESP046,"(43.62538123900049, -72.51764079099962)"
|
|
2016,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,188,55.5,48.9,62.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,AGE08,CAT3,_RFPSA21,RESP054,"(43.62538123900049, -72.51764079099962)"
|
|
2016,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,401,50.2,45.7,54.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,AGE09,CAT3,_RFPSA21,RESP046,"(43.62538123900049, -72.51764079099962)"
|
|
2016,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,408,49.8,45.4,54.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,AGE09,CAT3,_RFPSA21,RESP054,"(43.62538123900049, -72.51764079099962)"
|
|
2016,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,712,31.8,29.3,34.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,BO1,CAT1,_RFPSA21,RESP046,"(43.62538123900049, -72.51764079099962)"
|
|
2016,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1309,68.2,65.7,70.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,BO1,CAT1,_RFPSA21,RESP054,"(43.62538123900049, -72.51764079099962)"
|
|
2016,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,28,18.8,11.3,26.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,EDUCA1,CAT5,_RFPSA21,RESP046,"(43.62538123900049, -72.51764079099962)"
|
|
2016,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,108,81.2,73.8,88.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,EDUCA1,CAT5,_RFPSA21,RESP054,"(43.62538123900049, -72.51764079099962)"
|
|
2016,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,189,29.6,25.3,34,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,EDUCA2,CAT5,_RFPSA21,RESP046,"(43.62538123900049, -72.51764079099962)"
|
|
2016,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,412,70.4,66,74.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,EDUCA2,CAT5,_RFPSA21,RESP054,"(43.62538123900049, -72.51764079099962)"
|
|
2016,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,144,34.9,29.2,40.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,EDUCA3,CAT5,_RFPSA21,RESP046,"(43.62538123900049, -72.51764079099962)"
|
|
2016,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,262,65.1,59.3,70.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,EDUCA3,CAT5,_RFPSA21,RESP054,"(43.62538123900049, -72.51764079099962)"
|
|
2016,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,350,36.3,32.6,40.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,EDUCA4,CAT5,_RFPSA21,RESP046,"(43.62538123900049, -72.51764079099962)"
|
|
2016,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,525,63.7,59.9,67.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,EDUCA4,CAT5,_RFPSA21,RESP054,"(43.62538123900049, -72.51764079099962)"
|
|
2016,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,32,21,12.4,29.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,INCOME1,CAT6,_RFPSA21,RESP046,"(43.62538123900049, -72.51764079099962)"
|
|
2016,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,105,79,70.3,87.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,INCOME1,CAT6,_RFPSA21,RESP054,"(43.62538123900049, -72.51764079099962)"
|
|
2016,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,53,20.9,14.2,27.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,INCOME2,CAT6,_RFPSA21,RESP046,"(43.62538123900049, -72.51764079099962)"
|
|
2016,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,178,79.1,72.4,85.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,INCOME2,CAT6,_RFPSA21,RESP054,"(43.62538123900049, -72.51764079099962)"
|
|
2016,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,42,19.5,12.6,26.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,INCOME3,CAT6,_RFPSA21,RESP046,"(43.62538123900049, -72.51764079099962)"
|
|
2016,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,121,80.5,73.5,87.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,INCOME3,CAT6,_RFPSA21,RESP054,"(43.62538123900049, -72.51764079099962)"
|
|
2016,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,110,38.7,31.6,45.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,INCOME4,CAT6,_RFPSA21,RESP046,"(43.62538123900049, -72.51764079099962)"
|
|
2016,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,160,61.3,54.2,68.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,INCOME4,CAT6,_RFPSA21,RESP054,"(43.62538123900049, -72.51764079099962)"
|
|
2016,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,371,33.5,29.9,37,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,INCOME5,CAT6,_RFPSA21,RESP046,"(43.62538123900049, -72.51764079099962)"
|
|
2016,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,606,66.5,63,70.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,INCOME5,CAT6,_RFPSA21,RESP054,"(43.62538123900049, -72.51764079099962)"
|
|
2016,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,674,32.3,29.7,34.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,RACE01,CAT4,_RFPSA21,RESP046,"(43.62538123900049, -72.51764079099962)"
|
|
2016,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1208,67.7,65.1,70.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,RACE01,CAT4,_RFPSA21,RESP054,"(43.62538123900049, -72.51764079099962)"
|
|
2016,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,50,RACE02,CAT4,_RFPSA21,RESP046,"(43.62538123900049, -72.51764079099962)"
|
|
2016,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,13,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,50,RACE02,CAT4,_RFPSA21,RESP054,"(43.62538123900049, -72.51764079099962)"
|
|
2016,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,50,RACE03,CAT4,_RFPSA21,RESP046,"(43.62538123900049, -72.51764079099962)"
|
|
2016,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,26,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,50,RACE03,CAT4,_RFPSA21,RESP054,"(43.62538123900049, -72.51764079099962)"
|
|
2016,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,50,RACE04,CAT4,_RFPSA21,RESP046,"(43.62538123900049, -72.51764079099962)"
|
|
2016,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,50,RACE04,CAT4,_RFPSA21,RESP054,"(43.62538123900049, -72.51764079099962)"
|
|
2016,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,50,RACE05,CAT4,_RFPSA21,RESP046,"(43.62538123900049, -72.51764079099962)"
|
|
2016,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,50,RACE05,CAT4,_RFPSA21,RESP054,"(43.62538123900049, -72.51764079099962)"
|
|
2016,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,9,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,50,RACE06,CAT4,_RFPSA21,RESP046,"(43.62538123900049, -72.51764079099962)"
|
|
2016,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,20,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,50,RACE06,CAT4,_RFPSA21,RESP054,"(43.62538123900049, -72.51764079099962)"
|
|
2016,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,11,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,50,RACE07,CAT4,_RFPSA21,RESP046,"(43.62538123900049, -72.51764079099962)"
|
|
2016,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,22,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,50,RACE07,CAT4,_RFPSA21,RESP054,"(43.62538123900049, -72.51764079099962)"
|
|
2016,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,50,RACE08,CAT4,_RFPSA21,RESP046,"(43.62538123900049, -72.51764079099962)"
|
|
2016,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,12,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,50,RACE08,CAT4,_RFPSA21,RESP054,"(43.62538123900049, -72.51764079099962)"
|
|
2016,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,712,31.8,29.3,34.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,SEX1,CAT2,_RFPSA21,RESP046,"(43.62538123900049, -72.51764079099962)"
|
|
2016,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1309,68.2,65.7,70.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,SEX1,CAT2,_RFPSA21,RESP054,"(43.62538123900049, -72.51764079099962)"
|
|
2016,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,50,SEX2,CAT2,_RFPSA21,RESP046,"(43.62538123900049, -72.51764079099962)"
|
|
2016,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,50,SEX2,CAT2,_RFPSA21,RESP054,"(43.62538123900049, -72.51764079099962)"
|
|
2016,VI,Virgin Islands,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,15,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,78,AGE06,CAT3,_RFPSA21,RESP046,"(18.335765, -64.896335)"
|
|
2016,VI,Virgin Islands,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,49,79.6,67.1,92.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,78,AGE06,CAT3,_RFPSA21,RESP054,"(18.335765, -64.896335)"
|
|
2016,VI,Virgin Islands,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,41,44.4,29.5,59.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,78,AGE07,CAT3,_RFPSA21,RESP046,"(18.335765, -64.896335)"
|
|
2016,VI,Virgin Islands,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,38,55.6,40.6,70.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,78,AGE07,CAT3,_RFPSA21,RESP054,"(18.335765, -64.896335)"
|
|
2016,VI,Virgin Islands,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,32,59.9,42.6,77.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,78,AGE08,CAT3,_RFPSA21,RESP046,"(18.335765, -64.896335)"
|
|
2016,VI,Virgin Islands,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,20,40.1,22.9,57.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,78,AGE08,CAT3,_RFPSA21,RESP054,"(18.335765, -64.896335)"
|
|
2016,VI,Virgin Islands,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,109,59.1,45.4,72.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,78,AGE09,CAT3,_RFPSA21,RESP046,"(18.335765, -64.896335)"
|
|
2016,VI,Virgin Islands,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,49,40.9,27.2,54.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,78,AGE09,CAT3,_RFPSA21,RESP054,"(18.335765, -64.896335)"
|
|
2016,VI,Virgin Islands,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,197,42.8,35.1,50.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,78,BO1,CAT1,_RFPSA21,RESP046,"(18.335765, -64.896335)"
|
|
2016,VI,Virgin Islands,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,156,57.2,49.6,64.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,78,BO1,CAT1,_RFPSA21,RESP054,"(18.335765, -64.896335)"
|
|
2016,VI,Virgin Islands,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,44,35.2,22.1,48.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,78,EDUCA1,CAT5,_RFPSA21,RESP046,"(18.335765, -64.896335)"
|
|
2016,VI,Virgin Islands,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,42,64.8,51.7,77.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,78,EDUCA1,CAT5,_RFPSA21,RESP054,"(18.335765, -64.896335)"
|
|
2016,VI,Virgin Islands,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,60,58.2,44.5,71.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,78,EDUCA2,CAT5,_RFPSA21,RESP046,"(18.335765, -64.896335)"
|
|
2016,VI,Virgin Islands,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,38,41.8,28.1,55.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,78,EDUCA2,CAT5,_RFPSA21,RESP054,"(18.335765, -64.896335)"
|
|
2016,VI,Virgin Islands,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,25,31.1,16.3,45.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,78,EDUCA3,CAT5,_RFPSA21,RESP046,"(18.335765, -64.896335)"
|
|
2016,VI,Virgin Islands,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,28,68.9,54.1,83.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,78,EDUCA3,CAT5,_RFPSA21,RESP054,"(18.335765, -64.896335)"
|
|
2016,VI,Virgin Islands,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,63,45.9,33.7,58.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,78,EDUCA4,CAT5,_RFPSA21,RESP046,"(18.335765, -64.896335)"
|
|
2016,VI,Virgin Islands,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,44,54.1,41.9,66.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,78,EDUCA4,CAT5,_RFPSA21,RESP054,"(18.335765, -64.896335)"
|
|
2016,VI,Virgin Islands,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,26,37,20.3,53.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,78,INCOME1,CAT6,_RFPSA21,RESP046,"(18.335765, -64.896335)"
|
|
2016,VI,Virgin Islands,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,24,63,46.4,79.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,78,INCOME1,CAT6,_RFPSA21,RESP054,"(18.335765, -64.896335)"
|
|
2016,VI,Virgin Islands,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,35,41.8,23.5,60,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,78,INCOME2,CAT6,_RFPSA21,RESP046,"(18.335765, -64.896335)"
|
|
2016,VI,Virgin Islands,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,33,58.2,40,76.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,78,INCOME2,CAT6,_RFPSA21,RESP054,"(18.335765, -64.896335)"
|
|
2016,VI,Virgin Islands,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,23,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,78,INCOME3,CAT6,_RFPSA21,RESP046,"(18.335765, -64.896335)"
|
|
2016,VI,Virgin Islands,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,20,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,78,INCOME3,CAT6,_RFPSA21,RESP054,"(18.335765, -64.896335)"
|
|
2016,VI,Virgin Islands,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,25,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,78,INCOME4,CAT6,_RFPSA21,RESP046,"(18.335765, -64.896335)"
|
|
2016,VI,Virgin Islands,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,16,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,78,INCOME4,CAT6,_RFPSA21,RESP054,"(18.335765, -64.896335)"
|
|
2016,VI,Virgin Islands,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,76,52,40.8,63.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,78,INCOME5,CAT6,_RFPSA21,RESP046,"(18.335765, -64.896335)"
|
|
2016,VI,Virgin Islands,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,52,48,36.7,59.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,78,INCOME5,CAT6,_RFPSA21,RESP054,"(18.335765, -64.896335)"
|
|
2016,VI,Virgin Islands,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,30,36,19,53,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,78,RACE01,CAT4,_RFPSA21,RESP046,"(18.335765, -64.896335)"
|
|
2016,VI,Virgin Islands,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,32,64,47,81,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,78,RACE01,CAT4,_RFPSA21,RESP054,"(18.335765, -64.896335)"
|
|
2016,VI,Virgin Islands,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,136,45.6,35.4,55.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,78,RACE02,CAT4,_RFPSA21,RESP046,"(18.335765, -64.896335)"
|
|
2016,VI,Virgin Islands,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,85,54.4,44.3,64.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,78,RACE02,CAT4,_RFPSA21,RESP054,"(18.335765, -64.896335)"
|
|
2016,VI,Virgin Islands,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,78,RACE03,CAT4,_RFPSA21,RESP046,"(18.335765, -64.896335)"
|
|
2016,VI,Virgin Islands,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,78,RACE03,CAT4,_RFPSA21,RESP054,"(18.335765, -64.896335)"
|
|
2016,VI,Virgin Islands,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,78,RACE04,CAT4,_RFPSA21,RESP046,"(18.335765, -64.896335)"
|
|
2016,VI,Virgin Islands,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,78,RACE04,CAT4,_RFPSA21,RESP054,"(18.335765, -64.896335)"
|
|
2016,VI,Virgin Islands,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,78,RACE05,CAT4,_RFPSA21,RESP046,"(18.335765, -64.896335)"
|
|
2016,VI,Virgin Islands,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,78,RACE05,CAT4,_RFPSA21,RESP054,"(18.335765, -64.896335)"
|
|
2016,VI,Virgin Islands,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,78,RACE06,CAT4,_RFPSA21,RESP046,"(18.335765, -64.896335)"
|
|
2016,VI,Virgin Islands,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,78,RACE06,CAT4,_RFPSA21,RESP054,"(18.335765, -64.896335)"
|
|
2016,VI,Virgin Islands,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,78,RACE07,CAT4,_RFPSA21,RESP046,"(18.335765, -64.896335)"
|
|
2016,VI,Virgin Islands,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,78,RACE07,CAT4,_RFPSA21,RESP054,"(18.335765, -64.896335)"
|
|
2016,VI,Virgin Islands,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,18,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,78,RACE08,CAT4,_RFPSA21,RESP046,"(18.335765, -64.896335)"
|
|
2016,VI,Virgin Islands,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,24,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,78,RACE08,CAT4,_RFPSA21,RESP054,"(18.335765, -64.896335)"
|
|
2016,VI,Virgin Islands,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,197,42.8,35.1,50.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,78,SEX1,CAT2,_RFPSA21,RESP046,"(18.335765, -64.896335)"
|
|
2016,VI,Virgin Islands,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,156,57.2,49.6,64.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,78,SEX1,CAT2,_RFPSA21,RESP054,"(18.335765, -64.896335)"
|
|
2016,VI,Virgin Islands,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,78,SEX2,CAT2,_RFPSA21,RESP046,"(18.335765, -64.896335)"
|
|
2016,VI,Virgin Islands,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,78,SEX2,CAT2,_RFPSA21,RESP054,"(18.335765, -64.896335)"
|
|
2016,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,99,19.6,15.4,23.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,AGE06,CAT3,_RFPSA21,RESP046,"(37.54268067400045, -78.45789046299967)"
|
|
2016,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,402,80.4,76.2,84.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,AGE06,CAT3,_RFPSA21,RESP054,"(37.54268067400045, -78.45789046299967)"
|
|
2016,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,272,38.3,33.7,42.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,AGE07,CAT3,_RFPSA21,RESP046,"(37.54268067400045, -78.45789046299967)"
|
|
2016,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,415,61.7,57.1,66.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,AGE07,CAT3,_RFPSA21,RESP054,"(37.54268067400045, -78.45789046299967)"
|
|
2016,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,172,45.7,38.3,53.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,AGE08,CAT3,_RFPSA21,RESP046,"(37.54268067400045, -78.45789046299967)"
|
|
2016,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,155,54.3,46.8,61.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,AGE08,CAT3,_RFPSA21,RESP054,"(37.54268067400045, -78.45789046299967)"
|
|
2016,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,672,60.5,56.4,64.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,AGE09,CAT3,_RFPSA21,RESP046,"(37.54268067400045, -78.45789046299967)"
|
|
2016,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,367,39.5,35.4,43.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,AGE09,CAT3,_RFPSA21,RESP054,"(37.54268067400045, -78.45789046299967)"
|
|
2016,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1215,40.4,38,42.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,BO1,CAT1,_RFPSA21,RESP046,"(37.54268067400045, -78.45789046299967)"
|
|
2016,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1339,59.6,57.2,62,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,BO1,CAT1,_RFPSA21,RESP054,"(37.54268067400045, -78.45789046299967)"
|
|
2016,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,63,24.4,18.2,30.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,EDUCA1,CAT5,_RFPSA21,RESP046,"(37.54268067400045, -78.45789046299967)"
|
|
2016,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,163,75.6,69.5,81.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,EDUCA1,CAT5,_RFPSA21,RESP054,"(37.54268067400045, -78.45789046299967)"
|
|
2016,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,270,37.8,33.1,42.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,EDUCA2,CAT5,_RFPSA21,RESP046,"(37.54268067400045, -78.45789046299967)"
|
|
2016,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,363,62.2,57.5,66.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,EDUCA2,CAT5,_RFPSA21,RESP054,"(37.54268067400045, -78.45789046299967)"
|
|
2016,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,264,42.3,37.1,47.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,EDUCA3,CAT5,_RFPSA21,RESP046,"(37.54268067400045, -78.45789046299967)"
|
|
2016,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,293,57.7,52.5,62.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,EDUCA3,CAT5,_RFPSA21,RESP054,"(37.54268067400045, -78.45789046299967)"
|
|
2016,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,615,46.9,42.8,50.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,EDUCA4,CAT5,_RFPSA21,RESP046,"(37.54268067400045, -78.45789046299967)"
|
|
2016,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,516,53.1,49.1,57.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,EDUCA4,CAT5,_RFPSA21,RESP054,"(37.54268067400045, -78.45789046299967)"
|
|
2016,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,21,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,51,INCOME1,CAT6,_RFPSA21,RESP046,"(37.54268067400045, -78.45789046299967)"
|
|
2016,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,99,88.5,81.5,95.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,INCOME1,CAT6,_RFPSA21,RESP054,"(37.54268067400045, -78.45789046299967)"
|
|
2016,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,122,27.1,21.6,32.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,INCOME2,CAT6,_RFPSA21,RESP046,"(37.54268067400045, -78.45789046299967)"
|
|
2016,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,199,72.9,67.3,78.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,INCOME2,CAT6,_RFPSA21,RESP054,"(37.54268067400045, -78.45789046299967)"
|
|
2016,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,83,35.2,27.4,42.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,INCOME3,CAT6,_RFPSA21,RESP046,"(37.54268067400045, -78.45789046299967)"
|
|
2016,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,117,64.8,57.1,72.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,INCOME3,CAT6,_RFPSA21,RESP054,"(37.54268067400045, -78.45789046299967)"
|
|
2016,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,146,46.4,39.1,53.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,INCOME4,CAT6,_RFPSA21,RESP046,"(37.54268067400045, -78.45789046299967)"
|
|
2016,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,149,53.6,46.4,60.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,INCOME4,CAT6,_RFPSA21,RESP054,"(37.54268067400045, -78.45789046299967)"
|
|
2016,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,714,44.7,41.2,48.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,INCOME5,CAT6,_RFPSA21,RESP046,"(37.54268067400045, -78.45789046299967)"
|
|
2016,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,654,55.3,51.9,58.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,INCOME5,CAT6,_RFPSA21,RESP054,"(37.54268067400045, -78.45789046299967)"
|
|
2016,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1014,44.2,41.6,46.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,RACE01,CAT4,_RFPSA21,RESP046,"(37.54268067400045, -78.45789046299967)"
|
|
2016,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1022,55.8,53.1,58.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,RACE01,CAT4,_RFPSA21,RESP054,"(37.54268067400045, -78.45789046299967)"
|
|
2016,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,149,40.6,34.1,47.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,RACE02,CAT4,_RFPSA21,RESP046,"(37.54268067400045, -78.45789046299967)"
|
|
2016,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,184,59.4,52.8,65.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,RACE02,CAT4,_RFPSA21,RESP054,"(37.54268067400045, -78.45789046299967)"
|
|
2016,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,51,RACE03,CAT4,_RFPSA21,RESP046,"(37.54268067400045, -78.45789046299967)"
|
|
2016,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,16,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,51,RACE03,CAT4,_RFPSA21,RESP054,"(37.54268067400045, -78.45789046299967)"
|
|
2016,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,51,RACE04,CAT4,_RFPSA21,RESP046,"(37.54268067400045, -78.45789046299967)"
|
|
2016,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,36,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,51,RACE04,CAT4,_RFPSA21,RESP054,"(37.54268067400045, -78.45789046299967)"
|
|
2016,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,51,RACE05,CAT4,_RFPSA21,RESP046,"(37.54268067400045, -78.45789046299967)"
|
|
2016,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,51,RACE05,CAT4,_RFPSA21,RESP054,"(37.54268067400045, -78.45789046299967)"
|
|
2016,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,51,RACE06,CAT4,_RFPSA21,RESP046,"(37.54268067400045, -78.45789046299967)"
|
|
2016,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,9,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,51,RACE06,CAT4,_RFPSA21,RESP054,"(37.54268067400045, -78.45789046299967)"
|
|
2016,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,13,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,51,RACE07,CAT4,_RFPSA21,RESP046,"(37.54268067400045, -78.45789046299967)"
|
|
2016,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,15,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,51,RACE07,CAT4,_RFPSA21,RESP054,"(37.54268067400045, -78.45789046299967)"
|
|
2016,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,26,21.1,12.1,30.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,RACE08,CAT4,_RFPSA21,RESP046,"(37.54268067400045, -78.45789046299967)"
|
|
2016,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,57,78.9,69.9,87.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,RACE08,CAT4,_RFPSA21,RESP054,"(37.54268067400045, -78.45789046299967)"
|
|
2016,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1215,40.4,38,42.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,SEX1,CAT2,_RFPSA21,RESP046,"(37.54268067400045, -78.45789046299967)"
|
|
2016,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1339,59.6,57.2,62,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,SEX1,CAT2,_RFPSA21,RESP054,"(37.54268067400045, -78.45789046299967)"
|
|
2016,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,51,SEX2,CAT2,_RFPSA21,RESP046,"(37.54268067400045, -78.45789046299967)"
|
|
2016,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,51,SEX2,CAT2,_RFPSA21,RESP054,"(37.54268067400045, -78.45789046299967)"
|
|
2016,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,73,9.1,6.7,11.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,AGE06,CAT3,_RFPSA21,RESP046,"(47.52227862900048, -120.47001078999972)"
|
|
2016,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,645,90.9,88.6,93.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,AGE06,CAT3,_RFPSA21,RESP054,"(47.52227862900048, -120.47001078999972)"
|
|
2016,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,302,29.5,26.1,32.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,AGE07,CAT3,_RFPSA21,RESP046,"(47.52227862900048, -120.47001078999972)"
|
|
2016,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,692,70.5,67.1,73.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,AGE07,CAT3,_RFPSA21,RESP054,"(47.52227862900048, -120.47001078999972)"
|
|
2016,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,321,43.7,39.2,48.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,AGE08,CAT3,_RFPSA21,RESP046,"(47.52227862900048, -120.47001078999972)"
|
|
2016,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,359,56.3,51.8,60.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,AGE08,CAT3,_RFPSA21,RESP054,"(47.52227862900048, -120.47001078999972)"
|
|
2016,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,940,49.1,46.3,51.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,AGE09,CAT3,_RFPSA21,RESP046,"(47.52227862900048, -120.47001078999972)"
|
|
2016,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,871,50.9,48.1,53.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,AGE09,CAT3,_RFPSA21,RESP054,"(47.52227862900048, -120.47001078999972)"
|
|
2016,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1636,32,30.3,33.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,BO1,CAT1,_RFPSA21,RESP046,"(47.52227862900048, -120.47001078999972)"
|
|
2016,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,2567,68,66.4,69.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,BO1,CAT1,_RFPSA21,RESP054,"(47.52227862900048, -120.47001078999972)"
|
|
2016,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,33,12.3,7.4,17.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,EDUCA1,CAT5,_RFPSA21,RESP046,"(47.52227862900048, -120.47001078999972)"
|
|
2016,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,173,87.7,82.8,92.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,EDUCA1,CAT5,_RFPSA21,RESP054,"(47.52227862900048, -120.47001078999972)"
|
|
2016,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,295,28.4,25,31.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,EDUCA2,CAT5,_RFPSA21,RESP046,"(47.52227862900048, -120.47001078999972)"
|
|
2016,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,612,71.6,68.2,75,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,EDUCA2,CAT5,_RFPSA21,RESP054,"(47.52227862900048, -120.47001078999972)"
|
|
2016,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,434,34.4,31.1,37.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,EDUCA3,CAT5,_RFPSA21,RESP046,"(47.52227862900048, -120.47001078999972)"
|
|
2016,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,666,65.6,62.3,68.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,EDUCA3,CAT5,_RFPSA21,RESP054,"(47.52227862900048, -120.47001078999972)"
|
|
2016,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,871,37.6,35.1,40,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,EDUCA4,CAT5,_RFPSA21,RESP046,"(47.52227862900048, -120.47001078999972)"
|
|
2016,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,1106,62.4,60,64.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,EDUCA4,CAT5,_RFPSA21,RESP054,"(47.52227862900048, -120.47001078999972)"
|
|
2016,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,40,14,8.9,19.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,INCOME1,CAT6,_RFPSA21,RESP046,"(47.52227862900048, -120.47001078999972)"
|
|
2016,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,165,86,80.9,91.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,INCOME1,CAT6,_RFPSA21,RESP054,"(47.52227862900048, -120.47001078999972)"
|
|
2016,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,106,24.8,19.5,30.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,INCOME2,CAT6,_RFPSA21,RESP046,"(47.52227862900048, -120.47001078999972)"
|
|
2016,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,249,75.2,69.9,80.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,INCOME2,CAT6,_RFPSA21,RESP054,"(47.52227862900048, -120.47001078999972)"
|
|
2016,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,128,33.8,27.2,40.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,INCOME3,CAT6,_RFPSA21,RESP046,"(47.52227862900048, -120.47001078999972)"
|
|
2016,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,182,66.2,59.6,72.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,INCOME3,CAT6,_RFPSA21,RESP054,"(47.52227862900048, -120.47001078999972)"
|
|
2016,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,213,31.7,27,36.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,INCOME4,CAT6,_RFPSA21,RESP046,"(47.52227862900048, -120.47001078999972)"
|
|
2016,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,346,68.3,63.5,73,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,INCOME4,CAT6,_RFPSA21,RESP054,"(47.52227862900048, -120.47001078999972)"
|
|
2016,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,989,34.8,32.5,37.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,INCOME5,CAT6,_RFPSA21,RESP046,"(47.52227862900048, -120.47001078999972)"
|
|
2016,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,1349,65.2,62.9,67.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,INCOME5,CAT6,_RFPSA21,RESP054,"(47.52227862900048, -120.47001078999972)"
|
|
2016,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1490,35.1,33.3,36.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,RACE01,CAT4,_RFPSA21,RESP046,"(47.52227862900048, -120.47001078999972)"
|
|
2016,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,2152,64.9,63.1,66.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,RACE01,CAT4,_RFPSA21,RESP054,"(47.52227862900048, -120.47001078999972)"
|
|
2016,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,20,20.1,10.5,29.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,RACE02,CAT4,_RFPSA21,RESP046,"(47.52227862900048, -120.47001078999972)"
|
|
2016,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,60,79.9,70.3,89.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,RACE02,CAT4,_RFPSA21,RESP054,"(47.52227862900048, -120.47001078999972)"
|
|
2016,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,9,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,53,RACE03,CAT4,_RFPSA21,RESP046,"(47.52227862900048, -120.47001078999972)"
|
|
2016,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,29,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,53,RACE03,CAT4,_RFPSA21,RESP054,"(47.52227862900048, -120.47001078999972)"
|
|
2016,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,25,20.2,11.6,28.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,RACE04,CAT4,_RFPSA21,RESP046,"(47.52227862900048, -120.47001078999972)"
|
|
2016,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,84,79.8,71.2,88.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,RACE04,CAT4,_RFPSA21,RESP054,"(47.52227862900048, -120.47001078999972)"
|
|
2016,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,53,RACE05,CAT4,_RFPSA21,RESP046,"(47.52227862900048, -120.47001078999972)"
|
|
2016,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,53,RACE05,CAT4,_RFPSA21,RESP054,"(47.52227862900048, -120.47001078999972)"
|
|
2016,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,18,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,53,RACE06,CAT4,_RFPSA21,RESP046,"(47.52227862900048, -120.47001078999972)"
|
|
2016,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,27,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,53,RACE06,CAT4,_RFPSA21,RESP054,"(47.52227862900048, -120.47001078999972)"
|
|
2016,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,36,30.6,20.7,40.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,RACE07,CAT4,_RFPSA21,RESP046,"(47.52227862900048, -120.47001078999972)"
|
|
2016,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,68,69.4,59.4,79.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,RACE07,CAT4,_RFPSA21,RESP054,"(47.52227862900048, -120.47001078999972)"
|
|
2016,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,37,15.4,9.9,20.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,RACE08,CAT4,_RFPSA21,RESP046,"(47.52227862900048, -120.47001078999972)"
|
|
2016,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,137,84.6,79.1,90.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,RACE08,CAT4,_RFPSA21,RESP054,"(47.52227862900048, -120.47001078999972)"
|
|
2016,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1636,32,30.3,33.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,SEX1,CAT2,_RFPSA21,RESP046,"(47.52227862900048, -120.47001078999972)"
|
|
2016,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,2567,68,66.4,69.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,SEX1,CAT2,_RFPSA21,RESP054,"(47.52227862900048, -120.47001078999972)"
|
|
2016,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,53,SEX2,CAT2,_RFPSA21,RESP046,"(47.52227862900048, -120.47001078999972)"
|
|
2016,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,53,SEX2,CAT2,_RFPSA21,RESP054,"(47.52227862900048, -120.47001078999972)"
|
|
2016,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,208,53,47.3,58.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,AGE08,CAT3,_RFPSA21,RESP046,"(38.66551020200046, -80.71264013499967)"
|
|
2016,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,163,47,41.3,52.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,AGE08,CAT3,_RFPSA21,RESP054,"(38.66551020200046, -80.71264013499967)"
|
|
2016,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,73,16.7,12.8,20.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,AGE06,CAT3,_RFPSA21,RESP046,"(38.66551020200046, -80.71264013499967)"
|
|
2016,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,344,83.3,79.3,87.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,AGE06,CAT3,_RFPSA21,RESP054,"(38.66551020200046, -80.71264013499967)"
|
|
2016,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,227,36.5,32.2,40.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,AGE07,CAT3,_RFPSA21,RESP046,"(38.66551020200046, -80.71264013499967)"
|
|
2016,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,354,63.5,59.1,67.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,AGE07,CAT3,_RFPSA21,RESP054,"(38.66551020200046, -80.71264013499967)"
|
|
2016,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,554,62.1,58.4,65.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,AGE09,CAT3,_RFPSA21,RESP046,"(38.66551020200046, -80.71264013499967)"
|
|
2016,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,292,37.9,34.2,41.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,AGE09,CAT3,_RFPSA21,RESP054,"(38.66551020200046, -80.71264013499967)"
|
|
2016,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1062,42.8,40.5,45,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,BO1,CAT1,_RFPSA21,RESP046,"(38.66551020200046, -80.71264013499967)"
|
|
2016,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1153,57.2,55,59.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,BO1,CAT1,_RFPSA21,RESP054,"(38.66551020200046, -80.71264013499967)"
|
|
2016,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,82,27.8,22.1,33.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,EDUCA1,CAT5,_RFPSA21,RESP046,"(38.66551020200046, -80.71264013499967)"
|
|
2016,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,194,72.2,66.5,77.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,EDUCA1,CAT5,_RFPSA21,RESP054,"(38.66551020200046, -80.71264013499967)"
|
|
2016,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,391,43.9,40.3,47.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,EDUCA2,CAT5,_RFPSA21,RESP046,"(38.66551020200046, -80.71264013499967)"
|
|
2016,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,453,56.1,52.5,59.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,EDUCA2,CAT5,_RFPSA21,RESP054,"(38.66551020200046, -80.71264013499967)"
|
|
2016,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,221,44.5,39.6,49.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,EDUCA3,CAT5,_RFPSA21,RESP046,"(38.66551020200046, -80.71264013499967)"
|
|
2016,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,230,55.5,50.5,60.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,EDUCA3,CAT5,_RFPSA21,RESP054,"(38.66551020200046, -80.71264013499967)"
|
|
2016,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,367,52.6,48.4,56.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,EDUCA4,CAT5,_RFPSA21,RESP046,"(38.66551020200046, -80.71264013499967)"
|
|
2016,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,274,47.4,43.1,51.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,EDUCA4,CAT5,_RFPSA21,RESP054,"(38.66551020200046, -80.71264013499967)"
|
|
2016,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,66,26.3,20.1,32.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,INCOME1,CAT6,_RFPSA21,RESP046,"(38.66551020200046, -80.71264013499967)"
|
|
2016,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,157,73.7,67.5,79.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,INCOME1,CAT6,_RFPSA21,RESP054,"(38.66551020200046, -80.71264013499967)"
|
|
2016,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,131,37.6,31.9,43.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,INCOME2,CAT6,_RFPSA21,RESP046,"(38.66551020200046, -80.71264013499967)"
|
|
2016,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,196,62.4,56.6,68.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,INCOME2,CAT6,_RFPSA21,RESP054,"(38.66551020200046, -80.71264013499967)"
|
|
2016,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,115,46,39.1,52.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,INCOME3,CAT6,_RFPSA21,RESP046,"(38.66551020200046, -80.71264013499967)"
|
|
2016,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,130,54,47.1,60.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,INCOME3,CAT6,_RFPSA21,RESP054,"(38.66551020200046, -80.71264013499967)"
|
|
2016,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,146,43.2,36.9,49.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,INCOME4,CAT6,_RFPSA21,RESP046,"(38.66551020200046, -80.71264013499967)"
|
|
2016,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,145,56.8,50.5,63.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,INCOME4,CAT6,_RFPSA21,RESP054,"(38.66551020200046, -80.71264013499967)"
|
|
2016,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,446,47.8,43.9,51.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,INCOME5,CAT6,_RFPSA21,RESP046,"(38.66551020200046, -80.71264013499967)"
|
|
2016,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,366,52.2,48.3,56.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,INCOME5,CAT6,_RFPSA21,RESP054,"(38.66551020200046, -80.71264013499967)"
|
|
2016,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1003,43.1,40.8,45.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,RACE01,CAT4,_RFPSA21,RESP046,"(38.66551020200046, -80.71264013499967)"
|
|
2016,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1081,56.9,54.5,59.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,RACE01,CAT4,_RFPSA21,RESP054,"(38.66551020200046, -80.71264013499967)"
|
|
2016,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,26,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,54,RACE02,CAT4,_RFPSA21,RESP046,"(38.66551020200046, -80.71264013499967)"
|
|
2016,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,22,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,54,RACE02,CAT4,_RFPSA21,RESP054,"(38.66551020200046, -80.71264013499967)"
|
|
2016,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,54,RACE03,CAT4,_RFPSA21,RESP046,"(38.66551020200046, -80.71264013499967)"
|
|
2016,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,12,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,54,RACE03,CAT4,_RFPSA21,RESP054,"(38.66551020200046, -80.71264013499967)"
|
|
2016,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,54,RACE04,CAT4,_RFPSA21,RESP046,"(38.66551020200046, -80.71264013499967)"
|
|
2016,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,54,RACE04,CAT4,_RFPSA21,RESP054,"(38.66551020200046, -80.71264013499967)"
|
|
2016,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,54,RACE05,CAT4,_RFPSA21,RESP046,"(38.66551020200046, -80.71264013499967)"
|
|
2016,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,54,RACE05,CAT4,_RFPSA21,RESP054,"(38.66551020200046, -80.71264013499967)"
|
|
2016,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,54,RACE06,CAT4,_RFPSA21,RESP046,"(38.66551020200046, -80.71264013499967)"
|
|
2016,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,54,RACE06,CAT4,_RFPSA21,RESP054,"(38.66551020200046, -80.71264013499967)"
|
|
2016,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,15,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,54,RACE07,CAT4,_RFPSA21,RESP046,"(38.66551020200046, -80.71264013499967)"
|
|
2016,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,21,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,54,RACE07,CAT4,_RFPSA21,RESP054,"(38.66551020200046, -80.71264013499967)"
|
|
2016,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,54,RACE08,CAT4,_RFPSA21,RESP046,"(38.66551020200046, -80.71264013499967)"
|
|
2016,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,54,RACE08,CAT4,_RFPSA21,RESP054,"(38.66551020200046, -80.71264013499967)"
|
|
2016,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1062,42.8,40.5,45,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,SEX1,CAT2,_RFPSA21,RESP046,"(38.66551020200046, -80.71264013499967)"
|
|
2016,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1153,57.2,55,59.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,SEX1,CAT2,_RFPSA21,RESP054,"(38.66551020200046, -80.71264013499967)"
|
|
2016,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,54,SEX2,CAT2,_RFPSA21,RESP046,"(38.66551020200046, -80.71264013499967)"
|
|
2016,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,54,SEX2,CAT2,_RFPSA21,RESP054,"(38.66551020200046, -80.71264013499967)"
|
|
2016,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,36,14.3,8.7,19.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,AGE06,CAT3,_RFPSA21,RESP046,"(44.39319117400049, -89.81637074199966)"
|
|
2016,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,245,85.7,80.2,91.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,AGE06,CAT3,_RFPSA21,RESP054,"(44.39319117400049, -89.81637074199966)"
|
|
2016,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,138,32,26.3,37.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,AGE07,CAT3,_RFPSA21,RESP046,"(44.39319117400049, -89.81637074199966)"
|
|
2016,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,270,68,62.3,73.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,AGE07,CAT3,_RFPSA21,RESP054,"(44.39319117400049, -89.81637074199966)"
|
|
2016,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,114,40.8,33.5,48.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,AGE08,CAT3,_RFPSA21,RESP046,"(44.39319117400049, -89.81637074199966)"
|
|
2016,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,164,59.2,51.8,66.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,AGE08,CAT3,_RFPSA21,RESP054,"(44.39319117400049, -89.81637074199966)"
|
|
2016,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,356,57,51.9,62,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,AGE09,CAT3,_RFPSA21,RESP046,"(44.39319117400049, -89.81637074199966)"
|
|
2016,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,266,43,38,48.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,AGE09,CAT3,_RFPSA21,RESP054,"(44.39319117400049, -89.81637074199966)"
|
|
2016,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,644,36.3,33.2,39.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,BO1,CAT1,_RFPSA21,RESP046,"(44.39319117400049, -89.81637074199966)"
|
|
2016,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,945,63.7,60.6,66.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,BO1,CAT1,_RFPSA21,RESP054,"(44.39319117400049, -89.81637074199966)"
|
|
2016,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,29,27.7,16.8,38.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,EDUCA1,CAT5,_RFPSA21,RESP046,"(44.39319117400049, -89.81637074199966)"
|
|
2016,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,64,72.3,61.4,83.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,EDUCA1,CAT5,_RFPSA21,RESP054,"(44.39319117400049, -89.81637074199966)"
|
|
2016,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,192,33.6,28.7,38.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,EDUCA2,CAT5,_RFPSA21,RESP046,"(44.39319117400049, -89.81637074199966)"
|
|
2016,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,327,66.4,61.4,71.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,EDUCA2,CAT5,_RFPSA21,RESP054,"(44.39319117400049, -89.81637074199966)"
|
|
2016,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,160,40.1,34,46.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,EDUCA3,CAT5,_RFPSA21,RESP046,"(44.39319117400049, -89.81637074199966)"
|
|
2016,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,250,59.9,53.7,66,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,EDUCA3,CAT5,_RFPSA21,RESP054,"(44.39319117400049, -89.81637074199966)"
|
|
2016,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,263,39.1,34.3,43.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,EDUCA4,CAT5,_RFPSA21,RESP046,"(44.39319117400049, -89.81637074199966)"
|
|
2016,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,303,60.9,56.1,65.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,EDUCA4,CAT5,_RFPSA21,RESP054,"(44.39319117400049, -89.81637074199966)"
|
|
2016,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,24,21.8,10.7,32.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,INCOME1,CAT6,_RFPSA21,RESP046,"(44.39319117400049, -89.81637074199966)"
|
|
2016,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,77,78.2,67.2,89.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,INCOME1,CAT6,_RFPSA21,RESP054,"(44.39319117400049, -89.81637074199966)"
|
|
2016,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,75,34.8,25.2,44.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,INCOME2,CAT6,_RFPSA21,RESP046,"(44.39319117400049, -89.81637074199966)"
|
|
2016,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,103,65.2,55.5,74.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,INCOME2,CAT6,_RFPSA21,RESP054,"(44.39319117400049, -89.81637074199966)"
|
|
2016,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,65,38.6,27.8,49.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,INCOME3,CAT6,_RFPSA21,RESP046,"(44.39319117400049, -89.81637074199966)"
|
|
2016,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,87,61.4,50.5,72.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,INCOME3,CAT6,_RFPSA21,RESP054,"(44.39319117400049, -89.81637074199966)"
|
|
2016,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,84,32.2,24.6,39.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,INCOME4,CAT6,_RFPSA21,RESP046,"(44.39319117400049, -89.81637074199966)"
|
|
2016,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,139,67.8,60.2,75.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,INCOME4,CAT6,_RFPSA21,RESP054,"(44.39319117400049, -89.81637074199966)"
|
|
2016,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,346,38.4,34.1,42.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,INCOME5,CAT6,_RFPSA21,RESP046,"(44.39319117400049, -89.81637074199966)"
|
|
2016,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,465,61.6,57.4,65.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,INCOME5,CAT6,_RFPSA21,RESP054,"(44.39319117400049, -89.81637074199966)"
|
|
2016,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,586,37.2,34,40.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,RACE01,CAT4,_RFPSA21,RESP046,"(44.39319117400049, -89.81637074199966)"
|
|
2016,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,854,62.8,59.6,66,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,RACE01,CAT4,_RFPSA21,RESP054,"(44.39319117400049, -89.81637074199966)"
|
|
2016,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,26,34.9,16.9,52.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,RACE02,CAT4,_RFPSA21,RESP046,"(44.39319117400049, -89.81637074199966)"
|
|
2016,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,31,65.1,47.2,83.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,RACE02,CAT4,_RFPSA21,RESP054,"(44.39319117400049, -89.81637074199966)"
|
|
2016,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,55,SEX2,CAT2,_RFPSA21,RESP046,"(44.39319117400049, -89.81637074199966)"
|
|
2016,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,55,RACE03,CAT4,_RFPSA21,RESP046,"(44.39319117400049, -89.81637074199966)"
|
|
2016,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,55,RACE03,CAT4,_RFPSA21,RESP054,"(44.39319117400049, -89.81637074199966)"
|
|
2016,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,55,RACE04,CAT4,_RFPSA21,RESP046,"(44.39319117400049, -89.81637074199966)"
|
|
2016,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,55,RACE04,CAT4,_RFPSA21,RESP054,"(44.39319117400049, -89.81637074199966)"
|
|
2016,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,55,RACE05,CAT4,_RFPSA21,RESP046,"(44.39319117400049, -89.81637074199966)"
|
|
2016,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,55,RACE05,CAT4,_RFPSA21,RESP054,"(44.39319117400049, -89.81637074199966)"
|
|
2016,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,55,RACE06,CAT4,_RFPSA21,RESP046,"(44.39319117400049, -89.81637074199966)"
|
|
2016,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,13,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,55,RACE06,CAT4,_RFPSA21,RESP054,"(44.39319117400049, -89.81637074199966)"
|
|
2016,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,55,RACE07,CAT4,_RFPSA21,RESP046,"(44.39319117400049, -89.81637074199966)"
|
|
2016,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,55,RACE07,CAT4,_RFPSA21,RESP054,"(44.39319117400049, -89.81637074199966)"
|
|
2016,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,55,RACE08,CAT4,_RFPSA21,RESP046,"(44.39319117400049, -89.81637074199966)"
|
|
2016,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,21,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,55,RACE08,CAT4,_RFPSA21,RESP054,"(44.39319117400049, -89.81637074199966)"
|
|
2016,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,644,36.3,33.2,39.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,SEX1,CAT2,_RFPSA21,RESP046,"(44.39319117400049, -89.81637074199966)"
|
|
2016,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,945,63.7,60.6,66.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,SEX1,CAT2,_RFPSA21,RESP054,"(44.39319117400049, -89.81637074199966)"
|
|
2016,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,55,SEX2,CAT2,_RFPSA21,RESP054,"(44.39319117400049, -89.81637074199966)"
|
|
2016,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,37,15.2,9,21.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,AGE06,CAT3,_RFPSA21,RESP046,"(43.23554134300048, -108.10983035299967)"
|
|
2016,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,156,84.8,78.7,91,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,AGE06,CAT3,_RFPSA21,RESP054,"(43.23554134300048, -108.10983035299967)"
|
|
2016,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,166,48.9,42,55.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,AGE07,CAT3,_RFPSA21,RESP046,"(43.23554134300048, -108.10983035299967)"
|
|
2016,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,178,51.1,44.3,58,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,AGE07,CAT3,_RFPSA21,RESP054,"(43.23554134300048, -108.10983035299967)"
|
|
2016,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,186,68.6,61.6,75.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,AGE08,CAT3,_RFPSA21,RESP046,"(43.23554134300048, -108.10983035299967)"
|
|
2016,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,96,31.4,24.3,38.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,AGE08,CAT3,_RFPSA21,RESP054,"(43.23554134300048, -108.10983035299967)"
|
|
2016,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,431,65.4,60.6,70.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,AGE09,CAT3,_RFPSA21,RESP046,"(43.23554134300048, -108.10983035299967)"
|
|
2016,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,234,34.6,29.7,39.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,AGE09,CAT3,_RFPSA21,RESP054,"(43.23554134300048, -108.10983035299967)"
|
|
2016,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,820,49.3,45.8,52.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,BO1,CAT1,_RFPSA21,RESP046,"(43.23554134300048, -108.10983035299967)"
|
|
2016,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,664,50.7,47.2,54.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,BO1,CAT1,_RFPSA21,RESP054,"(43.23554134300048, -108.10983035299967)"
|
|
2016,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,20,30.8,16.1,45.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,EDUCA1,CAT5,_RFPSA21,RESP046,"(43.23554134300048, -108.10983035299967)"
|
|
2016,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,45,69.2,54.4,83.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,EDUCA1,CAT5,_RFPSA21,RESP054,"(43.23554134300048, -108.10983035299967)"
|
|
2016,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,191,41.6,35.3,47.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,EDUCA2,CAT5,_RFPSA21,RESP046,"(43.23554134300048, -108.10983035299967)"
|
|
2016,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,227,58.4,52.1,64.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,EDUCA2,CAT5,_RFPSA21,RESP054,"(43.23554134300048, -108.10983035299967)"
|
|
2016,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,240,49.1,42.8,55.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,EDUCA3,CAT5,_RFPSA21,RESP046,"(43.23554134300048, -108.10983035299967)"
|
|
2016,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,202,50.9,44.6,57.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,EDUCA3,CAT5,_RFPSA21,RESP054,"(43.23554134300048, -108.10983035299967)"
|
|
2016,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,368,62.8,57.2,68.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,EDUCA4,CAT5,_RFPSA21,RESP046,"(43.23554134300048, -108.10983035299967)"
|
|
2016,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,190,37.2,31.7,42.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,EDUCA4,CAT5,_RFPSA21,RESP054,"(43.23554134300048, -108.10983035299967)"
|
|
2016,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,20,27.6,13.1,42,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,INCOME1,CAT6,_RFPSA21,RESP046,"(43.23554134300048, -108.10983035299967)"
|
|
2016,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,44,72.4,58,86.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,INCOME1,CAT6,_RFPSA21,RESP054,"(43.23554134300048, -108.10983035299967)"
|
|
2016,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,71,40.2,29.4,50.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,INCOME2,CAT6,_RFPSA21,RESP046,"(43.23554134300048, -108.10983035299967)"
|
|
2016,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,96,59.8,49.1,70.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,INCOME2,CAT6,_RFPSA21,RESP054,"(43.23554134300048, -108.10983035299967)"
|
|
2016,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,61,41.9,30.2,53.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,INCOME3,CAT6,_RFPSA21,RESP046,"(43.23554134300048, -108.10983035299967)"
|
|
2016,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,71,58.1,46.4,69.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,INCOME3,CAT6,_RFPSA21,RESP054,"(43.23554134300048, -108.10983035299967)"
|
|
2016,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,119,54.4,45.4,63.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,INCOME4,CAT6,_RFPSA21,RESP046,"(43.23554134300048, -108.10983035299967)"
|
|
2016,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,94,45.6,36.5,54.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,INCOME4,CAT6,_RFPSA21,RESP054,"(43.23554134300048, -108.10983035299967)"
|
|
2016,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,467,52.6,47.7,57.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,INCOME5,CAT6,_RFPSA21,RESP046,"(43.23554134300048, -108.10983035299967)"
|
|
2016,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,287,47.4,42.5,52.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,INCOME5,CAT6,_RFPSA21,RESP054,"(43.23554134300048, -108.10983035299967)"
|
|
2016,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,776,50.7,47,54.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,RACE01,CAT4,_RFPSA21,RESP046,"(43.23554134300048, -108.10983035299967)"
|
|
2016,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,604,49.3,45.6,53,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,RACE01,CAT4,_RFPSA21,RESP054,"(43.23554134300048, -108.10983035299967)"
|
|
2016,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,56,RACE02,CAT4,_RFPSA21,RESP046,"(43.23554134300048, -108.10983035299967)"
|
|
2016,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,56,RACE02,CAT4,_RFPSA21,RESP054,"(43.23554134300048, -108.10983035299967)"
|
|
2016,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,56,RACE03,CAT4,_RFPSA21,RESP046,"(43.23554134300048, -108.10983035299967)"
|
|
2016,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,56,RACE03,CAT4,_RFPSA21,RESP054,"(43.23554134300048, -108.10983035299967)"
|
|
2016,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,56,RACE04,CAT4,_RFPSA21,RESP046,"(43.23554134300048, -108.10983035299967)"
|
|
2016,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,56,RACE04,CAT4,_RFPSA21,RESP054,"(43.23554134300048, -108.10983035299967)"
|
|
2016,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,56,RACE05,CAT4,_RFPSA21,RESP046,"(43.23554134300048, -108.10983035299967)"
|
|
2016,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,56,RACE05,CAT4,_RFPSA21,RESP054,"(43.23554134300048, -108.10983035299967)"
|
|
2016,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,56,RACE06,CAT4,_RFPSA21,RESP046,"(43.23554134300048, -108.10983035299967)"
|
|
2016,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,56,RACE06,CAT4,_RFPSA21,RESP054,"(43.23554134300048, -108.10983035299967)"
|
|
2016,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,56,RACE07,CAT4,_RFPSA21,RESP046,"(43.23554134300048, -108.10983035299967)"
|
|
2016,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,9,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,56,RACE07,CAT4,_RFPSA21,RESP054,"(43.23554134300048, -108.10983035299967)"
|
|
2016,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,22,25.3,12.8,37.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,RACE08,CAT4,_RFPSA21,RESP046,"(43.23554134300048, -108.10983035299967)"
|
|
2016,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,40,74.7,62.2,87.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,RACE08,CAT4,_RFPSA21,RESP054,"(43.23554134300048, -108.10983035299967)"
|
|
2016,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,820,49.3,45.8,52.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,SEX1,CAT2,_RFPSA21,RESP046,"(43.23554134300048, -108.10983035299967)"
|
|
2016,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,664,50.7,47.2,54.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,SEX1,CAT2,_RFPSA21,RESP054,"(43.23554134300048, -108.10983035299967)"
|
|
2016,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,56,SEX2,CAT2,_RFPSA21,RESP046,"(43.23554134300048, -108.10983035299967)"
|
|
2016,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,56,SEX2,CAT2,_RFPSA21,RESP054,"(43.23554134300048, -108.10983035299967)"
|
|
2018,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,840,38.5,35.8,41.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,BO1,CAT1,_RFPSA22,RESP046,"(32.84057112200048, -86.63186076199969)"
|
|
2018,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,41,9.9,6.5,13.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,AGE06,CAT3,_RFPSA22,RESP046,"(32.84057112200048, -86.63186076199969)"
|
|
2018,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,286,90.1,86.7,93.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,AGE06,CAT3,_RFPSA22,RESP054,"(32.84057112200048, -86.63186076199969)"
|
|
2018,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,165,39.3,33.7,44.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,AGE07,CAT3,_RFPSA22,RESP046,"(32.84057112200048, -86.63186076199969)"
|
|
2018,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,281,60.7,55.1,66.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,AGE07,CAT3,_RFPSA22,RESP054,"(32.84057112200048, -86.63186076199969)"
|
|
2018,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,123,37.8,31.2,44.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,AGE08,CAT3,_RFPSA22,RESP046,"(32.84057112200048, -86.63186076199969)"
|
|
2018,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,164,62.2,55.5,68.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,AGE08,CAT3,_RFPSA22,RESP054,"(32.84057112200048, -86.63186076199969)"
|
|
2018,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,511,60.9,56.8,65.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,AGE09,CAT3,_RFPSA22,RESP046,"(32.84057112200048, -86.63186076199969)"
|
|
2018,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,307,39.1,34.9,43.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,AGE09,CAT3,_RFPSA22,RESP054,"(32.84057112200048, -86.63186076199969)"
|
|
2018,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1038,61.5,58.8,64.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,BO1,CAT1,_RFPSA22,RESP054,"(32.84057112200048, -86.63186076199969)"
|
|
2018,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,56,26.8,19.3,34.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,EDUCA1,CAT5,_RFPSA22,RESP046,"(32.84057112200048, -86.63186076199969)"
|
|
2018,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,142,73.2,65.8,80.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,EDUCA1,CAT5,_RFPSA22,RESP054,"(32.84057112200048, -86.63186076199969)"
|
|
2018,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,188,31.5,26.7,36.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,EDUCA2,CAT5,_RFPSA22,RESP046,"(32.84057112200048, -86.63186076199969)"
|
|
2018,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,338,68.5,63.7,73.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,EDUCA2,CAT5,_RFPSA22,RESP054,"(32.84057112200048, -86.63186076199969)"
|
|
2018,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,243,44.3,39.2,49.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,EDUCA3,CAT5,_RFPSA22,RESP046,"(32.84057112200048, -86.63186076199969)"
|
|
2018,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,255,55.7,50.6,60.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,EDUCA3,CAT5,_RFPSA22,RESP054,"(32.84057112200048, -86.63186076199969)"
|
|
2018,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,351,47.1,42.5,51.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,EDUCA4,CAT5,_RFPSA22,RESP046,"(32.84057112200048, -86.63186076199969)"
|
|
2018,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,300,52.9,48.2,57.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,EDUCA4,CAT5,_RFPSA22,RESP054,"(32.84057112200048, -86.63186076199969)"
|
|
2018,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,39,25.2,15.3,35,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,INCOME1,CAT6,_RFPSA22,RESP046,"(32.84057112200048, -86.63186076199969)"
|
|
2018,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,114,74.8,65,84.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,INCOME1,CAT6,_RFPSA22,RESP054,"(32.84057112200048, -86.63186076199969)"
|
|
2018,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,95,31.5,24.8,38.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,INCOME2,CAT6,_RFPSA22,RESP046,"(32.84057112200048, -86.63186076199969)"
|
|
2018,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,165,68.5,61.8,75.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,INCOME2,CAT6,_RFPSA22,RESP054,"(32.84057112200048, -86.63186076199969)"
|
|
2018,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,61,38.5,28.8,48.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,INCOME3,CAT6,_RFPSA22,RESP046,"(32.84057112200048, -86.63186076199969)"
|
|
2018,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,78,61.5,51.8,71.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,INCOME3,CAT6,_RFPSA22,RESP054,"(32.84057112200048, -86.63186076199969)"
|
|
2018,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,110,41.9,34.6,49.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,INCOME4,CAT6,_RFPSA22,RESP046,"(32.84057112200048, -86.63186076199969)"
|
|
2018,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,130,58.1,50.7,65.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,INCOME4,CAT6,_RFPSA22,RESP054,"(32.84057112200048, -86.63186076199969)"
|
|
2018,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,416,43.9,39.7,48.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,INCOME5,CAT6,_RFPSA22,RESP046,"(32.84057112200048, -86.63186076199969)"
|
|
2018,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,385,56.1,51.9,60.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,INCOME5,CAT6,_RFPSA22,RESP054,"(32.84057112200048, -86.63186076199969)"
|
|
2018,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,654,41.6,38.4,44.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,RACE01,CAT4,_RFPSA22,RESP046,"(32.84057112200048, -86.63186076199969)"
|
|
2018,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,721,58.4,55.2,61.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,RACE01,CAT4,_RFPSA22,RESP054,"(32.84057112200048, -86.63186076199969)"
|
|
2018,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,149,30.7,25.3,36.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,RACE02,CAT4,_RFPSA22,RESP046,"(32.84057112200048, -86.63186076199969)"
|
|
2018,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,257,69.3,63.9,74.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,RACE02,CAT4,_RFPSA22,RESP054,"(32.84057112200048, -86.63186076199969)"
|
|
2018,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,9,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,01,RACE03,CAT4,_RFPSA22,RESP046,"(32.84057112200048, -86.63186076199969)"
|
|
2018,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,01,RACE03,CAT4,_RFPSA22,RESP054,"(32.84057112200048, -86.63186076199969)"
|
|
2018,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,01,RACE04,CAT4,_RFPSA22,RESP046,"(32.84057112200048, -86.63186076199969)"
|
|
2018,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,11,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,01,RACE04,CAT4,_RFPSA22,RESP054,"(32.84057112200048, -86.63186076199969)"
|
|
2018,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,01,RACE05,CAT4,_RFPSA22,RESP046,"(32.84057112200048, -86.63186076199969)"
|
|
2018,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,01,RACE05,CAT4,_RFPSA22,RESP054,"(32.84057112200048, -86.63186076199969)"
|
|
2018,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,01,RACE06,CAT4,_RFPSA22,RESP046,"(32.84057112200048, -86.63186076199969)"
|
|
2018,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,14,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,01,RACE06,CAT4,_RFPSA22,RESP054,"(32.84057112200048, -86.63186076199969)"
|
|
2018,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,15,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,01,RACE07,CAT4,_RFPSA22,RESP046,"(32.84057112200048, -86.63186076199969)"
|
|
2018,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,14,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,01,RACE07,CAT4,_RFPSA22,RESP054,"(32.84057112200048, -86.63186076199969)"
|
|
2018,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,01,RACE08,CAT4,_RFPSA22,RESP046,"(32.84057112200048, -86.63186076199969)"
|
|
2018,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,01,RACE08,CAT4,_RFPSA22,RESP054,"(32.84057112200048, -86.63186076199969)"
|
|
2018,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,840,38.5,35.8,41.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,SEX1,CAT2,_RFPSA22,RESP046,"(32.84057112200048, -86.63186076199969)"
|
|
2018,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1038,61.5,58.8,64.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,SEX1,CAT2,_RFPSA22,RESP054,"(32.84057112200048, -86.63186076199969)"
|
|
2018,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,01,SEX2,CAT2,_RFPSA22,RESP046,"(32.84057112200048, -86.63186076199969)"
|
|
2018,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,01,SEX2,CAT2,_RFPSA22,RESP054,"(32.84057112200048, -86.63186076199969)"
|
|
2018,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,590,70.9,66.9,75,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,SEX1,CAT2,_RFPSA22,RESP054,"(64.84507995700051, -147.72205903599973)"
|
|
2018,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,02,AGE06,CAT3,_RFPSA22,RESP046,"(64.84507995700051, -147.72205903599973)"
|
|
2018,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,135,92.5,87.3,97.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,AGE06,CAT3,_RFPSA22,RESP054,"(64.84507995700051, -147.72205903599973)"
|
|
2018,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,64,26.8,19,34.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,AGE07,CAT3,_RFPSA22,RESP046,"(64.84507995700051, -147.72205903599973)"
|
|
2018,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,172,73.2,65.3,81,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,AGE07,CAT3,_RFPSA22,RESP054,"(64.84507995700051, -147.72205903599973)"
|
|
2018,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,43,30.8,20.6,41,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,AGE08,CAT3,_RFPSA22,RESP046,"(64.84507995700051, -147.72205903599973)"
|
|
2018,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,97,69.2,59,79.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,AGE08,CAT3,_RFPSA22,RESP054,"(64.84507995700051, -147.72205903599973)"
|
|
2018,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,196,52.2,45.3,59.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,AGE09,CAT3,_RFPSA22,RESP046,"(64.84507995700051, -147.72205903599973)"
|
|
2018,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,186,47.8,40.8,54.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,AGE09,CAT3,_RFPSA22,RESP054,"(64.84507995700051, -147.72205903599973)"
|
|
2018,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,313,29.1,25,33.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,BO1,CAT1,_RFPSA22,RESP046,"(64.84507995700051, -147.72205903599973)"
|
|
2018,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,590,70.9,66.9,75,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,BO1,CAT1,_RFPSA22,RESP054,"(64.84507995700051, -147.72205903599973)"
|
|
2018,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,12,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,02,EDUCA1,CAT5,_RFPSA22,RESP046,"(64.84507995700051, -147.72205903599973)"
|
|
2018,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,45,88.3,80.6,96,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,EDUCA1,CAT5,_RFPSA22,RESP054,"(64.84507995700051, -147.72205903599973)"
|
|
2018,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,60,20.3,13.8,26.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,EDUCA2,CAT5,_RFPSA22,RESP046,"(64.84507995700051, -147.72205903599973)"
|
|
2018,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,193,79.7,73.2,86.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,EDUCA2,CAT5,_RFPSA22,RESP054,"(64.84507995700051, -147.72205903599973)"
|
|
2018,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,90,31.7,23.9,39.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,EDUCA3,CAT5,_RFPSA22,RESP046,"(64.84507995700051, -147.72205903599973)"
|
|
2018,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,167,68.3,60.4,76.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,EDUCA3,CAT5,_RFPSA22,RESP054,"(64.84507995700051, -147.72205903599973)"
|
|
2018,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,151,40.4,33.2,47.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,EDUCA4,CAT5,_RFPSA22,RESP046,"(64.84507995700051, -147.72205903599973)"
|
|
2018,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,184,59.6,52.5,66.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,EDUCA4,CAT5,_RFPSA22,RESP054,"(64.84507995700051, -147.72205903599973)"
|
|
2018,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,02,INCOME1,CAT6,_RFPSA22,RESP046,"(64.84507995700051, -147.72205903599973)"
|
|
2018,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,55,93.5,87.9,99.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,INCOME1,CAT6,_RFPSA22,RESP054,"(64.84507995700051, -147.72205903599973)"
|
|
2018,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,20,17.5,7.8,27.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,INCOME2,CAT6,_RFPSA22,RESP046,"(64.84507995700051, -147.72205903599973)"
|
|
2018,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,78,82.5,72.8,92.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,INCOME2,CAT6,_RFPSA22,RESP054,"(64.84507995700051, -147.72205903599973)"
|
|
2018,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,21,24.1,11.6,36.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,INCOME3,CAT6,_RFPSA22,RESP046,"(64.84507995700051, -147.72205903599973)"
|
|
2018,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,39,75.9,63.3,88.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,INCOME3,CAT6,_RFPSA22,RESP054,"(64.84507995700051, -147.72205903599973)"
|
|
2018,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,30,28.7,17.2,40.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,INCOME4,CAT6,_RFPSA22,RESP046,"(64.84507995700051, -147.72205903599973)"
|
|
2018,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,70,71.3,59.9,82.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,INCOME4,CAT6,_RFPSA22,RESP054,"(64.84507995700051, -147.72205903599973)"
|
|
2018,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,199,33.1,27.4,38.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,INCOME5,CAT6,_RFPSA22,RESP046,"(64.84507995700051, -147.72205903599973)"
|
|
2018,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,286,66.9,61.3,72.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,INCOME5,CAT6,_RFPSA22,RESP054,"(64.84507995700051, -147.72205903599973)"
|
|
2018,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,269,34.3,29.4,39.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,RACE01,CAT4,_RFPSA22,RESP046,"(64.84507995700051, -147.72205903599973)"
|
|
2018,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,416,65.7,60.8,70.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,RACE01,CAT4,_RFPSA22,RESP054,"(64.84507995700051, -147.72205903599973)"
|
|
2018,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,02,RACE02,CAT4,_RFPSA22,RESP046,"(64.84507995700051, -147.72205903599973)"
|
|
2018,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,11,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,02,RACE02,CAT4,_RFPSA22,RESP054,"(64.84507995700051, -147.72205903599973)"
|
|
2018,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,16,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,02,RACE03,CAT4,_RFPSA22,RESP046,"(64.84507995700051, -147.72205903599973)"
|
|
2018,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,104,88.9,81.9,95.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,RACE03,CAT4,_RFPSA22,RESP054,"(64.84507995700051, -147.72205903599973)"
|
|
2018,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,02,RACE04,CAT4,_RFPSA22,RESP046,"(64.84507995700051, -147.72205903599973)"
|
|
2018,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,13,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,02,RACE04,CAT4,_RFPSA22,RESP054,"(64.84507995700051, -147.72205903599973)"
|
|
2018,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,02,RACE05,CAT4,_RFPSA22,RESP046,"(64.84507995700051, -147.72205903599973)"
|
|
2018,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,02,RACE05,CAT4,_RFPSA22,RESP054,"(64.84507995700051, -147.72205903599973)"
|
|
2018,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,02,RACE06,CAT4,_RFPSA22,RESP046,"(64.84507995700051, -147.72205903599973)"
|
|
2018,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,02,RACE06,CAT4,_RFPSA22,RESP054,"(64.84507995700051, -147.72205903599973)"
|
|
2018,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,02,RACE07,CAT4,_RFPSA22,RESP046,"(64.84507995700051, -147.72205903599973)"
|
|
2018,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,17,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,02,RACE07,CAT4,_RFPSA22,RESP054,"(64.84507995700051, -147.72205903599973)"
|
|
2018,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,9,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,02,RACE08,CAT4,_RFPSA22,RESP046,"(64.84507995700051, -147.72205903599973)"
|
|
2018,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,18,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,02,RACE08,CAT4,_RFPSA22,RESP054,"(64.84507995700051, -147.72205903599973)"
|
|
2018,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,313,29.1,25,33.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,SEX1,CAT2,_RFPSA22,RESP046,"(64.84507995700051, -147.72205903599973)"
|
|
2018,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,02,SEX2,CAT2,_RFPSA22,RESP046,"(64.84507995700051, -147.72205903599973)"
|
|
2018,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,02,SEX2,CAT2,_RFPSA22,RESP054,"(64.84507995700051, -147.72205903599973)"
|
|
2018,UW,All States and DC (median) **,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,51,33.2,,,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,98,BO1,CAT1,_RFPSA22,RESP046,
|
|
2018,UW,All States and DC (median) **,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,51,66.8,,,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,98,BO1,CAT1,_RFPSA22,RESP054,
|
|
2018,US,"All States, DC and Territories (median) **",Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,53,33.2,,,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,99,BO1,CAT1,_RFPSA22,RESP046,
|
|
2018,US,"All States, DC and Territories (median) **",Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,53,66.8,,,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,99,BO1,CAT1,_RFPSA22,RESP054,
|
|
2018,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,39,10.8,6.6,15,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,AGE06,CAT3,_RFPSA22,RESP046,"(34.865970280000454, -111.76381127699972)"
|
|
2018,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,357,89.2,85,93.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,AGE06,CAT3,_RFPSA22,RESP054,"(34.865970280000454, -111.76381127699972)"
|
|
2018,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,146,27.3,21.7,33,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,AGE07,CAT3,_RFPSA22,RESP046,"(34.865970280000454, -111.76381127699972)"
|
|
2018,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,406,72.7,67,78.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,AGE07,CAT3,_RFPSA22,RESP054,"(34.865970280000454, -111.76381127699972)"
|
|
2018,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,127,39.2,30.6,47.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,AGE08,CAT3,_RFPSA22,RESP046,"(34.865970280000454, -111.76381127699972)"
|
|
2018,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,202,60.8,52.2,69.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,AGE08,CAT3,_RFPSA22,RESP054,"(34.865970280000454, -111.76381127699972)"
|
|
2018,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,671,55.7,51.6,59.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,AGE09,CAT3,_RFPSA22,RESP046,"(34.865970280000454, -111.76381127699972)"
|
|
2018,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,572,44.3,40.1,48.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,AGE09,CAT3,_RFPSA22,RESP054,"(34.865970280000454, -111.76381127699972)"
|
|
2018,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,983,34.5,31.8,37.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,BO1,CAT1,_RFPSA22,RESP046,"(34.865970280000454, -111.76381127699972)"
|
|
2018,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1537,65.5,62.7,68.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,BO1,CAT1,_RFPSA22,RESP054,"(34.865970280000454, -111.76381127699972)"
|
|
2018,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,30,12.6,6.1,19,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,EDUCA1,CAT5,_RFPSA22,RESP046,"(34.865970280000454, -111.76381127699972)"
|
|
2018,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,132,87.4,81,93.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,EDUCA1,CAT5,_RFPSA22,RESP054,"(34.865970280000454, -111.76381127699972)"
|
|
2018,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,153,25.1,19.8,30.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,EDUCA2,CAT5,_RFPSA22,RESP046,"(34.865970280000454, -111.76381127699972)"
|
|
2018,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,409,74.9,69.6,80.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,EDUCA2,CAT5,_RFPSA22,RESP054,"(34.865970280000454, -111.76381127699972)"
|
|
2018,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,280,36.7,31.5,42,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,EDUCA3,CAT5,_RFPSA22,RESP046,"(34.865970280000454, -111.76381127699972)"
|
|
2018,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,480,63.3,58,68.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,EDUCA3,CAT5,_RFPSA22,RESP054,"(34.865970280000454, -111.76381127699972)"
|
|
2018,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,519,47.9,43.4,52.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,EDUCA4,CAT5,_RFPSA22,RESP046,"(34.865970280000454, -111.76381127699972)"
|
|
2018,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,514,52.1,47.7,56.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,EDUCA4,CAT5,_RFPSA22,RESP054,"(34.865970280000454, -111.76381127699972)"
|
|
2018,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,41,19.8,11.2,28.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,INCOME1,CAT6,_RFPSA22,RESP046,"(34.865970280000454, -111.76381127699972)"
|
|
2018,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,147,80.2,71.5,88.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,INCOME1,CAT6,_RFPSA22,RESP054,"(34.865970280000454, -111.76381127699972)"
|
|
2018,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,79,18.8,12.5,25.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,INCOME2,CAT6,_RFPSA22,RESP046,"(34.865970280000454, -111.76381127699972)"
|
|
2018,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,250,81.2,74.9,87.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,INCOME2,CAT6,_RFPSA22,RESP054,"(34.865970280000454, -111.76381127699972)"
|
|
2018,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,70,28.4,19.4,37.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,INCOME3,CAT6,_RFPSA22,RESP046,"(34.865970280000454, -111.76381127699972)"
|
|
2018,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,141,71.6,62.6,80.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,INCOME3,CAT6,_RFPSA22,RESP054,"(34.865970280000454, -111.76381127699972)"
|
|
2018,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,111,32.6,23.4,41.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,INCOME4,CAT6,_RFPSA22,RESP046,"(34.865970280000454, -111.76381127699972)"
|
|
2018,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,191,67.4,58.2,76.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,INCOME4,CAT6,_RFPSA22,RESP054,"(34.865970280000454, -111.76381127699972)"
|
|
2018,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,551,40.2,36.2,44.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,INCOME5,CAT6,_RFPSA22,RESP046,"(34.865970280000454, -111.76381127699972)"
|
|
2018,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,630,59.8,55.8,63.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,INCOME5,CAT6,_RFPSA22,RESP054,"(34.865970280000454, -111.76381127699972)"
|
|
2018,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,843,41.7,38.4,45,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,RACE01,CAT4,_RFPSA22,RESP046,"(34.865970280000454, -111.76381127699972)"
|
|
2018,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1047,58.3,55,61.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,RACE01,CAT4,_RFPSA22,RESP054,"(34.865970280000454, -111.76381127699972)"
|
|
2018,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,14,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,04,RACE02,CAT4,_RFPSA22,RESP046,"(34.865970280000454, -111.76381127699972)"
|
|
2018,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,37,77.2,63.8,90.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,RACE02,CAT4,_RFPSA22,RESP054,"(34.865970280000454, -111.76381127699972)"
|
|
2018,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,23,10,4.1,15.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,RACE03,CAT4,_RFPSA22,RESP046,"(34.865970280000454, -111.76381127699972)"
|
|
2018,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,147,90,84.2,95.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,RACE03,CAT4,_RFPSA22,RESP054,"(34.865970280000454, -111.76381127699972)"
|
|
2018,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,04,RACE04,CAT4,_RFPSA22,RESP046,"(34.865970280000454, -111.76381127699972)"
|
|
2018,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,22,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,04,RACE04,CAT4,_RFPSA22,RESP054,"(34.865970280000454, -111.76381127699972)"
|
|
2018,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,04,RACE05,CAT4,_RFPSA22,RESP046,"(34.865970280000454, -111.76381127699972)"
|
|
2018,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,04,RACE05,CAT4,_RFPSA22,RESP054,"(34.865970280000454, -111.76381127699972)"
|
|
2018,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,14,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,04,RACE06,CAT4,_RFPSA22,RESP046,"(34.865970280000454, -111.76381127699972)"
|
|
2018,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,30,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,04,RACE06,CAT4,_RFPSA22,RESP054,"(34.865970280000454, -111.76381127699972)"
|
|
2018,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,04,RACE07,CAT4,_RFPSA22,RESP046,"(34.865970280000454, -111.76381127699972)"
|
|
2018,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,25,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,04,RACE07,CAT4,_RFPSA22,RESP054,"(34.865970280000454, -111.76381127699972)"
|
|
2018,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,74,19.6,13.1,26.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,RACE08,CAT4,_RFPSA22,RESP046,"(34.865970280000454, -111.76381127699972)"
|
|
2018,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,223,80.4,73.9,86.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,RACE08,CAT4,_RFPSA22,RESP054,"(34.865970280000454, -111.76381127699972)"
|
|
2018,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,983,34.5,31.8,37.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,SEX1,CAT2,_RFPSA22,RESP046,"(34.865970280000454, -111.76381127699972)"
|
|
2018,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1537,65.5,62.7,68.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,SEX1,CAT2,_RFPSA22,RESP054,"(34.865970280000454, -111.76381127699972)"
|
|
2018,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,04,SEX2,CAT2,_RFPSA22,RESP046,"(34.865970280000454, -111.76381127699972)"
|
|
2018,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,04,SEX2,CAT2,_RFPSA22,RESP054,"(34.865970280000454, -111.76381127699972)"
|
|
2018,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,103,77.3,69.1,85.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,EDUCA1,CAT5,_RFPSA22,RESP054,"(34.74865012400045, -92.27449074299966)"
|
|
2018,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,30,18.6,11.6,25.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,AGE06,CAT3,_RFPSA22,RESP046,"(34.74865012400045, -92.27449074299966)"
|
|
2018,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,155,81.4,74.4,88.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,AGE06,CAT3,_RFPSA22,RESP054,"(34.74865012400045, -92.27449074299966)"
|
|
2018,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,103,35,28.1,41.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,AGE07,CAT3,_RFPSA22,RESP046,"(34.74865012400045, -92.27449074299966)"
|
|
2018,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,159,65,58.2,71.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,AGE07,CAT3,_RFPSA22,RESP054,"(34.74865012400045, -92.27449074299966)"
|
|
2018,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,80,42.7,33.9,51.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,AGE08,CAT3,_RFPSA22,RESP046,"(34.74865012400045, -92.27449074299966)"
|
|
2018,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,102,57.3,48.5,66.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,AGE08,CAT3,_RFPSA22,RESP054,"(34.74865012400045, -92.27449074299966)"
|
|
2018,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,455,56.5,52.1,60.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,AGE09,CAT3,_RFPSA22,RESP046,"(34.74865012400045, -92.27449074299966)"
|
|
2018,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,340,43.5,39.1,47.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,AGE09,CAT3,_RFPSA22,RESP054,"(34.74865012400045, -92.27449074299966)"
|
|
2018,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,668,38.9,35.6,42.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,BO1,CAT1,_RFPSA22,RESP046,"(34.74865012400045, -92.27449074299966)"
|
|
2018,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,756,61.1,57.7,64.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,BO1,CAT1,_RFPSA22,RESP054,"(34.74865012400045, -92.27449074299966)"
|
|
2018,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,38,22.7,14.5,30.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,EDUCA1,CAT5,_RFPSA22,RESP046,"(34.74865012400045, -92.27449074299966)"
|
|
2018,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,176,33.6,28.1,39,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,EDUCA2,CAT5,_RFPSA22,RESP046,"(34.74865012400045, -92.27449074299966)"
|
|
2018,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,280,66.4,61,71.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,EDUCA2,CAT5,_RFPSA22,RESP054,"(34.74865012400045, -92.27449074299966)"
|
|
2018,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,161,45.5,38.6,52.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,EDUCA3,CAT5,_RFPSA22,RESP046,"(34.74865012400045, -92.27449074299966)"
|
|
2018,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,167,54.5,47.6,61.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,EDUCA3,CAT5,_RFPSA22,RESP054,"(34.74865012400045, -92.27449074299966)"
|
|
2018,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,291,51,45,57,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,EDUCA4,CAT5,_RFPSA22,RESP046,"(34.74865012400045, -92.27449074299966)"
|
|
2018,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,205,49,43,55,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,EDUCA4,CAT5,_RFPSA22,RESP054,"(34.74865012400045, -92.27449074299966)"
|
|
2018,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,43,22.4,14.3,30.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,INCOME1,CAT6,_RFPSA22,RESP046,"(34.74865012400045, -92.27449074299966)"
|
|
2018,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,94,77.6,69.6,85.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,INCOME1,CAT6,_RFPSA22,RESP054,"(34.74865012400045, -92.27449074299966)"
|
|
2018,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,65,27.5,19.9,35.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,INCOME2,CAT6,_RFPSA22,RESP046,"(34.74865012400045, -92.27449074299966)"
|
|
2018,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,137,72.5,64.9,80.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,INCOME2,CAT6,_RFPSA22,RESP054,"(34.74865012400045, -92.27449074299966)"
|
|
2018,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,53,32.3,22.6,42,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,INCOME3,CAT6,_RFPSA22,RESP046,"(34.74865012400045, -92.27449074299966)"
|
|
2018,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,87,67.7,58,77.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,INCOME3,CAT6,_RFPSA22,RESP054,"(34.74865012400045, -92.27449074299966)"
|
|
2018,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,88,37.9,29.4,46.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,INCOME4,CAT6,_RFPSA22,RESP046,"(34.74865012400045, -92.27449074299966)"
|
|
2018,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,108,62.1,53.5,70.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,INCOME4,CAT6,_RFPSA22,RESP054,"(34.74865012400045, -92.27449074299966)"
|
|
2018,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,328,48.8,43.1,54.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,INCOME5,CAT6,_RFPSA22,RESP046,"(34.74865012400045, -92.27449074299966)"
|
|
2018,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,234,51.2,45.5,56.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,INCOME5,CAT6,_RFPSA22,RESP054,"(34.74865012400045, -92.27449074299966)"
|
|
2018,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,547,39.1,35.5,42.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,RACE01,CAT4,_RFPSA22,RESP046,"(34.74865012400045, -92.27449074299966)"
|
|
2018,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,603,60.9,57.3,64.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,RACE01,CAT4,_RFPSA22,RESP054,"(34.74865012400045, -92.27449074299966)"
|
|
2018,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,81,41,31.1,50.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,RACE02,CAT4,_RFPSA22,RESP046,"(34.74865012400045, -92.27449074299966)"
|
|
2018,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,97,59,49.1,68.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,RACE02,CAT4,_RFPSA22,RESP054,"(34.74865012400045, -92.27449074299966)"
|
|
2018,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,9,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,05,RACE03,CAT4,_RFPSA22,RESP046,"(34.74865012400045, -92.27449074299966)"
|
|
2018,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,05,RACE03,CAT4,_RFPSA22,RESP054,"(34.74865012400045, -92.27449074299966)"
|
|
2018,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,05,RACE04,CAT4,_RFPSA22,RESP046,"(34.74865012400045, -92.27449074299966)"
|
|
2018,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,05,RACE04,CAT4,_RFPSA22,RESP054,"(34.74865012400045, -92.27449074299966)"
|
|
2018,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,05,RACE05,CAT4,_RFPSA22,RESP046,"(34.74865012400045, -92.27449074299966)"
|
|
2018,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,05,RACE05,CAT4,_RFPSA22,RESP054,"(34.74865012400045, -92.27449074299966)"
|
|
2018,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,05,RACE06,CAT4,_RFPSA22,RESP046,"(34.74865012400045, -92.27449074299966)"
|
|
2018,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,12,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,05,RACE06,CAT4,_RFPSA22,RESP054,"(34.74865012400045, -92.27449074299966)"
|
|
2018,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,11,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,05,RACE07,CAT4,_RFPSA22,RESP046,"(34.74865012400045, -92.27449074299966)"
|
|
2018,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,13,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,05,RACE07,CAT4,_RFPSA22,RESP054,"(34.74865012400045, -92.27449074299966)"
|
|
2018,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,12,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,05,RACE08,CAT4,_RFPSA22,RESP046,"(34.74865012400045, -92.27449074299966)"
|
|
2018,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,15,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,05,RACE08,CAT4,_RFPSA22,RESP054,"(34.74865012400045, -92.27449074299966)"
|
|
2018,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,668,38.9,35.6,42.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,SEX1,CAT2,_RFPSA22,RESP046,"(34.74865012400045, -92.27449074299966)"
|
|
2018,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,756,61.1,57.7,64.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,SEX1,CAT2,_RFPSA22,RESP054,"(34.74865012400045, -92.27449074299966)"
|
|
2018,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,05,SEX2,CAT2,_RFPSA22,RESP046,"(34.74865012400045, -92.27449074299966)"
|
|
2018,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,05,SEX2,CAT2,_RFPSA22,RESP054,"(34.74865012400045, -92.27449074299966)"
|
|
2018,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,52,6.1,4.2,8.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,AGE06,CAT3,_RFPSA22,RESP046,"(37.63864012300047, -120.99999953799971)"
|
|
2018,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,731,93.9,91.9,95.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,AGE06,CAT3,_RFPSA22,RESP054,"(37.63864012300047, -120.99999953799971)"
|
|
2018,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,219,24.7,21,28.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,AGE07,CAT3,_RFPSA22,RESP046,"(37.63864012300047, -120.99999953799971)"
|
|
2018,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,670,75.3,71.7,79,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,AGE07,CAT3,_RFPSA22,RESP054,"(37.63864012300047, -120.99999953799971)"
|
|
2018,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,188,44.4,37.8,51,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,AGE08,CAT3,_RFPSA22,RESP046,"(37.63864012300047, -120.99999953799971)"
|
|
2018,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,281,55.6,49,62.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,AGE08,CAT3,_RFPSA22,RESP054,"(37.63864012300047, -120.99999953799971)"
|
|
2018,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,502,46,41.7,50.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,AGE09,CAT3,_RFPSA22,RESP046,"(37.63864012300047, -120.99999953799971)"
|
|
2018,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,559,54,49.7,58.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,AGE09,CAT3,_RFPSA22,RESP054,"(37.63864012300047, -120.99999953799971)"
|
|
2018,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,961,28.5,26.4,30.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,BO1,CAT1,_RFPSA22,RESP046,"(37.63864012300047, -120.99999953799971)"
|
|
2018,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,2241,71.5,69.4,73.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,BO1,CAT1,_RFPSA22,RESP054,"(37.63864012300047, -120.99999953799971)"
|
|
2018,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,83,18.3,14,22.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,EDUCA1,CAT5,_RFPSA22,RESP046,"(37.63864012300047, -120.99999953799971)"
|
|
2018,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,417,81.7,77.5,86,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,EDUCA1,CAT5,_RFPSA22,RESP054,"(37.63864012300047, -120.99999953799971)"
|
|
2018,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,134,23.2,18.8,27.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,EDUCA2,CAT5,_RFPSA22,RESP046,"(37.63864012300047, -120.99999953799971)"
|
|
2018,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,398,76.8,72.4,81.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,EDUCA2,CAT5,_RFPSA22,RESP054,"(37.63864012300047, -120.99999953799971)"
|
|
2018,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,231,31.2,26.8,35.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,EDUCA3,CAT5,_RFPSA22,RESP046,"(37.63864012300047, -120.99999953799971)"
|
|
2018,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,522,68.8,64.4,73.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,EDUCA3,CAT5,_RFPSA22,RESP054,"(37.63864012300047, -120.99999953799971)"
|
|
2018,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,513,34.7,31.3,38.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,EDUCA4,CAT5,_RFPSA22,RESP046,"(37.63864012300047, -120.99999953799971)"
|
|
2018,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,903,65.3,61.8,68.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,EDUCA4,CAT5,_RFPSA22,RESP054,"(37.63864012300047, -120.99999953799971)"
|
|
2018,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,78,18.9,13.9,23.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,INCOME1,CAT6,_RFPSA22,RESP046,"(37.63864012300047, -120.99999953799971)"
|
|
2018,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,279,81.1,76.2,86.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,INCOME1,CAT6,_RFPSA22,RESP054,"(37.63864012300047, -120.99999953799971)"
|
|
2018,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,72,23.8,17.8,29.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,INCOME2,CAT6,_RFPSA22,RESP046,"(37.63864012300047, -120.99999953799971)"
|
|
2018,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,252,76.2,70.1,82.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,INCOME2,CAT6,_RFPSA22,RESP054,"(37.63864012300047, -120.99999953799971)"
|
|
2018,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,53,23.1,14.3,31.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,INCOME3,CAT6,_RFPSA22,RESP046,"(37.63864012300047, -120.99999953799971)"
|
|
2018,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,202,76.9,68.1,85.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,INCOME3,CAT6,_RFPSA22,RESP054,"(37.63864012300047, -120.99999953799971)"
|
|
2018,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,86,24.6,18.1,31.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,INCOME4,CAT6,_RFPSA22,RESP046,"(37.63864012300047, -120.99999953799971)"
|
|
2018,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,226,75.4,68.8,81.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,INCOME4,CAT6,_RFPSA22,RESP054,"(37.63864012300047, -120.99999953799971)"
|
|
2018,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,605,33.4,30.4,36.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,INCOME5,CAT6,_RFPSA22,RESP046,"(37.63864012300047, -120.99999953799971)"
|
|
2018,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,1106,66.6,63.7,69.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,INCOME5,CAT6,_RFPSA22,RESP054,"(37.63864012300047, -120.99999953799971)"
|
|
2018,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,622,33.8,31,36.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,RACE01,CAT4,_RFPSA22,RESP046,"(37.63864012300047, -120.99999953799971)"
|
|
2018,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1077,66.2,63.4,69,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,RACE01,CAT4,_RFPSA22,RESP054,"(37.63864012300047, -120.99999953799971)"
|
|
2018,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,57,32.2,23.4,41,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,RACE02,CAT4,_RFPSA22,RESP046,"(37.63864012300047, -120.99999953799971)"
|
|
2018,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,110,67.8,59,76.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,RACE02,CAT4,_RFPSA22,RESP054,"(37.63864012300047, -120.99999953799971)"
|
|
2018,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,06,RACE03,CAT4,_RFPSA22,RESP046,"(37.63864012300047, -120.99999953799971)"
|
|
2018,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,20,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,06,RACE03,CAT4,_RFPSA22,RESP054,"(37.63864012300047, -120.99999953799971)"
|
|
2018,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,48,26,18.2,33.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,RACE04,CAT4,_RFPSA22,RESP046,"(37.63864012300047, -120.99999953799971)"
|
|
2018,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,162,74,66.1,81.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,RACE04,CAT4,_RFPSA22,RESP054,"(37.63864012300047, -120.99999953799971)"
|
|
2018,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,06,RACE05,CAT4,_RFPSA22,RESP046,"(37.63864012300047, -120.99999953799971)"
|
|
2018,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,06,RACE05,CAT4,_RFPSA22,RESP054,"(37.63864012300047, -120.99999953799971)"
|
|
2018,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,17,23.9,10.9,36.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,RACE06,CAT4,_RFPSA22,RESP046,"(37.63864012300047, -120.99999953799971)"
|
|
2018,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,47,76.1,63.1,89.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,RACE06,CAT4,_RFPSA22,RESP054,"(37.63864012300047, -120.99999953799971)"
|
|
2018,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,14,25.4,10.5,40.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,RACE07,CAT4,_RFPSA22,RESP046,"(37.63864012300047, -120.99999953799971)"
|
|
2018,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,45,74.6,59.7,89.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,RACE07,CAT4,_RFPSA22,RESP054,"(37.63864012300047, -120.99999953799971)"
|
|
2018,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,193,20.8,17.6,24,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,RACE08,CAT4,_RFPSA22,RESP046,"(37.63864012300047, -120.99999953799971)"
|
|
2018,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,774,79.2,76,82.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,RACE08,CAT4,_RFPSA22,RESP054,"(37.63864012300047, -120.99999953799971)"
|
|
2018,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,961,28.5,26.4,30.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,SEX1,CAT2,_RFPSA22,RESP046,"(37.63864012300047, -120.99999953799971)"
|
|
2018,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,2241,71.5,69.4,73.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,SEX1,CAT2,_RFPSA22,RESP054,"(37.63864012300047, -120.99999953799971)"
|
|
2018,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,06,SEX2,CAT2,_RFPSA22,RESP046,"(37.63864012300047, -120.99999953799971)"
|
|
2018,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,06,SEX2,CAT2,_RFPSA22,RESP054,"(37.63864012300047, -120.99999953799971)"
|
|
2018,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,29,5.5,3.3,7.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,AGE06,CAT3,_RFPSA22,RESP046,"(38.843840757000464, -106.13361092099967)"
|
|
2018,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,490,94.5,92.3,96.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,AGE06,CAT3,_RFPSA22,RESP054,"(38.843840757000464, -106.13361092099967)"
|
|
2018,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,174,28.5,24.5,32.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,AGE07,CAT3,_RFPSA22,RESP046,"(38.843840757000464, -106.13361092099967)"
|
|
2018,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,425,71.5,67.5,75.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,AGE07,CAT3,_RFPSA22,RESP054,"(38.843840757000464, -106.13361092099967)"
|
|
2018,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,184,49.4,43.9,54.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,AGE08,CAT3,_RFPSA22,RESP046,"(38.843840757000464, -106.13361092099967)"
|
|
2018,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,192,50.6,45.1,56.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,AGE08,CAT3,_RFPSA22,RESP054,"(38.843840757000464, -106.13361092099967)"
|
|
2018,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,535,48.9,45.5,52.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,AGE09,CAT3,_RFPSA22,RESP046,"(38.843840757000464, -106.13361092099967)"
|
|
2018,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,529,51.1,47.7,54.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,AGE09,CAT3,_RFPSA22,RESP054,"(38.843840757000464, -106.13361092099967)"
|
|
2018,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,922,30.7,28.8,32.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,BO1,CAT1,_RFPSA22,RESP046,"(38.843840757000464, -106.13361092099967)"
|
|
2018,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1636,69.3,67.3,71.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,BO1,CAT1,_RFPSA22,RESP054,"(38.843840757000464, -106.13361092099967)"
|
|
2018,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,35,18.2,12,24.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,EDUCA1,CAT5,_RFPSA22,RESP046,"(38.843840757000464, -106.13361092099967)"
|
|
2018,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,141,81.8,75.7,88,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,EDUCA1,CAT5,_RFPSA22,RESP054,"(38.843840757000464, -106.13361092099967)"
|
|
2018,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,142,24.4,20.4,28.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,EDUCA2,CAT5,_RFPSA22,RESP046,"(38.843840757000464, -106.13361092099967)"
|
|
2018,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,359,75.6,71.6,79.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,EDUCA2,CAT5,_RFPSA22,RESP054,"(38.843840757000464, -106.13361092099967)"
|
|
2018,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,204,30.4,26.4,34.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,EDUCA3,CAT5,_RFPSA22,RESP046,"(38.843840757000464, -106.13361092099967)"
|
|
2018,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,390,69.6,65.5,73.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,EDUCA3,CAT5,_RFPSA22,RESP054,"(38.843840757000464, -106.13361092099967)"
|
|
2018,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,538,37.1,34.3,40,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,EDUCA4,CAT5,_RFPSA22,RESP046,"(38.843840757000464, -106.13361092099967)"
|
|
2018,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,742,62.9,60,65.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,EDUCA4,CAT5,_RFPSA22,RESP054,"(38.843840757000464, -106.13361092099967)"
|
|
2018,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,23,22.2,13.4,31.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,INCOME1,CAT6,_RFPSA22,RESP046,"(38.843840757000464, -106.13361092099967)"
|
|
2018,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,74,77.8,68.9,86.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,INCOME1,CAT6,_RFPSA22,RESP054,"(38.843840757000464, -106.13361092099967)"
|
|
2018,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,57,20.8,15.1,26.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,INCOME2,CAT6,_RFPSA22,RESP046,"(38.843840757000464, -106.13361092099967)"
|
|
2018,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,178,79.2,73.4,84.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,INCOME2,CAT6,_RFPSA22,RESP054,"(38.843840757000464, -106.13361092099967)"
|
|
2018,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,51,26.2,18.9,33.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,INCOME3,CAT6,_RFPSA22,RESP046,"(38.843840757000464, -106.13361092099967)"
|
|
2018,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,123,73.8,66.5,81.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,INCOME3,CAT6,_RFPSA22,RESP054,"(38.843840757000464, -106.13361092099967)"
|
|
2018,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,109,32.2,26.3,38.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,INCOME4,CAT6,_RFPSA22,RESP046,"(38.843840757000464, -106.13361092099967)"
|
|
2018,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,192,67.8,61.8,73.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,INCOME4,CAT6,_RFPSA22,RESP054,"(38.843840757000464, -106.13361092099967)"
|
|
2018,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,585,32.8,30.2,35.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,INCOME5,CAT6,_RFPSA22,RESP046,"(38.843840757000464, -106.13361092099967)"
|
|
2018,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,905,67.2,64.6,69.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,INCOME5,CAT6,_RFPSA22,RESP054,"(38.843840757000464, -106.13361092099967)"
|
|
2018,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,799,33,30.8,35.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,RACE01,CAT4,_RFPSA22,RESP046,"(38.843840757000464, -106.13361092099967)"
|
|
2018,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1270,67,64.8,69.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,RACE01,CAT4,_RFPSA22,RESP054,"(38.843840757000464, -106.13361092099967)"
|
|
2018,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,17,24,11.6,36.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,RACE02,CAT4,_RFPSA22,RESP046,"(38.843840757000464, -106.13361092099967)"
|
|
2018,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,39,76,63.6,88.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,RACE02,CAT4,_RFPSA22,RESP054,"(38.843840757000464, -106.13361092099967)"
|
|
2018,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,08,RACE03,CAT4,_RFPSA22,RESP046,"(38.843840757000464, -106.13361092099967)"
|
|
2018,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,12,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,08,RACE03,CAT4,_RFPSA22,RESP054,"(38.843840757000464, -106.13361092099967)"
|
|
2018,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,23,33.9,19.2,48.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,RACE04,CAT4,_RFPSA22,RESP046,"(38.843840757000464, -106.13361092099967)"
|
|
2018,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,33,66.1,51.3,80.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,RACE04,CAT4,_RFPSA22,RESP054,"(38.843840757000464, -106.13361092099967)"
|
|
2018,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,08,RACE05,CAT4,_RFPSA22,RESP046,"(38.843840757000464, -106.13361092099967)"
|
|
2018,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,08,RACE05,CAT4,_RFPSA22,RESP054,"(38.843840757000464, -106.13361092099967)"
|
|
2018,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,08,RACE06,CAT4,_RFPSA22,RESP046,"(38.843840757000464, -106.13361092099967)"
|
|
2018,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,25,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,08,RACE06,CAT4,_RFPSA22,RESP054,"(38.843840757000464, -106.13361092099967)"
|
|
2018,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,08,RACE07,CAT4,_RFPSA22,RESP046,"(38.843840757000464, -106.13361092099967)"
|
|
2018,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,26,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,08,RACE07,CAT4,_RFPSA22,RESP054,"(38.843840757000464, -106.13361092099967)"
|
|
2018,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,66,21.9,16.7,27.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,RACE08,CAT4,_RFPSA22,RESP046,"(38.843840757000464, -106.13361092099967)"
|
|
2018,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,230,78.1,72.9,83.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,RACE08,CAT4,_RFPSA22,RESP054,"(38.843840757000464, -106.13361092099967)"
|
|
2018,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,922,30.7,28.8,32.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,SEX1,CAT2,_RFPSA22,RESP046,"(38.843840757000464, -106.13361092099967)"
|
|
2018,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1636,69.3,67.3,71.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,SEX1,CAT2,_RFPSA22,RESP054,"(38.843840757000464, -106.13361092099967)"
|
|
2018,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,08,SEX2,CAT2,_RFPSA22,RESP046,"(38.843840757000464, -106.13361092099967)"
|
|
2018,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,08,SEX2,CAT2,_RFPSA22,RESP054,"(38.843840757000464, -106.13361092099967)"
|
|
2018,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,48,7,4.8,9.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,AGE06,CAT3,_RFPSA22,RESP046,"(41.56266102000046, -72.64984095199964)"
|
|
2018,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,473,93,90.7,95.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,AGE06,CAT3,_RFPSA22,RESP054,"(41.56266102000046, -72.64984095199964)"
|
|
2018,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,274,33.1,29.1,37.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,AGE07,CAT3,_RFPSA22,RESP046,"(41.56266102000046, -72.64984095199964)"
|
|
2018,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,557,66.9,62.8,70.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,AGE07,CAT3,_RFPSA22,RESP054,"(41.56266102000046, -72.64984095199964)"
|
|
2018,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,233,42.8,37.4,48.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,AGE08,CAT3,_RFPSA22,RESP046,"(41.56266102000046, -72.64984095199964)"
|
|
2018,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,276,57.2,51.9,62.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,AGE08,CAT3,_RFPSA22,RESP054,"(41.56266102000046, -72.64984095199964)"
|
|
2018,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,785,52,48.5,55.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,AGE09,CAT3,_RFPSA22,RESP046,"(41.56266102000046, -72.64984095199964)"
|
|
2018,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,585,48,44.4,51.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,AGE09,CAT3,_RFPSA22,RESP054,"(41.56266102000046, -72.64984095199964)"
|
|
2018,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1340,33.8,31.8,35.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,BO1,CAT1,_RFPSA22,RESP046,"(41.56266102000046, -72.64984095199964)"
|
|
2018,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1891,66.2,64.2,68.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,BO1,CAT1,_RFPSA22,RESP054,"(41.56266102000046, -72.64984095199964)"
|
|
2018,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,36,19.1,11.9,26.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,EDUCA1,CAT5,_RFPSA22,RESP046,"(41.56266102000046, -72.64984095199964)"
|
|
2018,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,140,80.9,73.8,88.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,EDUCA1,CAT5,_RFPSA22,RESP054,"(41.56266102000046, -72.64984095199964)"
|
|
2018,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,232,28.6,24.6,32.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,EDUCA2,CAT5,_RFPSA22,RESP046,"(41.56266102000046, -72.64984095199964)"
|
|
2018,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,483,71.4,67.4,75.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,EDUCA2,CAT5,_RFPSA22,RESP054,"(41.56266102000046, -72.64984095199964)"
|
|
2018,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,265,33.7,29.4,37.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,EDUCA3,CAT5,_RFPSA22,RESP046,"(41.56266102000046, -72.64984095199964)"
|
|
2018,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,411,66.3,62.1,70.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,EDUCA3,CAT5,_RFPSA22,RESP054,"(41.56266102000046, -72.64984095199964)"
|
|
2018,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,805,41.6,38.6,44.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,EDUCA4,CAT5,_RFPSA22,RESP046,"(41.56266102000046, -72.64984095199964)"
|
|
2018,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,857,58.4,55.5,61.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,EDUCA4,CAT5,_RFPSA22,RESP054,"(41.56266102000046, -72.64984095199964)"
|
|
2018,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,29,20.6,11.1,30,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,INCOME1,CAT6,_RFPSA22,RESP046,"(41.56266102000046, -72.64984095199964)"
|
|
2018,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,91,79.4,70,88.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,INCOME1,CAT6,_RFPSA22,RESP054,"(41.56266102000046, -72.64984095199964)"
|
|
2018,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,77,26.5,19.7,33.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,INCOME2,CAT6,_RFPSA22,RESP046,"(41.56266102000046, -72.64984095199964)"
|
|
2018,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,188,73.5,66.6,80.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,INCOME2,CAT6,_RFPSA22,RESP054,"(41.56266102000046, -72.64984095199964)"
|
|
2018,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,73,29.2,21.7,36.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,INCOME3,CAT6,_RFPSA22,RESP046,"(41.56266102000046, -72.64984095199964)"
|
|
2018,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,121,70.8,63.3,78.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,INCOME3,CAT6,_RFPSA22,RESP054,"(41.56266102000046, -72.64984095199964)"
|
|
2018,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,117,30.8,24.5,37.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,INCOME4,CAT6,_RFPSA22,RESP046,"(41.56266102000046, -72.64984095199964)"
|
|
2018,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,178,69.2,62.9,75.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,INCOME4,CAT6,_RFPSA22,RESP054,"(41.56266102000046, -72.64984095199964)"
|
|
2018,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,853,36.2,33.5,38.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,INCOME5,CAT6,_RFPSA22,RESP046,"(41.56266102000046, -72.64984095199964)"
|
|
2018,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,1101,63.8,61.2,66.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,INCOME5,CAT6,_RFPSA22,RESP054,"(41.56266102000046, -72.64984095199964)"
|
|
2018,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1192,37,34.7,39.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,RACE01,CAT4,_RFPSA22,RESP046,"(41.56266102000046, -72.64984095199964)"
|
|
2018,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1521,63,60.8,65.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,RACE01,CAT4,_RFPSA22,RESP054,"(41.56266102000046, -72.64984095199964)"
|
|
2018,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,52,24.5,16.8,32.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,RACE02,CAT4,_RFPSA22,RESP046,"(41.56266102000046, -72.64984095199964)"
|
|
2018,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,133,75.5,67.9,83.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,RACE02,CAT4,_RFPSA22,RESP054,"(41.56266102000046, -72.64984095199964)"
|
|
2018,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,15,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,09,RACE03,CAT4,_RFPSA22,RESP046,"(41.56266102000046, -72.64984095199964)"
|
|
2018,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,17,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,09,RACE03,CAT4,_RFPSA22,RESP054,"(41.56266102000046, -72.64984095199964)"
|
|
2018,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,14,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,09,RACE04,CAT4,_RFPSA22,RESP046,"(41.56266102000046, -72.64984095199964)"
|
|
2018,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,41,79.7,67.3,92.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,RACE04,CAT4,_RFPSA22,RESP054,"(41.56266102000046, -72.64984095199964)"
|
|
2018,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,09,RACE05,CAT4,_RFPSA22,RESP046,"(41.56266102000046, -72.64984095199964)"
|
|
2018,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,09,RACE05,CAT4,_RFPSA22,RESP054,"(41.56266102000046, -72.64984095199964)"
|
|
2018,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,17,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,09,RACE06,CAT4,_RFPSA22,RESP046,"(41.56266102000046, -72.64984095199964)"
|
|
2018,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,26,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,09,RACE06,CAT4,_RFPSA22,RESP054,"(41.56266102000046, -72.64984095199964)"
|
|
2018,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,13,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,09,RACE07,CAT4,_RFPSA22,RESP046,"(41.56266102000046, -72.64984095199964)"
|
|
2018,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,25,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,09,RACE07,CAT4,_RFPSA22,RESP054,"(41.56266102000046, -72.64984095199964)"
|
|
2018,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,37,18.1,11.6,24.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,RACE08,CAT4,_RFPSA22,RESP046,"(41.56266102000046, -72.64984095199964)"
|
|
2018,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,124,81.9,75.3,88.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,RACE08,CAT4,_RFPSA22,RESP054,"(41.56266102000046, -72.64984095199964)"
|
|
2018,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1340,33.8,31.8,35.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,SEX1,CAT2,_RFPSA22,RESP046,"(41.56266102000046, -72.64984095199964)"
|
|
2018,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1891,66.2,64.2,68.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,SEX1,CAT2,_RFPSA22,RESP054,"(41.56266102000046, -72.64984095199964)"
|
|
2018,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,09,SEX2,CAT2,_RFPSA22,RESP046,"(41.56266102000046, -72.64984095199964)"
|
|
2018,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,09,SEX2,CAT2,_RFPSA22,RESP054,"(41.56266102000046, -72.64984095199964)"
|
|
2018,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,17,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,10,AGE06,CAT3,_RFPSA22,RESP046,"(39.008830667000495, -75.57774116799965)"
|
|
2018,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,221,93,88.8,97.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,AGE06,CAT3,_RFPSA22,RESP054,"(39.008830667000495, -75.57774116799965)"
|
|
2018,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,133,37,30.6,43.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,AGE07,CAT3,_RFPSA22,RESP046,"(39.008830667000495, -75.57774116799965)"
|
|
2018,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,249,63,56.6,69.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,AGE07,CAT3,_RFPSA22,RESP054,"(39.008830667000495, -75.57774116799965)"
|
|
2018,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,92,44.1,35.8,52.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,AGE08,CAT3,_RFPSA22,RESP046,"(39.008830667000495, -75.57774116799965)"
|
|
2018,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,113,55.9,47.6,64.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,AGE08,CAT3,_RFPSA22,RESP054,"(39.008830667000495, -75.57774116799965)"
|
|
2018,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,384,55.5,51,60.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,AGE09,CAT3,_RFPSA22,RESP046,"(39.008830667000495, -75.57774116799965)"
|
|
2018,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,280,44.5,39.9,49,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,AGE09,CAT3,_RFPSA22,RESP054,"(39.008830667000495, -75.57774116799965)"
|
|
2018,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,626,37.7,34.6,40.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,BO1,CAT1,_RFPSA22,RESP046,"(39.008830667000495, -75.57774116799965)"
|
|
2018,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,863,62.3,59.3,65.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,BO1,CAT1,_RFPSA22,RESP054,"(39.008830667000495, -75.57774116799965)"
|
|
2018,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,21,14.4,7.5,21.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,EDUCA1,CAT5,_RFPSA22,RESP046,"(39.008830667000495, -75.57774116799965)"
|
|
2018,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,102,85.6,78.7,92.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,EDUCA1,CAT5,_RFPSA22,RESP054,"(39.008830667000495, -75.57774116799965)"
|
|
2018,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,146,35.1,29,41.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,EDUCA2,CAT5,_RFPSA22,RESP046,"(39.008830667000495, -75.57774116799965)"
|
|
2018,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,256,64.9,58.9,71,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,EDUCA2,CAT5,_RFPSA22,RESP054,"(39.008830667000495, -75.57774116799965)"
|
|
2018,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,161,39.9,33.9,45.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,EDUCA3,CAT5,_RFPSA22,RESP046,"(39.008830667000495, -75.57774116799965)"
|
|
2018,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,215,60.1,54.1,66.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,EDUCA3,CAT5,_RFPSA22,RESP054,"(39.008830667000495, -75.57774116799965)"
|
|
2018,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,295,45.4,40.5,50.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,EDUCA4,CAT5,_RFPSA22,RESP046,"(39.008830667000495, -75.57774116799965)"
|
|
2018,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,288,54.6,49.6,59.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,EDUCA4,CAT5,_RFPSA22,RESP054,"(39.008830667000495, -75.57774116799965)"
|
|
2018,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,18,18,8.8,27.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,INCOME1,CAT6,_RFPSA22,RESP046,"(39.008830667000495, -75.57774116799965)"
|
|
2018,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,67,82,72.9,91.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,INCOME1,CAT6,_RFPSA22,RESP054,"(39.008830667000495, -75.57774116799965)"
|
|
2018,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,53,27.4,19.4,35.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,INCOME2,CAT6,_RFPSA22,RESP046,"(39.008830667000495, -75.57774116799965)"
|
|
2018,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,136,72.6,64.5,80.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,INCOME2,CAT6,_RFPSA22,RESP054,"(39.008830667000495, -75.57774116799965)"
|
|
2018,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,37,29,18.9,39,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,INCOME3,CAT6,_RFPSA22,RESP046,"(39.008830667000495, -75.57774116799965)"
|
|
2018,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,65,71,61,81.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,INCOME3,CAT6,_RFPSA22,RESP054,"(39.008830667000495, -75.57774116799965)"
|
|
2018,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,72,37.3,28.2,46.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,INCOME4,CAT6,_RFPSA22,RESP046,"(39.008830667000495, -75.57774116799965)"
|
|
2018,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,112,62.7,53.5,71.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,INCOME4,CAT6,_RFPSA22,RESP054,"(39.008830667000495, -75.57774116799965)"
|
|
2018,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,359,41.9,37.4,46.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,INCOME5,CAT6,_RFPSA22,RESP046,"(39.008830667000495, -75.57774116799965)"
|
|
2018,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,389,58.1,53.7,62.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,INCOME5,CAT6,_RFPSA22,RESP054,"(39.008830667000495, -75.57774116799965)"
|
|
2018,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,509,40.1,36.7,43.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,RACE01,CAT4,_RFPSA22,RESP046,"(39.008830667000495, -75.57774116799965)"
|
|
2018,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,616,59.9,56.5,63.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,RACE01,CAT4,_RFPSA22,RESP054,"(39.008830667000495, -75.57774116799965)"
|
|
2018,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,64,32.2,23.6,40.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,RACE02,CAT4,_RFPSA22,RESP046,"(39.008830667000495, -75.57774116799965)"
|
|
2018,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,118,67.8,59.1,76.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,RACE02,CAT4,_RFPSA22,RESP054,"(39.008830667000495, -75.57774116799965)"
|
|
2018,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,12,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,10,RACE03,CAT4,_RFPSA22,RESP046,"(39.008830667000495, -75.57774116799965)"
|
|
2018,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,10,RACE03,CAT4,_RFPSA22,RESP054,"(39.008830667000495, -75.57774116799965)"
|
|
2018,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,11,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,10,RACE04,CAT4,_RFPSA22,RESP046,"(39.008830667000495, -75.57774116799965)"
|
|
2018,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,27,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,10,RACE04,CAT4,_RFPSA22,RESP054,"(39.008830667000495, -75.57774116799965)"
|
|
2018,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,10,RACE05,CAT4,_RFPSA22,RESP046,"(39.008830667000495, -75.57774116799965)"
|
|
2018,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,10,RACE05,CAT4,_RFPSA22,RESP054,"(39.008830667000495, -75.57774116799965)"
|
|
2018,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,10,RACE06,CAT4,_RFPSA22,RESP046,"(39.008830667000495, -75.57774116799965)"
|
|
2018,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,10,RACE06,CAT4,_RFPSA22,RESP054,"(39.008830667000495, -75.57774116799965)"
|
|
2018,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,9,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,10,RACE07,CAT4,_RFPSA22,RESP046,"(39.008830667000495, -75.57774116799965)"
|
|
2018,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,11,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,10,RACE07,CAT4,_RFPSA22,RESP054,"(39.008830667000495, -75.57774116799965)"
|
|
2018,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,18,20,9.4,30.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,RACE08,CAT4,_RFPSA22,RESP046,"(39.008830667000495, -75.57774116799965)"
|
|
2018,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,75,80,69.3,90.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,RACE08,CAT4,_RFPSA22,RESP054,"(39.008830667000495, -75.57774116799965)"
|
|
2018,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,626,37.7,34.6,40.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,SEX1,CAT2,_RFPSA22,RESP046,"(39.008830667000495, -75.57774116799965)"
|
|
2018,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,863,62.3,59.3,65.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,SEX1,CAT2,_RFPSA22,RESP054,"(39.008830667000495, -75.57774116799965)"
|
|
2018,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,10,SEX2,CAT2,_RFPSA22,RESP046,"(39.008830667000495, -75.57774116799965)"
|
|
2018,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,10,SEX2,CAT2,_RFPSA22,RESP054,"(39.008830667000495, -75.57774116799965)"
|
|
2018,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,35,14.6,9.3,19.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,AGE06,CAT3,_RFPSA22,RESP046,"(38.89037138500049, -77.03196112699965)"
|
|
2018,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,203,85.4,80.1,90.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,AGE06,CAT3,_RFPSA22,RESP054,"(38.89037138500049, -77.03196112699965)"
|
|
2018,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,96,34.5,28.3,40.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,AGE07,CAT3,_RFPSA22,RESP046,"(38.89037138500049, -77.03196112699965)"
|
|
2018,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,186,65.5,59.3,71.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,AGE07,CAT3,_RFPSA22,RESP054,"(38.89037138500049, -77.03196112699965)"
|
|
2018,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,80,40.1,31.7,48.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,AGE08,CAT3,_RFPSA22,RESP046,"(38.89037138500049, -77.03196112699965)"
|
|
2018,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,90,59.9,51.4,68.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,AGE08,CAT3,_RFPSA22,RESP054,"(38.89037138500049, -77.03196112699965)"
|
|
2018,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,294,50.2,45.4,55,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,AGE09,CAT3,_RFPSA22,RESP046,"(38.89037138500049, -77.03196112699965)"
|
|
2018,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,278,49.8,45,54.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,AGE09,CAT3,_RFPSA22,RESP054,"(38.89037138500049, -77.03196112699965)"
|
|
2018,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,505,33,29.9,36.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,BO1,CAT1,_RFPSA22,RESP046,"(38.89037138500049, -77.03196112699965)"
|
|
2018,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,757,67,63.9,70.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,BO1,CAT1,_RFPSA22,RESP054,"(38.89037138500049, -77.03196112699965)"
|
|
2018,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,25,24.9,14.9,34.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,EDUCA1,CAT5,_RFPSA22,RESP046,"(38.89037138500049, -77.03196112699965)"
|
|
2018,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,52,75.1,65.1,85.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,EDUCA1,CAT5,_RFPSA22,RESP054,"(38.89037138500049, -77.03196112699965)"
|
|
2018,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,57,23.8,17.4,30.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,EDUCA2,CAT5,_RFPSA22,RESP046,"(38.89037138500049, -77.03196112699965)"
|
|
2018,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,144,76.2,69.8,82.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,EDUCA2,CAT5,_RFPSA22,RESP054,"(38.89037138500049, -77.03196112699965)"
|
|
2018,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,62,36.4,28,44.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,EDUCA3,CAT5,_RFPSA22,RESP046,"(38.89037138500049, -77.03196112699965)"
|
|
2018,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,94,63.6,55.3,72,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,EDUCA3,CAT5,_RFPSA22,RESP054,"(38.89037138500049, -77.03196112699965)"
|
|
2018,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,360,37,33,41.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,EDUCA4,CAT5,_RFPSA22,RESP046,"(38.89037138500049, -77.03196112699965)"
|
|
2018,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,466,63,58.9,67,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,EDUCA4,CAT5,_RFPSA22,RESP054,"(38.89037138500049, -77.03196112699965)"
|
|
2018,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,31,24.1,15,33.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,INCOME1,CAT6,_RFPSA22,RESP046,"(38.89037138500049, -77.03196112699965)"
|
|
2018,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,84,75.9,66.8,85,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,INCOME1,CAT6,_RFPSA22,RESP054,"(38.89037138500049, -77.03196112699965)"
|
|
2018,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,44,26.1,18,34.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,INCOME2,CAT6,_RFPSA22,RESP046,"(38.89037138500049, -77.03196112699965)"
|
|
2018,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,93,73.9,65.8,82,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,INCOME2,CAT6,_RFPSA22,RESP054,"(38.89037138500049, -77.03196112699965)"
|
|
2018,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,24,29.7,17.2,42.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,INCOME3,CAT6,_RFPSA22,RESP046,"(38.89037138500049, -77.03196112699965)"
|
|
2018,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,48,70.3,57.9,82.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,INCOME3,CAT6,_RFPSA22,RESP054,"(38.89037138500049, -77.03196112699965)"
|
|
2018,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,33,39.6,26.1,53.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,INCOME4,CAT6,_RFPSA22,RESP046,"(38.89037138500049, -77.03196112699965)"
|
|
2018,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,47,60.4,46.9,73.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,INCOME4,CAT6,_RFPSA22,RESP054,"(38.89037138500049, -77.03196112699965)"
|
|
2018,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,322,36.4,32.2,40.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,INCOME5,CAT6,_RFPSA22,RESP046,"(38.89037138500049, -77.03196112699965)"
|
|
2018,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,404,63.6,59.3,67.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,INCOME5,CAT6,_RFPSA22,RESP054,"(38.89037138500049, -77.03196112699965)"
|
|
2018,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,275,34.9,30.7,39.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,RACE01,CAT4,_RFPSA22,RESP046,"(38.89037138500049, -77.03196112699965)"
|
|
2018,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,350,65.1,60.9,69.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,RACE01,CAT4,_RFPSA22,RESP054,"(38.89037138500049, -77.03196112699965)"
|
|
2018,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,194,32.3,27.8,36.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,RACE02,CAT4,_RFPSA22,RESP046,"(38.89037138500049, -77.03196112699965)"
|
|
2018,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,343,67.7,63.2,72.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,RACE02,CAT4,_RFPSA22,RESP054,"(38.89037138500049, -77.03196112699965)"
|
|
2018,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,11,RACE03,CAT4,_RFPSA22,RESP046,"(38.89037138500049, -77.03196112699965)"
|
|
2018,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,11,RACE03,CAT4,_RFPSA22,RESP054,"(38.89037138500049, -77.03196112699965)"
|
|
2018,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,11,RACE04,CAT4,_RFPSA22,RESP046,"(38.89037138500049, -77.03196112699965)"
|
|
2018,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,11,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,11,RACE04,CAT4,_RFPSA22,RESP054,"(38.89037138500049, -77.03196112699965)"
|
|
2018,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,11,RACE05,CAT4,_RFPSA22,RESP046,"(38.89037138500049, -77.03196112699965)"
|
|
2018,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,11,RACE05,CAT4,_RFPSA22,RESP054,"(38.89037138500049, -77.03196112699965)"
|
|
2018,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,11,RACE06,CAT4,_RFPSA22,RESP046,"(38.89037138500049, -77.03196112699965)"
|
|
2018,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,11,RACE06,CAT4,_RFPSA22,RESP054,"(38.89037138500049, -77.03196112699965)"
|
|
2018,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,11,RACE07,CAT4,_RFPSA22,RESP046,"(38.89037138500049, -77.03196112699965)"
|
|
2018,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,17,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,11,RACE07,CAT4,_RFPSA22,RESP054,"(38.89037138500049, -77.03196112699965)"
|
|
2018,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,12,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,11,RACE08,CAT4,_RFPSA22,RESP046,"(38.89037138500049, -77.03196112699965)"
|
|
2018,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,23,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,11,RACE08,CAT4,_RFPSA22,RESP054,"(38.89037138500049, -77.03196112699965)"
|
|
2018,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,505,33,29.9,36.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,SEX1,CAT2,_RFPSA22,RESP046,"(38.89037138500049, -77.03196112699965)"
|
|
2018,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,757,67,63.9,70.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,SEX1,CAT2,_RFPSA22,RESP054,"(38.89037138500049, -77.03196112699965)"
|
|
2018,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,11,SEX2,CAT2,_RFPSA22,RESP046,"(38.89037138500049, -77.03196112699965)"
|
|
2018,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,11,SEX2,CAT2,_RFPSA22,RESP054,"(38.89037138500049, -77.03196112699965)"
|
|
2018,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,2590,60.5,57.6,63.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,BO1,CAT1,_RFPSA22,RESP054,"(28.932040377000476, -81.92896053899966)"
|
|
2018,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,121,27.4,17.8,37,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,EDUCA1,CAT5,_RFPSA22,RESP046,"(28.932040377000476, -81.92896053899966)"
|
|
2018,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,84,11.1,6.9,15.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,AGE06,CAT3,_RFPSA22,RESP046,"(28.932040377000476, -81.92896053899966)"
|
|
2018,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,647,88.9,84.7,93.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,AGE06,CAT3,_RFPSA22,RESP054,"(28.932040377000476, -81.92896053899966)"
|
|
2018,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,317,31.7,26.3,37.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,AGE07,CAT3,_RFPSA22,RESP046,"(28.932040377000476, -81.92896053899966)"
|
|
2018,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,703,68.3,62.9,73.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,AGE07,CAT3,_RFPSA22,RESP054,"(28.932040377000476, -81.92896053899966)"
|
|
2018,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,230,40.1,32.2,48,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,AGE08,CAT3,_RFPSA22,RESP046,"(28.932040377000476, -81.92896053899966)"
|
|
2018,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,342,59.9,52,67.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,AGE08,CAT3,_RFPSA22,RESP054,"(28.932040377000476, -81.92896053899966)"
|
|
2018,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,1280,61.8,57.8,65.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,AGE09,CAT3,_RFPSA22,RESP046,"(28.932040377000476, -81.92896053899966)"
|
|
2018,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,898,38.2,34.2,42.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,AGE09,CAT3,_RFPSA22,RESP054,"(28.932040377000476, -81.92896053899966)"
|
|
2018,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1911,39.5,36.7,42.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,BO1,CAT1,_RFPSA22,RESP046,"(28.932040377000476, -81.92896053899966)"
|
|
2018,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,355,72.6,63,82.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,EDUCA1,CAT5,_RFPSA22,RESP054,"(28.932040377000476, -81.92896053899966)"
|
|
2018,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,460,34.6,29.1,40,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,EDUCA2,CAT5,_RFPSA22,RESP046,"(28.932040377000476, -81.92896053899966)"
|
|
2018,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,833,65.4,60,70.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,EDUCA2,CAT5,_RFPSA22,RESP054,"(28.932040377000476, -81.92896053899966)"
|
|
2018,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,514,39.9,34.9,45,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,EDUCA3,CAT5,_RFPSA22,RESP046,"(28.932040377000476, -81.92896053899966)"
|
|
2018,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,682,60.1,55,65.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,EDUCA3,CAT5,_RFPSA22,RESP054,"(28.932040377000476, -81.92896053899966)"
|
|
2018,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,810,49.8,45.2,54.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,EDUCA4,CAT5,_RFPSA22,RESP046,"(28.932040377000476, -81.92896053899966)"
|
|
2018,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,710,50.2,45.7,54.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,EDUCA4,CAT5,_RFPSA22,RESP054,"(28.932040377000476, -81.92896053899966)"
|
|
2018,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,102,25.6,14.4,36.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,INCOME1,CAT6,_RFPSA22,RESP046,"(28.932040377000476, -81.92896053899966)"
|
|
2018,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,284,74.4,63.2,85.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,INCOME1,CAT6,_RFPSA22,RESP054,"(28.932040377000476, -81.92896053899966)"
|
|
2018,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,196,26.8,19.8,33.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,INCOME2,CAT6,_RFPSA22,RESP046,"(28.932040377000476, -81.92896053899966)"
|
|
2018,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,488,73.2,66.2,80.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,INCOME2,CAT6,_RFPSA22,RESP054,"(28.932040377000476, -81.92896053899966)"
|
|
2018,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,169,30.9,21.9,40,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,INCOME3,CAT6,_RFPSA22,RESP046,"(28.932040377000476, -81.92896053899966)"
|
|
2018,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,251,69.1,60,78.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,INCOME3,CAT6,_RFPSA22,RESP054,"(28.932040377000476, -81.92896053899966)"
|
|
2018,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,225,39.3,30.5,48.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,INCOME4,CAT6,_RFPSA22,RESP046,"(28.932040377000476, -81.92896053899966)"
|
|
2018,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,339,60.7,51.8,69.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,INCOME4,CAT6,_RFPSA22,RESP054,"(28.932040377000476, -81.92896053899966)"
|
|
2018,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,946,44.7,40.7,48.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,INCOME5,CAT6,_RFPSA22,RESP046,"(28.932040377000476, -81.92896053899966)"
|
|
2018,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,915,55.3,51.3,59.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,INCOME5,CAT6,_RFPSA22,RESP054,"(28.932040377000476, -81.92896053899966)"
|
|
2018,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1590,43.7,40.8,46.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,RACE01,CAT4,_RFPSA22,RESP046,"(28.932040377000476, -81.92896053899966)"
|
|
2018,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1952,56.3,53.4,59.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,RACE01,CAT4,_RFPSA22,RESP054,"(28.932040377000476, -81.92896053899966)"
|
|
2018,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,126,27.8,19.5,36.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,RACE02,CAT4,_RFPSA22,RESP046,"(28.932040377000476, -81.92896053899966)"
|
|
2018,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,247,72.2,63.9,80.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,RACE02,CAT4,_RFPSA22,RESP054,"(28.932040377000476, -81.92896053899966)"
|
|
2018,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,32,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,12,RACE03,CAT4,_RFPSA22,RESP046,"(28.932040377000476, -81.92896053899966)"
|
|
2018,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,53,82.1,70.5,93.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,RACE03,CAT4,_RFPSA22,RESP054,"(28.932040377000476, -81.92896053899966)"
|
|
2018,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,20,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,12,RACE04,CAT4,_RFPSA22,RESP046,"(28.932040377000476, -81.92896053899966)"
|
|
2018,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,37,80.1,66.6,93.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,RACE04,CAT4,_RFPSA22,RESP054,"(28.932040377000476, -81.92896053899966)"
|
|
2018,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,12,RACE05,CAT4,_RFPSA22,RESP046,"(28.932040377000476, -81.92896053899966)"
|
|
2018,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,12,RACE05,CAT4,_RFPSA22,RESP054,"(28.932040377000476, -81.92896053899966)"
|
|
2018,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,11,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,12,RACE06,CAT4,_RFPSA22,RESP046,"(28.932040377000476, -81.92896053899966)"
|
|
2018,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,28,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,12,RACE06,CAT4,_RFPSA22,RESP054,"(28.932040377000476, -81.92896053899966)"
|
|
2018,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,26,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,12,RACE07,CAT4,_RFPSA22,RESP046,"(28.932040377000476, -81.92896053899966)"
|
|
2018,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,46,63.9,40.1,87.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,RACE07,CAT4,_RFPSA22,RESP054,"(28.932040377000476, -81.92896053899966)"
|
|
2018,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,104,36.1,26.9,45.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,RACE08,CAT4,_RFPSA22,RESP046,"(28.932040377000476, -81.92896053899966)"
|
|
2018,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,222,63.9,54.7,73.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,RACE08,CAT4,_RFPSA22,RESP054,"(28.932040377000476, -81.92896053899966)"
|
|
2018,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1911,39.5,36.7,42.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,SEX1,CAT2,_RFPSA22,RESP046,"(28.932040377000476, -81.92896053899966)"
|
|
2018,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,2590,60.5,57.6,63.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,SEX1,CAT2,_RFPSA22,RESP054,"(28.932040377000476, -81.92896053899966)"
|
|
2018,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,12,SEX2,CAT2,_RFPSA22,RESP046,"(28.932040377000476, -81.92896053899966)"
|
|
2018,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,12,SEX2,CAT2,_RFPSA22,RESP054,"(28.932040377000476, -81.92896053899966)"
|
|
2018,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,64,11.8,8.6,15,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,AGE06,CAT3,_RFPSA22,RESP046,"(32.83968109300048, -83.62758034599966)"
|
|
2018,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,446,88.2,85,91.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,AGE06,CAT3,_RFPSA22,RESP054,"(32.83968109300048, -83.62758034599966)"
|
|
2018,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,225,34.7,30.3,39,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,AGE07,CAT3,_RFPSA22,RESP046,"(32.83968109300048, -83.62758034599966)"
|
|
2018,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,404,65.3,61,69.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,AGE07,CAT3,_RFPSA22,RESP054,"(32.83968109300048, -83.62758034599966)"
|
|
2018,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,168,44.7,38.6,50.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,AGE08,CAT3,_RFPSA22,RESP046,"(32.83968109300048, -83.62758034599966)"
|
|
2018,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,188,55.3,49.2,61.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,AGE08,CAT3,_RFPSA22,RESP054,"(32.83968109300048, -83.62758034599966)"
|
|
2018,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,568,60.3,56.5,64.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,AGE09,CAT3,_RFPSA22,RESP046,"(32.83968109300048, -83.62758034599966)"
|
|
2018,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,384,39.7,35.8,43.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,AGE09,CAT3,_RFPSA22,RESP054,"(32.83968109300048, -83.62758034599966)"
|
|
2018,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1025,37,34.7,39.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,BO1,CAT1,_RFPSA22,RESP046,"(32.83968109300048, -83.62758034599966)"
|
|
2018,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1422,63,60.8,65.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,BO1,CAT1,_RFPSA22,RESP054,"(32.83968109300048, -83.62758034599966)"
|
|
2018,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,60,23.2,17.1,29.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,EDUCA1,CAT5,_RFPSA22,RESP046,"(32.83968109300048, -83.62758034599966)"
|
|
2018,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,192,76.8,70.7,82.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,EDUCA1,CAT5,_RFPSA22,RESP054,"(32.83968109300048, -83.62758034599966)"
|
|
2018,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,183,29.8,25.4,34.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,EDUCA2,CAT5,_RFPSA22,RESP046,"(32.83968109300048, -83.62758034599966)"
|
|
2018,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,375,70.2,65.8,74.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,EDUCA2,CAT5,_RFPSA22,RESP054,"(32.83968109300048, -83.62758034599966)"
|
|
2018,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,270,41.5,36.9,46,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,EDUCA3,CAT5,_RFPSA22,RESP046,"(32.83968109300048, -83.62758034599966)"
|
|
2018,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,323,58.5,54,63.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,EDUCA3,CAT5,_RFPSA22,RESP054,"(32.83968109300048, -83.62758034599966)"
|
|
2018,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,509,45.9,42.4,49.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,EDUCA4,CAT5,_RFPSA22,RESP046,"(32.83968109300048, -83.62758034599966)"
|
|
2018,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,527,54.1,50.6,57.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,EDUCA4,CAT5,_RFPSA22,RESP054,"(32.83968109300048, -83.62758034599966)"
|
|
2018,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,50,24.4,16.3,32.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,INCOME1,CAT6,_RFPSA22,RESP046,"(32.83968109300048, -83.62758034599966)"
|
|
2018,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,130,75.6,67.5,83.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,INCOME1,CAT6,_RFPSA22,RESP054,"(32.83968109300048, -83.62758034599966)"
|
|
2018,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,97,24.5,19.3,29.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,INCOME2,CAT6,_RFPSA22,RESP046,"(32.83968109300048, -83.62758034599966)"
|
|
2018,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,230,75.5,70.3,80.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,INCOME2,CAT6,_RFPSA22,RESP054,"(32.83968109300048, -83.62758034599966)"
|
|
2018,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,67,31.5,23.6,39.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,INCOME3,CAT6,_RFPSA22,RESP046,"(32.83968109300048, -83.62758034599966)"
|
|
2018,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,130,68.5,60.6,76.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,INCOME3,CAT6,_RFPSA22,RESP054,"(32.83968109300048, -83.62758034599966)"
|
|
2018,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,102,34.7,27.6,41.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,INCOME4,CAT6,_RFPSA22,RESP046,"(32.83968109300048, -83.62758034599966)"
|
|
2018,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,147,65.3,58.2,72.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,INCOME4,CAT6,_RFPSA22,RESP054,"(32.83968109300048, -83.62758034599966)"
|
|
2018,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,565,42.5,39.2,45.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,INCOME5,CAT6,_RFPSA22,RESP046,"(32.83968109300048, -83.62758034599966)"
|
|
2018,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,629,57.5,54.3,60.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,INCOME5,CAT6,_RFPSA22,RESP054,"(32.83968109300048, -83.62758034599966)"
|
|
2018,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,739,39.6,36.9,42.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,RACE01,CAT4,_RFPSA22,RESP046,"(32.83968109300048, -83.62758034599966)"
|
|
2018,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,918,60.4,57.7,63.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,RACE01,CAT4,_RFPSA22,RESP054,"(32.83968109300048, -83.62758034599966)"
|
|
2018,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,197,34.6,29.7,39.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,RACE02,CAT4,_RFPSA22,RESP046,"(32.83968109300048, -83.62758034599966)"
|
|
2018,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,298,65.4,60.5,70.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,RACE02,CAT4,_RFPSA22,RESP054,"(32.83968109300048, -83.62758034599966)"
|
|
2018,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,15,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,13,RACE03,CAT4,_RFPSA22,RESP046,"(32.83968109300048, -83.62758034599966)"
|
|
2018,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,21,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,13,RACE03,CAT4,_RFPSA22,RESP054,"(32.83968109300048, -83.62758034599966)"
|
|
2018,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,11,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,13,RACE04,CAT4,_RFPSA22,RESP046,"(32.83968109300048, -83.62758034599966)"
|
|
2018,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,30,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,13,RACE04,CAT4,_RFPSA22,RESP054,"(32.83968109300048, -83.62758034599966)"
|
|
2018,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,13,RACE05,CAT4,_RFPSA22,RESP046,"(32.83968109300048, -83.62758034599966)"
|
|
2018,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,13,RACE05,CAT4,_RFPSA22,RESP054,"(32.83968109300048, -83.62758034599966)"
|
|
2018,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,14,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,13,RACE06,CAT4,_RFPSA22,RESP046,"(32.83968109300048, -83.62758034599966)"
|
|
2018,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,13,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,13,RACE06,CAT4,_RFPSA22,RESP054,"(32.83968109300048, -83.62758034599966)"
|
|
2018,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,13,RACE07,CAT4,_RFPSA22,RESP046,"(32.83968109300048, -83.62758034599966)"
|
|
2018,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,27,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,13,RACE07,CAT4,_RFPSA22,RESP054,"(32.83968109300048, -83.62758034599966)"
|
|
2018,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,38,23.6,15.6,31.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,RACE08,CAT4,_RFPSA22,RESP046,"(32.83968109300048, -83.62758034599966)"
|
|
2018,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,114,76.4,68.5,84.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,RACE08,CAT4,_RFPSA22,RESP054,"(32.83968109300048, -83.62758034599966)"
|
|
2018,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1025,37,34.7,39.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,SEX1,CAT2,_RFPSA22,RESP046,"(32.83968109300048, -83.62758034599966)"
|
|
2018,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1422,63,60.8,65.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,SEX1,CAT2,_RFPSA22,RESP054,"(32.83968109300048, -83.62758034599966)"
|
|
2018,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,13,SEX2,CAT2,_RFPSA22,RESP046,"(32.83968109300048, -83.62758034599966)"
|
|
2018,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,13,SEX2,CAT2,_RFPSA22,RESP054,"(32.83968109300048, -83.62758034599966)"
|
|
2018,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,66,AGE06,CAT3,_RFPSA22,RESP046,"(13.444304, 144.793731)"
|
|
2018,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,100,97.3,94.6,99.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,AGE06,CAT3,_RFPSA22,RESP054,"(13.444304, 144.793731)"
|
|
2018,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,23,16.9,9.2,24.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,AGE07,CAT3,_RFPSA22,RESP046,"(13.444304, 144.793731)"
|
|
2018,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,112,83.1,75.3,90.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,AGE07,CAT3,_RFPSA22,RESP054,"(13.444304, 144.793731)"
|
|
2018,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,11,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,66,AGE08,CAT3,_RFPSA22,RESP046,"(13.444304, 144.793731)"
|
|
2018,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,49,85.7,76.5,94.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,AGE08,CAT3,_RFPSA22,RESP054,"(13.444304, 144.793731)"
|
|
2018,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,38,28.1,18.2,38.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,AGE09,CAT3,_RFPSA22,RESP046,"(13.444304, 144.793731)"
|
|
2018,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,85,71.9,61.9,81.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,AGE09,CAT3,_RFPSA22,RESP054,"(13.444304, 144.793731)"
|
|
2018,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,78,13.1,9.5,16.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,BO1,CAT1,_RFPSA22,RESP046,"(13.444304, 144.793731)"
|
|
2018,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,346,86.9,83.3,90.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,BO1,CAT1,_RFPSA22,RESP054,"(13.444304, 144.793731)"
|
|
2018,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,66,EDUCA1,CAT5,_RFPSA22,RESP046,"(13.444304, 144.793731)"
|
|
2018,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,34,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,66,EDUCA1,CAT5,_RFPSA22,RESP054,"(13.444304, 144.793731)"
|
|
2018,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,20,12.3,5.8,18.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,EDUCA2,CAT5,_RFPSA22,RESP046,"(13.444304, 144.793731)"
|
|
2018,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,132,87.7,81.2,94.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,EDUCA2,CAT5,_RFPSA22,RESP054,"(13.444304, 144.793731)"
|
|
2018,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,23,18.2,9.8,26.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,EDUCA3,CAT5,_RFPSA22,RESP046,"(13.444304, 144.793731)"
|
|
2018,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,76,81.8,73.4,90.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,EDUCA3,CAT5,_RFPSA22,RESP054,"(13.444304, 144.793731)"
|
|
2018,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,31,18.4,11.2,25.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,EDUCA4,CAT5,_RFPSA22,RESP046,"(13.444304, 144.793731)"
|
|
2018,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,104,81.6,74.4,88.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,EDUCA4,CAT5,_RFPSA22,RESP054,"(13.444304, 144.793731)"
|
|
2018,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,66,INCOME1,CAT6,_RFPSA22,RESP046,"(13.444304, 144.793731)"
|
|
2018,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,48,91.1,83.1,99.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,INCOME1,CAT6,_RFPSA22,RESP054,"(13.444304, 144.793731)"
|
|
2018,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,11,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,66,INCOME2,CAT6,_RFPSA22,RESP046,"(13.444304, 144.793731)"
|
|
2018,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,50,88.1,79.1,97.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,INCOME2,CAT6,_RFPSA22,RESP054,"(13.444304, 144.793731)"
|
|
2018,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,9,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,66,INCOME3,CAT6,_RFPSA22,RESP046,"(13.444304, 144.793731)"
|
|
2018,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,51,91.5,85.3,97.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,INCOME3,CAT6,_RFPSA22,RESP054,"(13.444304, 144.793731)"
|
|
2018,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,66,INCOME4,CAT6,_RFPSA22,RESP046,"(13.444304, 144.793731)"
|
|
2018,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,42,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,66,INCOME4,CAT6,_RFPSA22,RESP054,"(13.444304, 144.793731)"
|
|
2018,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,45,22.4,14.9,29.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,INCOME5,CAT6,_RFPSA22,RESP046,"(13.444304, 144.793731)"
|
|
2018,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,129,77.6,70.1,85.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,INCOME5,CAT6,_RFPSA22,RESP054,"(13.444304, 144.793731)"
|
|
2018,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,16,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,66,RACE01,CAT4,_RFPSA22,RESP046,"(13.444304, 144.793731)"
|
|
2018,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,40,76.6,62.2,91,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,RACE01,CAT4,_RFPSA22,RESP054,"(13.444304, 144.793731)"
|
|
2018,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,66,RACE02,CAT4,_RFPSA22,RESP046,"(13.444304, 144.793731)"
|
|
2018,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,66,RACE02,CAT4,_RFPSA22,RESP054,"(13.444304, 144.793731)"
|
|
2018,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,66,RACE03,CAT4,_RFPSA22,RESP046,"(13.444304, 144.793731)"
|
|
2018,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,66,RACE03,CAT4,_RFPSA22,RESP054,"(13.444304, 144.793731)"
|
|
2018,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,26,14.3,8,20.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,RACE04,CAT4,_RFPSA22,RESP046,"(13.444304, 144.793731)"
|
|
2018,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,110,85.7,79.4,92,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,RACE04,CAT4,_RFPSA22,RESP054,"(13.444304, 144.793731)"
|
|
2018,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,18,7.4,3.2,11.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,RACE05,CAT4,_RFPSA22,RESP046,"(13.444304, 144.793731)"
|
|
2018,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,123,92.6,88.4,96.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,RACE05,CAT4,_RFPSA22,RESP054,"(13.444304, 144.793731)"
|
|
2018,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,66,RACE06,CAT4,_RFPSA22,RESP046,"(13.444304, 144.793731)"
|
|
2018,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,66,RACE06,CAT4,_RFPSA22,RESP054,"(13.444304, 144.793731)"
|
|
2018,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,66,RACE07,CAT4,_RFPSA22,RESP046,"(13.444304, 144.793731)"
|
|
2018,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,23,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,66,RACE07,CAT4,_RFPSA22,RESP054,"(13.444304, 144.793731)"
|
|
2018,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,66,RACE08,CAT4,_RFPSA22,RESP046,"(13.444304, 144.793731)"
|
|
2018,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,37,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,66,RACE08,CAT4,_RFPSA22,RESP054,"(13.444304, 144.793731)"
|
|
2018,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,78,13.1,9.5,16.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,SEX1,CAT2,_RFPSA22,RESP046,"(13.444304, 144.793731)"
|
|
2018,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,346,86.9,83.3,90.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,SEX1,CAT2,_RFPSA22,RESP054,"(13.444304, 144.793731)"
|
|
2018,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,66,SEX2,CAT2,_RFPSA22,RESP046,"(13.444304, 144.793731)"
|
|
2018,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,66,SEX2,CAT2,_RFPSA22,RESP054,"(13.444304, 144.793731)"
|
|
2018,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,25,3.8,1.9,5.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,AGE06,CAT3,_RFPSA22,RESP046,"(21.304850435000446, -157.85774940299973)"
|
|
2018,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,492,96.2,94.2,98.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,AGE06,CAT3,_RFPSA22,RESP054,"(21.304850435000446, -157.85774940299973)"
|
|
2018,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,97,16,11.9,20.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,AGE07,CAT3,_RFPSA22,RESP046,"(21.304850435000446, -157.85774940299973)"
|
|
2018,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,498,84,79.9,88.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,AGE07,CAT3,_RFPSA22,RESP054,"(21.304850435000446, -157.85774940299973)"
|
|
2018,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,111,32,25,39,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,AGE08,CAT3,_RFPSA22,RESP046,"(21.304850435000446, -157.85774940299973)"
|
|
2018,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,223,68,61,75,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,AGE08,CAT3,_RFPSA22,RESP054,"(21.304850435000446, -157.85774940299973)"
|
|
2018,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,454,43.6,39.4,47.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,AGE09,CAT3,_RFPSA22,RESP046,"(21.304850435000446, -157.85774940299973)"
|
|
2018,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,592,56.4,52.4,60.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,AGE09,CAT3,_RFPSA22,RESP054,"(21.304850435000446, -157.85774940299973)"
|
|
2018,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,687,24.5,22.3,26.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,BO1,CAT1,_RFPSA22,RESP046,"(21.304850435000446, -157.85774940299973)"
|
|
2018,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1805,75.5,73.2,77.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,BO1,CAT1,_RFPSA22,RESP054,"(21.304850435000446, -157.85774940299973)"
|
|
2018,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,17,25,12.2,37.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,EDUCA1,CAT5,_RFPSA22,RESP046,"(21.304850435000446, -157.85774940299973)"
|
|
2018,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,77,75,62.3,87.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,EDUCA1,CAT5,_RFPSA22,RESP054,"(21.304850435000446, -157.85774940299973)"
|
|
2018,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,108,16.6,12.8,20.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,EDUCA2,CAT5,_RFPSA22,RESP046,"(21.304850435000446, -157.85774940299973)"
|
|
2018,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,481,83.4,79.4,87.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,EDUCA2,CAT5,_RFPSA22,RESP054,"(21.304850435000446, -157.85774940299973)"
|
|
2018,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,179,22.9,19,26.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,EDUCA3,CAT5,_RFPSA22,RESP046,"(21.304850435000446, -157.85774940299973)"
|
|
2018,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,524,77.1,73.2,81,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,EDUCA3,CAT5,_RFPSA22,RESP054,"(21.304850435000446, -157.85774940299973)"
|
|
2018,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,382,33,29.6,36.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,EDUCA4,CAT5,_RFPSA22,RESP046,"(21.304850435000446, -157.85774940299973)"
|
|
2018,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,720,67,63.6,70.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,EDUCA4,CAT5,_RFPSA22,RESP054,"(21.304850435000446, -157.85774940299973)"
|
|
2018,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,26,13,6.8,19.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,INCOME1,CAT6,_RFPSA22,RESP046,"(21.304850435000446, -157.85774940299973)"
|
|
2018,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,142,87,80.8,93.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,INCOME1,CAT6,_RFPSA22,RESP054,"(21.304850435000446, -157.85774940299973)"
|
|
2018,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,60,20.7,13.3,28.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,INCOME2,CAT6,_RFPSA22,RESP046,"(21.304850435000446, -157.85774940299973)"
|
|
2018,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,225,79.3,71.9,86.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,INCOME2,CAT6,_RFPSA22,RESP054,"(21.304850435000446, -157.85774940299973)"
|
|
2018,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,53,26.3,18,34.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,INCOME3,CAT6,_RFPSA22,RESP046,"(21.304850435000446, -157.85774940299973)"
|
|
2018,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,138,73.7,65.4,82,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,INCOME3,CAT6,_RFPSA22,RESP054,"(21.304850435000446, -157.85774940299973)"
|
|
2018,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,72,19.1,13.5,24.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,INCOME4,CAT6,_RFPSA22,RESP046,"(21.304850435000446, -157.85774940299973)"
|
|
2018,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,210,80.9,75.2,86.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,INCOME4,CAT6,_RFPSA22,RESP054,"(21.304850435000446, -157.85774940299973)"
|
|
2018,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,415,26.1,23.2,29.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,INCOME5,CAT6,_RFPSA22,RESP046,"(21.304850435000446, -157.85774940299973)"
|
|
2018,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,943,73.9,70.9,76.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,INCOME5,CAT6,_RFPSA22,RESP054,"(21.304850435000446, -157.85774940299973)"
|
|
2018,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,358,30.1,26.6,33.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,RACE01,CAT4,_RFPSA22,RESP046,"(21.304850435000446, -157.85774940299973)"
|
|
2018,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,683,69.9,66.4,73.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,RACE01,CAT4,_RFPSA22,RESP054,"(21.304850435000446, -157.85774940299973)"
|
|
2018,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,15,RACE02,CAT4,_RFPSA22,RESP046,"(21.304850435000446, -157.85774940299973)"
|
|
2018,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,20,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,15,RACE02,CAT4,_RFPSA22,RESP054,"(21.304850435000446, -157.85774940299973)"
|
|
2018,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,15,RACE03,CAT4,_RFPSA22,RESP046,"(21.304850435000446, -157.85774940299973)"
|
|
2018,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,14,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,15,RACE03,CAT4,_RFPSA22,RESP054,"(21.304850435000446, -157.85774940299973)"
|
|
2018,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,199,27.9,23.7,32,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,RACE04,CAT4,_RFPSA22,RESP046,"(21.304850435000446, -157.85774940299973)"
|
|
2018,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,483,72.1,68,76.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,RACE04,CAT4,_RFPSA22,RESP054,"(21.304850435000446, -157.85774940299973)"
|
|
2018,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,26,10.5,5.3,15.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,RACE05,CAT4,_RFPSA22,RESP046,"(21.304850435000446, -157.85774940299973)"
|
|
2018,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,189,89.5,84.3,94.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,RACE05,CAT4,_RFPSA22,RESP054,"(21.304850435000446, -157.85774940299973)"
|
|
2018,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,15,RACE06,CAT4,_RFPSA22,RESP046,"(21.304850435000446, -157.85774940299973)"
|
|
2018,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,11,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,15,RACE06,CAT4,_RFPSA22,RESP054,"(21.304850435000446, -157.85774940299973)"
|
|
2018,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,61,15,10.8,19.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,RACE07,CAT4,_RFPSA22,RESP046,"(21.304850435000446, -157.85774940299973)"
|
|
2018,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,279,85,80.8,89.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,RACE07,CAT4,_RFPSA22,RESP054,"(21.304850435000446, -157.85774940299973)"
|
|
2018,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,31,17.5,9.9,25.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,RACE08,CAT4,_RFPSA22,RESP046,"(21.304850435000446, -157.85774940299973)"
|
|
2018,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,126,82.5,74.8,90.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,RACE08,CAT4,_RFPSA22,RESP054,"(21.304850435000446, -157.85774940299973)"
|
|
2018,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,687,24.5,22.3,26.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,SEX1,CAT2,_RFPSA22,RESP046,"(21.304850435000446, -157.85774940299973)"
|
|
2018,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1805,75.5,73.2,77.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,SEX1,CAT2,_RFPSA22,RESP054,"(21.304850435000446, -157.85774940299973)"
|
|
2018,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,15,SEX2,CAT2,_RFPSA22,RESP046,"(21.304850435000446, -157.85774940299973)"
|
|
2018,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,15,SEX2,CAT2,_RFPSA22,RESP054,"(21.304850435000446, -157.85774940299973)"
|
|
2018,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,13,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,16,AGE06,CAT3,_RFPSA22,RESP046,"(43.682630005000476, -114.3637300419997)"
|
|
2018,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,173,94.2,90.6,97.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,AGE06,CAT3,_RFPSA22,RESP054,"(43.682630005000476, -114.3637300419997)"
|
|
2018,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,69,33.5,25.2,41.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,AGE07,CAT3,_RFPSA22,RESP046,"(43.682630005000476, -114.3637300419997)"
|
|
2018,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,176,66.5,58.2,74.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,AGE07,CAT3,_RFPSA22,RESP054,"(43.682630005000476, -114.3637300419997)"
|
|
2018,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,68,38.1,28.4,47.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,AGE08,CAT3,_RFPSA22,RESP046,"(43.682630005000476, -114.3637300419997)"
|
|
2018,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,96,61.9,52.2,71.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,AGE08,CAT3,_RFPSA22,RESP054,"(43.682630005000476, -114.3637300419997)"
|
|
2018,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,279,48.2,42.9,53.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,AGE09,CAT3,_RFPSA22,RESP046,"(43.682630005000476, -114.3637300419997)"
|
|
2018,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,304,51.8,46.5,57.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,AGE09,CAT3,_RFPSA22,RESP054,"(43.682630005000476, -114.3637300419997)"
|
|
2018,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,429,33.2,29.6,36.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,BO1,CAT1,_RFPSA22,RESP046,"(43.682630005000476, -114.3637300419997)"
|
|
2018,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,749,66.8,63.2,70.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,BO1,CAT1,_RFPSA22,RESP054,"(43.682630005000476, -114.3637300419997)"
|
|
2018,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,18,25.5,12.6,38.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,EDUCA1,CAT5,_RFPSA22,RESP046,"(43.682630005000476, -114.3637300419997)"
|
|
2018,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,75,74.5,61.5,87.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,EDUCA1,CAT5,_RFPSA22,RESP054,"(43.682630005000476, -114.3637300419997)"
|
|
2018,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,86,28,21.2,34.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,EDUCA2,CAT5,_RFPSA22,RESP046,"(43.682630005000476, -114.3637300419997)"
|
|
2018,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,208,72,65.4,78.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,EDUCA2,CAT5,_RFPSA22,RESP054,"(43.682630005000476, -114.3637300419997)"
|
|
2018,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,109,33.7,26.8,40.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,EDUCA3,CAT5,_RFPSA22,RESP046,"(43.682630005000476, -114.3637300419997)"
|
|
2018,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,188,66.3,59.4,73.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,EDUCA3,CAT5,_RFPSA22,RESP054,"(43.682630005000476, -114.3637300419997)"
|
|
2018,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,216,40.3,34.6,46,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,EDUCA4,CAT5,_RFPSA22,RESP046,"(43.682630005000476, -114.3637300419997)"
|
|
2018,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,277,59.7,54,65.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,EDUCA4,CAT5,_RFPSA22,RESP054,"(43.682630005000476, -114.3637300419997)"
|
|
2018,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,16,INCOME1,CAT6,_RFPSA22,RESP046,"(43.682630005000476, -114.3637300419997)"
|
|
2018,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,65,89.5,80.8,98.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,INCOME1,CAT6,_RFPSA22,RESP054,"(43.682630005000476, -114.3637300419997)"
|
|
2018,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,52,32.6,23.7,41.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,INCOME2,CAT6,_RFPSA22,RESP046,"(43.682630005000476, -114.3637300419997)"
|
|
2018,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,93,67.4,58.6,76.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,INCOME2,CAT6,_RFPSA22,RESP054,"(43.682630005000476, -114.3637300419997)"
|
|
2018,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,38,22.5,13.9,31.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,INCOME3,CAT6,_RFPSA22,RESP046,"(43.682630005000476, -114.3637300419997)"
|
|
2018,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,83,77.5,68.8,86.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,INCOME3,CAT6,_RFPSA22,RESP054,"(43.682630005000476, -114.3637300419997)"
|
|
2018,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,65,29.1,20.8,37.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,INCOME4,CAT6,_RFPSA22,RESP046,"(43.682630005000476, -114.3637300419997)"
|
|
2018,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,116,70.9,62.7,79.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,INCOME4,CAT6,_RFPSA22,RESP054,"(43.682630005000476, -114.3637300419997)"
|
|
2018,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,236,39,33.5,44.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,INCOME5,CAT6,_RFPSA22,RESP046,"(43.682630005000476, -114.3637300419997)"
|
|
2018,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,329,61,55.5,66.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,INCOME5,CAT6,_RFPSA22,RESP054,"(43.682630005000476, -114.3637300419997)"
|
|
2018,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,402,34.6,30.8,38.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,RACE01,CAT4,_RFPSA22,RESP046,"(43.682630005000476, -114.3637300419997)"
|
|
2018,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,671,65.4,61.6,69.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,RACE01,CAT4,_RFPSA22,RESP054,"(43.682630005000476, -114.3637300419997)"
|
|
2018,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,16,RACE02,CAT4,_RFPSA22,RESP046,"(43.682630005000476, -114.3637300419997)"
|
|
2018,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,16,RACE02,CAT4,_RFPSA22,RESP054,"(43.682630005000476, -114.3637300419997)"
|
|
2018,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,16,RACE03,CAT4,_RFPSA22,RESP046,"(43.682630005000476, -114.3637300419997)"
|
|
2018,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,11,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,16,RACE03,CAT4,_RFPSA22,RESP054,"(43.682630005000476, -114.3637300419997)"
|
|
2018,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,16,RACE04,CAT4,_RFPSA22,RESP046,"(43.682630005000476, -114.3637300419997)"
|
|
2018,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,16,RACE04,CAT4,_RFPSA22,RESP054,"(43.682630005000476, -114.3637300419997)"
|
|
2018,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,16,RACE05,CAT4,_RFPSA22,RESP046,"(43.682630005000476, -114.3637300419997)"
|
|
2018,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,16,RACE05,CAT4,_RFPSA22,RESP054,"(43.682630005000476, -114.3637300419997)"
|
|
2018,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,16,RACE06,CAT4,_RFPSA22,RESP046,"(43.682630005000476, -114.3637300419997)"
|
|
2018,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,16,RACE06,CAT4,_RFPSA22,RESP054,"(43.682630005000476, -114.3637300419997)"
|
|
2018,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,16,RACE07,CAT4,_RFPSA22,RESP046,"(43.682630005000476, -114.3637300419997)"
|
|
2018,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,9,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,16,RACE07,CAT4,_RFPSA22,RESP054,"(43.682630005000476, -114.3637300419997)"
|
|
2018,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,14,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,16,RACE08,CAT4,_RFPSA22,RESP046,"(43.682630005000476, -114.3637300419997)"
|
|
2018,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,45,77.4,62.7,92.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,RACE08,CAT4,_RFPSA22,RESP054,"(43.682630005000476, -114.3637300419997)"
|
|
2018,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,429,33.2,29.6,36.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,SEX1,CAT2,_RFPSA22,RESP046,"(43.682630005000476, -114.3637300419997)"
|
|
2018,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,749,66.8,63.2,70.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,SEX1,CAT2,_RFPSA22,RESP054,"(43.682630005000476, -114.3637300419997)"
|
|
2018,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,16,SEX2,CAT2,_RFPSA22,RESP046,"(43.682630005000476, -114.3637300419997)"
|
|
2018,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,16,SEX2,CAT2,_RFPSA22,RESP054,"(43.682630005000476, -114.3637300419997)"
|
|
2018,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,30,7.5,4.7,10.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,AGE06,CAT3,_RFPSA22,RESP046,"(40.48501028300046, -88.99771017799969)"
|
|
2018,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,287,92.5,89.7,95.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,AGE06,CAT3,_RFPSA22,RESP054,"(40.48501028300046, -88.99771017799969)"
|
|
2018,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,142,33,27.8,38.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,AGE07,CAT3,_RFPSA22,RESP046,"(40.48501028300046, -88.99771017799969)"
|
|
2018,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,288,67,61.8,72.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,AGE07,CAT3,_RFPSA22,RESP054,"(40.48501028300046, -88.99771017799969)"
|
|
2018,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,105,46.7,39.4,54,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,AGE08,CAT3,_RFPSA22,RESP046,"(40.48501028300046, -88.99771017799969)"
|
|
2018,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,132,53.3,46,60.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,AGE08,CAT3,_RFPSA22,RESP054,"(40.48501028300046, -88.99771017799969)"
|
|
2018,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,296,47.4,42.6,52.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,AGE09,CAT3,_RFPSA22,RESP046,"(40.48501028300046, -88.99771017799969)"
|
|
2018,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,298,52.6,47.9,57.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,AGE09,CAT3,_RFPSA22,RESP054,"(40.48501028300046, -88.99771017799969)"
|
|
2018,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,573,32.5,29.8,35.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,BO1,CAT1,_RFPSA22,RESP046,"(40.48501028300046, -88.99771017799969)"
|
|
2018,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1005,67.5,64.8,70.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,BO1,CAT1,_RFPSA22,RESP054,"(40.48501028300046, -88.99771017799969)"
|
|
2018,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,21,15.7,8.4,23,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,EDUCA1,CAT5,_RFPSA22,RESP046,"(40.48501028300046, -88.99771017799969)"
|
|
2018,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,121,84.3,77,91.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,EDUCA1,CAT5,_RFPSA22,RESP054,"(40.48501028300046, -88.99771017799969)"
|
|
2018,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,117,28.7,23.6,33.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,EDUCA2,CAT5,_RFPSA22,RESP046,"(40.48501028300046, -88.99771017799969)"
|
|
2018,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,270,71.3,66.2,76.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,EDUCA2,CAT5,_RFPSA22,RESP054,"(40.48501028300046, -88.99771017799969)"
|
|
2018,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,135,37.3,31.6,43,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,EDUCA3,CAT5,_RFPSA22,RESP046,"(40.48501028300046, -88.99771017799969)"
|
|
2018,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,207,62.7,57,68.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,EDUCA3,CAT5,_RFPSA22,RESP054,"(40.48501028300046, -88.99771017799969)"
|
|
2018,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,300,39.4,35.3,43.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,EDUCA4,CAT5,_RFPSA22,RESP046,"(40.48501028300046, -88.99771017799969)"
|
|
2018,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,404,60.6,56.5,64.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,EDUCA4,CAT5,_RFPSA22,RESP054,"(40.48501028300046, -88.99771017799969)"
|
|
2018,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,27,22.4,13.6,31.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,INCOME1,CAT6,_RFPSA22,RESP046,"(40.48501028300046, -88.99771017799969)"
|
|
2018,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,97,77.6,68.9,86.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,INCOME1,CAT6,_RFPSA22,RESP054,"(40.48501028300046, -88.99771017799969)"
|
|
2018,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,54,26,18.9,33.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,INCOME2,CAT6,_RFPSA22,RESP046,"(40.48501028300046, -88.99771017799969)"
|
|
2018,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,133,74,66.9,81.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,INCOME2,CAT6,_RFPSA22,RESP054,"(40.48501028300046, -88.99771017799969)"
|
|
2018,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,43,37,25.4,48.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,INCOME3,CAT6,_RFPSA22,RESP046,"(40.48501028300046, -88.99771017799969)"
|
|
2018,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,71,63,51.4,74.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,INCOME3,CAT6,_RFPSA22,RESP054,"(40.48501028300046, -88.99771017799969)"
|
|
2018,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,59,28.3,20.9,35.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,INCOME4,CAT6,_RFPSA22,RESP046,"(40.48501028300046, -88.99771017799969)"
|
|
2018,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,122,71.7,64.4,79.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,INCOME4,CAT6,_RFPSA22,RESP054,"(40.48501028300046, -88.99771017799969)"
|
|
2018,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,356,35,31.3,38.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,INCOME5,CAT6,_RFPSA22,RESP046,"(40.48501028300046, -88.99771017799969)"
|
|
2018,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,526,65,61.4,68.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,INCOME5,CAT6,_RFPSA22,RESP054,"(40.48501028300046, -88.99771017799969)"
|
|
2018,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,461,37.3,34,40.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,RACE01,CAT4,_RFPSA22,RESP046,"(40.48501028300046, -88.99771017799969)"
|
|
2018,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,675,62.7,59.4,66,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,RACE01,CAT4,_RFPSA22,RESP054,"(40.48501028300046, -88.99771017799969)"
|
|
2018,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,58,29.4,21.2,37.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,RACE02,CAT4,_RFPSA22,RESP046,"(40.48501028300046, -88.99771017799969)"
|
|
2018,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,125,70.6,62.5,78.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,RACE02,CAT4,_RFPSA22,RESP054,"(40.48501028300046, -88.99771017799969)"
|
|
2018,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,17,RACE03,CAT4,_RFPSA22,RESP046,"(40.48501028300046, -88.99771017799969)"
|
|
2018,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,11,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,17,RACE03,CAT4,_RFPSA22,RESP054,"(40.48501028300046, -88.99771017799969)"
|
|
2018,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,17,RACE04,CAT4,_RFPSA22,RESP046,"(40.48501028300046, -88.99771017799969)"
|
|
2018,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,36,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,17,RACE04,CAT4,_RFPSA22,RESP054,"(40.48501028300046, -88.99771017799969)"
|
|
2018,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,17,RACE05,CAT4,_RFPSA22,RESP046,"(40.48501028300046, -88.99771017799969)"
|
|
2018,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,17,RACE05,CAT4,_RFPSA22,RESP054,"(40.48501028300046, -88.99771017799969)"
|
|
2018,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,17,RACE06,CAT4,_RFPSA22,RESP046,"(40.48501028300046, -88.99771017799969)"
|
|
2018,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,17,RACE06,CAT4,_RFPSA22,RESP054,"(40.48501028300046, -88.99771017799969)"
|
|
2018,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,17,RACE07,CAT4,_RFPSA22,RESP046,"(40.48501028300046, -88.99771017799969)"
|
|
2018,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,17,RACE07,CAT4,_RFPSA22,RESP054,"(40.48501028300046, -88.99771017799969)"
|
|
2018,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,34,17.3,11.3,23.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,RACE08,CAT4,_RFPSA22,RESP046,"(40.48501028300046, -88.99771017799969)"
|
|
2018,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,142,82.7,76.6,88.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,RACE08,CAT4,_RFPSA22,RESP054,"(40.48501028300046, -88.99771017799969)"
|
|
2018,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,573,32.5,29.8,35.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,SEX1,CAT2,_RFPSA22,RESP046,"(40.48501028300046, -88.99771017799969)"
|
|
2018,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1005,67.5,64.8,70.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,SEX1,CAT2,_RFPSA22,RESP054,"(40.48501028300046, -88.99771017799969)"
|
|
2018,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,17,SEX2,CAT2,_RFPSA22,RESP046,"(40.48501028300046, -88.99771017799969)"
|
|
2018,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,17,SEX2,CAT2,_RFPSA22,RESP054,"(40.48501028300046, -88.99771017799969)"
|
|
2018,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,38,8,5.2,10.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,AGE06,CAT3,_RFPSA22,RESP046,"(39.766910452000445, -86.14996019399968)"
|
|
2018,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,316,92,89.1,94.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,AGE06,CAT3,_RFPSA22,RESP054,"(39.766910452000445, -86.14996019399968)"
|
|
2018,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,163,28,23.7,32.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,AGE07,CAT3,_RFPSA22,RESP046,"(39.766910452000445, -86.14996019399968)"
|
|
2018,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,373,72,67.8,76.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,AGE07,CAT3,_RFPSA22,RESP054,"(39.766910452000445, -86.14996019399968)"
|
|
2018,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,139,44.1,37.8,50.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,AGE08,CAT3,_RFPSA22,RESP046,"(39.766910452000445, -86.14996019399968)"
|
|
2018,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,163,55.9,49.5,62.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,AGE08,CAT3,_RFPSA22,RESP054,"(39.766910452000445, -86.14996019399968)"
|
|
2018,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,467,48.9,45,52.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,AGE09,CAT3,_RFPSA22,RESP046,"(39.766910452000445, -86.14996019399968)"
|
|
2018,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,471,51.1,47.2,55,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,AGE09,CAT3,_RFPSA22,RESP054,"(39.766910452000445, -86.14996019399968)"
|
|
2018,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,807,31.2,29,33.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,BO1,CAT1,_RFPSA22,RESP046,"(39.766910452000445, -86.14996019399968)"
|
|
2018,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1323,68.8,66.5,71,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,BO1,CAT1,_RFPSA22,RESP054,"(39.766910452000445, -86.14996019399968)"
|
|
2018,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,33,15.8,9.9,21.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,EDUCA1,CAT5,_RFPSA22,RESP046,"(39.766910452000445, -86.14996019399968)"
|
|
2018,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,123,84.2,78.4,90.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,EDUCA1,CAT5,_RFPSA22,RESP054,"(39.766910452000445, -86.14996019399968)"
|
|
2018,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,235,28.8,25.1,32.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,EDUCA2,CAT5,_RFPSA22,RESP046,"(39.766910452000445, -86.14996019399968)"
|
|
2018,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,487,71.2,67.5,74.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,EDUCA2,CAT5,_RFPSA22,RESP054,"(39.766910452000445, -86.14996019399968)"
|
|
2018,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,198,31.1,26.7,35.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,EDUCA3,CAT5,_RFPSA22,RESP046,"(39.766910452000445, -86.14996019399968)"
|
|
2018,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,335,68.9,64.5,73.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,EDUCA3,CAT5,_RFPSA22,RESP054,"(39.766910452000445, -86.14996019399968)"
|
|
2018,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,341,42.8,38.5,47,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,EDUCA4,CAT5,_RFPSA22,RESP046,"(39.766910452000445, -86.14996019399968)"
|
|
2018,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,371,57.2,53,61.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,EDUCA4,CAT5,_RFPSA22,RESP054,"(39.766910452000445, -86.14996019399968)"
|
|
2018,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,29,17.7,10.5,24.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,INCOME1,CAT6,_RFPSA22,RESP046,"(39.766910452000445, -86.14996019399968)"
|
|
2018,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,96,82.3,75.1,89.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,INCOME1,CAT6,_RFPSA22,RESP054,"(39.766910452000445, -86.14996019399968)"
|
|
2018,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,77,24.6,18.5,30.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,INCOME2,CAT6,_RFPSA22,RESP046,"(39.766910452000445, -86.14996019399968)"
|
|
2018,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,176,75.4,69.3,81.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,INCOME2,CAT6,_RFPSA22,RESP054,"(39.766910452000445, -86.14996019399968)"
|
|
2018,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,73,27.6,20.8,34.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,INCOME3,CAT6,_RFPSA22,RESP046,"(39.766910452000445, -86.14996019399968)"
|
|
2018,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,138,72.4,65.5,79.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,INCOME3,CAT6,_RFPSA22,RESP054,"(39.766910452000445, -86.14996019399968)"
|
|
2018,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,107,32.7,26.2,39.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,INCOME4,CAT6,_RFPSA22,RESP046,"(39.766910452000445, -86.14996019399968)"
|
|
2018,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,168,67.3,60.8,73.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,INCOME4,CAT6,_RFPSA22,RESP054,"(39.766910452000445, -86.14996019399968)"
|
|
2018,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,402,33.9,30.5,37.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,INCOME5,CAT6,_RFPSA22,RESP046,"(39.766910452000445, -86.14996019399968)"
|
|
2018,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,566,66.1,62.7,69.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,INCOME5,CAT6,_RFPSA22,RESP054,"(39.766910452000445, -86.14996019399968)"
|
|
2018,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,717,32.5,30.1,34.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,RACE01,CAT4,_RFPSA22,RESP046,"(39.766910452000445, -86.14996019399968)"
|
|
2018,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1118,67.5,65.1,69.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,RACE01,CAT4,_RFPSA22,RESP054,"(39.766910452000445, -86.14996019399968)"
|
|
2018,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,46,28.3,19.4,37.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,RACE02,CAT4,_RFPSA22,RESP046,"(39.766910452000445, -86.14996019399968)"
|
|
2018,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,91,71.7,62.8,80.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,RACE02,CAT4,_RFPSA22,RESP054,"(39.766910452000445, -86.14996019399968)"
|
|
2018,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,18,RACE03,CAT4,_RFPSA22,RESP046,"(39.766910452000445, -86.14996019399968)"
|
|
2018,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,23,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,18,RACE03,CAT4,_RFPSA22,RESP054,"(39.766910452000445, -86.14996019399968)"
|
|
2018,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,18,RACE04,CAT4,_RFPSA22,RESP046,"(39.766910452000445, -86.14996019399968)"
|
|
2018,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,18,RACE04,CAT4,_RFPSA22,RESP054,"(39.766910452000445, -86.14996019399968)"
|
|
2018,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,18,RACE05,CAT4,_RFPSA22,RESP046,"(39.766910452000445, -86.14996019399968)"
|
|
2018,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,18,RACE05,CAT4,_RFPSA22,RESP054,"(39.766910452000445, -86.14996019399968)"
|
|
2018,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,13,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,18,RACE06,CAT4,_RFPSA22,RESP046,"(39.766910452000445, -86.14996019399968)"
|
|
2018,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,16,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,18,RACE06,CAT4,_RFPSA22,RESP054,"(39.766910452000445, -86.14996019399968)"
|
|
2018,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,18,RACE07,CAT4,_RFPSA22,RESP046,"(39.766910452000445, -86.14996019399968)"
|
|
2018,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,22,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,18,RACE07,CAT4,_RFPSA22,RESP054,"(39.766910452000445, -86.14996019399968)"
|
|
2018,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,11,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,18,RACE08,CAT4,_RFPSA22,RESP046,"(39.766910452000445, -86.14996019399968)"
|
|
2018,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,42,88.4,80.9,95.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,RACE08,CAT4,_RFPSA22,RESP054,"(39.766910452000445, -86.14996019399968)"
|
|
2018,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,807,31.2,29,33.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,SEX1,CAT2,_RFPSA22,RESP046,"(39.766910452000445, -86.14996019399968)"
|
|
2018,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1323,68.8,66.5,71,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,SEX1,CAT2,_RFPSA22,RESP054,"(39.766910452000445, -86.14996019399968)"
|
|
2018,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,18,SEX2,CAT2,_RFPSA22,RESP046,"(39.766910452000445, -86.14996019399968)"
|
|
2018,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,18,SEX2,CAT2,_RFPSA22,RESP054,"(39.766910452000445, -86.14996019399968)"
|
|
2018,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,963,31.2,29.3,33,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,BO1,CAT1,_RFPSA22,RESP046,"(42.46940091300047, -93.81649055599968)"
|
|
2018,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,38,6,4,8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,AGE06,CAT3,_RFPSA22,RESP046,"(42.46940091300047, -93.81649055599968)"
|
|
2018,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,510,94,92,96,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,AGE06,CAT3,_RFPSA22,RESP054,"(42.46940091300047, -93.81649055599968)"
|
|
2018,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,187,26.3,22.8,29.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,AGE07,CAT3,_RFPSA22,RESP046,"(42.46940091300047, -93.81649055599968)"
|
|
2018,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,515,73.7,70.2,77.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,AGE07,CAT3,_RFPSA22,RESP054,"(42.46940091300047, -93.81649055599968)"
|
|
2018,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,183,43.5,38.3,48.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,AGE08,CAT3,_RFPSA22,RESP046,"(42.46940091300047, -93.81649055599968)"
|
|
2018,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,241,56.5,51.3,61.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,AGE08,CAT3,_RFPSA22,RESP054,"(42.46940091300047, -93.81649055599968)"
|
|
2018,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,555,48.8,45.5,52.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,AGE09,CAT3,_RFPSA22,RESP046,"(42.46940091300047, -93.81649055599968)"
|
|
2018,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,529,51.2,47.9,54.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,AGE09,CAT3,_RFPSA22,RESP054,"(42.46940091300047, -93.81649055599968)"
|
|
2018,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1795,68.8,67,70.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,BO1,CAT1,_RFPSA22,RESP054,"(42.46940091300047, -93.81649055599968)"
|
|
2018,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,26,18.9,11.9,25.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,EDUCA1,CAT5,_RFPSA22,RESP046,"(42.46940091300047, -93.81649055599968)"
|
|
2018,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,127,81.1,74.1,88.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,EDUCA1,CAT5,_RFPSA22,RESP054,"(42.46940091300047, -93.81649055599968)"
|
|
2018,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,303,30.7,27.6,33.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,EDUCA2,CAT5,_RFPSA22,RESP046,"(42.46940091300047, -93.81649055599968)"
|
|
2018,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,636,69.3,66.2,72.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,EDUCA2,CAT5,_RFPSA22,RESP054,"(42.46940091300047, -93.81649055599968)"
|
|
2018,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,249,29.9,26.5,33.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,EDUCA3,CAT5,_RFPSA22,RESP046,"(42.46940091300047, -93.81649055599968)"
|
|
2018,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,505,70.1,66.6,73.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,EDUCA3,CAT5,_RFPSA22,RESP054,"(42.46940091300047, -93.81649055599968)"
|
|
2018,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,383,37.5,34.3,40.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,EDUCA4,CAT5,_RFPSA22,RESP046,"(42.46940091300047, -93.81649055599968)"
|
|
2018,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,526,62.5,59.2,65.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,EDUCA4,CAT5,_RFPSA22,RESP054,"(42.46940091300047, -93.81649055599968)"
|
|
2018,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,25,16.8,9.9,23.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,INCOME1,CAT6,_RFPSA22,RESP046,"(42.46940091300047, -93.81649055599968)"
|
|
2018,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,91,83.2,76.3,90.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,INCOME1,CAT6,_RFPSA22,RESP054,"(42.46940091300047, -93.81649055599968)"
|
|
2018,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,99,29.7,24.1,35.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,INCOME2,CAT6,_RFPSA22,RESP046,"(42.46940091300047, -93.81649055599968)"
|
|
2018,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,197,70.3,64.7,75.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,INCOME2,CAT6,_RFPSA22,RESP054,"(42.46940091300047, -93.81649055599968)"
|
|
2018,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,67,25.8,19.7,31.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,INCOME3,CAT6,_RFPSA22,RESP046,"(42.46940091300047, -93.81649055599968)"
|
|
2018,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,162,74.2,68.1,80.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,INCOME3,CAT6,_RFPSA22,RESP054,"(42.46940091300047, -93.81649055599968)"
|
|
2018,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,124,30.8,25.8,35.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,INCOME4,CAT6,_RFPSA22,RESP046,"(42.46940091300047, -93.81649055599968)"
|
|
2018,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,245,69.2,64.2,74.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,INCOME4,CAT6,_RFPSA22,RESP054,"(42.46940091300047, -93.81649055599968)"
|
|
2018,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,581,33.3,30.8,35.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,INCOME5,CAT6,_RFPSA22,RESP046,"(42.46940091300047, -93.81649055599968)"
|
|
2018,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,952,66.7,64.2,69.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,INCOME5,CAT6,_RFPSA22,RESP054,"(42.46940091300047, -93.81649055599968)"
|
|
2018,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,923,32.2,30.2,34,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,RACE01,CAT4,_RFPSA22,RESP046,"(42.46940091300047, -93.81649055599968)"
|
|
2018,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1649,67.8,66,69.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,RACE01,CAT4,_RFPSA22,RESP054,"(42.46940091300047, -93.81649055599968)"
|
|
2018,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,19,RACE02,CAT4,_RFPSA22,RESP046,"(42.46940091300047, -93.81649055599968)"
|
|
2018,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,15,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,19,RACE02,CAT4,_RFPSA22,RESP054,"(42.46940091300047, -93.81649055599968)"
|
|
2018,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,19,RACE03,CAT4,_RFPSA22,RESP046,"(42.46940091300047, -93.81649055599968)"
|
|
2018,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,16,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,19,RACE03,CAT4,_RFPSA22,RESP054,"(42.46940091300047, -93.81649055599968)"
|
|
2018,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,19,RACE04,CAT4,_RFPSA22,RESP046,"(42.46940091300047, -93.81649055599968)"
|
|
2018,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,13,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,19,RACE04,CAT4,_RFPSA22,RESP054,"(42.46940091300047, -93.81649055599968)"
|
|
2018,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,19,RACE05,CAT4,_RFPSA22,RESP046,"(42.46940091300047, -93.81649055599968)"
|
|
2018,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,19,RACE05,CAT4,_RFPSA22,RESP054,"(42.46940091300047, -93.81649055599968)"
|
|
2018,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,19,RACE06,CAT4,_RFPSA22,RESP046,"(42.46940091300047, -93.81649055599968)"
|
|
2018,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,19,RACE06,CAT4,_RFPSA22,RESP054,"(42.46940091300047, -93.81649055599968)"
|
|
2018,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,19,RACE07,CAT4,_RFPSA22,RESP046,"(42.46940091300047, -93.81649055599968)"
|
|
2018,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,22,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,19,RACE07,CAT4,_RFPSA22,RESP054,"(42.46940091300047, -93.81649055599968)"
|
|
2018,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,15,16.8,8.4,25.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,RACE08,CAT4,_RFPSA22,RESP046,"(42.46940091300047, -93.81649055599968)"
|
|
2018,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,72,83.2,74.7,91.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,RACE08,CAT4,_RFPSA22,RESP054,"(42.46940091300047, -93.81649055599968)"
|
|
2018,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,963,31.2,29.3,33,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,SEX1,CAT2,_RFPSA22,RESP046,"(42.46940091300047, -93.81649055599968)"
|
|
2018,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1795,68.8,67,70.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,SEX1,CAT2,_RFPSA22,RESP054,"(42.46940091300047, -93.81649055599968)"
|
|
2018,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,19,SEX2,CAT2,_RFPSA22,RESP046,"(42.46940091300047, -93.81649055599968)"
|
|
2018,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,19,SEX2,CAT2,_RFPSA22,RESP054,"(42.46940091300047, -93.81649055599968)"
|
|
2018,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,54,9.1,6.4,11.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,AGE06,CAT3,_RFPSA22,RESP046,"(38.34774030000045, -98.20078122699965)"
|
|
2018,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,508,90.9,88.1,93.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,AGE06,CAT3,_RFPSA22,RESP054,"(38.34774030000045, -98.20078122699965)"
|
|
2018,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,223,27,23.5,30.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,AGE07,CAT3,_RFPSA22,RESP046,"(38.34774030000045, -98.20078122699965)"
|
|
2018,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,522,73,69.5,76.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,AGE07,CAT3,_RFPSA22,RESP054,"(38.34774030000045, -98.20078122699965)"
|
|
2018,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,217,38.7,34,43.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,AGE08,CAT3,_RFPSA22,RESP046,"(38.34774030000045, -98.20078122699965)"
|
|
2018,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,281,61.3,56.5,66,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,AGE08,CAT3,_RFPSA22,RESP054,"(38.34774030000045, -98.20078122699965)"
|
|
2018,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,813,54.7,51.7,57.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,AGE09,CAT3,_RFPSA22,RESP046,"(38.34774030000045, -98.20078122699965)"
|
|
2018,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,629,45.3,42.3,48.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,AGE09,CAT3,_RFPSA22,RESP054,"(38.34774030000045, -98.20078122699965)"
|
|
2018,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1307,32.9,31.1,34.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,BO1,CAT1,_RFPSA22,RESP046,"(38.34774030000045, -98.20078122699965)"
|
|
2018,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1940,67.1,65.3,68.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,BO1,CAT1,_RFPSA22,RESP054,"(38.34774030000045, -98.20078122699965)"
|
|
2018,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,50,25.1,18.1,32,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,EDUCA1,CAT5,_RFPSA22,RESP046,"(38.34774030000045, -98.20078122699965)"
|
|
2018,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,125,74.9,68,81.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,EDUCA1,CAT5,_RFPSA22,RESP054,"(38.34774030000045, -98.20078122699965)"
|
|
2018,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,262,26.6,23.3,29.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,EDUCA2,CAT5,_RFPSA22,RESP046,"(38.34774030000045, -98.20078122699965)"
|
|
2018,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,573,73.4,70.2,76.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,EDUCA2,CAT5,_RFPSA22,RESP054,"(38.34774030000045, -98.20078122699965)"
|
|
2018,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,325,30.9,27.6,34.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,EDUCA3,CAT5,_RFPSA22,RESP046,"(38.34774030000045, -98.20078122699965)"
|
|
2018,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,535,69.1,65.7,72.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,EDUCA3,CAT5,_RFPSA22,RESP054,"(38.34774030000045, -98.20078122699965)"
|
|
2018,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,669,42.6,39.6,45.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,EDUCA4,CAT5,_RFPSA22,RESP046,"(38.34774030000045, -98.20078122699965)"
|
|
2018,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,706,57.4,54.5,60.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,EDUCA4,CAT5,_RFPSA22,RESP054,"(38.34774030000045, -98.20078122699965)"
|
|
2018,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,32,16.6,10.1,23.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,INCOME1,CAT6,_RFPSA22,RESP046,"(38.34774030000045, -98.20078122699965)"
|
|
2018,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,126,83.4,76.9,89.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,INCOME1,CAT6,_RFPSA22,RESP054,"(38.34774030000045, -98.20078122699965)"
|
|
2018,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,96,21.8,16.9,26.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,INCOME2,CAT6,_RFPSA22,RESP046,"(38.34774030000045, -98.20078122699965)"
|
|
2018,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,245,78.2,73.4,83.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,INCOME2,CAT6,_RFPSA22,RESP054,"(38.34774030000045, -98.20078122699965)"
|
|
2018,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,101,31.8,25.5,38.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,INCOME3,CAT6,_RFPSA22,RESP046,"(38.34774030000045, -98.20078122699965)"
|
|
2018,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,157,68.2,61.9,74.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,INCOME3,CAT6,_RFPSA22,RESP054,"(38.34774030000045, -98.20078122699965)"
|
|
2018,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,200,39.2,34.1,44.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,INCOME4,CAT6,_RFPSA22,RESP046,"(38.34774030000045, -98.20078122699965)"
|
|
2018,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,257,60.8,55.7,65.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,INCOME4,CAT6,_RFPSA22,RESP054,"(38.34774030000045, -98.20078122699965)"
|
|
2018,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,761,36,33.5,38.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,INCOME5,CAT6,_RFPSA22,RESP046,"(38.34774030000045, -98.20078122699965)"
|
|
2018,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,958,64,61.4,66.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,INCOME5,CAT6,_RFPSA22,RESP054,"(38.34774030000045, -98.20078122699965)"
|
|
2018,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1215,35.4,33.5,37.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,RACE01,CAT4,_RFPSA22,RESP046,"(38.34774030000045, -98.20078122699965)"
|
|
2018,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1708,64.6,62.7,66.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,RACE01,CAT4,_RFPSA22,RESP054,"(38.34774030000045, -98.20078122699965)"
|
|
2018,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,35,21.2,13.2,29.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,RACE02,CAT4,_RFPSA22,RESP046,"(38.34774030000045, -98.20078122699965)"
|
|
2018,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,88,78.8,70.8,86.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,RACE02,CAT4,_RFPSA22,RESP054,"(38.34774030000045, -98.20078122699965)"
|
|
2018,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,17,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,20,RACE03,CAT4,_RFPSA22,RESP046,"(38.34774030000045, -98.20078122699965)"
|
|
2018,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,26,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,20,RACE03,CAT4,_RFPSA22,RESP054,"(38.34774030000045, -98.20078122699965)"
|
|
2018,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,20,RACE04,CAT4,_RFPSA22,RESP046,"(38.34774030000045, -98.20078122699965)"
|
|
2018,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,22,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,20,RACE04,CAT4,_RFPSA22,RESP054,"(38.34774030000045, -98.20078122699965)"
|
|
2018,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,20,RACE05,CAT4,_RFPSA22,RESP046,"(38.34774030000045, -98.20078122699965)"
|
|
2018,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,20,RACE05,CAT4,_RFPSA22,RESP054,"(38.34774030000045, -98.20078122699965)"
|
|
2018,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,20,RACE06,CAT4,_RFPSA22,RESP046,"(38.34774030000045, -98.20078122699965)"
|
|
2018,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,20,RACE06,CAT4,_RFPSA22,RESP054,"(38.34774030000045, -98.20078122699965)"
|
|
2018,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,17,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,20,RACE07,CAT4,_RFPSA22,RESP046,"(38.34774030000045, -98.20078122699965)"
|
|
2018,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,21,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,20,RACE07,CAT4,_RFPSA22,RESP054,"(38.34774030000045, -98.20078122699965)"
|
|
2018,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,19,18.2,9.6,26.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,RACE08,CAT4,_RFPSA22,RESP046,"(38.34774030000045, -98.20078122699965)"
|
|
2018,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,72,81.8,73.3,90.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,RACE08,CAT4,_RFPSA22,RESP054,"(38.34774030000045, -98.20078122699965)"
|
|
2018,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1307,32.9,31.1,34.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,SEX1,CAT2,_RFPSA22,RESP046,"(38.34774030000045, -98.20078122699965)"
|
|
2018,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1940,67.1,65.3,68.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,SEX1,CAT2,_RFPSA22,RESP054,"(38.34774030000045, -98.20078122699965)"
|
|
2018,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,20,SEX2,CAT2,_RFPSA22,RESP046,"(38.34774030000045, -98.20078122699965)"
|
|
2018,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,20,SEX2,CAT2,_RFPSA22,RESP054,"(38.34774030000045, -98.20078122699965)"
|
|
2018,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,33,6.4,3.3,9.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,AGE06,CAT3,_RFPSA22,RESP046,"(37.645970271000465, -84.77497104799966)"
|
|
2018,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,402,93.6,90.5,96.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,AGE06,CAT3,_RFPSA22,RESP054,"(37.645970271000465, -84.77497104799966)"
|
|
2018,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,189,31.3,24.7,38,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,AGE07,CAT3,_RFPSA22,RESP046,"(37.645970271000465, -84.77497104799966)"
|
|
2018,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,432,68.7,62,75.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,AGE07,CAT3,_RFPSA22,RESP054,"(37.645970271000465, -84.77497104799966)"
|
|
2018,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,181,49.2,41.3,57,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,AGE08,CAT3,_RFPSA22,RESP046,"(37.645970271000465, -84.77497104799966)"
|
|
2018,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,218,50.8,43,58.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,AGE08,CAT3,_RFPSA22,RESP054,"(37.645970271000465, -84.77497104799966)"
|
|
2018,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,514,53.2,47.8,58.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,AGE09,CAT3,_RFPSA22,RESP046,"(37.645970271000465, -84.77497104799966)"
|
|
2018,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,405,46.8,41.3,52.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,AGE09,CAT3,_RFPSA22,RESP054,"(37.645970271000465, -84.77497104799966)"
|
|
2018,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,917,35,31.8,38.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,BO1,CAT1,_RFPSA22,RESP046,"(37.645970271000465, -84.77497104799966)"
|
|
2018,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1457,65,61.9,68.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,BO1,CAT1,_RFPSA22,RESP054,"(37.645970271000465, -84.77497104799966)"
|
|
2018,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,64,24.5,16.2,32.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,EDUCA1,CAT5,_RFPSA22,RESP046,"(37.645970271000465, -84.77497104799966)"
|
|
2018,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,185,75.5,67.1,83.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,EDUCA1,CAT5,_RFPSA22,RESP054,"(37.645970271000465, -84.77497104799966)"
|
|
2018,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,263,32.6,27.2,37.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,EDUCA2,CAT5,_RFPSA22,RESP046,"(37.645970271000465, -84.77497104799966)"
|
|
2018,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,513,67.4,62.1,72.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,EDUCA2,CAT5,_RFPSA22,RESP054,"(37.645970271000465, -84.77497104799966)"
|
|
2018,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,236,40,33.4,46.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,EDUCA3,CAT5,_RFPSA22,RESP046,"(37.645970271000465, -84.77497104799966)"
|
|
2018,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,352,60,53.4,66.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,EDUCA3,CAT5,_RFPSA22,RESP054,"(37.645970271000465, -84.77497104799966)"
|
|
2018,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,353,40.9,35.5,46.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,EDUCA4,CAT5,_RFPSA22,RESP046,"(37.645970271000465, -84.77497104799966)"
|
|
2018,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,405,59.1,53.6,64.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,EDUCA4,CAT5,_RFPSA22,RESP054,"(37.645970271000465, -84.77497104799966)"
|
|
2018,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,62,29.9,19.2,40.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,INCOME1,CAT6,_RFPSA22,RESP046,"(37.645970271000465, -84.77497104799966)"
|
|
2018,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,180,70.1,59.4,80.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,INCOME1,CAT6,_RFPSA22,RESP054,"(37.645970271000465, -84.77497104799966)"
|
|
2018,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,84,24,16.8,31.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,INCOME2,CAT6,_RFPSA22,RESP046,"(37.645970271000465, -84.77497104799966)"
|
|
2018,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,197,76,68.8,83.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,INCOME2,CAT6,_RFPSA22,RESP054,"(37.645970271000465, -84.77497104799966)"
|
|
2018,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,91,40.6,29.1,52.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,INCOME3,CAT6,_RFPSA22,RESP046,"(37.645970271000465, -84.77497104799966)"
|
|
2018,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,121,59.4,47.8,70.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,INCOME3,CAT6,_RFPSA22,RESP054,"(37.645970271000465, -84.77497104799966)"
|
|
2018,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,121,33.9,25.6,42.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,INCOME4,CAT6,_RFPSA22,RESP046,"(37.645970271000465, -84.77497104799966)"
|
|
2018,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,175,66.1,57.8,74.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,INCOME4,CAT6,_RFPSA22,RESP054,"(37.645970271000465, -84.77497104799966)"
|
|
2018,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,432,36.5,31.7,41.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,INCOME5,CAT6,_RFPSA22,RESP046,"(37.645970271000465, -84.77497104799966)"
|
|
2018,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,578,63.5,58.7,68.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,INCOME5,CAT6,_RFPSA22,RESP054,"(37.645970271000465, -84.77497104799966)"
|
|
2018,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,802,35.4,32.1,38.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,RACE01,CAT4,_RFPSA22,RESP046,"(37.645970271000465, -84.77497104799966)"
|
|
2018,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1225,64.6,61.3,67.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,RACE01,CAT4,_RFPSA22,RESP054,"(37.645970271000465, -84.77497104799966)"
|
|
2018,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,80,33.9,19.6,48.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,RACE02,CAT4,_RFPSA22,RESP046,"(37.645970271000465, -84.77497104799966)"
|
|
2018,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,136,66.1,51.7,80.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,RACE02,CAT4,_RFPSA22,RESP054,"(37.645970271000465, -84.77497104799966)"
|
|
2018,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,9,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,21,RACE03,CAT4,_RFPSA22,RESP046,"(37.645970271000465, -84.77497104799966)"
|
|
2018,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,26,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,21,RACE03,CAT4,_RFPSA22,RESP054,"(37.645970271000465, -84.77497104799966)"
|
|
2018,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,21,RACE04,CAT4,_RFPSA22,RESP046,"(37.645970271000465, -84.77497104799966)"
|
|
2018,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,21,RACE04,CAT4,_RFPSA22,RESP054,"(37.645970271000465, -84.77497104799966)"
|
|
2018,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,21,RACE05,CAT4,_RFPSA22,RESP046,"(37.645970271000465, -84.77497104799966)"
|
|
2018,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,21,RACE05,CAT4,_RFPSA22,RESP054,"(37.645970271000465, -84.77497104799966)"
|
|
2018,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,21,RACE06,CAT4,_RFPSA22,RESP046,"(37.645970271000465, -84.77497104799966)"
|
|
2018,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,9,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,21,RACE06,CAT4,_RFPSA22,RESP054,"(37.645970271000465, -84.77497104799966)"
|
|
2018,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,15,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,21,RACE07,CAT4,_RFPSA22,RESP046,"(37.645970271000465, -84.77497104799966)"
|
|
2018,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,32,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,21,RACE07,CAT4,_RFPSA22,RESP054,"(37.645970271000465, -84.77497104799966)"
|
|
2018,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,21,RACE08,CAT4,_RFPSA22,RESP046,"(37.645970271000465, -84.77497104799966)"
|
|
2018,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,21,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,21,RACE08,CAT4,_RFPSA22,RESP054,"(37.645970271000465, -84.77497104799966)"
|
|
2018,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,917,35,31.8,38.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,SEX1,CAT2,_RFPSA22,RESP046,"(37.645970271000465, -84.77497104799966)"
|
|
2018,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1457,65,61.9,68.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,SEX1,CAT2,_RFPSA22,RESP054,"(37.645970271000465, -84.77497104799966)"
|
|
2018,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,21,SEX2,CAT2,_RFPSA22,RESP046,"(37.645970271000465, -84.77497104799966)"
|
|
2018,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,21,SEX2,CAT2,_RFPSA22,RESP054,"(37.645970271000465, -84.77497104799966)"
|
|
2018,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,208,43.3,37.8,48.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,AGE09,CAT3,_RFPSA22,RESP054,"(31.31266064400046, -92.44568007099969)"
|
|
2018,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,560,38.1,34.9,41.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,BO1,CAT1,_RFPSA22,RESP046,"(31.31266064400046, -92.44568007099969)"
|
|
2018,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,34,11.8,7.1,16.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,AGE06,CAT3,_RFPSA22,RESP046,"(31.31266064400046, -92.44568007099969)"
|
|
2018,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,234,88.2,83.5,92.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,AGE06,CAT3,_RFPSA22,RESP054,"(31.31266064400046, -92.44568007099969)"
|
|
2018,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,140,35.3,29.2,41.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,AGE07,CAT3,_RFPSA22,RESP046,"(31.31266064400046, -92.44568007099969)"
|
|
2018,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,249,64.7,58.5,70.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,AGE07,CAT3,_RFPSA22,RESP054,"(31.31266064400046, -92.44568007099969)"
|
|
2018,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,115,47.5,39.6,55.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,AGE08,CAT3,_RFPSA22,RESP046,"(31.31266064400046, -92.44568007099969)"
|
|
2018,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,118,52.5,44.6,60.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,AGE08,CAT3,_RFPSA22,RESP054,"(31.31266064400046, -92.44568007099969)"
|
|
2018,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,271,56.7,51.3,62.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,AGE09,CAT3,_RFPSA22,RESP046,"(31.31266064400046, -92.44568007099969)"
|
|
2018,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,809,61.9,58.8,65.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,BO1,CAT1,_RFPSA22,RESP054,"(31.31266064400046, -92.44568007099969)"
|
|
2018,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,39,25,16.8,33.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,EDUCA1,CAT5,_RFPSA22,RESP046,"(31.31266064400046, -92.44568007099969)"
|
|
2018,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,109,75,66.7,83.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,EDUCA1,CAT5,_RFPSA22,RESP054,"(31.31266064400046, -92.44568007099969)"
|
|
2018,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,166,36.3,31,41.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,EDUCA2,CAT5,_RFPSA22,RESP046,"(31.31266064400046, -92.44568007099969)"
|
|
2018,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,300,63.7,58.4,69,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,EDUCA2,CAT5,_RFPSA22,RESP054,"(31.31266064400046, -92.44568007099969)"
|
|
2018,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,125,39.4,33,45.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,EDUCA3,CAT5,_RFPSA22,RESP046,"(31.31266064400046, -92.44568007099969)"
|
|
2018,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,182,60.6,54.2,67,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,EDUCA3,CAT5,_RFPSA22,RESP054,"(31.31266064400046, -92.44568007099969)"
|
|
2018,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,229,51.2,45.8,56.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,EDUCA4,CAT5,_RFPSA22,RESP046,"(31.31266064400046, -92.44568007099969)"
|
|
2018,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,217,48.8,43.3,54.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,EDUCA4,CAT5,_RFPSA22,RESP054,"(31.31266064400046, -92.44568007099969)"
|
|
2018,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,36,23,14.2,31.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,INCOME1,CAT6,_RFPSA22,RESP046,"(31.31266064400046, -92.44568007099969)"
|
|
2018,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,102,77,68.2,85.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,INCOME1,CAT6,_RFPSA22,RESP054,"(31.31266064400046, -92.44568007099969)"
|
|
2018,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,45,21.4,14.6,28.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,INCOME2,CAT6,_RFPSA22,RESP046,"(31.31266064400046, -92.44568007099969)"
|
|
2018,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,132,78.6,71.8,85.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,INCOME2,CAT6,_RFPSA22,RESP054,"(31.31266064400046, -92.44568007099969)"
|
|
2018,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,44,34.5,23.6,45.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,INCOME3,CAT6,_RFPSA22,RESP046,"(31.31266064400046, -92.44568007099969)"
|
|
2018,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,71,65.5,54.6,76.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,INCOME3,CAT6,_RFPSA22,RESP054,"(31.31266064400046, -92.44568007099969)"
|
|
2018,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,59,45.3,34.8,55.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,INCOME4,CAT6,_RFPSA22,RESP046,"(31.31266064400046, -92.44568007099969)"
|
|
2018,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,73,54.7,44.3,65.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,INCOME4,CAT6,_RFPSA22,RESP054,"(31.31266064400046, -92.44568007099969)"
|
|
2018,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,323,46.4,41.7,51,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,INCOME5,CAT6,_RFPSA22,RESP046,"(31.31266064400046, -92.44568007099969)"
|
|
2018,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,351,53.6,49,58.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,INCOME5,CAT6,_RFPSA22,RESP054,"(31.31266064400046, -92.44568007099969)"
|
|
2018,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,435,41.3,37.5,45.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,RACE01,CAT4,_RFPSA22,RESP046,"(31.31266064400046, -92.44568007099969)"
|
|
2018,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,549,58.7,54.8,62.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,RACE01,CAT4,_RFPSA22,RESP054,"(31.31266064400046, -92.44568007099969)"
|
|
2018,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,99,34,27.4,40.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,RACE02,CAT4,_RFPSA22,RESP046,"(31.31266064400046, -92.44568007099969)"
|
|
2018,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,192,66,59.5,72.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,RACE02,CAT4,_RFPSA22,RESP054,"(31.31266064400046, -92.44568007099969)"
|
|
2018,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,22,RACE03,CAT4,_RFPSA22,RESP046,"(31.31266064400046, -92.44568007099969)"
|
|
2018,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,12,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,22,RACE03,CAT4,_RFPSA22,RESP054,"(31.31266064400046, -92.44568007099969)"
|
|
2018,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,22,RACE04,CAT4,_RFPSA22,RESP046,"(31.31266064400046, -92.44568007099969)"
|
|
2018,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,22,RACE04,CAT4,_RFPSA22,RESP054,"(31.31266064400046, -92.44568007099969)"
|
|
2018,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,22,RACE05,CAT4,_RFPSA22,RESP046,"(31.31266064400046, -92.44568007099969)"
|
|
2018,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,22,RACE05,CAT4,_RFPSA22,RESP054,"(31.31266064400046, -92.44568007099969)"
|
|
2018,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,22,RACE06,CAT4,_RFPSA22,RESP046,"(31.31266064400046, -92.44568007099969)"
|
|
2018,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,12,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,22,RACE06,CAT4,_RFPSA22,RESP054,"(31.31266064400046, -92.44568007099969)"
|
|
2018,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,22,RACE07,CAT4,_RFPSA22,RESP046,"(31.31266064400046, -92.44568007099969)"
|
|
2018,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,14,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,22,RACE07,CAT4,_RFPSA22,RESP054,"(31.31266064400046, -92.44568007099969)"
|
|
2018,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,9,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,22,RACE08,CAT4,_RFPSA22,RESP046,"(31.31266064400046, -92.44568007099969)"
|
|
2018,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,25,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,22,RACE08,CAT4,_RFPSA22,RESP054,"(31.31266064400046, -92.44568007099969)"
|
|
2018,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,560,38.1,34.9,41.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,SEX1,CAT2,_RFPSA22,RESP046,"(31.31266064400046, -92.44568007099969)"
|
|
2018,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,809,61.9,58.8,65.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,SEX1,CAT2,_RFPSA22,RESP054,"(31.31266064400046, -92.44568007099969)"
|
|
2018,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,22,SEX2,CAT2,_RFPSA22,RESP046,"(31.31266064400046, -92.44568007099969)"
|
|
2018,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,22,SEX2,CAT2,_RFPSA22,RESP054,"(31.31266064400046, -92.44568007099969)"
|
|
2018,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,21,3.9,1.7,6.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,AGE06,CAT3,_RFPSA22,RESP046,"(45.254228894000505, -68.98503133599962)"
|
|
2018,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,390,96.1,93.9,98.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,AGE06,CAT3,_RFPSA22,RESP054,"(45.254228894000505, -68.98503133599962)"
|
|
2018,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,145,20.8,16.6,25,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,AGE07,CAT3,_RFPSA22,RESP046,"(45.254228894000505, -68.98503133599962)"
|
|
2018,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,564,79.2,75,83.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,AGE07,CAT3,_RFPSA22,RESP054,"(45.254228894000505, -68.98503133599962)"
|
|
2018,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,163,39,32.8,45.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,AGE08,CAT3,_RFPSA22,RESP046,"(45.254228894000505, -68.98503133599962)"
|
|
2018,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,296,61,54.9,67.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,AGE08,CAT3,_RFPSA22,RESP054,"(45.254228894000505, -68.98503133599962)"
|
|
2018,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,713,42.2,39,45.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,AGE09,CAT3,_RFPSA22,RESP046,"(45.254228894000505, -68.98503133599962)"
|
|
2018,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,947,57.8,54.7,61,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,AGE09,CAT3,_RFPSA22,RESP054,"(45.254228894000505, -68.98503133599962)"
|
|
2018,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1042,27.3,25.2,29.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,BO1,CAT1,_RFPSA22,RESP046,"(45.254228894000505, -68.98503133599962)"
|
|
2018,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,2197,72.7,70.6,74.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,BO1,CAT1,_RFPSA22,RESP054,"(45.254228894000505, -68.98503133599962)"
|
|
2018,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,35,19.2,11.6,26.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,EDUCA1,CAT5,_RFPSA22,RESP046,"(45.254228894000505, -68.98503133599962)"
|
|
2018,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,147,80.8,73.1,88.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,EDUCA1,CAT5,_RFPSA22,RESP054,"(45.254228894000505, -68.98503133599962)"
|
|
2018,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,226,21,17.5,24.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,EDUCA2,CAT5,_RFPSA22,RESP046,"(45.254228894000505, -68.98503133599962)"
|
|
2018,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,709,79,75.5,82.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,EDUCA2,CAT5,_RFPSA22,RESP054,"(45.254228894000505, -68.98503133599962)"
|
|
2018,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,250,30.3,25.9,34.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,EDUCA3,CAT5,_RFPSA22,RESP046,"(45.254228894000505, -68.98503133599962)"
|
|
2018,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,520,69.7,65.2,74.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,EDUCA3,CAT5,_RFPSA22,RESP054,"(45.254228894000505, -68.98503133599962)"
|
|
2018,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,531,34.2,30.7,37.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,EDUCA4,CAT5,_RFPSA22,RESP046,"(45.254228894000505, -68.98503133599962)"
|
|
2018,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,816,65.8,62.4,69.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,EDUCA4,CAT5,_RFPSA22,RESP054,"(45.254228894000505, -68.98503133599962)"
|
|
2018,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,59,21.7,14.6,28.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,INCOME1,CAT6,_RFPSA22,RESP046,"(45.254228894000505, -68.98503133599962)"
|
|
2018,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,192,78.3,71.2,85.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,INCOME1,CAT6,_RFPSA22,RESP054,"(45.254228894000505, -68.98503133599962)"
|
|
2018,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,80,20.3,14.2,26.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,INCOME2,CAT6,_RFPSA22,RESP046,"(45.254228894000505, -68.98503133599962)"
|
|
2018,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,297,79.7,73.5,85.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,INCOME2,CAT6,_RFPSA22,RESP054,"(45.254228894000505, -68.98503133599962)"
|
|
2018,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,71,22.2,15.6,28.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,INCOME3,CAT6,_RFPSA22,RESP046,"(45.254228894000505, -68.98503133599962)"
|
|
2018,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,190,77.8,71.2,84.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,INCOME3,CAT6,_RFPSA22,RESP054,"(45.254228894000505, -68.98503133599962)"
|
|
2018,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,157,28.2,22.8,33.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,INCOME4,CAT6,_RFPSA22,RESP046,"(45.254228894000505, -68.98503133599962)"
|
|
2018,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,314,71.8,66.3,77.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,INCOME4,CAT6,_RFPSA22,RESP054,"(45.254228894000505, -68.98503133599962)"
|
|
2018,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,544,29.9,26.7,33,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,INCOME5,CAT6,_RFPSA22,RESP046,"(45.254228894000505, -68.98503133599962)"
|
|
2018,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,908,70.1,67,73.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,INCOME5,CAT6,_RFPSA22,RESP054,"(45.254228894000505, -68.98503133599962)"
|
|
2018,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,997,27.8,25.6,30,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,RACE01,CAT4,_RFPSA22,RESP046,"(45.254228894000505, -68.98503133599962)"
|
|
2018,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,2070,72.2,70,74.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,RACE01,CAT4,_RFPSA22,RESP054,"(45.254228894000505, -68.98503133599962)"
|
|
2018,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,23,RACE02,CAT4,_RFPSA22,RESP046,"(45.254228894000505, -68.98503133599962)"
|
|
2018,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,16,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,23,RACE02,CAT4,_RFPSA22,RESP054,"(45.254228894000505, -68.98503133599962)"
|
|
2018,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,11,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,23,RACE03,CAT4,_RFPSA22,RESP046,"(45.254228894000505, -68.98503133599962)"
|
|
2018,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,24,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,23,RACE03,CAT4,_RFPSA22,RESP054,"(45.254228894000505, -68.98503133599962)"
|
|
2018,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,23,RACE04,CAT4,_RFPSA22,RESP046,"(45.254228894000505, -68.98503133599962)"
|
|
2018,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,23,RACE04,CAT4,_RFPSA22,RESP054,"(45.254228894000505, -68.98503133599962)"
|
|
2018,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,23,RACE05,CAT4,_RFPSA22,RESP046,"(45.254228894000505, -68.98503133599962)"
|
|
2018,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,23,RACE05,CAT4,_RFPSA22,RESP054,"(45.254228894000505, -68.98503133599962)"
|
|
2018,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,23,RACE06,CAT4,_RFPSA22,RESP046,"(45.254228894000505, -68.98503133599962)"
|
|
2018,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,23,RACE06,CAT4,_RFPSA22,RESP054,"(45.254228894000505, -68.98503133599962)"
|
|
2018,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,9,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,23,RACE07,CAT4,_RFPSA22,RESP046,"(45.254228894000505, -68.98503133599962)"
|
|
2018,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,40,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,23,RACE07,CAT4,_RFPSA22,RESP054,"(45.254228894000505, -68.98503133599962)"
|
|
2018,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,15,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,23,RACE08,CAT4,_RFPSA22,RESP046,"(45.254228894000505, -68.98503133599962)"
|
|
2018,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,29,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,23,RACE08,CAT4,_RFPSA22,RESP054,"(45.254228894000505, -68.98503133599962)"
|
|
2018,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1042,27.3,25.2,29.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,SEX1,CAT2,_RFPSA22,RESP046,"(45.254228894000505, -68.98503133599962)"
|
|
2018,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,2197,72.7,70.6,74.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,SEX1,CAT2,_RFPSA22,RESP054,"(45.254228894000505, -68.98503133599962)"
|
|
2018,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,23,SEX2,CAT2,_RFPSA22,RESP046,"(45.254228894000505, -68.98503133599962)"
|
|
2018,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,23,SEX2,CAT2,_RFPSA22,RESP054,"(45.254228894000505, -68.98503133599962)"
|
|
2018,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,1139,49,46.1,52,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,AGE09,CAT3,_RFPSA22,RESP054,"(39.29058096400047, -76.60926011099963)"
|
|
2018,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,65,9.2,6.3,12,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,AGE06,CAT3,_RFPSA22,RESP046,"(39.29058096400047, -76.60926011099963)"
|
|
2018,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,651,90.8,88,93.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,AGE06,CAT3,_RFPSA22,RESP054,"(39.29058096400047, -76.60926011099963)"
|
|
2018,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,389,30.8,27.4,34.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,AGE07,CAT3,_RFPSA22,RESP046,"(39.29058096400047, -76.60926011099963)"
|
|
2018,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,868,69.2,65.8,72.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,AGE07,CAT3,_RFPSA22,RESP054,"(39.29058096400047, -76.60926011099963)"
|
|
2018,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,351,46.1,40.9,51.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,AGE08,CAT3,_RFPSA22,RESP046,"(39.29058096400047, -76.60926011099963)"
|
|
2018,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,377,53.9,48.8,59.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,AGE08,CAT3,_RFPSA22,RESP054,"(39.29058096400047, -76.60926011099963)"
|
|
2018,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,1367,51,48,53.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,AGE09,CAT3,_RFPSA22,RESP046,"(39.29058096400047, -76.60926011099963)"
|
|
2018,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,2172,33.5,31.7,35.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,BO1,CAT1,_RFPSA22,RESP046,"(39.29058096400047, -76.60926011099963)"
|
|
2018,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,3035,66.5,64.7,68.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,BO1,CAT1,_RFPSA22,RESP054,"(39.29058096400047, -76.60926011099963)"
|
|
2018,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,64,19.5,13.3,25.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,EDUCA1,CAT5,_RFPSA22,RESP046,"(39.29058096400047, -76.60926011099963)"
|
|
2018,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,213,80.5,74.3,86.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,EDUCA1,CAT5,_RFPSA22,RESP054,"(39.29058096400047, -76.60926011099963)"
|
|
2018,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,424,28.6,25.2,31.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,EDUCA2,CAT5,_RFPSA22,RESP046,"(39.29058096400047, -76.60926011099963)"
|
|
2018,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,815,71.4,68.1,74.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,EDUCA2,CAT5,_RFPSA22,RESP054,"(39.29058096400047, -76.60926011099963)"
|
|
2018,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,442,36.5,32.4,40.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,EDUCA3,CAT5,_RFPSA22,RESP046,"(39.29058096400047, -76.60926011099963)"
|
|
2018,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,565,63.5,59.3,67.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,EDUCA3,CAT5,_RFPSA22,RESP054,"(39.29058096400047, -76.60926011099963)"
|
|
2018,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,1240,38.2,35.8,40.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,EDUCA4,CAT5,_RFPSA22,RESP046,"(39.29058096400047, -76.60926011099963)"
|
|
2018,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,1440,61.8,59.3,64.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,EDUCA4,CAT5,_RFPSA22,RESP054,"(39.29058096400047, -76.60926011099963)"
|
|
2018,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,51,14.4,8.4,20.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,INCOME1,CAT6,_RFPSA22,RESP046,"(39.29058096400047, -76.60926011099963)"
|
|
2018,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,174,85.6,79.5,91.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,INCOME1,CAT6,_RFPSA22,RESP054,"(39.29058096400047, -76.60926011099963)"
|
|
2018,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,116,26,19.8,32.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,INCOME2,CAT6,_RFPSA22,RESP046,"(39.29058096400047, -76.60926011099963)"
|
|
2018,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,262,74,67.8,80.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,INCOME2,CAT6,_RFPSA22,RESP054,"(39.29058096400047, -76.60926011099963)"
|
|
2018,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,107,29.9,22.1,37.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,INCOME3,CAT6,_RFPSA22,RESP046,"(39.29058096400047, -76.60926011099963)"
|
|
2018,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,177,70.1,62.3,77.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,INCOME3,CAT6,_RFPSA22,RESP054,"(39.29058096400047, -76.60926011099963)"
|
|
2018,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,190,32.2,25.7,38.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,INCOME4,CAT6,_RFPSA22,RESP046,"(39.29058096400047, -76.60926011099963)"
|
|
2018,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,264,67.8,61.2,74.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,INCOME4,CAT6,_RFPSA22,RESP054,"(39.29058096400047, -76.60926011099963)"
|
|
2018,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,1448,35.6,33.3,37.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,INCOME5,CAT6,_RFPSA22,RESP046,"(39.29058096400047, -76.60926011099963)"
|
|
2018,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,1785,64.4,62.2,66.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,INCOME5,CAT6,_RFPSA22,RESP054,"(39.29058096400047, -76.60926011099963)"
|
|
2018,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1723,35.8,33.9,37.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,RACE01,CAT4,_RFPSA22,RESP046,"(39.29058096400047, -76.60926011099963)"
|
|
2018,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,2222,64.2,62.2,66.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,RACE01,CAT4,_RFPSA22,RESP054,"(39.29058096400047, -76.60926011099963)"
|
|
2018,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,327,34.1,30,38.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,RACE02,CAT4,_RFPSA22,RESP046,"(39.29058096400047, -76.60926011099963)"
|
|
2018,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,506,65.9,61.8,70,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,RACE02,CAT4,_RFPSA22,RESP054,"(39.29058096400047, -76.60926011099963)"
|
|
2018,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,25,56.9,37.9,75.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,RACE03,CAT4,_RFPSA22,RESP046,"(39.29058096400047, -76.60926011099963)"
|
|
2018,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,25,43.1,24.2,62.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,RACE03,CAT4,_RFPSA22,RESP054,"(39.29058096400047, -76.60926011099963)"
|
|
2018,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,34,21.2,12.6,29.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,RACE04,CAT4,_RFPSA22,RESP046,"(39.29058096400047, -76.60926011099963)"
|
|
2018,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,82,78.8,70.2,87.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,RACE04,CAT4,_RFPSA22,RESP054,"(39.29058096400047, -76.60926011099963)"
|
|
2018,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,24,RACE05,CAT4,_RFPSA22,RESP046,"(39.29058096400047, -76.60926011099963)"
|
|
2018,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,24,RACE05,CAT4,_RFPSA22,RESP054,"(39.29058096400047, -76.60926011099963)"
|
|
2018,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,20,42.2,24.4,60.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,RACE06,CAT4,_RFPSA22,RESP046,"(39.29058096400047, -76.60926011099963)"
|
|
2018,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,36,57.8,39.9,75.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,RACE06,CAT4,_RFPSA22,RESP054,"(39.29058096400047, -76.60926011099963)"
|
|
2018,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,18,18.2,8.7,27.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,RACE07,CAT4,_RFPSA22,RESP046,"(39.29058096400047, -76.60926011099963)"
|
|
2018,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,55,81.8,72.3,91.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,RACE07,CAT4,_RFPSA22,RESP054,"(39.29058096400047, -76.60926011099963)"
|
|
2018,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,24,20.5,11.6,29.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,RACE08,CAT4,_RFPSA22,RESP046,"(39.29058096400047, -76.60926011099963)"
|
|
2018,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,103,79.5,70.7,88.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,RACE08,CAT4,_RFPSA22,RESP054,"(39.29058096400047, -76.60926011099963)"
|
|
2018,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,2172,33.5,31.7,35.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,SEX1,CAT2,_RFPSA22,RESP046,"(39.29058096400047, -76.60926011099963)"
|
|
2018,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,3035,66.5,64.7,68.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,SEX1,CAT2,_RFPSA22,RESP054,"(39.29058096400047, -76.60926011099963)"
|
|
2018,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,24,SEX2,CAT2,_RFPSA22,RESP046,"(39.29058096400047, -76.60926011099963)"
|
|
2018,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,24,SEX2,CAT2,_RFPSA22,RESP054,"(39.29058096400047, -76.60926011099963)"
|
|
2018,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,301,94.4,91.3,97.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,AGE06,CAT3,_RFPSA22,RESP054,"(42.27687047000046, -72.08269067499964)"
|
|
2018,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,18,5.6,2.6,8.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,AGE06,CAT3,_RFPSA22,RESP046,"(42.27687047000046, -72.08269067499964)"
|
|
2018,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,142,30.6,25.4,35.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,AGE07,CAT3,_RFPSA22,RESP046,"(42.27687047000046, -72.08269067499964)"
|
|
2018,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,345,69.4,64.3,74.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,AGE07,CAT3,_RFPSA22,RESP054,"(42.27687047000046, -72.08269067499964)"
|
|
2018,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,123,44.7,37.2,52.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,AGE08,CAT3,_RFPSA22,RESP046,"(42.27687047000046, -72.08269067499964)"
|
|
2018,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,138,55.3,47.7,62.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,AGE08,CAT3,_RFPSA22,RESP054,"(42.27687047000046, -72.08269067499964)"
|
|
2018,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,354,44.5,40,49,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,AGE09,CAT3,_RFPSA22,RESP046,"(42.27687047000046, -72.08269067499964)"
|
|
2018,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,411,55.5,51,60,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,AGE09,CAT3,_RFPSA22,RESP054,"(42.27687047000046, -72.08269067499964)"
|
|
2018,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,637,30.7,28.1,33.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,BO1,CAT1,_RFPSA22,RESP046,"(42.27687047000046, -72.08269067499964)"
|
|
2018,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1195,69.3,66.7,71.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,BO1,CAT1,_RFPSA22,RESP054,"(42.27687047000046, -72.08269067499964)"
|
|
2018,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,14,12,5,19.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,EDUCA1,CAT5,_RFPSA22,RESP046,"(42.27687047000046, -72.08269067499964)"
|
|
2018,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,66,88,80.9,95,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,EDUCA1,CAT5,_RFPSA22,RESP054,"(42.27687047000046, -72.08269067499964)"
|
|
2018,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,85,24,18.5,29.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,EDUCA2,CAT5,_RFPSA22,RESP046,"(42.27687047000046, -72.08269067499964)"
|
|
2018,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,262,76,70.5,81.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,EDUCA2,CAT5,_RFPSA22,RESP054,"(42.27687047000046, -72.08269067499964)"
|
|
2018,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,130,34.2,28.4,40,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,EDUCA3,CAT5,_RFPSA22,RESP046,"(42.27687047000046, -72.08269067499964)"
|
|
2018,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,245,65.8,60,71.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,EDUCA3,CAT5,_RFPSA22,RESP054,"(42.27687047000046, -72.08269067499964)"
|
|
2018,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,407,36.8,33.2,40.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,EDUCA4,CAT5,_RFPSA22,RESP046,"(42.27687047000046, -72.08269067499964)"
|
|
2018,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,615,63.2,59.7,66.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,EDUCA4,CAT5,_RFPSA22,RESP054,"(42.27687047000046, -72.08269067499964)"
|
|
2018,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,22,29.4,16.2,42.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,INCOME1,CAT6,_RFPSA22,RESP046,"(42.27687047000046, -72.08269067499964)"
|
|
2018,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,54,70.6,57.4,83.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,INCOME1,CAT6,_RFPSA22,RESP054,"(42.27687047000046, -72.08269067499964)"
|
|
2018,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,26,19.6,11,28.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,INCOME2,CAT6,_RFPSA22,RESP046,"(42.27687047000046, -72.08269067499964)"
|
|
2018,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,99,80.4,71.8,89,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,INCOME2,CAT6,_RFPSA22,RESP054,"(42.27687047000046, -72.08269067499964)"
|
|
2018,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,35,29.8,18.7,40.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,INCOME3,CAT6,_RFPSA22,RESP046,"(42.27687047000046, -72.08269067499964)"
|
|
2018,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,76,70.2,59.2,81.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,INCOME3,CAT6,_RFPSA22,RESP054,"(42.27687047000046, -72.08269067499964)"
|
|
2018,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,51,25.9,17.8,34,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,INCOME4,CAT6,_RFPSA22,RESP046,"(42.27687047000046, -72.08269067499964)"
|
|
2018,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,114,74.1,66,82.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,INCOME4,CAT6,_RFPSA22,RESP054,"(42.27687047000046, -72.08269067499964)"
|
|
2018,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,417,32.3,29,35.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,INCOME5,CAT6,_RFPSA22,RESP046,"(42.27687047000046, -72.08269067499964)"
|
|
2018,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,675,67.7,64.4,71,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,INCOME5,CAT6,_RFPSA22,RESP054,"(42.27687047000046, -72.08269067499964)"
|
|
2018,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,568,32.7,29.8,35.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,RACE01,CAT4,_RFPSA22,RESP046,"(42.27687047000046, -72.08269067499964)"
|
|
2018,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,984,67.3,64.4,70.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,RACE01,CAT4,_RFPSA22,RESP054,"(42.27687047000046, -72.08269067499964)"
|
|
2018,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,19,26.6,13.4,39.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,RACE02,CAT4,_RFPSA22,RESP046,"(42.27687047000046, -72.08269067499964)"
|
|
2018,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,49,73.4,60.2,86.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,RACE02,CAT4,_RFPSA22,RESP054,"(42.27687047000046, -72.08269067499964)"
|
|
2018,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,25,RACE03,CAT4,_RFPSA22,RESP046,"(42.27687047000046, -72.08269067499964)"
|
|
2018,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,25,RACE03,CAT4,_RFPSA22,RESP054,"(42.27687047000046, -72.08269067499964)"
|
|
2018,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,25,RACE04,CAT4,_RFPSA22,RESP046,"(42.27687047000046, -72.08269067499964)"
|
|
2018,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,34,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,25,RACE04,CAT4,_RFPSA22,RESP054,"(42.27687047000046, -72.08269067499964)"
|
|
2018,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,25,RACE05,CAT4,_RFPSA22,RESP046,"(42.27687047000046, -72.08269067499964)"
|
|
2018,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,25,RACE05,CAT4,_RFPSA22,RESP054,"(42.27687047000046, -72.08269067499964)"
|
|
2018,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,25,RACE06,CAT4,_RFPSA22,RESP046,"(42.27687047000046, -72.08269067499964)"
|
|
2018,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,18,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,25,RACE06,CAT4,_RFPSA22,RESP054,"(42.27687047000046, -72.08269067499964)"
|
|
2018,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,25,RACE07,CAT4,_RFPSA22,RESP046,"(42.27687047000046, -72.08269067499964)"
|
|
2018,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,24,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,25,RACE07,CAT4,_RFPSA22,RESP054,"(42.27687047000046, -72.08269067499964)"
|
|
2018,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,25,21.3,12.5,30.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,RACE08,CAT4,_RFPSA22,RESP046,"(42.27687047000046, -72.08269067499964)"
|
|
2018,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,75,78.7,69.9,87.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,RACE08,CAT4,_RFPSA22,RESP054,"(42.27687047000046, -72.08269067499964)"
|
|
2018,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,637,30.7,28.1,33.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,SEX1,CAT2,_RFPSA22,RESP046,"(42.27687047000046, -72.08269067499964)"
|
|
2018,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1195,69.3,66.7,71.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,SEX1,CAT2,_RFPSA22,RESP054,"(42.27687047000046, -72.08269067499964)"
|
|
2018,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,25,SEX2,CAT2,_RFPSA22,RESP046,"(42.27687047000046, -72.08269067499964)"
|
|
2018,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,25,SEX2,CAT2,_RFPSA22,RESP054,"(42.27687047000046, -72.08269067499964)"
|
|
2018,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,44,8.6,5.7,11.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,AGE06,CAT3,_RFPSA22,RESP046,"(44.6613195430005, -84.71439026999968)"
|
|
2018,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,525,91.4,88.4,94.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,AGE06,CAT3,_RFPSA22,RESP054,"(44.6613195430005, -84.71439026999968)"
|
|
2018,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,253,31.8,27.8,35.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,AGE07,CAT3,_RFPSA22,RESP046,"(44.6613195430005, -84.71439026999968)"
|
|
2018,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,549,68.2,64.3,72.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,AGE07,CAT3,_RFPSA22,RESP054,"(44.6613195430005, -84.71439026999968)"
|
|
2018,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,195,42.3,36.9,47.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,AGE08,CAT3,_RFPSA22,RESP046,"(44.6613195430005, -84.71439026999968)"
|
|
2018,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,288,57.7,52.4,63.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,AGE08,CAT3,_RFPSA22,RESP054,"(44.6613195430005, -84.71439026999968)"
|
|
2018,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,625,50.8,47.1,54.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,AGE09,CAT3,_RFPSA22,RESP046,"(44.6613195430005, -84.71439026999968)"
|
|
2018,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,572,49.2,45.4,52.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,AGE09,CAT3,_RFPSA22,RESP054,"(44.6613195430005, -84.71439026999968)"
|
|
2018,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1117,33.9,31.8,36,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,BO1,CAT1,_RFPSA22,RESP046,"(44.6613195430005, -84.71439026999968)"
|
|
2018,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1934,66.1,64,68.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,BO1,CAT1,_RFPSA22,RESP054,"(44.6613195430005, -84.71439026999968)"
|
|
2018,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,37,25.2,17.3,33.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,EDUCA1,CAT5,_RFPSA22,RESP046,"(44.6613195430005, -84.71439026999968)"
|
|
2018,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,126,74.8,66.9,82.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,EDUCA1,CAT5,_RFPSA22,RESP054,"(44.6613195430005, -84.71439026999968)"
|
|
2018,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,212,26.9,23.2,30.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,EDUCA2,CAT5,_RFPSA22,RESP046,"(44.6613195430005, -84.71439026999968)"
|
|
2018,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,535,73.1,69.4,76.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,EDUCA2,CAT5,_RFPSA22,RESP054,"(44.6613195430005, -84.71439026999968)"
|
|
2018,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,323,37.6,33.7,41.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,EDUCA3,CAT5,_RFPSA22,RESP046,"(44.6613195430005, -84.71439026999968)"
|
|
2018,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,523,62.4,58.5,66.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,EDUCA3,CAT5,_RFPSA22,RESP054,"(44.6613195430005, -84.71439026999968)"
|
|
2018,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,543,40,36.9,43.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,EDUCA4,CAT5,_RFPSA22,RESP046,"(44.6613195430005, -84.71439026999968)"
|
|
2018,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,742,60,56.9,63.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,EDUCA4,CAT5,_RFPSA22,RESP054,"(44.6613195430005, -84.71439026999968)"
|
|
2018,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,46,23.1,16.2,30,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,INCOME1,CAT6,_RFPSA22,RESP046,"(44.6613195430005, -84.71439026999968)"
|
|
2018,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,164,76.9,70,83.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,INCOME1,CAT6,_RFPSA22,RESP054,"(44.6613195430005, -84.71439026999968)"
|
|
2018,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,86,23.9,18.2,29.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,INCOME2,CAT6,_RFPSA22,RESP046,"(44.6613195430005, -84.71439026999968)"
|
|
2018,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,238,76.1,70.5,81.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,INCOME2,CAT6,_RFPSA22,RESP054,"(44.6613195430005, -84.71439026999968)"
|
|
2018,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,76,25.6,19.1,32.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,INCOME3,CAT6,_RFPSA22,RESP046,"(44.6613195430005, -84.71439026999968)"
|
|
2018,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,169,74.4,67.8,80.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,INCOME3,CAT6,_RFPSA22,RESP054,"(44.6613195430005, -84.71439026999968)"
|
|
2018,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,155,39.1,32.8,45.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,INCOME4,CAT6,_RFPSA22,RESP046,"(44.6613195430005, -84.71439026999968)"
|
|
2018,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,229,60.9,54.6,67.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,INCOME4,CAT6,_RFPSA22,RESP054,"(44.6613195430005, -84.71439026999968)"
|
|
2018,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,626,37.5,34.6,40.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,INCOME5,CAT6,_RFPSA22,RESP046,"(44.6613195430005, -84.71439026999968)"
|
|
2018,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,909,62.5,59.5,65.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,INCOME5,CAT6,_RFPSA22,RESP054,"(44.6613195430005, -84.71439026999968)"
|
|
2018,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,992,34.7,32.5,37,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,RACE01,CAT4,_RFPSA22,RESP046,"(44.6613195430005, -84.71439026999968)"
|
|
2018,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1623,65.3,63,67.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,RACE01,CAT4,_RFPSA22,RESP054,"(44.6613195430005, -84.71439026999968)"
|
|
2018,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,77,35.5,28.1,42.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,RACE02,CAT4,_RFPSA22,RESP046,"(44.6613195430005, -84.71439026999968)"
|
|
2018,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,142,64.5,57.1,71.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,RACE02,CAT4,_RFPSA22,RESP054,"(44.6613195430005, -84.71439026999968)"
|
|
2018,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,9,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,26,RACE03,CAT4,_RFPSA22,RESP046,"(44.6613195430005, -84.71439026999968)"
|
|
2018,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,32,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,26,RACE03,CAT4,_RFPSA22,RESP054,"(44.6613195430005, -84.71439026999968)"
|
|
2018,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,26,RACE04,CAT4,_RFPSA22,RESP046,"(44.6613195430005, -84.71439026999968)"
|
|
2018,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,24,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,26,RACE04,CAT4,_RFPSA22,RESP054,"(44.6613195430005, -84.71439026999968)"
|
|
2018,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,26,RACE05,CAT4,_RFPSA22,RESP046,"(44.6613195430005, -84.71439026999968)"
|
|
2018,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,26,RACE05,CAT4,_RFPSA22,RESP054,"(44.6613195430005, -84.71439026999968)"
|
|
2018,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,9,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,26,RACE06,CAT4,_RFPSA22,RESP046,"(44.6613195430005, -84.71439026999968)"
|
|
2018,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,12,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,26,RACE06,CAT4,_RFPSA22,RESP054,"(44.6613195430005, -84.71439026999968)"
|
|
2018,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,14,24.2,11.9,36.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,RACE07,CAT4,_RFPSA22,RESP046,"(44.6613195430005, -84.71439026999968)"
|
|
2018,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,46,75.8,63.5,88.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,RACE07,CAT4,_RFPSA22,RESP054,"(44.6613195430005, -84.71439026999968)"
|
|
2018,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,11,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,26,RACE08,CAT4,_RFPSA22,RESP046,"(44.6613195430005, -84.71439026999968)"
|
|
2018,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,55,85.5,74.9,96,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,RACE08,CAT4,_RFPSA22,RESP054,"(44.6613195430005, -84.71439026999968)"
|
|
2018,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1117,33.9,31.8,36,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,SEX1,CAT2,_RFPSA22,RESP046,"(44.6613195430005, -84.71439026999968)"
|
|
2018,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1934,66.1,64,68.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,SEX1,CAT2,_RFPSA22,RESP054,"(44.6613195430005, -84.71439026999968)"
|
|
2018,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,26,SEX2,CAT2,_RFPSA22,RESP046,"(44.6613195430005, -84.71439026999968)"
|
|
2018,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,26,SEX2,CAT2,_RFPSA22,RESP054,"(44.6613195430005, -84.71439026999968)"
|
|
2018,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,1031,72.2,69.5,74.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,AGE07,CAT3,_RFPSA22,RESP054,"(46.35564873600049, -94.79420050299967)"
|
|
2018,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,54,4.3,3,5.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,AGE06,CAT3,_RFPSA22,RESP046,"(46.35564873600049, -94.79420050299967)"
|
|
2018,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,1004,95.7,94.4,97,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,AGE06,CAT3,_RFPSA22,RESP054,"(46.35564873600049, -94.79420050299967)"
|
|
2018,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,392,27.8,25.2,30.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,AGE07,CAT3,_RFPSA22,RESP046,"(46.35564873600049, -94.79420050299967)"
|
|
2018,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,333,37.8,34,41.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,AGE08,CAT3,_RFPSA22,RESP046,"(46.35564873600049, -94.79420050299967)"
|
|
2018,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,492,62.2,58.4,66,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,AGE08,CAT3,_RFPSA22,RESP054,"(46.35564873600049, -94.79420050299967)"
|
|
2018,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,946,47.3,44.7,50,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,AGE09,CAT3,_RFPSA22,RESP046,"(46.35564873600049, -94.79420050299967)"
|
|
2018,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,1007,52.7,50,55.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,AGE09,CAT3,_RFPSA22,RESP054,"(46.35564873600049, -94.79420050299967)"
|
|
2018,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1725,29.3,27.9,30.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,BO1,CAT1,_RFPSA22,RESP046,"(46.35564873600049, -94.79420050299967)"
|
|
2018,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,3534,70.7,69.3,72.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,BO1,CAT1,_RFPSA22,RESP054,"(46.35564873600049, -94.79420050299967)"
|
|
2018,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,47,21.4,15.2,27.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,EDUCA1,CAT5,_RFPSA22,RESP046,"(46.35564873600049, -94.79420050299967)"
|
|
2018,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,179,78.6,72.4,84.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,EDUCA1,CAT5,_RFPSA22,RESP054,"(46.35564873600049, -94.79420050299967)"
|
|
2018,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,331,25.1,22.3,27.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,EDUCA2,CAT5,_RFPSA22,RESP046,"(46.35564873600049, -94.79420050299967)"
|
|
2018,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,878,74.9,72.2,77.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,EDUCA2,CAT5,_RFPSA22,RESP054,"(46.35564873600049, -94.79420050299967)"
|
|
2018,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,517,31.4,28.8,34,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,EDUCA3,CAT5,_RFPSA22,RESP046,"(46.35564873600049, -94.79420050299967)"
|
|
2018,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,1028,68.6,66,71.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,EDUCA3,CAT5,_RFPSA22,RESP054,"(46.35564873600049, -94.79420050299967)"
|
|
2018,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,827,32.2,30,34.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,EDUCA4,CAT5,_RFPSA22,RESP046,"(46.35564873600049, -94.79420050299967)"
|
|
2018,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,1442,67.8,65.7,70,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,EDUCA4,CAT5,_RFPSA22,RESP054,"(46.35564873600049, -94.79420050299967)"
|
|
2018,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,44,16.8,11,22.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,INCOME1,CAT6,_RFPSA22,RESP046,"(46.35564873600049, -94.79420050299967)"
|
|
2018,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,161,83.2,77.5,89,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,INCOME1,CAT6,_RFPSA22,RESP054,"(46.35564873600049, -94.79420050299967)"
|
|
2018,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,132,24.9,20.4,29.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,INCOME2,CAT6,_RFPSA22,RESP046,"(46.35564873600049, -94.79420050299967)"
|
|
2018,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,355,75.1,70.7,79.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,INCOME2,CAT6,_RFPSA22,RESP054,"(46.35564873600049, -94.79420050299967)"
|
|
2018,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,137,32.7,27.2,38.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,INCOME3,CAT6,_RFPSA22,RESP046,"(46.35564873600049, -94.79420050299967)"
|
|
2018,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,273,67.3,61.8,72.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,INCOME3,CAT6,_RFPSA22,RESP054,"(46.35564873600049, -94.79420050299967)"
|
|
2018,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,217,32.4,28.2,36.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,INCOME4,CAT6,_RFPSA22,RESP046,"(46.35564873600049, -94.79420050299967)"
|
|
2018,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,393,67.6,63.3,71.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,INCOME4,CAT6,_RFPSA22,RESP054,"(46.35564873600049, -94.79420050299967)"
|
|
2018,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,1032,29.7,27.9,31.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,INCOME5,CAT6,_RFPSA22,RESP046,"(46.35564873600049, -94.79420050299967)"
|
|
2018,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,2025,70.3,68.5,72.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,INCOME5,CAT6,_RFPSA22,RESP054,"(46.35564873600049, -94.79420050299967)"
|
|
2018,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1639,30.9,29.4,32.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,RACE01,CAT4,_RFPSA22,RESP046,"(46.35564873600049, -94.79420050299967)"
|
|
2018,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,3156,69.1,67.6,70.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,RACE01,CAT4,_RFPSA22,RESP054,"(46.35564873600049, -94.79420050299967)"
|
|
2018,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,27,25,16,34,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,RACE02,CAT4,_RFPSA22,RESP046,"(46.35564873600049, -94.79420050299967)"
|
|
2018,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,84,75,66,84,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,RACE02,CAT4,_RFPSA22,RESP054,"(46.35564873600049, -94.79420050299967)"
|
|
2018,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,9,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,27,RACE03,CAT4,_RFPSA22,RESP046,"(46.35564873600049, -94.79420050299967)"
|
|
2018,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,64,88.6,79.9,97.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,RACE03,CAT4,_RFPSA22,RESP054,"(46.35564873600049, -94.79420050299967)"
|
|
2018,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,27,RACE04,CAT4,_RFPSA22,RESP046,"(46.35564873600049, -94.79420050299967)"
|
|
2018,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,66,93.2,87.8,98.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,RACE04,CAT4,_RFPSA22,RESP054,"(46.35564873600049, -94.79420050299967)"
|
|
2018,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,27,RACE05,CAT4,_RFPSA22,RESP046,"(46.35564873600049, -94.79420050299967)"
|
|
2018,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,27,RACE05,CAT4,_RFPSA22,RESP054,"(46.35564873600049, -94.79420050299967)"
|
|
2018,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,15,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,27,RACE06,CAT4,_RFPSA22,RESP046,"(46.35564873600049, -94.79420050299967)"
|
|
2018,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,25,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,27,RACE06,CAT4,_RFPSA22,RESP054,"(46.35564873600049, -94.79420050299967)"
|
|
2018,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,27,RACE07,CAT4,_RFPSA22,RESP046,"(46.35564873600049, -94.79420050299967)"
|
|
2018,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,32,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,27,RACE07,CAT4,_RFPSA22,RESP054,"(46.35564873600049, -94.79420050299967)"
|
|
2018,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,20,15.8,8.5,23.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,RACE08,CAT4,_RFPSA22,RESP046,"(46.35564873600049, -94.79420050299967)"
|
|
2018,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,104,84.2,76.8,91.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,RACE08,CAT4,_RFPSA22,RESP054,"(46.35564873600049, -94.79420050299967)"
|
|
2018,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1725,29.3,27.9,30.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,SEX1,CAT2,_RFPSA22,RESP046,"(46.35564873600049, -94.79420050299967)"
|
|
2018,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,3534,70.7,69.3,72.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,SEX1,CAT2,_RFPSA22,RESP054,"(46.35564873600049, -94.79420050299967)"
|
|
2018,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,27,SEX2,CAT2,_RFPSA22,RESP046,"(46.35564873600049, -94.79420050299967)"
|
|
2018,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,27,SEX2,CAT2,_RFPSA22,RESP054,"(46.35564873600049, -94.79420050299967)"
|
|
2018,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,43,12.5,8.4,16.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,AGE06,CAT3,_RFPSA22,RESP046,"(32.745510099000455, -89.53803082499968)"
|
|
2018,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,288,87.5,83.5,91.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,AGE06,CAT3,_RFPSA22,RESP054,"(32.745510099000455, -89.53803082499968)"
|
|
2018,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,163,32.6,27.3,38,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,AGE07,CAT3,_RFPSA22,RESP046,"(32.745510099000455, -89.53803082499968)"
|
|
2018,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,282,67.4,62,72.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,AGE07,CAT3,_RFPSA22,RESP054,"(32.745510099000455, -89.53803082499968)"
|
|
2018,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,105,39.1,31.7,46.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,AGE08,CAT3,_RFPSA22,RESP046,"(32.745510099000455, -89.53803082499968)"
|
|
2018,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,142,60.9,53.5,68.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,AGE08,CAT3,_RFPSA22,RESP054,"(32.745510099000455, -89.53803082499968)"
|
|
2018,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,364,56.5,51.4,61.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,AGE09,CAT3,_RFPSA22,RESP046,"(32.745510099000455, -89.53803082499968)"
|
|
2018,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,262,43.5,38.4,48.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,AGE09,CAT3,_RFPSA22,RESP054,"(32.745510099000455, -89.53803082499968)"
|
|
2018,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,675,35.4,32.5,38.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,BO1,CAT1,_RFPSA22,RESP046,"(32.745510099000455, -89.53803082499968)"
|
|
2018,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,974,64.6,61.8,67.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,BO1,CAT1,_RFPSA22,RESP054,"(32.745510099000455, -89.53803082499968)"
|
|
2018,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,66,25.6,18.6,32.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,EDUCA1,CAT5,_RFPSA22,RESP046,"(32.745510099000455, -89.53803082499968)"
|
|
2018,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,189,74.4,67.5,81.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,EDUCA1,CAT5,_RFPSA22,RESP054,"(32.745510099000455, -89.53803082499968)"
|
|
2018,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,183,33.5,28.5,38.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,EDUCA2,CAT5,_RFPSA22,RESP046,"(32.745510099000455, -89.53803082499968)"
|
|
2018,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,319,66.5,61.6,71.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,EDUCA2,CAT5,_RFPSA22,RESP054,"(32.745510099000455, -89.53803082499968)"
|
|
2018,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,196,37.9,32.6,43.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,EDUCA3,CAT5,_RFPSA22,RESP046,"(32.745510099000455, -89.53803082499968)"
|
|
2018,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,258,62.1,56.8,67.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,EDUCA3,CAT5,_RFPSA22,RESP054,"(32.745510099000455, -89.53803082499968)"
|
|
2018,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,228,45.7,40.2,51.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,EDUCA4,CAT5,_RFPSA22,RESP046,"(32.745510099000455, -89.53803082499968)"
|
|
2018,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,207,54.3,48.8,59.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,EDUCA4,CAT5,_RFPSA22,RESP054,"(32.745510099000455, -89.53803082499968)"
|
|
2018,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,60,31.2,22.4,40.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,INCOME1,CAT6,_RFPSA22,RESP046,"(32.745510099000455, -89.53803082499968)"
|
|
2018,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,125,68.8,59.9,77.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,INCOME1,CAT6,_RFPSA22,RESP054,"(32.745510099000455, -89.53803082499968)"
|
|
2018,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,107,31.1,24.4,37.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,INCOME2,CAT6,_RFPSA22,RESP046,"(32.745510099000455, -89.53803082499968)"
|
|
2018,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,192,68.9,62.3,75.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,INCOME2,CAT6,_RFPSA22,RESP054,"(32.745510099000455, -89.53803082499968)"
|
|
2018,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,71,30.9,22.9,38.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,INCOME3,CAT6,_RFPSA22,RESP046,"(32.745510099000455, -89.53803082499968)"
|
|
2018,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,103,69.1,61.1,77.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,INCOME3,CAT6,_RFPSA22,RESP054,"(32.745510099000455, -89.53803082499968)"
|
|
2018,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,74,33.6,25.9,41.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,INCOME4,CAT6,_RFPSA22,RESP046,"(32.745510099000455, -89.53803082499968)"
|
|
2018,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,123,66.4,58.8,74.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,INCOME4,CAT6,_RFPSA22,RESP054,"(32.745510099000455, -89.53803082499968)"
|
|
2018,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,277,41.8,37,46.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,INCOME5,CAT6,_RFPSA22,RESP046,"(32.745510099000455, -89.53803082499968)"
|
|
2018,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,290,58.2,53.4,63,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,INCOME5,CAT6,_RFPSA22,RESP054,"(32.745510099000455, -89.53803082499968)"
|
|
2018,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,418,36.3,32.7,39.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,RACE01,CAT4,_RFPSA22,RESP046,"(32.745510099000455, -89.53803082499968)"
|
|
2018,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,552,63.7,60.1,67.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,RACE01,CAT4,_RFPSA22,RESP054,"(32.745510099000455, -89.53803082499968)"
|
|
2018,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,232,34.4,29.5,39.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,RACE02,CAT4,_RFPSA22,RESP046,"(32.745510099000455, -89.53803082499968)"
|
|
2018,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,382,65.6,60.7,70.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,RACE02,CAT4,_RFPSA22,RESP054,"(32.745510099000455, -89.53803082499968)"
|
|
2018,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,28,RACE03,CAT4,_RFPSA22,RESP046,"(32.745510099000455, -89.53803082499968)"
|
|
2018,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,9,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,28,RACE03,CAT4,_RFPSA22,RESP054,"(32.745510099000455, -89.53803082499968)"
|
|
2018,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,28,RACE04,CAT4,_RFPSA22,RESP046,"(32.745510099000455, -89.53803082499968)"
|
|
2018,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,28,RACE04,CAT4,_RFPSA22,RESP054,"(32.745510099000455, -89.53803082499968)"
|
|
2018,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,28,RACE05,CAT4,_RFPSA22,RESP046,"(32.745510099000455, -89.53803082499968)"
|
|
2018,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,28,RACE05,CAT4,_RFPSA22,RESP054,"(32.745510099000455, -89.53803082499968)"
|
|
2018,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,28,RACE06,CAT4,_RFPSA22,RESP046,"(32.745510099000455, -89.53803082499968)"
|
|
2018,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,28,RACE06,CAT4,_RFPSA22,RESP054,"(32.745510099000455, -89.53803082499968)"
|
|
2018,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,28,RACE07,CAT4,_RFPSA22,RESP046,"(32.745510099000455, -89.53803082499968)"
|
|
2018,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,28,RACE07,CAT4,_RFPSA22,RESP054,"(32.745510099000455, -89.53803082499968)"
|
|
2018,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,28,RACE08,CAT4,_RFPSA22,RESP046,"(32.745510099000455, -89.53803082499968)"
|
|
2018,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,13,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,28,RACE08,CAT4,_RFPSA22,RESP054,"(32.745510099000455, -89.53803082499968)"
|
|
2018,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,675,35.4,32.5,38.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,SEX1,CAT2,_RFPSA22,RESP046,"(32.745510099000455, -89.53803082499968)"
|
|
2018,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,974,64.6,61.8,67.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,SEX1,CAT2,_RFPSA22,RESP054,"(32.745510099000455, -89.53803082499968)"
|
|
2018,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,28,SEX2,CAT2,_RFPSA22,RESP046,"(32.745510099000455, -89.53803082499968)"
|
|
2018,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,28,SEX2,CAT2,_RFPSA22,RESP054,"(32.745510099000455, -89.53803082499968)"
|
|
2018,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,31,10.3,5.8,14.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,AGE06,CAT3,_RFPSA22,RESP046,"(38.635790776000476, -92.56630005299968)"
|
|
2018,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,269,89.7,85.1,94.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,AGE06,CAT3,_RFPSA22,RESP054,"(38.635790776000476, -92.56630005299968)"
|
|
2018,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,125,24.7,19.7,29.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,AGE07,CAT3,_RFPSA22,RESP046,"(38.635790776000476, -92.56630005299968)"
|
|
2018,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,294,75.3,70.4,80.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,AGE07,CAT3,_RFPSA22,RESP054,"(38.635790776000476, -92.56630005299968)"
|
|
2018,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,102,42.2,34.7,49.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,AGE08,CAT3,_RFPSA22,RESP046,"(38.635790776000476, -92.56630005299968)"
|
|
2018,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,144,57.8,50.2,65.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,AGE08,CAT3,_RFPSA22,RESP054,"(38.635790776000476, -92.56630005299968)"
|
|
2018,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,486,54.1,49.6,58.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,AGE09,CAT3,_RFPSA22,RESP046,"(38.635790776000476, -92.56630005299968)"
|
|
2018,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,387,45.9,41.4,50.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,AGE09,CAT3,_RFPSA22,RESP054,"(38.635790776000476, -92.56630005299968)"
|
|
2018,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,744,32.1,29.3,34.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,BO1,CAT1,_RFPSA22,RESP046,"(38.635790776000476, -92.56630005299968)"
|
|
2018,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1094,67.9,65.2,70.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,BO1,CAT1,_RFPSA22,RESP054,"(38.635790776000476, -92.56630005299968)"
|
|
2018,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,33,17.7,10.2,25.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,EDUCA1,CAT5,_RFPSA22,RESP046,"(38.635790776000476, -92.56630005299968)"
|
|
2018,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,112,82.3,74.7,89.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,EDUCA1,CAT5,_RFPSA22,RESP054,"(38.635790776000476, -92.56630005299968)"
|
|
2018,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,202,27.8,23.2,32.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,EDUCA2,CAT5,_RFPSA22,RESP046,"(38.635790776000476, -92.56630005299968)"
|
|
2018,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,389,72.2,67.5,76.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,EDUCA2,CAT5,_RFPSA22,RESP054,"(38.635790776000476, -92.56630005299968)"
|
|
2018,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,180,32,26.7,37.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,EDUCA3,CAT5,_RFPSA22,RESP046,"(38.635790776000476, -92.56630005299968)"
|
|
2018,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,273,68,62.7,73.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,EDUCA3,CAT5,_RFPSA22,RESP054,"(38.635790776000476, -92.56630005299968)"
|
|
2018,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,328,44.7,39.6,49.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,EDUCA4,CAT5,_RFPSA22,RESP046,"(38.635790776000476, -92.56630005299968)"
|
|
2018,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,317,55.3,50.3,60.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,EDUCA4,CAT5,_RFPSA22,RESP054,"(38.635790776000476, -92.56630005299968)"
|
|
2018,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,20,13.7,6.2,21.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,INCOME1,CAT6,_RFPSA22,RESP046,"(38.635790776000476, -92.56630005299968)"
|
|
2018,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,82,86.3,78.7,93.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,INCOME1,CAT6,_RFPSA22,RESP054,"(38.635790776000476, -92.56630005299968)"
|
|
2018,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,78,26,18.8,33.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,INCOME2,CAT6,_RFPSA22,RESP046,"(38.635790776000476, -92.56630005299968)"
|
|
2018,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,155,74,66.7,81.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,INCOME2,CAT6,_RFPSA22,RESP054,"(38.635790776000476, -92.56630005299968)"
|
|
2018,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,68,25.4,17.9,32.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,INCOME3,CAT6,_RFPSA22,RESP046,"(38.635790776000476, -92.56630005299968)"
|
|
2018,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,101,74.6,67.1,82.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,INCOME3,CAT6,_RFPSA22,RESP054,"(38.635790776000476, -92.56630005299968)"
|
|
2018,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,102,34.6,26.6,42.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,INCOME4,CAT6,_RFPSA22,RESP046,"(38.635790776000476, -92.56630005299968)"
|
|
2018,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,137,65.4,57.3,73.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,INCOME4,CAT6,_RFPSA22,RESP054,"(38.635790776000476, -92.56630005299968)"
|
|
2018,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,385,36,32,40.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,INCOME5,CAT6,_RFPSA22,RESP046,"(38.635790776000476, -92.56630005299968)"
|
|
2018,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,452,64,59.9,68,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,INCOME5,CAT6,_RFPSA22,RESP054,"(38.635790776000476, -92.56630005299968)"
|
|
2018,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,656,34,31.1,37,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,RACE01,CAT4,_RFPSA22,RESP046,"(38.635790776000476, -92.56630005299968)"
|
|
2018,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,926,66,63,68.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,RACE01,CAT4,_RFPSA22,RESP054,"(38.635790776000476, -92.56630005299968)"
|
|
2018,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,54,23.5,14.7,32.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,RACE02,CAT4,_RFPSA22,RESP046,"(38.635790776000476, -92.56630005299968)"
|
|
2018,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,96,76.5,67.7,85.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,RACE02,CAT4,_RFPSA22,RESP054,"(38.635790776000476, -92.56630005299968)"
|
|
2018,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,29,RACE03,CAT4,_RFPSA22,RESP046,"(38.635790776000476, -92.56630005299968)"
|
|
2018,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,14,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,29,RACE03,CAT4,_RFPSA22,RESP054,"(38.635790776000476, -92.56630005299968)"
|
|
2018,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,29,RACE04,CAT4,_RFPSA22,RESP046,"(38.635790776000476, -92.56630005299968)"
|
|
2018,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,29,RACE04,CAT4,_RFPSA22,RESP054,"(38.635790776000476, -92.56630005299968)"
|
|
2018,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,29,RACE05,CAT4,_RFPSA22,RESP046,"(38.635790776000476, -92.56630005299968)"
|
|
2018,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,29,RACE05,CAT4,_RFPSA22,RESP054,"(38.635790776000476, -92.56630005299968)"
|
|
2018,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,29,RACE06,CAT4,_RFPSA22,RESP046,"(38.635790776000476, -92.56630005299968)"
|
|
2018,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,13,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,29,RACE06,CAT4,_RFPSA22,RESP054,"(38.635790776000476, -92.56630005299968)"
|
|
2018,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,29,RACE07,CAT4,_RFPSA22,RESP046,"(38.635790776000476, -92.56630005299968)"
|
|
2018,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,20,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,29,RACE07,CAT4,_RFPSA22,RESP054,"(38.635790776000476, -92.56630005299968)"
|
|
2018,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,9,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,29,RACE08,CAT4,_RFPSA22,RESP046,"(38.635790776000476, -92.56630005299968)"
|
|
2018,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,20,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,29,RACE08,CAT4,_RFPSA22,RESP054,"(38.635790776000476, -92.56630005299968)"
|
|
2018,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,744,32.1,29.3,34.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,SEX1,CAT2,_RFPSA22,RESP046,"(38.635790776000476, -92.56630005299968)"
|
|
2018,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1094,67.9,65.2,70.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,SEX1,CAT2,_RFPSA22,RESP054,"(38.635790776000476, -92.56630005299968)"
|
|
2018,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,29,SEX2,CAT2,_RFPSA22,RESP046,"(38.635790776000476, -92.56630005299968)"
|
|
2018,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,29,SEX2,CAT2,_RFPSA22,RESP054,"(38.635790776000476, -92.56630005299968)"
|
|
2018,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,20,7.4,3.6,11.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,AGE06,CAT3,_RFPSA22,RESP046,"(47.06652897200047, -109.42442064499971)"
|
|
2018,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,248,92.6,88.9,96.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,AGE06,CAT3,_RFPSA22,RESP054,"(47.06652897200047, -109.42442064499971)"
|
|
2018,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,119,30.3,24.5,36,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,AGE07,CAT3,_RFPSA22,RESP046,"(47.06652897200047, -109.42442064499971)"
|
|
2018,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,244,69.7,64,75.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,AGE07,CAT3,_RFPSA22,RESP054,"(47.06652897200047, -109.42442064499971)"
|
|
2018,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,112,47.1,39.5,54.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,AGE08,CAT3,_RFPSA22,RESP046,"(47.06652897200047, -109.42442064499971)"
|
|
2018,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,158,52.9,45.3,60.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,AGE08,CAT3,_RFPSA22,RESP054,"(47.06652897200047, -109.42442064499971)"
|
|
2018,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,398,52.8,47.9,57.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,AGE09,CAT3,_RFPSA22,RESP046,"(47.06652897200047, -109.42442064499971)"
|
|
2018,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,331,47.2,42.2,52.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,AGE09,CAT3,_RFPSA22,RESP054,"(47.06652897200047, -109.42442064499971)"
|
|
2018,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,649,35.9,33,38.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,BO1,CAT1,_RFPSA22,RESP046,"(47.06652897200047, -109.42442064499971)"
|
|
2018,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,981,64.1,61.2,67,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,BO1,CAT1,_RFPSA22,RESP054,"(47.06652897200047, -109.42442064499971)"
|
|
2018,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,30,20.4,11.4,29.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,EDUCA1,CAT5,_RFPSA22,RESP046,"(47.06652897200047, -109.42442064499971)"
|
|
2018,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,77,79.6,70.6,88.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,EDUCA1,CAT5,_RFPSA22,RESP054,"(47.06652897200047, -109.42442064499971)"
|
|
2018,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,149,28.3,23.2,33.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,EDUCA2,CAT5,_RFPSA22,RESP046,"(47.06652897200047, -109.42442064499971)"
|
|
2018,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,326,71.7,66.6,76.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,EDUCA2,CAT5,_RFPSA22,RESP054,"(47.06652897200047, -109.42442064499971)"
|
|
2018,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,175,37.4,31.8,43,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,EDUCA3,CAT5,_RFPSA22,RESP046,"(47.06652897200047, -109.42442064499971)"
|
|
2018,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,285,62.6,57,68.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,EDUCA3,CAT5,_RFPSA22,RESP054,"(47.06652897200047, -109.42442064499971)"
|
|
2018,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,294,47.7,42.6,52.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,EDUCA4,CAT5,_RFPSA22,RESP046,"(47.06652897200047, -109.42442064499971)"
|
|
2018,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,289,52.3,47.2,57.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,EDUCA4,CAT5,_RFPSA22,RESP054,"(47.06652897200047, -109.42442064499971)"
|
|
2018,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,29,22.4,12.2,32.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,INCOME1,CAT6,_RFPSA22,RESP046,"(47.06652897200047, -109.42442064499971)"
|
|
2018,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,77,77.6,67.5,87.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,INCOME1,CAT6,_RFPSA22,RESP054,"(47.06652897200047, -109.42442064499971)"
|
|
2018,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,69,26.7,18.9,34.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,INCOME2,CAT6,_RFPSA22,RESP046,"(47.06652897200047, -109.42442064499971)"
|
|
2018,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,139,73.3,65.5,81.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,INCOME2,CAT6,_RFPSA22,RESP054,"(47.06652897200047, -109.42442064499971)"
|
|
2018,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,57,34.3,24.9,43.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,INCOME3,CAT6,_RFPSA22,RESP046,"(47.06652897200047, -109.42442064499971)"
|
|
2018,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,96,65.7,56.4,75.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,INCOME3,CAT6,_RFPSA22,RESP054,"(47.06652897200047, -109.42442064499971)"
|
|
2018,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,104,38.1,30.2,46,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,INCOME4,CAT6,_RFPSA22,RESP046,"(47.06652897200047, -109.42442064499971)"
|
|
2018,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,133,61.9,54,69.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,INCOME4,CAT6,_RFPSA22,RESP054,"(47.06652897200047, -109.42442064499971)"
|
|
2018,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,323,41.3,36.8,45.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,INCOME5,CAT6,_RFPSA22,RESP046,"(47.06652897200047, -109.42442064499971)"
|
|
2018,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,399,58.7,54.3,63.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,INCOME5,CAT6,_RFPSA22,RESP054,"(47.06652897200047, -109.42442064499971)"
|
|
2018,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,584,37.6,34.4,40.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,RACE01,CAT4,_RFPSA22,RESP046,"(47.06652897200047, -109.42442064499971)"
|
|
2018,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,794,62.4,59.3,65.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,RACE01,CAT4,_RFPSA22,RESP054,"(47.06652897200047, -109.42442064499971)"
|
|
2018,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,30,RACE02,CAT4,_RFPSA22,RESP046,"(47.06652897200047, -109.42442064499971)"
|
|
2018,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,30,RACE02,CAT4,_RFPSA22,RESP054,"(47.06652897200047, -109.42442064499971)"
|
|
2018,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,32,13.2,6.4,20,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,RACE03,CAT4,_RFPSA22,RESP046,"(47.06652897200047, -109.42442064499971)"
|
|
2018,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,130,86.8,80,93.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,RACE03,CAT4,_RFPSA22,RESP054,"(47.06652897200047, -109.42442064499971)"
|
|
2018,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,30,RACE04,CAT4,_RFPSA22,RESP046,"(47.06652897200047, -109.42442064499971)"
|
|
2018,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,30,RACE04,CAT4,_RFPSA22,RESP054,"(47.06652897200047, -109.42442064499971)"
|
|
2018,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,30,RACE05,CAT4,_RFPSA22,RESP046,"(47.06652897200047, -109.42442064499971)"
|
|
2018,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,30,RACE05,CAT4,_RFPSA22,RESP054,"(47.06652897200047, -109.42442064499971)"
|
|
2018,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,30,RACE06,CAT4,_RFPSA22,RESP046,"(47.06652897200047, -109.42442064499971)"
|
|
2018,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,30,RACE06,CAT4,_RFPSA22,RESP054,"(47.06652897200047, -109.42442064499971)"
|
|
2018,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,9,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,30,RACE07,CAT4,_RFPSA22,RESP046,"(47.06652897200047, -109.42442064499971)"
|
|
2018,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,18,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,30,RACE07,CAT4,_RFPSA22,RESP054,"(47.06652897200047, -109.42442064499971)"
|
|
2018,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,30,RACE08,CAT4,_RFPSA22,RESP046,"(47.06652897200047, -109.42442064499971)"
|
|
2018,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,19,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,30,RACE08,CAT4,_RFPSA22,RESP054,"(47.06652897200047, -109.42442064499971)"
|
|
2018,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,649,35.9,33,38.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,SEX1,CAT2,_RFPSA22,RESP046,"(47.06652897200047, -109.42442064499971)"
|
|
2018,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,981,64.1,61.2,67,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,SEX1,CAT2,_RFPSA22,RESP054,"(47.06652897200047, -109.42442064499971)"
|
|
2018,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,30,SEX2,CAT2,_RFPSA22,RESP046,"(47.06652897200047, -109.42442064499971)"
|
|
2018,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,30,SEX2,CAT2,_RFPSA22,RESP054,"(47.06652897200047, -109.42442064499971)"
|
|
2018,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,69,8.6,5.8,11.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,AGE06,CAT3,_RFPSA22,RESP046,"(41.6410409880005, -99.36572062299967)"
|
|
2018,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,706,91.4,88.7,94.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,AGE06,CAT3,_RFPSA22,RESP054,"(41.6410409880005, -99.36572062299967)"
|
|
2018,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,269,24.2,20.6,27.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,AGE07,CAT3,_RFPSA22,RESP046,"(41.6410409880005, -99.36572062299967)"
|
|
2018,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,716,75.8,72.2,79.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,AGE07,CAT3,_RFPSA22,RESP054,"(41.6410409880005, -99.36572062299967)"
|
|
2018,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,295,40.2,35,45.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,AGE08,CAT3,_RFPSA22,RESP046,"(41.6410409880005, -99.36572062299967)"
|
|
2018,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,368,59.8,54.7,65,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,AGE08,CAT3,_RFPSA22,RESP054,"(41.6410409880005, -99.36572062299967)"
|
|
2018,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,1059,50.4,47.4,53.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,AGE09,CAT3,_RFPSA22,RESP046,"(41.6410409880005, -99.36572062299967)"
|
|
2018,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,971,49.6,46.6,52.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,AGE09,CAT3,_RFPSA22,RESP054,"(41.6410409880005, -99.36572062299967)"
|
|
2018,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1692,30.8,29,32.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,BO1,CAT1,_RFPSA22,RESP046,"(41.6410409880005, -99.36572062299967)"
|
|
2018,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,2761,69.2,67.3,71,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,BO1,CAT1,_RFPSA22,RESP054,"(41.6410409880005, -99.36572062299967)"
|
|
2018,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,63,15.5,10.3,20.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,EDUCA1,CAT5,_RFPSA22,RESP046,"(41.6410409880005, -99.36572062299967)"
|
|
2018,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,229,84.5,79.3,89.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,EDUCA1,CAT5,_RFPSA22,RESP054,"(41.6410409880005, -99.36572062299967)"
|
|
2018,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,551,31.4,28.1,34.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,EDUCA2,CAT5,_RFPSA22,RESP046,"(41.6410409880005, -99.36572062299967)"
|
|
2018,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,963,68.6,65.4,71.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,EDUCA2,CAT5,_RFPSA22,RESP054,"(41.6410409880005, -99.36572062299967)"
|
|
2018,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,476,30.1,26.7,33.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,EDUCA3,CAT5,_RFPSA22,RESP046,"(41.6410409880005, -99.36572062299967)"
|
|
2018,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,769,69.9,66.5,73.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,EDUCA3,CAT5,_RFPSA22,RESP054,"(41.6410409880005, -99.36572062299967)"
|
|
2018,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,601,36.2,32.7,39.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,EDUCA4,CAT5,_RFPSA22,RESP046,"(41.6410409880005, -99.36572062299967)"
|
|
2018,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,797,63.8,60.4,67.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,EDUCA4,CAT5,_RFPSA22,RESP054,"(41.6410409880005, -99.36572062299967)"
|
|
2018,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,51,13.4,8.2,18.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,INCOME1,CAT6,_RFPSA22,RESP046,"(41.6410409880005, -99.36572062299967)"
|
|
2018,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,202,86.6,81.3,91.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,INCOME1,CAT6,_RFPSA22,RESP054,"(41.6410409880005, -99.36572062299967)"
|
|
2018,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,158,20.3,15.8,24.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,INCOME2,CAT6,_RFPSA22,RESP046,"(41.6410409880005, -99.36572062299967)"
|
|
2018,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,388,79.7,75.1,84.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,INCOME2,CAT6,_RFPSA22,RESP054,"(41.6410409880005, -99.36572062299967)"
|
|
2018,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,164,31.3,25.5,37.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,INCOME3,CAT6,_RFPSA22,RESP046,"(41.6410409880005, -99.36572062299967)"
|
|
2018,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,274,68.7,62.9,74.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,INCOME3,CAT6,_RFPSA22,RESP054,"(41.6410409880005, -99.36572062299967)"
|
|
2018,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,279,38.1,32.8,43.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,INCOME4,CAT6,_RFPSA22,RESP046,"(41.6410409880005, -99.36572062299967)"
|
|
2018,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,391,61.9,56.7,67.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,INCOME4,CAT6,_RFPSA22,RESP054,"(41.6410409880005, -99.36572062299967)"
|
|
2018,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,906,32.5,29.8,35.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,INCOME5,CAT6,_RFPSA22,RESP046,"(41.6410409880005, -99.36572062299967)"
|
|
2018,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,1315,67.5,64.9,70.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,INCOME5,CAT6,_RFPSA22,RESP054,"(41.6410409880005, -99.36572062299967)"
|
|
2018,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1623,32.5,30.6,34.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,RACE01,CAT4,_RFPSA22,RESP046,"(41.6410409880005, -99.36572062299967)"
|
|
2018,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,2496,67.5,65.6,69.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,RACE01,CAT4,_RFPSA22,RESP054,"(41.6410409880005, -99.36572062299967)"
|
|
2018,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,16,26.2,12.9,39.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,RACE02,CAT4,_RFPSA22,RESP046,"(41.6410409880005, -99.36572062299967)"
|
|
2018,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,40,73.8,60.6,87.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,RACE02,CAT4,_RFPSA22,RESP054,"(41.6410409880005, -99.36572062299967)"
|
|
2018,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,31,RACE03,CAT4,_RFPSA22,RESP046,"(41.6410409880005, -99.36572062299967)"
|
|
2018,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,34,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,31,RACE03,CAT4,_RFPSA22,RESP054,"(41.6410409880005, -99.36572062299967)"
|
|
2018,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,31,RACE04,CAT4,_RFPSA22,RESP046,"(41.6410409880005, -99.36572062299967)"
|
|
2018,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,14,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,31,RACE04,CAT4,_RFPSA22,RESP054,"(41.6410409880005, -99.36572062299967)"
|
|
2018,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,31,RACE05,CAT4,_RFPSA22,RESP046,"(41.6410409880005, -99.36572062299967)"
|
|
2018,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,31,RACE05,CAT4,_RFPSA22,RESP054,"(41.6410409880005, -99.36572062299967)"
|
|
2018,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,31,RACE06,CAT4,_RFPSA22,RESP046,"(41.6410409880005, -99.36572062299967)"
|
|
2018,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,31,RACE06,CAT4,_RFPSA22,RESP054,"(41.6410409880005, -99.36572062299967)"
|
|
2018,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,31,RACE07,CAT4,_RFPSA22,RESP046,"(41.6410409880005, -99.36572062299967)"
|
|
2018,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,16,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,31,RACE07,CAT4,_RFPSA22,RESP054,"(41.6410409880005, -99.36572062299967)"
|
|
2018,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,25,13.5,6.9,20.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,RACE08,CAT4,_RFPSA22,RESP046,"(41.6410409880005, -99.36572062299967)"
|
|
2018,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,151,86.5,79.9,93.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,RACE08,CAT4,_RFPSA22,RESP054,"(41.6410409880005, -99.36572062299967)"
|
|
2018,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1692,30.8,29,32.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,SEX1,CAT2,_RFPSA22,RESP046,"(41.6410409880005, -99.36572062299967)"
|
|
2018,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,2761,69.2,67.3,71,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,SEX1,CAT2,_RFPSA22,RESP054,"(41.6410409880005, -99.36572062299967)"
|
|
2018,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,31,SEX2,CAT2,_RFPSA22,RESP046,"(41.6410409880005, -99.36572062299967)"
|
|
2018,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,31,SEX2,CAT2,_RFPSA22,RESP054,"(41.6410409880005, -99.36572062299967)"
|
|
2018,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,11,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,32,AGE06,CAT3,_RFPSA22,RESP046,"(39.493240390000494, -117.07184056399967)"
|
|
2018,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,166,94.2,89.8,98.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,AGE06,CAT3,_RFPSA22,RESP054,"(39.493240390000494, -117.07184056399967)"
|
|
2018,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,60,20,13.3,26.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,AGE07,CAT3,_RFPSA22,RESP046,"(39.493240390000494, -117.07184056399967)"
|
|
2018,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,185,80,73.4,86.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,AGE07,CAT3,_RFPSA22,RESP054,"(39.493240390000494, -117.07184056399967)"
|
|
2018,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,55,43.5,31.2,55.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,AGE08,CAT3,_RFPSA22,RESP046,"(39.493240390000494, -117.07184056399967)"
|
|
2018,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,80,56.5,44.2,68.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,AGE08,CAT3,_RFPSA22,RESP054,"(39.493240390000494, -117.07184056399967)"
|
|
2018,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,199,49,41.6,56.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,AGE09,CAT3,_RFPSA22,RESP046,"(39.493240390000494, -117.07184056399967)"
|
|
2018,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,200,51,43.5,58.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,AGE09,CAT3,_RFPSA22,RESP054,"(39.493240390000494, -117.07184056399967)"
|
|
2018,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,325,29.5,25.4,33.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,BO1,CAT1,_RFPSA22,RESP046,"(39.493240390000494, -117.07184056399967)"
|
|
2018,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,631,70.5,66.3,74.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,BO1,CAT1,_RFPSA22,RESP054,"(39.493240390000494, -117.07184056399967)"
|
|
2018,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,17,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,32,EDUCA1,CAT5,_RFPSA22,RESP046,"(39.493240390000494, -117.07184056399967)"
|
|
2018,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,55,79,66.3,91.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,EDUCA1,CAT5,_RFPSA22,RESP054,"(39.493240390000494, -117.07184056399967)"
|
|
2018,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,53,17.8,11.7,24,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,EDUCA2,CAT5,_RFPSA22,RESP046,"(39.493240390000494, -117.07184056399967)"
|
|
2018,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,171,82.2,76,88.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,EDUCA2,CAT5,_RFPSA22,RESP054,"(39.493240390000494, -117.07184056399967)"
|
|
2018,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,101,34,26.1,41.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,EDUCA3,CAT5,_RFPSA22,RESP046,"(39.493240390000494, -117.07184056399967)"
|
|
2018,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,188,66,58.1,73.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,EDUCA3,CAT5,_RFPSA22,RESP054,"(39.493240390000494, -117.07184056399967)"
|
|
2018,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,153,38.2,31.1,45.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,EDUCA4,CAT5,_RFPSA22,RESP046,"(39.493240390000494, -117.07184056399967)"
|
|
2018,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,217,61.8,54.8,68.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,EDUCA4,CAT5,_RFPSA22,RESP054,"(39.493240390000494, -117.07184056399967)"
|
|
2018,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,9,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,32,INCOME1,CAT6,_RFPSA22,RESP046,"(39.493240390000494, -117.07184056399967)"
|
|
2018,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,47,82.7,69.4,96.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,INCOME1,CAT6,_RFPSA22,RESP054,"(39.493240390000494, -117.07184056399967)"
|
|
2018,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,28,16.1,8.1,24.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,INCOME2,CAT6,_RFPSA22,RESP046,"(39.493240390000494, -117.07184056399967)"
|
|
2018,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,76,83.9,75.8,91.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,INCOME2,CAT6,_RFPSA22,RESP054,"(39.493240390000494, -117.07184056399967)"
|
|
2018,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,21,28.3,14.6,42,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,INCOME3,CAT6,_RFPSA22,RESP046,"(39.493240390000494, -117.07184056399967)"
|
|
2018,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,58,71.7,58,85.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,INCOME3,CAT6,_RFPSA22,RESP054,"(39.493240390000494, -117.07184056399967)"
|
|
2018,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,41,26.1,15.4,36.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,INCOME4,CAT6,_RFPSA22,RESP046,"(39.493240390000494, -117.07184056399967)"
|
|
2018,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,77,73.9,63.2,84.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,INCOME4,CAT6,_RFPSA22,RESP054,"(39.493240390000494, -117.07184056399967)"
|
|
2018,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,190,36.4,30,42.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,INCOME5,CAT6,_RFPSA22,RESP046,"(39.493240390000494, -117.07184056399967)"
|
|
2018,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,294,63.6,57.2,70,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,INCOME5,CAT6,_RFPSA22,RESP054,"(39.493240390000494, -117.07184056399967)"
|
|
2018,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,267,36,31,41,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,RACE01,CAT4,_RFPSA22,RESP046,"(39.493240390000494, -117.07184056399967)"
|
|
2018,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,436,64,59,69,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,RACE01,CAT4,_RFPSA22,RESP054,"(39.493240390000494, -117.07184056399967)"
|
|
2018,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,11,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,32,RACE02,CAT4,_RFPSA22,RESP046,"(39.493240390000494, -117.07184056399967)"
|
|
2018,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,24,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,32,RACE02,CAT4,_RFPSA22,RESP054,"(39.493240390000494, -117.07184056399967)"
|
|
2018,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,32,RACE03,CAT4,_RFPSA22,RESP046,"(39.493240390000494, -117.07184056399967)"
|
|
2018,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,11,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,32,RACE03,CAT4,_RFPSA22,RESP054,"(39.493240390000494, -117.07184056399967)"
|
|
2018,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,32,RACE04,CAT4,_RFPSA22,RESP046,"(39.493240390000494, -117.07184056399967)"
|
|
2018,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,16,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,32,RACE04,CAT4,_RFPSA22,RESP054,"(39.493240390000494, -117.07184056399967)"
|
|
2018,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,32,RACE05,CAT4,_RFPSA22,RESP046,"(39.493240390000494, -117.07184056399967)"
|
|
2018,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,32,RACE05,CAT4,_RFPSA22,RESP054,"(39.493240390000494, -117.07184056399967)"
|
|
2018,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,32,RACE06,CAT4,_RFPSA22,RESP046,"(39.493240390000494, -117.07184056399967)"
|
|
2018,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,12,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,32,RACE06,CAT4,_RFPSA22,RESP054,"(39.493240390000494, -117.07184056399967)"
|
|
2018,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,32,RACE07,CAT4,_RFPSA22,RESP046,"(39.493240390000494, -117.07184056399967)"
|
|
2018,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,24,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,32,RACE07,CAT4,_RFPSA22,RESP054,"(39.493240390000494, -117.07184056399967)"
|
|
2018,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,24,18.9,9.7,28.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,RACE08,CAT4,_RFPSA22,RESP046,"(39.493240390000494, -117.07184056399967)"
|
|
2018,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,101,81.1,71.9,90.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,RACE08,CAT4,_RFPSA22,RESP054,"(39.493240390000494, -117.07184056399967)"
|
|
2018,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,325,29.5,25.4,33.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,SEX1,CAT2,_RFPSA22,RESP046,"(39.493240390000494, -117.07184056399967)"
|
|
2018,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,631,70.5,66.3,74.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,SEX1,CAT2,_RFPSA22,RESP054,"(39.493240390000494, -117.07184056399967)"
|
|
2018,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,32,SEX2,CAT2,_RFPSA22,RESP046,"(39.493240390000494, -117.07184056399967)"
|
|
2018,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,32,SEX2,CAT2,_RFPSA22,RESP054,"(39.493240390000494, -117.07184056399967)"
|
|
2018,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,33,AGE06,CAT3,_RFPSA22,RESP046,"(43.65595011300047, -71.50036091999965)"
|
|
2018,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,231,97.2,94.8,99.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,AGE06,CAT3,_RFPSA22,RESP054,"(43.65595011300047, -71.50036091999965)"
|
|
2018,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,117,26.7,21.8,31.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,AGE07,CAT3,_RFPSA22,RESP046,"(43.65595011300047, -71.50036091999965)"
|
|
2018,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,331,73.3,68.4,78.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,AGE07,CAT3,_RFPSA22,RESP054,"(43.65595011300047, -71.50036091999965)"
|
|
2018,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,110,37.5,30.8,44.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,AGE08,CAT3,_RFPSA22,RESP046,"(43.65595011300047, -71.50036091999965)"
|
|
2018,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,171,62.5,55.9,69.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,AGE08,CAT3,_RFPSA22,RESP054,"(43.65595011300047, -71.50036091999965)"
|
|
2018,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,452,50.6,46.8,54.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,AGE09,CAT3,_RFPSA22,RESP046,"(43.65595011300047, -71.50036091999965)"
|
|
2018,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,440,49.4,45.5,53.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,AGE09,CAT3,_RFPSA22,RESP054,"(43.65595011300047, -71.50036091999965)"
|
|
2018,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,686,30.9,28.4,33.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,BO1,CAT1,_RFPSA22,RESP046,"(43.65595011300047, -71.50036091999965)"
|
|
2018,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1173,69.1,66.7,71.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,BO1,CAT1,_RFPSA22,RESP054,"(43.65595011300047, -71.50036091999965)"
|
|
2018,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,11,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,33,EDUCA1,CAT5,_RFPSA22,RESP046,"(43.65595011300047, -71.50036091999965)"
|
|
2018,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,55,81.8,71.1,92.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,EDUCA1,CAT5,_RFPSA22,RESP054,"(43.65595011300047, -71.50036091999965)"
|
|
2018,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,146,26.4,21.8,31.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,EDUCA2,CAT5,_RFPSA22,RESP046,"(43.65595011300047, -71.50036091999965)"
|
|
2018,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,335,73.6,68.9,78.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,EDUCA2,CAT5,_RFPSA22,RESP054,"(43.65595011300047, -71.50036091999965)"
|
|
2018,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,141,31,25.9,36.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,EDUCA3,CAT5,_RFPSA22,RESP046,"(43.65595011300047, -71.50036091999965)"
|
|
2018,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,273,69,63.8,74.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,EDUCA3,CAT5,_RFPSA22,RESP054,"(43.65595011300047, -71.50036091999965)"
|
|
2018,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,388,36.5,32.8,40.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,EDUCA4,CAT5,_RFPSA22,RESP046,"(43.65595011300047, -71.50036091999965)"
|
|
2018,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,507,63.5,59.8,67.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,EDUCA4,CAT5,_RFPSA22,RESP054,"(43.65595011300047, -71.50036091999965)"
|
|
2018,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,15,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,33,INCOME1,CAT6,_RFPSA22,RESP046,"(43.65595011300047, -71.50036091999965)"
|
|
2018,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,56,77.5,63.5,91.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,INCOME1,CAT6,_RFPSA22,RESP054,"(43.65595011300047, -71.50036091999965)"
|
|
2018,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,43,21.6,14.6,28.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,INCOME2,CAT6,_RFPSA22,RESP046,"(43.65595011300047, -71.50036091999965)"
|
|
2018,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,119,78.4,71.4,85.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,INCOME2,CAT6,_RFPSA22,RESP054,"(43.65595011300047, -71.50036091999965)"
|
|
2018,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,43,34.6,23.9,45.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,INCOME3,CAT6,_RFPSA22,RESP046,"(43.65595011300047, -71.50036091999965)"
|
|
2018,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,86,65.4,54.8,76.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,INCOME3,CAT6,_RFPSA22,RESP054,"(43.65595011300047, -71.50036091999965)"
|
|
2018,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,83,33.6,26.1,41.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,INCOME4,CAT6,_RFPSA22,RESP046,"(43.65595011300047, -71.50036091999965)"
|
|
2018,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,123,66.4,58.8,73.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,INCOME4,CAT6,_RFPSA22,RESP054,"(43.65595011300047, -71.50036091999965)"
|
|
2018,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,421,32,28.7,35.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,INCOME5,CAT6,_RFPSA22,RESP046,"(43.65595011300047, -71.50036091999965)"
|
|
2018,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,636,68,64.8,71.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,INCOME5,CAT6,_RFPSA22,RESP054,"(43.65595011300047, -71.50036091999965)"
|
|
2018,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,661,31.9,29.3,34.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,RACE01,CAT4,_RFPSA22,RESP046,"(43.65595011300047, -71.50036091999965)"
|
|
2018,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1091,68.1,65.6,70.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,RACE01,CAT4,_RFPSA22,RESP054,"(43.65595011300047, -71.50036091999965)"
|
|
2018,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,33,RACE02,CAT4,_RFPSA22,RESP046,"(43.65595011300047, -71.50036091999965)"
|
|
2018,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,13,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,33,RACE02,CAT4,_RFPSA22,RESP054,"(43.65595011300047, -71.50036091999965)"
|
|
2018,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,33,RACE03,CAT4,_RFPSA22,RESP046,"(43.65595011300047, -71.50036091999965)"
|
|
2018,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,16,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,33,RACE03,CAT4,_RFPSA22,RESP054,"(43.65595011300047, -71.50036091999965)"
|
|
2018,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,33,RACE04,CAT4,_RFPSA22,RESP046,"(43.65595011300047, -71.50036091999965)"
|
|
2018,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,33,RACE04,CAT4,_RFPSA22,RESP054,"(43.65595011300047, -71.50036091999965)"
|
|
2018,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,33,RACE05,CAT4,_RFPSA22,RESP046,"(43.65595011300047, -71.50036091999965)"
|
|
2018,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,33,RACE05,CAT4,_RFPSA22,RESP054,"(43.65595011300047, -71.50036091999965)"
|
|
2018,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,33,RACE06,CAT4,_RFPSA22,RESP046,"(43.65595011300047, -71.50036091999965)"
|
|
2018,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,12,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,33,RACE06,CAT4,_RFPSA22,RESP054,"(43.65595011300047, -71.50036091999965)"
|
|
2018,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,33,RACE07,CAT4,_RFPSA22,RESP046,"(43.65595011300047, -71.50036091999965)"
|
|
2018,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,12,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,33,RACE07,CAT4,_RFPSA22,RESP054,"(43.65595011300047, -71.50036091999965)"
|
|
2018,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,33,RACE08,CAT4,_RFPSA22,RESP046,"(43.65595011300047, -71.50036091999965)"
|
|
2018,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,17,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,33,RACE08,CAT4,_RFPSA22,RESP054,"(43.65595011300047, -71.50036091999965)"
|
|
2018,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,686,30.9,28.4,33.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,SEX1,CAT2,_RFPSA22,RESP046,"(43.65595011300047, -71.50036091999965)"
|
|
2018,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1173,69.1,66.7,71.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,SEX1,CAT2,_RFPSA22,RESP054,"(43.65595011300047, -71.50036091999965)"
|
|
2018,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,33,SEX2,CAT2,_RFPSA22,RESP046,"(43.65595011300047, -71.50036091999965)"
|
|
2018,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,33,SEX2,CAT2,_RFPSA22,RESP054,"(43.65595011300047, -71.50036091999965)"
|
|
2018,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,47,46.2,32.5,59.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,AGE08,CAT3,_RFPSA22,RESP054,"(40.13057004800049, -74.27369128799967)"
|
|
2018,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,23,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,34,AGE06,CAT3,_RFPSA22,RESP046,"(40.13057004800049, -74.27369128799967)"
|
|
2018,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,161,86.7,78.7,94.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,AGE06,CAT3,_RFPSA22,RESP054,"(40.13057004800049, -74.27369128799967)"
|
|
2018,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,77,37.4,27.3,47.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,AGE07,CAT3,_RFPSA22,RESP046,"(40.13057004800049, -74.27369128799967)"
|
|
2018,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,172,62.6,52.6,72.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,AGE07,CAT3,_RFPSA22,RESP054,"(40.13057004800049, -74.27369128799967)"
|
|
2018,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,65,53.8,40.1,67.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,AGE08,CAT3,_RFPSA22,RESP046,"(40.13057004800049, -74.27369128799967)"
|
|
2018,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,219,61.8,53.7,69.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,AGE09,CAT3,_RFPSA22,RESP046,"(40.13057004800049, -74.27369128799967)"
|
|
2018,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,135,38.2,30.2,46.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,AGE09,CAT3,_RFPSA22,RESP054,"(40.13057004800049, -74.27369128799967)"
|
|
2018,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,384,40.5,35.3,45.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,BO1,CAT1,_RFPSA22,RESP046,"(40.13057004800049, -74.27369128799967)"
|
|
2018,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,515,59.5,54.4,64.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,BO1,CAT1,_RFPSA22,RESP054,"(40.13057004800049, -74.27369128799967)"
|
|
2018,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,14,38.8,19.3,58.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,EDUCA1,CAT5,_RFPSA22,RESP046,"(40.13057004800049, -74.27369128799967)"
|
|
2018,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,47,61.2,41.8,80.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,EDUCA1,CAT5,_RFPSA22,RESP054,"(40.13057004800049, -74.27369128799967)"
|
|
2018,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,86,36.7,27.8,45.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,EDUCA2,CAT5,_RFPSA22,RESP046,"(40.13057004800049, -74.27369128799967)"
|
|
2018,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,138,63.3,54.3,72.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,EDUCA2,CAT5,_RFPSA22,RESP054,"(40.13057004800049, -74.27369128799967)"
|
|
2018,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,76,38.4,25.8,51,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,EDUCA3,CAT5,_RFPSA22,RESP046,"(40.13057004800049, -74.27369128799967)"
|
|
2018,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,113,61.6,49,74.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,EDUCA3,CAT5,_RFPSA22,RESP054,"(40.13057004800049, -74.27369128799967)"
|
|
2018,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,208,45.2,37.9,52.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,EDUCA4,CAT5,_RFPSA22,RESP046,"(40.13057004800049, -74.27369128799967)"
|
|
2018,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,215,54.8,47.6,62.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,EDUCA4,CAT5,_RFPSA22,RESP054,"(40.13057004800049, -74.27369128799967)"
|
|
2018,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,34,INCOME1,CAT6,_RFPSA22,RESP046,"(40.13057004800049, -74.27369128799967)"
|
|
2018,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,39,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,34,INCOME1,CAT6,_RFPSA22,RESP054,"(40.13057004800049, -74.27369128799967)"
|
|
2018,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,18,31,14.8,47.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,INCOME2,CAT6,_RFPSA22,RESP046,"(40.13057004800049, -74.27369128799967)"
|
|
2018,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,67,69,52.9,85.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,INCOME2,CAT6,_RFPSA22,RESP054,"(40.13057004800049, -74.27369128799967)"
|
|
2018,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,21,44.2,18.9,69.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,INCOME3,CAT6,_RFPSA22,RESP046,"(40.13057004800049, -74.27369128799967)"
|
|
2018,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,31,55.8,30.6,81.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,INCOME3,CAT6,_RFPSA22,RESP054,"(40.13057004800049, -74.27369128799967)"
|
|
2018,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,49,51.8,38.4,65.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,INCOME4,CAT6,_RFPSA22,RESP046,"(40.13057004800049, -74.27369128799967)"
|
|
2018,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,42,48.2,34.8,61.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,INCOME4,CAT6,_RFPSA22,RESP054,"(40.13057004800049, -74.27369128799967)"
|
|
2018,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,247,43.2,36.7,49.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,INCOME5,CAT6,_RFPSA22,RESP046,"(40.13057004800049, -74.27369128799967)"
|
|
2018,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,280,56.8,50.3,63.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,INCOME5,CAT6,_RFPSA22,RESP054,"(40.13057004800049, -74.27369128799967)"
|
|
2018,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,319,47,40.8,53.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,RACE01,CAT4,_RFPSA22,RESP046,"(40.13057004800049, -74.27369128799967)"
|
|
2018,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,351,53,46.7,59.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,RACE01,CAT4,_RFPSA22,RESP054,"(40.13057004800049, -74.27369128799967)"
|
|
2018,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,29,38.8,22.5,55,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,RACE02,CAT4,_RFPSA22,RESP046,"(40.13057004800049, -74.27369128799967)"
|
|
2018,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,56,61.2,45,77.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,RACE02,CAT4,_RFPSA22,RESP054,"(40.13057004800049, -74.27369128799967)"
|
|
2018,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,34,RACE03,CAT4,_RFPSA22,RESP046,"(40.13057004800049, -74.27369128799967)"
|
|
2018,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,34,RACE03,CAT4,_RFPSA22,RESP054,"(40.13057004800049, -74.27369128799967)"
|
|
2018,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,34,RACE04,CAT4,_RFPSA22,RESP046,"(40.13057004800049, -74.27369128799967)"
|
|
2018,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,31,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,34,RACE04,CAT4,_RFPSA22,RESP054,"(40.13057004800049, -74.27369128799967)"
|
|
2018,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,34,RACE05,CAT4,_RFPSA22,RESP046,"(40.13057004800049, -74.27369128799967)"
|
|
2018,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,34,RACE05,CAT4,_RFPSA22,RESP054,"(40.13057004800049, -74.27369128799967)"
|
|
2018,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,34,RACE06,CAT4,_RFPSA22,RESP046,"(40.13057004800049, -74.27369128799967)"
|
|
2018,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,34,RACE06,CAT4,_RFPSA22,RESP054,"(40.13057004800049, -74.27369128799967)"
|
|
2018,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,34,RACE07,CAT4,_RFPSA22,RESP046,"(40.13057004800049, -74.27369128799967)"
|
|
2018,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,34,RACE07,CAT4,_RFPSA22,RESP054,"(40.13057004800049, -74.27369128799967)"
|
|
2018,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,18,22,10,33.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,RACE08,CAT4,_RFPSA22,RESP046,"(40.13057004800049, -74.27369128799967)"
|
|
2018,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,69,78,66.2,90,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,RACE08,CAT4,_RFPSA22,RESP054,"(40.13057004800049, -74.27369128799967)"
|
|
2018,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,384,40.5,35.3,45.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,SEX1,CAT2,_RFPSA22,RESP046,"(40.13057004800049, -74.27369128799967)"
|
|
2018,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,515,59.5,54.4,64.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,SEX1,CAT2,_RFPSA22,RESP054,"(40.13057004800049, -74.27369128799967)"
|
|
2018,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,34,SEX2,CAT2,_RFPSA22,RESP046,"(40.13057004800049, -74.27369128799967)"
|
|
2018,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,34,SEX2,CAT2,_RFPSA22,RESP054,"(40.13057004800049, -74.27369128799967)"
|
|
2018,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,19,5.1,2.4,7.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,AGE06,CAT3,_RFPSA22,RESP046,"(34.52088095200048, -106.24058098499967)"
|
|
2018,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,327,94.9,92.2,97.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,AGE06,CAT3,_RFPSA22,RESP054,"(34.52088095200048, -106.24058098499967)"
|
|
2018,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,111,19.5,14.9,24.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,AGE07,CAT3,_RFPSA22,RESP046,"(34.52088095200048, -106.24058098499967)"
|
|
2018,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,377,80.5,75.9,85.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,AGE07,CAT3,_RFPSA22,RESP054,"(34.52088095200048, -106.24058098499967)"
|
|
2018,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,106,30.1,23.6,36.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,AGE08,CAT3,_RFPSA22,RESP046,"(34.52088095200048, -106.24058098499967)"
|
|
2018,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,218,69.9,63.4,76.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,AGE08,CAT3,_RFPSA22,RESP054,"(34.52088095200048, -106.24058098499967)"
|
|
2018,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,391,40.1,35.7,44.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,AGE09,CAT3,_RFPSA22,RESP046,"(34.52088095200048, -106.24058098499967)"
|
|
2018,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,518,59.9,55.4,64.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,AGE09,CAT3,_RFPSA22,RESP054,"(34.52088095200048, -106.24058098499967)"
|
|
2018,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,627,24.9,22.5,27.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,BO1,CAT1,_RFPSA22,RESP046,"(34.52088095200048, -106.24058098499967)"
|
|
2018,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1440,75.1,72.7,77.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,BO1,CAT1,_RFPSA22,RESP054,"(34.52088095200048, -106.24058098499967)"
|
|
2018,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,47,16.7,11,22.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,EDUCA1,CAT5,_RFPSA22,RESP046,"(34.52088095200048, -106.24058098499967)"
|
|
2018,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,202,83.3,77.6,89,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,EDUCA1,CAT5,_RFPSA22,RESP054,"(34.52088095200048, -106.24058098499967)"
|
|
2018,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,132,23.2,18.6,27.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,EDUCA2,CAT5,_RFPSA22,RESP046,"(34.52088095200048, -106.24058098499967)"
|
|
2018,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,398,76.8,72.1,81.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,EDUCA2,CAT5,_RFPSA22,RESP054,"(34.52088095200048, -106.24058098499967)"
|
|
2018,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,121,20.1,15.7,24.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,EDUCA3,CAT5,_RFPSA22,RESP046,"(34.52088095200048, -106.24058098499967)"
|
|
2018,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,346,79.9,75.5,84.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,EDUCA3,CAT5,_RFPSA22,RESP054,"(34.52088095200048, -106.24058098499967)"
|
|
2018,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,326,35.5,31.1,39.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,EDUCA4,CAT5,_RFPSA22,RESP046,"(34.52088095200048, -106.24058098499967)"
|
|
2018,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,493,64.5,60.1,68.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,EDUCA4,CAT5,_RFPSA22,RESP054,"(34.52088095200048, -106.24058098499967)"
|
|
2018,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,44,16.4,10.8,21.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,INCOME1,CAT6,_RFPSA22,RESP046,"(34.52088095200048, -106.24058098499967)"
|
|
2018,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,193,83.6,78.1,89.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,INCOME1,CAT6,_RFPSA22,RESP054,"(34.52088095200048, -106.24058098499967)"
|
|
2018,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,87,25.8,19.1,32.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,INCOME2,CAT6,_RFPSA22,RESP046,"(34.52088095200048, -106.24058098499967)"
|
|
2018,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,245,74.2,67.5,80.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,INCOME2,CAT6,_RFPSA22,RESP054,"(34.52088095200048, -106.24058098499967)"
|
|
2018,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,40,20.8,13,28.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,INCOME3,CAT6,_RFPSA22,RESP046,"(34.52088095200048, -106.24058098499967)"
|
|
2018,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,147,79.2,71.4,87,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,INCOME3,CAT6,_RFPSA22,RESP054,"(34.52088095200048, -106.24058098499967)"
|
|
2018,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,79,23.5,16.9,30.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,INCOME4,CAT6,_RFPSA22,RESP046,"(34.52088095200048, -106.24058098499967)"
|
|
2018,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,163,76.5,69.8,83.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,INCOME4,CAT6,_RFPSA22,RESP054,"(34.52088095200048, -106.24058098499967)"
|
|
2018,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,318,27.9,24.2,31.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,INCOME5,CAT6,_RFPSA22,RESP046,"(34.52088095200048, -106.24058098499967)"
|
|
2018,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,553,72.1,68.4,75.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,INCOME5,CAT6,_RFPSA22,RESP054,"(34.52088095200048, -106.24058098499967)"
|
|
2018,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,443,31,27.7,34.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,RACE01,CAT4,_RFPSA22,RESP046,"(34.52088095200048, -106.24058098499967)"
|
|
2018,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,742,69,65.6,72.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,RACE01,CAT4,_RFPSA22,RESP054,"(34.52088095200048, -106.24058098499967)"
|
|
2018,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,35,RACE02,CAT4,_RFPSA22,RESP046,"(34.52088095200048, -106.24058098499967)"
|
|
2018,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,22,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,35,RACE02,CAT4,_RFPSA22,RESP054,"(34.52088095200048, -106.24058098499967)"
|
|
2018,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,19,9.6,4.4,14.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,RACE03,CAT4,_RFPSA22,RESP046,"(34.52088095200048, -106.24058098499967)"
|
|
2018,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,141,90.4,85.1,95.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,RACE03,CAT4,_RFPSA22,RESP054,"(34.52088095200048, -106.24058098499967)"
|
|
2018,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,35,RACE04,CAT4,_RFPSA22,RESP046,"(34.52088095200048, -106.24058098499967)"
|
|
2018,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,35,RACE04,CAT4,_RFPSA22,RESP054,"(34.52088095200048, -106.24058098499967)"
|
|
2018,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,35,RACE05,CAT4,_RFPSA22,RESP046,"(34.52088095200048, -106.24058098499967)"
|
|
2018,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,35,RACE05,CAT4,_RFPSA22,RESP054,"(34.52088095200048, -106.24058098499967)"
|
|
2018,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,35,RACE06,CAT4,_RFPSA22,RESP046,"(34.52088095200048, -106.24058098499967)"
|
|
2018,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,16,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,35,RACE06,CAT4,_RFPSA22,RESP054,"(34.52088095200048, -106.24058098499967)"
|
|
2018,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,35,RACE07,CAT4,_RFPSA22,RESP046,"(34.52088095200048, -106.24058098499967)"
|
|
2018,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,18,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,35,RACE07,CAT4,_RFPSA22,RESP054,"(34.52088095200048, -106.24058098499967)"
|
|
2018,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,137,19.6,15.8,23.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,RACE08,CAT4,_RFPSA22,RESP046,"(34.52088095200048, -106.24058098499967)"
|
|
2018,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,489,80.4,76.5,84.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,RACE08,CAT4,_RFPSA22,RESP054,"(34.52088095200048, -106.24058098499967)"
|
|
2018,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,627,24.9,22.5,27.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,SEX1,CAT2,_RFPSA22,RESP046,"(34.52088095200048, -106.24058098499967)"
|
|
2018,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1440,75.1,72.7,77.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,SEX1,CAT2,_RFPSA22,RESP054,"(34.52088095200048, -106.24058098499967)"
|
|
2018,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,35,SEX2,CAT2,_RFPSA22,RESP046,"(34.52088095200048, -106.24058098499967)"
|
|
2018,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,35,SEX2,CAT2,_RFPSA22,RESP054,"(34.52088095200048, -106.24058098499967)"
|
|
2018,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,153,10.1,7.8,12.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,AGE06,CAT3,_RFPSA22,RESP046,"(42.82700103200045, -75.54397042699964)"
|
|
2018,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,1598,89.9,87.6,92.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,AGE06,CAT3,_RFPSA22,RESP054,"(42.82700103200045, -75.54397042699964)"
|
|
2018,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,759,28.7,25.7,31.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,AGE07,CAT3,_RFPSA22,RESP046,"(42.82700103200045, -75.54397042699964)"
|
|
2018,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,1888,71.3,68.3,74.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,AGE07,CAT3,_RFPSA22,RESP054,"(42.82700103200045, -75.54397042699964)"
|
|
2018,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,698,48.4,43.4,53.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,AGE08,CAT3,_RFPSA22,RESP046,"(42.82700103200045, -75.54397042699964)"
|
|
2018,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,853,51.6,46.6,56.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,AGE08,CAT3,_RFPSA22,RESP054,"(42.82700103200045, -75.54397042699964)"
|
|
2018,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,2075,54.1,50.8,57.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,AGE09,CAT3,_RFPSA22,RESP046,"(42.82700103200045, -75.54397042699964)"
|
|
2018,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,2034,45.9,42.7,49.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,AGE09,CAT3,_RFPSA22,RESP054,"(42.82700103200045, -75.54397042699964)"
|
|
2018,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,3685,35,33.3,36.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,BO1,CAT1,_RFPSA22,RESP046,"(42.82700103200045, -75.54397042699964)"
|
|
2018,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,6373,65,63.2,66.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,BO1,CAT1,_RFPSA22,RESP054,"(42.82700103200045, -75.54397042699964)"
|
|
2018,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,152,19.8,14.7,25,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,EDUCA1,CAT5,_RFPSA22,RESP046,"(42.82700103200045, -75.54397042699964)"
|
|
2018,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,671,80.2,75,85.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,EDUCA1,CAT5,_RFPSA22,RESP054,"(42.82700103200045, -75.54397042699964)"
|
|
2018,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,870,30.8,27.4,34.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,EDUCA2,CAT5,_RFPSA22,RESP046,"(42.82700103200045, -75.54397042699964)"
|
|
2018,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,2094,69.2,65.8,72.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,EDUCA2,CAT5,_RFPSA22,RESP054,"(42.82700103200045, -75.54397042699964)"
|
|
2018,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,930,36.5,32.9,40.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,EDUCA3,CAT5,_RFPSA22,RESP046,"(42.82700103200045, -75.54397042699964)"
|
|
2018,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,1555,63.5,59.8,67.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,EDUCA3,CAT5,_RFPSA22,RESP054,"(42.82700103200045, -75.54397042699964)"
|
|
2018,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,1721,44.2,41.4,47,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,EDUCA4,CAT5,_RFPSA22,RESP046,"(42.82700103200045, -75.54397042699964)"
|
|
2018,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,2029,55.8,53,58.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,EDUCA4,CAT5,_RFPSA22,RESP054,"(42.82700103200045, -75.54397042699964)"
|
|
2018,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,187,25.7,19.2,32.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,INCOME1,CAT6,_RFPSA22,RESP046,"(42.82700103200045, -75.54397042699964)"
|
|
2018,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,609,74.3,67.8,80.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,INCOME1,CAT6,_RFPSA22,RESP054,"(42.82700103200045, -75.54397042699964)"
|
|
2018,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,357,23.9,19.2,28.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,INCOME2,CAT6,_RFPSA22,RESP046,"(42.82700103200045, -75.54397042699964)"
|
|
2018,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,975,76.1,71.4,80.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,INCOME2,CAT6,_RFPSA22,RESP054,"(42.82700103200045, -75.54397042699964)"
|
|
2018,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,306,33,26.3,39.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,INCOME3,CAT6,_RFPSA22,RESP046,"(42.82700103200045, -75.54397042699964)"
|
|
2018,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,615,67,60.3,73.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,INCOME3,CAT6,_RFPSA22,RESP054,"(42.82700103200045, -75.54397042699964)"
|
|
2018,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,370,31.1,24.5,37.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,INCOME4,CAT6,_RFPSA22,RESP046,"(42.82700103200045, -75.54397042699964)"
|
|
2018,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,682,68.9,62.2,75.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,INCOME4,CAT6,_RFPSA22,RESP054,"(42.82700103200045, -75.54397042699964)"
|
|
2018,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,2017,40.1,37.6,42.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,INCOME5,CAT6,_RFPSA22,RESP046,"(42.82700103200045, -75.54397042699964)"
|
|
2018,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,2643,59.9,57.5,62.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,INCOME5,CAT6,_RFPSA22,RESP054,"(42.82700103200045, -75.54397042699964)"
|
|
2018,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,3173,39,37,41,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,RACE01,CAT4,_RFPSA22,RESP046,"(42.82700103200045, -75.54397042699964)"
|
|
2018,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,5010,61,59,63,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,RACE01,CAT4,_RFPSA22,RESP054,"(42.82700103200045, -75.54397042699964)"
|
|
2018,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,204,33.5,28.5,38.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,RACE02,CAT4,_RFPSA22,RESP046,"(42.82700103200045, -75.54397042699964)"
|
|
2018,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,428,66.5,61.4,71.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,RACE02,CAT4,_RFPSA22,RESP054,"(42.82700103200045, -75.54397042699964)"
|
|
2018,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,30,30.3,14.2,46.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,RACE03,CAT4,_RFPSA22,RESP046,"(42.82700103200045, -75.54397042699964)"
|
|
2018,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,96,69.7,53.7,85.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,RACE03,CAT4,_RFPSA22,RESP054,"(42.82700103200045, -75.54397042699964)"
|
|
2018,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,50,29.6,20.2,39,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,RACE04,CAT4,_RFPSA22,RESP046,"(42.82700103200045, -75.54397042699964)"
|
|
2018,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,151,70.4,61,79.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,RACE04,CAT4,_RFPSA22,RESP054,"(42.82700103200045, -75.54397042699964)"
|
|
2018,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,36,RACE05,CAT4,_RFPSA22,RESP046,"(42.82700103200045, -75.54397042699964)"
|
|
2018,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,16,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,36,RACE05,CAT4,_RFPSA22,RESP054,"(42.82700103200045, -75.54397042699964)"
|
|
2018,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,42,10.9,4.9,16.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,RACE06,CAT4,_RFPSA22,RESP046,"(42.82700103200045, -75.54397042699964)"
|
|
2018,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,130,89.1,83.1,95.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,RACE06,CAT4,_RFPSA22,RESP054,"(42.82700103200045, -75.54397042699964)"
|
|
2018,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,46,41.9,25.5,58.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,RACE07,CAT4,_RFPSA22,RESP046,"(42.82700103200045, -75.54397042699964)"
|
|
2018,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,102,58.1,41.8,74.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,RACE07,CAT4,_RFPSA22,RESP054,"(42.82700103200045, -75.54397042699964)"
|
|
2018,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,140,23.4,18.1,28.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,RACE08,CAT4,_RFPSA22,RESP046,"(42.82700103200045, -75.54397042699964)"
|
|
2018,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,440,76.6,71.4,81.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,RACE08,CAT4,_RFPSA22,RESP054,"(42.82700103200045, -75.54397042699964)"
|
|
2018,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,3685,35,33.3,36.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,SEX1,CAT2,_RFPSA22,RESP046,"(42.82700103200045, -75.54397042699964)"
|
|
2018,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,6373,65,63.2,66.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,SEX1,CAT2,_RFPSA22,RESP054,"(42.82700103200045, -75.54397042699964)"
|
|
2018,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,36,SEX2,CAT2,_RFPSA22,RESP046,"(42.82700103200045, -75.54397042699964)"
|
|
2018,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,36,SEX2,CAT2,_RFPSA22,RESP054,"(42.82700103200045, -75.54397042699964)"
|
|
2018,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,811,65.3,62.2,68.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,BO1,CAT1,_RFPSA22,RESP054,"(35.466220975000454, -79.15925046299964)"
|
|
2018,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,33,10.2,6.2,14.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,AGE06,CAT3,_RFPSA22,RESP046,"(35.466220975000454, -79.15925046299964)"
|
|
2018,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,255,89.8,85.9,93.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,AGE06,CAT3,_RFPSA22,RESP054,"(35.466220975000454, -79.15925046299964)"
|
|
2018,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,98,27.5,21.9,33.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,AGE07,CAT3,_RFPSA22,RESP046,"(35.466220975000454, -79.15925046299964)"
|
|
2018,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,247,72.5,66.8,78.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,AGE07,CAT3,_RFPSA22,RESP054,"(35.466220975000454, -79.15925046299964)"
|
|
2018,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,86,50.4,40.4,60.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,AGE08,CAT3,_RFPSA22,RESP046,"(35.466220975000454, -79.15925046299964)"
|
|
2018,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,81,49.6,39.6,59.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,AGE08,CAT3,_RFPSA22,RESP054,"(35.466220975000454, -79.15925046299964)"
|
|
2018,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,314,56.2,50.8,61.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,AGE09,CAT3,_RFPSA22,RESP046,"(35.466220975000454, -79.15925046299964)"
|
|
2018,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,228,43.8,38.4,49.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,AGE09,CAT3,_RFPSA22,RESP054,"(35.466220975000454, -79.15925046299964)"
|
|
2018,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,531,34.7,31.5,37.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,BO1,CAT1,_RFPSA22,RESP046,"(35.466220975000454, -79.15925046299964)"
|
|
2018,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,36,21.1,13.1,29.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,EDUCA1,CAT5,_RFPSA22,RESP046,"(35.466220975000454, -79.15925046299964)"
|
|
2018,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,116,78.9,70.8,86.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,EDUCA1,CAT5,_RFPSA22,RESP054,"(35.466220975000454, -79.15925046299964)"
|
|
2018,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,131,38.5,32.1,45,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,EDUCA2,CAT5,_RFPSA22,RESP046,"(35.466220975000454, -79.15925046299964)"
|
|
2018,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,209,61.5,55,67.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,EDUCA2,CAT5,_RFPSA22,RESP054,"(35.466220975000454, -79.15925046299964)"
|
|
2018,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,120,29.5,23.9,35.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,EDUCA3,CAT5,_RFPSA22,RESP046,"(35.466220975000454, -79.15925046299964)"
|
|
2018,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,242,70.5,64.8,76.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,EDUCA3,CAT5,_RFPSA22,RESP054,"(35.466220975000454, -79.15925046299964)"
|
|
2018,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,242,43.5,38.2,48.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,EDUCA4,CAT5,_RFPSA22,RESP046,"(35.466220975000454, -79.15925046299964)"
|
|
2018,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,242,56.5,51.2,61.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,EDUCA4,CAT5,_RFPSA22,RESP054,"(35.466220975000454, -79.15925046299964)"
|
|
2018,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,26,27.1,15.1,39.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,INCOME1,CAT6,_RFPSA22,RESP046,"(35.466220975000454, -79.15925046299964)"
|
|
2018,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,65,72.9,60.8,84.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,INCOME1,CAT6,_RFPSA22,RESP054,"(35.466220975000454, -79.15925046299964)"
|
|
2018,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,50,27.6,19.1,36.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,INCOME2,CAT6,_RFPSA22,RESP046,"(35.466220975000454, -79.15925046299964)"
|
|
2018,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,127,72.4,63.8,80.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,INCOME2,CAT6,_RFPSA22,RESP054,"(35.466220975000454, -79.15925046299964)"
|
|
2018,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,42,35.5,24.8,46.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,INCOME3,CAT6,_RFPSA22,RESP046,"(35.466220975000454, -79.15925046299964)"
|
|
2018,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,69,64.5,53.7,75.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,INCOME3,CAT6,_RFPSA22,RESP054,"(35.466220975000454, -79.15925046299964)"
|
|
2018,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,69,36.3,27,45.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,INCOME4,CAT6,_RFPSA22,RESP046,"(35.466220975000454, -79.15925046299964)"
|
|
2018,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,87,63.7,54.5,73,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,INCOME4,CAT6,_RFPSA22,RESP054,"(35.466220975000454, -79.15925046299964)"
|
|
2018,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,268,36.6,31.9,41.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,INCOME5,CAT6,_RFPSA22,RESP046,"(35.466220975000454, -79.15925046299964)"
|
|
2018,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,345,63.4,58.8,68.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,INCOME5,CAT6,_RFPSA22,RESP054,"(35.466220975000454, -79.15925046299964)"
|
|
2018,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,404,36.7,32.9,40.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,RACE01,CAT4,_RFPSA22,RESP046,"(35.466220975000454, -79.15925046299964)"
|
|
2018,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,569,63.3,59.6,67.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,RACE01,CAT4,_RFPSA22,RESP054,"(35.466220975000454, -79.15925046299964)"
|
|
2018,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,86,33.8,26.4,41.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,RACE02,CAT4,_RFPSA22,RESP046,"(35.466220975000454, -79.15925046299964)"
|
|
2018,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,132,66.2,58.9,73.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,RACE02,CAT4,_RFPSA22,RESP054,"(35.466220975000454, -79.15925046299964)"
|
|
2018,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,37,RACE03,CAT4,_RFPSA22,RESP046,"(35.466220975000454, -79.15925046299964)"
|
|
2018,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,19,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,37,RACE03,CAT4,_RFPSA22,RESP054,"(35.466220975000454, -79.15925046299964)"
|
|
2018,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,37,RACE04,CAT4,_RFPSA22,RESP046,"(35.466220975000454, -79.15925046299964)"
|
|
2018,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,37,RACE04,CAT4,_RFPSA22,RESP054,"(35.466220975000454, -79.15925046299964)"
|
|
2018,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,37,RACE05,CAT4,_RFPSA22,RESP046,"(35.466220975000454, -79.15925046299964)"
|
|
2018,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,37,RACE05,CAT4,_RFPSA22,RESP054,"(35.466220975000454, -79.15925046299964)"
|
|
2018,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,37,RACE06,CAT4,_RFPSA22,RESP046,"(35.466220975000454, -79.15925046299964)"
|
|
2018,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,37,RACE06,CAT4,_RFPSA22,RESP054,"(35.466220975000454, -79.15925046299964)"
|
|
2018,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,37,RACE07,CAT4,_RFPSA22,RESP046,"(35.466220975000454, -79.15925046299964)"
|
|
2018,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,16,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,37,RACE07,CAT4,_RFPSA22,RESP054,"(35.466220975000454, -79.15925046299964)"
|
|
2018,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,14,16,6.7,25.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,RACE08,CAT4,_RFPSA22,RESP046,"(35.466220975000454, -79.15925046299964)"
|
|
2018,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,60,84,74.8,93.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,RACE08,CAT4,_RFPSA22,RESP054,"(35.466220975000454, -79.15925046299964)"
|
|
2018,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,531,34.7,31.5,37.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,SEX1,CAT2,_RFPSA22,RESP046,"(35.466220975000454, -79.15925046299964)"
|
|
2018,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,811,65.3,62.2,68.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,SEX1,CAT2,_RFPSA22,RESP054,"(35.466220975000454, -79.15925046299964)"
|
|
2018,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,37,SEX2,CAT2,_RFPSA22,RESP046,"(35.466220975000454, -79.15925046299964)"
|
|
2018,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,37,SEX2,CAT2,_RFPSA22,RESP054,"(35.466220975000454, -79.15925046299964)"
|
|
2018,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,29,11.4,7.2,15.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,AGE06,CAT3,_RFPSA22,RESP046,"(47.47531977900047, -100.11842104899966)"
|
|
2018,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,239,88.6,84.4,92.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,AGE06,CAT3,_RFPSA22,RESP054,"(47.47531977900047, -100.11842104899966)"
|
|
2018,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,141,28.1,23.3,32.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,AGE07,CAT3,_RFPSA22,RESP046,"(47.47531977900047, -100.11842104899966)"
|
|
2018,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,296,71.9,67.1,76.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,AGE07,CAT3,_RFPSA22,RESP054,"(47.47531977900047, -100.11842104899966)"
|
|
2018,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,135,41.4,34.9,47.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,AGE08,CAT3,_RFPSA22,RESP046,"(47.47531977900047, -100.11842104899966)"
|
|
2018,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,167,58.6,52.1,65.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,AGE08,CAT3,_RFPSA22,RESP054,"(47.47531977900047, -100.11842104899966)"
|
|
2018,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,454,50.9,46.9,55,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,AGE09,CAT3,_RFPSA22,RESP046,"(47.47531977900047, -100.11842104899966)"
|
|
2018,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,421,49.1,45,53.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,AGE09,CAT3,_RFPSA22,RESP054,"(47.47531977900047, -100.11842104899966)"
|
|
2018,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,759,33.8,31.2,36.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,BO1,CAT1,_RFPSA22,RESP046,"(47.47531977900047, -100.11842104899966)"
|
|
2018,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1123,66.2,63.7,68.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,BO1,CAT1,_RFPSA22,RESP054,"(47.47531977900047, -100.11842104899966)"
|
|
2018,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,28,22.6,13.6,31.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,EDUCA1,CAT5,_RFPSA22,RESP046,"(47.47531977900047, -100.11842104899966)"
|
|
2018,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,84,77.4,68.4,86.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,EDUCA1,CAT5,_RFPSA22,RESP054,"(47.47531977900047, -100.11842104899966)"
|
|
2018,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,176,27.9,23.4,32.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,EDUCA2,CAT5,_RFPSA22,RESP046,"(47.47531977900047, -100.11842104899966)"
|
|
2018,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,354,72.1,67.7,76.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,EDUCA2,CAT5,_RFPSA22,RESP054,"(47.47531977900047, -100.11842104899966)"
|
|
2018,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,239,34.9,30.4,39.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,EDUCA3,CAT5,_RFPSA22,RESP046,"(47.47531977900047, -100.11842104899966)"
|
|
2018,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,337,65.1,60.6,69.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,EDUCA3,CAT5,_RFPSA22,RESP054,"(47.47531977900047, -100.11842104899966)"
|
|
2018,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,316,41.7,37.3,46.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,EDUCA4,CAT5,_RFPSA22,RESP046,"(47.47531977900047, -100.11842104899966)"
|
|
2018,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,348,58.3,53.8,62.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,EDUCA4,CAT5,_RFPSA22,RESP054,"(47.47531977900047, -100.11842104899966)"
|
|
2018,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,23,27,14.5,39.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,INCOME1,CAT6,_RFPSA22,RESP046,"(47.47531977900047, -100.11842104899966)"
|
|
2018,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,65,73,60.5,85.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,INCOME1,CAT6,_RFPSA22,RESP054,"(47.47531977900047, -100.11842104899966)"
|
|
2018,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,52,21.6,14.6,28.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,INCOME2,CAT6,_RFPSA22,RESP046,"(47.47531977900047, -100.11842104899966)"
|
|
2018,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,125,78.4,71.4,85.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,INCOME2,CAT6,_RFPSA22,RESP054,"(47.47531977900047, -100.11842104899966)"
|
|
2018,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,46,27.6,18.4,36.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,INCOME3,CAT6,_RFPSA22,RESP046,"(47.47531977900047, -100.11842104899966)"
|
|
2018,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,95,72.4,63.2,81.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,INCOME3,CAT6,_RFPSA22,RESP054,"(47.47531977900047, -100.11842104899966)"
|
|
2018,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,100,32.6,25.9,39.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,INCOME4,CAT6,_RFPSA22,RESP046,"(47.47531977900047, -100.11842104899966)"
|
|
2018,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,155,67.4,60.7,74.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,INCOME4,CAT6,_RFPSA22,RESP054,"(47.47531977900047, -100.11842104899966)"
|
|
2018,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,484,37.9,34.5,41.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,INCOME5,CAT6,_RFPSA22,RESP046,"(47.47531977900047, -100.11842104899966)"
|
|
2018,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,583,62.1,58.7,65.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,INCOME5,CAT6,_RFPSA22,RESP054,"(47.47531977900047, -100.11842104899966)"
|
|
2018,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,729,34.8,32.2,37.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,RACE01,CAT4,_RFPSA22,RESP046,"(47.47531977900047, -100.11842104899966)"
|
|
2018,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1035,65.2,62.6,67.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,RACE01,CAT4,_RFPSA22,RESP054,"(47.47531977900047, -100.11842104899966)"
|
|
2018,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,38,RACE02,CAT4,_RFPSA22,RESP046,"(47.47531977900047, -100.11842104899966)"
|
|
2018,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,16,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,38,RACE02,CAT4,_RFPSA22,RESP054,"(47.47531977900047, -100.11842104899966)"
|
|
2018,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,14,30.1,14.2,46.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,RACE03,CAT4,_RFPSA22,RESP046,"(47.47531977900047, -100.11842104899966)"
|
|
2018,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,36,69.9,53.9,85.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,RACE03,CAT4,_RFPSA22,RESP054,"(47.47531977900047, -100.11842104899966)"
|
|
2018,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,38,RACE04,CAT4,_RFPSA22,RESP046,"(47.47531977900047, -100.11842104899966)"
|
|
2018,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,38,RACE04,CAT4,_RFPSA22,RESP054,"(47.47531977900047, -100.11842104899966)"
|
|
2018,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,38,RACE05,CAT4,_RFPSA22,RESP046,"(47.47531977900047, -100.11842104899966)"
|
|
2018,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,38,RACE05,CAT4,_RFPSA22,RESP054,"(47.47531977900047, -100.11842104899966)"
|
|
2018,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,38,RACE06,CAT4,_RFPSA22,RESP046,"(47.47531977900047, -100.11842104899966)"
|
|
2018,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,38,RACE06,CAT4,_RFPSA22,RESP054,"(47.47531977900047, -100.11842104899966)"
|
|
2018,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,38,RACE07,CAT4,_RFPSA22,RESP046,"(47.47531977900047, -100.11842104899966)"
|
|
2018,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,38,RACE07,CAT4,_RFPSA22,RESP054,"(47.47531977900047, -100.11842104899966)"
|
|
2018,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,38,RACE08,CAT4,_RFPSA22,RESP046,"(47.47531977900047, -100.11842104899966)"
|
|
2018,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,17,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,38,RACE08,CAT4,_RFPSA22,RESP054,"(47.47531977900047, -100.11842104899966)"
|
|
2018,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,759,33.8,31.2,36.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,SEX1,CAT2,_RFPSA22,RESP046,"(47.47531977900047, -100.11842104899966)"
|
|
2018,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1123,66.2,63.7,68.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,SEX1,CAT2,_RFPSA22,RESP054,"(47.47531977900047, -100.11842104899966)"
|
|
2018,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,38,SEX2,CAT2,_RFPSA22,RESP046,"(47.47531977900047, -100.11842104899966)"
|
|
2018,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,38,SEX2,CAT2,_RFPSA22,RESP054,"(47.47531977900047, -100.11842104899966)"
|
|
2018,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,42,7,4.3,9.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,AGE06,CAT3,_RFPSA22,RESP046,"(40.06021014100048, -82.40426005599966)"
|
|
2018,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,548,93,90.3,95.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,AGE06,CAT3,_RFPSA22,RESP054,"(40.06021014100048, -82.40426005599966)"
|
|
2018,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,290,32.1,27.9,36.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,AGE07,CAT3,_RFPSA22,RESP046,"(40.06021014100048, -82.40426005599966)"
|
|
2018,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,651,67.9,63.6,72.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,AGE07,CAT3,_RFPSA22,RESP054,"(40.06021014100048, -82.40426005599966)"
|
|
2018,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,283,43.9,38.4,49.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,AGE08,CAT3,_RFPSA22,RESP046,"(40.06021014100048, -82.40426005599966)"
|
|
2018,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,329,56.1,50.6,61.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,AGE08,CAT3,_RFPSA22,RESP054,"(40.06021014100048, -82.40426005599966)"
|
|
2018,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,866,50.6,47.2,53.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,AGE09,CAT3,_RFPSA22,RESP046,"(40.06021014100048, -82.40426005599966)"
|
|
2018,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,795,49.4,46.1,52.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,AGE09,CAT3,_RFPSA22,RESP054,"(40.06021014100048, -82.40426005599966)"
|
|
2018,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1481,33.9,31.8,36,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,BO1,CAT1,_RFPSA22,RESP046,"(40.06021014100048, -82.40426005599966)"
|
|
2018,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,2323,66.1,64,68.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,BO1,CAT1,_RFPSA22,RESP054,"(40.06021014100048, -82.40426005599966)"
|
|
2018,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,50,17.3,11.3,23.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,EDUCA1,CAT5,_RFPSA22,RESP046,"(40.06021014100048, -82.40426005599966)"
|
|
2018,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,194,82.7,76.7,88.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,EDUCA1,CAT5,_RFPSA22,RESP054,"(40.06021014100048, -82.40426005599966)"
|
|
2018,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,486,31.8,28.3,35.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,EDUCA2,CAT5,_RFPSA22,RESP046,"(40.06021014100048, -82.40426005599966)"
|
|
2018,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,947,68.2,64.7,71.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,EDUCA2,CAT5,_RFPSA22,RESP054,"(40.06021014100048, -82.40426005599966)"
|
|
2018,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,380,35.7,31.6,39.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,EDUCA3,CAT5,_RFPSA22,RESP046,"(40.06021014100048, -82.40426005599966)"
|
|
2018,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,568,64.3,60.2,68.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,EDUCA3,CAT5,_RFPSA22,RESP054,"(40.06021014100048, -82.40426005599966)"
|
|
2018,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,562,42.2,38.3,46,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,EDUCA4,CAT5,_RFPSA22,RESP046,"(40.06021014100048, -82.40426005599966)"
|
|
2018,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,610,57.8,54,61.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,EDUCA4,CAT5,_RFPSA22,RESP054,"(40.06021014100048, -82.40426005599966)"
|
|
2018,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,60,24.7,14.8,34.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,INCOME1,CAT6,_RFPSA22,RESP046,"(40.06021014100048, -82.40426005599966)"
|
|
2018,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,204,75.3,65.4,85.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,INCOME1,CAT6,_RFPSA22,RESP054,"(40.06021014100048, -82.40426005599966)"
|
|
2018,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,184,29.1,24,34.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,INCOME2,CAT6,_RFPSA22,RESP046,"(40.06021014100048, -82.40426005599966)"
|
|
2018,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,378,70.9,65.8,76,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,INCOME2,CAT6,_RFPSA22,RESP054,"(40.06021014100048, -82.40426005599966)"
|
|
2018,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,135,32.6,26,39.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,INCOME3,CAT6,_RFPSA22,RESP046,"(40.06021014100048, -82.40426005599966)"
|
|
2018,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,243,67.4,60.8,74,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,INCOME3,CAT6,_RFPSA22,RESP054,"(40.06021014100048, -82.40426005599966)"
|
|
2018,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,205,32,26.6,37.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,INCOME4,CAT6,_RFPSA22,RESP046,"(40.06021014100048, -82.40426005599966)"
|
|
2018,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,313,68,62.5,73.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,INCOME4,CAT6,_RFPSA22,RESP054,"(40.06021014100048, -82.40426005599966)"
|
|
2018,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,715,36.2,33.1,39.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,INCOME5,CAT6,_RFPSA22,RESP046,"(40.06021014100048, -82.40426005599966)"
|
|
2018,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,947,63.8,60.6,66.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,INCOME5,CAT6,_RFPSA22,RESP054,"(40.06021014100048, -82.40426005599966)"
|
|
2018,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1357,34.8,32.6,37,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,RACE01,CAT4,_RFPSA22,RESP046,"(40.06021014100048, -82.40426005599966)"
|
|
2018,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,2057,65.2,63,67.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,RACE01,CAT4,_RFPSA22,RESP054,"(40.06021014100048, -82.40426005599966)"
|
|
2018,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,78,34,25.6,42.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,RACE02,CAT4,_RFPSA22,RESP046,"(40.06021014100048, -82.40426005599966)"
|
|
2018,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,128,66,57.7,74.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,RACE02,CAT4,_RFPSA22,RESP054,"(40.06021014100048, -82.40426005599966)"
|
|
2018,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,39,RACE03,CAT4,_RFPSA22,RESP046,"(40.06021014100048, -82.40426005599966)"
|
|
2018,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,29,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,39,RACE03,CAT4,_RFPSA22,RESP054,"(40.06021014100048, -82.40426005599966)"
|
|
2018,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,39,RACE04,CAT4,_RFPSA22,RESP046,"(40.06021014100048, -82.40426005599966)"
|
|
2018,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,20,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,39,RACE04,CAT4,_RFPSA22,RESP054,"(40.06021014100048, -82.40426005599966)"
|
|
2018,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,39,RACE05,CAT4,_RFPSA22,RESP046,"(40.06021014100048, -82.40426005599966)"
|
|
2018,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,39,RACE05,CAT4,_RFPSA22,RESP054,"(40.06021014100048, -82.40426005599966)"
|
|
2018,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,39,RACE06,CAT4,_RFPSA22,RESP046,"(40.06021014100048, -82.40426005599966)"
|
|
2018,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,12,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,39,RACE06,CAT4,_RFPSA22,RESP054,"(40.06021014100048, -82.40426005599966)"
|
|
2018,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,17,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,39,RACE07,CAT4,_RFPSA22,RESP046,"(40.06021014100048, -82.40426005599966)"
|
|
2018,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,44,73.6,56.9,90.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,RACE07,CAT4,_RFPSA22,RESP054,"(40.06021014100048, -82.40426005599966)"
|
|
2018,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,39,RACE08,CAT4,_RFPSA22,RESP046,"(40.06021014100048, -82.40426005599966)"
|
|
2018,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,32,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,39,RACE08,CAT4,_RFPSA22,RESP054,"(40.06021014100048, -82.40426005599966)"
|
|
2018,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1481,33.9,31.8,36,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,SEX1,CAT2,_RFPSA22,RESP046,"(40.06021014100048, -82.40426005599966)"
|
|
2018,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,2323,66.1,64,68.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,SEX1,CAT2,_RFPSA22,RESP054,"(40.06021014100048, -82.40426005599966)"
|
|
2018,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,39,SEX2,CAT2,_RFPSA22,RESP046,"(40.06021014100048, -82.40426005599966)"
|
|
2018,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,39,SEX2,CAT2,_RFPSA22,RESP054,"(40.06021014100048, -82.40426005599966)"
|
|
2018,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,26,9.4,5.5,13.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,AGE06,CAT3,_RFPSA22,RESP046,"(35.47203135600046, -97.52107021399968)"
|
|
2018,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,217,90.6,86.7,94.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,AGE06,CAT3,_RFPSA22,RESP054,"(35.47203135600046, -97.52107021399968)"
|
|
2018,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,94,26.3,20.6,31.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,AGE07,CAT3,_RFPSA22,RESP046,"(35.47203135600046, -97.52107021399968)"
|
|
2018,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,250,73.7,68.1,79.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,AGE07,CAT3,_RFPSA22,RESP054,"(35.47203135600046, -97.52107021399968)"
|
|
2018,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,91,40.6,33,48.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,AGE08,CAT3,_RFPSA22,RESP046,"(35.47203135600046, -97.52107021399968)"
|
|
2018,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,124,59.4,51.8,67,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,AGE08,CAT3,_RFPSA22,RESP054,"(35.47203135600046, -97.52107021399968)"
|
|
2018,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,394,55.5,51.2,59.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,AGE09,CAT3,_RFPSA22,RESP046,"(35.47203135600046, -97.52107021399968)"
|
|
2018,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,295,44.5,40.1,48.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,AGE09,CAT3,_RFPSA22,RESP054,"(35.47203135600046, -97.52107021399968)"
|
|
2018,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,605,32.8,30,35.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,BO1,CAT1,_RFPSA22,RESP046,"(35.47203135600046, -97.52107021399968)"
|
|
2018,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,886,67.2,64.5,70,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,BO1,CAT1,_RFPSA22,RESP054,"(35.47203135600046, -97.52107021399968)"
|
|
2018,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,23,18.8,10.3,27.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,EDUCA1,CAT5,_RFPSA22,RESP046,"(35.47203135600046, -97.52107021399968)"
|
|
2018,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,93,81.2,72.8,89.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,EDUCA1,CAT5,_RFPSA22,RESP054,"(35.47203135600046, -97.52107021399968)"
|
|
2018,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,137,29.9,24.8,35,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,EDUCA2,CAT5,_RFPSA22,RESP046,"(35.47203135600046, -97.52107021399968)"
|
|
2018,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,268,70.1,65,75.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,EDUCA2,CAT5,_RFPSA22,RESP054,"(35.47203135600046, -97.52107021399968)"
|
|
2018,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,170,34.9,29.8,40,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,EDUCA3,CAT5,_RFPSA22,RESP046,"(35.47203135600046, -97.52107021399968)"
|
|
2018,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,250,65.1,60,70.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,EDUCA3,CAT5,_RFPSA22,RESP054,"(35.47203135600046, -97.52107021399968)"
|
|
2018,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,275,41.8,37,46.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,EDUCA4,CAT5,_RFPSA22,RESP046,"(35.47203135600046, -97.52107021399968)"
|
|
2018,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,270,58.2,53.4,63,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,EDUCA4,CAT5,_RFPSA22,RESP054,"(35.47203135600046, -97.52107021399968)"
|
|
2018,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,17,15.5,6.9,24,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,INCOME1,CAT6,_RFPSA22,RESP046,"(35.47203135600046, -97.52107021399968)"
|
|
2018,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,71,84.5,76,93.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,INCOME1,CAT6,_RFPSA22,RESP054,"(35.47203135600046, -97.52107021399968)"
|
|
2018,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,55,23.9,16.2,31.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,INCOME2,CAT6,_RFPSA22,RESP046,"(35.47203135600046, -97.52107021399968)"
|
|
2018,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,145,76.1,68.4,83.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,INCOME2,CAT6,_RFPSA22,RESP054,"(35.47203135600046, -97.52107021399968)"
|
|
2018,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,62,39.3,29.7,48.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,INCOME3,CAT6,_RFPSA22,RESP046,"(35.47203135600046, -97.52107021399968)"
|
|
2018,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,71,60.7,51.1,70.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,INCOME3,CAT6,_RFPSA22,RESP054,"(35.47203135600046, -97.52107021399968)"
|
|
2018,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,93,35.4,27.5,43.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,INCOME4,CAT6,_RFPSA22,RESP046,"(35.47203135600046, -97.52107021399968)"
|
|
2018,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,108,64.6,56.7,72.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,INCOME4,CAT6,_RFPSA22,RESP054,"(35.47203135600046, -97.52107021399968)"
|
|
2018,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,322,37.8,33.6,41.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,INCOME5,CAT6,_RFPSA22,RESP046,"(35.47203135600046, -97.52107021399968)"
|
|
2018,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,378,62.2,58.1,66.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,INCOME5,CAT6,_RFPSA22,RESP054,"(35.47203135600046, -97.52107021399968)"
|
|
2018,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,502,34.9,31.8,38.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,RACE01,CAT4,_RFPSA22,RESP046,"(35.47203135600046, -97.52107021399968)"
|
|
2018,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,674,65.1,61.9,68.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,RACE01,CAT4,_RFPSA22,RESP054,"(35.47203135600046, -97.52107021399968)"
|
|
2018,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,22,26.5,14,38.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,RACE02,CAT4,_RFPSA22,RESP046,"(35.47203135600046, -97.52107021399968)"
|
|
2018,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,40,73.5,61.1,86,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,RACE02,CAT4,_RFPSA22,RESP054,"(35.47203135600046, -97.52107021399968)"
|
|
2018,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,35,29.1,18.1,40.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,RACE03,CAT4,_RFPSA22,RESP046,"(35.47203135600046, -97.52107021399968)"
|
|
2018,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,55,70.9,59.8,81.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,RACE03,CAT4,_RFPSA22,RESP054,"(35.47203135600046, -97.52107021399968)"
|
|
2018,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,40,RACE04,CAT4,_RFPSA22,RESP046,"(35.47203135600046, -97.52107021399968)"
|
|
2018,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,40,RACE04,CAT4,_RFPSA22,RESP054,"(35.47203135600046, -97.52107021399968)"
|
|
2018,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,40,RACE05,CAT4,_RFPSA22,RESP046,"(35.47203135600046, -97.52107021399968)"
|
|
2018,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,40,RACE05,CAT4,_RFPSA22,RESP054,"(35.47203135600046, -97.52107021399968)"
|
|
2018,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,40,RACE06,CAT4,_RFPSA22,RESP046,"(35.47203135600046, -97.52107021399968)"
|
|
2018,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,40,RACE06,CAT4,_RFPSA22,RESP054,"(35.47203135600046, -97.52107021399968)"
|
|
2018,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,28,23.7,14.4,33,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,RACE07,CAT4,_RFPSA22,RESP046,"(35.47203135600046, -97.52107021399968)"
|
|
2018,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,59,76.3,67,85.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,RACE07,CAT4,_RFPSA22,RESP054,"(35.47203135600046, -97.52107021399968)"
|
|
2018,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,40,RACE08,CAT4,_RFPSA22,RESP046,"(35.47203135600046, -97.52107021399968)"
|
|
2018,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,45,85.5,76,95,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,RACE08,CAT4,_RFPSA22,RESP054,"(35.47203135600046, -97.52107021399968)"
|
|
2018,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,605,32.8,30,35.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,SEX1,CAT2,_RFPSA22,RESP046,"(35.47203135600046, -97.52107021399968)"
|
|
2018,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,886,67.2,64.5,70,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,SEX1,CAT2,_RFPSA22,RESP054,"(35.47203135600046, -97.52107021399968)"
|
|
2018,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,40,SEX2,CAT2,_RFPSA22,RESP046,"(35.47203135600046, -97.52107021399968)"
|
|
2018,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,40,SEX2,CAT2,_RFPSA22,RESP054,"(35.47203135600046, -97.52107021399968)"
|
|
2018,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,480,27,24.4,29.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,BO1,CAT1,_RFPSA22,RESP046,"(44.56744942400047, -120.15503132599969)"
|
|
2018,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,14,3.1,1.4,4.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,AGE06,CAT3,_RFPSA22,RESP046,"(44.56744942400047, -120.15503132599969)"
|
|
2018,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,331,96.9,95.2,98.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,AGE06,CAT3,_RFPSA22,RESP054,"(44.56744942400047, -120.15503132599969)"
|
|
2018,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,90,23.8,18.4,29.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,AGE07,CAT3,_RFPSA22,RESP046,"(44.56744942400047, -120.15503132599969)"
|
|
2018,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,278,76.2,70.9,81.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,AGE07,CAT3,_RFPSA22,RESP054,"(44.56744942400047, -120.15503132599969)"
|
|
2018,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,72,32.1,24.5,39.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,AGE08,CAT3,_RFPSA22,RESP046,"(44.56744942400047, -120.15503132599969)"
|
|
2018,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,142,67.9,60.3,75.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,AGE08,CAT3,_RFPSA22,RESP054,"(44.56744942400047, -120.15503132599969)"
|
|
2018,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,304,45.8,40.8,50.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,AGE09,CAT3,_RFPSA22,RESP046,"(44.56744942400047, -120.15503132599969)"
|
|
2018,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,326,54.2,49.2,59.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,AGE09,CAT3,_RFPSA22,RESP054,"(44.56744942400047, -120.15503132599969)"
|
|
2018,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1077,73,70.4,75.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,BO1,CAT1,_RFPSA22,RESP054,"(44.56744942400047, -120.15503132599969)"
|
|
2018,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,41,EDUCA1,CAT5,_RFPSA22,RESP046,"(44.56744942400047, -120.15503132599969)"
|
|
2018,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,84,90,82.9,97,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,EDUCA1,CAT5,_RFPSA22,RESP054,"(44.56744942400047, -120.15503132599969)"
|
|
2018,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,74,22.9,17.4,28.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,EDUCA2,CAT5,_RFPSA22,RESP046,"(44.56744942400047, -120.15503132599969)"
|
|
2018,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,244,77.1,71.6,82.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,EDUCA2,CAT5,_RFPSA22,RESP054,"(44.56744942400047, -120.15503132599969)"
|
|
2018,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,131,26.4,21.8,31,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,EDUCA3,CAT5,_RFPSA22,RESP046,"(44.56744942400047, -120.15503132599969)"
|
|
2018,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,323,73.6,69,78.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,EDUCA3,CAT5,_RFPSA22,RESP054,"(44.56744942400047, -120.15503132599969)"
|
|
2018,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,265,34.3,30,38.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,EDUCA4,CAT5,_RFPSA22,RESP046,"(44.56744942400047, -120.15503132599969)"
|
|
2018,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,425,65.7,61.4,70,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,EDUCA4,CAT5,_RFPSA22,RESP054,"(44.56744942400047, -120.15503132599969)"
|
|
2018,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,21,14,7.1,20.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,INCOME1,CAT6,_RFPSA22,RESP046,"(44.56744942400047, -120.15503132599969)"
|
|
2018,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,91,86,79.1,92.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,INCOME1,CAT6,_RFPSA22,RESP054,"(44.56744942400047, -120.15503132599969)"
|
|
2018,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,48,26.2,18.3,34,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,INCOME2,CAT6,_RFPSA22,RESP046,"(44.56744942400047, -120.15503132599969)"
|
|
2018,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,136,73.8,66,81.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,INCOME2,CAT6,_RFPSA22,RESP054,"(44.56744942400047, -120.15503132599969)"
|
|
2018,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,36,22.6,14.5,30.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,INCOME3,CAT6,_RFPSA22,RESP046,"(44.56744942400047, -120.15503132599969)"
|
|
2018,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,94,77.4,69.3,85.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,INCOME3,CAT6,_RFPSA22,RESP054,"(44.56744942400047, -120.15503132599969)"
|
|
2018,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,58,31.6,23.1,40.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,INCOME4,CAT6,_RFPSA22,RESP046,"(44.56744942400047, -120.15503132599969)"
|
|
2018,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,125,68.4,59.9,76.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,INCOME4,CAT6,_RFPSA22,RESP054,"(44.56744942400047, -120.15503132599969)"
|
|
2018,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,260,29.1,25.5,32.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,INCOME5,CAT6,_RFPSA22,RESP046,"(44.56744942400047, -120.15503132599969)"
|
|
2018,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,517,70.9,67.2,74.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,INCOME5,CAT6,_RFPSA22,RESP054,"(44.56744942400047, -120.15503132599969)"
|
|
2018,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,438,29.9,27,32.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,RACE01,CAT4,_RFPSA22,RESP046,"(44.56744942400047, -120.15503132599969)"
|
|
2018,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,883,70.1,67.2,73,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,RACE01,CAT4,_RFPSA22,RESP054,"(44.56744942400047, -120.15503132599969)"
|
|
2018,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,41,RACE02,CAT4,_RFPSA22,RESP046,"(44.56744942400047, -120.15503132599969)"
|
|
2018,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,41,RACE02,CAT4,_RFPSA22,RESP054,"(44.56744942400047, -120.15503132599969)"
|
|
2018,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,41,RACE03,CAT4,_RFPSA22,RESP046,"(44.56744942400047, -120.15503132599969)"
|
|
2018,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,16,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,41,RACE03,CAT4,_RFPSA22,RESP054,"(44.56744942400047, -120.15503132599969)"
|
|
2018,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,41,RACE04,CAT4,_RFPSA22,RESP046,"(44.56744942400047, -120.15503132599969)"
|
|
2018,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,15,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,41,RACE04,CAT4,_RFPSA22,RESP054,"(44.56744942400047, -120.15503132599969)"
|
|
2018,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,41,RACE05,CAT4,_RFPSA22,RESP046,"(44.56744942400047, -120.15503132599969)"
|
|
2018,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,41,RACE05,CAT4,_RFPSA22,RESP054,"(44.56744942400047, -120.15503132599969)"
|
|
2018,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,41,RACE06,CAT4,_RFPSA22,RESP046,"(44.56744942400047, -120.15503132599969)"
|
|
2018,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,12,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,41,RACE06,CAT4,_RFPSA22,RESP054,"(44.56744942400047, -120.15503132599969)"
|
|
2018,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,13,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,41,RACE07,CAT4,_RFPSA22,RESP046,"(44.56744942400047, -120.15503132599969)"
|
|
2018,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,52,84.5,74.6,94.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,RACE07,CAT4,_RFPSA22,RESP054,"(44.56744942400047, -120.15503132599969)"
|
|
2018,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,13,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,41,RACE08,CAT4,_RFPSA22,RESP046,"(44.56744942400047, -120.15503132599969)"
|
|
2018,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,87,91.6,86.6,96.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,RACE08,CAT4,_RFPSA22,RESP054,"(44.56744942400047, -120.15503132599969)"
|
|
2018,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,480,27,24.4,29.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,SEX1,CAT2,_RFPSA22,RESP046,"(44.56744942400047, -120.15503132599969)"
|
|
2018,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1077,73,70.4,75.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,SEX1,CAT2,_RFPSA22,RESP054,"(44.56744942400047, -120.15503132599969)"
|
|
2018,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,41,SEX2,CAT2,_RFPSA22,RESP046,"(44.56744942400047, -120.15503132599969)"
|
|
2018,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,41,SEX2,CAT2,_RFPSA22,RESP054,"(44.56744942400047, -120.15503132599969)"
|
|
2018,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,378,52.5,47.5,57.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,AGE09,CAT3,_RFPSA22,RESP046,"(40.79373015200048, -77.86070029399963)"
|
|
2018,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,19,4.4,1.9,6.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,AGE06,CAT3,_RFPSA22,RESP046,"(40.79373015200048, -77.86070029399963)"
|
|
2018,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,335,95.6,93.2,98.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,AGE06,CAT3,_RFPSA22,RESP054,"(40.79373015200048, -77.86070029399963)"
|
|
2018,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,157,29.5,24.7,34.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,AGE07,CAT3,_RFPSA22,RESP046,"(40.79373015200048, -77.86070029399963)"
|
|
2018,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,336,70.5,65.6,75.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,AGE07,CAT3,_RFPSA22,RESP054,"(40.79373015200048, -77.86070029399963)"
|
|
2018,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,128,51.9,44.5,59.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,AGE08,CAT3,_RFPSA22,RESP046,"(40.79373015200048, -77.86070029399963)"
|
|
2018,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,130,48.1,40.7,55.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,AGE08,CAT3,_RFPSA22,RESP054,"(40.79373015200048, -77.86070029399963)"
|
|
2018,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,336,47.5,42.6,52.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,AGE09,CAT3,_RFPSA22,RESP054,"(40.79373015200048, -77.86070029399963)"
|
|
2018,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,682,34.5,31.8,37.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,BO1,CAT1,_RFPSA22,RESP046,"(40.79373015200048, -77.86070029399963)"
|
|
2018,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1137,65.5,62.8,68.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,BO1,CAT1,_RFPSA22,RESP054,"(40.79373015200048, -77.86070029399963)"
|
|
2018,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,26,20.6,12,29.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,EDUCA1,CAT5,_RFPSA22,RESP046,"(40.79373015200048, -77.86070029399963)"
|
|
2018,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,96,79.4,70.9,88,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,EDUCA1,CAT5,_RFPSA22,RESP054,"(40.79373015200048, -77.86070029399963)"
|
|
2018,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,195,36,31.1,40.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,EDUCA2,CAT5,_RFPSA22,RESP046,"(40.79373015200048, -77.86070029399963)"
|
|
2018,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,350,64,59.1,68.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,EDUCA2,CAT5,_RFPSA22,RESP054,"(40.79373015200048, -77.86070029399963)"
|
|
2018,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,136,31.3,25.9,36.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,EDUCA3,CAT5,_RFPSA22,RESP046,"(40.79373015200048, -77.86070029399963)"
|
|
2018,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,246,68.7,63.4,74.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,EDUCA3,CAT5,_RFPSA22,RESP054,"(40.79373015200048, -77.86070029399963)"
|
|
2018,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,325,41.1,37,45.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,EDUCA4,CAT5,_RFPSA22,RESP046,"(40.79373015200048, -77.86070029399963)"
|
|
2018,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,444,58.9,54.7,63,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,EDUCA4,CAT5,_RFPSA22,RESP054,"(40.79373015200048, -77.86070029399963)"
|
|
2018,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,29,30,16.6,43.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,INCOME1,CAT6,_RFPSA22,RESP046,"(40.79373015200048, -77.86070029399963)"
|
|
2018,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,77,70,56.6,83.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,INCOME1,CAT6,_RFPSA22,RESP054,"(40.79373015200048, -77.86070029399963)"
|
|
2018,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,49,27,19,35.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,INCOME2,CAT6,_RFPSA22,RESP046,"(40.79373015200048, -77.86070029399963)"
|
|
2018,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,146,73,64.9,81,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,INCOME2,CAT6,_RFPSA22,RESP054,"(40.79373015200048, -77.86070029399963)"
|
|
2018,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,41,37.8,26.9,48.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,INCOME3,CAT6,_RFPSA22,RESP046,"(40.79373015200048, -77.86070029399963)"
|
|
2018,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,85,62.2,51.2,73.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,INCOME3,CAT6,_RFPSA22,RESP054,"(40.79373015200048, -77.86070029399963)"
|
|
2018,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,73,31.2,23.7,38.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,INCOME4,CAT6,_RFPSA22,RESP046,"(40.79373015200048, -77.86070029399963)"
|
|
2018,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,134,68.8,61.2,76.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,INCOME4,CAT6,_RFPSA22,RESP054,"(40.79373015200048, -77.86070029399963)"
|
|
2018,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,401,36.2,32.6,39.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,INCOME5,CAT6,_RFPSA22,RESP046,"(40.79373015200048, -77.86070029399963)"
|
|
2018,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,574,63.8,60.2,67.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,INCOME5,CAT6,_RFPSA22,RESP054,"(40.79373015200048, -77.86070029399963)"
|
|
2018,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,584,35.6,32.7,38.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,RACE01,CAT4,_RFPSA22,RESP046,"(40.79373015200048, -77.86070029399963)"
|
|
2018,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,930,64.4,61.5,67.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,RACE01,CAT4,_RFPSA22,RESP054,"(40.79373015200048, -77.86070029399963)"
|
|
2018,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,60,32.6,23.4,41.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,RACE02,CAT4,_RFPSA22,RESP046,"(40.79373015200048, -77.86070029399963)"
|
|
2018,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,109,67.4,58.2,76.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,RACE02,CAT4,_RFPSA22,RESP054,"(40.79373015200048, -77.86070029399963)"
|
|
2018,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,42,RACE03,CAT4,_RFPSA22,RESP046,"(40.79373015200048, -77.86070029399963)"
|
|
2018,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,9,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,42,RACE03,CAT4,_RFPSA22,RESP054,"(40.79373015200048, -77.86070029399963)"
|
|
2018,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,42,RACE04,CAT4,_RFPSA22,RESP046,"(40.79373015200048, -77.86070029399963)"
|
|
2018,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,21,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,42,RACE04,CAT4,_RFPSA22,RESP054,"(40.79373015200048, -77.86070029399963)"
|
|
2018,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,42,RACE05,CAT4,_RFPSA22,RESP046,"(40.79373015200048, -77.86070029399963)"
|
|
2018,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,42,RACE05,CAT4,_RFPSA22,RESP054,"(40.79373015200048, -77.86070029399963)"
|
|
2018,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,42,RACE06,CAT4,_RFPSA22,RESP046,"(40.79373015200048, -77.86070029399963)"
|
|
2018,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,42,RACE06,CAT4,_RFPSA22,RESP054,"(40.79373015200048, -77.86070029399963)"
|
|
2018,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,42,RACE07,CAT4,_RFPSA22,RESP046,"(40.79373015200048, -77.86070029399963)"
|
|
2018,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,13,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,42,RACE07,CAT4,_RFPSA22,RESP054,"(40.79373015200048, -77.86070029399963)"
|
|
2018,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,15,25.2,11.5,38.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,RACE08,CAT4,_RFPSA22,RESP046,"(40.79373015200048, -77.86070029399963)"
|
|
2018,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,48,74.8,61.1,88.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,RACE08,CAT4,_RFPSA22,RESP054,"(40.79373015200048, -77.86070029399963)"
|
|
2018,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,682,34.5,31.8,37.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,SEX1,CAT2,_RFPSA22,RESP046,"(40.79373015200048, -77.86070029399963)"
|
|
2018,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1137,65.5,62.8,68.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,SEX1,CAT2,_RFPSA22,RESP054,"(40.79373015200048, -77.86070029399963)"
|
|
2018,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,42,SEX2,CAT2,_RFPSA22,RESP046,"(40.79373015200048, -77.86070029399963)"
|
|
2018,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,42,SEX2,CAT2,_RFPSA22,RESP054,"(40.79373015200048, -77.86070029399963)"
|
|
2018,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,104,23.3,18.7,27.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,AGE09,CAT3,_RFPSA22,RESP054,"(18.220833, -66.590149)"
|
|
2018,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,109,34.8,28,41.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,AGE06,CAT3,_RFPSA22,RESP046,"(18.220833, -66.590149)"
|
|
2018,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,190,65.2,58.4,72,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,AGE06,CAT3,_RFPSA22,RESP054,"(18.220833, -66.590149)"
|
|
2018,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,186,52,45.6,58.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,AGE07,CAT3,_RFPSA22,RESP046,"(18.220833, -66.590149)"
|
|
2018,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,156,48,41.6,54.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,AGE07,CAT3,_RFPSA22,RESP054,"(18.220833, -66.590149)"
|
|
2018,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,114,66.9,58.7,75.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,AGE08,CAT3,_RFPSA22,RESP046,"(18.220833, -66.590149)"
|
|
2018,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,60,33.1,24.8,41.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,AGE08,CAT3,_RFPSA22,RESP054,"(18.220833, -66.590149)"
|
|
2018,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,364,76.7,72.1,81.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,AGE09,CAT3,_RFPSA22,RESP046,"(18.220833, -66.590149)"
|
|
2018,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,773,57.7,54.4,61.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,BO1,CAT1,_RFPSA22,RESP046,"(18.220833, -66.590149)"
|
|
2018,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,510,42.3,38.9,45.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,BO1,CAT1,_RFPSA22,RESP054,"(18.220833, -66.590149)"
|
|
2018,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,141,55.7,48.7,62.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,EDUCA1,CAT5,_RFPSA22,RESP046,"(18.220833, -66.590149)"
|
|
2018,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,110,44.3,37.2,51.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,EDUCA1,CAT5,_RFPSA22,RESP054,"(18.220833, -66.590149)"
|
|
2018,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,197,55.9,49.4,62.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,EDUCA2,CAT5,_RFPSA22,RESP046,"(18.220833, -66.590149)"
|
|
2018,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,137,44.1,37.7,50.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,EDUCA2,CAT5,_RFPSA22,RESP054,"(18.220833, -66.590149)"
|
|
2018,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,188,56.7,50.4,63,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,EDUCA3,CAT5,_RFPSA22,RESP046,"(18.220833, -66.590149)"
|
|
2018,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,122,43.3,37,49.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,EDUCA3,CAT5,_RFPSA22,RESP054,"(18.220833, -66.590149)"
|
|
2018,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,247,62,56.3,67.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,EDUCA4,CAT5,_RFPSA22,RESP046,"(18.220833, -66.590149)"
|
|
2018,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,139,38,32.3,43.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,EDUCA4,CAT5,_RFPSA22,RESP054,"(18.220833, -66.590149)"
|
|
2018,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,192,52.5,46.2,58.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,INCOME1,CAT6,_RFPSA22,RESP046,"(18.220833, -66.590149)"
|
|
2018,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,186,47.5,41.2,53.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,INCOME1,CAT6,_RFPSA22,RESP054,"(18.220833, -66.590149)"
|
|
2018,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,228,61.2,55.1,67.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,INCOME2,CAT6,_RFPSA22,RESP046,"(18.220833, -66.590149)"
|
|
2018,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,130,38.8,32.8,44.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,INCOME2,CAT6,_RFPSA22,RESP054,"(18.220833, -66.590149)"
|
|
2018,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,86,55.6,45.2,66,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,INCOME3,CAT6,_RFPSA22,RESP046,"(18.220833, -66.590149)"
|
|
2018,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,49,44.4,34,54.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,INCOME3,CAT6,_RFPSA22,RESP054,"(18.220833, -66.590149)"
|
|
2018,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,71,66.1,55.4,76.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,INCOME4,CAT6,_RFPSA22,RESP046,"(18.220833, -66.590149)"
|
|
2018,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,33,33.9,23.1,44.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,INCOME4,CAT6,_RFPSA22,RESP054,"(18.220833, -66.590149)"
|
|
2018,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,101,58.5,49.4,67.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,INCOME5,CAT6,_RFPSA22,RESP046,"(18.220833, -66.590149)"
|
|
2018,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,55,41.5,32.4,50.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,INCOME5,CAT6,_RFPSA22,RESP054,"(18.220833, -66.590149)"
|
|
2018,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,72,RACE01,CAT4,_RFPSA22,RESP046,"(18.220833, -66.590149)"
|
|
2018,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,72,RACE01,CAT4,_RFPSA22,RESP054,"(18.220833, -66.590149)"
|
|
2018,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,72,RACE02,CAT4,_RFPSA22,RESP046,"(18.220833, -66.590149)"
|
|
2018,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,72,RACE02,CAT4,_RFPSA22,RESP054,"(18.220833, -66.590149)"
|
|
2018,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,72,RACE03,CAT4,_RFPSA22,RESP046,"(18.220833, -66.590149)"
|
|
2018,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,72,RACE03,CAT4,_RFPSA22,RESP054,"(18.220833, -66.590149)"
|
|
2018,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,72,RACE04,CAT4,_RFPSA22,RESP046,"(18.220833, -66.590149)"
|
|
2018,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,72,RACE04,CAT4,_RFPSA22,RESP054,"(18.220833, -66.590149)"
|
|
2018,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,72,RACE05,CAT4,_RFPSA22,RESP046,"(18.220833, -66.590149)"
|
|
2018,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,72,RACE05,CAT4,_RFPSA22,RESP054,"(18.220833, -66.590149)"
|
|
2018,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,72,RACE06,CAT4,_RFPSA22,RESP046,"(18.220833, -66.590149)"
|
|
2018,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,72,RACE06,CAT4,_RFPSA22,RESP054,"(18.220833, -66.590149)"
|
|
2018,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,72,RACE07,CAT4,_RFPSA22,RESP046,"(18.220833, -66.590149)"
|
|
2018,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,72,RACE07,CAT4,_RFPSA22,RESP054,"(18.220833, -66.590149)"
|
|
2018,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,769,57.8,54.4,61.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,RACE08,CAT4,_RFPSA22,RESP046,"(18.220833, -66.590149)"
|
|
2018,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,505,42.2,38.9,45.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,RACE08,CAT4,_RFPSA22,RESP054,"(18.220833, -66.590149)"
|
|
2018,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,773,57.7,54.4,61.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,SEX1,CAT2,_RFPSA22,RESP046,"(18.220833, -66.590149)"
|
|
2018,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,510,42.3,38.9,45.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,SEX1,CAT2,_RFPSA22,RESP054,"(18.220833, -66.590149)"
|
|
2018,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,72,SEX2,CAT2,_RFPSA22,RESP046,"(18.220833, -66.590149)"
|
|
2018,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,72,SEX2,CAT2,_RFPSA22,RESP054,"(18.220833, -66.590149)"
|
|
2018,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,29,10.7,6.4,15.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,AGE06,CAT3,_RFPSA22,RESP046,"(41.70828019300046, -71.52247031399963)"
|
|
2018,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,239,89.3,84.9,93.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,AGE06,CAT3,_RFPSA22,RESP054,"(41.70828019300046, -71.52247031399963)"
|
|
2018,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,119,26.2,20.9,31.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,AGE07,CAT3,_RFPSA22,RESP046,"(41.70828019300046, -71.52247031399963)"
|
|
2018,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,309,73.8,68.6,79.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,AGE07,CAT3,_RFPSA22,RESP054,"(41.70828019300046, -71.52247031399963)"
|
|
2018,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,109,36.3,29,43.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,AGE08,CAT3,_RFPSA22,RESP046,"(41.70828019300046, -71.52247031399963)"
|
|
2018,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,149,63.7,56.4,71,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,AGE08,CAT3,_RFPSA22,RESP054,"(41.70828019300046, -71.52247031399963)"
|
|
2018,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,383,52.7,48.2,57.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,AGE09,CAT3,_RFPSA22,RESP046,"(41.70828019300046, -71.52247031399963)"
|
|
2018,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,346,47.3,42.8,51.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,AGE09,CAT3,_RFPSA22,RESP054,"(41.70828019300046, -71.52247031399963)"
|
|
2018,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,640,32.1,29.3,34.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,BO1,CAT1,_RFPSA22,RESP046,"(41.70828019300046, -71.52247031399963)"
|
|
2018,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1043,67.9,65.1,70.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,BO1,CAT1,_RFPSA22,RESP054,"(41.70828019300046, -71.52247031399963)"
|
|
2018,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,34,20.8,13.1,28.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,EDUCA1,CAT5,_RFPSA22,RESP046,"(41.70828019300046, -71.52247031399963)"
|
|
2018,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,97,79.2,71.6,86.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,EDUCA1,CAT5,_RFPSA22,RESP054,"(41.70828019300046, -71.52247031399963)"
|
|
2018,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,106,24.5,19.4,29.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,EDUCA2,CAT5,_RFPSA22,RESP046,"(41.70828019300046, -71.52247031399963)"
|
|
2018,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,279,75.5,70.3,80.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,EDUCA2,CAT5,_RFPSA22,RESP054,"(41.70828019300046, -71.52247031399963)"
|
|
2018,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,130,34.2,28.1,40.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,EDUCA3,CAT5,_RFPSA22,RESP046,"(41.70828019300046, -71.52247031399963)"
|
|
2018,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,228,65.8,59.6,71.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,EDUCA3,CAT5,_RFPSA22,RESP054,"(41.70828019300046, -71.52247031399963)"
|
|
2018,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,369,41.7,37.5,45.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,EDUCA4,CAT5,_RFPSA22,RESP046,"(41.70828019300046, -71.52247031399963)"
|
|
2018,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,439,58.3,54.1,62.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,EDUCA4,CAT5,_RFPSA22,RESP054,"(41.70828019300046, -71.52247031399963)"
|
|
2018,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,23,20.3,11,29.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,INCOME1,CAT6,_RFPSA22,RESP046,"(41.70828019300046, -71.52247031399963)"
|
|
2018,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,94,79.7,70.3,89,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,INCOME1,CAT6,_RFPSA22,RESP054,"(41.70828019300046, -71.52247031399963)"
|
|
2018,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,47,23.9,16,31.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,INCOME2,CAT6,_RFPSA22,RESP046,"(41.70828019300046, -71.52247031399963)"
|
|
2018,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,131,76.1,68.3,84,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,INCOME2,CAT6,_RFPSA22,RESP054,"(41.70828019300046, -71.52247031399963)"
|
|
2018,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,34,29.4,18.4,40.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,INCOME3,CAT6,_RFPSA22,RESP046,"(41.70828019300046, -71.52247031399963)"
|
|
2018,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,78,70.6,59.5,81.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,INCOME3,CAT6,_RFPSA22,RESP054,"(41.70828019300046, -71.52247031399963)"
|
|
2018,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,65,37.6,27.8,47.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,INCOME4,CAT6,_RFPSA22,RESP046,"(41.70828019300046, -71.52247031399963)"
|
|
2018,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,80,62.4,52.5,72.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,INCOME4,CAT6,_RFPSA22,RESP054,"(41.70828019300046, -71.52247031399963)"
|
|
2018,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,383,34.9,30.9,38.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,INCOME5,CAT6,_RFPSA22,RESP046,"(41.70828019300046, -71.52247031399963)"
|
|
2018,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,520,65.1,61.2,69.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,INCOME5,CAT6,_RFPSA22,RESP054,"(41.70828019300046, -71.52247031399963)"
|
|
2018,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,587,34.6,31.6,37.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,RACE01,CAT4,_RFPSA22,RESP046,"(41.70828019300046, -71.52247031399963)"
|
|
2018,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,871,65.4,62.3,68.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,RACE01,CAT4,_RFPSA22,RESP054,"(41.70828019300046, -71.52247031399963)"
|
|
2018,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,15,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,44,RACE02,CAT4,_RFPSA22,RESP046,"(41.70828019300046, -71.52247031399963)"
|
|
2018,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,34,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,44,RACE02,CAT4,_RFPSA22,RESP054,"(41.70828019300046, -71.52247031399963)"
|
|
2018,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,44,RACE03,CAT4,_RFPSA22,RESP046,"(41.70828019300046, -71.52247031399963)"
|
|
2018,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,44,RACE03,CAT4,_RFPSA22,RESP054,"(41.70828019300046, -71.52247031399963)"
|
|
2018,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,44,RACE04,CAT4,_RFPSA22,RESP046,"(41.70828019300046, -71.52247031399963)"
|
|
2018,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,15,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,44,RACE04,CAT4,_RFPSA22,RESP054,"(41.70828019300046, -71.52247031399963)"
|
|
2018,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,44,RACE05,CAT4,_RFPSA22,RESP046,"(41.70828019300046, -71.52247031399963)"
|
|
2018,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,44,RACE05,CAT4,_RFPSA22,RESP054,"(41.70828019300046, -71.52247031399963)"
|
|
2018,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,44,RACE06,CAT4,_RFPSA22,RESP046,"(41.70828019300046, -71.52247031399963)"
|
|
2018,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,20,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,44,RACE06,CAT4,_RFPSA22,RESP054,"(41.70828019300046, -71.52247031399963)"
|
|
2018,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,44,RACE07,CAT4,_RFPSA22,RESP046,"(41.70828019300046, -71.52247031399963)"
|
|
2018,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,13,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,44,RACE07,CAT4,_RFPSA22,RESP054,"(41.70828019300046, -71.52247031399963)"
|
|
2018,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,22,17.1,8.7,25.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,RACE08,CAT4,_RFPSA22,RESP046,"(41.70828019300046, -71.52247031399963)"
|
|
2018,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,79,82.9,74.4,91.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,RACE08,CAT4,_RFPSA22,RESP054,"(41.70828019300046, -71.52247031399963)"
|
|
2018,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,640,32.1,29.3,34.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,SEX1,CAT2,_RFPSA22,RESP046,"(41.70828019300046, -71.52247031399963)"
|
|
2018,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1043,67.9,65.1,70.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,SEX1,CAT2,_RFPSA22,RESP054,"(41.70828019300046, -71.52247031399963)"
|
|
2018,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,44,SEX2,CAT2,_RFPSA22,RESP046,"(41.70828019300046, -71.52247031399963)"
|
|
2018,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,44,SEX2,CAT2,_RFPSA22,RESP054,"(41.70828019300046, -71.52247031399963)"
|
|
2018,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,67,12.3,9,15.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,AGE06,CAT3,_RFPSA22,RESP046,"(33.998821303000454, -81.04537120699968)"
|
|
2018,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,394,87.7,84.4,91,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,AGE06,CAT3,_RFPSA22,RESP054,"(33.998821303000454, -81.04537120699968)"
|
|
2018,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,221,34.1,29.5,38.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,AGE07,CAT3,_RFPSA22,RESP046,"(33.998821303000454, -81.04537120699968)"
|
|
2018,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,391,65.9,61.4,70.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,AGE07,CAT3,_RFPSA22,RESP054,"(33.998821303000454, -81.04537120699968)"
|
|
2018,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,213,45.8,40.2,51.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,AGE08,CAT3,_RFPSA22,RESP046,"(33.998821303000454, -81.04537120699968)"
|
|
2018,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,225,54.2,48.5,59.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,AGE08,CAT3,_RFPSA22,RESP054,"(33.998821303000454, -81.04537120699968)"
|
|
2018,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,955,57.7,54.6,60.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,AGE09,CAT3,_RFPSA22,RESP046,"(33.998821303000454, -81.04537120699968)"
|
|
2018,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,648,42.3,39.2,45.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,AGE09,CAT3,_RFPSA22,RESP054,"(33.998821303000454, -81.04537120699968)"
|
|
2018,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1456,38,35.9,40.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,BO1,CAT1,_RFPSA22,RESP046,"(33.998821303000454, -81.04537120699968)"
|
|
2018,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1658,62,59.9,64.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,BO1,CAT1,_RFPSA22,RESP054,"(33.998821303000454, -81.04537120699968)"
|
|
2018,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,102,24.3,19,29.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,EDUCA1,CAT5,_RFPSA22,RESP046,"(33.998821303000454, -81.04537120699968)"
|
|
2018,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,225,75.7,70.3,81,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,EDUCA1,CAT5,_RFPSA22,RESP054,"(33.998821303000454, -81.04537120699968)"
|
|
2018,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,370,34.7,30.9,38.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,EDUCA2,CAT5,_RFPSA22,RESP046,"(33.998821303000454, -81.04537120699968)"
|
|
2018,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,528,65.3,61.5,69.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,EDUCA2,CAT5,_RFPSA22,RESP054,"(33.998821303000454, -81.04537120699968)"
|
|
2018,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,337,41.1,36.6,45.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,EDUCA3,CAT5,_RFPSA22,RESP046,"(33.998821303000454, -81.04537120699968)"
|
|
2018,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,393,58.9,54.4,63.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,EDUCA3,CAT5,_RFPSA22,RESP054,"(33.998821303000454, -81.04537120699968)"
|
|
2018,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,646,46.5,42.8,50.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,EDUCA4,CAT5,_RFPSA22,RESP046,"(33.998821303000454, -81.04537120699968)"
|
|
2018,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,510,53.5,49.8,57.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,EDUCA4,CAT5,_RFPSA22,RESP054,"(33.998821303000454, -81.04537120699968)"
|
|
2018,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,75,31.6,23.8,39.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,INCOME1,CAT6,_RFPSA22,RESP046,"(33.998821303000454, -81.04537120699968)"
|
|
2018,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,128,68.4,60.6,76.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,INCOME1,CAT6,_RFPSA22,RESP054,"(33.998821303000454, -81.04537120699968)"
|
|
2018,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,134,30.5,24.9,36.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,INCOME2,CAT6,_RFPSA22,RESP046,"(33.998821303000454, -81.04537120699968)"
|
|
2018,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,251,69.5,63.8,75.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,INCOME2,CAT6,_RFPSA22,RESP054,"(33.998821303000454, -81.04537120699968)"
|
|
2018,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,117,32.4,25.8,39,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,INCOME3,CAT6,_RFPSA22,RESP046,"(33.998821303000454, -81.04537120699968)"
|
|
2018,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,190,67.6,61,74.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,INCOME3,CAT6,_RFPSA22,RESP054,"(33.998821303000454, -81.04537120699968)"
|
|
2018,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,196,37.5,31.7,43.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,INCOME4,CAT6,_RFPSA22,RESP046,"(33.998821303000454, -81.04537120699968)"
|
|
2018,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,219,62.5,56.7,68.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,INCOME4,CAT6,_RFPSA22,RESP054,"(33.998821303000454, -81.04537120699968)"
|
|
2018,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,745,42.5,39.1,45.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,INCOME5,CAT6,_RFPSA22,RESP046,"(33.998821303000454, -81.04537120699968)"
|
|
2018,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,669,57.5,54.2,60.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,INCOME5,CAT6,_RFPSA22,RESP054,"(33.998821303000454, -81.04537120699968)"
|
|
2018,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1070,39.3,36.7,41.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,RACE01,CAT4,_RFPSA22,RESP046,"(33.998821303000454, -81.04537120699968)"
|
|
2018,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1184,60.7,58.2,63.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,RACE01,CAT4,_RFPSA22,RESP054,"(33.998821303000454, -81.04537120699968)"
|
|
2018,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,328,38.1,33.4,42.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,RACE02,CAT4,_RFPSA22,RESP046,"(33.998821303000454, -81.04537120699968)"
|
|
2018,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,357,61.9,57.2,66.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,RACE02,CAT4,_RFPSA22,RESP054,"(33.998821303000454, -81.04537120699968)"
|
|
2018,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,9,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,45,RACE03,CAT4,_RFPSA22,RESP046,"(33.998821303000454, -81.04537120699968)"
|
|
2018,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,16,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,45,RACE03,CAT4,_RFPSA22,RESP054,"(33.998821303000454, -81.04537120699968)"
|
|
2018,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,9,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,45,RACE04,CAT4,_RFPSA22,RESP046,"(33.998821303000454, -81.04537120699968)"
|
|
2018,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,12,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,45,RACE04,CAT4,_RFPSA22,RESP054,"(33.998821303000454, -81.04537120699968)"
|
|
2018,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,45,RACE05,CAT4,_RFPSA22,RESP046,"(33.998821303000454, -81.04537120699968)"
|
|
2018,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,45,RACE05,CAT4,_RFPSA22,RESP054,"(33.998821303000454, -81.04537120699968)"
|
|
2018,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,15,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,45,RACE06,CAT4,_RFPSA22,RESP046,"(33.998821303000454, -81.04537120699968)"
|
|
2018,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,14,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,45,RACE06,CAT4,_RFPSA22,RESP054,"(33.998821303000454, -81.04537120699968)"
|
|
2018,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,18,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,45,RACE07,CAT4,_RFPSA22,RESP046,"(33.998821303000454, -81.04537120699968)"
|
|
2018,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,23,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,45,RACE07,CAT4,_RFPSA22,RESP054,"(33.998821303000454, -81.04537120699968)"
|
|
2018,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,45,RACE08,CAT4,_RFPSA22,RESP046,"(33.998821303000454, -81.04537120699968)"
|
|
2018,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,49,91.6,84.6,98.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,RACE08,CAT4,_RFPSA22,RESP054,"(33.998821303000454, -81.04537120699968)"
|
|
2018,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1456,38,35.9,40.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,SEX1,CAT2,_RFPSA22,RESP046,"(33.998821303000454, -81.04537120699968)"
|
|
2018,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1658,62,59.9,64.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,SEX1,CAT2,_RFPSA22,RESP054,"(33.998821303000454, -81.04537120699968)"
|
|
2018,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,45,SEX2,CAT2,_RFPSA22,RESP046,"(33.998821303000454, -81.04537120699968)"
|
|
2018,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,45,SEX2,CAT2,_RFPSA22,RESP054,"(33.998821303000454, -81.04537120699968)"
|
|
2018,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,797,34,30.6,37.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,SEX1,CAT2,_RFPSA22,RESP046,"(44.353130053000484, -100.3735306369997)"
|
|
2018,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1392,66,62.6,69.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,SEX1,CAT2,_RFPSA22,RESP054,"(44.353130053000484, -100.3735306369997)"
|
|
2018,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,23,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,46,AGE06,CAT3,_RFPSA22,RESP046,"(44.353130053000484, -100.3735306369997)"
|
|
2018,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,337,92.4,87.8,97,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,AGE06,CAT3,_RFPSA22,RESP054,"(44.353130053000484, -100.3735306369997)"
|
|
2018,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,157,30.2,23.5,36.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,AGE07,CAT3,_RFPSA22,RESP046,"(44.353130053000484, -100.3735306369997)"
|
|
2018,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,389,69.8,63.1,76.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,AGE07,CAT3,_RFPSA22,RESP054,"(44.353130053000484, -100.3735306369997)"
|
|
2018,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,128,36.9,27.9,45.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,AGE08,CAT3,_RFPSA22,RESP046,"(44.353130053000484, -100.3735306369997)"
|
|
2018,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,189,63.1,54.2,72.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,AGE08,CAT3,_RFPSA22,RESP054,"(44.353130053000484, -100.3735306369997)"
|
|
2018,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,489,53.6,48.1,59.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,AGE09,CAT3,_RFPSA22,RESP046,"(44.353130053000484, -100.3735306369997)"
|
|
2018,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,477,46.4,40.9,51.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,AGE09,CAT3,_RFPSA22,RESP054,"(44.353130053000484, -100.3735306369997)"
|
|
2018,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,797,34,30.6,37.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,BO1,CAT1,_RFPSA22,RESP046,"(44.353130053000484, -100.3735306369997)"
|
|
2018,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1392,66,62.6,69.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,BO1,CAT1,_RFPSA22,RESP054,"(44.353130053000484, -100.3735306369997)"
|
|
2018,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,21,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,46,EDUCA1,CAT5,_RFPSA22,RESP046,"(44.353130053000484, -100.3735306369997)"
|
|
2018,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,105,76.8,62.5,91.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,EDUCA1,CAT5,_RFPSA22,RESP054,"(44.353130053000484, -100.3735306369997)"
|
|
2018,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,213,27.9,22.4,33.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,EDUCA2,CAT5,_RFPSA22,RESP046,"(44.353130053000484, -100.3735306369997)"
|
|
2018,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,455,72.1,66.6,77.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,EDUCA2,CAT5,_RFPSA22,RESP054,"(44.353130053000484, -100.3735306369997)"
|
|
2018,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,200,33.8,27.6,40,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,EDUCA3,CAT5,_RFPSA22,RESP046,"(44.353130053000484, -100.3735306369997)"
|
|
2018,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,431,66.2,60,72.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,EDUCA3,CAT5,_RFPSA22,RESP054,"(44.353130053000484, -100.3735306369997)"
|
|
2018,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,363,46,40.2,51.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,EDUCA4,CAT5,_RFPSA22,RESP046,"(44.353130053000484, -100.3735306369997)"
|
|
2018,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,400,54,48.2,59.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,EDUCA4,CAT5,_RFPSA22,RESP054,"(44.353130053000484, -100.3735306369997)"
|
|
2018,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,35,35.9,18,53.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,INCOME1,CAT6,_RFPSA22,RESP046,"(44.353130053000484, -100.3735306369997)"
|
|
2018,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,102,64.1,46.1,82,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,INCOME1,CAT6,_RFPSA22,RESP054,"(44.353130053000484, -100.3735306369997)"
|
|
2018,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,57,24.6,14.9,34.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,INCOME2,CAT6,_RFPSA22,RESP046,"(44.353130053000484, -100.3735306369997)"
|
|
2018,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,185,75.4,65.8,85.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,INCOME2,CAT6,_RFPSA22,RESP054,"(44.353130053000484, -100.3735306369997)"
|
|
2018,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,65,31.7,21,42.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,INCOME3,CAT6,_RFPSA22,RESP046,"(44.353130053000484, -100.3735306369997)"
|
|
2018,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,144,68.3,57.6,79,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,INCOME3,CAT6,_RFPSA22,RESP054,"(44.353130053000484, -100.3735306369997)"
|
|
2018,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,126,38.9,29.3,48.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,INCOME4,CAT6,_RFPSA22,RESP046,"(44.353130053000484, -100.3735306369997)"
|
|
2018,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,193,61.1,51.5,70.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,INCOME4,CAT6,_RFPSA22,RESP054,"(44.353130053000484, -100.3735306369997)"
|
|
2018,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,400,36,31.1,40.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,INCOME5,CAT6,_RFPSA22,RESP046,"(44.353130053000484, -100.3735306369997)"
|
|
2018,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,592,64,59.1,68.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,INCOME5,CAT6,_RFPSA22,RESP054,"(44.353130053000484, -100.3735306369997)"
|
|
2018,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,715,35.2,31.6,38.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,RACE01,CAT4,_RFPSA22,RESP046,"(44.353130053000484, -100.3735306369997)"
|
|
2018,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1108,64.8,61.3,68.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,RACE01,CAT4,_RFPSA22,RESP054,"(44.353130053000484, -100.3735306369997)"
|
|
2018,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,46,RACE02,CAT4,_RFPSA22,RESP046,"(44.353130053000484, -100.3735306369997)"
|
|
2018,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,11,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,46,RACE02,CAT4,_RFPSA22,RESP054,"(44.353130053000484, -100.3735306369997)"
|
|
2018,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,59,31.9,13.2,50.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,RACE03,CAT4,_RFPSA22,RESP046,"(44.353130053000484, -100.3735306369997)"
|
|
2018,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,200,68.1,49.4,86.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,RACE03,CAT4,_RFPSA22,RESP054,"(44.353130053000484, -100.3735306369997)"
|
|
2018,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,46,RACE04,CAT4,_RFPSA22,RESP046,"(44.353130053000484, -100.3735306369997)"
|
|
2018,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,46,RACE04,CAT4,_RFPSA22,RESP054,"(44.353130053000484, -100.3735306369997)"
|
|
2018,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,46,RACE05,CAT4,_RFPSA22,RESP046,"(44.353130053000484, -100.3735306369997)"
|
|
2018,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,46,RACE05,CAT4,_RFPSA22,RESP054,"(44.353130053000484, -100.3735306369997)"
|
|
2018,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,46,RACE06,CAT4,_RFPSA22,RESP046,"(44.353130053000484, -100.3735306369997)"
|
|
2018,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,11,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,46,RACE06,CAT4,_RFPSA22,RESP054,"(44.353130053000484, -100.3735306369997)"
|
|
2018,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,9,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,46,RACE07,CAT4,_RFPSA22,RESP046,"(44.353130053000484, -100.3735306369997)"
|
|
2018,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,28,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,46,RACE07,CAT4,_RFPSA22,RESP054,"(44.353130053000484, -100.3735306369997)"
|
|
2018,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,46,RACE08,CAT4,_RFPSA22,RESP046,"(44.353130053000484, -100.3735306369997)"
|
|
2018,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,29,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,46,RACE08,CAT4,_RFPSA22,RESP054,"(44.353130053000484, -100.3735306369997)"
|
|
2018,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,46,SEX2,CAT2,_RFPSA22,RESP046,"(44.353130053000484, -100.3735306369997)"
|
|
2018,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,46,SEX2,CAT2,_RFPSA22,RESP054,"(44.353130053000484, -100.3735306369997)"
|
|
2018,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,38,10.1,5.8,14.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,AGE06,CAT3,_RFPSA22,RESP046,"(35.68094058000048, -85.77449091399967)"
|
|
2018,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,262,89.9,85.5,94.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,AGE06,CAT3,_RFPSA22,RESP054,"(35.68094058000048, -85.77449091399967)"
|
|
2018,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,104,26,20,31.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,AGE07,CAT3,_RFPSA22,RESP046,"(35.68094058000048, -85.77449091399967)"
|
|
2018,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,245,74,68.1,80,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,AGE07,CAT3,_RFPSA22,RESP054,"(35.68094058000048, -85.77449091399967)"
|
|
2018,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,103,46,37.7,54.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,AGE08,CAT3,_RFPSA22,RESP046,"(35.68094058000048, -85.77449091399967)"
|
|
2018,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,129,54,45.8,62.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,AGE08,CAT3,_RFPSA22,RESP054,"(35.68094058000048, -85.77449091399967)"
|
|
2018,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,326,53.2,47.8,58.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,AGE09,CAT3,_RFPSA22,RESP046,"(35.68094058000048, -85.77449091399967)"
|
|
2018,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,252,46.8,41.3,52.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,AGE09,CAT3,_RFPSA22,RESP054,"(35.68094058000048, -85.77449091399967)"
|
|
2018,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,571,33.4,30.2,36.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,BO1,CAT1,_RFPSA22,RESP046,"(35.68094058000048, -85.77449091399967)"
|
|
2018,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,888,66.6,63.5,69.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,BO1,CAT1,_RFPSA22,RESP054,"(35.68094058000048, -85.77449091399967)"
|
|
2018,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,33,16.7,10.3,23.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,EDUCA1,CAT5,_RFPSA22,RESP046,"(35.68094058000048, -85.77449091399967)"
|
|
2018,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,139,83.3,76.9,89.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,EDUCA1,CAT5,_RFPSA22,RESP054,"(35.68094058000048, -85.77449091399967)"
|
|
2018,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,131,29.4,23.6,35.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,EDUCA2,CAT5,_RFPSA22,RESP046,"(35.68094058000048, -85.77449091399967)"
|
|
2018,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,306,70.6,64.8,76.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,EDUCA2,CAT5,_RFPSA22,RESP054,"(35.68094058000048, -85.77449091399967)"
|
|
2018,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,138,38.6,32.1,45.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,EDUCA3,CAT5,_RFPSA22,RESP046,"(35.68094058000048, -85.77449091399967)"
|
|
2018,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,197,61.4,54.9,67.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,EDUCA3,CAT5,_RFPSA22,RESP054,"(35.68094058000048, -85.77449091399967)"
|
|
2018,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,268,45.3,39.8,50.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,EDUCA4,CAT5,_RFPSA22,RESP046,"(35.68094058000048, -85.77449091399967)"
|
|
2018,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,245,54.7,49.2,60.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,EDUCA4,CAT5,_RFPSA22,RESP054,"(35.68094058000048, -85.77449091399967)"
|
|
2018,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,27,18.4,9.9,26.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,INCOME1,CAT6,_RFPSA22,RESP046,"(35.68094058000048, -85.77449091399967)"
|
|
2018,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,112,81.6,73.2,90.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,INCOME1,CAT6,_RFPSA22,RESP054,"(35.68094058000048, -85.77449091399967)"
|
|
2018,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,55,25.7,17.2,34.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,INCOME2,CAT6,_RFPSA22,RESP046,"(35.68094058000048, -85.77449091399967)"
|
|
2018,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,156,74.3,65.7,82.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,INCOME2,CAT6,_RFPSA22,RESP054,"(35.68094058000048, -85.77449091399967)"
|
|
2018,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,51,26.1,17.1,35.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,INCOME3,CAT6,_RFPSA22,RESP046,"(35.68094058000048, -85.77449091399967)"
|
|
2018,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,81,73.9,64.8,82.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,INCOME3,CAT6,_RFPSA22,RESP054,"(35.68094058000048, -85.77449091399967)"
|
|
2018,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,77,33,24.6,41.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,INCOME4,CAT6,_RFPSA22,RESP046,"(35.68094058000048, -85.77449091399967)"
|
|
2018,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,106,67,58.7,75.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,INCOME4,CAT6,_RFPSA22,RESP054,"(35.68094058000048, -85.77449091399967)"
|
|
2018,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,294,39.4,34.5,44.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,INCOME5,CAT6,_RFPSA22,RESP046,"(35.68094058000048, -85.77449091399967)"
|
|
2018,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,352,60.6,55.6,65.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,INCOME5,CAT6,_RFPSA22,RESP054,"(35.68094058000048, -85.77449091399967)"
|
|
2018,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,494,34.6,31.2,37.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,RACE01,CAT4,_RFPSA22,RESP046,"(35.68094058000048, -85.77449091399967)"
|
|
2018,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,737,65.4,62.1,68.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,RACE01,CAT4,_RFPSA22,RESP054,"(35.68094058000048, -85.77449091399967)"
|
|
2018,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,47,31.5,20.8,42.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,RACE02,CAT4,_RFPSA22,RESP046,"(35.68094058000048, -85.77449091399967)"
|
|
2018,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,90,68.5,57.8,79.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,RACE02,CAT4,_RFPSA22,RESP054,"(35.68094058000048, -85.77449091399967)"
|
|
2018,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,47,SEX2,CAT2,_RFPSA22,RESP054,"(35.68094058000048, -85.77449091399967)"
|
|
2018,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,47,RACE03,CAT4,_RFPSA22,RESP046,"(35.68094058000048, -85.77449091399967)"
|
|
2018,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,17,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,47,RACE03,CAT4,_RFPSA22,RESP054,"(35.68094058000048, -85.77449091399967)"
|
|
2018,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,47,RACE04,CAT4,_RFPSA22,RESP046,"(35.68094058000048, -85.77449091399967)"
|
|
2018,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,47,RACE04,CAT4,_RFPSA22,RESP054,"(35.68094058000048, -85.77449091399967)"
|
|
2018,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,47,RACE05,CAT4,_RFPSA22,RESP046,"(35.68094058000048, -85.77449091399967)"
|
|
2018,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,47,RACE05,CAT4,_RFPSA22,RESP054,"(35.68094058000048, -85.77449091399967)"
|
|
2018,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,47,RACE06,CAT4,_RFPSA22,RESP046,"(35.68094058000048, -85.77449091399967)"
|
|
2018,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,11,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,47,RACE06,CAT4,_RFPSA22,RESP054,"(35.68094058000048, -85.77449091399967)"
|
|
2018,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,47,RACE07,CAT4,_RFPSA22,RESP046,"(35.68094058000048, -85.77449091399967)"
|
|
2018,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,20,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,47,RACE07,CAT4,_RFPSA22,RESP054,"(35.68094058000048, -85.77449091399967)"
|
|
2018,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,47,RACE08,CAT4,_RFPSA22,RESP046,"(35.68094058000048, -85.77449091399967)"
|
|
2018,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,47,RACE08,CAT4,_RFPSA22,RESP054,"(35.68094058000048, -85.77449091399967)"
|
|
2018,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,571,33.4,30.2,36.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,SEX1,CAT2,_RFPSA22,RESP046,"(35.68094058000048, -85.77449091399967)"
|
|
2018,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,888,66.6,63.5,69.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,SEX1,CAT2,_RFPSA22,RESP054,"(35.68094058000048, -85.77449091399967)"
|
|
2018,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,47,SEX2,CAT2,_RFPSA22,RESP046,"(35.68094058000048, -85.77449091399967)"
|
|
2018,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,56,11.8,6,17.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,AGE06,CAT3,_RFPSA22,RESP046,"(31.827240407000488, -99.42677020599967)"
|
|
2018,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,467,88.2,82.4,94,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,AGE06,CAT3,_RFPSA22,RESP054,"(31.827240407000488, -99.42677020599967)"
|
|
2018,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,211,22,16.3,27.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,AGE07,CAT3,_RFPSA22,RESP046,"(31.827240407000488, -99.42677020599967)"
|
|
2018,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,520,78,72.2,83.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,AGE07,CAT3,_RFPSA22,RESP054,"(31.827240407000488, -99.42677020599967)"
|
|
2018,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,163,42.3,31.7,52.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,AGE08,CAT3,_RFPSA22,RESP046,"(31.827240407000488, -99.42677020599967)"
|
|
2018,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,217,57.7,47.1,68.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,AGE08,CAT3,_RFPSA22,RESP054,"(31.827240407000488, -99.42677020599967)"
|
|
2018,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,666,40,33.7,46.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,AGE09,CAT3,_RFPSA22,RESP046,"(31.827240407000488, -99.42677020599967)"
|
|
2018,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,623,60,53.7,66.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,AGE09,CAT3,_RFPSA22,RESP054,"(31.827240407000488, -99.42677020599967)"
|
|
2018,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1096,27.1,23.8,30.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,BO1,CAT1,_RFPSA22,RESP046,"(31.827240407000488, -99.42677020599967)"
|
|
2018,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1827,72.9,69.6,76.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,BO1,CAT1,_RFPSA22,RESP054,"(31.827240407000488, -99.42677020599967)"
|
|
2018,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,42,12.1,5.7,18.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,EDUCA1,CAT5,_RFPSA22,RESP046,"(31.827240407000488, -99.42677020599967)"
|
|
2018,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,238,87.9,81.6,94.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,EDUCA1,CAT5,_RFPSA22,RESP054,"(31.827240407000488, -99.42677020599967)"
|
|
2018,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,184,29.6,21.5,37.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,EDUCA2,CAT5,_RFPSA22,RESP046,"(31.827240407000488, -99.42677020599967)"
|
|
2018,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,412,70.4,62.3,78.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,EDUCA2,CAT5,_RFPSA22,RESP054,"(31.827240407000488, -99.42677020599967)"
|
|
2018,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,245,25.9,19.9,31.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,EDUCA3,CAT5,_RFPSA22,RESP046,"(31.827240407000488, -99.42677020599967)"
|
|
2018,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,468,74.1,68.2,80.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,EDUCA3,CAT5,_RFPSA22,RESP054,"(31.827240407000488, -99.42677020599967)"
|
|
2018,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,624,38.2,33.2,43.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,EDUCA4,CAT5,_RFPSA22,RESP046,"(31.827240407000488, -99.42677020599967)"
|
|
2018,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,703,61.8,56.9,66.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,EDUCA4,CAT5,_RFPSA22,RESP054,"(31.827240407000488, -99.42677020599967)"
|
|
2018,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,38,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,48,INCOME1,CAT6,_RFPSA22,RESP046,"(31.827240407000488, -99.42677020599967)"
|
|
2018,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,168,82.2,71,93.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,INCOME1,CAT6,_RFPSA22,RESP054,"(31.827240407000488, -99.42677020599967)"
|
|
2018,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,80,14.9,9,20.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,INCOME2,CAT6,_RFPSA22,RESP046,"(31.827240407000488, -99.42677020599967)"
|
|
2018,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,253,85.1,79.1,91,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,INCOME2,CAT6,_RFPSA22,RESP054,"(31.827240407000488, -99.42677020599967)"
|
|
2018,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,67,15.7,8,23.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,INCOME3,CAT6,_RFPSA22,RESP046,"(31.827240407000488, -99.42677020599967)"
|
|
2018,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,146,84.3,76.6,92,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,INCOME3,CAT6,_RFPSA22,RESP054,"(31.827240407000488, -99.42677020599967)"
|
|
2018,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,123,28.8,16.2,41.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,INCOME4,CAT6,_RFPSA22,RESP046,"(31.827240407000488, -99.42677020599967)"
|
|
2018,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,179,71.2,58.5,83.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,INCOME4,CAT6,_RFPSA22,RESP054,"(31.827240407000488, -99.42677020599967)"
|
|
2018,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,654,33.9,29.2,38.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,INCOME5,CAT6,_RFPSA22,RESP046,"(31.827240407000488, -99.42677020599967)"
|
|
2018,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,830,66.1,61.5,70.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,INCOME5,CAT6,_RFPSA22,RESP054,"(31.827240407000488, -99.42677020599967)"
|
|
2018,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,857,33.8,29.8,37.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,RACE01,CAT4,_RFPSA22,RESP046,"(31.827240407000488, -99.42677020599967)"
|
|
2018,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1158,66.2,62.2,70.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,RACE01,CAT4,_RFPSA22,RESP054,"(31.827240407000488, -99.42677020599967)"
|
|
2018,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,78,28.9,19.6,38.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,RACE02,CAT4,_RFPSA22,RESP046,"(31.827240407000488, -99.42677020599967)"
|
|
2018,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,138,71.1,61.7,80.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,RACE02,CAT4,_RFPSA22,RESP054,"(31.827240407000488, -99.42677020599967)"
|
|
2018,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,12,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,48,RACE03,CAT4,_RFPSA22,RESP046,"(31.827240407000488, -99.42677020599967)"
|
|
2018,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,37,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,48,RACE03,CAT4,_RFPSA22,RESP054,"(31.827240407000488, -99.42677020599967)"
|
|
2018,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,12,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,48,RACE04,CAT4,_RFPSA22,RESP046,"(31.827240407000488, -99.42677020599967)"
|
|
2018,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,49,84.5,70.4,98.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,RACE04,CAT4,_RFPSA22,RESP054,"(31.827240407000488, -99.42677020599967)"
|
|
2018,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,48,RACE05,CAT4,_RFPSA22,RESP046,"(31.827240407000488, -99.42677020599967)"
|
|
2018,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,48,RACE05,CAT4,_RFPSA22,RESP054,"(31.827240407000488, -99.42677020599967)"
|
|
2018,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,13,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,48,RACE06,CAT4,_RFPSA22,RESP046,"(31.827240407000488, -99.42677020599967)"
|
|
2018,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,15,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,48,RACE06,CAT4,_RFPSA22,RESP054,"(31.827240407000488, -99.42677020599967)"
|
|
2018,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,15,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,48,RACE07,CAT4,_RFPSA22,RESP046,"(31.827240407000488, -99.42677020599967)"
|
|
2018,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,32,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,48,RACE07,CAT4,_RFPSA22,RESP054,"(31.827240407000488, -99.42677020599967)"
|
|
2018,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,107,17.5,11,24,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,RACE08,CAT4,_RFPSA22,RESP046,"(31.827240407000488, -99.42677020599967)"
|
|
2018,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,396,82.5,76,89,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,RACE08,CAT4,_RFPSA22,RESP054,"(31.827240407000488, -99.42677020599967)"
|
|
2018,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1096,27.1,23.8,30.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,SEX1,CAT2,_RFPSA22,RESP046,"(31.827240407000488, -99.42677020599967)"
|
|
2018,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1827,72.9,69.6,76.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,SEX1,CAT2,_RFPSA22,RESP054,"(31.827240407000488, -99.42677020599967)"
|
|
2018,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,48,SEX2,CAT2,_RFPSA22,RESP046,"(31.827240407000488, -99.42677020599967)"
|
|
2018,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,48,SEX2,CAT2,_RFPSA22,RESP054,"(31.827240407000488, -99.42677020599967)"
|
|
2018,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1855,71.2,69.2,73.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,RACE01,CAT4,_RFPSA22,RESP054,"(39.360700171000474, -111.58713063499971)"
|
|
2018,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,59,7.1,5.1,9.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,AGE06,CAT3,_RFPSA22,RESP046,"(39.360700171000474, -111.58713063499971)"
|
|
2018,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,790,92.9,90.8,94.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,AGE06,CAT3,_RFPSA22,RESP054,"(39.360700171000474, -111.58713063499971)"
|
|
2018,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,177,26.3,22.2,30.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,AGE07,CAT3,_RFPSA22,RESP046,"(39.360700171000474, -111.58713063499971)"
|
|
2018,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,501,73.7,69.6,77.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,AGE07,CAT3,_RFPSA22,RESP054,"(39.360700171000474, -111.58713063499971)"
|
|
2018,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,147,38.9,33,44.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,AGE08,CAT3,_RFPSA22,RESP046,"(39.360700171000474, -111.58713063499971)"
|
|
2018,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,242,61.1,55.2,67,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,AGE08,CAT3,_RFPSA22,RESP054,"(39.360700171000474, -111.58713063499971)"
|
|
2018,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,534,48.7,45.1,52.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,AGE09,CAT3,_RFPSA22,RESP046,"(39.360700171000474, -111.58713063499971)"
|
|
2018,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,554,51.3,47.6,54.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,AGE09,CAT3,_RFPSA22,RESP054,"(39.360700171000474, -111.58713063499971)"
|
|
2018,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,917,27.6,25.6,29.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,BO1,CAT1,_RFPSA22,RESP046,"(39.360700171000474, -111.58713063499971)"
|
|
2018,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,2087,72.4,70.5,74.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,BO1,CAT1,_RFPSA22,RESP054,"(39.360700171000474, -111.58713063499971)"
|
|
2018,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,917,27.6,25.6,29.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,SEX1,CAT2,_RFPSA22,RESP046,"(39.360700171000474, -111.58713063499971)"
|
|
2018,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,13,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,49,EDUCA1,CAT5,_RFPSA22,RESP046,"(39.360700171000474, -111.58713063499971)"
|
|
2018,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,124,89.2,82.4,96.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,EDUCA1,CAT5,_RFPSA22,RESP054,"(39.360700171000474, -111.58713063499971)"
|
|
2018,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,144,22.1,18.3,25.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,EDUCA2,CAT5,_RFPSA22,RESP046,"(39.360700171000474, -111.58713063499971)"
|
|
2018,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,502,77.9,74.1,81.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,EDUCA2,CAT5,_RFPSA22,RESP054,"(39.360700171000474, -111.58713063499971)"
|
|
2018,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,230,28.6,24.8,32.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,EDUCA3,CAT5,_RFPSA22,RESP046,"(39.360700171000474, -111.58713063499971)"
|
|
2018,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,556,71.4,67.7,75.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,EDUCA3,CAT5,_RFPSA22,RESP054,"(39.360700171000474, -111.58713063499971)"
|
|
2018,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,528,33.4,30.6,36.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,EDUCA4,CAT5,_RFPSA22,RESP046,"(39.360700171000474, -111.58713063499971)"
|
|
2018,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,899,66.6,63.8,69.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,EDUCA4,CAT5,_RFPSA22,RESP054,"(39.360700171000474, -111.58713063499971)"
|
|
2018,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,16,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,49,INCOME1,CAT6,_RFPSA22,RESP046,"(39.360700171000474, -111.58713063499971)"
|
|
2018,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,83,81.7,69.1,94.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,INCOME1,CAT6,_RFPSA22,RESP054,"(39.360700171000474, -111.58713063499971)"
|
|
2018,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,46,17.4,11.2,23.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,INCOME2,CAT6,_RFPSA22,RESP046,"(39.360700171000474, -111.58713063499971)"
|
|
2018,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,165,82.6,76.4,88.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,INCOME2,CAT6,_RFPSA22,RESP054,"(39.360700171000474, -111.58713063499971)"
|
|
2018,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,48,22.3,15.2,29.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,INCOME3,CAT6,_RFPSA22,RESP046,"(39.360700171000474, -111.58713063499971)"
|
|
2018,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,132,77.7,70.5,84.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,INCOME3,CAT6,_RFPSA22,RESP054,"(39.360700171000474, -111.58713063499971)"
|
|
2018,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,100,27.4,21.2,33.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,INCOME4,CAT6,_RFPSA22,RESP046,"(39.360700171000474, -111.58713063499971)"
|
|
2018,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,227,72.6,66.5,78.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,INCOME4,CAT6,_RFPSA22,RESP054,"(39.360700171000474, -111.58713063499971)"
|
|
2018,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,603,29.4,26.9,31.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,INCOME5,CAT6,_RFPSA22,RESP046,"(39.360700171000474, -111.58713063499971)"
|
|
2018,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,1262,70.6,68.2,73.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,INCOME5,CAT6,_RFPSA22,RESP054,"(39.360700171000474, -111.58713063499971)"
|
|
2018,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,850,28.8,26.7,30.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,RACE01,CAT4,_RFPSA22,RESP046,"(39.360700171000474, -111.58713063499971)"
|
|
2018,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,49,RACE02,CAT4,_RFPSA22,RESP046,"(39.360700171000474, -111.58713063499971)"
|
|
2018,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,15,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,49,RACE02,CAT4,_RFPSA22,RESP054,"(39.360700171000474, -111.58713063499971)"
|
|
2018,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,49,RACE03,CAT4,_RFPSA22,RESP046,"(39.360700171000474, -111.58713063499971)"
|
|
2018,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,26,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,49,RACE03,CAT4,_RFPSA22,RESP054,"(39.360700171000474, -111.58713063499971)"
|
|
2018,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,9,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,49,RACE04,CAT4,_RFPSA22,RESP046,"(39.360700171000474, -111.58713063499971)"
|
|
2018,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,12,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,49,RACE04,CAT4,_RFPSA22,RESP054,"(39.360700171000474, -111.58713063499971)"
|
|
2018,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,49,RACE05,CAT4,_RFPSA22,RESP046,"(39.360700171000474, -111.58713063499971)"
|
|
2018,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,49,RACE05,CAT4,_RFPSA22,RESP054,"(39.360700171000474, -111.58713063499971)"
|
|
2018,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,49,RACE06,CAT4,_RFPSA22,RESP046,"(39.360700171000474, -111.58713063499971)"
|
|
2018,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,49,RACE06,CAT4,_RFPSA22,RESP054,"(39.360700171000474, -111.58713063499971)"
|
|
2018,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,9,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,49,RACE07,CAT4,_RFPSA22,RESP046,"(39.360700171000474, -111.58713063499971)"
|
|
2018,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,13,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,49,RACE07,CAT4,_RFPSA22,RESP054,"(39.360700171000474, -111.58713063499971)"
|
|
2018,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,29,15.8,9.9,21.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,RACE08,CAT4,_RFPSA22,RESP046,"(39.360700171000474, -111.58713063499971)"
|
|
2018,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,155,84.2,78.4,90.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,RACE08,CAT4,_RFPSA22,RESP054,"(39.360700171000474, -111.58713063499971)"
|
|
2018,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,2087,72.4,70.5,74.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,SEX1,CAT2,_RFPSA22,RESP054,"(39.360700171000474, -111.58713063499971)"
|
|
2018,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,49,SEX2,CAT2,_RFPSA22,RESP046,"(39.360700171000474, -111.58713063499971)"
|
|
2018,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,49,SEX2,CAT2,_RFPSA22,RESP054,"(39.360700171000474, -111.58713063499971)"
|
|
2018,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,15,3.7,1.6,5.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,AGE06,CAT3,_RFPSA22,RESP046,"(43.62538123900049, -72.51764079099962)"
|
|
2018,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,318,96.3,94.1,98.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,AGE06,CAT3,_RFPSA22,RESP054,"(43.62538123900049, -72.51764079099962)"
|
|
2018,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,107,21.3,16.8,25.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,AGE07,CAT3,_RFPSA22,RESP046,"(43.62538123900049, -72.51764079099962)"
|
|
2018,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,392,78.7,74.2,83.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,AGE07,CAT3,_RFPSA22,RESP054,"(43.62538123900049, -72.51764079099962)"
|
|
2018,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,112,32.2,25.8,38.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,AGE08,CAT3,_RFPSA22,RESP046,"(43.62538123900049, -72.51764079099962)"
|
|
2018,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,210,67.8,61.3,74.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,AGE08,CAT3,_RFPSA22,RESP054,"(43.62538123900049, -72.51764079099962)"
|
|
2018,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,364,37.8,33.8,41.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,AGE09,CAT3,_RFPSA22,RESP046,"(43.62538123900049, -72.51764079099962)"
|
|
2018,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,523,62.2,58.1,66.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,AGE09,CAT3,_RFPSA22,RESP054,"(43.62538123900049, -72.51764079099962)"
|
|
2018,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,598,24.8,22.5,27.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,BO1,CAT1,_RFPSA22,RESP046,"(43.62538123900049, -72.51764079099962)"
|
|
2018,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1443,75.2,72.9,77.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,BO1,CAT1,_RFPSA22,RESP054,"(43.62538123900049, -72.51764079099962)"
|
|
2018,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,12,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,50,EDUCA1,CAT5,_RFPSA22,RESP046,"(43.62538123900049, -72.51764079099962)"
|
|
2018,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,89,90.2,84,96.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,EDUCA1,CAT5,_RFPSA22,RESP054,"(43.62538123900049, -72.51764079099962)"
|
|
2018,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,146,21.6,17.8,25.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,EDUCA2,CAT5,_RFPSA22,RESP046,"(43.62538123900049, -72.51764079099962)"
|
|
2018,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,430,78.4,74.5,82.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,EDUCA2,CAT5,_RFPSA22,RESP054,"(43.62538123900049, -72.51764079099962)"
|
|
2018,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,122,26.6,21.4,31.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,EDUCA3,CAT5,_RFPSA22,RESP046,"(43.62538123900049, -72.51764079099962)"
|
|
2018,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,309,73.4,68.2,78.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,EDUCA3,CAT5,_RFPSA22,RESP054,"(43.62538123900049, -72.51764079099962)"
|
|
2018,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,316,30.3,26.7,33.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,EDUCA4,CAT5,_RFPSA22,RESP046,"(43.62538123900049, -72.51764079099962)"
|
|
2018,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,613,69.7,66.1,73.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,EDUCA4,CAT5,_RFPSA22,RESP054,"(43.62538123900049, -72.51764079099962)"
|
|
2018,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,16,9,3.9,14.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,INCOME1,CAT6,_RFPSA22,RESP046,"(43.62538123900049, -72.51764079099962)"
|
|
2018,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,92,91,85.8,96.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,INCOME1,CAT6,_RFPSA22,RESP054,"(43.62538123900049, -72.51764079099962)"
|
|
2018,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,57,23.2,16.6,29.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,INCOME2,CAT6,_RFPSA22,RESP046,"(43.62538123900049, -72.51764079099962)"
|
|
2018,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,178,76.8,70.3,83.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,INCOME2,CAT6,_RFPSA22,RESP054,"(43.62538123900049, -72.51764079099962)"
|
|
2018,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,47,25.6,17,34.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,INCOME3,CAT6,_RFPSA22,RESP046,"(43.62538123900049, -72.51764079099962)"
|
|
2018,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,123,74.4,65.8,83,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,INCOME3,CAT6,_RFPSA22,RESP054,"(43.62538123900049, -72.51764079099962)"
|
|
2018,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,76,23.6,17.4,29.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,INCOME4,CAT6,_RFPSA22,RESP046,"(43.62538123900049, -72.51764079099962)"
|
|
2018,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,186,76.4,70.2,82.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,INCOME4,CAT6,_RFPSA22,RESP054,"(43.62538123900049, -72.51764079099962)"
|
|
2018,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,330,27.6,24.2,30.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,INCOME5,CAT6,_RFPSA22,RESP046,"(43.62538123900049, -72.51764079099962)"
|
|
2018,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,683,72.4,69.1,75.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,INCOME5,CAT6,_RFPSA22,RESP054,"(43.62538123900049, -72.51764079099962)"
|
|
2018,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,564,24.7,22.4,27,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,RACE01,CAT4,_RFPSA22,RESP046,"(43.62538123900049, -72.51764079099962)"
|
|
2018,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1348,75.3,73,77.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,RACE01,CAT4,_RFPSA22,RESP054,"(43.62538123900049, -72.51764079099962)"
|
|
2018,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,50,RACE02,CAT4,_RFPSA22,RESP046,"(43.62538123900049, -72.51764079099962)"
|
|
2018,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,50,RACE02,CAT4,_RFPSA22,RESP054,"(43.62538123900049, -72.51764079099962)"
|
|
2018,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,50,RACE03,CAT4,_RFPSA22,RESP046,"(43.62538123900049, -72.51764079099962)"
|
|
2018,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,25,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,50,RACE03,CAT4,_RFPSA22,RESP054,"(43.62538123900049, -72.51764079099962)"
|
|
2018,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,50,RACE04,CAT4,_RFPSA22,RESP046,"(43.62538123900049, -72.51764079099962)"
|
|
2018,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,50,RACE04,CAT4,_RFPSA22,RESP054,"(43.62538123900049, -72.51764079099962)"
|
|
2018,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,50,RACE05,CAT4,_RFPSA22,RESP046,"(43.62538123900049, -72.51764079099962)"
|
|
2018,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,50,RACE05,CAT4,_RFPSA22,RESP054,"(43.62538123900049, -72.51764079099962)"
|
|
2018,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,9,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,50,RACE06,CAT4,_RFPSA22,RESP046,"(43.62538123900049, -72.51764079099962)"
|
|
2018,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,12,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,50,RACE06,CAT4,_RFPSA22,RESP054,"(43.62538123900049, -72.51764079099962)"
|
|
2018,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,50,RACE07,CAT4,_RFPSA22,RESP046,"(43.62538123900049, -72.51764079099962)"
|
|
2018,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,27,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,50,RACE07,CAT4,_RFPSA22,RESP054,"(43.62538123900049, -72.51764079099962)"
|
|
2018,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,50,RACE08,CAT4,_RFPSA22,RESP046,"(43.62538123900049, -72.51764079099962)"
|
|
2018,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,19,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,50,RACE08,CAT4,_RFPSA22,RESP054,"(43.62538123900049, -72.51764079099962)"
|
|
2018,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,598,24.8,22.5,27.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,SEX1,CAT2,_RFPSA22,RESP046,"(43.62538123900049, -72.51764079099962)"
|
|
2018,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1443,75.2,72.9,77.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,SEX1,CAT2,_RFPSA22,RESP054,"(43.62538123900049, -72.51764079099962)"
|
|
2018,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,50,SEX2,CAT2,_RFPSA22,RESP046,"(43.62538123900049, -72.51764079099962)"
|
|
2018,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,50,SEX2,CAT2,_RFPSA22,RESP054,"(43.62538123900049, -72.51764079099962)"
|
|
2018,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,60,11.1,7.7,14.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,AGE06,CAT3,_RFPSA22,RESP046,"(37.54268067400045, -78.45789046299967)"
|
|
2018,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,500,88.9,85.5,92.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,AGE06,CAT3,_RFPSA22,RESP054,"(37.54268067400045, -78.45789046299967)"
|
|
2018,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,230,28.6,24.3,32.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,AGE07,CAT3,_RFPSA22,RESP046,"(37.54268067400045, -78.45789046299967)"
|
|
2018,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,534,71.4,67.1,75.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,AGE07,CAT3,_RFPSA22,RESP054,"(37.54268067400045, -78.45789046299967)"
|
|
2018,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,231,48.1,42.2,54,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,AGE08,CAT3,_RFPSA22,RESP046,"(37.54268067400045, -78.45789046299967)"
|
|
2018,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,228,51.9,46,57.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,AGE08,CAT3,_RFPSA22,RESP054,"(37.54268067400045, -78.45789046299967)"
|
|
2018,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,685,51.5,47.8,55.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,AGE09,CAT3,_RFPSA22,RESP046,"(37.54268067400045, -78.45789046299967)"
|
|
2018,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,594,48.5,44.8,52.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,AGE09,CAT3,_RFPSA22,RESP054,"(37.54268067400045, -78.45789046299967)"
|
|
2018,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1206,33.6,31.4,35.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,BO1,CAT1,_RFPSA22,RESP046,"(37.54268067400045, -78.45789046299967)"
|
|
2018,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1856,66.4,64.1,68.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,BO1,CAT1,_RFPSA22,RESP054,"(37.54268067400045, -78.45789046299967)"
|
|
2018,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,71,23.9,17.5,30.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,EDUCA1,CAT5,_RFPSA22,RESP046,"(37.54268067400045, -78.45789046299967)"
|
|
2018,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,203,76.1,69.6,82.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,EDUCA1,CAT5,_RFPSA22,RESP054,"(37.54268067400045, -78.45789046299967)"
|
|
2018,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,228,27.5,23.2,31.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,EDUCA2,CAT5,_RFPSA22,RESP046,"(37.54268067400045, -78.45789046299967)"
|
|
2018,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,490,72.5,68.3,76.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,EDUCA2,CAT5,_RFPSA22,RESP054,"(37.54268067400045, -78.45789046299967)"
|
|
2018,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,263,33.5,29,37.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,EDUCA3,CAT5,_RFPSA22,RESP046,"(37.54268067400045, -78.45789046299967)"
|
|
2018,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,418,66.5,62.1,71,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,EDUCA3,CAT5,_RFPSA22,RESP054,"(37.54268067400045, -78.45789046299967)"
|
|
2018,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,644,41.9,38.4,45.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,EDUCA4,CAT5,_RFPSA22,RESP046,"(37.54268067400045, -78.45789046299967)"
|
|
2018,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,742,58.1,54.6,61.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,EDUCA4,CAT5,_RFPSA22,RESP054,"(37.54268067400045, -78.45789046299967)"
|
|
2018,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,39,23.5,14,33,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,INCOME1,CAT6,_RFPSA22,RESP046,"(37.54268067400045, -78.45789046299967)"
|
|
2018,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,129,76.5,67,86,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,INCOME1,CAT6,_RFPSA22,RESP054,"(37.54268067400045, -78.45789046299967)"
|
|
2018,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,91,25,18.6,31.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,INCOME2,CAT6,_RFPSA22,RESP046,"(37.54268067400045, -78.45789046299967)"
|
|
2018,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,221,75,68.6,81.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,INCOME2,CAT6,_RFPSA22,RESP054,"(37.54268067400045, -78.45789046299967)"
|
|
2018,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,73,27.1,19.5,34.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,INCOME3,CAT6,_RFPSA22,RESP046,"(37.54268067400045, -78.45789046299967)"
|
|
2018,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,158,72.9,65.4,80.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,INCOME3,CAT6,_RFPSA22,RESP054,"(37.54268067400045, -78.45789046299967)"
|
|
2018,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,123,34.4,27.7,41.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,INCOME4,CAT6,_RFPSA22,RESP046,"(37.54268067400045, -78.45789046299967)"
|
|
2018,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,180,65.6,58.8,72.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,INCOME4,CAT6,_RFPSA22,RESP054,"(37.54268067400045, -78.45789046299967)"
|
|
2018,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,758,36.4,33.4,39.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,INCOME5,CAT6,_RFPSA22,RESP046,"(37.54268067400045, -78.45789046299967)"
|
|
2018,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,980,63.6,60.7,66.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,INCOME5,CAT6,_RFPSA22,RESP054,"(37.54268067400045, -78.45789046299967)"
|
|
2018,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,971,35.6,33.2,38,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,RACE01,CAT4,_RFPSA22,RESP046,"(37.54268067400045, -78.45789046299967)"
|
|
2018,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1385,64.4,62,66.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,RACE01,CAT4,_RFPSA22,RESP054,"(37.54268067400045, -78.45789046299967)"
|
|
2018,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,149,33.7,27.5,39.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,RACE02,CAT4,_RFPSA22,RESP046,"(37.54268067400045, -78.45789046299967)"
|
|
2018,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,246,66.3,60.1,72.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,RACE02,CAT4,_RFPSA22,RESP054,"(37.54268067400045, -78.45789046299967)"
|
|
2018,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,13,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,51,RACE03,CAT4,_RFPSA22,RESP046,"(37.54268067400045, -78.45789046299967)"
|
|
2018,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,22,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,51,RACE03,CAT4,_RFPSA22,RESP054,"(37.54268067400045, -78.45789046299967)"
|
|
2018,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,16,25.4,11.2,39.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,RACE04,CAT4,_RFPSA22,RESP046,"(37.54268067400045, -78.45789046299967)"
|
|
2018,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,48,74.6,60.4,88.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,RACE04,CAT4,_RFPSA22,RESP054,"(37.54268067400045, -78.45789046299967)"
|
|
2018,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,51,RACE05,CAT4,_RFPSA22,RESP046,"(37.54268067400045, -78.45789046299967)"
|
|
2018,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,51,RACE05,CAT4,_RFPSA22,RESP054,"(37.54268067400045, -78.45789046299967)"
|
|
2018,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,51,RACE06,CAT4,_RFPSA22,RESP046,"(37.54268067400045, -78.45789046299967)"
|
|
2018,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,51,RACE06,CAT4,_RFPSA22,RESP054,"(37.54268067400045, -78.45789046299967)"
|
|
2018,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,19,34.5,18.6,50.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,RACE07,CAT4,_RFPSA22,RESP046,"(37.54268067400045, -78.45789046299967)"
|
|
2018,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,35,65.5,49.7,81.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,RACE07,CAT4,_RFPSA22,RESP054,"(37.54268067400045, -78.45789046299967)"
|
|
2018,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,34,20.4,12.1,28.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,RACE08,CAT4,_RFPSA22,RESP046,"(37.54268067400045, -78.45789046299967)"
|
|
2018,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,108,79.6,71.3,87.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,RACE08,CAT4,_RFPSA22,RESP054,"(37.54268067400045, -78.45789046299967)"
|
|
2018,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1206,33.6,31.4,35.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,SEX1,CAT2,_RFPSA22,RESP046,"(37.54268067400045, -78.45789046299967)"
|
|
2018,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1856,66.4,64.1,68.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,SEX1,CAT2,_RFPSA22,RESP054,"(37.54268067400045, -78.45789046299967)"
|
|
2018,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,51,SEX2,CAT2,_RFPSA22,RESP046,"(37.54268067400045, -78.45789046299967)"
|
|
2018,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,51,SEX2,CAT2,_RFPSA22,RESP054,"(37.54268067400045, -78.45789046299967)"
|
|
2018,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,34,4.7,2.8,6.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,AGE06,CAT3,_RFPSA22,RESP046,"(47.52227862900048, -120.47001078999972)"
|
|
2018,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,615,95.3,93.3,97.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,AGE06,CAT3,_RFPSA22,RESP054,"(47.52227862900048, -120.47001078999972)"
|
|
2018,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,206,23.5,20,27,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,AGE07,CAT3,_RFPSA22,RESP046,"(47.52227862900048, -120.47001078999972)"
|
|
2018,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,603,76.5,73,80,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,AGE07,CAT3,_RFPSA22,RESP054,"(47.52227862900048, -120.47001078999972)"
|
|
2018,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,213,33,28.3,37.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,AGE08,CAT3,_RFPSA22,RESP046,"(47.52227862900048, -120.47001078999972)"
|
|
2018,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,373,67,62.4,71.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,AGE08,CAT3,_RFPSA22,RESP054,"(47.52227862900048, -120.47001078999972)"
|
|
2018,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,868,43.9,41.1,46.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,AGE09,CAT3,_RFPSA22,RESP046,"(47.52227862900048, -120.47001078999972)"
|
|
2018,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,1004,56.1,53.2,58.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,AGE09,CAT3,_RFPSA22,RESP054,"(47.52227862900048, -120.47001078999972)"
|
|
2018,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1321,26.4,24.7,28.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,BO1,CAT1,_RFPSA22,RESP046,"(47.52227862900048, -120.47001078999972)"
|
|
2018,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,2595,73.6,71.9,75.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,BO1,CAT1,_RFPSA22,RESP054,"(47.52227862900048, -120.47001078999972)"
|
|
2018,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,32,10.8,6.3,15.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,EDUCA1,CAT5,_RFPSA22,RESP046,"(47.52227862900048, -120.47001078999972)"
|
|
2018,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,189,89.2,84.7,93.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,EDUCA1,CAT5,_RFPSA22,RESP054,"(47.52227862900048, -120.47001078999972)"
|
|
2018,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,216,22.5,19,26.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,EDUCA2,CAT5,_RFPSA22,RESP046,"(47.52227862900048, -120.47001078999972)"
|
|
2018,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,558,77.5,73.9,81,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,EDUCA2,CAT5,_RFPSA22,RESP054,"(47.52227862900048, -120.47001078999972)"
|
|
2018,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,385,27.9,24.8,31.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,EDUCA3,CAT5,_RFPSA22,RESP046,"(47.52227862900048, -120.47001078999972)"
|
|
2018,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,741,72.1,68.9,75.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,EDUCA3,CAT5,_RFPSA22,RESP054,"(47.52227862900048, -120.47001078999972)"
|
|
2018,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,685,31.9,29.3,34.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,EDUCA4,CAT5,_RFPSA22,RESP046,"(47.52227862900048, -120.47001078999972)"
|
|
2018,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,1100,68.1,65.5,70.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,EDUCA4,CAT5,_RFPSA22,RESP054,"(47.52227862900048, -120.47001078999972)"
|
|
2018,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,41,14.2,8.8,19.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,INCOME1,CAT6,_RFPSA22,RESP046,"(47.52227862900048, -120.47001078999972)"
|
|
2018,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,170,85.8,80.4,91.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,INCOME1,CAT6,_RFPSA22,RESP054,"(47.52227862900048, -120.47001078999972)"
|
|
2018,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,92,20.8,15.8,25.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,INCOME2,CAT6,_RFPSA22,RESP046,"(47.52227862900048, -120.47001078999972)"
|
|
2018,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,257,79.2,74.2,84.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,INCOME2,CAT6,_RFPSA22,RESP054,"(47.52227862900048, -120.47001078999972)"
|
|
2018,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,62,17.3,11.7,22.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,INCOME3,CAT6,_RFPSA22,RESP046,"(47.52227862900048, -120.47001078999972)"
|
|
2018,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,214,82.7,77.1,88.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,INCOME3,CAT6,_RFPSA22,RESP054,"(47.52227862900048, -120.47001078999972)"
|
|
2018,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,157,24.8,19.9,29.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,INCOME4,CAT6,_RFPSA22,RESP046,"(47.52227862900048, -120.47001078999972)"
|
|
2018,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,310,75.2,70.3,80.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,INCOME4,CAT6,_RFPSA22,RESP054,"(47.52227862900048, -120.47001078999972)"
|
|
2018,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,816,30,27.6,32.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,INCOME5,CAT6,_RFPSA22,RESP046,"(47.52227862900048, -120.47001078999972)"
|
|
2018,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,1345,70,67.7,72.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,INCOME5,CAT6,_RFPSA22,RESP054,"(47.52227862900048, -120.47001078999972)"
|
|
2018,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1192,29.1,27.2,31,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,RACE01,CAT4,_RFPSA22,RESP046,"(47.52227862900048, -120.47001078999972)"
|
|
2018,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,2143,70.9,69,72.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,RACE01,CAT4,_RFPSA22,RESP054,"(47.52227862900048, -120.47001078999972)"
|
|
2018,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,24,23.1,12.2,34,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,RACE02,CAT4,_RFPSA22,RESP046,"(47.52227862900048, -120.47001078999972)"
|
|
2018,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,39,76.9,66,87.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,RACE02,CAT4,_RFPSA22,RESP054,"(47.52227862900048, -120.47001078999972)"
|
|
2018,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,20,34.2,20.2,48.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,RACE03,CAT4,_RFPSA22,RESP046,"(47.52227862900048, -120.47001078999972)"
|
|
2018,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,43,65.8,51.8,79.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,RACE03,CAT4,_RFPSA22,RESP054,"(47.52227862900048, -120.47001078999972)"
|
|
2018,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,13,9.3,4.1,14.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,RACE04,CAT4,_RFPSA22,RESP046,"(47.52227862900048, -120.47001078999972)"
|
|
2018,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,93,90.7,85.5,95.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,RACE04,CAT4,_RFPSA22,RESP054,"(47.52227862900048, -120.47001078999972)"
|
|
2018,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,9,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,53,RACE05,CAT4,_RFPSA22,RESP046,"(47.52227862900048, -120.47001078999972)"
|
|
2018,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,53,RACE05,CAT4,_RFPSA22,RESP054,"(47.52227862900048, -120.47001078999972)"
|
|
2018,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,13,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,53,RACE06,CAT4,_RFPSA22,RESP046,"(47.52227862900048, -120.47001078999972)"
|
|
2018,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,33,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,53,RACE06,CAT4,_RFPSA22,RESP054,"(47.52227862900048, -120.47001078999972)"
|
|
2018,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,22,27.7,15.1,40.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,RACE07,CAT4,_RFPSA22,RESP046,"(47.52227862900048, -120.47001078999972)"
|
|
2018,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,62,72.3,59.6,84.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,RACE07,CAT4,_RFPSA22,RESP054,"(47.52227862900048, -120.47001078999972)"
|
|
2018,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,28,12.2,7.2,17.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,RACE08,CAT4,_RFPSA22,RESP046,"(47.52227862900048, -120.47001078999972)"
|
|
2018,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,174,87.8,82.8,92.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,RACE08,CAT4,_RFPSA22,RESP054,"(47.52227862900048, -120.47001078999972)"
|
|
2018,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1321,26.4,24.7,28.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,SEX1,CAT2,_RFPSA22,RESP046,"(47.52227862900048, -120.47001078999972)"
|
|
2018,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,2595,73.6,71.9,75.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,SEX1,CAT2,_RFPSA22,RESP054,"(47.52227862900048, -120.47001078999972)"
|
|
2018,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,53,SEX2,CAT2,_RFPSA22,RESP046,"(47.52227862900048, -120.47001078999972)"
|
|
2018,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,53,SEX2,CAT2,_RFPSA22,RESP054,"(47.52227862900048, -120.47001078999972)"
|
|
2018,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,33,11.5,7.4,15.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,AGE06,CAT3,_RFPSA22,RESP046,"(38.66551020200046, -80.71264013499967)"
|
|
2018,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,219,88.5,84.3,92.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,AGE06,CAT3,_RFPSA22,RESP054,"(38.66551020200046, -80.71264013499967)"
|
|
2018,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,122,29.8,24.6,34.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,AGE07,CAT3,_RFPSA22,RESP046,"(38.66551020200046, -80.71264013499967)"
|
|
2018,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,260,70.2,65.1,75.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,AGE07,CAT3,_RFPSA22,RESP054,"(38.66551020200046, -80.71264013499967)"
|
|
2018,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,126,53,45.9,60.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,AGE08,CAT3,_RFPSA22,RESP046,"(38.66551020200046, -80.71264013499967)"
|
|
2018,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,118,47,39.8,54.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,AGE08,CAT3,_RFPSA22,RESP054,"(38.66551020200046, -80.71264013499967)"
|
|
2018,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,399,56.6,52.2,61,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,AGE09,CAT3,_RFPSA22,RESP046,"(38.66551020200046, -80.71264013499967)"
|
|
2018,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,274,43.4,39,47.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,AGE09,CAT3,_RFPSA22,RESP054,"(38.66551020200046, -80.71264013499967)"
|
|
2018,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,680,38.4,35.7,41.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,BO1,CAT1,_RFPSA22,RESP046,"(38.66551020200046, -80.71264013499967)"
|
|
2018,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,871,61.6,58.8,64.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,BO1,CAT1,_RFPSA22,RESP054,"(38.66551020200046, -80.71264013499967)"
|
|
2018,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,51,28.8,21.1,36.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,EDUCA1,CAT5,_RFPSA22,RESP046,"(38.66551020200046, -80.71264013499967)"
|
|
2018,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,105,71.2,63.5,78.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,EDUCA1,CAT5,_RFPSA22,RESP054,"(38.66551020200046, -80.71264013499967)"
|
|
2018,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,224,37.1,32.7,41.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,EDUCA2,CAT5,_RFPSA22,RESP046,"(38.66551020200046, -80.71264013499967)"
|
|
2018,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,348,62.9,58.6,67.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,EDUCA2,CAT5,_RFPSA22,RESP054,"(38.66551020200046, -80.71264013499967)"
|
|
2018,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,168,40.7,35.2,46.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,EDUCA3,CAT5,_RFPSA22,RESP046,"(38.66551020200046, -80.71264013499967)"
|
|
2018,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,202,59.3,53.8,64.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,EDUCA3,CAT5,_RFPSA22,RESP054,"(38.66551020200046, -80.71264013499967)"
|
|
2018,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,236,46.6,41.4,51.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,EDUCA4,CAT5,_RFPSA22,RESP046,"(38.66551020200046, -80.71264013499967)"
|
|
2018,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,216,53.4,48.3,58.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,EDUCA4,CAT5,_RFPSA22,RESP054,"(38.66551020200046, -80.71264013499967)"
|
|
2018,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,34,23.9,15.7,32.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,INCOME1,CAT6,_RFPSA22,RESP046,"(38.66551020200046, -80.71264013499967)"
|
|
2018,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,98,76.1,67.9,84.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,INCOME1,CAT6,_RFPSA22,RESP054,"(38.66551020200046, -80.71264013499967)"
|
|
2018,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,75,30.8,24.1,37.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,INCOME2,CAT6,_RFPSA22,RESP046,"(38.66551020200046, -80.71264013499967)"
|
|
2018,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,154,69.2,62.5,75.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,INCOME2,CAT6,_RFPSA22,RESP054,"(38.66551020200046, -80.71264013499967)"
|
|
2018,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,92,42.7,35,50.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,INCOME3,CAT6,_RFPSA22,RESP046,"(38.66551020200046, -80.71264013499967)"
|
|
2018,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,119,57.3,49.7,65,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,INCOME3,CAT6,_RFPSA22,RESP054,"(38.66551020200046, -80.71264013499967)"
|
|
2018,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,133,46.1,38.9,53.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,INCOME4,CAT6,_RFPSA22,RESP046,"(38.66551020200046, -80.71264013499967)"
|
|
2018,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,116,53.9,46.7,61.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,INCOME4,CAT6,_RFPSA22,RESP054,"(38.66551020200046, -80.71264013499967)"
|
|
2018,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,271,39.7,35,44.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,INCOME5,CAT6,_RFPSA22,RESP046,"(38.66551020200046, -80.71264013499967)"
|
|
2018,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,297,60.3,55.7,65,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,INCOME5,CAT6,_RFPSA22,RESP054,"(38.66551020200046, -80.71264013499967)"
|
|
2018,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,646,39,36.1,41.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,RACE01,CAT4,_RFPSA22,RESP046,"(38.66551020200046, -80.71264013499967)"
|
|
2018,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,813,61,58.2,63.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,RACE01,CAT4,_RFPSA22,RESP054,"(38.66551020200046, -80.71264013499967)"
|
|
2018,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,54,RACE02,CAT4,_RFPSA22,RESP046,"(38.66551020200046, -80.71264013499967)"
|
|
2018,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,20,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,54,RACE02,CAT4,_RFPSA22,RESP054,"(38.66551020200046, -80.71264013499967)"
|
|
2018,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,54,RACE03,CAT4,_RFPSA22,RESP046,"(38.66551020200046, -80.71264013499967)"
|
|
2018,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,54,RACE03,CAT4,_RFPSA22,RESP054,"(38.66551020200046, -80.71264013499967)"
|
|
2018,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,54,RACE04,CAT4,_RFPSA22,RESP046,"(38.66551020200046, -80.71264013499967)"
|
|
2018,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,54,RACE04,CAT4,_RFPSA22,RESP054,"(38.66551020200046, -80.71264013499967)"
|
|
2018,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,54,RACE05,CAT4,_RFPSA22,RESP046,"(38.66551020200046, -80.71264013499967)"
|
|
2018,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,54,RACE05,CAT4,_RFPSA22,RESP054,"(38.66551020200046, -80.71264013499967)"
|
|
2018,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,54,RACE06,CAT4,_RFPSA22,RESP046,"(38.66551020200046, -80.71264013499967)"
|
|
2018,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,54,RACE06,CAT4,_RFPSA22,RESP054,"(38.66551020200046, -80.71264013499967)"
|
|
2018,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,9,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,54,RACE07,CAT4,_RFPSA22,RESP046,"(38.66551020200046, -80.71264013499967)"
|
|
2018,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,15,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,54,RACE07,CAT4,_RFPSA22,RESP054,"(38.66551020200046, -80.71264013499967)"
|
|
2018,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,54,RACE08,CAT4,_RFPSA22,RESP046,"(38.66551020200046, -80.71264013499967)"
|
|
2018,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,54,RACE08,CAT4,_RFPSA22,RESP054,"(38.66551020200046, -80.71264013499967)"
|
|
2018,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,680,38.4,35.7,41.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,SEX1,CAT2,_RFPSA22,RESP046,"(38.66551020200046, -80.71264013499967)"
|
|
2018,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,871,61.6,58.8,64.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,SEX1,CAT2,_RFPSA22,RESP054,"(38.66551020200046, -80.71264013499967)"
|
|
2018,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,54,SEX2,CAT2,_RFPSA22,RESP046,"(38.66551020200046, -80.71264013499967)"
|
|
2018,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,54,SEX2,CAT2,_RFPSA22,RESP054,"(38.66551020200046, -80.71264013499967)"
|
|
2018,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,130,29.9,24.5,35.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,AGE07,CAT3,_RFPSA22,RESP046,"(44.39319117400049, -89.81637074199966)"
|
|
2018,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,23,9.1,4.4,13.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,AGE06,CAT3,_RFPSA22,RESP046,"(44.39319117400049, -89.81637074199966)"
|
|
2018,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,251,90.9,86.2,95.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,AGE06,CAT3,_RFPSA22,RESP054,"(44.39319117400049, -89.81637074199966)"
|
|
2018,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,261,70.1,64.6,75.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,AGE07,CAT3,_RFPSA22,RESP054,"(44.39319117400049, -89.81637074199966)"
|
|
2018,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,110,44.5,36.4,52.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,AGE08,CAT3,_RFPSA22,RESP046,"(44.39319117400049, -89.81637074199966)"
|
|
2018,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,129,55.5,47.4,63.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,AGE08,CAT3,_RFPSA22,RESP054,"(44.39319117400049, -89.81637074199966)"
|
|
2018,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,297,47.9,42.5,53.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,AGE09,CAT3,_RFPSA22,RESP046,"(44.39319117400049, -89.81637074199966)"
|
|
2018,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,308,52.1,46.7,57.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,AGE09,CAT3,_RFPSA22,RESP054,"(44.39319117400049, -89.81637074199966)"
|
|
2018,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,560,32.9,29.8,35.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,BO1,CAT1,_RFPSA22,RESP046,"(44.39319117400049, -89.81637074199966)"
|
|
2018,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,949,67.1,64.1,70.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,BO1,CAT1,_RFPSA22,RESP054,"(44.39319117400049, -89.81637074199966)"
|
|
2018,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,17,22.2,9.8,34.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,EDUCA1,CAT5,_RFPSA22,RESP046,"(44.39319117400049, -89.81637074199966)"
|
|
2018,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,57,77.8,65.5,90.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,EDUCA1,CAT5,_RFPSA22,RESP054,"(44.39319117400049, -89.81637074199966)"
|
|
2018,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,159,30.4,25.6,35.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,EDUCA2,CAT5,_RFPSA22,RESP046,"(44.39319117400049, -89.81637074199966)"
|
|
2018,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,332,69.6,64.7,74.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,EDUCA2,CAT5,_RFPSA22,RESP054,"(44.39319117400049, -89.81637074199966)"
|
|
2018,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,169,35.2,29.4,41,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,EDUCA3,CAT5,_RFPSA22,RESP046,"(44.39319117400049, -89.81637074199966)"
|
|
2018,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,244,64.8,59,70.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,EDUCA3,CAT5,_RFPSA22,RESP054,"(44.39319117400049, -89.81637074199966)"
|
|
2018,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,215,36.5,31.4,41.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,EDUCA4,CAT5,_RFPSA22,RESP046,"(44.39319117400049, -89.81637074199966)"
|
|
2018,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,314,63.5,58.4,68.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,EDUCA4,CAT5,_RFPSA22,RESP054,"(44.39319117400049, -89.81637074199966)"
|
|
2018,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,25,21.9,10.6,33.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,INCOME1,CAT6,_RFPSA22,RESP046,"(44.39319117400049, -89.81637074199966)"
|
|
2018,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,70,78.1,66.9,89.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,INCOME1,CAT6,_RFPSA22,RESP054,"(44.39319117400049, -89.81637074199966)"
|
|
2018,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,52,31.2,21,41.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,INCOME2,CAT6,_RFPSA22,RESP046,"(44.39319117400049, -89.81637074199966)"
|
|
2018,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,104,68.8,58.5,79,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,INCOME2,CAT6,_RFPSA22,RESP054,"(44.39319117400049, -89.81637074199966)"
|
|
2018,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,55,30.2,21.4,39.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,INCOME3,CAT6,_RFPSA22,RESP046,"(44.39319117400049, -89.81637074199966)"
|
|
2018,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,97,69.8,60.9,78.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,INCOME3,CAT6,_RFPSA22,RESP054,"(44.39319117400049, -89.81637074199966)"
|
|
2018,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,78,30.8,23.3,38.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,INCOME4,CAT6,_RFPSA22,RESP046,"(44.39319117400049, -89.81637074199966)"
|
|
2018,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,136,69.2,61.7,76.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,INCOME4,CAT6,_RFPSA22,RESP054,"(44.39319117400049, -89.81637074199966)"
|
|
2018,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,318,34.8,30.7,38.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,INCOME5,CAT6,_RFPSA22,RESP046,"(44.39319117400049, -89.81637074199966)"
|
|
2018,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,478,65.2,61.1,69.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,INCOME5,CAT6,_RFPSA22,RESP054,"(44.39319117400049, -89.81637074199966)"
|
|
2018,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,509,33.5,30.4,36.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,RACE01,CAT4,_RFPSA22,RESP046,"(44.39319117400049, -89.81637074199966)"
|
|
2018,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,843,66.5,63.4,69.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,RACE01,CAT4,_RFPSA22,RESP054,"(44.39319117400049, -89.81637074199966)"
|
|
2018,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,13,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,55,RACE02,CAT4,_RFPSA22,RESP046,"(44.39319117400049, -89.81637074199966)"
|
|
2018,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,24,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,55,RACE02,CAT4,_RFPSA22,RESP054,"(44.39319117400049, -89.81637074199966)"
|
|
2018,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,13,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,55,RACE03,CAT4,_RFPSA22,RESP046,"(44.39319117400049, -89.81637074199966)"
|
|
2018,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,31,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,55,RACE03,CAT4,_RFPSA22,RESP054,"(44.39319117400049, -89.81637074199966)"
|
|
2018,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,55,RACE04,CAT4,_RFPSA22,RESP046,"(44.39319117400049, -89.81637074199966)"
|
|
2018,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,55,RACE04,CAT4,_RFPSA22,RESP054,"(44.39319117400049, -89.81637074199966)"
|
|
2018,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,55,RACE05,CAT4,_RFPSA22,RESP046,"(44.39319117400049, -89.81637074199966)"
|
|
2018,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,55,RACE05,CAT4,_RFPSA22,RESP054,"(44.39319117400049, -89.81637074199966)"
|
|
2018,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,14,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,55,RACE06,CAT4,_RFPSA22,RESP046,"(44.39319117400049, -89.81637074199966)"
|
|
2018,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,13,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,55,RACE06,CAT4,_RFPSA22,RESP054,"(44.39319117400049, -89.81637074199966)"
|
|
2018,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,55,RACE07,CAT4,_RFPSA22,RESP046,"(44.39319117400049, -89.81637074199966)"
|
|
2018,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,55,RACE07,CAT4,_RFPSA22,RESP054,"(44.39319117400049, -89.81637074199966)"
|
|
2018,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,55,RACE08,CAT4,_RFPSA22,RESP046,"(44.39319117400049, -89.81637074199966)"
|
|
2018,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,24,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,55,RACE08,CAT4,_RFPSA22,RESP054,"(44.39319117400049, -89.81637074199966)"
|
|
2018,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,560,32.9,29.8,35.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,SEX1,CAT2,_RFPSA22,RESP046,"(44.39319117400049, -89.81637074199966)"
|
|
2018,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,949,67.1,64.1,70.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,SEX1,CAT2,_RFPSA22,RESP054,"(44.39319117400049, -89.81637074199966)"
|
|
2018,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,55,SEX2,CAT2,_RFPSA22,RESP046,"(44.39319117400049, -89.81637074199966)"
|
|
2018,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,55,SEX2,CAT2,_RFPSA22,RESP054,"(44.39319117400049, -89.81637074199966)"
|
|
2018,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,23,8.5,4.8,12.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,AGE06,CAT3,_RFPSA22,RESP046,"(43.23554134300048, -108.10983035299967)"
|
|
2018,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,198,91.5,87.7,95.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,AGE06,CAT3,_RFPSA22,RESP054,"(43.23554134300048, -108.10983035299967)"
|
|
2018,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,109,33.6,27.6,39.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,AGE07,CAT3,_RFPSA22,RESP046,"(43.23554134300048, -108.10983035299967)"
|
|
2018,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,199,66.4,60.5,72.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,AGE07,CAT3,_RFPSA22,RESP054,"(43.23554134300048, -108.10983035299967)"
|
|
2018,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,105,45.2,37.8,52.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,AGE08,CAT3,_RFPSA22,RESP046,"(43.23554134300048, -108.10983035299967)"
|
|
2018,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,116,54.8,47.5,62.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,AGE08,CAT3,_RFPSA22,RESP054,"(43.23554134300048, -108.10983035299967)"
|
|
2018,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,404,53.9,49.6,58.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,AGE09,CAT3,_RFPSA22,RESP046,"(43.23554134300048, -108.10983035299967)"
|
|
2018,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,293,46.1,41.8,50.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,AGE09,CAT3,_RFPSA22,RESP054,"(43.23554134300048, -108.10983035299967)"
|
|
2018,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,641,35.4,32.6,38.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,BO1,CAT1,_RFPSA22,RESP046,"(43.23554134300048, -108.10983035299967)"
|
|
2018,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,806,64.6,61.8,67.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,BO1,CAT1,_RFPSA22,RESP054,"(43.23554134300048, -108.10983035299967)"
|
|
2018,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,14,16.9,7.4,26.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,EDUCA1,CAT5,_RFPSA22,RESP046,"(43.23554134300048, -108.10983035299967)"
|
|
2018,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,48,83.1,73.6,92.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,EDUCA1,CAT5,_RFPSA22,RESP054,"(43.23554134300048, -108.10983035299967)"
|
|
2018,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,152,28.8,24.2,33.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,EDUCA2,CAT5,_RFPSA22,RESP046,"(43.23554134300048, -108.10983035299967)"
|
|
2018,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,279,71.2,66.5,75.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,EDUCA2,CAT5,_RFPSA22,RESP054,"(43.23554134300048, -108.10983035299967)"
|
|
2018,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,189,36,30.9,41.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,EDUCA3,CAT5,_RFPSA22,RESP046,"(43.23554134300048, -108.10983035299967)"
|
|
2018,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,239,64,58.9,69.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,EDUCA3,CAT5,_RFPSA22,RESP054,"(43.23554134300048, -108.10983035299967)"
|
|
2018,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,286,47,42.1,52,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,EDUCA4,CAT5,_RFPSA22,RESP046,"(43.23554134300048, -108.10983035299967)"
|
|
2018,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,239,53,48,57.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,EDUCA4,CAT5,_RFPSA22,RESP054,"(43.23554134300048, -108.10983035299967)"
|
|
2018,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,9,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,56,INCOME1,CAT6,_RFPSA22,RESP046,"(43.23554134300048, -108.10983035299967)"
|
|
2018,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,43,89.2,81,97.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,INCOME1,CAT6,_RFPSA22,RESP054,"(43.23554134300048, -108.10983035299967)"
|
|
2018,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,72,30.3,22.9,37.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,INCOME2,CAT6,_RFPSA22,RESP046,"(43.23554134300048, -108.10983035299967)"
|
|
2018,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,115,69.7,62.3,77.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,INCOME2,CAT6,_RFPSA22,RESP054,"(43.23554134300048, -108.10983035299967)"
|
|
2018,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,53,30.5,22,39,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,INCOME3,CAT6,_RFPSA22,RESP046,"(43.23554134300048, -108.10983035299967)"
|
|
2018,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,77,69.5,61,78,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,INCOME3,CAT6,_RFPSA22,RESP054,"(43.23554134300048, -108.10983035299967)"
|
|
2018,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,90,38.4,30.8,46.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,INCOME4,CAT6,_RFPSA22,RESP046,"(43.23554134300048, -108.10983035299967)"
|
|
2018,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,107,61.6,53.9,69.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,INCOME4,CAT6,_RFPSA22,RESP054,"(43.23554134300048, -108.10983035299967)"
|
|
2018,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,348,37.8,33.8,41.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,INCOME5,CAT6,_RFPSA22,RESP046,"(43.23554134300048, -108.10983035299967)"
|
|
2018,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,389,62.2,58.2,66.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,INCOME5,CAT6,_RFPSA22,RESP054,"(43.23554134300048, -108.10983035299967)"
|
|
2018,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,597,36.4,33.4,39.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,RACE01,CAT4,_RFPSA22,RESP046,"(43.23554134300048, -108.10983035299967)"
|
|
2018,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,716,63.6,60.7,66.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,RACE01,CAT4,_RFPSA22,RESP054,"(43.23554134300048, -108.10983035299967)"
|
|
2018,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,56,RACE02,CAT4,_RFPSA22,RESP046,"(43.23554134300048, -108.10983035299967)"
|
|
2018,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,56,RACE02,CAT4,_RFPSA22,RESP054,"(43.23554134300048, -108.10983035299967)"
|
|
2018,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,56,RACE03,CAT4,_RFPSA22,RESP046,"(43.23554134300048, -108.10983035299967)"
|
|
2018,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,14,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,56,RACE03,CAT4,_RFPSA22,RESP054,"(43.23554134300048, -108.10983035299967)"
|
|
2018,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,12,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,56,RACE04,CAT4,_RFPSA22,RESP046,"(43.23554134300048, -108.10983035299967)"
|
|
2018,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,56,RACE04,CAT4,_RFPSA22,RESP054,"(43.23554134300048, -108.10983035299967)"
|
|
2018,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,56,RACE05,CAT4,_RFPSA22,RESP046,"(43.23554134300048, -108.10983035299967)"
|
|
2018,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,56,RACE05,CAT4,_RFPSA22,RESP054,"(43.23554134300048, -108.10983035299967)"
|
|
2018,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,56,RACE06,CAT4,_RFPSA22,RESP046,"(43.23554134300048, -108.10983035299967)"
|
|
2018,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,56,RACE06,CAT4,_RFPSA22,RESP054,"(43.23554134300048, -108.10983035299967)"
|
|
2018,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,56,RACE07,CAT4,_RFPSA22,RESP046,"(43.23554134300048, -108.10983035299967)"
|
|
2018,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,14,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,56,RACE07,CAT4,_RFPSA22,RESP054,"(43.23554134300048, -108.10983035299967)"
|
|
2018,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,23,34.4,21.7,47.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,RACE08,CAT4,_RFPSA22,RESP046,"(43.23554134300048, -108.10983035299967)"
|
|
2018,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,44,65.6,52.9,78.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,RACE08,CAT4,_RFPSA22,RESP054,"(43.23554134300048, -108.10983035299967)"
|
|
2018,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,641,35.4,32.6,38.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,SEX1,CAT2,_RFPSA22,RESP046,"(43.23554134300048, -108.10983035299967)"
|
|
2018,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,806,64.6,61.8,67.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,SEX1,CAT2,_RFPSA22,RESP054,"(43.23554134300048, -108.10983035299967)"
|
|
2018,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,56,SEX2,CAT2,_RFPSA22,RESP046,"(43.23554134300048, -108.10983035299967)"
|
|
2018,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,***,No responses for this data cell,BRFSS,CLASS16,TOPIC47,56,SEX2,CAT2,_RFPSA22,RESP054,"(43.23554134300048, -108.10983035299967)"
|
|
2020,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,31,10.2,6.4,13.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,AGE06,CAT3,_RFPSA23,RESP046,"(32.84057112200048, -86.63186076199969)"
|
|
2020,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,235,89.8,86.1,93.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,AGE06,CAT3,_RFPSA23,RESP054,"(32.84057112200048, -86.63186076199969)"
|
|
2020,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,106,35.8,28.8,42.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,AGE07,CAT3,_RFPSA23,RESP046,"(32.84057112200048, -86.63186076199969)"
|
|
2020,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,210,64.2,57.3,71.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,AGE07,CAT3,_RFPSA23,RESP054,"(32.84057112200048, -86.63186076199969)"
|
|
2020,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,103,56.4,47.9,65,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,AGE08,CAT3,_RFPSA23,RESP046,"(32.84057112200048, -86.63186076199969)"
|
|
2020,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,91,43.6,35,52.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,AGE08,CAT3,_RFPSA23,RESP054,"(32.84057112200048, -86.63186076199969)"
|
|
2020,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,397,55.3,50.2,60.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,AGE09,CAT3,_RFPSA23,RESP046,"(32.84057112200048, -86.63186076199969)"
|
|
2020,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,252,44.7,39.6,49.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,AGE09,CAT3,_RFPSA23,RESP054,"(32.84057112200048, -86.63186076199969)"
|
|
2020,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,637,38.9,35.7,42.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,BO1,CAT1,_RFPSA23,RESP046,"(32.84057112200048, -86.63186076199969)"
|
|
2020,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,788,61.1,57.9,64.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,BO1,CAT1,_RFPSA23,RESP054,"(32.84057112200048, -86.63186076199969)"
|
|
2020,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,32,20.9,13.5,28.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,EDUCA1,CAT5,_RFPSA23,RESP046,"(32.84057112200048, -86.63186076199969)"
|
|
2020,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,98,79.1,71.6,86.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,EDUCA1,CAT5,_RFPSA23,RESP054,"(32.84057112200048, -86.63186076199969)"
|
|
2020,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,141,35.9,30,41.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,EDUCA2,CAT5,_RFPSA23,RESP046,"(32.84057112200048, -86.63186076199969)"
|
|
2020,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,246,64.1,58.2,70,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,EDUCA2,CAT5,_RFPSA23,RESP054,"(32.84057112200048, -86.63186076199969)"
|
|
2020,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,187,45,38.7,51.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,EDUCA3,CAT5,_RFPSA23,RESP046,"(32.84057112200048, -86.63186076199969)"
|
|
2020,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,194,55,48.7,61.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,EDUCA3,CAT5,_RFPSA23,RESP054,"(32.84057112200048, -86.63186076199969)"
|
|
2020,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,277,46.1,40.8,51.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,EDUCA4,CAT5,_RFPSA23,RESP046,"(32.84057112200048, -86.63186076199969)"
|
|
2020,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,249,53.9,48.6,59.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,EDUCA4,CAT5,_RFPSA23,RESP054,"(32.84057112200048, -86.63186076199969)"
|
|
2020,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,22,19.3,10.5,28.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,INCOME1,CAT6,_RFPSA23,RESP046,"(32.84057112200048, -86.63186076199969)"
|
|
2020,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,82,80.7,71.9,89.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,INCOME1,CAT6,_RFPSA23,RESP054,"(32.84057112200048, -86.63186076199969)"
|
|
2020,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,64,36.9,27,46.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,INCOME2,CAT6,_RFPSA23,RESP046,"(32.84057112200048, -86.63186076199969)"
|
|
2020,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,102,63.1,53.2,73,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,INCOME2,CAT6,_RFPSA23,RESP054,"(32.84057112200048, -86.63186076199969)"
|
|
2020,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,40,35.1,23.1,47,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,INCOME3,CAT6,_RFPSA23,RESP046,"(32.84057112200048, -86.63186076199969)"
|
|
2020,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,56,64.9,53,76.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,INCOME3,CAT6,_RFPSA23,RESP054,"(32.84057112200048, -86.63186076199969)"
|
|
2020,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,70,41.3,31.2,51.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,INCOME4,CAT6,_RFPSA23,RESP046,"(32.84057112200048, -86.63186076199969)"
|
|
2020,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,93,58.7,48.6,68.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,INCOME4,CAT6,_RFPSA23,RESP054,"(32.84057112200048, -86.63186076199969)"
|
|
2020,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,353,43.1,38.6,47.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,INCOME5,CAT6,_RFPSA23,RESP046,"(32.84057112200048, -86.63186076199969)"
|
|
2020,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,349,56.9,52.3,61.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,INCOME5,CAT6,_RFPSA23,RESP054,"(32.84057112200048, -86.63186076199969)"
|
|
2020,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,494,39.8,36.1,43.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,RACE01,CAT4,_RFPSA23,RESP046,"(32.84057112200048, -86.63186076199969)"
|
|
2020,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,566,60.2,56.5,63.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,RACE01,CAT4,_RFPSA23,RESP054,"(32.84057112200048, -86.63186076199969)"
|
|
2020,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,114,36.6,29.9,43.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,RACE02,CAT4,_RFPSA23,RESP046,"(32.84057112200048, -86.63186076199969)"
|
|
2020,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,169,63.4,56.7,70.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,RACE02,CAT4,_RFPSA23,RESP054,"(32.84057112200048, -86.63186076199969)"
|
|
2020,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,12,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,01,RACE03,CAT4,_RFPSA23,RESP046,"(32.84057112200048, -86.63186076199969)"
|
|
2020,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,13,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,01,RACE03,CAT4,_RFPSA23,RESP054,"(32.84057112200048, -86.63186076199969)"
|
|
2020,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,01,RACE04,CAT4,_RFPSA23,RESP046,"(32.84057112200048, -86.63186076199969)"
|
|
2020,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,01,RACE04,CAT4,_RFPSA23,RESP054,"(32.84057112200048, -86.63186076199969)"
|
|
2020,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,01,RACE05,CAT4,_RFPSA23,RESP046,"(32.84057112200048, -86.63186076199969)"
|
|
2020,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,01,RACE05,CAT4,_RFPSA23,RESP054,"(32.84057112200048, -86.63186076199969)"
|
|
2020,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,01,RACE06,CAT4,_RFPSA23,RESP046,"(32.84057112200048, -86.63186076199969)"
|
|
2020,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,01,RACE06,CAT4,_RFPSA23,RESP054,"(32.84057112200048, -86.63186076199969)"
|
|
2020,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,01,RACE07,CAT4,_RFPSA23,RESP046,"(32.84057112200048, -86.63186076199969)"
|
|
2020,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,15,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,01,RACE07,CAT4,_RFPSA23,RESP054,"(32.84057112200048, -86.63186076199969)"
|
|
2020,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,01,RACE08,CAT4,_RFPSA23,RESP046,"(32.84057112200048, -86.63186076199969)"
|
|
2020,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,11,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,01,RACE08,CAT4,_RFPSA23,RESP054,"(32.84057112200048, -86.63186076199969)"
|
|
2020,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,637,38.9,35.7,42.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,SEX1,CAT2,_RFPSA23,RESP046,"(32.84057112200048, -86.63186076199969)"
|
|
2020,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,788,61.1,57.9,64.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,01,SEX1,CAT2,_RFPSA23,RESP054,"(32.84057112200048, -86.63186076199969)"
|
|
2020,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,01,SEX2,CAT2,_RFPSA23,RESP046,"(32.84057112200048, -86.63186076199969)"
|
|
2020,AL,Alabama,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,01,SEX2,CAT2,_RFPSA23,RESP054,"(32.84057112200048, -86.63186076199969)"
|
|
2020,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,21,10.4,5.2,15.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,AGE06,CAT3,_RFPSA23,RESP046,"(64.84507995700051, -147.72205903599973)"
|
|
2020,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,216,89.6,84.4,94.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,AGE06,CAT3,_RFPSA23,RESP054,"(64.84507995700051, -147.72205903599973)"
|
|
2020,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,69,28.2,20.4,36,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,AGE07,CAT3,_RFPSA23,RESP046,"(64.84507995700051, -147.72205903599973)"
|
|
2020,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,203,71.8,64,79.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,AGE07,CAT3,_RFPSA23,RESP054,"(64.84507995700051, -147.72205903599973)"
|
|
2020,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,54,29.3,19.3,39.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,AGE08,CAT3,_RFPSA23,RESP046,"(64.84507995700051, -147.72205903599973)"
|
|
2020,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,119,70.7,60.6,80.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,AGE08,CAT3,_RFPSA23,RESP054,"(64.84507995700051, -147.72205903599973)"
|
|
2020,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,204,49.8,42.8,56.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,AGE09,CAT3,_RFPSA23,RESP046,"(64.84507995700051, -147.72205903599973)"
|
|
2020,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,248,50.2,43.3,57.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,AGE09,CAT3,_RFPSA23,RESP054,"(64.84507995700051, -147.72205903599973)"
|
|
2020,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,348,29.4,25.5,33.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,BO1,CAT1,_RFPSA23,RESP046,"(64.84507995700051, -147.72205903599973)"
|
|
2020,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,786,70.6,66.7,74.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,BO1,CAT1,_RFPSA23,RESP054,"(64.84507995700051, -147.72205903599973)"
|
|
2020,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,02,EDUCA1,CAT5,_RFPSA23,RESP046,"(64.84507995700051, -147.72205903599973)"
|
|
2020,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,48,79,63.9,94.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,EDUCA1,CAT5,_RFPSA23,RESP054,"(64.84507995700051, -147.72205903599973)"
|
|
2020,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,62,19.9,13.4,26.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,EDUCA2,CAT5,_RFPSA23,RESP046,"(64.84507995700051, -147.72205903599973)"
|
|
2020,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,249,80.1,73.6,86.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,EDUCA2,CAT5,_RFPSA23,RESP054,"(64.84507995700051, -147.72205903599973)"
|
|
2020,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,103,28,21.2,34.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,EDUCA3,CAT5,_RFPSA23,RESP046,"(64.84507995700051, -147.72205903599973)"
|
|
2020,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,231,72,65.2,78.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,EDUCA3,CAT5,_RFPSA23,RESP054,"(64.84507995700051, -147.72205903599973)"
|
|
2020,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,172,41.6,34.8,48.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,EDUCA4,CAT5,_RFPSA23,RESP046,"(64.84507995700051, -147.72205903599973)"
|
|
2020,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,256,58.4,51.6,65.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,EDUCA4,CAT5,_RFPSA23,RESP054,"(64.84507995700051, -147.72205903599973)"
|
|
2020,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,02,INCOME1,CAT6,_RFPSA23,RESP046,"(64.84507995700051, -147.72205903599973)"
|
|
2020,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,60,86.6,74.8,98.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,INCOME1,CAT6,_RFPSA23,RESP054,"(64.84507995700051, -147.72205903599973)"
|
|
2020,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,14,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,02,INCOME2,CAT6,_RFPSA23,RESP046,"(64.84507995700051, -147.72205903599973)"
|
|
2020,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,98,89.4,82.7,96.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,INCOME2,CAT6,_RFPSA23,RESP054,"(64.84507995700051, -147.72205903599973)"
|
|
2020,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,21,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,02,INCOME3,CAT6,_RFPSA23,RESP046,"(64.84507995700051, -147.72205903599973)"
|
|
2020,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,49,77.8,63.6,92.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,INCOME3,CAT6,_RFPSA23,RESP054,"(64.84507995700051, -147.72205903599973)"
|
|
2020,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,37,34.1,20.6,47.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,INCOME4,CAT6,_RFPSA23,RESP046,"(64.84507995700051, -147.72205903599973)"
|
|
2020,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,65,65.9,52.5,79.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,INCOME4,CAT6,_RFPSA23,RESP054,"(64.84507995700051, -147.72205903599973)"
|
|
2020,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,225,32,26.8,37.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,INCOME5,CAT6,_RFPSA23,RESP046,"(64.84507995700051, -147.72205903599973)"
|
|
2020,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,425,68,62.8,73.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,INCOME5,CAT6,_RFPSA23,RESP054,"(64.84507995700051, -147.72205903599973)"
|
|
2020,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,291,33,28.6,37.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,RACE01,CAT4,_RFPSA23,RESP046,"(64.84507995700051, -147.72205903599973)"
|
|
2020,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,564,67,62.6,71.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,RACE01,CAT4,_RFPSA23,RESP054,"(64.84507995700051, -147.72205903599973)"
|
|
2020,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,02,RACE02,CAT4,_RFPSA23,RESP046,"(64.84507995700051, -147.72205903599973)"
|
|
2020,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,02,RACE02,CAT4,_RFPSA23,RESP054,"(64.84507995700051, -147.72205903599973)"
|
|
2020,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,23,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,02,RACE03,CAT4,_RFPSA23,RESP046,"(64.84507995700051, -147.72205903599973)"
|
|
2020,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,139,87.8,80.6,95.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,RACE03,CAT4,_RFPSA23,RESP054,"(64.84507995700051, -147.72205903599973)"
|
|
2020,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,02,RACE04,CAT4,_RFPSA23,RESP046,"(64.84507995700051, -147.72205903599973)"
|
|
2020,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,17,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,02,RACE04,CAT4,_RFPSA23,RESP054,"(64.84507995700051, -147.72205903599973)"
|
|
2020,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,02,RACE05,CAT4,_RFPSA23,RESP046,"(64.84507995700051, -147.72205903599973)"
|
|
2020,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,02,RACE05,CAT4,_RFPSA23,RESP054,"(64.84507995700051, -147.72205903599973)"
|
|
2020,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,02,RACE06,CAT4,_RFPSA23,RESP046,"(64.84507995700051, -147.72205903599973)"
|
|
2020,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,02,RACE06,CAT4,_RFPSA23,RESP054,"(64.84507995700051, -147.72205903599973)"
|
|
2020,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,02,RACE07,CAT4,_RFPSA23,RESP046,"(64.84507995700051, -147.72205903599973)"
|
|
2020,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,26,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,02,RACE07,CAT4,_RFPSA23,RESP054,"(64.84507995700051, -147.72205903599973)"
|
|
2020,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,9,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,02,RACE08,CAT4,_RFPSA23,RESP046,"(64.84507995700051, -147.72205903599973)"
|
|
2020,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,20,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,02,RACE08,CAT4,_RFPSA23,RESP054,"(64.84507995700051, -147.72205903599973)"
|
|
2020,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,348,29.4,25.5,33.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,SEX1,CAT2,_RFPSA23,RESP046,"(64.84507995700051, -147.72205903599973)"
|
|
2020,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,786,70.6,66.7,74.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,02,SEX1,CAT2,_RFPSA23,RESP054,"(64.84507995700051, -147.72205903599973)"
|
|
2020,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,02,SEX2,CAT2,_RFPSA23,RESP046,"(64.84507995700051, -147.72205903599973)"
|
|
2020,AK,Alaska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,02,SEX2,CAT2,_RFPSA23,RESP054,"(64.84507995700051, -147.72205903599973)"
|
|
2020,UW,All States and DC (median) **,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,51,31.8,,,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,98,BO1,CAT1,_RFPSA23,RESP046,
|
|
2020,UW,All States and DC (median) **,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,51,68.2,,,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,98,BO1,CAT1,_RFPSA23,RESP054,
|
|
2020,US,"All States, DC and Territories (median) **",Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,53,31.8,,,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,99,BO1,CAT1,_RFPSA23,RESP046,
|
|
2020,US,"All States, DC and Territories (median) **",Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,53,68.2,,,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,99,BO1,CAT1,_RFPSA23,RESP054,
|
|
2020,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,31,3.9,2.2,5.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,AGE06,CAT3,_RFPSA23,RESP046,"(34.865970280000454, -111.76381127699972)"
|
|
2020,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,482,96.1,94.4,97.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,AGE06,CAT3,_RFPSA23,RESP054,"(34.865970280000454, -111.76381127699972)"
|
|
2020,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,155,26.8,22,31.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,AGE07,CAT3,_RFPSA23,RESP046,"(34.865970280000454, -111.76381127699972)"
|
|
2020,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,452,73.2,68.4,78,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,AGE07,CAT3,_RFPSA23,RESP054,"(34.865970280000454, -111.76381127699972)"
|
|
2020,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,152,37.9,31.2,44.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,AGE08,CAT3,_RFPSA23,RESP046,"(34.865970280000454, -111.76381127699972)"
|
|
2020,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,258,62.1,55.3,68.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,AGE08,CAT3,_RFPSA23,RESP054,"(34.865970280000454, -111.76381127699972)"
|
|
2020,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,719,49.8,45.8,53.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,AGE09,CAT3,_RFPSA23,RESP046,"(34.865970280000454, -111.76381127699972)"
|
|
2020,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,711,50.2,46.2,54.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,AGE09,CAT3,_RFPSA23,RESP054,"(34.865970280000454, -111.76381127699972)"
|
|
2020,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1057,30.7,28.3,33,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,BO1,CAT1,_RFPSA23,RESP046,"(34.865970280000454, -111.76381127699972)"
|
|
2020,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1903,69.3,67,71.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,BO1,CAT1,_RFPSA23,RESP054,"(34.865970280000454, -111.76381127699972)"
|
|
2020,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,35,18.4,11.3,25.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,EDUCA1,CAT5,_RFPSA23,RESP046,"(34.865970280000454, -111.76381127699972)"
|
|
2020,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,168,81.6,74.6,88.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,EDUCA1,CAT5,_RFPSA23,RESP054,"(34.865970280000454, -111.76381127699972)"
|
|
2020,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,146,21.1,16.7,25.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,EDUCA2,CAT5,_RFPSA23,RESP046,"(34.865970280000454, -111.76381127699972)"
|
|
2020,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,492,78.9,74.5,83.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,EDUCA2,CAT5,_RFPSA23,RESP054,"(34.865970280000454, -111.76381127699972)"
|
|
2020,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,278,30.2,25.7,34.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,EDUCA3,CAT5,_RFPSA23,RESP046,"(34.865970280000454, -111.76381127699972)"
|
|
2020,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,553,69.8,65.2,74.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,EDUCA3,CAT5,_RFPSA23,RESP054,"(34.865970280000454, -111.76381127699972)"
|
|
2020,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,597,42.8,39,46.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,EDUCA4,CAT5,_RFPSA23,RESP046,"(34.865970280000454, -111.76381127699972)"
|
|
2020,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,681,57.2,53.5,61,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,EDUCA4,CAT5,_RFPSA23,RESP054,"(34.865970280000454, -111.76381127699972)"
|
|
2020,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,47,16.9,10,23.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,INCOME1,CAT6,_RFPSA23,RESP046,"(34.865970280000454, -111.76381127699972)"
|
|
2020,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,197,83.1,76.3,90,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,INCOME1,CAT6,_RFPSA23,RESP054,"(34.865970280000454, -111.76381127699972)"
|
|
2020,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,76,17.6,12.6,22.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,INCOME2,CAT6,_RFPSA23,RESP046,"(34.865970280000454, -111.76381127699972)"
|
|
2020,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,271,82.4,77.5,87.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,INCOME2,CAT6,_RFPSA23,RESP054,"(34.865970280000454, -111.76381127699972)"
|
|
2020,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,66,28.9,20.4,37.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,INCOME3,CAT6,_RFPSA23,RESP046,"(34.865970280000454, -111.76381127699972)"
|
|
2020,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,149,71.1,62.6,79.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,INCOME3,CAT6,_RFPSA23,RESP054,"(34.865970280000454, -111.76381127699972)"
|
|
2020,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,116,32.7,25.4,40,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,INCOME4,CAT6,_RFPSA23,RESP046,"(34.865970280000454, -111.76381127699972)"
|
|
2020,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,211,67.3,60,74.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,INCOME4,CAT6,_RFPSA23,RESP054,"(34.865970280000454, -111.76381127699972)"
|
|
2020,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,591,33.3,29.8,36.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,INCOME5,CAT6,_RFPSA23,RESP046,"(34.865970280000454, -111.76381127699972)"
|
|
2020,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,841,66.7,63.2,70.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,INCOME5,CAT6,_RFPSA23,RESP054,"(34.865970280000454, -111.76381127699972)"
|
|
2020,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,906,37.2,34.2,40.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,RACE01,CAT4,_RFPSA23,RESP046,"(34.865970280000454, -111.76381127699972)"
|
|
2020,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1295,62.8,59.8,65.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,RACE01,CAT4,_RFPSA23,RESP054,"(34.865970280000454, -111.76381127699972)"
|
|
2020,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,23,22.4,12.6,32.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,RACE02,CAT4,_RFPSA23,RESP046,"(34.865970280000454, -111.76381127699972)"
|
|
2020,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,57,77.6,67.8,87.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,RACE02,CAT4,_RFPSA23,RESP054,"(34.865970280000454, -111.76381127699972)"
|
|
2020,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,15,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,04,RACE03,CAT4,_RFPSA23,RESP046,"(34.865970280000454, -111.76381127699972)"
|
|
2020,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,132,90.6,84.4,96.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,RACE03,CAT4,_RFPSA23,RESP054,"(34.865970280000454, -111.76381127699972)"
|
|
2020,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,04,RACE04,CAT4,_RFPSA23,RESP046,"(34.865970280000454, -111.76381127699972)"
|
|
2020,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,20,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,04,RACE04,CAT4,_RFPSA23,RESP054,"(34.865970280000454, -111.76381127699972)"
|
|
2020,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,04,RACE05,CAT4,_RFPSA23,RESP046,"(34.865970280000454, -111.76381127699972)"
|
|
2020,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,04,RACE05,CAT4,_RFPSA23,RESP054,"(34.865970280000454, -111.76381127699972)"
|
|
2020,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,21,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,04,RACE06,CAT4,_RFPSA23,RESP046,"(34.865970280000454, -111.76381127699972)"
|
|
2020,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,47,73.8,57.4,90.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,RACE06,CAT4,_RFPSA23,RESP054,"(34.865970280000454, -111.76381127699972)"
|
|
2020,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,9,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,04,RACE07,CAT4,_RFPSA23,RESP046,"(34.865970280000454, -111.76381127699972)"
|
|
2020,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,43,91.8,83.6,99.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,RACE07,CAT4,_RFPSA23,RESP054,"(34.865970280000454, -111.76381127699972)"
|
|
2020,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,76,17.3,12.5,22.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,RACE08,CAT4,_RFPSA23,RESP046,"(34.865970280000454, -111.76381127699972)"
|
|
2020,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,305,82.7,77.9,87.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,RACE08,CAT4,_RFPSA23,RESP054,"(34.865970280000454, -111.76381127699972)"
|
|
2020,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1057,30.7,28.3,33,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,SEX1,CAT2,_RFPSA23,RESP046,"(34.865970280000454, -111.76381127699972)"
|
|
2020,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1903,69.3,67,71.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,04,SEX1,CAT2,_RFPSA23,RESP054,"(34.865970280000454, -111.76381127699972)"
|
|
2020,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,04,SEX2,CAT2,_RFPSA23,RESP046,"(34.865970280000454, -111.76381127699972)"
|
|
2020,AZ,Arizona,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,04,SEX2,CAT2,_RFPSA23,RESP054,"(34.865970280000454, -111.76381127699972)"
|
|
2020,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,19,6.8,3.5,10.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,AGE06,CAT3,_RFPSA23,RESP046,"(34.74865012400045, -92.27449074299966)"
|
|
2020,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,181,93.2,89.9,96.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,AGE06,CAT3,_RFPSA23,RESP054,"(34.74865012400045, -92.27449074299966)"
|
|
2020,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,74,25.2,19.1,31.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,AGE07,CAT3,_RFPSA23,RESP046,"(34.74865012400045, -92.27449074299966)"
|
|
2020,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,184,74.8,68.8,80.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,AGE07,CAT3,_RFPSA23,RESP054,"(34.74865012400045, -92.27449074299966)"
|
|
2020,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,89,44.6,35.8,53.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,AGE08,CAT3,_RFPSA23,RESP046,"(34.74865012400045, -92.27449074299966)"
|
|
2020,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,102,55.4,46.7,64.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,AGE08,CAT3,_RFPSA23,RESP054,"(34.74865012400045, -92.27449074299966)"
|
|
2020,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,410,51.5,47.2,55.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,AGE09,CAT3,_RFPSA23,RESP046,"(34.74865012400045, -92.27449074299966)"
|
|
2020,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,399,48.5,44.2,52.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,AGE09,CAT3,_RFPSA23,RESP054,"(34.74865012400045, -92.27449074299966)"
|
|
2020,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,592,33,30,35.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,BO1,CAT1,_RFPSA23,RESP046,"(34.74865012400045, -92.27449074299966)"
|
|
2020,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,866,67,64.1,70,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,BO1,CAT1,_RFPSA23,RESP054,"(34.74865012400045, -92.27449074299966)"
|
|
2020,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,23,18.1,10.2,26,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,EDUCA1,CAT5,_RFPSA23,RESP046,"(34.74865012400045, -92.27449074299966)"
|
|
2020,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,99,81.9,74,89.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,EDUCA1,CAT5,_RFPSA23,RESP054,"(34.74865012400045, -92.27449074299966)"
|
|
2020,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,163,27.6,22.9,32.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,EDUCA2,CAT5,_RFPSA23,RESP046,"(34.74865012400045, -92.27449074299966)"
|
|
2020,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,303,72.4,67.7,77.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,EDUCA2,CAT5,_RFPSA23,RESP054,"(34.74865012400045, -92.27449074299966)"
|
|
2020,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,139,35.3,29.1,41.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,EDUCA3,CAT5,_RFPSA23,RESP046,"(34.74865012400045, -92.27449074299966)"
|
|
2020,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,194,64.7,58.5,70.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,EDUCA3,CAT5,_RFPSA23,RESP054,"(34.74865012400045, -92.27449074299966)"
|
|
2020,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,265,48.6,43.4,53.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,EDUCA4,CAT5,_RFPSA23,RESP046,"(34.74865012400045, -92.27449074299966)"
|
|
2020,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,270,51.4,46.2,56.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,EDUCA4,CAT5,_RFPSA23,RESP054,"(34.74865012400045, -92.27449074299966)"
|
|
2020,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,21,14,7,21.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,INCOME1,CAT6,_RFPSA23,RESP046,"(34.74865012400045, -92.27449074299966)"
|
|
2020,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,79,86,78.8,93,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,INCOME1,CAT6,_RFPSA23,RESP054,"(34.74865012400045, -92.27449074299966)"
|
|
2020,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,52,19.1,12.7,25.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,INCOME2,CAT6,_RFPSA23,RESP046,"(34.74865012400045, -92.27449074299966)"
|
|
2020,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,155,80.9,74.6,87.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,INCOME2,CAT6,_RFPSA23,RESP054,"(34.74865012400045, -92.27449074299966)"
|
|
2020,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,55,35.1,24.4,45.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,INCOME3,CAT6,_RFPSA23,RESP046,"(34.74865012400045, -92.27449074299966)"
|
|
2020,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,68,64.9,54.3,75.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,INCOME3,CAT6,_RFPSA23,RESP054,"(34.74865012400045, -92.27449074299966)"
|
|
2020,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,79,37.2,29.1,45.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,INCOME4,CAT6,_RFPSA23,RESP046,"(34.74865012400045, -92.27449074299966)"
|
|
2020,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,122,62.8,54.8,70.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,INCOME4,CAT6,_RFPSA23,RESP054,"(34.74865012400045, -92.27449074299966)"
|
|
2020,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,297,40.9,36,45.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,INCOME5,CAT6,_RFPSA23,RESP046,"(34.74865012400045, -92.27449074299966)"
|
|
2020,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,313,59.1,54.2,64,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,INCOME5,CAT6,_RFPSA23,RESP054,"(34.74865012400045, -92.27449074299966)"
|
|
2020,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,525,35.6,32.4,38.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,RACE01,CAT4,_RFPSA23,RESP046,"(34.74865012400045, -92.27449074299966)"
|
|
2020,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,699,64.4,61.1,67.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,RACE01,CAT4,_RFPSA23,RESP054,"(34.74865012400045, -92.27449074299966)"
|
|
2020,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,46,25.3,16.5,34.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,RACE02,CAT4,_RFPSA23,RESP046,"(34.74865012400045, -92.27449074299966)"
|
|
2020,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,91,74.7,65.8,83.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,RACE02,CAT4,_RFPSA23,RESP054,"(34.74865012400045, -92.27449074299966)"
|
|
2020,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,05,RACE03,CAT4,_RFPSA23,RESP046,"(34.74865012400045, -92.27449074299966)"
|
|
2020,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,20,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,05,RACE03,CAT4,_RFPSA23,RESP054,"(34.74865012400045, -92.27449074299966)"
|
|
2020,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,05,RACE04,CAT4,_RFPSA23,RESP046,"(34.74865012400045, -92.27449074299966)"
|
|
2020,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,05,RACE04,CAT4,_RFPSA23,RESP054,"(34.74865012400045, -92.27449074299966)"
|
|
2020,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,05,RACE05,CAT4,_RFPSA23,RESP046,"(34.74865012400045, -92.27449074299966)"
|
|
2020,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,05,RACE05,CAT4,_RFPSA23,RESP054,"(34.74865012400045, -92.27449074299966)"
|
|
2020,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,05,RACE06,CAT4,_RFPSA23,RESP046,"(34.74865012400045, -92.27449074299966)"
|
|
2020,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,11,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,05,RACE06,CAT4,_RFPSA23,RESP054,"(34.74865012400045, -92.27449074299966)"
|
|
2020,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,05,RACE07,CAT4,_RFPSA23,RESP046,"(34.74865012400045, -92.27449074299966)"
|
|
2020,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,23,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,05,RACE07,CAT4,_RFPSA23,RESP054,"(34.74865012400045, -92.27449074299966)"
|
|
2020,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,05,RACE08,CAT4,_RFPSA23,RESP046,"(34.74865012400045, -92.27449074299966)"
|
|
2020,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,21,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,05,RACE08,CAT4,_RFPSA23,RESP054,"(34.74865012400045, -92.27449074299966)"
|
|
2020,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,592,33,30,35.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,SEX1,CAT2,_RFPSA23,RESP046,"(34.74865012400045, -92.27449074299966)"
|
|
2020,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,866,67,64.1,70,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,05,SEX1,CAT2,_RFPSA23,RESP054,"(34.74865012400045, -92.27449074299966)"
|
|
2020,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,05,SEX2,CAT2,_RFPSA23,RESP046,"(34.74865012400045, -92.27449074299966)"
|
|
2020,AR,Arkansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,05,SEX2,CAT2,_RFPSA23,RESP054,"(34.74865012400045, -92.27449074299966)"
|
|
2020,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,14,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,06,AGE06,CAT3,_RFPSA23,RESP046,"(37.63864012300047, -120.99999953799971)"
|
|
2020,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,259,97.1,95.1,99.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,AGE06,CAT3,_RFPSA23,RESP054,"(37.63864012300047, -120.99999953799971)"
|
|
2020,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,76,25.6,18.7,32.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,AGE07,CAT3,_RFPSA23,RESP046,"(37.63864012300047, -120.99999953799971)"
|
|
2020,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,228,74.4,67.5,81.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,AGE07,CAT3,_RFPSA23,RESP054,"(37.63864012300047, -120.99999953799971)"
|
|
2020,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,63,40.8,30.4,51.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,AGE08,CAT3,_RFPSA23,RESP046,"(37.63864012300047, -120.99999953799971)"
|
|
2020,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,108,59.2,48.9,69.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,AGE08,CAT3,_RFPSA23,RESP054,"(37.63864012300047, -120.99999953799971)"
|
|
2020,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,208,46.2,39.5,52.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,AGE09,CAT3,_RFPSA23,RESP046,"(37.63864012300047, -120.99999953799971)"
|
|
2020,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,228,53.8,47.1,60.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,AGE09,CAT3,_RFPSA23,RESP054,"(37.63864012300047, -120.99999953799971)"
|
|
2020,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,361,28,24.5,31.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,BO1,CAT1,_RFPSA23,RESP046,"(37.63864012300047, -120.99999953799971)"
|
|
2020,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,823,72,68.4,75.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,BO1,CAT1,_RFPSA23,RESP054,"(37.63864012300047, -120.99999953799971)"
|
|
2020,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,24,14.8,7.2,22.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,EDUCA1,CAT5,_RFPSA23,RESP046,"(37.63864012300047, -120.99999953799971)"
|
|
2020,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,121,85.2,77.7,92.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,EDUCA1,CAT5,_RFPSA23,RESP054,"(37.63864012300047, -120.99999953799971)"
|
|
2020,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,38,20.6,12.6,28.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,EDUCA2,CAT5,_RFPSA23,RESP046,"(37.63864012300047, -120.99999953799971)"
|
|
2020,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,142,79.4,71.3,87.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,EDUCA2,CAT5,_RFPSA23,RESP054,"(37.63864012300047, -120.99999953799971)"
|
|
2020,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,84,31.3,23.9,38.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,EDUCA3,CAT5,_RFPSA23,RESP046,"(37.63864012300047, -120.99999953799971)"
|
|
2020,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,189,68.7,61.3,76.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,EDUCA3,CAT5,_RFPSA23,RESP054,"(37.63864012300047, -120.99999953799971)"
|
|
2020,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,214,35.4,29.9,40.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,EDUCA4,CAT5,_RFPSA23,RESP046,"(37.63864012300047, -120.99999953799971)"
|
|
2020,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,370,64.6,59.2,70.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,EDUCA4,CAT5,_RFPSA23,RESP054,"(37.63864012300047, -120.99999953799971)"
|
|
2020,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,22,22.8,10.6,34.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,INCOME1,CAT6,_RFPSA23,RESP046,"(37.63864012300047, -120.99999953799971)"
|
|
2020,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,90,77.2,65.1,89.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,INCOME1,CAT6,_RFPSA23,RESP054,"(37.63864012300047, -120.99999953799971)"
|
|
2020,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,21,14.6,7,22.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,INCOME2,CAT6,_RFPSA23,RESP046,"(37.63864012300047, -120.99999953799971)"
|
|
2020,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,99,85.4,77.8,93,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,INCOME2,CAT6,_RFPSA23,RESP054,"(37.63864012300047, -120.99999953799971)"
|
|
2020,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,13,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,06,INCOME3,CAT6,_RFPSA23,RESP046,"(37.63864012300047, -120.99999953799971)"
|
|
2020,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,55,83.2,73,93.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,INCOME3,CAT6,_RFPSA23,RESP054,"(37.63864012300047, -120.99999953799971)"
|
|
2020,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,34,34,21.8,46.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,INCOME4,CAT6,_RFPSA23,RESP046,"(37.63864012300047, -120.99999953799971)"
|
|
2020,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,73,66,53.8,78.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,INCOME4,CAT6,_RFPSA23,RESP054,"(37.63864012300047, -120.99999953799971)"
|
|
2020,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,240,31.3,26.4,36.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,INCOME5,CAT6,_RFPSA23,RESP046,"(37.63864012300047, -120.99999953799971)"
|
|
2020,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,443,68.7,63.8,73.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,INCOME5,CAT6,_RFPSA23,RESP054,"(37.63864012300047, -120.99999953799971)"
|
|
2020,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,254,35.5,30.8,40.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,RACE01,CAT4,_RFPSA23,RESP046,"(37.63864012300047, -120.99999953799971)"
|
|
2020,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,426,64.5,59.8,69.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,RACE01,CAT4,_RFPSA23,RESP054,"(37.63864012300047, -120.99999953799971)"
|
|
2020,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,18,32.1,15.5,48.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,RACE02,CAT4,_RFPSA23,RESP046,"(37.63864012300047, -120.99999953799971)"
|
|
2020,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,38,67.9,51.3,84.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,RACE02,CAT4,_RFPSA23,RESP054,"(37.63864012300047, -120.99999953799971)"
|
|
2020,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,06,RACE03,CAT4,_RFPSA23,RESP046,"(37.63864012300047, -120.99999953799971)"
|
|
2020,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,06,RACE03,CAT4,_RFPSA23,RESP054,"(37.63864012300047, -120.99999953799971)"
|
|
2020,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,18,29.7,16.4,42.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,RACE04,CAT4,_RFPSA23,RESP046,"(37.63864012300047, -120.99999953799971)"
|
|
2020,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,66,70.3,57.1,83.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,RACE04,CAT4,_RFPSA23,RESP054,"(37.63864012300047, -120.99999953799971)"
|
|
2020,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,06,RACE05,CAT4,_RFPSA23,RESP046,"(37.63864012300047, -120.99999953799971)"
|
|
2020,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,06,RACE05,CAT4,_RFPSA23,RESP054,"(37.63864012300047, -120.99999953799971)"
|
|
2020,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,06,RACE06,CAT4,_RFPSA23,RESP046,"(37.63864012300047, -120.99999953799971)"
|
|
2020,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,16,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,06,RACE06,CAT4,_RFPSA23,RESP054,"(37.63864012300047, -120.99999953799971)"
|
|
2020,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,06,RACE07,CAT4,_RFPSA23,RESP046,"(37.63864012300047, -120.99999953799971)"
|
|
2020,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,13,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,06,RACE07,CAT4,_RFPSA23,RESP054,"(37.63864012300047, -120.99999953799971)"
|
|
2020,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,58,14.8,9.7,19.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,RACE08,CAT4,_RFPSA23,RESP046,"(37.63864012300047, -120.99999953799971)"
|
|
2020,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,255,85.2,80.2,90.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,RACE08,CAT4,_RFPSA23,RESP054,"(37.63864012300047, -120.99999953799971)"
|
|
2020,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,361,28,24.5,31.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,SEX1,CAT2,_RFPSA23,RESP046,"(37.63864012300047, -120.99999953799971)"
|
|
2020,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,823,72,68.4,75.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,06,SEX1,CAT2,_RFPSA23,RESP054,"(37.63864012300047, -120.99999953799971)"
|
|
2020,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,06,SEX2,CAT2,_RFPSA23,RESP046,"(37.63864012300047, -120.99999953799971)"
|
|
2020,CA,California,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,06,SEX2,CAT2,_RFPSA23,RESP054,"(37.63864012300047, -120.99999953799971)"
|
|
2020,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,37,5.5,3.6,7.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,AGE06,CAT3,_RFPSA23,RESP046,"(38.843840757000464, -106.13361092099967)"
|
|
2020,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,631,94.5,92.7,96.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,AGE06,CAT3,_RFPSA23,RESP054,"(38.843840757000464, -106.13361092099967)"
|
|
2020,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,155,22.4,18.8,26,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,AGE07,CAT3,_RFPSA23,RESP046,"(38.843840757000464, -106.13361092099967)"
|
|
2020,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,543,77.6,74,81.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,AGE07,CAT3,_RFPSA23,RESP054,"(38.843840757000464, -106.13361092099967)"
|
|
2020,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,153,38.9,33.4,44.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,AGE08,CAT3,_RFPSA23,RESP046,"(38.843840757000464, -106.13361092099967)"
|
|
2020,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,236,61.1,55.6,66.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,AGE08,CAT3,_RFPSA23,RESP054,"(38.843840757000464, -106.13361092099967)"
|
|
2020,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,550,46.3,42.9,49.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,AGE09,CAT3,_RFPSA23,RESP046,"(38.843840757000464, -106.13361092099967)"
|
|
2020,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,595,53.7,50.3,57.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,AGE09,CAT3,_RFPSA23,RESP054,"(38.843840757000464, -106.13361092099967)"
|
|
2020,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,895,26.6,24.8,28.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,BO1,CAT1,_RFPSA23,RESP046,"(38.843840757000464, -106.13361092099967)"
|
|
2020,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,2005,73.4,71.6,75.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,BO1,CAT1,_RFPSA23,RESP054,"(38.843840757000464, -106.13361092099967)"
|
|
2020,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,28,12.5,7.6,17.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,EDUCA1,CAT5,_RFPSA23,RESP046,"(38.843840757000464, -106.13361092099967)"
|
|
2020,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,141,87.5,82.6,92.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,EDUCA1,CAT5,_RFPSA23,RESP054,"(38.843840757000464, -106.13361092099967)"
|
|
2020,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,114,19.1,15.3,22.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,EDUCA2,CAT5,_RFPSA23,RESP046,"(38.843840757000464, -106.13361092099967)"
|
|
2020,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,412,80.9,77.1,84.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,EDUCA2,CAT5,_RFPSA23,RESP054,"(38.843840757000464, -106.13361092099967)"
|
|
2020,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,199,26.6,23,30.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,EDUCA3,CAT5,_RFPSA23,RESP046,"(38.843840757000464, -106.13361092099967)"
|
|
2020,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,507,73.4,69.7,77,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,EDUCA3,CAT5,_RFPSA23,RESP054,"(38.843840757000464, -106.13361092099967)"
|
|
2020,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,551,33.1,30.5,35.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,EDUCA4,CAT5,_RFPSA23,RESP046,"(38.843840757000464, -106.13361092099967)"
|
|
2020,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,939,66.9,64.3,69.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,EDUCA4,CAT5,_RFPSA23,RESP054,"(38.843840757000464, -106.13361092099967)"
|
|
2020,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,22,14.8,7.8,21.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,INCOME1,CAT6,_RFPSA23,RESP046,"(38.843840757000464, -106.13361092099967)"
|
|
2020,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,129,85.2,78.2,92.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,INCOME1,CAT6,_RFPSA23,RESP054,"(38.843840757000464, -106.13361092099967)"
|
|
2020,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,57,19.2,13.7,24.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,INCOME2,CAT6,_RFPSA23,RESP046,"(38.843840757000464, -106.13361092099967)"
|
|
2020,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,196,80.8,75.3,86.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,INCOME2,CAT6,_RFPSA23,RESP054,"(38.843840757000464, -106.13361092099967)"
|
|
2020,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,42,19.9,13.3,26.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,INCOME3,CAT6,_RFPSA23,RESP046,"(38.843840757000464, -106.13361092099967)"
|
|
2020,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,127,80.1,73.5,86.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,INCOME3,CAT6,_RFPSA23,RESP054,"(38.843840757000464, -106.13361092099967)"
|
|
2020,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,82,22.8,17.7,28,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,INCOME4,CAT6,_RFPSA23,RESP046,"(38.843840757000464, -106.13361092099967)"
|
|
2020,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,196,77.2,72,82.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,INCOME4,CAT6,_RFPSA23,RESP054,"(38.843840757000464, -106.13361092099967)"
|
|
2020,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,563,27.9,25.6,30.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,INCOME5,CAT6,_RFPSA23,RESP046,"(38.843840757000464, -106.13361092099967)"
|
|
2020,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,1157,72.1,69.8,74.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,INCOME5,CAT6,_RFPSA23,RESP054,"(38.843840757000464, -106.13361092099967)"
|
|
2020,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,802,30.1,28,32.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,RACE01,CAT4,_RFPSA23,RESP046,"(38.843840757000464, -106.13361092099967)"
|
|
2020,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1565,69.9,67.8,72,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,RACE01,CAT4,_RFPSA23,RESP054,"(38.843840757000464, -106.13361092099967)"
|
|
2020,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,19,23.2,11.8,34.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,RACE02,CAT4,_RFPSA23,RESP046,"(38.843840757000464, -106.13361092099967)"
|
|
2020,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,49,76.8,65.5,88.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,RACE02,CAT4,_RFPSA23,RESP054,"(38.843840757000464, -106.13361092099967)"
|
|
2020,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,08,RACE03,CAT4,_RFPSA23,RESP046,"(38.843840757000464, -106.13361092099967)"
|
|
2020,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,26,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,08,RACE03,CAT4,_RFPSA23,RESP054,"(38.843840757000464, -106.13361092099967)"
|
|
2020,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,08,RACE04,CAT4,_RFPSA23,RESP046,"(38.843840757000464, -106.13361092099967)"
|
|
2020,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,25,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,08,RACE04,CAT4,_RFPSA23,RESP054,"(38.843840757000464, -106.13361092099967)"
|
|
2020,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,08,RACE05,CAT4,_RFPSA23,RESP046,"(38.843840757000464, -106.13361092099967)"
|
|
2020,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,08,RACE05,CAT4,_RFPSA23,RESP054,"(38.843840757000464, -106.13361092099967)"
|
|
2020,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,08,RACE06,CAT4,_RFPSA23,RESP046,"(38.843840757000464, -106.13361092099967)"
|
|
2020,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,34,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,08,RACE06,CAT4,_RFPSA23,RESP054,"(38.843840757000464, -106.13361092099967)"
|
|
2020,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,08,RACE07,CAT4,_RFPSA23,RESP046,"(38.843840757000464, -106.13361092099967)"
|
|
2020,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,36,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,08,RACE07,CAT4,_RFPSA23,RESP054,"(38.843840757000464, -106.13361092099967)"
|
|
2020,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,53,14.8,10.5,19,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,RACE08,CAT4,_RFPSA23,RESP046,"(38.843840757000464, -106.13361092099967)"
|
|
2020,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,265,85.2,81,89.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,RACE08,CAT4,_RFPSA23,RESP054,"(38.843840757000464, -106.13361092099967)"
|
|
2020,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,895,26.6,24.8,28.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,SEX1,CAT2,_RFPSA23,RESP046,"(38.843840757000464, -106.13361092099967)"
|
|
2020,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,2005,73.4,71.6,75.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,08,SEX1,CAT2,_RFPSA23,RESP054,"(38.843840757000464, -106.13361092099967)"
|
|
2020,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,08,SEX2,CAT2,_RFPSA23,RESP046,"(38.843840757000464, -106.13361092099967)"
|
|
2020,CO,Colorado,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,08,SEX2,CAT2,_RFPSA23,RESP054,"(38.843840757000464, -106.13361092099967)"
|
|
2020,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,32,5.1,2.9,7.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,AGE06,CAT3,_RFPSA23,RESP046,"(41.56266102000046, -72.64984095199964)"
|
|
2020,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,409,94.9,92.7,97.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,AGE06,CAT3,_RFPSA23,RESP054,"(41.56266102000046, -72.64984095199964)"
|
|
2020,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,207,29.9,25,34.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,AGE07,CAT3,_RFPSA23,RESP046,"(41.56266102000046, -72.64984095199964)"
|
|
2020,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,517,70.1,65.2,75,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,AGE07,CAT3,_RFPSA23,RESP054,"(41.56266102000046, -72.64984095199964)"
|
|
2020,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,162,34.6,28.2,41,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,AGE08,CAT3,_RFPSA23,RESP046,"(41.56266102000046, -72.64984095199964)"
|
|
2020,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,242,65.4,59,71.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,AGE08,CAT3,_RFPSA23,RESP054,"(41.56266102000046, -72.64984095199964)"
|
|
2020,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,550,49.4,44.7,54,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,AGE09,CAT3,_RFPSA23,RESP046,"(41.56266102000046, -72.64984095199964)"
|
|
2020,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,475,50.6,46,55.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,AGE09,CAT3,_RFPSA23,RESP054,"(41.56266102000046, -72.64984095199964)"
|
|
2020,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,951,31.7,29.2,34.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,BO1,CAT1,_RFPSA23,RESP046,"(41.56266102000046, -72.64984095199964)"
|
|
2020,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1643,68.3,65.8,70.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,BO1,CAT1,_RFPSA23,RESP054,"(41.56266102000046, -72.64984095199964)"
|
|
2020,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,22,15.3,7.4,23.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,EDUCA1,CAT5,_RFPSA23,RESP046,"(41.56266102000046, -72.64984095199964)"
|
|
2020,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,119,84.7,76.8,92.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,EDUCA1,CAT5,_RFPSA23,RESP054,"(41.56266102000046, -72.64984095199964)"
|
|
2020,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,180,27,22.2,31.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,EDUCA2,CAT5,_RFPSA23,RESP046,"(41.56266102000046, -72.64984095199964)"
|
|
2020,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,447,73,68.2,77.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,EDUCA2,CAT5,_RFPSA23,RESP054,"(41.56266102000046, -72.64984095199964)"
|
|
2020,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,203,30.5,25.4,35.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,EDUCA3,CAT5,_RFPSA23,RESP046,"(41.56266102000046, -72.64984095199964)"
|
|
2020,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,361,69.5,64.4,74.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,EDUCA3,CAT5,_RFPSA23,RESP054,"(41.56266102000046, -72.64984095199964)"
|
|
2020,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,546,40.4,36.6,44.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,EDUCA4,CAT5,_RFPSA23,RESP046,"(41.56266102000046, -72.64984095199964)"
|
|
2020,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,709,59.6,55.8,63.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,EDUCA4,CAT5,_RFPSA23,RESP054,"(41.56266102000046, -72.64984095199964)"
|
|
2020,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,19,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,09,INCOME1,CAT6,_RFPSA23,RESP046,"(41.56266102000046, -72.64984095199964)"
|
|
2020,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,87,85,76,93.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,INCOME1,CAT6,_RFPSA23,RESP054,"(41.56266102000046, -72.64984095199964)"
|
|
2020,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,53,27.1,17.4,36.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,INCOME2,CAT6,_RFPSA23,RESP046,"(41.56266102000046, -72.64984095199964)"
|
|
2020,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,160,72.9,63.3,82.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,INCOME2,CAT6,_RFPSA23,RESP054,"(41.56266102000046, -72.64984095199964)"
|
|
2020,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,39,25.6,15.9,35.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,INCOME3,CAT6,_RFPSA23,RESP046,"(41.56266102000046, -72.64984095199964)"
|
|
2020,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,103,74.4,64.7,84.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,INCOME3,CAT6,_RFPSA23,RESP054,"(41.56266102000046, -72.64984095199964)"
|
|
2020,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,79,30.8,22.5,39.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,INCOME4,CAT6,_RFPSA23,RESP046,"(41.56266102000046, -72.64984095199964)"
|
|
2020,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,118,69.2,60.9,77.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,INCOME4,CAT6,_RFPSA23,RESP054,"(41.56266102000046, -72.64984095199964)"
|
|
2020,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,627,34.4,31,37.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,INCOME5,CAT6,_RFPSA23,RESP046,"(41.56266102000046, -72.64984095199964)"
|
|
2020,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,948,65.6,62.3,69,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,INCOME5,CAT6,_RFPSA23,RESP054,"(41.56266102000046, -72.64984095199964)"
|
|
2020,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,842,35.2,32.2,38.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,RACE01,CAT4,_RFPSA23,RESP046,"(41.56266102000046, -72.64984095199964)"
|
|
2020,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1258,64.8,61.9,67.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,RACE01,CAT4,_RFPSA23,RESP054,"(41.56266102000046, -72.64984095199964)"
|
|
2020,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,37,23.3,14.1,32.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,RACE02,CAT4,_RFPSA23,RESP046,"(41.56266102000046, -72.64984095199964)"
|
|
2020,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,107,76.7,67.5,85.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,RACE02,CAT4,_RFPSA23,RESP054,"(41.56266102000046, -72.64984095199964)"
|
|
2020,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,09,RACE03,CAT4,_RFPSA23,RESP046,"(41.56266102000046, -72.64984095199964)"
|
|
2020,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,12,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,09,RACE03,CAT4,_RFPSA23,RESP054,"(41.56266102000046, -72.64984095199964)"
|
|
2020,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,09,RACE04,CAT4,_RFPSA23,RESP046,"(41.56266102000046, -72.64984095199964)"
|
|
2020,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,37,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,09,RACE04,CAT4,_RFPSA23,RESP054,"(41.56266102000046, -72.64984095199964)"
|
|
2020,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,09,RACE05,CAT4,_RFPSA23,RESP046,"(41.56266102000046, -72.64984095199964)"
|
|
2020,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,09,RACE05,CAT4,_RFPSA23,RESP054,"(41.56266102000046, -72.64984095199964)"
|
|
2020,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,13,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,09,RACE06,CAT4,_RFPSA23,RESP046,"(41.56266102000046, -72.64984095199964)"
|
|
2020,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,27,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,09,RACE06,CAT4,_RFPSA23,RESP054,"(41.56266102000046, -72.64984095199964)"
|
|
2020,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,09,RACE07,CAT4,_RFPSA23,RESP046,"(41.56266102000046, -72.64984095199964)"
|
|
2020,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,26,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,09,RACE07,CAT4,_RFPSA23,RESP054,"(41.56266102000046, -72.64984095199964)"
|
|
2020,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,44,20,12.4,27.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,RACE08,CAT4,_RFPSA23,RESP046,"(41.56266102000046, -72.64984095199964)"
|
|
2020,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,173,80,72.3,87.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,RACE08,CAT4,_RFPSA23,RESP054,"(41.56266102000046, -72.64984095199964)"
|
|
2020,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,951,31.7,29.2,34.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,SEX1,CAT2,_RFPSA23,RESP046,"(41.56266102000046, -72.64984095199964)"
|
|
2020,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1643,68.3,65.8,70.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,09,SEX1,CAT2,_RFPSA23,RESP054,"(41.56266102000046, -72.64984095199964)"
|
|
2020,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,09,SEX2,CAT2,_RFPSA23,RESP046,"(41.56266102000046, -72.64984095199964)"
|
|
2020,CT,Connecticut,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,09,SEX2,CAT2,_RFPSA23,RESP054,"(41.56266102000046, -72.64984095199964)"
|
|
2020,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,9,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,10,AGE06,CAT3,_RFPSA23,RESP046,"(39.008830667000495, -75.57774116799965)"
|
|
2020,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,204,95.2,91.1,99.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,AGE06,CAT3,_RFPSA23,RESP054,"(39.008830667000495, -75.57774116799965)"
|
|
2020,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,77,24.8,18.6,31,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,AGE07,CAT3,_RFPSA23,RESP046,"(39.008830667000495, -75.57774116799965)"
|
|
2020,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,185,75.2,69,81.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,AGE07,CAT3,_RFPSA23,RESP054,"(39.008830667000495, -75.57774116799965)"
|
|
2020,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,73,50.1,40.2,59.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,AGE08,CAT3,_RFPSA23,RESP046,"(39.008830667000495, -75.57774116799965)"
|
|
2020,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,87,49.9,40.1,59.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,AGE08,CAT3,_RFPSA23,RESP054,"(39.008830667000495, -75.57774116799965)"
|
|
2020,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,255,50.7,44.4,57,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,AGE09,CAT3,_RFPSA23,RESP046,"(39.008830667000495, -75.57774116799965)"
|
|
2020,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,222,49.3,43,55.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,AGE09,CAT3,_RFPSA23,RESP054,"(39.008830667000495, -75.57774116799965)"
|
|
2020,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,414,33.2,29.7,36.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,BO1,CAT1,_RFPSA23,RESP046,"(39.008830667000495, -75.57774116799965)"
|
|
2020,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,698,66.8,63.2,70.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,BO1,CAT1,_RFPSA23,RESP054,"(39.008830667000495, -75.57774116799965)"
|
|
2020,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,14,19.4,8.5,30.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,EDUCA1,CAT5,_RFPSA23,RESP046,"(39.008830667000495, -75.57774116799965)"
|
|
2020,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,79,80.6,69.7,91.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,EDUCA1,CAT5,_RFPSA23,RESP054,"(39.008830667000495, -75.57774116799965)"
|
|
2020,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,89,25,19.1,30.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,EDUCA2,CAT5,_RFPSA23,RESP046,"(39.008830667000495, -75.57774116799965)"
|
|
2020,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,228,75,69.2,80.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,EDUCA2,CAT5,_RFPSA23,RESP054,"(39.008830667000495, -75.57774116799965)"
|
|
2020,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,108,38.3,31.1,45.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,EDUCA3,CAT5,_RFPSA23,RESP046,"(39.008830667000495, -75.57774116799965)"
|
|
2020,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,166,61.7,54.5,68.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,EDUCA3,CAT5,_RFPSA23,RESP054,"(39.008830667000495, -75.57774116799965)"
|
|
2020,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,203,40.9,35,46.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,EDUCA4,CAT5,_RFPSA23,RESP046,"(39.008830667000495, -75.57774116799965)"
|
|
2020,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,225,59.1,53.2,65,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,EDUCA4,CAT5,_RFPSA23,RESP054,"(39.008830667000495, -75.57774116799965)"
|
|
2020,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,10,INCOME1,CAT6,_RFPSA23,RESP046,"(39.008830667000495, -75.57774116799965)"
|
|
2020,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,55,88.7,80.3,97.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,INCOME1,CAT6,_RFPSA23,RESP054,"(39.008830667000495, -75.57774116799965)"
|
|
2020,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,34,31.8,20.4,43.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,INCOME2,CAT6,_RFPSA23,RESP046,"(39.008830667000495, -75.57774116799965)"
|
|
2020,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,94,68.2,56.8,79.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,INCOME2,CAT6,_RFPSA23,RESP054,"(39.008830667000495, -75.57774116799965)"
|
|
2020,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,21,21.3,10.4,32.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,INCOME3,CAT6,_RFPSA23,RESP046,"(39.008830667000495, -75.57774116799965)"
|
|
2020,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,62,78.7,67.9,89.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,INCOME3,CAT6,_RFPSA23,RESP054,"(39.008830667000495, -75.57774116799965)"
|
|
2020,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,47,40.4,28.5,52.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,INCOME4,CAT6,_RFPSA23,RESP046,"(39.008830667000495, -75.57774116799965)"
|
|
2020,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,63,59.6,47.8,71.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,INCOME4,CAT6,_RFPSA23,RESP054,"(39.008830667000495, -75.57774116799965)"
|
|
2020,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,256,38.8,33.9,43.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,INCOME5,CAT6,_RFPSA23,RESP046,"(39.008830667000495, -75.57774116799965)"
|
|
2020,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,325,61.2,56.2,66.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,INCOME5,CAT6,_RFPSA23,RESP054,"(39.008830667000495, -75.57774116799965)"
|
|
2020,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,345,36.4,32.5,40.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,RACE01,CAT4,_RFPSA23,RESP046,"(39.008830667000495, -75.57774116799965)"
|
|
2020,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,511,63.6,59.6,67.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,RACE01,CAT4,_RFPSA23,RESP054,"(39.008830667000495, -75.57774116799965)"
|
|
2020,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,36,26.3,16.8,35.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,RACE02,CAT4,_RFPSA23,RESP046,"(39.008830667000495, -75.57774116799965)"
|
|
2020,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,74,73.7,64.1,83.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,RACE02,CAT4,_RFPSA23,RESP054,"(39.008830667000495, -75.57774116799965)"
|
|
2020,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,10,RACE03,CAT4,_RFPSA23,RESP046,"(39.008830667000495, -75.57774116799965)"
|
|
2020,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,10,RACE03,CAT4,_RFPSA23,RESP054,"(39.008830667000495, -75.57774116799965)"
|
|
2020,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,10,RACE04,CAT4,_RFPSA23,RESP046,"(39.008830667000495, -75.57774116799965)"
|
|
2020,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,12,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,10,RACE04,CAT4,_RFPSA23,RESP054,"(39.008830667000495, -75.57774116799965)"
|
|
2020,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,10,RACE05,CAT4,_RFPSA23,RESP046,"(39.008830667000495, -75.57774116799965)"
|
|
2020,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,10,RACE05,CAT4,_RFPSA23,RESP054,"(39.008830667000495, -75.57774116799965)"
|
|
2020,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,10,RACE06,CAT4,_RFPSA23,RESP046,"(39.008830667000495, -75.57774116799965)"
|
|
2020,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,10,RACE06,CAT4,_RFPSA23,RESP054,"(39.008830667000495, -75.57774116799965)"
|
|
2020,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,10,RACE07,CAT4,_RFPSA23,RESP046,"(39.008830667000495, -75.57774116799965)"
|
|
2020,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,17,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,10,RACE07,CAT4,_RFPSA23,RESP054,"(39.008830667000495, -75.57774116799965)"
|
|
2020,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,17,17.2,7.8,26.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,RACE08,CAT4,_RFPSA23,RESP046,"(39.008830667000495, -75.57774116799965)"
|
|
2020,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,72,82.8,73.4,92.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,RACE08,CAT4,_RFPSA23,RESP054,"(39.008830667000495, -75.57774116799965)"
|
|
2020,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,414,33.2,29.7,36.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,SEX1,CAT2,_RFPSA23,RESP046,"(39.008830667000495, -75.57774116799965)"
|
|
2020,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,698,66.8,63.2,70.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,10,SEX1,CAT2,_RFPSA23,RESP054,"(39.008830667000495, -75.57774116799965)"
|
|
2020,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,10,SEX2,CAT2,_RFPSA23,RESP046,"(39.008830667000495, -75.57774116799965)"
|
|
2020,DE,Delaware,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,10,SEX2,CAT2,_RFPSA23,RESP054,"(39.008830667000495, -75.57774116799965)"
|
|
2020,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,17,8.9,4.5,13.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,AGE06,CAT3,_RFPSA23,RESP046,"(38.89037138500049, -77.03196112699965)"
|
|
2020,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,176,91.1,86.7,95.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,AGE06,CAT3,_RFPSA23,RESP054,"(38.89037138500049, -77.03196112699965)"
|
|
2020,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,61,25.3,18.8,31.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,AGE07,CAT3,_RFPSA23,RESP046,"(38.89037138500049, -77.03196112699965)"
|
|
2020,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,164,74.7,68.1,81.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,AGE07,CAT3,_RFPSA23,RESP054,"(38.89037138500049, -77.03196112699965)"
|
|
2020,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,50,39.9,28.4,51.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,AGE08,CAT3,_RFPSA23,RESP046,"(38.89037138500049, -77.03196112699965)"
|
|
2020,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,64,60.1,48.5,71.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,AGE08,CAT3,_RFPSA23,RESP054,"(38.89037138500049, -77.03196112699965)"
|
|
2020,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,222,54.8,48.8,60.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,AGE09,CAT3,_RFPSA23,RESP046,"(38.89037138500049, -77.03196112699965)"
|
|
2020,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,167,45.2,39.2,51.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,AGE09,CAT3,_RFPSA23,RESP054,"(38.89037138500049, -77.03196112699965)"
|
|
2020,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,350,30.4,26.9,33.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,BO1,CAT1,_RFPSA23,RESP046,"(38.89037138500049, -77.03196112699965)"
|
|
2020,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,571,69.6,66.1,73.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,BO1,CAT1,_RFPSA23,RESP054,"(38.89037138500049, -77.03196112699965)"
|
|
2020,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,11,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,11,EDUCA1,CAT5,_RFPSA23,RESP046,"(38.89037138500049, -77.03196112699965)"
|
|
2020,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,26,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,11,EDUCA1,CAT5,_RFPSA23,RESP054,"(38.89037138500049, -77.03196112699965)"
|
|
2020,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,34,22,14.6,29.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,EDUCA2,CAT5,_RFPSA23,RESP046,"(38.89037138500049, -77.03196112699965)"
|
|
2020,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,100,78,70.6,85.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,EDUCA2,CAT5,_RFPSA23,RESP054,"(38.89037138500049, -77.03196112699965)"
|
|
2020,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,40,23.2,15.5,31,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,EDUCA3,CAT5,_RFPSA23,RESP046,"(38.89037138500049, -77.03196112699965)"
|
|
2020,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,92,76.8,69,84.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,EDUCA3,CAT5,_RFPSA23,RESP054,"(38.89037138500049, -77.03196112699965)"
|
|
2020,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,265,37.6,33.2,41.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,EDUCA4,CAT5,_RFPSA23,RESP046,"(38.89037138500049, -77.03196112699965)"
|
|
2020,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,352,62.4,58.1,66.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,EDUCA4,CAT5,_RFPSA23,RESP054,"(38.89037138500049, -77.03196112699965)"
|
|
2020,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,16,17.7,8.2,27.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,INCOME1,CAT6,_RFPSA23,RESP046,"(38.89037138500049, -77.03196112699965)"
|
|
2020,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,48,82.3,72.8,91.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,INCOME1,CAT6,_RFPSA23,RESP054,"(38.89037138500049, -77.03196112699965)"
|
|
2020,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,24,27,15.7,38.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,INCOME2,CAT6,_RFPSA23,RESP046,"(38.89037138500049, -77.03196112699965)"
|
|
2020,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,44,73,61.6,84.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,INCOME2,CAT6,_RFPSA23,RESP054,"(38.89037138500049, -77.03196112699965)"
|
|
2020,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,17,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,11,INCOME3,CAT6,_RFPSA23,RESP046,"(38.89037138500049, -77.03196112699965)"
|
|
2020,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,31,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,11,INCOME3,CAT6,_RFPSA23,RESP054,"(38.89037138500049, -77.03196112699965)"
|
|
2020,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,18,36.3,20.1,52.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,INCOME4,CAT6,_RFPSA23,RESP046,"(38.89037138500049, -77.03196112699965)"
|
|
2020,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,32,63.7,47.5,79.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,INCOME4,CAT6,_RFPSA23,RESP054,"(38.89037138500049, -77.03196112699965)"
|
|
2020,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,233,33,28.7,37.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,INCOME5,CAT6,_RFPSA23,RESP046,"(38.89037138500049, -77.03196112699965)"
|
|
2020,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,348,67,62.6,71.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,INCOME5,CAT6,_RFPSA23,RESP054,"(38.89037138500049, -77.03196112699965)"
|
|
2020,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,192,34.8,30,39.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,RACE01,CAT4,_RFPSA23,RESP046,"(38.89037138500049, -77.03196112699965)"
|
|
2020,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,274,65.2,60.3,70,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,RACE01,CAT4,_RFPSA23,RESP054,"(38.89037138500049, -77.03196112699965)"
|
|
2020,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,130,27.7,22.6,32.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,RACE02,CAT4,_RFPSA23,RESP046,"(38.89037138500049, -77.03196112699965)"
|
|
2020,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,237,72.3,67.2,77.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,RACE02,CAT4,_RFPSA23,RESP054,"(38.89037138500049, -77.03196112699965)"
|
|
2020,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,11,RACE03,CAT4,_RFPSA23,RESP046,"(38.89037138500049, -77.03196112699965)"
|
|
2020,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,11,RACE03,CAT4,_RFPSA23,RESP054,"(38.89037138500049, -77.03196112699965)"
|
|
2020,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,11,RACE04,CAT4,_RFPSA23,RESP046,"(38.89037138500049, -77.03196112699965)"
|
|
2020,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,12,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,11,RACE04,CAT4,_RFPSA23,RESP054,"(38.89037138500049, -77.03196112699965)"
|
|
2020,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,11,RACE05,CAT4,_RFPSA23,RESP046,"(38.89037138500049, -77.03196112699965)"
|
|
2020,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,11,RACE05,CAT4,_RFPSA23,RESP054,"(38.89037138500049, -77.03196112699965)"
|
|
2020,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,11,RACE06,CAT4,_RFPSA23,RESP046,"(38.89037138500049, -77.03196112699965)"
|
|
2020,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,11,RACE06,CAT4,_RFPSA23,RESP054,"(38.89037138500049, -77.03196112699965)"
|
|
2020,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,11,RACE07,CAT4,_RFPSA23,RESP046,"(38.89037138500049, -77.03196112699965)"
|
|
2020,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,12,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,11,RACE07,CAT4,_RFPSA23,RESP054,"(38.89037138500049, -77.03196112699965)"
|
|
2020,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,17,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,11,RACE08,CAT4,_RFPSA23,RESP046,"(38.89037138500049, -77.03196112699965)"
|
|
2020,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,26,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,11,RACE08,CAT4,_RFPSA23,RESP054,"(38.89037138500049, -77.03196112699965)"
|
|
2020,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,350,30.4,26.9,33.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,SEX1,CAT2,_RFPSA23,RESP046,"(38.89037138500049, -77.03196112699965)"
|
|
2020,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,571,69.6,66.1,73.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,11,SEX1,CAT2,_RFPSA23,RESP054,"(38.89037138500049, -77.03196112699965)"
|
|
2020,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,11,SEX2,CAT2,_RFPSA23,RESP046,"(38.89037138500049, -77.03196112699965)"
|
|
2020,DC,District of Columbia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,11,SEX2,CAT2,_RFPSA23,RESP054,"(38.89037138500049, -77.03196112699965)"
|
|
2020,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,44,12.3,5.8,18.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,AGE06,CAT3,_RFPSA23,RESP046,"(28.932040377000476, -81.92896053899966)"
|
|
2020,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,466,87.7,81.3,94.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,AGE06,CAT3,_RFPSA23,RESP054,"(28.932040377000476, -81.92896053899966)"
|
|
2020,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,204,27.9,21.5,34.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,AGE07,CAT3,_RFPSA23,RESP046,"(28.932040377000476, -81.92896053899966)"
|
|
2020,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,521,72.1,65.6,78.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,AGE07,CAT3,_RFPSA23,RESP054,"(28.932040377000476, -81.92896053899966)"
|
|
2020,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,194,48.5,38.6,58.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,AGE08,CAT3,_RFPSA23,RESP046,"(28.932040377000476, -81.92896053899966)"
|
|
2020,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,244,51.5,41.6,61.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,AGE08,CAT3,_RFPSA23,RESP054,"(28.932040377000476, -81.92896053899966)"
|
|
2020,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,969,52.8,48.2,57.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,AGE09,CAT3,_RFPSA23,RESP046,"(28.932040377000476, -81.92896053899966)"
|
|
2020,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,839,47.2,42.6,51.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,AGE09,CAT3,_RFPSA23,RESP054,"(28.932040377000476, -81.92896053899966)"
|
|
2020,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1411,36.4,33,39.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,BO1,CAT1,_RFPSA23,RESP046,"(28.932040377000476, -81.92896053899966)"
|
|
2020,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,2070,63.6,60.3,67,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,BO1,CAT1,_RFPSA23,RESP054,"(28.932040377000476, -81.92896053899966)"
|
|
2020,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,70,22.3,11.4,33.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,EDUCA1,CAT5,_RFPSA23,RESP046,"(28.932040377000476, -81.92896053899966)"
|
|
2020,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,278,77.7,66.7,88.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,EDUCA1,CAT5,_RFPSA23,RESP054,"(28.932040377000476, -81.92896053899966)"
|
|
2020,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,296,28.8,23.1,34.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,EDUCA2,CAT5,_RFPSA23,RESP046,"(28.932040377000476, -81.92896053899966)"
|
|
2020,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,591,71.2,65.4,76.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,EDUCA2,CAT5,_RFPSA23,RESP054,"(28.932040377000476, -81.92896053899966)"
|
|
2020,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,388,39.1,32.6,45.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,EDUCA3,CAT5,_RFPSA23,RESP046,"(28.932040377000476, -81.92896053899966)"
|
|
2020,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,547,60.9,54.3,67.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,EDUCA3,CAT5,_RFPSA23,RESP054,"(28.932040377000476, -81.92896053899966)"
|
|
2020,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,654,46.9,41.7,52.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,EDUCA4,CAT5,_RFPSA23,RESP046,"(28.932040377000476, -81.92896053899966)"
|
|
2020,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,648,53.1,47.9,58.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,EDUCA4,CAT5,_RFPSA23,RESP054,"(28.932040377000476, -81.92896053899966)"
|
|
2020,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,62,24.1,12.2,36,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,INCOME1,CAT6,_RFPSA23,RESP046,"(28.932040377000476, -81.92896053899966)"
|
|
2020,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,221,75.9,64,87.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,INCOME1,CAT6,_RFPSA23,RESP054,"(28.932040377000476, -81.92896053899966)"
|
|
2020,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,147,30.3,19.6,41.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,INCOME2,CAT6,_RFPSA23,RESP046,"(28.932040377000476, -81.92896053899966)"
|
|
2020,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,363,69.7,58.9,80.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,INCOME2,CAT6,_RFPSA23,RESP054,"(28.932040377000476, -81.92896053899966)"
|
|
2020,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,103,26.9,16.9,37,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,INCOME3,CAT6,_RFPSA23,RESP046,"(28.932040377000476, -81.92896053899966)"
|
|
2020,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,198,73.1,63,83.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,INCOME3,CAT6,_RFPSA23,RESP054,"(28.932040377000476, -81.92896053899966)"
|
|
2020,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,189,43.8,33.3,54.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,INCOME4,CAT6,_RFPSA23,RESP046,"(28.932040377000476, -81.92896053899966)"
|
|
2020,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,237,56.2,45.7,66.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,INCOME4,CAT6,_RFPSA23,RESP054,"(28.932040377000476, -81.92896053899966)"
|
|
2020,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,685,38.4,33.6,43.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,INCOME5,CAT6,_RFPSA23,RESP046,"(28.932040377000476, -81.92896053899966)"
|
|
2020,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,774,61.6,56.8,66.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,INCOME5,CAT6,_RFPSA23,RESP054,"(28.932040377000476, -81.92896053899966)"
|
|
2020,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1177,37.8,34.6,41.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,RACE01,CAT4,_RFPSA23,RESP046,"(28.932040377000476, -81.92896053899966)"
|
|
2020,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1524,62.2,58.9,65.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,RACE01,CAT4,_RFPSA23,RESP054,"(28.932040377000476, -81.92896053899966)"
|
|
2020,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,89,33.9,22.8,45,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,RACE02,CAT4,_RFPSA23,RESP046,"(28.932040377000476, -81.92896053899966)"
|
|
2020,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,164,66.1,55,77.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,RACE02,CAT4,_RFPSA23,RESP054,"(28.932040377000476, -81.92896053899966)"
|
|
2020,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,11,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,12,RACE03,CAT4,_RFPSA23,RESP046,"(28.932040377000476, -81.92896053899966)"
|
|
2020,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,25,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,12,RACE03,CAT4,_RFPSA23,RESP054,"(28.932040377000476, -81.92896053899966)"
|
|
2020,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,9,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,12,RACE04,CAT4,_RFPSA23,RESP046,"(28.932040377000476, -81.92896053899966)"
|
|
2020,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,20,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,12,RACE04,CAT4,_RFPSA23,RESP054,"(28.932040377000476, -81.92896053899966)"
|
|
2020,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,12,RACE05,CAT4,_RFPSA23,RESP046,"(28.932040377000476, -81.92896053899966)"
|
|
2020,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,12,RACE05,CAT4,_RFPSA23,RESP054,"(28.932040377000476, -81.92896053899966)"
|
|
2020,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,9,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,12,RACE06,CAT4,_RFPSA23,RESP046,"(28.932040377000476, -81.92896053899966)"
|
|
2020,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,32,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,12,RACE06,CAT4,_RFPSA23,RESP054,"(28.932040377000476, -81.92896053899966)"
|
|
2020,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,26,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,12,RACE07,CAT4,_RFPSA23,RESP046,"(28.932040377000476, -81.92896053899966)"
|
|
2020,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,37,65.2,41,89.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,RACE07,CAT4,_RFPSA23,RESP054,"(28.932040377000476, -81.92896053899966)"
|
|
2020,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,88,35.1,25.2,45,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,RACE08,CAT4,_RFPSA23,RESP046,"(28.932040377000476, -81.92896053899966)"
|
|
2020,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,262,64.9,55,74.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,RACE08,CAT4,_RFPSA23,RESP054,"(28.932040377000476, -81.92896053899966)"
|
|
2020,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1411,36.4,33,39.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,SEX1,CAT2,_RFPSA23,RESP046,"(28.932040377000476, -81.92896053899966)"
|
|
2020,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,2070,63.6,60.3,67,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,12,SEX1,CAT2,_RFPSA23,RESP054,"(28.932040377000476, -81.92896053899966)"
|
|
2020,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,12,SEX2,CAT2,_RFPSA23,RESP046,"(28.932040377000476, -81.92896053899966)"
|
|
2020,FL,Florida,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,12,SEX2,CAT2,_RFPSA23,RESP054,"(28.932040377000476, -81.92896053899966)"
|
|
2020,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,50,12.1,7.3,16.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,AGE06,CAT3,_RFPSA23,RESP046,"(32.83968109300048, -83.62758034599966)"
|
|
2020,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,410,87.9,83.1,92.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,AGE06,CAT3,_RFPSA23,RESP054,"(32.83968109300048, -83.62758034599966)"
|
|
2020,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,165,28.2,22.6,33.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,AGE07,CAT3,_RFPSA23,RESP046,"(32.83968109300048, -83.62758034599966)"
|
|
2020,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,384,71.8,66.2,77.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,AGE07,CAT3,_RFPSA23,RESP054,"(32.83968109300048, -83.62758034599966)"
|
|
2020,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,131,41.6,33.3,49.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,AGE08,CAT3,_RFPSA23,RESP046,"(32.83968109300048, -83.62758034599966)"
|
|
2020,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,178,58.4,50.2,66.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,AGE08,CAT3,_RFPSA23,RESP054,"(32.83968109300048, -83.62758034599966)"
|
|
2020,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,642,54,49.7,58.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,AGE09,CAT3,_RFPSA23,RESP046,"(32.83968109300048, -83.62758034599966)"
|
|
2020,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,525,46,41.7,50.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,AGE09,CAT3,_RFPSA23,RESP054,"(32.83968109300048, -83.62758034599966)"
|
|
2020,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,988,33.4,30.6,36.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,BO1,CAT1,_RFPSA23,RESP046,"(32.83968109300048, -83.62758034599966)"
|
|
2020,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1497,66.6,63.7,69.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,BO1,CAT1,_RFPSA23,RESP054,"(32.83968109300048, -83.62758034599966)"
|
|
2020,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,49,13.7,7.7,19.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,EDUCA1,CAT5,_RFPSA23,RESP046,"(32.83968109300048, -83.62758034599966)"
|
|
2020,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,229,86.3,80.4,92.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,EDUCA1,CAT5,_RFPSA23,RESP054,"(32.83968109300048, -83.62758034599966)"
|
|
2020,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,245,29,23.9,34.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,EDUCA2,CAT5,_RFPSA23,RESP046,"(32.83968109300048, -83.62758034599966)"
|
|
2020,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,471,71,65.9,76.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,EDUCA2,CAT5,_RFPSA23,RESP054,"(32.83968109300048, -83.62758034599966)"
|
|
2020,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,234,35.8,29.9,41.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,EDUCA3,CAT5,_RFPSA23,RESP046,"(32.83968109300048, -83.62758034599966)"
|
|
2020,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,386,64.2,58.4,70.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,EDUCA3,CAT5,_RFPSA23,RESP054,"(32.83968109300048, -83.62758034599966)"
|
|
2020,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,457,47.3,42.2,52.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,EDUCA4,CAT5,_RFPSA23,RESP046,"(32.83968109300048, -83.62758034599966)"
|
|
2020,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,408,52.7,47.6,57.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,EDUCA4,CAT5,_RFPSA23,RESP054,"(32.83968109300048, -83.62758034599966)"
|
|
2020,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,37,17.7,8.1,27.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,INCOME1,CAT6,_RFPSA23,RESP046,"(32.83968109300048, -83.62758034599966)"
|
|
2020,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,159,82.3,72.8,91.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,INCOME1,CAT6,_RFPSA23,RESP054,"(32.83968109300048, -83.62758034599966)"
|
|
2020,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,89,22.5,15.1,29.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,INCOME2,CAT6,_RFPSA23,RESP046,"(32.83968109300048, -83.62758034599966)"
|
|
2020,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,238,77.5,70.2,84.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,INCOME2,CAT6,_RFPSA23,RESP054,"(32.83968109300048, -83.62758034599966)"
|
|
2020,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,66,26.5,17.8,35.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,INCOME3,CAT6,_RFPSA23,RESP046,"(32.83968109300048, -83.62758034599966)"
|
|
2020,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,142,73.5,64.8,82.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,INCOME3,CAT6,_RFPSA23,RESP054,"(32.83968109300048, -83.62758034599966)"
|
|
2020,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,119,30.3,22.3,38.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,INCOME4,CAT6,_RFPSA23,RESP046,"(32.83968109300048, -83.62758034599966)"
|
|
2020,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,157,69.7,61.8,77.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,INCOME4,CAT6,_RFPSA23,RESP054,"(32.83968109300048, -83.62758034599966)"
|
|
2020,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,551,38.8,34.5,43,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,INCOME5,CAT6,_RFPSA23,RESP046,"(32.83968109300048, -83.62758034599966)"
|
|
2020,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,593,61.2,57,65.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,INCOME5,CAT6,_RFPSA23,RESP054,"(32.83968109300048, -83.62758034599966)"
|
|
2020,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,732,37.1,33.7,40.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,RACE01,CAT4,_RFPSA23,RESP046,"(32.83968109300048, -83.62758034599966)"
|
|
2020,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,969,62.9,59.6,66.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,RACE01,CAT4,_RFPSA23,RESP054,"(32.83968109300048, -83.62758034599966)"
|
|
2020,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,202,31.4,25.3,37.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,RACE02,CAT4,_RFPSA23,RESP046,"(32.83968109300048, -83.62758034599966)"
|
|
2020,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,377,68.6,62.5,74.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,RACE02,CAT4,_RFPSA23,RESP054,"(32.83968109300048, -83.62758034599966)"
|
|
2020,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,9,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,13,RACE03,CAT4,_RFPSA23,RESP046,"(32.83968109300048, -83.62758034599966)"
|
|
2020,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,17,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,13,RACE03,CAT4,_RFPSA23,RESP054,"(32.83968109300048, -83.62758034599966)"
|
|
2020,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,13,RACE04,CAT4,_RFPSA23,RESP046,"(32.83968109300048, -83.62758034599966)"
|
|
2020,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,24,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,13,RACE04,CAT4,_RFPSA23,RESP054,"(32.83968109300048, -83.62758034599966)"
|
|
2020,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,13,RACE05,CAT4,_RFPSA23,RESP046,"(32.83968109300048, -83.62758034599966)"
|
|
2020,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,13,RACE05,CAT4,_RFPSA23,RESP054,"(32.83968109300048, -83.62758034599966)"
|
|
2020,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,14,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,13,RACE06,CAT4,_RFPSA23,RESP046,"(32.83968109300048, -83.62758034599966)"
|
|
2020,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,16,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,13,RACE06,CAT4,_RFPSA23,RESP054,"(32.83968109300048, -83.62758034599966)"
|
|
2020,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,12,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,13,RACE07,CAT4,_RFPSA23,RESP046,"(32.83968109300048, -83.62758034599966)"
|
|
2020,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,30,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,13,RACE07,CAT4,_RFPSA23,RESP054,"(32.83968109300048, -83.62758034599966)"
|
|
2020,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,14,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,13,RACE08,CAT4,_RFPSA23,RESP046,"(32.83968109300048, -83.62758034599966)"
|
|
2020,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,62,82.1,67.6,96.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,RACE08,CAT4,_RFPSA23,RESP054,"(32.83968109300048, -83.62758034599966)"
|
|
2020,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,988,33.4,30.6,36.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,SEX1,CAT2,_RFPSA23,RESP046,"(32.83968109300048, -83.62758034599966)"
|
|
2020,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1497,66.6,63.7,69.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,13,SEX1,CAT2,_RFPSA23,RESP054,"(32.83968109300048, -83.62758034599966)"
|
|
2020,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,13,SEX2,CAT2,_RFPSA23,RESP046,"(32.83968109300048, -83.62758034599966)"
|
|
2020,GA,Georgia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,13,SEX2,CAT2,_RFPSA23,RESP054,"(32.83968109300048, -83.62758034599966)"
|
|
2020,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,66,AGE06,CAT3,_RFPSA23,RESP046,"(13.444304, 144.793731)"
|
|
2020,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,131,96.5,94.1,98.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,AGE06,CAT3,_RFPSA23,RESP054,"(13.444304, 144.793731)"
|
|
2020,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,31,16.4,10.2,22.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,AGE07,CAT3,_RFPSA23,RESP046,"(13.444304, 144.793731)"
|
|
2020,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,138,83.6,77.4,89.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,AGE07,CAT3,_RFPSA23,RESP054,"(13.444304, 144.793731)"
|
|
2020,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,23,18.6,9.1,28.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,AGE08,CAT3,_RFPSA23,RESP046,"(13.444304, 144.793731)"
|
|
2020,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,59,81.4,71.9,90.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,AGE08,CAT3,_RFPSA23,RESP054,"(13.444304, 144.793731)"
|
|
2020,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,66,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,66,AGE09,CAT3,_RFPSA23,RESP046,"(13.444304, 144.793731)"
|
|
2020,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,124,56.4,29.4,83.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,AGE09,CAT3,_RFPSA23,RESP054,"(13.444304, 144.793731)"
|
|
2020,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,130,16.1,9,23.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,BO1,CAT1,_RFPSA23,RESP046,"(13.444304, 144.793731)"
|
|
2020,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,452,83.9,76.9,91,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,BO1,CAT1,_RFPSA23,RESP054,"(13.444304, 144.793731)"
|
|
2020,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,66,EDUCA1,CAT5,_RFPSA23,RESP046,"(13.444304, 144.793731)"
|
|
2020,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,25,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,66,EDUCA1,CAT5,_RFPSA23,RESP054,"(13.444304, 144.793731)"
|
|
2020,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,17,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,66,EDUCA2,CAT5,_RFPSA23,RESP046,"(13.444304, 144.793731)"
|
|
2020,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,152,95.7,93,98.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,EDUCA2,CAT5,_RFPSA23,RESP054,"(13.444304, 144.793731)"
|
|
2020,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,29,12.7,5.6,19.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,EDUCA3,CAT5,_RFPSA23,RESP046,"(13.444304, 144.793731)"
|
|
2020,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,121,87.3,80.2,94.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,EDUCA3,CAT5,_RFPSA23,RESP054,"(13.444304, 144.793731)"
|
|
2020,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,79,25.5,18.9,32.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,EDUCA4,CAT5,_RFPSA23,RESP046,"(13.444304, 144.793731)"
|
|
2020,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,152,74.5,67.9,81.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,EDUCA4,CAT5,_RFPSA23,RESP054,"(13.444304, 144.793731)"
|
|
2020,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,66,INCOME1,CAT6,_RFPSA23,RESP046,"(13.444304, 144.793731)"
|
|
2020,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,39,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,66,INCOME1,CAT6,_RFPSA23,RESP054,"(13.444304, 144.793731)"
|
|
2020,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,15,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,66,INCOME2,CAT6,_RFPSA23,RESP046,"(13.444304, 144.793731)"
|
|
2020,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,67,92.2,86.2,98.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,INCOME2,CAT6,_RFPSA23,RESP054,"(13.444304, 144.793731)"
|
|
2020,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,11,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,66,INCOME3,CAT6,_RFPSA23,RESP046,"(13.444304, 144.793731)"
|
|
2020,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,44,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,66,INCOME3,CAT6,_RFPSA23,RESP054,"(13.444304, 144.793731)"
|
|
2020,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,14,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,66,INCOME4,CAT6,_RFPSA23,RESP046,"(13.444304, 144.793731)"
|
|
2020,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,65,88.4,81,95.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,INCOME4,CAT6,_RFPSA23,RESP054,"(13.444304, 144.793731)"
|
|
2020,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,80,17,11.4,22.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,INCOME5,CAT6,_RFPSA23,RESP046,"(13.444304, 144.793731)"
|
|
2020,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,199,83,77.4,88.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,INCOME5,CAT6,_RFPSA23,RESP054,"(13.444304, 144.793731)"
|
|
2020,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,33,22.5,13,32.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,RACE01,CAT4,_RFPSA23,RESP046,"(13.444304, 144.793731)"
|
|
2020,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,68,77.5,67.9,87,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,RACE01,CAT4,_RFPSA23,RESP054,"(13.444304, 144.793731)"
|
|
2020,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,66,RACE02,CAT4,_RFPSA23,RESP046,"(13.444304, 144.793731)"
|
|
2020,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,66,RACE02,CAT4,_RFPSA23,RESP054,"(13.444304, 144.793731)"
|
|
2020,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,66,RACE03,CAT4,_RFPSA23,RESP046,"(13.444304, 144.793731)"
|
|
2020,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,66,RACE03,CAT4,_RFPSA23,RESP054,"(13.444304, 144.793731)"
|
|
2020,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,39,10,5.4,14.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,RACE04,CAT4,_RFPSA23,RESP046,"(13.444304, 144.793731)"
|
|
2020,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,146,90,85.4,94.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,RACE04,CAT4,_RFPSA23,RESP054,"(13.444304, 144.793731)"
|
|
2020,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,35,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,66,RACE05,CAT4,_RFPSA23,RESP046,"(13.444304, 144.793731)"
|
|
2020,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,154,83.1,69.3,96.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,RACE05,CAT4,_RFPSA23,RESP054,"(13.444304, 144.793731)"
|
|
2020,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,66,RACE06,CAT4,_RFPSA23,RESP046,"(13.444304, 144.793731)"
|
|
2020,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,66,RACE06,CAT4,_RFPSA23,RESP054,"(13.444304, 144.793731)"
|
|
2020,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,15,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,66,RACE07,CAT4,_RFPSA23,RESP046,"(13.444304, 144.793731)"
|
|
2020,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,41,70.9,40.5,100,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,RACE07,CAT4,_RFPSA23,RESP054,"(13.444304, 144.793731)"
|
|
2020,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,66,RACE08,CAT4,_RFPSA23,RESP046,"(13.444304, 144.793731)"
|
|
2020,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,30,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,66,RACE08,CAT4,_RFPSA23,RESP054,"(13.444304, 144.793731)"
|
|
2020,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,130,16.1,9,23.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,SEX1,CAT2,_RFPSA23,RESP046,"(13.444304, 144.793731)"
|
|
2020,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,452,83.9,76.9,91,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,66,SEX1,CAT2,_RFPSA23,RESP054,"(13.444304, 144.793731)"
|
|
2020,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,66,SEX2,CAT2,_RFPSA23,RESP046,"(13.444304, 144.793731)"
|
|
2020,GU,Guam,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,66,SEX2,CAT2,_RFPSA23,RESP054,"(13.444304, 144.793731)"
|
|
2020,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,19,3.2,1.5,4.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,AGE06,CAT3,_RFPSA23,RESP046,"(21.304850435000446, -157.85774940299973)"
|
|
2020,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,433,96.8,95.1,98.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,AGE06,CAT3,_RFPSA23,RESP054,"(21.304850435000446, -157.85774940299973)"
|
|
2020,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,114,20.8,16.3,25.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,AGE07,CAT3,_RFPSA23,RESP046,"(21.304850435000446, -157.85774940299973)"
|
|
2020,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,427,79.2,74.7,83.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,AGE07,CAT3,_RFPSA23,RESP054,"(21.304850435000446, -157.85774940299973)"
|
|
2020,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,96,33.5,26.6,40.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,AGE08,CAT3,_RFPSA23,RESP046,"(21.304850435000446, -157.85774940299973)"
|
|
2020,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,207,66.5,59.5,73.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,AGE08,CAT3,_RFPSA23,RESP054,"(21.304850435000446, -157.85774940299973)"
|
|
2020,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,421,39.9,35.5,44.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,AGE09,CAT3,_RFPSA23,RESP046,"(21.304850435000446, -157.85774940299973)"
|
|
2020,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,547,60.1,55.7,64.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,AGE09,CAT3,_RFPSA23,RESP054,"(21.304850435000446, -157.85774940299973)"
|
|
2020,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,650,25.4,23,27.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,BO1,CAT1,_RFPSA23,RESP046,"(21.304850435000446, -157.85774940299973)"
|
|
2020,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1614,74.6,72.3,77,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,BO1,CAT1,_RFPSA23,RESP054,"(21.304850435000446, -157.85774940299973)"
|
|
2020,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,15,EDUCA1,CAT5,_RFPSA23,RESP046,"(21.304850435000446, -157.85774940299973)"
|
|
2020,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,58,88.9,80.4,97.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,EDUCA1,CAT5,_RFPSA23,RESP054,"(21.304850435000446, -157.85774940299973)"
|
|
2020,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,108,23.1,18.3,27.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,EDUCA2,CAT5,_RFPSA23,RESP046,"(21.304850435000446, -157.85774940299973)"
|
|
2020,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,408,76.9,72.1,81.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,EDUCA2,CAT5,_RFPSA23,RESP054,"(21.304850435000446, -157.85774940299973)"
|
|
2020,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,182,24.7,20.5,28.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,EDUCA3,CAT5,_RFPSA23,RESP046,"(21.304850435000446, -157.85774940299973)"
|
|
2020,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,471,75.3,71.1,79.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,EDUCA3,CAT5,_RFPSA23,RESP054,"(21.304850435000446, -157.85774940299973)"
|
|
2020,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,350,31.4,27.8,35,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,EDUCA4,CAT5,_RFPSA23,RESP046,"(21.304850435000446, -157.85774940299973)"
|
|
2020,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,675,68.6,65,72.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,EDUCA4,CAT5,_RFPSA23,RESP054,"(21.304850435000446, -157.85774940299973)"
|
|
2020,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,25,19.8,10.1,29.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,INCOME1,CAT6,_RFPSA23,RESP046,"(21.304850435000446, -157.85774940299973)"
|
|
2020,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,111,80.2,70.4,89.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,INCOME1,CAT6,_RFPSA23,RESP054,"(21.304850435000446, -157.85774940299973)"
|
|
2020,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,43,17.9,10.7,25.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,INCOME2,CAT6,_RFPSA23,RESP046,"(21.304850435000446, -157.85774940299973)"
|
|
2020,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,164,82.1,74.9,89.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,INCOME2,CAT6,_RFPSA23,RESP054,"(21.304850435000446, -157.85774940299973)"
|
|
2020,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,43,24.2,15.3,33.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,INCOME3,CAT6,_RFPSA23,RESP046,"(21.304850435000446, -157.85774940299973)"
|
|
2020,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,123,75.8,66.9,84.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,INCOME3,CAT6,_RFPSA23,RESP054,"(21.304850435000446, -157.85774940299973)"
|
|
2020,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,52,17.9,11.7,24,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,INCOME4,CAT6,_RFPSA23,RESP046,"(21.304850435000446, -157.85774940299973)"
|
|
2020,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,186,82.1,76,88.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,INCOME4,CAT6,_RFPSA23,RESP054,"(21.304850435000446, -157.85774940299973)"
|
|
2020,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,440,28.6,25.4,31.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,INCOME5,CAT6,_RFPSA23,RESP046,"(21.304850435000446, -157.85774940299973)"
|
|
2020,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,902,71.4,68.3,74.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,INCOME5,CAT6,_RFPSA23,RESP054,"(21.304850435000446, -157.85774940299973)"
|
|
2020,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,330,32.6,28.5,36.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,RACE01,CAT4,_RFPSA23,RESP046,"(21.304850435000446, -157.85774940299973)"
|
|
2020,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,610,67.4,63.3,71.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,RACE01,CAT4,_RFPSA23,RESP054,"(21.304850435000446, -157.85774940299973)"
|
|
2020,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,15,RACE02,CAT4,_RFPSA23,RESP046,"(21.304850435000446, -157.85774940299973)"
|
|
2020,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,24,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,15,RACE02,CAT4,_RFPSA23,RESP054,"(21.304850435000446, -157.85774940299973)"
|
|
2020,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,15,RACE03,CAT4,_RFPSA23,RESP046,"(21.304850435000446, -157.85774940299973)"
|
|
2020,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,15,RACE03,CAT4,_RFPSA23,RESP054,"(21.304850435000446, -157.85774940299973)"
|
|
2020,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,175,25.3,21.1,29.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,RACE04,CAT4,_RFPSA23,RESP046,"(21.304850435000446, -157.85774940299973)"
|
|
2020,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,479,74.7,70.6,78.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,RACE04,CAT4,_RFPSA23,RESP054,"(21.304850435000446, -157.85774940299973)"
|
|
2020,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,25,13.1,6.9,19.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,RACE05,CAT4,_RFPSA23,RESP046,"(21.304850435000446, -157.85774940299973)"
|
|
2020,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,109,86.9,80.7,93.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,RACE05,CAT4,_RFPSA23,RESP054,"(21.304850435000446, -157.85774940299973)"
|
|
2020,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,15,RACE06,CAT4,_RFPSA23,RESP046,"(21.304850435000446, -157.85774940299973)"
|
|
2020,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,15,RACE06,CAT4,_RFPSA23,RESP054,"(21.304850435000446, -157.85774940299973)"
|
|
2020,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,73,18.2,13.4,23,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,RACE07,CAT4,_RFPSA23,RESP046,"(21.304850435000446, -157.85774940299973)"
|
|
2020,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,285,81.8,77,86.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,RACE07,CAT4,_RFPSA23,RESP054,"(21.304850435000446, -157.85774940299973)"
|
|
2020,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,38,25,16.1,34,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,RACE08,CAT4,_RFPSA23,RESP046,"(21.304850435000446, -157.85774940299973)"
|
|
2020,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,94,75,66,83.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,RACE08,CAT4,_RFPSA23,RESP054,"(21.304850435000446, -157.85774940299973)"
|
|
2020,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,650,25.4,23,27.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,SEX1,CAT2,_RFPSA23,RESP046,"(21.304850435000446, -157.85774940299973)"
|
|
2020,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1614,74.6,72.3,77,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,15,SEX1,CAT2,_RFPSA23,RESP054,"(21.304850435000446, -157.85774940299973)"
|
|
2020,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,15,SEX2,CAT2,_RFPSA23,RESP046,"(21.304850435000446, -157.85774940299973)"
|
|
2020,HI,Hawaii,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,15,SEX2,CAT2,_RFPSA23,RESP054,"(21.304850435000446, -157.85774940299973)"
|
|
2020,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,22,4.3,2.2,6.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,AGE06,CAT3,_RFPSA23,RESP046,"(43.682630005000476, -114.3637300419997)"
|
|
2020,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,348,95.7,93.5,97.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,AGE06,CAT3,_RFPSA23,RESP054,"(43.682630005000476, -114.3637300419997)"
|
|
2020,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,98,21.6,15.6,27.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,AGE07,CAT3,_RFPSA23,RESP046,"(43.682630005000476, -114.3637300419997)"
|
|
2020,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,301,78.4,72.5,84.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,AGE07,CAT3,_RFPSA23,RESP054,"(43.682630005000476, -114.3637300419997)"
|
|
2020,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,86,39.6,30.3,48.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,AGE08,CAT3,_RFPSA23,RESP046,"(43.682630005000476, -114.3637300419997)"
|
|
2020,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,130,60.4,51.1,69.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,AGE08,CAT3,_RFPSA23,RESP054,"(43.682630005000476, -114.3637300419997)"
|
|
2020,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,356,51.4,46,56.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,AGE09,CAT3,_RFPSA23,RESP046,"(43.682630005000476, -114.3637300419997)"
|
|
2020,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,379,48.6,43.3,54,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,AGE09,CAT3,_RFPSA23,RESP054,"(43.682630005000476, -114.3637300419997)"
|
|
2020,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,562,30.4,27.3,33.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,BO1,CAT1,_RFPSA23,RESP046,"(43.682630005000476, -114.3637300419997)"
|
|
2020,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1158,69.6,66.5,72.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,BO1,CAT1,_RFPSA23,RESP054,"(43.682630005000476, -114.3637300419997)"
|
|
2020,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,21,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,16,EDUCA1,CAT5,_RFPSA23,RESP046,"(43.682630005000476, -114.3637300419997)"
|
|
2020,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,82,82.2,70.9,93.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,EDUCA1,CAT5,_RFPSA23,RESP054,"(43.682630005000476, -114.3637300419997)"
|
|
2020,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,108,26.4,20.3,32.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,EDUCA2,CAT5,_RFPSA23,RESP046,"(43.682630005000476, -114.3637300419997)"
|
|
2020,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,320,73.6,67.6,79.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,EDUCA2,CAT5,_RFPSA23,RESP054,"(43.682630005000476, -114.3637300419997)"
|
|
2020,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,188,33.5,27.6,39.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,EDUCA3,CAT5,_RFPSA23,RESP046,"(43.682630005000476, -114.3637300419997)"
|
|
2020,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,353,66.5,60.7,72.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,EDUCA3,CAT5,_RFPSA23,RESP054,"(43.682630005000476, -114.3637300419997)"
|
|
2020,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,243,34,29,39,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,EDUCA4,CAT5,_RFPSA23,RESP046,"(43.682630005000476, -114.3637300419997)"
|
|
2020,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,400,66,61,71,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,EDUCA4,CAT5,_RFPSA23,RESP054,"(43.682630005000476, -114.3637300419997)"
|
|
2020,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,9,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,16,INCOME1,CAT6,_RFPSA23,RESP046,"(43.682630005000476, -114.3637300419997)"
|
|
2020,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,70,91.3,84.3,98.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,INCOME1,CAT6,_RFPSA23,RESP054,"(43.682630005000476, -114.3637300419997)"
|
|
2020,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,48,21.6,13.5,29.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,INCOME2,CAT6,_RFPSA23,RESP046,"(43.682630005000476, -114.3637300419997)"
|
|
2020,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,131,78.4,70.3,86.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,INCOME2,CAT6,_RFPSA23,RESP054,"(43.682630005000476, -114.3637300419997)"
|
|
2020,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,52,30.2,19.5,40.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,INCOME3,CAT6,_RFPSA23,RESP046,"(43.682630005000476, -114.3637300419997)"
|
|
2020,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,114,69.8,59.1,80.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,INCOME3,CAT6,_RFPSA23,RESP054,"(43.682630005000476, -114.3637300419997)"
|
|
2020,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,85,36.6,27.1,46.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,INCOME4,CAT6,_RFPSA23,RESP046,"(43.682630005000476, -114.3637300419997)"
|
|
2020,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,154,63.4,53.8,72.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,INCOME4,CAT6,_RFPSA23,RESP054,"(43.682630005000476, -114.3637300419997)"
|
|
2020,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,282,32.9,28.3,37.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,INCOME5,CAT6,_RFPSA23,RESP046,"(43.682630005000476, -114.3637300419997)"
|
|
2020,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,498,67.1,62.5,71.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,INCOME5,CAT6,_RFPSA23,RESP054,"(43.682630005000476, -114.3637300419997)"
|
|
2020,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,533,32.6,29.3,36,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,RACE01,CAT4,_RFPSA23,RESP046,"(43.682630005000476, -114.3637300419997)"
|
|
2020,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1032,67.4,64,70.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,RACE01,CAT4,_RFPSA23,RESP054,"(43.682630005000476, -114.3637300419997)"
|
|
2020,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,16,RACE02,CAT4,_RFPSA23,RESP046,"(43.682630005000476, -114.3637300419997)"
|
|
2020,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,16,RACE02,CAT4,_RFPSA23,RESP054,"(43.682630005000476, -114.3637300419997)"
|
|
2020,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,16,RACE03,CAT4,_RFPSA23,RESP046,"(43.682630005000476, -114.3637300419997)"
|
|
2020,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,14,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,16,RACE03,CAT4,_RFPSA23,RESP054,"(43.682630005000476, -114.3637300419997)"
|
|
2020,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,16,RACE04,CAT4,_RFPSA23,RESP046,"(43.682630005000476, -114.3637300419997)"
|
|
2020,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,16,RACE04,CAT4,_RFPSA23,RESP054,"(43.682630005000476, -114.3637300419997)"
|
|
2020,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,16,RACE05,CAT4,_RFPSA23,RESP046,"(43.682630005000476, -114.3637300419997)"
|
|
2020,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,16,RACE05,CAT4,_RFPSA23,RESP054,"(43.682630005000476, -114.3637300419997)"
|
|
2020,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,16,RACE06,CAT4,_RFPSA23,RESP046,"(43.682630005000476, -114.3637300419997)"
|
|
2020,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,16,RACE06,CAT4,_RFPSA23,RESP054,"(43.682630005000476, -114.3637300419997)"
|
|
2020,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,16,RACE07,CAT4,_RFPSA23,RESP046,"(43.682630005000476, -114.3637300419997)"
|
|
2020,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,21,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,16,RACE07,CAT4,_RFPSA23,RESP054,"(43.682630005000476, -114.3637300419997)"
|
|
2020,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,13,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,16,RACE08,CAT4,_RFPSA23,RESP046,"(43.682630005000476, -114.3637300419997)"
|
|
2020,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,74,88,80,95.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,RACE08,CAT4,_RFPSA23,RESP054,"(43.682630005000476, -114.3637300419997)"
|
|
2020,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,562,30.4,27.3,33.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,SEX1,CAT2,_RFPSA23,RESP046,"(43.682630005000476, -114.3637300419997)"
|
|
2020,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1158,69.6,66.5,72.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,16,SEX1,CAT2,_RFPSA23,RESP054,"(43.682630005000476, -114.3637300419997)"
|
|
2020,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,16,SEX2,CAT2,_RFPSA23,RESP046,"(43.682630005000476, -114.3637300419997)"
|
|
2020,ID,Idaho,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,16,SEX2,CAT2,_RFPSA23,RESP054,"(43.682630005000476, -114.3637300419997)"
|
|
2020,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,22,11.7,6.4,17.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,AGE06,CAT3,_RFPSA23,RESP046,"(40.48501028300046, -88.99771017799969)"
|
|
2020,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,187,88.3,82.9,93.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,AGE06,CAT3,_RFPSA23,RESP054,"(40.48501028300046, -88.99771017799969)"
|
|
2020,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,70,27.2,20,34.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,AGE07,CAT3,_RFPSA23,RESP046,"(40.48501028300046, -88.99771017799969)"
|
|
2020,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,154,72.8,65.6,80,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,AGE07,CAT3,_RFPSA23,RESP054,"(40.48501028300046, -88.99771017799969)"
|
|
2020,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,69,39.6,30.1,49.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,AGE08,CAT3,_RFPSA23,RESP046,"(40.48501028300046, -88.99771017799969)"
|
|
2020,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,80,60.4,50.8,69.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,AGE08,CAT3,_RFPSA23,RESP054,"(40.48501028300046, -88.99771017799969)"
|
|
2020,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,226,46.2,40,52.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,AGE09,CAT3,_RFPSA23,RESP046,"(40.48501028300046, -88.99771017799969)"
|
|
2020,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,217,53.8,47.6,60,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,AGE09,CAT3,_RFPSA23,RESP054,"(40.48501028300046, -88.99771017799969)"
|
|
2020,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,387,31,27.6,34.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,BO1,CAT1,_RFPSA23,RESP046,"(40.48501028300046, -88.99771017799969)"
|
|
2020,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,638,69,65.5,72.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,BO1,CAT1,_RFPSA23,RESP054,"(40.48501028300046, -88.99771017799969)"
|
|
2020,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,17,EDUCA1,CAT5,_RFPSA23,RESP046,"(40.48501028300046, -88.99771017799969)"
|
|
2020,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,37,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,17,EDUCA1,CAT5,_RFPSA23,RESP054,"(40.48501028300046, -88.99771017799969)"
|
|
2020,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,80,22.8,17.2,28.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,EDUCA2,CAT5,_RFPSA23,RESP046,"(40.48501028300046, -88.99771017799969)"
|
|
2020,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,178,77.2,71.6,82.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,EDUCA2,CAT5,_RFPSA23,RESP054,"(40.48501028300046, -88.99771017799969)"
|
|
2020,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,98,35.1,27.9,42.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,EDUCA3,CAT5,_RFPSA23,RESP046,"(40.48501028300046, -88.99771017799969)"
|
|
2020,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,150,64.9,57.7,72.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,EDUCA3,CAT5,_RFPSA23,RESP054,"(40.48501028300046, -88.99771017799969)"
|
|
2020,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,199,40.1,34.7,45.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,EDUCA4,CAT5,_RFPSA23,RESP046,"(40.48501028300046, -88.99771017799969)"
|
|
2020,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,272,59.9,54.6,65.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,EDUCA4,CAT5,_RFPSA23,RESP054,"(40.48501028300046, -88.99771017799969)"
|
|
2020,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,17,INCOME1,CAT6,_RFPSA23,RESP046,"(40.48501028300046, -88.99771017799969)"
|
|
2020,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,22,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,17,INCOME1,CAT6,_RFPSA23,RESP054,"(40.48501028300046, -88.99771017799969)"
|
|
2020,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,22,19.8,9.8,29.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,INCOME2,CAT6,_RFPSA23,RESP046,"(40.48501028300046, -88.99771017799969)"
|
|
2020,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,53,80.2,70.2,90.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,INCOME2,CAT6,_RFPSA23,RESP054,"(40.48501028300046, -88.99771017799969)"
|
|
2020,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,24,33,18.1,48,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,INCOME3,CAT6,_RFPSA23,RESP046,"(40.48501028300046, -88.99771017799969)"
|
|
2020,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,32,67,52,81.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,INCOME3,CAT6,_RFPSA23,RESP054,"(40.48501028300046, -88.99771017799969)"
|
|
2020,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,37,27,17.4,36.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,INCOME4,CAT6,_RFPSA23,RESP046,"(40.48501028300046, -88.99771017799969)"
|
|
2020,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,69,73,63.4,82.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,INCOME4,CAT6,_RFPSA23,RESP054,"(40.48501028300046, -88.99771017799969)"
|
|
2020,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,210,35.1,30.1,40.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,INCOME5,CAT6,_RFPSA23,RESP046,"(40.48501028300046, -88.99771017799969)"
|
|
2020,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,305,64.9,59.8,69.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,INCOME5,CAT6,_RFPSA23,RESP054,"(40.48501028300046, -88.99771017799969)"
|
|
2020,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,328,34.9,30.9,39,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,RACE01,CAT4,_RFPSA23,RESP046,"(40.48501028300046, -88.99771017799969)"
|
|
2020,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,482,65.1,61,69.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,RACE01,CAT4,_RFPSA23,RESP054,"(40.48501028300046, -88.99771017799969)"
|
|
2020,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,35,25.9,16.3,35.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,RACE02,CAT4,_RFPSA23,RESP046,"(40.48501028300046, -88.99771017799969)"
|
|
2020,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,67,74.1,64.6,83.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,RACE02,CAT4,_RFPSA23,RESP054,"(40.48501028300046, -88.99771017799969)"
|
|
2020,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,17,RACE03,CAT4,_RFPSA23,RESP046,"(40.48501028300046, -88.99771017799969)"
|
|
2020,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,17,RACE03,CAT4,_RFPSA23,RESP054,"(40.48501028300046, -88.99771017799969)"
|
|
2020,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,17,RACE04,CAT4,_RFPSA23,RESP046,"(40.48501028300046, -88.99771017799969)"
|
|
2020,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,33,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,17,RACE04,CAT4,_RFPSA23,RESP054,"(40.48501028300046, -88.99771017799969)"
|
|
2020,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,17,RACE05,CAT4,_RFPSA23,RESP046,"(40.48501028300046, -88.99771017799969)"
|
|
2020,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,17,RACE05,CAT4,_RFPSA23,RESP054,"(40.48501028300046, -88.99771017799969)"
|
|
2020,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,17,RACE06,CAT4,_RFPSA23,RESP046,"(40.48501028300046, -88.99771017799969)"
|
|
2020,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,17,RACE06,CAT4,_RFPSA23,RESP054,"(40.48501028300046, -88.99771017799969)"
|
|
2020,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,17,RACE07,CAT4,_RFPSA23,RESP046,"(40.48501028300046, -88.99771017799969)"
|
|
2020,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,17,RACE07,CAT4,_RFPSA23,RESP054,"(40.48501028300046, -88.99771017799969)"
|
|
2020,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,11,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,17,RACE08,CAT4,_RFPSA23,RESP046,"(40.48501028300046, -88.99771017799969)"
|
|
2020,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,39,79.1,66.1,92.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,RACE08,CAT4,_RFPSA23,RESP054,"(40.48501028300046, -88.99771017799969)"
|
|
2020,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,387,31,27.6,34.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,SEX1,CAT2,_RFPSA23,RESP046,"(40.48501028300046, -88.99771017799969)"
|
|
2020,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,638,69,65.5,72.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,17,SEX1,CAT2,_RFPSA23,RESP054,"(40.48501028300046, -88.99771017799969)"
|
|
2020,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,17,SEX2,CAT2,_RFPSA23,RESP046,"(40.48501028300046, -88.99771017799969)"
|
|
2020,IL,Illinois,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,17,SEX2,CAT2,_RFPSA23,RESP054,"(40.48501028300046, -88.99771017799969)"
|
|
2020,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,31,6.9,4.3,9.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,AGE06,CAT3,_RFPSA23,RESP046,"(39.766910452000445, -86.14996019399968)"
|
|
2020,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,411,93.1,90.5,95.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,AGE06,CAT3,_RFPSA23,RESP054,"(39.766910452000445, -86.14996019399968)"
|
|
2020,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,147,23.5,19.7,27.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,AGE07,CAT3,_RFPSA23,RESP046,"(39.766910452000445, -86.14996019399968)"
|
|
2020,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,424,76.5,72.7,80.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,AGE07,CAT3,_RFPSA23,RESP054,"(39.766910452000445, -86.14996019399968)"
|
|
2020,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,133,35.2,29.8,40.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,AGE08,CAT3,_RFPSA23,RESP046,"(39.766910452000445, -86.14996019399968)"
|
|
2020,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,232,64.8,59.4,70.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,AGE08,CAT3,_RFPSA23,RESP054,"(39.766910452000445, -86.14996019399968)"
|
|
2020,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,489,47.4,43.8,50.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,AGE09,CAT3,_RFPSA23,RESP046,"(39.766910452000445, -86.14996019399968)"
|
|
2020,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,517,52.6,49.1,56.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,AGE09,CAT3,_RFPSA23,RESP054,"(39.766910452000445, -86.14996019399968)"
|
|
2020,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,800,28.9,26.9,30.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,BO1,CAT1,_RFPSA23,RESP046,"(39.766910452000445, -86.14996019399968)"
|
|
2020,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1584,71.1,69.1,73.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,BO1,CAT1,_RFPSA23,RESP054,"(39.766910452000445, -86.14996019399968)"
|
|
2020,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,26,14.9,8.9,20.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,EDUCA1,CAT5,_RFPSA23,RESP046,"(39.766910452000445, -86.14996019399968)"
|
|
2020,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,139,85.1,79.2,91.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,EDUCA1,CAT5,_RFPSA23,RESP054,"(39.766910452000445, -86.14996019399968)"
|
|
2020,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,194,21.9,18.8,25,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,EDUCA2,CAT5,_RFPSA23,RESP046,"(39.766910452000445, -86.14996019399968)"
|
|
2020,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,572,78.1,75,81.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,EDUCA2,CAT5,_RFPSA23,RESP054,"(39.766910452000445, -86.14996019399968)"
|
|
2020,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,213,32,27.9,36,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,EDUCA3,CAT5,_RFPSA23,RESP046,"(39.766910452000445, -86.14996019399968)"
|
|
2020,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,392,68,64,72.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,EDUCA3,CAT5,_RFPSA23,RESP054,"(39.766910452000445, -86.14996019399968)"
|
|
2020,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,366,40.4,36.7,44,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,EDUCA4,CAT5,_RFPSA23,RESP046,"(39.766910452000445, -86.14996019399968)"
|
|
2020,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,478,59.6,56,63.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,EDUCA4,CAT5,_RFPSA23,RESP054,"(39.766910452000445, -86.14996019399968)"
|
|
2020,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,24,18.6,11,26.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,INCOME1,CAT6,_RFPSA23,RESP046,"(39.766910452000445, -86.14996019399968)"
|
|
2020,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,102,81.4,73.7,89,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,INCOME1,CAT6,_RFPSA23,RESP054,"(39.766910452000445, -86.14996019399968)"
|
|
2020,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,64,20.2,14.9,25.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,INCOME2,CAT6,_RFPSA23,RESP046,"(39.766910452000445, -86.14996019399968)"
|
|
2020,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,214,79.8,74.6,85.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,INCOME2,CAT6,_RFPSA23,RESP054,"(39.766910452000445, -86.14996019399968)"
|
|
2020,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,50,25.1,18.2,32,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,INCOME3,CAT6,_RFPSA23,RESP046,"(39.766910452000445, -86.14996019399968)"
|
|
2020,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,139,74.9,68,81.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,INCOME3,CAT6,_RFPSA23,RESP054,"(39.766910452000445, -86.14996019399968)"
|
|
2020,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,108,30.7,24.9,36.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,INCOME4,CAT6,_RFPSA23,RESP046,"(39.766910452000445, -86.14996019399968)"
|
|
2020,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,201,69.3,63.5,75.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,INCOME4,CAT6,_RFPSA23,RESP054,"(39.766910452000445, -86.14996019399968)"
|
|
2020,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,436,32.5,29.5,35.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,INCOME5,CAT6,_RFPSA23,RESP046,"(39.766910452000445, -86.14996019399968)"
|
|
2020,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,697,67.5,64.5,70.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,INCOME5,CAT6,_RFPSA23,RESP054,"(39.766910452000445, -86.14996019399968)"
|
|
2020,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,711,30.3,28.1,32.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,RACE01,CAT4,_RFPSA23,RESP046,"(39.766910452000445, -86.14996019399968)"
|
|
2020,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1333,69.7,67.6,71.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,RACE01,CAT4,_RFPSA23,RESP054,"(39.766910452000445, -86.14996019399968)"
|
|
2020,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,48,23.1,15.9,30.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,RACE02,CAT4,_RFPSA23,RESP046,"(39.766910452000445, -86.14996019399968)"
|
|
2020,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,126,76.9,69.7,84.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,RACE02,CAT4,_RFPSA23,RESP054,"(39.766910452000445, -86.14996019399968)"
|
|
2020,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,18,RACE03,CAT4,_RFPSA23,RESP046,"(39.766910452000445, -86.14996019399968)"
|
|
2020,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,11,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,18,RACE03,CAT4,_RFPSA23,RESP054,"(39.766910452000445, -86.14996019399968)"
|
|
2020,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,18,RACE04,CAT4,_RFPSA23,RESP046,"(39.766910452000445, -86.14996019399968)"
|
|
2020,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,18,RACE04,CAT4,_RFPSA23,RESP054,"(39.766910452000445, -86.14996019399968)"
|
|
2020,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,18,RACE05,CAT4,_RFPSA23,RESP046,"(39.766910452000445, -86.14996019399968)"
|
|
2020,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,18,RACE05,CAT4,_RFPSA23,RESP054,"(39.766910452000445, -86.14996019399968)"
|
|
2020,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,14,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,18,RACE06,CAT4,_RFPSA23,RESP046,"(39.766910452000445, -86.14996019399968)"
|
|
2020,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,17,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,18,RACE06,CAT4,_RFPSA23,RESP054,"(39.766910452000445, -86.14996019399968)"
|
|
2020,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,13,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,18,RACE07,CAT4,_RFPSA23,RESP046,"(39.766910452000445, -86.14996019399968)"
|
|
2020,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,19,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,18,RACE07,CAT4,_RFPSA23,RESP054,"(39.766910452000445, -86.14996019399968)"
|
|
2020,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,9,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,18,RACE08,CAT4,_RFPSA23,RESP046,"(39.766910452000445, -86.14996019399968)"
|
|
2020,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,68,86.7,76.5,96.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,RACE08,CAT4,_RFPSA23,RESP054,"(39.766910452000445, -86.14996019399968)"
|
|
2020,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,800,28.9,26.9,30.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,SEX1,CAT2,_RFPSA23,RESP046,"(39.766910452000445, -86.14996019399968)"
|
|
2020,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1584,71.1,69.1,73.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,18,SEX1,CAT2,_RFPSA23,RESP054,"(39.766910452000445, -86.14996019399968)"
|
|
2020,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,18,SEX2,CAT2,_RFPSA23,RESP046,"(39.766910452000445, -86.14996019399968)"
|
|
2020,IN,Indiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,18,SEX2,CAT2,_RFPSA23,RESP054,"(39.766910452000445, -86.14996019399968)"
|
|
2020,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,38,6.2,4.1,8.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,AGE06,CAT3,_RFPSA23,RESP046,"(42.46940091300047, -93.81649055599968)"
|
|
2020,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,552,93.8,91.8,95.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,AGE06,CAT3,_RFPSA23,RESP054,"(42.46940091300047, -93.81649055599968)"
|
|
2020,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,182,25.3,21.7,29,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,AGE07,CAT3,_RFPSA23,RESP046,"(42.46940091300047, -93.81649055599968)"
|
|
2020,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,508,74.7,71,78.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,AGE07,CAT3,_RFPSA23,RESP054,"(42.46940091300047, -93.81649055599968)"
|
|
2020,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,170,40,34.8,45.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,AGE08,CAT3,_RFPSA23,RESP046,"(42.46940091300047, -93.81649055599968)"
|
|
2020,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,241,60,54.8,65.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,AGE08,CAT3,_RFPSA23,RESP054,"(42.46940091300047, -93.81649055599968)"
|
|
2020,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,578,46.8,43.5,50.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,AGE09,CAT3,_RFPSA23,RESP046,"(42.46940091300047, -93.81649055599968)"
|
|
2020,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,629,53.2,49.9,56.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,AGE09,CAT3,_RFPSA23,RESP054,"(42.46940091300047, -93.81649055599968)"
|
|
2020,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,968,30.3,28.4,32.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,BO1,CAT1,_RFPSA23,RESP046,"(42.46940091300047, -93.81649055599968)"
|
|
2020,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1930,69.7,67.9,71.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,BO1,CAT1,_RFPSA23,RESP054,"(42.46940091300047, -93.81649055599968)"
|
|
2020,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,23,16.9,9.5,24.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,EDUCA1,CAT5,_RFPSA23,RESP046,"(42.46940091300047, -93.81649055599968)"
|
|
2020,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,121,83.1,75.7,90.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,EDUCA1,CAT5,_RFPSA23,RESP054,"(42.46940091300047, -93.81649055599968)"
|
|
2020,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,272,28.3,25,31.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,EDUCA2,CAT5,_RFPSA23,RESP046,"(42.46940091300047, -93.81649055599968)"
|
|
2020,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,681,71.7,68.5,75,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,EDUCA2,CAT5,_RFPSA23,RESP054,"(42.46940091300047, -93.81649055599968)"
|
|
2020,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,264,29.4,26,32.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,EDUCA3,CAT5,_RFPSA23,RESP046,"(42.46940091300047, -93.81649055599968)"
|
|
2020,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,524,70.6,67.1,74,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,EDUCA3,CAT5,_RFPSA23,RESP054,"(42.46940091300047, -93.81649055599968)"
|
|
2020,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,408,37.8,34.5,41.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,EDUCA4,CAT5,_RFPSA23,RESP046,"(42.46940091300047, -93.81649055599968)"
|
|
2020,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,598,62.2,58.9,65.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,EDUCA4,CAT5,_RFPSA23,RESP054,"(42.46940091300047, -93.81649055599968)"
|
|
2020,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,17,11.7,5.8,17.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,INCOME1,CAT6,_RFPSA23,RESP046,"(42.46940091300047, -93.81649055599968)"
|
|
2020,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,101,88.3,82.3,94.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,INCOME1,CAT6,_RFPSA23,RESP054,"(42.46940091300047, -93.81649055599968)"
|
|
2020,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,55,17.7,12.3,23.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,INCOME2,CAT6,_RFPSA23,RESP046,"(42.46940091300047, -93.81649055599968)"
|
|
2020,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,220,82.3,76.9,87.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,INCOME2,CAT6,_RFPSA23,RESP054,"(42.46940091300047, -93.81649055599968)"
|
|
2020,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,66,31,23.6,38.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,INCOME3,CAT6,_RFPSA23,RESP046,"(42.46940091300047, -93.81649055599968)"
|
|
2020,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,148,69,61.6,76.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,INCOME3,CAT6,_RFPSA23,RESP054,"(42.46940091300047, -93.81649055599968)"
|
|
2020,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,143,34,28.5,39.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,INCOME4,CAT6,_RFPSA23,RESP046,"(42.46940091300047, -93.81649055599968)"
|
|
2020,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,258,66,60.5,71.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,INCOME4,CAT6,_RFPSA23,RESP054,"(42.46940091300047, -93.81649055599968)"
|
|
2020,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,582,31.9,29.4,34.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,INCOME5,CAT6,_RFPSA23,RESP046,"(42.46940091300047, -93.81649055599968)"
|
|
2020,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,1033,68.1,65.6,70.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,INCOME5,CAT6,_RFPSA23,RESP054,"(42.46940091300047, -93.81649055599968)"
|
|
2020,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,939,31.4,29.4,33.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,RACE01,CAT4,_RFPSA23,RESP046,"(42.46940091300047, -93.81649055599968)"
|
|
2020,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1789,68.6,66.7,70.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,RACE01,CAT4,_RFPSA23,RESP054,"(42.46940091300047, -93.81649055599968)"
|
|
2020,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,13,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,19,RACE02,CAT4,_RFPSA23,RESP046,"(42.46940091300047, -93.81649055599968)"
|
|
2020,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,30,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,19,RACE02,CAT4,_RFPSA23,RESP054,"(42.46940091300047, -93.81649055599968)"
|
|
2020,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,19,RACE03,CAT4,_RFPSA23,RESP046,"(42.46940091300047, -93.81649055599968)"
|
|
2020,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,12,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,19,RACE03,CAT4,_RFPSA23,RESP054,"(42.46940091300047, -93.81649055599968)"
|
|
2020,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,19,RACE04,CAT4,_RFPSA23,RESP046,"(42.46940091300047, -93.81649055599968)"
|
|
2020,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,11,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,19,RACE04,CAT4,_RFPSA23,RESP054,"(42.46940091300047, -93.81649055599968)"
|
|
2020,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,19,RACE05,CAT4,_RFPSA23,RESP046,"(42.46940091300047, -93.81649055599968)"
|
|
2020,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,19,RACE05,CAT4,_RFPSA23,RESP054,"(42.46940091300047, -93.81649055599968)"
|
|
2020,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,19,RACE06,CAT4,_RFPSA23,RESP046,"(42.46940091300047, -93.81649055599968)"
|
|
2020,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,19,RACE06,CAT4,_RFPSA23,RESP054,"(42.46940091300047, -93.81649055599968)"
|
|
2020,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,19,RACE07,CAT4,_RFPSA23,RESP046,"(42.46940091300047, -93.81649055599968)"
|
|
2020,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,12,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,19,RACE07,CAT4,_RFPSA23,RESP054,"(42.46940091300047, -93.81649055599968)"
|
|
2020,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,19,RACE08,CAT4,_RFPSA23,RESP046,"(42.46940091300047, -93.81649055599968)"
|
|
2020,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,71,89.1,81.3,96.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,RACE08,CAT4,_RFPSA23,RESP054,"(42.46940091300047, -93.81649055599968)"
|
|
2020,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,968,30.3,28.4,32.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,SEX1,CAT2,_RFPSA23,RESP046,"(42.46940091300047, -93.81649055599968)"
|
|
2020,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1930,69.7,67.9,71.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,19,SEX1,CAT2,_RFPSA23,RESP054,"(42.46940091300047, -93.81649055599968)"
|
|
2020,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,19,SEX2,CAT2,_RFPSA23,RESP046,"(42.46940091300047, -93.81649055599968)"
|
|
2020,IA,Iowa,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,19,SEX2,CAT2,_RFPSA23,RESP054,"(42.46940091300047, -93.81649055599968)"
|
|
2020,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,51,7.8,5.3,10.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,AGE06,CAT3,_RFPSA23,RESP046,"(38.34774030000045, -98.20078122699965)"
|
|
2020,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,548,92.2,89.8,94.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,AGE06,CAT3,_RFPSA23,RESP054,"(38.34774030000045, -98.20078122699965)"
|
|
2020,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,196,24.8,21.2,28.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,AGE07,CAT3,_RFPSA23,RESP046,"(38.34774030000045, -98.20078122699965)"
|
|
2020,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,508,75.2,71.5,78.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,AGE07,CAT3,_RFPSA23,RESP054,"(38.34774030000045, -98.20078122699965)"
|
|
2020,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,196,43.9,38.5,49.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,AGE08,CAT3,_RFPSA23,RESP046,"(38.34774030000045, -98.20078122699965)"
|
|
2020,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,239,56.1,50.6,61.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,AGE08,CAT3,_RFPSA23,RESP054,"(38.34774030000045, -98.20078122699965)"
|
|
2020,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,764,52.9,49.7,56,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,AGE09,CAT3,_RFPSA23,RESP046,"(38.34774030000045, -98.20078122699965)"
|
|
2020,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,649,47.1,44,50.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,AGE09,CAT3,_RFPSA23,RESP054,"(38.34774030000045, -98.20078122699965)"
|
|
2020,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1207,32.5,30.6,34.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,BO1,CAT1,_RFPSA23,RESP046,"(38.34774030000045, -98.20078122699965)"
|
|
2020,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1944,67.5,65.6,69.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,BO1,CAT1,_RFPSA23,RESP054,"(38.34774030000045, -98.20078122699965)"
|
|
2020,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,17,14.4,7.2,21.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,EDUCA1,CAT5,_RFPSA23,RESP046,"(38.34774030000045, -98.20078122699965)"
|
|
2020,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,96,85.6,78.4,92.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,EDUCA1,CAT5,_RFPSA23,RESP054,"(38.34774030000045, -98.20078122699965)"
|
|
2020,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,249,27.1,23.6,30.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,EDUCA2,CAT5,_RFPSA23,RESP046,"(38.34774030000045, -98.20078122699965)"
|
|
2020,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,578,72.9,69.5,76.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,EDUCA2,CAT5,_RFPSA23,RESP054,"(38.34774030000045, -98.20078122699965)"
|
|
2020,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,323,33.6,30,37.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,EDUCA3,CAT5,_RFPSA23,RESP046,"(38.34774030000045, -98.20078122699965)"
|
|
2020,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,527,66.4,62.8,70,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,EDUCA3,CAT5,_RFPSA23,RESP054,"(38.34774030000045, -98.20078122699965)"
|
|
2020,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,616,41.6,38.6,44.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,EDUCA4,CAT5,_RFPSA23,RESP046,"(38.34774030000045, -98.20078122699965)"
|
|
2020,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,741,58.4,55.4,61.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,EDUCA4,CAT5,_RFPSA23,RESP054,"(38.34774030000045, -98.20078122699965)"
|
|
2020,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,22,12.3,6.4,18.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,INCOME1,CAT6,_RFPSA23,RESP046,"(38.34774030000045, -98.20078122699965)"
|
|
2020,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,101,87.7,81.8,93.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,INCOME1,CAT6,_RFPSA23,RESP054,"(38.34774030000045, -98.20078122699965)"
|
|
2020,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,91,25.4,19.3,31.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,INCOME2,CAT6,_RFPSA23,RESP046,"(38.34774030000045, -98.20078122699965)"
|
|
2020,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,209,74.6,68.4,80.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,INCOME2,CAT6,_RFPSA23,RESP054,"(38.34774030000045, -98.20078122699965)"
|
|
2020,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,82,28.3,21.2,35.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,INCOME3,CAT6,_RFPSA23,RESP046,"(38.34774030000045, -98.20078122699965)"
|
|
2020,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,153,71.7,64.5,78.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,INCOME3,CAT6,_RFPSA23,RESP054,"(38.34774030000045, -98.20078122699965)"
|
|
2020,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,156,36.9,31,42.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,INCOME4,CAT6,_RFPSA23,RESP046,"(38.34774030000045, -98.20078122699965)"
|
|
2020,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,223,63.1,57.2,69,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,INCOME4,CAT6,_RFPSA23,RESP054,"(38.34774030000045, -98.20078122699965)"
|
|
2020,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,707,34.2,31.6,36.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,INCOME5,CAT6,_RFPSA23,RESP046,"(38.34774030000045, -98.20078122699965)"
|
|
2020,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,1063,65.8,63.3,68.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,INCOME5,CAT6,_RFPSA23,RESP054,"(38.34774030000045, -98.20078122699965)"
|
|
2020,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1124,35,32.9,37,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,RACE01,CAT4,_RFPSA23,RESP046,"(38.34774030000045, -98.20078122699965)"
|
|
2020,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1720,65,63,67.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,RACE01,CAT4,_RFPSA23,RESP054,"(38.34774030000045, -98.20078122699965)"
|
|
2020,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,37,26.9,18.2,35.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,RACE02,CAT4,_RFPSA23,RESP046,"(38.34774030000045, -98.20078122699965)"
|
|
2020,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,69,73.1,64.4,81.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,RACE02,CAT4,_RFPSA23,RESP054,"(38.34774030000045, -98.20078122699965)"
|
|
2020,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,20,RACE03,CAT4,_RFPSA23,RESP046,"(38.34774030000045, -98.20078122699965)"
|
|
2020,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,21,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,20,RACE03,CAT4,_RFPSA23,RESP054,"(38.34774030000045, -98.20078122699965)"
|
|
2020,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,20,RACE04,CAT4,_RFPSA23,RESP046,"(38.34774030000045, -98.20078122699965)"
|
|
2020,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,13,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,20,RACE04,CAT4,_RFPSA23,RESP054,"(38.34774030000045, -98.20078122699965)"
|
|
2020,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,20,RACE05,CAT4,_RFPSA23,RESP046,"(38.34774030000045, -98.20078122699965)"
|
|
2020,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,20,RACE05,CAT4,_RFPSA23,RESP054,"(38.34774030000045, -98.20078122699965)"
|
|
2020,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,20,RACE06,CAT4,_RFPSA23,RESP046,"(38.34774030000045, -98.20078122699965)"
|
|
2020,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,15,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,20,RACE06,CAT4,_RFPSA23,RESP054,"(38.34774030000045, -98.20078122699965)"
|
|
2020,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,18,33.9,19,48.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,RACE07,CAT4,_RFPSA23,RESP046,"(38.34774030000045, -98.20078122699965)"
|
|
2020,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,34,66.1,51.1,81,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,RACE07,CAT4,_RFPSA23,RESP054,"(38.34774030000045, -98.20078122699965)"
|
|
2020,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,14,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,20,RACE08,CAT4,_RFPSA23,RESP046,"(38.34774030000045, -98.20078122699965)"
|
|
2020,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,69,88.2,81.1,95.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,RACE08,CAT4,_RFPSA23,RESP054,"(38.34774030000045, -98.20078122699965)"
|
|
2020,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1207,32.5,30.6,34.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,SEX1,CAT2,_RFPSA23,RESP046,"(38.34774030000045, -98.20078122699965)"
|
|
2020,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1944,67.5,65.6,69.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,20,SEX1,CAT2,_RFPSA23,RESP054,"(38.34774030000045, -98.20078122699965)"
|
|
2020,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,20,SEX2,CAT2,_RFPSA23,RESP046,"(38.34774030000045, -98.20078122699965)"
|
|
2020,KS,Kansas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,20,SEX2,CAT2,_RFPSA23,RESP054,"(38.34774030000045, -98.20078122699965)"
|
|
2020,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,16,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,21,AGE06,CAT3,_RFPSA23,RESP046,"(37.645970271000465, -84.77497104799966)"
|
|
2020,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,201,93.4,89.3,97.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,AGE06,CAT3,_RFPSA23,RESP054,"(37.645970271000465, -84.77497104799966)"
|
|
2020,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,82,30,23.8,36.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,AGE07,CAT3,_RFPSA23,RESP046,"(37.645970271000465, -84.77497104799966)"
|
|
2020,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,227,70,63.7,76.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,AGE07,CAT3,_RFPSA23,RESP054,"(37.645970271000465, -84.77497104799966)"
|
|
2020,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,68,42.9,33.6,52.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,AGE08,CAT3,_RFPSA23,RESP046,"(37.645970271000465, -84.77497104799966)"
|
|
2020,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,85,57.1,47.8,66.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,AGE08,CAT3,_RFPSA23,RESP054,"(37.645970271000465, -84.77497104799966)"
|
|
2020,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,223,49.1,43.2,55.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,AGE09,CAT3,_RFPSA23,RESP046,"(37.645970271000465, -84.77497104799966)"
|
|
2020,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,232,50.9,44.9,56.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,AGE09,CAT3,_RFPSA23,RESP054,"(37.645970271000465, -84.77497104799966)"
|
|
2020,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,389,32.2,28.9,35.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,BO1,CAT1,_RFPSA23,RESP046,"(37.645970271000465, -84.77497104799966)"
|
|
2020,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,745,67.8,64.5,71.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,BO1,CAT1,_RFPSA23,RESP054,"(37.645970271000465, -84.77497104799966)"
|
|
2020,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,28,20,11.6,28.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,EDUCA1,CAT5,_RFPSA23,RESP046,"(37.645970271000465, -84.77497104799966)"
|
|
2020,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,94,80,71.6,88.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,EDUCA1,CAT5,_RFPSA23,RESP054,"(37.645970271000465, -84.77497104799966)"
|
|
2020,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,107,30.4,24.6,36.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,EDUCA2,CAT5,_RFPSA23,RESP046,"(37.645970271000465, -84.77497104799966)"
|
|
2020,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,250,69.6,63.8,75.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,EDUCA2,CAT5,_RFPSA23,RESP054,"(37.645970271000465, -84.77497104799966)"
|
|
2020,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,116,36.8,30.2,43.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,EDUCA3,CAT5,_RFPSA23,RESP046,"(37.645970271000465, -84.77497104799966)"
|
|
2020,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,192,63.2,56.7,69.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,EDUCA3,CAT5,_RFPSA23,RESP054,"(37.645970271000465, -84.77497104799966)"
|
|
2020,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,138,38.2,32,44.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,EDUCA4,CAT5,_RFPSA23,RESP046,"(37.645970271000465, -84.77497104799966)"
|
|
2020,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,207,61.8,55.5,68,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,EDUCA4,CAT5,_RFPSA23,RESP054,"(37.645970271000465, -84.77497104799966)"
|
|
2020,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,17,13.9,6.1,21.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,INCOME1,CAT6,_RFPSA23,RESP046,"(37.645970271000465, -84.77497104799966)"
|
|
2020,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,73,86.1,78.3,93.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,INCOME1,CAT6,_RFPSA23,RESP054,"(37.645970271000465, -84.77497104799966)"
|
|
2020,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,37,22,14.1,29.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,INCOME2,CAT6,_RFPSA23,RESP046,"(37.645970271000465, -84.77497104799966)"
|
|
2020,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,117,78,70.1,85.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,INCOME2,CAT6,_RFPSA23,RESP054,"(37.645970271000465, -84.77497104799966)"
|
|
2020,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,34,34,22.8,45.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,INCOME3,CAT6,_RFPSA23,RESP046,"(37.645970271000465, -84.77497104799966)"
|
|
2020,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,69,66,54.9,77.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,INCOME3,CAT6,_RFPSA23,RESP054,"(37.645970271000465, -84.77497104799966)"
|
|
2020,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,45,31.4,21.8,41,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,INCOME4,CAT6,_RFPSA23,RESP046,"(37.645970271000465, -84.77497104799966)"
|
|
2020,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,82,68.6,59,78.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,INCOME4,CAT6,_RFPSA23,RESP054,"(37.645970271000465, -84.77497104799966)"
|
|
2020,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,196,39.2,34.1,44.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,INCOME5,CAT6,_RFPSA23,RESP046,"(37.645970271000465, -84.77497104799966)"
|
|
2020,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,298,60.8,55.7,65.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,INCOME5,CAT6,_RFPSA23,RESP054,"(37.645970271000465, -84.77497104799966)"
|
|
2020,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,357,33.4,29.9,36.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,RACE01,CAT4,_RFPSA23,RESP046,"(37.645970271000465, -84.77497104799966)"
|
|
2020,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,667,66.6,63.1,70.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,RACE01,CAT4,_RFPSA23,RESP054,"(37.645970271000465, -84.77497104799966)"
|
|
2020,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,16,19.4,8.1,30.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,RACE02,CAT4,_RFPSA23,RESP046,"(37.645970271000465, -84.77497104799966)"
|
|
2020,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,40,80.6,69.3,91.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,RACE02,CAT4,_RFPSA23,RESP054,"(37.645970271000465, -84.77497104799966)"
|
|
2020,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,21,RACE03,CAT4,_RFPSA23,RESP046,"(37.645970271000465, -84.77497104799966)"
|
|
2020,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,21,RACE03,CAT4,_RFPSA23,RESP054,"(37.645970271000465, -84.77497104799966)"
|
|
2020,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,21,RACE04,CAT4,_RFPSA23,RESP046,"(37.645970271000465, -84.77497104799966)"
|
|
2020,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,21,RACE04,CAT4,_RFPSA23,RESP054,"(37.645970271000465, -84.77497104799966)"
|
|
2020,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,21,RACE05,CAT4,_RFPSA23,RESP046,"(37.645970271000465, -84.77497104799966)"
|
|
2020,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,21,RACE05,CAT4,_RFPSA23,RESP054,"(37.645970271000465, -84.77497104799966)"
|
|
2020,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,21,RACE06,CAT4,_RFPSA23,RESP046,"(37.645970271000465, -84.77497104799966)"
|
|
2020,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,21,RACE06,CAT4,_RFPSA23,RESP054,"(37.645970271000465, -84.77497104799966)"
|
|
2020,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,21,RACE07,CAT4,_RFPSA23,RESP046,"(37.645970271000465, -84.77497104799966)"
|
|
2020,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,11,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,21,RACE07,CAT4,_RFPSA23,RESP054,"(37.645970271000465, -84.77497104799966)"
|
|
2020,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,21,RACE08,CAT4,_RFPSA23,RESP046,"(37.645970271000465, -84.77497104799966)"
|
|
2020,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,21,RACE08,CAT4,_RFPSA23,RESP054,"(37.645970271000465, -84.77497104799966)"
|
|
2020,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,389,32.2,28.9,35.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,SEX1,CAT2,_RFPSA23,RESP046,"(37.645970271000465, -84.77497104799966)"
|
|
2020,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,745,67.8,64.5,71.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,21,SEX1,CAT2,_RFPSA23,RESP054,"(37.645970271000465, -84.77497104799966)"
|
|
2020,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,21,SEX2,CAT2,_RFPSA23,RESP046,"(37.645970271000465, -84.77497104799966)"
|
|
2020,KY,Kentucky,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,21,SEX2,CAT2,_RFPSA23,RESP054,"(37.645970271000465, -84.77497104799966)"
|
|
2020,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,26,6.9,3.8,10,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,AGE06,CAT3,_RFPSA23,RESP046,"(31.31266064400046, -92.44568007099969)"
|
|
2020,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,232,93.1,90,96.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,AGE06,CAT3,_RFPSA23,RESP054,"(31.31266064400046, -92.44568007099969)"
|
|
2020,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,104,29.8,24,35.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,AGE07,CAT3,_RFPSA23,RESP046,"(31.31266064400046, -92.44568007099969)"
|
|
2020,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,219,70.2,64.4,76,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,AGE07,CAT3,_RFPSA23,RESP054,"(31.31266064400046, -92.44568007099969)"
|
|
2020,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,101,44.3,36,52.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,AGE08,CAT3,_RFPSA23,RESP046,"(31.31266064400046, -92.44568007099969)"
|
|
2020,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,125,55.7,47.4,64,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,AGE08,CAT3,_RFPSA23,RESP054,"(31.31266064400046, -92.44568007099969)"
|
|
2020,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,332,51.4,46.2,56.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,AGE09,CAT3,_RFPSA23,RESP046,"(31.31266064400046, -92.44568007099969)"
|
|
2020,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,237,48.6,43.4,53.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,AGE09,CAT3,_RFPSA23,RESP054,"(31.31266064400046, -92.44568007099969)"
|
|
2020,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,563,33.2,30.2,36.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,BO1,CAT1,_RFPSA23,RESP046,"(31.31266064400046, -92.44568007099969)"
|
|
2020,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,813,66.8,63.7,69.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,BO1,CAT1,_RFPSA23,RESP054,"(31.31266064400046, -92.44568007099969)"
|
|
2020,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,23,18.2,10.1,26.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,EDUCA1,CAT5,_RFPSA23,RESP046,"(31.31266064400046, -92.44568007099969)"
|
|
2020,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,105,81.8,73.7,89.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,EDUCA1,CAT5,_RFPSA23,RESP054,"(31.31266064400046, -92.44568007099969)"
|
|
2020,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,131,29,24,34.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,EDUCA2,CAT5,_RFPSA23,RESP046,"(31.31266064400046, -92.44568007099969)"
|
|
2020,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,270,71,65.9,76,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,EDUCA2,CAT5,_RFPSA23,RESP054,"(31.31266064400046, -92.44568007099969)"
|
|
2020,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,143,37,30.7,43.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,EDUCA3,CAT5,_RFPSA23,RESP046,"(31.31266064400046, -92.44568007099969)"
|
|
2020,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,194,63,56.6,69.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,EDUCA3,CAT5,_RFPSA23,RESP054,"(31.31266064400046, -92.44568007099969)"
|
|
2020,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,264,47.2,41.9,52.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,EDUCA4,CAT5,_RFPSA23,RESP046,"(31.31266064400046, -92.44568007099969)"
|
|
2020,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,242,52.8,47.5,58.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,EDUCA4,CAT5,_RFPSA23,RESP054,"(31.31266064400046, -92.44568007099969)"
|
|
2020,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,18,14,6.9,21.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,INCOME1,CAT6,_RFPSA23,RESP046,"(31.31266064400046, -92.44568007099969)"
|
|
2020,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,81,86,78.9,93.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,INCOME1,CAT6,_RFPSA23,RESP054,"(31.31266064400046, -92.44568007099969)"
|
|
2020,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,39,22.3,14.2,30.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,INCOME2,CAT6,_RFPSA23,RESP046,"(31.31266064400046, -92.44568007099969)"
|
|
2020,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,109,77.7,69.5,85.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,INCOME2,CAT6,_RFPSA23,RESP054,"(31.31266064400046, -92.44568007099969)"
|
|
2020,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,33,28.3,17.6,38.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,INCOME3,CAT6,_RFPSA23,RESP046,"(31.31266064400046, -92.44568007099969)"
|
|
2020,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,61,71.7,61.1,82.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,INCOME3,CAT6,_RFPSA23,RESP054,"(31.31266064400046, -92.44568007099969)"
|
|
2020,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,66,34.4,24.8,43.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,INCOME4,CAT6,_RFPSA23,RESP046,"(31.31266064400046, -92.44568007099969)"
|
|
2020,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,78,65.6,56.1,75.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,INCOME4,CAT6,_RFPSA23,RESP054,"(31.31266064400046, -92.44568007099969)"
|
|
2020,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,316,38,33.5,42.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,INCOME5,CAT6,_RFPSA23,RESP046,"(31.31266064400046, -92.44568007099969)"
|
|
2020,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,373,62,57.6,66.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,INCOME5,CAT6,_RFPSA23,RESP054,"(31.31266064400046, -92.44568007099969)"
|
|
2020,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,447,36.5,33,40.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,RACE01,CAT4,_RFPSA23,RESP046,"(31.31266064400046, -92.44568007099969)"
|
|
2020,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,581,63.5,59.9,67,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,RACE01,CAT4,_RFPSA23,RESP054,"(31.31266064400046, -92.44568007099969)"
|
|
2020,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,87,29.9,23.3,36.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,RACE02,CAT4,_RFPSA23,RESP046,"(31.31266064400046, -92.44568007099969)"
|
|
2020,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,159,70.1,63.6,76.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,RACE02,CAT4,_RFPSA23,RESP054,"(31.31266064400046, -92.44568007099969)"
|
|
2020,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,22,RACE03,CAT4,_RFPSA23,RESP046,"(31.31266064400046, -92.44568007099969)"
|
|
2020,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,14,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,22,RACE03,CAT4,_RFPSA23,RESP054,"(31.31266064400046, -92.44568007099969)"
|
|
2020,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,22,RACE04,CAT4,_RFPSA23,RESP046,"(31.31266064400046, -92.44568007099969)"
|
|
2020,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,22,RACE04,CAT4,_RFPSA23,RESP054,"(31.31266064400046, -92.44568007099969)"
|
|
2020,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,22,RACE05,CAT4,_RFPSA23,RESP046,"(31.31266064400046, -92.44568007099969)"
|
|
2020,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,22,RACE05,CAT4,_RFPSA23,RESP054,"(31.31266064400046, -92.44568007099969)"
|
|
2020,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,22,RACE06,CAT4,_RFPSA23,RESP046,"(31.31266064400046, -92.44568007099969)"
|
|
2020,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,11,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,22,RACE06,CAT4,_RFPSA23,RESP054,"(31.31266064400046, -92.44568007099969)"
|
|
2020,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,22,RACE07,CAT4,_RFPSA23,RESP046,"(31.31266064400046, -92.44568007099969)"
|
|
2020,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,12,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,22,RACE07,CAT4,_RFPSA23,RESP054,"(31.31266064400046, -92.44568007099969)"
|
|
2020,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,22,RACE08,CAT4,_RFPSA23,RESP046,"(31.31266064400046, -92.44568007099969)"
|
|
2020,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,30,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,22,RACE08,CAT4,_RFPSA23,RESP054,"(31.31266064400046, -92.44568007099969)"
|
|
2020,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,563,33.2,30.2,36.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,SEX1,CAT2,_RFPSA23,RESP046,"(31.31266064400046, -92.44568007099969)"
|
|
2020,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,813,66.8,63.7,69.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,22,SEX1,CAT2,_RFPSA23,RESP054,"(31.31266064400046, -92.44568007099969)"
|
|
2020,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,22,SEX2,CAT2,_RFPSA23,RESP046,"(31.31266064400046, -92.44568007099969)"
|
|
2020,LA,Louisiana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,22,SEX2,CAT2,_RFPSA23,RESP054,"(31.31266064400046, -92.44568007099969)"
|
|
2020,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,24,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,23,AGE06,CAT3,_RFPSA23,RESP046,"(45.254228894000505, -68.98503133599962)"
|
|
2020,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,400,95.4,91.7,99.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,AGE06,CAT3,_RFPSA23,RESP054,"(45.254228894000505, -68.98503133599962)"
|
|
2020,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,123,21.5,17,26.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,AGE07,CAT3,_RFPSA23,RESP046,"(45.254228894000505, -68.98503133599962)"
|
|
2020,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,496,78.5,73.9,83,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,AGE07,CAT3,_RFPSA23,RESP054,"(45.254228894000505, -68.98503133599962)"
|
|
2020,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,152,33.1,26.9,39.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,AGE08,CAT3,_RFPSA23,RESP046,"(45.254228894000505, -68.98503133599962)"
|
|
2020,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,283,66.9,60.7,73.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,AGE08,CAT3,_RFPSA23,RESP054,"(45.254228894000505, -68.98503133599962)"
|
|
2020,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,715,40,36.7,43.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,AGE09,CAT3,_RFPSA23,RESP046,"(45.254228894000505, -68.98503133599962)"
|
|
2020,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,962,60,56.6,63.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,AGE09,CAT3,_RFPSA23,RESP054,"(45.254228894000505, -68.98503133599962)"
|
|
2020,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1014,26.8,24.6,29,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,BO1,CAT1,_RFPSA23,RESP046,"(45.254228894000505, -68.98503133599962)"
|
|
2020,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,2141,73.2,71,75.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,BO1,CAT1,_RFPSA23,RESP054,"(45.254228894000505, -68.98503133599962)"
|
|
2020,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,17,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,23,EDUCA1,CAT5,_RFPSA23,RESP046,"(45.254228894000505, -68.98503133599962)"
|
|
2020,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,120,88.1,79.4,96.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,EDUCA1,CAT5,_RFPSA23,RESP054,"(45.254228894000505, -68.98503133599962)"
|
|
2020,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,228,22,18.3,25.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,EDUCA2,CAT5,_RFPSA23,RESP046,"(45.254228894000505, -68.98503133599962)"
|
|
2020,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,653,78,74.3,81.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,EDUCA2,CAT5,_RFPSA23,RESP054,"(45.254228894000505, -68.98503133599962)"
|
|
2020,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,247,29.2,24.8,33.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,EDUCA3,CAT5,_RFPSA23,RESP046,"(45.254228894000505, -68.98503133599962)"
|
|
2020,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,557,70.8,66.3,75.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,EDUCA3,CAT5,_RFPSA23,RESP054,"(45.254228894000505, -68.98503133599962)"
|
|
2020,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,521,34.4,30.8,37.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,EDUCA4,CAT5,_RFPSA23,RESP046,"(45.254228894000505, -68.98503133599962)"
|
|
2020,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,803,65.6,62.1,69.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,EDUCA4,CAT5,_RFPSA23,RESP054,"(45.254228894000505, -68.98503133599962)"
|
|
2020,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,36,18,10,26.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,INCOME1,CAT6,_RFPSA23,RESP046,"(45.254228894000505, -68.98503133599962)"
|
|
2020,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,115,82,73.9,90,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,INCOME1,CAT6,_RFPSA23,RESP054,"(45.254228894000505, -68.98503133599962)"
|
|
2020,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,87,20.6,14.7,26.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,INCOME2,CAT6,_RFPSA23,RESP046,"(45.254228894000505, -68.98503133599962)"
|
|
2020,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,276,79.4,73.4,85.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,INCOME2,CAT6,_RFPSA23,RESP054,"(45.254228894000505, -68.98503133599962)"
|
|
2020,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,88,31,21.7,40.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,INCOME3,CAT6,_RFPSA23,RESP046,"(45.254228894000505, -68.98503133599962)"
|
|
2020,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,184,69,59.6,78.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,INCOME3,CAT6,_RFPSA23,RESP054,"(45.254228894000505, -68.98503133599962)"
|
|
2020,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,104,21.1,15.8,26.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,INCOME4,CAT6,_RFPSA23,RESP046,"(45.254228894000505, -68.98503133599962)"
|
|
2020,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,254,78.9,73.6,84.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,INCOME4,CAT6,_RFPSA23,RESP054,"(45.254228894000505, -68.98503133599962)"
|
|
2020,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,480,30.2,26.8,33.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,INCOME5,CAT6,_RFPSA23,RESP046,"(45.254228894000505, -68.98503133599962)"
|
|
2020,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,844,69.8,66.4,73.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,INCOME5,CAT6,_RFPSA23,RESP054,"(45.254228894000505, -68.98503133599962)"
|
|
2020,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,975,27.2,24.9,29.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,RACE01,CAT4,_RFPSA23,RESP046,"(45.254228894000505, -68.98503133599962)"
|
|
2020,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,2043,72.8,70.6,75.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,RACE01,CAT4,_RFPSA23,RESP054,"(45.254228894000505, -68.98503133599962)"
|
|
2020,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,23,RACE02,CAT4,_RFPSA23,RESP046,"(45.254228894000505, -68.98503133599962)"
|
|
2020,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,23,RACE02,CAT4,_RFPSA23,RESP054,"(45.254228894000505, -68.98503133599962)"
|
|
2020,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,23,RACE03,CAT4,_RFPSA23,RESP046,"(45.254228894000505, -68.98503133599962)"
|
|
2020,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,18,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,23,RACE03,CAT4,_RFPSA23,RESP054,"(45.254228894000505, -68.98503133599962)"
|
|
2020,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,23,RACE04,CAT4,_RFPSA23,RESP046,"(45.254228894000505, -68.98503133599962)"
|
|
2020,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,23,RACE04,CAT4,_RFPSA23,RESP054,"(45.254228894000505, -68.98503133599962)"
|
|
2020,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,23,RACE05,CAT4,_RFPSA23,RESP046,"(45.254228894000505, -68.98503133599962)"
|
|
2020,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,23,RACE05,CAT4,_RFPSA23,RESP054,"(45.254228894000505, -68.98503133599962)"
|
|
2020,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,13,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,23,RACE06,CAT4,_RFPSA23,RESP046,"(45.254228894000505, -68.98503133599962)"
|
|
2020,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,14,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,23,RACE06,CAT4,_RFPSA23,RESP054,"(45.254228894000505, -68.98503133599962)"
|
|
2020,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,9,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,23,RACE07,CAT4,_RFPSA23,RESP046,"(45.254228894000505, -68.98503133599962)"
|
|
2020,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,19,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,23,RACE07,CAT4,_RFPSA23,RESP054,"(45.254228894000505, -68.98503133599962)"
|
|
2020,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,23,RACE08,CAT4,_RFPSA23,RESP046,"(45.254228894000505, -68.98503133599962)"
|
|
2020,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,35,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,23,RACE08,CAT4,_RFPSA23,RESP054,"(45.254228894000505, -68.98503133599962)"
|
|
2020,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1014,26.8,24.6,29,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,SEX1,CAT2,_RFPSA23,RESP046,"(45.254228894000505, -68.98503133599962)"
|
|
2020,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,2141,73.2,71,75.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,23,SEX1,CAT2,_RFPSA23,RESP054,"(45.254228894000505, -68.98503133599962)"
|
|
2020,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,23,SEX2,CAT2,_RFPSA23,RESP046,"(45.254228894000505, -68.98503133599962)"
|
|
2020,ME,Maine,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,23,SEX2,CAT2,_RFPSA23,RESP054,"(45.254228894000505, -68.98503133599962)"
|
|
2020,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,30,4.7,2.7,6.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,AGE06,CAT3,_RFPSA23,RESP046,"(39.29058096400047, -76.60926011099963)"
|
|
2020,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,590,95.3,93.3,97.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,AGE06,CAT3,_RFPSA23,RESP054,"(39.29058096400047, -76.60926011099963)"
|
|
2020,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,261,27,23.2,30.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,AGE07,CAT3,_RFPSA23,RESP046,"(39.29058096400047, -76.60926011099963)"
|
|
2020,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,741,73,69.2,76.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,AGE07,CAT3,_RFPSA23,RESP054,"(39.29058096400047, -76.60926011099963)"
|
|
2020,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,252,44.1,38.5,49.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,AGE08,CAT3,_RFPSA23,RESP046,"(39.29058096400047, -76.60926011099963)"
|
|
2020,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,326,55.9,50.4,61.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,AGE08,CAT3,_RFPSA23,RESP054,"(39.29058096400047, -76.60926011099963)"
|
|
2020,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,864,52.4,49,55.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,AGE09,CAT3,_RFPSA23,RESP046,"(39.29058096400047, -76.60926011099963)"
|
|
2020,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,815,47.6,44.2,51,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,AGE09,CAT3,_RFPSA23,RESP054,"(39.29058096400047, -76.60926011099963)"
|
|
2020,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1407,32.2,30.2,34.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,BO1,CAT1,_RFPSA23,RESP046,"(39.29058096400047, -76.60926011099963)"
|
|
2020,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,2472,67.8,65.8,69.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,BO1,CAT1,_RFPSA23,RESP054,"(39.29058096400047, -76.60926011099963)"
|
|
2020,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,36,22.9,14.3,31.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,EDUCA1,CAT5,_RFPSA23,RESP046,"(39.29058096400047, -76.60926011099963)"
|
|
2020,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,196,77.1,68.4,85.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,EDUCA1,CAT5,_RFPSA23,RESP054,"(39.29058096400047, -76.60926011099963)"
|
|
2020,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,284,25.4,21.7,29.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,EDUCA2,CAT5,_RFPSA23,RESP046,"(39.29058096400047, -76.60926011099963)"
|
|
2020,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,719,74.6,70.8,78.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,EDUCA2,CAT5,_RFPSA23,RESP054,"(39.29058096400047, -76.60926011099963)"
|
|
2020,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,264,31.9,27.5,36.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,EDUCA3,CAT5,_RFPSA23,RESP046,"(39.29058096400047, -76.60926011099963)"
|
|
2020,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,495,68.1,63.7,72.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,EDUCA3,CAT5,_RFPSA23,RESP054,"(39.29058096400047, -76.60926011099963)"
|
|
2020,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,819,38.6,35.7,41.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,EDUCA4,CAT5,_RFPSA23,RESP046,"(39.29058096400047, -76.60926011099963)"
|
|
2020,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,1054,61.4,58.5,64.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,EDUCA4,CAT5,_RFPSA23,RESP054,"(39.29058096400047, -76.60926011099963)"
|
|
2020,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,34,15.4,8.2,22.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,INCOME1,CAT6,_RFPSA23,RESP046,"(39.29058096400047, -76.60926011099963)"
|
|
2020,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,168,84.6,77.5,91.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,INCOME1,CAT6,_RFPSA23,RESP054,"(39.29058096400047, -76.60926011099963)"
|
|
2020,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,56,16.9,10.5,23.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,INCOME2,CAT6,_RFPSA23,RESP046,"(39.29058096400047, -76.60926011099963)"
|
|
2020,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,231,83.1,76.7,89.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,INCOME2,CAT6,_RFPSA23,RESP054,"(39.29058096400047, -76.60926011099963)"
|
|
2020,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,69,27,19.1,34.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,INCOME3,CAT6,_RFPSA23,RESP046,"(39.29058096400047, -76.60926011099963)"
|
|
2020,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,168,73,65.2,80.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,INCOME3,CAT6,_RFPSA23,RESP054,"(39.29058096400047, -76.60926011099963)"
|
|
2020,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,106,28.7,22.1,35.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,INCOME4,CAT6,_RFPSA23,RESP046,"(39.29058096400047, -76.60926011099963)"
|
|
2020,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,213,71.3,64.8,77.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,INCOME4,CAT6,_RFPSA23,RESP054,"(39.29058096400047, -76.60926011099963)"
|
|
2020,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,923,34.5,31.9,37.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,INCOME5,CAT6,_RFPSA23,RESP046,"(39.29058096400047, -76.60926011099963)"
|
|
2020,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,1396,65.5,62.9,68.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,INCOME5,CAT6,_RFPSA23,RESP054,"(39.29058096400047, -76.60926011099963)"
|
|
2020,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1104,35.8,33.5,38.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,RACE01,CAT4,_RFPSA23,RESP046,"(39.29058096400047, -76.60926011099963)"
|
|
2020,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1730,64.2,61.9,66.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,RACE01,CAT4,_RFPSA23,RESP054,"(39.29058096400047, -76.60926011099963)"
|
|
2020,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,222,31.4,26.9,35.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,RACE02,CAT4,_RFPSA23,RESP046,"(39.29058096400047, -76.60926011099963)"
|
|
2020,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,447,68.6,64.2,73.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,RACE02,CAT4,_RFPSA23,RESP054,"(39.29058096400047, -76.60926011099963)"
|
|
2020,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,24,RACE03,CAT4,_RFPSA23,RESP046,"(39.29058096400047, -76.60926011099963)"
|
|
2020,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,14,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,24,RACE03,CAT4,_RFPSA23,RESP054,"(39.29058096400047, -76.60926011099963)"
|
|
2020,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,23,24.7,13.1,36.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,RACE04,CAT4,_RFPSA23,RESP046,"(39.29058096400047, -76.60926011099963)"
|
|
2020,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,70,75.3,63.7,86.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,RACE04,CAT4,_RFPSA23,RESP054,"(39.29058096400047, -76.60926011099963)"
|
|
2020,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,24,RACE05,CAT4,_RFPSA23,RESP046,"(39.29058096400047, -76.60926011099963)"
|
|
2020,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,24,RACE05,CAT4,_RFPSA23,RESP054,"(39.29058096400047, -76.60926011099963)"
|
|
2020,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,23,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,24,RACE06,CAT4,_RFPSA23,RESP046,"(39.29058096400047, -76.60926011099963)"
|
|
2020,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,22,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,24,RACE06,CAT4,_RFPSA23,RESP054,"(39.29058096400047, -76.60926011099963)"
|
|
2020,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,24,RACE07,CAT4,_RFPSA23,RESP046,"(39.29058096400047, -76.60926011099963)"
|
|
2020,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,47,82.6,66.5,98.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,RACE07,CAT4,_RFPSA23,RESP054,"(39.29058096400047, -76.60926011099963)"
|
|
2020,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,24,16.5,9.3,23.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,RACE08,CAT4,_RFPSA23,RESP046,"(39.29058096400047, -76.60926011099963)"
|
|
2020,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,139,83.5,76.2,90.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,RACE08,CAT4,_RFPSA23,RESP054,"(39.29058096400047, -76.60926011099963)"
|
|
2020,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1407,32.2,30.2,34.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,SEX1,CAT2,_RFPSA23,RESP046,"(39.29058096400047, -76.60926011099963)"
|
|
2020,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,2472,67.8,65.8,69.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,24,SEX1,CAT2,_RFPSA23,RESP054,"(39.29058096400047, -76.60926011099963)"
|
|
2020,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,24,SEX2,CAT2,_RFPSA23,RESP046,"(39.29058096400047, -76.60926011099963)"
|
|
2020,MD,Maryland,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,24,SEX2,CAT2,_RFPSA23,RESP054,"(39.29058096400047, -76.60926011099963)"
|
|
2020,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,22,6.2,3.1,9.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,AGE06,CAT3,_RFPSA23,RESP046,"(42.27687047000046, -72.08269067499964)"
|
|
2020,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,300,93.8,90.7,96.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,AGE06,CAT3,_RFPSA23,RESP054,"(42.27687047000046, -72.08269067499964)"
|
|
2020,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,142,27,22.2,31.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,AGE07,CAT3,_RFPSA23,RESP046,"(42.27687047000046, -72.08269067499964)"
|
|
2020,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,329,73,68.2,77.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,AGE07,CAT3,_RFPSA23,RESP054,"(42.27687047000046, -72.08269067499964)"
|
|
2020,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,117,45.9,37.3,54.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,AGE08,CAT3,_RFPSA23,RESP046,"(42.27687047000046, -72.08269067499964)"
|
|
2020,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,166,54.1,45.5,62.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,AGE08,CAT3,_RFPSA23,RESP054,"(42.27687047000046, -72.08269067499964)"
|
|
2020,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,415,50.8,45.9,55.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,AGE09,CAT3,_RFPSA23,RESP046,"(42.27687047000046, -72.08269067499964)"
|
|
2020,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,338,49.2,44.3,54.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,AGE09,CAT3,_RFPSA23,RESP054,"(42.27687047000046, -72.08269067499964)"
|
|
2020,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,696,32.5,29.7,35.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,BO1,CAT1,_RFPSA23,RESP046,"(42.27687047000046, -72.08269067499964)"
|
|
2020,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1133,67.5,64.7,70.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,BO1,CAT1,_RFPSA23,RESP054,"(42.27687047000046, -72.08269067499964)"
|
|
2020,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,17,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,25,EDUCA1,CAT5,_RFPSA23,RESP046,"(42.27687047000046, -72.08269067499964)"
|
|
2020,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,64,78.2,65.3,91.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,EDUCA1,CAT5,_RFPSA23,RESP054,"(42.27687047000046, -72.08269067499964)"
|
|
2020,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,102,26.5,20.8,32.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,EDUCA2,CAT5,_RFPSA23,RESP046,"(42.27687047000046, -72.08269067499964)"
|
|
2020,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,251,73.5,67.9,79.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,EDUCA2,CAT5,_RFPSA23,RESP054,"(42.27687047000046, -72.08269067499964)"
|
|
2020,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,161,37.5,31.7,43.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,EDUCA3,CAT5,_RFPSA23,RESP046,"(42.27687047000046, -72.08269067499964)"
|
|
2020,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,243,62.5,56.7,68.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,EDUCA3,CAT5,_RFPSA23,RESP054,"(42.27687047000046, -72.08269067499964)"
|
|
2020,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,415,36.8,33.1,40.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,EDUCA4,CAT5,_RFPSA23,RESP046,"(42.27687047000046, -72.08269067499964)"
|
|
2020,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,570,63.2,59.6,66.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,EDUCA4,CAT5,_RFPSA23,RESP054,"(42.27687047000046, -72.08269067499964)"
|
|
2020,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,9,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,25,INCOME1,CAT6,_RFPSA23,RESP046,"(42.27687047000046, -72.08269067499964)"
|
|
2020,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,36,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,25,INCOME1,CAT6,_RFPSA23,RESP054,"(42.27687047000046, -72.08269067499964)"
|
|
2020,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,35,22.4,13.2,31.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,INCOME2,CAT6,_RFPSA23,RESP046,"(42.27687047000046, -72.08269067499964)"
|
|
2020,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,97,77.6,68.4,86.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,INCOME2,CAT6,_RFPSA23,RESP054,"(42.27687047000046, -72.08269067499964)"
|
|
2020,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,34,34.8,22.5,47.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,INCOME3,CAT6,_RFPSA23,RESP046,"(42.27687047000046, -72.08269067499964)"
|
|
2020,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,55,65.2,52.8,77.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,INCOME3,CAT6,_RFPSA23,RESP054,"(42.27687047000046, -72.08269067499964)"
|
|
2020,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,49,28.6,18.7,38.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,INCOME4,CAT6,_RFPSA23,RESP046,"(42.27687047000046, -72.08269067499964)"
|
|
2020,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,89,71.4,61.6,81.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,INCOME4,CAT6,_RFPSA23,RESP054,"(42.27687047000046, -72.08269067499964)"
|
|
2020,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,442,34.5,30.8,38.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,INCOME5,CAT6,_RFPSA23,RESP046,"(42.27687047000046, -72.08269067499964)"
|
|
2020,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,664,65.5,61.7,69.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,INCOME5,CAT6,_RFPSA23,RESP054,"(42.27687047000046, -72.08269067499964)"
|
|
2020,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,640,36.4,33.2,39.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,RACE01,CAT4,_RFPSA23,RESP046,"(42.27687047000046, -72.08269067499964)"
|
|
2020,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,917,63.6,60.5,66.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,RACE01,CAT4,_RFPSA23,RESP054,"(42.27687047000046, -72.08269067499964)"
|
|
2020,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,21,27,13.2,40.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,RACE02,CAT4,_RFPSA23,RESP046,"(42.27687047000046, -72.08269067499964)"
|
|
2020,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,49,73,59.2,86.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,RACE02,CAT4,_RFPSA23,RESP054,"(42.27687047000046, -72.08269067499964)"
|
|
2020,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,25,RACE03,CAT4,_RFPSA23,RESP046,"(42.27687047000046, -72.08269067499964)"
|
|
2020,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,25,RACE03,CAT4,_RFPSA23,RESP054,"(42.27687047000046, -72.08269067499964)"
|
|
2020,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,25,RACE04,CAT4,_RFPSA23,RESP046,"(42.27687047000046, -72.08269067499964)"
|
|
2020,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,39,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,25,RACE04,CAT4,_RFPSA23,RESP054,"(42.27687047000046, -72.08269067499964)"
|
|
2020,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,25,RACE05,CAT4,_RFPSA23,RESP046,"(42.27687047000046, -72.08269067499964)"
|
|
2020,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,25,RACE05,CAT4,_RFPSA23,RESP054,"(42.27687047000046, -72.08269067499964)"
|
|
2020,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,25,RACE06,CAT4,_RFPSA23,RESP046,"(42.27687047000046, -72.08269067499964)"
|
|
2020,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,25,RACE06,CAT4,_RFPSA23,RESP054,"(42.27687047000046, -72.08269067499964)"
|
|
2020,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,25,RACE07,CAT4,_RFPSA23,RESP046,"(42.27687047000046, -72.08269067499964)"
|
|
2020,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,11,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,25,RACE07,CAT4,_RFPSA23,RESP054,"(42.27687047000046, -72.08269067499964)"
|
|
2020,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,15,9.6,4.1,15.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,RACE08,CAT4,_RFPSA23,RESP046,"(42.27687047000046, -72.08269067499964)"
|
|
2020,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,104,90.4,84.8,95.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,RACE08,CAT4,_RFPSA23,RESP054,"(42.27687047000046, -72.08269067499964)"
|
|
2020,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,696,32.5,29.7,35.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,SEX1,CAT2,_RFPSA23,RESP046,"(42.27687047000046, -72.08269067499964)"
|
|
2020,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1133,67.5,64.7,70.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,25,SEX1,CAT2,_RFPSA23,RESP054,"(42.27687047000046, -72.08269067499964)"
|
|
2020,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,25,SEX2,CAT2,_RFPSA23,RESP046,"(42.27687047000046, -72.08269067499964)"
|
|
2020,MA,Massachusetts,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,25,SEX2,CAT2,_RFPSA23,RESP054,"(42.27687047000046, -72.08269067499964)"
|
|
2020,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,19,4.9,2.2,7.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,AGE06,CAT3,_RFPSA23,RESP046,"(44.6613195430005, -84.71439026999968)"
|
|
2020,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,321,95.1,92.5,97.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,AGE06,CAT3,_RFPSA23,RESP054,"(44.6613195430005, -84.71439026999968)"
|
|
2020,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,143,26.9,22.3,31.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,AGE07,CAT3,_RFPSA23,RESP046,"(44.6613195430005, -84.71439026999968)"
|
|
2020,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,333,73.1,68.4,77.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,AGE07,CAT3,_RFPSA23,RESP054,"(44.6613195430005, -84.71439026999968)"
|
|
2020,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,122,37,30.4,43.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,AGE08,CAT3,_RFPSA23,RESP046,"(44.6613195430005, -84.71439026999968)"
|
|
2020,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,193,63,56.5,69.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,AGE08,CAT3,_RFPSA23,RESP054,"(44.6613195430005, -84.71439026999968)"
|
|
2020,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,527,56.6,52.6,60.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,AGE09,CAT3,_RFPSA23,RESP046,"(44.6613195430005, -84.71439026999968)"
|
|
2020,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,412,43.4,39.4,47.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,AGE09,CAT3,_RFPSA23,RESP054,"(44.6613195430005, -84.71439026999968)"
|
|
2020,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,811,33.3,30.8,35.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,BO1,CAT1,_RFPSA23,RESP046,"(44.6613195430005, -84.71439026999968)"
|
|
2020,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1259,66.7,64.3,69.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,BO1,CAT1,_RFPSA23,RESP054,"(44.6613195430005, -84.71439026999968)"
|
|
2020,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,15,13.4,5.8,20.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,EDUCA1,CAT5,_RFPSA23,RESP046,"(44.6613195430005, -84.71439026999968)"
|
|
2020,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,67,86.6,79.1,94.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,EDUCA1,CAT5,_RFPSA23,RESP054,"(44.6613195430005, -84.71439026999968)"
|
|
2020,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,136,25.5,21.2,29.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,EDUCA2,CAT5,_RFPSA23,RESP046,"(44.6613195430005, -84.71439026999968)"
|
|
2020,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,324,74.5,70.1,78.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,EDUCA2,CAT5,_RFPSA23,RESP054,"(44.6613195430005, -84.71439026999968)"
|
|
2020,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,243,39.6,34.9,44.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,EDUCA3,CAT5,_RFPSA23,RESP046,"(44.6613195430005, -84.71439026999968)"
|
|
2020,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,350,60.4,55.8,65.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,EDUCA3,CAT5,_RFPSA23,RESP054,"(44.6613195430005, -84.71439026999968)"
|
|
2020,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,417,40.2,36.5,44,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,EDUCA4,CAT5,_RFPSA23,RESP046,"(44.6613195430005, -84.71439026999968)"
|
|
2020,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,513,59.8,56,63.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,EDUCA4,CAT5,_RFPSA23,RESP054,"(44.6613195430005, -84.71439026999968)"
|
|
2020,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,23,14,7.3,20.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,INCOME1,CAT6,_RFPSA23,RESP046,"(44.6613195430005, -84.71439026999968)"
|
|
2020,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,65,86,79.3,92.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,INCOME1,CAT6,_RFPSA23,RESP054,"(44.6613195430005, -84.71439026999968)"
|
|
2020,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,69,28.1,20.4,35.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,INCOME2,CAT6,_RFPSA23,RESP046,"(44.6613195430005, -84.71439026999968)"
|
|
2020,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,138,71.9,64.2,79.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,INCOME2,CAT6,_RFPSA23,RESP054,"(44.6613195430005, -84.71439026999968)"
|
|
2020,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,54,35.3,25.7,44.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,INCOME3,CAT6,_RFPSA23,RESP046,"(44.6613195430005, -84.71439026999968)"
|
|
2020,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,94,64.7,55.1,74.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,INCOME3,CAT6,_RFPSA23,RESP054,"(44.6613195430005, -84.71439026999968)"
|
|
2020,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,105,32.3,25.7,38.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,INCOME4,CAT6,_RFPSA23,RESP046,"(44.6613195430005, -84.71439026999968)"
|
|
2020,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,172,67.7,61.1,74.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,INCOME4,CAT6,_RFPSA23,RESP054,"(44.6613195430005, -84.71439026999968)"
|
|
2020,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,459,35,31.6,38.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,INCOME5,CAT6,_RFPSA23,RESP046,"(44.6613195430005, -84.71439026999968)"
|
|
2020,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,660,65,61.6,68.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,INCOME5,CAT6,_RFPSA23,RESP054,"(44.6613195430005, -84.71439026999968)"
|
|
2020,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,728,35.3,32.6,37.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,RACE01,CAT4,_RFPSA23,RESP046,"(44.6613195430005, -84.71439026999968)"
|
|
2020,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1052,64.7,62.1,67.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,RACE01,CAT4,_RFPSA23,RESP054,"(44.6613195430005, -84.71439026999968)"
|
|
2020,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,58,29.6,21.4,37.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,RACE02,CAT4,_RFPSA23,RESP046,"(44.6613195430005, -84.71439026999968)"
|
|
2020,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,110,70.4,62.3,78.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,RACE02,CAT4,_RFPSA23,RESP054,"(44.6613195430005, -84.71439026999968)"
|
|
2020,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,26,RACE03,CAT4,_RFPSA23,RESP046,"(44.6613195430005, -84.71439026999968)"
|
|
2020,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,9,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,26,RACE03,CAT4,_RFPSA23,RESP054,"(44.6613195430005, -84.71439026999968)"
|
|
2020,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,26,RACE04,CAT4,_RFPSA23,RESP046,"(44.6613195430005, -84.71439026999968)"
|
|
2020,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,28,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,26,RACE04,CAT4,_RFPSA23,RESP054,"(44.6613195430005, -84.71439026999968)"
|
|
2020,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,26,RACE05,CAT4,_RFPSA23,RESP046,"(44.6613195430005, -84.71439026999968)"
|
|
2020,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,26,RACE05,CAT4,_RFPSA23,RESP054,"(44.6613195430005, -84.71439026999968)"
|
|
2020,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,26,RACE06,CAT4,_RFPSA23,RESP046,"(44.6613195430005, -84.71439026999968)"
|
|
2020,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,26,RACE06,CAT4,_RFPSA23,RESP054,"(44.6613195430005, -84.71439026999968)"
|
|
2020,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,26,RACE07,CAT4,_RFPSA23,RESP046,"(44.6613195430005, -84.71439026999968)"
|
|
2020,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,22,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,26,RACE07,CAT4,_RFPSA23,RESP054,"(44.6613195430005, -84.71439026999968)"
|
|
2020,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,26,RACE08,CAT4,_RFPSA23,RESP046,"(44.6613195430005, -84.71439026999968)"
|
|
2020,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,28,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,26,RACE08,CAT4,_RFPSA23,RESP054,"(44.6613195430005, -84.71439026999968)"
|
|
2020,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,811,33.3,30.8,35.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,SEX1,CAT2,_RFPSA23,RESP046,"(44.6613195430005, -84.71439026999968)"
|
|
2020,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1259,66.7,64.3,69.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,26,SEX1,CAT2,_RFPSA23,RESP054,"(44.6613195430005, -84.71439026999968)"
|
|
2020,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,26,SEX2,CAT2,_RFPSA23,RESP046,"(44.6613195430005, -84.71439026999968)"
|
|
2020,MI,Michigan,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,26,SEX2,CAT2,_RFPSA23,RESP054,"(44.6613195430005, -84.71439026999968)"
|
|
2020,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,45,4.3,3,5.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,AGE06,CAT3,_RFPSA23,RESP046,"(46.35564873600049, -94.79420050299967)"
|
|
2020,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,962,95.7,94.4,97,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,AGE06,CAT3,_RFPSA23,RESP054,"(46.35564873600049, -94.79420050299967)"
|
|
2020,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,253,21.6,18.8,24.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,AGE07,CAT3,_RFPSA23,RESP046,"(46.35564873600049, -94.79420050299967)"
|
|
2020,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,915,78.4,75.7,81.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,AGE07,CAT3,_RFPSA23,RESP054,"(46.35564873600049, -94.79420050299967)"
|
|
2020,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,229,32.3,28.3,36.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,AGE08,CAT3,_RFPSA23,RESP046,"(46.35564873600049, -94.79420050299967)"
|
|
2020,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,478,67.7,63.8,71.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,AGE08,CAT3,_RFPSA23,RESP054,"(46.35564873600049, -94.79420050299967)"
|
|
2020,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,793,44.8,42,47.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,AGE09,CAT3,_RFPSA23,RESP046,"(46.35564873600049, -94.79420050299967)"
|
|
2020,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,926,55.2,52.3,58,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,AGE09,CAT3,_RFPSA23,RESP054,"(46.35564873600049, -94.79420050299967)"
|
|
2020,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1320,26.1,24.6,27.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,BO1,CAT1,_RFPSA23,RESP046,"(46.35564873600049, -94.79420050299967)"
|
|
2020,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,3281,73.9,72.4,75.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,BO1,CAT1,_RFPSA23,RESP054,"(46.35564873600049, -94.79420050299967)"
|
|
2020,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,30,13,7.9,18.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,EDUCA1,CAT5,_RFPSA23,RESP046,"(46.35564873600049, -94.79420050299967)"
|
|
2020,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,157,87,81.9,92.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,EDUCA1,CAT5,_RFPSA23,RESP054,"(46.35564873600049, -94.79420050299967)"
|
|
2020,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,247,20.4,17.8,23,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,EDUCA2,CAT5,_RFPSA23,RESP046,"(46.35564873600049, -94.79420050299967)"
|
|
2020,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,917,79.6,77,82.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,EDUCA2,CAT5,_RFPSA23,RESP054,"(46.35564873600049, -94.79420050299967)"
|
|
2020,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,401,28.4,25.7,31.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,EDUCA3,CAT5,_RFPSA23,RESP046,"(46.35564873600049, -94.79420050299967)"
|
|
2020,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,946,71.6,68.8,74.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,EDUCA3,CAT5,_RFPSA23,RESP054,"(46.35564873600049, -94.79420050299967)"
|
|
2020,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,641,31.3,28.9,33.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,EDUCA4,CAT5,_RFPSA23,RESP046,"(46.35564873600049, -94.79420050299967)"
|
|
2020,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,1257,68.7,66.4,71.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,EDUCA4,CAT5,_RFPSA23,RESP054,"(46.35564873600049, -94.79420050299967)"
|
|
2020,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,24,10.4,5.3,15.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,INCOME1,CAT6,_RFPSA23,RESP046,"(46.35564873600049, -94.79420050299967)"
|
|
2020,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,166,89.6,84.5,94.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,INCOME1,CAT6,_RFPSA23,RESP054,"(46.35564873600049, -94.79420050299967)"
|
|
2020,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,101,19,14.9,23.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,INCOME2,CAT6,_RFPSA23,RESP046,"(46.35564873600049, -94.79420050299967)"
|
|
2020,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,358,81,76.9,85.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,INCOME2,CAT6,_RFPSA23,RESP054,"(46.35564873600049, -94.79420050299967)"
|
|
2020,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,87,29.2,23,35.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,INCOME3,CAT6,_RFPSA23,RESP046,"(46.35564873600049, -94.79420050299967)"
|
|
2020,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,232,70.8,64.7,77,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,INCOME3,CAT6,_RFPSA23,RESP054,"(46.35564873600049, -94.79420050299967)"
|
|
2020,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,159,26.7,22.3,31.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,INCOME4,CAT6,_RFPSA23,RESP046,"(46.35564873600049, -94.79420050299967)"
|
|
2020,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,365,73.3,68.8,77.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,INCOME4,CAT6,_RFPSA23,RESP054,"(46.35564873600049, -94.79420050299967)"
|
|
2020,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,807,27.4,25.5,29.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,INCOME5,CAT6,_RFPSA23,RESP046,"(46.35564873600049, -94.79420050299967)"
|
|
2020,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,1834,72.6,70.7,74.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,INCOME5,CAT6,_RFPSA23,RESP054,"(46.35564873600049, -94.79420050299967)"
|
|
2020,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1262,28.1,26.5,29.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,RACE01,CAT4,_RFPSA23,RESP046,"(46.35564873600049, -94.79420050299967)"
|
|
2020,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,2896,71.9,70.4,73.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,RACE01,CAT4,_RFPSA23,RESP054,"(46.35564873600049, -94.79420050299967)"
|
|
2020,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,19,14.3,7.9,20.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,RACE02,CAT4,_RFPSA23,RESP046,"(46.35564873600049, -94.79420050299967)"
|
|
2020,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,100,85.7,79.3,92.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,RACE02,CAT4,_RFPSA23,RESP054,"(46.35564873600049, -94.79420050299967)"
|
|
2020,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,27,RACE03,CAT4,_RFPSA23,RESP046,"(46.35564873600049, -94.79420050299967)"
|
|
2020,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,35,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,27,RACE03,CAT4,_RFPSA23,RESP054,"(46.35564873600049, -94.79420050299967)"
|
|
2020,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,27,RACE04,CAT4,_RFPSA23,RESP046,"(46.35564873600049, -94.79420050299967)"
|
|
2020,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,47,82.2,71.4,93,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,RACE04,CAT4,_RFPSA23,RESP054,"(46.35564873600049, -94.79420050299967)"
|
|
2020,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,27,RACE05,CAT4,_RFPSA23,RESP046,"(46.35564873600049, -94.79420050299967)"
|
|
2020,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,27,RACE05,CAT4,_RFPSA23,RESP054,"(46.35564873600049, -94.79420050299967)"
|
|
2020,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,27,RACE06,CAT4,_RFPSA23,RESP046,"(46.35564873600049, -94.79420050299967)"
|
|
2020,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,17,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,27,RACE06,CAT4,_RFPSA23,RESP054,"(46.35564873600049, -94.79420050299967)"
|
|
2020,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,9,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,27,RACE07,CAT4,_RFPSA23,RESP046,"(46.35564873600049, -94.79420050299967)"
|
|
2020,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,40,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,27,RACE07,CAT4,_RFPSA23,RESP054,"(46.35564873600049, -94.79420050299967)"
|
|
2020,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,27,RACE08,CAT4,_RFPSA23,RESP046,"(46.35564873600049, -94.79420050299967)"
|
|
2020,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,144,94.9,91.5,98.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,RACE08,CAT4,_RFPSA23,RESP054,"(46.35564873600049, -94.79420050299967)"
|
|
2020,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1320,26.1,24.6,27.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,SEX1,CAT2,_RFPSA23,RESP046,"(46.35564873600049, -94.79420050299967)"
|
|
2020,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,3281,73.9,72.4,75.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,27,SEX1,CAT2,_RFPSA23,RESP054,"(46.35564873600049, -94.79420050299967)"
|
|
2020,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,27,SEX2,CAT2,_RFPSA23,RESP046,"(46.35564873600049, -94.79420050299967)"
|
|
2020,MN,Minnesota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,27,SEX2,CAT2,_RFPSA23,RESP054,"(46.35564873600049, -94.79420050299967)"
|
|
2020,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,41,12.2,8.1,16.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,AGE06,CAT3,_RFPSA23,RESP046,"(32.745510099000455, -89.53803082499968)"
|
|
2020,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,286,87.8,83.7,91.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,AGE06,CAT3,_RFPSA23,RESP054,"(32.745510099000455, -89.53803082499968)"
|
|
2020,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,157,35.5,30.1,41,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,AGE07,CAT3,_RFPSA23,RESP046,"(32.745510099000455, -89.53803082499968)"
|
|
2020,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,259,64.5,59,69.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,AGE07,CAT3,_RFPSA23,RESP054,"(32.745510099000455, -89.53803082499968)"
|
|
2020,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,109,40.8,33.5,48.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,AGE08,CAT3,_RFPSA23,RESP046,"(32.745510099000455, -89.53803082499968)"
|
|
2020,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,138,59.2,51.9,66.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,AGE08,CAT3,_RFPSA23,RESP054,"(32.745510099000455, -89.53803082499968)"
|
|
2020,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,484,56.5,52.3,60.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,AGE09,CAT3,_RFPSA23,RESP046,"(32.745510099000455, -89.53803082499968)"
|
|
2020,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,354,43.5,39.4,47.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,AGE09,CAT3,_RFPSA23,RESP054,"(32.745510099000455, -89.53803082499968)"
|
|
2020,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,791,37,34.4,39.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,BO1,CAT1,_RFPSA23,RESP046,"(32.745510099000455, -89.53803082499968)"
|
|
2020,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1037,63,60.3,65.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,BO1,CAT1,_RFPSA23,RESP054,"(32.745510099000455, -89.53803082499968)"
|
|
2020,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,76,26.8,20.5,33,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,EDUCA1,CAT5,_RFPSA23,RESP046,"(32.745510099000455, -89.53803082499968)"
|
|
2020,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,175,73.2,67,79.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,EDUCA1,CAT5,_RFPSA23,RESP054,"(32.745510099000455, -89.53803082499968)"
|
|
2020,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,214,33.3,28.9,37.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,EDUCA2,CAT5,_RFPSA23,RESP046,"(32.745510099000455, -89.53803082499968)"
|
|
2020,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,381,66.7,62.3,71.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,EDUCA2,CAT5,_RFPSA23,RESP054,"(32.745510099000455, -89.53803082499968)"
|
|
2020,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,214,42,36.7,47.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,EDUCA3,CAT5,_RFPSA23,RESP046,"(32.745510099000455, -89.53803082499968)"
|
|
2020,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,240,58,52.7,63.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,EDUCA3,CAT5,_RFPSA23,RESP054,"(32.745510099000455, -89.53803082499968)"
|
|
2020,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,286,46.7,41.8,51.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,EDUCA4,CAT5,_RFPSA23,RESP046,"(32.745510099000455, -89.53803082499968)"
|
|
2020,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,238,53.3,48.3,58.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,EDUCA4,CAT5,_RFPSA23,RESP054,"(32.745510099000455, -89.53803082499968)"
|
|
2020,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,28,23.7,14.4,33,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,INCOME1,CAT6,_RFPSA23,RESP046,"(32.745510099000455, -89.53803082499968)"
|
|
2020,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,96,76.3,67,85.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,INCOME1,CAT6,_RFPSA23,RESP054,"(32.745510099000455, -89.53803082499968)"
|
|
2020,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,96,29.9,23.5,36.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,INCOME2,CAT6,_RFPSA23,RESP046,"(32.745510099000455, -89.53803082499968)"
|
|
2020,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,197,70.1,63.7,76.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,INCOME2,CAT6,_RFPSA23,RESP054,"(32.745510099000455, -89.53803082499968)"
|
|
2020,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,71,39.1,29.8,48.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,INCOME3,CAT6,_RFPSA23,RESP046,"(32.745510099000455, -89.53803082499968)"
|
|
2020,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,93,60.9,51.6,70.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,INCOME3,CAT6,_RFPSA23,RESP054,"(32.745510099000455, -89.53803082499968)"
|
|
2020,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,93,43.6,34.6,52.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,INCOME4,CAT6,_RFPSA23,RESP046,"(32.745510099000455, -89.53803082499968)"
|
|
2020,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,87,56.4,47.4,65.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,INCOME4,CAT6,_RFPSA23,RESP054,"(32.745510099000455, -89.53803082499968)"
|
|
2020,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,356,42.4,38,46.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,INCOME5,CAT6,_RFPSA23,RESP046,"(32.745510099000455, -89.53803082499968)"
|
|
2020,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,343,57.6,53.3,62,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,INCOME5,CAT6,_RFPSA23,RESP054,"(32.745510099000455, -89.53803082499968)"
|
|
2020,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,567,39.7,36.4,43,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,RACE01,CAT4,_RFPSA23,RESP046,"(32.745510099000455, -89.53803082499968)"
|
|
2020,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,632,60.3,57,63.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,RACE01,CAT4,_RFPSA23,RESP054,"(32.745510099000455, -89.53803082499968)"
|
|
2020,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,211,33.6,28.9,38.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,RACE02,CAT4,_RFPSA23,RESP046,"(32.745510099000455, -89.53803082499968)"
|
|
2020,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,357,66.4,61.8,71.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,RACE02,CAT4,_RFPSA23,RESP054,"(32.745510099000455, -89.53803082499968)"
|
|
2020,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,28,RACE03,CAT4,_RFPSA23,RESP046,"(32.745510099000455, -89.53803082499968)"
|
|
2020,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,28,RACE03,CAT4,_RFPSA23,RESP054,"(32.745510099000455, -89.53803082499968)"
|
|
2020,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,28,RACE04,CAT4,_RFPSA23,RESP046,"(32.745510099000455, -89.53803082499968)"
|
|
2020,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,28,RACE04,CAT4,_RFPSA23,RESP054,"(32.745510099000455, -89.53803082499968)"
|
|
2020,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,28,RACE05,CAT4,_RFPSA23,RESP046,"(32.745510099000455, -89.53803082499968)"
|
|
2020,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,28,RACE05,CAT4,_RFPSA23,RESP054,"(32.745510099000455, -89.53803082499968)"
|
|
2020,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,28,RACE06,CAT4,_RFPSA23,RESP046,"(32.745510099000455, -89.53803082499968)"
|
|
2020,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,28,RACE06,CAT4,_RFPSA23,RESP054,"(32.745510099000455, -89.53803082499968)"
|
|
2020,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,28,RACE07,CAT4,_RFPSA23,RESP046,"(32.745510099000455, -89.53803082499968)"
|
|
2020,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,12,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,28,RACE07,CAT4,_RFPSA23,RESP054,"(32.745510099000455, -89.53803082499968)"
|
|
2020,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,28,RACE08,CAT4,_RFPSA23,RESP046,"(32.745510099000455, -89.53803082499968)"
|
|
2020,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,11,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,28,RACE08,CAT4,_RFPSA23,RESP054,"(32.745510099000455, -89.53803082499968)"
|
|
2020,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,791,37,34.4,39.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,SEX1,CAT2,_RFPSA23,RESP046,"(32.745510099000455, -89.53803082499968)"
|
|
2020,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1037,63,60.3,65.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,28,SEX1,CAT2,_RFPSA23,RESP054,"(32.745510099000455, -89.53803082499968)"
|
|
2020,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,28,SEX2,CAT2,_RFPSA23,RESP046,"(32.745510099000455, -89.53803082499968)"
|
|
2020,MS,Mississippi,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,28,SEX2,CAT2,_RFPSA23,RESP054,"(32.745510099000455, -89.53803082499968)"
|
|
2020,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,35,6.7,4.1,9.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,AGE06,CAT3,_RFPSA23,RESP046,"(38.635790776000476, -92.56630005299968)"
|
|
2020,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,434,93.3,90.7,95.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,AGE06,CAT3,_RFPSA23,RESP054,"(38.635790776000476, -92.56630005299968)"
|
|
2020,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,181,28.6,24.2,33.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,AGE07,CAT3,_RFPSA23,RESP046,"(38.635790776000476, -92.56630005299968)"
|
|
2020,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,435,71.4,66.9,75.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,AGE07,CAT3,_RFPSA23,RESP054,"(38.635790776000476, -92.56630005299968)"
|
|
2020,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,162,37.8,31.5,44.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,AGE08,CAT3,_RFPSA23,RESP046,"(38.635790776000476, -92.56630005299968)"
|
|
2020,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,203,62.2,55.9,68.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,AGE08,CAT3,_RFPSA23,RESP054,"(38.635790776000476, -92.56630005299968)"
|
|
2020,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,609,53.7,49.7,57.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,AGE09,CAT3,_RFPSA23,RESP046,"(38.635790776000476, -92.56630005299968)"
|
|
2020,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,534,46.3,42.3,50.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,AGE09,CAT3,_RFPSA23,RESP054,"(38.635790776000476, -92.56630005299968)"
|
|
2020,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,987,32.9,30.5,35.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,BO1,CAT1,_RFPSA23,RESP046,"(38.635790776000476, -92.56630005299968)"
|
|
2020,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1606,67.1,64.8,69.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,BO1,CAT1,_RFPSA23,RESP054,"(38.635790776000476, -92.56630005299968)"
|
|
2020,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,47,24.4,16.1,32.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,EDUCA1,CAT5,_RFPSA23,RESP046,"(38.635790776000476, -92.56630005299968)"
|
|
2020,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,133,75.6,67.2,83.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,EDUCA1,CAT5,_RFPSA23,RESP054,"(38.635790776000476, -92.56630005299968)"
|
|
2020,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,273,27.1,23.4,30.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,EDUCA2,CAT5,_RFPSA23,RESP046,"(38.635790776000476, -92.56630005299968)"
|
|
2020,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,552,72.9,69.2,76.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,EDUCA2,CAT5,_RFPSA23,RESP054,"(38.635790776000476, -92.56630005299968)"
|
|
2020,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,248,35.7,31.2,40.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,EDUCA3,CAT5,_RFPSA23,RESP046,"(38.635790776000476, -92.56630005299968)"
|
|
2020,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,433,64.3,59.8,68.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,EDUCA3,CAT5,_RFPSA23,RESP054,"(38.635790776000476, -92.56630005299968)"
|
|
2020,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,419,40.5,36.5,44.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,EDUCA4,CAT5,_RFPSA23,RESP046,"(38.635790776000476, -92.56630005299968)"
|
|
2020,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,486,59.5,55.6,63.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,EDUCA4,CAT5,_RFPSA23,RESP054,"(38.635790776000476, -92.56630005299968)"
|
|
2020,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,33,17,9.6,24.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,INCOME1,CAT6,_RFPSA23,RESP046,"(38.635790776000476, -92.56630005299968)"
|
|
2020,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,126,83,75.5,90.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,INCOME1,CAT6,_RFPSA23,RESP054,"(38.635790776000476, -92.56630005299968)"
|
|
2020,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,79,28,20.6,35.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,INCOME2,CAT6,_RFPSA23,RESP046,"(38.635790776000476, -92.56630005299968)"
|
|
2020,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,209,72,64.6,79.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,INCOME2,CAT6,_RFPSA23,RESP054,"(38.635790776000476, -92.56630005299968)"
|
|
2020,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,79,27.2,20,34.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,INCOME3,CAT6,_RFPSA23,RESP046,"(38.635790776000476, -92.56630005299968)"
|
|
2020,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,151,72.8,65.7,80,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,INCOME3,CAT6,_RFPSA23,RESP054,"(38.635790776000476, -92.56630005299968)"
|
|
2020,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,142,35.8,29,42.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,INCOME4,CAT6,_RFPSA23,RESP046,"(38.635790776000476, -92.56630005299968)"
|
|
2020,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,176,64.2,57.3,71,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,INCOME4,CAT6,_RFPSA23,RESP054,"(38.635790776000476, -92.56630005299968)"
|
|
2020,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,510,35,31.7,38.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,INCOME5,CAT6,_RFPSA23,RESP046,"(38.635790776000476, -92.56630005299968)"
|
|
2020,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,728,65,61.7,68.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,INCOME5,CAT6,_RFPSA23,RESP054,"(38.635790776000476, -92.56630005299968)"
|
|
2020,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,885,34.6,32.1,37.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,RACE01,CAT4,_RFPSA23,RESP046,"(38.635790776000476, -92.56630005299968)"
|
|
2020,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1378,65.4,62.8,67.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,RACE01,CAT4,_RFPSA23,RESP054,"(38.635790776000476, -92.56630005299968)"
|
|
2020,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,62,29,20.2,37.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,RACE02,CAT4,_RFPSA23,RESP046,"(38.635790776000476, -92.56630005299968)"
|
|
2020,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,125,71,62.1,79.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,RACE02,CAT4,_RFPSA23,RESP054,"(38.635790776000476, -92.56630005299968)"
|
|
2020,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,11,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,29,RACE03,CAT4,_RFPSA23,RESP046,"(38.635790776000476, -92.56630005299968)"
|
|
2020,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,24,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,29,RACE03,CAT4,_RFPSA23,RESP054,"(38.635790776000476, -92.56630005299968)"
|
|
2020,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,29,RACE04,CAT4,_RFPSA23,RESP046,"(38.635790776000476, -92.56630005299968)"
|
|
2020,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,13,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,29,RACE04,CAT4,_RFPSA23,RESP054,"(38.635790776000476, -92.56630005299968)"
|
|
2020,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,29,RACE05,CAT4,_RFPSA23,RESP046,"(38.635790776000476, -92.56630005299968)"
|
|
2020,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,29,RACE05,CAT4,_RFPSA23,RESP054,"(38.635790776000476, -92.56630005299968)"
|
|
2020,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,29,RACE06,CAT4,_RFPSA23,RESP046,"(38.635790776000476, -92.56630005299968)"
|
|
2020,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,11,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,29,RACE06,CAT4,_RFPSA23,RESP054,"(38.635790776000476, -92.56630005299968)"
|
|
2020,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,11,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,29,RACE07,CAT4,_RFPSA23,RESP046,"(38.635790776000476, -92.56630005299968)"
|
|
2020,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,23,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,29,RACE07,CAT4,_RFPSA23,RESP054,"(38.635790776000476, -92.56630005299968)"
|
|
2020,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,29,RACE08,CAT4,_RFPSA23,RESP046,"(38.635790776000476, -92.56630005299968)"
|
|
2020,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,31,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,29,RACE08,CAT4,_RFPSA23,RESP054,"(38.635790776000476, -92.56630005299968)"
|
|
2020,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,987,32.9,30.5,35.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,SEX1,CAT2,_RFPSA23,RESP046,"(38.635790776000476, -92.56630005299968)"
|
|
2020,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1606,67.1,64.8,69.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,29,SEX1,CAT2,_RFPSA23,RESP054,"(38.635790776000476, -92.56630005299968)"
|
|
2020,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,29,SEX2,CAT2,_RFPSA23,RESP046,"(38.635790776000476, -92.56630005299968)"
|
|
2020,MO,Missouri,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,29,SEX2,CAT2,_RFPSA23,RESP054,"(38.635790776000476, -92.56630005299968)"
|
|
2020,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,21,4.1,2,6.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,AGE06,CAT3,_RFPSA23,RESP046,"(47.06652897200047, -109.42442064499971)"
|
|
2020,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,341,95.9,93.7,98,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,AGE06,CAT3,_RFPSA23,RESP054,"(47.06652897200047, -109.42442064499971)"
|
|
2020,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,136,25.7,21.3,30.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,AGE07,CAT3,_RFPSA23,RESP046,"(47.06652897200047, -109.42442064499971)"
|
|
2020,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,318,74.3,69.9,78.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,AGE07,CAT3,_RFPSA23,RESP054,"(47.06652897200047, -109.42442064499971)"
|
|
2020,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,112,32.9,26.7,39.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,AGE08,CAT3,_RFPSA23,RESP046,"(47.06652897200047, -109.42442064499971)"
|
|
2020,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,184,67.1,60.9,73.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,AGE08,CAT3,_RFPSA23,RESP054,"(47.06652897200047, -109.42442064499971)"
|
|
2020,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,481,48.9,45.1,52.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,AGE09,CAT3,_RFPSA23,RESP046,"(47.06652897200047, -109.42442064499971)"
|
|
2020,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,446,51.1,47.3,54.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,AGE09,CAT3,_RFPSA23,RESP054,"(47.06652897200047, -109.42442064499971)"
|
|
2020,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,750,30.4,28.2,32.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,BO1,CAT1,_RFPSA23,RESP046,"(47.06652897200047, -109.42442064499971)"
|
|
2020,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1289,69.6,67.3,71.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,BO1,CAT1,_RFPSA23,RESP054,"(47.06652897200047, -109.42442064499971)"
|
|
2020,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,15,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,30,EDUCA1,CAT5,_RFPSA23,RESP046,"(47.06652897200047, -109.42442064499971)"
|
|
2020,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,64,87,79.2,94.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,EDUCA1,CAT5,_RFPSA23,RESP054,"(47.06652897200047, -109.42442064499971)"
|
|
2020,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,153,24,19.9,28.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,EDUCA2,CAT5,_RFPSA23,RESP046,"(47.06652897200047, -109.42442064499971)"
|
|
2020,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,410,76,71.9,80.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,EDUCA2,CAT5,_RFPSA23,RESP054,"(47.06652897200047, -109.42442064499971)"
|
|
2020,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,199,29.9,25.7,34.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,EDUCA3,CAT5,_RFPSA23,RESP046,"(47.06652897200047, -109.42442064499971)"
|
|
2020,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,358,70.1,65.9,74.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,EDUCA3,CAT5,_RFPSA23,RESP054,"(47.06652897200047, -109.42442064499971)"
|
|
2020,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,381,40.6,36.9,44.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,EDUCA4,CAT5,_RFPSA23,RESP046,"(47.06652897200047, -109.42442064499971)"
|
|
2020,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,455,59.4,55.6,63.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,EDUCA4,CAT5,_RFPSA23,RESP054,"(47.06652897200047, -109.42442064499971)"
|
|
2020,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,20,13.1,6.5,19.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,INCOME1,CAT6,_RFPSA23,RESP046,"(47.06652897200047, -109.42442064499971)"
|
|
2020,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,85,86.9,80.3,93.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,INCOME1,CAT6,_RFPSA23,RESP054,"(47.06652897200047, -109.42442064499971)"
|
|
2020,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,62,21.9,15.4,28.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,INCOME2,CAT6,_RFPSA23,RESP046,"(47.06652897200047, -109.42442064499971)"
|
|
2020,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,181,78.1,71.6,84.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,INCOME2,CAT6,_RFPSA23,RESP054,"(47.06652897200047, -109.42442064499971)"
|
|
2020,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,57,30.5,22.4,38.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,INCOME3,CAT6,_RFPSA23,RESP046,"(47.06652897200047, -109.42442064499971)"
|
|
2020,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,108,69.5,61.4,77.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,INCOME3,CAT6,_RFPSA23,RESP054,"(47.06652897200047, -109.42442064499971)"
|
|
2020,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,86,25.5,19.7,31.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,INCOME4,CAT6,_RFPSA23,RESP046,"(47.06652897200047, -109.42442064499971)"
|
|
2020,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,175,74.5,68.7,80.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,INCOME4,CAT6,_RFPSA23,RESP054,"(47.06652897200047, -109.42442064499971)"
|
|
2020,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,452,35,31.8,38.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,INCOME5,CAT6,_RFPSA23,RESP046,"(47.06652897200047, -109.42442064499971)"
|
|
2020,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,618,65,61.8,68.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,INCOME5,CAT6,_RFPSA23,RESP054,"(47.06652897200047, -109.42442064499971)"
|
|
2020,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,702,31.8,29.5,34.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,RACE01,CAT4,_RFPSA23,RESP046,"(47.06652897200047, -109.42442064499971)"
|
|
2020,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1163,68.2,65.8,70.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,RACE01,CAT4,_RFPSA23,RESP054,"(47.06652897200047, -109.42442064499971)"
|
|
2020,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,30,RACE02,CAT4,_RFPSA23,RESP046,"(47.06652897200047, -109.42442064499971)"
|
|
2020,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,30,RACE02,CAT4,_RFPSA23,RESP054,"(47.06652897200047, -109.42442064499971)"
|
|
2020,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,22,18.2,8.5,27.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,RACE03,CAT4,_RFPSA23,RESP046,"(47.06652897200047, -109.42442064499971)"
|
|
2020,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,65,81.8,72.1,91.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,RACE03,CAT4,_RFPSA23,RESP054,"(47.06652897200047, -109.42442064499971)"
|
|
2020,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,30,RACE04,CAT4,_RFPSA23,RESP046,"(47.06652897200047, -109.42442064499971)"
|
|
2020,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,30,RACE04,CAT4,_RFPSA23,RESP054,"(47.06652897200047, -109.42442064499971)"
|
|
2020,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,30,RACE05,CAT4,_RFPSA23,RESP046,"(47.06652897200047, -109.42442064499971)"
|
|
2020,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,30,RACE05,CAT4,_RFPSA23,RESP054,"(47.06652897200047, -109.42442064499971)"
|
|
2020,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,30,RACE06,CAT4,_RFPSA23,RESP046,"(47.06652897200047, -109.42442064499971)"
|
|
2020,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,30,RACE06,CAT4,_RFPSA23,RESP054,"(47.06652897200047, -109.42442064499971)"
|
|
2020,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,9,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,30,RACE07,CAT4,_RFPSA23,RESP046,"(47.06652897200047, -109.42442064499971)"
|
|
2020,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,28,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,30,RACE07,CAT4,_RFPSA23,RESP054,"(47.06652897200047, -109.42442064499971)"
|
|
2020,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,30,RACE08,CAT4,_RFPSA23,RESP046,"(47.06652897200047, -109.42442064499971)"
|
|
2020,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,20,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,30,RACE08,CAT4,_RFPSA23,RESP054,"(47.06652897200047, -109.42442064499971)"
|
|
2020,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,750,30.4,28.2,32.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,SEX1,CAT2,_RFPSA23,RESP046,"(47.06652897200047, -109.42442064499971)"
|
|
2020,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1289,69.6,67.3,71.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,30,SEX1,CAT2,_RFPSA23,RESP054,"(47.06652897200047, -109.42442064499971)"
|
|
2020,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,30,SEX2,CAT2,_RFPSA23,RESP046,"(47.06652897200047, -109.42442064499971)"
|
|
2020,MT,Montana,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,30,SEX2,CAT2,_RFPSA23,RESP054,"(47.06652897200047, -109.42442064499971)"
|
|
2020,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,43,5.5,3.3,7.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,AGE06,CAT3,_RFPSA23,RESP046,"(41.6410409880005, -99.36572062299967)"
|
|
2020,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,772,94.5,92.4,96.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,AGE06,CAT3,_RFPSA23,RESP054,"(41.6410409880005, -99.36572062299967)"
|
|
2020,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,268,26.6,22.8,30.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,AGE07,CAT3,_RFPSA23,RESP046,"(41.6410409880005, -99.36572062299967)"
|
|
2020,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,709,73.4,69.6,77.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,AGE07,CAT3,_RFPSA23,RESP054,"(41.6410409880005, -99.36572062299967)"
|
|
2020,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,249,39.7,34.4,45.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,AGE08,CAT3,_RFPSA23,RESP046,"(41.6410409880005, -99.36572062299967)"
|
|
2020,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,348,60.3,54.9,65.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,AGE08,CAT3,_RFPSA23,RESP054,"(41.6410409880005, -99.36572062299967)"
|
|
2020,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,988,48.8,45.8,51.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,AGE09,CAT3,_RFPSA23,RESP046,"(41.6410409880005, -99.36572062299967)"
|
|
2020,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,947,51.2,48.2,54.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,AGE09,CAT3,_RFPSA23,RESP054,"(41.6410409880005, -99.36572062299967)"
|
|
2020,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1548,29.5,27.7,31.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,BO1,CAT1,_RFPSA23,RESP046,"(41.6410409880005, -99.36572062299967)"
|
|
2020,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,2776,70.5,68.6,72.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,BO1,CAT1,_RFPSA23,RESP054,"(41.6410409880005, -99.36572062299967)"
|
|
2020,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,48,13.9,8.5,19.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,EDUCA1,CAT5,_RFPSA23,RESP046,"(41.6410409880005, -99.36572062299967)"
|
|
2020,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,230,86.1,80.7,91.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,EDUCA1,CAT5,_RFPSA23,RESP054,"(41.6410409880005, -99.36572062299967)"
|
|
2020,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,460,28.5,25.2,31.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,EDUCA2,CAT5,_RFPSA23,RESP046,"(41.6410409880005, -99.36572062299967)"
|
|
2020,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,944,71.5,68.2,74.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,EDUCA2,CAT5,_RFPSA23,RESP054,"(41.6410409880005, -99.36572062299967)"
|
|
2020,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,454,30,26.6,33.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,EDUCA3,CAT5,_RFPSA23,RESP046,"(41.6410409880005, -99.36572062299967)"
|
|
2020,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,752,70,66.6,73.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,EDUCA3,CAT5,_RFPSA23,RESP054,"(41.6410409880005, -99.36572062299967)"
|
|
2020,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,585,34.4,31.1,37.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,EDUCA4,CAT5,_RFPSA23,RESP046,"(41.6410409880005, -99.36572062299967)"
|
|
2020,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,846,65.6,62.3,68.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,EDUCA4,CAT5,_RFPSA23,RESP054,"(41.6410409880005, -99.36572062299967)"
|
|
2020,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,37,13.4,7.9,18.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,INCOME1,CAT6,_RFPSA23,RESP046,"(41.6410409880005, -99.36572062299967)"
|
|
2020,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,169,86.6,81.2,92.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,INCOME1,CAT6,_RFPSA23,RESP054,"(41.6410409880005, -99.36572062299967)"
|
|
2020,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,135,21.7,17.1,26.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,INCOME2,CAT6,_RFPSA23,RESP046,"(41.6410409880005, -99.36572062299967)"
|
|
2020,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,341,78.3,73.6,82.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,INCOME2,CAT6,_RFPSA23,RESP054,"(41.6410409880005, -99.36572062299967)"
|
|
2020,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,120,23.4,18.2,28.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,INCOME3,CAT6,_RFPSA23,RESP046,"(41.6410409880005, -99.36572062299967)"
|
|
2020,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,281,76.6,71.4,81.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,INCOME3,CAT6,_RFPSA23,RESP054,"(41.6410409880005, -99.36572062299967)"
|
|
2020,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,209,32.7,27,38.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,INCOME4,CAT6,_RFPSA23,RESP046,"(41.6410409880005, -99.36572062299967)"
|
|
2020,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,374,67.3,61.5,73,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,INCOME4,CAT6,_RFPSA23,RESP054,"(41.6410409880005, -99.36572062299967)"
|
|
2020,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,884,32.7,30.1,35.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,INCOME5,CAT6,_RFPSA23,RESP046,"(41.6410409880005, -99.36572062299967)"
|
|
2020,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,1364,67.3,64.7,69.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,INCOME5,CAT6,_RFPSA23,RESP054,"(41.6410409880005, -99.36572062299967)"
|
|
2020,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1494,32.2,30.3,34.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,RACE01,CAT4,_RFPSA23,RESP046,"(41.6410409880005, -99.36572062299967)"
|
|
2020,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,2476,67.8,65.8,69.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,RACE01,CAT4,_RFPSA23,RESP054,"(41.6410409880005, -99.36572062299967)"
|
|
2020,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,14,20.4,8.9,31.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,RACE02,CAT4,_RFPSA23,RESP046,"(41.6410409880005, -99.36572062299967)"
|
|
2020,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,55,79.6,68.2,91.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,RACE02,CAT4,_RFPSA23,RESP054,"(41.6410409880005, -99.36572062299967)"
|
|
2020,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,31,RACE03,CAT4,_RFPSA23,RESP046,"(41.6410409880005, -99.36572062299967)"
|
|
2020,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,28,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,31,RACE03,CAT4,_RFPSA23,RESP054,"(41.6410409880005, -99.36572062299967)"
|
|
2020,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,31,RACE04,CAT4,_RFPSA23,RESP046,"(41.6410409880005, -99.36572062299967)"
|
|
2020,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,13,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,31,RACE04,CAT4,_RFPSA23,RESP054,"(41.6410409880005, -99.36572062299967)"
|
|
2020,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,31,RACE05,CAT4,_RFPSA23,RESP046,"(41.6410409880005, -99.36572062299967)"
|
|
2020,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,31,RACE05,CAT4,_RFPSA23,RESP054,"(41.6410409880005, -99.36572062299967)"
|
|
2020,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,31,RACE06,CAT4,_RFPSA23,RESP046,"(41.6410409880005, -99.36572062299967)"
|
|
2020,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,31,RACE06,CAT4,_RFPSA23,RESP054,"(41.6410409880005, -99.36572062299967)"
|
|
2020,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,31,RACE07,CAT4,_RFPSA23,RESP046,"(41.6410409880005, -99.36572062299967)"
|
|
2020,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,19,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,31,RACE07,CAT4,_RFPSA23,RESP054,"(41.6410409880005, -99.36572062299967)"
|
|
2020,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,20,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,31,RACE08,CAT4,_RFPSA23,RESP046,"(41.6410409880005, -99.36572062299967)"
|
|
2020,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,180,91.9,86.5,97.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,RACE08,CAT4,_RFPSA23,RESP054,"(41.6410409880005, -99.36572062299967)"
|
|
2020,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1548,29.5,27.7,31.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,SEX1,CAT2,_RFPSA23,RESP046,"(41.6410409880005, -99.36572062299967)"
|
|
2020,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,2776,70.5,68.6,72.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,31,SEX1,CAT2,_RFPSA23,RESP054,"(41.6410409880005, -99.36572062299967)"
|
|
2020,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,31,SEX2,CAT2,_RFPSA23,RESP046,"(41.6410409880005, -99.36572062299967)"
|
|
2020,NE,Nebraska,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,31,SEX2,CAT2,_RFPSA23,RESP054,"(41.6410409880005, -99.36572062299967)"
|
|
2020,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,13,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,32,AGE06,CAT3,_RFPSA23,RESP046,"(39.493240390000494, -117.07184056399967)"
|
|
2020,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,149,91.8,86.3,97.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,AGE06,CAT3,_RFPSA23,RESP054,"(39.493240390000494, -117.07184056399967)"
|
|
2020,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,42,24.3,15.3,33.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,AGE07,CAT3,_RFPSA23,RESP046,"(39.493240390000494, -117.07184056399967)"
|
|
2020,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,129,75.7,66.8,84.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,AGE07,CAT3,_RFPSA23,RESP054,"(39.493240390000494, -117.07184056399967)"
|
|
2020,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,43,31.6,19.5,43.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,AGE08,CAT3,_RFPSA23,RESP046,"(39.493240390000494, -117.07184056399967)"
|
|
2020,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,52,68.4,56.2,80.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,AGE08,CAT3,_RFPSA23,RESP054,"(39.493240390000494, -117.07184056399967)"
|
|
2020,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,169,51,42.1,59.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,AGE09,CAT3,_RFPSA23,RESP046,"(39.493240390000494, -117.07184056399967)"
|
|
2020,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,164,49,40.2,57.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,AGE09,CAT3,_RFPSA23,RESP054,"(39.493240390000494, -117.07184056399967)"
|
|
2020,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,267,29.5,24.8,34.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,BO1,CAT1,_RFPSA23,RESP046,"(39.493240390000494, -117.07184056399967)"
|
|
2020,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,494,70.5,65.8,75.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,BO1,CAT1,_RFPSA23,RESP054,"(39.493240390000494, -117.07184056399967)"
|
|
2020,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,14,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,32,EDUCA1,CAT5,_RFPSA23,RESP046,"(39.493240390000494, -117.07184056399967)"
|
|
2020,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,34,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,32,EDUCA1,CAT5,_RFPSA23,RESP054,"(39.493240390000494, -117.07184056399967)"
|
|
2020,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,43,15.9,9.9,21.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,EDUCA2,CAT5,_RFPSA23,RESP046,"(39.493240390000494, -117.07184056399967)"
|
|
2020,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,145,84.1,78.1,90.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,EDUCA2,CAT5,_RFPSA23,RESP054,"(39.493240390000494, -117.07184056399967)"
|
|
2020,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,93,37.7,28.7,46.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,EDUCA3,CAT5,_RFPSA23,RESP046,"(39.493240390000494, -117.07184056399967)"
|
|
2020,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,145,62.3,53.3,71.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,EDUCA3,CAT5,_RFPSA23,RESP054,"(39.493240390000494, -117.07184056399967)"
|
|
2020,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,117,34.6,27.5,41.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,EDUCA4,CAT5,_RFPSA23,RESP046,"(39.493240390000494, -117.07184056399967)"
|
|
2020,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,169,65.4,58.3,72.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,EDUCA4,CAT5,_RFPSA23,RESP054,"(39.493240390000494, -117.07184056399967)"
|
|
2020,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,32,INCOME1,CAT6,_RFPSA23,RESP046,"(39.493240390000494, -117.07184056399967)"
|
|
2020,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,33,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,32,INCOME1,CAT6,_RFPSA23,RESP054,"(39.493240390000494, -117.07184056399967)"
|
|
2020,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,27,32.2,16.5,47.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,INCOME2,CAT6,_RFPSA23,RESP046,"(39.493240390000494, -117.07184056399967)"
|
|
2020,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,55,67.8,52.1,83.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,INCOME2,CAT6,_RFPSA23,RESP054,"(39.493240390000494, -117.07184056399967)"
|
|
2020,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,15,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,32,INCOME3,CAT6,_RFPSA23,RESP046,"(39.493240390000494, -117.07184056399967)"
|
|
2020,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,31,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,32,INCOME3,CAT6,_RFPSA23,RESP054,"(39.493240390000494, -117.07184056399967)"
|
|
2020,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,21,22.4,9.3,35.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,INCOME4,CAT6,_RFPSA23,RESP046,"(39.493240390000494, -117.07184056399967)"
|
|
2020,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,54,77.6,64.6,90.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,INCOME4,CAT6,_RFPSA23,RESP054,"(39.493240390000494, -117.07184056399967)"
|
|
2020,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,164,33.7,27.2,40.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,INCOME5,CAT6,_RFPSA23,RESP046,"(39.493240390000494, -117.07184056399967)"
|
|
2020,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,249,66.3,59.8,72.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,INCOME5,CAT6,_RFPSA23,RESP054,"(39.493240390000494, -117.07184056399967)"
|
|
2020,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,222,34,28.8,39.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,RACE01,CAT4,_RFPSA23,RESP046,"(39.493240390000494, -117.07184056399967)"
|
|
2020,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,364,66,60.9,71.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,RACE01,CAT4,_RFPSA23,RESP054,"(39.493240390000494, -117.07184056399967)"
|
|
2020,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,32,RACE02,CAT4,_RFPSA23,RESP046,"(39.493240390000494, -117.07184056399967)"
|
|
2020,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,21,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,32,RACE02,CAT4,_RFPSA23,RESP054,"(39.493240390000494, -117.07184056399967)"
|
|
2020,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,32,RACE03,CAT4,_RFPSA23,RESP046,"(39.493240390000494, -117.07184056399967)"
|
|
2020,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,32,RACE03,CAT4,_RFPSA23,RESP054,"(39.493240390000494, -117.07184056399967)"
|
|
2020,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,32,RACE04,CAT4,_RFPSA23,RESP046,"(39.493240390000494, -117.07184056399967)"
|
|
2020,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,9,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,32,RACE04,CAT4,_RFPSA23,RESP054,"(39.493240390000494, -117.07184056399967)"
|
|
2020,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,32,RACE05,CAT4,_RFPSA23,RESP046,"(39.493240390000494, -117.07184056399967)"
|
|
2020,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,32,RACE05,CAT4,_RFPSA23,RESP054,"(39.493240390000494, -117.07184056399967)"
|
|
2020,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,32,RACE06,CAT4,_RFPSA23,RESP046,"(39.493240390000494, -117.07184056399967)"
|
|
2020,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,9,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,32,RACE06,CAT4,_RFPSA23,RESP054,"(39.493240390000494, -117.07184056399967)"
|
|
2020,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,32,RACE07,CAT4,_RFPSA23,RESP046,"(39.493240390000494, -117.07184056399967)"
|
|
2020,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,13,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,32,RACE07,CAT4,_RFPSA23,RESP054,"(39.493240390000494, -117.07184056399967)"
|
|
2020,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,18,18.4,8.2,28.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,RACE08,CAT4,_RFPSA23,RESP046,"(39.493240390000494, -117.07184056399967)"
|
|
2020,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,66,81.6,71.4,91.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,RACE08,CAT4,_RFPSA23,RESP054,"(39.493240390000494, -117.07184056399967)"
|
|
2020,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,267,29.5,24.8,34.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,SEX1,CAT2,_RFPSA23,RESP046,"(39.493240390000494, -117.07184056399967)"
|
|
2020,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,494,70.5,65.8,75.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,32,SEX1,CAT2,_RFPSA23,RESP054,"(39.493240390000494, -117.07184056399967)"
|
|
2020,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,32,SEX2,CAT2,_RFPSA23,RESP046,"(39.493240390000494, -117.07184056399967)"
|
|
2020,NV,Nevada,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,32,SEX2,CAT2,_RFPSA23,RESP054,"(39.493240390000494, -117.07184056399967)"
|
|
2020,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,12,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,33,AGE06,CAT3,_RFPSA23,RESP046,"(43.65595011300047, -71.50036091999965)"
|
|
2020,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,226,94.5,90.7,98.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,AGE06,CAT3,_RFPSA23,RESP054,"(43.65595011300047, -71.50036091999965)"
|
|
2020,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,103,23.1,18.4,27.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,AGE07,CAT3,_RFPSA23,RESP046,"(43.65595011300047, -71.50036091999965)"
|
|
2020,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,327,76.9,72.1,81.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,AGE07,CAT3,_RFPSA23,RESP054,"(43.65595011300047, -71.50036091999965)"
|
|
2020,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,129,38.9,32.6,45.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,AGE08,CAT3,_RFPSA23,RESP046,"(43.65595011300047, -71.50036091999965)"
|
|
2020,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,177,61.1,54.7,67.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,AGE08,CAT3,_RFPSA23,RESP054,"(43.65595011300047, -71.50036091999965)"
|
|
2020,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,466,46.2,42.2,50.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,AGE09,CAT3,_RFPSA23,RESP046,"(43.65595011300047, -71.50036091999965)"
|
|
2020,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,532,53.8,49.8,57.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,AGE09,CAT3,_RFPSA23,RESP054,"(43.65595011300047, -71.50036091999965)"
|
|
2020,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,710,30.5,28,33,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,BO1,CAT1,_RFPSA23,RESP046,"(43.65595011300047, -71.50036091999965)"
|
|
2020,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1262,69.5,67,72,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,BO1,CAT1,_RFPSA23,RESP054,"(43.65595011300047, -71.50036091999965)"
|
|
2020,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,12,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,33,EDUCA1,CAT5,_RFPSA23,RESP046,"(43.65595011300047, -71.50036091999965)"
|
|
2020,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,66,83.8,74.1,93.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,EDUCA1,CAT5,_RFPSA23,RESP054,"(43.65595011300047, -71.50036091999965)"
|
|
2020,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,142,26.7,21.8,31.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,EDUCA2,CAT5,_RFPSA23,RESP046,"(43.65595011300047, -71.50036091999965)"
|
|
2020,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,332,73.3,68.4,78.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,EDUCA2,CAT5,_RFPSA23,RESP054,"(43.65595011300047, -71.50036091999965)"
|
|
2020,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,163,29.3,24.6,34,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,EDUCA3,CAT5,_RFPSA23,RESP046,"(43.65595011300047, -71.50036091999965)"
|
|
2020,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,326,70.7,66,75.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,EDUCA3,CAT5,_RFPSA23,RESP054,"(43.65595011300047, -71.50036091999965)"
|
|
2020,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,392,37.4,33.7,41.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,EDUCA4,CAT5,_RFPSA23,RESP046,"(43.65595011300047, -71.50036091999965)"
|
|
2020,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,534,62.6,58.9,66.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,EDUCA4,CAT5,_RFPSA23,RESP054,"(43.65595011300047, -71.50036091999965)"
|
|
2020,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,16,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,33,INCOME1,CAT6,_RFPSA23,RESP046,"(43.65595011300047, -71.50036091999965)"
|
|
2020,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,59,81.9,70.8,93,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,INCOME1,CAT6,_RFPSA23,RESP054,"(43.65595011300047, -71.50036091999965)"
|
|
2020,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,33,17.3,9.9,24.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,INCOME2,CAT6,_RFPSA23,RESP046,"(43.65595011300047, -71.50036091999965)"
|
|
2020,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,131,82.7,75.2,90.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,INCOME2,CAT6,_RFPSA23,RESP054,"(43.65595011300047, -71.50036091999965)"
|
|
2020,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,43,27.1,18.1,36.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,INCOME3,CAT6,_RFPSA23,RESP046,"(43.65595011300047, -71.50036091999965)"
|
|
2020,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,94,72.9,63.8,81.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,INCOME3,CAT6,_RFPSA23,RESP054,"(43.65595011300047, -71.50036091999965)"
|
|
2020,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,63,28.7,21.1,36.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,INCOME4,CAT6,_RFPSA23,RESP046,"(43.65595011300047, -71.50036091999965)"
|
|
2020,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,141,71.3,63.6,78.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,INCOME4,CAT6,_RFPSA23,RESP054,"(43.65595011300047, -71.50036091999965)"
|
|
2020,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,440,32.4,29.2,35.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,INCOME5,CAT6,_RFPSA23,RESP046,"(43.65595011300047, -71.50036091999965)"
|
|
2020,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,664,67.6,64.3,70.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,INCOME5,CAT6,_RFPSA23,RESP054,"(43.65595011300047, -71.50036091999965)"
|
|
2020,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,685,31.3,28.7,33.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,RACE01,CAT4,_RFPSA23,RESP046,"(43.65595011300047, -71.50036091999965)"
|
|
2020,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1172,68.7,66.2,71.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,RACE01,CAT4,_RFPSA23,RESP054,"(43.65595011300047, -71.50036091999965)"
|
|
2020,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,33,RACE02,CAT4,_RFPSA23,RESP046,"(43.65595011300047, -71.50036091999965)"
|
|
2020,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,33,RACE02,CAT4,_RFPSA23,RESP054,"(43.65595011300047, -71.50036091999965)"
|
|
2020,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,33,RACE03,CAT4,_RFPSA23,RESP046,"(43.65595011300047, -71.50036091999965)"
|
|
2020,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,17,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,33,RACE03,CAT4,_RFPSA23,RESP054,"(43.65595011300047, -71.50036091999965)"
|
|
2020,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,33,RACE04,CAT4,_RFPSA23,RESP046,"(43.65595011300047, -71.50036091999965)"
|
|
2020,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,14,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,33,RACE04,CAT4,_RFPSA23,RESP054,"(43.65595011300047, -71.50036091999965)"
|
|
2020,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,33,RACE05,CAT4,_RFPSA23,RESP046,"(43.65595011300047, -71.50036091999965)"
|
|
2020,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,33,RACE05,CAT4,_RFPSA23,RESP054,"(43.65595011300047, -71.50036091999965)"
|
|
2020,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,33,RACE06,CAT4,_RFPSA23,RESP046,"(43.65595011300047, -71.50036091999965)"
|
|
2020,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,16,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,33,RACE06,CAT4,_RFPSA23,RESP054,"(43.65595011300047, -71.50036091999965)"
|
|
2020,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,33,RACE07,CAT4,_RFPSA23,RESP046,"(43.65595011300047, -71.50036091999965)"
|
|
2020,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,17,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,33,RACE07,CAT4,_RFPSA23,RESP054,"(43.65595011300047, -71.50036091999965)"
|
|
2020,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,33,RACE08,CAT4,_RFPSA23,RESP046,"(43.65595011300047, -71.50036091999965)"
|
|
2020,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,19,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,33,RACE08,CAT4,_RFPSA23,RESP054,"(43.65595011300047, -71.50036091999965)"
|
|
2020,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,710,30.5,28,33,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,SEX1,CAT2,_RFPSA23,RESP046,"(43.65595011300047, -71.50036091999965)"
|
|
2020,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1262,69.5,67,72,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,33,SEX1,CAT2,_RFPSA23,RESP054,"(43.65595011300047, -71.50036091999965)"
|
|
2020,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,33,SEX2,CAT2,_RFPSA23,RESP046,"(43.65595011300047, -71.50036091999965)"
|
|
2020,NH,New Hampshire,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,33,SEX2,CAT2,_RFPSA23,RESP054,"(43.65595011300047, -71.50036091999965)"
|
|
2020,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,53,7,4.8,9.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,AGE06,CAT3,_RFPSA23,RESP046,"(40.13057004800049, -74.27369128799967)"
|
|
2020,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,564,93,90.8,95.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,AGE06,CAT3,_RFPSA23,RESP054,"(40.13057004800049, -74.27369128799967)"
|
|
2020,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,258,29.3,25.6,33,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,AGE07,CAT3,_RFPSA23,RESP046,"(40.13057004800049, -74.27369128799967)"
|
|
2020,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,594,70.7,67,74.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,AGE07,CAT3,_RFPSA23,RESP054,"(40.13057004800049, -74.27369128799967)"
|
|
2020,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,239,47.6,41.8,53.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,AGE08,CAT3,_RFPSA23,RESP046,"(40.13057004800049, -74.27369128799967)"
|
|
2020,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,224,52.4,46.5,58.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,AGE08,CAT3,_RFPSA23,RESP054,"(40.13057004800049, -74.27369128799967)"
|
|
2020,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,692,54.3,50.4,58.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,AGE09,CAT3,_RFPSA23,RESP046,"(40.13057004800049, -74.27369128799967)"
|
|
2020,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,513,45.7,41.8,49.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,AGE09,CAT3,_RFPSA23,RESP054,"(40.13057004800049, -74.27369128799967)"
|
|
2020,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1242,33.9,31.8,36,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,BO1,CAT1,_RFPSA23,RESP046,"(40.13057004800049, -74.27369128799967)"
|
|
2020,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1895,66.1,64,68.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,BO1,CAT1,_RFPSA23,RESP054,"(40.13057004800049, -74.27369128799967)"
|
|
2020,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,36,15.7,9.8,21.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,EDUCA1,CAT5,_RFPSA23,RESP046,"(40.13057004800049, -74.27369128799967)"
|
|
2020,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,169,84.3,78.4,90.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,EDUCA1,CAT5,_RFPSA23,RESP054,"(40.13057004800049, -74.27369128799967)"
|
|
2020,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,228,30.5,26.4,34.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,EDUCA2,CAT5,_RFPSA23,RESP046,"(40.13057004800049, -74.27369128799967)"
|
|
2020,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,508,69.5,65.5,73.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,EDUCA2,CAT5,_RFPSA23,RESP054,"(40.13057004800049, -74.27369128799967)"
|
|
2020,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,273,38.6,33.9,43.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,EDUCA3,CAT5,_RFPSA23,RESP046,"(40.13057004800049, -74.27369128799967)"
|
|
2020,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,382,61.4,56.8,66.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,EDUCA3,CAT5,_RFPSA23,RESP054,"(40.13057004800049, -74.27369128799967)"
|
|
2020,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,699,40.2,37.2,43.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,EDUCA4,CAT5,_RFPSA23,RESP046,"(40.13057004800049, -74.27369128799967)"
|
|
2020,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,826,59.8,56.8,62.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,EDUCA4,CAT5,_RFPSA23,RESP054,"(40.13057004800049, -74.27369128799967)"
|
|
2020,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,36,21.1,12.9,29.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,INCOME1,CAT6,_RFPSA23,RESP046,"(40.13057004800049, -74.27369128799967)"
|
|
2020,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,105,78.9,70.6,87.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,INCOME1,CAT6,_RFPSA23,RESP054,"(40.13057004800049, -74.27369128799967)"
|
|
2020,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,58,20,13.1,26.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,INCOME2,CAT6,_RFPSA23,RESP046,"(40.13057004800049, -74.27369128799967)"
|
|
2020,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,201,80,73.1,86.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,INCOME2,CAT6,_RFPSA23,RESP054,"(40.13057004800049, -74.27369128799967)"
|
|
2020,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,44,27.4,18.9,36,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,INCOME3,CAT6,_RFPSA23,RESP046,"(40.13057004800049, -74.27369128799967)"
|
|
2020,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,122,72.6,64,81.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,INCOME3,CAT6,_RFPSA23,RESP054,"(40.13057004800049, -74.27369128799967)"
|
|
2020,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,104,33.3,26.2,40.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,INCOME4,CAT6,_RFPSA23,RESP046,"(40.13057004800049, -74.27369128799967)"
|
|
2020,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,145,66.7,59.6,73.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,INCOME4,CAT6,_RFPSA23,RESP054,"(40.13057004800049, -74.27369128799967)"
|
|
2020,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,763,36.6,33.8,39.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,INCOME5,CAT6,_RFPSA23,RESP046,"(40.13057004800049, -74.27369128799967)"
|
|
2020,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,1034,63.4,60.6,66.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,INCOME5,CAT6,_RFPSA23,RESP054,"(40.13057004800049, -74.27369128799967)"
|
|
2020,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1027,40.9,38.4,43.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,RACE01,CAT4,_RFPSA23,RESP046,"(40.13057004800049, -74.27369128799967)"
|
|
2020,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1218,59.1,56.6,61.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,RACE01,CAT4,_RFPSA23,RESP054,"(40.13057004800049, -74.27369128799967)"
|
|
2020,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,87,32.2,25.2,39.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,RACE02,CAT4,_RFPSA23,RESP046,"(40.13057004800049, -74.27369128799967)"
|
|
2020,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,192,67.8,60.8,74.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,RACE02,CAT4,_RFPSA23,RESP054,"(40.13057004800049, -74.27369128799967)"
|
|
2020,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,34,RACE03,CAT4,_RFPSA23,RESP046,"(40.13057004800049, -74.27369128799967)"
|
|
2020,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,34,RACE03,CAT4,_RFPSA23,RESP054,"(40.13057004800049, -74.27369128799967)"
|
|
2020,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,18,17.4,9.5,25.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,RACE04,CAT4,_RFPSA23,RESP046,"(40.13057004800049, -74.27369128799967)"
|
|
2020,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,95,82.6,74.7,90.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,RACE04,CAT4,_RFPSA23,RESP054,"(40.13057004800049, -74.27369128799967)"
|
|
2020,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,34,RACE05,CAT4,_RFPSA23,RESP046,"(40.13057004800049, -74.27369128799967)"
|
|
2020,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,34,RACE05,CAT4,_RFPSA23,RESP054,"(40.13057004800049, -74.27369128799967)"
|
|
2020,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,15,18.7,8.1,29.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,RACE06,CAT4,_RFPSA23,RESP046,"(40.13057004800049, -74.27369128799967)"
|
|
2020,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,55,81.3,70.7,91.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,RACE06,CAT4,_RFPSA23,RESP054,"(40.13057004800049, -74.27369128799967)"
|
|
2020,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,20,30.4,16.9,44,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,RACE07,CAT4,_RFPSA23,RESP046,"(40.13057004800049, -74.27369128799967)"
|
|
2020,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,36,69.6,56,83.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,RACE07,CAT4,_RFPSA23,RESP054,"(40.13057004800049, -74.27369128799967)"
|
|
2020,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,72,18.2,13.4,22.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,RACE08,CAT4,_RFPSA23,RESP046,"(40.13057004800049, -74.27369128799967)"
|
|
2020,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,288,81.8,77.1,86.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,RACE08,CAT4,_RFPSA23,RESP054,"(40.13057004800049, -74.27369128799967)"
|
|
2020,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1242,33.9,31.8,36,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,SEX1,CAT2,_RFPSA23,RESP046,"(40.13057004800049, -74.27369128799967)"
|
|
2020,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1895,66.1,64,68.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,34,SEX1,CAT2,_RFPSA23,RESP054,"(40.13057004800049, -74.27369128799967)"
|
|
2020,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,34,SEX2,CAT2,_RFPSA23,RESP046,"(40.13057004800049, -74.27369128799967)"
|
|
2020,NJ,New Jersey,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,34,SEX2,CAT2,_RFPSA23,RESP054,"(40.13057004800049, -74.27369128799967)"
|
|
2020,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,13,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,35,AGE06,CAT3,_RFPSA23,RESP046,"(34.52088095200048, -106.24058098499967)"
|
|
2020,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,314,95,91.5,98.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,AGE06,CAT3,_RFPSA23,RESP054,"(34.52088095200048, -106.24058098499967)"
|
|
2020,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,99,20.6,15.4,25.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,AGE07,CAT3,_RFPSA23,RESP046,"(34.52088095200048, -106.24058098499967)"
|
|
2020,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,304,79.4,74.1,84.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,AGE07,CAT3,_RFPSA23,RESP054,"(34.52088095200048, -106.24058098499967)"
|
|
2020,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,102,30.2,22.1,38.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,AGE08,CAT3,_RFPSA23,RESP046,"(34.52088095200048, -106.24058098499967)"
|
|
2020,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,195,69.8,61.7,77.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,AGE08,CAT3,_RFPSA23,RESP054,"(34.52088095200048, -106.24058098499967)"
|
|
2020,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,461,43.8,38.9,48.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,AGE09,CAT3,_RFPSA23,RESP046,"(34.52088095200048, -106.24058098499967)"
|
|
2020,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,551,56.2,51.3,61.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,AGE09,CAT3,_RFPSA23,RESP054,"(34.52088095200048, -106.24058098499967)"
|
|
2020,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,675,26.7,23.8,29.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,BO1,CAT1,_RFPSA23,RESP046,"(34.52088095200048, -106.24058098499967)"
|
|
2020,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1364,73.3,70.5,76.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,BO1,CAT1,_RFPSA23,RESP054,"(34.52088095200048, -106.24058098499967)"
|
|
2020,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,25,13.2,6.1,20.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,EDUCA1,CAT5,_RFPSA23,RESP046,"(34.52088095200048, -106.24058098499967)"
|
|
2020,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,168,86.8,79.7,93.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,EDUCA1,CAT5,_RFPSA23,RESP054,"(34.52088095200048, -106.24058098499967)"
|
|
2020,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,141,25,19,31.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,EDUCA2,CAT5,_RFPSA23,RESP046,"(34.52088095200048, -106.24058098499967)"
|
|
2020,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,395,75,68.9,81,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,EDUCA2,CAT5,_RFPSA23,RESP054,"(34.52088095200048, -106.24058098499967)"
|
|
2020,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,145,23.7,18.8,28.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,EDUCA3,CAT5,_RFPSA23,RESP046,"(34.52088095200048, -106.24058098499967)"
|
|
2020,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,353,76.3,71.5,81.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,EDUCA3,CAT5,_RFPSA23,RESP054,"(34.52088095200048, -106.24058098499967)"
|
|
2020,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,362,39.5,34.5,44.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,EDUCA4,CAT5,_RFPSA23,RESP046,"(34.52088095200048, -106.24058098499967)"
|
|
2020,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,445,60.5,55.5,65.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,EDUCA4,CAT5,_RFPSA23,RESP054,"(34.52088095200048, -106.24058098499967)"
|
|
2020,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,33,28.7,15.2,42.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,INCOME1,CAT6,_RFPSA23,RESP046,"(34.52088095200048, -106.24058098499967)"
|
|
2020,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,130,71.3,57.7,84.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,INCOME1,CAT6,_RFPSA23,RESP054,"(34.52088095200048, -106.24058098499967)"
|
|
2020,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,82,21,14.2,27.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,INCOME2,CAT6,_RFPSA23,RESP046,"(34.52088095200048, -106.24058098499967)"
|
|
2020,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,259,79,72.2,85.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,INCOME2,CAT6,_RFPSA23,RESP054,"(34.52088095200048, -106.24058098499967)"
|
|
2020,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,39,14.2,7.8,20.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,INCOME3,CAT6,_RFPSA23,RESP046,"(34.52088095200048, -106.24058098499967)"
|
|
2020,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,129,85.8,79.4,92.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,INCOME3,CAT6,_RFPSA23,RESP054,"(34.52088095200048, -106.24058098499967)"
|
|
2020,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,67,24.6,16.4,32.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,INCOME4,CAT6,_RFPSA23,RESP046,"(34.52088095200048, -106.24058098499967)"
|
|
2020,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,144,75.4,67.3,83.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,INCOME4,CAT6,_RFPSA23,RESP054,"(34.52088095200048, -106.24058098499967)"
|
|
2020,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,383,32.6,28.4,36.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,INCOME5,CAT6,_RFPSA23,RESP046,"(34.52088095200048, -106.24058098499967)"
|
|
2020,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,549,67.4,63.2,71.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,INCOME5,CAT6,_RFPSA23,RESP054,"(34.52088095200048, -106.24058098499967)"
|
|
2020,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,501,35.1,31.3,39,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,RACE01,CAT4,_RFPSA23,RESP046,"(34.52088095200048, -106.24058098499967)"
|
|
2020,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,755,64.9,61,68.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,RACE01,CAT4,_RFPSA23,RESP054,"(34.52088095200048, -106.24058098499967)"
|
|
2020,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,35,RACE02,CAT4,_RFPSA23,RESP046,"(34.52088095200048, -106.24058098499967)"
|
|
2020,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,17,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,35,RACE02,CAT4,_RFPSA23,RESP054,"(34.52088095200048, -106.24058098499967)"
|
|
2020,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,19,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,35,RACE03,CAT4,_RFPSA23,RESP046,"(34.52088095200048, -106.24058098499967)"
|
|
2020,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,125,80.7,63.1,98.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,RACE03,CAT4,_RFPSA23,RESP054,"(34.52088095200048, -106.24058098499967)"
|
|
2020,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,35,RACE04,CAT4,_RFPSA23,RESP046,"(34.52088095200048, -106.24058098499967)"
|
|
2020,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,35,RACE04,CAT4,_RFPSA23,RESP054,"(34.52088095200048, -106.24058098499967)"
|
|
2020,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,35,RACE05,CAT4,_RFPSA23,RESP046,"(34.52088095200048, -106.24058098499967)"
|
|
2020,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,35,RACE05,CAT4,_RFPSA23,RESP054,"(34.52088095200048, -106.24058098499967)"
|
|
2020,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,35,RACE06,CAT4,_RFPSA23,RESP046,"(34.52088095200048, -106.24058098499967)"
|
|
2020,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,35,RACE06,CAT4,_RFPSA23,RESP054,"(34.52088095200048, -106.24058098499967)"
|
|
2020,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,35,RACE07,CAT4,_RFPSA23,RESP046,"(34.52088095200048, -106.24058098499967)"
|
|
2020,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,13,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,35,RACE07,CAT4,_RFPSA23,RESP054,"(34.52088095200048, -106.24058098499967)"
|
|
2020,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,134,18.3,14.1,22.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,RACE08,CAT4,_RFPSA23,RESP046,"(34.52088095200048, -106.24058098499967)"
|
|
2020,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,445,81.7,77.5,85.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,RACE08,CAT4,_RFPSA23,RESP054,"(34.52088095200048, -106.24058098499967)"
|
|
2020,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,675,26.7,23.8,29.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,SEX1,CAT2,_RFPSA23,RESP046,"(34.52088095200048, -106.24058098499967)"
|
|
2020,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1364,73.3,70.5,76.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,35,SEX1,CAT2,_RFPSA23,RESP054,"(34.52088095200048, -106.24058098499967)"
|
|
2020,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,35,SEX2,CAT2,_RFPSA23,RESP046,"(34.52088095200048, -106.24058098499967)"
|
|
2020,NM,New Mexico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,35,SEX2,CAT2,_RFPSA23,RESP054,"(34.52088095200048, -106.24058098499967)"
|
|
2020,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,65,8.3,5.8,10.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,AGE06,CAT3,_RFPSA23,RESP046,"(42.82700103200045, -75.54397042699964)"
|
|
2020,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,675,91.7,89.2,94.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,AGE06,CAT3,_RFPSA23,RESP054,"(42.82700103200045, -75.54397042699964)"
|
|
2020,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,328,29.9,26.1,33.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,AGE07,CAT3,_RFPSA23,RESP046,"(42.82700103200045, -75.54397042699964)"
|
|
2020,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,685,70.1,66.4,73.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,AGE07,CAT3,_RFPSA23,RESP054,"(42.82700103200045, -75.54397042699964)"
|
|
2020,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,275,42.6,37.4,47.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,AGE08,CAT3,_RFPSA23,RESP046,"(42.82700103200045, -75.54397042699964)"
|
|
2020,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,343,57.4,52.2,62.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,AGE08,CAT3,_RFPSA23,RESP054,"(42.82700103200045, -75.54397042699964)"
|
|
2020,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,872,51.2,47.6,54.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,AGE09,CAT3,_RFPSA23,RESP046,"(42.82700103200045, -75.54397042699964)"
|
|
2020,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,714,48.8,45.1,52.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,AGE09,CAT3,_RFPSA23,RESP054,"(42.82700103200045, -75.54397042699964)"
|
|
2020,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1540,33.3,31.3,35.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,BO1,CAT1,_RFPSA23,RESP046,"(42.82700103200045, -75.54397042699964)"
|
|
2020,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,2417,66.7,64.8,68.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,BO1,CAT1,_RFPSA23,RESP054,"(42.82700103200045, -75.54397042699964)"
|
|
2020,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,48,15.2,10.2,20.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,EDUCA1,CAT5,_RFPSA23,RESP046,"(42.82700103200045, -75.54397042699964)"
|
|
2020,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,256,84.8,79.8,89.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,EDUCA1,CAT5,_RFPSA23,RESP054,"(42.82700103200045, -75.54397042699964)"
|
|
2020,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,305,28.8,25.1,32.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,EDUCA2,CAT5,_RFPSA23,RESP046,"(42.82700103200045, -75.54397042699964)"
|
|
2020,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,674,71.2,67.6,74.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,EDUCA2,CAT5,_RFPSA23,RESP054,"(42.82700103200045, -75.54397042699964)"
|
|
2020,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,387,38.7,34.5,42.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,EDUCA3,CAT5,_RFPSA23,RESP046,"(42.82700103200045, -75.54397042699964)"
|
|
2020,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,517,61.3,57.1,65.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,EDUCA3,CAT5,_RFPSA23,RESP054,"(42.82700103200045, -75.54397042699964)"
|
|
2020,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,798,42.2,39.3,45.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,EDUCA4,CAT5,_RFPSA23,RESP046,"(42.82700103200045, -75.54397042699964)"
|
|
2020,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,952,57.8,54.9,60.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,EDUCA4,CAT5,_RFPSA23,RESP054,"(42.82700103200045, -75.54397042699964)"
|
|
2020,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,47,15.6,9.2,21.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,INCOME1,CAT6,_RFPSA23,RESP046,"(42.82700103200045, -75.54397042699964)"
|
|
2020,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,212,84.4,78.1,90.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,INCOME1,CAT6,_RFPSA23,RESP054,"(42.82700103200045, -75.54397042699964)"
|
|
2020,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,117,23.5,18.1,28.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,INCOME2,CAT6,_RFPSA23,RESP046,"(42.82700103200045, -75.54397042699964)"
|
|
2020,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,289,76.5,71.1,81.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,INCOME2,CAT6,_RFPSA23,RESP054,"(42.82700103200045, -75.54397042699964)"
|
|
2020,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,80,25.5,18.2,32.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,INCOME3,CAT6,_RFPSA23,RESP046,"(42.82700103200045, -75.54397042699964)"
|
|
2020,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,179,74.5,67.2,81.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,INCOME3,CAT6,_RFPSA23,RESP054,"(42.82700103200045, -75.54397042699964)"
|
|
2020,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,146,28.1,22.4,33.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,INCOME4,CAT6,_RFPSA23,RESP046,"(42.82700103200045, -75.54397042699964)"
|
|
2020,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,242,71.9,66.2,77.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,INCOME4,CAT6,_RFPSA23,RESP054,"(42.82700103200045, -75.54397042699964)"
|
|
2020,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,934,40.8,38,43.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,INCOME5,CAT6,_RFPSA23,RESP046,"(42.82700103200045, -75.54397042699964)"
|
|
2020,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,1120,59.2,56.5,62,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,INCOME5,CAT6,_RFPSA23,RESP054,"(42.82700103200045, -75.54397042699964)"
|
|
2020,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1275,39.4,37.2,41.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,RACE01,CAT4,_RFPSA23,RESP046,"(42.82700103200045, -75.54397042699964)"
|
|
2020,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1671,60.6,58.3,62.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,RACE01,CAT4,_RFPSA23,RESP054,"(42.82700103200045, -75.54397042699964)"
|
|
2020,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,108,31.5,25.3,37.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,RACE02,CAT4,_RFPSA23,RESP046,"(42.82700103200045, -75.54397042699964)"
|
|
2020,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,208,68.5,62.4,74.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,RACE02,CAT4,_RFPSA23,RESP054,"(42.82700103200045, -75.54397042699964)"
|
|
2020,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,36,RACE03,CAT4,_RFPSA23,RESP046,"(42.82700103200045, -75.54397042699964)"
|
|
2020,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,25,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,36,RACE03,CAT4,_RFPSA23,RESP054,"(42.82700103200045, -75.54397042699964)"
|
|
2020,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,21,16.4,8.3,24.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,RACE04,CAT4,_RFPSA23,RESP046,"(42.82700103200045, -75.54397042699964)"
|
|
2020,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,112,83.6,75.6,91.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,RACE04,CAT4,_RFPSA23,RESP054,"(42.82700103200045, -75.54397042699964)"
|
|
2020,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,36,RACE05,CAT4,_RFPSA23,RESP046,"(42.82700103200045, -75.54397042699964)"
|
|
2020,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,36,RACE05,CAT4,_RFPSA23,RESP054,"(42.82700103200045, -75.54397042699964)"
|
|
2020,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,37,38.7,26.6,50.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,RACE06,CAT4,_RFPSA23,RESP046,"(42.82700103200045, -75.54397042699964)"
|
|
2020,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,68,61.3,49.1,73.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,RACE06,CAT4,_RFPSA23,RESP054,"(42.82700103200045, -75.54397042699964)"
|
|
2020,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,17,36,17.4,54.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,RACE07,CAT4,_RFPSA23,RESP046,"(42.82700103200045, -75.54397042699964)"
|
|
2020,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,35,64,45.4,82.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,RACE07,CAT4,_RFPSA23,RESP054,"(42.82700103200045, -75.54397042699964)"
|
|
2020,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,76,19.4,14.5,24.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,RACE08,CAT4,_RFPSA23,RESP046,"(42.82700103200045, -75.54397042699964)"
|
|
2020,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,292,80.6,75.7,85.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,RACE08,CAT4,_RFPSA23,RESP054,"(42.82700103200045, -75.54397042699964)"
|
|
2020,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1540,33.3,31.3,35.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,SEX1,CAT2,_RFPSA23,RESP046,"(42.82700103200045, -75.54397042699964)"
|
|
2020,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,2417,66.7,64.8,68.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,36,SEX1,CAT2,_RFPSA23,RESP054,"(42.82700103200045, -75.54397042699964)"
|
|
2020,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,36,SEX2,CAT2,_RFPSA23,RESP046,"(42.82700103200045, -75.54397042699964)"
|
|
2020,NY,New York,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,36,SEX2,CAT2,_RFPSA23,RESP054,"(42.82700103200045, -75.54397042699964)"
|
|
2020,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,37,11.2,7.3,15.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,AGE06,CAT3,_RFPSA23,RESP046,"(35.466220975000454, -79.15925046299964)"
|
|
2020,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,277,88.8,84.8,92.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,AGE06,CAT3,_RFPSA23,RESP054,"(35.466220975000454, -79.15925046299964)"
|
|
2020,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,129,32.1,26.8,37.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,AGE07,CAT3,_RFPSA23,RESP046,"(35.466220975000454, -79.15925046299964)"
|
|
2020,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,270,67.9,62.6,73.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,AGE07,CAT3,_RFPSA23,RESP054,"(35.466220975000454, -79.15925046299964)"
|
|
2020,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,97,49.2,40.8,57.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,AGE08,CAT3,_RFPSA23,RESP046,"(35.466220975000454, -79.15925046299964)"
|
|
2020,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,108,50.8,42.4,59.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,AGE08,CAT3,_RFPSA23,RESP054,"(35.466220975000454, -79.15925046299964)"
|
|
2020,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,357,56.8,51.9,61.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,AGE09,CAT3,_RFPSA23,RESP046,"(35.466220975000454, -79.15925046299964)"
|
|
2020,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,257,43.2,38.2,48.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,AGE09,CAT3,_RFPSA23,RESP054,"(35.466220975000454, -79.15925046299964)"
|
|
2020,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,620,37.4,34.5,40.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,BO1,CAT1,_RFPSA23,RESP046,"(35.466220975000454, -79.15925046299964)"
|
|
2020,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,912,62.6,59.7,65.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,BO1,CAT1,_RFPSA23,RESP054,"(35.466220975000454, -79.15925046299964)"
|
|
2020,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,45,30.1,20.4,39.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,EDUCA1,CAT5,_RFPSA23,RESP046,"(35.466220975000454, -79.15925046299964)"
|
|
2020,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,84,69.9,60.2,79.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,EDUCA1,CAT5,_RFPSA23,RESP054,"(35.466220975000454, -79.15925046299964)"
|
|
2020,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,128,34.5,28.7,40.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,EDUCA2,CAT5,_RFPSA23,RESP046,"(35.466220975000454, -79.15925046299964)"
|
|
2020,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,247,65.5,59.8,71.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,EDUCA2,CAT5,_RFPSA23,RESP054,"(35.466220975000454, -79.15925046299964)"
|
|
2020,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,162,35.2,29.9,40.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,EDUCA3,CAT5,_RFPSA23,RESP046,"(35.466220975000454, -79.15925046299964)"
|
|
2020,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,275,64.8,59.6,70.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,EDUCA3,CAT5,_RFPSA23,RESP054,"(35.466220975000454, -79.15925046299964)"
|
|
2020,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,284,45.4,40.8,50,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,EDUCA4,CAT5,_RFPSA23,RESP046,"(35.466220975000454, -79.15925046299964)"
|
|
2020,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,304,54.6,50,59.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,EDUCA4,CAT5,_RFPSA23,RESP054,"(35.466220975000454, -79.15925046299964)"
|
|
2020,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,24,30.8,15.4,46.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,INCOME1,CAT6,_RFPSA23,RESP046,"(35.466220975000454, -79.15925046299964)"
|
|
2020,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,44,69.2,53.9,84.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,INCOME1,CAT6,_RFPSA23,RESP054,"(35.466220975000454, -79.15925046299964)"
|
|
2020,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,65,32.6,23.8,41.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,INCOME2,CAT6,_RFPSA23,RESP046,"(35.466220975000454, -79.15925046299964)"
|
|
2020,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,117,67.4,58.6,76.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,INCOME2,CAT6,_RFPSA23,RESP054,"(35.466220975000454, -79.15925046299964)"
|
|
2020,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,43,35.1,25.2,44.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,INCOME3,CAT6,_RFPSA23,RESP046,"(35.466220975000454, -79.15925046299964)"
|
|
2020,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,74,64.9,55.1,74.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,INCOME3,CAT6,_RFPSA23,RESP054,"(35.466220975000454, -79.15925046299964)"
|
|
2020,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,65,39.8,30.6,49,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,INCOME4,CAT6,_RFPSA23,RESP046,"(35.466220975000454, -79.15925046299964)"
|
|
2020,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,91,60.2,51,69.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,INCOME4,CAT6,_RFPSA23,RESP054,"(35.466220975000454, -79.15925046299964)"
|
|
2020,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,341,40.9,36.8,45,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,INCOME5,CAT6,_RFPSA23,RESP046,"(35.466220975000454, -79.15925046299964)"
|
|
2020,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,442,59.1,55,63.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,INCOME5,CAT6,_RFPSA23,RESP054,"(35.466220975000454, -79.15925046299964)"
|
|
2020,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,447,38,34.6,41.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,RACE01,CAT4,_RFPSA23,RESP046,"(35.466220975000454, -79.15925046299964)"
|
|
2020,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,651,62,58.6,65.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,RACE01,CAT4,_RFPSA23,RESP054,"(35.466220975000454, -79.15925046299964)"
|
|
2020,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,124,37.7,30.8,44.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,RACE02,CAT4,_RFPSA23,RESP046,"(35.466220975000454, -79.15925046299964)"
|
|
2020,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,151,62.3,55.3,69.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,RACE02,CAT4,_RFPSA23,RESP054,"(35.466220975000454, -79.15925046299964)"
|
|
2020,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,11,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,37,RACE03,CAT4,_RFPSA23,RESP046,"(35.466220975000454, -79.15925046299964)"
|
|
2020,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,36,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,37,RACE03,CAT4,_RFPSA23,RESP054,"(35.466220975000454, -79.15925046299964)"
|
|
2020,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,37,RACE04,CAT4,_RFPSA23,RESP046,"(35.466220975000454, -79.15925046299964)"
|
|
2020,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,37,RACE04,CAT4,_RFPSA23,RESP054,"(35.466220975000454, -79.15925046299964)"
|
|
2020,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,37,RACE05,CAT4,_RFPSA23,RESP046,"(35.466220975000454, -79.15925046299964)"
|
|
2020,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,37,RACE05,CAT4,_RFPSA23,RESP054,"(35.466220975000454, -79.15925046299964)"
|
|
2020,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,37,RACE06,CAT4,_RFPSA23,RESP046,"(35.466220975000454, -79.15925046299964)"
|
|
2020,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,37,RACE06,CAT4,_RFPSA23,RESP054,"(35.466220975000454, -79.15925046299964)"
|
|
2020,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,37,RACE07,CAT4,_RFPSA23,RESP046,"(35.466220975000454, -79.15925046299964)"
|
|
2020,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,16,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,37,RACE07,CAT4,_RFPSA23,RESP054,"(35.466220975000454, -79.15925046299964)"
|
|
2020,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,26,34.2,21.5,47,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,RACE08,CAT4,_RFPSA23,RESP046,"(35.466220975000454, -79.15925046299964)"
|
|
2020,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,40,65.8,53,78.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,RACE08,CAT4,_RFPSA23,RESP054,"(35.466220975000454, -79.15925046299964)"
|
|
2020,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,620,37.4,34.5,40.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,SEX1,CAT2,_RFPSA23,RESP046,"(35.466220975000454, -79.15925046299964)"
|
|
2020,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,912,62.6,59.7,65.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,37,SEX1,CAT2,_RFPSA23,RESP054,"(35.466220975000454, -79.15925046299964)"
|
|
2020,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,37,SEX2,CAT2,_RFPSA23,RESP046,"(35.466220975000454, -79.15925046299964)"
|
|
2020,NC,North Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,37,SEX2,CAT2,_RFPSA23,RESP054,"(35.466220975000454, -79.15925046299964)"
|
|
2020,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,38,AGE06,CAT3,_RFPSA23,RESP046,"(47.47531977900047, -100.11842104899966)"
|
|
2020,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,198,97.2,94.9,99.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,AGE06,CAT3,_RFPSA23,RESP054,"(47.47531977900047, -100.11842104899966)"
|
|
2020,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,72,24.4,18.4,30.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,AGE07,CAT3,_RFPSA23,RESP046,"(47.47531977900047, -100.11842104899966)"
|
|
2020,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,195,75.6,69.7,81.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,AGE07,CAT3,_RFPSA23,RESP054,"(47.47531977900047, -100.11842104899966)"
|
|
2020,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,90,37.4,29.6,45.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,AGE08,CAT3,_RFPSA23,RESP046,"(47.47531977900047, -100.11842104899966)"
|
|
2020,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,121,62.6,54.8,70.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,AGE08,CAT3,_RFPSA23,RESP054,"(47.47531977900047, -100.11842104899966)"
|
|
2020,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,355,46.8,42.4,51.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,AGE09,CAT3,_RFPSA23,RESP046,"(47.47531977900047, -100.11842104899966)"
|
|
2020,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,383,53.2,48.7,57.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,AGE09,CAT3,_RFPSA23,RESP054,"(47.47531977900047, -100.11842104899966)"
|
|
2020,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,525,29.3,26.5,32,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,BO1,CAT1,_RFPSA23,RESP046,"(47.47531977900047, -100.11842104899966)"
|
|
2020,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,897,70.7,68,73.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,BO1,CAT1,_RFPSA23,RESP054,"(47.47531977900047, -100.11842104899966)"
|
|
2020,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,19,15.9,7.8,24,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,EDUCA1,CAT5,_RFPSA23,RESP046,"(47.47531977900047, -100.11842104899966)"
|
|
2020,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,51,84.1,76,92.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,EDUCA1,CAT5,_RFPSA23,RESP054,"(47.47531977900047, -100.11842104899966)"
|
|
2020,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,132,30,24.7,35.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,EDUCA2,CAT5,_RFPSA23,RESP046,"(47.47531977900047, -100.11842104899966)"
|
|
2020,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,251,70,64.8,75.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,EDUCA2,CAT5,_RFPSA23,RESP054,"(47.47531977900047, -100.11842104899966)"
|
|
2020,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,158,28.3,23.6,33,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,EDUCA3,CAT5,_RFPSA23,RESP046,"(47.47531977900047, -100.11842104899966)"
|
|
2020,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,312,71.7,67,76.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,EDUCA3,CAT5,_RFPSA23,RESP054,"(47.47531977900047, -100.11842104899966)"
|
|
2020,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,216,34.8,29.8,39.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,EDUCA4,CAT5,_RFPSA23,RESP046,"(47.47531977900047, -100.11842104899966)"
|
|
2020,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,282,65.2,60.3,70.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,EDUCA4,CAT5,_RFPSA23,RESP054,"(47.47531977900047, -100.11842104899966)"
|
|
2020,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,15,28.2,11.8,44.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,INCOME1,CAT6,_RFPSA23,RESP046,"(47.47531977900047, -100.11842104899966)"
|
|
2020,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,41,71.8,55.4,88.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,INCOME1,CAT6,_RFPSA23,RESP054,"(47.47531977900047, -100.11842104899966)"
|
|
2020,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,33,25.1,15.3,34.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,INCOME2,CAT6,_RFPSA23,RESP046,"(47.47531977900047, -100.11842104899966)"
|
|
2020,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,88,74.9,65.2,84.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,INCOME2,CAT6,_RFPSA23,RESP054,"(47.47531977900047, -100.11842104899966)"
|
|
2020,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,35,33.6,22.3,44.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,INCOME3,CAT6,_RFPSA23,RESP046,"(47.47531977900047, -100.11842104899966)"
|
|
2020,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,64,66.4,55.1,77.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,INCOME3,CAT6,_RFPSA23,RESP054,"(47.47531977900047, -100.11842104899966)"
|
|
2020,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,52,26,18.2,33.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,INCOME4,CAT6,_RFPSA23,RESP046,"(47.47531977900047, -100.11842104899966)"
|
|
2020,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,110,74,66.2,81.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,INCOME4,CAT6,_RFPSA23,RESP054,"(47.47531977900047, -100.11842104899966)"
|
|
2020,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,309,29.6,26,33.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,INCOME5,CAT6,_RFPSA23,RESP046,"(47.47531977900047, -100.11842104899966)"
|
|
2020,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,489,70.4,66.8,74,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,INCOME5,CAT6,_RFPSA23,RESP054,"(47.47531977900047, -100.11842104899966)"
|
|
2020,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,501,30.8,27.9,33.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,RACE01,CAT4,_RFPSA23,RESP046,"(47.47531977900047, -100.11842104899966)"
|
|
2020,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,819,69.2,66.3,72.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,RACE01,CAT4,_RFPSA23,RESP054,"(47.47531977900047, -100.11842104899966)"
|
|
2020,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,38,RACE02,CAT4,_RFPSA23,RESP046,"(47.47531977900047, -100.11842104899966)"
|
|
2020,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,38,RACE02,CAT4,_RFPSA23,RESP054,"(47.47531977900047, -100.11842104899966)"
|
|
2020,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,13,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,38,RACE03,CAT4,_RFPSA23,RESP046,"(47.47531977900047, -100.11842104899966)"
|
|
2020,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,40,82.4,71.4,93.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,RACE03,CAT4,_RFPSA23,RESP054,"(47.47531977900047, -100.11842104899966)"
|
|
2020,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,38,RACE04,CAT4,_RFPSA23,RESP046,"(47.47531977900047, -100.11842104899966)"
|
|
2020,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,38,RACE04,CAT4,_RFPSA23,RESP054,"(47.47531977900047, -100.11842104899966)"
|
|
2020,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,38,RACE05,CAT4,_RFPSA23,RESP046,"(47.47531977900047, -100.11842104899966)"
|
|
2020,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,38,RACE05,CAT4,_RFPSA23,RESP054,"(47.47531977900047, -100.11842104899966)"
|
|
2020,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,38,RACE06,CAT4,_RFPSA23,RESP046,"(47.47531977900047, -100.11842104899966)"
|
|
2020,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,38,RACE06,CAT4,_RFPSA23,RESP054,"(47.47531977900047, -100.11842104899966)"
|
|
2020,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,38,RACE07,CAT4,_RFPSA23,RESP046,"(47.47531977900047, -100.11842104899966)"
|
|
2020,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,38,RACE07,CAT4,_RFPSA23,RESP054,"(47.47531977900047, -100.11842104899966)"
|
|
2020,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,38,RACE08,CAT4,_RFPSA23,RESP046,"(47.47531977900047, -100.11842104899966)"
|
|
2020,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,38,RACE08,CAT4,_RFPSA23,RESP054,"(47.47531977900047, -100.11842104899966)"
|
|
2020,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,525,29.3,26.5,32,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,SEX1,CAT2,_RFPSA23,RESP046,"(47.47531977900047, -100.11842104899966)"
|
|
2020,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,897,70.7,68,73.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,38,SEX1,CAT2,_RFPSA23,RESP054,"(47.47531977900047, -100.11842104899966)"
|
|
2020,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,38,SEX2,CAT2,_RFPSA23,RESP046,"(47.47531977900047, -100.11842104899966)"
|
|
2020,ND,North Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,38,SEX2,CAT2,_RFPSA23,RESP054,"(47.47531977900047, -100.11842104899966)"
|
|
2020,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,56,6.4,4,8.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,AGE06,CAT3,_RFPSA23,RESP046,"(40.06021014100048, -82.40426005599966)"
|
|
2020,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,708,93.6,91.3,96,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,AGE06,CAT3,_RFPSA23,RESP054,"(40.06021014100048, -82.40426005599966)"
|
|
2020,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,285,28.1,24.4,31.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,AGE07,CAT3,_RFPSA23,RESP046,"(40.06021014100048, -82.40426005599966)"
|
|
2020,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,733,71.9,68.2,75.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,AGE07,CAT3,_RFPSA23,RESP054,"(40.06021014100048, -82.40426005599966)"
|
|
2020,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,267,40.9,35.7,46.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,AGE08,CAT3,_RFPSA23,RESP046,"(40.06021014100048, -82.40426005599966)"
|
|
2020,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,359,59.1,53.9,64.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,AGE08,CAT3,_RFPSA23,RESP054,"(40.06021014100048, -82.40426005599966)"
|
|
2020,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,884,49.4,46.1,52.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,AGE09,CAT3,_RFPSA23,RESP046,"(40.06021014100048, -82.40426005599966)"
|
|
2020,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,800,50.6,47.2,53.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,AGE09,CAT3,_RFPSA23,RESP054,"(40.06021014100048, -82.40426005599966)"
|
|
2020,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1492,32,30.1,33.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,BO1,CAT1,_RFPSA23,RESP046,"(40.06021014100048, -82.40426005599966)"
|
|
2020,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,2600,68,66.1,69.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,BO1,CAT1,_RFPSA23,RESP054,"(40.06021014100048, -82.40426005599966)"
|
|
2020,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,61,18.4,12.6,24.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,EDUCA1,CAT5,_RFPSA23,RESP046,"(40.06021014100048, -82.40426005599966)"
|
|
2020,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,213,81.6,75.8,87.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,EDUCA1,CAT5,_RFPSA23,RESP054,"(40.06021014100048, -82.40426005599966)"
|
|
2020,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,450,27.5,24.4,30.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,EDUCA2,CAT5,_RFPSA23,RESP046,"(40.06021014100048, -82.40426005599966)"
|
|
2020,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,1021,72.5,69.4,75.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,EDUCA2,CAT5,_RFPSA23,RESP054,"(40.06021014100048, -82.40426005599966)"
|
|
2020,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,398,35.4,31.5,39.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,EDUCA3,CAT5,_RFPSA23,RESP046,"(40.06021014100048, -82.40426005599966)"
|
|
2020,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,606,64.6,60.7,68.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,EDUCA3,CAT5,_RFPSA23,RESP054,"(40.06021014100048, -82.40426005599966)"
|
|
2020,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,581,39.3,36,42.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,EDUCA4,CAT5,_RFPSA23,RESP046,"(40.06021014100048, -82.40426005599966)"
|
|
2020,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,755,60.7,57.3,64,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,EDUCA4,CAT5,_RFPSA23,RESP054,"(40.06021014100048, -82.40426005599966)"
|
|
2020,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,55,15,9.7,20.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,INCOME1,CAT6,_RFPSA23,RESP046,"(40.06021014100048, -82.40426005599966)"
|
|
2020,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,210,85,79.8,90.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,INCOME1,CAT6,_RFPSA23,RESP054,"(40.06021014100048, -82.40426005599966)"
|
|
2020,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,165,26.6,21.2,31.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,INCOME2,CAT6,_RFPSA23,RESP046,"(40.06021014100048, -82.40426005599966)"
|
|
2020,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,379,73.4,68.1,78.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,INCOME2,CAT6,_RFPSA23,RESP054,"(40.06021014100048, -82.40426005599966)"
|
|
2020,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,138,35.8,29,42.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,INCOME3,CAT6,_RFPSA23,RESP046,"(40.06021014100048, -82.40426005599966)"
|
|
2020,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,213,64.2,57.5,71,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,INCOME3,CAT6,_RFPSA23,RESP054,"(40.06021014100048, -82.40426005599966)"
|
|
2020,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,203,35.5,30.1,40.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,INCOME4,CAT6,_RFPSA23,RESP046,"(40.06021014100048, -82.40426005599966)"
|
|
2020,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,325,64.5,59.1,69.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,INCOME4,CAT6,_RFPSA23,RESP054,"(40.06021014100048, -82.40426005599966)"
|
|
2020,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,712,33.6,30.7,36.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,INCOME5,CAT6,_RFPSA23,RESP046,"(40.06021014100048, -82.40426005599966)"
|
|
2020,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,1112,66.4,63.6,69.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,INCOME5,CAT6,_RFPSA23,RESP054,"(40.06021014100048, -82.40426005599966)"
|
|
2020,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1368,33.7,31.7,35.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,RACE01,CAT4,_RFPSA23,RESP046,"(40.06021014100048, -82.40426005599966)"
|
|
2020,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,2295,66.3,64.3,68.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,RACE01,CAT4,_RFPSA23,RESP054,"(40.06021014100048, -82.40426005599966)"
|
|
2020,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,56,22.5,15.5,29.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,RACE02,CAT4,_RFPSA23,RESP046,"(40.06021014100048, -82.40426005599966)"
|
|
2020,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,159,77.5,70.5,84.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,RACE02,CAT4,_RFPSA23,RESP054,"(40.06021014100048, -82.40426005599966)"
|
|
2020,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,39,RACE03,CAT4,_RFPSA23,RESP046,"(40.06021014100048, -82.40426005599966)"
|
|
2020,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,22,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,39,RACE03,CAT4,_RFPSA23,RESP054,"(40.06021014100048, -82.40426005599966)"
|
|
2020,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,39,RACE04,CAT4,_RFPSA23,RESP046,"(40.06021014100048, -82.40426005599966)"
|
|
2020,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,15,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,39,RACE04,CAT4,_RFPSA23,RESP054,"(40.06021014100048, -82.40426005599966)"
|
|
2020,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,39,RACE05,CAT4,_RFPSA23,RESP046,"(40.06021014100048, -82.40426005599966)"
|
|
2020,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,39,RACE05,CAT4,_RFPSA23,RESP054,"(40.06021014100048, -82.40426005599966)"
|
|
2020,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,39,RACE06,CAT4,_RFPSA23,RESP046,"(40.06021014100048, -82.40426005599966)"
|
|
2020,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,22,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,39,RACE06,CAT4,_RFPSA23,RESP054,"(40.06021014100048, -82.40426005599966)"
|
|
2020,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,35,56.5,40.1,72.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,RACE07,CAT4,_RFPSA23,RESP046,"(40.06021014100048, -82.40426005599966)"
|
|
2020,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,41,43.5,27.2,59.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,RACE07,CAT4,_RFPSA23,RESP054,"(40.06021014100048, -82.40426005599966)"
|
|
2020,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,39,RACE08,CAT4,_RFPSA23,RESP046,"(40.06021014100048, -82.40426005599966)"
|
|
2020,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,45,89.6,81.8,97.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,RACE08,CAT4,_RFPSA23,RESP054,"(40.06021014100048, -82.40426005599966)"
|
|
2020,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1492,32,30.1,33.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,SEX1,CAT2,_RFPSA23,RESP046,"(40.06021014100048, -82.40426005599966)"
|
|
2020,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,2600,68,66.1,69.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,39,SEX1,CAT2,_RFPSA23,RESP054,"(40.06021014100048, -82.40426005599966)"
|
|
2020,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,39,SEX2,CAT2,_RFPSA23,RESP046,"(40.06021014100048, -82.40426005599966)"
|
|
2020,OH,Ohio,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,39,SEX2,CAT2,_RFPSA23,RESP054,"(40.06021014100048, -82.40426005599966)"
|
|
2020,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,16,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,40,AGE06,CAT3,_RFPSA23,RESP046,"(35.47203135600046, -97.52107021399968)"
|
|
2020,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,241,94,90.5,97.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,AGE06,CAT3,_RFPSA23,RESP054,"(35.47203135600046, -97.52107021399968)"
|
|
2020,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,74,22,16.8,27.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,AGE07,CAT3,_RFPSA23,RESP046,"(35.47203135600046, -97.52107021399968)"
|
|
2020,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,238,78,72.9,83.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,AGE07,CAT3,_RFPSA23,RESP054,"(35.47203135600046, -97.52107021399968)"
|
|
2020,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,85,41.6,33.2,49.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,AGE08,CAT3,_RFPSA23,RESP046,"(35.47203135600046, -97.52107021399968)"
|
|
2020,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,102,58.4,50.1,66.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,AGE08,CAT3,_RFPSA23,RESP054,"(35.47203135600046, -97.52107021399968)"
|
|
2020,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,292,46,41.1,50.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,AGE09,CAT3,_RFPSA23,RESP046,"(35.47203135600046, -97.52107021399968)"
|
|
2020,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,294,54,49.2,58.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,AGE09,CAT3,_RFPSA23,RESP054,"(35.47203135600046, -97.52107021399968)"
|
|
2020,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,467,28.7,25.9,31.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,BO1,CAT1,_RFPSA23,RESP046,"(35.47203135600046, -97.52107021399968)"
|
|
2020,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,875,71.3,68.5,74.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,BO1,CAT1,_RFPSA23,RESP054,"(35.47203135600046, -97.52107021399968)"
|
|
2020,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,9,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,40,EDUCA1,CAT5,_RFPSA23,RESP046,"(35.47203135600046, -97.52107021399968)"
|
|
2020,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,89,92.2,86.1,98.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,EDUCA1,CAT5,_RFPSA23,RESP054,"(35.47203135600046, -97.52107021399968)"
|
|
2020,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,95,24.6,19.4,29.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,EDUCA2,CAT5,_RFPSA23,RESP046,"(35.47203135600046, -97.52107021399968)"
|
|
2020,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,276,75.4,70.3,80.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,EDUCA2,CAT5,_RFPSA23,RESP054,"(35.47203135600046, -97.52107021399968)"
|
|
2020,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,140,32.6,27.3,37.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,EDUCA3,CAT5,_RFPSA23,RESP046,"(35.47203135600046, -97.52107021399968)"
|
|
2020,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,240,67.4,62.1,72.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,EDUCA3,CAT5,_RFPSA23,RESP054,"(35.47203135600046, -97.52107021399968)"
|
|
2020,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,222,39.7,34.7,44.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,EDUCA4,CAT5,_RFPSA23,RESP046,"(35.47203135600046, -97.52107021399968)"
|
|
2020,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,265,60.3,55.4,65.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,EDUCA4,CAT5,_RFPSA23,RESP054,"(35.47203135600046, -97.52107021399968)"
|
|
2020,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,40,INCOME1,CAT6,_RFPSA23,RESP046,"(35.47203135600046, -97.52107021399968)"
|
|
2020,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,82,90.9,84.5,97.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,INCOME1,CAT6,_RFPSA23,RESP054,"(35.47203135600046, -97.52107021399968)"
|
|
2020,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,36,15.6,9.8,21.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,INCOME2,CAT6,_RFPSA23,RESP046,"(35.47203135600046, -97.52107021399968)"
|
|
2020,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,114,84.4,78.5,90.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,INCOME2,CAT6,_RFPSA23,RESP054,"(35.47203135600046, -97.52107021399968)"
|
|
2020,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,44,30.2,21.2,39.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,INCOME3,CAT6,_RFPSA23,RESP046,"(35.47203135600046, -97.52107021399968)"
|
|
2020,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,93,69.8,60.9,78.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,INCOME3,CAT6,_RFPSA23,RESP054,"(35.47203135600046, -97.52107021399968)"
|
|
2020,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,59,28.8,20.8,36.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,INCOME4,CAT6,_RFPSA23,RESP046,"(35.47203135600046, -97.52107021399968)"
|
|
2020,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,110,71.2,63.3,79.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,INCOME4,CAT6,_RFPSA23,RESP054,"(35.47203135600046, -97.52107021399968)"
|
|
2020,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,260,35.1,30.7,39.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,INCOME5,CAT6,_RFPSA23,RESP046,"(35.47203135600046, -97.52107021399968)"
|
|
2020,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,365,64.9,60.6,69.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,INCOME5,CAT6,_RFPSA23,RESP054,"(35.47203135600046, -97.52107021399968)"
|
|
2020,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,405,32.8,29.5,36,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,RACE01,CAT4,_RFPSA23,RESP046,"(35.47203135600046, -97.52107021399968)"
|
|
2020,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,639,67.2,64,70.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,RACE01,CAT4,_RFPSA23,RESP054,"(35.47203135600046, -97.52107021399968)"
|
|
2020,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,19,27,14.8,39.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,RACE02,CAT4,_RFPSA23,RESP046,"(35.47203135600046, -97.52107021399968)"
|
|
2020,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,46,73,60.8,85.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,RACE02,CAT4,_RFPSA23,RESP054,"(35.47203135600046, -97.52107021399968)"
|
|
2020,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,25,16.5,9.6,23.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,RACE03,CAT4,_RFPSA23,RESP046,"(35.47203135600046, -97.52107021399968)"
|
|
2020,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,82,83.5,76.7,90.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,RACE03,CAT4,_RFPSA23,RESP054,"(35.47203135600046, -97.52107021399968)"
|
|
2020,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,40,RACE04,CAT4,_RFPSA23,RESP046,"(35.47203135600046, -97.52107021399968)"
|
|
2020,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,40,RACE04,CAT4,_RFPSA23,RESP054,"(35.47203135600046, -97.52107021399968)"
|
|
2020,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,40,RACE05,CAT4,_RFPSA23,RESP046,"(35.47203135600046, -97.52107021399968)"
|
|
2020,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,40,RACE05,CAT4,_RFPSA23,RESP054,"(35.47203135600046, -97.52107021399968)"
|
|
2020,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,40,RACE06,CAT4,_RFPSA23,RESP046,"(35.47203135600046, -97.52107021399968)"
|
|
2020,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,40,RACE06,CAT4,_RFPSA23,RESP054,"(35.47203135600046, -97.52107021399968)"
|
|
2020,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,40,RACE07,CAT4,_RFPSA23,RESP046,"(35.47203135600046, -97.52107021399968)"
|
|
2020,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,53,87.6,79,96.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,RACE07,CAT4,_RFPSA23,RESP054,"(35.47203135600046, -97.52107021399968)"
|
|
2020,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,40,RACE08,CAT4,_RFPSA23,RESP046,"(35.47203135600046, -97.52107021399968)"
|
|
2020,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,48,89.6,79.7,99.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,RACE08,CAT4,_RFPSA23,RESP054,"(35.47203135600046, -97.52107021399968)"
|
|
2020,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,467,28.7,25.9,31.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,SEX1,CAT2,_RFPSA23,RESP046,"(35.47203135600046, -97.52107021399968)"
|
|
2020,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,875,71.3,68.5,74.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,40,SEX1,CAT2,_RFPSA23,RESP054,"(35.47203135600046, -97.52107021399968)"
|
|
2020,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,40,SEX2,CAT2,_RFPSA23,RESP046,"(35.47203135600046, -97.52107021399968)"
|
|
2020,OK,Oklahoma,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,40,SEX2,CAT2,_RFPSA23,RESP054,"(35.47203135600046, -97.52107021399968)"
|
|
2020,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,24,6.3,3.7,9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,AGE06,CAT3,_RFPSA23,RESP046,"(44.56744942400047, -120.15503132599969)"
|
|
2020,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,310,93.7,91,96.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,AGE06,CAT3,_RFPSA23,RESP054,"(44.56744942400047, -120.15503132599969)"
|
|
2020,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,70,19.2,14.8,23.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,AGE07,CAT3,_RFPSA23,RESP046,"(44.56744942400047, -120.15503132599969)"
|
|
2020,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,277,80.8,76.3,85.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,AGE07,CAT3,_RFPSA23,RESP054,"(44.56744942400047, -120.15503132599969)"
|
|
2020,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,68,34.4,26.8,42,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,AGE08,CAT3,_RFPSA23,RESP046,"(44.56744942400047, -120.15503132599969)"
|
|
2020,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,119,65.6,58,73.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,AGE08,CAT3,_RFPSA23,RESP054,"(44.56744942400047, -120.15503132599969)"
|
|
2020,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,283,44.2,39.5,48.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,AGE09,CAT3,_RFPSA23,RESP046,"(44.56744942400047, -120.15503132599969)"
|
|
2020,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,323,55.8,51.1,60.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,AGE09,CAT3,_RFPSA23,RESP054,"(44.56744942400047, -120.15503132599969)"
|
|
2020,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,445,26.3,23.8,28.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,BO1,CAT1,_RFPSA23,RESP046,"(44.56744942400047, -120.15503132599969)"
|
|
2020,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1029,73.7,71.3,76.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,BO1,CAT1,_RFPSA23,RESP054,"(44.56744942400047, -120.15503132599969)"
|
|
2020,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,14,15.1,7.2,23,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,EDUCA1,CAT5,_RFPSA23,RESP046,"(44.56744942400047, -120.15503132599969)"
|
|
2020,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,62,84.9,77,92.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,EDUCA1,CAT5,_RFPSA23,RESP054,"(44.56744942400047, -120.15503132599969)"
|
|
2020,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,74,21,16.4,25.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,EDUCA2,CAT5,_RFPSA23,RESP046,"(44.56744942400047, -120.15503132599969)"
|
|
2020,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,259,79,74.3,83.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,EDUCA2,CAT5,_RFPSA23,RESP054,"(44.56744942400047, -120.15503132599969)"
|
|
2020,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,134,26.6,22.2,31,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,EDUCA3,CAT5,_RFPSA23,RESP046,"(44.56744942400047, -120.15503132599969)"
|
|
2020,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,298,73.4,69,77.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,EDUCA3,CAT5,_RFPSA23,RESP054,"(44.56744942400047, -120.15503132599969)"
|
|
2020,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,222,32.6,28.5,36.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,EDUCA4,CAT5,_RFPSA23,RESP046,"(44.56744942400047, -120.15503132599969)"
|
|
2020,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,403,67.4,63.4,71.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,EDUCA4,CAT5,_RFPSA23,RESP054,"(44.56744942400047, -120.15503132599969)"
|
|
2020,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,12,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,41,INCOME1,CAT6,_RFPSA23,RESP046,"(44.56744942400047, -120.15503132599969)"
|
|
2020,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,38,80.9,68.9,92.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,INCOME1,CAT6,_RFPSA23,RESP054,"(44.56744942400047, -120.15503132599969)"
|
|
2020,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,35,19.8,12.8,26.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,INCOME2,CAT6,_RFPSA23,RESP046,"(44.56744942400047, -120.15503132599969)"
|
|
2020,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,105,80.2,73.2,87.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,INCOME2,CAT6,_RFPSA23,RESP054,"(44.56744942400047, -120.15503132599969)"
|
|
2020,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,24,22,12,31.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,INCOME3,CAT6,_RFPSA23,RESP046,"(44.56744942400047, -120.15503132599969)"
|
|
2020,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,70,78,68.1,88,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,INCOME3,CAT6,_RFPSA23,RESP054,"(44.56744942400047, -120.15503132599969)"
|
|
2020,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,43,26.9,19.1,34.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,INCOME4,CAT6,_RFPSA23,RESP046,"(44.56744942400047, -120.15503132599969)"
|
|
2020,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,97,73.1,65.4,80.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,INCOME4,CAT6,_RFPSA23,RESP054,"(44.56744942400047, -120.15503132599969)"
|
|
2020,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,204,26.6,23,30.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,INCOME5,CAT6,_RFPSA23,RESP046,"(44.56744942400047, -120.15503132599969)"
|
|
2020,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,488,73.4,69.8,77,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,INCOME5,CAT6,_RFPSA23,RESP054,"(44.56744942400047, -120.15503132599969)"
|
|
2020,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,407,28.1,25.4,30.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,RACE01,CAT4,_RFPSA23,RESP046,"(44.56744942400047, -120.15503132599969)"
|
|
2020,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,896,71.9,69.2,74.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,RACE01,CAT4,_RFPSA23,RESP054,"(44.56744942400047, -120.15503132599969)"
|
|
2020,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,41,RACE02,CAT4,_RFPSA23,RESP046,"(44.56744942400047, -120.15503132599969)"
|
|
2020,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,12,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,41,RACE02,CAT4,_RFPSA23,RESP054,"(44.56744942400047, -120.15503132599969)"
|
|
2020,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,41,RACE03,CAT4,_RFPSA23,RESP046,"(44.56744942400047, -120.15503132599969)"
|
|
2020,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,15,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,41,RACE03,CAT4,_RFPSA23,RESP054,"(44.56744942400047, -120.15503132599969)"
|
|
2020,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,41,RACE04,CAT4,_RFPSA23,RESP046,"(44.56744942400047, -120.15503132599969)"
|
|
2020,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,20,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,41,RACE04,CAT4,_RFPSA23,RESP054,"(44.56744942400047, -120.15503132599969)"
|
|
2020,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,41,RACE05,CAT4,_RFPSA23,RESP046,"(44.56744942400047, -120.15503132599969)"
|
|
2020,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,41,RACE05,CAT4,_RFPSA23,RESP054,"(44.56744942400047, -120.15503132599969)"
|
|
2020,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,41,RACE06,CAT4,_RFPSA23,RESP046,"(44.56744942400047, -120.15503132599969)"
|
|
2020,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,11,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,41,RACE06,CAT4,_RFPSA23,RESP054,"(44.56744942400047, -120.15503132599969)"
|
|
2020,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,41,RACE07,CAT4,_RFPSA23,RESP046,"(44.56744942400047, -120.15503132599969)"
|
|
2020,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,19,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,41,RACE07,CAT4,_RFPSA23,RESP054,"(44.56744942400047, -120.15503132599969)"
|
|
2020,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,13,14.9,6.5,23.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,RACE08,CAT4,_RFPSA23,RESP046,"(44.56744942400047, -120.15503132599969)"
|
|
2020,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,52,85.1,76.8,93.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,RACE08,CAT4,_RFPSA23,RESP054,"(44.56744942400047, -120.15503132599969)"
|
|
2020,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,445,26.3,23.8,28.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,SEX1,CAT2,_RFPSA23,RESP046,"(44.56744942400047, -120.15503132599969)"
|
|
2020,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1029,73.7,71.3,76.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,41,SEX1,CAT2,_RFPSA23,RESP054,"(44.56744942400047, -120.15503132599969)"
|
|
2020,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,41,SEX2,CAT2,_RFPSA23,RESP046,"(44.56744942400047, -120.15503132599969)"
|
|
2020,OR,Oregon,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,41,SEX2,CAT2,_RFPSA23,RESP054,"(44.56744942400047, -120.15503132599969)"
|
|
2020,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,17,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,42,AGE06,CAT3,_RFPSA23,RESP046,"(40.79373015200048, -77.86070029399963)"
|
|
2020,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,314,95,92,98,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,AGE06,CAT3,_RFPSA23,RESP054,"(40.79373015200048, -77.86070029399963)"
|
|
2020,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,117,28.7,23.2,34.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,AGE07,CAT3,_RFPSA23,RESP046,"(40.79373015200048, -77.86070029399963)"
|
|
2020,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,294,71.3,65.8,76.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,AGE07,CAT3,_RFPSA23,RESP054,"(40.79373015200048, -77.86070029399963)"
|
|
2020,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,93,44.8,36.8,52.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,AGE08,CAT3,_RFPSA23,RESP046,"(40.79373015200048, -77.86070029399963)"
|
|
2020,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,127,55.2,47.2,63.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,AGE08,CAT3,_RFPSA23,RESP054,"(40.79373015200048, -77.86070029399963)"
|
|
2020,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,320,50.9,45.5,56.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,AGE09,CAT3,_RFPSA23,RESP046,"(40.79373015200048, -77.86070029399963)"
|
|
2020,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,279,49.1,43.6,54.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,AGE09,CAT3,_RFPSA23,RESP054,"(40.79373015200048, -77.86070029399963)"
|
|
2020,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,547,34.1,31.1,37.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,BO1,CAT1,_RFPSA23,RESP046,"(40.79373015200048, -77.86070029399963)"
|
|
2020,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1014,65.9,62.9,68.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,BO1,CAT1,_RFPSA23,RESP054,"(40.79373015200048, -77.86070029399963)"
|
|
2020,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,12,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,42,EDUCA1,CAT5,_RFPSA23,RESP046,"(40.79373015200048, -77.86070029399963)"
|
|
2020,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,71,82.7,72.1,93.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,EDUCA1,CAT5,_RFPSA23,RESP054,"(40.79373015200048, -77.86070029399963)"
|
|
2020,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,115,30.1,24.7,35.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,EDUCA2,CAT5,_RFPSA23,RESP046,"(40.79373015200048, -77.86070029399963)"
|
|
2020,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,324,69.9,64.4,75.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,EDUCA2,CAT5,_RFPSA23,RESP054,"(40.79373015200048, -77.86070029399963)"
|
|
2020,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,115,35.2,28.9,41.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,EDUCA3,CAT5,_RFPSA23,RESP046,"(40.79373015200048, -77.86070029399963)"
|
|
2020,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,213,64.8,58.6,71.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,EDUCA3,CAT5,_RFPSA23,RESP054,"(40.79373015200048, -77.86070029399963)"
|
|
2020,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,303,42.7,38.1,47.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,EDUCA4,CAT5,_RFPSA23,RESP046,"(40.79373015200048, -77.86070029399963)"
|
|
2020,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,405,57.3,52.8,61.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,EDUCA4,CAT5,_RFPSA23,RESP054,"(40.79373015200048, -77.86070029399963)"
|
|
2020,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,42,INCOME1,CAT6,_RFPSA23,RESP046,"(40.79373015200048, -77.86070029399963)"
|
|
2020,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,67,89.7,82.3,97.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,INCOME1,CAT6,_RFPSA23,RESP054,"(40.79373015200048, -77.86070029399963)"
|
|
2020,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,31,25.6,15.3,36,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,INCOME2,CAT6,_RFPSA23,RESP046,"(40.79373015200048, -77.86070029399963)"
|
|
2020,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,109,74.4,64,84.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,INCOME2,CAT6,_RFPSA23,RESP054,"(40.79373015200048, -77.86070029399963)"
|
|
2020,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,37,36,25.3,46.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,INCOME3,CAT6,_RFPSA23,RESP046,"(40.79373015200048, -77.86070029399963)"
|
|
2020,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,74,64,53.2,74.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,INCOME3,CAT6,_RFPSA23,RESP054,"(40.79373015200048, -77.86070029399963)"
|
|
2020,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,56,37.9,27.5,48.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,INCOME4,CAT6,_RFPSA23,RESP046,"(40.79373015200048, -77.86070029399963)"
|
|
2020,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,90,62.1,51.8,72.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,INCOME4,CAT6,_RFPSA23,RESP054,"(40.79373015200048, -77.86070029399963)"
|
|
2020,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,334,36.3,32.3,40.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,INCOME5,CAT6,_RFPSA23,RESP046,"(40.79373015200048, -77.86070029399963)"
|
|
2020,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,552,63.7,59.7,67.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,INCOME5,CAT6,_RFPSA23,RESP054,"(40.79373015200048, -77.86070029399963)"
|
|
2020,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,493,36.7,33.4,40,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,RACE01,CAT4,_RFPSA23,RESP046,"(40.79373015200048, -77.86070029399963)"
|
|
2020,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,855,63.3,60,66.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,RACE01,CAT4,_RFPSA23,RESP054,"(40.79373015200048, -77.86070029399963)"
|
|
2020,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,36,30,20,40.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,RACE02,CAT4,_RFPSA23,RESP046,"(40.79373015200048, -77.86070029399963)"
|
|
2020,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,78,70,59.9,80,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,RACE02,CAT4,_RFPSA23,RESP054,"(40.79373015200048, -77.86070029399963)"
|
|
2020,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,42,RACE03,CAT4,_RFPSA23,RESP046,"(40.79373015200048, -77.86070029399963)"
|
|
2020,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,42,RACE03,CAT4,_RFPSA23,RESP054,"(40.79373015200048, -77.86070029399963)"
|
|
2020,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,42,RACE04,CAT4,_RFPSA23,RESP046,"(40.79373015200048, -77.86070029399963)"
|
|
2020,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,17,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,42,RACE04,CAT4,_RFPSA23,RESP054,"(40.79373015200048, -77.86070029399963)"
|
|
2020,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,42,RACE05,CAT4,_RFPSA23,RESP046,"(40.79373015200048, -77.86070029399963)"
|
|
2020,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,42,RACE05,CAT4,_RFPSA23,RESP054,"(40.79373015200048, -77.86070029399963)"
|
|
2020,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,42,RACE06,CAT4,_RFPSA23,RESP046,"(40.79373015200048, -77.86070029399963)"
|
|
2020,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,42,RACE06,CAT4,_RFPSA23,RESP054,"(40.79373015200048, -77.86070029399963)"
|
|
2020,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,42,RACE07,CAT4,_RFPSA23,RESP046,"(40.79373015200048, -77.86070029399963)"
|
|
2020,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,15,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,42,RACE07,CAT4,_RFPSA23,RESP054,"(40.79373015200048, -77.86070029399963)"
|
|
2020,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,42,RACE08,CAT4,_RFPSA23,RESP046,"(40.79373015200048, -77.86070029399963)"
|
|
2020,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,36,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,42,RACE08,CAT4,_RFPSA23,RESP054,"(40.79373015200048, -77.86070029399963)"
|
|
2020,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,547,34.1,31.1,37.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,SEX1,CAT2,_RFPSA23,RESP046,"(40.79373015200048, -77.86070029399963)"
|
|
2020,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1014,65.9,62.9,68.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,42,SEX1,CAT2,_RFPSA23,RESP054,"(40.79373015200048, -77.86070029399963)"
|
|
2020,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,42,SEX2,CAT2,_RFPSA23,RESP046,"(40.79373015200048, -77.86070029399963)"
|
|
2020,PA,Pennsylvania,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,42,SEX2,CAT2,_RFPSA23,RESP054,"(40.79373015200048, -77.86070029399963)"
|
|
2020,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,130,37,30.6,43.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,AGE06,CAT3,_RFPSA23,RESP046,"(18.220833, -66.590149)"
|
|
2020,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,224,63,56.6,69.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,AGE06,CAT3,_RFPSA23,RESP054,"(18.220833, -66.590149)"
|
|
2020,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,207,56.5,50.2,62.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,AGE07,CAT3,_RFPSA23,RESP046,"(18.220833, -66.590149)"
|
|
2020,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,169,43.5,37.2,49.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,AGE07,CAT3,_RFPSA23,RESP054,"(18.220833, -66.590149)"
|
|
2020,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,117,71.8,60.9,82.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,AGE08,CAT3,_RFPSA23,RESP046,"(18.220833, -66.590149)"
|
|
2020,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,51,28.2,17.3,39.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,AGE08,CAT3,_RFPSA23,RESP054,"(18.220833, -66.590149)"
|
|
2020,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,297,67.7,57.1,78.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,AGE09,CAT3,_RFPSA23,RESP046,"(18.220833, -66.590149)"
|
|
2020,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,98,32.3,21.8,42.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,AGE09,CAT3,_RFPSA23,RESP054,"(18.220833, -66.590149)"
|
|
2020,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,751,56.4,51.7,61.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,BO1,CAT1,_RFPSA23,RESP046,"(18.220833, -66.590149)"
|
|
2020,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,542,43.6,38.9,48.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,BO1,CAT1,_RFPSA23,RESP054,"(18.220833, -66.590149)"
|
|
2020,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,117,54.6,43.4,65.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,EDUCA1,CAT5,_RFPSA23,RESP046,"(18.220833, -66.590149)"
|
|
2020,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,87,45.4,34.2,56.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,EDUCA1,CAT5,_RFPSA23,RESP054,"(18.220833, -66.590149)"
|
|
2020,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,194,53.4,45,61.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,EDUCA2,CAT5,_RFPSA23,RESP046,"(18.220833, -66.590149)"
|
|
2020,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,166,46.6,38.1,55,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,EDUCA2,CAT5,_RFPSA23,RESP054,"(18.220833, -66.590149)"
|
|
2020,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,164,56.7,49.3,64.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,EDUCA3,CAT5,_RFPSA23,RESP046,"(18.220833, -66.590149)"
|
|
2020,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,124,43.3,35.9,50.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,EDUCA3,CAT5,_RFPSA23,RESP054,"(18.220833, -66.590149)"
|
|
2020,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,275,62,56.3,67.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,EDUCA4,CAT5,_RFPSA23,RESP046,"(18.220833, -66.590149)"
|
|
2020,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,164,38,32.4,43.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,EDUCA4,CAT5,_RFPSA23,RESP054,"(18.220833, -66.590149)"
|
|
2020,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,196,54.9,44.5,65.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,INCOME1,CAT6,_RFPSA23,RESP046,"(18.220833, -66.590149)"
|
|
2020,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,157,45.1,34.7,55.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,INCOME1,CAT6,_RFPSA23,RESP054,"(18.220833, -66.590149)"
|
|
2020,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,183,55.4,48,62.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,INCOME2,CAT6,_RFPSA23,RESP046,"(18.220833, -66.590149)"
|
|
2020,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,143,44.6,37.1,52,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,INCOME2,CAT6,_RFPSA23,RESP054,"(18.220833, -66.590149)"
|
|
2020,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,79,58,47,68.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,INCOME3,CAT6,_RFPSA23,RESP046,"(18.220833, -66.590149)"
|
|
2020,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,48,42,31.1,53,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,INCOME3,CAT6,_RFPSA23,RESP054,"(18.220833, -66.590149)"
|
|
2020,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,65,50.2,39.7,60.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,INCOME4,CAT6,_RFPSA23,RESP046,"(18.220833, -66.590149)"
|
|
2020,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,51,49.8,39.2,60.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,INCOME4,CAT6,_RFPSA23,RESP054,"(18.220833, -66.590149)"
|
|
2020,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,112,56.1,47.6,64.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,INCOME5,CAT6,_RFPSA23,RESP046,"(18.220833, -66.590149)"
|
|
2020,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,75,43.9,35.4,52.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,INCOME5,CAT6,_RFPSA23,RESP054,"(18.220833, -66.590149)"
|
|
2020,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,72,RACE01,CAT4,_RFPSA23,RESP046,"(18.220833, -66.590149)"
|
|
2020,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,72,RACE01,CAT4,_RFPSA23,RESP054,"(18.220833, -66.590149)"
|
|
2020,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,72,RACE02,CAT4,_RFPSA23,RESP046,"(18.220833, -66.590149)"
|
|
2020,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,72,RACE02,CAT4,_RFPSA23,RESP054,"(18.220833, -66.590149)"
|
|
2020,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,72,RACE03,CAT4,_RFPSA23,RESP046,"(18.220833, -66.590149)"
|
|
2020,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,72,RACE03,CAT4,_RFPSA23,RESP054,"(18.220833, -66.590149)"
|
|
2020,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,72,RACE04,CAT4,_RFPSA23,RESP046,"(18.220833, -66.590149)"
|
|
2020,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,72,RACE04,CAT4,_RFPSA23,RESP054,"(18.220833, -66.590149)"
|
|
2020,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,72,RACE05,CAT4,_RFPSA23,RESP046,"(18.220833, -66.590149)"
|
|
2020,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,72,RACE05,CAT4,_RFPSA23,RESP054,"(18.220833, -66.590149)"
|
|
2020,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,72,RACE06,CAT4,_RFPSA23,RESP046,"(18.220833, -66.590149)"
|
|
2020,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,72,RACE06,CAT4,_RFPSA23,RESP054,"(18.220833, -66.590149)"
|
|
2020,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,72,RACE07,CAT4,_RFPSA23,RESP046,"(18.220833, -66.590149)"
|
|
2020,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,72,RACE07,CAT4,_RFPSA23,RESP054,"(18.220833, -66.590149)"
|
|
2020,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,742,56.4,51.7,61.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,RACE08,CAT4,_RFPSA23,RESP046,"(18.220833, -66.590149)"
|
|
2020,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,538,43.6,38.9,48.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,RACE08,CAT4,_RFPSA23,RESP054,"(18.220833, -66.590149)"
|
|
2020,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,751,56.4,51.7,61.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,SEX1,CAT2,_RFPSA23,RESP046,"(18.220833, -66.590149)"
|
|
2020,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,542,43.6,38.9,48.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,72,SEX1,CAT2,_RFPSA23,RESP054,"(18.220833, -66.590149)"
|
|
2020,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,72,SEX2,CAT2,_RFPSA23,RESP046,"(18.220833, -66.590149)"
|
|
2020,PR,Puerto Rico,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,72,SEX2,CAT2,_RFPSA23,RESP054,"(18.220833, -66.590149)"
|
|
2020,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,24,9.9,5.1,14.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,AGE06,CAT3,_RFPSA23,RESP046,"(41.70828019300046, -71.52247031399963)"
|
|
2020,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,236,90.1,85.3,94.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,AGE06,CAT3,_RFPSA23,RESP054,"(41.70828019300046, -71.52247031399963)"
|
|
2020,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,99,26.1,20.2,32,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,AGE07,CAT3,_RFPSA23,RESP046,"(41.70828019300046, -71.52247031399963)"
|
|
2020,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,263,73.9,68,79.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,AGE07,CAT3,_RFPSA23,RESP054,"(41.70828019300046, -71.52247031399963)"
|
|
2020,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,89,41.2,33.2,49.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,AGE08,CAT3,_RFPSA23,RESP046,"(41.70828019300046, -71.52247031399963)"
|
|
2020,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,137,58.8,50.8,66.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,AGE08,CAT3,_RFPSA23,RESP054,"(41.70828019300046, -71.52247031399963)"
|
|
2020,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,338,49.1,44,54.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,AGE09,CAT3,_RFPSA23,RESP046,"(41.70828019300046, -71.52247031399963)"
|
|
2020,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,302,50.9,45.8,56,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,AGE09,CAT3,_RFPSA23,RESP054,"(41.70828019300046, -71.52247031399963)"
|
|
2020,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,550,31.8,28.7,34.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,BO1,CAT1,_RFPSA23,RESP046,"(41.70828019300046, -71.52247031399963)"
|
|
2020,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,938,68.2,65.2,71.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,BO1,CAT1,_RFPSA23,RESP054,"(41.70828019300046, -71.52247031399963)"
|
|
2020,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,25,21.4,12.4,30.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,EDUCA1,CAT5,_RFPSA23,RESP046,"(41.70828019300046, -71.52247031399963)"
|
|
2020,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,86,78.6,69.6,87.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,EDUCA1,CAT5,_RFPSA23,RESP054,"(41.70828019300046, -71.52247031399963)"
|
|
2020,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,94,25.2,19.6,30.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,EDUCA2,CAT5,_RFPSA23,RESP046,"(41.70828019300046, -71.52247031399963)"
|
|
2020,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,248,74.8,69.2,80.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,EDUCA2,CAT5,_RFPSA23,RESP054,"(41.70828019300046, -71.52247031399963)"
|
|
2020,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,116,35.5,28.7,42.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,EDUCA3,CAT5,_RFPSA23,RESP046,"(41.70828019300046, -71.52247031399963)"
|
|
2020,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,187,64.5,57.7,71.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,EDUCA3,CAT5,_RFPSA23,RESP054,"(41.70828019300046, -71.52247031399963)"
|
|
2020,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,314,38.8,34.1,43.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,EDUCA4,CAT5,_RFPSA23,RESP046,"(41.70828019300046, -71.52247031399963)"
|
|
2020,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,414,61.2,56.5,65.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,EDUCA4,CAT5,_RFPSA23,RESP054,"(41.70828019300046, -71.52247031399963)"
|
|
2020,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,23,33.6,19.9,47.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,INCOME1,CAT6,_RFPSA23,RESP046,"(41.70828019300046, -71.52247031399963)"
|
|
2020,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,52,66.4,52.7,80.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,INCOME1,CAT6,_RFPSA23,RESP054,"(41.70828019300046, -71.52247031399963)"
|
|
2020,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,36,20.4,12.2,28.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,INCOME2,CAT6,_RFPSA23,RESP046,"(41.70828019300046, -71.52247031399963)"
|
|
2020,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,107,79.6,71.4,87.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,INCOME2,CAT6,_RFPSA23,RESP054,"(41.70828019300046, -71.52247031399963)"
|
|
2020,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,39,32.6,20.2,45.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,INCOME3,CAT6,_RFPSA23,RESP046,"(41.70828019300046, -71.52247031399963)"
|
|
2020,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,57,67.4,54.9,79.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,INCOME3,CAT6,_RFPSA23,RESP054,"(41.70828019300046, -71.52247031399963)"
|
|
2020,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,49,31.4,21.9,40.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,INCOME4,CAT6,_RFPSA23,RESP046,"(41.70828019300046, -71.52247031399963)"
|
|
2020,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,110,68.6,59.2,78.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,INCOME4,CAT6,_RFPSA23,RESP054,"(41.70828019300046, -71.52247031399963)"
|
|
2020,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,328,32.7,28.6,36.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,INCOME5,CAT6,_RFPSA23,RESP046,"(41.70828019300046, -71.52247031399963)"
|
|
2020,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,496,67.3,63.2,71.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,INCOME5,CAT6,_RFPSA23,RESP054,"(41.70828019300046, -71.52247031399963)"
|
|
2020,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,492,35,31.6,38.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,RACE01,CAT4,_RFPSA23,RESP046,"(41.70828019300046, -71.52247031399963)"
|
|
2020,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,759,65,61.6,68.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,RACE01,CAT4,_RFPSA23,RESP054,"(41.70828019300046, -71.52247031399963)"
|
|
2020,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,44,RACE02,CAT4,_RFPSA23,RESP046,"(41.70828019300046, -71.52247031399963)"
|
|
2020,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,39,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,44,RACE02,CAT4,_RFPSA23,RESP054,"(41.70828019300046, -71.52247031399963)"
|
|
2020,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,44,RACE03,CAT4,_RFPSA23,RESP046,"(41.70828019300046, -71.52247031399963)"
|
|
2020,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,44,RACE03,CAT4,_RFPSA23,RESP054,"(41.70828019300046, -71.52247031399963)"
|
|
2020,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,44,RACE04,CAT4,_RFPSA23,RESP046,"(41.70828019300046, -71.52247031399963)"
|
|
2020,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,13,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,44,RACE04,CAT4,_RFPSA23,RESP054,"(41.70828019300046, -71.52247031399963)"
|
|
2020,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,44,RACE05,CAT4,_RFPSA23,RESP046,"(41.70828019300046, -71.52247031399963)"
|
|
2020,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,44,RACE05,CAT4,_RFPSA23,RESP054,"(41.70828019300046, -71.52247031399963)"
|
|
2020,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,11,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,44,RACE06,CAT4,_RFPSA23,RESP046,"(41.70828019300046, -71.52247031399963)"
|
|
2020,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,26,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,44,RACE06,CAT4,_RFPSA23,RESP054,"(41.70828019300046, -71.52247031399963)"
|
|
2020,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,44,RACE07,CAT4,_RFPSA23,RESP046,"(41.70828019300046, -71.52247031399963)"
|
|
2020,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,15,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,44,RACE07,CAT4,_RFPSA23,RESP054,"(41.70828019300046, -71.52247031399963)"
|
|
2020,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,28,22.6,13.3,31.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,RACE08,CAT4,_RFPSA23,RESP046,"(41.70828019300046, -71.52247031399963)"
|
|
2020,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,77,77.4,68.1,86.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,RACE08,CAT4,_RFPSA23,RESP054,"(41.70828019300046, -71.52247031399963)"
|
|
2020,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,550,31.8,28.7,34.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,SEX1,CAT2,_RFPSA23,RESP046,"(41.70828019300046, -71.52247031399963)"
|
|
2020,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,938,68.2,65.2,71.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,44,SEX1,CAT2,_RFPSA23,RESP054,"(41.70828019300046, -71.52247031399963)"
|
|
2020,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,44,SEX2,CAT2,_RFPSA23,RESP046,"(41.70828019300046, -71.52247031399963)"
|
|
2020,RI,Rhode Island,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,44,SEX2,CAT2,_RFPSA23,RESP054,"(41.70828019300046, -71.52247031399963)"
|
|
2020,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,15,10.1,4.8,15.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,AGE06,CAT3,_RFPSA23,RESP046,"(33.998821303000454, -81.04537120699968)"
|
|
2020,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,187,89.9,84.6,95.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,AGE06,CAT3,_RFPSA23,RESP054,"(33.998821303000454, -81.04537120699968)"
|
|
2020,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,70,22.5,16.8,28.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,AGE07,CAT3,_RFPSA23,RESP046,"(33.998821303000454, -81.04537120699968)"
|
|
2020,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,197,77.5,71.7,83.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,AGE07,CAT3,_RFPSA23,RESP054,"(33.998821303000454, -81.04537120699968)"
|
|
2020,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,74,41.6,32.8,50.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,AGE08,CAT3,_RFPSA23,RESP046,"(33.998821303000454, -81.04537120699968)"
|
|
2020,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,100,58.4,49.7,67.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,AGE08,CAT3,_RFPSA23,RESP054,"(33.998821303000454, -81.04537120699968)"
|
|
2020,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,293,53,48,58.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,AGE09,CAT3,_RFPSA23,RESP046,"(33.998821303000454, -81.04537120699968)"
|
|
2020,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,246,47,41.9,52,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,AGE09,CAT3,_RFPSA23,RESP054,"(33.998821303000454, -81.04537120699968)"
|
|
2020,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,452,32.8,29.7,36,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,BO1,CAT1,_RFPSA23,RESP046,"(33.998821303000454, -81.04537120699968)"
|
|
2020,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,730,67.2,64,70.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,BO1,CAT1,_RFPSA23,RESP054,"(33.998821303000454, -81.04537120699968)"
|
|
2020,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,17,16.2,8.1,24.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,EDUCA1,CAT5,_RFPSA23,RESP046,"(33.998821303000454, -81.04537120699968)"
|
|
2020,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,78,83.8,75.7,91.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,EDUCA1,CAT5,_RFPSA23,RESP054,"(33.998821303000454, -81.04537120699968)"
|
|
2020,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,92,26.4,20.8,32,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,EDUCA2,CAT5,_RFPSA23,RESP046,"(33.998821303000454, -81.04537120699968)"
|
|
2020,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,216,73.6,68,79.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,EDUCA2,CAT5,_RFPSA23,RESP054,"(33.998821303000454, -81.04537120699968)"
|
|
2020,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,130,38.1,31.9,44.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,EDUCA3,CAT5,_RFPSA23,RESP046,"(33.998821303000454, -81.04537120699968)"
|
|
2020,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,189,61.9,55.7,68.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,EDUCA3,CAT5,_RFPSA23,RESP054,"(33.998821303000454, -81.04537120699968)"
|
|
2020,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,213,42.2,37,47.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,EDUCA4,CAT5,_RFPSA23,RESP046,"(33.998821303000454, -81.04537120699968)"
|
|
2020,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,245,57.8,52.6,63,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,EDUCA4,CAT5,_RFPSA23,RESP054,"(33.998821303000454, -81.04537120699968)"
|
|
2020,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,14,20.6,10.7,30.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,INCOME1,CAT6,_RFPSA23,RESP046,"(33.998821303000454, -81.04537120699968)"
|
|
2020,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,63,79.4,69.6,89.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,INCOME1,CAT6,_RFPSA23,RESP054,"(33.998821303000454, -81.04537120699968)"
|
|
2020,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,30,24.3,14.1,34.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,INCOME2,CAT6,_RFPSA23,RESP046,"(33.998821303000454, -81.04537120699968)"
|
|
2020,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,86,75.7,65.5,85.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,INCOME2,CAT6,_RFPSA23,RESP054,"(33.998821303000454, -81.04537120699968)"
|
|
2020,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,32,22.3,13.9,30.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,INCOME3,CAT6,_RFPSA23,RESP046,"(33.998821303000454, -81.04537120699968)"
|
|
2020,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,67,77.7,69.3,86.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,INCOME3,CAT6,_RFPSA23,RESP054,"(33.998821303000454, -81.04537120699968)"
|
|
2020,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,53,35.5,25.9,45.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,INCOME4,CAT6,_RFPSA23,RESP046,"(33.998821303000454, -81.04537120699968)"
|
|
2020,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,74,64.5,54.9,74.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,INCOME4,CAT6,_RFPSA23,RESP054,"(33.998821303000454, -81.04537120699968)"
|
|
2020,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,256,37.3,32.8,41.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,INCOME5,CAT6,_RFPSA23,RESP046,"(33.998821303000454, -81.04537120699968)"
|
|
2020,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,345,62.7,58.3,67.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,INCOME5,CAT6,_RFPSA23,RESP054,"(33.998821303000454, -81.04537120699968)"
|
|
2020,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,370,34.8,31.3,38.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,RACE01,CAT4,_RFPSA23,RESP046,"(33.998821303000454, -81.04537120699968)"
|
|
2020,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,546,65.2,61.7,68.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,RACE01,CAT4,_RFPSA23,RESP054,"(33.998821303000454, -81.04537120699968)"
|
|
2020,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,66,26.6,19.5,33.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,RACE02,CAT4,_RFPSA23,RESP046,"(33.998821303000454, -81.04537120699968)"
|
|
2020,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,146,73.4,66.2,80.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,RACE02,CAT4,_RFPSA23,RESP054,"(33.998821303000454, -81.04537120699968)"
|
|
2020,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,45,RACE03,CAT4,_RFPSA23,RESP046,"(33.998821303000454, -81.04537120699968)"
|
|
2020,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,45,RACE03,CAT4,_RFPSA23,RESP054,"(33.998821303000454, -81.04537120699968)"
|
|
2020,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,45,RACE04,CAT4,_RFPSA23,RESP046,"(33.998821303000454, -81.04537120699968)"
|
|
2020,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,45,RACE04,CAT4,_RFPSA23,RESP054,"(33.998821303000454, -81.04537120699968)"
|
|
2020,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,45,RACE05,CAT4,_RFPSA23,RESP046,"(33.998821303000454, -81.04537120699968)"
|
|
2020,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,45,RACE05,CAT4,_RFPSA23,RESP054,"(33.998821303000454, -81.04537120699968)"
|
|
2020,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,45,RACE06,CAT4,_RFPSA23,RESP046,"(33.998821303000454, -81.04537120699968)"
|
|
2020,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,45,RACE06,CAT4,_RFPSA23,RESP054,"(33.998821303000454, -81.04537120699968)"
|
|
2020,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,45,RACE07,CAT4,_RFPSA23,RESP046,"(33.998821303000454, -81.04537120699968)"
|
|
2020,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,45,RACE07,CAT4,_RFPSA23,RESP054,"(33.998821303000454, -81.04537120699968)"
|
|
2020,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,45,RACE08,CAT4,_RFPSA23,RESP046,"(33.998821303000454, -81.04537120699968)"
|
|
2020,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,9,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,45,RACE08,CAT4,_RFPSA23,RESP054,"(33.998821303000454, -81.04537120699968)"
|
|
2020,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,452,32.8,29.7,36,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,SEX1,CAT2,_RFPSA23,RESP046,"(33.998821303000454, -81.04537120699968)"
|
|
2020,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,730,67.2,64,70.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,45,SEX1,CAT2,_RFPSA23,RESP054,"(33.998821303000454, -81.04537120699968)"
|
|
2020,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,45,SEX2,CAT2,_RFPSA23,RESP046,"(33.998821303000454, -81.04537120699968)"
|
|
2020,SC,South Carolina,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,45,SEX2,CAT2,_RFPSA23,RESP054,"(33.998821303000454, -81.04537120699968)"
|
|
2020,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,23,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,46,AGE06,CAT3,_RFPSA23,RESP046,"(44.353130053000484, -100.3735306369997)"
|
|
2020,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,352,93.1,88.6,97.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,AGE06,CAT3,_RFPSA23,RESP054,"(44.353130053000484, -100.3735306369997)"
|
|
2020,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,123,31.5,22.6,40.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,AGE07,CAT3,_RFPSA23,RESP046,"(44.353130053000484, -100.3735306369997)"
|
|
2020,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,320,68.5,59.5,77.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,AGE07,CAT3,_RFPSA23,RESP054,"(44.353130053000484, -100.3735306369997)"
|
|
2020,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,115,49.9,37.2,62.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,AGE08,CAT3,_RFPSA23,RESP046,"(44.353130053000484, -100.3735306369997)"
|
|
2020,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,175,50.1,37.5,62.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,AGE08,CAT3,_RFPSA23,RESP054,"(44.353130053000484, -100.3735306369997)"
|
|
2020,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,510,59.5,53,66,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,AGE09,CAT3,_RFPSA23,RESP046,"(44.353130053000484, -100.3735306369997)"
|
|
2020,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,412,40.5,34,47,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,AGE09,CAT3,_RFPSA23,RESP054,"(44.353130053000484, -100.3735306369997)"
|
|
2020,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,771,39.2,34.7,43.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,BO1,CAT1,_RFPSA23,RESP046,"(44.353130053000484, -100.3735306369997)"
|
|
2020,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1259,60.8,56.3,65.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,BO1,CAT1,_RFPSA23,RESP054,"(44.353130053000484, -100.3735306369997)"
|
|
2020,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,22,41,19.5,62.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,EDUCA1,CAT5,_RFPSA23,RESP046,"(44.353130053000484, -100.3735306369997)"
|
|
2020,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,62,59,37.4,80.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,EDUCA1,CAT5,_RFPSA23,RESP054,"(44.353130053000484, -100.3735306369997)"
|
|
2020,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,203,37,29.1,44.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,EDUCA2,CAT5,_RFPSA23,RESP046,"(44.353130053000484, -100.3735306369997)"
|
|
2020,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,402,63,55.1,70.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,EDUCA2,CAT5,_RFPSA23,RESP054,"(44.353130053000484, -100.3735306369997)"
|
|
2020,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,205,35.2,27.6,42.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,EDUCA3,CAT5,_RFPSA23,RESP046,"(44.353130053000484, -100.3735306369997)"
|
|
2020,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,399,64.8,57.2,72.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,EDUCA3,CAT5,_RFPSA23,RESP054,"(44.353130053000484, -100.3735306369997)"
|
|
2020,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,339,47.2,40,54.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,EDUCA4,CAT5,_RFPSA23,RESP046,"(44.353130053000484, -100.3735306369997)"
|
|
2020,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,395,52.8,45.6,60,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,EDUCA4,CAT5,_RFPSA23,RESP054,"(44.353130053000484, -100.3735306369997)"
|
|
2020,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,21,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,46,INCOME1,CAT6,_RFPSA23,RESP046,"(44.353130053000484, -100.3735306369997)"
|
|
2020,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,75,69.2,35.4,100,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,INCOME1,CAT6,_RFPSA23,RESP054,"(44.353130053000484, -100.3735306369997)"
|
|
2020,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,65,31.6,18.9,44.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,INCOME2,CAT6,_RFPSA23,RESP046,"(44.353130053000484, -100.3735306369997)"
|
|
2020,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,153,68.4,55.8,81.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,INCOME2,CAT6,_RFPSA23,RESP054,"(44.353130053000484, -100.3735306369997)"
|
|
2020,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,52,38.2,22.4,54,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,INCOME3,CAT6,_RFPSA23,RESP046,"(44.353130053000484, -100.3735306369997)"
|
|
2020,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,120,61.8,46,77.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,INCOME3,CAT6,_RFPSA23,RESP054,"(44.353130053000484, -100.3735306369997)"
|
|
2020,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,90,44.7,31.8,57.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,INCOME4,CAT6,_RFPSA23,RESP046,"(44.353130053000484, -100.3735306369997)"
|
|
2020,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,164,55.3,42.4,68.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,INCOME4,CAT6,_RFPSA23,RESP054,"(44.353130053000484, -100.3735306369997)"
|
|
2020,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,429,37.9,31.9,43.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,INCOME5,CAT6,_RFPSA23,RESP046,"(44.353130053000484, -100.3735306369997)"
|
|
2020,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,565,62.1,56.1,68.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,INCOME5,CAT6,_RFPSA23,RESP054,"(44.353130053000484, -100.3735306369997)"
|
|
2020,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,698,41.7,36.9,46.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,RACE01,CAT4,_RFPSA23,RESP046,"(44.353130053000484, -100.3735306369997)"
|
|
2020,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1008,58.3,53.6,63.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,RACE01,CAT4,_RFPSA23,RESP054,"(44.353130053000484, -100.3735306369997)"
|
|
2020,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,46,RACE02,CAT4,_RFPSA23,RESP046,"(44.353130053000484, -100.3735306369997)"
|
|
2020,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,46,RACE02,CAT4,_RFPSA23,RESP054,"(44.353130053000484, -100.3735306369997)"
|
|
2020,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,43,15.1,7.1,23,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,RACE03,CAT4,_RFPSA23,RESP046,"(44.353130053000484, -100.3735306369997)"
|
|
2020,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,183,84.9,77,92.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,RACE03,CAT4,_RFPSA23,RESP054,"(44.353130053000484, -100.3735306369997)"
|
|
2020,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,46,RACE04,CAT4,_RFPSA23,RESP046,"(44.353130053000484, -100.3735306369997)"
|
|
2020,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,46,RACE04,CAT4,_RFPSA23,RESP054,"(44.353130053000484, -100.3735306369997)"
|
|
2020,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,46,RACE05,CAT4,_RFPSA23,RESP046,"(44.353130053000484, -100.3735306369997)"
|
|
2020,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,46,RACE05,CAT4,_RFPSA23,RESP054,"(44.353130053000484, -100.3735306369997)"
|
|
2020,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,46,RACE06,CAT4,_RFPSA23,RESP046,"(44.353130053000484, -100.3735306369997)"
|
|
2020,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,11,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,46,RACE06,CAT4,_RFPSA23,RESP054,"(44.353130053000484, -100.3735306369997)"
|
|
2020,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,46,RACE07,CAT4,_RFPSA23,RESP046,"(44.353130053000484, -100.3735306369997)"
|
|
2020,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,23,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,46,RACE07,CAT4,_RFPSA23,RESP054,"(44.353130053000484, -100.3735306369997)"
|
|
2020,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,11,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,46,RACE08,CAT4,_RFPSA23,RESP046,"(44.353130053000484, -100.3735306369997)"
|
|
2020,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,21,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,46,RACE08,CAT4,_RFPSA23,RESP054,"(44.353130053000484, -100.3735306369997)"
|
|
2020,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,771,39.2,34.7,43.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,SEX1,CAT2,_RFPSA23,RESP046,"(44.353130053000484, -100.3735306369997)"
|
|
2020,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1259,60.8,56.3,65.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,46,SEX1,CAT2,_RFPSA23,RESP054,"(44.353130053000484, -100.3735306369997)"
|
|
2020,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,46,SEX2,CAT2,_RFPSA23,RESP046,"(44.353130053000484, -100.3735306369997)"
|
|
2020,SD,South Dakota,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,46,SEX2,CAT2,_RFPSA23,RESP054,"(44.353130053000484, -100.3735306369997)"
|
|
2020,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,33,11.1,6.1,16,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,AGE06,CAT3,_RFPSA23,RESP046,"(35.68094058000048, -85.77449091399967)"
|
|
2020,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,224,88.9,84,93.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,AGE06,CAT3,_RFPSA23,RESP054,"(35.68094058000048, -85.77449091399967)"
|
|
2020,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,110,32.1,25.8,38.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,AGE07,CAT3,_RFPSA23,RESP046,"(35.68094058000048, -85.77449091399967)"
|
|
2020,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,207,67.9,61.6,74.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,AGE07,CAT3,_RFPSA23,RESP054,"(35.68094058000048, -85.77449091399967)"
|
|
2020,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,67,41.4,31.5,51.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,AGE08,CAT3,_RFPSA23,RESP046,"(35.68094058000048, -85.77449091399967)"
|
|
2020,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,94,58.6,48.7,68.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,AGE08,CAT3,_RFPSA23,RESP054,"(35.68094058000048, -85.77449091399967)"
|
|
2020,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,247,46.7,41,52.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,AGE09,CAT3,_RFPSA23,RESP046,"(35.68094058000048, -85.77449091399967)"
|
|
2020,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,236,53.3,47.5,59,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,AGE09,CAT3,_RFPSA23,RESP054,"(35.68094058000048, -85.77449091399967)"
|
|
2020,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,457,32.9,29.6,36.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,BO1,CAT1,_RFPSA23,RESP046,"(35.68094058000048, -85.77449091399967)"
|
|
2020,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,761,67.1,63.8,70.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,BO1,CAT1,_RFPSA23,RESP054,"(35.68094058000048, -85.77449091399967)"
|
|
2020,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,16,10,4.4,15.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,EDUCA1,CAT5,_RFPSA23,RESP046,"(35.68094058000048, -85.77449091399967)"
|
|
2020,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,102,90,84.4,95.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,EDUCA1,CAT5,_RFPSA23,RESP054,"(35.68094058000048, -85.77449091399967)"
|
|
2020,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,110,27.1,21.5,32.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,EDUCA2,CAT5,_RFPSA23,RESP046,"(35.68094058000048, -85.77449091399967)"
|
|
2020,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,243,72.9,67.3,78.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,EDUCA2,CAT5,_RFPSA23,RESP054,"(35.68094058000048, -85.77449091399967)"
|
|
2020,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,100,34.2,27.3,41.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,EDUCA3,CAT5,_RFPSA23,RESP046,"(35.68094058000048, -85.77449091399967)"
|
|
2020,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,193,65.8,58.8,72.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,EDUCA3,CAT5,_RFPSA23,RESP054,"(35.68094058000048, -85.77449091399967)"
|
|
2020,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,220,50.8,44.8,56.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,EDUCA4,CAT5,_RFPSA23,RESP046,"(35.68094058000048, -85.77449091399967)"
|
|
2020,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,216,49.2,43.2,55.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,EDUCA4,CAT5,_RFPSA23,RESP054,"(35.68094058000048, -85.77449091399967)"
|
|
2020,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,11,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,47,INCOME1,CAT6,_RFPSA23,RESP046,"(35.68094058000048, -85.77449091399967)"
|
|
2020,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,86,89,81.8,96.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,INCOME1,CAT6,_RFPSA23,RESP054,"(35.68094058000048, -85.77449091399967)"
|
|
2020,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,39,17.1,10.9,23.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,INCOME2,CAT6,_RFPSA23,RESP046,"(35.68094058000048, -85.77449091399967)"
|
|
2020,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,126,82.9,76.7,89.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,INCOME2,CAT6,_RFPSA23,RESP054,"(35.68094058000048, -85.77449091399967)"
|
|
2020,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,31,33.3,20.2,46.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,INCOME3,CAT6,_RFPSA23,RESP046,"(35.68094058000048, -85.77449091399967)"
|
|
2020,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,62,66.7,53.7,79.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,INCOME3,CAT6,_RFPSA23,RESP054,"(35.68094058000048, -85.77449091399967)"
|
|
2020,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,54,35.6,25.6,45.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,INCOME4,CAT6,_RFPSA23,RESP046,"(35.68094058000048, -85.77449091399967)"
|
|
2020,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,81,64.4,54.4,74.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,INCOME4,CAT6,_RFPSA23,RESP054,"(35.68094058000048, -85.77449091399967)"
|
|
2020,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,245,39.6,34.3,44.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,INCOME5,CAT6,_RFPSA23,RESP046,"(35.68094058000048, -85.77449091399967)"
|
|
2020,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,311,60.4,55.1,65.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,INCOME5,CAT6,_RFPSA23,RESP054,"(35.68094058000048, -85.77449091399967)"
|
|
2020,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,412,36.4,32.8,40.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,RACE01,CAT4,_RFPSA23,RESP046,"(35.68094058000048, -85.77449091399967)"
|
|
2020,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,626,63.6,59.9,67.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,RACE01,CAT4,_RFPSA23,RESP054,"(35.68094058000048, -85.77449091399967)"
|
|
2020,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,26,21.8,11.7,32,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,RACE02,CAT4,_RFPSA23,RESP046,"(35.68094058000048, -85.77449091399967)"
|
|
2020,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,71,78.2,68,88.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,RACE02,CAT4,_RFPSA23,RESP054,"(35.68094058000048, -85.77449091399967)"
|
|
2020,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,47,RACE03,CAT4,_RFPSA23,RESP046,"(35.68094058000048, -85.77449091399967)"
|
|
2020,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,12,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,47,RACE03,CAT4,_RFPSA23,RESP054,"(35.68094058000048, -85.77449091399967)"
|
|
2020,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,47,RACE04,CAT4,_RFPSA23,RESP046,"(35.68094058000048, -85.77449091399967)"
|
|
2020,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,47,RACE04,CAT4,_RFPSA23,RESP054,"(35.68094058000048, -85.77449091399967)"
|
|
2020,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,47,RACE05,CAT4,_RFPSA23,RESP046,"(35.68094058000048, -85.77449091399967)"
|
|
2020,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,47,RACE05,CAT4,_RFPSA23,RESP054,"(35.68094058000048, -85.77449091399967)"
|
|
2020,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,47,RACE06,CAT4,_RFPSA23,RESP046,"(35.68094058000048, -85.77449091399967)"
|
|
2020,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,47,RACE06,CAT4,_RFPSA23,RESP054,"(35.68094058000048, -85.77449091399967)"
|
|
2020,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,47,RACE07,CAT4,_RFPSA23,RESP046,"(35.68094058000048, -85.77449091399967)"
|
|
2020,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,14,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,47,RACE07,CAT4,_RFPSA23,RESP054,"(35.68094058000048, -85.77449091399967)"
|
|
2020,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,47,RACE08,CAT4,_RFPSA23,RESP046,"(35.68094058000048, -85.77449091399967)"
|
|
2020,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,22,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,47,RACE08,CAT4,_RFPSA23,RESP054,"(35.68094058000048, -85.77449091399967)"
|
|
2020,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,457,32.9,29.6,36.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,SEX1,CAT2,_RFPSA23,RESP046,"(35.68094058000048, -85.77449091399967)"
|
|
2020,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,761,67.1,63.8,70.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,47,SEX1,CAT2,_RFPSA23,RESP054,"(35.68094058000048, -85.77449091399967)"
|
|
2020,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,47,SEX2,CAT2,_RFPSA23,RESP046,"(35.68094058000048, -85.77449091399967)"
|
|
2020,TN,Tennessee,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,47,SEX2,CAT2,_RFPSA23,RESP054,"(35.68094058000048, -85.77449091399967)"
|
|
2020,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,44,7.4,3.4,11.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,AGE06,CAT3,_RFPSA23,RESP046,"(31.827240407000488, -99.42677020599967)"
|
|
2020,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,605,92.6,88.6,96.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,AGE06,CAT3,_RFPSA23,RESP054,"(31.827240407000488, -99.42677020599967)"
|
|
2020,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,182,25.7,19.9,31.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,AGE07,CAT3,_RFPSA23,RESP046,"(31.827240407000488, -99.42677020599967)"
|
|
2020,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,577,74.3,68.5,80.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,AGE07,CAT3,_RFPSA23,RESP054,"(31.827240407000488, -99.42677020599967)"
|
|
2020,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,156,39.4,30.2,48.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,AGE08,CAT3,_RFPSA23,RESP046,"(31.827240407000488, -99.42677020599967)"
|
|
2020,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,271,60.6,51.4,69.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,AGE08,CAT3,_RFPSA23,RESP054,"(31.827240407000488, -99.42677020599967)"
|
|
2020,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,548,41.3,35.3,47.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,AGE09,CAT3,_RFPSA23,RESP046,"(31.827240407000488, -99.42677020599967)"
|
|
2020,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,576,58.7,52.7,64.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,AGE09,CAT3,_RFPSA23,RESP054,"(31.827240407000488, -99.42677020599967)"
|
|
2020,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,930,27.2,24.2,30.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,BO1,CAT1,_RFPSA23,RESP046,"(31.827240407000488, -99.42677020599967)"
|
|
2020,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,2029,72.8,69.8,75.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,BO1,CAT1,_RFPSA23,RESP054,"(31.827240407000488, -99.42677020599967)"
|
|
2020,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,54,12.4,6.3,18.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,EDUCA1,CAT5,_RFPSA23,RESP046,"(31.827240407000488, -99.42677020599967)"
|
|
2020,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,355,87.6,81.6,93.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,EDUCA1,CAT5,_RFPSA23,RESP054,"(31.827240407000488, -99.42677020599967)"
|
|
2020,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,178,26.8,20.5,33.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,EDUCA2,CAT5,_RFPSA23,RESP046,"(31.827240407000488, -99.42677020599967)"
|
|
2020,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,518,73.2,66.8,79.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,EDUCA2,CAT5,_RFPSA23,RESP054,"(31.827240407000488, -99.42677020599967)"
|
|
2020,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,223,27,21.2,32.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,EDUCA3,CAT5,_RFPSA23,RESP046,"(31.827240407000488, -99.42677020599967)"
|
|
2020,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,515,73,67.2,78.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,EDUCA3,CAT5,_RFPSA23,RESP054,"(31.827240407000488, -99.42677020599967)"
|
|
2020,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,473,37,31.9,42,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,EDUCA4,CAT5,_RFPSA23,RESP046,"(31.827240407000488, -99.42677020599967)"
|
|
2020,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,635,63,58,68.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,EDUCA4,CAT5,_RFPSA23,RESP054,"(31.827240407000488, -99.42677020599967)"
|
|
2020,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,46,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,48,INCOME1,CAT6,_RFPSA23,RESP046,"(31.827240407000488, -99.42677020599967)"
|
|
2020,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,216,87.7,79.4,96,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,INCOME1,CAT6,_RFPSA23,RESP054,"(31.827240407000488, -99.42677020599967)"
|
|
2020,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,89,24.6,16.3,33,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,INCOME2,CAT6,_RFPSA23,RESP046,"(31.827240407000488, -99.42677020599967)"
|
|
2020,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,322,75.4,67,83.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,INCOME2,CAT6,_RFPSA23,RESP054,"(31.827240407000488, -99.42677020599967)"
|
|
2020,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,55,17.3,7.5,27.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,INCOME3,CAT6,_RFPSA23,RESP046,"(31.827240407000488, -99.42677020599967)"
|
|
2020,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,157,82.7,72.9,92.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,INCOME3,CAT6,_RFPSA23,RESP054,"(31.827240407000488, -99.42677020599967)"
|
|
2020,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,96,26.6,17.4,35.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,INCOME4,CAT6,_RFPSA23,RESP046,"(31.827240407000488, -99.42677020599967)"
|
|
2020,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,218,73.4,64.3,82.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,INCOME4,CAT6,_RFPSA23,RESP054,"(31.827240407000488, -99.42677020599967)"
|
|
2020,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,519,32.5,28,36.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,INCOME5,CAT6,_RFPSA23,RESP046,"(31.827240407000488, -99.42677020599967)"
|
|
2020,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,849,67.5,63.1,72,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,INCOME5,CAT6,_RFPSA23,RESP054,"(31.827240407000488, -99.42677020599967)"
|
|
2020,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,689,35.2,31.3,39.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,RACE01,CAT4,_RFPSA23,RESP046,"(31.827240407000488, -99.42677020599967)"
|
|
2020,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1110,64.8,60.8,68.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,RACE01,CAT4,_RFPSA23,RESP054,"(31.827240407000488, -99.42677020599967)"
|
|
2020,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,53,27.2,16.4,38.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,RACE02,CAT4,_RFPSA23,RESP046,"(31.827240407000488, -99.42677020599967)"
|
|
2020,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,140,72.8,61.9,83.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,RACE02,CAT4,_RFPSA23,RESP054,"(31.827240407000488, -99.42677020599967)"
|
|
2020,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,48,RACE03,CAT4,_RFPSA23,RESP046,"(31.827240407000488, -99.42677020599967)"
|
|
2020,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,20,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,48,RACE03,CAT4,_RFPSA23,RESP054,"(31.827240407000488, -99.42677020599967)"
|
|
2020,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,48,RACE04,CAT4,_RFPSA23,RESP046,"(31.827240407000488, -99.42677020599967)"
|
|
2020,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,38,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,48,RACE04,CAT4,_RFPSA23,RESP054,"(31.827240407000488, -99.42677020599967)"
|
|
2020,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,48,RACE05,CAT4,_RFPSA23,RESP046,"(31.827240407000488, -99.42677020599967)"
|
|
2020,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,48,RACE05,CAT4,_RFPSA23,RESP054,"(31.827240407000488, -99.42677020599967)"
|
|
2020,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,22,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,48,RACE06,CAT4,_RFPSA23,RESP046,"(31.827240407000488, -99.42677020599967)"
|
|
2020,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,30,62.9,38.6,87.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,RACE06,CAT4,_RFPSA23,RESP054,"(31.827240407000488, -99.42677020599967)"
|
|
2020,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,14,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,48,RACE07,CAT4,_RFPSA23,RESP046,"(31.827240407000488, -99.42677020599967)"
|
|
2020,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,32,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,48,RACE07,CAT4,_RFPSA23,RESP054,"(31.827240407000488, -99.42677020599967)"
|
|
2020,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,136,15.9,11.2,20.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,RACE08,CAT4,_RFPSA23,RESP046,"(31.827240407000488, -99.42677020599967)"
|
|
2020,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,657,84.1,79.3,88.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,RACE08,CAT4,_RFPSA23,RESP054,"(31.827240407000488, -99.42677020599967)"
|
|
2020,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,930,27.2,24.2,30.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,SEX1,CAT2,_RFPSA23,RESP046,"(31.827240407000488, -99.42677020599967)"
|
|
2020,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,2029,72.8,69.8,75.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,48,SEX1,CAT2,_RFPSA23,RESP054,"(31.827240407000488, -99.42677020599967)"
|
|
2020,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,48,SEX2,CAT2,_RFPSA23,RESP046,"(31.827240407000488, -99.42677020599967)"
|
|
2020,TX,Texas,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,48,SEX2,CAT2,_RFPSA23,RESP054,"(31.827240407000488, -99.42677020599967)"
|
|
2020,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,59,6.4,4.4,8.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,AGE06,CAT3,_RFPSA23,RESP046,"(39.360700171000474, -111.58713063499971)"
|
|
2020,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,708,93.6,91.7,95.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,AGE06,CAT3,_RFPSA23,RESP054,"(39.360700171000474, -111.58713063499971)"
|
|
2020,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,150,22,18.1,25.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,AGE07,CAT3,_RFPSA23,RESP046,"(39.360700171000474, -111.58713063499971)"
|
|
2020,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,512,78,74.1,81.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,AGE07,CAT3,_RFPSA23,RESP054,"(39.360700171000474, -111.58713063499971)"
|
|
2020,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,159,37.8,32,43.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,AGE08,CAT3,_RFPSA23,RESP046,"(39.360700171000474, -111.58713063499971)"
|
|
2020,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,246,62.2,56.3,68,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,AGE08,CAT3,_RFPSA23,RESP054,"(39.360700171000474, -111.58713063499971)"
|
|
2020,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,599,48.4,44.9,51.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,AGE09,CAT3,_RFPSA23,RESP046,"(39.360700171000474, -111.58713063499971)"
|
|
2020,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,655,51.6,48.1,55.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,AGE09,CAT3,_RFPSA23,RESP054,"(39.360700171000474, -111.58713063499971)"
|
|
2020,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,967,26.7,24.8,28.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,BO1,CAT1,_RFPSA23,RESP046,"(39.360700171000474, -111.58713063499971)"
|
|
2020,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,2121,73.3,71.4,75.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,BO1,CAT1,_RFPSA23,RESP054,"(39.360700171000474, -111.58713063499971)"
|
|
2020,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,12,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,49,EDUCA1,CAT5,_RFPSA23,RESP046,"(39.360700171000474, -111.58713063499971)"
|
|
2020,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,109,89.7,83.1,96.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,EDUCA1,CAT5,_RFPSA23,RESP054,"(39.360700171000474, -111.58713063499971)"
|
|
2020,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,124,18.9,15,22.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,EDUCA2,CAT5,_RFPSA23,RESP046,"(39.360700171000474, -111.58713063499971)"
|
|
2020,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,442,81.1,77.2,85,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,EDUCA2,CAT5,_RFPSA23,RESP054,"(39.360700171000474, -111.58713063499971)"
|
|
2020,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,286,28.5,24.9,32,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,EDUCA3,CAT5,_RFPSA23,RESP046,"(39.360700171000474, -111.58713063499971)"
|
|
2020,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,617,71.5,68,75.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,EDUCA3,CAT5,_RFPSA23,RESP054,"(39.360700171000474, -111.58713063499971)"
|
|
2020,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,545,32.7,30,35.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,EDUCA4,CAT5,_RFPSA23,RESP046,"(39.360700171000474, -111.58713063499971)"
|
|
2020,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,948,67.3,64.6,70,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,EDUCA4,CAT5,_RFPSA23,RESP054,"(39.360700171000474, -111.58713063499971)"
|
|
2020,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,15,22.5,9.6,35.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,INCOME1,CAT6,_RFPSA23,RESP046,"(39.360700171000474, -111.58713063499971)"
|
|
2020,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,60,77.5,64.6,90.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,INCOME1,CAT6,_RFPSA23,RESP054,"(39.360700171000474, -111.58713063499971)"
|
|
2020,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,43,18.2,10.8,25.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,INCOME2,CAT6,_RFPSA23,RESP046,"(39.360700171000474, -111.58713063499971)"
|
|
2020,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,175,81.8,74.4,89.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,INCOME2,CAT6,_RFPSA23,RESP054,"(39.360700171000474, -111.58713063499971)"
|
|
2020,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,52,23.4,16.2,30.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,INCOME3,CAT6,_RFPSA23,RESP046,"(39.360700171000474, -111.58713063499971)"
|
|
2020,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,120,76.6,69.3,83.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,INCOME3,CAT6,_RFPSA23,RESP054,"(39.360700171000474, -111.58713063499971)"
|
|
2020,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,94,23.7,18,29.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,INCOME4,CAT6,_RFPSA23,RESP046,"(39.360700171000474, -111.58713063499971)"
|
|
2020,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,233,76.3,70.6,82,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,INCOME4,CAT6,_RFPSA23,RESP054,"(39.360700171000474, -111.58713063499971)"
|
|
2020,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,642,27.4,25.1,29.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,INCOME5,CAT6,_RFPSA23,RESP046,"(39.360700171000474, -111.58713063499971)"
|
|
2020,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,1335,72.6,70.2,74.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,INCOME5,CAT6,_RFPSA23,RESP054,"(39.360700171000474, -111.58713063499971)"
|
|
2020,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,932,29.4,27.4,31.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,RACE01,CAT4,_RFPSA23,RESP046,"(39.360700171000474, -111.58713063499971)"
|
|
2020,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1887,70.6,68.6,72.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,RACE01,CAT4,_RFPSA23,RESP054,"(39.360700171000474, -111.58713063499971)"
|
|
2020,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,49,RACE02,CAT4,_RFPSA23,RESP046,"(39.360700171000474, -111.58713063499971)"
|
|
2020,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,23,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,49,RACE02,CAT4,_RFPSA23,RESP054,"(39.360700171000474, -111.58713063499971)"
|
|
2020,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,49,RACE03,CAT4,_RFPSA23,RESP046,"(39.360700171000474, -111.58713063499971)"
|
|
2020,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,16,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,49,RACE03,CAT4,_RFPSA23,RESP054,"(39.360700171000474, -111.58713063499971)"
|
|
2020,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,49,RACE04,CAT4,_RFPSA23,RESP046,"(39.360700171000474, -111.58713063499971)"
|
|
2020,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,28,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,49,RACE04,CAT4,_RFPSA23,RESP054,"(39.360700171000474, -111.58713063499971)"
|
|
2020,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,49,RACE05,CAT4,_RFPSA23,RESP046,"(39.360700171000474, -111.58713063499971)"
|
|
2020,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,49,RACE05,CAT4,_RFPSA23,RESP054,"(39.360700171000474, -111.58713063499971)"
|
|
2020,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,49,RACE06,CAT4,_RFPSA23,RESP046,"(39.360700171000474, -111.58713063499971)"
|
|
2020,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,12,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,49,RACE06,CAT4,_RFPSA23,RESP054,"(39.360700171000474, -111.58713063499971)"
|
|
2020,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,49,RACE07,CAT4,_RFPSA23,RESP046,"(39.360700171000474, -111.58713063499971)"
|
|
2020,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,22,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,49,RACE07,CAT4,_RFPSA23,RESP054,"(39.360700171000474, -111.58713063499971)"
|
|
2020,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,14,13,5.8,20.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,RACE08,CAT4,_RFPSA23,RESP046,"(39.360700171000474, -111.58713063499971)"
|
|
2020,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,125,87,79.8,94.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,RACE08,CAT4,_RFPSA23,RESP054,"(39.360700171000474, -111.58713063499971)"
|
|
2020,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,967,26.7,24.8,28.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,SEX1,CAT2,_RFPSA23,RESP046,"(39.360700171000474, -111.58713063499971)"
|
|
2020,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,2121,73.3,71.4,75.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,49,SEX1,CAT2,_RFPSA23,RESP054,"(39.360700171000474, -111.58713063499971)"
|
|
2020,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,49,SEX2,CAT2,_RFPSA23,RESP046,"(39.360700171000474, -111.58713063499971)"
|
|
2020,UT,Utah,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,49,SEX2,CAT2,_RFPSA23,RESP054,"(39.360700171000474, -111.58713063499971)"
|
|
2020,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,50,AGE06,CAT3,_RFPSA23,RESP046,"(43.62538123900049, -72.51764079099962)"
|
|
2020,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,297,97,94.6,99.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,AGE06,CAT3,_RFPSA23,RESP054,"(43.62538123900049, -72.51764079099962)"
|
|
2020,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,83,16.8,12.9,20.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,AGE07,CAT3,_RFPSA23,RESP046,"(43.62538123900049, -72.51764079099962)"
|
|
2020,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,362,83.2,79.2,87.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,AGE07,CAT3,_RFPSA23,RESP054,"(43.62538123900049, -72.51764079099962)"
|
|
2020,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,112,34.4,27.2,41.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,AGE08,CAT3,_RFPSA23,RESP046,"(43.62538123900049, -72.51764079099962)"
|
|
2020,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,217,65.6,58.5,72.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,AGE08,CAT3,_RFPSA23,RESP054,"(43.62538123900049, -72.51764079099962)"
|
|
2020,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,372,39.3,35,43.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,AGE09,CAT3,_RFPSA23,RESP046,"(43.62538123900049, -72.51764079099962)"
|
|
2020,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,567,60.7,56.4,65,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,AGE09,CAT3,_RFPSA23,RESP054,"(43.62538123900049, -72.51764079099962)"
|
|
2020,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,577,25.2,22.9,27.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,BO1,CAT1,_RFPSA23,RESP046,"(43.62538123900049, -72.51764079099962)"
|
|
2020,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1443,74.8,72.4,77.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,BO1,CAT1,_RFPSA23,RESP054,"(43.62538123900049, -72.51764079099962)"
|
|
2020,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,15,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,50,EDUCA1,CAT5,_RFPSA23,RESP046,"(43.62538123900049, -72.51764079099962)"
|
|
2020,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,83,88,80.7,95.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,EDUCA1,CAT5,_RFPSA23,RESP054,"(43.62538123900049, -72.51764079099962)"
|
|
2020,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,138,21.1,17,25.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,EDUCA2,CAT5,_RFPSA23,RESP046,"(43.62538123900049, -72.51764079099962)"
|
|
2020,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,465,78.9,74.7,83,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,EDUCA2,CAT5,_RFPSA23,RESP054,"(43.62538123900049, -72.51764079099962)"
|
|
2020,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,122,28.4,22.9,33.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,EDUCA3,CAT5,_RFPSA23,RESP046,"(43.62538123900049, -72.51764079099962)"
|
|
2020,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,300,71.6,66.1,77.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,EDUCA3,CAT5,_RFPSA23,RESP054,"(43.62538123900049, -72.51764079099962)"
|
|
2020,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,301,30.8,27.1,34.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,EDUCA4,CAT5,_RFPSA23,RESP046,"(43.62538123900049, -72.51764079099962)"
|
|
2020,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,593,69.2,65.5,72.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,EDUCA4,CAT5,_RFPSA23,RESP054,"(43.62538123900049, -72.51764079099962)"
|
|
2020,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,19,19,8.7,29.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,INCOME1,CAT6,_RFPSA23,RESP046,"(43.62538123900049, -72.51764079099962)"
|
|
2020,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,79,81,70.6,91.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,INCOME1,CAT6,_RFPSA23,RESP054,"(43.62538123900049, -72.51764079099962)"
|
|
2020,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,38,16,9.6,22.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,INCOME2,CAT6,_RFPSA23,RESP046,"(43.62538123900049, -72.51764079099962)"
|
|
2020,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,164,84,77.7,90.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,INCOME2,CAT6,_RFPSA23,RESP054,"(43.62538123900049, -72.51764079099962)"
|
|
2020,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,49,26.3,17.4,35.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,INCOME3,CAT6,_RFPSA23,RESP046,"(43.62538123900049, -72.51764079099962)"
|
|
2020,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,120,73.7,64.8,82.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,INCOME3,CAT6,_RFPSA23,RESP054,"(43.62538123900049, -72.51764079099962)"
|
|
2020,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,63,28.7,20.5,36.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,INCOME4,CAT6,_RFPSA23,RESP046,"(43.62538123900049, -72.51764079099962)"
|
|
2020,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,155,71.3,63.1,79.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,INCOME4,CAT6,_RFPSA23,RESP054,"(43.62538123900049, -72.51764079099962)"
|
|
2020,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,323,25.8,22.6,28.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,INCOME5,CAT6,_RFPSA23,RESP046,"(43.62538123900049, -72.51764079099962)"
|
|
2020,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,750,74.2,71.1,77.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,INCOME5,CAT6,_RFPSA23,RESP054,"(43.62538123900049, -72.51764079099962)"
|
|
2020,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,554,25.6,23.1,28,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,RACE01,CAT4,_RFPSA23,RESP046,"(43.62538123900049, -72.51764079099962)"
|
|
2020,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1366,74.4,72,76.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,RACE01,CAT4,_RFPSA23,RESP054,"(43.62538123900049, -72.51764079099962)"
|
|
2020,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,50,RACE02,CAT4,_RFPSA23,RESP046,"(43.62538123900049, -72.51764079099962)"
|
|
2020,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,50,RACE02,CAT4,_RFPSA23,RESP054,"(43.62538123900049, -72.51764079099962)"
|
|
2020,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,50,RACE03,CAT4,_RFPSA23,RESP046,"(43.62538123900049, -72.51764079099962)"
|
|
2020,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,15,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,50,RACE03,CAT4,_RFPSA23,RESP054,"(43.62538123900049, -72.51764079099962)"
|
|
2020,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,50,RACE04,CAT4,_RFPSA23,RESP046,"(43.62538123900049, -72.51764079099962)"
|
|
2020,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,50,RACE04,CAT4,_RFPSA23,RESP054,"(43.62538123900049, -72.51764079099962)"
|
|
2020,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,50,RACE05,CAT4,_RFPSA23,RESP046,"(43.62538123900049, -72.51764079099962)"
|
|
2020,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,50,RACE05,CAT4,_RFPSA23,RESP054,"(43.62538123900049, -72.51764079099962)"
|
|
2020,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,50,RACE06,CAT4,_RFPSA23,RESP046,"(43.62538123900049, -72.51764079099962)"
|
|
2020,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,16,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,50,RACE06,CAT4,_RFPSA23,RESP054,"(43.62538123900049, -72.51764079099962)"
|
|
2020,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,50,RACE07,CAT4,_RFPSA23,RESP046,"(43.62538123900049, -72.51764079099962)"
|
|
2020,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,29,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,50,RACE07,CAT4,_RFPSA23,RESP054,"(43.62538123900049, -72.51764079099962)"
|
|
2020,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,50,RACE08,CAT4,_RFPSA23,RESP046,"(43.62538123900049, -72.51764079099962)"
|
|
2020,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,50,RACE08,CAT4,_RFPSA23,RESP054,"(43.62538123900049, -72.51764079099962)"
|
|
2020,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,577,25.2,22.9,27.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,SEX1,CAT2,_RFPSA23,RESP046,"(43.62538123900049, -72.51764079099962)"
|
|
2020,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1443,74.8,72.4,77.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,50,SEX1,CAT2,_RFPSA23,RESP054,"(43.62538123900049, -72.51764079099962)"
|
|
2020,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,50,SEX2,CAT2,_RFPSA23,RESP046,"(43.62538123900049, -72.51764079099962)"
|
|
2020,VT,Vermont,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,50,SEX2,CAT2,_RFPSA23,RESP054,"(43.62538123900049, -72.51764079099962)"
|
|
2020,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,45,7.4,4.8,10,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,AGE06,CAT3,_RFPSA23,RESP046,"(37.54268067400045, -78.45789046299967)"
|
|
2020,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,448,92.6,90,95.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,AGE06,CAT3,_RFPSA23,RESP054,"(37.54268067400045, -78.45789046299967)"
|
|
2020,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,196,28.2,23.8,32.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,AGE07,CAT3,_RFPSA23,RESP046,"(37.54268067400045, -78.45789046299967)"
|
|
2020,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,428,71.8,67.5,76.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,AGE07,CAT3,_RFPSA23,RESP054,"(37.54268067400045, -78.45789046299967)"
|
|
2020,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,170,43,36.5,49.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,AGE08,CAT3,_RFPSA23,RESP046,"(37.54268067400045, -78.45789046299967)"
|
|
2020,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,233,57,50.5,63.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,AGE08,CAT3,_RFPSA23,RESP054,"(37.54268067400045, -78.45789046299967)"
|
|
2020,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,655,56,52.1,59.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,AGE09,CAT3,_RFPSA23,RESP046,"(37.54268067400045, -78.45789046299967)"
|
|
2020,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,511,44,40.1,47.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,AGE09,CAT3,_RFPSA23,RESP054,"(37.54268067400045, -78.45789046299967)"
|
|
2020,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1066,33.5,31.2,35.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,BO1,CAT1,_RFPSA23,RESP046,"(37.54268067400045, -78.45789046299967)"
|
|
2020,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1620,66.5,64.2,68.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,BO1,CAT1,_RFPSA23,RESP054,"(37.54268067400045, -78.45789046299967)"
|
|
2020,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,45,18.2,12,24.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,EDUCA1,CAT5,_RFPSA23,RESP046,"(37.54268067400045, -78.45789046299967)"
|
|
2020,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,159,81.8,75.7,88,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,EDUCA1,CAT5,_RFPSA23,RESP054,"(37.54268067400045, -78.45789046299967)"
|
|
2020,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,199,28.6,24,33.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,EDUCA2,CAT5,_RFPSA23,RESP046,"(37.54268067400045, -78.45789046299967)"
|
|
2020,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,413,71.4,66.8,76,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,EDUCA2,CAT5,_RFPSA23,RESP054,"(37.54268067400045, -78.45789046299967)"
|
|
2020,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,247,34.6,29.9,39.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,EDUCA3,CAT5,_RFPSA23,RESP046,"(37.54268067400045, -78.45789046299967)"
|
|
2020,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,388,65.4,60.6,70.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,EDUCA3,CAT5,_RFPSA23,RESP054,"(37.54268067400045, -78.45789046299967)"
|
|
2020,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,573,40.6,36.9,44.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,EDUCA4,CAT5,_RFPSA23,RESP046,"(37.54268067400045, -78.45789046299967)"
|
|
2020,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,656,59.4,55.7,63.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,EDUCA4,CAT5,_RFPSA23,RESP054,"(37.54268067400045, -78.45789046299967)"
|
|
2020,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,15,9.9,4.2,15.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,INCOME1,CAT6,_RFPSA23,RESP046,"(37.54268067400045, -78.45789046299967)"
|
|
2020,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,112,90.1,84.3,95.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,INCOME1,CAT6,_RFPSA23,RESP054,"(37.54268067400045, -78.45789046299967)"
|
|
2020,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,82,23.7,17.4,30.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,INCOME2,CAT6,_RFPSA23,RESP046,"(37.54268067400045, -78.45789046299967)"
|
|
2020,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,180,76.3,69.9,82.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,INCOME2,CAT6,_RFPSA23,RESP054,"(37.54268067400045, -78.45789046299967)"
|
|
2020,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,68,28.8,18.5,39,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,INCOME3,CAT6,_RFPSA23,RESP046,"(37.54268067400045, -78.45789046299967)"
|
|
2020,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,122,71.2,61,81.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,INCOME3,CAT6,_RFPSA23,RESP054,"(37.54268067400045, -78.45789046299967)"
|
|
2020,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,102,36.6,29.1,44.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,INCOME4,CAT6,_RFPSA23,RESP046,"(37.54268067400045, -78.45789046299967)"
|
|
2020,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,149,63.4,55.8,70.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,INCOME4,CAT6,_RFPSA23,RESP054,"(37.54268067400045, -78.45789046299967)"
|
|
2020,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,658,36.9,33.7,40.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,INCOME5,CAT6,_RFPSA23,RESP046,"(37.54268067400045, -78.45789046299967)"
|
|
2020,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,858,63.1,59.9,66.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,INCOME5,CAT6,_RFPSA23,RESP054,"(37.54268067400045, -78.45789046299967)"
|
|
2020,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,870,36.3,33.6,38.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,RACE01,CAT4,_RFPSA23,RESP046,"(37.54268067400045, -78.45789046299967)"
|
|
2020,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1222,63.7,61.1,66.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,RACE01,CAT4,_RFPSA23,RESP054,"(37.54268067400045, -78.45789046299967)"
|
|
2020,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,129,30.2,24.2,36.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,RACE02,CAT4,_RFPSA23,RESP046,"(37.54268067400045, -78.45789046299967)"
|
|
2020,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,222,69.8,63.8,75.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,RACE02,CAT4,_RFPSA23,RESP054,"(37.54268067400045, -78.45789046299967)"
|
|
2020,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,51,RACE03,CAT4,_RFPSA23,RESP046,"(37.54268067400045, -78.45789046299967)"
|
|
2020,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,12,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,51,RACE03,CAT4,_RFPSA23,RESP054,"(37.54268067400045, -78.45789046299967)"
|
|
2020,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,17,27.9,13,42.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,RACE04,CAT4,_RFPSA23,RESP046,"(37.54268067400045, -78.45789046299967)"
|
|
2020,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,38,72.1,57.2,87,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,RACE04,CAT4,_RFPSA23,RESP054,"(37.54268067400045, -78.45789046299967)"
|
|
2020,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,51,RACE05,CAT4,_RFPSA23,RESP046,"(37.54268067400045, -78.45789046299967)"
|
|
2020,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,51,RACE05,CAT4,_RFPSA23,RESP054,"(37.54268067400045, -78.45789046299967)"
|
|
2020,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,51,RACE06,CAT4,_RFPSA23,RESP046,"(37.54268067400045, -78.45789046299967)"
|
|
2020,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,13,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,51,RACE06,CAT4,_RFPSA23,RESP054,"(37.54268067400045, -78.45789046299967)"
|
|
2020,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,18,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,51,RACE07,CAT4,_RFPSA23,RESP046,"(37.54268067400045, -78.45789046299967)"
|
|
2020,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,28,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,51,RACE07,CAT4,_RFPSA23,RESP054,"(37.54268067400045, -78.45789046299967)"
|
|
2020,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,24,20.7,10.9,30.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,RACE08,CAT4,_RFPSA23,RESP046,"(37.54268067400045, -78.45789046299967)"
|
|
2020,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,84,79.3,69.5,89.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,RACE08,CAT4,_RFPSA23,RESP054,"(37.54268067400045, -78.45789046299967)"
|
|
2020,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1066,33.5,31.2,35.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,SEX1,CAT2,_RFPSA23,RESP046,"(37.54268067400045, -78.45789046299967)"
|
|
2020,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1620,66.5,64.2,68.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,51,SEX1,CAT2,_RFPSA23,RESP054,"(37.54268067400045, -78.45789046299967)"
|
|
2020,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,51,SEX2,CAT2,_RFPSA23,RESP046,"(37.54268067400045, -78.45789046299967)"
|
|
2020,VA,Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,51,SEX2,CAT2,_RFPSA23,RESP054,"(37.54268067400045, -78.45789046299967)"
|
|
2020,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,24,4.1,2.2,6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,AGE06,CAT3,_RFPSA23,RESP046,"(47.52227862900048, -120.47001078999972)"
|
|
2020,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,631,95.9,94,97.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,AGE06,CAT3,_RFPSA23,RESP054,"(47.52227862900048, -120.47001078999972)"
|
|
2020,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,192,22.5,19,25.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,AGE07,CAT3,_RFPSA23,RESP046,"(47.52227862900048, -120.47001078999972)"
|
|
2020,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,665,77.5,74.1,81,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,AGE07,CAT3,_RFPSA23,RESP054,"(47.52227862900048, -120.47001078999972)"
|
|
2020,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,188,35.7,30.5,40.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,AGE08,CAT3,_RFPSA23,RESP046,"(47.52227862900048, -120.47001078999972)"
|
|
2020,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,337,64.3,59.2,69.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,AGE08,CAT3,_RFPSA23,RESP054,"(47.52227862900048, -120.47001078999972)"
|
|
2020,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,721,40.3,37.1,43.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,AGE09,CAT3,_RFPSA23,RESP046,"(47.52227862900048, -120.47001078999972)"
|
|
2020,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,1022,59.7,56.5,62.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,AGE09,CAT3,_RFPSA23,RESP054,"(47.52227862900048, -120.47001078999972)"
|
|
2020,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,1125,25.6,23.9,27.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,BO1,CAT1,_RFPSA23,RESP046,"(47.52227862900048, -120.47001078999972)"
|
|
2020,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,2655,74.4,72.6,76.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,BO1,CAT1,_RFPSA23,RESP054,"(47.52227862900048, -120.47001078999972)"
|
|
2020,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,28,11.3,6.4,16.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,EDUCA1,CAT5,_RFPSA23,RESP046,"(47.52227862900048, -120.47001078999972)"
|
|
2020,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,158,88.7,83.8,93.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,EDUCA1,CAT5,_RFPSA23,RESP054,"(47.52227862900048, -120.47001078999972)"
|
|
2020,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,182,19.9,16.6,23.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,EDUCA2,CAT5,_RFPSA23,RESP046,"(47.52227862900048, -120.47001078999972)"
|
|
2020,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,605,80.1,76.8,83.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,EDUCA2,CAT5,_RFPSA23,RESP054,"(47.52227862900048, -120.47001078999972)"
|
|
2020,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,286,26.1,22.7,29.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,EDUCA3,CAT5,_RFPSA23,RESP046,"(47.52227862900048, -120.47001078999972)"
|
|
2020,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,746,73.9,70.4,77.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,EDUCA3,CAT5,_RFPSA23,RESP054,"(47.52227862900048, -120.47001078999972)"
|
|
2020,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,627,31.5,28.8,34.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,EDUCA4,CAT5,_RFPSA23,RESP046,"(47.52227862900048, -120.47001078999972)"
|
|
2020,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,1142,68.5,65.7,71.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,EDUCA4,CAT5,_RFPSA23,RESP054,"(47.52227862900048, -120.47001078999972)"
|
|
2020,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,25,12.8,6.8,18.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,INCOME1,CAT6,_RFPSA23,RESP046,"(47.52227862900048, -120.47001078999972)"
|
|
2020,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,157,87.2,81.1,93.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,INCOME1,CAT6,_RFPSA23,RESP054,"(47.52227862900048, -120.47001078999972)"
|
|
2020,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,64,17.6,12,23.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,INCOME2,CAT6,_RFPSA23,RESP046,"(47.52227862900048, -120.47001078999972)"
|
|
2020,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,236,82.4,76.7,88,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,INCOME2,CAT6,_RFPSA23,RESP054,"(47.52227862900048, -120.47001078999972)"
|
|
2020,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,59,22.9,14.9,30.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,INCOME3,CAT6,_RFPSA23,RESP046,"(47.52227862900048, -120.47001078999972)"
|
|
2020,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,183,77.1,69.2,85.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,INCOME3,CAT6,_RFPSA23,RESP054,"(47.52227862900048, -120.47001078999972)"
|
|
2020,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,142,26.9,21.4,32.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,INCOME4,CAT6,_RFPSA23,RESP046,"(47.52227862900048, -120.47001078999972)"
|
|
2020,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,307,73.1,67.5,78.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,INCOME4,CAT6,_RFPSA23,RESP054,"(47.52227862900048, -120.47001078999972)"
|
|
2020,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,719,27.9,25.6,30.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,INCOME5,CAT6,_RFPSA23,RESP046,"(47.52227862900048, -120.47001078999972)"
|
|
2020,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,1482,72.1,69.8,74.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,INCOME5,CAT6,_RFPSA23,RESP054,"(47.52227862900048, -120.47001078999972)"
|
|
2020,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,1002,27,25.1,28.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,RACE01,CAT4,_RFPSA23,RESP046,"(47.52227862900048, -120.47001078999972)"
|
|
2020,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,2218,73,71.2,74.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,RACE01,CAT4,_RFPSA23,RESP054,"(47.52227862900048, -120.47001078999972)"
|
|
2020,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,23,35.2,21.9,48.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,RACE02,CAT4,_RFPSA23,RESP046,"(47.52227862900048, -120.47001078999972)"
|
|
2020,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,58,64.8,51.5,78.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,RACE02,CAT4,_RFPSA23,RESP054,"(47.52227862900048, -120.47001078999972)"
|
|
2020,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,53,RACE03,CAT4,_RFPSA23,RESP046,"(47.52227862900048, -120.47001078999972)"
|
|
2020,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,51,81.4,66.7,96,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,RACE03,CAT4,_RFPSA23,RESP054,"(47.52227862900048, -120.47001078999972)"
|
|
2020,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,24,19,11.3,26.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,RACE04,CAT4,_RFPSA23,RESP046,"(47.52227862900048, -120.47001078999972)"
|
|
2020,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,92,81,73.3,88.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,RACE04,CAT4,_RFPSA23,RESP054,"(47.52227862900048, -120.47001078999972)"
|
|
2020,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,53,RACE05,CAT4,_RFPSA23,RESP046,"(47.52227862900048, -120.47001078999972)"
|
|
2020,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,13,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,53,RACE05,CAT4,_RFPSA23,RESP054,"(47.52227862900048, -120.47001078999972)"
|
|
2020,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,13,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,53,RACE06,CAT4,_RFPSA23,RESP046,"(47.52227862900048, -120.47001078999972)"
|
|
2020,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,24,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,53,RACE06,CAT4,_RFPSA23,RESP054,"(47.52227862900048, -120.47001078999972)"
|
|
2020,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,25,24,13.4,34.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,RACE07,CAT4,_RFPSA23,RESP046,"(47.52227862900048, -120.47001078999972)"
|
|
2020,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,62,76,65.4,86.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,RACE07,CAT4,_RFPSA23,RESP054,"(47.52227862900048, -120.47001078999972)"
|
|
2020,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,29,16.5,10.1,22.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,RACE08,CAT4,_RFPSA23,RESP046,"(47.52227862900048, -120.47001078999972)"
|
|
2020,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,137,83.5,77.1,89.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,RACE08,CAT4,_RFPSA23,RESP054,"(47.52227862900048, -120.47001078999972)"
|
|
2020,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,1125,25.6,23.9,27.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,SEX1,CAT2,_RFPSA23,RESP046,"(47.52227862900048, -120.47001078999972)"
|
|
2020,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,2655,74.4,72.6,76.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,53,SEX1,CAT2,_RFPSA23,RESP054,"(47.52227862900048, -120.47001078999972)"
|
|
2020,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,53,SEX2,CAT2,_RFPSA23,RESP046,"(47.52227862900048, -120.47001078999972)"
|
|
2020,WA,Washington,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,53,SEX2,CAT2,_RFPSA23,RESP054,"(47.52227862900048, -120.47001078999972)"
|
|
2020,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,23,7.5,4.1,10.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,AGE06,CAT3,_RFPSA23,RESP046,"(38.66551020200046, -80.71264013499967)"
|
|
2020,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,284,92.5,89.1,95.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,AGE06,CAT3,_RFPSA23,RESP054,"(38.66551020200046, -80.71264013499967)"
|
|
2020,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,120,26.6,21.6,31.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,AGE07,CAT3,_RFPSA23,RESP046,"(38.66551020200046, -80.71264013499967)"
|
|
2020,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,288,73.4,68.4,78.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,AGE07,CAT3,_RFPSA23,RESP054,"(38.66551020200046, -80.71264013499967)"
|
|
2020,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,143,47.1,40.5,53.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,AGE08,CAT3,_RFPSA23,RESP046,"(38.66551020200046, -80.71264013499967)"
|
|
2020,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,153,52.9,46.3,59.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,AGE08,CAT3,_RFPSA23,RESP054,"(38.66551020200046, -80.71264013499967)"
|
|
2020,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,461,52.2,48.2,56.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,AGE09,CAT3,_RFPSA23,RESP046,"(38.66551020200046, -80.71264013499967)"
|
|
2020,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,370,47.8,43.8,51.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,AGE09,CAT3,_RFPSA23,RESP054,"(38.66551020200046, -80.71264013499967)"
|
|
2020,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,747,34.3,31.8,36.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,BO1,CAT1,_RFPSA23,RESP046,"(38.66551020200046, -80.71264013499967)"
|
|
2020,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1095,65.7,63.3,68.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,BO1,CAT1,_RFPSA23,RESP054,"(38.66551020200046, -80.71264013499967)"
|
|
2020,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,46,25.5,18.2,32.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,EDUCA1,CAT5,_RFPSA23,RESP046,"(38.66551020200046, -80.71264013499967)"
|
|
2020,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,131,74.5,67.2,81.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,EDUCA1,CAT5,_RFPSA23,RESP054,"(38.66551020200046, -80.71264013499967)"
|
|
2020,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,250,31.8,27.9,35.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,EDUCA2,CAT5,_RFPSA23,RESP046,"(38.66551020200046, -80.71264013499967)"
|
|
2020,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,444,68.2,64.3,72.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,EDUCA2,CAT5,_RFPSA23,RESP054,"(38.66551020200046, -80.71264013499967)"
|
|
2020,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,186,37.4,32.4,42.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,EDUCA3,CAT5,_RFPSA23,RESP046,"(38.66551020200046, -80.71264013499967)"
|
|
2020,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,251,62.6,57.6,67.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,EDUCA3,CAT5,_RFPSA23,RESP054,"(38.66551020200046, -80.71264013499967)"
|
|
2020,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,264,43.1,38.4,47.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,EDUCA4,CAT5,_RFPSA23,RESP046,"(38.66551020200046, -80.71264013499967)"
|
|
2020,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,267,56.9,52.2,61.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,EDUCA4,CAT5,_RFPSA23,RESP054,"(38.66551020200046, -80.71264013499967)"
|
|
2020,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,25,19.7,11.2,28.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,INCOME1,CAT6,_RFPSA23,RESP046,"(38.66551020200046, -80.71264013499967)"
|
|
2020,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,106,80.3,71.9,88.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,INCOME1,CAT6,_RFPSA23,RESP054,"(38.66551020200046, -80.71264013499967)"
|
|
2020,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,70,22.3,16.7,27.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,INCOME2,CAT6,_RFPSA23,RESP046,"(38.66551020200046, -80.71264013499967)"
|
|
2020,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,192,77.7,72.1,83.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,INCOME2,CAT6,_RFPSA23,RESP054,"(38.66551020200046, -80.71264013499967)"
|
|
2020,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,88,33.2,26,40.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,INCOME3,CAT6,_RFPSA23,RESP046,"(38.66551020200046, -80.71264013499967)"
|
|
2020,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,140,66.8,59.6,74,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,INCOME3,CAT6,_RFPSA23,RESP054,"(38.66551020200046, -80.71264013499967)"
|
|
2020,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,140,43.6,36.9,50.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,INCOME4,CAT6,_RFPSA23,RESP046,"(38.66551020200046, -80.71264013499967)"
|
|
2020,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,158,56.4,49.8,63.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,INCOME4,CAT6,_RFPSA23,RESP054,"(38.66551020200046, -80.71264013499967)"
|
|
2020,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,358,39.6,35.6,43.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,INCOME5,CAT6,_RFPSA23,RESP046,"(38.66551020200046, -80.71264013499967)"
|
|
2020,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,386,60.4,56.4,64.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,INCOME5,CAT6,_RFPSA23,RESP054,"(38.66551020200046, -80.71264013499967)"
|
|
2020,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,710,35,32.4,37.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,RACE01,CAT4,_RFPSA23,RESP046,"(38.66551020200046, -80.71264013499967)"
|
|
2020,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,1025,65,62.4,67.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,RACE01,CAT4,_RFPSA23,RESP054,"(38.66551020200046, -80.71264013499967)"
|
|
2020,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,14,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,54,RACE02,CAT4,_RFPSA23,RESP046,"(38.66551020200046, -80.71264013499967)"
|
|
2020,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,27,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,54,RACE02,CAT4,_RFPSA23,RESP054,"(38.66551020200046, -80.71264013499967)"
|
|
2020,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,54,RACE03,CAT4,_RFPSA23,RESP046,"(38.66551020200046, -80.71264013499967)"
|
|
2020,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,54,RACE03,CAT4,_RFPSA23,RESP054,"(38.66551020200046, -80.71264013499967)"
|
|
2020,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,54,RACE04,CAT4,_RFPSA23,RESP046,"(38.66551020200046, -80.71264013499967)"
|
|
2020,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,54,RACE04,CAT4,_RFPSA23,RESP054,"(38.66551020200046, -80.71264013499967)"
|
|
2020,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,54,RACE05,CAT4,_RFPSA23,RESP046,"(38.66551020200046, -80.71264013499967)"
|
|
2020,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,54,RACE05,CAT4,_RFPSA23,RESP054,"(38.66551020200046, -80.71264013499967)"
|
|
2020,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,54,RACE06,CAT4,_RFPSA23,RESP046,"(38.66551020200046, -80.71264013499967)"
|
|
2020,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,54,RACE06,CAT4,_RFPSA23,RESP054,"(38.66551020200046, -80.71264013499967)"
|
|
2020,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,54,RACE07,CAT4,_RFPSA23,RESP046,"(38.66551020200046, -80.71264013499967)"
|
|
2020,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,15,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,54,RACE07,CAT4,_RFPSA23,RESP054,"(38.66551020200046, -80.71264013499967)"
|
|
2020,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,3,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,54,RACE08,CAT4,_RFPSA23,RESP046,"(38.66551020200046, -80.71264013499967)"
|
|
2020,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,54,RACE08,CAT4,_RFPSA23,RESP054,"(38.66551020200046, -80.71264013499967)"
|
|
2020,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,747,34.3,31.8,36.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,SEX1,CAT2,_RFPSA23,RESP046,"(38.66551020200046, -80.71264013499967)"
|
|
2020,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1095,65.7,63.3,68.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,54,SEX1,CAT2,_RFPSA23,RESP054,"(38.66551020200046, -80.71264013499967)"
|
|
2020,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,54,SEX2,CAT2,_RFPSA23,RESP046,"(38.66551020200046, -80.71264013499967)"
|
|
2020,WV,West Virginia,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,54,SEX2,CAT2,_RFPSA23,RESP054,"(38.66551020200046, -80.71264013499967)"
|
|
2020,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,20,7.5,3.8,11.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,AGE06,CAT3,_RFPSA23,RESP046,"(44.39319117400049, -89.81637074199966)"
|
|
2020,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,256,92.5,88.8,96.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,AGE06,CAT3,_RFPSA23,RESP054,"(44.39319117400049, -89.81637074199966)"
|
|
2020,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,138,33.2,27.1,39.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,AGE07,CAT3,_RFPSA23,RESP046,"(44.39319117400049, -89.81637074199966)"
|
|
2020,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,246,66.8,60.6,72.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,AGE07,CAT3,_RFPSA23,RESP054,"(44.39319117400049, -89.81637074199966)"
|
|
2020,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,102,41.6,33.6,49.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,AGE08,CAT3,_RFPSA23,RESP046,"(44.39319117400049, -89.81637074199966)"
|
|
2020,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,138,58.4,50.4,66.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,AGE08,CAT3,_RFPSA23,RESP054,"(44.39319117400049, -89.81637074199966)"
|
|
2020,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,364,50.7,45.7,55.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,AGE09,CAT3,_RFPSA23,RESP046,"(44.39319117400049, -89.81637074199966)"
|
|
2020,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,364,49.3,44.4,54.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,AGE09,CAT3,_RFPSA23,RESP054,"(44.39319117400049, -89.81637074199966)"
|
|
2020,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,624,34.5,31.6,37.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,BO1,CAT1,_RFPSA23,RESP046,"(44.39319117400049, -89.81637074199966)"
|
|
2020,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,1004,65.5,62.6,68.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,BO1,CAT1,_RFPSA23,RESP054,"(44.39319117400049, -89.81637074199966)"
|
|
2020,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,55,EDUCA1,CAT5,_RFPSA23,RESP046,"(44.39319117400049, -89.81637074199966)"
|
|
2020,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,58,80.6,67.8,93.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,EDUCA1,CAT5,_RFPSA23,RESP054,"(44.39319117400049, -89.81637074199966)"
|
|
2020,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,175,32.2,27.2,37.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,EDUCA2,CAT5,_RFPSA23,RESP046,"(44.39319117400049, -89.81637074199966)"
|
|
2020,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,343,67.8,62.7,72.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,EDUCA2,CAT5,_RFPSA23,RESP054,"(44.39319117400049, -89.81637074199966)"
|
|
2020,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,171,38.7,32.7,44.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,EDUCA3,CAT5,_RFPSA23,RESP046,"(44.39319117400049, -89.81637074199966)"
|
|
2020,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,248,61.3,55.3,67.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,EDUCA3,CAT5,_RFPSA23,RESP054,"(44.39319117400049, -89.81637074199966)"
|
|
2020,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,268,37.7,33,42.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,EDUCA4,CAT5,_RFPSA23,RESP046,"(44.39319117400049, -89.81637074199966)"
|
|
2020,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,353,62.3,57.6,67,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,EDUCA4,CAT5,_RFPSA23,RESP054,"(44.39319117400049, -89.81637074199966)"
|
|
2020,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,24,38.1,21.5,54.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,INCOME1,CAT6,_RFPSA23,RESP046,"(44.39319117400049, -89.81637074199966)"
|
|
2020,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,53,61.9,45.3,78.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,INCOME1,CAT6,_RFPSA23,RESP054,"(44.39319117400049, -89.81637074199966)"
|
|
2020,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,56,21.7,14.3,29,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,INCOME2,CAT6,_RFPSA23,RESP046,"(44.39319117400049, -89.81637074199966)"
|
|
2020,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,126,78.3,71,85.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,INCOME2,CAT6,_RFPSA23,RESP054,"(44.39319117400049, -89.81637074199966)"
|
|
2020,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,46,31.7,21.2,42.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,INCOME3,CAT6,_RFPSA23,RESP046,"(44.39319117400049, -89.81637074199966)"
|
|
2020,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,94,68.3,57.8,78.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,INCOME3,CAT6,_RFPSA23,RESP054,"(44.39319117400049, -89.81637074199966)"
|
|
2020,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,91,42.3,33.4,51.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,INCOME4,CAT6,_RFPSA23,RESP046,"(44.39319117400049, -89.81637074199966)"
|
|
2020,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,119,57.7,48.7,66.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,INCOME4,CAT6,_RFPSA23,RESP054,"(44.39319117400049, -89.81637074199966)"
|
|
2020,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,351,34.9,30.9,38.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,INCOME5,CAT6,_RFPSA23,RESP046,"(44.39319117400049, -89.81637074199966)"
|
|
2020,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,529,65.1,61.1,69.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,INCOME5,CAT6,_RFPSA23,RESP054,"(44.39319117400049, -89.81637074199966)"
|
|
2020,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,569,34.9,31.9,37.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,RACE01,CAT4,_RFPSA23,RESP046,"(44.39319117400049, -89.81637074199966)"
|
|
2020,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,907,65.1,62.1,68.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,RACE01,CAT4,_RFPSA23,RESP054,"(44.39319117400049, -89.81637074199966)"
|
|
2020,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,29,36.7,16.9,56.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,RACE02,CAT4,_RFPSA23,RESP046,"(44.39319117400049, -89.81637074199966)"
|
|
2020,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,22,63.3,43.6,83.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,RACE02,CAT4,_RFPSA23,RESP054,"(44.39319117400049, -89.81637074199966)"
|
|
2020,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,8,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,55,RACE03,CAT4,_RFPSA23,RESP046,"(44.39319117400049, -89.81637074199966)"
|
|
2020,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,22,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,55,RACE03,CAT4,_RFPSA23,RESP054,"(44.39319117400049, -89.81637074199966)"
|
|
2020,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,1,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,55,RACE04,CAT4,_RFPSA23,RESP046,"(44.39319117400049, -89.81637074199966)"
|
|
2020,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,55,RACE04,CAT4,_RFPSA23,RESP054,"(44.39319117400049, -89.81637074199966)"
|
|
2020,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,55,RACE05,CAT4,_RFPSA23,RESP046,"(44.39319117400049, -89.81637074199966)"
|
|
2020,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,55,RACE05,CAT4,_RFPSA23,RESP054,"(44.39319117400049, -89.81637074199966)"
|
|
2020,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,55,RACE06,CAT4,_RFPSA23,RESP046,"(44.39319117400049, -89.81637074199966)"
|
|
2020,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,15,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,55,RACE06,CAT4,_RFPSA23,RESP054,"(44.39319117400049, -89.81637074199966)"
|
|
2020,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,55,RACE07,CAT4,_RFPSA23,RESP046,"(44.39319117400049, -89.81637074199966)"
|
|
2020,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,7,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,55,RACE07,CAT4,_RFPSA23,RESP054,"(44.39319117400049, -89.81637074199966)"
|
|
2020,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,55,RACE08,CAT4,_RFPSA23,RESP046,"(44.39319117400049, -89.81637074199966)"
|
|
2020,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,25,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,55,RACE08,CAT4,_RFPSA23,RESP054,"(44.39319117400049, -89.81637074199966)"
|
|
2020,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,624,34.5,31.6,37.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,SEX1,CAT2,_RFPSA23,RESP046,"(44.39319117400049, -89.81637074199966)"
|
|
2020,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,1004,65.5,62.6,68.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,55,SEX1,CAT2,_RFPSA23,RESP054,"(44.39319117400049, -89.81637074199966)"
|
|
2020,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,55,SEX2,CAT2,_RFPSA23,RESP046,"(44.39319117400049, -89.81637074199966)"
|
|
2020,WI,Wisconsin,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,55,SEX2,CAT2,_RFPSA23,RESP054,"(44.39319117400049, -89.81637074199966)"
|
|
2020,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,40-49,Age Group,33,13.7,8.3,19,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,AGE06,CAT3,_RFPSA23,RESP046,"(43.23554134300048, -108.10983035299967)"
|
|
2020,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,40-49,Age Group,183,86.3,81,91.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,AGE06,CAT3,_RFPSA23,RESP054,"(43.23554134300048, -108.10983035299967)"
|
|
2020,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,50-59,Age Group,88,26,19.8,32.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,AGE07,CAT3,_RFPSA23,RESP046,"(43.23554134300048, -108.10983035299967)"
|
|
2020,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,50-59,Age Group,198,74,67.9,80.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,AGE07,CAT3,_RFPSA23,RESP054,"(43.23554134300048, -108.10983035299967)"
|
|
2020,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,60-64,Age Group,132,53.6,45.5,61.8,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,AGE08,CAT3,_RFPSA23,RESP046,"(43.23554134300048, -108.10983035299967)"
|
|
2020,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,60-64,Age Group,108,46.4,38.2,54.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,AGE08,CAT3,_RFPSA23,RESP054,"(43.23554134300048, -108.10983035299967)"
|
|
2020,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,65+,Age Group,495,57.8,53.1,62.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,AGE09,CAT3,_RFPSA23,RESP046,"(43.23554134300048, -108.10983035299967)"
|
|
2020,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,65+,Age Group,363,42.2,37.6,46.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,AGE09,CAT3,_RFPSA23,RESP054,"(43.23554134300048, -108.10983035299967)"
|
|
2020,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Overall,Overall,748,38.3,35.1,41.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,BO1,CAT1,_RFPSA23,RESP046,"(43.23554134300048, -108.10983035299967)"
|
|
2020,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Overall,Overall,852,61.7,58.6,64.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,BO1,CAT1,_RFPSA23,RESP054,"(43.23554134300048, -108.10983035299967)"
|
|
2020,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Less than H.S.,Education Attained,18,17.3,7.8,26.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,EDUCA1,CAT5,_RFPSA23,RESP046,"(43.23554134300048, -108.10983035299967)"
|
|
2020,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Less than H.S.,Education Attained,52,82.7,73.3,92.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,EDUCA1,CAT5,_RFPSA23,RESP054,"(43.23554134300048, -108.10983035299967)"
|
|
2020,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,H.S. or G.E.D.,Education Attained,192,36.4,30.8,42.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,EDUCA2,CAT5,_RFPSA23,RESP046,"(43.23554134300048, -108.10983035299967)"
|
|
2020,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,H.S. or G.E.D.,Education Attained,266,63.6,57.9,69.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,EDUCA2,CAT5,_RFPSA23,RESP054,"(43.23554134300048, -108.10983035299967)"
|
|
2020,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Some post-H.S.,Education Attained,204,39.4,33.4,45.3,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,EDUCA3,CAT5,_RFPSA23,RESP046,"(43.23554134300048, -108.10983035299967)"
|
|
2020,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Some post-H.S.,Education Attained,250,60.6,54.7,66.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,EDUCA3,CAT5,_RFPSA23,RESP054,"(43.23554134300048, -108.10983035299967)"
|
|
2020,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,College graduate,Education Attained,332,44.8,39.6,50,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,EDUCA4,CAT5,_RFPSA23,RESP046,"(43.23554134300048, -108.10983035299967)"
|
|
2020,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,College graduate,Education Attained,283,55.2,50,60.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,EDUCA4,CAT5,_RFPSA23,RESP054,"(43.23554134300048, -108.10983035299967)"
|
|
2020,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Less than $15,000",Household Income,15,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,56,INCOME1,CAT6,_RFPSA23,RESP046,"(43.23554134300048, -108.10983035299967)"
|
|
2020,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Less than $15,000",Household Income,29,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,56,INCOME1,CAT6,_RFPSA23,RESP054,"(43.23554134300048, -108.10983035299967)"
|
|
2020,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$15,000-$24,999",Household Income,52,27.6,18.5,36.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,INCOME2,CAT6,_RFPSA23,RESP046,"(43.23554134300048, -108.10983035299967)"
|
|
2020,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$15,000-$24,999",Household Income,111,72.4,63.4,81.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,INCOME2,CAT6,_RFPSA23,RESP054,"(43.23554134300048, -108.10983035299967)"
|
|
2020,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$25,000-$34,999",Household Income,60,32.7,22.5,42.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,INCOME3,CAT6,_RFPSA23,RESP046,"(43.23554134300048, -108.10983035299967)"
|
|
2020,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$25,000-$34,999",Household Income,81,67.3,57.1,77.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,INCOME3,CAT6,_RFPSA23,RESP054,"(43.23554134300048, -108.10983035299967)"
|
|
2020,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$35,000-$49,999",Household Income,102,45.1,35.4,54.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,INCOME4,CAT6,_RFPSA23,RESP046,"(43.23554134300048, -108.10983035299967)"
|
|
2020,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$35,000-$49,999",Household Income,100,54.9,45.1,64.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,INCOME4,CAT6,_RFPSA23,RESP054,"(43.23554134300048, -108.10983035299967)"
|
|
2020,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"$50,000+",Household Income,431,40.1,35.8,44.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,INCOME5,CAT6,_RFPSA23,RESP046,"(43.23554134300048, -108.10983035299967)"
|
|
2020,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"$50,000+",Household Income,437,59.9,55.6,64.2,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,INCOME5,CAT6,_RFPSA23,RESP054,"(43.23554134300048, -108.10983035299967)"
|
|
2020,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"White, non-Hispanic",Race/Ethnicity,709,40.2,36.9,43.5,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,RACE01,CAT4,_RFPSA23,RESP046,"(43.23554134300048, -108.10983035299967)"
|
|
2020,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"White, non-Hispanic",Race/Ethnicity,764,59.8,56.5,63.1,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,RACE01,CAT4,_RFPSA23,RESP054,"(43.23554134300048, -108.10983035299967)"
|
|
2020,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Black, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,56,RACE02,CAT4,_RFPSA23,RESP046,"(43.23554134300048, -108.10983035299967)"
|
|
2020,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Black, non-Hispanic",Race/Ethnicity,5,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,56,RACE02,CAT4,_RFPSA23,RESP054,"(43.23554134300048, -108.10983035299967)"
|
|
2020,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,56,RACE03,CAT4,_RFPSA23,RESP046,"(43.23554134300048, -108.10983035299967)"
|
|
2020,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"American Indian or Alaskan Native, non-Hispanic",Race/Ethnicity,13,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,56,RACE03,CAT4,_RFPSA23,RESP054,"(43.23554134300048, -108.10983035299967)"
|
|
2020,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Asian, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,56,RACE04,CAT4,_RFPSA23,RESP046,"(43.23554134300048, -108.10983035299967)"
|
|
2020,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Asian, non-Hispanic",Race/Ethnicity,2,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,56,RACE04,CAT4,_RFPSA23,RESP054,"(43.23554134300048, -108.10983035299967)"
|
|
2020,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,56,RACE05,CAT4,_RFPSA23,RESP046,"(43.23554134300048, -108.10983035299967)"
|
|
2020,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Native Hawaiian or other Pacific Islander, non-Hispanic",Race/Ethnicity,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,56,RACE05,CAT4,_RFPSA23,RESP054,"(43.23554134300048, -108.10983035299967)"
|
|
2020,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Other, non-Hispanic",Race/Ethnicity,6,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,56,RACE06,CAT4,_RFPSA23,RESP046,"(43.23554134300048, -108.10983035299967)"
|
|
2020,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Other, non-Hispanic",Race/Ethnicity,10,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,56,RACE06,CAT4,_RFPSA23,RESP054,"(43.23554134300048, -108.10983035299967)"
|
|
2020,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,"Multiracial, non-Hispanic",Race/Ethnicity,4,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,56,RACE07,CAT4,_RFPSA23,RESP046,"(43.23554134300048, -108.10983035299967)"
|
|
2020,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,"Multiracial, non-Hispanic",Race/Ethnicity,14,,,,1,%,Crude Prevalence,*,Prevalence estimate not available if the unweighted sample size for the denominator was < 50 or the Relative Standard Error (RSE) is > 0.3 or if the state did not collect data for that calendar year.,BRFSS,CLASS16,TOPIC47,56,RACE07,CAT4,_RFPSA23,RESP054,"(43.23554134300048, -108.10983035299967)"
|
|
2020,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Hispanic,Race/Ethnicity,15,22,9.3,34.6,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,RACE08,CAT4,_RFPSA23,RESP046,"(43.23554134300048, -108.10983035299967)"
|
|
2020,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Hispanic,Race/Ethnicity,44,78,65.4,90.7,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,RACE08,CAT4,_RFPSA23,RESP054,"(43.23554134300048, -108.10983035299967)"
|
|
2020,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Male,Gender,748,38.3,35.1,41.4,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,SEX1,CAT2,_RFPSA23,RESP046,"(43.23554134300048, -108.10983035299967)"
|
|
2020,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Male,Gender,852,61.7,58.6,64.9,1,%,Crude Prevalence,,,BRFSS,CLASS16,TOPIC47,56,SEX1,CAT2,_RFPSA23,RESP054,"(43.23554134300048, -108.10983035299967)"
|
|
2020,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),Yes,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,56,SEX2,CAT2,_RFPSA23,RESP046,"(43.23554134300048, -108.10983035299967)"
|
|
2020,WY,Wyoming,Prostate Cancer,PSA Test,Men aged 40+ who have had a PSA test within the past two years (variable calculated from one or more BRFSS questions),No,Female,Gender,0,,,,1,%,Crude Prevalence,**,No responses for this data cell,BRFSS,CLASS16,TOPIC47,56,SEX2,CAT2,_RFPSA23,RESP054,"(43.23554134300048, -108.10983035299967)"
|